PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dick, A; Graf, L; Olal, D; von der Malsburg, A; Gao, S; Kochs, G; Daumke, O				Dick, Alexej; Graf, Laura; Olal, Daniel; von der Malsburg, Alexander; Gao, Song; Kochs, Georg; Daumke, Oliver			Role of Nucleotide Binding and GTPase Domain Dimerization in Dynamin-like Myxovirus Resistance Protein A for GTPase Activation and Antiviral Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MXA PROTEIN; SMOOTH ENDOPLASMIC-RETICULUM; THOGOTO-VIRUS; HIV-1 INFECTION; INNATE IMMUNITY; INFLUENZA; OLIGOMERIZATION; SPECIFICITY; ENDOCYTOSIS; HYDROLYSIS	Myxovirus resistance (Mx) GTPases are induced by interferon and inhibit multiple viruses, including influenza and human immunodeficiency viruses. They have the characteristic domain architecture of dynamin-related proteins with an N-terminal GTPase (G) domain, a bundle signaling element, and a C-terminal stalk responsible for self-assembly and effector functions. Human MxA (also called MX1) is expressed in the cytoplasm and is partly associated with membranes of the smooth endoplasmic reticulum. It shows a protein concentration-dependent increase in GTPase activity, indicating regulation of GTP hydrolysis via G domain dimerization. Here, we characterized a panel of G domain mutants in MxA to clarify the role of GTP binding and the importance of the G domain interface for the catalytic and antiviral function of MxA. Residues in the catalytic center of MxA and the nucleotide itself were essential for G domain dimerization and catalytic activation. In pulldown experiments, MxA recognized Thogoto virus nucleocapsid proteins independently of nucleotide binding. However, both nucleotide binding and hydrolysis were required for the antiviral activity against Thogoto, influenza, and La Crosse viruses. We further demonstrate that GTP binding facilitates formation of stable MxA assemblies associated with endoplasmic reticulum membranes, whereas nucleotide hydrolysis promotes dynamic redistribution of MxA from cellular membranes to viral targets. Our study highlights the role of nucleotide binding and hydrolysis for the intracellular dynamics of MxA during its antiviral action.	[Dick, Alexej; Olal, Daniel; Daumke, Oliver] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Dick, Alexej; Daumke, Oliver] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Graf, Laura; von der Malsburg, Alexander; Kochs, Georg] Univ Med Ctr, Inst Virol, D-79104 Freiburg, Germany; [Graf, Laura; Kochs, Georg] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Gao, Song] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China; [Gao, Song] Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; University of Freiburg; University of Freiburg; State Key Lab Oncology South China; Sun Yat Sen University	Kochs, G (corresponding author), Univ Med Ctr, Inst Virol, Hermann Herder Str 11, D-79104 Freiburg, Germany.	georg.kochs@uniklinik-freiburg.de; oliver.daumke@mdc-berlin.de		Gao, Song/0000-0001-7427-6681; Dick, Alexej/0000-0003-0580-1897	Deutsche Forschungsgemeinschaft [Ko 1579/8-2, DA1127/1-1, SFB958/A12]; National Natural Science Foundation of China [31200553]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Deutsche Forschungsgemeinschaft Grants Ko 1579/8-2 (to G. K.) and DA1127/1-1 and SFB958/A12 (to O. D.) and National Natural Science Foundation of China Grant 31200553 (to S. G.).	Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Busnadiego I, 2014, J VIROL, V88, P7738, DOI 10.1128/JVI.00214-14; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Cool RH, 1999, MOL CELL BIOL, V19, P6297; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Di Paolo C, 1999, J BIOL CHEM, V274, P32071, DOI 10.1074/jbc.274.45.32071; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; FRESE M, 1995, J VIROL, V69, P3904, DOI 10.1128/JVI.69.6.3904-3909.1995; Gao S, 2011, IMMUNITY, V35, P514, DOI 10.1016/j.immuni.2011.07.012; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Gordien E, 2001, J VIROL, V75, P2684, DOI 10.1128/JVI.75.6.2684-2691.2001; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Haller O, 2010, J BIOL CHEM, V285, P28419, DOI 10.1074/jbc.R110.145839; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Kochs G, 2002, J BIOL CHEM, V277, P14172, DOI 10.1074/jbc.M200244200; Kochs G, 2000, J VIROL, V74, P10785, DOI 10.1128/JVI.74.22.10785-10789.2000; Kochs G, 1999, J BIOL CHEM, V274, P4370, DOI 10.1074/jbc.274.7.4370; Kochs G, 2002, P NATL ACAD SCI USA, V99, P3153, DOI 10.1073/pnas.052430399; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; MELEN K, 1992, J BIOL CHEM, V267, P25898; Mitchell PS, 2012, CELL HOST MICROBE, V12, P598, DOI 10.1016/j.chom.2012.09.005; Netherton CL, 2009, J VIROL, V83, P2310, DOI 10.1128/JVI.00781-08; Patzina C, 2014, J BIOL CHEM, V289, P6020, DOI 10.1074/jbc.M113.543892; PAVLOVIC J, 1995, J VIROL, V69, P4506, DOI 10.1128/JVI.69.7.4506-4510.1995; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; Reichelt M, 2004, TRAFFIC, V5, P772, DOI 10.1111/j.1600-0854.2004.00219.x; Rennie ML, 2014, STRUCTURE, V22, P1433, DOI 10.1016/j.str.2014.08.015; Schmidt G, 1996, ONCOGENE, V12, P87; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; Shan SO, 2005, BIOCHEMISTRY-US, V44, P6214, DOI 10.1021/bi0500980; Song BD, 2004, J BIOL CHEM, V279, P40431, DOI 10.1074/jbc.M407007200; Staeheli Peter, 1993, Trends in Cell Biology, V3, P268, DOI 10.1016/0962-8924(93)90055-6; Steegmaier M, 2000, MOL BIOL CELL, V11, P2719, DOI 10.1091/mbc.11.8.2719; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; Sundborger AC, 2014, CELL REP, V8, P734, DOI 10.1016/j.celrep.2014.06.054; Tam TTD, 2012, MOL BIOL REP, V39, P8533, DOI 10.1007/s11033-012-1708-7; Tazi-Ahnini R, 2000, HUM GENET, V106, P639, DOI 10.1007/s004390050037; THOMPSON WH, 1965, AM J EPIDEMIOL, V81, P245, DOI 10.1093/oxfordjournals.aje.a120512; Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13; von der Malsburg A, 2011, J BIOL CHEM, V286, P37858, DOI 10.1074/jbc.M111.249037; Wenger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071835	56	36	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12779	12792		10.1074/jbc.M115.650325	http://dx.doi.org/10.1074/jbc.M115.650325			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25829498	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000354569000029
J	Eckhoff, J; Dohmen, RJ				Eckhoff, Julia; Dohmen, R. Juergen			In Vitro Studies Reveal a Sequential Mode of Chain Processing by the Yeast SUMO (Small Ubiquitin-related Modifier)-specific Protease Ulp2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protease; protein degradation; Saccharomyces cerevisiae; small ubiquitin-like modifier (SUMO); sumoylation	CELL-CYCLE PROGRESSION; SUMOYLATED PROTEINS; SACCHAROMYCES-CEREVISIAE; GLOBAL ANALYSIS; ISOPEPTIDASE; IDENTIFICATION; SMT4; CONJUGATION; PROTEOME; ENCODES	Background: Modification of proteins with small ubiquitin-related modifier has many important functions in cell biology. Results: Substrate-attached SUMO chains are processed by the yeast enzymes Ulp1 and Ulp2 via different mechanisms. Conclusion: Ulp2 recognizes chains with three or more SUMO units and releases single SUMO molecules from their distal ends. Significance: Ulp2 controls the dynamic length range of cellular SUMO chains. Sumoylation is a post-translational modification essential in most eukaryotes that regulates stability, localization, activity, or interaction of a multitude of proteins. It is a reversible process wherein counteracting ligases and proteases, respectively, mediate the conjugation and deconjugation of SUMO molecules to/from target proteins. Apart from attachment of single SUMO moieties to targets, formation of poly-SUMO chains occurs by the attachment of additional SUMO molecules to lysine residues in the N-terminal extensions of SUMO. In Saccharomyces cerevisiae there are apparently only two SUMO(Smt3)-specific proteases: Ulp1 and Ulp2. Ulp2 has been shown to be important for the control of poly-SUMO conjugates in cells and to dismantle SUMO chains in vitro, but the mechanism by which it acts remains to be elucidated. Applying an in vitro approach, we found that Ulp2 acts sequentially rather than stochastically, processing substrate-linked poly-SUMO chains from their distal ends down to two linked SUMO moieties. Furthermore, three linked SUMO units turned out to be the minimum length of a substrate-linked chain required for efficient binding to and processing by Ulp2. Our data suggest that Ulp2 disassembles SUMO chains by removing one SUMO moiety at a time from their ends (exo mechanism). Apparently, Ulp2 recognizes surfaces at or near the N terminus of the distal SUMO moiety, as attachments to this end significantly reduce cleavage efficiency. Our studies suggest that Ulp2 controls the dynamic range of SUMO chain lengths by trimming them from the distal ends.	[Eckhoff, Julia; Dohmen, R. Juergen] Univ Cologne, Inst Genet, Bioctr, D-50674 Cologne, Germany	University of Cologne	Dohmen, RJ (corresponding author), Univ Cologne, Inst Genet, Bioctr, Zulpicher Str 47a, D-50674 Cologne, Germany.	j.dohmen@uni-koeln.de	Dohmen, R. Jürgen/AAD-6649-2022	Dohmen, R. Jürgen/0000-0002-5756-6780	North Rhine-Westphalia International Graduate School in Development, Health and Disease	North Rhine-Westphalia International Graduate School in Development, Health and Disease	Supported by a pre-doctoral fellowship from the North Rhine-Westphalia International Graduate School in Development, Health and Disease.	Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Baek SH, 1997, J BIOL CHEM, V272, P25560, DOI 10.1074/jbc.272.41.25560; Bekes M, 2011, J BIOL CHEM, V286, P10238, DOI 10.1074/jbc.M110.205153; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Da Silva-Ferrada E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01690; Da Silva-Ferrada E, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/875148; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Fox Jeffrey D, 2003, Methods Mol Biol, V205, P99; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hay RT, 2013, BIOCHEM SOC T, V41, P463, DOI 10.1042/BST20130015; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hunter T, 2009, ERNST SCHERING FOUND, V1, P1, DOI 10.1007/2789_2008_098; Hutchins AP, 2013, MOL BIOL EVOL, V30, P1172, DOI 10.1093/molbev/mst022; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kim JH, 2009, BBA-MOL BASIS DIS, V1792, P155, DOI 10.1016/j.bbadis.2008.12.008; Kim KI, 2000, J BIOL CHEM, V275, P14102, DOI 10.1074/jbc.275.19.14102; Klug H, 2013, MOL CELL, V50, P625, DOI 10.1016/j.molcel.2013.03.027; Kolli N, 2010, BIOCHEM J, V430, P335, DOI 10.1042/BJ20100504; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kroetz MB, 2009, MOL BIOL CELL, V20, P2196, DOI 10.1091/mbc.E08-10-1090; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Lima CD, 2008, J BIOL CHEM, V283, P32045, DOI 10.1074/jbc.M805655200; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Mullen JR, 2010, MOL CELL BIOL, V30, P3737, DOI 10.1128/MCB.01649-09; Nayak A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0422-2; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; Schimmel J, 2014, MOL CELL, V53, P1053, DOI 10.1016/j.molcel.2014.02.001; Schou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100692; Schwartz DC, 2007, MOL CELL BIOL, V27, P6948, DOI 10.1128/MCB.00774-07; Schwienhorst I, 2000, MOL GEN GENET, V263, P771, DOI 10.1007/s004380000254; Shen LN, 2009, BIOCHEM J, V421, P223, DOI 10.1042/BJ20090246; Shin EJ, 2012, EMBO REP, V13, P339, DOI 10.1038/embor.2012.3; Srikumar T, 2013, J CELL BIOL, V201, P145, DOI 10.1083/jcb.201210019; Sriramachandran AM, 2014, BBA-MOL CELL RES, V1843, P75, DOI 10.1016/j.bbamcr.2013.08.022; Stingele J, 2014, CELL, V158, P327, DOI 10.1016/j.cell.2014.04.053; Strunnikov AV, 2001, GENETICS, V158, P95; Su D, 2010, MOL CELL BIOL, V30, P3734, DOI 10.1128/MCB.00673-10; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Vertegaal ACO, 2010, BIOCHEM SOC T, V38, P46, DOI 10.1042/BST0380046; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wohlschlegel JA, 2006, J PROTEOME RES, V5, P761, DOI 10.1021/pr050451o; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wykoff DD, 2005, MOL CELL PROTEOMICS, V4, P73, DOI 10.1074/mcp.M400166-MCP200; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	66	15	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12268	12281		10.1074/jbc.M114.622217	http://dx.doi.org/10.1074/jbc.M114.622217			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25833950	hybrid, Green Published			2022-12-28	WOS:000354388600037
J	Kumbrink, J; Soni, S; Laumbacher, B; Loesch, B; Kirsch, KH				Kumbrink, Joerg; Soni, Shefali; Laumbacher, Barbara; Loesch, Barbara; Kirsch, Kathrin H.			Identification of Novel Crk-associated Substrate (p130(Cas)) Variants with Functionally Distinct Focal Adhesion Kinase Binding Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell migration; cell signaling; PTK2 protein tyrosine kinase 2 (PTK2) (focal adhesion kinase) (FAK); signal transduction; SH3 domain binding; alternative splice variants; N-terminal SH3 domain extensions; exon 1; p130Cas	BREAST-CANCER CELLS; P130CAS LOCALIZATION; GENE-EXPRESSION; RESISTANCE; DOMAIN; CAS; TRANSFORMATION; ORGANIZATION; SEQUENCES; DYNAMICS	Background: The tumor promoter p130(Cas) utilizes its SH3 domain to control cell adhesion and migration. Results: We identified N-terminal extended p130(Cas) variants with enhanced SH3 domain binding activity which modulates cell migration and invasion. Conclusion: Naturally occurring p130(Cas) variants exhibit differential biological activities. Significance: Knowledge on these variants may explain how p130(Cas) controls cellular programs and drives carcinogenesis. Elevated levels of p130(Cas) (Crk-associated substrate)/BCAR1 (breast cancer antiestrogen resistance 1 gene) are associated with aggressiveness of breast tumors. Following phosphorylation of its substrate domain, p130(Cas) promotes the integration of protein complexes involved in multiple signaling pathways and mediates cell proliferation, adhesion, and migration. In addition to the known BCAR1-1A (wild-type) and 1C variants, we identified four novel BCAR1 mRNA variants, generated by alternative first exon usage (1B, 1B1, 1D, and 1E). Exons 1A and 1C encode for four amino acids (aa), whereas 1D and 1E encode for 22 aa and 1B1 encodes for 50 aa. Exon 1B is non-coding, resulting in a truncated p130(Cas) protein (Cas1B). BCAR1-1A, 1B1, and variant 1C mRNAs were ubiquitously expressed in cell lines and a survey of human tissues, whereas 1B, 1D, and 1E expression was more restricted. Reconstitution of all isoforms except for 1B in p130(Cas)-deficient murine fibroblasts induced lamellipodia formation and membrane ruffling, which was unrelated to the substrate domain phosphorylation status. The longer isoforms exhibited increased binding to focal adhesion kinase (FAK), a molecule important for migration and adhesion. The shorter 1B isoform exhibited diminished FAK binding activity and significantly reduced migration and invasion. In contrast, the longest variant 1B1 established the most efficient FAK binding and greatly enhanced migration. Our results indicate that the p130(Cas) exon 1 variants display altered functional properties. The truncated variant 1B and the longer isoform 1B1 may contribute to the diverse effects of p130(Cas) on cell biology and therefore will be the target of future studies.	[Kumbrink, Joerg; Soni, Shefali; Kirsch, Kathrin H.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Laumbacher, Barbara] Immunotherapy Res Ctr, D-80336 Munich, Germany; [Loesch, Barbara] Immunis eV, D-80336 Munich, Germany	Boston University	Kirsch, KH (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St, Boston, MA 02118 USA.	kirschk@bu.edu		Kirsch, Kathrin/0000-0003-1532-1715	Public Health Service Grant from NCI, National Institutes of Health [CA106468]; Susan G. Komen for the Cure Breast Cancer Foundation Grant [KG101208]; NATIONAL CANCER INSTITUTE [R01CA106468] Funding Source: NIH RePORTER	Public Health Service Grant from NCI, National Institutes of Health; Susan G. Komen for the Cure Breast Cancer Foundation Grant(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service Grant CA106468 from the NCI, National Institutes of Health (to K. H. K.) and Susan G. Komen for the Cure Breast Cancer Foundation Grant KG101208.	Akagi T, 2002, MOL CELL BIOL, V22, P7015, DOI 10.1128/MCB.22.20.7015-7023.2002; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen CH, 2013, CARDIOVASC RES, V100, P461, DOI 10.1093/cvr/cvt207; Deramaudt T. B, 2014, PLOS ONE, V9; Donato DM, 2010, J BIOL CHEM, V285, P20769, DOI 10.1074/jbc.M109.091207; DORSSERS LCJ, 1993, MOL ENDOCRINOL, V7, P870, DOI 10.1210/me.7.7.870; Dorssers LCJ, 2001, DRUGS, V61, P1721, DOI 10.2165/00003495-200161120-00004; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Fujita-Becker S, 2006, J BIOL CHEM, V281, P36102, DOI 10.1074/jbc.M605171200; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Graham LJ, 1998, BIOCHEM BIOPH RES CO, V249, P537, DOI 10.1006/bbrc.1998.9177; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harte MT, 2000, BBA-MOL CELL RES, V1499, P34, DOI 10.1016/S0167-4889(00)00104-X; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Huang JH, 2002, J BIOL CHEM, V277, P27265, DOI 10.1074/jbc.M203063200; Janostiak R, 2014, CELL MOL LIFE SCI, V71, P727, DOI 10.1007/s00018-013-1450-x; Kirsch KH, 1998, J BIOL CHEM, V273, P25673, DOI 10.1074/jbc.273.40.25673; Kogerman P, 2002, ONCOGENE, V21, P6007, DOI 10.1038/sj.onc.1205865; Kos M, 2001, MOL ENDOCRINOL, V15, P2057, DOI 10.1210/me.15.12.2057; Kumbrink J, 2011, BREAST CANC CURRENT, P37; Kumbrink J, 2013, INT J BIOCHEM CELL B, V45, P531, DOI 10.1016/j.biocel.2012.12.017; Kumbrink J, 2012, NEOPLASIA, V14, P108, DOI 10.1593/neo.111760; Kumbrink J, 2010, J CELL BIOCHEM, V111, P207, DOI 10.1002/jcb.22690; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Tu L, 2012, AM J RESP CRIT CARE, V186, P666, DOI 10.1164/rccm.201202-0309OC; Makkinje A, 2009, CELL SIGNAL, V21, P1423, DOI 10.1016/j.cellsig.2009.05.006; Meenderink LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013412; Nakamoto T, 1997, MOL CELL BIOL, V17, P3884, DOI 10.1128/MCB.17.7.3884; Nikonova AS, 2014, IUBMB LIFE, V66, P387, DOI 10.1002/iub.1282; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Soni S, 2009, J CELL BIOCHEM, V107, P364, DOI 10.1002/jcb.22136; Streb JW, 2004, J BIOL CHEM, V279, P56014, DOI 10.1074/jbc.M408828200; Ta HQ, 2008, CANCER RES, V68, P8796, DOI 10.1158/0008-5472.CAN-08-2426; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Vancheri C, 2013, EUR RESPIR REV, V22, P265, DOI 10.1183/09059180.00003613; Wang HZ, 2009, ENDOCRINOLOGY, V150, P3301, DOI 10.1210/en.2008-1812; Zhao YS, 2013, CARCINOGENESIS, V34, P2880, DOI 10.1093/carcin/bgt238	43	4	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12247	12255		10.1074/jbc.M115.649947	http://dx.doi.org/10.1074/jbc.M115.649947			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25805500	Green Published, hybrid			2022-12-28	WOS:000354388600035
J	Wei, ZY; Li, YJ; Ye, F; Zhang, MJ				Wei, Zhiyi; Li, Youjun; Ye, Fei; Zhang, Mingjie			Structural Basis for the Phosphorylation-regulated Interaction between the Cytoplasmic Tail of Cell Polarity Protein Crumbs and the Actin-binding Protein Moesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA EPITHELIAL-CELLS; ZONULA ADHERENS FORMATION; ERM PROTEINS; APICAL MEMBRANE; FERM DOMAIN; CARGO RECOGNITION; HIPPO PATHWAY; COMPLEX; ORGANIZATION; REVEALS	The type I transmembrane protein crumbs (Crb) plays critical roles in the establishment and maintenance of cell polarities in diverse tissues. As such, mutations of Crb can cause different forms of cancers. The cell intrinsic role of Crb in cell polarity is governed by its conserved, 37-residue cytoplasmic tail (Crb-CT) via binding to moesin and protein associated with Lin7-1 (PALS1). However, the detailed mechanism governing the Crb center dot moesin interaction and the balance of Crb in binding to moesin and PALS1 are not well understood. Here we report the 1.5 angstrom resolution crystal structure of the moesin proin 4.1/ez-rin/radixin/moesin (FERM)center dot Crb-CT complex, revealing that both the canonical FERM binding motif and the postsynaptic density protein-95/Disc large-1/Zonula occludens-1 (PDZ) binding motif of Crb contribute to the Crb center dot moesin interaction. We further demonstrate that phosphorylation of Crb-CT by atypical protein kinase C (aPKC) disrupts the Crb center dot moesin association but has no impact on the Crb center dot PALS1 interaction. The above results indicate that, upon the establishment of the apical-basal polarity in epithelia, apical-localized aPKC can actively prevent the Crb center dot moesin complex formation and thereby shift Crb to form complex with PALS1 at apical junctions. Therefore, Crb may serve as an aPKC-mediated sensor in coordinating contact-dependent cell growth inhibition in epithelial tissues.	[Wei, Zhiyi; Li, Youjun; Ye, Fei; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Wei, Zhiyi; Ye, Fei; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Sch Sci, Kowloon, Hong Kong, Peoples R China; [Wei, Zhiyi; Ye, Fei; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Inst Adv Study, Kowloon, Hong Kong, Peoples R China; [Wei, Zhiyi] South Univ Sci & Technol China, Dept Biol, Shenzhen 518055, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Southern University of Science & Technology	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	Wei, Zhiyi/C-4315-2014; Wei, Zhiyi/N-9995-2019	Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Zhang, Mingjie/0000-0001-9404-0190	Research Grants Council of Hong Kong [663811, 663812, 664113, AoE/M09/12, T13-607/12R]; Asia Fund for Cancer Research	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Asia Fund for Cancer Research	This work was supported by Research Grants Council of Hong Kong Grants 663811, 663812, 664113, AoE/M09/12, and T13-607/12R and by the Asia Fund for Cancer Research (to M. Z.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Bulgakova NA, 2009, J CELL SCI, V122, P2587, DOI 10.1242/jcs.023648; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; FUNAYAMA N, 1991, J CELL BIOL, V115, P1039, DOI 10.1083/jcb.115.4.1039; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; GOULD KL, 1989, EMBO J, V8, P4133, DOI 10.1002/j.1460-2075.1989.tb08598.x; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Hirano Y, 2011, EMBO J, V30, P2734, DOI 10.1038/emboj.2011.177; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Klose S, 2013, G3-GENES GENOM GENET, V3, P153, DOI 10.1534/g3.112.005074; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001; Li YJ, 2014, P NATL ACAD SCI USA, V111, P17444, DOI 10.1073/pnas.1416515111; Li YJ, 2014, J BIOL CHEM, V289, P14674, DOI 10.1074/jbc.M114.551184; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Low BC, 2014, FEBS LETT, V588, P2663, DOI 10.1016/j.febslet.2014.04.012; Margolis B, 2005, J CELL SCI, V118, P5157, DOI 10.1242/jcs.02597; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Nakamura F, 1999, MOL BIOL CELL, V10, P2669, DOI 10.1091/mbc.10.8.2669; Nance J, 2011, DEVELOPMENT, V138, P799, DOI 10.1242/dev.053538; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Pocha SM, 2013, CURR BIOL, V23, pR289, DOI 10.1016/j.cub.2013.03.001; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; SATO N, 1992, J CELL SCI, V103, P131; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Takai Y, 2008, J MOL BIOL, V381, P634, DOI 10.1016/j.jmb.2008.05.085; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Terawaki S, 2007, J BIOL CHEM, V282, P19854, DOI 10.1074/jbc.M609232200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wei ZY, 2011, P NATL ACAD SCI USA, V108, P3572, DOI 10.1073/pnas.1016567108; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WODARZ A, 1993, MECH DEVELOP, V44, P175, DOI 10.1016/0925-4773(93)90066-7; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111	60	41	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11384	11392		10.1074/jbc.M115.643791	http://dx.doi.org/10.1074/jbc.M115.643791			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792740	Green Published, hybrid			2022-12-28	WOS:000353719400015
J	Muhic, M; Vardjan, N; Chowdhury, HH; Zorec, R; Kreft, M				Muhic, Marko; Vardjan, Nina; Chowdhury, Helena H.; Zorec, Robert; Kreft, Marko			Insulin and Insulin-like Growth Factor 1 (IGF-1) Modulate Cytoplasmic Glucose and Glycogen Levels but Not Glucose Transport across the Membrane in Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; CULTURED MOUSE ASTROCYTES; RAT-BRAIN; CEREBROSPINAL-FLUID; FACTOR-I; ALZHEIMERS-DISEASE; WHITE-MATTER; INTRANASAL INSULIN; ENERGY-METABOLISM	Astrocytes contain glycogen, an energy buffer, which can bridge local short term energy requirements in the brain. Glycogen levels reflect a dynamic equilibrium between glycogen synthesis and glycogenolysis. Many factors that include hormones and neuropeptides, such as insulin and insulin-like growth factor 1 (IGF-1) likely modulate glycogen stores in astrocytes, but detailed mechanisms at the cellular level are sparse. We used a glucose nanosensor based on Forster resonance energy transfer to monitor cytosolic glucose concentration with high temporal resolution and a cytochemical approach to determine glycogen stores in single cells. The results show that after glucose depletion, glycogen stores are replenished. Insulin and IGF-1 boost the process of glycogen formation. Although astrocytes appear to express glucose transporter GLUT4, glucose entry across the astrocyte plasma membrane is not affected by insulin. Stimulation of cells with insulin and IGF-1 decreased cytosolic glucose concentration, likely because of elevated glucose utilization for glycogen synthesis.	[Muhic, Marko; Vardjan, Nina; Chowdhury, Helena H.; Zorec, Robert; Kreft, Marko] Univ Ljubljana, Fac Med, Inst Pathophysiol, Lab Neuroendocrinol Mol Cell Physiol, Ljubljana 1000, Slovenia; [Vardjan, Nina; Chowdhury, Helena H.; Zorec, Robert; Kreft, Marko] Celica Biomed, Ljubljana 1000, Slovenia; [Kreft, Marko] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana 1000, Slovenia	University of Ljubljana; University of Ljubljana	Zorec, R (corresponding author), Univ Ljubljana, Fac Med, Inst Pathophysiol, Lab Neuroendocrinol Mol Cell Physiol, Zaloska 4, Ljubljana 1000, Slovenia.	robert.zorec@celica.si; marko.kreft@celica.si	Vardjan, Nina/AAP-1496-2021; Chowdhury, Helena/ADV-0582-2022; Zorec, Robert/AAD-7180-2021	Chowdhury, Helena/0000-0001-8252-573X; Zorec, Robert/0000-0002-7478-3875	Slovenian Research Agency [P3 310, J3 4051, J3 4146]; COST Action [BM1002]; EduGlia Initial Training Network European Union (ITN EU)	Slovenian Research Agency(Slovenian Research Agency - Slovenia); COST Action(European Cooperation in Science and Technology (COST)); EduGlia Initial Training Network European Union (ITN EU)	This work was supported by Grants P3 310, J3 4051, and J3 4146 from the Slovenian Research Agency, COST Action BM1002, and an EduGlia Initial Training Network European Union (ITN EU) grant.	Armstrong CS, 2000, J NEUROSCI RES, V59, P649, DOI 10.1002/(SICI)1097-4547(20000301)59:5<649::AID-JNR8>3.0.CO;2-W; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Banks WA, 2004, EUR J PHARMACOL, V490, P5, DOI 10.1016/j.ejphar.2004.02.040; Banks WA, 1997, PEPTIDES, V18, P1423, DOI 10.1016/S0196-9781(97)00231-3; BASKIN DG, 1987, ANNU REV PHYSIOL, V49, P335, DOI 10.1146/annurev.ph.49.030187.002003; Bassil F, 2014, PROG NEUROBIOL, V118, P1, DOI 10.1016/j.pneurobio.2014.02.005; BAURA GD, 1993, J CLIN INVEST, V92, P1824, DOI 10.1172/JCI116773; Benedict C, 2007, NEUROENDOCRINOLOGY, V86, P136, DOI 10.1159/000106378; Bittner C.X., 2010, FRONT NEUROENERGETIC, V2; Blakesley Vicky A., 1996, Cytokine and Growth Factor Reviews, V7, P153, DOI 10.1016/1359-6101(96)00015-9; BRANT AM, 1993, BIOCHEM BIOPH RES CO, V192, P1297, DOI 10.1006/bbrc.1993.1557; Brown AM, 2003, J PHYSIOL-LONDON, V549, P501, DOI 10.1113/jphysiol.2003.042416; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; CATALDO AM, 1986, J NEUROCYTOL, V15, P511, DOI 10.1007/BF01611733; Cheng CL, 2005, WORLD J GASTROENTERO, V11, P1891; Choi IY, 2003, J NEUROSCI RES, V72, P25, DOI 10.1002/jnr.10574; Craft S, 1999, ARCH GEN PSYCHIAT, V56, P1135, DOI 10.1001/archpsyc.56.12.1135; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; CRERAR MM, 1995, J BIOL CHEM, V270, P13748, DOI 10.1074/jbc.270.23.13748; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cruz NF, 2002, J CEREBR BLOOD F MET, V22, P1476, DOI 10.1097/01.WCB.0000034362.37277.C0; DENT P, 1990, NATURE, V348, P302, DOI 10.1038/348302a0; DiNuzzo M, 2011, BIOESSAYS, V33, P319, DOI 10.1002/bies.201000151; DiNuzzo M, 2010, J CEREBR BLOOD F MET, V30, P1895, DOI 10.1038/jcbfm.2010.151; DRINGEN R, 1993, NEUROSCI LETT, V163, P5, DOI 10.1016/0304-3940(93)90215-7; DRINGEN R, 1993, BRAIN RES, V623, P208, DOI 10.1016/0006-8993(93)91429-V; DRINGEN R, 1992, J NEUROCHEM, V58, P511, DOI 10.1111/j.1471-4159.1992.tb09750.x; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Gil-Bea FJ, 2010, J ALZHEIMERS DIS, V22, P405, DOI 10.3233/JAD-2010-100795; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; GOODE N, 1992, J BIOL CHEM, V267, P16878; Hamai M, 1999, J NEUROCHEM, V73, P400, DOI 10.1046/j.1471-4159.1999.0730400.x; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Heni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021594; INOUE N, 1988, J NEUROCHEM, V50, P400, DOI 10.1111/j.1471-4159.1988.tb02926.x; Kacem K, 1998, GLIA, V23, P1; Kern W, 2001, NEUROENDOCRINOLOGY, V74, P270, DOI 10.1159/000054694; Kodl CT, 2008, ENDOCR REV, V29, P494, DOI 10.1210/er.2007-0034; Kong JM, 2002, J NEUROSCI, V22, P5581; KUM W, 1992, GLIA, V6, P264, DOI 10.1002/glia.440060404; Laron Zvi, 2009, Archives of Physiology and Biochemistry, V115, P112, DOI 10.1080/13813450902949012; MAGISTRETTI PJ, 1988, DIABETES METAB, V14, P237; Mangia S, 2009, J NEUROCHEM, V109, P55, DOI 10.1111/j.1471-4159.2009.06003.x; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; McCall AL, 1997, BRAIN RES, V744, P318, DOI 10.1016/S0006-8993(96)01122-5; McEwen BS, 2002, J PSYCHOSOM RES, V53, P883, DOI 10.1016/S0022-3999(02)00307-0; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Ngarmukos C, 2001, BRAIN RES, V900, P1, DOI 10.1016/S0006-8993(01)02184-9; Nijland PG, 2014, GLIA, V62, P1125, DOI 10.1002/glia.22667; OCRANT I, 1988, ENDOCRINOLOGY, V123, P1023, DOI 10.1210/endo-123-2-1023; Pellegri G, 1996, MOL BRAIN RES, V38, P191, DOI 10.1016/0169-328X(95)00305-C; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; PFEIFFER B, 1990, HISTOCHEMISTRY, V94, P73; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Prebil M, 2011, GLIA, V59, P903, DOI 10.1002/glia.21161; Ransom BR, 1997, GLIA, V21, P134; RAYNER DV, 1994, CAN J PHYSIOL PHARM, V72, P476, DOI 10.1139/y94-069; Reagan LP, 2007, CURR OPIN PHARMACOL, V7, P633, DOI 10.1016/j.coph.2007.10.012; RODIN J, 1985, METABOLISM, V34, P826, DOI 10.1016/0026-0495(85)90106-4; ROSENBERG PA, 1985, J NEUROSCI METH, V15, P101, DOI 10.1016/0165-0270(85)90048-2; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; SCHWARTZ JP, 1992, GLIA, V5, P75, DOI 10.1002/glia.440050111; SCHWARTZ MW, 1990, AM J PHYSIOL, V259, pE378, DOI 10.1152/ajpendo.1990.259.3.E378; Shulman RG, 2001, P NATL ACAD SCI USA, V98, P6417, DOI 10.1073/pnas.101129298; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; STEFFENS AB, 1988, AM J PHYSIOL, V255, pR200, DOI 10.1152/ajpregu.1988.255.2.R200; Suh SW, 2007, J PHARMACOL EXP THER, V321, P45, DOI 10.1124/jpet.106.115550; Swanson RA, 1992, CAN J PHYSIOL PHARM, V70, P138; Takahashi M, 1996, NEUROSCI LETT, V204, P201, DOI 10.1016/0304-3940(96)12357-0; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Walls AB, 2009, NEUROSCIENCE, V158, P284, DOI 10.1016/j.neuroscience.2008.09.058; WALZ W, 1988, NEUROSCI LETT, V86, P296, DOI 10.1016/0304-3940(88)90499-5; Weindl A, 1981, Adv Biochem Psychopharmacol, V28, P303; Werner Haim, 2008, Archives of Physiology and Biochemistry, V114, P17, DOI [10.1080/13813450801900694, 10.1080/13813450801900694 ]; Wiesinger H, 1997, GLIA, V21, P22, DOI 10.1002/(SICI)1098-1136(199709)21:1<22::AID-GLIA3>3.0.CO;2-3; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Woods SC, 2003, CURR PHARM DESIGN, V9, P795, DOI 10.2174/1381612033455323; ZHU SQ, 1990, BRAIN RES, V529, P329, DOI 10.1016/0006-8993(90)90846-4	83	41	43	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11167	11176		10.1074/jbc.M114.629063	http://dx.doi.org/10.1074/jbc.M114.629063			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25792745	Green Published, hybrid			2022-12-28	WOS:000353404500049
J	Drobnak, I; Braselmann, E; Clark, PL				Drobnak, Igor; Braselmann, Esther; Clark, Patricia L.			Multiple Driving Forces Required for Efficient Secretion of Autotransporter Virulence Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Kinetics; Outer Membrane; Protein Folding; Protein Secretion; Thermodynamics; Translocation; Virulence Factor; Autotransporter; Periplasm	BACTERIAL OUTER MEMBRANES; GRAM-NEGATIVE BACTERIA; TOXIN-B-SUBUNIT; BORDETELLA-PERTUSSIS; PASSENGER DOMAIN; ESCHERICHIA-COLI; EXTRACELLULAR TRANSPORT; STOCHASTIC SIMULATION; RECOMBINANT PROTEINS; FOLDING MECHANISM	Autotransporter (AT) proteins are a broad class of virulence proteins from Gram-negative bacterial pathogens that require their own C-terminal transmembrane domain to translocate their N-terminal passenger across the bacterial outer membrane (OM). But given the unavailability of ATP or a proton gradient across the OM, it is unknown what energy source(s) drives this process. Here we used a combination of computational and experimental approaches to quantitatively compare proposed AT OM translocation mechanisms. We show directly for the first time that when translocation was blocked an AT passenger remained unfolded in the periplasm. We demonstrate that AT secretion is a kinetically controlled, non-equilibrium process coupled to folding of the passenger and propose a model connecting passenger conformation to secretion kinetics. These results reconcile seemingly contradictory reports regarding the importance of passenger folding as a driving force for OM translocation but also reveal that another energy source is required to initiate translocation.	[Drobnak, Igor; Braselmann, Esther; Clark, Patricia L.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame	Clark, PL (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 251 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.	pclark1@nd.edu		Clark, Patricia/0000-0001-5462-8248	National Institutes of Health, a Chemistry-Biochemistry-Biology Interface Graduate Program fellowship [R01 GM097573, T32 GM075762]; College of Science at the University of Notre Dame; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097573, T32GM075762] Funding Source: NIH RePORTER	National Institutes of Health, a Chemistry-Biochemistry-Biology Interface Graduate Program fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Science at the University of Notre Dame; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM097573 (to P. L. C.) and T32 GM075762, a Chemistry-Biochemistry-Biology Interface Graduate Program fellowship (to E. B.).; Recipient of an Entrepreneurial Innovation postdoctoral fellowship from the College of Science at the University of Notre Dame. Present address: Department of Biotechnology, National Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia.	Besingi RN, 2013, MOL MICROBIOL, V90, P1028, DOI 10.1111/mmi.12414; Braselmann E, 2012, J PHYS CHEM LETT, V3, P1063, DOI 10.1021/jz201654k; Celik N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043245; Charbonneau ME, 2006, J BACTERIOL, V188, P8504, DOI 10.1128/JB.00864-06; CHARLES IG, 1989, P NATL ACAD SCI USA, V86, P3554, DOI 10.1073/pnas.86.10.3554; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Dautin N, 2007, EMBO J, V26, P1942, DOI 10.1038/sj.emboj.7601638; DECAD GM, 1976, J BACTERIOL, V128, P325, DOI 10.1128/JB.128.1.325-336.1976; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Drobnak I, 2015, MOL MICROBIOL, V95, P1, DOI 10.1111/mmi.12838; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gruss F, 2013, NAT STRUCT MOL BIOL, V20, P1318, DOI 10.1038/nsmb.2689; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jong WSP, 2010, CURR OPIN BIOTECH, V21, P646, DOI 10.1016/j.copbio.2010.07.009; Jose J, 2007, MICROBIOL MOL BIOL R, V71, P600, DOI 10.1128/MMBR.00011-07; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Junker M, 2010, PROTEINS, V78, P812, DOI 10.1002/prot.22609; Junker M, 2009, MOL MICROBIOL, V71, P1323, DOI 10.1111/j.1365-2958.2009.06607.x; Kang'ethe W, 2013, J BIOL CHEM, V288, P35028, DOI 10.1074/jbc.M113.515635; Kang'ethe W, 2013, P NATL ACAD SCI USA, V110, pE4246, DOI 10.1073/pnas.1310345110; KLAUSER T, 1990, EMBO J, V9, P1991, DOI 10.1002/j.1460-2075.1990.tb08327.x; KLAUSER T, 1992, EMBO J, V11, P2327, DOI 10.1002/j.1460-2075.1992.tb05292.x; Leyton DL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5239; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Leyton DL, 2011, J BIOL CHEM, V286, P42283, DOI 10.1074/jbc.M111.306118; Li H, 2008, BIOTECHNOL PROGR, V24, P56, DOI 10.1021/bp070255h; MAKOFF AJ, 1990, BIO-TECHNOL, V8, P1030, DOI 10.1038/nbt1190-1030; Mansell TJ, 2010, PROTEIN SCI, V19, P1079, DOI 10.1002/pro.388; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; Miyazaki Kentaro, 2003, Methods Mol Biol, V231, P23; Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Peterson JH, 2010, P NATL ACAD SCI USA, V107, P17739, DOI 10.1073/pnas.1009491107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Renn JP, 2008, BIOPOLYMERS, V89, P420, DOI 10.1002/bip.20924; Renn JP, 2012, CHEM BIOL, V19, P287, DOI 10.1016/j.chembiol.2011.11.009; Roman-Hernandez G, 2014, ELIFE, V3, DOI 10.7554/eLife.04234; Ruiz-Perez F, 2009, J BACTERIOL, V191, P6571, DOI 10.1128/JB.00754-09; Sauri A, 2012, J MOL BIOL, V416, P335, DOI 10.1016/j.jmb.2011.12.047; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; Selkrig J, 2014, BBA-MOL CELL RES, V1843, P1542, DOI 10.1016/j.bbamcr.2013.10.009; Selkrig J, 2012, NAT STRUCT MOL BIOL, V19, P506, DOI 10.1038/nsmb.2261; Sevastsyanovich YR, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-69; Shen HH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6078; Shi LX, 2013, P NATL ACAD SCI USA, V110, P930, DOI 10.1073/pnas.1115886110; Suzuki T, 1995, J BIOL CHEM, V270, P30874, DOI 10.1074/jbc.270.52.30874; Thanassi DG, 2005, MOL MEMBR BIOL, V22, P63, DOI 10.1080/09687860500063290; Velarde JJ, 2004, J BIOL CHEM, V279, P31495, DOI 10.1074/jbc.M404424200; Zhai YJ, 2011, BIOCHEM J, V435, P577, DOI 10.1042/BJ20101548	54	18	20	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10104	10116		10.1074/jbc.M114.629170	http://dx.doi.org/10.1074/jbc.M114.629170			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25670852	Green Published, hybrid			2022-12-28	WOS:000353241100017
J	Li, SM; Bhave, D; Chow, JM; Riera, TV; Schlee, S; Rauch, S; Atanasova, M; Cate, RL; Whitty, A				Li, Simin; Bhave, Devayani; Chow, Jennifer M.; Riera, Thomas V.; Schlee, Sandra; Rauch, Simone; Atanasova, Mariya; Cate, Richard L.; Whitty, Adrian			Quantitative Analysis of Receptor Tyrosine Kinase-Effector Coupling at Functionally Relevant Stimulus Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; Extracellular Signal-regulated Kinase (ERK); Kinetics; Mitogen-activated Protein Kinase (MAPK); Neurite Outgrowth; Signal Transduction; Systems Biology; RET; Artemin; Signal Gain	SIGNAL-REGULATED KINASE; GDNF FAMILY; IN-VIVO; GROWTH; RET; DYNAMICS; ARTEMIN; ERK; TRANSIENT; CELLS	A major goal of current signaling research is to develop a quantitative understanding of how receptor activation is coupled to downstream signaling events and to functional cellular responses. Here, we measure how activation of the RET receptor tyrosine kinase on mouse neuroblastoma cells by the neurotrophin artemin (ART) is quantitatively coupled to key downstream effectors. We show that the efficiency of RET coupling to ERK and Akt depends strongly on ART concentration, and it is highest at the low (approximate to 100 pm) ART levels required for neurite outgrowth. Quantitative discrimination between ERK and Akt pathway signaling similarly is highest at this low ART concentration. Stimulation of the cells with 100 pm ART activated RET at the rate of approximate to 10 molecules/cell/min, leading at 5-10 min to a transient peak of approximate to 150 phospho-ERK (pERK) molecules and approximate to 50 pAkt molecules per pRET, after which time the levels of these two signaling effectors fell by 25-50% while the pRET levels continued to slowly rise. Kinetic experiments showed that signaling effectors in different pathways respond to RET activation with different lag times, such that the balance of signal flux among the different pathways evolves over time. Our results illustrate that measurements using high, super-physiological growth factor levels can be misleading about quantitative features of receptor signaling. We propose a quantitative model describing how receptor-effector coupling efficiency links signal amplification to signal sensitization between receptor and effector, thereby providing insight into design principles underlying how receptors and their associated signaling machinery decode an extracellular signal to trigger a functional cellular outcome.	[Li, Simin; Bhave, Devayani; Chow, Jennifer M.; Riera, Thomas V.; Schlee, Sandra; Rauch, Simone; Atanasova, Mariya; Cate, Richard L.; Whitty, Adrian] Boston Univ, Dept Chem, Boston, MA 02215 USA	Boston University	Whitty, A (corresponding author), Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA.	whitty@bu.edu	Bhave, Devayani/D-1915-2017	Bhave, Devayani/0000-0002-0773-9962; Riera, Thomas/0000-0001-7427-2728; Atanasova, Mariya/0000-0002-4707-6833	National Institutes of Health [GM087469]; F31 Predoctoral Fellowship [CA177224]; NATIONAL CANCER INSTITUTE [F31CA177224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F31 Predoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM087469 (to A. W.) and F31 Predoctoral Fellowship CA177224 (to J. M. C.).	Adachi T, 2002, J CELL PHYSIOL, V192, P151, DOI 10.1002/jcp.10124; Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Andres R, 2001, DEVELOPMENT, V128, P3685; Androulakis IP, 2013, ANNU REV BIOMED ENG, V15, P1, DOI 10.1146/annurev-bioeng-071812-152425; [Anonymous], MAN DAT SHEET PDF PA; Awais M, 2011, MOL BIOSYST, V7, P1376, DOI 10.1039/c0mb00328j; Bakstad D, 2012, CURR OPIN BIOTECH, V23, P103, DOI 10.1016/j.copbio.2011.11.007; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; Birtwistle MR, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-109; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Carmillo P, 2005, BIOCHEMISTRY-US, V44, P2545, DOI 10.1021/bi049247p; Carter Y, 2013, NEUROENDOCRINOLOGY, V97, P57, DOI 10.1159/000335136; Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Cheong R, 2008, TRENDS CELL BIOL, V18, P112, DOI 10.1016/j.tcb.2008.01.005; Chew YH, 2014, PLANT CELL, V26, P5, DOI 10.1105/tpc.113.120006; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Fujita KA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000810; Ganesan A, 2012, PROTEIN SCI, V21, P918, DOI 10.1002/pro.2089; Gardell LR, 2003, NAT MED, V9, P1383, DOI 10.1038/nm944; Gattelli A, 2013, EMBO MOL MED, V5, P1335, DOI 10.1002/emmm.201302625; Gherardini PF, 2013, NEW BIOTECHNOL, V30, P327, DOI 10.1016/j.nbt.2012.11.007; Guthridge MA, 2006, EMBO J, V25, P479, DOI 10.1038/sj.emboj.7600948; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Haugh JM, 2012, BIOESSAYS, V34, P528, DOI 10.1002/bies.201200077; Houser B, 2012, ARCH PHYSIOL BIOCHEM, V118, P192, DOI 10.3109/13813455.2012.705301; Huang PH, 2008, MOL CELL, V31, P777, DOI 10.1016/j.molcel.2008.09.001; Hughey JJ, 2010, WIRES SYST BIOL MED, V2, P194, DOI 10.1002/wsbm.52; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Ibanez CF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009134; Janes KA, 2013, J CELL SCI, V126, P1913, DOI 10.1242/jcs.112045; Kawamoto Y, 2004, J BIOL CHEM, V279, P14213, DOI 10.1074/jbc.M312600200; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kolitz SE, 2012, BIOCHEMISTRY-US, V51, P7433, DOI 10.1021/bi300846p; Lee HW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2507; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Marunaka Y, 2005, J MEMBRANE BIOL, V203, P31, DOI 10.1007/s00232-004-0729-0; Masure S, 1999, EUR J BIOCHEM, V266, P892, DOI 10.1046/j.1432-1327.1999.00925.x; Meyer R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00451; Morandi A, 2013, CANCER RES, V73, P3783, DOI 10.1158/0008-5472.CAN-12-4265; Nandagopal K, 2001, J CELL BIOCHEM, V83, P326, DOI 10.1002/jcb.1222; Park CS, 2003, J BIOL CHEM, V278, P37064, DOI 10.1074/jbc.M304968200; Paveliev M, 2004, MOL CELL NEUROSCI, V25, P453, DOI 10.1016/j.mcn.2003.11.010; Perrett RM, 2013, J BIOL CHEM, V288, P21001, DOI 10.1074/jbc.M113.455345; Phay JE, 2010, CLIN CANCER RES, V16, P5936, DOI 10.1158/1078-0432.CCR-09-0786; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Plaza-Menacho I, 2010, ONCOGENE, V29, P4648, DOI 10.1038/onc.2010.209; Prazeres H, 2011, J THROID RES, V2011, DOI 10.4061/2011/678357; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148; Rogne M, 2013, NEW BIOTECHNOL, V30, P333, DOI 10.1016/j.nbt.2013.01.003; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Runeberg-Roos P, 2007, ANN MED, V39, P572, DOI 10.1080/07853890701646256; Runkel L, 2000, BIOCHEMISTRY-US, V39, P2538, DOI 10.1021/bi991631c; Salehian B, 2013, J CLIN RES PEDIATR E, V5, P70, DOI 10.4274/Jcrpe.870; Samaga R, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-43; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schlee S, 2006, NAT CHEM BIOL, V2, P636, DOI 10.1038/nchembio823; Schmierer B, 2008, P NATL ACAD SCI USA, V105, P6608, DOI 10.1073/pnas.0710134105; Shankaran H, 2007, PLOS COMPUT BIOL, V3, P986, DOI 10.1371/journal.pcbi.0030101; Shankaran H, 2010, CURR OPIN GENET DEV, V20, P650, DOI 10.1016/j.gde.2010.08.002; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Slusarczyk AL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003092; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Wang CC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.4; Warnecke A, 2010, NEUROREPORT, V21, P517, DOI 10.1097/WNR.0b013e328339045b; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Yosef N, 2011, CELL, V144, P886, DOI 10.1016/j.cell.2011.02.015; ZHU BT, 1993, J PHARMACOL TOXICOL, V29, P85, DOI 10.1016/1056-8719(93)90055-J; Zi ZK, 2012, FEBS LETT, V586, P1921, DOI 10.1016/j.febslet.2012.03.063; Zi ZK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.22; Zihlmann KB, 2005, BRAIN RES BULL, V68, P42, DOI 10.1016/j.brainresbull.2004.10.012	76	2	2	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10018	10036		10.1074/jbc.M114.602268	http://dx.doi.org/10.1074/jbc.M114.602268			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25635057	Green Published, hybrid			2022-12-28	WOS:000353241100010
J	Mourer, T; Jacques, JF; Brault, A; Bisaillon, M; Labbe, S				Mourer, Thierry; Jacques, Jean-Francois; Brault, Ariane; Bisaillon, Martin; Labbe, Simon			Shu1 Is a Cell-surface Protein Involved in Iron Acquisition from Heme in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell-surface Protein; Heme; Iron Metabolism; Transcription Regulation; Yeast Physiology	GLOBAL TRANSCRIPTIONAL RESPONSES; BINDING FACTOR PHP4; FISSION YEAST; CRYPTOCOCCUS-NEOFORMANS; CANDIDA-ALBICANS; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; CAPSULE FORMATION; TRANSPORT-SYSTEM; FACTOR FEP1	Iron is an essential metal cofactor that is required for many biological processes. Eukaryotic cells have consequently developed different strategies for its acquisition. Until now, Schizosaccharomyces pombe was known to use reductive iron uptake and siderophore-bound iron transport to scavenge iron from the environment. Here, we report the identification of a gene designated shu1(+) that encodes a protein that enables S. pombe to take up extracellular heme for cell growth. When iron levels are low, the transcription of shu1(+) is induced, although its expression is repressed when iron levels rise. The iron-dependent down-regulation of shu1(+) requires the GATA-type transcriptional repressor Fep1, which strongly associates with a proximal promoter region of shu1(+)in vivo in response to iron repletion. HA(4)-tagged Shu1 localizes to the plasma membrane in cells expressing a functional shu1(+)-HA(4) allele. When heme biosynthesis is selectively blocked in mutated S. pombe cells, their ability to acquire exogenous hemin or the fluorescent heme analog zinc mesoporphyrin IX is dependent on the expression of Shu1. Further analysis by absorbance spectroscopy and hemin-agarose pulldown assays showed that Shu1 interacts with hemin, with a K-D of approximate to 2.2 m. Taken together, results reported here revealed that S. pombe possesses an unexpected pathway for heme assimilation, which may also serve as a source of iron for cell growth.	[Mourer, Thierry; Jacques, Jean-Francois; Brault, Ariane; Bisaillon, Martin; Labbe, Simon] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Labbe, S (corresponding author), Fac Med & Sci Sante, 3201,Pavillon Z-8,Jean Mignault St, Sherbrooke, PQ J1E 4K8, Canada.	Simon.Labbe@USherbrooke.ca		Labbe, Simon/0000-0002-4947-523X; Mourer, Thierry/0000-0003-1651-6768	Natural Sciences and Engineering Research Council of Canada [MOP-238238-2010-15, MOP-396029-2010-DAS]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grants MOP-238238-2010-15 and MOP-396029-2010-DAS (to S. L.).	Askwith C, 1997, J BIOL CHEM, V272, P401; Beaudoin J, 2006, MICROBIOL-SGM, V152, P209, DOI 10.1099/mic.0.28392-0; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Brown WV, 2011, J CLIN LIPIDOL, V5, P1, DOI 10.1016/j.jacl.2010.11.010; Cadieux B, 2013, J INFECT DIS, V207, P1339, DOI 10.1093/infdis/jit029; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; Desuzinges-Mandon E, 2010, J BIOL CHEM, V285, P33123, DOI 10.1074/jbc.M110.139170; Ding C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028151; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hogle SL, 2014, METALLOMICS, V6, P1107, DOI 10.1039/c4mt00031e; Hu GG, 2013, INFECT IMMUN, V81, P292, DOI 10.1128/IAI.01037-12; Jacques JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098959; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; Jung WH, 2006, PLOS BIOL, V4, P2282, DOI 10.1371/journal.pbio.0040410; Kaplan J, 2013, CURR BIOL, V23, pR642, DOI 10.1016/j.cub.2013.05.033; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kornitzer D, 2009, CURR OPIN MICROBIOL, V12, P377, DOI 10.1016/j.mib.2009.05.005; Korolnek T, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00126; Kronstad JW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003498; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Kuznets G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004407; Labbe S, 2013, CURR OPIN MICROBIOL, V16, P669, DOI 10.1016/j.mib.2013.07.007; LEUPOLD U., 1950, Comptes rendus des Travaux du Laboratoire Carlsberg, V24, P381; Lian TS, 2005, MOL MICROBIOL, V55, P1452, DOI 10.1111/j.1365-2958.2004.04474.x; Lindner P, 1893, WOCHENSCHRIFT BRAUER, V10, P1298; Bailao EFLC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002856; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Mercier A, 2010, APPL ENVIRON MICROB, V76, P3806, DOI 10.1128/AEM.00659-10; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Paul V. D., 2015, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j.bbamcr.2014.12.18, DOI 10.1016/J.BBAMCR.2014.12.18]; Pelletier B, 2005, J BIOL CHEM, V280, P25146, DOI 10.1074/jbc.M502947200; Pelletier B, 2003, NUCLEIC ACIDS RES, V31, P4332, DOI 10.1093/nar/gkg647; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Pendrak ML, 2004, J BIOL CHEM, V279, P3426, DOI 10.1074/jbc.M311550200; Philpott CC, 2012, BBA-MOL CELL RES, V1823, P1509, DOI 10.1016/j.bbamcr.2012.01.012; Pouliot B, 2010, EUKARYOT CELL, V9, P59, DOI 10.1128/EC.00262-09; Protchenko O, 2008, EUKARYOT CELL, V7, P859, DOI 10.1128/EC.00414-07; Protchenko O, 2006, J BIOL CHEM, V281, P21445, DOI 10.1074/jbc.M512812200; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rustici G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r73; Santos R, 2003, MICROBIOL-SGM, V149, P579, DOI 10.1099/mic.0.26108-0; Schrettl M, 2004, BIOMETALS, V17, P647, DOI 10.1007/s10534-004-1230-z; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Teoh AL, 2004, INT J FOOD MICROBIOL, V95, P119, DOI 10.1016/j.ijfoodmicro.2003.12.020; Weissman Z, 2004, MOL MICROBIOL, V53, P1209, DOI 10.1111/j.1365-2958.2004.04199.x; Weissman Z, 2008, MOL MICROBIOL, V69, P201, DOI 10.1111/j.1365-2958.2008.06277.x; Worthington MT, 2001, AM J PHYSIOL-GASTR L, V280, pG1172, DOI 10.1152/ajpgi.2001.280.6.G1172	50	25	27	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10176	10190		10.1074/jbc.M115.642058	http://dx.doi.org/10.1074/jbc.M115.642058			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25733668	Green Published, hybrid			2022-12-28	WOS:000353241100024
J	Xu, HM; Malinin, NL; Awasthi, N; Schwarz, RE; Schwarz, MA				Xu, Haiming; Malinin, Nikolay L.; Awasthi, Niranjan; Schwarz, Roderich E.; Schwarz, Margaret A.			The N Terminus of Pro-endothelial Monocyte-activating Polypeptide II (EMAP II) Regulates Its Binding with the C Terminus, Arginyl-tRNA Synthetase, and Neurofilament Light Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTISYNTHETASE COMPLEX; AIMP1/P43 MUTATION; SH-SY5Y CELLS; CYTOKINE; P43; EXPRESSION; NEOVASCULARIZATION; COMPONENT; PHOSPHORYLATION; IDENTIFICATION	Pro-endothelial monocyte-activating polypeptide II (EMAP II), one component of the multi-aminoacyl tRNA synthetase complex, plays multiple roles in physiological and pathological processes of protein translation, signal transduction, immunity, lung development, and tumor growth. Recent studies have determined that pro-EMAP II has an essential role in maintaining axon integrity in central and peripheral neural systems where deletion of the C terminus of pro-EMAP II has been reported in a consanguineous Israeli Bedouin kindred suffering from Pelizaeus-Merzbacher-like disease. We hypothesized that the N terminus of pro-EMAP II has an important role in the regulation of protein-protein interactions. Using a GFP reporter system, we defined a putative leucine zipper in the N terminus of human pro-EMAP II protein (amino acid residues 1-70) that can form specific strip-like punctate structures. Through GFP punctum analysis, we uncovered that the pro-EMAP II C terminus (amino acids 147-312) can repress GFP punctum formation. Pulldown assays confirmed that the binding between the pro-EMAP II N terminus and its C terminus is mediated by a putative leucine zipper. Furthermore, the pro-EMAP 11 1-70 amino acid region was identified as the binding partner of arginyl-tRNA synthetase, a polypeptide of the multi-aminoacyl tRNA synthetase complex. We also determined that the punctate GFP pro-EMAP II 1-70 amino acid aggregate colocalizes and binds to the neurofilament light subunit protein that is associated with pathologic neurofilament network disorganization and degeneration of motor neurons. These findings indicate the structure and binding interaction of pro-EMAP II protein and suggest a role of this protein in pathological neurodegenerative diseases.	[Xu, Haiming; Schwarz, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Malinin, Nikolay L.; Awasthi, Niranjan; Schwarz, Roderich E.; Schwarz, Margaret A.] Indiana Univ Sch Med, South Bend, IN 46617 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Indiana University System; Indiana University South Bend	Schwarz, MA (corresponding author), Indiana Univ Sch Med South Bend, Dept Pediat, 1234 Notre Dame Ave, South Bend, IN 46617 USA.	schwarma@iupui.edu	Malinin, Nikolay/Z-5308-2019	Malinin, Nikolay/0000-0002-2654-1783	National Institutes of Health [R01HL60061, 5R01HL114977]; University of Texas Southwestern Simmons Comprehensive Cancer Center; Lilly Endowment, Inc. Physician Scientist Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114977, R01HL060061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Southwestern Simmons Comprehensive Cancer Center; Lilly Endowment, Inc. Physician Scientist Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL60061 and 5R01HL114977 (to M. A. S.). This work was also supported by the University of Texas Southwestern Simmons Comprehensive Cancer Center (to M. A. S.) and the Lilly Endowment, Inc. Physician Scientist Initiative (to M. A. S.).	Ahn HC, 2003, FEBS LETT, V542, P119, DOI 10.1016/S0014-5793(03)00362-4; Awasthi N, 2009, LAB INVEST, V89, P38, DOI 10.1038/labinvest.2008.106; Biancheri R, 2011, AM J HUM GENET, V88, P391, DOI 10.1016/j.ajhg.2011.02.003; Boespflug-Tanguy O, 2011, AM J HUM GENET, V88, P392, DOI 10.1016/j.ajhg.2010.12.015; Deineko V, 2006, PROTEIN PEPTIDE LETT, V13, P687, DOI 10.2174/092986606777790584; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Feinstein M, 2010, AM J HUM GENET, V87, P820, DOI 10.1016/j.ajhg.2010.10.016; Gauthier DJ, 2008, PROTEOMICS, V8, P3848, DOI 10.1002/pmic.200700969; Guo H, 2014, J NEUROSCI RES, V92, P1374, DOI 10.1002/jnr.23403; Han JM, 2007, AM J PATHOL, V170, P2042, DOI 10.2353/ajpath.2007.061266; KAO J, 1992, J BIOL CHEM, V267, P20239; KAO J, 1994, J BIOL CHEM, V269, P25106; Kao J, 1993, Behring Inst Mitt, P92; Kim G, 2010, BIOCHEM BIOPH RES CO, V397, P100, DOI 10.1016/j.bbrc.2010.05.075; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Kim SS, 2011, TUMORI, V97, P380, DOI 10.1700/912.10038; Kim T, 2000, J BIOL CHEM, V275, P21768, DOI 10.1074/jbc.M002404200; Kim TS, 2008, VACCINE, V26, P5928, DOI 10.1016/j.vaccine.2008.08.051; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Lee SW, 2008, EXPERT OPIN DRUG DIS, V3, P945, DOI 10.1517/17460441.3.8.945; Lee YS, 2008, BIOCHEM BIOPH RES CO, V371, P395, DOI 10.1016/j.bbrc.2008.04.099; Li GB, 2014, INT J MOL SCI, V15, P15845, DOI 10.3390/ijms150915845; Liu J, 2006, EXP CELL RES, V312, P2231, DOI 10.1016/j.yexcr.2006.03.024; Miller M, 2009, CURR PROTEIN PEPT SC, V10, P244, DOI 10.2174/138920309788452164; Park SG, 2006, P NATL ACAD SCI USA, V103, P14913, DOI 10.1073/pnas.0602045103; Park SG, 2010, IUBMB LIFE, V62, P296, DOI 10.1002/iub.324; Park SG, 2005, AM J PATHOL, V166, P387, DOI 10.1016/S0002-9440(10)62262-6; Park SG, 1999, J BIOL CHEM, V274, P16673, DOI 10.1074/jbc.274.24.16673; Perfeito R, 2014, MOL CELL NEUROSCI, V62, P51, DOI 10.1016/j.mcn.2014.08.002; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Schwarz M, 1999, AM J PHYSIOL-LUNG C, V276, pL365, DOI 10.1152/ajplung.1999.276.2.L365; Schwarz MA, 1999, J EXP MED, V190, P341, DOI 10.1084/jem.190.3.341; Schwarz MA, 2005, EXP CELL RES, V311, P229, DOI 10.1016/j.yexcr.2005.09.008; Schwarz MA, 2004, AM J RESP CELL MOL, V30, P784, DOI 10.1165/rcmb.2003-0145OC; Schwarz MA, 2000, MECH DEVELOP, V95, P123, DOI 10.1016/S0925-4773(00)00361-0; Schwarz MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033101; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Tanaka K, 2012, J BIOCHEM, V151, P611, DOI 10.1093/jb/mvs033; Trinh R, 2004, MOL IMMUNOL, V40, P717, DOI 10.1016/j.molimm.2003.08.006; van Horssen R, 2006, CYTOKINE GROWTH F R, V17, P339, DOI 10.1016/j.cytogfr.2006.08.001; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Wu PC, 1999, CANCER RES, V59, P205; Yamamoto M, 2000, ANTICANCER RES, V20, P4081; Zhang FR, 2002, AM J PHYSIOL-LUNG C, V282, pL1239, DOI 10.1152/ajplung.00141.2001; Zhang X, 2014, NEUROSCIENCE, V280, P88, DOI 10.1016/j.neuroscience.2014.08.052; Zhu XD, 2009, P NATL ACAD SCI USA, V106, P15944, DOI 10.1073/pnas.0901872106; Zogovic N, 2015, J NEUROCHEM, V133, P223, DOI 10.1111/jnc.12980	48	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9753	9766		10.1074/jbc.M114.630533	http://dx.doi.org/10.1074/jbc.M114.630533			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25724651	hybrid, Green Published			2022-12-28	WOS:000352729400036
J	Gaspard, GJ; McMaster, CR				Gaspard, Gerard J.; McMaster, Christopher R.			The Mitochondrial Quality Control Protein Yme1 Is Necessary to Prevent Defective Mitophagy in a Yeast Model of Barth Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BEEF-HEART MITOCHONDRIA; ADP/ATP CARRIER PROTEIN; TAZ GENE MUTATION; SACCHAROMYCES-CEREVISIAE; CARDIOLIPIN METABOLISM; INNER MEMBRANE; TAFAZZIN; DNA; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPIDS	The Saccharomyces cerevisiae TAZ1 gene is an orthologue of human TAZ; both encode the protein tafazzin. Tafazzin is a transacylase that transfers acyl chains with unsaturated fatty acids from phospholipids to monolysocardiolipin to generate cardiolipin with unsaturated fatty acids. Mutations in human TAZ cause Barth syndrome, a fatal childhood cardiomyopathy biochemically characterized by reduced cardiolipin mass and increased monolysocardiolipin levels. To uncover cellular processes that require tafazzin to maintain cell health, we performed a synthetic genetic array screen using taz1 Delta yeast cells to identify genes whose deletion aggravated its fitness. The synthetic genetic array screen uncovered several mitochondrial cellular processes that require tafazzin. Focusing on the i-AAA protease Yme1, a mitochondrial quality control protein that degrades misfolded proteins, we determined that in cells lacking both Yme1 and Taz1 function, there were substantive mitochondrial ultrastructural defects, ineffective superoxide scavenging, and a severe defect in mitophagy. We identify an important role for the mitochondrial protease Yme1 in the ability of cells that lack tafazzin function to maintain mitochondrial structural integrity and mitochondrial quality control and to undergo mitophagy.	[Gaspard, Gerard J.; McMaster, Christopher R.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [McMaster, Christopher R.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University	McMaster, CR (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada.	Christopher.mcmaster@dal.ca		McMaster, Christopher/0000-0003-0822-5776	Genome Canada; Genome Atlantic; Barth Syndrome Foundation of Canada; Canadian Institutes of Health Research	Genome Canada(Genome Canada); Genome Atlantic; Barth Syndrome Foundation of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Genome Canada, Genome Atlantic, and the Barth Syndrome Foundation of Canada. This study was also supported by a Canadian Institutes of Health Research grant (to C. R. M.).	Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; Beyer K, 1996, BIOCHEMISTRY-US, V35, P15784, DOI 10.1021/bi9610055; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; CAMPBELL CL, 1994, MOL BIOL CELL, V5, P899, DOI 10.1091/mbc.5.8.899; Campbell CL, 1998, J CELL SCI, V111, P2455; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Jefferies JL, 2013, AM J MED GENET C, V163, P198, DOI 10.1002/ajmg.c.31372; Johnston J, 1997, AM J HUM GENET, V61, P1053, DOI 10.1086/301604; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Kanki T, 2009, AUTOPHAGY, V5, P1186, DOI 10.4161/auto.5.8.9854; Khuchua Z, 2006, CIRC RES, V99, P201, DOI 10.1161/01.RES.0000233378.95325.ce; Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Nebauer R, 2007, FEBS J, V274, P6180, DOI 10.1111/j.1742-4658.2007.06138.x; Neuwald AF, 1997, CURR BIOL, V7, pR465; Patil VA, 2013, J BIOL CHEM, V288, P1696, DOI 10.1074/jbc.M112.428938; Phoon CKL, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000455; Potting C, 2010, EMBO J, V29, P2888, DOI 10.1038/emboj.2010.169; Ronvelia D, 2012, MOL GENET METAB, V107, P428, DOI 10.1016/j.ymgme.2012.09.013; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Swamy Mahima, 2006, Sci STKE, V2006, ppl4, DOI 10.1126/stke.3452006pl4; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; THORSNESS PE, 1993, MOL CELL BIOL, V13, P5418, DOI 10.1128/MCB.13.9.5418; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Whited K, 2013, HUM MOL GENET, V22, P483, DOI 10.1093/hmg/dds447; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200	47	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9284	9298		10.1074/jbc.M115.641878	http://dx.doi.org/10.1074/jbc.M115.641878			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25688091	hybrid, Green Published			2022-12-28	WOS:000352207100049
J	Rayavarapu, RR; Heiden, B; Pagani, N; Shaw, MM; Shuff, S; Zhang, SY; Schafer, ZT				Rayavarapu, Raju R.; Heiden, Brendan; Pagani, Nicholas; Shaw, Melissa M.; Shuff, Sydney; Zhang, Siyuan; Schafer, Zachary T.			The Role of Multicellular Aggregation in the Survival of ErbB2-positive Breast Cancer Cells during Extracellular Matrix Detachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; ERBB2 REQUIRES; ANOIKIS; GROWTH; METASTASIS; ACTIVATION; SUPPRESSION; AUTOPHAGY; EGFR	The metastasis of cancer cells from the site of the primary tumor to distant sites in the body represents the most deadly manifestation of cancer. In order for metastasis to occur, cancer cells need to evade anoikis, which is defined as apoptosis caused by loss of attachment to extracellular matrix (ECM). Signaling from ErbB2 has previously been linked to the evasion of anoikis in breast cancer cells but the precise molecular mechanisms by which ErbB2 blocks anoikis have yet to be unveiled. In this study, we have identified a novel mechanism by which anoikis is inhibited in ErbB2-expressing cells: multicellular aggregation during ECM-detachment. Our data demonstrate that disruption of aggregation in ErbB2-positive cells is sufficient to induce anoikis and that this anoikis inhibition is a result of aggregation-induced stabilization of EGFR and consequent ERK/MAPK survival signaling. Furthermore, these data suggest that ECM-detached ErbB2-expressing cells may be uniquely susceptible to targeted therapy against EGFR and that this sensitivity could be exploited for specific elimination of ECM-detached cancer cells.	[Rayavarapu, Raju R.; Heiden, Brendan; Pagani, Nicholas; Shaw, Melissa M.; Shuff, Sydney; Zhang, Siyuan; Schafer, Zachary T.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Schafer, ZT (corresponding author), Univ Notre Dame, Dept Biol Sci, Galvin Life Sci Ctr 222, Notre Dame, IN 46556 USA.	zschafe1@nd.edu	Zhang, Siyuan/A-1276-2014; Zhang, Siyuan/AAH-1157-2021	Zhang, Siyuan/0000-0003-0910-3666; Zhang, Siyuan/0000-0003-0910-3666; Shuff, Sydney/0000-0002-5026-3461; Heiden, Brendan/0000-0002-0116-7377	Glynn Family Honors Program; Notre Dame NSF-REU program in biology; NIH [5R00CA158066]; Lee National Denim Day Research Scholar Grant from the American Cancer Society [RSG-14-145-01-CSM]; Career Catalyst Grant from Susan G. Komen [CCR14302768]; NATIONAL CANCER INSTITUTE [R00CA158066] Funding Source: NIH RePORTER	Glynn Family Honors Program; Notre Dame NSF-REU program in biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lee National Denim Day Research Scholar Grant from the American Cancer Society; Career Catalyst Grant from Susan G. Komen(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Glynn Family Honors Program and the Notre Dame NSF-REU program in biology (to N. P.).; Recipient of a Pathway to Independence Award (5R00CA158066) from the NIH.; Recipient of a Lee National Denim Day Research Scholar Grant (RSG-14-145-01-CSM) from the American Cancer Society and a Career Catalyst Grant (CCR14302768) from Susan G. Komen.	Adachi M, 2003, FEBS LETT, V551, P147, DOI 10.1016/S0014-5793(03)00915-3; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Avivar-Valderas A, 2013, ONCOGENE, V32, P4932, DOI 10.1038/onc.2012.512; Avivar-Valderas A, 2011, MOL CELL BIOL, V31, P3616, DOI 10.1128/MCB.05164-11; Bossy-Wetzel E, 2000, METHOD ENZYMOL, V322, P235; Bremm A, 2008, CANCER RES, V68, P707, DOI 10.1158/0008-5472.CAN-07-1588; Buchheit C. L., 2014, CELL DEATH DIFFER, DOI [10.1038/cdd.2014.1209, DOI 10.1038/CDD.2014.1209]; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Buchheit CL, 2012, SEMIN CELL DEV BIOL, V23, P402, DOI 10.1016/j.semcdb.2012.04.007; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Davison CA, 2013, CANCER RES, V73, P3704, DOI 10.1158/0008-5472.CAN-12-2482; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Fernandez SV, 2013, BREAST CANCER RES TR, V140, P23, DOI 10.1007/s10549-013-2600-4; FIDLER IJ, 1973, EUR J CANCER, V9, P223, DOI 10.1016/S0014-2964(73)80022-2; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Grassian AR, 2011, J BIOL CHEM, V286, P79, DOI 10.1074/jbc.M110.169821; Haenssen KK, 2010, J CELL SCI, V123, P1373, DOI 10.1242/jcs.050906; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Kumar S, 2011, MOL CELL BIOL, V31, P4036, DOI 10.1128/MCB.01342-10; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; PIERCEALL WE, 1995, ONCOGENE, V11, P1319; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Robertson FM, 2010, CA-CANCER J CLIN, V60, P351, DOI 10.3322/caac.20082; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; van Roy F, 2014, NAT REV CANCER, V14, P121, DOI 10.1038/nrc3647; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; WATANABE S, 1954, CANCER, V7, P215, DOI 10.1002/1097-0142(195403)7:2<215::AID-CNCR2820070203>3.0.CO;2-6; Weigel KJ, 2014, MOL CANCER RES, V12, P855, DOI 10.1158/1541-7786.MCR-14-0090; Whelan KA, 2013, J BIOL CHEM, V288, P15865, DOI 10.1074/jbc.M112.426999; Whelan KA, 2010, MOL BIOL CELL, V21, P3829, DOI 10.1091/mbc.E10-04-0353; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	54	29	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8722	8733		10.1074/jbc.M114.612754	http://dx.doi.org/10.1074/jbc.M114.612754			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25681438	hybrid, Green Published			2022-12-28	WOS:000352207100004
J	Yao, JW; Rock, CO				Yao, Jiangwei; Rock, Charles O.			How Bacterial Pathogens Eat Host Lipids: Implications for the Development of Fatty Acid Synthesis Therapeutics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACYL CARRIER PROTEIN; MEMBRANE PHOSPHOLIPID-SYNTHESIS; IN-VITRO ACTIVITY; ESCHERICHIA-COLI; ENZYMATIC-SYNTHESIS; ACETYL-COENZYME; FABI INHIBITOR; BIOSYNTHESIS; SYNTHETASE; CHLAMYDIA	Bacterial type II fatty acid synthesis (FASII) is a target for the development of novel therapeutics. Bacteria incorporate extracellular fatty acids into membrane lipids, raising the question of whether pathogens use host fatty acids to bypass FASII and defeat FASII therapeutics. Some pathogens suppress FASII when exogenous fatty acids are present to bypass FASII therapeutics. FASII inhibition cannot be bypassed in many bacteria because essential fatty acids cannot be obtained from the host. FASII antibiotics may not be effective against all bacteria, but a broad spectrum of Gram-negative and -positive pathogens can be effectively treated with FASII inhibitors.	[Yao, Jiangwei; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org		Yao, Jiangwei/0000-0001-7088-3468	National Institutes of Health [GM034496]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034496, R01GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM034496 (to C. O. R.). This work was also supported by Cancer Center Support Grant CA21765 and the American Lebanese Syrian Associated Charities.	Albanesi D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003108; Banevicius MA, 2013, J CHEMOTHERAPY, V25, P26, DOI 10.1179/1973947812Y.0000000061; BECKER Y, 1978, MICROBIOL REV, V42, P274, DOI 10.1128/MMBR.42.2.274-306.1978; Beld J, 2014, CHEM BIOL, V21, P1293, DOI 10.1016/j.chembiol.2014.08.015; BLACK PN, 1992, J BIOL CHEM, V267, P25513; Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; BYERS DM, 1989, J BACTERIOL, V171, P59, DOI 10.1128/jb.171.1.59-64.1989; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; COLEMAN J, 1992, MOL GEN GENET, V232, P295, DOI 10.1007/BF00280009; Collado MC, 2007, LETT APPL MICROBIOL, V45, P454, DOI 10.1111/j.1472-765X.2007.02212.x; COOPER CL, 1989, J BIOL CHEM, V264, P7384; Cronan JE, 1998, MOL MICROBIOL, V29, P937, DOI 10.1046/j.1365-2958.1998.00917.x; CRONAN JE, 1988, J BIOL CHEM, V263, P10332; Cronan Jr J. E., 2008, ECOSAL ESCHERICHIA C, DOI [10.1128/ecosalplus.3.6.4, DOI 10.1128/EC0SALPLUS.3.6.4]; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Davis MS, 2001, J BACTERIOL, V183, P1499, DOI 10.1128/JB.183.4.1499-1503.2001; Denou E, 2008, J BACTERIOL, V190, P3161, DOI 10.1128/JB.01637-07; Escaich S, 2011, ANTIMICROB AGENTS CH, V55, P4692, DOI 10.1128/AAC.01248-10; FICE D, 1993, J BACTERIOL, V175, P1865, DOI 10.1128/JB.175.7.1865-1870.1993; Freiberg C, 2006, ANTIMICROB AGENTS CH, V50, P2707, DOI 10.1128/AAC.00012-06; Gerusz V, 2012, J MED CHEM, V55, P9914, DOI 10.1021/jm301113w; GREEN PR, 1981, J BIOL CHEM, V256, P1151; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Heath RJ, 2001, PROG LIPID RES, V40, P467, DOI 10.1016/S0163-7827(01)00012-1; HSU L, 1991, J BIOL CHEM, V266, P13783; JACKOWSKI S, 1994, J BIOL CHEM, V269, P2921; Jerga A, 2009, J BIOL CHEM, V284, P15364, DOI 10.1074/jbc.C109.002410; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Jiang YF, 2006, BIOCHEMISTRY-US, V45, P10008, DOI 10.1021/bi060842w; Jiang YF, 2010, BIOCHEMISTRY-US, V49, P718, DOI 10.1021/bi901890a; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kaplan N, 2013, EUR J PHARM SCI, V50, P440, DOI 10.1016/j.ejps.2013.08.019; Kaplan N, 2013, J CHEMOTHERAPY, V25, P18, DOI 10.1179/1973947812Y.0000000063; Kaplan N, 2012, ANTIMICROB AGENTS CH, V56, P5865, DOI 10.1128/AAC.01411-12; Langston KG, 2004, BIOCHEMISTRY-US, V43, P4338, DOI 10.1021/bi035919k; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Li XC, 2003, ORG LETT, V5, P539, DOI 10.1021/ol027458l; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; Lu YJ, 2006, MOL MICROBIOL, V59, P551, DOI 10.1111/j.1365-2958.2005.04951.x; More MI, 1996, SCIENCE, V272, P1655, DOI 10.1126/science.272.5268.1655; Muller JA, 2011, APPL ENVIRON MICROB, V77, P6889, DOI 10.1128/AEM.05213-11; Nguyen BD, 2011, P NATL ACAD SCI USA, V108, P10284, DOI 10.1073/pnas.1107478108; NIKAIDO H, 1968, ADV ENZYMOL RAMB, V31, P77; OVERATH P, 1967, BIOCHEM BIOPH RES CO, V29, P28, DOI 10.1016/0006-291X(67)90535-9; Parsons JB, 2014, P NATL ACAD SCI USA, V111, P10532, DOI 10.1073/pnas.1408797111; Parsons JB, 2014, MOL MICROBIOL, V92, P234, DOI 10.1111/mmi.12556; Parsons JB, 2013, ANTIMICROB AGENTS CH, V57, P5729, DOI 10.1128/AAC.01038-13; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Parsons JB, 2013, ANTIMICROB AGENTS CH, V57, P2182, DOI 10.1128/AAC.02307-12; Parsons JB, 2011, CURR OPIN MICROBIOL, V14, P544, DOI 10.1016/j.mib.2011.07.029; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Pelz A, 2005, J BIOL CHEM, V280, P32493, DOI 10.1074/jbc.M505070200; Piddock LJV, 2012, LANCET INFECT DIS, V12, P249, DOI 10.1016/S1473-3099(11)70316-4; Raetz C. R. H., 1987, ESCHERICHIA COLI SAL, P498; RAETZ CRH, 1978, MICROBIOL REV, V42, P614, DOI 10.1128/MMBR.42.3.614-659.1978; RAY TK, 1976, P NATL ACAD SCI USA, V73, P4374, DOI 10.1073/pnas.73.12.4374; ROCK CO, 1979, J BIOL CHEM, V254, P7123; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Schiebel J, 2014, J BIOL CHEM, V289, P15987, DOI 10.1074/jbc.M113.532804; Schujman GE, 2003, DEV CELL, V4, P663, DOI 10.1016/S1534-5807(03)00123-0; Sherman PM, 2005, INFECT IMMUN, V73, P5183, DOI 10.1128/IAI.73.8.5183-5188.2005; Singh VK, 2008, APPL ENVIRON MICROB, V74, P5882, DOI 10.1128/AEM.00882-08; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; VANDENBOOM TJ, 1991, J BACTERIOL, V173, P6411, DOI 10.1128/jb.173.20.6411-6420.1991; Vinale F, 2012, J NAT PROD, V75, P103, DOI 10.1021/np200577t; Wang Y, 2013, CHEMMEDCHEM, V8, P1589, DOI 10.1002/cmdc.201300209; WEEKS G, 1969, J BACTERIOL, V97, P827, DOI 10.1128/JB.97.2.827-836.1969; WILLIAMS WL, 1947, J BIOL CHEM, V170, P619; Wright HT, 2007, CURR OPIN MICROBIOL, V10, P447, DOI 10.1016/j.mib.2007.07.001; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Yao JW, 2014, J BIOL CHEM, V289, P22365, DOI 10.1074/jbc.M114.584185; Yao JW, 2013, J BIOL CHEM, V288, P36261, DOI 10.1074/jbc.M113.512905; Yao JW, 2013, BBA-MOL CELL BIOL L, V1831, P495, DOI 10.1016/j.bbalip.2012.08.018; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	77	72	75	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					5940	5946		10.1074/jbc.R114.636241	http://dx.doi.org/10.1074/jbc.R114.636241			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25648887	Green Published, hybrid			2022-12-28	WOS:000350732500001
J	Petherick, KJ; Conway, OJL; Mpamhanga, C; Osborne, SA; Kamal, A; Saxty, B; Ganley, IG				Petherick, Katy J.; Conway, Owen J. L.; Mpamhanga, Chido; Osborne, Simon A.; Kamal, Ahmad; Saxty, Barbara; Ganley, Ian G.			Pharmacological inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy (vol 290, pg 11376, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Ganley, Ian/0000-0003-1481-9407; Conway, Owen/0000-0002-0640-1038	Medical Research Council [MC_UP_A500_1019, MC_UU_12016/4] Funding Source: Medline; MRC [MC_UU_12016/4] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Petherick KJ, 2015, J BIOL CHEM, V290, P28726, DOI [10.1074/jbc.C114.627778, 10.1074/jbc.A114.627778]	1	207	217	4	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28726	28726		10.1074/jbc.A114.627778	http://dx.doi.org/10.1074/jbc.A114.627778			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	25833948	Green Published, hybrid			2022-12-28	WOS:000365762300015
J	Armstrong, DL; Eisenstein, M; Zidovetzki, R; Jacob, CO				Armstrong, Don L.; Eisenstein, Miriam; Zidovetzki, Raphael; Jacob, Chaim O.			Systemic Lupus Erythematosus-associated Neutrophil Cytosolic Factor 2 Mutation Affects the Structure of NADPH Oxidase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; CONTROLS PHAGOSOMAL PH; REVISED CRITERIA; PROTEIN; VAV1; CLASSIFICATION; SUSCEPTIBILITY; LYMPHOCYTES; P67(PHOX); ADMIXTURE	In a case-control association study with 3716 North Americans of Hispanic descent and 4867 North Americans of European descent, we show that the associations of rs17849502 (NCF2 His-389 -> Gln) and rs13306575 (NCF2 Arg-395 -> Trp) with systemic lupus erythematosus are independent. We have shown that His-389 -> Gln disrupts the binding of NCF2 to the ZF domain of VAV1, resulting in decreased NADPH oxidase activity. With respect to Arg-395 -> Trp, using protein docking and structure analyses, we provide a model for the involvement of this mutation in the structure and function of the NADPH oxidase complex. This model assigns a central role to Arg-395 in the structure and stability of the quaternary NCF2/NCF4/VAV1/RAC1 NADPH oxidase complex. Arg-395 stabilizes the C-terminal tail of NCF4 and the conformation of NCF2 loop 395-402, which in turn stabilize the evolutionarily conserved interactions of NCF2/NCF4 with the DH domain of VAV1 and RAC1 region 120-137. Our findings are consistent with the high levels of conservation of all of the residues involved in these interactions.	[Armstrong, Don L.; Zidovetzki, Raphael; Jacob, Chaim O.] Univ So Calif, Dept Med, Lupus Genet Grp, Los Angeles, CA 90089 USA; [Zidovetzki, Raphael] Univ Calif Riverside, Cell Biol & Neurosci, Riverside, CA 92521 USA; [Eisenstein, Miriam] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel	University of Southern California; University of California System; University of California Riverside; Weizmann Institute of Science	Jacob, CO (corresponding author), Univ So Calif, Dept Med, Lupus Genet Grp, Los Angeles, CA 90089 USA.	jacob@usc.edu		Armstrong, Don/0000-0002-4904-638X	National Institutes of health from NIGMS [P41-GM103311]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	National Institutes of health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Systemic Lupus Erythematosus Genetics Consortium (John B. Harley, Marta E Alarcon-Riquelme, Lindsey A. Criswell, Patrick M. Gaffney, Chaim O. Jacob, Robert P. Kimberly, Kathy L. M. Sivils, Betty P. Tsao, Timothy J. Vyse, and Carl D. Langefeld) for their involvement in the collection of samples and genotyping of these variants. We thank Mary C. Dinauer invaluable insights into the function of the NADPH oxidase complex. Chimera was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of health Grant P41-GM103311 from NIGMS).	Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Baye TM, 2009, BIODATA MIN, V2, DOI 10.1186/1756-0381-2-1; Ben-Shimon A, 2010, J MOL BIOL, V402, P259, DOI 10.1016/j.jmb.2010.07.021; Berchanski A, 2004, PROTEINS, V56, P130, DOI 10.1002/prot.20145; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bouaziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028845; Cale CM, 2007, CLIN EXP IMMUNOL, V148, P79, DOI 10.1111/j.1365-2249.2007.03321.x; De Ravin SS, 2008, J ALLERGY CLIN IMMUN, V122, P1097, DOI 10.1016/j.jaci.2008.07.050; Deng HW, 2001, GENETICS, V159, P1319; Dhillon SS, 2014, GASTROENTEROLOGY, V147, P680, DOI 10.1053/j.gastro.2014.06.005; Doherty E, 2014, ANTIOXID REDOX SIGN, V21, P56, DOI 10.1089/ars.2013.5702; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Honbou K, 2007, EMBO J, V26, P1176, DOI 10.1038/sj.emboj.7601561; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Hultqvist M, 2009, TRENDS IMMUNOL, V30, P201, DOI 10.1016/j.it.2009.03.004; Jacob CO, 2012, P NATL ACAD SCI USA, V109, pE59, DOI 10.1073/pnas.1113251108; Katzav S, 2009, INT J BIOCHEM CELL B, V41, P1245, DOI 10.1016/j.biocel.2008.11.006; Kim-Howard X, 2014, HUM MOL GENET, V23, P1656, DOI 10.1093/hmg/ddt532; Kowalsman N, 2009, PROTEINS, V77, P297, DOI 10.1002/prot.22436; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; Ming WY, 2007, MOL CELL BIOL, V27, P312, DOI 10.1128/MCB.00985-06; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Paclet MH, 2001, EUR J BIOCHEM, V268, P5197, DOI 10.1046/j.0014-2956.2001.02455.x; Patino PJ, 1999, BLOOD, V94, P2505, DOI 10.1182/blood.V94.7.2505.419k10_2505_2514; Perl A, 2013, NAT REV RHEUMATOL, V9, P674, DOI 10.1038/nrrheum.2013.147; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; R Core Team, 2012, R LANG ENV STAT COMP; Rapley J, 2008, EMBO REP, V9, P655, DOI 10.1038/embor.2008.80; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schappi MG, 2008, SEMIN IMMUNOPATHOL, V30, P255, DOI 10.1007/s00281-008-0119-2; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; Vyshkina T, 2008, CLIN IMMUNOL, V129, P31, DOI 10.1016/j.clim.2008.07.011; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003	43	22	22	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12595	12602		10.1074/jbc.M115.639021	http://dx.doi.org/10.1074/jbc.M115.639021			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25795782	Green Published, hybrid			2022-12-28	WOS:000354569000015
J	Korasick, DA; Chatterjee, S; Tonelli, M; Dashti, H; Lee, SG; Westfall, CS; Fulton, DB; Andreotti, AH; Amarasinghe, GK; Strader, LC; Jez, JM				Korasick, David A.; Chatterjee, Srirupa; Tonelli, Marco; Dashti, Hesam; Lee, Soon Goo; Westfall, Corey S.; Fulton, D. Bruce; Andreotti, Amy H.; Amarasinghe, Gaya K.; Strader, Lucia C.; Jez, Joseph M.			Defining a Two-pronged Structural Model for PB1 (Phox/Bem1p) Domain Interaction in Plant Auxin Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; AUX/IAA PROTEINS; MUTATIONAL ANALYSIS; NMR; BINDING; BIOSYNTHESIS; SPECTROSCOPY; SPECIFICITY; PERCEPTION; ASSIGNMENT	Phox/Bem1p (PB1) domains are universal structural modules that use surfaces of different charge for protein-protein association. In plants, PB1-mediated interactions of auxin response factors (ARF) and auxin/indole 3-acetic acid inducible proteins regulate transcriptional events modulated by the phytohormone auxin. Here we investigate the thermodynamic and structural basis for Arabidopsis thaliana ARF7 PB1 domain self-interaction. Isothermal titration calorimetry and NMR experiments indicate that key residues on both the basic and acidic faces of the PB1 domain contribute to and organize coordinately to stabilize protein-protein interactions. Calorimetric analysis of ARF7PB1 site-directed mutants defines a two-pronged electrostatic interaction. The canonical PB1 interaction between a lysine and a cluster of acidic residues provides one prong with an arginine and a second cluster of acidic residues defining the other prong. Evolutionary conservation of this core recognition feature and other co-varying interface sequences allows for versatile PB1-mediated interactions in auxin signaling.	[Korasick, David A.; Lee, Soon Goo; Westfall, Corey S.; Strader, Lucia C.; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Chatterjee, Srirupa; Amarasinghe, Gaya K.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Tonelli, Marco; Dashti, Hesam] Univ Wisconsin, Dept Biochem, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Fulton, D. Bruce; Andreotti, Amy H.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Washington University (WUSTL); Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; Iowa State University	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu	Regan, Clinton/E-6250-2012	Strader, Lucia/0000-0002-7600-7204; Korasick, David/0000-0002-6337-2085; Lee, Soon Goo/0000-0002-1541-8587	National Institutes of Health (NIGMS) [P41GM103399]; University of Wisconsin-Madison; National Institutes of Health [P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, S10RR029220]; National Science Foundation [DMB-8415048, OIA-9977486, BIR-9214394]; United States Department of Agriculture; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR008438, S10RR002781, S10RR023438, S10RR025062, S10RR029220, P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103399, R00GM089987] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Wisconsin-Madison; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work made use of the National Magnetic Resonance Facility at Madison, which is supported by National Institutes of Health Grant P41GM103399 (NIGMS; old number: P41RR002301). Equipment was purchased with funds from the University of Wisconsin-Madison, National Institutes of Health Grants P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, and S10RR029220, National Science Foundation Grants DMB-8415048, OIA-9977486, and BIR-9214394, and by the United States Department of Agriculture.	Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Christian F, 2014, BBA-MOL CELL RES, V1843, P2765, DOI 10.1016/j.bbamcr.2014.07.021; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Enders TA, 2015, AM J BOT, V102, P180, DOI 10.3732/ajb.1400285; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guilfoyle TJ, 2015, PLANT CELL, V27, P33, DOI 10.1105/tpc.114.132753; Guilfoyle TJ, 2012, PLANT SCI, V190, P82, DOI 10.1016/j.plantsci.2012.04.003; Han M, 2014, P NATL ACAD SCI USA, V111, P18613, DOI 10.1073/pnas.1419525112; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Korasick DA, 2014, P NATL ACAD SCI USA, V111, P5427, DOI 10.1073/pnas.1400074111; Korasick DA, 2013, J EXP BOT, V64, P2541, DOI 10.1093/jxb/ert080; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lavenus J, 2013, TRENDS PLANT SCI, V18, P455, DOI 10.1016/j.tplants.2013.04.006; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Nanao MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4617; Ni J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085358; Pearce KH, 1996, BIOCHEMISTRY-US, V35, P10300, DOI 10.1021/bi960513b; Piya S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00744; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Boer DR, 2014, CELL, V156, P577, DOI 10.1016/j.cell.2013.12.027; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; SUMIMOTO H, 2007, SCI STKE, pRE6, DOI DOI 10.1126/STKE.4012007RE6; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Wang RH, 2014, CURR OPIN PLANT BIOL, V21, P51, DOI 10.1016/j.pbi.2014.06.006; Wells JA, 1996, ANNU REV BIOCHEM, V65, P609, DOI 10.1146/annurev.bi.65.070196.003141; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308	39	25	28	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12868	12878		10.1074/jbc.M115.648253	http://dx.doi.org/10.1074/jbc.M115.648253			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25839233	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000354569000037
J	Carlson, SM; Moore, KE; Sankaran, SM; Reynoird, N; Elias, JE; Gozani, O				Carlson, Scott M.; Moore, Kaitlyn E.; Sankaran, Saumya M.; Reynoird, Nicolas; Elias, Joshua E.; Gozani, Or			A Proteomic Strategy Identifies Lysine Methylation of Splicing Factor snRNP70 by the SETMAR Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Histone Methylation; Mass Spectrometry (MS); Protein Methylation; Proteomics; Substrate Specificity	ENHANCES DNA-REPAIR; CHROMOSOME DECATENATION; MASS-SPECTROMETRY; CELL-CULTURE; AMINO-ACIDS; HISTONE H3; IN-VIVO; PROTEIN; METHYLTRANSFERASES; ENRICHMENT	Background: SETMAR is a lysine methyltransferase (KMT) that contributes to DNA repair, but its biochemical function is not well understood. Results: A novel proteomic strategy identifies splicing factor snRNP70 as a SETMAR substrate. Conclusion: SETMAR is the first KMT identified to target splicing factors. Significance: Proteomics can be harnessed to discover methyltransferase substrates. Lysine methylation may be a new mode of regulation for mRNA splicing. The lysine methyltransferase (KMT) SETMAR is implicated in the response to and repair of DNA damage, but its molecular function is not clear. SETMAR has been associated with dimethylation of histone H3 lysine 36 (H3K36) at sites of DNA damage. However, SETMAR does not methylate H3K36 in vitro. This and the observation that SETMAR is not active on nucleosomes suggest that H3K36 methylation is not a physiologically relevant activity. To identify potential non-histone substrates, we utilized a strategy on the basis of quantitative proteomic analysis of methylated lysine. Our approach identified lysine 130 of the mRNA splicing factor snRNP70 as a SETMAR substrate in vitro, and we show that the enzyme primarily generates monomethylation at this position. Furthermore, we show that SETMAR methylates snRNP70 Lys-130 in cells. Because snRNP70 is a key early regulator of 5 splice site selection, our results suggest a model in which methylation of snRNP70 by SETMAR regulates constitutive and/or alternative splicing. In addition, the proteomic strategy described here is broadly applicable and is a promising route for large-scale mapping of KMT substrates.	[Carlson, Scott M.; Moore, Kaitlyn E.; Sankaran, Saumya M.; Reynoird, Nicolas; Gozani, Or] Stanford Univ, Dept Biol, Sch Med, Stanford, CA 94305 USA; [Moore, Kaitlyn E.; Elias, Joshua E.] Stanford Univ, Sch Med, Dept Chem & Syst, Stanford, CA 94305 USA	Stanford University; Stanford University	Carlson, SM (corresponding author), Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA 94305 USA.	scottmc@stanford.edu	reynoird, nicolas/M-7568-2017; Reynoird, Nicolas/AAX-4043-2020	reynoird, nicolas/0000-0003-1578-2781; Reynoird, Nicolas/0000-0003-1578-2781; Gozani, Or/0000-0002-1365-4463; Carlson, Scott/0000-0003-1996-0012	National Institute of Health [R01 GM079641]; American Cancer Society Illinois Division [123711-PF-13-093-01-TBE]; National Science Foundation Graduate Research Fellowship [DGE-1147470]; Hubert Shaw and Sandra Lui Stanford Graduate Fellowship; W. M. Keck Foundation; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079641] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Illinois Division(American Cancer Society); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Hubert Shaw and Sandra Lui Stanford Graduate Fellowship; W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institute of Health Grants R01 GM079641 (to O. G.).; Supported in part by Postdoctoral Fellowship 123711-PF-13-093-01-TBE from the American Cancer Society Illinois Division. To whom correspondence may be addressed: Dept. of Biology, Stanford University, 371 Serra Mall, Stanford, CA. Tel.: 617-301-0242; E-mail: scottmc@stanford.edu.; Supported by a National Science Foundation Graduate Research Fellowship under Grant DGE-1147470 and by the Hubert Shaw and Sandra Lui Stanford Graduate Fellowship.; Supported by funds from the W. M. Keck Foundation.	Beck BD, 2008, J BIOL CHEM, V283, P9023, DOI 10.1074/jbc.M800150200; Beck BD, 2011, BIOCHEMISTRY-US, V50, P4360, DOI 10.1021/bi200333k; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bua DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006789; Cao XJ, 2013, EPIGENETICS-US, V8, P477, DOI 10.4161/epi.24547; Carlson SM, 2014, J MOL BIOL, V426, P3350, DOI 10.1016/j.jmb.2014.04.024; Carlson SM, 2014, NAT PROTOC, V9, P37, DOI 10.1038/nprot.2013.164; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Haro LP, 2010, NUCLEIC ACIDS RES, V38, P5681, DOI 10.1093/nar/gkq339; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Fuchs SM, 2011, CURR BIOL, V21, P53, DOI 10.1016/j.cub.2010.11.058; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Hromas R, 2012, ONCOGENE, V31, P4245, DOI 10.1038/onc.2011.586; Hromas R, 2008, DNA REPAIR, V7, P1927, DOI 10.1016/j.dnarep.2008.08.002; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lee SH, 2005, P NATL ACAD SCI USA, V102, P18075, DOI 10.1073/pnas.0503676102; Liu HD, 2013, MOL CELL, V50, P723, DOI 10.1016/j.molcel.2013.04.025; Moore KE, 2013, MOL CELL, V50, P444, DOI 10.1016/j.molcel.2013.03.005; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong Shao-En, 2007, Methods Mol Biol, V359, P37; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Su ZL, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-7; West LE, 2010, J BIOL CHEM, V285, P37725, DOI 10.1074/jbc.M110.139527; Williamson EA, 2008, NUCLEIC ACIDS RES, V36, P5822, DOI 10.1093/nar/gkn560; Wray J, 2009, BLOOD, V114, P1852, DOI 10.1182/blood-2008-08-175760; Wray J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005323; Wu ZX, 2015, MOL CELL PROTEOMICS, V14, P329, DOI 10.1074/mcp.M114.044255; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100	35	23	25	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12040	12047		10.1074/jbc.M115.641530	http://dx.doi.org/10.1074/jbc.M115.641530			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25795785	Green Published, hybrid			2022-12-28	WOS:000354388600019
J	Du, J; Hong, SL; Dong, L; Cheng, B; Lin, L; Zhao, B; Chen, YG; Chen, X				Du, Jun; Hong, Senlian; Dong, Lu; Cheng, Bo; Lin, Liang; Zhao, Bing; Chen, Ye-Guang; Chen, Xing			Dynamic Sialylation in Transforming Growth Factor- (TGF-)-induced Epithelial to Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; Cell Signaling; Epithelial-Mesenchymal Transition (EMT); Glycosylation; Sialic Acid; TGF-	TGF-BETA; CANCER-CELLS; ALTERED GLYCOSYLATION; PROTEIN GLYCOSYLATION; PROTEOMIC ANALYSIS; TUMOR-CELLS; SIALIC-ACID; PROGRESSION; GLYCANS; SIALYLTRANSFERASES	Background: Changes in cell surface sialylation have recently been implicated in mediating epithelial-mesenchymal transition (EMT). Results: Cell surface sialylation was first down-regulated but then reverted and up-regulated during EMT, and inhibition of sialylation promoted EMT. Conclusion: Sialylation dynamics plays an important role in regulating EMT. Significance: Sialylation may have important functions in EMT-related diseases. Epithelial-mesenchymal transition (EMT) is a fundamental process in embryonic development and organ formation. Aberrant regulation of EMT often leads to tumor progression. Changes in cell surface sialylation have recently been implicated in mediating EMT. Herein we report the visualization of dynamic changes of sialylation and glycoproteomic analysis of newly synthesized sialylated proteins in EMT by metabolic labeling of sialylated glycans with azides, followed by click labeling with fluorophores or affinity tags. We discovered that sialylation was down-regulated during EMT but then reverted and up-regulated in the mesenchymal state after EMT, accompanied by mRNA expression level changes of genes involved in the sialic acid biosynthesis. Quantitative proteomic analysis identified a list of sialylated proteins whose biosynthesis was dynamically regulated during EMT. Sialylation of cell surface adherent receptor integrin (4) was found to be down-regulated, which may regulate integrin functions during EMT. Furthermore, a global sialylation inhibitor was used to probe the functional role of sialylation during EMT. We found that inhibition of sialylation promoted EMT. Taken together, our findings suggest the important role of sialylation in regulating EMT and imply its possible function in related pathophysiological events, such as cancer metastasis.	[Du, Jun; Zhao, Bing; Chen, Ye-Guang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Hong, Senlian; Dong, Lu; Cheng, Bo; Lin, Liang; Chen, Xing] Peking Univ, Beijing Natl Lab Mol Sci, Key Lab Bioorgan Chem & Mol Engn, Minist Educ,Coll Chem & Mol Engn,Synthet & Funct, Beijing 100871, Peoples R China; [Hong, Senlian; Dong, Lu; Cheng, Bo; Lin, Liang; Chen, Xing] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Peking University; Peking University	Chen, YG (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn; xingchen@pku.edu.cn	Chen, Ye-Guang/L-6998-2019	Chen, Xing/0000-0002-3058-7370	National Basic Research Program of China (973 Program) [2012CB917303, 2013CB933700, 2011CB943803]; National Natural Science Foundation of China [21172013, 91127034, 31221064, 31330049]; Peking-Tsinghua Center for Life Sciences	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking-Tsinghua Center for Life Sciences	This work was supported by National Basic Research Program of China (973 Program) Grants 2012CB917303 (to X. C.) and 2013CB933700 and 2011CB943803 (to Y.-G. C.) and National Natural Science Foundation of China Grants 21172013 and 91127034 (to X. C.) and 31221064 and 31330049 (to Y.-G. C.).; Supported in part by a postdoctoral fellowship from the Peking-Tsinghua Center for Life Sciences.	Baritaki S, 2009, ONCOGENE, V28, P3573, DOI 10.1038/onc.2009.214; Besanceney-Webler C, 2011, ANGEW CHEM INT EDIT, V50, P8051, DOI 10.1002/anie.201101817; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; DENNIS J, 1982, NATURE, V300, P274, DOI 10.1038/300274a0; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Du J, 2009, GLYCOBIOLOGY, V19, P1382, DOI 10.1093/glycob/cwp115; Finnson KW, 2006, FASEB J, V20, P1525, DOI 10.1096/fj.05-5229fje; Freire-De-Lima L, 2011, P NATL ACAD SCI USA, V108, P17690, DOI 10.1073/pnas.1115191108; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Guan F, 2010, FASEB J, V24, P4889, DOI 10.1096/fj.10-162107; Guan F, 2009, P NATL ACAD SCI USA, V106, P7461, DOI 10.1073/pnas.0902368106; Hagiwara S, 2010, ONCOGENE, V29, P2181, DOI 10.1038/onc.2009.506; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karhemo PR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00192; Kobata A, 2005, IMMUNOL CELL BIOL, V83, P429, DOI 10.1111/j.1440-1711.2005.01351.x; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Laughlin ST, 2009, P NATL ACAD SCI USA, V106, P12, DOI 10.1073/pnas.0811481106; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Macauley MS, 2014, J BIOL CHEM, V289, P35149, DOI 10.1074/jbc.M114.606517; Maupin KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013002; Latini FRM, 2013, BLOOD CELL MOL DIS, V50, P161, DOI 10.1016/j.bcmd.2012.10.009; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Moustakas A, 2014, BBA-GEN SUBJECTS, V1840, P2621, DOI 10.1016/j.bbagen.2014.02.004; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; PAULSON JC, 1989, J BIOL CHEM, V264, P10931; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Sawa M, 2006, P NATL ACAD SCI USA, V103, P12371, DOI 10.1073/pnas.0605418103; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Smith BA, 2001, CANCER RES, V61, P1678; Taylor ME, 2007, CURR OPIN CELL BIOL, V19, P572, DOI 10.1016/j.ceb.2007.09.004; TAYLORPAPADIMITRIOU J, 1994, TRENDS BIOTECHNOL, V12, P227, DOI 10.1016/0167-7799(94)90121-X; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomiya N, 2001, ANAL BIOCHEM, V293, P129, DOI 10.1006/abio.2001.5091; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Xie R, 2014, ANGEW CHEM INT EDIT, V53, P14082, DOI 10.1002/anie.201408442; Xie R, 2012, J AM CHEM SOC, V134, P9914, DOI 10.1021/ja303853y; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zadran S, 2014, P NATL ACAD SCI USA, V111, P13235, DOI 10.1073/pnas.1414714111; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zhou Dapeng, 2011, Front Biosci (Schol Ed), V3, P1520	49	43	45	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12000	12013		10.1074/jbc.M115.636969	http://dx.doi.org/10.1074/jbc.M115.636969			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25809486	hybrid, Green Published			2022-12-28	WOS:000354388600016
J	Handali, M; Neupane, DP; Roychowdhury, H; Yukl, ET				Handali, Melody; Neupane, Durga P.; Roychowdhury, Hridindu; Yukl, Erik T.			Transcriptional Regulation, Metal Binding Properties and Structure of Pden1597, an Unusual Zinc Transport Protein from Paracoccus denitrificans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Manganese; Metal Homeostasis; Metalloprotein; Transcription Regulation; Zinc	TREPONEMA-PALLIDUM TROA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STREPTOCOCCUS-PNEUMONIAE; SALMONELLA-ENTERICA; ABC TRANSPORTER; FULL VIRULENCE; UPTAKE SYSTEM; ION-BINDING; MANGANESE	Background: Bacterial cluster 9 ATP binding cassette (ABC) transporters are responsible for import of Zn2+ and Mn2+. Results: A solute-binding protein of the cluster 9 family is shown to preferentially bind Zn2+ in an unusual coordination sphere. Conclusion: A subclass of Zn2+ transporter has been identified with distinct structural properties. Significance: Cluster 9 ABC transporters are important virulence factors. ATP-binding cassette (ABC) transporters of the cluster 9 family are ubiquitous among bacteria and essential for acquiring Zn2+ and Mn2+ from the environment or, in the case of pathogens, from the host. These rely on a substrate-binding protein (SBP) to coordinate the relevant metal with high affinity and specificity and subsequently release it to a membrane permease for translocation into the cytoplasm. Although a number of cluster 9 SBP structures have been determined, the structural attributes conferring Zn2+ or Mn2+ specificity remain ambiguous. Here we describe the gene expression profile, in vitro metal binding properties, and crystal structure of a new cluster 9 SBP from Paracoccus denitrificans we have called AztC. Although all of our results strongly indicate Zn2+ over Mn2+ specificity, the Zn2+ ion is coordinated by a conserved Asp residue only observed to date as a metal ligand in Mn2+-specific SBPs. The unusual sequence properties of this protein are shared among close homologues, including members from the human pathogens Klebsiella pneumonia and Enterobacter aerogenes, and would seem to suggest a subclass of Zn2+-specific transporters among the cluster 9 family. In any case, the unusual coordination environment of AztC expands the already considerable range of those available to Zn2+-specific SBPs and highlights the presence of a His-rich loop as the most reliable indicator of Zn2+ specificity.	[Handali, Melody; Neupane, Durga P.; Roychowdhury, Hridindu; Yukl, Erik T.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	New Mexico State University	Yukl, ET (corresponding author), 1175 N Horseshoe Dr, Las Cruces, NM 88003 USA.	etyukl@nmsu.edu		Yukl, Erik/0000-0001-6519-6938	National Institutes of Health, NIGMS; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences of the United States Dept. of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM111170] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences of the United States Dept. of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We recognize Tanner Schaub at the Center for Animal Health, Food Safety and Bio-Security, New Mexico State University, for assistance with mass spectrometry and Tanis Hogg at Texas Tech University Health Sciences Center, El Paso, TX, for assistance in screening crystals. We further acknowledge the staff at the Berkeley Center for Structural Biology at Lawrence Berkeley National Laboratory for assistance at the beam line. Finally, we thank Dr. Carrie Wilmot, University of Minnesota, and Dr. Victor Davidson for critical reading of our manuscript. Final x-ray diffraction data was collected at the Berkeley Center for Structural Biology, which is supported in part by the National Institutes of Health, NIGMS, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Dept. of Energy under Contract DE-AC02-05CH11231.	Abate F, 2014, BIOSCIENCE REP, V34, P743, DOI 10.1042/BSR20140088; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Ammendola S, 2007, INFECT IMMUN, V75, P5867, DOI 10.1128/IAI.00559-07; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Banerjee S, 2003, J MOL BIOL, V333, P1061, DOI 10.1016/j.jmb.2003.09.008; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bearden SW, 1999, MOL MICROBIOL, V32, P403, DOI 10.1046/j.1365-2958.1999.01360.x; Burmeister WP, 2000, ACTA CRYSTALLOGR D, V56, P328, DOI 10.1107/S0907444999016261; Chandra BR, 2007, J MOL BIOL, V367, P970, DOI 10.1016/j.jmb.2007.01.041; Claverys JP, 2001, RES MICROBIOL, V152, P231, DOI 10.1016/S0923-2508(01)01195-0; CLOHESSY PA, 1995, SCAND J IMMUNOL, V42, P551, DOI 10.1111/j.1365-3083.1995.tb03695.x; Counago RM, 2014, NAT CHEM BIOL, V10, P35, DOI [10.1038/NCHEMBIO.1382, 10.1038/nchembio.1382]; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; de Seny D, 2001, J BIOL CHEM, V276, P45065, DOI 10.1074/jbc.M106447200; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Dintilhac A, 1997, RES MICROBIOL, V148, P119, DOI 10.1016/S0923-2508(97)87643-7; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Dow BA, 2015, PROTEIN EXPRES PURIF, V108, P9, DOI 10.1016/j.pep.2014.12.017; Dutta SJ, 2006, BIOCHEMISTRY-US, V45, P5923, DOI 10.1021/bi0523456; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gat O, 2005, MOL MICROBIOL, V58, P533, DOI 10.1111/j.1365-2958.2005.04848.x; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; Graham AI, 2009, J BIOL CHEM, V284, P18377, DOI 10.1074/jbc.M109.001503; Gribenko A, 2013, J MOL BIOL, V425, P3429, DOI 10.1016/j.jmb.2013.06.033; Ilari A, 2011, J MOL BIOL, V409, P630, DOI 10.1016/j.jmb.2011.04.036; Kanteev M, 2013, ACTA CRYSTALLOGR F, V69, P237, DOI 10.1107/S174430911300153X; Kehl-Fie TE, 2013, INFECT IMMUN, V81, P3395, DOI 10.1128/IAI.00420-13; Klein JS, 2011, METALLOMICS, V3, P1098, DOI 10.1039/c1mt00073j; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Lee YH, 2002, J BACTERIOL, V184, P2300, DOI 10.1128/JB.184.8.2300-2304.2002; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; Li H, 2007, J MOL BIOL, V368, P1358, DOI 10.1016/j.jmb.2007.02.107; Liu JB, 2006, BIOCHEMISTRY-US, V45, P763, DOI 10.1021/bi051836n; Liu JB, 2005, BIOCHEMISTRY-US, V44, P5159, DOI 10.1021/bi0476275; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Porcheron G, 2013, FRONT CELL INFECT MI, V3, P90, DOI [DOI 10.3389/FCIMB.2013.00090, 10.3389/fcimb.2013.00090]; Rukhman V, 2005, J MOL BIOL, V348, P961, DOI 10.1016/j.jmb.2005.03.006; Schreur PJW, 2011, J BACTERIOL, V193, P5073, DOI 10.1128/JB.05305-11; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shin JH, 2007, J BACTERIOL, V189, P4070, DOI 10.1128/JB.01851-06; Sullivan MJ, 2013, P NATL ACAD SCI USA, V110, P19926, DOI 10.1073/pnas.1314529110; Sun XS, 2009, BIOCHEMISTRY-US, V48, P6184, DOI 10.1021/bi900552c; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Wang YT, 2003, BIOCHEMISTRY-US, V42, P7318, DOI 10.1021/bi034243q; Wei BX, 2007, BIOCHEMISTRY-US, V46, P8734, DOI 10.1021/bi700763w; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0; Zheng BW, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019510, 10.1371/journal.pone.0019976]	57	16	16	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11878	11889		10.1074/jbc.M115.645853	http://dx.doi.org/10.1074/jbc.M115.645853			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25787075	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000354388600007
J	Russwurm, C; Koesling, D; Russwurm, M				Russwurm, Corina; Koesling, Doris; Russwurm, Michael			Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						A-kinase Anchoring Protein (AKAP); Cell Signaling; Cyclic AMP (cAMP); Phosphodiesterases; Protein Complex; Protein Kinase A (PKA)	DEPENDENT PROTEIN-KINASE; CAMP-SPECIFIC PHOSPHODIESTERASE; NUCLEOTIDE PHOSPHODIESTERASE; ENRICHED PHOSPHODIESTERASE; SUBCELLULAR-LOCALIZATION; PDE10A; PHOSPHORYLATION; ACTIVATION; CGMP; CALCINEURIN	Background: In striatum, cortical glutamatergic and midbrain dopaminergic inputs are integrated via cAMP. Results: PDE10A, the major cAMP-hydrolyzing enzyme in striatum, is targeted into a signaling complex containing the scaffolding proteins AKAP150, PSD95, and the NMDA receptor and released upon phosphorylation. Conclusion: Targeting of PDE10 is under control of cAMP/PKA activity. Significance: Phosphorylation-dependent release of PDE10 gives rise to a feed forward mechanism. Phosphodiesterase 10A (PDE10A) is a dual substrate PDE that can hydrolyze both cGMP and cAMP. In brain, PDE10A is almost exclusively expressed in the striatum. In several studies, PDE10A has been implicated in regulation of striatal output using either specific inhibitors or PDE10A knock-out mice and has been suggested as a promising target for novel antipsychotic drugs. In striatal medium spiny neurons, PDE10A is localized at the plasma membrane and in dendritic spines close to postsynaptic densities. In the present study, we identify PDE10A as the major cAMP PDE in mouse striatum and monitor PKA-dependent PDE10A phosphorylation. With recombinantly expressed PDE10A we demonstrate that phosphorylation does not alter PDE10A activity. In striatum, PDE10A was found to be associated with the A kinase anchoring protein AKAP150 suggesting the existence of a multiprotein signaling complex localizing PDE10A to a specific functional context at synaptic membranes. Furthermore, the cAMP effector PKA, the NMDA receptor subunits NR2A and -B, as well as PSD95, were tethered to the complex. In agreement, PDE10A was almost exclusively found in multiprotein complexes as indicated by migration in high molecular weight fractions in size exclusion chromatography. Finally, affinity of PDE10A to the signaling complexes formed around AKAP150 was reduced by PDE10A phosphorylation. The data indicate that phosphorylation of PDE10 has an impact on the interaction with other signaling proteins and adds an additional line of complexity to the role of PDE10 in regulation of synaptic transmission.	[Russwurm, Corina; Koesling, Doris; Russwurm, Michael] Ruhr Univ Bochum, Fak Med, Inst Pharmakol & Toxikol, D-44780 Bochum, Germany	Ruhr University Bochum	Russwurm, M (corresponding author), Ruhr Univ Bochum, Fak Med, Inst Pharmakol & Toxikol, D-44780 Bochum, Germany.	michael.russwurm@ruhr-uni-bochum.de			Deutsche Forschungsgemeinschaft [KO 1157/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant KO 1157/4-1.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P9876, DOI 10.1073/pnas.0703589104; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Charych EI, 2010, J NEUROSCI, V30, P9027, DOI 10.1523/JNEUROSCI.1635-10.2010; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fujishige K, 1999, EUR J BIOCHEM, V266, P1118, DOI 10.1046/j.1432-1327.1999.00963.x; Fujishige K, 2000, EUR J BIOCHEM, V267, P5943, DOI 10.1046/j.1432-1327.2000.01661.x; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; GRANT PG, 1988, P NATL ACAD SCI USA, V85, P9071, DOI 10.1073/pnas.85.23.9071; Gross-Langenhoff M, 2006, J BIOL CHEM, V281, P2841, DOI 10.1074/jbc.M511468200; Han P, 1997, J BIOL CHEM, V272, P16152, DOI 10.1074/jbc.272.26.16152; Hebb ALO, 2008, EUR NEUROPSYCHOPHARM, V18, P339, DOI 10.1016/j.euroneuro.2007.08.002; Jager R, 2012, J BIOL CHEM, V287, P1210, DOI 10.1074/jbc.M111.263806; Jager R, 2010, BRIT J PHARMACOL, V161, P1645, DOI 10.1111/j.1476-5381.2010.00977.x; Kapur S, 2004, TRENDS PHARMACOL SCI, V25, P402, DOI 10.1016/j.tips.2004.06.005; Kotera J, 2004, J BIOL CHEM, V279, P4366, DOI 10.1074/jbc.M308471200; Kotera J, 1999, BIOCHEM BIOPH RES CO, V261, P551, DOI 10.1006/bbrc.1999.1013; Li HM, 2012, NAT STRUCT MOL BIOL, V19, P337, DOI 10.1038/nsmb.2238; Lin DTS, 2010, SYNAPSE, V64, P460, DOI 10.1002/syn.20750; Liu HG, 1999, J BIOL CHEM, V274, P10557, DOI 10.1074/jbc.274.15.10557; Loughney K, 1999, GENE, V234, P109, DOI 10.1016/S0378-1119(99)00171-7; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Nishi A, 1999, J NEUROCHEM, V72, P2015, DOI 10.1046/j.1471-4159.1999.0722015.x; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; Nishi A, 2010, J PHARMACOL SCI, V114, P6, DOI 10.1254/jphs.10R01FM; O'Connor V, 2004, J BIOL CHEM, V279, P15841, DOI 10.1074/jbc.M312500200; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Ostroveanu A, 2007, BRAIN RES, V1145, P97, DOI 10.1016/j.brainres.2007.01.117; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Russwurm C, 2009, J BIOL CHEM, V284, P25782, DOI 10.1074/jbc.M109.017194; Russwurm M, 2001, J BIOL CHEM, V276, P44647, DOI 10.1074/jbc.M105587200; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Sano H, 2008, J NEUROCHEM, V105, P546, DOI 10.1111/j.1471-4159.2007.05152.x; Schmidt CJ, 2008, J PHARMACOL EXP THER, V325, P681, DOI 10.1124/jpet.107.132910; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; SETTE C, 1994, J BIOL CHEM, V269, P9245; SHARMA RK, 1985, P NATL ACAD SCI USA, V82, P2603, DOI 10.1073/pnas.82.9.2603; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P386, DOI 10.1016/j.neuropharm.2006.04.013; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P374, DOI 10.1016/j.neuropharm.2006.01.012; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Wyatt TA, 1998, AM J PHYSIOL-HEART C, V274, pH448, DOI 10.1152/ajpheart.1998.274.2.H448; Xie Z, 2006, NEUROSCIENCE, V139, P597, DOI 10.1016/j.neuroscience.2005.12.042; Yuasa K, 2000, J BIOL CHEM, V275, P31469, DOI 10.1074/jbc.M003041200	54	28	28	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11936	11947		10.1074/jbc.M114.595769	http://dx.doi.org/10.1074/jbc.M114.595769			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25762721	Green Published, hybrid			2022-12-28	WOS:000354388600012
J	Feldmann, EA; De Bona, P; Galletto, R				Feldmann, Erik A.; De Bona, Paolo; Galletto, Roberto			The Wrapping Loop and Rap1 C-terminal (RCT) Domain of Yeast Rap1 Modulate Access to Different DNA Binding Modes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPRESSOR ACTIVATOR PROTEIN-1; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; TELOMERE STRUCTURE; LAMM EQUATION; FACTOR TUF; SEQUENCES; INTERACTS; SILENCER; COMPLEX	Budding yeast Rap1 is a specific double-stranded DNA-binding protein involved in repression and activation of gene transcription and in the establishment of the nucleoprotein complex formed at telomeres. The DNA-binding domain (DBD) of Rap1 forms a high affinity complex with DNA where both Myb-like domains bind to the recognition site. However, we recently showed that the DBD can also access an alternative, lower affinity DNA-binding mode where a single Myb-like domain binds. This results in Rap1-DNA complexes with stoichiometry higher than previously anticipated. In this work, we show that the ability of the DBD to form higher stoichiometry complexes on DNA is maintained also in larger Rap1 constructs. This indicates that transition between at least two DNA-binding modes is a general property of the protein and not a specific feature of the DBD in isolation. The transition between binding modes is modulated by the C-terminal wrapping loop within the DBD, consistent with the proposed model in which the transient opening of this region allows a switch between binding modes. Finally, we provide evidence that the Rap1 C terminus interacts with the DNA-binding domain, suggesting a complex network of interactions that couples changes in conformation of the protein to the binding of its DNA recognition sequence.	[Feldmann, Erik A.; De Bona, Paolo; Galletto, Roberto] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Galletto, R (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 S Euclid Ave,Box 8231, St Louis, MO 63110 USA.	galletto@biochem.wustl.edu	Regan, Clinton/E-6250-2012	Galletto, Roberto/0000-0001-6435-122X	National Institutes of Health [GM098509]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM098509 (to R. G.).	Balbo Andrea, 2007, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1808s79; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Feldmann EA, 2014, BIOCHEMISTRY-US, V53, P7471, DOI 10.1021/bi501049b; FREEMAN K, 1995, GENETICS, V141, P1253; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRAHAM IR, 1994, NUCLEIC ACIDS RES, V22, P124, DOI 10.1093/nar/22.2.124; HARDY CFJ, 1992, MOL CELL BIOL, V12, P1209, DOI 10.1128/MCB.12.3.1209; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; KURTZ S, 1991, GENE DEV, V5, P616, DOI 10.1101/gad.5.4.616; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lopez MC, 1998, P NATL ACAD SCI USA, V95, P14112, DOI 10.1073/pnas.95.24.14112; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; Matot B, 2012, NUCLEIC ACIDS RES, V40, P3197, DOI 10.1093/nar/gkr1166; Mizuno T, 2004, YEAST, V21, P851, DOI 10.1002/yea.1123; Moretti P, 2001, MOL CELL BIOL, V21, P8082, DOI 10.1128/MCB.21.23.8082-8094.2001; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; MULLER T, 1994, J STRUCT BIOL, V113, P1, DOI 10.1006/jsbi.1994.1027; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PALLADINO F, 1993, CELL, V75, P543, DOI 10.1016/0092-8674(93)90388-7; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Taylor HOB, 2000, J MOL BIOL, V303, P693, DOI 10.1006/jmbi.2000.4161; VIGNAIS ML, 1990, J BIOL CHEM, V265, P14669; VIGNAIS ML, 1989, J BIOL CHEM, V264, P8463; Wahlin J, 2000, NUCLEIC ACIDS RES, V28, P2292, DOI 10.1093/nar/28.12.2292; WANG SS, 1990, MOL CELL BIOL, V10, P4415, DOI 10.1128/MCB.10.8.4415; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; WRIGHT JH, 1995, NUCLEIC ACIDS RES, V23, P1454, DOI 10.1093/nar/23.9.1454	38	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11455	11466		10.1074/jbc.M115.637678	http://dx.doi.org/10.1074/jbc.M115.637678			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25805496	hybrid, Green Published			2022-12-28	WOS:000353719400022
J	Oligschlaeger, Y; Miglianico, M; Chanda, D; Scholz, R; Thali, RF; Tuerk, R; Stapleton, DI; Gooley, PR; Neumann, D				Oligschlaeger, Yvonne; Miglianico, Marie; Chanda, Dipanjan; Scholz, Roland; Thali, Ramon F.; Tuerk, Roland; Stapleton, David I.; Gooley, Paul R.; Neumann, Dietbert			The Recruitment of AMP-activated Protein Kinase to Glycogen Is Regulated by Autophosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; CARBOHYDRATE-BINDING; POSTTRANSLATIONAL MODIFICATIONS; SUBCELLULAR-LOCALIZATION; GLUCOSE-UPTAKE; SUBUNIT; PHOSPHORYLATION; SYNTHASE; DOMAIN; SITE	The mammalian AMP-activated protein kinase (AMPK) is an obligatory alpha beta gamma heterotrimeric complex carrying a carbohydrate-binding module (CBM) in the beta-subunit (AMPK beta) capable of attaching AMPK to glycogen. Nonetheless, AMPK localizes at many different cellular compartments, implying the existence of mechanisms that prevent AMPK from glycogen binding. Cell-free carbohydrate binding assays revealed that AMPK autophosphorylation abolished its carbohydrate-binding capacity. X-ray structural data of the CBM displays the central positioning of threonine 148 within the binding pocket. Substitution of Thr-148 for a phospho-mimicking aspartate (T148D) prevents AMPK from binding to carbohydrate. Overexpression of isolated CBM or beta 1-containing AMPK in cellular models revealed that wild type( WT) localizes to glycogen particles, whereas T148D shows a diffuse pattern. Pharmacological AMPK activation and glycogen degradation by glucose deprivation but not forskolin enhanced cellular Thr-148 phosphorylation. Cellular glycogen content was higher if pharmacological AMPK activation was combined with overexpression of T148D mutant relative to WT AMPK. In summary, these data show that glycogen-binding capacity of AMPK beta is regulated by Thr-148 autophosphorylation with likely implications in the regulation of glycogen turnover. The findings further raise the possibility of regulated carbohydrate-binding function in a wider variety of CBM-containing proteins.	[Oligschlaeger, Yvonne; Miglianico, Marie; Chanda, Dipanjan; Neumann, Dietbert] Maastricht Univ, CARIM Sch Cardiovasc Dis, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Scholz, Roland; Thali, Ramon F.; Tuerk, Roland; Neumann, Dietbert] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Stapleton, David I.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Gooley, Paul R.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	Maastricht University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Neumann, D (corresponding author), Maastricht Univ, CARIM Sch Cardiovasc Dis, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands.	d.neumann@maastrichtuniversity.nl	Scholz, Roland W./AAH-8385-2020; Chanda, Dipanjan/AAU-3996-2021	Scholz, Roland W./0000-0003-2506-3254; Chanda, Dipanjan/0000-0003-0685-187X; Neumann, Dietbert/0000-0002-4316-684X; Gooley, Paul/0000-0002-0323-449X	Netherlands Organization for Scientific Research (NWO) [864.10.007]; Swiss National Science Foundation [3100A-0114137]; EU [LSHM-CT-2004-005272]; Marie Curie fellowship [PIIF-GA-2012-332230];  [ETHIIRA 36/05-3];  [32/05-3]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); Marie Curie fellowship(European Commission); ; 	Research in the laboratory of D. N. was supported by the Netherlands Organization for Scientific Research (NWO) (VIDI Grant 864.10.007). This work was also supported by Swiss National Science Foundation Grant 3100A-0114137, EU FP6 Contract LSHM-CT-2004-005272 (EXGENESIS), and Graduate Training Fellowships ETHIIRA 36/05-3 and 32/05-3 (for R. S. and R. F. T.).; Recipient of a Marie Curie fellowship (Grant PIIF-GA-2012-332230).	Abu-Elheiga L, 2000, P NATL ACAD SCI USA, V97, P1444, DOI 10.1073/pnas.97.4.1444; Avila-Castaneda A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00199; Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Bieri M, 2012, BIOPHYS J, V102, P305, DOI 10.1016/j.bpj.2011.12.012; Bouskila M, 2008, AM J PHYSIOL-ENDOC M, V294, pE28, DOI 10.1152/ajpendo.00481.2007; Bullen JW, 2014, J BIOL CHEM, V289, P10592, DOI 10.1074/jbc.M113.523068; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARLING D, 1989, BIOCHIM BIOPHYS ACTA, V1012, P81, DOI 10.1016/0167-4889(89)90014-1; Chen ZP, 1999, FEBS LETT, V460, P343, DOI 10.1016/S0014-5793(99)01371-X; Diaz A, 2011, J BIOL CHEM, V286, P18505, DOI 10.1074/jbc.M111.236109; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Han GH, 2010, ELECTROPHORESIS, V31, P1080, DOI 10.1002/elps.200900493; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hashimoto YK, 2008, J CELL BIOCHEM, V104, P1724, DOI 10.1002/jcb.21737; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Hegarty BD, 2009, ACTA PHYSIOL, V196, P129, DOI 10.1111/j.1748-1716.2009.01968.x; HIRAGA A, 1986, EUR J BIOCHEM, V161, P763, DOI 10.1111/j.1432-1033.1986.tb10505.x; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Hunter RW, 2011, DIABETES, V60, P766, DOI 10.2337/db10-1148; Janecek S, 2011, ENZYME MICROB TECH, V49, P429, DOI 10.1016/j.enzmictec.2011.07.002; Jensen J, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00112; Jorgensen SB, 2004, DIABETES, V53, P3074, DOI 10.2337/diabetes.53.12.3074; Kazgan N, 2010, MOL BIOL CELL, V21, P3433, DOI 10.1091/mbc.E10-04-0347; Kim N, 2014, CELL SIGNAL, V26, P1800, DOI 10.1016/j.cellsig.2014.03.023; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Koay A, 2010, FEBS LETT, V584, P3499, DOI 10.1016/j.febslet.2010.07.015; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Li XD, 2015, CELL RES, V25, P50, DOI 10.1038/cr.2014.150; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; MACKINTOSH C, 1988, FEBS LETT, V234, P189, DOI 10.1016/0014-5793(88)81331-0; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; McMahon RJ, 1996, AM J PHYSIOL-ENDOC M, V270, pE640, DOI 10.1152/ajpendo.1996.270.4.E640; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mitchelhill KI, 1997, J BIOL CHEM, V272, P24475, DOI 10.1074/jbc.272.39.24475; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Neumann D, 2007, MOL BIOTECHNOL, V36, P220, DOI 10.1007/s12033-007-0029-x; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Prats C, 2011, EXP PHYSIOL, V96, P385, DOI 10.1113/expphysiol.2010.052860; Riek U, 2008, J BIOL CHEM, V283, P18331, DOI 10.1074/jbc.M708379200; Roma-Mateo C, 2011, BIOCHEM J, V439, P265, DOI 10.1042/BJ20110150; Sakoda H, 2005, AM J PHYSIOL-ENDOC M, V289, pE474, DOI 10.1152/ajpendo.00003.2005; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Scholz R, 2009, J BIOL CHEM, V284, P27425, DOI 10.1074/jbc.M109.047670; Scott JW, 2014, CHEM BIOL, V21, P619, DOI 10.1016/j.chembiol.2014.03.006; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Singh PK, 2012, MOL CELL BIOL, V32, P652, DOI 10.1128/MCB.06353-11; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tuerk RD, 2009, ANAL BIOCHEM, V390, P141, DOI 10.1016/j.ab.2009.04.015; Vernia S, 2009, J BIOL CHEM, V284, P8247, DOI 10.1074/jbc.M808492200; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Wiatrowski HA, 2004, MOL CELL BIOL, V24, P352, DOI 10.1128/MCB.24.1.352-361.2004; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200	59	35	36	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11715	11728		10.1074/jbc.M114.633271	http://dx.doi.org/10.1074/jbc.M114.633271			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792737	Green Published, hybrid			2022-12-28	WOS:000353719400044
J	Lajoie, DM; Roberts, SA; Zobel-Thropp, PA; Delahaye, JL; Bandarian, V; Binford, GJ; Cordes, MHJ				Lajoie, Daniel M.; Roberts, Sue A.; Zobel-Thropp, Pamela A.; Delahaye, Jared L.; Bandarian, Vahe; Binford, Greta J.; Cordes, Matthew H. J.			Variable Substrate Preference among Phospholipase D Toxins from Sicariid Spiders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOXOSCELES-INTERMEDIA VENOM; BROWN RECLUSE SPIDER; DERMONECROTIC TOXIN; SPHINGOMYELINASE-D; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; MEMBRANE PHOSPHOLIPIDS; CATALYTIC MECHANISM; EVOLUTIONARY RELATIONSHIP; PHOSPHODIESTERASE GDPD	Venoms of the sicariid spiders contain phospholipase D enzyme toxins that can cause severe dermonecrosis and even death in humans. These enzymes convert sphingolipid and lysolipid substrates to cyclic phosphates by activating a hydroxyl nucleophile present in both classes of lipid. The most medically relevant substrates are thought to be sphingomyelin and/or lysophosphatidylcholine. To better understand the substrate preference of these toxins, we used P-31 NMR to compare the activity of three related but phylogenetically diverse sicariid toxins against a diverse panel of sphingolipid and lysolipid substrates. Two of the three showed significantly faster turnover of sphingolipids over lysolipids, and all three showed a strong preference for positively charged (choline and/or ethanolamine) over neutral (glycerol and serine) headgroups. Strikingly, however, the enzymes vary widely in their preference for choline, the headgroup of both sphingomyelin and lysophosphatidylcholine, versus ethanolamine. An enzyme from Sicarius terrosus showed a strong preference for ethanolamine overcholine, whereas two paralogous enzymes from Loxosceles arizonica either preferred choline or showed no significant preference. Intrigued by the novel substrate preference of the Sicarius enzyme, we solved its crystal structure at 2.1 angstrom resolution. The evolution of variable substrate specificity may help explain the reduced dermonecrotic potential of some natural toxin variants, because mammalian sphingolipids use primarily choline as a positively charged headgroup; it may also be relevant for sicariid predatory behavior, because ethanolamine-containing sphingolipids are common in insect prey.	[Lajoie, Daniel M.; Roberts, Sue A.; Bandarian, Vahe; Cordes, Matthew H. J.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA; [Zobel-Thropp, Pamela A.; Delahaye, Jared L.; Binford, Greta J.] Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA	University of Arizona	Cordes, MHJ (corresponding author), Univ Arizona, Dept Chem & Biochem, 1041 E Lowell St,Biosci West 436, Tucson, AZ 85721 USA.	cordes@email.arizona.edu			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health from NIGMS [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM072623, R15GM097676] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Stanford Synchrotron Radiation Light-source SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health Grant P41GM103393 from NIGMS.	Alarcon-Chaidez FJ, 2009, PARASITE IMMUNOL, V31, P210, DOI 10.1111/j.1365-3024.2009.01095.x; Appel MH, 2008, BBA-GEN SUBJECTS, V1780, P167, DOI 10.1016/j.bbagen.2007.11.007; BANERJEE P, 1995, CHEM PHYS LIPIDS, V77, P65, DOI 10.1016/0009-3084(95)02455-R; Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; Bey TA, 1997, ANN EMERG MED, V30, P701, DOI 10.1016/S0196-0644(97)70092-1; Binford GJ, 2009, MOL BIOL EVOL, V26, P547, DOI 10.1093/molbev/msn274; BRIDGES RG, 1973, COMP BIOCHEM PHYSIOL, V44, P191, DOI 10.1016/0305-0491(73)90356-8; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Catalan A, 2011, J BIOCHEM MOL TOXIC, V25, P393, DOI 10.1002/jbt.20399; Catalan A, 2014, TOXICON, V81, P43, DOI 10.1016/j.toxicon.2014.01.011; Chaim OM, 2011, BBA-MOL CELL BIOL L, V1811, P84, DOI 10.1016/j.bbalip.2010.11.005; Chaim OM, 2006, TOXICOL APPL PHARM, V211, P64, DOI 10.1016/j.taap.2005.05.015; Chaves-Moreira D, 2011, J CELL BIOCHEM, V112, P2529, DOI 10.1002/jcb.23177; Cordes MHJ, 2006, BIOINFORMATICS, V22, P264, DOI 10.1093/bioinformatics/bti811; da Silva PH, 2004, TOXICON, V44, P693, DOI 10.1016/j.toxicon.2004.07.012; da Silveira RB, 2007, BIOCHIMIE, V89, P289, DOI 10.1016/j.biochi.2006.12.002; da Silveira RB, 2006, BIOCHIMIE, V88, P1241, DOI 10.1016/j.biochi.2006.02.008; de Andrade SA, 2006, TOXICON, V47, P380, DOI 10.1016/j.toxicon.2005.12.005; de Giuseppe PO, 2011, BIOCHEM BIOPH RES CO, V409, P622, DOI 10.1016/j.bbrc.2011.05.053; Ferrara GID, 2009, TOXICON, V53, P743, DOI 10.1016/j.toxicon.2009.02.013; ELSAYED MY, 1985, BIOCHIM BIOPHYS ACTA, V831, P133, DOI 10.1016/0167-4838(85)90160-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FORRESTER LJ, 1978, ARCH BIOCHEM BIOPHYS, V187, P355, DOI 10.1016/0003-9861(78)90046-2; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Ghosh A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003980; Gremski LH, 2014, TOXICON, V83, P91, DOI 10.1016/j.toxicon.2014.02.023; HENDERSON TO, 1974, BIOCHEMISTRY-US, V13, P623, DOI 10.1021/bi00700a034; Hogan CJ, 2004, ANN EMERG MED, V44, P608, DOI 10.1016/j.annemergmed.2004.08.028; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jain MK, 2006, CURR OPIN CHEM BIOL, V10, P473, DOI 10.1016/j.cbpa.2006.08.015; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; Kurpiewski G, 1981, Int J Tissue React, V3, P39; Kusma J, 2008, BIOCHIMIE, V90, P1722, DOI 10.1016/j.biochi.2008.07.011; Lajoie DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072372; Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043; Lopes PH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002394; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Magalhaes GS, 2013, BIOCHIMIE, V95, P1773, DOI 10.1016/j.biochi.2013.06.002; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Wille ACM, 2013, TOXICON, V67, P17, DOI 10.1016/j.toxicon.2013.01.027; Matsuo Y, 1996, PROTEIN SCI, V5, P2459, DOI 10.1002/pro.5560051208; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Murakami MT, 2006, BIOCHEM BIOPH RES CO, V342, P323, DOI 10.1016/j.bbrc.2006.01.123; Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NEWLANDS G, 1988, S AFR MED J, V73, P235; Olvera A, 2006, TOXICON, V48, P64, DOI 10.1016/j.toxicon.2006.04.010; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2005, ACTA CRYSTALLOGR D, V61, P465, DOI 10.1107/S0907444905001897; Pedrosa MD, 2002, BIOCHEM BIOPH RES CO, V298, P638, DOI 10.1016/S0006-291X(02)02521-4; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramos-Cerrillo B, 2004, TOXICON, V44, P507, DOI 10.1016/j.toxicon.2004.06.013; Ribeiro ROS, 2007, TOXICON, V50, P1162, DOI 10.1016/j.toxicon.2007.08.001; Richardson-Boedler C., 1999, BR HOMEOPATH J, V88, P24; Rivero Elena Riet Correa, 2006, Ann Diagn Pathol, V10, P36, DOI 10.1016/j.anndiagpath.2005.04.006; ROBERTS MF, 1991, METHOD ENZYMOL, V197, P31; RUSSELL FE, 1969, TOXICON, V7, P109, DOI 10.1016/0041-0101(69)90073-7; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Shi L, 2008, PROTEINS, V72, P280, DOI 10.1002/prot.21921; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Swanson DL, 2006, CLIN DERMATOL, V24, P213, DOI 10.1016/j.clindermatol.2005.11.006; Tambourgi DV, 2010, TOXICON, V56, P1113, DOI 10.1016/j.toxicon.2010.01.021; Tambourgi DV, 1998, BIOCHEM BIOPH RES CO, V251, P366, DOI 10.1006/bbrc.1998.9474; Tambourgi DV, 2004, MOL IMMUNOL, V41, P831, DOI 10.1016/j.molimm.2004.03.027; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ullah A, 2011, ACTA CRYSTALLOGR F, V67, P234, DOI 10.1107/S1744309110050931; Vacaru AM, 2013, J BIOL CHEM, V288, P11520, DOI 10.1074/jbc.M113.460972; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200; VanAswegen G, 1997, TOXICON, V35, P1149, DOI 10.1016/S0041-0101(96)00203-6; VERHEIJ HM, 1981, REV PHYSIOL BIOCH P, V91, P91; Vuitika L, 2013, J CELL BIOCHEM, V114, P2479, DOI 10.1002/jcb.24594; Wilkins MR, 1999, METH MOL B, V112, P531; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zobel-Thropp PA, 2012, TOXICON, V60, P265, DOI 10.1016/j.toxicon.2012.04.350	79	23	25	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10994	11007		10.1074/jbc.M115.636951	http://dx.doi.org/10.1074/jbc.M115.636951			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25752604	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000353404500036
J	Pery, E; Sheehy, A; Nebane, NM; Brazier, AJ; Misra, V; Rajendran, KS; Buhrlage, SJ; Mankowski, MK; Rasmussen, L; White, EL; Ptak, RG; Gabuzda, D				Pery, Erez; Sheehy, Ann; Nebane, N. Miranda; Brazier, Andrew Jay; Misra, Vikas; Rajendran, Kottampatty S.; Buhrlage, Sara J.; Mankowski, Marie K.; Rasmussen, Lynn; White, E. Lucile; Ptak, Roger G.; Gabuzda, Dana			Identification of a Novel HIV-1 Inhibitor Targeting Vif-dependent Degradation of Human APOBEC3G Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antiviral Agent; Cytidine Deaminase; High Throughput Screening (HTS); Human Immunodeficiency Virus (HIV); Viral Protein; Virology	IMMUNODEFICIENCY-VIRUS TYPE-1; VIRION INFECTIVITY FACTOR; E3 UBIQUITIN LIGASE; SMALL-MOLECULE INHIBITION; AMINO-ACID-RESIDUES; CD4(+) T-CELLS; CYTIDINE DEAMINATION; ANTIVIRAL ACTIVITY; SOCS-BOX; CBF-BETA	Background: The interaction between HIV Vif protein and innate antiviral factor APOBEC3G represents a potential therapeutic target. Results: Screening for inhibitors of Vif-APOBEC3G interaction identified a small molecule, N.41, that protects APOBEC3G from Vif-mediated degradation and exhibits antiviral activity. Conclusion: N.41 is a lead for further development as an antiviral. Significance: These findings suggest new strategies for developing anti-HIV therapeutics. APOBEC3G (A3G) is a cellular cytidine deaminase that restricts HIV-1 replication by inducing G-to-A hypermutation in viral DNA and by deamination-independent mechanisms. HIV-1 Vif binds to A3G, resulting in its degradation via the 26 S proteasome. Therefore, this interaction represents a potential therapeutic target. To identify compounds that inhibit interaction between A3G and HIV-1 Vif in a high throughput format, we developed a homogeneous time-resolved fluorescence resonance energy transfer assay. A 307,520 compound library from the NIH Molecular Libraries Small Molecule Repository was screened. Secondary screens to evaluate dose-response performance and off-target effects, cell-based assays to identify compounds that attenuate Vif-dependent degradation of A3G, and assays testing antiviral activity in peripheral blood mononuclear cells and T cells were employed. One compound, N.41, showed potent antiviral activity in A3G(+) but not in A3G(-) T cells and had an IC50 as low as 8.4 m and a TC50 of >100 m when tested against HIV-1(Ba-L) replication in peripheral blood mononuclear cells. N.41 inhibited the Vif-A3G interaction and increased cellular A3G levels and incorporation of A3G into virions, thereby attenuating virus infectivity in a Vif-dependent manner. N.41 activity was also species- and Vif-dependent. Preliminary structure-activity relationship studies suggest that a hydroxyl moiety located at a phenylamino group is critical for N.41 anti-HIV activity and identified N.41 analogs with better potency (IC50 as low as 4.2 m). These findings identify a new lead compound that attenuates HIV replication by liberating A3G from Vif regulation and increasing its innate antiviral activity.	[Pery, Erez; Brazier, Andrew Jay; Misra, Vikas; Rajendran, Kottampatty S.; Gabuzda, Dana] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Buhrlage, Sara J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Pery, Erez; Rajendran, Kottampatty S.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Gabuzda, Dana] Harvard Univ, Sch Med, Dept Neurol Microbiol, Boston, MA 02115 USA; [Sheehy, Ann] Coll Holy Cross, Dept Biol, Worcester, MA 01610 USA; [Nebane, N. Miranda; Rasmussen, Lynn; White, E. Lucile] Southern Res Inst High Throughput Screening Ctr, Birmingham, AL 35205 USA; [Mankowski, Marie K.; Ptak, Roger G.] So Res Inst, Dept Infect Dis Res, Frederick, MD 21701 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; College of the Holy Cross	Gabuzda, D (corresponding author), CLS 1010,450 Brookline Ave, Boston, MA 02215 USA.	dana_gabuzda@dfci.harvard.edu			Harvard Center for AIDS Research Grant [P30 AI060354]; Dana-Farber Cancer Institute/Harvard Cancer Center Research Grant [P30 CA06516]; NATIONAL CANCER INSTITUTE [P30CA006516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R21AI067032, R21AI087458] Funding Source: NIH RePORTER	Harvard Center for AIDS Research Grant; Dana-Farber Cancer Institute/Harvard Cancer Center Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Caroline Shamu and staff at the Institute of Chemistry and Cell Biology Longwood Screening Facility, Harvard Medical School, Boston, MA, for helpful discussions and advice during performance of the high throughput screening and Dr. Marintha Heil, Southern Research Institute Department of Infectious Disease Research, for helpful discussions and advice. Core facilities received support from the Harvard Center for AIDS Research Grant P30 AI060354 and Dana-Farber Cancer Institute/Harvard Cancer Center Research Grant P30 CA06516.	Aydin H, 2014, STRUCTURE, V22, P668, DOI 10.1016/j.str.2014.02.011; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Bohn MF, 2013, STRUCTURE, V21, P1042, DOI 10.1016/j.str.2013.04.010; Brown HEV, 1999, J VIROL, V73, P9011, DOI 10.1128/JVI.73.11.9011-9020.1999; BUCKHEIT RW, 1991, AIDS RES HUM RETROV, V7, P295, DOI 10.1089/aid.1991.7.295; Cen S, 2010, J BIOL CHEM, V285, P16546, DOI 10.1074/jbc.M109.085308; Chaipan C, 2013, J VIROL, V87, P444, DOI 10.1128/JVI.00676-12; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Dang Y, 2010, J VIROL, V84, P8561, DOI 10.1128/JVI.00960-10; Dang Y, 2010, J VIROL, V84, P5741, DOI 10.1128/JVI.00079-10; Esnault C, 2006, NUCLEIC ACIDS RES, V34, P1522, DOI 10.1093/nar/gkl054; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gillick K, 2013, J VIROL, V87, P1508, DOI 10.1128/JVI.02587-12; GONCALVES J, 1994, J VIROL, V68, P704, DOI 10.1128/JVI.68.2.704-712.1994; Goncalves J, 1996, J VIROL, V70, P8701, DOI 10.1128/JVI.70.12.8701-8709.1996; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; Kao Sandra, 2004, Retrovirology, V1, P27, DOI 10.1186/1742-4690-1-27; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Knecht W, 2000, FEBS LETT, V467, P27, DOI 10.1016/S0014-5793(00)01117-0; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; LOUWAGIE J, 1994, AIDS RES HUM RETROV, V10, P561, DOI 10.1089/aid.1994.10.561; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Mehle A, 2007, J VIROL, V81, P13235, DOI 10.1128/JVI.00204-07; Mehle A, 2006, J BIOL CHEM, V281, P17259, DOI 10.1074/jbc.M602413200; Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Paul I, 2006, P NATL ACAD SCI USA, V103, P18475, DOI 10.1073/pnas.0604150103; Pery E, 2009, J VIROL, V83, P2374, DOI 10.1128/JVI.01898-08; Ptak RG, 2008, ANTIMICROB AGENTS CH, V52, P1302, DOI 10.1128/AAC.01324-07; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Santa-Marta M, 2005, J BIOL CHEM, V280, P8765, DOI 10.1074/jbc.M409309200; Schrofelbauer B, 2006, J VIROL, V80, P5984, DOI 10.1128/JVI.00388-06; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200; Simon V, 2005, PLOS PATHOG, V1, P20, DOI 10.1371/journal.ppat.0010006; Siu KK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3593; Stanley BJ, 2008, J VIROL, V82, P8656, DOI 10.1128/JVI.00767-08; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Wang XD, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-94; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wichroski MJ, 2005, J BIOL CHEM, V280, P8387, DOI 10.1074/jbc.M408048200; Xiao ZX, 2007, FASEB J, V21, P217, DOI 10.1096/fj.06-6773com; Xu HZ, 2004, P NATL ACAD SCI USA, V101, P5652, DOI 10.1073/pnas.0400830101; Yamashita T, 2008, MICROBES INFECT, V10, P1142, DOI 10.1016/j.micinf.2008.06.003; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004; Zuo T, 2012, J VIROL, V86, P5497, DOI 10.1128/JVI.06957-11	70	28	30	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10504	10517		10.1074/jbc.M114.626903	http://dx.doi.org/10.1074/jbc.M114.626903			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25724652	Green Published, hybrid			2022-12-28	WOS:000353241100049
J	Liu, CX; Zhang, YQ; Li, J; Wang, YY; Ren, FL; Zhou, YF; Wu, YY; Feng, YR; Zhou, Y; Su, FQ; Jia, BQ; Wang, D; Chang, ZJ				Liu, Chunxiao; Zhang, Yanquan; Li, Jun; Wang, Yinyin; Ren, Fangli; Zhou, Yifan; Wu, Yinyuan; Feng, Yarui; Zhou, Yu; Su, Fuqin; Jia, Baoqing; Wang, Dong; Chang, Zhijie			p15RS/RPRD1A (p15INK4b-related Sequence/Regulation of Nuclear Pre-mRNA Domain-containing Protein 1A) Interacts with HDAC2 in Inhibition of the Wnt/beta-Catenin Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE 1; C-TERMINAL DOMAIN; BETA-CATENIN; POLYMERASE-II; TRANSCRIPTION TERMINATION; P15RS; DIFFERENTIATION; ACETYLATION; COMPLEX; BINDING	We previously reported that p15RS (p15INK4b-related sequence), a regulation of nuclear pre-mRNA domain containing protein, inhibited Wnt signaling by interrupting the formation of the beta-catenin.TCF4 complex. However, how p15RS functions as an intrinsic repressor to repress transcription remains unclear. In this study, we show that p15RS, through a specific interaction with HDAC2 (histone deacetylase 2), a deacetylase that regulates gene transcription, maintains histone H3 in a deacetylated state in the promoter region of Wnt-targeted genes where beta-catenin.TCF4 is bound. We observed that histone deacetylase inhibitors impair the ability of p15RS in inhibiting Wnt/beta-catenin signaling. Depletion of HDAC2 markedly disabled p15RS inhibition of Wnt/beta-catenin-mediated transcription. Interestingly, overexpression of p15RS decreases the level of acetylated histone H3 in the c-MYC promoter. Finally, we demonstrate that p15RS significantly enhances the association of HDAC2 and TCF4 and enhances the occupancy of HDAC2 to DNA, resulting in the deacetylation of histone H3 and the failure of p-catenin interaction. We propose that p15RS acts as an intrinsic transcriptional repressor for Wnt/beta-catenin-mediated gene transcription at least partially through recruiting HDAC2 to occupy the promoter and maintaining deacetylated histone H3.	[Liu, Chunxiao; Zhang, Yanquan; Wang, Yinyin; Ren, Fangli; Zhou, Yifan; Wu, Yinyuan; Feng, Yarui; Zhou, Yu; Su, Fuqin; Wang, Dong; Chang, Zhijie] Tsinghua Univ, Sch Med, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci,Natl Engn Lab Antitumor Therapeut, Beijing 100084, Peoples R China; [Liu, Chunxiao; Zhang, Yanquan; Wang, Yinyin; Ren, Fangli; Feng, Yarui; Wang, Dong; Chang, Zhijie] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Li, Jun] Third Mil Med Sch, Dept Immunol, Chongqing 610041, Peoples R China; [Wu, Yinyuan] Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Jia, Baoqing] Chinese Peoples Liberat Army Gen Hosp, Dept Surg Oncol, Beijing 100853, Peoples R China; [Jia, Baoqing] Chinese Peoples Liberat Army Gen Hosp, Dept Pathol, Beijing 100853, Peoples R China; [Wang, Dong] Tsinghua Univ, Bioinformat Div, Beijing 100084, Peoples R China; [Wang, Dong] Tsinghua Univ, Ctr Synthet & Syst Biol, Beijing 100084, Peoples R China	Tsinghua University; Sichuan University; Harvard University; Boston Children's Hospital; Harvard Medical School; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Tsinghua University; Tsinghua University	Chang, ZJ (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.	zhijiec@tsinghua.edu.cn	Wang, Dong/C-8775-2013; Zhou, Yifan/HIR-8602-2022; Chang, Zhijie/AAH-8109-2019; Wang, Dong/AAH-5611-2020; Zhang, Yanquan/D-5615-2017	Wang, Dong/0000-0001-7877-7440; Zhang, Yanquan/0000-0003-3527-9972; Wang, Dong/0000-0002-3656-329X; Chang, Zhijie/0000-0003-1567-3227	973 Project Grant [2011CB910502]; National Natural Science Foundation of China [30871286, 31071225, 31030040, 81372372]; Tsinghua Science Foundation [20121080018]; Major Program Grant [2013ZX08011-006]; 863 Project Grant in China [SS2014AA020802]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA020802] Funding Source: NIH RePORTER	973 Project Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua Science Foundation; Major Program Grant; 863 Project Grant in China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by 973 Project Grant 2011CB910502, National Natural Science Foundation of China Grants 30871286, 31071225, 31030040, and 81372372, Tsinghua Science Foundation Grant 20121080018, Major Program Grant 2013ZX08011-006, and 863 Project Grant SS2014AA020802 in China.	Aghdassi A, 2012, GUT, V61, P439, DOI 10.1136/gutjnl-2011-300060; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Beumer JH, 2010, CURR CLIN PHARMACOL, V5, P196, DOI 10.2174/157488410791498770; Bieliauskas AV, 2008, CHEM SOC REV, V37, P1402, DOI 10.1039/b703830p; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Cadigan KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007906; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Harms KL, 2007, CANCER RES, V67, P3145, DOI 10.1158/0008-5472.CAN-06-4397; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Li HL, 2009, NAT NEUROSCI, V12, P815, DOI 10.1038/nn0709-815; Liu J, 2002, BIOCHEM BIOPH RES CO, V299, P880, DOI 10.1016/S0006-291X(02)02684-0; Lu DD, 2012, CANCER CELL, V21, P92, DOI 10.1016/j.ccr.2011.12.016; Lunde BM, 2010, NAT STRUCT MOL BIOL, V17, P1195, DOI 10.1038/nsmb.1893; Mei KR, 2014, SCI CHINA LIFE SCI, V57, P97, DOI 10.1007/s11427-013-4589-7; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Ni ZY, 2014, NAT STRUCT MOL BIOL, V21, P686, DOI 10.1038/nsmb.2853; Ni ZY, 2011, TRANSCR-AUSTIN, V2, P237, DOI 10.4161/trns.2.5.17803; Reichert N, 2012, CELL MOL LIFE SCI, V69, P2173, DOI 10.1007/s00018-012-0921-9; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Sakai H, 2002, J BIOL CHEM, V277, P48714, DOI 10.1074/jbc.M208461200; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Toh Y, 2000, J EXP CLIN CANC RES, V19, P105; Winkler CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010166; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Wu YY, 2010, J BIOL CHEM, V285, P34621, DOI 10.1074/jbc.M110.148791; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Zhang XC, 2012, CELL CYCLE, V11, P1988, DOI 10.4161/cc.20400; Zhang YQ, 2014, J BIOL CHEM, V289, P22589, DOI 10.1074/jbc.M114.560979	40	28	28	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9701	9713		10.1074/jbc.M114.620872	http://dx.doi.org/10.1074/jbc.M114.620872			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25697359	Green Published, hybrid			2022-12-28	WOS:000352729400032
J	Brito, JA; Denkmann, K; Pereira, IAC; Archer, M; Dahl, C				Brito, Jose A.; Denkmann, Kevin; Pereira, Ines A. C.; Archer, Margarida; Dahl, Christiane			Thiosulfate Dehydrogenase (TsdA) from Allochromatium vinosum STRUCTURAL AND FUNCTIONAL INSIGHTS INTO THIOSULFATE OXIDATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME COMPLEX SOXXA; C NITRITE REDUCTASE; SULFUR-OXIDATION; HEME PROTEIN; PARACOCCUS-PANTOTROPHUS; STRUCTURE REFINEMENT; STRUCTURE VALIDATION; DENSITY MODIFICATION; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE	Although the oxidative condensation of two thiosulfate anions to tetrathionate constitutes a well documented and significant part of the natural sulfur cycle, little is known about the enzymes catalyzing this reaction. In the purple sulfur bacterium Allochromatium vinosum, the reaction is catalyzed by the periplasmic diheme c-type cytochrome thiosulfate dehydrogenase (TsdA). Here, we report the crystal structure of the "as isolated" form of A. vinosum TsdA to 1.98 angstrom resolution and those of several redox states of the enzyme to different resolutions. The protein contains two typical class I c-type cytochrome domains wrapped around two hemes axially coordinated by His(53)/Cys(96) and His(164)/Lys(208). These domains are very similar, suggesting a gene duplication event during evolution. A ligand switch from Lys(208) to Met(209) is observed upon reduction of the enzyme. Cys(96) is an essential residue for catalysis, with the specific activity of the enzyme being completely abolished in several TsdA-Cys(96) variants. TsdA-K208N, K208G, and M209G variants were catalytically active in thiosulfate oxidation as well as in tetrathionate reduction, pointing to heme 2 as the electron exit point. In this study, we provide spectroscopic and structural evidence that the TsdA reaction cycle involves the transient presence of heme 1 in the high-spin state caused by movement of the S gamma atom of Cys(96) out of the iron coordination sphere. Based on the presented data, we draw important conclusions about the enzyme and propose a possible reaction mechanism for TsdA.	Univ Nova Lisboa ITQB UNL, Inst Tecnol Quim & Biol Antonio Xavier, P-2780157 Oeiras, Portugal; [Denkmann, Kevin; Dahl, Christiane] Univ Bonn, Inst Mikrobiol & Biotechnol, D-53115 Bonn, Germany	Universidade Nova de Lisboa; University of Bonn		archer@itqb.unl.pt; ChDahl@uni-bonn.de	Brito, Jose A./A-5605-2011; Pereira, Inês/C-2748-2009; Dahl, Christiane/H-4786-2019	Brito, Jose A./0000-0002-8307-2282; Pereira, Inês/0000-0003-3283-4520; Dahl, Christiane/0000-0001-8288-7546; Archer, Margarida/0000-0001-8419-5420	Deutsche Forschungsgemeinschaft [DA351/7-1]; Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/BBB-BQB/0684/2012, PTDC/BIA-PRO/118535/2010, PEst-OE/EQB/LA0004/2011]; German Academic Exchange Service; Conselho de Reitores das Universidades Portuguesas; BioStruct-X [1493]; FCT [SFRH/BPD/79224/2011]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Conselho de Reitores das Universidades Portuguesas; BioStruct-X; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant DA351/7-1; Fundacao para a Ciencia e a Tecnologia (FCT) Grants PTDC/BBB-BQB/0684/2012, PTDC/BIA-PRO/118535/2010, and PEst-OE/EQB/LA0004/2011; the German Academic Exchange Service; Conselho de Reitores das Universidades Portuguesas; and BioStruct-X (Proposal 1493).; Recipient of FCT Fellowship SFRH/BPD/79224/2011.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alric J, 2004, J BIOL CHEM, V279, P26090, DOI 10.1074/jbc.M400361200; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Bamford VA, 2002, BIOCHEM SOC T, V30, P638, DOI 10.1042/bst0300638; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BLATTNER FR, 1977, SCIENCE, V196, P161, DOI 10.1126/science.847462; Bradley JM, 2012, J BIOL CHEM, V287, P40350, DOI 10.1074/jbc.M112.396192; Brito JA, 2014, ACTA CRYSTALLOGR F, V70, P1424, DOI 10.1107/S2053230X14019384; Cheesman MR, 2001, BIOCHEMISTRY-US, V40, P10562, DOI 10.1021/bi0100081; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; Dahl C, 2008, J MOL BIOL, V384, P1287, DOI 10.1016/j.jmb.2008.10.016; Dambe T, 2005, J STRUCT BIOL, V152, P229, DOI 10.1016/j.jsb.2005.09.002; DeLano W. L, 2013, PYMOL MOL GRAPHICS S; Denkmann K, 2012, ENVIRON MICROBIOL, V14, P2673, DOI 10.1111/j.1462-2920.2012.02820.x; Einsle O, 2000, J BIOL CHEM, V275, P39608, DOI 10.1074/jbc.M006188200; Einsle O, 1999, NATURE, V400, P476, DOI 10.1038/22802; Einsle O, 2002, ACTA CRYSTALLOGR D, V58, P341, DOI 10.1107/S090744490102039X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; FUKUMORI Y, 1979, CURR MICROBIOL, V3, P117, DOI 10.1007/BF02602443; Girvan HM, 2007, J BIOL CHEM, V282, P564, DOI 10.1074/jbc.M607949200; Grein F, 2010, BIOCHEMISTRY-US, V49, P8290, DOI 10.1021/bi1007673; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hartshorne RS, 2007, MOL MICROBIOL, V64, P1049, DOI 10.1111/j.1365-2958.2007.05712.x; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Imhoff JF, 1998, INT J SYST BACTERIOL, V48, P1129, DOI 10.1099/00207713-48-4-1129; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kappler U, 2004, J BIOL CHEM, V279, P6252, DOI 10.1074/jbc.M310644200; Kappler U, 2008, J BIOL CHEM, V283, P22206, DOI 10.1074/jbc.M800315200; Kappler U, 2013, CELL MOL LIFE SCI, V70, P977, DOI 10.1007/s00018-012-1098-y; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kilmartin JR, 2011, J BIOL CHEM, V286, P24872, DOI 10.1074/jbc.M110.212183; Lemberg R., 1973, CYTOCHROMES; Leys D, 2000, J BIOL CHEM, V275, P16050, DOI 10.1074/jbc.275.21.16050; Liu YW, 2013, MOL MICROBIOL, V88, P173, DOI 10.1111/mmi.12176; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Marques MC, 2013, INT J HYDROGEN ENERG, V38, P8664, DOI 10.1016/j.ijhydene.2013.04.132; Martinez SE, 1996, PROTEIN SCI, V5, P1081; Marvin KA, 2008, BIOCHEMISTRY-US, V47, P9016, DOI 10.1021/bi800486x; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MILES CS, 1993, BIOCHIM BIOPHYS ACTA, V1202, P82, DOI 10.1016/0167-4838(93)90066-Z; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Pereira I. A., 2005, ENCY INORGANIC CHEM, V5, P3360; Pires RH, 2006, BIOCHEMISTRY-US, V45, P249, DOI 10.1021/bi0515265; Pott AS, 1998, MICROBIOL-SGM, V144, P1881, DOI 10.1099/00221287-144-7-1881; Reedy CJ, 2008, NUCLEIC ACIDS RES, V36, pD307, DOI 10.1093/nar/gkm814; Reedy CJ, 2004, CHEM REV, V104, P617, DOI 10.1021/cr0206115; Reijerse EJ, 2007, BIOCHEMISTRY-US, V46, P7804, DOI 10.1021/bi7003526; Rodrigues ML, 2006, EMBO J, V25, P5951, DOI 10.1038/sj.emboj.7601439; Rother D, 2002, BBA-PROTEINS PROTEOM, V1598, P65, DOI 10.1016/S0167-4838(02)00332-1; Simon J, 2002, FEMS MICROBIOL REV, V26, P285, DOI 10.1111/j.1574-6976.2002.tb00616.x; Suga M, 2013, FEBS LETT, V587, P3267, DOI 10.1016/j.febslet.2013.08.023; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P1688, DOI 10.1107/S0907444903015142; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Van Driessche G, 2006, FEBS J, V273, P2801, DOI 10.1111/j.1742-4658.2006.05296.x; Williams PA, 1997, NATURE, V389, P406, DOI 10.1038/38775; WOOD PM, 1983, FEBS LETT, V164, P223, DOI 10.1016/0014-5793(83)80289-0; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008; Zhong FF, 2014, P NATL ACAD SCI USA, V111, pE306, DOI 10.1073/pnas.1317173111	67	28	29	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9222	9238		10.1074/jbc.M114.623397	http://dx.doi.org/10.1074/jbc.M114.623397			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25673691	Green Published, hybrid			2022-12-28	WOS:000352207100044
J	Linn, S				Linn, Stuart			Radicals in Berkeley?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC ACID MODIFICATION; ESCHERICHIA-COLI K-12; HYDROGEN-PEROXIDE; DNA-DAMAGE; CATALYTIC PROPERTIES; RESTRICTION ENZYMES; SUBUNIT STRUCTURE; FENTON REACTIONS; REPAIR; TOXICITY	In a previous autobiographical sketch for DNA Repair (Linn, S. (2012) Life in the serendipitous lane: excitement and gratification in studying DNA repair. DNA Repair 11, 595-605), I wrote about my involvement in research on mechanisms of DNA repair. In this Reflections, I look back at how I became interested in free radical chemistry and biology and outline some of our bizarre (at the time) observations. Of course, these studies could never have succeeded without the exceptional aid of my mentors: my teachers; the undergraduate and graduate students, postdoctoral fellows, and senior lab visitors in my laboratory; and my faculty and staff colleagues here at Berkeley. I am so indebted to each and every one of these individuals for their efforts to overcome my ignorance and set me on the straight and narrow path to success in research. I regret that I cannot mention and thank each of these mentors individually.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Linn, S (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	slinn@berkeley.edu						Brumaghim JL, 2003, J BIOL CHEM, V278, P42495, DOI 10.1074/jbc.M306251200; DEMPLE B, 1983, NATURE, V304, P466, DOI 10.1038/304466a0; ESKIN B, 1972, J BIOL CHEM, V247, P6183; Henle ES, 1999, J BIOL CHEM, V274, P962, DOI 10.1074/jbc.274.2.962; Henle ES, 1997, J BIOL CHEM, V272, P19095, DOI 10.1074/jbc.272.31.19095; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; IMLAY JA, 1987, J BACTERIOL, V169, P2967, DOI 10.1128/jb.169.7.2967-2976.1987; IMLAY JA, 1986, J BACTERIOL, V166, P519, DOI 10.1128/jb.166.2.519-527.1986; KARU AE, 1973, J BIOL CHEM, V248, P4874; KRAUSS SW, 1986, J CELL PHYSIOL, V126, P99, DOI 10.1002/jcp.1041260114; LAUTENBERGER JA, 1972, J BIOL CHEM, V247, P6176; LINN S, 1976, P NATL ACAD SCI USA, V73, P2818, DOI 10.1073/pnas.73.8.2818; LINN S, 1987, J CELL SCI, P289; LINN S, 1961, ANN NY ACAD SCI, V92, P419, DOI 10.1111/j.1749-6632.1961.tb44991.x; Linn S, 2012, DNA REPAIR, V11, P595, DOI 10.1016/j.dnarep.2011.08.001; LUO YZ, 1994, P NATL ACAD SCI USA, V91, P12438, DOI 10.1073/pnas.91.26.12438; MACKAY V, 1974, J BIOL CHEM, V249, P4286; Rai P, 2005, NUCLEIC ACIDS RES, V33, P497, DOI 10.1093/nar/gki192; Rai P, 2001, J MOL BIOL, V312, P1089, DOI 10.1006/jmbi.2001.5010; ROBERTS M, 1961, ANN NY ACAD SCI, V92, P724, DOI 10.1111/j.1749-6632.1961.tb45021.x; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664	23	0	0	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8748	8757		10.1074/jbc.X115.644989	http://dx.doi.org/10.1074/jbc.X115.644989			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25713083	Green Published, hybrid			2022-12-28	WOS:000352207100006
J	Hellmuth, S; Pohlmann, C; Brown, A; Bottger, F; Sprinzl, M; Stemmann, O				Hellmuth, Susanne; Poehlmann, Christopher; Brown, Andreas; Boettger, Franziska; Sprinzl, Mathias; Stemmann, Olaf			Positive and Negative Regulation of Vertebrate Separase by Cdk1-Cyclin B1 May Explain Why Securin Is Dispensable	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromosomes; Cyclin-dependent Kinase (CDK); Cysteine Protease; Mitosis; Phosphorylation; Cdk1-Cyclin B1; Centriole Disengagement; Securin; Separase; Sister Chromatid Separation	SISTER-CHROMATID SEPARATION; CASPASE-ACTIVATED DNASE; CENTRIOLE DUPLICATION; HUMAN-CELLS; COHESIN; CLEAVAGE; PHOSPHORYLATION; INHIBITION; YEAST; OVEREXPRESSION	Background: Separase, the trigger protease of eukaryotic anaphase, remains regulated in the absence of its inhibitor, securin. Results: Cdk1-cyclin B1 triggers precipitation of separase by phosphorylation but stabilizes it by inhibitory binding. Conclusion: Only separase that is first complexed by Cdk1-cyclin B1 can later be activated by cyclin B1 degradation. Significance: These minimal requirements of separase regulation could explain the faithful execution of anaphase in the absence of securin. Sister chromatid cohesion is established during replication by entrapment of both dsDNAs within the cohesin ring complex. It is dissolved in anaphase when separase, a giant cysteine endopeptidase, cleaves the Scc1/Rad21 subunit of cohesin, thereby triggering chromosome segregation. Separase is held inactive by association with securin until this anaphase inhibitor is destroyed at the metaphase-to-anaphase transition by ubiquitin-dependent degradation. The relevant ubiquitin ligase, the anaphase-promoting complex/cyclosome, also targets cyclin B1, thereby causing inactivation of Cdk1 and mitotic exit. Although separase is essential, securin knock-out mice are surprisingly viable and fertile. Capitalizing on our previous finding that Cdk1-cyclin B1 can also bind and inhibit separase, we investigated whether this kinase might be suitable to maintain faithful timing and execution of anaphase in the absence of securin. We found that, similar to securin, Cdk1-cyclin B1 regulates separase in both a positive and negative manner. Although securin associates with nascent separase to co-translationally assist proper folding, Cdk1-cyclin B1 acts on native state separase. Upon entry into mitosis, Cdk1-cyclin B1-dependent phosphorylation of Ser-1126 renders separase prone to inactivation by aggregation/precipitation. Stable association of Cdk1-cyclin B1 with phosphorylated separase counteracts this tendency and stabilizes separase in an inhibited yet activatable state. These opposing effects are suited to prevent premature cleavage of cohesin in early mitosis while ensuring timely activation of separase by anaphase-promoting complex/cyclosome-dependent degradation of cyclin B1. Coupling sister chromatid separation with subsequent exit from mitosis by this simplified mode might have been the common scheme of mitotic control prior to the evolution of securin.	[Hellmuth, Susanne; Brown, Andreas; Boettger, Franziska; Stemmann, Olaf] Univ Bayreuth, Chair Genet, D-95440 Bayreuth, Germany; [Poehlmann, Christopher; Sprinzl, Mathias] Univ Bayreuth, Chair Biochem, D-95440 Bayreuth, Germany	University of Bayreuth; University of Bayreuth	Stemmann, O (corresponding author), Univ Bayreuth, Dept Genet, Univ Str 30, D-95440 Bayreuth, Germany.	olaf.stemmann@uni-bayreuth.de	Pöhlmann, Christopher/ABC-9093-2020	Stemmann, Olaf/0000-0003-3044-2515; Brown, Andreas/0000-0002-1249-1316; Pohlmann, Christopher/0000-0001-9797-8643	Deutsche Forschungsgemeinschaft (DFG) [STE 997/3-2, STE 997/4-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants STE 997/3-2 (within the priority program SPP1384) and STE 997/4-1 (to O. S.).	Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Bernal JA, 2002, NAT GENET, V32, P306, DOI 10.1038/ng997; Boos D, 2008, J BIOL CHEM, V283, P816, DOI 10.1074/jbc.M706748200; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hamid T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-18; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hellmuth S, 2014, EMBO J, V33, P1134, DOI 10.1002/embj.201488098; Holland AJ, 2006, J CELL SCI, V119, P3325, DOI 10.1242/jcs.03083; Huang XX, 2008, PLOS BIOL, V6, P52, DOI 10.1371/journal.pbio.0060015; Huang XX, 2009, MOL CELL BIOL, V29, P1498, DOI 10.1128/MCB.01778-08; Huang XX, 2005, MOL BIOL CELL, V16, P4725, DOI 10.1091/mbc.E05-03-0190; Jager H, 2001, GENE DEV, V15, P2572, DOI 10.1101/gad.207301; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Lee K, 2012, CELL CYCLE, V11, P2476, DOI 10.4161/cc.20878; Matsuo K, 2012, CURR BIOL, V22, P915, DOI 10.1016/j.cub.2012.03.048; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; Meyer R, 2009, CLIN CANCER RES, V15, P2703, DOI 10.1158/1078-0432.CCR-08-2454; Mukherjee M, 2014, ONCOGENE, V33, P5511, DOI 10.1038/onc.2013.493; Mukherjee M, 2014, J NEURO-ONCOL, V119, P27, DOI 10.1007/s11060-014-1458-6; Mukherjee M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022167; Pei L, 2001, J BIOL CHEM, V276, P8484, DOI 10.1074/jbc.M009654200; Pfleghaar K, 2005, PLOS BIOL, V3, P2127, DOI 10.1371/journal.pbio.0030416; Poehlmann C, 2010, ANAL CHEM, V82, P4434, DOI 10.1021/ac100186p; Sakahira H, 2000, J BIOL CHEM, V275, P8091, DOI 10.1074/jbc.275.11.8091; Sakahira H, 2002, J BIOL CHEM, V277, P3364, DOI 10.1074/jbc.M110071200; Schockel L, 2011, NAT CELL BIOL, V13, P966, DOI 10.1038/ncb2280; Shepard JL, 2007, GENE DEV, V21, P55, DOI 10.1101/gad.1470407; Stemmann O, 2006, CELL CYCLE, V5, P11, DOI 10.4161/cc.5.1.2296; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Sun YX, 2006, CELL CYCLE, V5, P2537, DOI 10.4161/cc.5.21.3407; Tong YG, 2009, J MOL ENDOCRINOL, V43, P179, DOI 10.1677/JME-08-0176; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wang YR, 2007, BIOSENS BIOELECTRON, V22, P1798, DOI 10.1016/j.bios.2006.08.046; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	41	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					8002	8010		10.1074/jbc.M114.615310	http://dx.doi.org/10.1074/jbc.M114.615310			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25659430	Green Published, hybrid			2022-12-28	WOS:000351613600057
J	Maeshima, N; Evans-Atkinson, T; Hajjar, AM; Fernandez, RC				Maeshima, Nina; Evans-Atkinson, Tara; Hajjar, Adeline M.; Fernandez, Rachel C.			Bordetella pertussis Lipid A Recognition by Toll-like Receptor 4 and MD-2 Is Dependent on Distinct Charged and Uncharged Interfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATE GROUPS; LIPOPOLYSACCHARIDE RECOGNITION; IONIC INTERACTIONS; STRUCTURAL BASIS; ESSENTIAL ROLES; ACTIVATION; TLR4; ENDOTOXIN; IVA; GLUCOSAMINE	Lipid A in LPS activates innate immunity through the Toll-like receptor 4 (TLR4)-MD-2 complex on host cells. Variation in lipid A has significant consequences for TLR4 activation and thus may be a means by which Gram-negative bacteria modulate host immunity. However, although even minor changes in lipid A structure have been shown to affect downstream immune responses, the mechanism by which the TLR4-MD-2 receptor complex recognizes these changes is not well understood. We previously showed that strain BP338 of the human pathogen Bordetella pertussis, the causative agent of whooping cough, modifies its lipid A by the addition of glucosamine moieties that promote TLR4 activation in human, but not mouse, macrophages. Using site-directed mutagenesis and an NF kappa B reporter assay screen, we have identified several charged amino acid residues in TLR4 and MD-2 that are important for these species-specific responses; some of these are novel for responses to penta-acyl B. pertussis LPS, and their mutation does not affect the response to hexa-acylated Escherichia coli LPS or tetra-acylated lipid IVA. We additionally show evidence that suggests that recognition of penta-acylated B. pertussis lipid A is dependent on uncharged amino acids in TLR4 and MD-2 and that this is true for both human and mouse TLR4-MD-2 receptors. Taken together, we have demonstrated that the TLR4-MD-2 receptor complex recognizes variation in lipid A molecules using multiple sites for receptor-ligand interaction and propose that host-specific immunity to a particular Gram-negative bacterium is, at least in part, mediated by very subtle tuning of one of the earliest interactions at the host-pathogen interface.	[Maeshima, Nina; Evans-Atkinson, Tara; Fernandez, Rachel C.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Hajjar, Adeline M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	University of British Columbia; University of Washington; University of Washington Seattle	Fernandez, RC (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 2350 Hlth Sci Mall,Rm 2559, Vancouver, BC V6T 1Z3, Canada.	rachelf@mail.ubc.ca	Maeshima, Nina/AAB-4660-2021	Hajjar, Adeline/0000-0002-4838-8070	Canadian Institutes of Health Research [MOP-102706]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Operating Grant MOP-102706.	Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Chilton PM, 2013, INFECT IMMUN, V81, P3317, DOI 10.1128/IAI.01150-12; Cui WG, 2014, J IMMUNOL, V192, P4221, DOI 10.4049/jimmunol.1302569; Fedele G, 2008, J IMMUNOL, V181, P208, DOI 10.4049/jimmunol.181.1.208; Fornuskova A., 2013, BMC EVOL BIOL, V13, P194, DOI DOI 10.1186/1471-2148-13-194); Hajjar AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002963; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Kawahara K, 2002, INFECT IMMUN, V70, P4092, DOI 10.1128/IAI.70.8.4092-4098.2002; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Marr N, 2008, J BACTERIOL, V190, P4281, DOI 10.1128/JB.01875-07; Marr N, 2010, J INFECT DIS, V202, P1897, DOI 10.1086/657409; Marr N, 2010, INFECT IMMUN, V78, P2060, DOI 10.1128/IAI.01346-09; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Meng JM, 2011, J IMMUNOL, V187, P3683, DOI 10.4049/jimmunol.1101397; Meng JM, 2010, J BIOL CHEM, V285, P27935, DOI 10.1074/jbc.M110.134668; Meng JM, 2010, J BIOL CHEM, V285, P8695, DOI 10.1074/jbc.M109.075127; Muroi M, 2006, J BIOL CHEM, V281, P5484, DOI 10.1074/jbc.M509193200; Muta T, 2001, EUR J BIOCHEM, V268, P4580, DOI 10.1046/j.1432-1327.2001.02385.x; Needham BD, 2013, P NATL ACAD SCI USA, V110, P1464, DOI 10.1073/pnas.1218080110; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Resman N, 2014, J IMMUNOL, V192, P1887, DOI 10.4049/jimmunol.1302119; Resman N, 2009, J BIOL CHEM, V284, P15052, DOI 10.1074/jbc.M901429200; Shah NR, 2013, J BIOL CHEM, V288, P11751, DOI 10.1074/jbc.M112.434365; Tanamoto K, 2000, J IMMUNOL, V164, P3149, DOI 10.4049/jimmunol.164.6.3149; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245	33	13	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13440	13453		10.1074/jbc.M115.653881	http://dx.doi.org/10.1074/jbc.M115.653881			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25837248	hybrid, Green Published			2022-12-28	WOS:000354975700039
J	Tanaka, H; Goto, H; Inoko, A; Makihara, H; Enomoto, A; Horimoto, K; Matsuyama, M; Kurita, K; Izawa, I; Inagaki, M				Tanaka, Hiroki; Goto, Hidemasa; Inoko, Akihito; Makihara, Hiroyuki; Enomoto, Atsushi; Horimoto, Katsuhisa; Matsuyama, Makoto; Kurita, Kenichi; Izawa, Ichiro; Inagaki, Masaki			Cytokinetic Failure-induced Tetraploidy Develops into Aneuploidy, Triggering Skin Aging in Phosphovimentin-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; INTERMEDIATE-FILAMENT PROTEINS; ONCOGENE-INDUCED SENESCENCE; RHO-ASSOCIATED KINASE; VIMENTIN PHOSPHORYLATION; CELL-CYCLE; POLYPLOIDY; BUBR1; SEGREGATION; ROLES	Tetraploidy, a state in which cells have doubled chromosomal sets, is observed in similar to 20% of solid tumors and is considered to frequently precede aneuploidy in carcinogenesis. Tetraploidy is also detected during terminal differentiation and represents a hallmark of aging. Most tetraploid cultured cells are arrested by p53 stabilization. However, the fate of tetraploid cells in vivo remains largely unknown. Here, we analyze the ability to repair wounds in the skin of phosphovimentin-deficient (VIMSA/SA) mice. Early into wound healing, subcutaneous fibroblasts failed to undergo cytokinesis, resulting in binucleate tetraploidy. Accordingly, the mRNA level of p21 (a p53-responsive gene) was elevated in a VIMSA/SA-specific manner. Disappearance of tetraploidy coincided with an increase in aneuploidy. Thereafter, senescence-related markers were significantly elevated in VIMSA/SA mice. Because our tetraploidy-prone mouse model also exhibited subcutaneous fat loss at the age of 14 months, another premature aging phenotype, our data suggest that following cytokinetic failure, a subset of tetraploid cells enters a new cell cycle and develops into aneuploid cells in vivo, which promote premature aging.	[Tanaka, Hiroki; Goto, Hidemasa; Inoko, Akihito; Makihara, Hiroyuki; Matsuyama, Makoto; Izawa, Ichiro; Inagaki, Masaki] Aichi Canc Ctr, Res Inst, Div Biochem, Nagoya, Aichi 4648681, Japan; [Goto, Hidemasa; Inagaki, Masaki] Nagoya Univ, Grad Sch Med, Dept Cellular Oncol, Nagoya, Aichi 4668550, Japan; [Enomoto, Atsushi] Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4668550, Japan; [Makihara, Hiroyuki; Kurita, Kenichi] Aichi Gakuin Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4668550, Japan; [Horimoto, Katsuhisa] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Tokyo 1350064, Japan	Aichi Cancer Center; Nagoya University; Nagoya University; Aichi Gakuin University; National Institute of Advanced Industrial Science & Technology (AIST)	Inagaki, M (corresponding author), Aichi Canc Ctr, Res Inst, Div Biochem, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	minagaki@aichi-cc.jp	Enomoto, Atsushi/I-7272-2014; Inagaki, Masaki/B-9920-2016	Enomoto, Atsushi/0000-0002-9206-6116; Goto, Hidemasa/0000-0002-6796-4467; TANAKA, HIROKI/0000-0003-3469-6555; Matsuyama, Makoto/0000-0003-2606-059X; Inoko, Akihito/0000-0002-6739-2948	Japan Society for the Promotion of Science; Ministry of Education, Science, Technology, Sports and Culture of Japan; Takeda Science Foundation; Grants-in-Aid for Scientific Research [15K08324, 26670650] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Technology, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science and from the Ministry of Education, Science, Technology, Sports and Culture of Japan and by a research grant from the Takeda Science Foundation.	Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Baker DJ, 2013, CELL REP, V3, P1164, DOI 10.1016/j.celrep.2013.03.028; Baker DJ, 2013, NAT CELL BIOL, V15, P96, DOI 10.1038/ncb2643; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928; Bornheim R, 2008, J CELL SCI, V121, P3737, DOI 10.1242/jcs.030312; CHOU YH, 1991, J BIOL CHEM, V266, P7325; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Coulombe PA, 2001, J CELL SCI, V114, P4345; Coulombe PA, 2003, J INVEST DERMATOL, V121, P219, DOI 10.1046/j.1523-1747.2003.12387.x; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Da Q, 2014, BLOOD, V123, P2715, DOI 10.1182/blood-2013-10-530428; Davoli T, 2012, CANCER CELL, V21, P765, DOI 10.1016/j.ccr.2012.03.044; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; dos Santos G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7574; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; Enomoto M, 2009, J BIOL CHEM, V284, P34223, DOI 10.1074/jbc.C109.051540; ERIKSSON J E, 1992, Current Opinion in Cell Biology, V4, P99, DOI 10.1016/0955-0674(92)90065-K; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gentric G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/282430; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; Goto H, 2014, IUBMB LIFE, V66, P195, DOI 10.1002/iub.1260; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Hanselmann RG, 2001, MED HYPOTHESES, V56, P58, DOI 10.1054/mehy.2000.1111; Homberg M, 2014, INT REV CEL MOL BIO, V311, P265, DOI 10.1016/B978-0-12-800179-0.00007-6; Inagaki M, 1996, BIOESSAYS, V18, P481, DOI 10.1002/bies.950180610; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Kasahara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2879; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita-Kikuta E, 2007, MOL CELL PROTEOMICS, V6, P356, DOI 10.1074/mcp.T600044-MCP200; Kroemer G, 2010, NAT REV MOL CELL BIO, V11, P539, DOI 10.1038/nrm2924; Kuffer C, 2013, CHROMOSOMA, V122, P305, DOI 10.1007/s00412-013-0414-0; KUSUBATA M, 1992, J BIOL CHEM, V267, P20937; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Li P, 2012, MOL BIOL CELL, V23, P1582, DOI 10.1091/mbc.E11-10-0883; Margolis RL, 2005, CANCER CELL, V8, P353, DOI 10.1016/j.ccr.2005.10.017; Matsuyama M, 2013, J BIOL CHEM, V288, P35626, DOI 10.1074/jbc.M113.514737; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mor-Vaknin N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01045; Mosieniak G, 2010, CURR PHARM DESIGN, V16, P734, DOI 10.2174/138161210790883714; Mueller M, 2009, HUM MOL GENET, V18, P1052, DOI 10.1093/hmg/ddn440; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; North BJ, 2014, EMBO J, V33, P1438, DOI 10.15252/embj.201386907; O'Connell CB, 1999, J CELL BIOL, V144, P305, DOI 10.1083/jcb.144.2.305; PARRY D A D, 1992, Current Opinion in Cell Biology, V4, P94, DOI 10.1016/0955-0674(92)90064-J; Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Ricke RM, 2013, J CELL BIOL, V201, P11, DOI 10.1083/jcb.201301061; Rogel MR, 2011, FASEB J, V25, P3873, DOI 10.1096/fj.10-170795; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Song SH, 2009, J CLIN INVEST, V119, P1837, DOI 10.1172/JCI38277; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; Yang D, 2007, AGING CELL, V6, P257, DOI 10.1111/j.1474-9726.2007.00274.x; Yasui Y, 1998, J CELL BIOL, V143, P1249, DOI 10.1083/jcb.143.5.1249; Yasui Y, 2001, ONCOGENE, V20, P2868, DOI 10.1038/sj.onc.1204407; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	73	39	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					12984	12998		10.1074/jbc.M114.633891	http://dx.doi.org/10.1074/jbc.M114.633891			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847236	hybrid, Green Published			2022-12-28	WOS:000354975700002
J	Merceron, R; Awama, AM; Montserret, R; Marcillat, O; Gouet, P				Merceron, Romain; Awama, Ayman M.; Montserret, Roland; Marcillat, Olivier; Gouet, Patrice			The Substrate-free and -bound Crystal Structures of the Duplicated Taurocyamine Kinase from the Human Parasite Schistosoma mansoni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE CREATINE-KINASE; SMALL-ANGLE SCATTERING; STATE ANALOG COMPLEX; PROTEIN SECONDARY STRUCTURE; 2-DOMAIN ARGININE KINASE; X-RAY-SCATTERING; PHOSPHAGEN KINASE; GENE DUPLICATION; GUANIDINO KINASE; LIGAND-BINDING	The taurocyamine kinase from the blood fluke Schistosoma mansoni (SmTK) belongs to the phosphagen kinase (PK) family and catalyzes the reversible Mg2+-dependent transfer of a phosphoryl group between ATP and taurocyamine. SmTK is derived from gene duplication, as are all known trematode TKs. Our crystallographic study of SmTK reveals the first atomic structure of both a TK and a PK with a bilobal structure. The two unliganded lobes present a canonical open conformation and interact via their respective C-and N-terminal domains at a helix-mediated interface. This spatial arrangement differs from that observed in true dimeric PKs, in which both N-terminal domains make contact. Our structures of SmTK complexed with taurocyamine or L-arginine compounds explain the mechanism by which an arginine residue of the phosphagen specificity loop is crucial for substrate specificity. An SmTK crystal was soaked with the dead end transition state analog (TSA) components taurocyamine-NO32--MgADP. One SmTK monomer was observed with two bound TSAs and an asymmetric conformation, with the first lobe semiclosed and the second closed. However, isothermal titration calorimetry and enzyme kinetics experiments showed that the two lobes function independently. A small angle x-ray scattering model of SmTK-TSA in solution with two closed active sites was generated.	[Merceron, Romain; Montserret, Roland; Gouet, Patrice] Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot,BMSSI IBCP, F-69367 Lyon 07, France; [Awama, Ayman M.; Marcillat, Olivier] Univ Lyon 1, CNRS, UMR 5246, Inst Chim & Biochim Mol & Supramol, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Marcillat, O (corresponding author), Univ Lyon 1, CNRS, UMR 5246, Inst Chim & Biochim Mol & Supramol, F-69622 Villeurbanne, France.	olivier.marcillat@univ-lyon1.fr; p.gouet@ibcp.fr		gouet, patrice/0000-0001-9485-6157	European Community [283570]	European Community(European Commission)	The crystallization work in the study benefited from the IBCP/UMS 3444/US8 crystallogenesis facilities of SFR Biosciences. This work was supported by the European Community's Seventh Framework Program (FP7/2007-2013) under Grant Agreement 283570 (BioStruct-X).	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Awama AM, 2008, ACTA CRYSTALLOGR F, V64, P854, DOI 10.1107/S1744309108025979; Awama AM, 2007, ARCH BIOCHEM BIOPHYS, V458, P158, DOI 10.1016/j.abb.2006.09.001; Azzi A, 2004, PROTEIN SCI, V13, P575, DOI 10.1110/ps.03428304; Bong SM, 2008, FEBS LETT, V582, P3959, DOI 10.1016/j.febslet.2008.10.039; Borders CL, 2002, BIOCHEMISTRY-US, V41, P6995, DOI 10.1021/bi020105+; Bush DJ, 2011, J BIOL CHEM, V286, P9338, DOI 10.1074/jbc.M110.202796; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark SA, 2012, BIOCHEM BIOPH RES CO, V427, P212, DOI 10.1016/j.bbrc.2012.09.053; Compaan DM, 2003, J EXP BIOL, V206, P1545, DOI 10.1242/jeb.00299; Davulcu O, 2009, STRUCTURE, V17, P1356, DOI 10.1016/j.str.2009.08.014; DEGANI C, 1980, J BIOL CHEM, V255, P8221; DUMAS C, 1983, FEBS LETT, V153, P128, DOI 10.1016/0014-5793(83)80132-X; Eder M, 1999, PROTEIN SCI, V8, P2258; Eder M, 2000, PROTEINS, V39, P216, DOI 10.1002/(SICI)1097-0134(20000515)39:3<216::AID-PROT40>3.0.CO;2-#; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez P, 2007, PROTEINS, V69, P209, DOI 10.1002/prot.21557; Forstner M, 1996, J MOL STRUCT, V383, P217, DOI 10.1016/S0022-2860(96)09289-7; Forstner M, 1999, FEBS LETT, V461, P111, DOI 10.1016/S0014-5793(99)01431-3; Forstner M, 1998, BIOPHYS J, V75, P1016, DOI 10.1016/S0006-3495(98)77590-3; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; FritzWolf K, 1996, NATURE, V381, P341, DOI 10.1038/381341a0; Gaffney JP, 2012, BBA-GEN SUBJECTS, V1820, P212, DOI 10.1016/j.bbagen.2011.09.014; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hoffman GG, 2008, FEBS J, V275, P646, DOI 10.1111/j.1742-4658.2007.06226.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jarilla BR, 2010, KOREAN J PARASITOL, V48, P281, DOI 10.3347/kjp.2010.48.4.281; Jarilla BR, 2009, FEBS LETT, V583, P2218, DOI 10.1016/j.febslet.2009.05.049; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P13861, DOI 10.1021/bi026655p; Lim K, 2010, BIOCHEMISTRY-US, V49, P2031, DOI 10.1021/bi9020988; Londergan CH, 2015, BIOCHEMISTRY-US, V54, P83, DOI 10.1021/bi5008063; Lopez-Zavala AA, 2013, J BIOENERG BIOMEMBR, V45, P511, DOI 10.1007/s10863-013-9521-0; MARCILLAT O, 1987, BIOCHIM BIOPHYS ACTA, V890, P233, DOI 10.1016/0005-2728(87)90024-7; Mazon H, 2003, BIOCHEMISTRY-US, V42, P13596, DOI 10.1021/bi035208m; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; MORRISON JF, 1958, BIOCHEM J, V68, P447, DOI 10.1042/bj0680447; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Niu XG, 2011, J MOL BIOL, V405, P479, DOI 10.1016/j.jmb.2010.11.007; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; PRICE NC, 1976, BIOCHIM BIOPHYS ACTA, V445, P364, DOI 10.1016/0005-2744(76)90090-5; Pruett PS, 2003, J BIOL CHEM, V278, P26952, DOI 10.1074/jbc.M212931200; Rao JK, 1998, FEBS LETT, V439, P133; Riviere G, 2012, FEBS J, V279, P2863, DOI 10.1111/j.1742-4658.2012.08667.x; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shen YQ, 2001, ACTA CRYSTALLOGR D, V57, P1196, DOI 10.1107/S0907444901007703; SHOEMAKER CB, 1994, MOL BIOCHEM PARASIT, V68, P319, DOI 10.1016/0166-6851(94)90177-5; STEIN LD, 1990, J BIOL CHEM, V265, P6582; Suzuki T, 1998, BBA-PROTEIN STRUCT M, V1388, P253, DOI 10.1016/S0167-4838(98)00167-8; Suzuki T, 1997, BBA-PROTEIN STRUCT M, V1343, P152, DOI 10.1016/S0167-4838(97)00128-3; Suzuki T, 2002, INT J BIOCHEM CELL B, V34, P1221, DOI 10.1016/S1357-2725(02)00050-X; Suzuki T, 2013, INT J BIOL MACROMOL, V57, P273, DOI 10.1016/j.ijbiomac.2013.02.023; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tisi D, 2001, ACTA CRYSTALLOGR D, V57, P187, DOI 10.1107/S0907444900015614; Tokuhiro S, 2014, MOL BIOCHEM PARASIT, V194, P56, DOI 10.1016/j.molbiopara.2014.04.010; Tokuhiro S, 2013, MOL BIOCHEM PARASIT, V188, P91, DOI 10.1016/j.molbiopara.2013.04.001; Uda K, 2008, COMP BIOCHEM PHYS B, V151, P176, DOI 10.1016/j.cbpb.2008.06.012; VIAL C, 1986, ARCH BIOCHEM BIOPHYS, V251, P558, DOI 10.1016/0003-9861(86)90364-4; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wu XA, 2010, FASEB J, V24, P242, DOI 10.1096/fj.09-140194; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xiao JY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002548; Yousef MS, 2003, PROTEIN SCI, V12, P103, DOI 10.1110/ps.0226303; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhou GF, 1998, P NATL ACAD SCI USA, V95, P8449, DOI 10.1073/pnas.95.15.8449; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	73	8	8	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12951	12963		10.1074/jbc.M114.628909	http://dx.doi.org/10.1074/jbc.M114.628909			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25837252	hybrid, Green Published			2022-12-28	WOS:000354569000044
J	Ogren, JI; Yi, A; Mamaev, S; Li, H; Spudich, JL; Rothschild, KJ				Ogren, John I.; Yi, Adrian; Mamaev, Sergey; Li, Hai; Spudich, John L.; Rothschild, Kenneth J.			Proton Transfers in a Channelrhodopsin-1 Studied by Fourier Transform Infrared (FTIR) Difference Spectroscopy and Site-directed Mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIFF-BASE COUNTERION; BACTERIORHODOPSIN PHOTOCYCLE; VIBRATIONAL SPECTROSCOPY; SENSORY RHODOPSIN; CONFORMATIONAL-CHANGES; RETINAL CHROMOPHORE; STRUCTURAL-CHANGES; PHOTOACTIVE SITE; NEURAL CIRCUITRY; RESONANCE RAMAN	Channelrhodopsin-1 from the alga Chlamydomonas augustae (CaChR1) is a low-efficiency light-activated cation channel that exhibits properties useful for optogenetic applications such as a slow light inactivation and a red-shifted visible absorption maximum as compared with the more extensively studied channelrhodopsin-2 from Chlamydomonas reinhardtii (CrChR2). Previously, both resonance Raman and low-temperature FTIR difference spectroscopy revealed that unlike CrChR2, CaChR1 under our conditions exhibits an almost pure all-trans retinal composition in the unphotolyzed ground state and undergoes an all-trans to 13-cis isomerization during the primary photo-transition typical of other microbial rhodopsins such as bacteriorhodopsin (BR). Here, we apply static and rapid-scan FTIR difference spectroscopy along with site-directed mutagenesis to characterize the proton transfer events occurring upon the formation of the long-lived conducting P-2(380) state of CaChR1. Assignment of carboxylic C = O stretch bands indicates that Asp-299 (homolog to Asp-212 in BR) becomes protonated and Asp-169 (homolog to Asp-85 in BR) undergoes a net change in hydrogen bonding relative to the unphotolyzed ground state of CaChR1. These data along with earlier FTIR measurements on the CaChR1 -> P1 transition are consistent with a two-step proton relay mechanism that transfers a proton from Glu-169 to Asp-299 during the primary phototransition and from the Schiff base to Glu-169 during P-2(380) formation. The unusual charge neutrality of both Schiff base counterions in the P-2(380) conducting state suggests that these residues may function as part of a cation selective filter in the open channel state of CaChR1 as well as other low-efficiency ChRs.	[Ogren, John I.; Yi, Adrian; Mamaev, Sergey; Rothschild, Kenneth J.] Boston Univ, Photon Ctr, Mol Biophys Lab, Boston, MA 02215 USA; [Ogren, John I.; Yi, Adrian; Mamaev, Sergey; Rothschild, Kenneth J.] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Li, Hai; Spudich, John L.] Univ Texas Houston, Hlth Sci Ctr, Ctr Membrane Biol, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Boston University; Boston University; University of Texas System; University of Texas Health Science Center Houston	Rothschild, KJ (corresponding author), Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA.	kjr@bu.edu	Regan, Clinton/E-6250-2012; Rothschild, Kenneth J/P-6177-2018	Rothschild, Kenneth J/0000-0002-2847-6671	National Science Foundation [CBET-1264434]; National Institutes of Health [5R01EY21022, R01GM027750]; Robert A. Welch Foundation [AU-0009]; NATIONAL EYE INSTITUTE [R01EY021022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027750] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1264434] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Science Foundation Grant CBET-1264434 and National Institutes of Health Grants 5R01EY21022 (to K. J. R.) and R01GM027750 (to J. L. S.). This work was also supported by the Hermann Eye Fund and Endowed Chair AU-0009 from the Robert A. Welch Foundation (to J. L. S.).	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bergo V, 2004, BIOCHEMISTRY-US, V43, P9075, DOI 10.1021/bi0361968; Bergo V, 2003, J BIOL CHEM, V278, P36556, DOI 10.1074/jbc.M303719200; Bergo V, 2002, PHOTOCHEM PHOTOBIOL, V76, P341, DOI 10.1562/0031-8655(2002)076<0341:AFTISO>2.0.CO;2; Bergo VB, 2006, J BIOL CHEM, V281, P15208, DOI 10.1074/jbc.M600033200; BOUSCHE O, 1992, PHOTOCHEM PHOTOBIOL, V56, P1085, DOI 10.1111/j.1751-1097.1992.tb09732.x; BOUSCHE O, 1991, J BIOL CHEM, V266, P11063; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; BROWN LS, 1995, J BIOL CHEM, V270, P27122, DOI 10.1074/jbc.270.45.27122; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P5862, DOI 10.1021/bi00073a020; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Hendler RW, 2011, APPL SPECTROSC, V65, P1029, DOI 10.1366/11-06302; HIRAYMA J, 1995, FEBS LETT, V364, P168, DOI 10.1016/0014-5793(95)00381-I; HONIG B, 1979, J AM CHEM SOC, V101, P7084, DOI 10.1021/ja00517a060; Hou SY, 2012, PHOTOCHEM PHOTOBIOL, V88, P119, DOI 10.1111/j.1751-1097.2011.01027.x; Ito S, 2014, J AM CHEM SOC, V136, P3475, DOI 10.1021/ja410836g; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kokaia M, 2011, DRUG TODAY, V47, P53, DOI 10.1358/dot.2011.47.1.1543306; Kraj JM, 2008, BIOCHEMISTRY-US, V47, P3447, DOI 10.1021/bi7018964; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Li H, 2014, BIOPHYS J, V106, P1607, DOI 10.1016/j.bpj.2014.03.002; Lorenz-Fonfria VA, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4895796; Luecke H, 2000, J MOL BIOL, V300, P1237, DOI 10.1006/jmbi.2000.3884; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MAEDA A, 1992, BIOCHEMISTRY-US, V31, P4684, DOI 10.1021/bi00134a022; Muders V, 2014, FEBS LETT, V588, P2301, DOI 10.1016/j.febslet.2014.05.019; Nack M, 2009, FEBS LETT, V583, P3676, DOI 10.1016/j.febslet.2009.10.052; Neumann-Verhoefen MK, 2013, J AM CHEM SOC, V135, P6968, DOI 10.1021/ja400554y; Ogren JI, 2015, BIOCHEMISTRY-US, V54, P377, DOI 10.1021/bi501243y; Ogren JI, 2014, BIOCHEMISTRY-US, V53, P3961, DOI 10.1021/bi500445c; Rath P, 1996, BIOCHEMISTRY-US, V35, P6690, DOI 10.1021/bi9600355; RATH P, 1993, J BIOL CHEM, V268, P17742; ROEPE P, 1987, BIOCHEMISTRY-US, V26, P6696, DOI 10.1021/bi00395a020; ROEPE PD, 1988, J BIOL CHEM, V263, P5110; ROTHSCHILD KJ, 1990, J BIOL CHEM, V265, P16985; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Sineshchekov OA, 2013, BIOPHYS J, V104, P807, DOI 10.1016/j.bpj.2013.01.002; SMITH SO, 1987, J PHYS CHEM-US, V91, P804, DOI 10.1021/j100288a011; Spudich JL, 2014, BBA-BIOENERGETICS, V1837, P546, DOI 10.1016/j.bbabio.2013.06.006; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	41	20	20	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12719	12730		10.1074/jbc.M114.634840	http://dx.doi.org/10.1074/jbc.M114.634840			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25802337	Green Published, hybrid			2022-12-28	WOS:000354569000024
J	Ma, BY; Liu, BF; Cao, WP; Gao, C; Qi, Z; Ning, YH; Chen, YG				Ma, Benyu; Liu, Bofeng; Cao, Weipeng; Gao, Chan; Qi, Zhen; Ning, Yuanheng; Chen, Ye-Guang			The Wnt Signaling Antagonist Dapper1 Accelerates Dishevelled2 Degradation via Promoting Its Ubiquitination and Aggregate-induced Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; p62 (sequestosome 1(SQSTM1)); protein aggregation; protein degradation; ubiquitylation (ubiquitination); Dishevelled; Dpr1; pVHL	SELECTIVE AUTOPHAGY; PROTEIN; CLEARANCE; DOMAIN; MACHINERY; RECEPTORS; REQUIRES; DISEASE; CATENIN; BINDING	Background: Protein aggregates could be degraded through autophagy. Results: Dpr1 promotes pVHL-induced Dvl2 ubiquitination and mediates the Vps34-Beclin1 complex formation induced by protein aggregates. Conclusion: Protein aggregates stimulate autophagy initiation in a Dpr1-dependent manner. Significance: This study shows that protein aggregates can induce autophagy to facilitate their clearance. Autophagy is a regulated process that sequesters and transports cytoplasmic materials such as protein aggregates via autophagosomes to lysosomes for degradation. Dapper1 (Dpr1), an interacting protein of Dishevelled (Dvl), antagonizes Wnt signaling by promoting Dishevelled degradation via lysosomes. However, the mechanism is unclear. Here, we show that Dpr1 promotes the von Hippel-Lindau tumor suppressor (VHL)-mediated ubiquitination of Dvl2 and its autophagic degradation. Knockdown of Dpr1 decreases the interaction between Dvl2 and pVHL, resulting in reduced ubiquitination of Dvl2. Dpr1-mediated autophagic degradation of Dvl2 depends on Dvl2 aggregation. Moreover, the aggregate-prone proteins Dvl2, p62, and the huntingtin mutant Htt103Q promote autophagy in a Dpr1-dependent manner. These protein aggregates enhance the Beclin1-Vps34 interaction and Atg14L puncta formation, indicating that aggregated proteins stimulate autophagy initiation. Ubiquitination is not essential for the aggregate-induced autophagy initiation as inhibition of the ubiquitin-activation E1 enzyme activity did not block the aggregate-induced Atg14L puncta formation. Our findings suggest that Dpr1 promotes the ubiquitination of Dvl2 by pVHL and mediates the protein aggregate-elicited autophagy initiation.	[Ma, Benyu; Liu, Bofeng; Cao, Weipeng; Gao, Chan; Qi, Zhen; Ning, Yuanheng; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University	Chen, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019		National Natural Science Foundation of China [31221064]; 973 Program [2010CB833706, 2011CB943803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grant 31221064 and the 973 Program Grants 2010CB833706 and 2011CB943803 (to Y. G. C.).	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chaari A, 2013, INT J BIOL MACROMOL, V60, P196, DOI 10.1016/j.ijbiomac.2013.05.032; Chen H, 2011, J BIOL CHEM, V286, P14870, DOI 10.1074/jbc.M110.211607; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041; Ding Y, 2013, J BIOL CHEM, V288, P8289, DOI 10.1074/jbc.M112.433185; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Fujita N, 2013, J CELL BIOL, V203, P115, DOI 10.1083/jcb.201304188; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Hurley JH, 2014, CELL, V157, P300, DOI 10.1016/j.cell.2014.01.070; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Kaelin WG, 2005, COLD SH Q B, V70, P159, DOI 10.1101/sqb.2005.70.001; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Kraft C, 2012, CURR OPIN CELL BIOL, V24, P496, DOI 10.1016/j.ceb.2012.05.001; Lamark Trond, 2012, Int J Cell Biol, V2012, P736905, DOI 10.1155/2012/736905; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Ma BY, 2014, CELL RES, V24, P912, DOI 10.1038/cr.2014.84; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Shibutani ST, 2014, CELL RES, V24, P58, DOI 10.1038/cr.2013.159; Suriben R, 2009, NAT GENET, V41, P977, DOI 10.1038/ng.435; Svenning S, 2013, ESSAYS BIOCHEM, V55, P79, DOI [10.1042/bse0550079, 10.1042/BSE0550079]; Wen J, 2010, J BIOL CHEM, V285, P11023, DOI 10.1074/jbc.M109.085381; Wong E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2244; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Yang YH, 2013, P NATL ACAD SCI USA, V110, P6841, DOI 10.1073/pnas.1217692110; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200	42	30	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12346	12354		10.1074/jbc.M115.654590	http://dx.doi.org/10.1074/jbc.M115.654590			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25825496	Green Published, hybrid			2022-12-28	WOS:000354388600043
J	Noh, KT; Son, KH; Jung, ID; Kang, TH; Choi, CH; Park, YM				Noh, Kyung Tae; Son, Kwang Hee; Jung, In Duk; Kang, Tae Heung; Choi, Chang Hun; Park, Yeong-Min			Glycogen Synthase Kinase-3 (GSK-3) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon--induced Indoleamine 2,3-Dioxygenase Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; dendritic cell; glycogen synthase kinase 3 (GSK-3); indoleamine-pyrrole 2; 3-dioxygenase (IDO1); interferon; cancer vaccine	IFN-GAMMA; REJECTION; ACTIVATION; TOLERANCE; STAT1; GENE; LPS	Background: IDO functions as a crucial mediator of tumor-mediated immune tolerance. Results: Here, we found that GSK-3-dependent IDO expression in the dendritic cell plays a role in anti-tumor activity via the regulation of CD8(+) T-cell proliferation and CTL activity. Conclusion: GSK-3 activity functions in the immune enhancement-mediated anti-tumor response via IDO regulation. Significance: We proved the effectiveness of the GSK-3-dependent IDO regulatory mechanism in DC-based cancer vaccination. Indoleamine 2,3-dioxygenase (IDO) functions as a crucial mediator of tumor-mediated immune tolerance by causing T-cell suppression via tryptophan starvation in a tumor environment. Glycogen synthase kinase-3 (GSK-3) is also involved in immune and anti-tumor responses. However, the relativity of these proteins has not been as well defined. Here, we found that GSK-3-dependent IDO expression in the dendritic cell (DC) plays a role in anti-tumor activity via the regulation of CD8(+) T-cell polarization and cytotoxic T lymphocyte activity. By the inhibition of GSK-3, attenuated IDO expression and impaired JAK1/2-Stat signaling crucial for IDO expression were observed. Protein kinase C (PKC) activity and the interaction between JAK1/2 and Stat3, which are important for IDO expression, were also reduced by GSK-3 inhibition. CD8(+) T-cell proliferation mediated by OVA-pulsed DC was blocked by interferon (IFN)--induced IDO expression via GSK-3 activity. Specific cytotoxic T lymphocyte activity mediated by OVA-pulsed DC against OVA-expressing EG7 thymoma cells but not OVA-nonexpressing EL4 thymoma cells was also attenuated by the expressed IDO via IFN--induced activation of GSK-3. Furthermore, tumor growth that was suppressed with OVA-pulsed DC vaccination was restored by IDO-expressing DC via IFN--induced activation of GSK-3 in an OVA-expressing murine EG7 thymoma model. Taken together, DC-based immune response mediated by interferon--induced IDO expression via GSK-3 activity not only regulates CD8(+) T-cell proliferation and cytotoxic T lymphocyte activity but also modulates OVA-pulsed DC vaccination against EG7 thymoma.	[Noh, Kyung Tae; Choi, Chang Hun] Armed Forces Med Res Inst, Dept Infect Dis, Taejon 305878, South Korea; [Son, Kwang Hee; Jung, In Duk; Kang, Tae Heung; Park, Yeong-Min] Konkuk Univ, Sch Med, Dept Immunol, Lab Dendrit Cell Differentiat & Regulat, Chungju 380701, South Korea	Konkuk University; Konkuk University Medical Center	Noh, KT (corresponding author), Armed Forces Med Res Inst, Dept Infect Dis, 90bun, Taejon 305878, South Korea.	nkt2062@hanmail.net; immun3023@kku.ac.kr			Basic Science Research Program through National Research Foundation of Korea - Ministry of Education, Science and Technology [2012R1A1A2042924, 2012R1A2A1A03008433]	Basic Science Research Program through National Research Foundation of Korea - Ministry of Education, Science and Technology	This work was supported by the Basic Science Research Program Grants 2012R1A1A2042924 and 2012R1A2A1A03008433 through National Research Foundation of Korea funded by the Ministry of Education, Science and Technology.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Chon SY, 1996, J BIOL CHEM, V271, P17247, DOI 10.1074/jbc.271.29.17247; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Ferrantini M, 2008, CYTOKINE GROWTH F R, V19, P93, DOI 10.1016/j.cytogfr.2007.10.003; Friberg M, 2002, INT J CANCER, V101, P151, DOI 10.1002/ijc.10645; Hayashi T, 2004, J CLIN INVEST, V114, P270, DOI 10.1172/JCI200421275; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jeong YI, 2009, J BIOL CHEM, V284, P3700, DOI 10.1074/jbc.M807328200; Lin CF, 2008, J CELL BIOCHEM, V105, P746, DOI 10.1002/jcb.21868; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Lob S, 2009, NAT REV CANCER, V9, P445, DOI 10.1038/nrc2639; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Muller AJ, 2007, CURR CANCER DRUG TAR, V7, P31, DOI 10.2174/156800907780006896; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Noh KT, 2011, EXP CELL RES, V317, P1663, DOI 10.1016/j.yexcr.2011.03.022; Noh KT, 2010, FEBS LETT, V584, P4097, DOI 10.1016/j.febslet.2010.08.029; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Rodionova E, 2007, BLOOD, V109, P1584, DOI 10.1182/blood-2006-06-028951; TAKIKAWA O, 1990, J IMMUNOL, V145, P1246; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Zhang YY, 2000, BLOOD, V95, P138	26	14	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12394	12402		10.1074/jbc.M114.628578	http://dx.doi.org/10.1074/jbc.M114.628578			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25814664	Green Published, hybrid			2022-12-28	WOS:000354388600047
J	Bagheri-Yarmand, R; Sinha, KM; Gururaj, AE; Ahmed, Z; Rizvi, YQ; Huang, SC; Ladbury, JE; Bogler, O; Williams, MD; Cote, GJ; Gagel, RF				Bagheri-Yarmand, Rozita; Sinha, Krishna M.; Gururaj, Anupama E.; Ahmed, Zamal; Rizvi, Yasmeen Q.; Huang, Su-Chen; Ladbury, John E.; Bogler, Oliver; Williams, Michelle D.; Cote, Gilbert J.; Gagel, Robert F.			A Novel Dual Kinase Function of the RET Proto-oncogene Negatively Regulates Activating Transcription Factor 4-mediated Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY-THYROID-CARCINOMA; ENDOPLASMIC-RETICULUM STRESS; RECEPTOR TYROSINE KINASES; BREAST-CANCER CELLS; FACTOR 4 ATF4; ER-STRESS; NEUROTROPHIC FACTOR; UP-REGULATION; BCL-2 FAMILY; LUNG-CANCER	The RET proto-oncogene, a tyrosine kinase receptor, is widely known for its essential role in cell survival. Germ line missense mutations, which give rise to constitutively active oncogenic RET, were found to cause multiple endocrine neoplasia type 2, a dominant inherited cancer syndrome that affects neuroendocrine organs. However, the mechanisms by which RET promotes cell survival and prevents cell death remain elusive. We demonstrate that in addition to cytoplasmic localization, RET is localized in the nucleus and functions as a tyrosine-threonine dual specificity kinase. Knockdown of RET by shRNA in medullary thyroid cancer-derived cells stimulated expression of activating transcription factor 4 (ATF4), a master transcription factor for stress-induced apoptosis, through activation of its target proapoptotic genes NOXA and PUMA. RET knockdown also increased sensitivity to cisplatin-induced apoptosis. We observed that RET physically interacted with and phosphorylated ATF4 at tyrosine and threonine residues. Indeed, RET kinase activity was required to inhibit the ATF4-dependent activation of the NOXA gene because the site-specific substitution mutations that block threonine phosphorylation increased ATF4 stability and activated its targets NOXA and PUMA. Moreover, chromatin immunoprecipitation assays revealed that ATF4 occupancy increased at the NOXA promoter in TT cells treated with tyrosine kinase inhibitors or the ATF4 inducer eeyarestatin as well as in RET-depleted TT cells. Together these findings reveal RET as a novel dual kinase with nuclear localization and provide mechanisms by which RET represses the proapoptotic genes through direct interaction with and phosphorylation-dependent inactivation of ATF4 during the pathogenesis of medullary thyroid cancer.	[Bagheri-Yarmand, Rozita; Sinha, Krishna M.; Rizvi, Yasmeen Q.; Huang, Su-Chen; Cote, Gilbert J.; Gagel, Robert F.] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA; [Gururaj, Anupama E.; Bogler, Oliver] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Ahmed, Zamal; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Ahmed, Zamal; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Ctr Biomol Struct & Funct, Houston, TX 77030 USA; [Williams, Michelle D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Bagheri-Yarmand, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Unit 1461,1515 Holcombe Blvd, Houston, TX 77030 USA.	ryarmand@mdanderson.org		Williams, Michelle D./0000-0002-9133-7332; Bogler, Oliver/0000-0002-3700-0480; Ladbury, John/0000-0002-6328-7200; Bagheri-Yarmand, Rozita/0000-0001-5139-6381	American Thyroid Association; Kosberg Foundation; National Institutes of Health Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA168505] Funding Source: NIH RePORTER	American Thyroid Association; Kosberg Foundation; National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an American Thyroid Association research grant (to R. B.Y.) and by a Kosberg Foundation grant (to R. F. G.). This work was also supported, in whole or in part, by National Institutes of Health Cancer Center Support Grant CA016672 (to the University of Texas M.D. Anderson Cancer Center).	Ahmed Z, 2013, J CELL BIOL, V200, P493, DOI 10.1083/jcb.201204106; Ahmed Z, 2010, CELL SIGNAL, V22, P23, DOI 10.1016/j.cellsig.2009.08.011; Ampofo E, 2013, BBA-MOL CELL RES, V1833, P439, DOI 10.1016/j.bbamcr.2012.10.025; Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; Bagheri-Yarmand R, 2001, J BIOL CHEM, V276, P29403, DOI 10.1074/jbc.M103129200; Ballerini P, 2012, LEUKEMIA, V26, P2384, DOI 10.1038/leu.2012.109; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; COOLEY LD, 1995, CANCER GENET CYTOGEN, V80, P138, DOI 10.1016/0165-4608(94)00185-E; Diaz-Beya M, 2013, LEUKEMIA, V27, P595, DOI 10.1038/leu.2012.278; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Drosten M, 2004, JNCI-J NATL CANCER I, V96, P1231, DOI 10.1093/jnci/djh226; Fonseca-Pereira D, 2014, NATURE, V514, P98, DOI 10.1038/nature13498; Frank CL, 2010, J BIOL CHEM, V285, P33324, DOI 10.1074/jbc.M110.140699; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Gattelli A, 2013, EMBO MOL MED, V5, P1335, DOI 10.1002/emmm.201302625; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Kawai K, 2000, CANCER RES, V60, P5254; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Koyanagi S, 2011, J BIOL CHEM, V286, P32416, DOI 10.1074/jbc.M111.258970; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Nakajima W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.6; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Nikiforov YE, 1997, CANCER RES, V57, P1690; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ohshima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010279; Parthasarathy R, 1999, CANCER RES, V59, P3911; Pike LRG, 2013, BIOCHEM J, V449, P389, DOI 10.1042/BJ20120972; Portella G, 1996, ONCOGENE, V13, P2021; Qing GL, 2012, CANCER CELL, V22, P631, DOI 10.1016/j.ccr.2012.09.021; Richardson DS, 2012, MOL BIOL CELL, V23, P3838, DOI 10.1091/mbc.E12-02-0114; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Velasco JA, 1997, INT J CANCER, V73, P449, DOI 10.1002/(SICI)1097-0215(19971104)73:3<449::AID-IJC21>3.0.CO;2-6; Vitagliano D, 2011, ENDOCR-RELAT CANCER, V18, P1, DOI 10.1677/ERC-09-0292; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wells SA, 2009, CLIN CANCER RES, V15, P7119, DOI 10.1158/1078-0432.CCR-08-2742; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Zeng Q, 2008, J INT MED RES, V36, P656, DOI 10.1177/147323000803600406; Zhang L, 2011, CELL DEATH DIFFER, V18, P864, DOI 10.1038/cdd.2010.152; Zhu W, 2010, J CLIN ENDOCR METAB, V95, P439, DOI 10.1210/jc.2009-1485	52	34	35	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11749	11761		10.1074/jbc.M114.619833	http://dx.doi.org/10.1074/jbc.M114.619833			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25795775	hybrid, Green Published			2022-12-28	WOS:000353719400047
J	Tykvart, J; Barinka, C; Svoboda, M; Navratil, V; Soucek, R; Hubalek, M; Hradilek, M; Sacha, P; Lubkowski, J; Konvalinka, J				Tykvart, Jan; Barinka, Cyril; Svoboda, Michal; Navratil, Vaclav; Soucek, Radko; Hubalek, Martin; Hradilek, Martin; Sacha, Pavel; Lubkowski, Jacek; Konvalinka, Jan			Structural and Biochemical Characterization of a Novel Aminopeptidase from Human Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE-CARBOXYPEPTIDASE-II; REACTION-MECHANISM; EXPRESSION; PEPTIDASE; CRYSTALLOGRAPHY; INHIBITION; PROTEINS; ENZYME; RAT	N-acetylated alpha-linked acidic dipeptidase-like protein (NAALADase L), encoded by the NAALADL1 gene, is a close homolog of glutamate carboxypeptidase II, a metallopeptidase that has been intensively studied as a target for imaging and therapy of solid malignancies and neuropathologies. However, neither the physiological functions nor structural features of NAALADase L are known at present. Here, we report a thorough characterization of the protein product of the human NAALADL1 gene, including heterologous overexpression and purification, structural and biochemical characterization, and analysis of its expression profile. By solving the NAALADase L x-ray structure, we provide the first experimental evidence that it is a zinc-dependent metallopeptidase with a catalytic mechanism similar to that of glutamate carboxypeptidase II yet distinct substrate specificity. Aproteome-based assay revealed that the NAALADL1 gene product possesses previously unrecognized aminopeptidase activity but no carboxy-or endopeptidase activity. These findings were corroborated by site-directed mutagenesis and identification of bestatin as a potent inhibitor of the enzyme. Analysis of NAALADL1 gene expression at both the mRNA and protein levels revealed the small intestine as the major site of protein expression and points toward extensive alternative splicing of the NAALADL1 gene transcript. Taken together, our data imply that the NAALADL1 gene product's primary physiological function is associated with the final stages of protein/peptide digestion and absorption in the human digestive system. Based on these results, we suggest a new name for this enzyme: human ileal aminopeptidase (HILAP).	[Tykvart, Jan; Svoboda, Michal; Navratil, Vaclav; Soucek, Radko; Hubalek, Martin; Hradilek, Martin; Sacha, Pavel; Konvalinka, Jan] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Gilead Sci & IOCB Res Ctr, CR-16610 Prague 6, Czech Republic; [Tykvart, Jan; Navratil, Vaclav; Sacha, Pavel; Konvalinka, Jan] Charles Univ Prague, Fac Nat Sci, Dept Biochem, Prague 2, Czech Republic; [Svoboda, Michal] Charles Univ Prague, Fac Nat Sci, Dept Phys & Macromol Chem, Prague 2, Czech Republic; [Barinka, Cyril] Acad Sci Czech Republic, Inst Biotechnol, Prague 4, Czech Republic; [Lubkowski, Jacek] NCI, Ctr Canc Res, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Gilead Sciences; Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Konvalinka, J (corresponding author), Acad Sci Czech Republic, Inst Organ Chem & Biochem, Vvi, Flemingovo 2, Prague 16610 6, Czech Republic.	jan.konvalinka@uochb.cas.cz	Sacha, Pavel/G-9729-2014; Tykvart, Jan/G-6770-2014; Navrátil, Václav/G-6756-2014; Hubalek, Martin/H-1400-2014; Barinka, Cyril/G-9803-2014	Sacha, Pavel/0000-0001-6198-9826; Tykvart, Jan/0000-0002-6938-1513; Navrátil, Václav/0000-0002-6019-5394; Hubalek, Martin/0000-0003-0247-7956; Barinka, Cyril/0000-0003-2751-3060; Konvalinka, Jan/0000-0003-0695-9266	Grant Agency of the Czech Republic [P304-12-0847]; InterBioMed Project from Ministry of Education of the Czech Republic [LO 1302]; National Institutes of Health, NCI, Center for Cancer Research, Intramural Research Program; European Regional Development Fund [CZ.1.05/1.1.00/02.0109]; United States Department of Energy [W-31-109-Eng38]; EMBO [1978, 249220]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); InterBioMed Project from Ministry of Education of the Czech Republic; National Institutes of Health, NCI, Center for Cancer Research, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Regional Development Fund(European Commission); United States Department of Energy(United States Department of Energy (DOE)); EMBO(European Molecular Biology Organization (EMBO))	This work was supported by Grant Agency of the Czech Republic (Grant P304-12-0847) and InterBioMed Project LO 1302 from the Ministry of Education of the Czech Republic. This work was also supported in part by the National Institutes of Health, NCI, Center for Cancer Research, Intramural Research Program (to J. L.) and also in part by project "BIOCEV" (CZ.1.05/1.1.00/02.0109) from the European Regional Development Fund (to C. B.). The use of the Advanced Photon Source was supported by United States Department of Energy Contract W-31-109-Eng38.; Supported by EMBO Installation Grant 1978 and Installation Research Grant Project 249220.	Barinka C, 2002, J NEUROCHEM, V80, P477, DOI 10.1046/j.0022-3042.2001.00715.x; BARLOS K, 1991, INT J PEPT PROT RES, V37, P513; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hlouchova K, 2007, J NEUROCHEM, V101, P682, DOI 10.1111/j.1471-4159.2006.04341.x; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Klusak V, 2009, BIOCHEMISTRY-US, V48, P4126, DOI 10.1021/bi900220s; Kozisek M, 2008, J VIROL, V82, P5869, DOI 10.1128/JVI.02325-07; Krissinel Evgeny, 2012, J Mol Biochem, V1, P76; Langone J. J., 1986, METHOD ENZYMOL, V121, P1; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Lindner HA, 2003, J BIOL CHEM, V278, P44496, DOI 10.1074/jbc.M304233200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mesters JR, 2006, EMBO J, V25, P1375, DOI 10.1038/sj.emboj.7600969; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navratil M, 2014, FEBS J, V281, P3228, DOI 10.1111/febs.12857; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pangalos MN, 1999, J BIOL CHEM, V274, P8470, DOI 10.1074/jbc.274.13.8470; Pavlicek J, 2012, CURR MED CHEM, V19, P1300, DOI 10.2174/092986712799462667; Rovenska M, 2008, PROSTATE, V68, P171, DOI 10.1002/pros.20676; Schilling O, 2011, NAT PROTOC, V6, P111, DOI 10.1038/nprot.2010.178; Sedo A, 2001, BBA-PROTEIN STRUCT M, V1550, P107, DOI 10.1016/S0167-4838(01)00278-3; Shneider BL, 1997, J BIOL CHEM, V272, P31006, DOI 10.1074/jbc.272.49.31006; Taylor A., 1996, THE AMINOPEPTIDASES, P1; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tykvart J, 2012, PROTEIN EXPRES PURIF, V82, P106, DOI 10.1016/j.pep.2011.11.016; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Woodward C., 2007, Agilent Technologies Application Note 5989-6297 EN, Patent No. 59896297; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006	31	9	9	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11321	11336		10.1074/jbc.M114.628149	http://dx.doi.org/10.1074/jbc.M114.628149			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25752612	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000353719400010
J	Kubota, S; Morii, M; Yuki, R; Yamaguchi, N; Yamaguchi, H; Aoyama, K; Kuga, T; Tomonaga, T; Yamaguchi, N				Kubota, Sho; Morii, Mariko; Yuki, Ryuzaburo; Yamaguchi, Noritaka; Yamaguchi, Hiromi; Aoyama, Kazumasa; Kuga, Takahisa; Tomonaga, Takeshi; Yamaguchi, Naoto			Role for Tyrosine Phosphorylation of A-kinase Anchoring Protein 8 (AKAP8) in Its Dissociation from Chromatin and the Nuclear Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOME CONDENSATION; OXIDATIVE STRESS; GROWTH-FACTOR; ATM PROTEIN; AURORA-B; SRC; ABL; LYN; ACTIVATION; LOCALIZATION	Protein-tyrosine phosphorylation regulates a wide variety of cellular processes at the plasma membrane. Recently, we showed that nuclear tyrosine kinases induce global nuclear structure changes, which we called chromatin structural changes. However, the mechanisms are not fully understood. In this study we identify protein kinase A anchoring protein 8 (AKAP8/AKAP95), which associates with chromatin and the nuclear matrix, as a nuclear tyrosine-phosphorylated protein. Tyrosine phosphorylation of AKAP8 is induced by several tyrosine kinases, such as Src, Fyn, and c-Abl but not Syk. Nucleus-targeted Lyn and c-Src strongly dissociate AKAP8 from chromatin and the nuclear matrix in a kinase activity-dependent manner. The levels of tyrosine phosphorylation of AKAP8 are decreased by substitution of multiple tyrosine residues on AKAP8 into phenylalanine. Importantly, the phenylalanine mutations of AKAP8 inhibit its dissociation from nuclear structures, suggesting that the association/dissociation of AKAP8 with/from nuclear structures is regulated by its tyrosine phosphorylation. Furthermore, the phenylalanine mutations of AKAP8 suppress the levels of nuclear tyrosine kinase-induced chromatin structural changes. In contrast, AKAP8 knockdown increases the levels of chromatin structural changes. Intriguingly, stimulation with hydrogen peroxide induces chromatin structural changes accompanied by the dissociation of AKAP8 from nuclear structures. These results suggest that AKAP8 is involved in the regulation of chromatin structural changes through nuclear tyrosine phosphorylation.	[Kubota, Sho; Morii, Mariko; Yuki, Ryuzaburo; Yamaguchi, Noritaka; Yamaguchi, Hiromi; Aoyama, Kazumasa; Yamaguchi, Naoto] Chiba Univ, Dept Mol Cell Biol, Grad Sch Pharmaceut Sci, Chuo Ku, Inahana 1-8-1, Chiba 2608675, Japan; [Kubota, Sho; Morii, Mariko; Yuki, Ryuzaburo; Yamaguchi, Noritaka; Yamaguchi, Hiromi; Aoyama, Kazumasa; Yamaguchi, Naoto] Chiba Univ, Dept Mol Cell Biol, Grad Sch Pharmaceut Sci, Chiba 2608675, Japan; [Kuga, Takahisa; Tomonaga, Takeshi] Natl Inst Biomed Innovat, Lab Proteome Res, Osaka 5670085, Japan	Chiba University; Chiba University; National Institute of Health Sciences - Japan	Yamaguchi, N (corresponding author), Chiba Univ, Dept Mol Cell Biol, Grad Sch Pharmaceut Sci, Chuo Ku, Inahana 1-8-1, Chiba 2608675, Japan.	nyama@faculty.chiba-u.jp	Kuga, Takahisa/AAX-9334-2020	Kubota, Sho/0000-0001-6119-1259	Global COE Program (Global Center for Education and Research in Immune Regulation and Treatment); Program for Leading Graduate Schools (Nurture of Creative Research Leaders in Immune System Regulation and Innovative Therapeutics) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology;  [25460356];  [264367]; Grants-in-Aid for Scientific Research [15K19545, 26460081] Funding Source: KAKEN	Global COE Program (Global Center for Education and Research in Immune Regulation and Treatment)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Leading Graduate Schools (Nurture of Creative Research Leaders in Immune System Regulation and Innovative Therapeutics) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research C 25460356 (to N. Y.) and JSPS fellows 264367 (to S. K.), the Global COE Program (Global Center for Education and Research in Immune Regulation and Treatment), and the Program for Leading Graduate Schools (Nurture of Creative Research Leaders in Immune System Regulation and Innovative Therapeutics) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology.	Akileswaran L, 2001, J BIOL CHEM, V276, P17448, DOI 10.1074/jbc.M101171200; Amanchy R, 2008, J PROTEOME RES, V7, P3900, DOI 10.1021/pr800198w; Aoyama K, 2015, CELL BIOL INT, V39, P446, DOI 10.1002/cbin.10413; Aoyama K, 2013, EXP CELL RES, V319, P3251, DOI 10.1016/j.yexcr.2013.09.003; Aoyama K, 2011, EXP CELL RES, V317, P2874, DOI 10.1016/j.yexcr.2011.09.013; BJORGE JD, 1995, J BIOL CHEM, V270, P24222, DOI 10.1074/jbc.270.41.24222; Cans C, 2000, BIOCHEM PHARMACOL, V60, P1203, DOI 10.1016/S0006-2952(00)00434-2; Cencioni C, 2013, INT J MOL SCI, V14, P17643, DOI 10.3390/ijms140917643; Chan H. L., 2010, J BIOL CHEM, V285, P4307; Chellappa K, 2012, P NATL ACAD SCI USA, V109, P2302, DOI 10.1073/pnas.1106799109; Chou RH, 2014, DEV CELL, V30, P224, DOI 10.1016/j.devcel.2014.06.008; Eide T, 2003, J BIOL CHEM, V278, P26750, DOI 10.1074/jbc.M300765200; Eide T, 2002, EMBO REP, V3, P426, DOI 10.1093/embo-reports/kvf089; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Gonzalez-Zuniga M, 2014, MOL CELL, V56, P163, DOI 10.1016/j.molcel.2014.08.013; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Guilluy C, 2014, NAT CELL BIOL, V16, P376, DOI 10.1038/ncb2927; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Hasegawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116048; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Ikeda K, 2008, EXP CELL RES, V314, P3392, DOI 10.1016/j.yexcr.2008.08.019; Ishibashi K, 2013, J CELL SCI, V126, P625, DOI 10.1242/jcs.116277; Jiang H, 2013, NAT STRUCT MOL BIOL, V20, P1156, DOI 10.1038/nsmb.2656; Kaidi A, 2013, NATURE, V498, P70, DOI 10.1038/nature12201; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kubota S, 2013, J BIOL CHEM, V288, P17871, DOI 10.1074/jbc.M112.437756; Kubota S, 2014, J BIOL CHEM, V289, P5730, DOI 10.1074/jbc.M113.546655; LAW CL, 1994, J BIOL CHEM, V269, P12310; Li Y, 2006, GENE DEV, V20, P2566, DOI 10.1101/gad.1455006; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Nakayama Y, 2005, EXP CELL RES, V304, P570, DOI 10.1016/j.yexcr.2004.11.027; Nakayama Y, 2006, EXP CELL RES, V312, P2252, DOI 10.1016/j.yexcr.2006.03.021; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Nishibuchi G., 2014, NUCLEIC ACIDS RES, V42, P12498; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Obata Y, 2010, J CELL SCI, V123, P2649, DOI 10.1242/jcs.066266; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Reynolds AB, 2014, ONCOGENE, V33, P4537, DOI 10.1038/onc.2013.416; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Soeda S, 2013, EXP CELL RES, V319, P1382, DOI 10.1016/j.yexcr.2013.02.023; Sun XG, 2000, J BIOL CHEM, V275, P17237, DOI 10.1074/jbc.C000099200; Sundar IK, 2013, ANTIOXID REDOX SIGN, V18, P1956, DOI 10.1089/ars.2012.4863; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Tamura T, 2000, INT IMMUNOL, V12, P1205, DOI 10.1093/intimm/12.8.1205; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yamaguchi N, 2001, J CELL SCI, V114, P1631; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237; Yuki R., 2015, J CELL BIOCHEM, DOI [10.1002/icb.25046, DOI 10.1002/ICB.25046]	58	18	19	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10891	10904		10.1074/jbc.M115.643882	http://dx.doi.org/10.1074/jbc.M115.643882			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25770215	Green Published, hybrid			2022-12-28	WOS:000353404500028
J	Martin, J; Hudson, J; Hornung, T; Frasch, WD				Martin, James; Hudson, Jennifer; Hornung, Tassilo; Frasch, Wayne D.			F-o-driven Rotation in the ATP Synthase Direction against the Force of F-1 ATPase in the FoF1 ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUBSTITUTIONS; ESCHERICHIA-COLI; ROTOR RING; SUBUNIT-C; MOLECULAR MOTORS; ALPHA-SUBUNIT; CROSS-LINKING; MECHANISM; F-1-ATPASE; TRANSLOCATION	Living organisms rely on the FoF1 ATP synthase to maintain the non-equilibrium chemical gradient of ATP to ADP and phosphate that provides the primary energy source for cellular processes. How the F-o motor uses a transmembrane electrochemical ion gradient to create clockwise torque that overcomes F-1 ATPase-driven counterclockwise torque at high ATP is a major unresolved question. Using single FoF1 molecules embedded in lipid bilayer nanodiscs, we now report the observation of F-o-dependent rotation of the c10 ring in the ATP synthase (clockwise) direction against the counterclockwise force of ATPase-driven rotation that occurs upon formation of a leash with F-o stator subunit a. Mutational studies indicate that the leash is important for ATP synthase activity and support a mechanism in which residues aGlu-196 and cArg-50 participate in the cytoplasmic proton half-channel to promote leash formation.	[Martin, James; Hudson, Jennifer; Hornung, Tassilo; Frasch, Wayne D.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Frasch, WD (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	frasch@asu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01GM097510]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported, in whole or in part, by National Institutes of Health Grant R01GM097510 (to W. D. F.).	Aksimentiev A., 2004, INSIGHTS MOL MECH RO; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; BREEN GAM, 1986, J BIOL CHEM, V261, P1680; Chen RM, 2004, J BIOL CHEM, V279, P21883, DOI 10.1074/jbc.M402074200; COX GB, 1986, BIOCHIM BIOPHYS ACTA, V849, P62, DOI 10.1016/0005-2728(86)90096-4; Dautant A, 2010, J BIOL CHEM, V285, P29502, DOI 10.1074/jbc.M110.124529; DeLeon-Rangel J, 2013, FEBS LETT, V587, P892, DOI 10.1016/j.febslet.2013.02.012; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Fillingame R. H., 2014, BIOCHIM BIOPHYS ACTA, P1063; FILLINGAME RH, 1984, J BACTERIOL, V158, P1078, DOI 10.1128/JB.158.3.1078-1083.1984; GIRVIN ME, 1994, BIOCHEMISTRY-US, V33, P665, DOI 10.1021/bi00169a006; Hakulinen JK, 2012, P NATL ACAD SCI USA, V109, pE2050, DOI 10.1073/pnas.1203971109; Hornung T, 2011, METHODS MOL BIOL, V778, P273, DOI 10.1007/978-1-61779-261-8_18; Ishmukhametov R, 2010, EMBO J, V29, P3911, DOI 10.1038/emboj.2010.259; Ishmukhametov RR, 2008, BBA-BIOENERGETICS, V1777, P32, DOI 10.1016/j.bbabio.2007.11.004; JOHN UP, 1986, FEBS LETT, V207, P79, DOI 10.1016/0014-5793(86)80016-3; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; KUSHMERICK MJ, 1992, AM J PHYSIOL, V263, pC598, DOI 10.1152/ajpcell.1992.263.3.C598; KUSHMERICK MJ, 1992, P NATL ACAD SCI USA, V89, P7521, DOI 10.1073/pnas.89.16.7521; LIGHTOWLERS RN, 1987, BIOCHIM BIOPHYS ACTA, V894, P399, DOI 10.1016/0005-2728(87)90118-6; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; Lowry DS, 2005, BIOCHEMISTRY-US, V44, P7275, DOI 10.1021/bi047293j; Martin JL, 2014, P NATL ACAD SCI USA, V111, P3715, DOI 10.1073/pnas.1317784111; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Moore KJ, 2008, J BIOL CHEM, V283, P13044, DOI 10.1074/jbc.M800900200; Moore KJ, 2013, J BIOL CHEM, V288, P25535, DOI 10.1074/jbc.M113.496794; Noji H, 2001, J BIOL CHEM, V276, P25480, DOI 10.1074/jbc.M102200200; Oster G, 2000, PHILOS T ROY SOC B, V355, P523, DOI 10.1098/rstb.2000.0593; Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; RAY MK, 1988, BIOCHIM BIOPHYS ACTA, V951, P213, DOI 10.1016/0167-4781(88)90042-5; Saroussi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043045; Schulz S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001596; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; Spetzler D, 2006, BIOCHEMISTRY-US, V45, P3117, DOI 10.1021/bi052363n; Spetzler D, 2012, ADV PHOTOSYNTH RESP, V34, P561, DOI 10.1007/978-94-007-1579-0_22; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Symersky J, 2012, NAT STRUCT MOL BIOL, V19, P485, DOI 10.1038/nsmb.2284; Turina P, 2003, EMBO J, V22, P418, DOI 10.1093/emboj/cdg073; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; VIK SB, 1988, J BIOL CHEM, V263, P6599; VIK SB, 1994, J BIOL CHEM, V269, P30364; Vollmar M, 2009, J BIOL CHEM, V284, P18228, DOI 10.1074/jbc.M109.006916; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; Walpole TB, 2015, MOL CELL PROTEOMICS, V14, P828, DOI 10.1074/mcp.M114.047456; Watanabe R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2631; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Zhang D, 2003, J BIOL CHEM, V278, P12319, DOI 10.1074/jbc.M212413200	52	11	13	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10717	10728		10.1074/jbc.M115.646430	http://dx.doi.org/10.1074/jbc.M115.646430			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25713065	hybrid, Green Published			2022-12-28	WOS:000353404500014
J	Sarma, T; Koutsouris, A; Yu, JZ; Krbanjevic, A; Hope, TJ; Rasenick, MM				Sarma, Tulika; Koutsouris, Athanasia; Yu, Jiang Zhu; Krbanjevic, Aleksandar; Hope, Thomas J.; Rasenick, Mark M.			Activation of Microtubule Dynamics Increases Neuronal Growth via the Nerve Growth Factor (NGF)- and G alpha(s)-mediated Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein; Growth Factor; Microtubule; Neurite Outgrowth; Neurotrophin	HETEROTRIMERIC G-PROTEINS; FLUID SHEAR-STRESS; CELL-SHAPE CHANGE; MEMBRANE EXPANSION; ACTIN CYTOSKELETON; NEURITE OUTGROWTH; ENDOTHELIAL-CELLS; PLASMA-MEMBRANE; ALPHA-SUBUNITS; LIPID RAFTS	Signals that activate the G protein G(s) and promote neuronal differentiation evoke G(s) internalization in rat pheochromocytoma (PC12) cells. These agents also significantly increase G(s) association with microtubules, resulting in an increase in microtubule dynamics because of the activation of tubulin GTPase by G(s). To determine the function of G(s)/microtubule association in neuronal development, we used real-time trafficking of a GFP-G(s) fusion protein. GFP-G(s) concentrates at the distal end of the neurites in differentiated living PC12 cells as well as in cultured hippocampal neurons. G(s) translocates to specialized membrane compartments at tips of growing neurites. A dominant-negative G chimera that interferes with G(s) binding to tubulin and activation of tubulin GTPase attenuates neurite elongation and neurite number both in PC12 cells and primary hippocampal neurons. This effect is greatest on differentiation induced by activated G(s). Together, these data suggest that activated G(s) translocates from the plasma membrane and, through interaction with tubulin/microtubules in the cytosol, is important for neurite formation, development, and outgrowth. Characterization of neuronal G protein dynamics and their contribution to microtubule dynamics is important for understanding the molecular mechanisms by which G protein-coupled receptor signaling orchestrates neuronal growth and differentiation.	[Sarma, Tulika; Koutsouris, Athanasia; Yu, Jiang Zhu; Krbanjevic, Aleksandar; Rasenick, Mark M.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Krbanjevic, Aleksandar; Rasenick, Mark M.] Univ Illinois, Coll Med, Psychiat, Chicago, IL 60612 USA; [Hope, Thomas J.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Rasenick, Mark M.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Rasenick, MM (corresponding author), Univ Illinois, Dept Physiol & Biophys, 835 S Wolcott M-C 901, Chicago, IL 60680 USA.	raz@uic.edu			Veterans Affairs merit award [BX11049]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	Veterans Affairs merit award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Veterans Affairs merit award BX11049.	ALETTA JM, 1988, J NEUROSCI, V8, P1425; Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Chen NF, 2003, J BIOL CHEM, V278, P15285, DOI 10.1074/jbc.M300841200; Chieregatti E, 2005, NAT REV MOL CELL BIO, V6, P181, DOI 10.1038/nrm1572; Czysz A. H., 2014, NEUROPSYCHOPHARMACOL; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dave RH, 2011, J BIOL CHEM, V286, P4319, DOI 10.1074/jbc.M110.196436; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Efendiev R, 2013, J BIOL CHEM, V288, P3929, DOI 10.1074/jbc.M112.428144; Emery AC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003993; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HEIDEMANN SR, 1985, J CELL BIOL, V100, P916, DOI 10.1083/jcb.100.3.916; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; Hu XD, 2011, J NEUROSCI, V31, P15597, DOI 10.1523/JNEUROSCI.2445-11.2011; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Ishida T, 1997, ANN NY ACAD SCI, V811, P12, DOI 10.1111/j.1749-6632.1997.tb51984.x; Jalali S, 1998, ARTERIOSCL THROM VAS, V18, P227, DOI 10.1161/01.ATV.18.2.227; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Malek AM, 1996, J CELL SCI, V109, P713; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Pfenninger KH, 2003, J CELL SCI, V116, P1209, DOI 10.1242/jcs.00285; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Popova JS, 2003, J BIOL CHEM, V278, P34299, DOI 10.1074/jbc.M301748200; Pyne NJ, 2011, TRENDS PHARMACOL SCI, V32, P443, DOI 10.1016/j.tips.2011.04.002; ROSETTE C, 1995, J CELL BIOL, V128, P1111, DOI 10.1083/jcb.128.6.1111; Roychowdhury S, 1999, J BIOL CHEM, V274, P13485, DOI 10.1074/jbc.274.19.13485; Roychowdhury S, 1997, J BIOL CHEM, V272, P31576, DOI 10.1074/jbc.272.50.31576; Saini DK, 2009, TRENDS PHARMACOL SCI, V30, P278, DOI 10.1016/j.tips.2009.04.001; Sarma T, 2003, FASEB J, V17, P848, DOI 10.1096/fj.02-0730com; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Vilardaga JP, 2012, TRENDS PHARMACOL SCI, V33, P423, DOI 10.1016/j.tips.2012.05.004; WANG N, 1990, J BIOL CHEM, V265, P1239; Wedegaertner PB, 1996, MOL BIOL CELL, V7, P1225, DOI 10.1091/mbc.7.8.1225; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Wolfgang WJ, 2004, DEV BIOL, V268, P295, DOI 10.1016/j.ydbio.2004.01.007; Yu JZ, 2009, J BIOL CHEM, V284, P10462, DOI 10.1074/jbc.M809166200; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352	45	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10045	10056		10.1074/jbc.M114.630632	http://dx.doi.org/10.1074/jbc.M114.630632			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25691569	hybrid, Green Published			2022-12-28	WOS:000353241100012
J	Khanna, RS; Le, HT; Wang, J; Fung, TCH; Pallen, CJ				Khanna, Ranvikram S.; Le, Hoa T.; Wang, Jing; Fung, Thomas C. H.; Pallen, Catherine J.			The Interaction of Protein-tyrosine Phosphatase alpha (PTP alpha) and RACK1 Protein Enables Insulin-like Growth Factor 1 (IGF-1)-stimulated Abl-dependent and -independent Tyrosine Phosphorylation of PTP alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; IGF-I RECEPTOR; BREAST-CANCER CELLS; SCAFFOLDING PROTEIN; RPTP-ALPHA; FAMILY KINASES; BETA-SUBUNIT; C-ABL; MIGRATION; EXPRESSION	Protein tyrosine phosphatase alpha (PTP alpha) promotes integrinstimulated cell migration in part through the role of Src-phosphorylated PTP alpha-Tyr(P)-789 in recruiting and localizing p130Cas to focal adhesions. The growth factor IGF-1 also stimulatesPTP alpha-Tyr-789 phosphorylation to positively regulate cell movement. This is in contrast to integrin-induced PTP alpha phosphorylation, that induced by IGF-1 can occur in cells lacking Src family kinases (SFKs), indicating that an unknown kinase distinct from SFKs can target PTP alpha. We show that this IGF-1stimulated tyrosine kinase is Abl. We found that PTP alpha binds to the scaffold protein RACK1 and that RACK1 coordinates the IGF-1 receptor, PTP alpha, and Abl in a complex to enable IGF-1stimulated and Abl-dependent PTP alpha-Tyr-789 phosphorylation. In cells expressing SFKs, IGF-1-stimulated phosphorylation of PTP alpha is mediated by RACK1 but is Abl-independent. Furthermore, expressing the SFKs Src and Fyn in SFK-deficient cells switches IGF-1-induced PTP alpha phosphorylation to occur in an Abl-independent manner, suggesting that SFK activity dominantly regulates IGF-1/IGF-1 receptor signaling to PTP alpha. RACK1 is a molecular scaffold that integrates growth factor and integrin signaling, and our identification of PTP alpha as a RACK1 binding protein suggests that RACK1 may coordinate PTP alpha Tyr- 789 phosphorylation in these signaling networks to promote cell migration.	[Khanna, Ranvikram S.] Univ British Columbia, Dept Med, Vancouver, BC V5Z 4H4, Canada; [Le, Hoa T.; Wang, Jing; Pallen, Catherine J.] Univ British Columbia, Dept Pediat, Vancouver, BC V5Z 4H4, Canada; [Khanna, Ranvikram S.; Le, Hoa T.; Wang, Jing; Fung, Thomas C. H.; Pallen, Catherine J.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada	University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia	Pallen, CJ (corresponding author), Child & Family Res Inst, 3102-950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	cpallen@mail.ubc.ca		Pallen, Catherine/0000-0002-3576-5295	Canadian Institutes of Health Research [MOP-49410]; Michael Cuccione Studentship; Michael Cuccione Fellowship; Child and Family Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Cuccione Studentship; Michael Cuccione Fellowship; Child and Family Research Institute	This work was supported by Canadian Institutes of Health Research Grant MOP-49410 (to C. J. P.).r Recipient of a Michael Cuccione Studentship.r Recipient of a Michael Cuccione Fellowship.r Recipient of an investigator award from the Child and Family Research Institute.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Ardini E, 2000, ONCOGENE, V19, P4979, DOI 10.1038/sj.onc.1203869; Berndt A, 1999, HISTOCHEM CELL BIOL, V111, P399, DOI 10.1007/s004180050373; Bhandari V, 1998, J BIOL CHEM, V273, P8691, DOI 10.1074/jbc.273.15.8691; Boivin B, 2013, J BIOL CHEM, V288, P36926, DOI 10.1074/jbc.M113.527564; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chang BY, 2002, ONCOGENE, V21, P7619, DOI 10.1038/sj.onc.1206002; Chen M, 2006, J BIOL CHEM, V281, P11972, DOI 10.1074/jbc.M600561200; Chen SC, 2009, AM J PHYSIOL-CELL PH, V297, pC133, DOI 10.1152/ajpcell.00110.2009; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Cox EA, 2003, MOL BIOL CELL, V14, P658, DOI 10.1091/mbc.E02-03-0142; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Gandin Valentina, 2013, Genes Cancer, V4, P369, DOI 10.1177/1947601913486348; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Guvakova MA, 2007, INT J BIOCHEM CELL B, V39, P890, DOI 10.1016/j.biocel.2006.10.013; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kiely PA, 2005, J BIOL CHEM, V280, P7624, DOI 10.1074/jbc.M412889200; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Krndija D, 2010, ONCOGENE, V29, P2724, DOI 10.1038/onc.2010.25; Lammers R, 2000, J BIOL CHEM, V275, P3391, DOI 10.1074/jbc.275.5.3391; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Li JJ, 2015, ONCOGENE, V34, P1890, DOI 10.1038/onc.2014.127; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Mourton T, 2001, J BIOL CHEM, V276, P14896, DOI 10.1074/jbc.M010823200; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Sun GB, 2012, MOL CELL BIOL, V32, P3776, DOI 10.1128/MCB.00214-12; TABITI K, 1995, CANCER LETT, V93, P239, DOI 10.1016/0304-3835(95)03816-F; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; TENHOEVE J, 1994, CANCER RES, V54, P2563; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wu CW, 2006, CANCER LETT, V242, P95, DOI 10.1016/j.canlet.2005.10.046; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049	41	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9886	9895		10.1074/jbc.M114.624247	http://dx.doi.org/10.1074/jbc.M114.624247			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25694432	Green Published, hybrid			2022-12-28	WOS:000352729400047
J	Wongnate, T; Ragsdale, SW				Wongnate, Thanyaporn; Ragsdale, Stephen W.			The Reaction Mechanism of Methyl-Coenzyme M Reductase HOW AN ENZYME ENFORCES STRICT BINDING ORDER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGICAL METHANE FORMATION; METHANOBACTERIUM-THERMOAUTOTROPHICUM; METHANOGENIC ARCHAEA; ANAEROBIC OXIDATION; ALKYL-NICKEL; METHYLREDUCTASE SYSTEM; TITANIUM(III) CITRATE; COMPONENT-C; NI; ACTIVATION	Methyl-coenzyme M reductase (MCR) is a nickel tetrahydro-corphinoid (coenzyme F430) containing enzyme involved in the biological synthesis and anaerobic oxidation of methane. MCR catalyzes the conversion of methyl-2-mercaptoethanesulfonate (methyl-SCoM) and N-7-mercaptoheptanoylthreonine phosphate (CoB7SH) to CH, and the mixed disulfide CoBS-SCoM. In this study, the reaction of MCR from Methanothermobacter marburgensis, with its native substrates was investigated using static binding, chemical quench, and stopped-flow techniques. Rate constants were measured for each step in this strictly ordered ternary complex catalytic mechanism. Surprisingly, in the absence of the other substrate, MCR can bind either substrate; however, only one binary complex (MCR center dot methyl-SCoM) is productive whereas the other (MCR center dot CoB7SH) is inhibitory. Moreover, the kinetic data demonstrate that binding of methyl-SCoM to the inhibitory NICR center dot CoB7SH complex is highly disfavored (K-d = 56 mm). However, binding of CoB7SH to the productive MCR center dot methyl-SCoM complex to form the active ternary complex (CoB7SH.MCR(Ni-1)center dot CH3SCoM) is highly favored (K-d = 79 mu m). Only then can the, chemical reaction occur (k(obs) = 20 s(-1) at 25 degrees C), leading to rapid formation and dissociation of CH4 leaving the binary product complex (MCR(Ni-II)center dot CoB7S-center dot SCoM), which undergoes electron transfer to regenerate Ni(I) and the final product CoBS-SCoM. This first rapid kinetics study of MCR with its natural substrates describes how an enzyme can enforce a strictly ordered ternary complex mechanism and serves as a template for identification of the reaction intermediates.	[Wongnate, Thanyaporn; Ragsdale, Stephen W.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ragsdale, SW (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu			U.S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences [DE-FG02-08ER15931]	U.S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the U.S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences Award DE-FG02-08ER15931.	Becker DF, 1998, BIOCHEMISTRY-US, V37, P2639, DOI 10.1021/bi972145x; BOBIK TA, 1988, P NATL ACAD SCI USA, V85, P60, DOI 10.1073/pnas.85.1.60; BONACKER LG, 1993, EUR J BIOCHEM, V217, P587, DOI 10.1111/j.1432-1033.1993.tb18281.x; Cedervall PE, 2011, J AM CHEM SOC, V133, P5626, DOI 10.1021/ja110492p; Cedervall PE, 2010, BIOCHEMISTRY-US, V49, P7683, DOI 10.1021/bi100458d; Chen SL, 2012, CHEM-EUR J, V18, P6309, DOI 10.1002/chem.201200274; Chen SL, 2009, J AM CHEM SOC, V131, P9912, DOI 10.1021/ja904301f; Dey M, 2007, BIOCHEMISTRY-US, V46, P11969, DOI 10.1021/bi700925n; Dey M, 2007, J AM CHEM SOC, V129, P11030, DOI 10.1021/ja074556z; Dey M, 2010, BIOCHEMISTRY-US, V49, P10902, DOI 10.1021/bi101562m; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; Ebner S, 2010, J AM CHEM SOC, V132, P567, DOI 10.1021/ja906367h; ELLEFSON WL, 1981, J BIOL CHEM, V256, P4259; ELLERMANN J, 1988, EUR J BIOCHEM, V172, P669, DOI 10.1111/j.1432-1033.1988.tb13941.x; Ermler U, 2005, DALTON T, P3451, DOI 10.1039/b506697b; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Goenrich M, 2005, J BIOL INORG CHEM, V10, P333, DOI 10.1007/s00775-005-0636-6; Goenrich M, 2004, J BIOL INORG CHEM, V9, P691, DOI 10.1007/s00775-004-0552-1; Goubeaud M, 1997, EUR J BIOCHEM, V243, P110, DOI 10.1111/j.1432-1033.1997.00110.x; Grabarse W, 2001, J MOL BIOL, V309, P315, DOI 10.1006/jmbi.2001.4647; Grabarse WG, 2000, J MOL BIOL, V303, P329, DOI 10.1006/jmbi.2000.4136; GUNSALUS RP, 1978, BIOCHEMISTRY-US, V17, P2374, DOI 10.1021/bi00605a019; Horng YC, 2001, BIOCHEMISTRY-US, V40, P12875, DOI 10.1021/bi011196y; Kunz RC, 2008, BIOCHEMISTRY-US, V47, P2661, DOI 10.1021/bi701942w; Kunz RC, 2006, J BIOL CHEM, V281, P34663, DOI 10.1074/jbc.M606715200; LAHIRI GK, 1993, INORG CHEM, V32, P4409, DOI 10.1021/ic00072a041; Li XH, 2010, BIOCHEMISTRY-US, V49, P6866, DOI 10.1021/bi100650m; Mahlert F, 2002, J BIOL INORG CHEM, V7, P500, DOI 10.1007/s00775-001-0325-z; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; NOLL KM, 1987, J BIOL CHEM, V262, P513; Pelmenschikov V, 2003, J BIOL INORG CHEM, V8, P653, DOI 10.1007/s00775-003-0461-8; Pelmenschikov V, 2002, J AM CHEM SOC, V124, P4039, DOI 10.1021/ja011664r; Prakash D, 2014, J BACTERIOL, V196, P2491, DOI 10.1128/JB.01658-14; Scheller S, 2013, J AM CHEM SOC, V135, P14985, DOI 10.1021/ja4064876; Scheller S, 2013, J AM CHEM SOC, V135, P14975, DOI 10.1021/ja406485z; Scheller S, 2010, ANGEW CHEM INT EDIT, V49, P8112, DOI 10.1002/anie.201003214; Scheller S, 2010, NATURE, V465, P606, DOI 10.1038/nature09015; Shima S, 2005, CURR OPIN MICROBIOL, V8, P643, DOI 10.1016/j.mib.2005.10.002; Signor L, 2000, CHEM-EUR J, V6, P3508, DOI 10.1002/1521-3765(20001002)6:19<3508::AID-CHEM3508>3.3.CO;2-N; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Yang N, 2007, J AM CHEM SOC, V129, P11028, DOI 10.1021/ja0734501; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008; Zhou YZ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00069	43	37	36	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9322	9334		10.1074/jbc.M115.636761	http://dx.doi.org/10.1074/jbc.M115.636761			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25691570	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000352729400002
J	Diamond, MI; Cai, SR; Boudreau, A; Carey, CJ; Lyle, N; Pappu, RV; Swamidass, SJ; Bissell, M; Piwnica-Worms, H; Shao, J				Diamond, Marc I.; Cai, Shirong; Boudreau, Aaron; Carey, Clifton J., Jr.; Lyle, Nicholas; Pappu, Rohit V.; Swamidass, S. Joshua; Bissell, Mina; Piwnica-Worms, Helen; Shao, Jieya			Subcellular Localization and Ser-137 Phosphorylation Regulate Tumor-suppressive Activity of Profilin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; PANCREATIC-CANCER; NUCLEAR ACTIN; IN-VITRO; APOPTOSIS; PROLIFERATION; CARCINOMA; TUMORIGENICITY; STAUROSPORINE; TRANSCRIPTION	The actin-binding protein profilin-1 (Pfn1) inhibits tumor growth and yet is also required for cell proliferation and survival, an apparent paradox. We previously identified Ser-137 of Pfn1 as a phosphorylation site within the poly-L-proline (PLP) binding pocket. Here we confirm that Ser-137 phosphorylation disrupts Pfn1 binding to its PLP-containing ligands with little effect on actin binding. We find in mouse xenografts of breast cancer cells that mimicking Ser-137 phosphorylation abolishes cell cycle arrest and apoptotic sensitization by Pfn1 and confers a growth advantage to tumors. This indicates a previously unrecognized role of PLP binding in Pfn1 antitumor effects. Spatial restriction of Pfn1 to the nucleus or cytoplasm indicates that inhibition of tumor cell growth by Pfn1 requires its nuclear localization, and this activity is abolished by a phosphomimetic mutation on Ser-137. In contrast, cytoplasmic Pfn1 lacks inhibitory effects on tumor cell growth but rescues morphological and proliferative defects of PFN1 null mouse chondrocytes. These results help reconcile seemingly opposed cellular effects of Pfn1, provide new insights into the antitumor mechanism of Pfn1, and implicate Ser-137 phosphorylation as a potential therapeutic target for breast cancer.	[Diamond, Marc I.] Univ Texas SW Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, Dallas, TX 75390 USA; [Cai, Shirong; Piwnica-Worms, Helen] Washington Univ, Dept Cell Biol & Physiol, Sch Med, St Louis, MO 63110 USA; [Cai, Shirong; Piwnica-Worms, Helen] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77230 USA; [Boudreau, Aaron] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Lab Med, San Francisco, CA 94143 USA; [Carey, Clifton J., Jr.; Swamidass, S. Joshua] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Lab & Genom Med, St Louis, MO 63110 USA; [Lyle, Nicholas; Pappu, Rohit V.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Bissell, Mina] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Shao, Jieya] Washington Univ, Sch Med, Dept Internal Med, Breast Oncol Program,Div Oncol, St Louis, MO 63110 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Washington University (WUSTL); Washington University (WUSTL); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Washington University (WUSTL)	Shao, J (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Breast Oncol Program,Div Oncol, 660 S Euclid Ave,Campus Box 8069, St Louis, MO 63110 USA.	jshao1@dom.wustl.edu	Swamidass, Sanjay Joshua/H-3331-2019; Piwnica-Worms, Helen/C-5214-2012	Swamidass, Sanjay Joshua/0000-0003-2191-0778; 	Neuroscience Blueprint Core National Institutes of Health [P30 NS057105]; National Institutes of Health Grant NCI Cancer Center Support Grant [P30 CA91842]; National Institutes of Health [P50 CA94056]; P30 Neuroscience Blueprint Interdisciplinary Center [P30 NS057105]; Children's Discovery Institute; NATIONAL CANCER INSTITUTE [P30CA091842, R01CA131226, R01CA140663, U54CA112970, P50CA094056, R37CA064786, U01CA143233, U54CA143836, R01CA057621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050284, P30NS057105, R01NS056114] Funding Source: NIH RePORTER	Neuroscience Blueprint Core National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant NCI Cancer Center Support Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P30 Neuroscience Blueprint Interdisciplinary Center; Children's Discovery Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Byron Hann for the MDA-MB-231 cell line stably expressing the tri-modal reporter fusion, Dr. Ralph T Bottcher and Dr. Reinhard Fassler for providing the PFN1 null chondrocytes, Dr. Eric Campeau for the pLenti-CMV/TO-Neo-DEST (685-3) destination vector, Dr. Sofia Origanti for scientific advice, Dr. Mingjie Li and Nada Husic for assisting in lentiviral production, Dr. William Eades for assistance with flow cytometry and analysis, Gary London and Dr. Kris Hyrc for assistance with confocal and whole-slide imaging, and Dr. Dyche Mullins and Dr. Brad Zuchero for the PLP-conjugated Sepharose beads. The Hope Center Viral Vectors Core is supported by Neuroscience Blueprint Core National Institutes of Health Grant P30 NS057105 (to Washington University). The Siteman Cancer Center is supported in part by National Institutes of Health Grant NCI Cancer Center Support Grant P30 CA91842. The Molecular Imaging Center is supported in part by National Institutes of Health P50 CA94056 (to Washington University). The Hope Center Alafi Neuroimaging Core is supported by a P30 Neuroscience Blueprint Interdisciplinary Center Core award to Washington University (P30 NS057105). The RNAi consortium at the Genome Institute of Washington University is supported by the Children's Discovery Institute.	Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; BALASUBRAMANIAN MK, 1994, J CELL BIOL, V125, P1289, DOI 10.1083/jcb.125.6.1289; Birbach A, 2008, BIOESSAYS, V30, P994, DOI 10.1002/bies.20822; Bottcher RT, 2009, EMBO J, V28, P1157, DOI 10.1038/emboj.2009.58; BOUSQUET PF, 1990, CANCER RES, V50, P1431; Cheng H, 2013, CURR MOL MED, V13, P1368, DOI 10.2174/15665240113139990060; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Fan Y, 2014, NAT CELL BIOL, V16, P445, DOI 10.1038/ncb2954; Fan YH, 2012, SOL PHYS, V277, P1, DOI 10.1007/s11207-011-9913-4; Feng Yunfeng, 2010, Genomics Proteomics & Bioinformatics, V8, P238, DOI 10.1016/S1672-0229(10)60025-3; Giesemann T, 1999, J BIOL CHEM, V274, P37908, DOI 10.1074/jbc.274.53.37908; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Harpen M, 2009, J VIROL, V83, P10869, DOI 10.1128/JVI.01271-09; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; Jockusch BM, 2006, TRENDS CELL BIOL, V16, P391, DOI 10.1016/j.tcb.2006.06.006; Lederer M, 2005, J CELL SCI, V118, P331, DOI 10.1242/jcs.01618; Odaka C, 2000, CLIN DIAGN LAB IMMUN, V7, P947, DOI 10.1128/CDLI.7.6.947-952.2000; Percipalle P, 2006, J CELL BIOL, V172, P967, DOI 10.1083/jcb.200512083; Ray P, 2007, CANCER RES, V67, P3085, DOI 10.1158/0008-5472.CAN-06-2402; Schluter K, 1997, BBA-MOL CELL RES, V1359, P97, DOI 10.1016/S0167-4889(97)00100-6; SENDEROWICZ AMJ, 1995, J NATL CANCER I, V87, P46, DOI 10.1093/jnci/87.1.46; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Singh SS, 1996, RECEPT SIGNAL TRANS, V6, P77; Skare P, 2003, EXP CELL RES, V286, P12, DOI 10.1016/S0014-4827(03)00102-2; Soderberg E, 2012, NUCLEUS-PHILA, V3, P290, DOI 10.4161/nucl.20327; Spencer VA, 2011, J CELL SCI, V124, P123, DOI 10.1242/jcs.073197; Stehn JR, 2013, CANCER RES, V73, P5169, DOI 10.1158/0008-5472.CAN-12-4501; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; TAKASUKA T, 1987, EXP CELL RES, V173, P287, DOI 10.1016/0014-4827(87)90355-7; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Wittenmayer N, 2004, MOL BIOL CELL, V15, P1600, DOI 10.1091/mbc.E03-12-0873; Wu N, 2006, PROTEOMICS, V6, P6095, DOI 10.1002/pmic.200500321; Yao W, 2013, CURR MOL MED, V13, P417; Yao WT, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-187; Yao WT, 2012, J CELL MOL MED, V16, P824, DOI 10.1111/j.1582-4934.2011.01369.x; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x; Zoidakis J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009449; Zou L, 2007, BRIT J CANCER, V97, P1361, DOI 10.1038/sj.bjc.6604038; Zou L, 2010, J CELL PHYSIOL, V223, P623, DOI 10.1002/jcp.22058	42	18	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9075	9086		10.1074/jbc.M114.619874	http://dx.doi.org/10.1074/jbc.M114.619874			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25681442	Green Published, hybrid			2022-12-28	WOS:000352207100031
J	Wang, RZ; Wang, HJ; Carrera, I; Xu, SH; Lakshmana, MK				Wang, Ruizhi; Wang, Hongjie; Carrera, Ivan; Xu, Shaohua; Lakshmana, Madepalli K.			COPS5 Protein Overexpression Increases Amyloid Plaque Burden, Decreases Spinophilin-immunoreactive Puncta, and Exacerbates Learning and Memory Deficits in the Mouse Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; SYNAPSE LOSS; PRECURSOR PROTEIN; GAMMA-SECRETASE; PIVOTAL ROLE; RANBP9; BETA; BACE1; APP; PALMITOYLATION	Brain accumulation of neurotoxic amyloid beta (A beta) peptide because of increased processing of amyloid precursor protein (APP), resulting in loss of synapses and neurodegeneration, is central to the pathogenesis of Alzheimer disease (AD). Therefore, the identification of molecules that regulate A beta generation and those that cause synaptic damage is crucial for future therapeutic approaches for AD. We demonstrated previously that COPS5 regulates A beta generation in neuronal cell lines in a RanBP9-dependent manner. Consistent with the data from cell lines, even by 6 months, COPS5 overexpression in AP beta E9 mice (AP beta E9/COPS5-Tg) significantly increased A beta 40 levels by 32% (p < 0.01) in the cortex and by 28% (p < 0.01) in the hippocampus, whereas the increases for A beta 42 were 37% (p < 0.05) and 34% (p < 0.05), respectively. By 12 months, the increase was even more robust. A beta 40 levels increased by 63% (p < 0.001) in the cortex and by 65% (p< 0.001) in the hippocampus. Similarly, A beta 42 levels were increased by 69% (p< 0.001) in the cortex and by 71% (p < 0.011) in the hippocampus. Increased A beta levels were translated into an increased amyloid plaque burden both in the cortex (54%, p < 0.01) and hippocampus (64%, p < 0.01). Interestingly, COPS5 overexpression increased RanBP9 levels in the brain, which, in turn, led to increased amyloidogenic processing of APP, as reflected by increased levels of sAPP beta and decreased levels of sAPP alpha. Furthermore, COPS5 overexpression reduced spinophilin in both the cortex (19%, p < 0.05) and the hippocampus (20%, p < 0.05), leading to significant deficits in learning and memory skills. Therefore, like RanBP9, COPS5 also plays a pivotal role in amyloid pathology in vivo.	[Wang, Ruizhi; Wang, Hongjie; Lakshmana, Madepalli K.] Torrey Pines Inst Mol Studies, Neurobiol Sect, Port St Lucie, FL 34987 USA; [Carrera, Ivan] Euroespes Biotechnol, Dept Neurosci, La Coruna 15165A, Spain; [Xu, Shaohua] Florida Inst Technol, Melbourne, FL 32901 USA	Torrey Pines Institute for Molecular Studies, Florida; Florida Institute of Technology	Lakshmana, MK (corresponding author), Torrey Pines Inst Mol Studies, 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA.	mlakshmana@tpims.org		Xu, Shaohua/0000-0003-1221-6354	National Institute on Aging (NIA)/National Institutes of Health [R01AG036859-01]; NATIONAL INSTITUTE ON AGING [R01AG036859] Funding Source: NIH RePORTER	National Institute on Aging (NIA)/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institute on Aging (NIA)/National Institutes of Health Grant R01AG036859-01 (to M. K. L.).	Arefin AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045535; Bhattacharyya R, 2013, J NEUROSCI, V33, P11169, DOI 10.1523/JNEUROSCI.4704-12.2013; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Brown DF, 1998, J NEUROPATH EXP NEUR, V57, P955, DOI 10.1097/00005072-199810000-00007; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Cheng L, 2005, J NEUROCHEM, V94, P1102, DOI 10.1111/j.1471-4159.2005.03254.x; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Djagaeva I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007598; Guo L, 2007, P NATL ACAD SCI USA, V104, P13444, DOI 10.1073/pnas.0703707104; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hattori C, 2006, J NEUROSCI RES, V84, P912, DOI 10.1002/jnr.20981; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Lakshmana MK, 2012, FASEB J, V26, P2072, DOI 10.1096/fj.11-196709; Lakshmana MK, 2010, FASEB J, V24, P119, DOI 10.1096/fj.09-136457; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Lakshmana MK, 2008, J CELL MOL MED, V12, P2665, DOI 10.1111/j.1582-4934.2008.00320.x; Li J, 2009, MOL PHARMACOL, V76, P81, DOI 10.1124/mol.109.054551; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Lipton AM, 2001, ARCH NEUROL-CHICAGO, V58, P1233, DOI 10.1001/archneur.58.8.1233; MASLIAH E, 1993, BRAIN RES, V617, P258, DOI 10.1016/0006-8993(93)91093-8; Nistor A, 2007, NEUROBIOL AGING, V28, P1493, DOI 10.1016/j.neurobiolaging.2006.06.023; Palavicini JP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.183; Palavicini JP, 2014, J ALZHEIMERS DIS, V39, P727, DOI 10.3233/JAD-131550; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; SAMUEL W, 1994, NEUROLOGY, V44, P2081, DOI 10.1212/WNL.44.11.2081; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839; Spijkers PPEM, 2005, BLOOD, V105, P170, DOI 10.1182/blood-2004-02-0498; Subramanian M, 2014, J CLIN INVEST, V124, P1296, DOI 10.1172/JCI72051; Sydow A, 2011, J MOL NEUROSCI, V45, P432, DOI 10.1007/s12031-011-9604-5; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tigges J, 1996, ACTA ANAT, V157, P63; Uylings HBM, 2002, BRAIN COGNITION, V49, P268, DOI 10.1006/brcg.2001.1500; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Wang H, 2014, NEUROSCIENCE, V265, P253, DOI 10.1016/j.neuroscience.2014.01.045; Wang HJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085484, 10.1371/journal.pone.0097917]; Wang HJ, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-121; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010; Woo JA, 2012, CELL DEATH DIFFER, V19, P1413, DOI 10.1038/cdd.2012.14; Woo JA, 2012, FASEB J, V26, P1672, DOI 10.1096/fj.11-194423; Zou YL, 2003, J BIOL CHEM, V278, P49573, DOI 10.1074/jbc.M307556200	45	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9299	9309		10.1074/jbc.M114.595926	http://dx.doi.org/10.1074/jbc.M114.595926			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25713139	hybrid, Green Published			2022-12-28	WOS:000352207100050
J	Wang, T; Wang, RP; Cleary, RA; Gannon, OJ; Tang, DD				Wang, Tao; Wang, Ruping; Cleary, Rachel A.; Gannon, Olivia J.; Tang, Dale D.			Recruitment of beta-Catenin to N-Cadherin Is Necessary for Smooth Muscle Contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRK-ASSOCIATED SUBSTRATE; ACTIN POLYMERIZATION; ADHERENS JUNCTIONS; P21-ACTIVATED KINASE; VIMENTIN NETWORK; TYROSINE KINASE; MYOSIN-II; ACTIVATION; DYNAMICS; PHOSPHORYLATION	beta-Catenin is a key component that connects transmembrane cadherin with the actin cytoskeleton at the cell-cell interface. However, the role of the beta-catenin/cadherin interaction in smooth muscle has not been well characterized. Here stimulation with acetylcholine promoted the recruitment of beta-catenin to N-cadherin in smooth muscle cells/tissues. Knockdown of beta-catenin by lentivirus-mediated shRNA attenuated smooth muscle contraction. Nevertheless, myosin light chain phosphorylation at Ser-19 and actin polymerization in response to contractile activation were not reduced by beta-catenin knockdown. In addition, the expression of the beta-catenin armadillo domain disrupted the recruitment of beta-catenin to N-cadherin. Force development, but not myosin light chain phosphorylation and actin polymerization, was reduced by the expression of the beta-catenin armadillo domain. Furthermore, actin polymerization and microtubules have been implicated in intracellular trafficking. In this study, the treatment with the inhibitor latrunculin A diminished the interaction of beta-catenin with N-cadherin in smooth muscle. In contrast, the exposure of smooth muscle to the microtubule depolymerizer nocodazole did not affect the protein-protein interaction. Together, these findings suggest that smooth muscle contraction is mediated by the recruitment of beta-catenin to N-cadherin, which may facilitate intercellular mechanotransduction. The association of beta-catenin with N-cadherin is regulated by actin polymerization during contractile activation.	[Wang, Tao; Wang, Ruping; Cleary, Rachel A.; Gannon, Olivia J.; Tang, Dale D.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	Albany Medical College	Tang, DD (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, 47 New Scotland Ave,MC-8, Albany, NY 12208 USA.	tangd@mail.amc.edu	T, Dale/AAE-9643-2020	T, Dale/0000-0002-7339-9249; Wang, Ruping/0000-0003-4233-7755	NHLBI/National Institutes of Health [HL-110951, HL-113208]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113208, R01HL110951] Funding Source: NIH RePORTER	NHLBI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI/National Institutes of Health Grants HL-110951 and HL-113208 (to D. D. T.).	Amrani Y, 2003, INT J BIOCHEM CELL B, V35, P272, DOI 10.1016/S1357-2725(02)00259-5; Anfinogenova Y, 2007, CIRC RES, V101, P420, DOI 10.1161/CIRCRESAHA.107.156463; Balamatsias D, 2011, J BIOL CHEM, V286, P43229, DOI 10.1074/jbc.M111.306621; Castano J, 2002, J BIOL CHEM, V277, P31541, DOI 10.1074/jbc.M204376200; Cleary RA, 2014, AM J PHYSIOL-CELL PH, V306, pC753, DOI 10.1152/ajpcell.00327.2013; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; De Santis G, 2009, ONCOGENE, V28, P1206, DOI 10.1038/onc.2008.470; Demarco RS, 2012, PLOS GENET, V8, P513, DOI 10.1371/journal.pgen.1002665; Dose M, 2014, P NATL ACAD SCI USA, V111, P391, DOI 10.1073/pnas.1315752111; Eddinger TJ, 2007, J PHARMACOL EXP THER, V320, P865, DOI 10.1124/jpet.106.109363; Erez N, 2005, EUR J CELL BIOL, V84, P235, DOI 10.1016/j.ejcb.2004.12.007; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963, DOI 10.1152/jappl.2001.91.2.963; Gunst SJ, 2000, EUR RESPIR J, V15, P600, DOI 10.1034/j.1399-3003.2000.15.29.x; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Guntur AR, 2012, BONE, V50, P54, DOI 10.1016/j.bone.2011.09.036; Herrera AM, 2004, AM J PHYSIOL-LUNG C, V286, pL1161, DOI 10.1152/ajplung.00298.2003; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Huang YL, 2011, J BIOL CHEM, V286, P3630, DOI 10.1074/jbc.M110.139923; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jansen SR, 2010, AM J PHYSIOL-LUNG C, V299, pL204, DOI 10.1152/ajplung.00020.2010; Jia L, 2012, AM J PHYSIOL-CELL PH, V302, pC1026, DOI 10.1152/ajpcell.00373.2011; KAMM KE, 1989, ANNU REV PHYSIOL, V51, P299; Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ajpcell.00174.2008; Kumawat K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094801; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Li QF, 2009, AM J PHYSIOL-CELL PH, V297, pC299, DOI 10.1152/ajpcell.00037.2009; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Morgan KG, 2008, J CELL MOL MED, V12, P2157, DOI 10.1111/j.1582-4934.2008.00565.x; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Priya R, 2013, DIFFERENTIATION, V86, P133, DOI 10.1016/j.diff.2013.01.002; Ratheesh A, 2013, PROG MOL BIOL TRANSL, V116, P49, DOI 10.1016/B978-0-12-394311-8.00003-0; Ray S, 2013, J CELL BIOL, V202, P45, DOI 10.1083/jcb.201212140; Rembold CM, 2007, AM J PHYSIOL-CELL PH, V293, pC993, DOI 10.1152/ajpcell.00090.2007; Rosenbluh J, 2014, TRENDS PHARMACOL SCI, V35, P103, DOI 10.1016/j.tips.2013.11.007; Somlyo AV, 2004, PHILOS T R SOC B, V359, P1921, DOI 10.1098/rstb.2004.1562; Tang DD, 2008, J CARDIOVASC PHARM T, V13, P130, DOI 10.1177/1074248407313737; Tang DD, 2009, J CARDIOVASC PHARM T, V14, P89, DOI 10.1177/1074248409333490; Wang RP, 2007, AM J PHYSIOL-LUNG C, V292, pL240, DOI 10.1152/ajplung.00199.2006; Wang RP, 2006, AM J PHYSIOL-CELL PH, V291, pC483, DOI 10.1152/ajpcell.00097.2006; Wang RP, 2014, J BIOL CHEM, V289, P14157, DOI 10.1074/jbc.M114.548099; Wang RP, 2013, AM J RESP CELL MOL, V48, P172, DOI 10.1165/rcmb.2012-0315OC; Wang T, 2014, AM J RESP CELL MOL, V51, P652, DOI 10.1165/rcmb.2014-0125OC; Wang T, 2013, J BIOL CHEM, V288, P20713, DOI 10.1074/jbc.M112.439877; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836; Zhao R, 2008, J BIOL CHEM, V283, P36522, DOI 10.1074/jbc.M805294200	48	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8913	8924		10.1074/jbc.M114.621003	http://dx.doi.org/10.1074/jbc.M114.621003			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25713069	hybrid, Green Published			2022-12-28	WOS:000352207100019
J	Balan, M; Teran, EMY; Waaga-Gasser, AM; Gasser, M; Choueiri, TK; Freeman, G; Pal, S				Balan, Murugabaskar; Mier y Teran, Eduardo; Waaga-Gasser, Ana Maria; Gasser, Martin; Choueiri, Toni K.; Freeman, Gordon; Pal, Soumitro			Novel Roles of c-Met in the Survival of Renal Cancer Cells through the Regulation of HO-1 and PD-L1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; HEME OXYGENASE-1; TYROSINE KINASE; CARCINOMA PATIENTS; T-CELLS; RECEPTOR; RAS; PROTEIN; B7-H1; ACTIVATION	The receptor tyrosine kinase c-Met is overexpressed in renal cancer cells and can play major role in the growth and survival of tumor. We investigated how the c-Met-mediated signaling through binding to its ligand hepatocyte growth factor (HGF) can modulate the apoptosis and immune escape mechanism(s) of renal cancer cells by the regulations of novel molecules heme oxygenase-1 (HO-1) and programmed death-1 ligand 1 (PD-L1). We found that HGF/c-Met-mediated signaling activated the Ras/Raf pathway and down-regulated cancer cell apoptosis; and it was associated with the overexpression of cytoprotective HO-1 and anti-apoptotic Bcl-2/Bcl-xL. c-Met-induced HO-1 overexpression was regulated at the transcriptional level. Next, we observed that c-Met induction markedly up-regulated the expression of the negative co-stimulatory molecule PD-L1, and this can be prevented following treatment of the cells with pharmacological inhibitors of c-Met. Interestingly, HGF/c-Met-mediated signaling could not induce PD-L1 at the optimum level when either Ras or HO-1 was knocked down. To study the functional significance of c-Met-induced PD-L1 expression, we performed a co-culture assay using mouse splenocytes (expressing PD-L1 receptor PD-1) and murine renal cancer cells (RENCA, expressing high PD-L1). We observed that the splenocyte-mediated apoptosis of cancer cells during co-culture was markedly increased in the presence of either c-Met inhibitor or PD-L1 neutralizing antibody. Finally, we found that both c-Met and PD-L1 are significantly up-regulated and co-localized in human renal cancer tissues. Together, our study suggests a novel mechanism(s) by which c-Met can promote increased survival of renal cancer cells through the regulation of HO-1 and PD-L1.	[Balan, Murugabaskar; Mier y Teran, Eduardo; Pal, Soumitro] Boston Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Balan, Murugabaskar; Choueiri, Toni K.; Freeman, Gordon; Pal, Soumitro] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Choueiri, Toni K.; Freeman, Gordon] Dana Farber Canc Inst, Boston, MA 02115 USA; [Waaga-Gasser, Ana Maria; Gasser, Martin] Univ Wurzburg, Dept Surg Mol Oncol & Immunol, D-97080 Wurzburg, Germany	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Wurzburg	Pal, S (corresponding author), Childrens Hosp, Div Nephrol, 300 Longwood Ave, Boston, MA 02115 USA.	soumitro.pal@childrens.harvard.edu	Freeman, Gordon/AAC-5380-2019; Choueiri, Toni/K-5238-2019	Freeman, Gordon/0000-0002-7210-5616; Choueiri, Toni/0000-0002-9201-3217	National Institutes of Health [R01 CA131145, R21 CA172946]; NATIONAL CANCER INSTITUTE [R21CA172946, R01CA131145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01 CA131145 and R21 CA172946 (to S. P.).	Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965; Baek JH, 2012, J IMMUNOL, V189, P1699, DOI 10.4049/jimmunol.1200729; Balan M, 2014, J BIOL CHEM, V289, P3126, DOI 10.1074/jbc.M113.508044; Banerjee P, 2011, J BIOL CHEM, V286, P33580, DOI 10.1074/jbc.M111.248401; Bellon SF, 2008, J BIOL CHEM, V283, P2675, DOI 10.1074/jbc.M705774200; Benkhoucha M, 2010, P NATL ACAD SCI USA, V107, P6424, DOI 10.1073/pnas.0912437107; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Blank C, 2005, CANCER IMMUNOL IMMUN, V54, P307, DOI 10.1007/s00262-004-0593-x; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Datta D, 2006, CANCER RES, V66, P9509, DOI 10.1158/0008-5472.CAN-05-4345; Datta D, 2009, CANCER RES, V69, P8902, DOI 10.1158/0008-5472.CAN-09-1404; FUJITA J, 1988, CANCER RES, V48, P5251; Gao CF, 2005, CELL RES, V15, P49, DOI 10.1038/sj.cr.7290264; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gibney GT, 2013, ANN ONCOL, V24, P343, DOI 10.1093/annonc/mds463; Gusenbauer S, 2013, ONCOGENE, V32, P3846, DOI 10.1038/onc.2012.396; Hirano F, 2005, CANCER RES, V65, P1089; Kamimoto M, 2009, BIOCHEM BIOPH RES CO, V380, P333, DOI 10.1016/j.bbrc.2009.01.080; Ke BB, 2012, J HEPATOL, V56, P359, DOI 10.1016/j.jhep.2011.05.023; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Kuroda N, 2010, PATHOL INT, V60, P9, DOI 10.1111/j.1440-1827.2009.02467.x; Maina F, 2001, MOL CELL, V7, P1293, DOI 10.1016/S1097-2765(01)00261-1; MARGOLIS B, 1994, J AM SOC NEPHROL, V5, P1288; Miyata Y, 2006, CLIN CANCER RES, V12, P4876, DOI 10.1158/1078-0432.CCR-06-0362; Mizuno S, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/909350; Nakaigawa N, 2006, CANCER RES, V66, P3699, DOI 10.1158/0008-5472.CAN-05-0617; Natali PG, 1996, INT J CANCER, V69, P212, DOI 10.1002/(SICI)1097-0215(19960621)69:3<212::AID-IJC11>3.0.CO;2-9; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Pilon-Thomas S, 2010, J IMMUNOL, V184, P3442, DOI 10.4049/jimmunol.0904114; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Rayman P, 2004, CLIN CANCER RES, V10, p6360S, DOI 10.1158/1078-0432.CCR-050011; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Singhal E, 2011, J BIOL CHEM, V286, P32054, DOI 10.1074/jbc.M111.271247; Skibinski G, 2003, ARCH IMMUNOL THER EX, V51, P277; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Tanimoto S, 2008, J MED INVESTIG, V55, P106, DOI 10.2152/jmi.55.106; Thompson RH, 2007, CLIN CANCER RES, V13, P1757, DOI 10.1158/1078-0432.CCR-06-2599; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Tzima S, 2009, J EXP MED, V206, P1167, DOI 10.1084/jem.20081582; Uzzo RG, 1999, CLIN CANCER RES, V5, P1219; Was H, 2010, CURR DRUG TARGETS, V11, P1551, DOI 10.2174/1389450111009011551; Yakes FM, 2011, MOL CANCER THER, V10, P2298, DOI 10.1158/1535-7163.MCT-11-0264; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686	49	108	114	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8110	8120		10.1074/jbc.M114.612689	http://dx.doi.org/10.1074/jbc.M114.612689			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25645920	Green Published, hybrid			2022-12-28	WOS:000351662600009
J	Hesketh, EL; Parker-Manuel, RP; Chaban, Y; Satti, R; Coverley, D; Orlova, EV; Chong, JPJ				Hesketh, Emma L.; Parker-Manuel, Richard P.; Chaban, Yuriy; Satti, Rabab; Coverley, Dawn; Orlova, Elena V.; Chong, James P. J.			DNA Induces Conformational Changes in a Recombinant Human Minichromosome Maintenance Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; DNA Helicase; DNA Replication; Electron Microscopy (EM); Recombinant Protein Expression; MCM; Minichromosome Maintenance	REPLICATIVE HELICASE; SACCHAROMYCES-CEREVISIAE; MCM2-7 COMPLEX; ATP HYDROLYSIS; HUMAN-CELLS; CYCLIN-E; PROTEIN; FORK; ORGANIZATION; ACTIVATION	Background: The human minichromosome maintenance (hMCM) complex is an important component of the DNA replication apparatus. Results: After being produced in Escherichia coli, hMCM has ATPase and DNA helicase activity and undergoes a conformational change when bound to DNA. Conclusion: Recombinant hMCM is functional in vitro. Significance: hMCM provides an important tool for the biochemical reconstitution of the human replicative helicase. ATP-dependent DNA unwinding activity has been demonstrated for recombinant archaeal homohexameric minichromosome maintenance (MCM) complexes and their yeast heterohexameric counterparts, but in higher eukaryotes such as Drosophila, MCM-associated DNA helicase activity has been observed only in the context of a co-purified Cdc45-MCM-GINS complex. Here, we describe the production of the recombinant human MCM (hMCM) complex in Escherichia coli. This protein displays ATP hydrolysis activity and is capable of unwinding duplex DNA. Using single-particle asymmetric EM reconstruction, we demonstrate that recombinant hMCM forms a hexamer that undergoes a conformational change when bound to DNA. Recombinant hMCM produced without post-translational modifications is functional in vitro and provides an important tool for biochemical reconstitution of the human replicative helicase.	[Hesketh, Emma L.; Parker-Manuel, Richard P.; Satti, Rabab; Coverley, Dawn; Chong, James P. J.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Chaban, Yuriy; Orlova, Elena V.] Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England	University of York - UK; University of London; Birkbeck University London	Chong, JPJ (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	james.chong@york.ac.uk	Chong, James/AAC-4957-2019; Orlova, Elena/CAF-8290-2022	Coverley, Dawn/0000-0001-8262-7023; Chong, James/0000-0001-9447-7421; Orlova, Elena/0000-0003-3371-415X	Cancer Research UK [A7771, A10945]; Wellcome VIP funds; Yorkshire Cancer Research Grant [Y002PhD]; BBSRC [BB/J006920/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J006920/1] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome VIP funds; Yorkshire Cancer Research Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Cancer Research UK Grants A7771 and A10945; Wellcome VIP funds administered by the Department of Biology, University of York; and Yorkshire Cancer Research Grant Y002PhD.	Biswas-Fiss EE, 2005, BIOCHEMISTRY-US, V44, P2916, DOI 10.1021/bi0491649; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Brewster AS, 2008, P NATL ACAD SCI USA, V105, P20191, DOI 10.1073/pnas.0808037105; BYERS B, 1975, J BACTERIOL, V124, P511, DOI 10.1128/JB.124.1.511-523.1975; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Coster G, 2014, MOL CELL, V55, P666, DOI 10.1016/j.molcel.2014.06.034; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ishimi Y, 1998, J BIOL CHEM, V273, P8369, DOI 10.1074/jbc.273.14.8369; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Jenkinson ER, 2006, P NATL ACAD SCI USA, V103, P7613, DOI 10.1073/pnas.0509297103; Kang S, 2014, MOL CELL, V55, P655, DOI 10.1016/j.molcel.2014.06.033; Kim JH, 2010, ANN VASC SURG, V24, P538, DOI 10.1016/j.avsg.2010.01.007; Lyubimov AY, 2012, P NATL ACAD SCI USA, V109, P11999, DOI 10.1073/pnas.1209406109; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Munkley J, 2011, NUCLEIC ACIDS RES, V39, P2671, DOI 10.1093/nar/gkq1190; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Samel SA, 2014, GENE DEV, V28, P1653, DOI 10.1101/gad.242404.114; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Stead BE, 2011, NUCLEIC ACIDS RES, V39, P6998, DOI 10.1093/nar/gkr371; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Poh WT, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130138; You ZY, 2003, EMBO J, V22, P6148, DOI 10.1093/emboj/cdg576	36	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7973	7979		10.1074/jbc.M114.622738	http://dx.doi.org/10.1074/jbc.M114.622738			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25648893	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000351613600054
J	Abdelmagid, SM; Sondag, GR; Moussa, FM; Belcher, JY; Yu, B; Stinnett, H; Novak, K; Mbimba, T; Khol, M; Hankenson, KD; Malcuit, C; Safadi, FF				Abdelmagid, Samir M.; Sondag, Gregory R.; Moussa, Fouad M.; Belcher, Joyce Y.; Yu, Bing; Stinnett, Hilary; Novak, Kimberly; Mbimba, Thomas; Khol, Matthew; Hankenson, Kurt D.; Malcuit, Christopher; Safadi, Fayez F.			Mutation in Osteoactivin Promotes Receptor Activator of NF kappa B Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT ACID-PHOSPHATASE; GLYCOGEN-SYNTHASE KINASE-3-BETA; COLONY-STIMULATING FACTOR; OSTEOBLAST DIFFERENTIATION; TRANSMEMBRANE PROTEIN; KINASE-ACTIVITY; BONE-FORMATION; FAMILY-MEMBER; BCL-2 FAMILY; DC-STAMP	We previously reported on the importance of osteoactivin (OA/Gpnmb) in osteogenesis. In this study, we examined the role of OA in osteoclastogenesis, using mice with a nonsense mutation in the Gpnmb gene (D2J) and wild-type controls (D2J/Gpnmb(+)). In these D2J mice, micro-computed tomography and histomorphometric analyses revealed increased cortical thickness, whereas total porosity and eroded surface were significantly reduced in D2J mice compared with wildtype controls, and these results were corroborated by lower serum levels of CTX-1. Contrary to these observations and counterintuitively, temporal gene expression analyses supported up-regulated osteoclastogenesis in D2J mice and increased osteoclast differentiation rates ex vivo, marked by increased number and size. The finding that MAPK was activated in early differentiating and mature D2J osteoclasts and that survival of D2J osteoclasts was enhanced and mediated by activation of the AKT-GSK3 beta pathway supports this observation. Furthermore, this was abrogated by the addition of recombinant OA to cultures, which restored osteoclastogenesis to wild-type levels. Moreover, mix and match co-cultures demonstrated an induction of osteoclastogenesis in D2J osteoblasts co-cultured with osteoclasts of D2J or wild-type. Last, in functional osteo-assays, we show that bone resorption activity of D2J osteoclasts is dramatically reduced, and these osteoclasts present an abnormal ruffled border over the bone surface. Collectively, these data support a model whereby OA/Gpnmb acts as a negative regulator of osteoclast differentiation and survival but not function by inhibiting the ERK/AKT signaling pathways.	[Abdelmagid, Samir M.; Sondag, Gregory R.; Moussa, Fouad M.; Yu, Bing; Stinnett, Hilary; Novak, Kimberly; Mbimba, Thomas; Khol, Matthew; Safadi, Fayez F.] Northeast Ohio Med Univ, Dept Anat & Neurobiol, Coll Med, Rootstown, OH 44272 USA; [Sondag, Gregory R.; Moussa, Fouad M.; Malcuit, Christopher; Safadi, Fayez F.] Kent State Univ, Sch Biomed Sci, Kent, OH 44240 USA; [Malcuit, Christopher] Kent State Univ, Dept Biol Sci, Kent, OH 44240 USA; [Belcher, Joyce Y.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Hankenson, Kurt D.] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA	Northeast Ohio Medical University (NEOMED); University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Safadi, FF (corresponding author), NE Ohio Med Univ, Dept Anat & Neurobiol, 4209 State Rt 44, Rootstown, OH 44224 USA.	fayez.safadi@neomed.edu	Hankenson, Kurt/AFS-9417-2022; Hankenson, Kurt/ABI-1547-2020; Safadi, Fayez/AAU-8699-2021	Hankenson, Kurt/0000-0001-6361-143X; 	National Institutes of Health, NIAMS [R01AR048892]; Ohio State Department of Development; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048892] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Ohio State Department of Development; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, NIAMS, Grant R01AR048892. This work was also supported by a grant from the Ohio State Department of Development.	Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006; Abdelmagid SM, 2007, J CELL PHYSIOL, V210, P26, DOI 10.1002/jcp.20841; Abdelmagid SM, 2014, AM J PATHOL, V184, P697, DOI 10.1016/j.ajpath.2013.11.031; Abdelmagid SM, 2010, J CELL BIOCHEM, V111, P295, DOI 10.1002/jcb.22702; Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Anderson MG, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-1; Arosarena OA, 2011, J CELL PHYSIOL, V226, P2943, DOI 10.1002/jcp.22639; Bain SD, 2005, TOP BON BIO, V2, P58; Bandari PS, 2003, REGUL PEPTIDES, V111, P169, DOI 10.1016/S0167-0115(02)00288-4; Bateman JP, 2012, J PERIODONTAL RES, V47, P243, DOI 10.1111/j.1600-0765.2011.01428.x; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Borah B, 2010, J BONE MINER RES, V25, P41, DOI 10.1359/jbmr.090711; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Crockett JC, 2011, OSTEOPOROSIS INT, V22, P1, DOI 10.1007/s00198-010-1272-8; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Dobbins DE, 2002, J BONE MINER RES, V17, P1761, DOI 10.1359/jbmr.2002.17.10.1761; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; ERIKSEN EF, 1993, BONE, V14, P443, DOI 10.1016/8756-3282(93)90177-C; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hayashi H, 2008, FEBS LETT, V582, P3243, DOI 10.1016/j.febslet.2008.08.023; He YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024780; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Janckila AJ, 2007, AM J CLIN PATHOL, V127, P556, DOI 10.1309/DGEA9BE2VE5VCFYH; Jang HD, 2011, J BIOL CHEM, V286, P39043, DOI 10.1074/jbc.M111.256768; Kanazawa K, 2005, J BONE MINER RES, V20, P2053, DOI 10.1359/JBMR.050706; Kanzaki H, 2001, J DENT RES, V80, P887, DOI 10.1177/00220345010800030801; Kominsky SL, 2008, CANCER RES, V68, P1261, DOI 10.1158/0008-5472.CAN-07-6122; Kukita T, 1996, HISTOL HISTOPATHOL, V11, P821; Kwon OH, 2005, BIOCHEM BIOPH RES CO, V335, P437, DOI 10.1016/j.bbrc.2005.07.092; Lassus J, 1998, CLIN ORTHOP RELAT R, P7; Lau KHW, 2003, J BONE MINER RES, V18, P1897, DOI 10.1359/jbmr.2003.18.10.1897; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Lemaire V, 2004, J THEOR BIOL, V229, P293, DOI 10.1016/j.jtbi.2004.03.023; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Loftus SK, 2009, PIGM CELL MELANOMA R, V22, P99, DOI 10.1111/j.1755-148X.2008.00518.x; Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840; Margolis DS, 2008, CALCIFIED TISSUE INT, V82, P66, DOI 10.1007/s00223-007-9098-x; MILLER SC, 1982, CALCIFIED TISSUE INT, V34, P422, DOI 10.1007/BF02411278; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; MIYAUCHI A, 1993, OSTEOPOROSIS INT, V3, pS132; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; MOUTIER R, 1980, PATHOL RES PRACT, V168, P65, DOI 10.1016/S0344-0338(80)80207-X; Neutzsky-Wulff AV, 2010, DEV BIOL, V344, P1001, DOI 10.1016/j.ydbio.2010.06.018; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Ohishi M, 2009, AM J PATHOL, V174, P2160, DOI 10.2353/ajpath.2009.081026; Owen TA, 2003, CRIT REV EUKAR GENE, V13, P205; Partington GA, 2004, BONE, V34, P237, DOI 10.1016/j.bone.2003.11.010; PHILIPPART C, 1989, J ORAL PATHOL MED, V18, P163, DOI 10.1111/j.1600-0714.1989.tb00755.x; Pogoda P, 2005, OSTEOPOROSIS INT, V16, pS18, DOI 10.1007/s00198-004-1787-y; Popoff SN, 1996, MOL MED TODAY, V2, P349, DOI 10.1016/1357-4310(96)81801-6; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; RAISZ LG, 1981, METAB BONE DIS RELAT, V3, P117, DOI 10.1016/0221-8747(81)90029-1; Raynaud CM, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/658356; Ripoll VM, 2008, GENE, V413, P32, DOI 10.1016/j.gene.2008.01.014; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; Sheng MHC, 2008, FEBS LETT, V582, P1451, DOI 10.1016/j.febslet.2008.03.030; Sheng MHC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035280; Shih MS, 2009, BONE PATHOLOGY, SECOND EDITION, P129, DOI 10.1007/978-1-59745-347-9_8; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; Singh M, 2010, CRIT REV EUKAR GENE, V20, P341, DOI 10.1615/CritRevEukarGeneExpr.v20.i4.50; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Sun Y, 2005, J BIOL CHEM, V280, P32356, DOI 10.1074/jbc.M414213200; Takahashi N, 1999, BIOCHEM BIOPH RES CO, V256, P449, DOI 10.1006/bbrc.1999.0252; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Tsurukai T, 2000, J BONE MINER METAB, V18, P177, DOI 10.1007/s007740070018; Turque N, 1996, EMBO J, V15, P3338, DOI 10.1002/j.1460-2075.1996.tb00699.x; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Watcharasit P, 2002, P NATL ACAD SCI USA, V99, P7951, DOI 10.1073/pnas.122062299; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Xing LP, 2002, J BONE MINER RES, V17, P1200, DOI 10.1359/jbmr.2002.17.7.1200; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yagi M, 2006, J BONE MINER METAB, V24, P355, DOI 10.1007/s00774-006-0697-9; Yam LT, 2003, J BONE MINER RES, V18, P1894, DOI 10.1359/jbmr.2003.18.10.1894; Zhao HB, 2001, J BIOL CHEM, V276, P39295, DOI 10.1074/jbc.M010999200	84	25	26	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20128	20146		10.1074/jbc.M114.624270	http://dx.doi.org/10.1074/jbc.M114.624270			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	25837253	Green Published, hybrid			2022-12-28	WOS:000359608900016
J	Nguyen, H; Allali-Hassani, A; Antonysamy, S; Chang, S; Chen, LH; Curtis, C; Emtage, S; Fan, L; Gheyi, T; Li, FL; Liu, SC; Martin, JR; Mendel, D; Olsen, JB; Pelletier, L; Shatseva, T; Wu, S; Zhang, FF; Arrowsmith, CH; Brown, PJ; Campbell, RM; Garcia, BA; Barsyte-Lovejoy, D; Mader, M; Vedadi, M				Nguyen, Hannah; Allali-Hassani, Abdellah; Antonysamy, Stephen; Chang, Shawn; Chen, Lisa Hong; Curtis, Carmen; Emtage, Spencer; Fan, Li; Gheyi, Tarun; Li, Fengling; Liu, Shichong; Martin, Joseph R.; Mendel, David; Olsen, Jonathan B.; Pelletier, Laura; Shatseva, Tatiana; Wu, Song; Zhang, Feiyu Fred; Arrowsmith, Cheryl H.; Brown, Peter J.; Campbell, Robert M.; Garcia, Benjamin A.; Barsyte-Lovejoy, Dalia; Mader, Mary; Vedadi, Masoud			LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE; ESTROGEN-RECEPTOR; DRUG DISCOVERY; CANCER-CELLS; METHYLATION; IDENTIFICATION; PROLIFERATION; ORGANIZATION; CARCINOMA; INSIGHTS	SMYD2 is a lysine methyltransferase that catalyzes the monomethylation of several protein substrates including p53. SMYD2 is overexpressed in a significant percentage of esophageal squamous primary carcinomas, and that overexpression correlates with poor patient survival. However, the mechanism(s) by which SMYD2 promotes oncogenesis is not understood. A small molecule probe for SMYD2 would allow for the pharmacological dissection of this biology. In this report, we disclose LLY-507, a cell-active, potent small molecule inhibitor of SMYD2. LLY-507 is >100-fold selective for SMYD2 over a broad range of methyltransferase and non-methyltransferase targets. A1.63- A resolution crystal structure of SMYD 2 in complex with LLY-507 shows the inhibitor binding in the substrate peptide binding pocket. LLY-507 is active in cells as measured by reduction of SMYD2-induced monomethylation of p53 Lys(370) at submicromolar concentrations. We used LLY-507 to further test other potential roles of SMYD2. Mass spectrometry-based proteomics showed that cellular global histone methylation levels were not significantly affected by SMYD2 inhibition with LLY-507, and subcellular fractionation studies indicate that SMYD2 is primarily cytoplasmic, suggesting that SMYD2 targets a very small subset of histones at specific chromatin loci and/or non-histone substrates. Breast and liver cancers were identified through in silico data mining as tumor types that display amplification and/or overexpression of SMYD2. LLY-507 inhibited the proliferation of several esophageal, liver, and breast cancer cell lines in a dose-dependent manner. These findings suggest that LLY-507 serves as a valuable chemical probe to aid in the dissection of SMYD2 function in cancer and other biological processes.	[Nguyen, Hannah; Antonysamy, Stephen; Chang, Shawn; Chen, Lisa Hong; Curtis, Carmen; Emtage, Spencer; Fan, Li; Gheyi, Tarun; Martin, Joseph R.; Mendel, David; Olsen, Jonathan B.; Pelletier, Laura; Wu, Song; Zhang, Feiyu Fred; Campbell, Robert M.; Mader, Mary] Eli Lilly & Co, Dept Oncol Discovery, Indianapolis, IN 46285 USA; [Nguyen, Hannah; Antonysamy, Stephen; Chang, Shawn; Chen, Lisa Hong; Curtis, Carmen; Emtage, Spencer; Fan, Li; Gheyi, Tarun; Martin, Joseph R.; Mendel, David; Olsen, Jonathan B.; Pelletier, Laura; Wu, Song; Zhang, Feiyu Fred; Campbell, Robert M.; Mader, Mary] Eli Lilly & Co, Dept Biol Struct, Indianapolis, IN 46285 USA; [Nguyen, Hannah; Antonysamy, Stephen; Chang, Shawn; Chen, Lisa Hong; Curtis, Carmen; Emtage, Spencer; Fan, Li; Gheyi, Tarun; Martin, Joseph R.; Mendel, David; Olsen, Jonathan B.; Pelletier, Laura; Wu, Song; Zhang, Feiyu Fred; Campbell, Robert M.; Mader, Mary] Eli Lilly & Co, Dept Tailored Therapeut, Indianapolis, IN 46285 USA; [Nguyen, Hannah; Antonysamy, Stephen; Chang, Shawn; Chen, Lisa Hong; Curtis, Carmen; Emtage, Spencer; Fan, Li; Gheyi, Tarun; Martin, Joseph R.; Mendel, David; Olsen, Jonathan B.; Pelletier, Laura; Wu, Song; Zhang, Feiyu Fred; Campbell, Robert M.; Mader, Mary] Eli Lilly & Co, Dept Discovery Chem Res & Technol, Indianapolis, IN 46285 USA; [Allali-Hassani, Abdellah; Li, Fengling; Shatseva, Tatiana; Arrowsmith, Cheryl H.; Brown, Peter J.; Barsyte-Lovejoy, Dalia; Vedadi, Masoud] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Arrowsmith, Cheryl H.] Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Liu, Shichong; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly; University of Toronto; Structural Genomics Consortium; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Pennsylvania	Nguyen, H (corresponding author), Eli Lilly & Co, Indianapolis, IN 46285 USA.	nguyen_anh-quan_hannah@lilly.com	Chen, Lisa/GXN-0315-2022	Arrowsmith, Cheryl/0000-0002-4971-3250; Brown, Peter/0000-0002-8454-0367	DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research used resources from the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract Number DE-AC02-06CH11357. We thank Dr. Shelley Berger for providing the methyl-p53 antibody. We thank Steven Bray, Philip Ebert, and Yong Yue for help with data mining for tumor cell line p53 or Rb status. We thank Alexander Horvath for technical assistance.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Abu-Farha M, 2011, J MOL CELL BIOL, V3, P301, DOI 10.1093/jmcb/mjr025; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Campbell RM, 2014, J CLIN INVEST, V124, P64, DOI 10.1172/JCI71605; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cho HS, 2012, NEOPLASIA, V14, P476, DOI 10.1593/neo.12656; Diehl F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009748; Donlin LT, 2012, GENE DEV, V26, P114, DOI 10.1101/gad.177758.111; Ferguson AD, 2011, STRUCTURE, V19, P1262, DOI 10.1016/j.str.2011.06.011; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Hu LP, 2009, CANCER RES, V69, P4067, DOI 10.1158/0008-5472.CAN-08-4097; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Jiang YY, 2014, J MOL BIOL, V426, P3413, DOI 10.1016/j.jmb.2014.02.019; Jiang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021640; Komatsu S, 2009, CARCINOGENESIS, V30, P1139, DOI 10.1093/carcin/bgp116; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Piao L, 2014, NEOPLASIA, V16, DOI 10.1016/j.neo.2014.03.002; Proserpio V, 2013, GENE DEV, V27, P1299, DOI 10.1101/gad.217240.113; Saddic LA, 2010, J BIOL CHEM, V285, P37733, DOI 10.1074/jbc.M110.137612; Skawran B, 2008, MODERN PATHOL, V21, P505, DOI 10.1038/modpathol.3800998; Stender JD, 2012, MOL CELL, V48, P28, DOI 10.1016/j.molcel.2012.07.020; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Sakamoto LHT, 2014, LEUKEMIA RES, V38, P496, DOI 10.1016/j.leukres.2014.01.013; Van Aller GS, 2012, EPIGENETICS-US, V7, P340, DOI 10.4161/epi.19506; Wang L, 2011, J BIOL CHEM, V286, P38725, DOI 10.1074/jbc.M111.262410; Wu JQ, 2011, BIOCHEMISTRY-US, V50, P6488, DOI 10.1021/bi200725p; Xu ST, 2011, J MOL CELL BIOL, V3, P293, DOI 10.1093/jmcb/mjr015; Zhang X, 2013, P NATL ACAD SCI USA, V110, P17284, DOI 10.1073/pnas.1307959110	34	87	94	30	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13641	13653		10.1074/jbc.M114.626861	http://dx.doi.org/10.1074/jbc.M114.626861			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25825497	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000355313000002
J	Tsang, F; James, C; Kato, M; Myers, V; Ilyas, I; Tsang, M; Lin, SJ				Tsang, Felicia; James, Christol; Kato, Michiko; Myers, Victoria; Ilyas, Irtqa; Tsang, Matthew; Lin, Su-Ju			Reduced Ssy1-Ptr3-Ssy5 (SPS) Signaling Extends Replicative Life Span by Enhancing NAD(+) Homeostasis in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MEMBRANE PROTEINS; AMINO-ACID; CALORIE RESTRICTION; NICOTINAMIDE RIBOSIDE; TRANSCRIPTION FACTORS; SENSING PATHWAY; GENE DISRUPTION; YEAST; METABOLISM; SENSOR	Attenuated nutrient signaling extends the life span in yeast and higher eukaryotes; however, the mechanisms are not completely understood. Here we identify the Ssy1-Ptr3-Ssy5 (SPS) amino acid sensing pathway as a novel longevity factor. A null mutation of SSY5 (ssy5 Delta) increases replicative life span (RLS) by similar to 50%. Our results demonstrate that several NAD(+) homeostasis factors play key roles in this life span extension. First, expression of the putative malate-pyruvate NADH shuttle increases in ssy5 Delta cells, and deleting components of this shuttle, MAE1 and OAC1, largely abolishes RLS extension. Next, we show that Stp1, a transcription factor of the SPS pathway, directly binds to the promoter of MAE1 and OAC1 to regulate their expression. Additionally, deletion of SSY5 increases nicotinamide riboside (NR) levels and phosphate-responsive (PHO) signaling activity, suggesting that ssy5 Delta increases NR salvaging. This increase contributes to NAD(+) homeostasis, partially ameliorating the NAD(+) deficiency and rescuing the short life span of the npt1 Delta mutant. Moreover, we observed that vacuolar phosphatase, Pho8, is partially required for ssy5 Delta-mediated NR increase and RLS extension. Together, our studies present evidence that supports SPS signaling is a novel NAD(+) homeostasis factor and ssy5 Delta-mediated life span extension is likely due to concomitantly increased mitochondrial and vacuolar function. Our findings may contribute to understanding the molecular basis of NAD(+) metabolism, cellular life span, and diseases associated with NAD(+) deficiency and aging.	[Tsang, Felicia; James, Christol; Kato, Michiko; Myers, Victoria; Ilyas, Irtqa; Tsang, Matthew; Lin, Su-Ju] Univ Calif Davis, Dept Microbiol & Mol Genet, Coll Biol Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Lin, SJ (corresponding author), Univ Calif Davis, Dept Microbiol & Mol Genet, One Shields Ave, Davis, CA 95616 USA.	slin@ucdavis.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [GM102297]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102297, T34GM083894] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM102297 (NIGMS).	Abdel-Sater F, 2004, GENETICS, V166, P1727, DOI 10.1534/genetics.166.4.1727; Abdel-Sater F, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.200592; Andreasson C, 2006, GENE DEV, V20, P1563, DOI 10.1101/gad.374206; Bakker BM, 2001, FEMS MICROBIOL REV, V25, P15, DOI 10.1016/S0168-6445(00)00039-5; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Brachmann CB, 1998, YEAST, V14, P115; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Brown KM, 2008, MOL ECOL, V17, P2985, DOI 10.1111/j.1365-294X.2008.03765.x; Burke D., 2000, METHODS YEAST GENETI, P171; de Boer M, 2000, NUCLEIC ACIDS RES, V28, P974; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; Easlon E, 2007, J BIOL CHEM, V282, P6161, DOI 10.1074/jbc.M607661200; Eckert-Boulet N, 2004, YEAST, V21, P635, DOI 10.1002/yea.1120; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Foresti O, 2014, SCIENCE, V346, P751, DOI 10.1126/science.1255638; Forsberg H, 2001, MOL MICROBIOL, V42, P215, DOI 10.1046/j.1365-2958.2001.02627.x; Forsberg H, 2001, MOL CELL BIOL, V21, P814, DOI 10.1128/MCB.21.3.814-826.2001; Forsberg H, 2001, GENETICS, V158, P973; Gertz J, 2005, GENOME RES, V15, P1145, DOI 10.1101/gr.3859605; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gordan R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r125; GRAUSLUND M, 1995, BBA-MOL CELL RES, V1269, P275, DOI 10.1016/0167-4889(95)00138-8; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; KANEKO Y, 1985, MOL CELL BIOL, V5, P248, DOI 10.1128/MCB.5.1.248; Kato M, 2014, DNA REPAIR, V23, P49, DOI 10.1016/j.dnarep.2014.07.009; Kato M, 2014, J BIOL CHEM, V289, P15577, DOI 10.1074/jbc.M114.558643; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Kodama Y, 2002, CURR GENET, V41, P63, DOI 10.1007/s00294-002-0291-1; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Li MG, 2010, MOL CELL BIOL, V30, P3329, DOI 10.1128/MCB.01590-09; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Liu ZC, 2008, MOL CELL BIOL, V28, P551, DOI 10.1128/MCB.00929-07; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; Lodhi N, 2011, METHODS MOL BIOL, V780, P191, DOI 10.1007/978-1-61779-270-0_12; Lu SP, 2011, J BIOL CHEM, V286, P14271, DOI 10.1074/jbc.M110.217885; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; Noda T, 2008, METHOD ENZYMOL, V451, P33, DOI 10.1016/S0076-6879(08)03203-5; Ohashi K, 2013, EUKARYOT CELL, V12, P648, DOI 10.1128/EC.00339-12; Omnus DJ, 2014, MOL BIOL CELL, V25, P3823, DOI 10.1091/mbc.E14-06-1140; Omnus DJ, 2011, MOL BIOL CELL, V22, P2754, DOI 10.1091/mbc.E11-04-0282; Pinson B, 2009, GENE DEV, V23, P1399, DOI 10.1101/gad.521809; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Schreve JL, 1998, J BACTERIOL, V180, P2556, DOI 10.1128/JB.180.9.2556-2559.1998; Serrano R, 2002, MOL MICROBIOL, V46, P1319, DOI 10.1046/j.1365-2958.2002.03246.x; Sies H., 1982, METABOLIC COMPARTMEN, P205; Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263; Tumusiime S, 2011, J BIOL CHEM, V286, P4620, DOI 10.1074/jbc.M110.195313; Wang C, 2009, GENETICS, V183, P1373, DOI 10.1534/genetics.109.107797; Wielemans K, 2010, J BIOL CHEM, V285, P855, DOI 10.1074/jbc.M109.015263; Wykoff DD, 2001, GENETICS, V159, P1491; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Zargari A, 2007, J BIOL CHEM, V282, P594, DOI 10.1074/jbc.M609201200	65	13	14	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12753	12764		10.1074/jbc.M115.644534	http://dx.doi.org/10.1074/jbc.M115.644534			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25825491	hybrid, Green Published			2022-12-28	WOS:000354569000027
J	Shen, XC; Xi, G; Wai, C; Clemmons, DR				Shen, Xinchun; Xi, Gang; Wai, Christine; Clemmons, David R.			The Coordinate Cellular Response to Insulin-like Growth Factor-I (IGF-I) and Insulin-like Growth Factor-binding Protein-2 (IGFBP-2) Is Regulated through Vimentin Binding to Receptor Tyrosine Phosphatase beta (RPTP beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; INTEGRIN-LINKED KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; P21-ACTIVATED KINASE; C-ZETA; PHOSPHORYLATION; ACTIVATION; ILK; PSEUDOKINASE; DIFFERENTIATION	Insulin-like growth factor-binding protein-2 (IGFBP-2) functions coordinately with IGF-I to stimulate cellular proliferation and differentiation. IGFBP-2 binds to receptor tyrosine phosphatase beta (RPTP beta), and this binding in conjunction with IGF-I receptor stimulation induces RPTP beta polymerization leading to phosphatase and tensin homolog inactivation, AKT stimulation, and enhanced cell proliferation. To determine the mechanism by which RPTP beta polymerization is regulated, we analyzed the protein(s) that associated with RPTP beta in response to IGF-I and IGFBP-2 in vascular smooth muscle cells. Proteomic experiments revealed that IGF-I stimulated the intermediate filament protein vimentin to bind to RPTP beta, and knockdown of vimentin resulted in failure of IGFBP-2 and IGF-I to stimulate RPTP beta polymerization. Knockdown of IGFBP-2 or inhibition of IGF-IR tyrosine kinase disrupted vimentin/RPTP beta association. Vimentin binding to RPTP beta was mediated through vimentin serine phosphorylation. The serine threonine kinase PKC zeta was recruited to vimentin in response to IGF-I and inhibition of PKC zeta activation blocked these signaling events. A cell-permeable peptide that contained the vimentin phosphorylation site disrupted vimentin/RPTP beta association, and IGF-I stimulated RPTP beta polymerization and AKT activation. Integrin-linked kinase recruited PKC zeta to SHPS-1-associated vimentin in response to IGF-I and inhibition of integrin-linked kinase/PKC zeta association reduced vimentin serine phosphorylation. PKC zeta stimulation of vimentin phosphorylation required high glucose and vimentin/RPTP beta-association occurred only during hyperglycemia. Disruption of vimetin/RPTP beta in diabetic mice inhibited RPTP beta polymerization, vimentin serine phosphorylation, and AKT activation in response to IGF-I, whereas nondiabetic mice showed no difference. The induction of vimentin phosphorylation is important for IGFBP-2-mediated enhancement of IGF-I-stimulated proliferation during hyperglycemia, and it coordinates signaling between these two receptor-linked signaling systems.	[Xi, Gang; Wai, Christine; Clemmons, David R.] Univ N Carolina, Dept Med, Sch Med, Chapel Hill, NC 27599 USA; [Shen, Xinchun] Nanjing Univ Finance & Econ, Coll Food Sci & Engn, Key Lab Grains & Oils Qual Control & Proc, Nanjing 210023, Jiangsu, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Nanjing University of Finance & Economics	Clemmons, DR (corresponding author), Univ N Carolina, Div Endocrinol, CB 7170,8024 Burnett Womack, Chapel Hill, NC 27599 USA.	david_clemmons@med.unc.edu	, Proteomics Core UNC/AFQ-7201-2022; , Proteomics Core UNC/AAH-3777-2022; Regan, Clinton/E-6250-2012		National Institutes of Health [AG-02331]; National Natural Science Foundation of China [31271983]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG002331, R37AG002331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG-02331. This work was also supported by Grant 31271983 from the National Natural Science Foundation of China (to X. S.).	Brauksiepe Bastienne, 2008, BMC Biochemistry, V9, P25, DOI 10.1186/1471-2091-9-25; Dedhar S, 2000, CURR OPIN CELL BIOL, V12, P250, DOI 10.1016/S0955-0674(99)00083-6; DeMambro V. E., 2007, ENDOCRINOLOGY, V149, P2015; DeMambro VE, 2012, J BONE MINER RES, V27, P390, DOI 10.1002/jbmr.545; DEMELLOW JSM, 1988, BIOCHEM BIOPH RES CO, V156, P199, DOI 10.1016/S0006-291X(88)80824-6; Deuel TF, 2013, BBA-PROTEINS PROTEOM, V1834, P2219, DOI 10.1016/j.bbapap.2013.06.004; Dobreva I, 2008, J PROTEOME RES, V7, P1740, DOI 10.1021/pr700852r; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fukuda K, 2011, J BIOL CHEM, V286, P21886, DOI 10.1074/jbc.M111.240093; Galiano RD, 1996, J CLIN INVEST, V98, P2462, DOI 10.1172/JCI119064; Ghatak S, 2013, BIOCHEM SOC T, V41, P995, DOI 10.1042/BST20130062; GOCKERMAN A, 1995, CIRC RES, V76, P514, DOI 10.1161/01.RES.76.4.514; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Hoeflich A, 2001, ENDOCRINOLOGY, V142, P1889, DOI 10.1210/en.142.5.1889; Ingermann AR, 2010, J BIOL CHEM, V285, P30233, DOI 10.1074/jbc.M110.122226; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; JONES JI, 1993, P NATL ACAD SCI USA, V90, P10553, DOI 10.1073/pnas.90.22.10553; Kimura M, 2010, J CELL SCI, V123, P747, DOI 10.1242/jcs.052498; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Liu Q, 1998, J IMMUNOL, V160, P1393; Maile LA, 2008, DIABETES, V57, P2637, DOI 10.2337/db08-0326; Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155; OGAWARA M, 1995, J CELL BIOL, V131, P1055, DOI 10.1083/jcb.131.4.1055; Qin J, 2012, CURR OPIN CELL BIOL, V24, P607, DOI 10.1016/j.ceb.2012.06.003; Radhakrishnan Y, 2008, J BIOL CHEM, V283, P16320, DOI 10.1074/jbc.M801687200; Radhakrishnan Y, 2011, MOL ENDOCRINOL, V25, P1636, DOI 10.1210/me.2011-0035; Rajah R, 1997, J BIOL CHEM, V272, P12181, DOI 10.1074/jbc.272.18.12181; Shen XC, 2012, MOL CELL BIOL, V32, P4116, DOI 10.1128/MCB.01011-12; Shen XC, 2009, MOL CELL PROTEOMICS, V8, P1539, DOI 10.1074/mcp.M800543-MCP200; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Tang DD, 2005, BIOCHEM J, V388, P773, DOI 10.1042/BJ20050065; Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200; Wang HV, 2008, J CELL BIOL, V180, P1037, DOI 10.1083/jcb.200707175; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Widmaier M, 2012, J CELL SCI, V125, P1839, DOI 10.1242/jcs.093864; Xi G, 2014, J BONE MINER RES, V29, P2427, DOI 10.1002/jbmr.2282; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Xu CY, 2014, BIOL PHARM BULL, V37, P511, DOI 10.1248/bpb.b13-00845; Zuloaga R, 2013, BIOCHEM BIOPH RES CO, V440, P258, DOI 10.1016/j.bbrc.2013.09.067	41	18	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11578	11590		10.1074/jbc.M114.620237	http://dx.doi.org/10.1074/jbc.M114.620237			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25787077	Green Published, hybrid			2022-12-28	WOS:000353719400033
J	Piao, CM; Cai, L; Qiu, SL; Jia, LX; Song, WC; Du, J				Piao, Chunmei; Cai, Lun; Qiu, Shulan; Jia, Lixin; Song, Wenchao; Du, Jie			Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-mediated Inflammatory Cell Infiltration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DECAY-ACCELERATING FACTOR; INDUCED CARDIAC INFLAMMATION; MEMBRANE COFACTOR PROTEIN; SMALL-SUBUNIT P53R2; TUMOR MICROENVIRONMENT; REGULATORY PROTEINS; IN-VIVO; CONTRIBUTES; PROGRESSION; CARCINOMA	Complement 5a (C5a), a potent immune mediator generated by complement activation, promotes tumor growth; however, its role in tumor metastasis remains unclear. We demonstrate that C5a contributes to tumor metastases by modulating tumor inflammation in hepatic metastases of colon cancer. Colon cancer cell lines generate C5a under serum-free conditions, and C5a levels increase over time in a murine syngeneic colon cancer hepatic metastasis model. Furthermore, in the absence of C5a receptor or upon pharmacological inhibition of C5a production with an anti-C5 monoclonal antibody, tumor metastasis is severely impaired. A lack of C5a receptor in colon cancer metastatic foci reduces the infiltration of macrophages, neutrophils, and dendritic cells, and the role for C5a receptor on these cells were further verified by bone marrow transplantation experiments. Moreover, C5a signaling increases the expression of the chemokine monocyte chemoattractant protein-1 and the anti-inflammatory molecules arginase-1, interleukin 10, and transforming growth factor beta, but is inversely correlated with the expression of pro-inflammatory molecules, which suggests a mechanism for the role of C5a in the inflammatory microenvironment required for tumor metastasis. Our results indicate a new and potentially promising therapeutic application of complement C5a inhibitor for the treatment of malignant tumors.	[Piao, Chunmei; Cai, Lun; Qiu, Shulan; Jia, Lixin; Song, Wenchao; Du, Jie] Capital Med Univ, Beijing Anzhen Hosp, Beijing 100029, Peoples R China; [Piao, Chunmei; Du, Jie] Capital Med Univ, Key Lab Remodeling Related Cardiovasc Dis, Beijing Inst Heart Lung & Blood Vessel Dis, Minist Educ, Beijing 100029, Peoples R China	Capital Medical University; Capital Medical University	Du, J (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China.	jdu@bcm.edu		, Chunmei/0000-0002-2975-7336	Chinese High Technology Research and Development Program [2012AA02A201]; National Natural Science Foundation of China [81301797, 31090363, 81430050]; Beijing Natural Science Foundation [7122026]	Chinese High Technology Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by Chinese High Technology Research and Development Program Grant 2012AA02A201, National Natural Science Foundation of China Grants 81301797, 31090363, and 81430050, and Beijing Natural Science Foundation Grant 7122026.	Benoit ME, 2013, J BIOL CHEM, V288, P654, DOI 10.1074/jbc.M112.400168; Bjorge L, 2005, BRIT J CANCER, V92, P895, DOI 10.1038/sj.bjc.6602334; Corrales L, 2012, J IMMUNOL, V189, P4674, DOI 10.4049/jimmunol.1201654; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; de Visser KE, 2006, CONTRIB MICROBIOL, V13, P118, DOI 10.1159/000092969; Erreni M, 2011, CANCER MICROENVIRON, V4, P141, DOI 10.1007/s12307-010-0052-5; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Gao D, 2009, TRENDS MOL MED, V15, P333, DOI 10.1016/j.molmed.2009.06.006; Ghebrehiwet B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00278; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hu HY, 2006, J PHARM SCI-US, V95, P192, DOI 10.1002/jps.20517; INOUE H, 1994, ACTA MED OKAYAMA, V48, P271; Ji RC, 2014, CANCER LETT, V346, P6, DOI 10.1016/j.canlet.2013.12.001; Lanca T, 2012, ONCOIMMUNOLOGY, V1, P717, DOI 10.4161/onci.20068; Li YL, 2012, ARTERIOSCL THROM VAS, V32, P1662, DOI 10.1161/ATVBAHA.112.249706; Liu JN, 2005, J EXP MED, V201, P567, DOI 10.1084/jem.20040863; Ma FF, 2014, J IMMUNOL, V192, P3365, DOI 10.4049/jimmunol.1301522; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Markiewski MM, 2009, TRENDS IMMUNOL, V30, P286, DOI 10.1016/j.it.2009.04.002; Miwa T, 2013, J IMMUNOL, V190, P3552, DOI 10.4049/jimmunol.1202275; Morimoto-Tomita M, 2005, CLIN EXP METASTAS, V22, P513, DOI 10.1007/s10585-005-3585-0; Motz GT, 2011, NAT REV IMMUNOL, V11, P702, DOI 10.1038/nri3064; Mueller-Ortiz SL, 2014, J IMMUNOL, V193, P1278, DOI 10.4049/jimmunol.1302787; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; NICULESCU F, 1992, AM J PATHOL, V140, P1039; Niehans GA, 1996, AM J PATHOL, V149, P129; Ostrand-Rosenberg S, 2008, NAT BIOTECHNOL, V26, P1348, DOI 10.1038/nbt1208-1348; Pan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035315; Peerschke EIB, 2014, MOL IMMUNOL, V61, P100, DOI 10.1016/j.molimm.2014.06.011; Peng Q, 2009, J IMMUNOL, V183, P6058, DOI 10.4049/jimmunol.0804186; Piao C, 2009, ONCOGENE, V28, P2173, DOI 10.1038/onc.2009.84; Piao C, 2012, CELL CYCLE, V11, P3237, DOI 10.4161/cc.21591; Qiu SL, 2014, J BIOL CHEM, V289, P9449, DOI 10.1074/jbc.M113.543447; Rombouts K, 2013, CANCER LETT, V333, P244, DOI 10.1016/j.canlet.2013.01.040; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Saxena A, 2013, INT J COLORECTAL DIS, V28, P1267, DOI 10.1007/s00384-013-1664-2; SCHEELE J, 1990, BRIT J SURG, V77, P1241, DOI 10.1002/bjs.1800771115; Tang Hui, 2013, Adv Biosci Biotechnol, V4, P30; Thorsteinsson L, 1998, APMIS, V106, P869, DOI 10.1111/j.1699-0463.1998.tb00233.x; Wang SY, 2008, EXPERT OPIN BIOL TH, V8, P759, DOI [10.1517/14712598.8.6.759, 10.1517/14712598.8.6.759 ]; Wilczek E, 2008, INT J CANCER, V122, P2030, DOI 10.1002/ijc.23238; Wu YN, 2014, HYPERTENSION, V63, P1241, DOI 10.1161/HYPERTENSIONAHA.113.02843; Xu B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/437950; Yang M, 2014, CELL DEATH DIFFER, V21, P1290, DOI 10.1038/cdd.2014.45; Yang M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-43; Zhang CC, 2014, ARTERIOSCL THROM VAS, V34, P1240, DOI 10.1161/ATVBAHA.113.303120; Zheng J, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-141; Zhou WD, 2012, IMMUNOBIOLOGY, V217, P225, DOI 10.1016/j.imbio.2011.07.016	50	60	61	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10667	10676		10.1074/jbc.M114.612622	http://dx.doi.org/10.1074/jbc.M114.612622			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25739439	hybrid, Green Published			2022-12-28	WOS:000353404500010
J	Evans, JC; Robinson, CM; Shi, MJ; Webb, DJ				Evans, J. Corey; Robinson, Cristina M.; Shi, Mingjian; Webb, Donna J.			The Guanine Nucleotide Exchange Factor (GEF) Asef2 Promotes Dendritic Spine Formation via Rac Activation and Spinophilin-dependent Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dendrite; Guanine Nucleotide Exchange Factor (GEF); Neuron; Rac (Rac GTPase); Rho (Rho GTPase); Synapse	LINKED MENTAL-RETARDATION; ACTIN-BASED PLASTICITY; HIPPOCAMPAL-NEURONS; RHO-GTPASE; CRYSTAL-STRUCTURE; BINDING-PROTEIN; CELL-MIGRATION; NMDA RECEPTOR; N-WASP; MORPHOGENESIS	Dendritic spines are actin-rich protrusions that establish excitatory synaptic contacts with surrounding neurons. Reorganization of the actin cytoskeleton is critical for the development and plasticity of dendritic spines, which is the basis for learning and memory. Rho family GTPases are emerging as important modulators of spines and synapses, predominantly through their ability to regulate actin dynamics. Much less is known, however, about the function of guanine nucleotide exchange factors (GEFs), which activate these GTPases, in spine and synapse development. In this study we show that the Rho family GEF Asef2 is found at synaptic sites, where it promotes dendritic spine and synapse formation. Knockdown of endogenous Asef2 with shRNAs impairs spine and synapse formation, whereas exogenous expression of Asef2 causes an increase in spine and synapse density. This effect of Asef2 on spines and synapses is abrogated by expression of GEF activity-deficient Asef2 mutants or by knockdown of Rac, suggesting that Asef2-Rac signaling mediates spine development. Because Asef2 interacts with the F-actin-binding protein spinophilin, which localizes to spines, we investigated the role of spinophilin in Asef2-promoted spine formation. Spinophilin recruits Asef2 to spines, and knockdown of spinophilin hinders spine and synapse formation in Asef2-expressing neurons. Furthermore, inhibition of N-methyl-d-aspartate receptor (NMDA) activity blocks spinophilin-mediated localization of Asef2 to spines. These results collectively point to spinophilin-Asef2-Rac signaling as a novel mechanism for the development of dendritic spines and synapses.	[Evans, J. Corey; Robinson, Cristina M.; Shi, Mingjian; Webb, Donna J.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Evans, J. Corey; Robinson, Cristina M.; Shi, Mingjian; Webb, Donna J.] Vanderbilt Univ, Kennedy Ctr Res Human Dev, Nashville, TN 37235 USA; [Webb, Donna J.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Webb, DJ (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B,Box 35-1634, Nashville, TN 37235 USA.	donna.webb@vanderbilt.edu	Shi, Mingjian/HII-8660-2022	Shi, Mingjian/0000-0003-1569-9822	National Institutes of Health [GM092914, MH071674, GM008554]; National Center for Research Resources [S10RR025524]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092914, T32GM008554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants GM092914 and MH071674 and by National Center for Research Resources Grant S10RR025524 (to D. J. W.).; Supported by National Institutes of Health Predoctoral Training Grant GM008554.	Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Allison DW, 1998, J NEUROSCI, V18, P2423; Barnes AP, 2004, MOL BRAIN RES, V124, P105, DOI 10.1016/j.molbrainres.2003.12.020; Becker JAJ, 2008, NEUROSCIENCE, V156, P950, DOI 10.1016/j.neuroscience.2008.07.070; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Bristow JM, 2009, J CELL SCI, V122, P4535, DOI 10.1242/jcs.053728; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Dailey ME, 1996, J NEUROSCI, V16, P2983; DAVIES J, 1981, NEUROSCI LETT, V21, P77, DOI 10.1016/0304-3940(81)90061-6; De Roo M, 2008, PLOS BIOL, V6, P1850, DOI 10.1371/journal.pbio.0060219; DRENCKHAHN D, 1984, BRAIN RES, V300, P381, DOI 10.1016/0006-8993(84)90851-5; Edwards AC, 2012, PSYCHIAT GENET, V22, P31, DOI 10.1097/YPG.0b013e32834acd07; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gass JT, 2012, ACS CHEM NEUROSCI, V3, P494, DOI 10.1021/cn300013p; Gloster A, 1999, J COMP NEUROL, V405, P45, DOI 10.1002/(SICI)1096-9861(19990301)405:1<45::AID-CNE4>3.0.CO;2-M; Goslin K., 1998, CULTURING NERVE CELL, P339; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; GRAY EG, 1959, J ANAT, V93, P420; Grossman SD, 2002, NEUROMOL MED, V2, P61, DOI 10.1385/NMM:2:1:61; Hamann MJ, 2007, MOL CELL BIOL, V27, P1380, DOI 10.1128/MCB.01608-06; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jean L, 2013, J CELL SCI, V126, P5585, DOI 10.1242/jcs.131060; Kasri NN, 2009, GENE DEV, V23, P1289, DOI 10.1101/gad.1783809; Kawasaki Y, 2007, ONCOGENE, V26, P7620, DOI 10.1038/sj.onc.1210574; Kawasaki Y, 2009, J BIOL CHEM, V284, P22436, DOI 10.1074/jbc.M109.020768; Kelker MS, 2007, BIOCHEMISTRY-US, V46, P2333, DOI 10.1021/bi602341c; Knaus Ulla G., 2007, V412, P59, DOI 10.1007/978-1-59745-467-4_5; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Leuner B, 2003, J NEUROSCI, V23, P659, DOI 10.1523/JNEUROSCI.23-02-00659.2003; Lin WH, 2010, J BIOL CHEM, V285, P36010, DOI 10.1074/jbc.M110.129841; Luscher C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005710; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Ma XM, 2003, J NEUROSCI, V23, P10593; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Murayama K, 2007, J BIOL CHEM, V282, P4238, DOI 10.1074/jbc.C600234200; Muroya K, 2007, BIOCHEM BIOPH RES CO, V355, P85, DOI 10.1016/j.bbrc.2007.01.131; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nakayama AY, 2000, HIPPOCAMPUS, V10, P582, DOI 10.1002/1098-1063(2000)10:5<582::AID-HIPO8>3.0.CO;2-K; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Ota KT, 2013, NEUROBIOL DIS, V57, P28, DOI 10.1016/j.nbd.2012.05.022; PAPA M, 1995, J NEUROSCI, V15, P1; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Rajagopal S, 2010, J BIOL CHEM, V285, P18060, DOI 10.1074/jbc.M109.051490; Reddy-Alla S, 2010, EUR J NEUROSCI, V31, P1173, DOI 10.1111/j.1460-9568.2010.07149.x; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Sagara M, 2009, ONCOGENE, V28, P1357, DOI 10.1038/onc.2008.478; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Scott EK, 2003, J NEUROSCI, V23, P3118; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Stafstrom-Davis CA, 2001, LEARN MEMORY, V8, P272, DOI 10.1101/lm.42101; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; Walther DM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004523; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; WEST M, 1990, FEBS LETT, V259, P245, DOI 10.1016/0014-5793(90)80019-F; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Yoshizawa M, 2003, GENE EXPR PATTERNS, V3, P375, DOI 10.1016/S1567-133X(03)00002-4; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368; Zhu KJ, 2000, J BIOL CHEM, V275, P25993, DOI 10.1074/jbc.M003780200; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	80	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10295	10308		10.1074/jbc.M114.605543	http://dx.doi.org/10.1074/jbc.M114.605543			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25750125	hybrid, Green Published			2022-12-28	WOS:000353241100033
J	Planque, SA; Nishiyama, Y; Sonoda, S; Lin, Y; Taguchi, H; Hara, M; Kolodziej, S; Mitsuda, Y; Gonzalez, V; Sait, HBR; Fukuchi, K; Massey, RJ; Friedland, RP; O'Nuallain, B; Sigurdsson, EM; Paul, S				Planque, Stephanie A.; Nishiyama, Yasuhiro; Sonoda, Sari; Lin, Yan; Taguchi, Hiroaki; Hara, Mariko; Kolodziej, Steven; Mitsuda, Yukie; Gonzalez, Veronica; Sait, Hameetha B. R.; Fukuchi, Ken-ichiro; Massey, Richard J.; Friedland, Robert P.; O'Nuallain, Brian; Sigurdsson, Einar M.; Paul, Sudhir			Specific Amyloid beta Clearance by a Catalytic Antibody Construct	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid- (Abeta); Antibody Engineering; Enzyme Catalysis; Immunotherapy; Innate Immunity; Catalytic Antibodies; Light Chain Variable Domain; Neurotoxicity	BLOOD-BRAIN-BARRIER; MODERATE ALZHEIMERS-DISEASE; A-BETA; PRECURSOR PROTEIN; TRANSGENIC MICE; MOUSE MODEL; CHAIN ANTIBODIES; HEAVY-CHAIN; OLIGOMERS; PEPTIDES	Classical immunization methods do not generate catalytic antibodies (catabodies), but recent findings suggest that the innate antibody repertoire is a rich catabody source. We describe the specificity and amyloid (A)-clearing effect of a catabody construct engineered from innate immunity principles. The catabody recognized the A C terminus noncovalently and hydrolyzed A rapidly, with no reactivity to the A precursor protein, transthyretin amyloid aggregates, or irrelevant proteins containing the catabody-sensitive A dipeptide unit. The catabody dissolved preformed A aggregates and inhibited A aggregation more potently than an A-binding IgG. Intravenous catabody treatment reduced brain A deposits in a mouse Alzheimer disease model without inducing microgliosis or microhemorrhages. Specific A hydrolysis appears to be an innate immune function that could be applied for therapeutic A removal.	[Planque, Stephanie A.; Nishiyama, Yasuhiro; Sonoda, Sari; Taguchi, Hiroaki; Hara, Mariko; Kolodziej, Steven; Mitsuda, Yukie; Paul, Sudhir] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Chem Immunol Res Ctr, Houston, TX 77030 USA; [Lin, Yan; Gonzalez, Veronica; Sait, Hameetha B. R.; Sigurdsson, Einar M.] NYU, Sch Med, Dept Neurosci & Physiol, New York, NY 10016 USA; [Lin, Yan; Gonzalez, Veronica; Sait, Hameetha B. R.; Sigurdsson, Einar M.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Fukuchi, Ken-ichiro] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61605 USA; [Massey, Richard J.] Covalent Biosci Inc, Houston, TX 77054 USA; [Friedland, Robert P.] Univ Louisville, Dept Neurol, Sch Med, Louisville, KY 40202 USA; [O'Nuallain, Brian] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [O'Nuallain, Brian] Harvard Univ, Sch Med, Boston, MA 02115 USA	University of Texas System; University of Texas Health Science Center Houston; New York University; New York University; University of Illinois System; University of Illinois Peoria; University of Louisville; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sigurdsson, EM (corresponding author), NYU, Sch Med, Dept Neurosci & Physiol, 450 East 29th St, New York, NY 10016 USA.	Einar.Sigurdsson@nyumc.org; Sudhir.Paul@uth.tmc.edu	Friedland, Robert/A-2834-2010	Friedland, Robert/0000-0001-5721-1843; Sigurdsson, Einar/0000-0003-1451-0952	National Institutes of Health [R01AG025304, 5U01AG033183, R01AG020197]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032611, U01AG033183, R01AG020197, R01AG025304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG025304, 5U01AG033183, and R01AG020197. S. A. P., Y. N., R. J. M., and S. P. have a financial interest in Covalent Bioscience, Inc. and patents concerning catalytic antibodies.	Adolfsson O, 2012, J NEUROSCI, V32, P9677, DOI 10.1523/JNEUROSCI.4742-11.2012; Asuni AA, 2006, EUR J NEUROSCI, V24, P2530, DOI 10.1111/j.1460-9568.2006.05149.x; Attems J, 2011, NEUROPATH APPL NEURO, V37, P75, DOI 10.1111/j.1365-2990.2010.01137.x; Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9; Banks WA, 2007, EXP NEUROL, V206, P248, DOI 10.1016/j.expneurol.2007.05.005; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Berger V, 2013, PROTEIN ENG DES SEL, V26, P581, DOI 10.1093/protein/gzt044; Chesneau V, 2000, BIOCHEM J, V351, P509, DOI 10.1042/0264-6021:3510509; Colcher D, 1998, Q J NUCL MED, V42, P225; Cruys-Bagger N, 2013, FEBS J, V280, P3952, DOI 10.1111/febs.12397; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Efthimiopoulos S, 1996, P NATL ACAD SCI USA, V93, P8046, DOI 10.1073/pnas.93.15.8046; Fukuchi K, 2006, NEUROBIOL DIS, V23, P502, DOI 10.1016/j.nbd.2006.04.012; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Goodyear CS, 2005, SPRINGER SEMIN IMMUN, V26, P463, DOI 10.1007/s00281-004-0190-2; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Kalinin S, 2013, NEUROBIOL AGING, V34, P2361, DOI 10.1016/j.neurobiolaging.2013.03.023; Kasturirangan S, 2010, BIOCHEMISTRY-US, V49, P4501, DOI 10.1021/bi902030m; Kitazume S, 2012, J BIOL CHEM, V287, P40817, DOI 10.1074/jbc.M112.398578; Kou JH, 2015, MOL NEUROBIOL, V51, P43, DOI 10.1007/s12035-014-8691-z; Kuroda D, 2012, PROTEIN ENG DES SEL, V25, P507, DOI 10.1093/protein/gzs024; Lei CY, 2013, J NEUROL NEUROSUR PS, V84, P693, DOI 10.1136/jnnp-2012-303948; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Li L, 1996, MOL IMMUNOL, V33, P593, DOI 10.1016/0161-5890(96)00021-1; Miao J, 2005, AM J PATHOL, V167, P505, DOI 10.1016/S0002-9440(10)62993-8; Morkuniene R, 2013, J NEUROCHEM, V126, P604, DOI 10.1111/jnc.12332; Mukherjee A, 2000, J NEUROSCI, V20, P8745; Nishiyama Y, 2006, J MOL RECOGNIT, V19, P423, DOI 10.1002/jmr.795; Nishiyama Y, 2014, J BIOTECHNOL, V180, P17, DOI 10.1016/j.jbiotec.2014.03.026; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; Paul S, 2012, ADV EXP MED BIOL, V750, P56, DOI 10.1007/978-1-4614-3461-0_5; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Piazza F, 2013, ANN NEUROL, V73, P449, DOI 10.1002/ana.23857; Planque SA, 2014, J BIOL CHEM, V289, P13243, DOI 10.1074/jbc.M114.557231; POLLACK SJ, 1989, J AM CHEM SOC, V111, P5961, DOI 10.1021/ja00197a078; Purushothuman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059740; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Randall AD, 2010, NEUROPHARMACOLOGY, V59, P243, DOI 10.1016/j.neuropharm.2010.02.011; Robert R, 2012, ARCH BIOCHEM BIOPHYS, V526, P132, DOI 10.1016/j.abb.2012.02.022; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Sapparapu G, 2009, J BIOL CHEM, V284, P24622, DOI 10.1074/jbc.M109.011858; SCHURR JM, 1966, SCIENCE, V152, P1064, DOI 10.1126/science.152.3725.1064; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Spencer BJ, 2007, P NATL ACAD SCI USA, V104, P7594, DOI 10.1073/pnas.0702170104; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Sumitomo M, 2005, BBA-PROTEINS PROTEOM, V1751, P52, DOI 10.1016/j.bbapap.2004.11.001; Taguchi H, 2008, J BIOL CHEM, V283, P36724, DOI 10.1074/jbc.M806766200; Thomas FC, 2009, PHARM RES-DORDR, V26, P2486, DOI 10.1007/s11095-009-9964-5; Tucker HM, 2002, J NEUROSCI RES, V70, P249, DOI 10.1002/jnr.10417; Vasilevko V, 2007, J NEUROSCI, V27, P13376, DOI 10.1523/JNEUROSCI.2788-07.2007; Yoshihara T, 2008, J BIOCHEM, V143, P475, DOI 10.1093/jb/mvm239; Zago Wagner, 2013, Alzheimers Dement, V9, pS105, DOI 10.1016/j.jalz.2012.11.010; Zhang JB, 2009, PROTEIN EXPRES PURIF, V65, P77, DOI 10.1016/j.pep.2008.10.011	61	23	29	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10229	10241		10.1074/jbc.M115.641738	http://dx.doi.org/10.1074/jbc.M115.641738			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25724648	hybrid, Green Published			2022-12-28	WOS:000353241100029
J	Kim, EJ; Juhnn, YS				Kim, Eui-Jun; Juhnn, Yong-Sung			Cyclic AMP Signaling Reduces Sirtuin 6 Expression in Non-small Cell Lung Cancer Cells by Promoting Ubiquitin-Proteasomal Degradation via Inhibition of the Raf-MEK-ERK (Raf/Mitogen-activated Extracellular Signal-regulated Kinase/Extracellular Signal-regulated Kinase) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CISPLATIN-INDUCED APOPTOSIS; BAK EXPRESSION; HISTONE; DEACETYLASE; BINDING; LIGASE; LEPTIN	The cAMP signaling system regulates various cellular functions, including metabolism, gene expression, and death. Sirtuin 6 (SIRT6) removes acetyl groups from histones and regulates genomic stability and cell viability. We hypothesized that cAMP modulates SIRT6 activity to regulate apoptosis. Therefore, we examined the effects of cAMP signaling on SIRT6 expression and radiation-induced apoptosis in lung cancer cells. cAMP signaling in H1299 and A549 human non-small cell lung cancer cells was activated via the expression of constitutively active G alpha(s) plus treatment with prostaglandin E2 (PGE2), isoproterenol, or forskolin. The expression of sirtuins and signaling molecules were analyzed by Western blotting. Activation of cAMP signaling reduced SIRT6 protein expression in lung cancer cells. cAMP signaling increased the ubiquitination of snrr6 protein and promoted its degradation. Treatment with MG132 and inhibiting PKA with H89 or with a dominant-negative PKA abolished the cAMP-mediated reduction in SIRT6 levels, Treatment with PGE2 inhibited c-Raf activation by increasing inhibitory phosphorylation at Ser-259 in a PKA-dependent manner, thereby inhibiting downstream MEK-ERK signaling. Inhibiting ERK with inhibitors or with dominant-negative ERKs reduced SIRT6 expression, whereas activation of ERK by constitutively active MEK abolished the SIRT6-depleting effects of PGE2. cAMP signaling also augmented radiation-induced apoptosis in lung cancer cells. This effect was abolished by exogenous expression of SIRT6. It is concluded that cAMP signaling reduces SIRT6 expression by promoting its ubiquitin-protea-some-dependent degradation, a process mediated by the PKA-dependent inhibition of the Raf-MEK-ERK pathway. Reduced SIRT6 expression mediates the augmentation of radiation-induced apoptosis by cAMP signaling in lung cancer cells.	[Juhnn, Yong-Sung] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, 103 Daehak Ro, Seoul 110799, South Korea; Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Juhnn, YS (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, 103 Daehak Ro, Seoul 110799, South Korea.	juhnn@snu.ac.kr	Kim, Eui-Jun/S-3747-2017	Kim, Eui-Jun/0000-0002-8475-5229	Basic Science Research Program through the National Research Foundation - Ministry of Education, Science, and Technology [2012R1A1A2044374]; National RAMP;D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea [0720540]; Education and Research Supporting Fund from Seoul National University Hospital	Basic Science Research Program through the National Research Foundation - Ministry of Education, Science, and Technology(National Research Foundation of Korea); National RAMP;D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea; Education and Research Supporting Fund from Seoul National University Hospital	This work was supported by the Basic Science Research Program through the National Research Foundation funded by the Ministry of Education, Science, and Technology (2012R1A1A2044374), a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (0720540), and by the Education and Research Supporting Fund from Seoul National University Hospital.	Cho EA, 2011, CANCER SCI, V102, P837, DOI 10.1111/j.1349-7006.2011.01883.x; Choi YJ, 2009, EXP MOL MED, V41, P592, DOI 10.3858/emm.2009.41.8.065; Choi YJ, 2009, CANCER SCI, V100, P1069, DOI 10.1111/j.1349-7006.2009.01136.x; CLEGG CH, 1987, J BIOL CHEM, V262, P13111; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fu JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078522; Goncalves DAP, 2009, ENDOCRINOLOGY, V150, P5395, DOI 10.1210/en.2009-0428; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Hong EH, 2011, J BIOL CHEM, V286, P28619, DOI 10.1074/jbc.M111.219832; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johnson DH, 2014, J CLIN ONCOL, V32, P973, DOI 10.1200/JCO.2013.53.1228; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim SY, 2008, J BIOL CHEM, V283, P1350, DOI 10.1074/jbc.M702344200; Kim YK, 2005, J APPL TOXICOL, V25, P374, DOI 10.1002/jat.1081; Lefkimmiatis K, 2014, PHARMACOL THERAPEUT, V143, P295, DOI 10.1016/j.pharmthera.2014.03.008; Li YP, 2013, J BIOL CHEM, V288, P27646, DOI 10.1074/jbc.M113.463067; Lin ZH, 2013, CELL REP, V5, P1639, DOI 10.1016/j.celrep.2013.11.029; Liu YW, 2013, PROTEIN CELL, V4, P702, DOI 10.1007/s13238-013-3054-5; Lu TP, 2010, CANCER EPIDEM BIOMAR, V19, P2590, DOI 10.1158/1055-9965.EPI-10-0332; Luan B, 2014, CELL METAB, V19, P1058, DOI 10.1016/j.cmet.2014.03.024; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Ming M, 2014, CANCER RES, V74, P5925, DOI 10.1158/0008-5472.CAN-14-1308; Polidoro L, 2013, J CARDIOVASC TRANSL, V6, P221, DOI 10.1007/s12265-012-9436-x; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Ronnebaum SM, 2013, MOL CELL BIOL, V33, P4461, DOI 10.1128/MCB.00480-13; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; Spina A, 2013, FRONT BIOSCI-LANDMRK, V18, P133, DOI 10.2741/4092; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Thirumurthi U, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005076; Venugopal B, 2011, CURR MED CHEM, V18, P1658, DOI 10.2174/092986711795471284; Wiseman SL, 2013, J BIOL CHEM, V288, P17803, DOI 10.1074/jbc.M113.477182; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017057; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zochbauer-Muller S, 2002, ANNU REV PHYSIOL, V64, P681, DOI 10.1146/annurev.physiol.64.081501.155828	40	47	49	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9604	9613		10.1074/jbc.M114.633198	http://dx.doi.org/10.1074/jbc.M114.633198			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713071	Green Published, hybrid			2022-12-28	WOS:000352729400025
J	McIlwain, BC; Vandenberg, RJ; Ryan, RM				McIlwain, Benjamin C.; Vandenberg, Robert J.; Ryan, Renae M.			Transport Rates of a Glutamate Transporter Homologue Are Influenced by the Lipid Bilayer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ASPARTATE TRANSPORTER; MEMBRANE; BINDING; PROTEIN; ORIENTATION; DYNAMICS; CARRIER; ACID; LOOP	The aspartate transporter from Pyrococcus horikoshii (Glt(Ph)) is a model for the structure of the SLC1 family of amino acid transporters. Crystal structures of Glt(Ph) provide insight into mechanisms of ion coupling and substrate transport; however, structures have been solved in the absence of a lipid bilayer so they provide limited information regarding interactions that occur between the protein and lipids of the membrane. Here, we investigated the effect of the lipid environment on aspartate transport by reconstituting Glt(Ph) into liposomes of defined lipid composition where the primary lipid is phosphatidylethanolamine (PE) or its methyl derivatives. We showed that the rate of aspartate transport and the transmembrane orientation of Glt(Ph) were influenced by the primary lipid in the liposomes. In PE liposomes, we observed the highest transport rate and showed that 85% of the transporters were orientated right-side out, whereas in trimethyl PE liposomes, 50% of transporters were right-side out, and we observed a 4-fold reduction in transport rate. Differences in orientation can only partially explain the lipid composition effect on transport rate. Crystal structures of Glt(Ph) revealed a tyrosine residue (Tyr-33) that we propose interacts with lipid headgroups during the transport cycle. Based on site-directed mutagenesis, we propose that a cation-pi interaction between Tyr-33 and the lipid headgroups can influence conformational flexibility of the trimerization domain and thus the rate of transport. These results provide a specific example of how interactions between membrane lipids and membrane-bound proteins can influence function and highlight the importance of the role of the membrane in transporter function.	Univ Sydney, Transporter Biol Grp, Discipline Pharmacol, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Ryan, RM (corresponding author), Univ Sydney, Sydney Med Sch, Transporter Biol Grp, Discipline Pharmacol,Bosch Inst, Sydney, NSW 2006, Australia.	renae.ryan@sydney.edu.au	Ryan, Renae/AAC-3540-2021; Vandenberg, Robert/E-6018-2016	Ryan, Renae/0000-0002-8680-4610; Vandenberg, Robert/0000-0003-1523-4814	National Health and Medical Research Council of Australia [APP 1048784]; Australian postgraduate award; National Health and Medical Research Council Career Development Fellowship [571093]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian postgraduate award(Australian Government); National Health and Medical Research Council Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council of Australia Project Grant APP 1048784.r Supported by an Australian postgraduate award.r Supported by National Health and Medical Research Council Career Development Fellowship 571093. To whom correspondence should be addressed: Transporter Biology Group, Discipline of Pharmacology, Bosch Inst., Sydney Medical School, University of Sydney, Sydney, New South Wales 2006, Australia. Tel.: 61-2-9351-2669; Fax: 61-2-9351-3868; E-mail: renae.ryan@sydney.edu.au.	Akyuz N, 2013, NATURE, V502, P114, DOI 10.1038/nature12265; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; Bastug T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033058; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Compton ELR, 2010, P NATL ACAD SCI USA, V107, P12840, DOI 10.1073/pnas.1003046107; daCosta CJB, 2004, J BIOL CHEM, V279, P14967, DOI 10.1074/jbc.M310037200; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; de Planque MRR, 2003, BIOCHEMISTRY-US, V42, P5341, DOI 10.1021/bi027000r; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Erkens GB, 2013, NATURE, V502, P119, DOI 10.1038/nature12538; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Gustot A, 2010, J BIOL CHEM, V285, P14144, DOI 10.1074/jbc.M109.079673; Hakizimana P, 2008, J BIOL CHEM, V283, P9369, DOI 10.1074/jbc.M708427200; Hanelt I, 2013, NAT STRUCT MOL BIOL, V20, P210, DOI 10.1038/nsmb.2471; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; Kapri-Pardes E, 2011, J BIOL CHEM, V286, P42888, DOI 10.1074/jbc.M111.293852; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lezon TR, 2012, BIOPHYS J, V102, P1331, DOI 10.1016/j.bpj.2012.02.028; Mulligan C, 2013, J BIOL CHEM, V288, P35266, DOI 10.1074/jbc.M113.508408; Reyes N, 2013, NAT STRUCT MOL BIOL, V20, P634, DOI 10.1038/nsmb.2548; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Schiller D, 2006, J BIOL CHEM, V281, P7737, DOI 10.1074/jbc.M513052200; Serre L, 1998, STRUCTURE, V6, P1255, DOI 10.1016/S0969-2126(98)00126-9; Simister PC, 2002, ACTA CRYSTALLOGR D, V58, P1077, DOI 10.1107/S090744490200522X; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; Tsai MF, 2012, BIOCHEMISTRY-US, V51, P1577, DOI 10.1021/bi201897t; Tunuguntla R, 2013, BIOPHYS J, V105, P1388, DOI 10.1016/j.bpj.2013.07.043; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vandenberg RJ, 2013, PHYSIOL REV, V93, P1621, DOI 10.1152/physrev.00007.2013; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Wadiche JI, 1998, J NEUROSCI, V18, P7650; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	37	27	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9780	9788		10.1074/jbc.M114.630590	http://dx.doi.org/10.1074/jbc.M114.630590			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713135	Green Published, hybrid			2022-12-28	WOS:000352729400038
J	Saeed, S; Jowitt, TA; Warwicker, J; Hayes, F				Saeed, Sadia; Jowitt, Thomas A.; Warwicker, Jim; Hayes, Finbarr			Breaking and Restoring the Hydrophobic Core of a Centromere-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-DNA SEGREGATION; TUBULIN HOMOLOG TUBZ; ARC REPRESSOR DIMER; PLASMID-PARTITION; CHROMOSOME SEGREGATION; CRYSTAL-STRUCTURE; TRANSCRIPTION FACTORS; SCANNING MUTAGENESIS; F-PLASMID; STABILITY	The ribbon-helix-helix (RHH) superfamily of DNA-binding proteins is dispersed widely in procaryotes. The dimeric RHH fold is generated by interlocking of two monomers into a 2-fold symmetrical structure that comprises four alpha-helices enwrapping a pair of antiparallel beta-strands (ribbon). Residues in the ribbon region are the principal determinants of DNA binding, whereas the RHH hydrophobic core is assembled from amino acids in both the alpha-helices and ribbon element. The ParG protein encoded by multiresistance plasmid TP228 is a RHH protein that functions dually as a centromere binding factor during segrosome assembly and as a transcriptional repressor. Here we identify residues in the alpha-helices of ParG that are critical for DNA segregation and in organization of the protein hydrophobic core. Akey hydrophobic aromatic amino acid at one position was functionally substitutable by other aromatic residues, but not by non-aromatic hydrophobic amino acids. Nevertheless, intramolecular suppression of the latter by complementary change of a residue that approaches nearby from the partner monomer fully restored activity in vivo and in vitro. The interactions involved in assembling the ParG core may be highly malleable and suggest that RHH proteins are tractable platforms for the rational design of diverse DNA binding factors useful for synthetic biology and other purposes.	[Saeed, Sadia; Jowitt, Thomas A.; Warwicker, Jim; Hayes, Finbarr] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England	University of Manchester	Hayes, F (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England.	finbarr.hayes@manchester.ac.uk		Warwicker, Jim/0000-0002-1302-0815; Hayes, Finbarr/0000-0003-3212-4326; Jowitt, Thomas/0000-0002-4045-0933	Government of Pakistan	Government of Pakistan	Supported by a scholarship from the Government of Pakistan.	Banigan EJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002145; Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Barilla D, 2003, MOL MICROBIOL, V49, P487, DOI 10.1046/j.1365-2958.2003.03564.x; Barilla D, 2007, P NATL ACAD SCI USA, V104, P1811, DOI 10.1073/pnas.0607216104; Barilla D, 2010, P NATL ACAD SCI USA, V107, P12061, DOI 10.1073/pnas.1007331107; Batt SM, 2009, J MOL BIOL, V385, P1361, DOI 10.1016/j.jmb.2008.12.016; Bouet JY, 2007, MOL MICROBIOL, V63, P468, DOI 10.1111/j.1365-2958.2006.05537.x; BOWIE JU, 1989, P NATL ACAD SCI USA, V86, P2152, DOI 10.1073/pnas.86.7.2152; BROWN BM, 1994, NAT STRUCT BIOL, V1, P164, DOI 10.1038/nsb0394-164; Carmelo E, 2005, J BIOL CHEM, V280, P28683, DOI 10.1074/jbc.M501173200; Castaing JP, 2008, MOL MICROBIOL, V70, P1000, DOI 10.1111/j.1365-2958.2008.06465.x; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Delano W. L., 2001, PYMOL MOL GRAPHICS S; Ditkowski B, 2010, MOL MICROBIOL, V78, P1403, DOI 10.1111/j.1365-2958.2010.07409.x; Dmowski M, 2011, MICROBIOL-SGM, V157, P1009, DOI 10.1099/mic.0.045369-0; Dobruk-Serkowska A, 2012, J BIOL CHEM, V287, P42545, DOI 10.1074/jbc.M112.410324; Dunham TD, 2009, EMBO J, V28, P1792, DOI 10.1038/emboj.2009.120; Ebersbach G, 2001, P NATL ACAD SCI USA, V98, P15078, DOI 10.1073/pnas.261569598; Ebersbach G, 2006, MOL MICROBIOL, V61, P1428, DOI 10.1111/j.1365-2958.2006.05322.x; Golovanov AP, 2003, MOL MICROBIOL, V50, P1141, DOI 10.1046/j.1365-2958.2003.03750.x; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Hatano T, 2007, MOL MICROBIOL, V64, P1198, DOI 10.1111/j.1365-2958.2007.05728.x; Hatano T, 2010, MOL MICROBIOL, V78, P1182, DOI 10.1111/j.1365-2958.2010.07398.x; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hayes F, 2000, MOL MICROBIOL, V37, P528, DOI 10.1046/j.1365-2958.2000.02030.x; Hayes F, 2010, BACTERIAL CHROMATIN, P49, DOI 10.1007/978-90-481-3473-1_4; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hui MP, 2010, P NATL ACAD SCI USA, V107, P4590, DOI 10.1073/pnas.0913060107; Hwang LC, 2013, EMBO J, V32, P1238, DOI 10.1038/emboj.2013.34; Jain RK, 2004, P NATL ACAD SCI USA, V101, P111, DOI 10.1073/pnas.2534352100; Kalliomaa-Sanford AK, 2012, P NATL ACAD SCI USA, V109, P3754, DOI 10.1073/pnas.1113384109; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; Lioy VS, 2010, PLASMID, V64, P1, DOI 10.1016/j.plasmid.2010.04.002; LUDTKE DN, 1989, J MOL BIOL, V209, P393, DOI 10.1016/0022-2836(89)90005-3; Machon C, 2007, J MOL BIOL, V374, P1, DOI 10.1016/j.jmb.2007.09.025; MILLA ME, 1994, NAT STRUCT BIOL, V1, P518, DOI 10.1038/nsb0894-518; MILLA ME, 1995, BIOCHEMISTRY-US, V34, P13914, DOI 10.1021/bi00042a024; MILLA ME, 1995, BIOCHEMISTRY-US, V34, P3344, DOI 10.1021/bi00010a025; Murayama K, 2001, J MOL BIOL, V314, P789, DOI 10.1006/jmbi.2001.5157; Ni LS, 2010, P NATL ACAD SCI USA, V107, P11763, DOI 10.1073/pnas.1003817107; Nohaile MJ, 2001, P NATL ACAD SCI USA, V98, P3109, DOI 10.1073/pnas.051624498; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; RAUMANN BE, 1994, NATURE, V367, P754, DOI 10.1038/367754a0; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; Robinson CR, 1997, J MOL BIOL, V273, P692, DOI 10.1006/jmbi.1997.1342; Salje J, 2010, NAT REV MICROBIOL, V8, P683, DOI 10.1038/nrmicro2425; Sauer RT, 1996, FASEB J, V10, P42, DOI 10.1096/fasebj.10.1.8566546; Schreiter ER, 2007, NAT REV MICROBIOL, V5, P710, DOI 10.1038/nrmicro1717; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schumacher MA, 2012, J BIOL CHEM, V287, P26146, DOI 10.1074/jbc.M112.373696; Schumacher MA, 2012, CURR OPIN STRUC BIOL, V22, P72, DOI 10.1016/j.sbi.2011.11.001; Sengupta M, 2011, INFECT IMMUN, V79, P2502, DOI 10.1128/IAI.00127-11; SHAH S, 1991, J BACTERIOL, V173, P3238, DOI 10.1128/JB.173.10.3238-3242.1991; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Vecchiarelli AG, 2010, MOL MICROBIOL, V78, P78, DOI 10.1111/j.1365-2958.2010.07314.x; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; Warwicker J, 1999, PROTEIN SCI, V8, P418; WELLS JA, 1985, GENE, V34, P315, DOI 10.1016/0378-1119(85)90140-4; Wu MY, 2011, NUCLEIC ACIDS RES, V39, P5082, DOI 10.1093/nar/gkr115; Zampini M, 2012, NUCLEIC ACIDS RES, V40, P6673, DOI 10.1093/nar/gks314; Zampini M, 2009, J BACTERIOL, V191, P3832, DOI 10.1128/JB.01630-08	71	1	1	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9273	9283		10.1074/jbc.M115.638148	http://dx.doi.org/10.1074/jbc.M115.638148			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25713077	hybrid, Green Published			2022-12-28	WOS:000352207100048
J	Yamada, KJ; Barker, T; Dyer, KD; Rice, TA; Percopo, CM; Garcia-Crespo, KE; Cho, S; Lee, JJ; Druey, KM; Rosenberg, HF				Yamada, Kelsey J.; Barker, Tolga; Dyer, Kimberly D.; Rice, Tyler A.; Percopo, Caroline M.; Garcia-Crespo, Katia E.; Cho, Soochin; Lee, James J.; Druey, Kirk M.; Rosenberg, Helene F.			Eosinophil-associated Ribonuclease 11 Is a Macrophage Chemoattractant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNASE-A RIBONUCLEASES; CATIONIC PROTEIN; HOST-DEFENSE; PNEUMOVIRUS INFECTION; MOUSE EOSINOPHILS; MOLECULAR-CLONING; RAPID EVOLUTION; VIRUS-INFECTION; GENE; EXPRESSION	RNase A is the prototype of an extensive family of divergent proteins whose members share a unique disulfide-bonded tertiary structure, conserved catalytic motifs, and the ability to hydrolyze polymeric RNA. Several members of this family maintain independent roles as ribonucleases and modulators of innate immunity. Here we characterize mouse eosinophil-associated RNase (Ear) 11, a divergent member of the eosinophil ribonuclease cluster, and the only known RNase A ribonuclease expressed specifically in response to Th2 cytokine stimulation. Mouse Ear 11 is differentially expressed in somatic tissues at baseline (brain << liver < lung < spleen); systemic stimulation with IL-33 results in 10-5000-fold increased expression in lung and spleen, respectively. Ear 11 is also expressed in response to protective priming of the respiratory mucosa with Lactobacillus plantarum; transcripts are detected both locally in lung as well as systemically in bone marrow and spleen. Mouse Ear 11 is enzymatically active, although substantially less so than mEar 1 and mEar 2; the relative catalytic efficiency (k(cat)/K-m) of mEar 11 is diminished similar to 1000-1500-fold. However, in contrast to RNase 2/EDN and mEar 2, which have been characterized as selective chemoattractants for CD11c(+) dendritic cells, mEar 11 has prominent chemoattractant activity for F4/80(+)CD11c(-) tissue macrophages. Chemoattractant activity is not dependent on full enzymatic activity, and requires no interaction with the pattern recognition receptor, Toll-like receptor 2 (TLR2). Taken together, this work characterizes a divergent RNase A ribonuclease with a unique expression pattern and function, and highlights the versatility of this family in promoting innate immunity.	[Yamada, Kelsey J.; Dyer, Kimberly D.; Rice, Tyler A.; Percopo, Caroline M.; Garcia-Crespo, Katia E.; Rosenberg, Helene F.] NIAID, Inflammat Immunobiol, NIH, Bethesda, MD 20892 USA; [Barker, Tolga; Druey, Kirk M.] NIAID, Mol Signal Transduct Sect, NIH, Bethesda, MD 20892 USA; [Cho, Soochin] Creighton Univ, Dept Biol, Omaha, NE 68178 USA; [Lee, James J.] Mayo Clin, Div Pulm Med, Dept Biochem & Mol Biol, Scottsdale, AZ 85259 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Creighton University; Mayo Clinic; Mayo Clinic Phoenix	Rosenberg, HF (corresponding author), NIAID, IIS, LAD, NIH, Bldg 10,Rm 11C215,9000 Rockville Pike, Bethesda, MD 20892 USA.	hrosenberg@niaid.nih.gov	Rice, Tyler/GZL-7820-2022		National Institutes of Health from the NIAID Division of Intramural Research [AI000942]; National Institutes of Health [AI000746]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000941, ZIAAI000746, Z01AI000746, ZIAAI000942, Z01AI000942] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID Division of Intramural Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI000942 from the NIAID Division of Intramural Research (to H. F. R.) and AI000746 (to K. M. D.).	ACKERMAN SJ, 1983, J IMMUNOL, V131, P2977; Andrews K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073143; BARKER RL, 1989, J IMMUNOL, V143, P952; Becknell B, 2015, KIDNEY INT, V87, P151, DOI 10.1038/ki.2014.268; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Chatani E, 2001, J BIOSCI BIOENG, V92, P98, DOI 10.1263/jbb.92.98; Cho S, 2007, MOL BIOL EVOL, V24, P1259, DOI 10.1093/molbev/msm047; Cormier SA, 2002, AM J RESP CELL MOL, V27, P678, DOI 10.1165/rcmb.4882; Cregg JM, 2009, METHOD ENZYMOL, V463, P169, DOI 10.1016/S0076-6879(09)63013-5; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Dickson KA, 2005, PROG NUCLEIC ACID RE, V80, P349, DOI 10.1016/S0079-6603(05)80009-1; Didierlaurent A, 2007, IMMUNOLOGY, V122, P457, DOI 10.1111/j.1365-2567.2007.02729.x; DURACK DT, 1981, P NATL ACAD SCI-BIOL, V78, P5165, DOI 10.1073/pnas.78.8.5165; Dyer KD, 2006, MOL DIVERS, V10, P585, DOI 10.1007/s11030-006-9028-2; Dyer KD, 2013, IMMUNOL LETT, V150, P41, DOI 10.1016/j.imlet.2012.12.002; Egesten A, 1997, BBA-MOL CELL RES, V1358, P255, DOI 10.1016/S0167-4889(97)00081-5; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Gabryszewski SJ, 2011, J IMMUNOL, V186, P1151, DOI 10.4049/jimmunol.1001751; Garcia-Crespo KE, 2013, ANTIVIR RES, V97, P270, DOI 10.1016/j.antiviral.2012.12.022; Garvey TL, 2005, J IMMUNOL, V175, P4735, DOI 10.4049/jimmunol.175.7.4735; Goo SM, 2013, GENOME BIOL EVOL, V5, P2124, DOI 10.1093/gbe/evt161; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; HAMANN KJ, 1989, GENE, V83, P161, DOI 10.1016/0378-1119(89)90414-9; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Kaisho T, 2000, CRIT REV IMMUNOL, V20, P393; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; KURACHI K, 1985, BIOCHEMISTRY-US, V24, P5494, DOI 10.1021/bi00341a032; Larson KA, 1996, P NATL ACAD SCI USA, V93, P12370, DOI 10.1073/pnas.93.22.12370; Lee NA, 1997, J IMMUNOL, V158, P1332; Levy O, 2014, PEDIATR RES, V75, P184, DOI 10.1038/pr.2013.214; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; McDevitt AL, 2001, GENE, V267, P23, DOI 10.1016/S0378-1119(01)00392-4; Moles A, 2014, J HEPATOL, V60, P782, DOI 10.1016/j.jhep.2013.12.005; Moreau JM, 2003, ANTIVIR RES, V59, P181, DOI 10.1016/S0166-3542(03)00111-6; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Nei M, 2001, P NATL ACAD SCI USA, V98, P2497, DOI 10.1073/pnas.051611498; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Nitto T, 2004, GENES IMMUN, V5, P668, DOI 10.1038/sj.gene.6364143; Nitto T, 2006, J BIOL CHEM, V281, P25622, DOI 10.1074/jbc.M604313200; O'Reilly MA, 2012, AM J PATHOL, V181, P441, DOI 10.1016/j.ajpath.2012.05.005; Oliveira AC, 2004, J IMMUNOL, V173, P5688, DOI 10.4049/jimmunol.173.9.5688; OLSSON I, 1977, LAB INVEST, V36, P493; Percopo CM, 2014, METHODS MOL BIOL, V1178, P257, DOI 10.1007/978-1-4939-1016-8_22; Percopo CM, 2014, J IMMUNOL, V192, P5265, DOI 10.4049/jimmunol.1400087; Rosenberg HF, 2008, J LEUKOCYTE BIOL, V83, P1079, DOI 10.1189/jlb.1107725; Rosenberg HF, 2013, EOSINOPHILS IN HEALTH AND DISEASE, P281; Rosenberg HF, 1999, IMMUNOL RES, V20, P261, DOI 10.1007/BF02790409; ROSENBERG HF, 1995, J BIOL CHEM, V270, P21539, DOI 10.1074/jbc.270.37.21539; ROSENBERG HF, 1989, P NATL ACAD SCI USA, V86, P4460, DOI 10.1073/pnas.86.12.4460; Rosenberg HF, 2001, METHOD ENZYMOL, V341, P273, DOI 10.1016/S0076-6879(01)41158-X; ROSENBERG HF, 1995, NAT GENET, V10, P219, DOI 10.1038/ng0695-219; Rosenberg HF, 2001, J LEUKOCYTE BIOL, V70, P691; ROSENBERG HF, 1989, J EXP MED, V170, P163, DOI 10.1084/jem.170.1.163; Shamri R, 2013, ALLERGY, V68, P880, DOI 10.1111/all.12163; Shamri R, 2012, FASEB J, V26, P2084, DOI 10.1096/fj.11-200246; Singhania NA, 1999, J MOL EVOL, V49, P721, DOI 10.1007/PL00006594; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Yang D, 2003, BLOOD, V102, P3396, DOI 10.1182/blood-2003-01-0151; Yang D, 2008, J EXP MED, V205, P79, DOI 10.1084/jem.20062027; Zanfardino A, 2010, FEBS J, V277, P1921, DOI 10.1111/j.1742-4658.2010.07614.x; Zhang JZ, 2000, P NATL ACAD SCI USA, V97, P4701, DOI 10.1073/pnas.080071397; Zhang JZ, 2002, NUCLEIC ACIDS RES, V30, P1169, DOI 10.1093/nar/30.5.1169; Zhang JZ, 2003, NUCLEIC ACIDS RES, V31, P602, DOI 10.1093/nar/gkg157; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852	67	14	14	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8863	8875		10.1074/jbc.M114.626648	http://dx.doi.org/10.1074/jbc.M114.626648			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25713137	hybrid, Green Published			2022-12-28	WOS:000352207100015
J	Guyer, RA; Macara, IG				Guyer, Richard A.; Macara, Ian G.			Loss of the Polarity Protein PAR3 Activates STAT3 Signaling via an Atypical Protein Kinase C (aPKC)/NF-kappa B/Interleukin-6 (IL-6) Axis in Mouse Mammary Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-SUPPRESSOR; ONCOGENIC RAS; ZETA; TUMORIGENESIS; INTERLEUKIN-6; IOTA; PHOSPHORYLATION; EXPRESSION; GROWTH	PAR3suppresses tumor growth and metastasis in vivo and cell invasion through matrix in vitro. We propose that PAR3 organizes and limits multiple signaling pathways and that inappropriate activation of these pathways occurs without PAR3. Silencing Pard3 in conjunction with oncogenic activation promotes invasion and metastasis via constitutiveSTAT3activity in mouse models, but the mechanism for this is unknown. Wenow show that loss of PAR3 triggers increased production of interleukin- 6, which induces STAT3 signaling in an autocrine manner. Activation of atypical protein kinase C iota/lambda (aPKC iota/lambda) mediates this effect by stimulating NF-kappa B signaling and IL-6 expression. Our results suggest that PAR3 restrains aPKC iota/lambda activity and thus prevents aPKC iota/lambda from activating an oncogenic signaling network.	[Guyer, Richard A.; Macara, Ian G.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Guyer, Richard A.] Vanderbilt Univ, Med Scientist Training Program, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Macara, IG (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, U 3209 MRB 3,465 21st Ave S, Nashville, TN 37232 USA.	ian.g.macara@vanderbilt.edu	Guyer, Richard A./AAC-3850-2022	Guyer, Richard A./0000-0001-5075-1767	National Institutes of Health [CA132898, T32-GM07347]; NATIONAL CANCER INSTITUTE [R01CA132898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070902, T32GM007347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA132898 to Ian Macara, and T32-GM07347 to the Vanderbilt Medical-Scientist Training Program.	AGRAWAL N, 1995, DEV BIOL, V172, P218, DOI 10.1006/dbio.1995.0017; Barbieri I, 2010, CANCER RES, V70, P2558, DOI 10.1158/0008-5472.CAN-09-2840; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Chatterjee SJ, 2014, BREAST CANCER-TARGET, V6, P15, DOI 10.2147/BCTT.S43764; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Cordero JB, 2010, DEV CELL, V18, P999, DOI 10.1016/j.devcel.2010.05.014; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; DOMINGUEZ I, 1993, MOL CELL BIOL, V13, P1290, DOI 10.1128/MCB.13.2.1290; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; Forteza R, 2013, BIOL OPEN, V2, P1263; Galvez AS, 2009, MOL CELL BIOL, V29, P104, DOI 10.1128/MCB.01294-08; GATEFF E, 1974, ROUX ARCH DEV BIOL, V176, P23, DOI 10.1007/BF00577830; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Hammacher A, 1998, J BIOL CHEM, V273, P22701, DOI 10.1074/jbc.273.35.22701; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Iden S, 2012, CANCER CELL, V22, P389, DOI 10.1016/j.ccr.2012.08.004; Ishiguro H, 2009, P NATL ACAD SCI USA, V106, P16369, DOI 10.1073/pnas.0907044106; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kusne Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005196; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Lee AM, 2013, NATURE, V493, P416, DOI 10.1038/nature11803; Leong GR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-62; Linch M, 2014, CARCINOGENESIS, V35, P396, DOI 10.1093/carcin/bgt313; Ling C, 2012, CANCER DISCOV, V2, P68, DOI 10.1158/2159-8290.CD-11-0189; Litherland GJ, 2010, J BIOL CHEM, V285, P22414, DOI 10.1074/jbc.M110.120121; Maeda S, 2009, HEPATOLOGY, V50, P1851, DOI 10.1002/hep.23199; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Nolan ME, 2008, CANCER RES, V68, P8201, DOI 10.1158/0008-5472.CAN-07-6567; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Rothenberg SM, 2010, CANCER RES, V70, P2158, DOI 10.1158/0008-5472.CAN-09-3458; Russ A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047734; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P2424, DOI 10.1128/MCB.9.6.2424; STARNES HF, 1990, J IMMUNOL, V145, P4185; Takagawa R, 2010, ANN SURG ONCOL, V17, P81, DOI 10.1245/s10434-009-0708-x; Taniguchi K, 2014, SEMIN IMMUNOL, V26, P54, DOI 10.1016/j.smim.2014.01.001; TIMMONS L, 1993, DEV BIOL, V158, P364, DOI 10.1006/dbio.1993.1195; Tran CS, 2014, CELL HOST MICROBE, V15, P636, DOI 10.1016/j.chom.2014.04.007; Uberall F, 1999, J CELL BIOL, V144, P413, DOI 10.1083/jcb.144.3.413; Volk LJ, 2013, NATURE, V493, P420, DOI 10.1038/nature11802; Win HY, 2008, CANCER LETT, V270, P302, DOI 10.1016/j.canlet.2008.05.023; Wooten MW, 1999, J NEUROSCI RES, V58, P607, DOI 10.1002/(SICI)1097-4547(19991201)58:5<607::AID-JNR1>3.0.CO;2-M; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Xue B, 2013, NAT CELL BIOL, V15, P189, DOI 10.1038/ncb2663; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zen K, 2009, ONCOGENE, V28, P2910, DOI 10.1038/onc.2009.148; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhuang ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067431	56	23	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8457	8468		10.1074/jbc.M114.621011	http://dx.doi.org/10.1074/jbc.M114.621011			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25657002	hybrid, Green Published			2022-12-28	WOS:000351662600038
J	Singh, M; Shin, YK; Yang, XQ; Zehr, B; Chakrabarti, P; Kandror, KV				Singh, Maneet; Shin, Yu-Kyong; Yang, Xiaoqing; Zehr, Brad; Chakrabarti, Partha; Kandror, Konstantin V.			4E-BPs Control Fat Storage by Regulating the Expression of Egr1 and ATGL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; MAMMALIAN TARGET; TRANSLATION INITIATION; TRANSCRIPTION FACTORS; SIGNALING PATHWAYS; LIPID HOMEOSTASIS; GENE-EXPRESSION; RESPONSE GENES	Early growth response transcription factor Egr1 controls multiple aspects of cell physiology and metabolism. In particular, Egr1 suppresses lipolysis and promotes fat accumulation in adipocytes by inhibiting the expression of adipose triglyceride lipase. According to current dogma, regulation of the Egr1 expression takes place primarily at the level of transcription. Correspondingly, treatment of cultured adipocytes with insulin stimulates expression of Egr1 mRNA and protein. Unexpectedly, the MEK inhibitor PD98059 completely blocks insulin-stimulated increase in the Egr1 mRNA but has only a moderate effect on the Egr1 protein. At the same time, mTORC1 inhibitors rapamycin and PP242 suppress expression of the Egr1 protein and have an opposite effect on the Egr1 mRNA. Mouse embryonic fibroblasts with genetic ablations of TSC2 or 4E-BP1/2 express less Egr1 mRNA but more Egr1 protein than wild type controls. S-35-labeling has confirmed that translation of the Egr1 mRNA is much more effective in 4E-BP1/2-null cells than in control. A selective agonist of the CB1 receptors, ACEA, up-regulates Egr1 mRNA, but does not activate mTORC1 and does not increase Egr1 protein in adipocytes. These data suggest that although insulin activates both the Erk and the mTORC1 signaling pathways in adipocytes, regulation of the Egr1 expression takes place predominantly via the mTORC1/4E-BP-mediated axis. In confirmation of this model, we show that 4E-BP1/2-null MEFs express less ATGL and accumulate more fat than control cells, while knock down of Egr1 in 4E-BP1/2-null MEFs increases ATGL expression and decreases fat storage.	[Singh, Maneet; Shin, Yu-Kyong; Yang, Xiaoqing; Zehr, Brad; Chakrabarti, Partha; Kandror, Konstantin V.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Kandror, KV (corresponding author), Boston Univ, Sch Med, Dept Biochem, K123D,715 Albany St, Boston, MA 02118 USA.	kkandror@bu.edu	Regan, Clinton/E-6250-2012	Kandror, Konstantin/0000-0002-8601-9313	National Institutes of Health [DK52057, AG039612]; American Diabetes Association [7-11-BS-76]; NIH [2T32DK007201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, R56DK052057, T32DK007201, R01DK052057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG039612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Research Grants DK52057 and AG039612 from the National Institutes of Health, and Research Grant 7-11-BS-76 from the American Diabetes Association (to K. V. K.).; Supported by the institutional training grant 2T32DK007201 from the NIH.	ALEXANDERBRIDGES M, 1992, MOL CELL BIOCHEM, V109, P99; Aramburu J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005326; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Boyle KB, 2009, CELL DEATH DIFFER, V16, P782, DOI 10.1038/cdd.2009.11; Brand E, 2000, J MOL MED-JMM, V78, P81, DOI 10.1007/s001090000074; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Chakrabarti P, 2013, MOL CELL BIOL, V33, P3659, DOI 10.1128/MCB.01584-12; Chakrabarti P, 2010, DIABETES, V59, P775, DOI 10.2337/db09-1602; Csibi A, 2014, CURR BIOL, V24, P2274, DOI 10.1016/j.cub.2014.08.007; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Ge YJ, 2011, J BIOL CHEM, V286, P35675, DOI 10.1074/jbc.M111.262881; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gokey NG, 2011, J BIOL CHEM, V286, P29501, DOI 10.1074/jbc.M111.263509; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hoang B, 2012, J BIOL CHEM, V287, P21796, DOI 10.1074/jbc.M111.304626; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Lamming DW, 2013, CELL METAB, V18, P465, DOI 10.1016/j.cmet.2013.08.002; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Luong N, 2006, CELL METAB, V4, P133, DOI 10.1016/j.cmet.2006.05.013; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Muller I, 2012, ENDOCRINOLOGY, V153, P3040, DOI 10.1210/en.2012-1064; Pagel JI, 2011, INDIAN J BIOCHEM BIO, V48, P226; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5; Sartipy P, 2003, J BIOL CHEM, V278, P52298, DOI 10.1074/jbc.M306922200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shen N, 2011, J BIOL CHEM, V286, P14508, DOI 10.1074/jbc.M110.190165; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Takeuchi K, 2001, J BIOL CHEM, V276, P26077, DOI 10.1074/jbc.M102704200; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Thiel G, 2010, CELL CALCIUM, V47, P397, DOI 10.1016/j.ceca.2010.02.005; Tremblay F, 2005, ENDOCRINOLOGY, V146, P1328, DOI 10.1210/en.2004-0777; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Vesely PW, 2009, MUTAT RES-REV MUTAT, V682, P7, DOI 10.1016/j.mrrev.2009.01.001; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; West MJ, 1998, ONCOGENE, V17, P769, DOI 10.1038/sj.onc.1201990; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	59	19	19	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17331	17338		10.1074/jbc.M114.631895	http://dx.doi.org/10.1074/jbc.M114.631895			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25814662	Green Published, hybrid			2022-12-28	WOS:000357730900028
J	Kuzmenkov, AI; Vassilevski, AA; Kudryashova, KS; Nekrasova, OV; Peigneur, S; Tytgat, J; Feofanov, AV; Kirpichnikov, MP; Grishin, EV				Kuzmenkov, Alexey I.; Vassilevski, Alexander A.; Kudryashova, Kseniya S.; Nekrasova, Oksana V.; Peigneur, Steve; Tytgat, Jan; Feofanov, Alexey V.; Kirpichnikov, Mikhail P.; Grishin, Eugene V.			Variability of Potassium Channel Blockers in Mesobuthus eupeus Scorpion Venom with Focus on Kv1.1 AN INTEGRATED TRANSCRIPTOMIC AND PROTEOMIC STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drug Screening; Fluorescence; Molecular Pharmacology; Neurotoxin; Potassium Channel; Protein Chimera; Protein Drug Interaction; Proteomics; Toxin; Transcriptomics	K+ CHANNELS; BUTHUS-MARTENSI; BINDING-SITES; INNER MOUTH; TOXINS; PEPTIDES; INHIBITOR; POTENT; PURIFICATION; DIVERSITY	Background: Scorpion venoms are an ample source of toxins targeting potassium channels. Results: A comprehensive search for new toxins was performed by combining transcriptomics and peptidomics with a fluorescent test system. Conclusion: We identified five new high affinity potassium channel blockers in the venom of Mesobuthus eupeus. Significance: The proposed integrated approach is of general utility for potassium channel pharmacology. The lesser Asian scorpion Mesobuthus eupeus (Buthidae) is one of the most widely spread and dispersed species of the Mesobuthus genus, and its venom is actively studied. Nevertheless, a considerable amount of active compounds is still under-investigated due to the high complexity of this venom. Here, we report a comprehensive analysis of putative potassium channel toxins (KTxs) from the cDNA library of M. eupeus venom glands, and we compare the deduced KTx structures with peptides purified from the venom. For the transcriptome analysis, we used conventional tools as well as a search for structural motifs characteristic of scorpion venom components in the form of regular expressions. We found 59 candidate KTxs distributed in 30 subfamilies and presenting the cysteine-stabilized / and inhibitor cystine knot types of fold. M. eupeus venom was then separated to individual components by multistage chromatography. A facile fluorescent system based on the expression of the KcsA-Kv1.1 hybrid channels in Escherichia coli and utilization of a labeled scorpion toxin was elaborated and applied to follow Kv1.1 pore binding activity during venom separation. As a result, eight high affinity Kv1.1 channel blockers were identified, including five novel peptides, which extend the panel of potential pharmacologically important Kv1 ligands. Activity of the new peptides against rat Kv1.1 channel was confirmed (IC50 in the range of 1-780 nm) by the two-electrode voltage clamp technique using a standard Xenopus oocyte system. Our integrated approach is of general utility and efficiency to mine natural venoms for KTxs.	[Kuzmenkov, Alexey I.; Vassilevski, Alexander A.; Kudryashova, Kseniya S.; Nekrasova, Oksana V.; Feofanov, Alexey V.; Kirpichnikov, Mikhail P.; Grishin, Eugene V.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Kudryashova, Kseniya S.; Feofanov, Alexey V.; Kirpichnikov, Mikhail P.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119992, Russia; [Peigneur, Steve; Tytgat, Jan] Univ Leuven, Lab Toxicol & Pharmacol, B-3000 Leuven, Belgium	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University; KU Leuven	Vassilevski, AA (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia.	avas@ibch.ru	Kudryashova, Ksenia S/A-9510-2014; Vassilevski, Alexander/S-3824-2016; Kudryashova, Ksenia/AAR-9066-2020; Nekrasova, Oksana/V-1851-2018; Kuzmenkov, Alexey I/M-3293-2017; Feofanov, Alexey V/K-3082-2012	Vassilevski, Alexander/0000-0002-1359-0076; Kudryashova, Ksenia/0000-0002-6937-3193; Nekrasova, Oksana/0000-0002-7216-1618; Feofanov, Alexey V/0000-0002-1596-9506; Kuzmenkov, Alexey/0000-0002-5416-1825; Kirpichnikov, Mikhail/0000-0001-8170-1607; Tytgat, Jan/0000-0003-1778-6022; Peigneur, Steve/0000-0003-0504-5702	Russian Foundation for Basic Research [14-04-32091, 13-04-01857]; Program for Fundamental Research of the Presidium of Russian Academy of Sciences [24]; Moscow State University Program of Development; F.W.O. Vlaanderen [G.0433.12]; KU Leuven [OT/12/081]; Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy [IUAP 7/10]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program for Fundamental Research of the Presidium of Russian Academy of Sciences(Russian Academy of Sciences); Moscow State University Program of Development; F.W.O. Vlaanderen(FWO); KU Leuven(KU Leuven); Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported in part by Russian Foundation for Basic Research Grants 14-04-32091 and 13-04-01857, Program for Fundamental Research of the Presidium of Russian Academy of Sciences No. 24, and by the Moscow State University Program of Development.; Supported by grants G.0433.12 from F.W.O. Vlaanderen, Grant OT/12/081 from KU Leuven, and IUAP 7/10 from the Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy.	Abbas N, 2008, BIOCHEM BIOPH RES CO, V376, P525, DOI 10.1016/j.bbrc.2008.09.033; Abdel-Mottaleb Y, 2008, TOXICON, V51, P1424, DOI 10.1016/j.toxicon.2008.03.027; Abdel-Rahman MA, 2013, TOXICON, V74, P193, DOI 10.1016/j.toxicon.2013.08.064; Almeida DD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-362; Andalib P, 2004, BIOPHYS J, V87, P3148, DOI 10.1529/biophysj.104.046664; Anthis NJ, 2013, PROTEIN SCI, V22, P851, DOI 10.1002/pro.2253; Beeton C, 2003, J BIOL CHEM, V278, P9928, DOI 10.1074/jbc.M212868200; Beraud E, 2006, ANN NEUROL, V60, P586, DOI 10.1002/ana.21007; Camerino DC, 2007, NEUROTHERAPEUTICS, V4, P184; Chen R, 2012, BIOCHEMISTRY-US, V51, P1976, DOI 10.1021/bi201811j; Chen ZY, 2012, J BIOL CHEM, V287, P13813, DOI 10.1074/jbc.M112.343996; CREST M, 1992, J BIOL CHEM, V267, P1640; Dai L, 2000, BIOCHEM J, V346, P805, DOI 10.1042/0264-6021:3460805; Darbon H., 1999, PERSPECTIVES DRUG DI, V15; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; de la Vega RCR, 2003, TRENDS PHARMACOL SCI, V24, P222, DOI 10.1016/S0165-6147(02)00080-4; Diego-Garcia E, 2013, TOXICON, V61, P72, DOI 10.1016/j.toxicon.2012.10.010; Eskandari G, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.9666; Filippov AK, 1996, FEBS LETT, V384, P277, DOI 10.1016/0014-5793(96)00333-X; Freudenthaler G, 2002, HISTOCHEM CELL BIOL, V117, P197, DOI 10.1007/s00418-001-0374-y; Gao B, 2013, BIOSCIENCE REP, V33, P513, DOI 10.1042/BSR20130052; Gao B, 2011, COMP BIOCHEM PHYS A, V159, P313, DOI 10.1016/j.cbpa.2011.03.027; Gao B, 2010, BIOCHIMIE, V92, P1847, DOI 10.1016/j.biochi.2010.08.003; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Hayes KC, 2004, CNS DRUG REV, V10, P295; He YW, 2013, J PROTEOMICS, V89, P1, DOI 10.1016/j.jprot.2013.06.007; Helms LMH, 1997, BIOCHEMISTRY-US, V36, P3737, DOI 10.1021/bi962351p; Hille B., 2001, ION CHANNELS EXCITAB, P131; Holaday SK, 2000, ARCH BIOCHEM BIOPHYS, V379, P18, DOI 10.1006/abbi.2000.1858; Jang SH, 2011, J VET SCI, V12, P35, DOI 10.4142/jvs.2011.12.1.35; Jeon WI, 2012, ANTICANCER RES, V32, P5279; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; Kharrat R, 1997, FEBS LETT, V406, P284, DOI 10.1016/S0014-5793(97)00285-8; KIRSCH GE, 1993, NEURON, V11, P503, DOI 10.1016/0896-6273(93)90154-J; Korolkova YV, 2001, J BIOL CHEM, V276, P9868, DOI 10.1074/jbc.M005973200; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Kudryashova KS, 2013, ANAL BIOANAL CHEM, V405, P2379, DOI 10.1007/s00216-012-6655-6; Legros C, 2000, J BIOL CHEM, V275, P16918, DOI 10.1074/jbc.275.22.16918; Legros C, 2002, BIOCHEMISTRY-US, V41, P15369, DOI 10.1021/bi026264a; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Luna-Ramirez K, 2013, TOXICON, V63, P44, DOI 10.1016/j.toxicon.2012.11.017; Ma YB, 2012, J PROTEOMICS, V75, P1563, DOI 10.1016/j.jprot.2011.11.029; MARTINS JC, 1990, FEBS LETT, V260, P249, DOI 10.1016/0014-5793(90)80115-Y; Mille BG, 2014, TOXICON, V83, P75, DOI 10.1016/j.toxicon.2014.03.001; Mouhat S, 2005, BIOCHEM J, V385, P95, DOI 10.1042/BJ20041379; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Mouhat S, 2008, CURR PHARM DESIGN, V14, P2503, DOI 10.2174/138161208785777441; MOZHAEVA GN, 1979, BIOFIZIKA+, V24, P235; Nekrasova O, 2009, ACTA NATURAE, V1, P91, DOI 10.32607/20758251-2009-1-1-91-95; Nekrasova OV, 2009, J NEUROIMMUNE PHARM, V4, P83, DOI 10.1007/s11481-008-9116-4; Ouadid-Ahidouch H, 2000, BIOCHEM BIOPH RES CO, V278, P272, DOI 10.1006/bbrc.2000.3790; Panyi G, 2006, CURR PHARM DESIGN, V12, P2199, DOI 10.2174/138161206777585120; Peigneur S, 2011, BIOCHEM PHARMACOL, V82, P81, DOI 10.1016/j.bcp.2011.03.023; Quintero-Hernandez V, 2011, TOXICON, V58, P644, DOI 10.1016/j.toxicon.2011.09.015; de la Vega RCR, 2010, TOXICON, V56, P1155, DOI 10.1016/j.toxicon.2009.11.010; RomiLebrun R, 1997, BIOCHEMISTRY-US, V36, P13473, DOI 10.1021/bi971044w; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saucedo AL, 2012, J BIOL CHEM, V287, P12321, DOI 10.1074/jbc.M111.329607; SHIEH CC, 1994, BIOPHYS J, V67, P2316, DOI 10.1016/S0006-3495(94)80718-0; Srinivasan KN, 2002, J BIOL CHEM, V277, P30040, DOI 10.1074/jbc.M111258200; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; Takacs Z, 2009, P NATL ACAD SCI USA, V106, P22211, DOI 10.1073/pnas.0910123106; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terstappen GC, 2010, FUTURE MED CHEM, V2, P715, DOI 10.4155/FMC.10.180; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Varga Z, 2012, MOL PHARMACOL, V82, P372, DOI 10.1124/mol.112.078006; Vassilevski AA, 2008, BIOCHEM J, V411, P687, DOI [10.1042/BJ20071123, 10.1042/bj20071123]; Vassilevski AA, 2010, METHODS MOL BIOL, V615, P87, DOI 10.1007/978-1-60761-535-4_7; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Yin SJ, 2008, PEPTIDES, V29, P1514, DOI 10.1016/j.peptides.2008.04.021; Zhu SY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002832; Zhu SY, 2010, BBA-PROTEINS PROTEOM, V1804, P872, DOI 10.1016/j.bbapap.2009.12.017	73	34	43	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12195	12209		10.1074/jbc.M115.637611	http://dx.doi.org/10.1074/jbc.M115.637611			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25792741	Green Published, hybrid			2022-12-28	WOS:000354388600031
J	Owens, GP; Ritchie, A; Rossi, A; Schaller, K; Wemlinger, S; Schumann, H; Shearer, A; Verkman, AS; Bennett, JL				Owens, Gregory P.; Ritchie, Alanna; Rossi, Andrea; Schaller, Kristin; Wemlinger, Scott; Schumann, Hannah; Shearer, Andrew; Verkman, Alan S.; Bennett, Jeffrey L.			Mutagenesis of the Aquaporin 4 Extracellular Domains Defines Restricted Binding Patterns of Pathogenic Neuromyelitis Optica IgG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aquaporin; Autoimmunity; Epitope Mapping; Monoclonal Antibody; Neuroimmunology; Demyelination; Neuromyelitis Optica	MULTIPLE-SCLEROSIS; ORTHOGONAL ARRAYS; WATER CHANNEL; CEREBROSPINAL-FLUID; AUTOANTIBODIES; REVEALS; LESIONS; MARKER; MICE	Background: Patient-derived aquaporin 4 (AQP4)-specific recombinant monoclonal antibodies (rAbs) cause neuromyelitis optica (NMO)-specific nervous system injury in animal models. Results: AQP4-specific rAbs bind human AQP4 based on differential sensitivity to loop A and C mutations. Conclusion: AQP4-specific rAbs derived from NMO patients recognize multiple conformational epitopes within the extracellular domains of human AQP4. Significance: High resolution mapping of AQP4 autoantibody epitopes identifies target regions for potential blocking therapies. Neuromyelitis optica-immunoglobulin G (NMO-IgG) binds to aquaporin-4 (AQP4) water channels in the central nervous system leading to immune-mediated injury. We have previously demonstrated that a high proportion of CSF plasma cells of NMO patients produce antibody to the extracellular domains of the AQP4 protein and that recombinant IgG (rAb) derived from these cells recapitulate pathogenic features of disease. We performed a comprehensive mutational analysis of the three extracellular loops of the M23 isoform of human AQP4 using both serial and single point mutations, and we evaluated the effects on binding of NMO AQP4-reactive rAbs by quantitative immunofluorescence. Whereas all NMO rAbs required conserved loop C ((TP138)-T-137 and Val(150)) and loop E ((HW231)-H-230) amino acids for binding, two broad patterns of NMO-IgG recognition could be distinguished based on differential sensitivity to loop A amino acid changes. Pattern 1 NMO rAbs were insensitive to loop A mutations and could be further discriminated by differential sensitivity to amino acid changes in loop C ((TM149)-T-148 and His(151)) and loop E (Asn(226) and Glu(228)). Alternatively, pattern 2 NMO rAbs showed significantly reduced binding following amino acid changes in loop A ((EKP65)-E-63 and Asp(69)) and loop C (Val(141), His(151), and Leu(154)). Amino acid substitutions at (TP138)-T-137 altered loop C conformation and abolished the binding of all NMO rAbs and NMO-IgG, indicating the global importance of loop C conformation to the recognition of AQP4 by pathogenic NMO Abs. The generation of human NMO rAbs has allowed the first high resolution mapping of extracellular loop amino acids critical for NMO-IgG binding and identified regions of AQP4 extracellular structure that may represent prime targets for drug therapy.	[Owens, Gregory P.; Ritchie, Alanna; Schaller, Kristin; Wemlinger, Scott; Schumann, Hannah; Shearer, Andrew; Bennett, Jeffrey L.] Univ Colorado Denver, Dept Neurol, Aurora, CO 80045 USA; [Bennett, Jeffrey L.] Univ Colorado Denver, Dept Ophthalmol, Aurora, CO 80045 USA; [Bennett, Jeffrey L.] Univ Colorado Denver, Neurosci Program, Aurora, CO 80045 USA; [Rossi, Andrea] Max Planck Inst Heart & Lung Res, Dept Dev Genet 3, D-61231 Bad Nauheim, Germany; [Verkman, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Verkman, Alan S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Max Planck Society; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bennett, JL (corresponding author), Univ Colorado, Sch Med, Dept Neurol, 12700 East 19th Ave,Mail Stop B182, Aurora, CO 80045 USA.	jeffrey.bennett@ucdenver.edu	Regan, Clinton/E-6250-2012	Rossi, Andrea/0000-0001-5863-6448	National Institutes of Health [EY022936, NS072141, EY13574, EB00415, DK35124, HL73856, DK86125, DK72517]; Guthy-Jackson Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022936, R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI110503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, R37DK035124, P30DK072517, RC1DK086125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy-Jackson Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY022936 (to J. L. B.), NS072141 (to G. P. O.), and EY13574, EB00415, DK35124, HL73856, DK86125, and DK72517 (to A. S. V.). This work was also supported by the Guthy-Jackson Foundation (to J. L. B. and A. S. V.). G. P. O., J. L. B., and A. S. V. receive license and royalties for a patent regarding Compositions and Methods for the Treatment of Neuromyelitis Optica.	Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Crane JM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227298; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; Iorio R, 2013, J AUTOIMMUN, V40, P21, DOI 10.1016/j.jaut.2012.07.008; Kampylafka EI, 2011, J AUTOIMMUN, V36, P221, DOI 10.1016/j.jaut.2011.01.004; Kowarik MC, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0240-9; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lucchinetti CF, 2004, ANN NEUROL, V56, P308, DOI 10.1002/ana.20182; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Owens GP, 2003, J IMMUNOL, V171, P2725, DOI 10.4049/jimmunol.171.5.2725; Parratt JDE, 2010, MULT SCLER J, V16, P1156, DOI 10.1177/1352458510382324; Phuan PW, 2012, J BIOL CHEM, V287, P13829, DOI 10.1074/jbc.M112.344325; Pisani F, 2014, J BIOL CHEM, V289, P30578, DOI 10.1074/jbc.M114.582221; Pisani F, 2011, J BIOL CHEM, V286, P9216, DOI 10.1074/jbc.M110.123000; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Tradtrantip L, 2012, ANN NEUROL, V71, P314, DOI 10.1002/ana.22657; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Wrzos C, 2014, ACTA NEUROPATHOL, V127, P523, DOI 10.1007/s00401-013-1220-8; Yang BX, 1996, J BIOL CHEM, V271, P4577; Zhang H, 2011, ANN NEUROL, V70, P943, DOI 10.1002/ana.22551	22	26	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12123	12134		10.1074/jbc.M115.647149	http://dx.doi.org/10.1074/jbc.M115.647149			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25792738	Green Published, hybrid			2022-12-28	WOS:000354388600026
J	Selvan, N; Mariappa, D; van den Toorn, HWP; Heck, AJR; Ferenbach, AT; van Aalten, DMF				Selvan, Nithya; Mariappa, Daniel; van den Toorn, Henk W. P.; Heck, Albert J. R.; Ferenbach, Andrew T.; van Aalten, Daan M. F.			The Early Metazoan Trichoplax adhaerens Possesses a Functional O-GlcNAc System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Animal Model; Drosophila Genetics; Evolution; O-GlcNAcylation; Post-translational Modification (PTM); Trichoplax adhaerens	LINKED N-ACETYLGLUCOSAMINE; TETRATRICOPEPTIDE REPEATS; TRANSFERASE OGT; CROSS-TALK; CYTOPLASMIC PROTEINS; CYTOSOLIC PROTEINS; KINETIC-ANALYSIS; GLCNACYLATION; GLYCOSYLATION; NUCLEAR	Background: Protein O-GlcNAcylation and orthologues of O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) occur separately or together in all kingdoms of life. Results: The basal metazoan Trichoplax adhaerens is the simplest organism to possess functional OGT, OGA, and protein O-GlcNAcylation together. Conclusion: Reversible protein O-GlcNAcylation is conserved throughout the metazoan lineage. Significance:T. adhaerens can be used as a reductionist model to identify evolutionarily conserved O-GlcNAc targets. Protein O-GlcNAcylation is a reversible post-translational signaling modification of nucleocytoplasmic proteins that is essential for embryonic development in bilateria. In a search for a reductionist model to study O-GlcNAc signaling, we discovered the presence of functional O-GlcNAc transferase (OGT), O-GlcNAcase (OGA), and nucleocytoplasmic protein O-GlcNAcylation in the most basal extant animal, the placozoan Trichoplax adhaerens. We show via enzymatic characterization of Trichoplax OGT/OGA and genetic rescue experiments in Drosophila melanogaster that these proteins possess activities/functions similar to their bilaterian counterparts. The acquisition of O-GlcNAc signaling by metazoa may have facilitated the rapid and complex signaling mechanisms required for the evolution of multicellular organisms.	[Selvan, Nithya; Ferenbach, Andrew T.; van Aalten, Daan M. F.] Univ Dundee, Div Mol Microbiol, Coll Life Sci, Dundee DD1 5EH, Scotland; [Mariappa, Daniel; van Aalten, Daan M. F.] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [van den Toorn, Henk W. P.; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands; [van den Toorn, Henk W. P.; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands	University of Dundee; University of Dundee; Utrecht University; Utrecht University	van Aalten, DMF (corresponding author), Univ Dundee, Div Mol Microbiol, Coll Life Sci, Dow St, Dundee DD1 5EH, Scotland.	dmfvanaalten@dundee.ac.uk	Heck, Albert/D-7098-2011; van den Toorn, Henk W.P./K-8232-2015; Mariappa, Daniel/AAQ-7135-2020	Heck, Albert/0000-0002-2405-4404; van den Toorn, Henk W.P./0000-0002-0270-5763; van Aalten, Daan/0000-0002-1499-6908; Ferenbach, Andrew/0000-0002-1562-7987; Mariyappa, Daniel/0000-0003-4775-1656	Wellcome Trust [WT087590MA]; MRC [MR/M004139/1, G0900138] Funding Source: UKRI; Medical Research Council [MR/M004139/1, G0900138] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust Senior Research Fellowship WT087590MA (to D. M. F. v. A).	Banerjee S, 2009, GLYCOBIOLOGY, V19, P331, DOI 10.1093/glycob/cwn107; Borodkin VS, 2014, BIOCHEM J, V457, P497, DOI 10.1042/BJ20131272; Bullen JW, 2014, J BIOL CHEM, V289, P10592, DOI 10.1074/jbc.M113.523068; Butkinaree C, 2008, J BIOL CHEM, V283, P23557, DOI 10.1074/jbc.M804116200; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Comtesse N, 2001, BIOCHEM BIOPH RES CO, V283, P634, DOI 10.1006/bbrc.2001.4815; Dehennaut V, 2008, BIOCHEM BIOPH RES CO, V369, P539, DOI 10.1016/j.bbrc.2008.02.063; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Dorfmueller HC, 2006, J AM CHEM SOC, V128, P16484, DOI 10.1021/ja066743n; Dorfmueller HC, 2010, FEBS LETT, V584, P694, DOI 10.1016/j.febslet.2009.12.020; Dorfmueller HC, 2009, BIOCHEM J, V420, P221, DOI 10.1042/BJ20090110; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Frederic MY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003804; Fredriksen L, 2012, J BACTERIOL, V194, P325, DOI 10.1128/JB.06314-11; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Hadrys T, 2005, MOL BIOL EVOL, V22, P1569, DOI 10.1093/molbev/msi150; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; He Y, 2014, ACTA CRYSTALLOGR D, V70, P186, DOI 10.1107/S1399004713029155; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; JACKSON SP, 1989, P NATL ACAD SCI USA, V86, P1781, DOI 10.1073/pnas.86.6.1781; Jakob W, 2004, DEV GENES EVOL, V214, P170, DOI 10.1007/s00427-004-0390-8; Keembiyehetty CN, 2011, J CELL SCI, V124, P2851, DOI 10.1242/jcs.083287; Khidekel N, 2003, J AM CHEM SOC, V125, P16162, DOI 10.1021/ja038545r; Kim EJ, 2006, CARBOHYD RES, V341, P971, DOI 10.1016/j.carres.2006.03.004; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lazarus BD, 2005, J BIOL CHEM, V280, P35537, DOI 10.1074/jbc.M504948200; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lee HS, 2011, ANAL BIOCHEM, V418, P85, DOI 10.1016/j.ab.2011.06.016; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Macauley MS, 2009, CARBOHYD RES, V344, P1079, DOI 10.1016/j.carres.2009.04.017; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; MACHIDA M, 1994, BIOSCI BIOTECH BIOCH, V58, P344, DOI 10.1271/bbb.58.344; Martinelli C, 2004, GENE EXPR PATTERNS, V4, P443, DOI 10.1016/j.modgep.2004.01.002; Martinelli C, 2003, DEV GENES EVOL, V213, P492, DOI 10.1007/s00427-003-0353-5; Nolte D, 2002, MAMM GENOME, V13, P62, DOI 10.1007/s00335-001-2108-9; Ojida A, 2008, J AM CHEM SOC, V130, P12095, DOI 10.1021/ja803262w; Olszewski NE, 2010, BBA-GEN SUBJECTS, V1800, P49, DOI 10.1016/j.bbagen.2009.11.016; Perez-Cervera Y, 2011, AMINO ACIDS, V40, P847, DOI 10.1007/s00726-010-0702-4; Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; Rao FV, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130021; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Ringrose JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2424; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Schierwater B, 2005, BIOESSAYS, V27, P1294, DOI 10.1002/bies.20320; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; Schimpl M, 2010, BIOCHEM J, V432, P1, DOI 10.1042/BJ20101338; Schirm M, 2004, J BACTERIOL, V186, P6721, DOI 10.1128/JB.186.20.6721-6727.2004; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shen DL, 2012, J BIOL CHEM, V287, P15395, DOI 10.1074/jbc.M111.310664; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Smith CL, 2014, CURR BIOL, V24, P1565, DOI 10.1016/j.cub.2014.05.046; Sohn KC, 2005, BIOCHEM BIOPH RES CO, V337, P256, DOI 10.1016/j.bbrc.2005.09.049; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; STARR CM, 1990, J BIOL CHEM, V265, P6868; Sumegi M, 2003, BIOCHEM BIOPH RES CO, V312, P1284, DOI 10.1016/j.bbrc.2003.11.074; Tarrant MK, 2012, NAT CHEM BIOL, V8, P262, DOI [10.1038/NCHEMBIO.771, 10.1038/nchembio.771]; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; von der Chevallerie K, 2014, DEV GENES EVOL, V224, P79, DOI 10.1007/s00427-014-0465-0; Wang P, 2013, AUTOPHAGY, V9, P604, DOI 10.4161/auto.23459; Wang P, 2012, P NATL ACAD SCI USA, V109, P17669, DOI 10.1073/pnas.1205748109; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	88	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11969	11982		10.1074/jbc.M114.628750	http://dx.doi.org/10.1074/jbc.M114.628750			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25778404	hybrid, Green Published			2022-12-28	WOS:000354388600014
J	Gherasim, C; Ruetz, M; Li, Z; Hudolin, S; Banerjee, R				Gherasim, Carmen; Ruetz, Markus; Li, Zhu; Hudolin, Stephanie; Banerjee, Ruma			Pathogenic Mutations Differentially Affect the Catalytic Activities of the Human B-12-processing Chaperone CblC and Increase Futile Redox Cycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMBINED METHYLMALONIC ACIDURIA; B-12 TRAFFICKING CHAPERONE; GLUTATHIONE TRANSFERASES; VITAMIN-B-12 METABOLISM; DIRECTED MUTAGENESIS; HOMOCYSTINURIA CBLC; ARGININE RESIDUES; STRUCTURAL BASIS; COBALAMIN; MMACHC	Human CblC catalyzes the elimination of the upper axial ligand in cobalamin or B-12 derivatives entering the cell from circulation. This processing step is critical for assimilation of dietary cobalamin into the active cofactor forms that support the B-12-dependent enzymes, methionine synthase and methylmalonyl-CoA mutase. Using a modified nitroreductase scaffold tailored to bind cobalamin and glutathione, CblC exhibits versatility in the mechanism by which it removes cyano versus alkyl ligands in cobalamin. In this study, we have characterized the effects of two pathogenic missense mutations at the same residue, R161G and R161Q, which are associated with early and late onset of the CblC disorder, respectively. Wefind that the R161Q and R161G CblC mutants display lower protein stability and decreased dealkylation but not decyanation activity, suggesting that cyanocobalamin might be therapeutically useful for patients carrying mutations at Arg-161. The mutant proteins also exhibit impaired glutathione binding. In the presence of physiologically relevant glutathione concentrations, stabilization of the cob(II) alamin derivative is observed, which occurs at the expense of increased oxidation of glutathione. Futile redox cycling, which is suppressed in wild-type human CblC, explains the reported increase in oxidative stress levels associated with the CblC disorder.	[Gherasim, Carmen; Ruetz, Markus; Li, Zhu; Hudolin, Stephanie; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Regan, Clinton/E-6250-2012	Li, Zhu/0000-0003-1536-9401	National Institutes of Health [DK45776]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045776, R01DK045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK45776 (to R. B.).	Andersson HC, 1998, J PEDIATR-US, V132, P121, DOI 10.1016/S0022-3476(98)70496-2; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; ARONOVITCH J, 1962, BIOCHEM BIOPH RES CO, V8, P416, DOI 10.1016/0006-291X(62)90288-7; Balagopalakrishna C, 1998, BIOCHEMISTRY-US, V37, P13194, DOI 10.1021/bi980941c; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Banerjee R, 2001, BIOCHEMISTRY-US, V40, P6191, DOI 10.1021/bi0104423; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; BARTHOLOMEW DW, 1988, J PEDIATR-US, V112, P32, DOI 10.1016/S0022-3476(88)80114-8; Bommer M, 2014, SCIENCE, V346, P455, DOI 10.1126/science.1258118; Coelho D, 2012, NAT GENET, V44, P1152, DOI 10.1038/ng.2386; Froese DS, 2010, MOL GENET METAB, V100, P29, DOI 10.1016/j.ymgme.2010.02.005; Froese DS, 2009, MOL GENET METAB, V98, P338, DOI 10.1016/j.ymgme.2009.07.014; Froese DS, 2012, BIOCHEMISTRY-US, V51, P5083, DOI 10.1021/bi300150y; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Gunduz M, 2014, EUR J PEDIATR, V173, P1707, DOI 10.1007/s00431-014-2330-6; Hannibal L, 2009, MOL GENET METAB, V97, P260, DOI 10.1016/j.ymgme.2009.04.005; Jeong J, 2014, BIOCHEM BIOPH RES CO, V443, P173, DOI 10.1016/j.bbrc.2013.11.075; Jeong J, 2011, BMB REP, V44, P170, DOI 10.5483/BMBRep.2011.44.3.170; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; Kim J, 2009, J BIOL CHEM, V284, P33418, DOI 10.1074/jbc.M109.057877; Koutmos M, 2011, J BIOL CHEM, V286, P29780, DOI 10.1074/jbc.M111.261370; Lerner-Ellis JP, 2009, HUM MUTAT, V30, P1072, DOI 10.1002/humu.21001; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; LEXA D, 1983, ACCOUNTS CHEM RES, V16, P235, DOI 10.1021/ar00091a001; Li Z, 2014, J BIOL CHEM, V289, P16487, DOI 10.1074/jbc.M114.567339; Liu MY, 2010, J HUM GENET, V55, P621, DOI 10.1038/jhg.2010.81; Madej E, 2007, ARCH BIOCHEM BIOPHYS, V462, P94, DOI 10.1016/j.abb.2007.03.002; Mc Guire PJ, 2009, MOL GENET METAB, V98, P173, DOI 10.1016/j.ymgme.2009.06.007; MEISTER A, 1995, METHOD ENZYMOL, V251, P3, DOI 10.1016/0076-6879(95)51106-7; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Pal A, 2001, CARCINOGENESIS, V22, P1301, DOI 10.1093/carcin/22.8.1301; Pastore A, 2014, J INHERIT METAB DIS, V37, P125, DOI 10.1007/s10545-013-9605-3; Payne KAP, 2015, NATURE, V517, P513, DOI 10.1038/nature13901; PEEL JL, 1962, J BIOL CHEM, V237, pP263; Ramasamy S, 2012, J PORPHYR PHTHALOCYA, V16, P25, DOI 10.1142/S1088424611004051; Richard E, 2009, HUM MUTAT, V30, P1558, DOI 10.1002/humu.21107; Rosenblatt DS, 1997, J INHERIT METAB DIS, V20, P528, DOI 10.1023/A:1005353530303; Ruetz M, 2013, ANGEW CHEM INT EDIT, V52, P2606, DOI 10.1002/anie.201209651; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; SCHRAUZER GN, 1969, ARCH BIOCHEM BIOPHYS, V130, P257, DOI 10.1016/0003-9861(69)90032-0; SHEVELL MI, 1992, CAN J NEUROL SCI, V19, P472, DOI 10.1017/S0317167100041676; STENBERG G, 1991, BIOCHEM J, V274, P549, DOI 10.1042/bj2740549; Suarez-Moreira E, 2009, J AM CHEM SOC, V131, P15078, DOI 10.1021/ja904670x; TAKAHASHI K, 1968, J BIOL CHEM, V243, P6171; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; WANG RW, 1993, J BIOL CHEM, V268, P23981; Watkins D, 2012, J INHERIT METAB DIS, V35, P665, DOI 10.1007/s10545-011-9418-1; WOOD PM, 1988, BIOCHEM J, V253, P287, DOI 10.1042/bj2530287; Yamanishi M, 2005, J AM CHEM SOC, V127, P526, DOI 10.1021/ja044365l; Yu HC, 2013, AM J HUM GENET, V93, P506, DOI 10.1016/j.ajhg.2013.07.022	50	24	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11393	11402		10.1074/jbc.M115.637132	http://dx.doi.org/10.1074/jbc.M115.637132			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25809485	Green Published, hybrid			2022-12-28	WOS:000353719400016
J	Flanagan, JJ; Mukherjee, I; Barlowe, C				Flanagan, John J.; Mukherjee, Indrani; Barlowe, Charles			Examination of Sec22 Homodimer Formation and Role in SNARE-dependent Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; TRANSPORT VESICLES; PROTEIN-TRANSPORT; SYNAPTIC VESICLE; GOLGI TRANSPORT; BIOCHEMICAL REQUIREMENTS; NEUROTRANSMITTER RELEASE; TRANSMEMBRANE SEGMENT; CRYSTAL-STRUCTURE	Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) protein complexes play essential roles in catalyzing intracellular membrane fusion events although the assembly pathway and molecular arrangement of SNARE complexes in membrane fusion reactions are not well understood. Here we monitored interactions of the R-SNARE protein Sec22 through a cysteine scanning approach and detected efficient formation of cross-linked Sec22 homodimers in cellular membranes when cysteine residues were positioned in the SNARE motif or C terminus of the transmembrane domain. When specific Sec22 cysteine derivatives are present on both donor COPII vesicles and acceptor Golgi membranes, the formation of disulfide cross-links provide clear readouts on trans-and cis-SNARE arrangements during this fusion event. The Sec22 transmembrane domain was required for efficient homodimer formation and for membrane fusion suggesting a functional role for Sec22 homodimers. We propose that Sec22 homodimers promote assembly of higher-order SNARE complexes to catalyze membrane fusion. Sec22 is also reported to function in macroautophagy and in formation of endoplasmic reticulum-plasma membrane contact sites therefore homodimer assembly may regulate Sec22 activity across a range of cellular processes.	[Flanagan, John J.; Mukherjee, Indrani; Barlowe, Charles] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Barlowe, C (corresponding author), Geisel Sch Med Dartmouth, HB 7200, Hanover, NH 03755 USA.	charles.barlowe@dartmouth.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [GM52549, GM070096]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052549, F32GM070096, R37GM052549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM52549 (to C. B.) and GM070096 (to J. J. F.).	Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; BAKER D, 1990, P NATL ACAD SCI USA, V87, P355, DOI 10.1073/pnas.87.1.355; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097; Barlowe CK, 2013, GENETICS, V193, P383, DOI 10.1534/genetics.112.142810; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; Belden WJ, 2001, MOL BIOL CELL, V12, P957, DOI 10.1091/mbc.12.4.957; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; Chen JL, 2002, J BIOL CHEM, V277, P35682, DOI 10.1074/jbc.M204157200; Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fdez E, 2008, MOL BIOL CELL, V19, P3379, DOI 10.1091/mbc.E08-01-0010; Fdez E, 2010, J CELL SCI, V123, P2473, DOI 10.1242/jcs.061325; Flanagan JJ, 2006, J BIOL CHEM, V281, P2281, DOI 10.1074/jbc.M511695200; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; Hernandez JM, 2014, P NATL ACAD SCI USA, V111, P12037, DOI 10.1073/pnas.1407435111; Hofmann MW, 2006, J MOL BIOL, V364, P1048, DOI 10.1016/j.jmb.2006.09.077; Inadome H, 2005, MOL CELL BIOL, V25, P7696, DOI 10.1128/MCB.25.17.7696-7710.2005; Laage R, 1997, EUR J BIOCHEM, V249, P540, DOI 10.1111/j.1432-1033.1997.00540.x; Liu YT, 2004, J BIOL CHEM, V279, P27225, DOI 10.1074/jbc.M312122200; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu XB, 2008, NAT STRUCT MOL BIOL, V15, P700, DOI 10.1038/nsmb.1433; Lupashin VV, 1996, J CELL BIOL, V132, P277, DOI 10.1083/jcb.132.3.277; Matern H, 2000, EMBO J, V19, P4485, DOI 10.1093/emboj/19.17.4485; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; NEWMAN AP, 1990, MOL CELL BIOL, V10, P3405, DOI 10.1128/MCB.10.7.3405; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Parkinson K, 2014, NAT CELL BIOL, V16, P87, DOI 10.1038/ncb2887; Parlati F, 2000, NATURE, V407, P194, DOI 10.1038/35025076; Petkovic M, 2014, NAT CELL BIOL, V16, P434, DOI 10.1038/ncb2937; Porat A, 2000, J BIOL CHEM, V275, P29233, DOI 10.1074/jbc.M005316200; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; Rizo J, 2012, J MOL CELL BIOL, V4, P270, DOI 10.1093/jmcb/mjs036; Roy R, 2004, BIOCHEMISTRY-US, V43, P4964, DOI 10.1021/bi0362875; Roy R, 2006, BIOCHEMISTRY-US, V45, P7654, DOI 10.1021/bi052620o; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; SIKORSKI RS, 1989, GENETICS, V122, P19; Sinha R, 2011, P NATL ACAD SCI USA, V108, P14318, DOI 10.1073/pnas.1101818108; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; van den Bogaart G, 2013, CURR TOP MEMBR, V72, P193, DOI 10.1016/B978-0-12-417027-8.00006-4; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135; Zhang YH, 2006, BIOCHEMISTRY-US, V45, P4173, DOI 10.1021/bi052178+; Zhou P, 2013, NEURON, V80, P470, DOI 10.1016/j.neuron.2013.09.010	61	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10657	10666		10.1074/jbc.M114.626911	http://dx.doi.org/10.1074/jbc.M114.626911			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25750128	Green Published, hybrid			2022-12-28	WOS:000353404500009
J	Watanabe, T; Sekine, S; Naguro, I; Sekine, Y; Ichijo, H				Watanabe, Takeshi; Sekine, Shiori; Naguro, Isao; Sekine, Yusuke; Ichijo, Hidenori			Apoptosis Signal-regulating Kinase 1 (ASK1)-p38 Pathway-dependent Cytoplasmic Translocation of the Orphan Nuclear Receptor NR4A2 Is Required for Oxidative Stress-induced Necrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; CELL-DEATH; STEROID-RECEPTOR; NUR77; PROTEIN; ACTIVATION; MACROPHAGE; EXPRESSION; NURR1; ASK1	p38 mitogen-activated protein kinases (MAPKs) play important roles in various cellular stress responses, including cell death, which is roughly categorized into apoptosis and necrosis. Although p38 signaling has been extensively studied, the molecular mechanisms of p38-mediated cell death are unclear. ASK1 is a stress-responsive MAP3K that acts as an upstream kinase of p38 and is activated by various stresses, such as oxidative stress. Here, we show that NR4A2, a member of the NR4A nuclear receptor family, acts as a necrosis promoter downstream of ASK1-p38 pathway during oxidative stress. Although NR4A2 is well known as a nucleus-localized transcription factor, we found that it is translocated into the cytosol after phosphorylation by p38. Because the phosphorylation site mutants of NR4A2 cannot rescue the cell death-promoting activity, ASK1-p38 pathway-dependent phosphorylation and subsequent cytoplasmic translocation of NR4A2 may be required for oxidative stress-induced cell death. In addition, NR4A2-mediated cell death does not depend on caspases and receptor-interacting protein 1 (RIP1)-RIP3 complex, suggesting that NR4A2 promotes an RIP kinase-independent necrotic type of cell death. Our findings may enable a more precise understanding of molecular mechanisms that regulate oxidative stress-induced and p38-mediated necrosis.	[Watanabe, Takeshi; Sekine, Shiori; Naguro, Isao; Sekine, Yusuke; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Bunkyo Ku, Tokyo 1130033, Japan; [Watanabe, Takeshi] Tokyo Med & Dent Univ, Dept Cellular Physiol Chem, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138510, Japan; [Sekine, Yusuke] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Tokyo; Tokyo Medical & Dental University (TMDU); University of Cambridge	Ichijo, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ichijo@mol.f.u-tokyo.ac.jp	Sekine, Yusuke/AHI-8340-2022; Naguro, Isao/P-1337-2019	Naguro, Isao/0000-0002-0338-8026; Ichijo, Hidenori/0000-0002-5005-6438; Sekine, Yusuke/0000-0003-0345-1416; Watanabe, Takeshi/0000-0002-4532-0556	KAKENHI from the Japan Society for the Promotion of Science; MEXT; Strategic Approach to Drug Discovery and Development in Pharmaceutical Sciences; GCOE program; National Institute of Biomedical Innovation; Naito Foundation Natural Science Scholarship; Cosmetology Research Foundation; Tokyo Biochemical Research Foundation; Grants-in-Aid for Scientific Research [25650004, 26111007, 26114009] Funding Source: KAKEN	KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Approach to Drug Discovery and Development in Pharmaceutical Sciences; GCOE program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Naito Foundation Natural Science Scholarship; Cosmetology Research Foundation; Tokyo Biochemical Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI from the Japan Society for the Promotion of Science and MEXT, the Strategic Approach to Drug Discovery and Development in Pharmaceutical Sciences, the GCOE program, the "Understanding of Environmental Bases for Brain Health" that was conducted under the Strategic Research Program for Brain Sciences by MEXT, the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation, the Naito Foundation Natural Science Scholarship, the Cosmetology Research Foundation, and the Tokyo Biochemical Research Foundation.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Baker KD, 2003, CELL, V113, P731, DOI 10.1016/S0092-8674(03)00420-3; Erdo F, 2004, ACTA NEUROPATHOL, V107, P127, DOI 10.1007/s00401-003-0789-8; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Inamoto T, 2010, CANCER-AM CANCER SOC, V116, P340, DOI 10.1002/cncr.24737; Garcia-Yague AJ, 2013, J BIOL CHEM, V288, P5506, DOI 10.1074/jbc.M112.439190; Kim JY, 2011, APOPTOSIS, V16, P114, DOI 10.1007/s10495-010-0550-4; Kim SO, 2003, J EXP MED, V197, P1441, DOI 10.1084/jem.20021842; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Martin ED, 2012, CIRCULATION, V126, P357, DOI 10.1161/CIRCULATIONAHA.111.071886; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Nagai H, 2009, MOL CELL, V36, P805, DOI 10.1016/j.molcel.2009.10.016; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Noguchi T, 2008, J BIOL CHEM, V283, P7657, DOI 10.1074/jbc.M708402200; NOSSERI C, 1994, EXP CELL RES, V212, P367, DOI 10.1006/excr.1994.1156; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sekine Y, 2011, J CELL SCI, V124, P3006, DOI 10.1242/jcs.085902; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Xing L, 2009, BIOCHEMISTRY-US, V48, P6402, DOI 10.1021/bi900655f; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	31	31	32	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10791	10803		10.1074/jbc.M114.623280	http://dx.doi.org/10.1074/jbc.M114.623280			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25752609	Green Published, hybrid			2022-12-28	WOS:000353404500020
J	Yamasaki, T; Oohata, Y; Nakamura, T; Watanabe, Y				Yamasaki, Takashi; Oohata, Yukiko; Nakamura, Toshiki; Watanabe, Yo-hei			Analysis of the Cooperative ATPase Cycle of the AAA plus Chaperone ClpB from Thermus thermophilus by Using Ordered Heterohexamers with an Alternating Subunit Arrangement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; NUCLEOTIDE-BINDING; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL HSP78; DNAJ COMPLEX; COILED-COIL; PROTEIN; HSP104; OLIGOMERIZATION; DISAGGREGATION	The ClpB/Hsp104 chaperone solubilizes and reactivates protein aggregates in cooperation with llnaK/Hsp70 and its cofactors. The CIpB/Hsp104 protomer has two AAA+ modules, AAA-1 and AAA-2, and forms a homohexamer. In the hexamer, these modules form a two-tiered ring in which each tier consists of homotypic AAA+ modules. By ATP binding and its hydrolysis at these AAA+ modules, ClpB/Hsp104 exerts the mechanical power required for protein disaggregation. Although ATPase cycle of this chaperone has been studied by several groups, an integrated understanding of this cycle has not been obtained because of the complexity of the mechanism and differences between species. To improve our understanding of the ATPase cycle, we prepared many ordered heterohexamers of ClpB from Thermus thermophilus, in which two subunits having different mutations were cross-linked to each other and arranged alternately and measured their nucleotide binding, ATP hydrolysis, and disaggregation abilities. The results indicated that the AT Pase cycle of ClpB proceeded as follows: (i) the 12 AAA+ modules randomly bound ATP, (ii) the binding of four or more ATP to one AAA+ ring was sensed by a conserved Arg residue and converted another AAA+ ring into the ATPase-active form, and (iii) ATP hydrolysis occurred cooperatively in each ring. We also found that cooperative ATP hydrolysis in at least one ring was needed for the disaggregation activity of ClpB.	[Yamasaki, Takashi; Oohata, Yukiko; Nakamura, Toshiki; Watanabe, Yo-hei] Konan Univ, Dept Biol, Fac Sci & Engn, Okamoto 8-9-1, Kobe, Hyogo 6588501, Japan; [Yamasaki, Takashi; Watanabe, Yo-hei] Konan Univ, Inst Integrat Neurobiol, Kobe, Hyogo 6588501, Japan	Konan University; Konan University	Watanabe, Y (corresponding author), Konan Univ, Dept Biol, Fac Sci & Engn, Okamoto 8-9-1, Kobe, Hyogo 6588501, Japan.	ywatanab@center.konan-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [24241048, 26440085]; Japan Science Society; Grants-in-Aid for Scientific Research [26440085] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science Society; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 24241048 and 26440085 and by a Sasakawa Scientific Research Grant from the Japan Science Society.	Akoev V, 2004, PROTEIN SCI, V13, P567, DOI 10.1110/ps.03422604; Fernandez-Higuero JA, 2011, J BIOL CHEM, V286, P25547, DOI 10.1074/jbc.M111.231365; Biter AB, 2012, P NATL ACAD SCI USA, V109, P12515, DOI 10.1073/pnas.1207040109; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Carroni M, 2014, ELIFE, V3, DOI 10.7554/eLife.02481; del Castillo U, 2010, FEBS LETT, V584, P929, DOI 10.1016/j.febslet.2010.01.029; Franzmann TM, 2011, J BIOL CHEM, V286, P17992, DOI 10.1074/jbc.M110.216176; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Glynn SE, 2012, NAT STRUCT MOL BIOL, V19, P616, DOI 10.1038/nsmb.2288; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; Krzewska J, 2001, J MOL BIOL, V314, P901, DOI 10.1006/jmbi.2001.5190; Krzewska J, 2001, FEBS LETT, V489, P92, DOI 10.1016/S0014-5793(00)02423-6; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Mizuno S, 2012, FEBS J, V279, P1474, DOI 10.1111/j.1742-4658.2012.08540.x; Mizutani T, 2009, GENES CELLS, V14, P1405, DOI 10.1111/j.1365-2443.2009.01357.x; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; Motohashi K, 1996, J BIOL CHEM, V271, P17343, DOI 10.1074/jbc.271.29.17343; Motohashi K, 1997, FEBS LETT, V412, P633, DOI 10.1016/S0014-5793(97)00847-8; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; PARSELL DA, 1994, J BIOL CHEM, V269, P4480; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schlee S, 2001, J MOL BIOL, V306, P889, DOI 10.1006/jmbi.2001.4455; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; Thomas JG, 1998, J BACTERIOL, V180, P5165, DOI 10.1128/JB.180.19.5165-5172.1998; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Watanabe Y, 2005, J BIOL CHEM, V280, P24562, DOI 10.1074/jbc.M414623200; Watanabe Y, 2004, J BIOL CHEM, V279, P15723, DOI 10.1074/jbc.M308782200; Watanabe YH, 2002, J BIOL CHEM, V277, P5804, DOI 10.1074/jbc.M109349200; Watanabe YH, 2009, BIOCHEM J, V421, P71, DOI 10.1042/BJ20082238; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Yamasaki T, 2011, FEBS J, V278, P2395, DOI 10.1111/j.1742-4658.2011.08167.x; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083; Zolkiewski M, 1999, PROTEIN SCI, V8, P1899, DOI 10.1110/ps.8.9.1899	44	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9789	9800		10.1074/jbc.M114.617696	http://dx.doi.org/10.1074/jbc.M114.617696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713084	Green Published, hybrid			2022-12-28	WOS:000352729400039
J	Jeansonne, D; DeLuca, M; Marrero, L; Lassak, A; Pacifici, M; Wyczechowska, D; Wilk, A; Reiss, K; Peruzzi, F				Jeansonne, Duane; DeLuca, Mariacristina; Marrero, Luis; Lassak, Adam; Pacifici, Marco; Wyczechowska, Dorota; Wilk, Anna; Reiss, Krzysztof; Peruzzi, Francesca			Anti-tumoral Effects of miR-3189-3p in Glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED GENE NAG-1/GDF15; EXPRESSION; GROWTH; TEMOZOLOMIDE; INHIBITION; MICRORNAS; RECEPTOR; PATHWAY; TARGETS; NAG-1	Glioblastoma is one of the most aggressive brain tumors. We have previously found up-regulation of growth differentiation factor 15 (GDF15) in glioblastoma cells treated with the anticancer agent fenofibrate. Sequence analysis of GDF15 revealed the presence of a microRNA, miR-3189, in the single intron. We then asked whether miR-3189 was expressed in clinical samples and whether it was functional in glioblastoma cells. We found that expression of miR-3189-3p was down-regulated in astrocytoma and glioblastoma clinical samples compared with control brain tissue. In vitro, the functionality of miR-3189-3p was tested by RNA-binding protein immunoprecipitation, and miR3189- 3p coimmunoprecipitated with Argonaute 2 together with two of its major predicted gene targets, the SF3B2 splicing factor and the guanine nucleotide exchange factor p63RhoGEF. Overexpression of miR-3189-3p resulted in a significant inhibition of cell proliferation and migration through direct targeting of SF3B2 and p63RhoGEF, respectively. Interestingly, miR3189- 3p levels were increased by treatment of glioblastoma cells with fenofibrate, a lipid-lowering drug with multiple anticancer activities. The attenuated expression of miR-3189-3p in clinical samples paralleled the elevated expression of SF3B2, which could contribute to the activation of SF3B2 growth-promoting pathways in these tumors. Finally, miR-3189-3p-mediated inhibition of tumor growth in vivo further supported the function of this microRNA as a tumor suppressor.	[Wyczechowska, Dorota; Wilk, Anna; Reiss, Krzysztof; Peruzzi, Francesca] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70112 USA; [Jeansonne, Duane; DeLuca, Mariacristina; Lassak, Adam; Pacifici, Marco; Wyczechowska, Dorota; Wilk, Anna; Reiss, Krzysztof; Peruzzi, Francesca] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Peruzzi, F (corresponding author), LSU Hlth Sci Ctr, Dept Med, 1700 Tulane Ave, New Orleans, LA USA.	fperuz@lsuhsc.edu			NIGMS/National Institutes of Health [1U54 GM104940]; National Institutes of Health [P20 GM103501, RO1 CA095518]; Stanley S Scott Cancer Research Center, LSUHSC, Louisiana Cancer Research Center; Department of Biological and Clinical Sciences, University of Milan, Italy; NATIONAL CANCER INSTITUTE [R01CA095518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940, P20GM103501] Funding Source: NIH RePORTER	NIGMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley S Scott Cancer Research Center, LSUHSC, Louisiana Cancer Research Center; Department of Biological and Clinical Sciences, University of Milan, Italy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS/National Institutes of Health Grant 1U54 GM104940, which funds the Louisiana Clinical and Translational Science Center, and by National Institutes of Health Grants P20 GM103501 (to F.P. and K.R.) and RO1 CA095518 (to K.R.). This work was also supported by the Stanley S Scott Cancer Research Center, LSUHSC, Louisiana Cancer Research Center.; Supported by the Department of Biological and Clinical Sciences, University of Milan, Italy.	Araki H, 2009, ANGIOGENESIS, V12, P221, DOI 10.1007/s10456-009-9142-8; Chiu SC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-146; Curtale G, 2013, P NATL ACAD SCI USA, V110, P11499, DOI 10.1073/pnas.1219852110; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Drukala J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-159; Eletto D, 2008, J CELL PHYSIOL, V216, P764, DOI 10.1002/jcp.21452; Eling TE, 2006, J BIOCHEM MOL BIOL, V39, P649; Hayashi A, 2013, FEBS LETT, V587, P698, DOI 10.1016/j.febslet.2013.01.043; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jeansonne D, 2013, GENES-BASEL, V4, P46, DOI 10.3390/genes4010046; Kim JM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/641851; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Marrero L, 2014, NEOPLASIA, V16, P874, DOI 10.1016/j.neo.2014.08.015; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Mimeault M, 2010, J CELL PHYSIOL, V224, P626, DOI 10.1002/jcp.22196; Nagasawa DT, 2012, NEUROSURG CLIN N AM, V23, P307, DOI 10.1016/j.nec.2012.01.007; Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Orr SJ, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.5; Pacifici M, 2013, J CELL PHYSIOL, V228, P1070, DOI 10.1002/jcp.24254; Panigrahy D, 2008, P NATL ACAD SCI USA, V105, P985, DOI 10.1073/pnas.0711281105; Rom S, 2010, FASEB J, V24, P2292, DOI 10.1096/fj.09-143503; Shimizu S, 2013, BIOCHEM BIOPH RES CO, V430, P1277, DOI 10.1016/j.bbrc.2012.11.137; Sivadas VP, 2013, GENE CHROMOSOME CANC, V52, P1042, DOI 10.1002/gcc.22099; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Swenson-Fields KI, 2008, MOL CELL, V32, P43, DOI 10.1016/j.molcel.2008.09.007; Tang XL, 2013, CANCER RES, V73, P6206, DOI 10.1158/0008-5472.CAN-13-1049; Urbanska K, 2008, INT J CANCER, V123, P1015, DOI 10.1002/ijc.23588; Wang XY, 2013, BIOCHEM PHARMACOL, V85, P597, DOI 10.1016/j.bcp.2012.11.025; Wilk A, 2015, MOL CELL BIOL, V35, P182, DOI 10.1128/MCB.00562-14; Wilk A, 2012, CELL CYCLE, V11, P2660, DOI 10.4161/cc.21015; Yoshioka H, 2008, J BIOL CHEM, V283, P33129, DOI 10.1074/jbc.M805248200	33	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8067	8080		10.1074/jbc.M114.633081	http://dx.doi.org/10.1074/jbc.M114.633081			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25645911	hybrid, Green Published			2022-12-28	WOS:000351662600006
J	Maenpuen, S; Amornwatcharapong, W; Krasatong, P; Sucharitakul, J; Palfey, BA; Yuthavong, Y; Chitnumsub, P; Leartsakulpanich, U; Chaiyen, P				Maenpuen, Somchart; Amornwatcharapong, Watcharee; Krasatong, Pasupat; Sucharitakul, Jeerus; Palfey, Bruce A.; Yuthavong, Yongyuth; Chitnumsub, Penchit; Leartsakulpanich, Ubolsree; Chaiyen, Pimchai			Kinetic Mechanism and the Rate-limiting Step of Plasmodium vivax Serine Hydroxymethyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENTIAL ANTIMALARIAL TARGET; BACILLUS-STEAROTHERMOPHILUS; METHYLENETETRAHYDROFOLATE REDUCTASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ENZYME; BINDING; SPECIFICITY; COMPLEXES; SUBSTRATE	Serine hydroxymethyltransferase (SHMT) is a pyridoxal 5 '-phosphate (PLP)-dependent enzyme that catalyzes a hydroxymethyl group transfer from L-serine to tetrahydrofolate (H(4)folate) to yield glycine and 5,10-methylenetetrahydrofolate (CH2-H(4)folate). SHMT is crucial for deoxythymidylate biosynthesis and a target for antimalarial drug development. Our previous studies indicate that PvSHMT catalyzes the reaction via a ternary complex mechanism. To define the kinetic mechanism of this catalysis, we explored the PvSHMT reaction by employing various methodologies including ligand binding, transient, and steady-state kinetics as well as product analysis by rapid-quench and HPLC/MS techniques. The results indicate that PvSHMT can bind first to either L-serine or H(4)folate. The dissociation constants for the enzyme.L-serine and enzyme.H(4)folate complexes were determined as 0.18 +/- 0.08 and 0.35 +/- 0.06 mM, respectively. The amounts of glycine formed after single turnovers of different preformed binary complexes were similar, indicating that the reaction proceeds via a random-order binding mechanism. In addition, the rate constant of glycine formation measured by rapid-quench and HPLC/MS analysis is similar to the k(cat) value (1.09 +/- 0.05 s(-1)) obtained from the steady-state kinetics, indicating that glycine formation is the rate-limiting step of SHMT catalysis. This information will serve as a basis for future investigation on species-specific inhibition of SHMT for antimalarial drug development.	[Maenpuen, Somchart; Amornwatcharapong, Watcharee; Chaiyen, Pimchai] Mahidol Univ, Dept Biochem, Bangkok 10400, Thailand; [Maenpuen, Somchart; Amornwatcharapong, Watcharee; Chaiyen, Pimchai] Mahidol Univ, Ctr Excellence Prot Struct & Funct, Fac Sci, Bangkok 10400, Thailand; [Maenpuen, Somchart; Krasatong, Pasupat] Burapha Univ, Dept Biochem, Fac Sci, Chon Buri 20131, Thailand; [Sucharitakul, Jeerus] Chulalongkorn Univ, Dept Biochem, Fac Dent, Bangkok 10330, Thailand; [Palfey, Bruce A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Yuthavong, Yongyuth; Chitnumsub, Penchit; Leartsakulpanich, Ubolsree] Natl Ctr Genet Engn & Biotechnol, Natl Sci & Technol Dev Agcy, Pathum Thani 12120, Thailand	Mahidol University; Mahidol University; Burapha University; Chulalongkorn University; University of Michigan System; University of Michigan; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Leartsakulpanich, U (corresponding author), 113 Paholyothin Rd,Klong 1, Klongluang 12120, Pathumthani, Thailand.	ubolsree@biotec.or.th; pimchai.cha@mahidol.ac.th	Chaiyen, Pimchai/R-5052-2019	Chaiyen, Pimchai/0000-0002-8533-1604; Palfey, Bruce/0000-0001-5098-259X; Maenpuen, Somchart/0000-0001-7770-4178; Yuthavong, Yongyuth/0000-0002-3582-8401	Cluster and Program Management office, National Science and Technology Development Agency (NSTDA) [P-13-00835]; Thailand Research Fund [RTA5680001, MRG5580066]; Faculty of Science, Mahidol University; Faculty of Science, Burapha University	Cluster and Program Management office, National Science and Technology Development Agency (NSTDA); Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; Faculty of Science, Burapha University	This work was supported by Cluster and Program Management office, National Science and Technology Development Agency (NSTDA) Grant P-13-00835 (to U. L., P. C., and P. C. C.), Thailand Research Fund Grant RTA5680001 and the Faculty of Science, Mahidol University (to P. C.), and Thailand Research Fund Grant MRG5580066 and the Faculty of Science, Burapha University (to S. M.).	Angelaccio S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/851428; Bhavani BS, 2008, FEBS J, V275, P4606, DOI 10.1111/j.1742-4658.2008.06603.x; Chiba Y, 2012, FEBS J, V279, P504, DOI 10.1111/j.1742-4658.2011.08443.x; Chitnumsub P, 2014, ACTA CRYSTALLOGR D, V70, P3177, DOI 10.1107/S1399004714023128; Chitnumsub P, 2014, ACTA CRYSTALLOGR D, V70, P1517, DOI 10.1107/S1399004714005598; Contestabile R, 2000, BIOCHEMISTRY-US, V39, P7492, DOI 10.1021/bi000032z; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; Florio R, 2011, BBA-PROTEINS PROTEOM, V1814, P1489, DOI 10.1016/j.bbapap.2010.10.010; Harris E L, 1988, Methods Mol Biol, V3, P33, DOI 10.1385/0-89603-126-8:33; Hiromi K., 1979, KINETICS FAST ENZYME; Kappes B, 2011, BBA-PROTEINS PROTEOM, V1814, P1567, DOI 10.1016/j.bbapap.2011.07.018; Maenpuen S, 2009, MOL BIOCHEM PARASIT, V168, P63, DOI 10.1016/j.molbiopara.2009.06.010; MATTHEWS RG, 1982, BIOCHEMISTRY-US, V21, P1230, DOI 10.1021/bi00535a019; MATTHEWS RG, 1990, CHEM REV, V90, P1275, DOI 10.1021/cr00105a010; Pai VR, 2009, BIOCHEM J, V418, P635, DOI 10.1042/BJ20081739; Pang CKT, 2009, MOL BIOCHEM PARASIT, V168, P74, DOI 10.1016/j.molbiopara.2009.06.011; Pinthong C, 2014, FEBS J, V281, P2570, DOI 10.1111/febs.12803; Pornthanakasem W, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-387; Rajaram V, 2007, FEBS J, V274, P4148, DOI 10.1111/j.1742-4658.2007.05943.x; ROSENTHAL S, 1965, J BIOL CHEM, V240, P836; Scarsdale JN, 2000, J MOL BIOL, V296, P155, DOI 10.1006/jmbi.1999.3453; SCHIRCH L, 1977, BIOCHEMISTRY-US, V16, P410, DOI 10.1021/bi00622a011; SCHIRCH L, 1980, J BIOL CHEM, V255, P7801; SCHIRCH L, 1964, J BIOL CHEM, V239, P3801; SCHIRCH L, 1982, ADV ENZYMOL RAMB, V53, P83; Schirch L. V., 1984, FOLATES PTERINS CHEM, V1, P399; Schirch V, 2005, CURR OPIN CHEM BIOL, V9, P482, DOI 10.1016/j.cbpa.2005.08.017; Schirch V., 1998, COMPREHENSIVE BIOL C, P223; Scrimgeour K G, 1980, Methods Enzymol, V66, P517; Sopitthummakhun K, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-194; Sopitthummakhun K, 2009, FEBS J, V276, P4023, DOI 10.1111/j.1742-4658.2009.07111.x; STRONG WB, 1989, BIOCHEMISTRY-US, V28, P106, DOI 10.1021/bi00427a016; Szebenyi DME, 2004, BIOCHEMISTRY-US, V43, P6865, DOI 10.1021/bi049791y; Toney MD, 2011, BBA-PROTEINS PROTEOM, V1814, P1407, DOI 10.1016/j.bbapap.2011.05.019; Trimmer EE, 2001, BIOCHEMISTRY-US, V40, P6205, DOI 10.1021/bi002789w; Trivedi V, 2002, J BIOL CHEM, V277, P17161, DOI 10.1074/jbc.M111976200; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Wahba A. J., 1961, J BIOL CHEM, V236, P11	38	9	9	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8656	8665		10.1074/jbc.M114.612275	http://dx.doi.org/10.1074/jbc.M114.612275			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25678710	Green Published, hybrid			2022-12-28	WOS:000351662600055
J	Zhu, K; Yi, JX; Xiao, YJ; Lai, YM; Song, PP; Zheng, W; Jiao, HL; Fan, J; Wu, CY; Chen, D; Zhou, JS; Xiao, GZ				Zhu, Ke; Yi, Jianxun; Xiao, Yajuan; Lai, Yumei; Song, Pingping; Zheng, Wei; Jiao, Hongli; Fan, Jie; Wu, Chuanyue; Chen, Di; Zhou, Jingsong; Xiao, Guozhi			Impaired Bone Homeostasis in Amyotrophic Lateral Sclerosis Mice with Muscle Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; MUSCULAR-DYSTROPHY; WNT; DIFFERENTIATION; EXPRESSION; OSTEOCYTES; OSTEOBLAST; DENSITY; PROTEIN; CELLS	There is an intimate relationship between muscle and bone throughout life. However, how alterations in muscle functions indiseaseimpactbonehomeostasisispoorlyunderstood. Amyotrophic lateral sclerosis (ALS) is a neuromuscular disease characterized by progressive muscle atrophy. In this study we analyzed the effects of ALS on bone using the well established G93A transgenic mouse model, which harbors an ALS-causing mutation in the gene encoding superoxide dismutase 1. We found that 4-month-old G93A mice with severe muscle atrophy had dramatically reduced trabecular and cortical bone mass compared with their sex-matched wild type (WT) control littermates. Mechanically, we found that multiple osteoblast properties, such as the formation of osteoprogenitors, activation of Akt and Erk1/2 pathways, and osteoblast differentiation capacity, were severely impaired in primary cultures and bones from G93A relative to WT mice; this could contribute to reduced bone formation in the mutant mice. Conversely, osteoclast formation and bone resorption were strikingly enhanced in primary bone marrow cultures and bones of G93A mice compared withWTmice. Furthermore, sclerostin and RANKL expression in osteocytes embedded in the bone matrix were greatly up-regulated, and beta-catenin was down-regulated in osteoblasts from G93A mice when compared with those of WT mice. Interestingly, calvarial bone that does not load and long bones from 2-month-old G93A mice without muscle atrophy displayed no detectable changes in parameters for osteoblast and osteoclast functions. Thus, for the first time to our knowledge, we have demonstrated that ALS causes abnormal bone remodeling and defined the underlying molecular and cellular mechanisms.	[Zhu, Ke; Lai, Yumei; Song, Pingping; Zheng, Wei; Jiao, Hongli; Chen, Di; Xiao, Guozhi] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Yi, Jianxun; Xiao, Yajuan; Zhou, Jingsong] Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA; [Fan, Jie] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15261 USA; [Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Xiao, Guozhi] South Univ Sci & Technol China, Dept Biol, Shenzhen 518055, Peoples R China; [Xiao, Guozhi] South Univ Sci & Technol China, Shenzhen Key Lab Cell Microenvironm, Shenzhen 518055, Peoples R China	Rush University; Rush University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Southern University of Science & Technology; Southern University of Science & Technology	Zhou, JS (corresponding author), Kansas City Univ Med & Biosci, Dept Physiol, Kansas City, MO 64106 USA.	Guozhi_Xiao@rush.edu	Chen, Di/AAJ-3665-2021	Jiao, Hongli/0000-0001-8005-8496	National Institutes of Health [AR059647, GM65188, AR057404]; National Natural Science Foundation of China [81472049]; Muscular Dystrophy Association [MDA-4351]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054465, R01AR059647, R01AR057404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR059647 (to G. X.), GM65188 (to C. W.), and AR057404 (to J. Z.). This work was in part supported by National Natural Science Foundation of China Grant 81472049 (to G. X.) and Muscular Dystrophy Association Research Grant MDA-4351 (to J. Z.).	Ausk BJ, 2013, BONE, V57, P413, DOI 10.1016/j.bone.2013.09.009; Bikle Daniel D, 2003, Gravit Space Biol Bull, V16, P45; Bivi N, 2013, J ORTHOP RES, V31, P1075, DOI 10.1002/jor.22341; Bonewald LF, 2013, J BONE MINER RES, V28, P1857, DOI 10.1002/jbmr.1980; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Cao HL, 2013, J BIOL CHEM, V288, P30399, DOI 10.1074/jbc.M113.469973; Cao HL, 2010, J CLIN INVEST, V120, P2755, DOI 10.1172/JCI42106; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Di Monaco M, 2011, ARCH GERONTOL GERIAT, V52, P71, DOI 10.1016/j.archger.2010.02.002; Edwards MH, 2013, J BONE MINER RES, V28, P2295, DOI 10.1002/jbmr.1972; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Galli C, 2010, J DENT RES, V89, P331, DOI 10.1177/0022034510363963; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hamrick M, 2010, J MUSCULOSKEL NEURON, V10, P1; Hamrick MW, 2010, J MUSCULOSKEL NEURON, V10, P64; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Jansen JHW, 2004, J CELL BIOCHEM, V93, P542, DOI 10.1002/jcb.20162; Javaheri B, 2014, J BONE MINER RES, V29, P705, DOI 10.1002/jbmr.2064; Kaji Hiroshi, 2014, [Journal of Bone Metabolism, 대한골대사학회지], V21, P29; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Khatri Ismail A, 2008, J Clin Neuromuscul Dis, V10, P11, DOI 10.1097/CND.0b013e318183e0fa; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; Kostenuik PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE1133; Lang TF, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/702735; Larson CM, 2000, J PEDIATR ORTHOPED, V20, P71, DOI 10.1097/00004694-200001000-00016; LeBrasseur NK, 2012, J BONE MINER RES, V27, P2159, DOI 10.1002/jbmr.1666; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Lloyd SA, 2014, J BONE MINER RES, V29, P1118, DOI 10.1002/jbmr.2113; McGoldrick P, 2013, BBA-MOL BASIS DIS, V1832, P1421, DOI 10.1016/j.bbadis.2013.03.012; Morikawa D, 2013, J BONE MINER RES, V28, P2368, DOI 10.1002/jbmr.1981; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rufo A, 2011, J BONE MINER RES, V26, P1891, DOI 10.1002/jbmr.410; Sato K, 2007, J BIOMECH, V40, P1246, DOI 10.1016/j.jbiomech.2006.05.028; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Sbrocchi AM, 2012, OSTEOPOROSIS INT, V23, P2703, DOI 10.1007/s00198-012-1911-3; Shackelford LC, 2004, J APPL PHYSIOL, V97, P119, DOI 10.1152/japplphysiol.00741.2003; Sudkamp N P, 1993, Aktuelle Traumatol, V23, P59; ten Dijke P, 2008, J BONE JOINT SURG AM, V90A, P31, DOI 10.2106/JBJS.G.01183; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; Vestergaard P, 2001, J REHABIL MED, V33, P150, DOI 10.1080/165019701750300609; Warner SE, 2006, BONE, V38, P257, DOI 10.1016/j.bone.2005.08.009; Xiao GZ, 2012, J BIOL CHEM, V287, P21450, DOI 10.1074/jbc.M111.331249; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang SY, 2011, J BIOL CHEM, V286, P19149, DOI 10.1074/jbc.M110.197905; Yu SB, 2013, INT J BIOL SCI, V9, P256, DOI 10.7150/ijbs.5898; Zhang XY, 2008, J CELL BIOCHEM, V105, P885, DOI 10.1002/jcb.21888; Zhao LM, 2013, BONE, V54, P35, DOI 10.1016/j.bone.2013.01.033; Zhu K, 2013, J BONE MINER RES, V28, P1870, DOI 10.1002/jbmr.1958	62	24	28	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8081	8094		10.1074/jbc.M114.603985	http://dx.doi.org/10.1074/jbc.M114.603985			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25648889	Green Published, hybrid			2022-12-28	WOS:000351662600007
J	Mao, XM; Luo, S; Zhou, RC; Wang, F; Yu, P; Sun, N; Chen, XX; Tang, Y; Li, YQ				Mao, Xu-Ming; Luo, Shuai; Zhou, Ri-Cheng; Wang, Feng; Yu, Pin; Sun, Ning; Chen, Xiao-Xia; Tang, Yi; Li, Yong-Quan			Transcriptional Regulation of the Daptomycin Gene Cluster in Streptomyces roseosporus by an Autoregulator, AtrA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics; Bacterial Genetics; Gene Regulation; Protein-DNA Interaction; Secondary Metabolism	SECONDARY METABOLISM; TETR-FAMILY; ADPA; COELICOLOR; BIOSYNTHESIS; GRISEUS; CLONING; IMPROVEMENT; EXPRESSION; ACTIVATOR	Background: No investigation on daptomycin production at the transcriptional regulatory level has been reported. Results: The autoregulator AtrA directly regulates daptomycin gene cluster expression, and atrA is the transcriptional target of AdpA. Conclusion: The AtrA-mediated transcriptional signaling pathway directly regulates daptomycin production. Significance: We reveal for the first time the transcriptional regulatory mechanism of daptomycin production for its potential rational genetic engineering. Daptomycin is a cyclic lipopeptide antibiotic produced by Streptomyces roseosporus. To reveal the transcriptional regulatory mechanism of daptomycin biosynthesis, we used the biotinylated dptE promoter (dptEp) as a probe to affinity isolate the dptEp-interactive protein AtrA, a TetR family transcriptional regulator, from the proteome of mycelia. AtrA bound directly to dptEp to positively regulate gene cluster expression and daptomycin production. Meanwhile, both atrA and adpA mutants showed bald phenotype and null production of daptomycin. AdpA positively regulated atrA expression by direct interaction with atrA promoter (atrAp), and removal of ArpA in S. roseosporus, a homolog of the A-factor receptor, resulted in accelerated morphological development and increased daptomycin production, suggesting that atrA was the target of AdpA to mediate the A-factor signaling pathway. Furthermore, AtrA was positively autoregulated by binding to its own promoter atrAp. Thus, for the first time at the transcriptional level, we have identified an autoregulator, AtrA, that directly mediates the A-factor signaling pathway to regulate the proper production of daptomycin.	[Mao, Xu-Ming; Luo, Shuai; Zhou, Ri-Cheng; Wang, Feng; Yu, Pin; Sun, Ning; Li, Yong-Quan] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Mao, Xu-Ming; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Mao, Xu-Ming; Luo, Shuai; Zhou, Ri-Cheng; Wang, Feng; Yu, Pin; Sun, Ning; Chen, Xiao-Xia; Li, Yong-Quan] Key Lab Microbial Biochem & Metab Engn Zhejiang P, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Xiao-Xia] Hangzhou Huadong Med Grp Biotechnol Inst Co Ltd, Hangzhou 310011, Zhejiang, Peoples R China	Zhejiang University; University of California System; University of California Los Angeles	Mao, XM (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	xmmao@zju.edu.cn; lyq@zju.edu.cn	Mao, Xu-Ming/AAI-4212-2020		National Basic Research Program of China (973 Program) [2012CB721005]; National Natural Science Foundation of China [31370103]; National High Technology Research and Development Program of China (863 Program) [2012AA02A706]; Key Program of Zhejiang Provincial Natural Science Foundation of China [LZ12C01001]; New Star Project from Zhejiang University	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Key Program of Zhejiang Provincial Natural Science Foundation of China; New Star Project from Zhejiang University	This work was supported by Grants 2012CB721005 from the National Basic Research Program of China (973 Program), 31370103 from the National Natural Science Foundation of China, 2012AA02A706 from the National High Technology Research and Development Program of China (863 Program), and LZ12C01001 from the Key Program of Zhejiang Provincial Natural Science Foundation of China and by fellowships from the New Star Project from Zhejiang University. The nucleotide sequence(s) reported in this paper has been submitted to the DDBJ/GenBankTM/EBI Data Bank with accession number(s) KM091937, KM091938, KM091939, and KM091940.	Ahn SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050562; Arbeit RD, 2004, CLIN INFECT DIS, V38, P1673, DOI 10.1086/420818; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Chen L, 2008, APPL MICROBIOL BIOT, V80, P277, DOI 10.1007/s00253-008-1545-8; Higo A, 2012, DNA RES, V19, P259, DOI 10.1093/dnares/dss010; Hirano S, 2008, MICROBIOL-SGM, V154, P905, DOI 10.1099/mic.0.2007/014381-0; Huang D, 2012, APPL MICROBIOL BIOT, V94, P637, DOI 10.1007/s00253-011-3773-6; Huang D, 2011, APPL BIOCHEM BIOTECH, V165, P1725, DOI 10.1007/s12010-011-9390-0; INGRAM C, 1989, J BACTERIOL, V171, P6617, DOI 10.1128/jb.171.12.6617-6624.1989; Jones GH, 2011, PLASMID, V65, P219, DOI 10.1016/j.plasmid.2011.02.002; Kieser T., 2000, PRACTICAL STREPTOMYC, P125; Lee HN, 2013, APPL ENVIRON MICROB, V79, P4159, DOI 10.1128/AEM.00546-13; Li LL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/479742; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Mao XM, 2013, J BACTERIOL, V195, P2072, DOI 10.1128/JB.00040-13; Miao V, 2005, MICROBIOL-SGM, V151, P1507, DOI 10.1099/mic.0.27757-0; Ohnishi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P431, DOI 10.1271/bbb.69.431; ONAKA H, 1995, J BACTERIOL, V177, P6083, DOI 10.1128/jb.177.21.6083-6092.1995; Pan YY, 2009, MOL MICROBIOL, V72, P710, DOI 10.1111/j.1365-2958.2009.06681.x; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Sader HS, 2013, ANTIMICROB AGENTS CH, V57, P6378, DOI 10.1128/AAC.01906-13; Uguru GC, 2005, MOL MICROBIOL, V58, P131, DOI 10.1111/j.1365-2958.2005.04817.x; Wang F, 2014, GENE, V544, P208, DOI 10.1016/j.gene.2014.04.044; Wang L, 2012, J APPL MICROBIOL, V112, P1095, DOI 10.1111/j.1365-2672.2012.05302.x; Wolanski M, 2011, J BACTERIOL, V193, P6358, DOI 10.1128/JB.05734-11; Yamazaki H, 2004, MOL MICROBIOL, V53, P555, DOI 10.1111/j.1365-2958.2004.04153.x; Yang YH, 2012, APPL MICROBIOL BIOT, V96, P113, DOI 10.1007/s00253-011-3803-4; Yu GH, 2011, APPL BIOCHEM BIOTECH, V163, P729, DOI 10.1007/s12010-010-9078-x	28	50	52	0	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7992	8001		10.1074/jbc.M114.608273	http://dx.doi.org/10.1074/jbc.M114.608273			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25648897	Green Published, hybrid			2022-12-28	WOS:000351613600056
J	Cebrian, J; Castan, A; Martinez, V; Kadomatsu-Hermosa, MJ; Parra, C; Fernandez-Nestosa, MJ; Schaerer, C; Hernandez, P; Krimer, DB; Schvartzman, JB				Cebrian, Jorge; Castan, Alicia; Martinez, Vctor; Kadomatsu-Hermosa, Maridian J.; Parra, Cristina; Jose Fernandez-Nestosa, Maria; Schaerer, Christian; Hernandez, Pablo; Krimer, Dora B.; Schvartzman, Jorge B.			Direct Evidence for the Formation of Precatenanes during DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGAROSE-GEL ELECTROPHORESIS; INTERTWINED CATENATED DIMERS; SITE-SPECIFIC RECOMBINATION; COLE1 PLASMID REPLICATION; ESCHERICHIA-COLI; TOPOISOMERASE-IV; FORK REVERSAL; II TOPOISOMERASES; SISTER DUPLEXES; SUPERCOILED DNA	The dynamics of DNA topology during replication are still poorly understood. Bacterial plasmids are negatively super-coiled. This underwinding facilitates strand separation of the DNA duplex during replication. Leading the replisome, a DNA helicase separates the parental strands that are to be used as templates. This strand separation causes overwinding of the duplex ahead. If this overwinding persists, it would eventually impede fork progression. In bacteria, DNA gyrase and topoisomerase IV act ahead of the fork to keep DNA underwound. However, the processivity of the DNA helicase might overcome DNA gyrase and topoisomerase IV. It was proposed that the overwinding that builds up ahead of the fork could force it to swivel and diffuse this positive supercoiling behind the fork where topoisomerase IV would also act to maintain replicating the DNA underwound. Putative intertwining of sister duplexes in the replicated region are called precatenanes. Fork swiveling and the formation of precatenanes, however, are still questioned. Here, we used classical genetics and high resolution two-dimensional agarose gel electrophoresis to examine the torsional tension of replication intermediates of three bacterial plasmids with the fork stalled at different sites before termination. The results obtained indicated that precatenanes do form as replication progresses before termination.	[Cebrian, Jorge; Castan, Alicia; Hernandez, Pablo; Krimer, Dora B.; Schvartzman, Jorge B.] Ctr Invest Biol, Dept Cellular & Mol Biol, Madrid 28040, Spain; [Martinez, Vctor; Kadomatsu-Hermosa, Maridian J.; Parra, Cristina; Jose Fernandez-Nestosa, Maria; Schaerer, Christian] Natl Univ Asuncion, Polytech Sch, Sci & Appl Comp Lab, Sl San Lorenzo, Paraguay	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidad Nacional de Asuncion	Schvartzman, JB (corresponding author), Ctr Invest Biol, Dept Cellular & Mol Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	schvartzman@cib.csic.es	Krimer, Dora/J-9176-2014; Cebrián, Jorge/B-5836-2018; Fernández De Nestosa, María José/GXZ-5768-2022; Schaerer, Christian/AAL-4203-2021; Schvartzman, Jorge B/J-9171-2014	Krimer, Dora/0000-0001-9972-3994; Cebrián, Jorge/0000-0001-5070-0070; Schaerer, Christian/0000-0002-0587-7704; Pablo, Hernandez/0000-0002-8113-1277	Spanish Ministerio de Economia y Competitividad [BFU2011-22489]; European FEDER Funds	Spanish Ministerio de Economia y Competitividad(Spanish Government); European FEDER Funds(European Commission)	This work was supported by Grant BFU2011-22489 from the Spanish Ministerio de Economia y Competitividad and European FEDER Funds (to J. B. S.).	ADAMS DE, 1992, CELL, V71, P277, DOI 10.1016/0092-8674(92)90356-H; Alexandrov AI, 1999, GENETICA, V106, P131, DOI 10.1023/A:1003749416449; Bastia Deepak, 1996, V31, P177; Bates A. D., 2005, DNA TOPOLOGY; BEDNAR J, 1994, J MOL BIOL, V235, P825, DOI 10.1006/jmbi.1994.1042; Bidnenko V, 2002, EMBO J, V21, P3898, DOI 10.1093/emboj/cdf369; BLISKA JB, 1987, J MOL BIOL, V194, P205, DOI 10.1016/0022-2836(87)90369-X; Cebrian J, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1255; CESARENI G, 1991, TRENDS GENET, V7, P230, DOI 10.1016/0168-9525(91)90370-6; Champoux JJ, 1980, MECH STUDIES DNA REP, P809; Charvin G, 2003, P NATL ACAD SCI USA, V100, P9820, DOI 10.1073/pnas.1631550100; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Crisona NJ, 2000, GENE DEV, V14, P2881, DOI 10.1101/gad.838900; De Septenville AL, 2012, PLOS GENET, V8, P116, DOI 10.1371/journal.pgen.1002622; DINARDO S, 1982, CELL, V31, P43, DOI 10.1016/0092-8674(82)90403-2; Eckstein F., 1995, NUCLEIC ACIDS MOL BI, P115; Espeli O, 2004, MOL MICROBIOL, V52, P925, DOI 10.1111/j.1365-2958.2004.04047.x; Fierro-Fernandez M, 2007, J BIOL CHEM, V282, P18190, DOI 10.1074/jbc.M701559200; Fierro-Fernandez M, 2007, P NATL ACAD SCI USA, V104, P1500, DOI 10.1073/pnas.0609204104; FUNNELL BE, 1987, J BIOL CHEM, V262, P10327; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; Hiasa H, 1996, J BIOL CHEM, V271, P21529, DOI 10.1074/jbc.271.35.21529; Higgins N. P., 2004, TOPOLOGICAL BEHAV PL; HILL TM, 1988, CELL, V55, P459, DOI 10.1016/0092-8674(88)90032-3; KANAAR R, 1992, CURR OPIN STRUC BIOL, V2, P369, DOI DOI 10.1016/0959-440X(92)90227-X; KATO J, 1990, CELL, V63, P393, DOI 10.1016/0092-8674(90)90172-B; Katritch V, 1996, NATURE, V384, P142, DOI 10.1038/384142a0; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P9419, DOI 10.1073/pnas.97.17.9419; Labib K, 2007, EMBO REP, V8, P346, DOI 10.1038/sj.embor.7400940; Levine C, 1998, BBA-GENE STRUCT EXPR, V1400, P29, DOI 10.1016/S0167-4781(98)00126-2; Liu ZR, 2010, J MOL BIOL, V400, P963, DOI 10.1016/j.jmb.2010.05.007; Lopez V, 2012, NUCLEIC ACIDS RES, V40, P3563, DOI 10.1093/nar/gkr1237; Lucas I, 2001, EMBO J, V20, P6509, DOI 10.1093/emboj/20.22.6509; Martinez-Robles ML, 2009, NUCLEIC ACIDS RES, V37, P5126, DOI 10.1093/nar/gkp530; MARIANS KJ, 1986, PROG NUCLEIC ACID RE, V33, P111, DOI 10.1016/S0079-6603(08)60021-5; Marians KJ, 2000, TRENDS BIOCHEM SCI, V25, P185, DOI 10.1016/S0968-0004(00)01565-6; Martin-Parras L, 1998, NUCLEIC ACIDS RES, V26, P3424, DOI 10.1093/nar/26.14.3424; MARTINPARRAS L, 1992, J BIOL CHEM, V267, P22496; MARTINPARRAS L, 1991, J MOL BIOL, V220, P843, DOI 10.1016/0022-2836(91)90357-C; Mayan-Santos MD, 2007, ELECTROPHORESIS, V28, P3845, DOI 10.1002/elps.200700294; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Moreau MJJ, 2012, MOL BIOSYST, V8, P2783, DOI 10.1039/c2mb25281c; Mulcair MD, 2006, CELL, V125, P1309, DOI 10.1016/j.cell.2006.04.040; Mulugu S, 2001, P NATL ACAD SCI USA, V98, P9569, DOI 10.1073/pnas.171065898; Neuman KC, 2009, P NATL ACAD SCI USA, V106, P6986, DOI 10.1073/pnas.0900574106; Olavarrieta L, 2002, MOL MICROBIOL, V46, P699, DOI 10.1046/j.1365-2958.2002.03217.x; Olavarrieta L, 2002, J MOL BIOL, V322, P1, DOI 10.1016/S0022-2836(02)00740-4; Olavarrieta L, 2002, NUCLEIC ACIDS RES, V30, P656, DOI 10.1093/nar/30.3.656; Peter BJ, 1998, CELL, V94, P819, DOI 10.1016/S0092-8674(00)81740-7; Postow L, 1999, BIOESSAYS, V21, P805, DOI 10.1002/(SICI)1521-1878(199910)21:10<805::AID-BIES1>3.0.CO;2-7; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Santamaria D, 2000, J MOL BIOL, V300, P75, DOI 10.1006/jmbi.2000.3843; Santamaria D, 1998, J BIOL CHEM, V273, P33386, DOI 10.1074/jbc.273.50.33386; Schvartzman JB, 2004, EMBO REP, V5, P256, DOI 10.1038/sj.embor.7400101; Schvartzman JB, 2013, METHODS MOL BIOL, V1054, P121, DOI 10.1007/978-1-62703-565-1_7; Schvartzman JB, 2013, BIOCHEM SOC T, V41, P646, DOI 10.1042/BST20120281; Sogo JM, 1999, J MOL BIOL, V286, P637, DOI 10.1006/jmbi.1998.2510; Stone MD, 2003, P NATL ACAD SCI USA, V100, P8654, DOI 10.1073/pnas.1133178100; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; SUNDIN O, 1981, CELL, V25, P659, DOI 10.1016/0092-8674(81)90173-2; Timsit Y, 2011, NUCLEIC ACIDS RES, V39, P8665, DOI 10.1093/nar/gkr556; TOMIZAWA J, 1984, CELL, V38, P871, DOI 10.1016/0092-8674(84)90282-4; Trigueros S, 2004, J MOL BIOL, V335, P723, DOI 10.1016/j.jmb.2003.11.011; Ullsperger C, 1996, J BIOL CHEM, V271, P31549, DOI 10.1074/jbc.271.49.31549; Viguera E, 1996, J BIOL CHEM, V271, P22414, DOI 10.1074/jbc.271.37.22414; Wang JC, 2009, UNTANGLING DOUBLE HE; Witz G, 2011, CELL CYCLE, V10, P1339, DOI 10.4161/cc.10.9.15293; Witz G, 2011, P NATL ACAD SCI USA, V108, P3608, DOI 10.1073/pnas.1016150108; Witz G, 2010, NUCLEIC ACIDS RES, V38, P2119, DOI 10.1093/nar/gkp1161; Zechiedrich EL, 1997, GENE DEV, V11, P2580, DOI 10.1101/gad.11.19.2580; ZECHIEDRICH EL, 1995, GENE DEV, V9, P2859, DOI 10.1101/gad.9.22.2859; Zechiedrich EL, 2000, J BIOL CHEM, V275, P8103, DOI 10.1074/jbc.275.11.8103	72	25	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13725	13735		10.1074/jbc.M115.642272	http://dx.doi.org/10.1074/jbc.M115.642272			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25829493	Green Published, hybrid			2022-12-28	WOS:000355313000009
J	Sumida, M; Hane, M; Yabe, U; Shimoda, Y; Pearce, OMT; Kiso, M; Miyagi, T; Sawada, M; Varki, A; Kitajima, K; Sato, C				Sumida, Mizuki; Hane, Masaya; Yabe, Uichiro; Shimoda, Yasushi; Pearce, Oliver M. T.; Kiso, Makoto; Miyagi, Taeko; Sawada, Makoto; Varki, Ajit; Kitajima, Ken; Sato, Chihiro			Rapid Trimming of Cell Surface Polysialic Acid (PolySia) by Exovesicular Sialidase Triggers Release of Preexisting Surface Neurotrophin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATED POLYSIALYLTRANSFERASE; FUNCTIONAL IMPAIRMENTS; MEMBRANE-VESICLES; MAMMALIAN BRAIN; HUMAN SIGLEC-11; NERVOUS-SYSTEM; EXPRESSION; MICROGLIA; GLYCOPROTEINS; RESIDUES	As acidic glycocalyx on primary mouse microglial cells and a mouse microglial cell line Ra2, expression of polysialic acid (polySia/PSA), a polymer of the sialic acid Neu5Ac (N-acetylneuraminic acid), was demonstrated. PolySia is known to modulate cell adhesion, migration, and localization of neurotrophins mainly on neural cells. PolySia on Ra2 cells disappeared very rapidly after an inflammatory stimulus. Results of knockdown and inhibitor studies indicated that rapid surface clearance of polySia was achieved by secretion of endogenous sialidase Neu1 as an exovesicular component. Neu1-mediated polySia turnover was accompanied by the release of brain-derived neurotrophic factor normally retained by polySia molecules. Introduction of a single oxygen atom change into polySia by exogenous feeding of the non-neural sialic acid Neu5Gc (N-glycolylneuraminic acid) caused resistance to Neu1-induced polySia turnover and also inhibited the associated release of brain-derived neurotrophic factor. These results indicate the importance of rapid turnover of the polySia glycocalyx by exovesicular sialidases in neurotrophin regulation.	[Sumida, Mizuki; Hane, Masaya; Yabe, Uichiro; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Sumida, Mizuki; Hane, Masaya; Yabe, Uichiro; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Shimoda, Yasushi] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 9402188, Japan; [Pearce, Oliver M. T.; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, La Jolla, CA 92093 USA; [Pearce, Oliver M. T.; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kiso, Makoto] Gifu Univ, Dept Appl Bioorgan Chem, Gifu 5011193, Japan; [Miyagi, Taeko] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Sendai, Miyagi 9818558, Japan; [Sawada, Makoto] Nagoya Univ, Environm Med Res Inst, Dept Brain Funct, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University; Nagaoka University of Technology; University of California System; University of California San Diego; University of California System; University of California San Diego; Gifu University; Tohoku Medical & Pharmaceutical University; Nagoya University	Kitajima, K (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	kitajima@agr.nagoya-u.ac.jp; chi@agr.nagoya-u.ac.jp	SATO, Chihiro/B-7396-2014; Naganawa, Shinji/I-1572-2012; Regan, Clinton/E-6250-2012	Naganawa, Shinji/0000-0002-0214-613X; Pearce, Oliver/0000-0003-3953-1629	National Institutes of Health [R01GM32373]; Ministry of Education, Science, Sports, and Culture [23570133, 23110002, 24110506, 26110708]; Hayashi Foundation; CREST of Japan Science and Technology Agency; Naito Foundation Subsidy for Promotion of Specific Research Projects; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hayashi Foundation; CREST of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Naito Foundation Subsidy for Promotion of Specific Research Projects; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM32373 (to O. P. and A. V.). This work was also supported in part by Grants-in-aid for Scientific Research (C) (23570133) and Scientific Research on Innovative Areas (23110002, Deciphering sugar chain-based signals regulating integrative neural functions) (24110506 and 26110708) from the Ministry of Education, Science, Sports, and Culture and the Hayashi Foundation (to C. S.) and CREST of Japan Science and Technology Agency and the Naito Foundation Subsidy for Promotion of Specific Research Projects (to K. K.).	Adachi T, 2007, BIOCHEM BIOPH RES CO, V358, P848, DOI 10.1016/j.bbrc.2007.04.197; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Angata T, 2002, J BIOL CHEM, V277, P24466, DOI 10.1074/jbc.M202833200; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; Arar S, 2007, CARBOHYD RES, V342, P1110, DOI 10.1016/j.carres.2007.02.016; Azuma Y, 2007, BIOL PHARM BULL, V30, P1680, DOI 10.1248/bpb.30.1680; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Chen TY, 2011, J IMMUNOL, V186, P2219, DOI 10.4049/jimmunol.1002991; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Colley KJ, 2014, CRIT REV BIOCHEM MOL, V49, P498, DOI 10.3109/10409238.2014.976606; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Davies LRL, 2012, J BIOL CHEM, V287, P28917, DOI 10.1074/jbc.M112.365056; Dhungana S, 2009, MOL CELL PROTEOMICS, V8, P201, DOI 10.1074/mcp.M800286-MCP200; Flori F, 2007, FERTIL STERIL, V88, P1212, DOI 10.1016/j.fertnstert.2007.01.209; Graeber MB, 2011, FEBS LETT, V585, P3798, DOI 10.1016/j.febslet.2011.08.033; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; Hane M, 2012, PURE APPL CHEM, V84, P1895, DOI 10.1351/PAC-CON-11-12-10; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Inoko E, 2010, GLYCOBIOLOGY, V20, P916, DOI 10.1093/glycob/cwq049; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Jansen AJG, 2012, BLOOD, V119, P1263, DOI 10.1182/blood-2011-05-355628; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; Mackowiak M, 2005, BRAIN RES, V1055, P149, DOI 10.1016/j.brainres.2005.07.001; Magesh S, 2008, BIOORG MED CHEM LETT, V18, P532, DOI 10.1016/j.bmcl.2007.11.084; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Meesmann HM, 2010, J CELL SCI, V123, P3347, DOI 10.1242/jcs.066696; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Nan XL, 2007, J LEUKOCYTE BIOL, V81, P284, DOI 10.1189/jlb.1105692; Ohta K, 1999, BIOCHEM BIOPH RES CO, V258, P616, DOI 10.1006/bbrc.1999.0686; Ono S, 2012, J BIOL CHEM, V287, P3710, DOI 10.1074/jbc.M111.276618; Oshima K, 2002, EUR J BIOCHEM, V269, P1209, DOI 10.1046/j.1432-1033.2002.02758.x; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Pshezhetsky AV, 2011, GLYCOCONJUGATE J, V28, P441, DOI 10.1007/s10719-011-9350-5; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sato C, 2004, TRENDS GLYCOSCI GLYC, V16, P331, DOI 10.4052/tigg.16.331; SATO C, 1995, J BIOL CHEM, V270, P18923, DOI 10.1074/jbc.270.32.18923; Sato C, 1998, J BIOL CHEM, V273, P2575, DOI 10.1074/jbc.273.5.2575; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Sawada M, 1998, FEBS LETT, V433, P37, DOI 10.1016/S0014-5793(98)00879-5; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Suzumura A, 1998, BRAIN RES, V787, P139, DOI 10.1016/S0006-8993(97)01166-9; Takahashi K, 2012, J BIOL CHEM, V287, P14816, DOI 10.1074/jbc.M111.324186; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Varki NM, 2011, ANNU REV PATHOL-MECH, V6, P365, DOI 10.1146/annurev-pathol-011110-130315; Vilcaes AA, 2011, J BIOL CHEM, V286, P31437, DOI 10.1074/jbc.M111.257196; Wang Y, 2010, J NEUROSCI, V30, P3482, DOI 10.1523/JNEUROSCI.3940-09.2010	54	68	68	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13202	13214		10.1074/jbc.M115.638759	http://dx.doi.org/10.1074/jbc.M115.638759			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25750127	Green Published, hybrid			2022-12-28	WOS:000354975700022
J	Binda, C; Robinson, RM; del Campo, JSM; Keul, ND; Rodriguez, PJ; Robinson, HH; Mattevi, A; Sobrado, P				Binda, Claudia; Robinson, Reeder M.; del Campo, Julia S. Martin; Keul, Nicholas D.; Rodriguez, Pedro J.; Robinson, Howard H.; Mattevi, Andrea; Sobrado, Pablo			An Unprecedented NADPH Domain Conformation in Lysine Monooxygenase NbtG Provides Insights into Uncoupling of Oxygen Consumption from Substrate Hydroxylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-HYDROXYLASE; PSEUDOMONAS-AERUGINOSA; PHENYLACETONE MONOOXYGENASE; CYCLOHEXANONE MONOOXYGENASE; KINETIC MECHANISM; FLAVIN; IDENTIFICATION; BIOSYNTHESIS; SELECTIVITY; PROTEINS	N-Hydroxylating monooxygenases are involved in the biosynthesis of iron-chelating hydroxamate-containing siderophores that play a role in microbial virulence. These flavoenzymes catalyze the NADPH- and oxygen-dependent hydroxylation of amines such as those found on the side chains of lysine and ornithine. In this work we report the biochemical and structural characterization of Nocardia farcinica Lys monooxygenase (NbtG), which has similar biochemical properties to mycobacterial homologs. NbtG is also active on D-Lys, although it binds L-Lys with a higher affinity. Differently from the ornithine monooxygenases PvdA, SidA, andKtzI, NbtG can use both NADH and NADPH and is highly uncoupled, producing more superoxide and hydrogen peroxide than hydroxylated Lys. The crystal structure of NbtG solved at 2.4 angstrom resolution revealed an unexpected protein conformation with a 30 degrees rotation of the NAD(P)H domain with respect to the flavin adenine dinucleotide (FAD) domain that precludes binding of the nicotinamide cofactor. This "occluded" structure may explain the biochemical properties of NbtG, specifically with regard to the substantial uncoupling and limited stabilization of the C4a-hydroperoxyflavin intermediate. Biological implications of these findings are discussed.	[Binda, Claudia; Mattevi, Andrea] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy; [Robinson, Reeder M.; del Campo, Julia S. Martin; Keul, Nicholas D.; Rodriguez, Pedro J.; Sobrado, Pablo] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Robinson, Howard H.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	University of Pavia; Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Brookhaven National Laboratory	Mattevi, A (corresponding author), Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy.	andrea.mattevi@unipv.it; psobrado@vt.edu	Mattevi, Andrea/R-4469-2019; mattevi, andrea/K-5464-2012	Mattevi, Andrea/0000-0002-9523-7128; mattevi, andrea/0000-0002-9523-7128; S. Martin del Campo, Julia/0000-0001-8914-2504; Keul, Nicholas/0000-0002-5302-006X; Binda, Claudia/0000-0003-2038-9845	BioStruct-X program [5275]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473] Funding Source: NIH RePORTER; Direct For Biological Sciences [1021384] Funding Source: National Science Foundation	BioStruct-X program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the European Synchrotron Radiation Facility (ESRF) and the Swiss Light Source (SLS) for providing beam time and assistance and the BioStruct-X program (project 5275) for funding synchrotron trips. We thank the anonymous reviewers for suggestions.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; Barona-Gomez F, 2004, J AM CHEM SOC, V126, P16282, DOI 10.1021/ja045774k; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BEATY NB, 1981, J BIOL CHEM, V256, P4619; Chocklett SW, 2010, BIOCHEMISTRY-US, V49, P6777, DOI 10.1021/bi100291n; CSAKY TZ, 1948, ACTA CHEM SCAND, V2, P450, DOI 10.3891/acta.chem.scand.02-0450; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Dhatwalia R, 2012, J AM CHEM SOC, V134, P18132, DOI 10.1021/ja308188z; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Dudek HM, 2010, APPL MICROBIOL BIOT, V88, P1135, DOI 10.1007/s00253-010-2769-y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fox Brian G, 2009, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0523s56; Franceschini S, 2012, BIOCHEMISTRY-US, V51, P7043, DOI 10.1021/bi301072w; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Heemstra JR, 2009, J AM CHEM SOC, V131, P15317, DOI 10.1021/ja9056008; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Hoshino Y, 2011, J BACTERIOL, V193, P441, DOI 10.1128/JB.00897-10; JEONG SS, 1994, ANAL BIOCHEM, V221, P273, DOI 10.1006/abio.1994.1411; Kang HY, 1996, J BACTERIOL, V178, P4877, DOI 10.1128/jb.178.16.4877-4884.1996; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Lynch D, 2001, J BACTERIOL, V183, P2576, DOI 10.1128/JB.183.8.2576-2585.2001; MACHEROUX P, 1993, EUR J BIOCHEM, V213, P995, DOI 10.1111/j.1432-1033.1993.tb17846.x; Malito E, 2004, P NATL ACAD SCI USA, V101, P13157, DOI 10.1073/pnas.0404538101; Mayfield JA, 2010, J BIOL CHEM, V285, P30375, DOI 10.1074/jbc.M110.157578; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Meneely KM, 2007, BIOCHEMISTRY-US, V46, P11930, DOI 10.1021/bi700932q; Meneely KM, 2009, BIOCHEMISTRY-US, V48, P4371, DOI 10.1021/bi900442z; Mirza IA, 2009, J AM CHEM SOC, V131, P8848, DOI 10.1021/ja9010578; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olucha J, 2011, BIOORG CHEM, V39, P171, DOI 10.1016/j.bioorg.2011.07.006; Olucha J, 2011, J BIOL CHEM, V286, P31789, DOI 10.1074/jbc.M111.265876; Orru R, 2011, J BIOL CHEM, V286, P29284, DOI 10.1074/jbc.M111.255075; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pazmino DET, 2008, BIOCHEMISTRY-US, V47, P4082, DOI 10.1021/bi702296k; Plattner H J, 1989, Biol Met, V2, P1, DOI 10.1007/BF01116193; Robinson R, 2014, BBA-PROTEINS PROTEOM, V1844, P778, DOI 10.1016/j.bbapap.2014.02.005; Robinson R, 2011, BIOCHEMISTRY-US, V50, P8489, DOI 10.1021/bi200933h; Robinson RM, 2014, ARCH BIOCHEM BIOPHYS, V550, P58, DOI 10.1016/j.abb.2014.04.006; Romero E, 2012, BBA-PROTEINS PROTEOM, V1824, P850, DOI 10.1016/j.bbapap.2012.03.004; Setser JW, 2014, BIOCHEMISTRY-US, V53, P6063, DOI 10.1021/bi500655q; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Takase H, 2000, INFECT IMMUN, V68, P1834, DOI 10.1128/IAI.68.4.1834-1839.2000; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	45	32	32	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12676	12688		10.1074/jbc.M114.629485	http://dx.doi.org/10.1074/jbc.M114.629485			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25802330	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000354569000021
J	Di, CX; Lin, XL; Zhang, YJ; Zhong, WW; Yuan, YF; Zhou, T; Liu, JL; Xia, ZW				Di, Caixia; Lin, Xiaoliang; Zhang, Yanjie; Zhong, Wenwei; Yuan, Yufan; Zhou, Tong; Liu, Junling; Xia, Zhenwei			Basophil-associated OX40 Ligand Participates in the Initiation of Th2 Responses during Airway Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELLS INDUCE; MAST-CELL; MURINE MODEL; T-CELLS; IN-VIVO; EXPRESSION; ASTHMA; IMMUNITY; DIFFERENTIATION; PROTEASES	Asthma is characterized by increased airway submucosal infiltration of T helper (Th) cells and myeloid cells that co-conspire to sustain a chronic inflammation. While recent studies have demonstrated that the myeloid basophils promote Th2 cells in response to various types of allergens, the underlying mechanisms are poorly understood. Here, we found for the first time that in a mouse model of allergic asthma basophils highly expressed OX40 ligand (OX40L) after activation. Interestingly, blockade of OX40-OX40L interaction suppressed basophils-primed Th2 cell differentiation in vitro and ameliorated ovalbumin (OVA)-induced allergic eosinophilic inflammation mediated by Th2 activation. In accordance, the adoptive transfer of basophils derived from mediastinal lymph nodes (MLN) of OVA-immunized mice triggered a robust Th2 response and eosinophilic inflammation in wild-type mice but largely muted in OX40(-/-) mice and mice receiving OX40L-blocked basophils. Taken together, our results reveal a critical role of OX40L presented by the activated basophils to initiate Th2 responses in an allergic asthma model, implicating OX40-OX40L signaling as a potential therapeutic target in the treatment of allergic airway inflammation.	[Di, Caixia; Lin, Xiaoliang; Zhang, Yanjie; Yuan, Yufan; Zhou, Tong; Xia, Zhenwei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pediat, Shanghai 200025, Peoples R China; [Zhong, Wenwei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Pediat, Shanghai 200127, Peoples R China; [Liu, Junling] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xia, ZW (corresponding author), Ruijin Hosp, Dept Pediat, Ruijin 2nd Rd 197, Shanghai 200025, Peoples R China.	xzw63@hotmail.com			National Natural Science Foundation of China [81470217, 81270084, 81070022]; Shanghai Municipal Science and Technology Commission Foundation [13XD1402800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission Foundation	This work was supported by grants from the National Natural Science Foundation of China (81470217, 81270084, and 81070022) and the Shanghai Municipal Science and Technology Commission Foundation (13XD1402800).	Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Burgess JK, 2004, J ALLERGY CLIN IMMUN, V113, P683, DOI 10.1016/j.jaci.2003.12.311; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Croft M, 2012, TRENDS IMMUNOL, V33, P144, DOI 10.1016/j.it.2011.10.004; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Gopisetty A, 2013, J IMMUNOL, V190, P5516, DOI 10.4049/jimmunol.1202298; Gramaglia I, 1998, J IMMUNOL, V161, P6510; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Hoshino A, 2003, EUR J IMMUNOL, V33, P861, DOI 10.1002/eji.200323455; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jember AGH, 2001, J EXP MED, V193, P387, DOI 10.1084/jem.193.3.387; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Kawamata S, 1998, J BIOL CHEM, V273, P5808, DOI 10.1074/jbc.273.10.5808; Kim MS, 2013, ALLERGY ASTHMA IMMUN, V5, P197, DOI 10.4168/aair.2013.5.4.197; Leyva-Castillo JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3847; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Lutzelschwab C, 1998, EUR J IMMUNOL, V28, P1022, DOI 10.1002/(SICI)1521-4141(199803)28:03<1022::AID-IMMU1022>3.0.CO;2-1; Metcalf D, 2013, P NATL ACAD SCI USA, V110, P9031, DOI 10.1073/pnas.1307711110; Morimoto S, 2000, J IMMUNOL, V164, P4097, DOI 10.4049/jimmunol.164.8.4097; Murata K, 2000, J EXP MED, V191, P365, DOI 10.1084/jem.191.2.365; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; Salek-Ardakani S, 2008, J IMMUNOL, V181, P7969, DOI 10.4049/jimmunol.181.11.7969; Siddiqui S, 2010, CHEST, V137, P797, DOI 10.1378/chest.09-1839; Siracusa MC, 2013, J ALLERGY CLIN IMMUN, V132, P789, DOI 10.1016/j.jaci.2013.07.046; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; Tanaka H, 2000, J EXP MED, V192, P405, DOI 10.1084/jem.192.3.405; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Ugajin T, 2009, J LEUKOCYTE BIOL, V86, P1417, DOI 10.1189/jlb.0609400; van Beek AA, 2013, INT ARCH ALLERGY IMM, V160, P7, DOI 10.1159/000341633; Wakahara K, 2013, ALLERGY, V68, P180, DOI 10.1111/all.12072; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0; Weinberg AD, 1999, J IMMUNOL, V162, P1818; Wynn TA, 2009, NAT IMMUNOL, V10, P679, DOI 10.1038/ni0709-679; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zhang JY, 2013, EUR J IMMUNOL, V43, P1953, DOI 10.1002/eji.201243097; Zhang YJ, 2013, J BIOL CHEM, V288, P34612, DOI 10.1074/jbc.M113.494369; Zhong WW, 2014, IMMUNOLOGY, V142, P202, DOI 10.1111/imm.12240; Zingoni A, 2004, J IMMUNOL, V173, P3716, DOI 10.4049/jimmunol.173.6.3716	46	15	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12523	12536		10.1074/jbc.M115.642637	http://dx.doi.org/10.1074/jbc.M115.642637			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25839234	hybrid, Green Published			2022-12-28	WOS:000354569000009
J	Zhang, ZX; He, F; Constantine, R; Baker, ML; Baehr, W; Schmid, MF; Wensel, TG; Agosto, MA				Zhang, Zhixian; He, Feng; Constantine, Ryan; Baker, Matthew L.; Baehr, Wolfgang; Schmid, Michael F.; Wensel, Theodore G.; Agosto, Melina A.			Domain Organization and Conformational Plasticity of the G Protein Effector, PDE6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD CGMP-PHOSPHODIESTERASE; CYCLIC-GMP PHOSPHODIESTERASE; INHIBITORY GAMMA-SUBUNIT; OUTER SEGMENT PHOSPHODIESTERASE; PHOTORECEPTOR PHOSPHODIESTERASE; CATALYTIC SUBUNITS; GAF DOMAINS; STRUCTURAL BASIS; BINDING-PROTEIN; DELTA-SUBUNIT	The cGMP phosphodiesterase of rod photoreceptor cells, PDE6, is the key effector enzyme in phototransduction. Two large catalytic subunits, PDE6 alpha and -beta, each contain one catalytic domain and two non-catalytic GAF domains, whereas two small inhibitory PDE6 gamma subunits allow tight regulation by the G protein transducin. The structure of holo-PDE6 in complex with the ROS-1 antibody Fab fragment was determined by cryoelectron microscopy. The similar to 11 angstrom map revealed previously unseen features of PDE6, and each domain was readily fit with high resolution structures. A structure of PDE6 in complex with prenyl-binding protein ( PrBP/delta) indicated the location of the PDE6 C-terminal prenylations. Reconstructions of complexes with Fab fragments bound to N or C termini of PDE6 gamma revealed that PDE6 gamma stretches from the catalytic domain at one end of the holoenzyme to the GAF-A domain at the other. Removal of PDE6 gamma caused dramatic structural rearrangements, which were reversed upon its restoration.	[Zhang, Zhixian; He, Feng; Baker, Matthew L.; Schmid, Michael F.; Wensel, Theodore G.; Agosto, Melina A.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Constantine, Ryan; Baehr, Wolfgang] Univ Utah, Dept Ophthalmol, Moran Eye Ctr, Salt Lake City, UT 84132 USA	Baylor College of Medicine; Utah System of Higher Education; University of Utah	Wensel, TG (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, One Baylor Plaza, Houston, TX 77030 USA.	twensel@bcm.edu	Regan, Clinton/E-6250-2012	Wensel, Theodore/0000-0003-3518-9352; Agosto, Melina/0000-0002-3647-1926; Schmid, Michael/0000-0003-1077-5750	National Institutes of Health [R01-EY07981, R01-EY008123, P41-GM103832, P41-RR002250]; Welch Foundation [Q-0035]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250, P41RR001081] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY007981, R01EY008123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311, P41GM103832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-EY07981 (to T. G. W.), R01-EY008123 (to W. B.), P41-GM103832, and P41-RR002250. This work was also supported by the Welch Foundation, Q-0035.	ANANT JS, 1992, J BIOL CHEM, V267, P687; ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; BAEHR W, 1979, J BIOL CHEM, V254, P1669; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; BROWN RL, 1992, BIOCHEMISTRY-US, V31, P5918, DOI 10.1021/bi00140a031; BROWN RL, 1989, P NATL ACAD SCI USA, V86, P4922, DOI 10.1073/pnas.86.13.4922; Card GL, 2004, STRUCTURE, V12, P2233, DOI 10.1016/j.str.2004.10.004; CATTY P, 1991, EUR J BIOCHEM, V199, P263, DOI 10.1111/j.1432-1033.1991.tb16119.x; CATTY P, 1992, J BIOL CHEM, V267, P19489; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Cook TA, 2000, BIOCHEMISTRY-US, V39, P13516, DOI 10.1021/bi001070l; Cote Rick H., 2005, V307, P141; DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424; Francis SH, 2001, PROG NUCLEIC ACID RE, V65, P1; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; Goc A, 2010, J MOL BIOL, V401, P363, DOI 10.1016/j.jmb.2010.06.044; Granovsky AE, 1997, J BIOL CHEM, V272, P11686, DOI 10.1074/jbc.272.18.11686; Granovsky AE, 2000, J BIOL CHEM, V275, P41258, DOI 10.1074/jbc.M008094200; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; Guo LW, 2010, J BIOL CHEM, V285, P15209, DOI 10.1074/jbc.M109.086116; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; He F, 2004, J BIOL CHEM, V279, P8986, DOI 10.1074/jbc.M311488200; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Huai Q, 2004, J BIOL CHEM, V279, P13095, DOI 10.1074/jbc.M311556200; Huang DM, 2004, J BIOL CHEM, V279, P48143, DOI 10.1074/jbc.M404338200; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; HURWITZ RL, 1984, J BIOL CHEM, V259, P8612; HURWITZ RL, 1984, ADV CYCLIC NUCL PROT, V17, P239; Jiang W, 2001, J MOL BIOL, V308, P1033, DOI 10.1006/jmbi.2001.4633; Kajimura N, 2002, J STRUCT BIOL, V139, P27, DOI 10.1016/S1047-8477(02)00502-6; Kolandaivelu S, 2009, J BIOL CHEM, V284, P30853, DOI 10.1074/jbc.M109.036780; LEE RH, 1985, INVEST OPHTH VIS SCI, V26, P1569; LIEBMAN PA, 1982, VISION RES, V22, P1475, DOI 10.1016/0042-6989(82)90212-7; LIPKIN VM, 1988, FEBS LETT, V234, P287, DOI 10.1016/0014-5793(88)80100-5; Litman BJ, 2001, J MOL NEUROSCI, V16, P237, DOI 10.1385/JMN:16:2-3:237; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MALINSKI JA, 1992, BIOCHEMISTRY-US, V31, P9502, DOI 10.1021/bi00154a024; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Martinez SE, 2008, J BIOL CHEM, V283, P25913, DOI 10.1074/jbc.M802891200; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Melia TJ, 2000, J BIOL CHEM, V275, P3535, DOI 10.1074/jbc.275.5.3535; MILLER JL, 1987, BIOCHIM BIOPHYS ACTA, V898, P81, DOI 10.1016/0005-2736(87)90111-8; Mitchell DC, 2003, J PEDIATR-US, V143, pS80, DOI 10.1067/S0022-3476(03)00405-0; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov KG, 2002, BIOCHEMISTRY-US, V41, P3884, DOI 10.1021/bi015935m; Norton AW, 2000, J BIOL CHEM, V275, P38611, DOI 10.1074/jbc.M004606200; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Schmid MF, 2008, J STRUCT BIOL, V161, P243, DOI 10.1016/j.jsb.2007.09.018; SITARAMAYYA A, 1986, BIOCHEMISTRY-US, V25, P651, DOI 10.1021/bi00351a021; SKIBA NP, 1995, J BIOL CHEM, V270, P13210, DOI 10.1074/jbc.270.22.13210; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; Trakhanov S, 1999, ACTA CRYSTALLOGR D, V55, P122, DOI 10.1107/S090744499800938X; Walz J, 1997, J STRUCT BIOL, V120, P387, DOI 10.1006/jsbi.1997.3934; WENSEL T G, 1986, Proteins Structure Function and Genetics, V1, P90, DOI 10.1002/prot.340010114; Wensel Theodore G., 2005, V307, P289; Yamazaki M, 2002, J BIOL CHEM, V277, P40675, DOI 10.1074/jbc.M203469200; Zeng-Elmore X, 2014, J MOL BIOL, V426, P3713, DOI 10.1016/j.jmb.2014.07.033; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200; Zhang KYJ, 2004, MOL CELL, V15, P279, DOI 10.1016/j.molcel.2004.07.005; Zhang XJ, 2010, J BIOL CHEM, V285, P4455, DOI 10.1074/jbc.M109.057406	64	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12833	12843		10.1074/jbc.M115.647636	http://dx.doi.org/10.1074/jbc.M115.647636			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25809480	hybrid, Green Published			2022-12-28	WOS:000354569000034
J	Gupta, N; Madapura, MP; Bhat, UA; Rao, MRS				Gupta, Nikhil; Madapura, M. Pradeepa; Bhat, U. Anayat; Rao, M. R. Satyanarayana			Mapping of Post-translational Modifications of Transition Proteins, TP1 and TP2, and Identification of Protein Arginine Methyltransferase 4 and Lysine Methyltransferase 7 as Methyltransferase for TP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin remodeling; epigenetics; mass spectrometry (MS); post-translational modification (PTM); protein methylation	EPIGENETIC INHERITANCE; ZINC-METALLOPROTEIN; NUCLEAR PROTEINS; MAMMALIAN SPERM; DNA-REPAIR; KINASE-A; METHYLATION; CHROMATIN; HISTONE; PHOSPHORYLATION	Background: Transition proteins replace 90% of the nucleosomal histones during nucleo-histone to nucleo-protamine chromatin reconfiguration in mammalian spermiogenesis. Results: Major transition proteins, TP1 and TP2, harbor several post-translational modifications. TP2 is methylated by PRMT4 and KMT7 methyltransferase. Conclusion: Endogenous transition proteins, TP1 and TP2, exhibit extensive post-translational modifications. Significance: This work provides insight into the chromatin remodeling events during spermiogenesis and establishment of the sperm epigenome. In a unique global chromatin remodeling process during mammalian spermiogenesis, 90% of the nucleosomal histones are replaced by testis-specific transition proteins, TP1, TP2, and TP4. These proteins are further substituted by sperm-specific protamines, P1 and P2, to form a highly condensed sperm chromatin. In spermatozoa, a small proportion of chromatin, which ranges from 1 to 10% in mammals, retains the nucleosomal architecture and is implicated to play a role in transgenerational inheritance. However, there is still no mechanistic understanding of the interaction of chromatin machinery with histones and transition proteins, which facilitate this selective histone replacement from chromatin. Here, we report the identification of 16 and 19 novel post-translational modifications on rat endogenous transition proteins, TP1 and TP2, respectively, by mass spectrometry. By in vitro assays and mutational analysis, we demonstrate that protein arginine methyltransferase PRMT4 (CARM1) methylates TP2 at Arg(71), Arg(75), and Arg(92) residues, and lysine methyltransferase KMT7 (Set9) methylates TP2 at Lys(88) and Lys(91) residues. Further studies with modification-specific antibodies that recognize TP2K88me1 and TP2R92me1 modifications showed that they appear in elongating to condensing spermatids and predominantly associated with the chromatin-bound TP2. This work establishes the repertoire of post-translational modifications that occur on TP1 and TP2, which may play a significant role in various chromatin-templated events during spermiogenesis and in the establishment of the sperm epigenome.	[Gupta, Nikhil; Madapura, M. Pradeepa; Bhat, U. Anayat; Rao, M. R. Satyanarayana] Jawaharlal Nehru Ctr Adv Sci Res, Chromatin Biol Lab, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Rao, MRS (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Chromatin Biol Lab, Mol Biol & Genet Unit, Jakkur PO, Bangalore 560064, Karnataka, India.	mrsrao@jncasr.ac.in		Bhat, Anayat/0000-0002-8906-6924	Department of Biotechnology, India; Council of Scientific and Industrial Research, India; Department of Science and Technology	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India))	This work was supported by the Department of Biotechnology, India.; Supported by a Council of Scientific and Industrial Research, India, senior research fellowship.; Supported by Department of Science and Technology, J. C. Bose and S. E. R. B. Distinguished Fellowships. To whom correspondence should be addressed. Tel.: 91-80-2208-2864; Fax: 91-80-2208-2758; E-mail: mrsrao@jncasr.ac.in.	Akama K, 1999, FEBS LETT, V442, P189, DOI 10.1016/S0014-5793(98)01649-4; Balhorn R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-227; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; BASKARAN R, 1990, J BIOL CHEM, V265, P21039; BASKARAN R, 1991, BIOCHEM BIOPH RES CO, V179, P1491, DOI 10.1016/0006-291X(91)91741-T; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Braun RE, 2001, NAT GENET, V28, P10, DOI 10.1038/88194; Brewer L, 2002, J BIOL CHEM, V277, P38895, DOI 10.1074/jbc.M204755200; Brunner AM, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-2; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Caron C, 2003, EMBO REP, V4, P877, DOI 10.1038/sj.embor.embor917; Caron N, 2001, MOL REPROD DEV, V58, P437, DOI 10.1002/1098-2795(20010401)58:4&lt;437::AID-MRD12&gt;3.0.CO;2-Q; Carone BR, 2014, DEV CELL, V30, P11, DOI 10.1016/j.devcel.2014.05.024; Carrell DT, 2012, FERTIL STERIL, V97, P267, DOI 10.1016/j.fertnstert.2011.12.036; Chesneau V, 1996, J CELL SCI, V109, P2737; Cook JR, 2006, BIOCHEM BIOPH RES CO, V342, P472, DOI 10.1016/j.bbrc.2006.01.167; Del Rizzo PA, 2011, EPIGENETICS-US, V6, P1059, DOI 10.4161/epi.6.9.16069; Dhar S, 2012, J BIOL CHEM, V287, P6387, DOI 10.1074/jbc.M111.288167; Dhayalan A, 2011, CHEM BIOL, V18, P111, DOI 10.1016/j.chembiol.2010.11.014; Erkek S, 2013, NAT STRUCT MOL BIOL, V20, P868, DOI 10.1038/nsmb.2599; Escamilla-Del-Arenal M, 2013, MOL CELL BIOL, V33, P5005, DOI 10.1128/MCB.00866-13; Foster HA, 2005, J CELL SCI, V118, P1811, DOI 10.1242/jcs.02301; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Gardiner-Garden M, 1998, MOL CELL BIOL, V18, P3350, DOI 10.1128/MCB.18.6.3350; Gaucher J, 2012, EMBO J, V31, P3809, DOI 10.1038/emboj.2012.233; Gaucher J, 2010, FEBS J, V277, P599, DOI 10.1111/j.1742-4658.2009.07504.x; Govin J, 2006, J BIOL CHEM, V281, P37888, DOI 10.1074/jbc.M608147200; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Kiani J, 2013, CELL RES, V23, P18, DOI 10.1038/cr.2012.181; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kolthur-Seetharam U, 2009, J HISTOCHEM CYTOCHEM, V57, P951, DOI 10.1369/jhc.2009.953414; KUNDU TK, 1994, FEBS LETT, V351, P6, DOI 10.1016/0014-5793(94)00799-3; KUNDU TK, 1995, BIOCHEMISTRY-US, V34, P5143, DOI 10.1021/bi00015a027; Lane M, 2014, SCIENCE, V345, P756, DOI 10.1126/science.1254400; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Levesque D, 1998, BIOCHEM BIOPH RES CO, V252, P602, DOI 10.1006/bbrc.1998.9687; Li J, 2012, J BIOL CHEM, V287, P10089, DOI 10.1074/jbc.M111.313965; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; Martins RP, 2004, J BIOL CHEM, V279, P51862, DOI 10.1074/jbc.M409415200; Meetei AR, 1996, PROTEIN EXPRES PURIF, V8, P409, DOI 10.1006/prep.1996.0118; Meetei AR, 1998, PROTEIN EXPRES PURIF, V13, P184, DOI 10.1006/prep.1998.0887; Meetei AR, 2000, J BIOL CHEM, V275, P38500, DOI 10.1074/jbc.M002734200; Meetei AR, 2002, BIOCHEMISTRY-US, V41, P185, DOI 10.1021/bi0117652; Meistrich ML, 2003, CHROMOSOMA, V111, P483, DOI 10.1007/s00412-002-0227-z; Mylonis I, 2004, J BIOL CHEM, V279, P11626, DOI 10.1074/jbc.M311949200; Niemitz EL, 2004, AM J HUM GENET, V74, P599, DOI 10.1086/382897; Ohkura N, 2005, J BIOL CHEM, V280, P28927, DOI 10.1074/jbc.M502173200; PEROSA F, 1990, J IMMUNOL METHODS, V128, P9, DOI 10.1016/0022-1759(90)90458-8; Pradeepa MM, 2008, MOL CELL BIOL, V28, P4331, DOI 10.1128/MCB.00519-07; Pradeepa M M, 2007, Soc Reprod Fertil Suppl, V63, P1; Pradeepa MM, 2009, J BIOL CHEM, V284, P29956, DOI 10.1074/jbc.M109.052043; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020; Rathke C, 2007, J CELL SCI, V120, P1689, DOI 10.1242/jcs.004663; Rathke C, 2014, BBA-GENE REGUL MECH, V1839, P155, DOI 10.1016/j.bbagrm.2013.08.004; Samans B, 2014, DEV CELL, V30, P23, DOI 10.1016/j.devcel.2014.05.023; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Sendler E, 2013, NUCLEIC ACIDS RES, V41, P4104, DOI 10.1093/nar/gkt132; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shirley CR, 2004, BIOL REPROD, V71, P1220, DOI 10.1095/biolreprod.104.029363; SINGH J, 1987, J BIOL CHEM, V262, P734; Siomi MC, 2010, GENE DEV, V24, P636, DOI 10.1101/gad.1899210; Soubry A, 2014, BIOESSAYS, V36, P359, DOI 10.1002/bies.201300113; Swanson WJ, 2002, ANNU REV ECOL SYST, V33, P161, DOI 10.1146/annurev.ecolsys.33.010802.150439; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ullas KS, 2003, J BIOL CHEM, V278, P52673, DOI 10.1074/jbc.M308365200; Vicens A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091302; Waterborg J. H., 2002, PROTEIN PROTOCOLS HD, P113; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100	81	19	19	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12101	12122		10.1074/jbc.M114.620443	http://dx.doi.org/10.1074/jbc.M114.620443			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25818198	hybrid, Green Published			2022-12-28	WOS:000354388600025
J	Liu, L; Leung, LH; Cooney, AJ; Chen, CY; Rosengare, TK; Ma, YP; Yang, JC				Liu, Liang; Leung, Lai-Han; Cooney, Austin J.; Chen, Changyi; Rosengare, Todd K.; Ma, Yupo; Yang, Jianchang			Knockdown of SALL4 Protein Enhances All-trans Retinoic Acid-induced Cellular Differentiation in Acute Myeloid Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; STEM/PROGENITOR CELLS; GENE SALL4; RAR-ALPHA; TRANSCRIPTION; TARGET; IDENTIFICATION; ACCUMULATION; RECRUITMENT; INHIBITION	All-trans retinoic acid (ATRA) is a differentiation agent that revolutionized the treatment of acute promyelocytic leukemia. However, it has not been useful for other types of acute myeloid leukemia (AML). Here we explored the effect of SALL4, a stem cell factor, on ATRA-induced AML differentiation in both ATRA-sensitive and ATRA-resistant AML cells. Aberrant SALL4 expression has been found in nearly all human AML cases, whereas, in normal bone marrow and peripheral blood cells, its expression is only restricted to hematopoietic stem/progenitor cells. We reason that, in AMLs, SALL4 activation may prevent cell differentiation and/or protect self-renewal that is seen in normal hematopoietic stem/progenitor cells. Indeed, our studies show that ATRA-mediated myeloid differentiation can be largely blocked by exogenous expression of SALL4, whereas ATRA plus SALL4 knockdown causes significantly increased AML differentiation and cell death. Mechanistic studies indicate that SALL4 directly associates with retinoic acid receptor alpha and modulates ATRA target gene expression. SALL4 is shown to recruit lysine-specific histone demethylase 1 (LSD1) to target genes and alter the histone methylation status. Furthermore, coinhibition of LSD1 and SALL4 plus ATRA treatment exhibited the strongest anti-AML effect. These findings suggest that SALL4 plays an unfavorable role in ATRA-based regimes, highlighting an important aspect of leukemia therapy.	[Liu, Liang; Yang, Jianchang] SUNY Stony Brook, Dept Surg, Stony Brook, NY 11794 USA; [Ma, Yupo; Yang, Jianchang] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Leung, Lai-Han; Cooney, Austin J.] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, Macau 519020, Peoples R China; [Cooney, Austin J.; Chen, Changyi; Rosengare, Todd K.] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Macau University of Science & Technology; Baylor College of Medicine	Yang, JC (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.	jianchang.yang@bcm.edu			American Cancer Society [RSG-12-216-01-LIB]; New York State Stem Cell Science [C0281148, C026716]	American Cancer Society(American Cancer Society); New York State Stem Cell Science	This work was supported by American Cancer Society Research Scholar Grant RSG-12-216-01-LIB (to J. Y.) and New York State Stem Cell Science Grants C0281148 (to Y. M.) and C026716 (to the Stony Brook Stem Cell Center).	Aguila JR, 2011, BLOOD, V118, P576, DOI 10.1182/blood-2011-01-333641; Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Brown G., 2012, LEUK RES TREATMENT; Glasow A, 2005, BLOOD, V105, P341, DOI 10.1182/blood-2004-03-1074; Jeong HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018372; Jones JE, 2009, LEUKEMIA, V23, P1933, DOI 10.1038/leu.2009.118; Klein ES, 2000, J BIOL CHEM, V275, P19401, DOI 10.1074/jbc.M002472200; Kohlhase J, 1996, GENOMICS, V38, P291, DOI 10.1006/geno.1996.0631; Launay S, 2003, BLOOD, V101, P3220, DOI 10.1182/blood-2002-09-2730; Lee SW, 2010, J BIOL CHEM, V285, P18, DOI 10.1074/jbc.M109.065862; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Liu L, 2013, J BIOL CHEM, V288, P34719, DOI 10.1074/jbc.M113.506568; Lubbert M., 2014, CANCER, V121, P498; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Nigten J, 2005, LEUKEMIA, V19, P799, DOI 10.1038/sj.leu.2403699; Oikawa T, 2009, GASTROENTEROLOGY, V136, P1000, DOI 10.1053/j.gastro.2008.11.018; Ozpolat B, 2003, J PHARM PHARM SCI, V6, P292; Sakamoto K, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.25; Savory JGA, 2014, DEV BIOL, V395, P199, DOI 10.1016/j.ydbio.2014.09.013; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Stegmaier K, 2005, BLOOD, V106, P2841, DOI 10.1182/blood-2005-02-0488; Uribesalgo I, 2011, NAT CELL BIOL, V13, P1443, DOI 10.1038/ncb2355; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Yang JC, 2012, CURR OPIN HEMATOL, V19, P287, DOI 10.1097/MOH.0b013e328353c684; Yang JC, 2012, J BIOL CHEM, V287, P1996, DOI 10.1074/jbc.M111.308734; Yang JC, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-38; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Zeng SS, 2014, J HEPATOL, V60, P127, DOI 10.1016/j.jhep.2013.08.024; Zhang X, 2015, CANCER LETT, V357, P55, DOI 10.1016/j.canlet.2014.11.037	31	9	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10599	10609		10.1074/jbc.M114.634790	http://dx.doi.org/10.1074/jbc.M114.634790			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25737450	Green Published, hybrid			2022-12-28	WOS:000353404500003
J	Morante, K; Caaveiro, JMM; Tanaka, K; Gonzalez-Manas, JM; Tsumoto, K				Morante, Koldo; Caaveiro, Jose M. M.; Tanaka, Koji; Manuel Gonzalez-Manas, Juan; Tsumoto, Kouhei			A Pore-Forming Toxin Requires a Specific Residue for Its Activity in Membranes with Particular Physicochemical Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANEMONE ACTINIA-EQUINA; DETERGENT-RESISTANT MEMBRANES; LIPID PHASE COEXISTENCE; AMINO-ACID-SEQUENCE; SEA-ANEMONE; STICHOLYSIN-II; STICHODACTYLA-HELIANTHUS; PERFRINGOLYSIN-O; MODEL MEMBRANES; FUNCTIONAL EXPRESSION	The physicochemical landscape of the bilayer modulates membrane protein function. Actinoporins are a family of potent hemolytic proteins from sea anemones acting at the membrane level. This family of cytolysins preferentially binds to target membranes containing sphingomyelin, where they form lytic pores giving rise to cell death. Although the cytolytic activity of the actinoporin fragaceatoxin C (FraC) is sensitive to vesicles made of various lipid compositions, it is far from clear how this toxin adjusts its mechanism of action to a broad range of physiochemical landscapes. Herein, we show that the conserved residue Phe-16 of FraC is critical for pore formation in cholesterol-rich membranes such as those of red blood cells. The interaction of a panel of muteins of Phe-16 with model membranes composed of raft-like lipid domains is inactivated in cholesterol-rich membranes but not in cholesterol-depleted membranes. These results indicate that actinoporins recognize different membrane environments, resulting in a wider repertoire of susceptible target membranes (and preys) for sea anemones. In addition, this study has unveiled promising candidates for the development of protein-based biosensors highly sensitive to the concentration of cholesterol within the membrane.	[Morante, Koldo; Caaveiro, Jose M. M.; Tsumoto, Kouhei] Univ Tokyo, Dept Bioengn, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Tanaka, Koji; Tsumoto, Kouhei] Univ Tokyo, Dept Chem & Biotechnol, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Morante, Koldo; Manuel Gonzalez-Manas, Juan] Univ Basque Country, Dept Biochem & Mol Biol, Leioa 48940, Spain; [Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; University of Tokyo; University of Basque Country; University of Tokyo	Caaveiro, JMM (corresponding author), Univ Tokyo, Dept Bioengn, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan.	jose@bioeng.t.u-tokyo.ac.jp; tsumoto@bioeng.t.u-tokyo.ac.jp	Caaveiro, Jose/J-2790-2013	Caaveiro, Jose/0000-0001-5568-2369; GONZALEZ MANAS, JUAN MANUEL/0000-0002-1833-6982; Morante, Koldo/0000-0002-9877-9168	Funding Program for World-Leading Innovative R&D on Science and Technology of the Japan Society for the Promotion of Science; Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Spanish Ministerio de Ciencia e Innovacion; Grants-in-Aid for Scientific Research [14J07513] Funding Source: KAKEN	Funding Program for World-Leading Innovative R&D on Science and Technology of the Japan Society for the Promotion of Science; Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Funding Program for World-Leading Innovative R&D on Science and Technology of the Japan Society for the Promotion of Science and by the Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology of Japan.; Recipient of a fellowship from the Spanish Ministerio de Ciencia e Innovacion.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Alegre-Cebollada J, 2006, FEBS J, V273, P863, DOI 10.1111/j.1742-4658.2006.05122.x; Alegre-Cebollada J, 2008, J MOL BIOL, V382, P920, DOI 10.1016/j.jmb.2008.07.053; Alm I, 2015, BBA-BIOMEMBRANES, V1848, P925, DOI 10.1016/j.bbamem.2014.12.017; Alouf JE, 2003, FOLIA MICROBIOL, V48, P5, DOI 10.1007/BF02931271; Anderluh G, 1999, TOXICON, V37, P1391, DOI 10.1016/S0041-0101(99)00082-3; Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5; Baker MAB, 2014, CHEMBIOCHEM, V15, P2139, DOI 10.1002/cbic.201300799; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Barlic A, 2004, J BIOL CHEM, V279, P34209, DOI 10.1074/jbc.M313817200; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bellomio A, 2009, TOXICON, V54, P869, DOI 10.1016/j.toxicon.2009.06.022; BELMONTE G, 1994, BBA-BIOMEMBRANES, V1192, P197, DOI 10.1016/0005-2736(94)90119-8; Bhat HB, 2013, J LIPID RES, V54, P2933, DOI 10.1194/jlr.D041731; Blank N, 2007, IMMUNOL CELL BIOL, V85, P378, DOI 10.1038/sj.icb.7100045; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Caaveiro JMM, 2001, BIOPHYS J, V80, P1343, DOI 10.1016/S0006-3495(01)76107-3; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; De los Rios V, 1998, EUR J BIOCHEM, V252, P284, DOI 10.1046/j.1432-1327.1998.2520284.x; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FORTI S, 1989, EUR J BIOCHEM, V181, P767, DOI 10.1111/j.1432-1033.1989.tb14790.x; Garcia-Ortega L, 2011, BBA-BIOMEMBRANES, V1808, P2275, DOI 10.1016/j.bbamem.2011.05.012; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Goni FM, 2014, BBA-BIOMEMBRANES, V1838, P1467, DOI 10.1016/j.bbamem.2014.01.006; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; HANADA K, 1995, J BIOL CHEM, V270, P6254, DOI 10.1074/jbc.270.11.6254; Huerta V, 2001, TOXICON, V39, P1253, DOI 10.1016/S0041-0101(00)00247-6; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; Il'ina A, 2006, TOXICON, V47, P517, DOI 10.1016/j.toxicon.2005.12.014; Jiang XY, 2003, BIOCHEM BIOPH RES CO, V312, P562, DOI 10.1016/j.bbrc.2003.10.159; Kristan K, 2004, J BIOL CHEM, V279, P46509, DOI 10.1074/jbc.M406193200; Lin QQ, 2014, J BIOL CHEM, V289, P5467, DOI 10.1074/jbc.M113.533943; Litman BJ, 1996, LIPIDS, V31, pS193, DOI 10.1007/BF02637075; Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019; Maula T, 2013, BBA-BIOMEMBRANES, V1828, P1390, DOI 10.1016/j.bbamem.2013.01.018; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mechaly AE, 2012, J STRUCT BIOL, V180, P312, DOI 10.1016/j.jsb.2012.06.003; Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013; MICHAEL SF, 1994, BIOTECHNIQUES, V16, P410; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagai H, 2002, BIOSCI BIOTECH BIOCH, V66, P2621, DOI 10.1271/bbb.66.2621; Nelson LD, 2010, BIOPHYS J, V99, P3255, DOI 10.1016/j.bpj.2010.09.028; Ohno-Iwashita Y, 2004, ANAEROBE, V10, P125, DOI 10.1016/j.anaerobe.2003.09.003; Oscarsson J, 1999, MOL MICROBIOL, V32, P1226, DOI 10.1046/j.1365-2958.1999.01435.x; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Pedrera L, 2014, BBA-BIOMEMBRANES, V1838, P1752, DOI 10.1016/j.bbamem.2014.03.011; Pontani LL, 2009, BIOPHYS J, V96, P192, DOI 10.1016/j.bpj.2008.09.029; Pungercar J, 1997, BBA-PROTEIN STRUCT M, V1341, P105, DOI 10.1016/S0167-4838(97)00083-6; Ray S, 2012, J BIOL CHEM, V287, P30395, DOI 10.1074/jbc.M112.385575; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; Saha N, 1997, J BIOL CHEM, V272, P162, DOI 10.1074/jbc.272.1.162; Schon P, 2008, BIOPHYS J, V95, P691, DOI 10.1529/biophysj.108.129981; SCHWARZ G, 1992, BIOCHIM BIOPHYS ACTA, V1110, P97, DOI 10.1016/0005-2736(92)90299-2; Shogomori H, 2005, J BIOL CHEM, V280, P18931, DOI 10.1074/jbc.M500247200; SIMPSON RJ, 1990, EUR J BIOCHEM, V190, P319, DOI 10.1111/j.1432-1033.1990.tb15579.x; Skocaj M, 2013, CURR MED CHEM, V20, P491; Tanaka K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7337; Tanford C., 1980, HYDROPHOBIC EFFECT F, V2; Tejuca M, 2004, INT IMMUNOPHARMACOL, V4, P731, DOI 10.1016/j.intimp.2004.02.010; Tejuca M, 1996, BIOCHEMISTRY-US, V35, P14947, DOI 10.1021/bi960787z; Tziakas DN, 2011, INT J CARDIOL, V150, P22, DOI 10.1016/j.ijcard.2010.02.022; Uechi GI, 2005, TOXICON, V45, P761, DOI 10.1016/j.toxicon.2005.01.015; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Uitert I, 2010, SOFT MATTER, V6, P4420, DOI 10.1039/c0sm00181c; Wang YW, 2000, BBA-PROTEIN STRUCT M, V1478, P9, DOI 10.1016/S0167-4838(99)00289-7; Wong E. V., 2009, CELLS MOL MECH; Yasuda T, 2014, BIOPHYS J, V106, P631, DOI 10.1016/j.bpj.2013.12.034; Zitzer A, 1999, J BIOL CHEM, V274, P1375, DOI 10.1074/jbc.274.3.1375	74	28	30	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10850	10861		10.1074/jbc.M114.615211	http://dx.doi.org/10.1074/jbc.M114.615211			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25759390	hybrid, Green Published			2022-12-28	WOS:000353404500025
J	Batchu, KC; Hokynar, K; Jeltsch, M; Mattonet, K; Somerharju, P				Batchu, Krishna Chaithanya; Hokynar, Kati; Jeltsch, Michael; Mattonet, Kenny; Somerharju, Pentti			Substrate Efflux Propensity Is the Key Determinant of Ca2+-independent Phospholipase A-beta (iPLA beta)-mediated Glycerophospholipid Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Homeostasis; Mass Spectrometry (MS); Membrane; Membrane Bilayer; Phospholipase A	EXCHANGE MASS-SPECTROMETRY; NEUROPATHY TARGET ESTERASE; CDP-ETHANOLAMINE PATHWAY; HAMSTER OVARY CELLS; HYDROGEN/DEUTERIUM EXCHANGE; MEMBRANE-LIPIDS; PHOSPHATIDYLCHOLINE METABOLISM; PLASMA-MEMBRANE; A(2) ACTIVITY; PHOSPHATIDYLSERINE	The A-type phospholipases (PLAs) are key players in glycerophospholipid (GPL) homeostasis and in mammalian cells; Ca2+-independent PLA- (iPLA) in particular has been implicated in this essential process. However, the regulation of this enzyme, which is necessary to avoid futile competition between synthesis and degradation, is not understood. Recently, we provided evidence that the efflux of the substrate molecules from the bilayer is the rate-limiting step in the hydrolysis of GPLs by some secretory (nonhomeostatic) PLAs. To study whether this is the case with iPLA as well, a mass spectrometric assay was employed to determine the rate of hydrolysis of multiple saturated and unsaturated GPL species in parallel using micelles or vesicle bilayers as the macrosubstrate. With micelles, the hydrolysis decreased with increasing acyl chain length independent of unsaturation, and modest discrimination between acyl positional isomers was observed, presumably due to the differences in the structure of the sn-1 and sn-2 acyl-binding sites of the protein. In striking contrast, no significant discrimination between positional isomers was observed with bilayers, and the rate of hydrolysis decreased with the acyl chain length logarithmically and far more than with micelles. These data provide compelling evidence that efflux of the substrate molecule from the bilayer, which also decreases monotonously with acyl chain length, is the rate-determining step in iPLA-mediated hydrolysis of GPLs in membranes. This finding is intriguing as it may help to understand how homeostatic PLAs are regulated and how degradation and biosynthesis are coordinated.	[Batchu, Krishna Chaithanya; Hokynar, Kati; Somerharju, Pentti] Univ Helsinki, Dept Biochem & Dev Biol, Fac Med, FIN-00014 Helsinki, Finland; [Jeltsch, Michael; Mattonet, Kenny] Univ Helsinki, Fac Med, Dept Biomed, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Somerharju, P (corresponding author), Univ Helsinki, Dept Biochem & Dev Biol, Fac Med, Haartmaninkatu 8,PL 63, FIN-00014 Helsinki, Finland.	pentti.somerharju@helsinki.fi	Jeltsch, Michael/I-5340-2012; Mattonet, Kenny/M-7194-2014	Jeltsch, Michael/0000-0003-2890-7790; Mattonet, Kenny/0000-0002-9705-8086	Finnish Academy; Sigrid Juselius Foundation; Magnus Ehnrooth Foundation	Finnish Academy(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Magnus Ehnrooth Foundation	This work was supported by research grants from Finnish Academy, Sigrid Juselius Foundation, and Magnus Ehnrooth Foundation (to P. S.).	ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Barbour SE, 1999, BBA-MOL CELL BIOL L, V1439, P77, DOI 10.1016/S1388-1981(99)00078-5; BARTLETT EM, 1970, ANAL BIOCHEM, V36, P159, DOI 10.1016/0003-2697(70)90343-X; BAYBURT T, 1993, BIOCHEMISTRY-US, V32, P573, DOI 10.1021/bi00053a024; Ben-Tekaya H, 2010, MOL BIOL CELL, V21, P4130, DOI 10.1091/mbc.E10-01-0022; Bucher D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003156; BURACK WR, 1994, CHEM PHYS LIPIDS, V73, P209, DOI 10.1016/0009-3084(94)90182-1; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Cao J, 2013, J BIOL CHEM, V288, P1806, DOI 10.1074/jbc.R112.421909; Chiu CH, 2001, BIOCHEM BIOPH RES CO, V287, P600, DOI 10.1006/bbrc.2001.5632; Chong PLG, 2009, BBA-BIOMEMBRANES, V1788, P2, DOI 10.1016/j.bbamem.2008.10.010; Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Fazekas de St Groth S., 1963, BIOCHIM BIOPHYS ACTA, V71, P377; FOLCH J, 1957, J BIOL CHEM, V226, P497; GABRIEL NE, 1987, BIOCHEMISTRY-US, V26, P7409, DOI 10.1021/bi00397a032; GARDAM MA, 1989, BIOCHEMISTRY-US, V28, P884, DOI 10.1021/bi00428a072; Gelb MH, 2000, BBA-MOL CELL BIOL L, V1488, P20, DOI 10.1016/S1388-1981(00)00106-2; GELB MH, 1995, ANNU REV BIOCHEM, V64, P653; Ghomashchi F, 2010, J BIOL CHEM, V285, P36100, DOI 10.1074/jbc.M110.165647; Glynn P, 2005, BBA-MOL CELL BIOL L, V1736, P87, DOI 10.1016/j.bbalip.2005.08.002; Haimi P, 2010, J BIOL CHEM, V285, P751, DOI 10.1074/jbc.M109.061218; Haimi P, 2006, ANAL CHEM, V78, P8324, DOI 10.1021/ac061390w; Heikinheimo L, 2002, TRAFFIC, V3, P367, DOI 10.1034/j.1600-0854.2002.30506.x; Hermansson M, 2005, ANAL CHEM, V77, P2166, DOI 10.1021/ac048489s; Hermansson M, 2011, PROG LIPID RES, V50, P240, DOI 10.1016/j.plipres.2011.02.004; Hsu YH, 2013, J AM CHEM SOC, V135, P1330, DOI 10.1021/ja306490g; Hsu YH, 2009, J BIOL CHEM, V284, P23652, DOI 10.1074/jbc.M109.021857; Huang HW, 1996, BIOCHEM BIOPH RES CO, V220, P834, DOI 10.1006/bbrc.1996.0490; IMAI A, 1987, J BIOL CHEM, V262, P6457; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; JONES JD, 1990, BIOCHEMISTRY-US, V29, P1593, DOI 10.1021/bi00458a034; Kainu V, 2008, J BIOL CHEM, V283, P3676, DOI 10.1074/jbc.M709176200; Kuge O, 1998, P NATL ACAD SCI USA, V95, P4199, DOI 10.1073/pnas.95.8.4199; Kuge O, 1999, J BIOL CHEM, V274, P23844, DOI 10.1074/jbc.274.34.23844; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lange Y, 2008, PROG LIPID RES, V47, P319, DOI 10.1016/j.plipres.2008.03.001; Lin QS, 2000, BIOCHEMISTRY-US, V39, P9335, DOI 10.1021/bi000017u; Lio YC, 1998, BBA-LIPID LIPID MET, V1392, P320, DOI 10.1016/S0005-2760(98)00049-6; Liu F, 1999, BIOCHEMISTRY-US, V38, P3867, DOI 10.1021/bi982693q; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lykidis A, 2001, J BIOL CHEM, V276, P2174, DOI 10.1074/jbc.M008794200; MacCallum JL, 2006, J AM CHEM SOC, V128, P125, DOI 10.1021/ja0535099; Manguikian AD, 2004, J BIOL CHEM, V279, P52881, DOI 10.1074/jbc.M410659200; MASSEY JB, 1985, BIOCHIM BIOPHYS ACTA, V835, P124, DOI 10.1016/0005-2760(85)90038-4; Murakami M, 2005, J BIOL CHEM, V280, P14028, DOI 10.1074/jbc.M413766200; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; NICHOLS JW, 1988, BIOCHEMISTRY-US, V27, P3925, DOI 10.1021/bi00411a006; NISHIJIMA M, 1984, J BIOL CHEM, V259, P7101; OPDENKAMP JAF, 1975, BIOCHIM BIOPHYS ACTA, V406, P169, DOI 10.1016/0005-2736(75)90001-2; PATEL KM, 1979, J LIPID RES, V20, P674; PETE MJ, 1995, BBA-LIPID LIPID MET, V1256, P367, DOI 10.1016/0005-2760(95)00047-G; PLESNIAK LA, 1995, BIOCHEMISTRY-US, V34, P4943, DOI 10.1021/bi00015a005; POLOKOFF MA, 1981, J BIOL CHEM, V256, P7687; ROBINSON M, 1983, J BIOL CHEM, V258, P4371; SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788; SILVIUS JR, 1993, BIOCHEMISTRY-US, V32, P13318, DOI 10.1021/bi00211a045; Somerharju P, 2009, BBA-BIOMEMBRANES, V1788, P12, DOI 10.1016/j.bbamem.2008.10.004; Stone SJ, 1998, J BIOL CHEM, V273, P7293, DOI 10.1074/jbc.273.13.7293; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; THUREN T, 1990, BIOCHIM BIOPHYS ACTA, V1046, P178, DOI 10.1016/0005-2760(90)90186-2; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Vance DE, 2009, J LIPID RES, V50, pS132, DOI 10.1194/jlr.R800048-JLR200; WALKEY CJ, 1994, J BIOL CHEM, V269, P5742; Wenk MR, 1997, BIOPHYS J, V72, P1719, DOI 10.1016/S0006-3495(97)78818-0; WINKLER H, 1967, BIOCHEM J, V105, pC38, DOI 10.1042/bj1050038C; Wolf MJ, 1996, J BIOL CHEM, V271, P30879, DOI 10.1074/jbc.271.48.30879; Yang HC, 1999, J NEUROCHEM, V73, P1278, DOI 10.1046/j.1471-4159.1999.0731278.x	72	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10093	10103		10.1074/jbc.M115.642835	http://dx.doi.org/10.1074/jbc.M115.642835			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25713085	hybrid, Green Published			2022-12-28	WOS:000353241100016
J	Jung, SA; Park, YM; Hong, SW; Moon, JH; Shin, JS; Lee, HR; Ha, SH; Lee, DH; Kim, JH; Kim, SM; Kim, JE; Kim, KP; Hong, YS; Choi, EK; Lee, JS; Jin, DH; Kim, T				Jung, Soo-A; Park, Yong-Man; Hong, Seung-Woo; Moon, Jai-Hee; Shin, Jae-Sik; Lee, Ha-Reum; Ha, Seung-Hee; Lee, Dae-Hee; Kim, Jeong Hee; Kim, Seung-Mi; Kim, Jeong Eun; Kim, Kyu-pyo; Hong, Yong Sang; Choi, Eun Kyung; Lee, Jung Shin; Jin, Dong-Hoon; Kim, TaeWon			Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) Stability Contributes to YM155 Resistance in Human Gastric Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Apoptosis; Gastric Cancer; Survivin; Ubiquitylation (Ubiquitination); YM155; cIAP1	SYNERGISTIC ANTITUMOR ACTIVITIES; SEPANTRONIUM BROMIDE YM155; MCL-1 DOWN-REGULATION; TARGETED THERAPIES; CISPLATIN RESISTANCE; SURVIVIN SUPPRESSANT	YM155, which blocks the expression of survivin, a member of the inhibitor of apoptosis (IAP) family, induces cell death in a variety of cancer types, including prostate, bladder, breast, leukemia, and non-small lung cancer. However, the mechanism underlying gastric cancer susceptibility and resistance to YM155 is yet to be specified. Here, we demonstrate that cIAP1 stability dictates resistance to YM155 in human gastric cancer cells. Treatment of human gastric cancer cells with YM155 differentially induced cell death dependent on the stability of cIAP1 as well as survivin. Transfection with cIAP1 expression plasmids decreased cell sensitivity to YM155, whereas knockdown of endogenous cIAP1 using RNA interference enhanced sensitivity to YM155. In addition, double knockdown of survivin and cIAP1 significantly induced cell death in the YM155-resistant cell line, MKN45. We also showed that YM155 induced autoubiquitination and proteasome-dependent degradation of cIAP1. Surprisingly, survivin affected the stability of cIAP1 through binding, contributing to cell sensitivity to YM155. Thus, our findings reveal that YM155 sensitizes human gastric cancer cells to apoptotic cell death by degrading cIAP1, and furthermore, cIAP1 in gastric cancer cells may act as a PD marker for YM155 treatment.	[Jung, Soo-A; Park, Yong-Man; Hong, Seung-Woo; Moon, Jai-Hee; Shin, Jae-Sik; Lee, Ha-Reum; Ha, Seung-Hee; Lee, Dae-Hee; Kim, Jeong Hee; Kim, Seung-Mi; Kim, Jeong Eun; Kim, Kyu-pyo; Hong, Yong Sang; Choi, Eun Kyung; Lee, Jung Shin; Jin, Dong-Hoon; Kim, TaeWon] Univ Ulsan, Coll Med, Asan Med Ctr, Innovat Canc Res,Asan Inst Life Sci, Seoul, South Korea; [Jung, Soo-A; Park, Yong-Man; Hong, Seung-Woo; Moon, Jai-Hee; Shin, Jae-Sik; Lee, Ha-Reum; Ha, Seung-Hee; Lee, Dae-Hee; Kim, Jeong Hee; Kim, Seung-Mi; Kim, Jeong Eun; Kim, Kyu-pyo; Hong, Yong Sang; Lee, Jung Shin; Jin, Dong-Hoon; Kim, TaeWon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Choi, Eun Kyung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Jin, Dong-Hoon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Convergence Med, Seoul, South Korea; [Lee, Ha-Reum] Sookmyung Womens Univ, Dept Life Sci, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Sookmyung Women's University	Jin, DH (corresponding author), Asan Med Ctr, Dept Oncol, 88 Olympicro 43gil, Seoul 138736, South Korea.	inno183@amc.seoul.kr		Lee, Ha-Reum/0000-0001-9200-4372	Korea Health 21 R&D Project, Ministry of Health and Welfare and Family Affairs Grant, Republic of Korea [HI06C0868]; National Research Foundation of Korea (NRF) - Korea government (MEST) [2013R1A2A2A01067394]; National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1420030]	Korea Health 21 R&D Project, Ministry of Health and Welfare and Family Affairs Grant, Republic of Korea; National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korea Health 21 R&D Project, Ministry of Health and Welfare and Family Affairs Grant HI06C0868, Republic of Korea, the National Research Foundation of Korea (NRF) funded by Korea government (MEST) Grant 2013R1A2A2A01067394, and National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea Grant 1420030.	Aspe JR, 2010, ONCOTARGETS THER, V3, P247, DOI 10.2147/OTT.S15293; Cheng Qiuying, 2012, Int J Biochem Mol Biol, V3, P179; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Custodio A, 2012, CANCER TREAT REV, V38, P36, DOI 10.1016/j.ctrv.2011.04.001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kaneko N, 2013, BIOL PHARM BULL, V36, P1921, DOI 10.1248/bpb.b13-00515; Kasper S, 2014, EUR J CANCER, V50, P1247, DOI 10.1016/j.ejca.2014.01.009; Kumar B, 2012, MOL CANCER THER, V11, P1988, DOI 10.1158/1535-7163.MCT-12-0167; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Mohamed A, 2013, AM J PATHOL, V183, P1096, DOI 10.1016/j.ajpath.2013.07.005; Na Y. S., 2012, PLOS ONE, V7; Nakahara T, 2011, ANTI-CANCER DRUG, V22, P454, DOI 10.1097/CAD.0b013e328344ac68; Premkumar DR, 2013, J PHARMACOL EXP THER, V346, P201, DOI 10.1124/jpet.113.204743; Rauch A, 2014, BBA-REV CANCER, V1845, P202, DOI 10.1016/j.bbcan.2014.01.003; Singer EA, 2012, CURR OPIN ONCOL, V24, P284, DOI 10.1097/CCO.0b013e328351c646; Sun XP, 2014, FEBS J, V281, P115, DOI 10.1111/febs.12577; Tabernero J, 2004, ANN ONCOL, V15, P55, DOI 10.1093/annonc/mdh905; Tang HK, 2011, BIOCHEM PHARMACOL, V82, P1066, DOI 10.1016/j.bcp.2011.07.064; Yamauchi T, 2012, BIOCHEM BIOPH RES CO, V425, P711, DOI 10.1016/j.bbrc.2012.07.103; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yoon DH, 2012, ANTICANCER RES, V32, P1681; Yoong J, 2011, DRUGS, V71, P1367, DOI 10.2165/11592530-000000000-00000	22	9	9	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					9974	9985		10.1074/jbc.M114.600874	http://dx.doi.org/10.1074/jbc.M114.600874			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25635055	Green Published, hybrid			2022-12-28	WOS:000353241100007
J	Tenopoulou, M; Chen, J; Bastin, J; Bennett, MJ; Ischiropoulos, H; Doulias, PT				Tenopoulou, Margarita; Chen, Jie; Bastin, Jean; Bennett, Michael J.; Ischiropoulos, Harry; Doulias, Paschalis-Thomas			Strategies for Correcting Very Long Chain Acyl- CoA Dehydrogenase Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme; Mitochondrial Metabolism; Nitric Oxide; Post-transcriptional Regulation; S-Nitrosylation; -Oxidation Disorder; Pediatric Disorder; Very Long Chain Acyl-CoA Dehydrogenase; Very Long Chain Acyl-CoA Dehydrogenase Deficiency	PROTEIN S-NITROSYLATION; COENZYME-A DEHYDROGENASE; ACID OXIDATION DISORDERS; NITRIC-OXIDE; GUANYLATE-CYCLASE; MUTATION ANALYSIS; SUDDEN-DEATH; IDENTIFICATION; FIBROBLASTS; GENOTYPE	Background: VLCAD deficiency is a mitochondrial fatty acid -oxidation disorder. Results:S-Nitrosylation of Cys-237 in VLCAD increased enzymatic activity and normalized -oxidation capacity and acylcarnitine levels in VLCAD-deficient cells. Conclusion: Correction of VLCAD deficiency alleviates disease-associated metabolic derangement and biomarker accumulation. Significance: Data provide proof-of-concept for a potential therapeutic approach that may significantly impact the lives of children and adults with -oxidation deficiencies. Very long acyl-CoA dehydrogenase (VLCAD) deficiency is a genetic pediatric disorder presenting with a spectrum of phenotypes that remains for the most part untreatable. Here, we present a novel strategy for the correction of VLCAD deficiency by increasing mutant VLCAD enzymatic activity. Treatment of VLCAD-deficient fibroblasts, which express distinct mutant VLCAD protein and exhibit deficient fatty acid -oxidation, with S-nitroso-N-acetylcysteine induced site-specific S-nitrosylation of VLCAD mutants at cysteine residue 237. Cysteine 237 S-nitrosylation was associated with an 8-17-fold increase in VLCAD-specific activity and concomitant correction of acylcarnitine profile and -oxidation capacity, two hallmarks of the disorder. Overall, this study provides biochemical evidence for a potential therapeutic modality to correct -oxidation deficiencies.	[Tenopoulou, Margarita; Ischiropoulos, Harry; Doulias, Paschalis-Thomas] Childrens Hosp Philadelphia, Res Inst, Dept Pediat, Div Neonatol, Philadelphia, PA 19104 USA; [Chen, Jie; Bennett, Michael J.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Michael Palmieri Metab Lab,Childrens Hosp Philade, Philadelphia, PA 19104 USA; [Ischiropoulos, Harry] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Bastin, Jean] Univ Paris 05, INSERM, F-75270 Paris 6, France	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Doulias, PT (corresponding author), Childrens Hosp Philadelphia, Res Inst, Abramson Pediat Res Ctr 416D, Philadelphia, PA 19104 USA.	doulias@email.chop.edu	Bastin, Jean/E-3083-2016; DeltaOmicronUpsilonLambdaIotaAlphaSigma, PiAlphaSigmaChiAlphaLambdaEtaSigma-ThetaOmegaMuAlphaSigma/AAY-1665-2020	Doulias, Paschalis-Thomas/0000-0001-7891-3131; Bastin, Jean/0000-0001-8350-8667	National Institutes of Health [HL054926]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL054926.	Andresen BS, 1996, HUM MOL GENET, V5, P461, DOI 10.1093/hmg/5.4.461; Andresen BS, 1996, J INHERIT METAB DIS, V19, P169, DOI 10.1007/BF01799421; Andresen BS, 1999, AM J HUM GENET, V64, P479, DOI 10.1086/302261; Andresen BS, 2001, AM J HUM GENET, V68, P1408, DOI 10.1086/320602; AOYAMA T, 1995, J CLIN INVEST, V95, P2465, DOI 10.1172/JCI117947; AOYAMA T, 1995, AM J HUM GENET, V57, P273; AOYAMA T, 1993, BIOCHEM BIOPH RES CO, V191, P1369, DOI 10.1006/bbrc.1993.1368; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Baruteau J, 2013, J INHERIT METAB DIS, V36, P795, DOI 10.1007/s10545-012-9542-6; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Chegary M, 2009, BBA-MOL CELL BIOL L, V1791, P806, DOI 10.1016/j.bbalip.2009.05.006; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Djouadi F, 2005, HUM MOL GENET, V14, P2695, DOI 10.1093/hmg/ddi303; Doulias PT, 2013, J PROTEOMICS, V92, P195, DOI 10.1016/j.jprot.2013.05.033; Doulias PT, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003252; Doulias PT, 2010, P NATL ACAD SCI USA, V107, P16958, DOI 10.1073/pnas.1008036107; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engbers HM, 2005, J INHERIT METAB DIS, V28, P1151, DOI 10.1007/s10545-005-0190-y; Exil VJ, 2006, AM J PHYSIOL-HEART C, V290, pH1289, DOI 10.1152/ajpheart.00811.2005; Ficicioglu C, 2010, J PEDIATR-US, V156, P492, DOI 10.1016/j.jpeds.2009.10.031; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Gobin-Limballe S, 2007, AM J HUM GENET, V81, P1133, DOI 10.1086/522375; Goetzman ES, 2007, MOL GENET METAB, V91, P138, DOI 10.1016/j.ymgme.2007.01.013; Gregersen N, 2001, HUM MUTAT, V18, P169, DOI 10.1002/humu.1174.abs; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; IGNARRO LJ, 1986, J PHARMACOL EXP THER, V237, P893; Isackson PJ, 2013, MUSCLE NERVE, V47, P224, DOI 10.1002/mus.23498; IZAI K, 1992, J BIOL CHEM, V267, P1027; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jia J, 2014, CELL, V159, P623, DOI 10.1016/j.cell.2014.09.032; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; LEHMAN TC, 1990, ANAL BIOCHEM, V186, P280, DOI 10.1016/0003-2697(90)90080-S; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Mathur A, 1999, CIRCULATION, V99, P1337, DOI 10.1161/01.CIR.99.10.1337; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; McGoey RR, 2011, J PEDIATR-US, V158, P1031, DOI 10.1016/j.jpeds.2011.01.063; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Schiff M, 2013, MOL GENET METAB, V109, P21, DOI 10.1016/j.ymgme.2013.02.002; Shen JJ, 2000, J INHERIT METAB DIS, V23, P27, DOI 10.1023/A:1005694712583; Souri M, 1996, AM J HUM GENET, V58, P97; Souri M, 1998, FEBS LETT, V426, P187, DOI 10.1016/S0014-5793(98)00343-3; Spiekerkoetter U, 2006, HORM METAB RES, V38, P625, DOI 10.1055/s-2006-954581; Spiekerkoetter U, 2004, EUR J CLIN INVEST, V34, P191, DOI 10.1111/j.1365-2362.2004.01308.x; Spiekerkoetter U, 2010, J PEDIATR-US, V157, P668, DOI 10.1016/j.jpeds.2010.04.063; Spiekerkoetter U, 2010, J INHERIT METAB DIS, V33, P527, DOI 10.1007/s10545-010-9090-x; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; STRAUSS AW, 1995, P NATL ACAD SCI USA, V92, P10496, DOI 10.1073/pnas.92.23.10496; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Wood JC, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e19; YAMAGUCHI S, 1993, PEDIATR RES, V34, P111, DOI 10.1203/00006450-199307000-00025; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016	54	4	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10486	10494		10.1074/jbc.M114.635102	http://dx.doi.org/10.1074/jbc.M114.635102			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25737446	Green Published, hybrid			2022-12-28	WOS:000353241100047
J	Kommaddi, RP; Jean-Charles, PY; Shenoy, SK				Kommaddi, Reddy Peera; Jean-Charles, Pierre-Yves; Shenoy, Sudha K.			Phosphorylation of the Deubiquitinase USP20 by Protein Kinase A Regulates Post-endocytic Trafficking of beta(2) Adrenergic Receptors to Autophagosomes during Physiological Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; COUPLED RECEPTORS; SELECTIVE AUTOPHAGY; MEMBRANE-PROTEINS; UBIQUITIN; ARRESTIN; ENZYMES; HEART; ROLES	Ubiquitination by the E3 ligase Nedd4 and deubiquitination by the deubiquitinases USP20 and USP33 have been shown to regulate the lysosomal trafficking and recycling of agonist-activated beta(2) adrenergic receptors (beta(2)ARs). In this work, we demonstrate that, in cells subjected to physiological stress by nutrient starvation, agonist-activated ubiquitinated beta(2)ARs traffic to autophagosomes to colocalize with the autophagy marker protein LC3-II. Furthermore, this trafficking is synchronized by dynamic posttranslational modifications of USP20 that, in turn, are induced in a beta(2)AR-dependent manner. Upon beta(2)AR activation, a specific isoform of the second messenger cAMP-dependent protein kinaseA(PKA alpha) rapidly phosphorylates USP20 on serine 333 located in its unique insertion domain. This phosphorylation of USP20 correlates with a characteristic SDS-PAGE mobility shift of the protein, blocks its deubiquitinase activity, promotes its dissociation from the activated beta(2)AR complex, and facilitates trafficking of the ubiquitinated beta(2)AR to autophagosomes, which fuse with lysosomes to form autolysosomes where receptors are degraded. Dephosphorylation of USP20 has reciprocal effects and blocks trafficking of the beta(2)AR to autophagosomes while promoting plasma membrane recycling of internalized beta(2)ARs. Our findings reveal a dynamic regulation of USP20 by site-specific phosphorylation as well as the interdependence of signal transduction and trafficking pathways in balancing adrenergic stimulation and maintaining cellular homeostasis.	[Kommaddi, Reddy Peera; Jean-Charles, Pierre-Yves; Shenoy, Sudha K.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Shenoy, Sudha K.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University	Shenoy, SK (corresponding author), 412 SANDS Bldg,303 Res Dr, Durham, NC 27710 USA.	skshenoy@dm.duke.edu	Shenoy, Sudha/AAN-4075-2021	Shenoy, Sudha/0000-0002-2565-4663	National Institutes of Health [HL080525, T32 HL00710]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118369, R01HL080525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL080525 (to S. K. S.).; Supported by National Institutes of Health Training Grant T32 HL00710.	Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; BOUVIER M, 1989, J BIOL CHEM, V264, P16786; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Ferrara N, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00396; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gottlieb RA, 2013, HEART FAIL REV, V18, P575, DOI 10.1007/s10741-012-9367-2; Guo YR, 2012, BIOCHEMISTRY-US, V51, P9323, DOI 10.1021/bi301282k; Han SO, 2013, EMBO REP, V14, P164, DOI 10.1038/embor.2012.187; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; He CC, 2013, CELL, V154, P1085, DOI 10.1016/j.cell.2013.07.035; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Hiebel C, 2014, J NEUROCHEM, V131, P484, DOI 10.1111/jnc.12839; Hislop JN, 2011, TRAFFIC, V12, P137, DOI 10.1111/j.1600-0854.2010.01121.x; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kessler BM, 2011, CELL BIOCHEM BIOPHYS, V60, P21, DOI 10.1007/s12013-011-9176-6; Kim IM, 2008, P NATL ACAD SCI USA, V105, P14555, DOI 10.1073/pnas.0804745105; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liang W, 2008, BIOCHEMISTRY-US, V47, P11750, DOI 10.1021/bi800219q; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; Luttrell LM, 2002, J CELL SCI, V115, P455; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2013, CELL SIGNAL, V25, P707, DOI 10.1016/j.cellsig.2012.11.024; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Schwarz LA, 2012, MOL CELL NEUROSCI, V49, P387, DOI 10.1016/j.mcn.2011.08.006; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; SIBLEY DR, 1985, NATURE, V317, P124, DOI 10.1038/317124a0; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Tian Xufan, 2014, Handb Exp Pharmacol, V219, P173, DOI 10.1007/978-3-642-41199-1_9; Vasudevan NT, 2011, CELL CYCLE, V10, P3684, DOI 10.4161/cc.10.21.18042; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Xiao KH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203091; Xie M, 2011, CURR OPIN CARDIOL, V26, P216, DOI 10.1097/HCO.0b013e328345980a; Ye Y, 2009, MOL BIOSYST, V5, P1797, DOI 10.1039/b907669g; Zambon AC, 2005, P NATL ACAD SCI USA, V102, P8561, DOI 10.1073/pnas.0503363102	60	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8888	8903		10.1074/jbc.M114.630541	http://dx.doi.org/10.1074/jbc.M114.630541			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25666616	Green Published, hybrid			2022-12-28	WOS:000352207100017
J	Scholer, J; Ferralli, J; Thiry, S; Chiquet-Ehrismann, R				Schoeler, Jonas; Ferralli, Jacqueline; Thiry, Stephane; Chiquet-Ehrismann, Ruth			The Intracellular Domain of Teneurin-1 Induces the Activity of Microphthalmia-associated Transcription Factor (MITF) by Binding to Transcriptional Repressor HINT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIR-RULE GENE; RNA-POLYMERASE-II; FIBROBLAST-GROWTH-FACTOR; IN-VITRO; TRANSMEMBRANE PROTEIN; PHYLOGENETIC ANALYSIS; NEURITE OUTGROWTH; CELL-ADHESION; EXPRESSION; FAMILY	Teneurins are large type II transmembrane proteins that are necessary for the normal development of the CNS. Although many studies highlight the significance of teneurins, especially during development, there is only limited information known about the molecular mechanisms of function. Previous studies have shown that the N-terminal intracellular domain (ICD) of teneurins can be cleaved at the membrane and subsequently translocates to the nucleus, where it can influence gene transcription. Because teneurin ICDs do not contain any intrinsic DNA binding sequences, interaction partners are required to affect transcription. Here, we identified histidine triad nucleotide binding protein 1 (HINT1) as a human teneurin-1 ICD interaction partner in a yeast two-hybrid screen. This interaction was confirmed in human cells, where HINT1 is known to inhibit the transcription of target genes by directly binding to transcription factors at the promoter. In a whole transcriptome analysis of BS149 glioblastoma cells overexpressing the teneurin- 1 ICD, several microphthalmia-associated transcription factor (MITF) target genes were found to be up-regulated. Directly comparing the transcriptomes of MITF versus TEN1-ICD-overexpressing BS149 cells revealed 42 co-regulated genes, including glycoprotein non-metastatic b (GPNMB). Using real-time quantitative PCR to detect endogenous GPNMB expression upon overexpression of MITF and HINT1 as well as promoter reporter assays using GPNMB promoter constructs, we could demonstrate that the teneurin-1 ICD binds HINT1, thus switching on MITF-dependent transcription of GPNMB.	[Schoeler, Jonas; Ferralli, Jacqueline; Thiry, Stephane; Chiquet-Ehrismann, Ruth] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Schoeler, Jonas; Chiquet-Ehrismann, Ruth] Univ Basel, Fac Sci, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Chiquet-Ehrismann, R (corresponding author), Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	ruth.chiquet@fmi.ch						Abdelmagid SM, 2010, J CELL BIOCHEM, V111, P295, DOI 10.1002/jcb.22702; Adijanto J, 2012, J BIOL CHEM, V287, P20491, DOI 10.1074/jbc.M112.354761; Anastassiadis K, 2002, GENE, V298, P159, DOI 10.1016/S0378-1119(02)00979-4; Bagutti C, 2003, J CELL SCI, V116, P2957, DOI 10.1242/jcs.00603; BAUMGARTNER S, 1993, MECH DEVELOP, V40, P165, DOI 10.1016/0925-4773(93)90074-8; BAUMGARTNER S, 1994, EMBO J, V13, P3728, DOI 10.1002/j.1460-2075.1994.tb06682.x; Beckmann J, 2013, NANO LETT, V13, P2937, DOI 10.1021/nl4013248; Ben-Zur T, 2000, DEV BIOL, V217, P107, DOI 10.1006/dbio.1999.9532; Boucard AA, 2014, J BIOL CHEM, V289, P387, DOI 10.1074/jbc.M113.504779; Broz DK, 2010, INT J DEV BIOL, V54, P1509, DOI 10.1387/ijdb.103139dk; Busby JN, 2013, NATURE, V501, P547, DOI 10.1038/nature12465; Cao JY, 2014, MOL CELL BIOL, V34, P246, DOI 10.1128/MCB.00968-13; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Carter BD, 2006, EMBO REP, V7, P382, DOI 10.1038/sj.embor.7400675; Cheung HNM, 2014, FASEB J, V28, P337, DOI 10.1096/fj.13-232694; Drabikowski K, 2005, DEV BIOL, V282, P27, DOI 10.1016/j.ydbio.2005.02.017; Dui Y, 2014, BIOCHEM BIOPH RES CO, V445, P58, DOI 10.1016/j.bbrc.2014.01.119; Durrin LK, 2002, GENOMICS, V79, P809, DOI 10.1006/geno.2002.6772; Enneking EM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001537; Fanciulli M, 2000, FASEB J, V14, P904, DOI 10.1096/fasebj.14.7.904; Feng K, 2002, J BIOL CHEM, V277, P26128, DOI 10.1074/jbc.M203722200; Genovese G, 2012, CELL CYCLE, V11, P2206, DOI 10.4161/cc.20765; Gharesouran J, 2014, J MOL NEUROSCI, V54, P780, DOI 10.1007/s12031-014-0377-5; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Huang JJ, 2012, BRAIN BEHAV, V2, P85, DOI 10.1002/brb3.39; Kenzelmann D, 2007, CELL MOL LIFE SCI, V64, P1452, DOI 10.1007/s00018-007-7108-9; Kenzelmann D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-30; Kolpakova E, 1998, BIOCHEM J, V336, P213, DOI 10.1042/bj3360213; Kypri E, 2014, CELL MOL LIFE SCI, V71, P517, DOI 10.1007/s00018-013-1401-6; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; LEVINE A, 1994, CELL, V77, P587, DOI 10.1016/0092-8674(94)90220-8; Li WM, 2009, ARCH OTOLARYNGOL, V135, P896, DOI 10.1001/archoto.2009.121; Liu Q, 2008, NEUROCHEM RES, V33, P1263, DOI 10.1007/s11064-007-9578-4; Lovejoy DA, 2006, GEN COMP ENDOCR, V148, P299, DOI 10.1016/j.ygcen.2006.01.012; Margaron Y, 2013, J BIOL CHEM, V288, P1184, DOI 10.1074/jbc.M112.431825; Maric G, 2013, ONCOTARGETS THER, V6, P839, DOI 10.2147/OTT.S44906; Minet AD, 1999, J CELL SCI, V112, P2019; Minet AD, 2000, GENE, V257, P87, DOI 10.1016/S0378-1119(00)00388-7; Morck C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-55; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Murakami T, 2010, J ANAT, V217, P236, DOI 10.1111/j.1469-7580.2010.01267.x; Myers JP, 2011, DEV NEUROBIOL, V71, P901, DOI 10.1002/dneu.20931; Nunes SM, 2005, EXP CELL RES, V305, P122, DOI 10.1016/j.yexcr.2004.12.020; Oohashi T, 1999, J CELL BIOL, V145, P563, DOI 10.1083/jcb.145.3.563; Proshkin SA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P976, DOI 10.1134/S0006297911080141; Razin E, 1999, J BIOL CHEM, V274, P34272, DOI 10.1074/jbc.274.48.34272; Ripoll VM, 2008, GENE, V413, P32, DOI 10.1016/j.gene.2008.01.014; Rubin BP, 1999, DEV BIOL, V216, P195, DOI 10.1006/dbio.1999.9503; Sabo SL, 2003, J NEUROSCI, V23, P5407; Sanchez-Soriano N, 2009, J CELL SCI, V122, P2534, DOI 10.1242/jcs.046268; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Suzuki N, 2014, J ORTHOP RES, V32, P915, DOI 10.1002/jor.22616; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Tian Y, 2013, P NATL ACAD SCI USA, V110, P17071, DOI 10.1073/pnas.1315110110; Tucker RP, 2012, MOL BIOL EVOL, V29, P1019, DOI 10.1093/molbev/msr271; Tucker RP, 2000, MECH DEVELOP, V98, P187, DOI 10.1016/S0925-4773(00)00444-5; Tucker RP, 2006, DEV BIOL, V290, P237, DOI 10.1016/j.ydbio.2005.11.038; Tucker RP, 2001, DEV DYNAM, V220, P27, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1084>3.0.CO;2-B; Vilar M, 2006, EMBO J, V25, P1219, DOI 10.1038/sj.emboj.7601017; Wang L, 2009, INT J CANCER, V124, P1526, DOI 10.1002/ijc.24072; Wang LQ, 2005, MOL BRAIN RES, V133, P253, DOI 10.1016/j.molbrainres.2004.10.019; Young TR, 2013, J NEUROSCI, V33, P12490, DOI 10.1523/JNEUROSCI.4708-12.2013; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zheng LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022956; Zheng YH, 2013, CHIN J CANCER, V32, P75, DOI [10.5732/cjc.012.10084, 10.5732/cjc.012.1008]; Zhou XH, 2003, GENE EXPR PATTERNS, V3, P397, DOI 10.1016/S1567-133X(03)00087-5; Ziegler A, 2012, CANCER LETT, V326, P1, DOI 10.1016/j.canlet.2012.07.021	70	23	24	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8154	8165		10.1074/jbc.M114.615922	http://dx.doi.org/10.1074/jbc.M114.615922			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25648896	Green Published, hybrid			2022-12-28	WOS:000351662600013
J	Tsitoura, P; Koussis, K; Iatrou, K				Tsitoura, Panagiota; Koussis, Konstantinos; Iatrou, Kostas			Inhibition of Anopheles gambiae Odorant Receptor Function by Mosquito Repellents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biosensor; Chemical Biology; High-throughput Screening (HTS); Insect; Recombinant Protein Expression; Orco Co-receptor Antagonism; Lepidopteran Insect Cells; Mosquito Olfaction; Olfactory Receptors	THROUGHPUT SCREENING PLATFORMS; INSECT-CELL-LINES; ION CHANNELS; AMILORIDE DERIVATIVES; OLFACTORY RECEPTORS; OPIOID RECEPTORS; MOLECULAR-BASIS; BOMBYX-MORI; IN-VITRO; DEET	Background: The mode of action of insect repellents on odorant receptor (OR) function remains unclear. Results:Anopheles gambiae OR function in vitro is inhibited by specific repellents. Conclusion: The identified inhibitory effects are due to functional blocking of Orco, the common subunit of OR heteromers. Significance: The specific mechanism of action is distinct from the proposed modes of DEET function. The identification of molecular targets of insect repellents has been a challenging task, with their effects on odorant receptors (ORs) remaining a debatable issue. Here, we describe a study on the effects of selected mosquito repellents, including the widely used repellent N,N-diethyl-meta-toluamide (DEET), on the function of specific ORs of the African malaria vector Anopheles gambiae. This study, which has been based on quantitative measurements of a Ca2+-activated photoprotein biosensor of recombinant OR function in an insect cell-based expression platform and a sequential compound addition protocol, revealed that heteromeric OR (ORx/Orco) function was susceptible to strong inhibition by all tested mosquito repellents except DEET. Moreover, our results demonstrated that the observed inhibition was due to efficient blocking of Orco (olfactory receptor coreceptor) function. This mechanism of repellent action, which is reported for the first time, is distinct from the mode of action of other characterized insect repellents including DEET.	[Tsitoura, Panagiota; Iatrou, Kostas] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Insect Mol Genet & Biotechnol Grp, Athens 15310, Greece; [Koussis, Konstantinos] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 70013, Crete, Greece	National Centre of Scientific Research "Demokritos"; Foundation for Research & Technology - Hellas (FORTH)	Iatrou, K (corresponding author), Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens 15310, Greece.	iatrou@bio.demokritos.gr	Kousis, Konstantinos/K-7371-2019	Kousis, Konstantinos/0000-0002-6737-8724	European Union (ENAROMaTIC - European Network for Advanced Research on Olfaction for Malaria Transmitting Insect Control) [FP7-222927]	European Union (ENAROMaTIC - European Network for Advanced Research on Olfaction for Malaria Transmitting Insect Control)	This work was supported by a grant from the European Union (FP7-222927, ENAROMaTIC - European Network for Advanced Research on Olfaction for Malaria Transmitting Insect Control).	AMANN R, 1991, LIFE SCI, V49, P849, DOI 10.1016/0024-3205(91)90169-C; AMATRUDA TT, 1991, P NATL ACAD SCI USA, V88, P5587, DOI 10.1073/pnas.88.13.5587; Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Bohbot JD, 2012, NEUROPHARMACOLOGY, V62, P2086, DOI 10.1016/j.neuropharm.2012.01.004; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Bovolenta S, 2007, J BIOMOL SCREEN, V12, P694, DOI 10.1177/1087057107301497; Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chen SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084575; Chen Sisi, 2014, F1000Res, V3, P84, DOI 10.12688/f1000research.3825.1; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; CHRISTOPHERS SR, 1947, J HYG-CAMBRIDGE, V45, P176, DOI 10.1017/S0022172400013863; Corcoran JA, 2014, INSECT BIOCHEM MOLEC, V54, P22, DOI 10.1016/j.ibmb.2014.08.005; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Dickens JC, 2013, PESTIC BIOCHEM PHYS, V106, P149, DOI 10.1016/j.pestbp.2013.02.006; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Dogan EB, 1999, MED VET ENTOMOL, V13, P97, DOI 10.1046/j.1365-2915.1999.00145.x; Douris V, 2006, ADV VIRUS RES, V68, P113, DOI 10.1016/S0065-3527(06)68004-4; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Hall S. A., 1945, U.S. Patent, Patent No. [2,390,249A, 2390249]; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Iatrou K, 2008, INSECT BIOCHEM MOLEC, V38, P268, DOI 10.1016/j.ibmb.2007.11.008; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; Kiely A, 2007, J NEUROSCI METH, V159, P189, DOI 10.1016/j.jneumeth.2006.07.005; King W. V., 1954, CHEM EVALUATED INSEC; Krober T, 2010, J AM MOSQUITO CONTR, V26, P381, DOI 10.2987/10-6044.1; Kwon HW, 2011, J MED ENTOMOL, V48, P61, DOI 10.1603/ME10042; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 2010, NATURE, V464, P37, DOI 10.1038/464037a; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Lu M, 1997, J BIOL CHEM, V272, P30724, DOI 10.1074/jbc.272.49.30724; Lu ML, 1996, VIROLOGY, V218, P103, DOI 10.1006/viro.1996.0170; Molokanova M, 2008, DRUG DISCOV TODAY, V13, P14, DOI 10.1016/j.drudis.2007.11.009; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Pask GM, 2013, CHEM SENSES, V38, P221, DOI 10.1093/chemse/bjs100; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Rinker DC, 2012, PHYSIOL ENTOMOL, V37, P33, DOI 10.1111/j.1365-3032.2011.00821.x; Rollecke K, 2013, CHEM SENSES, V38, P231, DOI 10.1093/chemse/bjs140; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Suh E, 2014, CURR OPIN INSECT SCI, V6, P86, DOI 10.1016/j.cois.2014.10.006; Swevers L, 2005, CELL MOL LIFE SCI, V62, P919, DOI 10.1007/s00018-005-4537-1; Swevers L, 2004, FASEB J, V18, P134, DOI 10.1096/fj.03-0627fje; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Tabanca N, 2013, J AGR FOOD CHEM, V61, P8573, DOI 10.1021/jf402182h; Thompson AJ, 2010, BIOTECHNIQUES, V49, P822, DOI 10.2144/000113538; Tsitoura P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015428; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; WICKHAM TJ, 1992, BIOTECHNOL PROGR, V8, P391, DOI 10.1021/bp00017a003; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; Xu PX, 2014, P NATL ACAD SCI USA, V111, P16592, DOI 10.1073/pnas.1417244111; YASUDA K, 1993, P NATL ACAD SCI USA, V90, P6736, DOI 10.1073/pnas.90.14.6736	64	22	22	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7961	7972		10.1074/jbc.M114.632299	http://dx.doi.org/10.1074/jbc.M114.632299			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25657000	Green Published, hybrid			2022-12-28	WOS:000351613600053
J	Didiasova, M; Zakrzewicz, D; Magdolen, V; Nagaraj, C; Balint, Z; Rohde, M; Preissner, KT; Wygrecka, M				Didiasova, Miroslava; Zakrzewicz, Dariusz; Magdolen, Viktor; Nagaraj, Chandran; Balint, Zoltan; Rohde, Manfred; Preissner, Klaus T.; Wygrecka, Malgorzata			STIM1/ORAI1-mediated Ca2+ Influx Regulates Enolase-1 Exteriorization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; cancer; inflammation; membrane trafficking; stromal interaction molecule 1 (STIM1); enolase-1	MATRIX-DEGRADING PROTEASES; ALPHA-ENOLASE; PLASMINOGEN BINDING; CAVEOLIN-1 EXPRESSION; CELL-ADHESION; CANCER CELLS; TUMOR-GROWTH; RECEPTOR; ACTIVATION; GENE	Background: Cell surface-associated enolase-1 regulates plasmin formation and thus pericellular proteolysis. Results: STIM1/ORAI1-mediated Ca2+ influx controls enolase-1 exteriorization in cancer cells. Conclusion: Extracellular enolase-1 regulates migratory and invasive properties of cancer cells. Significance: Enhanced exteriorization of enolase-1 may aggravate the malignant behavior of cancer cells and thus contribute to metastasis formation. Tumor cells use broad spectrum proteolytic activity of plasmin to invade tissue and form metastatic foci. Cell surface-associated enolase-1 (ENO-1) enhances plasmin formation and thus participates in the regulation of pericellular proteolysis. Although increased levels of cell surface bound ENO-1 have been described in different types of cancer, the molecular mechanism responsible for ENO-1 exteriorization remains elusive. In the present study, increased ENO-1 protein levels were found in ductal breast carcinoma and on the cell surface of highly metastatic breast cancer cell line MDA-MB-231. Elevated cell surface-associated ENO-1 expression correlated with augmented MDA-MB-231 cell migratory and invasive properties. Exposure of MDA-MB-231 cells to LPS potentiated translocation of ENO-1 to the cell surface and its release into the extracellular space in the form of exosomes. These effects were independent of de novo protein synthesis and did not require the classical endoplasmic reticulum/Golgi pathway. LPS-triggered ENO-1 exteriorization was suppressed by pretreatment of MDA-MB-231 cells with the Ca2+ chelator BAPTA or an inhibitor of endoplasmic reticulum Ca2+-ATPase pump, cyclopiazonic acid. In line with these observations, the stromal interaction molecule (STIM) 1 and the calcium release-activated calcium modulator (ORAI) 1-mediated store-operated Ca2+ entry were found to regulate LPS-induced ENO-1 exteriorization. Pharmacological blockage or knockdown of STIM1 or ORAI1 reduced ENO-1-dependent migration of MDA-MB-231 cells. Collectively, our results demonstrate the pivotal role of store-operated Ca2+ channel-mediated Ca2+ influx in the regulation of ENO-1 exteriorization and thus in the modulation of cancer cell migratory and invasive properties.	[Didiasova, Miroslava; Zakrzewicz, Dariusz; Preissner, Klaus T.; Wygrecka, Malgorzata] Univ Giessen, Lung Ctr, Dept Biochem, D-35392 Giessen, Germany; [Magdolen, Viktor] Tech Univ Munich, Dept Obstet & Gynecol, Clin Res Unit, D-81675 Munich, Germany; [Nagaraj, Chandran; Balint, Zoltan] Ludwig Boltzmann Inst Lung Vasc Res, A-8010 Graz, Austria; [Rohde, Manfred] Helmholtz Ctr Infect Res, Cent Facil Microscopy, D-38124 Braunschweig, Germany	Justus Liebig University Giessen; Technical University of Munich; Ludwig Boltzmann Institute; Helmholtz Association; Helmholtz-Center for Infection Research	Wygrecka, M (corresponding author), Univ Giessen, Lung Ctr, Dept Biochem, Friedrichstr 24, D-35392 Giessen, Germany.	malgorzata.wygrecka@innere.med.uni-giessen.de	Bálint, Zoltán/AAJ-3080-2020; Chandran, Nagaraj/AAP-2007-2020; Wygrecka, Malgorzata/AAZ-3679-2020	Chandran, Nagaraj/0000-0003-3825-8587; Wygrecka, Malgorzata/0000-0002-3656-2932; Zakrzewicz, Dariusz/0000-0003-3292-9706; Balint, Zoltan/0000-0001-8598-2784	University Medical Center Giessen; University Medical Center Marburg; Deutsche Forschungsgemeinschaft [WY119/1-1, Sonderforschungsbereich-Transregio 84]; Excellence Cluster Cardiopulmonary System; Deutsches Zentrum fur Lungenforschung	University Medical Center Giessen; University Medical Center Marburg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG)); Deutsches Zentrum fur Lungenforschung	This work was supported by the University Medical Center Giessen and Marburg (to M. W.), Deutsche Forschungsgemeinschaft Grant WY119/1-1 (to M. W. and K. T. P.), Sonderforschungsbereich-Transregio 84 Project A2 (to M. W. and K. T. P.), the Excellence Cluster Cardiopulmonary System (to M. W. and D. Z.), and the Deutsches Zentrum fur Lungenforschung.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Andronicos NM, 2001, BRIT J CANCER, V85, P909, DOI 10.1054/bjoc.2001.2022; Balint Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063776; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Capello M, 2011, FEBS J, V278, P1064, DOI 10.1111/j.1742-4658.2011.08025.x; Cappello P, 2009, INT J CANCER, V125, P639, DOI 10.1002/ijc.24355; Chang GC, 2006, CLIN CANCER RES, V12, P5746, DOI 10.1158/1078-0432.CCR-06-0324; Chen YF, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-23; DANCONA GG, 1977, CYTOGENET CELL GENET, V18, P327, DOI 10.1159/000130779; Das R, 2009, CIRC RES, V105, P167, DOI 10.1161/CIRCRESAHA.109.200311; Del Pozo JL, 2010, PANCREATOLOGY, V10, P114, DOI 10.1159/000299987; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Didiasova M, 2014, INT J MOL SCI, V15, P21229, DOI 10.3390/ijms151121229; ELLIS V, 1991, J BIOL CHEM, V266, P12752; Fang WB, 2012, J BIOL CHEM, V287, P36593, DOI 10.1074/jbc.M112.365999; Gandhirajan RK, 2013, J CLIN INVEST, V123, P887, DOI 10.1172/JCI65647; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; GONZALEZGRONOW M, 1991, ARCH BIOCHEM BIOPHYS, V286, P625, DOI 10.1016/0003-9861(91)90090-6; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALL SW, 1991, J BIOL CHEM, V266, P12329; He P, 2007, CANCER SCI, V98, P1234, DOI 10.1111/j.1349-7006.2007.00509.x; Hsiao KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069354; Hsu RYC, 2011, CANCER RES, V71, P1989, DOI 10.1158/0008-5472.CAN-10-2833; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6; Li GL, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-20; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lund LR, 1999, EMBO J, V18, P4645, DOI 10.1093/emboj/18.17.4645; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matrisian LM, 1999, CURR BIOL, V9, pR776, DOI 10.1016/S0960-9822(00)80011-1; McDonald B, 2009, INT J CANCER, V125, P1298, DOI 10.1002/ijc.24409; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Pei ZY, 2008, CELL IMMUNOL, V254, P20, DOI 10.1016/j.cellimm.2008.06.007; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Pidgeon GP, 1999, BRIT J CANCER, V81, P1311, DOI 10.1038/sj.bjc.6694369; Plow EF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/141806; Plow EF, 2009, BLOOD, V113, P5371, DOI 10.1182/blood-2009-03-208546; PLOW EF, 1986, J CELL BIOL, V103, P2411, DOI 10.1083/jcb.103.6.2411; RAY RB, 1995, CANCER RES, V55, P3747; REDLITZ A, 1995, EUR J BIOCHEM, V227, P407, DOI 10.1111/j.1432-1033.1995.tb20403.x; ROBBINS KC, 1967, J BIOL CHEM, V242, P2333; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Senetta R, 2013, J CELL MOL MED, V17, P325, DOI 10.1111/jcmm.12030; Seweryn E, 2009, Z NATURFORSCH C, V64, P754; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Sun RJ, 2012, CELL BIOL INT, V36, P475, DOI 10.1042/CBI20110535; Szkaradkiewicz A, 2009, ARCH IMMUNOL THER EX, V57, P291, DOI 10.1007/s00005-009-0031-z; Tiruppathi C, 2008, J BIOL CHEM, V283, P4210, DOI 10.1074/jbc.M703153200; Urbanelli L, 2013, GENES-BASEL, V4, P152, DOI 10.3390/genes4020152; Valapala M, 2011, J BIOL CHEM, V286, P30911, DOI 10.1074/jbc.M111.271155; Werb Z, 1999, APMIS, V107, P11, DOI 10.1111/j.1699-0463.1999.tb01521.x; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yang XY, 2012, BIOCHEM BIOPH RES CO, V426, P334, DOI 10.1016/j.bbrc.2012.08.079; Zakrzewicz D, 2014, BIOCHEM J, V460, P295, DOI 10.1042/BJ20130945; Zhang F, 2010, ACTA PHARMACOL SIN, V31, P111, DOI 10.1038/aps.2009.178; Zhu H, 2008, J PHARMACOL SCI, V106, P287, DOI 10.1254/jphs.FP0071192	60	29	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11983	11999		10.1074/jbc.M114.598425	http://dx.doi.org/10.1074/jbc.M114.598425			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25805497	Green Published, hybrid			2022-12-28	WOS:000354388600015
J	Bhattacharyya, S; Feferman, L; Tobacman, JK				Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.			Carrageenan Inhibits Insulin Signaling through GRB10-mediated Decrease in Tyr(P)-IRS1 and through Inflammation-induced Increase in Ser(P)(307)-IRS1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN GRB10; ALPHA-GAL EPITOPE; SERINE/THREONINE PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; RECEPTOR SUBSTRATE-1; EPITHELIAL-CELLS; IMPRINTED GRB10; RESISTANCE; PATHWAY; ASSOCIATION	Inflammation induced by exposure to the common food additive carrageenan leads to insulin resistance by increase in Ser(P)(307)-insulin receptor substrate 1 (IRS1) and subsequent decline in the insulin-stimulated increase in Ser(P)(473)-AKT. Inhibition of carrageenan-induced inflammation reversed the increase in Ser(P)(307)-IRS1 but did not completely reverse the carrageenan-induced decline in Ser(P)(473)-AKT. To identify the additional mechanism responsible for the decrease in Ser(P)(473)-AKT, studies were performed in human HepG2 cells and in C57BL/6J mice. Following carrageenan, expression of GRB10 (growth factor receptor-bound 10 protein), an adaptor protein that binds to the insulin receptor and inhibits insulin signaling, increased significantly. GRB10 silencing blocked the carrageenan-induced reduction of the insulin-stimulated increase in Tyr(P)-IRS1 and partially reversed the decline in Ser(P)(473)-AKT. The combination of GRB10 silencing with BCL10 silencing and the reactive oxygen species inhibitor Tempol completely reversed the decline in Ser(P)(473)-AKT. After carrageenan, GRB10 promoter activity was enhanced because of activation by GATA2. A direct correlation between Ser(P)(473)-AKT and Ser(P)(401)-GATA2 was evident, and inhibition of AKT phosphorylation by the PI3K inhibitor LY294002 blocked Ser(401)-GATA2 phosphorylation and the increase in GRB10 expression. Studies indicated that carrageenan inhibited insulin signaling by two mechanisms: through the inflammation-mediated increase in Ser(P)(307)-IRS1, a negative regulator of insulin signaling, and through a transcriptional mechanism leading to increase in GRB10 expression and GRB10-inhibition of Tyr(P)-IRS1, a positive regulator of insulin signaling. These mechanisms converge to inhibit the insulin-induced increase in Ser(P)(473)-AKT. They provide internal feedback, mediated by Ser(P)(473)-AKT, Ser(P)(401)-GATA2, and nuclear GATA2, which links the opposing effects of serine and tyrosine phosphorylations of IRS1 and can modulate insulin responsiveness.	[Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.] Lesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Tobacman, JK (corresponding author), Univ Illinois, Dept Med, ESN 440,M-C 718, Chicago, IL 60612 USA.	jkt@uic.edu						Ballou LM, 2007, J BIOL CHEM, V282, P24463, DOI 10.1074/jbc.M704741200; Bhattacharyya S, 2014, ONCOGENE, V33, P5467, DOI 10.1038/onc.2013.483; Bhattacharyya S, 2012, DIABETOLOGIA, V55, P194, DOI 10.1007/s00125-011-2333-z; Bhattacharyya S, 2008, BBA-GEN SUBJECTS, V1780, P973, DOI 10.1016/j.bbagen.2008.03.019; Bhattacharyya S, 2008, J BIOL CHEM, V283, P10550, DOI 10.1074/jbc.M708833200; Bhattacharyya S, 2007, J IMMUNOASS IMMUNOCH, V28, P173, DOI 10.1080/15321810701454573; Bhattacharyya S, 2010, J NUTR BIOCHEM, V21, P906, DOI 10.1016/j.jnutbio.2009.07.002; Bhattacharyya S, 2010, J BIOL CHEM, V285, P522, DOI 10.1074/jbc.M109.050815; Borthakur A, 2007, AM J PHYSIOL-GASTR L, V292, pG829, DOI 10.1152/ajpgi.00380.2006; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Depetris RS, 2009, NAT STRUCT MOL BIOL, V16, P833, DOI 10.1038/nsmb.1642; Di Paola R, 2006, DIABETES CARE, V29, P1181, DOI 10.2337/dc06-2551; Paola R, 2010, J INTERN MED, V267, P132, DOI 10.1111/j.1365-2796.2009.02089.x; Dong LQ, 1997, J BIOL CHEM, V272, P29104, DOI 10.1074/jbc.272.46.29104; Dufresne AM, 2005, ENDOCRINOLOGY, V146, P4399, DOI 10.1210/en.2005-0150; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Garfield AS, 2011, NATURE, V469, P534, DOI 10.1038/nature09651; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Hansen H, 1996, J BIOL CHEM, V271, P8882, DOI 10.1074/jbc.271.15.8882; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Huret JL, 2013, NUCLEIC ACIDS RES, V41, pD920, DOI 10.1093/nar/gks1082; KANETY H, 1995, J BIOL CHEM, V270, P23780, DOI 10.1074/jbc.270.40.23780; Laviola L, 1997, J CLIN INVEST, V99, P830, DOI 10.1172/JCI119246; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Menghini R, 2005, CIRCULATION, V111, P1946, DOI 10.1161/01.CIR.0000161814.02942.B2; Mohammad MK, 2006, INT IMMUNOL, V18, P1101, DOI 10.1093/intimm/dxl045; Monk D, 2009, HUM MOL GENET, V18, P3066, DOI 10.1093/hmg/ddp248; Nakamori Y, 2006, J CELL BIOL, V173, P665, DOI 10.1083/jcb.200601065; Prokopenko I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004235; Rampersaud E, 2007, DIABETES, V56, P3053, DOI 10.2337/db07-0457; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shiura H, 2005, BIOCHEM BIOPH RES CO, V329, P909, DOI 10.1016/j.bbrc.2005.02.047; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Tanemura M, 2000, J CLIN INVEST, V105, P301, DOI 10.1172/JCI7358; TOWATARI M, 1995, J BIOL CHEM, V270, P4101, DOI 10.1074/jbc.270.8.4101; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Wick KR, 2003, J BIOL CHEM, V278, P8460, DOI 10.1074/jbc.M208518200; Yamamoto Y, 2008, EXP ANIM TOKYO, V57, P385, DOI 10.1538/expanim.57.385	43	30	31	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10764	10774		10.1074/jbc.M114.630053	http://dx.doi.org/10.1074/jbc.M114.630053			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25784556	hybrid, Green Published			2022-12-28	WOS:000353404500018
J	Choi, JY; Duraisingh, MT; Marti, M; Ben Mamoun, C; Voelker, DR				Choi, Jae-Yeon; Duraisingh, Manoj T.; Marti, Matthias; Ben Mamoun, Choukri; Voelker, Dennis R.			From Protease to Decarboxylase THE MOLECULAR METAMORPHOSIS OF PHOSPHATIDYLSERINE DECARBOXYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PHOSPHATIDYLETHANOLAMINE; GENE; IDENTIFICATION; MECHANISM; MUTANTS; YEAST; ACID	Phosphatidylserine decarboxylase (PSDs) play a central role in the synthesis of phosphatidylethanolamine in numerous species of prokaryotes and eukaryotes. PSDs are unusual decarboxylase containing a pyruvoyl prosthetic group within the active site. The covalently attached pyruvoyl moiety is formed in a concerted reaction when the PSD proenzyme undergoes an endoproteolytic cleavage into a large beta-subunit, and a smaller alpha-subunit, which harbors the prosthetic group at its N terminus. The mechanism of PSD proenzyme cleavage has long been unclear. Using a coupled in vitro transcription/translation system with the soluble Plasmodium knowlesi enzyme (PkPSD), we demonstrate that the post-translational processing is inhibited by the serine protease inhibitor, phenylmethylsulfonyl fluoride. Comparison of PSD sequences across multiple phyla reveals a uniquely conserved aspartic acid within an FFXRX6RX12PXD motif, two uniquely conserved histidine residues within a PXXYHXXHXP motif, and a uniquely conserved serine residue within a GS(S/T) motif, suggesting that PSDs belong to the D-H-S serine protease family. The function of the conserved D-H-S residues was probed using site-directed mutagenesis of PkPSD. The results from these mutagenesis experiments reveal that Asp-139, His-198, and Ser-308 are all essential for endoproteolytic processing of PkPSD, which occurs in cis. In addition, within the GS(S/T) motif found in all PSDs, the Gly-307 residue is also essential, but the Ser/Thr-309 is non-essential. These results define the mechanism whereby PSDs begin their biochemical existence as proteases that execute one autoendoproteolytic cleavage reaction to give rise to a mature PSD harboring a pyruvoyl prosthetic group.	[Choi, Jae-Yeon; Voelker, Dennis R.] Natl Jewish Hlth, Dept Med, Basic Sci Sect, Denver, CO 80206 USA; [Ben Mamoun, Choukri] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA; [Duraisingh, Manoj T.; Marti, Matthias] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	National Jewish Health; Yale University; Harvard University; Harvard T.H. Chan School of Public Health	Voelker, DR (corresponding author), 1400 Jackson St, Denver, CO 80206 USA.	voelkerd@njhealth.org			National Institutes of Health [GM104485, AI097218, AI09486]; Bill and Melinda Gates Foundation [OPP1086229, OPP1069779, 1021571]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM104485 (to D.R.V) and AI097218 and AI09486 and Bill and Melinda Gates Foundation Grants OPP1086229, OPP1069779, and 1021571 (to C.B.M.).	Bale S, 2010, AMINO ACIDS, V38, P451, DOI 10.1007/s00726-009-0404-y; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Choi JY, 2012, J BIOL CHEM, V287, P222, DOI 10.1074/jbc.M111.313676; CRAIK CS, 1987, SCIENCE, V237, P909, DOI 10.1126/science.3303334; de Villiers J, 2010, CHEM-EUR J, V16, P10030, DOI 10.1002/chem.201000622; DOWHAN W, 1992, METHOD ENZYMOL, V209, P348; DOWHAN W, 1992, METHOD ENZYMOL, V209, P287; Fox Jeffrey D, 2003, Methods Mol Biol, V205, P99; Giles TN, 2007, J BACTERIOL, V189, P7376, DOI 10.1128/JB.00772-07; HAWROT E, 1975, P NATL ACAD SCI USA, V72, P1112, DOI 10.1073/pnas.72.3.1112; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kuge O, 1996, BIOCHEM J, V319, P33, DOI 10.1042/bj3190033; LI QX, 1988, J BIOL CHEM, V263, P11516; LI QX, 1990, J BIOL CHEM, V265, P4111; Raran-Kurussi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049589; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Riekhof WR, 2009, BBA-MOL CELL BIOL L, V1791, P620, DOI 10.1016/j.bbalip.2009.02.013; SATRE M, 1978, J BIOL CHEM, V253, P479; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Storey MK, 2001, J BIOL CHEM, V276, P48539, DOI 10.1074/jbc.M109043200; SUNDLER R, 1974, FEBS LETT, V43, P303, DOI 10.1016/0014-5793(74)80667-8; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; VANPOELJE PD, 1990, ANNU REV BIOCHEM, V59, P29, DOI 10.1146/annurev.bi.59.070190.000333; Voelker DR, 2009, ANNU REV BIOCHEM, V78, P827, DOI 10.1146/annurev.biochem.78.081307.112144; Voelker DR, 1997, BBA-LIPID LIPID MET, V1348, P236, DOI 10.1016/S0005-2760(97)00101-X	30	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10972	10980		10.1074/jbc.M115.642413	http://dx.doi.org/10.1074/jbc.M115.642413			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25724650	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000353404500034
J	Lau, G; Labrecque, J; Metz, M; Vaz, R; Fricker, SP				Lau, Gloria; Labrecque, Jean; Metz, Markus; Vaz, Roy; Fricker, Simon P.			Specificity for a CCR5 Inhibitor Is Conferred by a Single Amino Acid Residue ROLE OF ILE198	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CCR5; SMALL-MOLECULE CCR5; BICYCLAM NONPEPTIDE ANTAGONISTS; HIV-1 INFECTION; ACCURATE DOCKING; ENTRY INHIBITORS; BINDING; MARAVIROC; CXCR4; TYPE-1	The chemokine receptors CCR5 and CCR2b share 89% amino acid homology. CCR5 is a co-receptor for HIV and CCR5 antagonists have been investigated as inhibitors of HIV infection. We describe the use of two CCR5 antagonists, Schering-C (SCH-C), which is specific for CCR5, and TAK-779, a dual inhibitor of CCR5 and CCR2b, to probe the CCR5 inhibitor binding site using CCR5/CCR2b chimeric receptors. Compound inhibition in the different chimeras was assessed by inhibition of chemokine-induced calcium flux. SCH-C inhibited RANTES (regulated on activation, normal T cell expressed and secreted) (CCL5)-mediated calcium flux on CCR5 with an IC50 of 22.8 nM but was inactive against monocyte chemoattractant protein-1 (CCL2)-mediated calcium flux on CCR2b. However, SCH-C inhibited CCL2-induced calcium flux against a CCR5/CCR2b chimera consisting of transmembrane domains IV-VI of CCR5 with an IC50 of 55 nM. A sequence comparison of CCR5 and CCR2b identified a divergent amino acid sequence located at the junction of transmembrane domain V and second extracellular loop. Transfer of the CCR5 sequence KNFQTLKIV into CCR2b conferred SCH-C inhibition (IC50 of 122 nM) into the predominantly CCR2b chimera. Furthermore, a single substitution, R206I, conferred partial but significant inhibition (IC50 of 1023 nM) by SCH-C. These results show that a limited amino acid sequence is responsible for SCH-C specificity to CCR5, and we propose a model showing the interaction with CCR5 Ile(198).	Anormed Inc, Langley, BC V2Y 1N5, Canada; [Metz, Markus; Vaz, Roy] Sanofi, Lead Generat Candidate Realizat, Waltham, MA 02451 USA; [Fricker, Simon P.] Sanofi Genzyme R&D Ctr, Framingham, MA 01701 USA	AnorMED Inc; Sanofi-Aventis; Sanofi-Aventis; Genzyme Corporation	Fricker, SP (corresponding author), Sanofi Genzyme R&D Ctr, 49 New York Ave, Framingham, MA 01701 USA.	simonpfricker@gmail.com						Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Berkhout TA, 2003, J MED CHEM, V46, P4070, DOI 10.1021/jm030862l; Billick E., 2004, J VIROL, V78, P4134; Calandra G, 2010, CURR TOP MICROBIOL, V341, P173, DOI 10.1007/82_2010_26; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; DiPersio JF, 2009, J CLIN ONCOL, V27, P4767, DOI 10.1200/JCO.2008.20.7209; DiPersio JF, 2009, BLOOD, V113, P5720, DOI 10.1182/blood-2008-08-174946; Doranz BJ, 1997, IMMUNOL RES, V16, P15, DOI 10.1007/BF02786321; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Filer A. D., 2004, Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, V3, P103, DOI 10.2174/1568014043355393; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Fricker SP, 2014, FUTURE MED CHEM, V6, P91, DOI [10.4155/FMC.13.194, 10.4155/fmc.13.194]; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Garcia-Perez J, 2011, J BIOL CHEM, V286, P33409, DOI 10.1074/jbc.M111.279596; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; Ghorban K, 2013, INFLAMMATION, V36, P633, DOI 10.1007/s10753-012-9585-8; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Jones KL, 2011, BRIT J PHARMACOL, V162, P1453, DOI 10.1111/j.1476-5381.2010.01147.x; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Kothandan G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032864; Kromdijk W, 2010, EXPERT OPIN PHARMACO, V11, P1215, DOI 10.1517/14656561003801081; Labrecque J, 2011, VIROLOGY, V413, P231, DOI 10.1016/j.virol.2011.02.016; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Metz M, 2011, J AM CHEM SOC, V133, P16477, DOI 10.1021/ja2043722; Moore JP, 2003, P NATL ACAD SCI USA, V100, P10598, DOI 10.1073/pnas.1932511100; Moyle G, 2009, CLIN INFECT DIS, V48, P798, DOI 10.1086/597097; Mueller A, 2004, INT J BIOCHEM CELL B, V36, P35, DOI 10.1016/S1357-2725(03)00172-9; Nishikawa M, 2005, ANTIMICROB AGENTS CH, V49, P4708, DOI 10.1128/AAC.49.11.4708-4715.2005; Perry CM, 2010, DRUGS, V70, P1189, DOI 10.2165/11203940-000000000-00000; Rosenkilde MM, 2007, J BIOL CHEM, V282, P27354, DOI 10.1074/jbc.M704739200; Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1; Samson M, 1997, J BIOL CHEM, V272, P24934, DOI 10.1074/jbc.272.40.24934; Sayana S, 2009, EXPERT REV ANTI-INFE, V7, P9, DOI 10.1586/14787210.7.1.9; Seibert C, 2006, VIROLOGY, V349, P41, DOI 10.1016/j.virol.2006.01.018; Shiraishi M, 2000, J MED CHEM, V43, P2049, DOI 10.1021/jm9906264; Skerlj R, 2013, J MED CHEM, V56, P8049, DOI 10.1021/jm401101p; Skerlj RT, 2010, J MED CHEM, V53, P3376, DOI 10.1021/jm100073m; Sorce S, 2011, PROG NEUROBIOL, V93, P297, DOI 10.1016/j.pneurobio.2010.12.003; Strizki JM, 2001, P NATL ACAD SCI USA, V98, P12718, DOI 10.1073/pnas.221375398; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Thiele S, 2011, J BIOL CHEM, V286, P37543, DOI 10.1074/jbc.M111.243808; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Tsamis F, 2003, J VIROL, V77, P5201, DOI 10.1128/JVI.77.9.5201-5208.2003; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Wong RSY, 2008, MOL PHARMACOL, V74, P1485, DOI 10.1124/mol.108.049775; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Yamasaki R., 2012, CLIN EXP NEUROIMMUNO, V3, P16, DOI [DOI 10.1111/J.1759-1961.2011.00024.X, 10.1111/j.1759-1961.2011.00024.x]; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	52	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11041	11051		10.1074/jbc.M115.640169	http://dx.doi.org/10.1074/jbc.M115.640169			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25767113	Green Published, hybrid			2022-12-28	WOS:000353404500040
J	Koc, C; Gerlach, D; Beck, S; Peschel, A; Xia, GQ; Stehle, T				Koc, Cengiz; Gerlach, David; Beck, Sebastian; Peschel, Andreas; Xia, Guoqing; Stehle, Thilo			Structural and Enzymatic Analysis of TarM Glycosyltransferase from Staphylococcus aureus Reveals an Oligomeric Protein Specific for the Glycosylation of Wall Teichoic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHICILLIN RESISTANCE; BIOSYNTHESIS; INSIGHTS; LIPOPOLYSACCHARIDE; ORGANIZATION; VIRULENCE; REFMAC5; BINDING; FAMILY; CELLS	Anionic glycopolymers known as wall teichoic acids (WTAs) functionalize the peptidoglycan layers of many Gram-positive bacteria. WTAs play central roles in many fundamental aspects of bacterial physiology, and they are important determinants of pathogenesis and antibiotic resistance. A number of enzymes that glycosylate WTA in Staphylococcus aureus have recently been identified. Among these is the glycosyltransferase TarM, a component of the WTA de novo biosynthesis pathway. TarM performs the synthesis of alpha-O-N-acetylglycosylated poly-5'-phosphoribitol in the WTA structure. We have solved the crystal structure ofTarMat 2.4 angstrom resolution, and we have also determined a structure of the enzyme in complex with its substrate UDPGlcNAcat2.8A angstrom resolution. Theproteinassemblesintoapropellerlike homotrimer in which each blade contains a GT-B-type glycosyltransferase domain with a typical Rossmann fold. The enzymatic reaction retains the stereochemistry of the anomeric center of the transferred GlcNAc-moiety on the polyribitol backbone. TarM assembles into a trimer using a novel trimerization domain, here termed the HUB domain. Structure-guided mutagenesis experiments of TarM identify residues critical for enzyme activity, assign a putative role for the HUB in TarM function, and allow us to propose a likely reaction mechanism.	[Koc, Cengiz; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Gerlach, David; Beck, Sebastian; Peschel, Andreas; Xia, Guoqing] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Cellular & Mol Microbiol Sect, D-72076 Tubingen, Germany; [Peschel, Andreas; Stehle, Thilo] German Ctr Infect Res DZIF, D-72076 Tubingen, Germany; [Xia, Guoqing] Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Stopford Bld,Oxford Rd, Manchester M13 9PT, Lancs, England; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN USA	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; German Center for Infection Research; University of Manchester; Vanderbilt University	Xia, GQ (corresponding author), Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Stopford Bld,Oxford Rd, Manchester M13 9PT, Lancs, England.	guoqing.xia@manchester.ac.uk; thilo.stehle@uni-tuebingen.de	Xia, Guoqing/C-2365-2015	Xia, Guoqing/0000-0003-4492-9156	German Research Foundation [SFB766, TRR34]; German Center for Infection Research (DZIF)	German Research Foundation(German Research Foundation (DFG)); German Center for Infection Research (DZIF)	This work was supported by Collaborative Research Grant SFB766 (to A.P., G.X., and T.S.) and TRR34 (to T.S. and A. P.) from the German Research Foundation and by the German Center for Infection Research (DZIF; to G. X. and A. P.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baron, 1996, VIRAL PATHOGENESIS M; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batt SM, 2010, J BIOL CHEM, V285, P37741, DOI 10.1074/jbc.M110.165407; Baur S, 2009, J BACTERIOL, V191, P1200, DOI 10.1128/JB.01120-08; Bera A, 2007, J BACTERIOL, V189, P280, DOI 10.1128/JB.01221-06; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Brown S, 2008, CHEM BIOL, V15, P12, DOI 10.1016/j.chembiol.2007.11.011; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Brown S, 2012, P NATL ACAD SCI USA, V109, P18909, DOI 10.1073/pnas.1209126109; Campeotto I, 2014, J BIOL CHEM, V289, P28054, DOI 10.1074/jbc.M114.590570; DeLano WL., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Greenfield LK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412577; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; KOJIMA N, 1985, J BACTERIOL, V161, P299, DOI 10.1128/JB.161.1.299-306.1985; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristian SA, 2003, J INFECT DIS, V188, P414, DOI 10.1086/376533; Kurokawa K, 2013, J BIOL CHEM, V288, P30956, DOI 10.1074/jbc.M113.509893; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leonard PG, 2013, P NATL ACAD SCI USA, V110, P8525, DOI 10.1073/pnas.1302819110; Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104; Lovering AL, 2010, NAT STRUCT MOL BIOL, V17, P582, DOI 10.1038/nsmb.1819; MAKI H, 1994, J BACTERIOL, V176, P4993, DOI 10.1128/jb.176.16.4993-5000.1994; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; MULDER GJ, 1975, BIOCHEM J, V151, P131, DOI 10.1042/bj1510131; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Parsonage D, 2010, BIOCHEMISTRY-US, V49, P8398, DOI 10.1021/bi100698n; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Qamar A, 2012, ANTIMICROB AGENTS CH, V56, P3797, DOI 10.1128/AAC.00187-12; Schaffer C, 2005, MICROBIOL-SGM, V151, P643, DOI 10.1099/mic.0.27749-0; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shi WW, 2014, J BIOL CHEM, V289, P20898, DOI 10.1074/jbc.M114.581934; Steiner K, 2010, J MOL BIOL, V397, P436, DOI 10.1016/j.jmb.2010.01.035; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Velloso LM, 2008, EMBO REP, V9, P199, DOI 10.1038/sj.embor.7401154; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weidenmaier C, 2005, INFECT IMMUN, V73, P8033, DOI 10.1128/IAI.73.12.8033-8038.2005; Weidenmaier C, 2005, J INFECT DIS, V191, P1771, DOI 10.1086/429692; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Wendlinger G, 1996, MICROBIOL-UK, V142, P985, DOI 10.1099/00221287-142-4-985; Winstel V, 2014, MBIO, V5, DOI 10.1128/mBio.00869-14; WRIGHT AK, 1973, BIOPHYS J, V13, P795, DOI 10.1016/S0006-3495(73)86025-4; Xia GQ, 2011, J BACTERIOL, V193, P4006, DOI 10.1128/JB.01412-10; Xia GQ, 2010, J BIOL CHEM, V285, P13405, DOI 10.1074/jbc.M109.096172; Xiang Y, 2010, J VIROL, V84, P12265, DOI 10.1128/JVI.01303-10	55	15	17	1	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9874	9885		10.1074/jbc.M114.619924	http://dx.doi.org/10.1074/jbc.M114.619924			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25697358	Green Published, hybrid			2022-12-28	WOS:000352729400046
J	Zheng, YH; Zou, FY; Wang, JJ; Yin, GF; Le, V; Fei, ZW; Liu, JW				Zheng, Yuanhong; Zou, Fangyuan; Wang, Jingjing; Yin, Guifang; Le, Vanminh; Fei, Zhewei; Liu, Jianwen			Photodynamic Therapy-mediated Cancer Vaccination Enhances Stem-like Phenotype and Immune Escape, Which Can Be Blocked by Thrombospondin-1 Signaling through CD47 Receptor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOGENOUS INHIBITOR; TUMOR-CELLS; T-CELLS; IMMUNOTHERAPY; PATHWAY; IDENTIFICATION; GROWTH; ANGIOGENESIS; RESISTANCE; POPULATION	Like most of the strategies for cancer immunotherapy, photodynamic therapy-mediated vaccination has shown poor clinical outcomes in application. The aim of this study is to offer a glimpse at the mechanisms that are responsible for the failure based on cancer immuno-editing theory and to search for a positive solution. In this study we found that tumor cells were able to adapt themselves to the immune pressure exerted by vaccination. The survived tumor cells exhibited enhanced tumorigenic and stem-like phenotypes as well as undermined immunogenicity. Viewed as a whole, immune-selected tumor cells showed more malignant characteristics and the ability of immune escape, which might contribute to the eventual relapse. Thrombospondin-1 signaling via CD47 helped prevent tumor cells from becoming stem-like and rendered them vulnerable to immune attack. These findings prove that the TSP-1/CD47/SIRP-alpha signal axis is important to the evolution of tumor cells in the microenvironment of immunotherapy and identify thrombospondin-1 as a key signal with therapeutic benefits in overcoming long term relapse, providing new evidence for the clinical promise of cancer vaccination.	[Zheng, Yuanhong; Zou, Fangyuan; Wang, Jingjing; Yin, Guifang; Le, Vanminh; Liu, Jianwen] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Biomed Nanotechnol Ctr, Sch Pharm,Dept Mol & Cellular Pharmacol, Shanghai 200237, Peoples R China; [Zheng, Yuanhong; Zou, Fangyuan; Wang, Jingjing; Yin, Guifang; Le, Vanminh; Liu, Jianwen] E China Univ Sci & Technol, Shanghai Key Lab New Drug Design, Sch Pharm, Shanghai 200237, Peoples R China; [Fei, Zhewei] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg,Chongming Branch, Chengqiaozhen 202150, Chongming Shang, Peoples R China	East China University of Science & Technology; East China University of Science & Technology; Shanghai Jiao Tong University	Fei, ZW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg,Chongming Branch, 25 Nanmen Rd, Chengqiaozhen 202150, Chongming Shang, Peoples R China.	zheweifei@xinhuamed.com.cn; liujian@ecust.edu.cn	WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022		Shanghai Committee of Science and Technology [13140902300, 11DZ2260600]	Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by Shanghai Committee of Science and Technology Grants 13140902300 and 11DZ2260600.	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Aptsiauri N, 2008, CANCER IMMUNOL IMMUN, V57, P1727, DOI 10.1007/s00262-008-0532-3; Baek KH, 2013, J CLIN INVEST, V123, P4375, DOI 10.1172/JCI67465; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Burger P, 2012, BLOOD, V119, P5512, DOI 10.1182/blood-2011-10-386805; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Dasgupta P, 2011, JNCI-J NATL CANCER I, V103, P317, DOI 10.1093/jnci/djq541; Di Stefano B, 2009, STEM CELLS DEV, V18, P707, DOI 10.1089/scd.2008.0180; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fucikova J, 2011, CANCER RES, V71, P4821, DOI 10.1158/0008-5472.CAN-11-0950; Galluzzi L, 2012, EMBO J, V31, P1055, DOI 10.1038/emboj.2012.2; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Garg AD, 2012, CANCER IMMUNOL IMMUN, V61, P215, DOI 10.1007/s00262-011-1184-2; Garg AD, 2010, APOPTOSIS, V15, P1050, DOI 10.1007/s10495-010-0479-7; Grimbert P, 2006, J IMMUNOL, V177, P3534, DOI 10.4049/jimmunol.177.6.3534; Herreros-Villanueva M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.23; Huang CP, 2013, CANCER LETT, V328, P144, DOI 10.1016/j.canlet.2012.08.021; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Jung NC, 2012, CANCER LETT, V324, P58, DOI 10.1016/j.canlet.2012.04.024; Kabingu E, 2007, BRIT J CANCER, V96, P1839, DOI 10.1038/sj.bjc.6603792; Kaur S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01673; Kaur S, 2010, J BIOL CHEM, V285, P38923, DOI 10.1074/jbc.M110.172304; Korbelik M, 2012, CANCER IMMUNOL IMMUN, V61, P1387, DOI 10.1007/s00262-012-1206-8; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Liu TC, 2010, INT J ONCOL, V36, P777, DOI 10.3892/ijo_00000553; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2014, BIOCHEM BIOPH RES CO, V450, P353, DOI 10.1016/j.bbrc.2014.05.110; Miller TW, 2013, MATRIX BIOL, V32, P316, DOI 10.1016/j.matbio.2013.02.009; Morrison BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049752; Mroz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015194; Noh KH, 2012, CANCER RES, V72, P1717, DOI 10.1158/0008-5472.CAN-11-3758; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Ramakrishnan R, 2010, J CLIN INVEST, V120, P1111, DOI 10.1172/JCI40269; Rivera C, 2011, J ONCOL, V2011, DOI 10.1155/2011/549181; Sarfati M, 2008, CURR DRUG TARGETS, V9, P842, DOI 10.2174/138945008785909310; Schatton T, 2009, ANN NY ACAD SCI, V1176, P154, DOI 10.1111/j.1749-6632.2009.04568.x; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Shen K, 2012, BIOCHEM PHARMACOL, V84, P320, DOI 10.1016/j.bcp.2012.04.017; Shirota Y, 2012, J IMMUNOL, V188, P1592, DOI 10.4049/jimmunol.1101304; Taraboletti G, 2010, ONCOTARGET, V1, P662; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Vermeer DW, 2013, INT J CANCER, V133, P120, DOI 10.1002/ijc.28015; Wang WJ, 2013, CANCER RES, V73, P1219, DOI 10.1158/0008-5472.CAN-12-1408; Wilczynski JR, 2010, ARCH IMMUNOL THER EX, V58, P435, DOI 10.1007/s00005-010-0102-1; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Zhang AM, 2012, ASIAN PAC J CANCER P, V13, P761, DOI 10.7314/APJCP.2012.13.3.761; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108; Zheng YH, 2013, CELL STRESS CHAPERON, V18, P203, DOI 10.1007/s12192-012-0374-y	52	17	18	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8975	8986		10.1074/jbc.M114.624965	http://dx.doi.org/10.1074/jbc.M114.624965			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25697354	Green Published, hybrid			2022-12-28	WOS:000352207100024
J	Papadopoulos, T; Schemm, R; Grubmuller, H; Brose, N				Papadopoulos, Theofilos; Schemm, Rudolf; Grubmueller, Helmut; Brose, Nils			Lipid Binding Defects and Perturbed Synaptogenic Activity of a Collybistin R290H Mutant That Causes Epilepsy and Intellectual Disability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR COLLYBISTIN; LINKED MENTAL-RETARDATION; MOLECULAR SIMULATION; INHIBITORY SYNAPSES; GEPHYRIN; CDC42; ACTIVATION; ARHGEF9; IDENTIFICATION; TRAFFICKING	Signaling at nerve cell synapses is a key determinant of proper brain function, and synaptic defects-or synaptopathies-are at the basis of many neurological and psychiatric disorders. In key areas of the mammalian brain, such as the hippocampus or the basolateral amygdala, the clustering of the scaffolding protein Gephyrin and of gamma-aminobutyric acid type A receptors at inhibitory neuronal synapses is critically dependent upon the brainspecific guanine nucleotide exchange factor Collybistin (Cb). Accordingly, it was discovered recently that an R290H missense mutation in the diffuse B-cell lymphoma homology domain of Cb, which carries the guanine nucleotide exchange factor activity, leads to epilepsy and intellectual disability in human patients. In the present study, we determined the mechanism by which the CbR290H mutation perturbs inhibitory synapse formation and causes brain dysfunction. Based on a combination of biochemical, cell biological, and molecular dynamics simulation approaches, we demonstrate that the R290H mutation alters the strength of intramolecular interactions between the diffuse B-cell lymphoma homology domain and the pleckstrin homology domain of Cb. This defect reduces the phosphatidylinositol 3-phosphate binding affinity of Cb, which limits its normal synaptogenic activity. Our data indicate that impairment of the membrane lipid binding activity of Cb and a consequent defect in inhibitory synapse maturation represent a likely molecular pathomechanism of epilepsy and mental retardation in humans.	[Papadopoulos, Theofilos; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Schemm, Rudolf; Grubmueller, Helmut] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Brose, N (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, Hermann Rein Str 3, D-37075 Gottingen, Germany.	brose@em.mpg.de		Papadopoulos, Theofilos/0000-0002-0684-2407	Max Planck Society; German Research Foundation (Center of Nanoscale Microscopy and Molecular Physiology) [PA2087/1-1]; European Commission Innovative Medicines Initiative [FP7-115300]	Max Planck Society(Max Planck Society); German Research Foundation (Center of Nanoscale Microscopy and Molecular Physiology); European Commission Innovative Medicines Initiative	This work was supported by the Max Planck Society (to N. B.), the German Research Foundation (Center of Nanoscale Microscopy and Molecular Physiology of the Brain grant to N. B. and Grant PA2087/1-1 to T. P.) and European Commission Innovative Medicines Initiative FP7-115300 (to N. B.).	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chiou TT, 2011, J BIOL CHEM, V286, P22456, DOI 10.1074/jbc.M111.236190; DARDEN TA, 1993, ENVIRON HEALTH PERSP, V101, P410, DOI 10.2307/3431897; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Falasca Marco, 2006, Archives of Physiology and Biochemistry, V112, P274, DOI 10.1080/13813450601094664; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Grosskreutz Y, 2001, BIOL CHEM, V382, P1455, DOI 10.1515/BC.2001.179; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalscheuer VM, 2009, HUM MUTAT, V30, P61, DOI 10.1002/humu.20814; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Lesca G, 2011, AM J MED GENET A, V155A, P1706, DOI 10.1002/ajmg.a.34004; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; Marco EJ, 2008, J MED GENET, V45, P100, DOI 10.1136/jmg.2007.052324; Mayer S, 2013, P NATL ACAD SCI USA, V110, P20795, DOI 10.1073/pnas.1309078110; Neudauer CL, 1998, CURR BIOL, V8, P1151, DOI 10.1016/S0960-9822(07)00486-1; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Papadopoulos Theofilos, 2011, Front Cell Neurosci, V5, P11, DOI 10.3389/fncel.2011.00011; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Raiborg C, 2013, FEBS J, V280, P2730, DOI 10.1111/febs.12116; Ramamoorthi K, 2011, TRENDS MOL MED, V17, P452, DOI 10.1016/j.molmed.2011.03.003; Reddy-Alla S, 2010, EUR J NEUROSCI, V31, P1173, DOI 10.1111/j.1460-9568.2010.07149.x; Reid T, 1999, J BIOL CHEM, V274, P33587, DOI 10.1074/jbc.274.47.33587; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Shimojima K, 2011, J HUM GENET, V56, P561, DOI 10.1038/jhg.2011.58; Smith KR, 2010, CURR OPIN NEUROBIOL, V20, P550, DOI 10.1016/j.conb.2010.06.001; Tyagarajan SK, 2011, J CELL SCI, V124, P2786, DOI 10.1242/jcs.086199; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verpelli C, 2014, DEV NEUROBIOL, V74, P197, DOI 10.1002/dneu.22093; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Xiang S, 2006, J MOL BIOL, V359, P35, DOI 10.1016/j.jmb.2006.03.019	42	26	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8256	8270		10.1074/jbc.M114.633024	http://dx.doi.org/10.1074/jbc.M114.633024			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25678704	hybrid, Green Published			2022-12-28	WOS:000351662600022
J	Staubert, C; Bhuiyan, H; Lindahl, A; Broom, OJ; Zhu, YF; Islam, S; Linnarsson, S; Lehtio, J; Nordstrom, A				Staeubert, Claudia; Bhuiyan, Hasanuzzaman; Lindahl, Anna; Broom, Oliver Jay; Zhu, Yafeng; Islam, Saiful; Linnarsson, Sten; Lehtio, Janne; Nordstrom, Anders			Rewired Metabolism in Drug-resistant Leukemia Cells A METABOLIC SWITCH HALLMARKED BY REDUCED DEPENDENCE ON EXOGENOUS GLUTAMINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; FATTY-ACID OXIDATION; MULTIDRUG-RESISTANCE; CANCER; EXPRESSION; CHAIN; DAUNORUBICIN; METHYLATION; RELAPSE; ORIGIN	Cancer cells that escape induction therapy are a major cause of relapse. Understanding metabolic alterations associated with drug resistance opens up unexplored opportunities for the development of new therapeutic strategies. Here, we applied a broad spectrum of technologies including RNA sequencing, global untargeted metabolomics, and stable isotope labeling mass spectrometry to identify metabolic changes in P-glycoprotein overexpressing T-cell acute lymphoblastic leukemia (ALL) cells, which escaped a therapeutically relevant daunorubicin treatment. We show that compared with sensitive ALL cells, resistant leukemia cells possess a fundamentally rewired central metabolism characterized by reduced dependence on glutamine despite a lack of expression of glutamate-ammonia ligase (GLUL), a higher demand for glucose and an altered rate of fatty acid beta-xidation, accompanied by a decreased pantothenic acid uptake capacity. We experimentally validate our findings by selectively targeting components of this metabolic switch, using approved drugs and starvation approaches followed by cell viability analyses in both the ALL cells and in an acute myeloid leukemia (AML) sensitive/resistant cell line pair. We demonstrate how comparative metabolomics andRNAexpression profiling of drug-sensitive and -resistant cells expose targetable metabolic changes and potential resistance markers. Our results show that drug resistance is associated with significant metabolic costs in cancer cells, which could be exploited using new therapeutic strategies.	[Staeubert, Claudia; Broom, Oliver Jay; Nordstrom, Anders] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Staeubert, Claudia; Nordstrom, Anders] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden; [Islam, Saiful; Linnarsson, Sten] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Bhuiyan, Hasanuzzaman; Lindahl, Anna; Zhu, Yafeng; Lehtio, Janne; Nordstrom, Anders] Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, S-17177 Stockholm, Sweden; [Staeubert, Claudia] Univ Leipzig, Inst Biochem, Fac Med, D-04103 Leipzig, Germany	Umea University; Swedish University of Agricultural Sciences; Karolinska Institutet; Karolinska Institutet; Leipzig University	Nordstrom, A (corresponding author), Dept Mol Biol, SE-90187 Umea, Sweden.	anders.nordstrom@molbiol.umu.se	Linnarsson, Sten/HCH-3909-2022; Stäubert, Claudia/I-7397-2015	Stäubert, Claudia/0000-0003-0721-8507; Lehtio, Janne/0000-0002-8100-9562	Swedish Research Council [2007-5143, 2012-5145]; Erling-Persson family foundation; Swedish Foundation for Strategic Research; Swedish Cancer Society; Jane and Dan Olsson Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Erling-Persson family foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Cancer Society(Swedish Cancer Society); Jane and Dan Olsson Foundation	This work was supported by Swedish Research Council Grants 2007-5143 (to A. N.) and 2012-5145 (to J. L.), grants from the Erling-Persson family foundation (to Umea University), the Swedish Foundation for Strategic Research (to A. N.), the Swedish Cancer Society (to J. L.), and Jane and Dan Olsson Foundation (to A. N.).	Amiri-Kordestani L, 2012, DRUG RESIST UPDATE, V15, P50, DOI 10.1016/j.drup.2012.02.002; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Araki Y, 2001, EUR J GASTROEN HEPAT, V13, P107, DOI 10.1097/00042737-200102000-00004; Bogason A, 2011, BRIT J CLIN PHARMACO, V71, P514, DOI 10.1111/j.1365-2125.2010.03894.x; Borst P, 2013, J CLIN INVEST, V123, P4131, DOI 10.1172/JCI70430; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Castro-Perez J, 2011, J LIPID RES, V52, P159, DOI 10.1194/jlr.D009787; Castro-Perez JM, 2011, J PROTEOME RES, V10, P4281, DOI 10.1021/pr200480g; Chen KG, 2012, CLIN CANCER RES, V18, P1863, DOI 10.1158/1078-0432.CCR-11-1590; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Clendening JW, 2012, ONCOGENE, V31, P4967, DOI 10.1038/onc.2012.6; Daye D, 2012, SEMIN CELL DEV BIOL, V23, P362, DOI 10.1016/j.semcdb.2012.02.002; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Haffner MC, 2013, J CLIN INVEST, V123, P4918, DOI 10.1172/JCI70354; Hatle KM, 2007, MOL CELL BIOL, V27, P2952, DOI 10.1128/MCB.01804-06; Hatle KM, 2013, MOL CELL BIOL, V33, P2302, DOI 10.1128/MCB.00189-13; Hoffmann K, 2008, BRIT J HAEMATOL, V140, P656, DOI 10.1111/j.1365-2141.2008.06981.x; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; JONSSON K, 1995, BIOCHEM PHARMACOL, V49, P755, DOI 10.1016/0006-2952(94)00511-J; Kanda M, 2015, GASTRIC CANCER, V18, P288, DOI 10.1007/s10120-014-0372-0; Kerner J, 2007, FEBS LETT, V581, P4491, DOI 10.1016/j.febslet.2007.08.026; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lindsey JC, 2006, INT J CANCER, V118, P346, DOI 10.1002/ijc.21353; Ling B, 2013, LUNG CANCER, V79, P104, DOI 10.1016/j.lungcan.2012.10.012; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Munoz-Pinedo C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.123; Nordstrom A, 2008, ANAL CHEM, V80, P421, DOI 10.1021/ac701982e; Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052; Panigrahy D, 2008, P NATL ACAD SCI USA, V105, P985, DOI 10.1073/pnas.0711281105; Roe DS, 2000, MOL GENET METAB, V69, P69, DOI 10.1006/mgme.1999.2950; Shridhar V, 2001, CANCER RES, V61, P4258; Singh B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036510; Stock W, 2013, CANCER-AM CANCER SOC, V119, P90, DOI 10.1002/cncr.27617; Strathdee G, 2004, CARCINOGENESIS, V25, P693, DOI 10.1093/carcin/bgh066; Styczynski J, 2007, J CANCER RES CLIN, V133, P875, DOI 10.1007/s00432-007-0274-1; Tein I, 2013, HAND CLINIC, V113, P1675, DOI 10.1016/B978-0-444-59565-2.00035-6; TSERNG KY, 1991, BIOCHEMISTRY-US, V30, P2508, DOI 10.1021/bi00223a030; Violante S, 2013, BBA-MOL BASIS DIS, V1832, P773, DOI 10.1016/j.bbadis.2013.02.012; Witham J, 2008, INT J CANCER, V122, P2641, DOI 10.1002/ijc.23427; Zahreddine H, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00028; Zajac P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085270; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	46	54	56	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8348	8359		10.1074/jbc.M114.618769	http://dx.doi.org/10.1074/jbc.M114.618769			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25697355	Green Published, hybrid			2022-12-28	WOS:000351662600029
J	Wadhwa, R; Ryu, J; Ahn, HM; Saxena, N; Chaudhary, A; Yun, CO; Kaul, SC				Wadhwa, Renu; Ryu, Jihoon; Ahn, Hyo Min; Saxena, Nishant; Chaudhary, Anupama; Yun, Chae-Ok; Kaul, Sunil C.			Functional Significance of Point Mutations in Stress Chaperone Mortalin and Their Relevance to Parkinson Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-PROTEIN L11; CELLULAR SENESCENCE; INDUCED APOPTOSIS; CANCER-CELLS; MOLECULAR CHAPERONES; HUMAN FIBROBLASTS; OXIDATIVE STRESS; HSP70 FAMILY; MOUSE MOT-1; IN-VITRO	Mortalin/mtHsp70/Grp75 (mot-2), a heat shock protein 70 family member, is an essential chaperone, enriched in cancers, and has been shown to possess pro-proliferative and anti-apoptosis functions. An allelic form of mouse mortalin (mot-1) that differs by two amino acids, M618V and G624R, in the C terminus substrate-binding domain has been reported. Furthermore, genome sequencing of mortalin from Parkinson disease patients identified two missense mutants, R126W and P509S. In the present study, we investigated the significance of these mutations in survival, proliferation, and oxidative stress tolerance in human cells. Using mot-1 and mot-2 recombinant proteins and specific antibodies, we performed screening to find their binding proteins and then identified ribosomal protein L-7 (RPL-7) and elongation factor-1 alpha (EF-1 alpha), which differentially bind to mot-1 and mot-2, respectively. We demonstrate that mot-1, R126W, or P509S mutant (i) lacks mot-2 functions involved in carcinogenesis, such as p53 inactivation and hTERT/hnRNP-K (heterogeneous nuclear ribonucleoprotein K) activation; (ii) causes increased level of endogenous oxidative stress; (iii) results in decreased tolerance of cells to exogenous oxidative stress; and (iv) shows differential binding and impact on the RPL-7 and EF-1 alpha proteins. These factors may mediate the transformation of longevity/pro-proliferative function of mot-2 to the premature aging/anti-proliferative effect of mutants, and hence may have significance in cellular aging, Parkinson disease pathology, and prognosis.	[Wadhwa, Renu; Ryu, Jihoon; Ahn, Hyo Min; Saxena, Nishant; Chaudhary, Anupama; Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, Int Lab Adv Biomedicine DAILAB, Cell Proliferat Res Grp, Tsukuba, Ibaraki 3058562, Japan; [Wadhwa, Renu; Ryu, Jihoon; Ahn, Hyo Min; Saxena, Nishant; Chaudhary, Anupama; Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, Int Lab Adv Biomedicine DAILAB, Dept Biotechnol DBT India, Tsukuba, Ibaraki 3058562, Japan; [Yun, Chae-Ok] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Hanyang University	Yun, CO (corresponding author), Hanyang Univ, Coll Engn, Dept Bioengn, 222 Wangsimni Ro, Seoul 133791, South Korea.	chaeok@hanyang.ac.kr; s-kaul@aist.go.jp	Wadhwa, Renu/L-8898-2018; Yun, Chae-Ok/P-3698-2015; Chaudhary, Anupama/AAF-8156-2020; Kaul, Sunil C/L-8671-2018	Wadhwa, Renu/0000-0001-8248-5192; Chaudhary, Anupama/0000-0001-9619-8813; Kaul, Sunil C/0000-0002-0046-3916; Yun, Chae-Ok/0000-0002-9466-4531	Japanese Society for the Promotion of Science, Japan; Korea Food and Drug Administration [13172KFDA306]; Korea Science, Engineering Foundation [2010-0029220, 2013K1A1A2A02050188, 2013M3A9D3045879]	Japanese Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); Korea Science, Engineering Foundation(Korea Science and Engineering Foundation)	This study was partly supported by grants-in-aid for scientific research (Kakenhi) from the Japanese Society for the Promotion of Science, Japan (to S. C. K.) and grants from the Korea Food and Drug Administration (13172KFDA306) and the Korea Science, Engineering Foundation (2010-0029220, 2013K1A1A2A02050188, 2013M3A9D3045879, brain Korea 21 plus) (to C. O. Y.)	Banerjee S, 2014, INT J BIOCHEM CELL B, V54, P36, DOI 10.1016/j.biocel.2014.05.041; Berghofer-Hochheimer Y, 1998, J CELL BIOCHEM, V69, P1, DOI 10.1002/(SICI)1097-4644(19980401)69:1<1::AID-JCB1>3.0.CO;2-X; Blanch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066436; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; Burbulla LF, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.103; Burbulla LF, 2010, HUM MOL GENET, V19, P4437, DOI 10.1093/hmg/ddq370; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cheung CT, 2010, ANN NY ACAD SCI, V1197, P129, DOI 10.1111/j.1749-6632.2009.05392.x; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Dai MS, 2012, J BIOL CHEM, V287, P17120, DOI 10.1074/jbc.M111.311902; De Mena L, 2009, J NEURAL TRANSM, V116, P1289, DOI 10.1007/s00702-009-0273-2; Deocaris CC, 2006, ANN NY ACAD SCI, V1067, P220, DOI 10.1196/annals.1354.027; Gaweda-Walerych K, 2013, CURR GENOMICS, V14, P543, DOI 10.2174/1389202914666131210211033; Giffard RG, 2013, J CLIN INVEST, V123, P3206, DOI 10.1172/JCI70799; GRANT AG, 1992, INT J CANCER, V50, P740, DOI 10.1002/ijc.2910500513; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hayflick L, 1998, EXP GERONTOL, V33, P639, DOI 10.1016/S0531-5565(98)00023-0; HEMMERICH P, 1993, NUCLEIC ACIDS RES, V21, P223, DOI 10.1093/nar/21.2.223; Kaul SC, 1998, ONCOGENE, V17, P907, DOI 10.1038/sj.onc.1202017; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kaul SC, 2003, EXP CELL RES, V286, P96, DOI 10.1016/S0014-4827(03)00101-0; Kaul SC, 2000, BIOCHEM BIOPH RES CO, V279, P602, DOI 10.1006/bbrc.2000.3986; Kaul SC, 2007, EXP GERONTOL, V42, P263, DOI 10.1016/j.exger.2006.10.020; Kaul Z, 2012, EMBO REP, V13, P52, DOI 10.1038/embor.2011.227; Lu WJ, 2011, CELL DEATH DIFFER, V18, P1046, DOI 10.1038/cdd.2010.177; Lu WJ, 2011, INT J CANCER, V129, P1806, DOI 10.1002/ijc.25857; Ma Z, 2006, ONCOGENE, V25, P5377, DOI 10.1038/sj.onc.1209543; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Nakabayashi K, 1997, EXP CELL RES, V235, P345, DOI 10.1006/excr.1997.3678; Park SJ, 2014, J BIOL CHEM, V289, P2195, DOI 10.1074/jbc.M113.492587; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Pecorari L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-58; Qu MY, 2012, NEUROSCI RES, V72, P94, DOI 10.1016/j.neures.2011.09.009; Ryu J, 2014, J BIOL CHEM, V289, P24832, DOI 10.1074/jbc.M114.565929; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Shi YQ, 2004, EXP CELL RES, V296, P337, DOI 10.1016/j.yexcr.2004.02.009; Shibata Y, 2014, CURR BIOL, V24, pR463, DOI 10.1016/j.cub.2014.03.033; Shih YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026236; Slepenkov SV, 2003, BIOCHEMISTRY-US, V42, P5867, DOI 10.1021/bi034126v; Soti C, 2003, EXP GERONTOL, V38, P1037, DOI 10.1016/S0531-5565(03)00185-2; Soti C, 2003, AGING CELL, V2, P39, DOI 10.1046/j.1474-9728.2003.00031.x; Strub A, 2003, J MOL BIOL, V334, P1087, DOI 10.1016/j.jmb.2003.10.023; Tai-Nagara I, 2014, BLOOD, V123, P41, DOI 10.1182/blood-2013-06-508333; Talapatra S, 2002, CELL DEATH DIFFER, V9, P856, DOI 10.1038/sj.cdd.4401078; Verbeke P, 2001, FREE RADICAL BIO MED, V31, P1593, DOI 10.1016/S0891-5849(01)00752-3; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; WADHWA R, 1993, J BIOL CHEM, V268, P22239; WADHWA R, 1993, J BIOL CHEM, V268, P6615; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; Yang LM, 2011, C IND ELECT APPL, P2011, DOI 10.1109/ICIEA.2011.5975922; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5; Zhu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083714	54	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8447	8456		10.1074/jbc.M114.627463	http://dx.doi.org/10.1074/jbc.M114.627463			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25645922	Green Published, hybrid			2022-12-28	WOS:000351662600037
J	Weiser, BP; Eckenhoff, RG				Weiser, Brian P.; Eckenhoff, Roderic G.			Propofol Inhibits SIRT2 Deacetylase through a Conformation-specific, Allosteric Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERAL ANESTHETIC PROPOFOL; SWISS-MODEL; HISTONE DEACETYLASE; RAT-BRAIN; EMBL-EBI; PROTEIN; MECHANISM; ACETYLATION; INFORMATION; TUBULIN	meta-Azi-propofol (AziPm) is a photoactive analog of the general anesthetic propofol. We photolabeled a myelin-enriched fraction from rat brain with [H-3]AziPm and identified the sirtuin deacetylase SIRT2 as a target of the anesthetic. AziPm photolabeled three SIRT2 residues (Tyr(139), Phe(190), and Met(206)) that are located in a single allosteric protein site, and propofol inhibited [H-3]AziPm photolabeling of this site in myelin SIRT2. Structural modeling and in vitro experiments with recombinant human SIRT2 determined that propofol and [H-3]AziPm only bind specifically and competitively to the enzyme when co-equilibrated with other substrates, which suggests that the anesthetic site is either created or stabilized in enzymatic conformations that are induced by substrate binding. In contrast to SIRT2, specific binding of [H-3]AziPm or propofol to recombinant human SIRT1 was not observed. Residues that line the propofol binding site on SIRT2 contact the sirtuin co-substrate NAD(+) during enzymatic catalysis, and assays that measured SIRT2 deacetylation of acetylated alpha-tubulin revealed that propofol inhibits enzymatic function. We conclude that propofol inhibits the mammalian deacetylase SIRT2 through a conformation-specific, allosteric protein site that is unique from the previously described binding sites of other inhibitors. This suggests that propofol might influence cellular events that are regulated by protein acetylation state.	[Weiser, Brian P.; Eckenhoff, Roderic G.] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Weiser, Brian P.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Eckenhoff, RG (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	roderic.eckenhoff@uphs.upenn.edu		Eckenhoff, Roderic/0000-0002-5581-746X	National Institutes of Health [P01-GM055876, F31-NS080519]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM055876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS080519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-GM055876 (to R.G.E.) and F31-NS080519 (to B.P.W.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Avalos JL, 2004, MOL CELL, V13, P639, DOI 10.1016/S1097-2765(04)00082-6; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Ballatore C, 2012, J MED CHEM, V55, P8979, DOI 10.1021/jm301079z; Beirowski B, 2011, P NATL ACAD SCI USA, V108, pE952, DOI 10.1073/pnas.1104969108; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Creeley C, 2013, BRIT J ANAESTH, V110, P29, DOI 10.1093/bja/aet173; Darbandi-Tonkabon R, 2003, J BIOL CHEM, V278, P13196, DOI 10.1074/jbc.M213168200; Davenport AM, 2014, J MOL BIOL, V426, P526, DOI 10.1016/j.jmb.2013.10.009; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emerson DJ, 2013, J AM CHEM SOC, V135, P5389, DOI 10.1021/ja311171u; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Gertz M, 2013, P NATL ACAD SCI USA, V110, pE2772, DOI 10.1073/pnas.1303628110; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hall MA, 2010, J MED CHEM, V53, P5667, DOI 10.1021/jm1004072; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Jin L, 2009, J BIOL CHEM, V284, P24394, DOI 10.1074/jbc.M109.014928; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kretschmannova K, 2013, J NEUROSCI, V33, P7264, DOI 10.1523/JNEUROSCI.5475-12.2013; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Li WB, 2007, J NEUROSCI, V27, P2606, DOI 10.1523/JNEUROSCI.4181-06.2007; Liu L, 2012, J BIOL CHEM, V287, P32307, DOI 10.1074/jbc.C112.403048; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Moniot S, 2013, J STRUCT BIOL, V182, P136, DOI 10.1016/j.jsb.2013.02.012; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Patel S, 2003, BRIT J PHARMACOL, V139, P1005, DOI 10.1038/sj.bjp.0705334; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Southwood CM, 2007, NEUROCHEM RES, V32, P187, DOI 10.1007/s11064-006-9127-6; Stewart DS, 2011, J MED CHEM, V54, P8124, DOI 10.1021/jm200943f; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; Weiser BP, 2014, FEBS LETT, V588, P4398, DOI 10.1016/j.febslet.2014.10.009; Weiser Brian P, 2014, Curr Anesthesiol Rep, V4, P57; Weiser BP, 2013, J BIOL CHEM, V288, P1279, DOI 10.1074/jbc.M112.413989; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; Whittington RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016648; Xi J, 2004, J BIOL CHEM, V279, P19628, DOI 10.1074/jbc.M313864200; Yip GMS, 2013, NAT CHEM BIOL, V9, P715, DOI [10.1038/NCHEMBIO.1340, 10.1038/nchembio.1340]; Zhang XN, 2009, NEUROSCI LETT, V465, P165, DOI 10.1016/j.neulet.2009.08.025	46	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8559	8568		10.1074/jbc.M114.620732	http://dx.doi.org/10.1074/jbc.M114.620732			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25666612	hybrid, Green Published			2022-12-28	WOS:000351662600046
J	Gilder, AS; Jones, KA; Hu, JJ; Wang, L; Chen, CC; Carter, BS; Gonias, SL				Gilder, Andrew S.; Jones, Karra A.; Hu, Jingjing; Wang, Lei; Chen, Clark C.; Carter, Bob S.; Gonias, Steven L.			Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; EGF RECEPTOR; MUTANT EGFR; PROGNOSTIC VALUE; CLEAVED FORMS; IN-VIVO; UPAR; HETEROGENEITY; SURVIVAL; CANCER	Genomic heterogeneity is characteristic of glioblastoma (GBM). In many GBMs, the EGF receptor gene (EGFR) is amplified and may be truncated to generate a constitutively active form of the receptor called EGFRvIII. EGFR gene amplification and EGFRvIII are associated with GBM progression, even when only a small fraction of the tumor cells express EGFRvIII. In this study, we show that EGFRvIII-positive GBM cells express significantly increased levels of cellular urokinase receptor (uPAR) and release increased amounts of soluble uPAR (suPAR). When mice were xenografted with human EGFRvIII-expressing GBM cells, tumor-derived suPAR was detected in the plasma, and the level was significantly increased compared with that detected in plasma samples from control mice xenografted with EGFRvIII-negative GBM cells. suPAR also was increased in plasma from patients with EGFRvIII-positive GBMs. Purified suPAR was biologically active when added to cultures of EGFRvIII-negative GBM cells, activating cell signaling and promoting cell migration and invasion. suPAR did not significantly stimulate cell signaling or migration of EGFRvIII-positive cells, probably because cell signaling was already substantially activated in these cells. The activities of suPAR were replicated by conditioned medium (CM) from EGFRvIII-positive GBM cells. When the CM was preincubated with uPAR-neutralizing antibody or when uPAR gene expression was silenced in cells used to prepare CM, the activity of the CM was significantly attenuated. These results suggest that suPAR may function as an important paracrine signaling factor in EGFRvIII-positive GBMs, inducing an aggressive phenotype in tumor cells that are EGFRvIII-negative.	[Gilder, Andrew S.; Jones, Karra A.; Hu, Jingjing; Wang, Lei; Gonias, Steven L.] Univ Calif San Diego, Div Neurosurg, Dept Pathol, La Jolla, CA 92093 USA; [Chen, Clark C.; Carter, Bob S.] Univ Calif San Diego, Div Neurosurg, Dept Surg, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Gonias, SL (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sgonias@ucsd.edu	Jones, Karra A/GXM-8805-2022; Regan, Clinton/E-6250-2012; Carter, Bob/AAB-4868-2021	Jones, Karra A/0000-0002-8819-8992; Carter, Bob/0000-0002-3586-1324; Gilder, Andrew/0000-0002-3938-4086	National Institutes of Health [R01 CA169096, 2P01CA069246-15A, UH2TR000931]; Doris Duke Charitable Foundation Clinical Scientist Development Award; Sontag Foundation Distinguished Scientist Award; Burroughs Wellcome Fund Career Awards for Medical Scientists; Kimmel Scholar award; American Brain Tumor Association; Accelerated Brain Cancer Cure; William Guy Forbeck Research Foundation; NATIONAL CANCER INSTITUTE [R01CA169096, P01CA069246] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000931] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); Sontag Foundation Distinguished Scientist Award; Burroughs Wellcome Fund Career Awards for Medical Scientists; Kimmel Scholar award; American Brain Tumor Association; Accelerated Brain Cancer Cure; William Guy Forbeck Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA169096 (to S. L. G.) and 2P01CA069246-15A and UH2TR000931 (to B. S. C.).; Supported by the Doris Duke Charitable Foundation Clinical Scientist Development Award, the Sontag Foundation Distinguished Scientist Award, the Burroughs Wellcome Fund Career Awards for Medical Scientists, the Kimmel Scholar award, a Discovery Grant from the American Brain Tumor Association, a grant from Accelerated Brain Cancer Cure, and the William Guy Forbeck Research Foundation.	Almasi CE, 2011, PROSTATE, V71, P899, DOI 10.1002/pros.21306; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Bruntz RC, 2014, J BIOL CHEM, V289, P600, DOI 10.1074/jbc.M113.532978; Chumbalkar V, 2011, J PROTEOME RES, V10, P1343, DOI 10.1021/pr101075e; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Degryse B, 2005, J BIOL CHEM, V280, P24792, DOI 10.1074/jbc.M413954200; Edsfeldt A, 2012, STROKE, V43, P3305, DOI 10.1161/STROKEAHA.112.664094; EKSTRAND AJ, 1994, ONCOGENE, V9, P2313; Francis JM, 2014, CANCER DISCOV, V4, P956, DOI 10.1158/2159-8290.CD-13-0879; Gill BJ, 2014, P NATL ACAD SCI USA, V111, P12550, DOI 10.1073/pnas.1405839111; Gonias SL, 2011, CURR PHARM DESIGN, V17, P1962; Harada K, 1998, CANCER RES, V58, P4694; Henic E, 2008, CLIN CANCER RES, V14, P5785, DOI 10.1158/1078-0432.CCR-08-0096; Holst-Hansen C, 1999, BRIT J CANCER, V81, P203, DOI 10.1038/sj.bjc.6690678; Hu J, 2015, ONCOGENE, V34, P4078, DOI 10.1038/onc.2014.336; Hu JJ, 2011, P NATL ACAD SCI USA, V108, P15984, DOI 10.1073/pnas.1113416108; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jing JX, 2012, J CLIN LAB ANAL, V26, P16, DOI 10.1002/jcla.20499; Jo M, 2007, ONCOGENE, V26, P2585, DOI 10.1038/sj.onc.1210066; Jo MJ, 2005, J BIOL CHEM, V280, P17449, DOI 10.1074/jbc.M413141200; Jo MJ, 2003, J BIOL CHEM, V278, P46692, DOI 10.1074/jbc.M308808200; Koga T, 2011, CLIN EXP RHEUMATOL, V29, P811; Langkilde A, 2011, CANCER EPIDEM BIOMAR, V20, P609, DOI 10.1158/1055-9965.EPI-10-1009; LIBERMANN TA, 1984, CANCER RES, V44, P753; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Lomholt AF, 2010, ACTA ONCOL, V49, P805, DOI 10.3109/0284186X.2010.491086; MANDRIOTA SJ, 1995, J BIOL CHEM, V270, P9709, DOI 10.1074/jbc.270.17.9709; Mazzieri R, 2006, MOL BIOL CELL, V17, P367, DOI 10.1091/mbc.E05-07-0635; Montuori N, 2002, J BIOL CHEM, V277, P46932, DOI 10.1074/jbc.M207494200; Montuori N, 2009, FRONT BIOSCI-LANDMRK, V14, P2494, DOI 10.2741/3392; Mukasa A, 2010, P NATL ACAD SCI USA, V107, P2616, DOI 10.1073/pnas.0914356107; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; PLESNER T, 1994, AM J CLIN PATHOL, V102, P835, DOI 10.1093/ajcp/102.6.835; PYKE C, 1993, FEBS LETT, V326, P69, DOI 10.1016/0014-5793(93)81763-P; Rao JS, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.19; Reidy MA, 1996, CIRC RES, V78, P405, DOI 10.1161/01.RES.78.3.405; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Rigolin GM, 2003, BRIT J HAEMATOL, V120, P953, DOI 10.1046/j.1365-2141.2003.04176.x; Riisbro R, 2002, CLIN CANCER RES, V8, P1132; Salkeni MA, 2013, J NEURO-ONCOL, V115, P27, DOI 10.1007/s11060-013-1209-0; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Savva A, 2011, J INFECTION, V63, P344, DOI 10.1016/j.jinf.2011.07.016; Selleri C, 2005, BLOOD, V105, P2198, DOI 10.1182/blood-2004-06-2424; Shariat SF, 2007, J CLIN ONCOL, V25, P349, DOI 10.1200/JCO.2006.05.6853; Shetty S, 1996, AM J RESP CELL MOL, V15, P78, DOI 10.1165/ajrcmb.15.1.8679225; Shinojima N, 2003, CANCER RES, V63, P6962; Sidenius N, 2000, FEBS LETT, V475, P52, DOI 10.1016/S0014-5793(00)01624-0; Sidenius N, 2000, BLOOD, V96, P4091; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Solberg H, 2001, J HISTOCHEM CYTOCHEM, V49, P237, DOI 10.1177/002215540104900211; Tarui T, 2001, J BIOL CHEM, V276, P3983, DOI 10.1074/jbc.M008220200; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wilhelm OG, 1999, J CELL PHYSIOL, V180, P225, DOI 10.1002/(SICI)1097-4652(199908)180:2<225::AID-JCP10>3.0.CO;2-2; Wykosky J, 2015, CANCER RES, V75, P394, DOI 10.1158/0008-5472.CAN-14-2004; Zimmermann HW, 2012, LIVER INT, V32, P500, DOI 10.1111/j.1478-3231.2011.02665.x	60	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14798	14809		10.1074/jbc.M115.637488	http://dx.doi.org/10.1074/jbc.M115.637488			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25837250	Green Published, hybrid			2022-12-28	WOS:000356177300001
J	Kobayashi, Y; Kiguchi, N; Fukazawa, Y; Saika, F; Maeda, T; Kishioka, S				Kobayashi, Yuka; Kiguchi, Norikazu; Fukazawa, Yohji; Saika, Fumihiro; Maeda, Takehiko; Kishioka, Shiroh			Macrophage-T Cell Interactions Mediate Neuropathic Pain through the Glucocorticoid-induced Tumor Necrosis Factor Ligand System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-NERVE INJURY; SCIATIC-NERVE; IMMUNE-SYSTEM; UP-REGULATION; RECEPTOR; INFLAMMATION; FAMILY; GITR; INTERLEUKIN-1-BETA; NEUROINFLAMMATION	Peripheral neuroinflammation caused by activated immune cells can provoke neuropathic pain. Herein, we investigate the actions of macrophages and T cells through glucocorticoid-induced tumor neurosis factor receptor ligand (GITRL) and its receptor (GITR) in neuropathic pain. After partial sciatic nerve ligation (PSL) in enhanced green fluorescent protein (eGFP) chimeric mice generated by the transplantation of eGFP(+) bone marrow cells, eGFP(+) macrophages, and T cells markedly migrated to the injured site after PSL. Administration of agents to deplete macrophages (liposome-clodronate and Clophosome-A (TM)) or T cells (anti-CD4 antibody and FTY720) could suppress PSL-induced thermal hyperalgesia and tactile allodynia. The expression levels of co-stimulatory molecules GITRL and GITR were increased on infiltrating macrophages and T cells, respectively. The perineural injection of a GITRL neutralizing antibody that could inhibit the function of the GITRL-GITR pathway attenuated PSL-induced neuropathic pain. Additionally, the induction of inflammatory cytokines and the accumulation of GITR(+) T cells in the injured SCN were abrogated after macrophage depletion by Clophosome-A (TM). In conclusion, GITRL expressed on macrophages drives cytokine release and T cell activation, resulting in neuropathic pain via GITR-dependent actions. The GITRL-GITR pathway might represent a novel target for the treatment of neuropathic pain.	[Kobayashi, Yuka; Kiguchi, Norikazu; Fukazawa, Yohji; Saika, Fumihiro; Kishioka, Shiroh] Wakayama Med Univ, Dept Pharmacol, Wakayama 6410012, Japan; [Maeda, Takehiko] Niigata Univ Pharm & Appl Life Sci, Dept Pharmacol, Niigata 9568603, Japan	Wakayama Medical University; Niigata University	Kishioka, S (corresponding author), Wakayama Med Univ, Dept Pharmacol, 811-1 Kimiidera, Wakayama 6410012, Japan.	kishioka@wakayama-med.ac.jp		Maeda, Takehiko/0000-0002-3184-0999	Japan Society for the Promotion of Science (Tokyo, Japan) [B:23791724]	Japan Society for the Promotion of Science (Tokyo, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Young Scientists Grant B:23791724 from the Japan Society for the Promotion of Science (Tokyo, Japan).	Austin PJ, 2012, PAIN, V153, P1916, DOI 10.1016/j.pain.2012.06.005; Baron R, 2006, NAT CLIN PRACT NEURO, V2, P95, DOI 10.1038/ncpneuro0113; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Coste O, 2008, J CELL MOL MED, V12, P995, DOI 10.1111/j.1582-4934.2008.00160.x; Cuzzocrea S, 2006, J IMMUNOL, V177, P631, DOI 10.4049/jimmunol.177.1.631; Gurney AL, 1999, CURR BIOL, V9, P215, DOI 10.1016/S0960-9822(99)80093-1; Hall BM, 2011, CURR OPIN IMMUNOL, V23, P641, DOI 10.1016/j.coi.2011.07.012; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Kiguchi N, 2012, NEUROCHEM INT, V61, P1212, DOI 10.1016/j.neuint.2012.09.001; Kiguchi N, 2012, CURR OPIN PHARMACOL, V12, P55, DOI 10.1016/j.coph.2011.10.007; Kiguchi N, 2012, J PHARMACOL EXP THER, V340, P577, DOI 10.1124/jpet.111.187724; Kiguchi N, 2010, PAIN, V149, P305, DOI 10.1016/j.pain.2010.02.025; Kleinschnitz C, 2006, EXP NEUROL, V200, P480, DOI 10.1016/j.expneurol.2006.03.014; Kobayashi Y, 2012, BIOCHEM BIOPH RES CO, V421, P318, DOI 10.1016/j.bbrc.2012.03.153; Li JJ, 2005, PAIN, V118, P232, DOI 10.1016/j.pain.2005.08.023; Liao GX, 2014, FASEB J, V28, P474, DOI 10.1096/fj.13-236505; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Nocentini G, 2008, MOL PHARMACOL, V73, P1610, DOI 10.1124/mol.107.044354; Okada Y, 2011, AM J PATHOL, V178, P2654, DOI 10.1016/j.ajpath.2011.02.043; Saika F, 2012, EUR J PAIN, V16, P1271, DOI 10.1002/j.1532-2149.2012.00146.x; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Shevach EM, 2006, NAT REV IMMUNOL, V6, P613, DOI 10.1038/nri1867; Steward-Tharp SM, 2010, ANN NY ACAD SCI, V1183, P123, DOI 10.1111/j.1749-6632.2009.05124.x; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; Thacker MA, 2007, ANESTH ANALG, V105, P838, DOI 10.1213/01.ane.0000275190.42912.37; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wei XH, 2007, EXP NEUROL, V205, P471, DOI 10.1016/j.expneurol.2007.03.012; You S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007848; Zelenka M, 2005, PAIN, V116, P257, DOI 10.1016/j.pain.2005.04.018	33	54	55	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12603	12613		10.1074/jbc.M115.636506	http://dx.doi.org/10.1074/jbc.M115.636506			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25787078	Green Published, hybrid			2022-12-28	WOS:000354569000016
J	Han, XZ; Pozo, FM; Wisotsky, JN; Wang, BL; Jacobberger, JW; Zhang, YW				Han, Xiangzi; Pozo, Franklin Mayca; Wisotsky, Jacob N.; Wang, Benlian; Jacobberger, James W.; Zhang, Youwei			Phosphorylation of Minichromosome Maintenance 3 (MCM3) by Checkpoint Kinase 1 (Chk1) Negatively Regulates DNA Replication and Checkpoint Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; DNA Damage; DNA Replication; Phosphorylation; Signal Transduction	CELL-CYCLE CHECKPOINT; S-PHASE; DAMAGE CHECKPOINT; COMPLEX; PROTEIN; ATR; INITIATION; STRESS; HELICASE; PROMOTES	Background: Chk1 and the MCM complex play important roles in DNA replication and replication checkpoint. Results: Chk1 phosphorylates MCM3. Conclusion: Phosphorylation of MCM3 by Chk1 regulates normal DNA replication and checkpoint. Significance: These results provide insights into our understanding of DNA replication control and replication checkpoint activation. Mechanisms controlling DNA replication and replication checkpoint are critical for the maintenance of genome stability and the prevention or treatment of human cancers. Checkpoint kinase 1 (Chk1) is a key effector protein kinase that regulates the DNA damage response and replication checkpoint. The heterohexameric minichromosome maintenance (MCM) complex is the core component of mammalian DNA helicase and has been implicated in replication checkpoint activation. Here we report that Chk1 phosphorylates the MCM3 subunit of the MCM complex at Ser-205 under normal growth conditions. Mutating the Ser-205 of MCM3 to Ala increased the length of DNA replication track and shortened the S phase duration, indicating that Ser-205 phosphorylation negatively controls normal DNA replication. Upon replicative stress treatment, the inhibitory phosphorylation of MCM3 at Ser-205 was reduced, and this reduction was accompanied with the generation of single strand DNA, the key platform for ataxia telangiectasia mutated and Rad3-related (ATR) activation. As a result, the replication checkpoint is activated. Together, these data provide significant insights into the regulation of both normal DNA replication and replication checkpoint activation through the novel phosphorylation of MCM3 by Chk1.	[Han, Xiangzi; Pozo, Franklin Mayca; Zhang, Youwei] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Wisotsky, Jacob N.; Zhang, Youwei] Case Western Reserve Univ, Dept Genet & Genome Sci, Sch Med, Cleveland, OH 44106 USA; [Jacobberger, James W.; Zhang, Youwei] Case Western Reserve Univ, Case Comprehens Canc Ctr, Sch Med, Cleveland, OH 44106 USA; [Wang, Benlian] Case Western Reserve Univ, Ctr Prote & Bioinformat, Sch Med, Cleveland, OH 44106 USA; [Jacobberger, James W.] Case Western Reserve Univ, Div Gen Med Sci, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Zhang, YW (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Case Comprehens Canc Ctr, 2123 Adelbert Rd,Wood Bldg W343A, Cleveland, OH 44106 USA.	yxz169@case.edu	Regan, Clinton/E-6250-2012; Jacobberger, James/P-9183-2014	Jacobberger, James/0000-0002-3092-5157	National Institutes of Health [R00 CA126173]; NCI; NCI [R01 CA163214]; American Cancer Society Pilot Grant ACS [IRG-91-022-15]; NATIONAL CANCER INSTITUTE [R00CA126173, R01CA163214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society Pilot Grant ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R00 CA126173, a career development award from the NCI, and R01 CA163214 from the NCI (to Y. Z.). This work was also supported by American Cancer Society Pilot Grant ACS IRG-91-022-15 (to Y. Z.).	Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bialik S, 2008, MOL CELL PROTEOMICS, V7, P1089, DOI 10.1074/mcp.M700579-MCP200; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Guo C, 2015, MOL CELL, V57, P492, DOI 10.1016/j.molcel.2014.12.003; Han XZ, 2014, J BIOL CHEM, V289, P24716, DOI 10.1074/jbc.M114.575035; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ilves I, 2012, P NATL ACAD SCI USA, V109, P13163, DOI 10.1073/pnas.1211525109; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Lin DI, 2008, P NATL ACAD SCI USA, V105, P8079, DOI 10.1073/pnas.0800077105; Liu QH, 2000, GENE DEV, V14, P1448; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Pereverzeva I, 2000, MOL CELL BIOL, V20, P3667, DOI 10.1128/MCB.20.10.3667-3676.2000; Petermann E, 2010, P NATL ACAD SCI USA, V107, P16090, DOI 10.1073/pnas.1005031107; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Scorah J, 2008, J BIOL CHEM, V283, P17250, DOI 10.1074/jbc.M800369200; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Shi YL, 2007, J BIOL CHEM, V282, P9236, DOI 10.1074/jbc.M609256200; Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takai H, 2000, GENE DEV, V14, P1439; Taricani L, 2009, CELL CYCLE, V8, P482, DOI 10.4161/cc.8.3.7661; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Tye BK, 2000, J BIOL CHEM, V275, P34833, DOI 10.1074/jbc.R000018200; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Wang JN, 2012, J BIOL CHEM, V287, P25501, DOI 10.1074/jbc.M112.350397; Wang JN, 2011, CELL CYCLE, V10, P500, DOI 10.4161/cc.10.3.14753; Yoo HY, 2004, J BIOL CHEM, V279, P53353, DOI 10.1074/jbc.M408026200; Zachos G, 2005, MOL CELL BIOL, V25, P563, DOI 10.1128/MCB.25.2.563-574.2005; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2014, INT J CANCER, V134, P1013, DOI 10.1002/ijc.28226; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019	41	22	24	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12370	12378		10.1074/jbc.M114.621532	http://dx.doi.org/10.1074/jbc.M114.621532			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25809478	hybrid, Green Published			2022-12-28	WOS:000354388600045
J	Frey, PA				Frey, Perry Allen			Transient Intermediates in Enzymology, 1964-2008	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; BARRIER HYDROGEN-BONDS; ELECTRON-PARAMAGNETIC-RESONANCE; RIBONUCLEOSIDE TRIPHOSPHATE REDUCTASE; DIPHOSPHATE GALACTOSE 4-EPIMERASE; SUBSTRATE RADICAL INTERMEDIATE; NUCLEAR-MAGNETIC-RESONANCE; LYASE-ACTIVATING ENZYME; ACTIVE-SITE RESIDUES; ESCHERICHIA-COLI		Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Frey, PA (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	frey@biochem.wisc.edu	Chen, Ruidong/J-9522-2014		National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences of the National Institutes of Health	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I am exceedingly grateful to my graduate and postdoctoral students for sharing the of discovery with me. I am also grateful to senior investigators in Asia, Europe, and the Americas for valuable collaborations. I am equally grateful to the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of General Medical Sciences of the National Institutes of Health for continuously supporting in research through predoctoral fellowships from 1964 to 1967, a postdoctoral fellowship in 1968, and individual research grants from 1969 to my retirement in 2008.	Abend A, 2000, BIOCHEMISTRY-US, V39, P6250, DOI 10.1021/bi992963k; Abend A, 1999, BIOCHEMISTRY-US, V38, P3668, DOI 10.1021/bi981895j; ARABSHAHI A, 1986, BIOCHEMISTRY-US, V25, P5583, DOI 10.1021/bi00367a036; BAKER JJ, 1973, BIOCHEMISTRY-US, V12, P1054, DOI 10.1021/bi00730a006; BALLINGER MD, 1992, BIOCHEMISTRY-US, V31, P949, DOI 10.1021/bi00119a001; BALLINGER MD, 1995, BIOCHEMISTRY-US, V34, P10086, DOI 10.1021/bi00031a033; BALLINGER MD, 1992, BIOCHEMISTRY-US, V31, P10782, DOI 10.1021/bi00159a020; BARANIAK J, 1989, J BIOL CHEM, V264, P1357; Behshad E, 2006, BIOCHEMISTRY-US, V45, P12639, DOI 10.1021/bi061328t; Berkovitch F, 2004, P NATL ACAD SCI USA, V101, P15870, DOI 10.1073/pnas.0407074101; BRADY K, 1990, BIOCHEMISTRY-US, V29, P7600, DOI 10.1021/bi00485a009; BRADY K, 1990, BIOCHEMISTRY-US, V29, P7608, DOI 10.1021/bi00485a010; Broderick JB, 2000, BIOCHEM BIOPH RES CO, V269, P451, DOI 10.1006/bbrc.2000.2313; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; BRODY RS, 1982, BIOCHEMISTRY-US, V21, P2570, DOI 10.1021/bi00539a042; BRODY RS, 1981, BIOCHEMISTRY-US, V20, P1245, DOI 10.1021/bi00508a030; BRUICE TC, 1962, BIOCHEMISTRY-US, V1, P7, DOI 10.1021/bi00907a002; BRYANT FR, 1981, J BIOL CHEM, V256, P5965; CAJACOB CA, 1985, BIOCHEMISTRY-US, V24, P2425, DOI 10.1021/bi00331a006; CAJACOB CA, 1985, J BIOL CHEM, V260, P4610; Cassidy CS, 2000, BIOCHEM BIOPH RES CO, V273, P789, DOI 10.1006/bbrc.2000.2986; Cassidy CS, 1998, BIOORG CHEM, V26, P213, DOI 10.1006/bioo.1998.1102; Cassidy CS, 1997, BIOCHEMISTRY-US, V36, P4576, DOI 10.1021/bi962013o; Chang CH, 1996, BIOCHEMISTRY-US, V35, P11081, DOI 10.1021/bi960850k; Chang CH, 2000, J BIOL CHEM, V275, P106, DOI 10.1074/jbc.275.1.106; Chen DW, 2003, BIOCHEMISTRY-US, V42, P4578, DOI 10.1021/bi030018x; Chen DW, 2003, J AM CHEM SOC, V125, P11788, DOI 10.1021/ja036120z; CHIRPICH TP, 1970, J BIOL CHEM, V245, P1778; CLELAND WW, 1992, BIOCHEMISTRY-US, V31, P317, DOI 10.1021/bi00117a001; CLELAND WW, 1994, SCIENCE, V264, P1887, DOI 10.1126/science.8009219; Cloninger MJ, 1998, BIOORG CHEM, V26, P323, DOI 10.1006/bioo.1998.1115; CONRADT H, 1984, ARCH BIOCHEM BIOPHYS, V228, P133, DOI 10.1016/0003-9861(84)90054-7; Cosper NJ, 2000, BIOCHEMISTRY-US, V39, P15668, DOI 10.1021/bi0022184; ELIASSON R, 1990, P NATL ACAD SCI USA, V87, P3314, DOI 10.1073/pnas.87.9.3314; FINKE RG, 1984, INORG CHEM, V23, P3041, DOI 10.1021/ic00188a002; FLENTKE GR, 1990, BIOCHEMISTRY-US, V29, P2430, DOI 10.1021/bi00461a029; FLORENTIN D, 1994, CR ACAD SCI III-VIE, V317, P485; FLOURNOY DS, 1986, BIOCHEMISTRY-US, V25, P6036, DOI 10.1021/bi00368a030; Frey P. A., 1992, ENZYMES, V20, P141; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Frey PA, 1999, J STRUCT BIOL, V127, P94, DOI 10.1006/jsbi.1999.4150; FREY PA, 1994, SCIENCE, V264, P1927, DOI 10.1126/science.7661899; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Frey PA, 2014, ACCOUNTS CHEM RES, V47, P540, DOI 10.1021/ar400194k; Frey PA, 2013, ACCOUNTS CHEM RES, V46, P1417, DOI 10.1021/ar300246k; Frey PA, 2010, NEW J CHEM, V34, P820, DOI 10.1039/b9nj00619b; Frey PA, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P501; GERLT JA, 1993, BIOCHEMISTRY-US, V32, P11943, DOI 10.1021/bi00096a001; Graham JD, 2014, BIOCHEMISTRY-US, V53, P344, DOI 10.1021/bi4014566; Gross JW, 2001, BIOCHEMISTRY-US, V40, P12497, DOI 10.1021/bi011138c; GRUYS KJ, 1987, BIOCHEMISTRY-US, V26, P7575, DOI 10.1021/bi00398a007; Halkides CJ, 1996, BIOCHEMISTRY-US, V35, P15941, DOI 10.1021/bi961805f; HALPERN J, 1985, SCIENCE, V227, P869, DOI 10.1126/science.2857503; HARDER J, 1992, J BIOL CHEM, V267, P25548; HENDERSON R, 1971, BIOCHEM J, V124, P13, DOI 10.1042/bj1240013; Hibbert F., 1990, ADV PHYS ORG CHEM, V26, P255, DOI DOI 10.1016/S0065-3160(08)60047-7; Hinckley GT, 2006, BIOCHEMISTRY-US, V45, P3219, DOI 10.1021/bi0519497; IMPERIALI B, 1986, BIOCHEMISTRY-US, V25, P3760, DOI 10.1021/bi00361a005; IYENGAR R, 1988, BIOORG CHEM, V16, P52, DOI 10.1016/0045-2068(88)90037-5; IYENGAR R, 1986, BIOCHEMISTRY-US, V25, P4693, DOI 10.1021/bi00364a036; Jeffrey G. A., 1997, INTRO HYDROGEN BONDI, P41; JOHNSON HM, 1964, P SOC EXP BIOL MED, V117, P425, DOI 10.3181/00379727-117-29599; KONOPKA JM, 1986, BIOCHEMISTRY-US, V25, P5571, DOI 10.1021/bi00367a034; Kuhn P, 1998, BIOCHEMISTRY-US, V37, P13446, DOI 10.1021/bi9813983; Lepore BW, 2005, P NATL ACAD SCI USA, V102, P13819, DOI 10.1073/pnas.0505726102; LEUNG LS, 1978, BIOCHEM BIOPH RES CO, V81, P274, DOI 10.1016/0006-291X(78)91529-2; LIANG TC, 1987, BIOCHEMISTRY-US, V26, P7603, DOI 10.1021/bi00398a011; Lin J, 2000, J AM CHEM SOC, V122, P11258, DOI 10.1021/ja003060d; Lin J, 1998, BIOCHEMISTRY-US, V37, P11940, DOI 10.1021/bi980278s; Lin J, 1998, P NATL ACAD SCI USA, V95, P14664, DOI 10.1073/pnas.95.25.14664; Liu YJ, 1996, BIOCHEMISTRY-US, V35, P7615, DOI 10.1021/bi960102v; Magnusson OT, 2001, BIOCHEMISTRY-US, V40, P7773, DOI 10.1021/bi0104569; Mansoorabadi SO, 2006, BIOCHEMISTRY-US, V45, P14362, DOI 10.1021/bi061586q; MARKLEY JL, 1978, BIOCHEMISTRY-US, V17, P4648, DOI 10.1021/bi00615a010; McAllister MA, 1997, CAN J CHEM, V75, P1195, DOI 10.1139/v97-144; MEADE TJ, 1985, J ORG CHEM, V50, P936, DOI 10.1021/jo00207a005; Miller J, 2001, ARCH BIOCHEM BIOPHYS, V387, P281, DOI 10.1006/abbi.2001.2261; Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n; MOSS M, 1987, J BIOL CHEM, V262, P14859; MULLIEZ E, 1993, J BIOL CHEM, V268, P2296; PETROVICH RM, 1992, BIOCHEMISTRY-US, V31, P10774, DOI 10.1021/bi00159a019; PETROVICH RM, 1991, J BIOL CHEM, V266, P7656; PLIURA DH, 1980, BIOCHEMISTRY-US, V19, P325, DOI 10.1021/bi00543a012; REED KE, 1993, J BACTERIOL, V175, P1325, DOI 10.1128/JB.175.5.1325-1336.1993; RICHARD JP, 1979, J BIOL CHEM, V254, P4339; RICHARD JP, 1980, BIOCHEM BIOPH RES CO, V94, P1052, DOI 10.1016/0006-291X(80)90525-2; RICHARD JP, 1983, J AM CHEM SOC, V105, P6605, DOI 10.1021/ja00360a010; RICHARD JP, 1978, J AM CHEM SOC, V100, P7756, DOI 10.1021/ja00492a068; RICHARD JP, 1978, J AM CHEM SOC, V100, P7757, DOI 10.1021/ja00492a069; ROBILLARD G, 1972, J MOL BIOL, V71, P507, DOI 10.1016/0022-2836(72)90366-X; RUZICKA F, 1990, BIOCHEMISTRY-US, V29, P1696, DOI 10.1021/bi00459a005; Ruzicka FJ, 2007, BBA-PROTEINS PROTEOM, V1774, P286, DOI 10.1016/j.bbapap.2006.11.008; SAMMONS RD, 1982, J BIOL CHEM, V257, P1138; Sandala GM, 2004, J AM CHEM SOC, V126, P12206, DOI 10.1021/ja047377f; SANYAL I, 1994, BIOCHEMISTRY-US, V33, P3625, DOI 10.1021/bi00178a020; Schwartz PA, 2007, BIOCHEMISTRY-US, V46, P7293, DOI 10.1021/bi700078z; Schwartz PA, 2007, BIOCHEMISTRY-US, V46, P7284, DOI 10.1021/bi700077v; SHEU KF, 1984, BIOCHEMISTRY-US, V23, P1779, DOI 10.1021/bi00303a030; SHEU KFR, 1979, BIOCHEMISTRY-US, V18, P5548, DOI 10.1021/bi00592a004; SHEU KFR, 1977, J BIOL CHEM, V252, P4445; SHEU KFR, 1978, J BIOL CHEM, V253, P3378; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; STEGINSKY CA, 1984, J BIOL CHEM, V259, P4023; Stich TA, 2014, ACCOUNTS CHEM RES, V47, P2235, DOI 10.1021/ar400235n; Tang KH, 2009, BIOCHEMISTRY-US, V48, P8151, DOI 10.1021/bi900828f; Tittmann K, 2005, BIOCHEMISTRY-US, V44, P13291, DOI 10.1021/bi051058z; TOBIN JB, 1995, BIOCHEMISTRY-US, V34, P6919, DOI 10.1021/bi00021a002; Ugulava NB, 2000, BIOCHEMISTRY-US, V39, P5206, DOI 10.1021/bi9926227; VANPELT JE, 1986, J BIOL CHEM, V261, P5995; Walsby CJ, 2002, J AM CHEM SOC, V124, P11270, DOI 10.1021/ja027078v; Wang SC, 2007, BIOCHEMISTRY-US, V46, P12889, DOI 10.1021/bi701745h; Wei YM, 2001, BIOCHEMISTRY-US, V40, P11279, DOI 10.1021/bi011085z; Westler WM, 2002, J AM CHEM SOC, V124, P4196, DOI 10.1021/ja017860f; WONG YHH, 1979, BIOCHEMISTRY-US, V18, P5337, DOI 10.1021/bi00591a012; WU WM, 1995, BIOCHEMISTRY-US, V34, P10532, DOI 10.1021/bi00033a027; Wu WM, 2000, BIOCHEMISTRY-US, V39, P9561, DOI 10.1021/bi000658p; YANG H, 1986, BIOPHYS J, V49, P56, DOI 10.1016/S0006-3495(86)83591-3; YANG H, 1985, J BIOL CHEM, V260, P6049; YANG YS, 1986, BIOCHEMISTRY-US, V25, P8173, DOI 10.1021/bi00373a008; YANG YS, 1994, BIOCHEMISTRY-US, V33, P9428, DOI 10.1021/bi00198a008	120	3	3	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10610	10626		10.1074/jbc.X115.650879	http://dx.doi.org/10.1074/jbc.X115.650879			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25752608	Green Published, hybrid			2022-12-28	WOS:000353404500004
J	Meyer, MB; Benkusky, NA; Pike, JW				Meyer, Mark B.; Benkusky, Nancy A.; Pike, J. Wesley			Selective Distal Enhancer Control of the Mmp13 Gene Identified through Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) Genomic Deletions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; KAPPA-B LIGAND; 1,25-DIHYDROXYVITAMIN D-3; TRANSCRIPTION FACTOR; OSTEOBLASTIC CELLS; PARATHYROID-HORMONE; BONE-FORMATION; BINDING-SITES; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; INTERSTITIAL COLLAGENASE	Matrix metalloproteinase 13 (Mmp13, collagenase-3) plays an essential role in bone metabolism and mineral homeostasis. It is regulated by numerous factors, including BMP-2, parathyroid hormone, and 1 alpha,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3), through transcription factors such as Runt-related transcription factor 2 (RUNX2), CCAAT/enhancer-binding protein beta (C/EBP beta), OSX, and vitamin D receptor (VDR). During osteoblast maturation, the basal expression of Mmp13 and its sensitivity to 1,25(OH)(2)D-3 are strikingly increased. In this report, ChIP-sequencing analysis in mouse preosteoblasts revealed that the Mmp13 gene was probably regulated by three major enhancers located -10, -20, and -30 kb upstream of the gene promoter, occupied by activated VDR and prebound C/EBP beta and RUNX2, respectively. Initially, bacterial artificial chromosome clone recombineering and traditional mutagenesis defined binding sites for VDR and RUNX2. We then employed a CRISPR/Cas9 gene editing approach to delete the -10 and -30 kb Mmp13 enhancers, a region proximal to the promoter, and VDR or RUNX2. VDR-mediated up-regulation of Mmp13 transcription was completely abrogated upon removal of the -10 kb enhancer, resulting in a 1,25(OH)(2)D-3-directed repression of Mmp13. Deletion of either the -30 kb enhancer or RUNX2 resulted in a complete loss of basal transcript activity and a ChIP-identified destabilization of the chromatin enhancer environment and factor binding. Whereas enhancer deletions only affected Mmp13 expression, the RUNX2 deletion led to changes in gene expression, a reduction in cellular proliferation, and an inability to differentiate. We conclude that the Mmp13 gene is regulated via at least three specific distal enhancers that display independent activities yet are able to integrate response from multiple signaling pathways in a model of activation and suppression.	[Meyer, Mark B.; Benkusky, Nancy A.; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pike, JW (corresponding author), Univ Wisconsin, Dept Biochem, Hector F Deluca Biochem Labs, Rm 543D,433 Babcock Dr, Madison, WI 53706 USA.	pike@biochem.wisc.edu			National Institutes of Health, NIDDK [DK-072281]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072281] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant DK-072281 (to J. W. P.).	Achari Y, 2009, BBA-MOL BASIS DIS, V1792, P211, DOI 10.1016/j.bbadis.2009.01.002; Benderdour M, 2002, BIOCHEM BIOPH RES CO, V291, P1151, DOI 10.1006/bbrc.2002.6580; Borden P, 1996, J BIOL CHEM, V271, P23577, DOI 10.1074/jbc.271.38.23577; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cheng Y, 2014, NATURE, V515, P371, DOI 10.1038/nature13985; Chimge NO, 2012, CLIN CANCER RES, V18, P901, DOI 10.1158/1078-0432.CCR-11-1530; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; Etoh T, 2000, GUT, V47, P50, DOI 10.1136/gut.47.1.50; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Gao P, 2014, TUMOR BIOL, V35, P10137, DOI 10.1007/s13277-014-2309-y; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grumbles RM, 1996, J CELL BIOCHEM, V63, P395; Hashimoto K, 2013, J BIOL CHEM, V288, P10061, DOI 10.1074/jbc.M112.421156; Hirata M, 2012, HUM MOL GENET, V21, P1111, DOI 10.1093/hmg/ddr540; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lian JB, 2013, J BONE MINER RES, V28, P2060, DOI 10.1002/jbmr.2076; Meyer MB, 2007, J BIOL CHEM, V282, P22344, DOI 10.1074/jbc.M703475200; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Meyer MB, 2014, J BIOL CHEM, V289, P19539, DOI 10.1074/jbc.M114.578104; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Meyer MB, 2014, J STEROID BIOCHEM, V144, P19, DOI 10.1016/j.jsbmb.2013.09.005; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; Meyer MB, 2010, J BIOL CHEM, V285, P15599, DOI 10.1074/jbc.M110.119958; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301; Paredes R, 2004, MOL CELL BIOL, V24, P8847, DOI 10.1128/MCB.24.20.8847-8861.2004; Peeters-Joris C, 1998, BBA-MOL CELL RES, V1405, P14, DOI 10.1016/S0167-4889(98)00094-9; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rydziel S, 1997, J CELL BIOCHEM, V67, P176, DOI 10.1002/(SICI)1097-4644(19971101)67:2<176::AID-JCB3>3.0.CO;2-U; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Selvamurugan N, 2006, J CELL BIOCHEM, V99, P545, DOI 10.1002/jcb.20878; Stein GS, 2010, ADV ENZYME REGUL, V50, P160, DOI 10.1016/j.advenzreg.2009.10.026; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Tsuji K, 2001, BBA-MOL CELL RES, V1539, P122, DOI 10.1016/S0167-4889(01)00099-4; Uchida M, 2001, J BONE MINER RES, V16, P221, DOI 10.1359/jbmr.2001.16.2.221; Uria JA, 1998, AM J PATHOL, V153, P91, DOI 10.1016/S0002-9440(10)65549-6; Varghese S, 1997, ENDOCRINOLOGY, V138, P1035, DOI 10.1210/en.138.3.1035; Walling HW, 1998, J CELL PHYSIOL, V177, P563, DOI 10.1002/(SICI)1097-4652(199812)177:4<563::AID-JCP7>3.0.CO;2-B; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Winchester SK, 2000, J BIOL CHEM, V275, P23310, DOI 10.1074/jbc.M003004200; Winchester SK, 1999, J CELL PHYSIOL, V181, P479, DOI 10.1002/(SICI)1097-4652(199912)181:3<479::AID-JCP12>3.0.CO;2-D; Yamamoto H, 2003, J BIOL CHEM, V278, P31756, DOI 10.1074/jbc.M304737200; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827; Zanotti S, 2009, J ENDOCRINOL, V201, P263, DOI 10.1677/JOE-08-0514; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015	53	38	40	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11093	11107		10.1074/jbc.M115.648394	http://dx.doi.org/10.1074/jbc.M115.648394			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25773540	hybrid, Green Published			2022-12-28	WOS:000353404500044
J	Burgos, ES; Wilczek, C; Onikubo, T; Bonanno, JB; Jansong, J; Reimer, U; Shechter, D				Burgos, Emmanuel S.; Wilczek, Carola; Onikubo, Takashi; Bonanno, Jeffrey B.; Jansong, Janina; Reimer, Ulf; Shechter, David			Histone H2A and H4 N-terminal Tails Are Positioned by the MEP50 WD Repeat Protein for Efficient Methylation by the PRMT5 Arginine Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SM PROTEINS; GROWTH; TRANSCRIPTION; COMPLEX; CELLS; DIMETHYLARGININE; RECOGNITION; METHYLOSOME; EXPRESSION; PREDICTION	The protein arginine methyltransferase PRMT5 is complexed with the WD repeat protein MEP50 (also known as Wdr77 or androgen coactivator p44) in vertebrates in a tetramer of heterodimers. MEP50 is hypothesized to be required for protein substrate recruitment to the catalytic domain of PRMT5. Here we demonstrate that the cross-dimer MEP50 is paired with its cognate PRMT5 molecule to promote histone methylation. We employed qualitative methylation assays and a novel ultrasensitive continuous assay to measure enzyme kinetics. We demonstrate that neither full-length human PRMT5 nor the Xenopus laevis PRMT5 catalytic domain has appreciable protein methyltransferase activity. We show that histones H4 and H3 bind PRMT5-MEP50 more efficiently compared with histone H2A(1-20) and H4(1-20) peptides. Histone binding is mediated through histone fold interactions as determined by competition experiments and by high density histone peptide array interaction studies. Nucleosomes are not a substrate for PRMT5-MEP50, consistent with the primary mode of interaction via the histone fold of H3-H4, obscured by DNA in the nucleosome. Mutation of a conserved arginine (Arg-42) on the MEP50 insertion loop impaired the PRMT5-MEP50 enzymatic efficiency by increasing its histone substrate K-m comparable with that of Caenorhabditis elegans PRMT5. We show that PRMT5-MEP50 prefers unmethylated substrates, consistent with a distributive model for dimethylation and suggesting discrete biological roles for mono- and dimethylarginine-modified proteins. We propose a model in which MEP50 and PRMT5 simultaneously engage the protein substrate, orienting its targeted arginine to the catalytic site.	[Burgos, Emmanuel S.; Wilczek, Carola; Onikubo, Takashi; Bonanno, Jeffrey B.; Shechter, David] Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Jansong, Janina; Reimer, Ulf] JPT Peptide Technol GmbH, D-12489 Berlin, Germany	Yeshiva University; Albert Einstein College of Medicine	Shechter, D (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA.	david.shechter@einstein.yu.edu	Shechter, David/B-4660-2008	Shechter, David/0000-0001-9388-6004; Burgos, Emmanuel/0000-0003-4555-7673; Reimer, Ulf/0000-0002-3375-6889	National Institutes of Health [R01GM108646-01A1]; Albert Einstein College of Medicine, an Alexander and Alexandrine Sinsheimer Foundation Scholar Award; American Cancer Society Robbie Sue Mudd Kidney Cancer Research Scholar Grant [124891-RSG-13-396-01-DMC]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine, an Alexander and Alexandrine Sinsheimer Foundation Scholar Award; American Cancer Society Robbie Sue Mudd Kidney Cancer Research Scholar Grant(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM108646-01A1 (to D. S.). This work was also supported by startup funds from the Albert Einstein College of Medicine, an Alexander and Alexandrine Sinsheimer Foundation Scholar Award, and American Cancer Society Robbie Sue Mudd Kidney Cancer Research Scholar Grant 124891-RSG-13-396-01-DMC (all to D. S.). U. R. and J. S. are employees of JPT Peptide Technologies. The peptide array used in this study has been developed and manufactured by JPT. The library on this array has been extended and is marketed as "Histone Code Peptide Microarray" (His-MA_01) by JPT.	Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Bao XX, 2013, J HISTOCHEM CYTOCHEM, V61, P206, DOI 10.1369/0022155413475452; Bezzi M, 2013, GENE DEV, V27, P1903, DOI 10.1101/gad.219899.113; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Feng Y, 2011, J BIOL CHEM, V286, P20323, DOI 10.1074/jbc.M110.207258; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Furuno K, 2006, BIOCHEM BIOPH RES CO, V345, P1051, DOI 10.1016/j.bbrc.2006.05.014; Gu ZP, 2012, BIOCHEM J, V446, P235, DOI 10.1042/BJ20120768; Guderian G, 2011, J BIOL CHEM, V286, P1976, DOI 10.1074/jbc.M110.148486; Gui SY, 2014, J BIOL CHEM, V289, P9320, DOI 10.1074/jbc.M113.535278; Gurung B, 2013, CANCER RES, V73, P2650, DOI 10.1158/0008-5472.CAN-12-3158; Hemeon I, 2011, ANAL CHEM, V83, P4996, DOI 10.1021/ac200816m; Ho MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057008; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; Lacroix M, 2008, EMBO REP, V9, P452, DOI 10.1038/embor.2008.45; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Majumder S, 2010, J CELL BIOCHEM, V109, P553, DOI 10.1002/jcb.22432; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Scoumanne A, 2009, NUCLEIC ACIDS RES, V37, P4965, DOI 10.1093/nar/gkp516; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shechter D, 2009, J BIOL CHEM, V284, P1064, DOI 10.1074/jbc.M807273200; Sturm MB, 2009, ANAL CHEM, V81, P2847, DOI 10.1021/ac8026433; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; WANG HC, 1988, BIOCHEMISTRY-US, V27, P625, DOI 10.1021/bi00402a020; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wang M, 2014, BIOCHEMISTRY-US, V53, P7884, DOI 10.1021/bi501279g; Wang M, 2013, BIOCHEMISTRY-US, V52, P5430, DOI 10.1021/bi4005123; Wang WL, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-22; Wilczek C, 2011, J BIOL CHEM, V286, P42221, DOI 10.1074/jbc.M111.303677; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; Yan FT, 2014, CANCER RES, V74, P1752, DOI 10.1158/0008-5472.CAN-13-0884; Zhang QC, 2011, NUCLEIC ACIDS RES, V39, pW283, DOI 10.1093/nar/gkr311; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	49	61	63	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9674	9689		10.1074/jbc.M115.636894	http://dx.doi.org/10.1074/jbc.M115.636894			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713080	hybrid, Green Published			2022-12-28	WOS:000352729400030
J	Toniolo, C; Balducci, E; Romano, MR; Proietti, D; Ferlenghi, I; Grandi, G; Berti, F; Ros, IMY; Janulczyk, R				Toniolo, Chiara; Balducci, Evita; Romano, Maria Rosaria; Proietti, Daniela; Ferlenghi, Ilaria; Grandi, Guido; Berti, Francesco; Ros, Immaculada Margarit Y.; Janulczyk, Robert			Streptococcus agalactiae Capsule Polymer Length and Attachment Is Determined by the Proteins CpsABCD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCUS; BACTERIAL-CELL WALL; POLYSACCHARIDE BIOSYNTHESIS; TYROSINE PHOSPHORYLATION; FUNCTIONAL-ANALYSIS; ESCHERICHIA-COLI; PNEUMONIAE; GENES; CPSD; PARADIGMS	The production of capsular polysaccharides ((PS) or secreted exopolysaccharides is ubiquitous in bacteria, and the Wzy pathway constitutes a prototypical mechanism to produce these structures. Despite the differences in polysaccharide composition among species, a group of proteins involved in this pathway is well conserved. Streptococcus agalactiae (group B Streptococcus; GBS) produces a CPS that represents the main virulence factor of the bacterium and is a prime target in current vaccine development. We used this human pathogen to investigate the roles and potential interdependencies of the conserved proteins CpsABCD encoded in the cps operon, by developing knock-out and functional mutant strains. The mutant strains were examined for CPS quantity, size, and attachment to the cell surface as well as CpsD phosphorylation. We observed that CpsB, -C, and -D compose a phosphoregulatory system where the CpsD autokinase phosphorylates its C-terminal tyrosines in a CpsC-dependent manner. These Tyr residues are also the target of the cognate CpsB phosphatase. An interaction between CpsD and CpsC was observed, and the phosphorylation state of CpsD influenced the subsequent action of CpsC. The CpsC extracellular domain appeared necessary for the production of high molecular weight polysaccharides by influencing CpsA-mediated attachment of the CPS to the bacterial cell surface. In conclusion, although having no impact on cps transcription or the synthesis of the basal repeating unit, we suggest that these proteins are fine-tuning the last steps of CPS biosynthesis (i.e. the balance between polymerization and attachment to the cell wall).	[Toniolo, Chiara; Balducci, Evita; Romano, Maria Rosaria; Proietti, Daniela; Ferlenghi, Ilaria; Grandi, Guido; Berti, Francesco; Ros, Immaculada Margarit Y.; Janulczyk, Robert] Novartis Vaccines & Diagnost, Res Ctr, Via Fiorentino 1, I-53100 Siena, Italy	Novartis	Janulczyk, R (corresponding author), Novartis Vaccines & Diagnost, Res Ctr, Via Fiorentino 1, I-53100 Siena, Italy.	robert.janulczyk@novartis.com	Toniolo, Chiara/ABH-6697-2020	Toniolo, Chiara/0000-0002-2167-2936; Grandi, Guido/0000-0001-9724-2185				Avci FY, 2010, ANNU REV IMMUNOL, V28, P107, DOI 10.1146/annurev-immunol-030409-101159; BAKER CJ, 1973, J PEDIATR-US, V83, P919, DOI 10.1016/S0022-3476(73)80524-4; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; BARTON LL, 1973, J PEDIATR-US, V82, P719, DOI 10.1016/S0022-3476(73)80605-5; Berti F, 2014, J BIOL CHEM, V289, P23437, DOI 10.1074/jbc.M114.567974; Byrne JP, 2011, J BACTERIOL, V193, P2341, DOI 10.1128/JB.00074-11; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; Deng LY, 2000, J BIOL CHEM, V275, P7497, DOI 10.1074/jbc.275.11.7497; Eberhardt A, 2012, MICROB DRUG RESIST, V18, P240, DOI 10.1089/mdr.2011.0232; Faralla C, 2014, MBIO, V5, DOI 10.1128/mBio.00870-14; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; FRANCIOSI RA, 1973, J PEDIATR-US, V82, P707, DOI 10.1016/S0022-3476(73)80604-3; Hagelueken G, 2009, J MOL BIOL, V392, P678, DOI 10.1016/j.jmb.2009.07.026; Hanson BR, 2012, J BACTERIOL, V194, P1668, DOI 10.1128/JB.06373-11; Hanson BR, 2011, J BACTERIOL, V193, P411, DOI 10.1128/JB.01098-10; Henriques MX, 2011, MOL MICROBIOL, V82, P515, DOI 10.1111/j.1365-2958.2011.07828.x; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hubscher J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-617; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; MARQUES MB, 1992, INFECT IMMUN, V60, P3986, DOI 10.1128/IAI.60.10.3986-3993.1992; Morona JK, 2000, MOL MICROBIOL, V35, P1431, DOI 10.1046/j.1365-2958.2000.01808.x; Morona JK, 2003, J BACTERIOL, V185, P3009, DOI 10.1128/JB.185.10.3009-3019.2003; Olivares-Illana V, 2008, PLOS BIOL, V6, P1321, DOI 10.1371/journal.pbio.0060143; OLSEN DB, 1989, NUCLEIC ACIDS RES, V17, P9613, DOI 10.1093/nar/17.23.9613; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; RUBENS CE, 1993, MOL MICROBIOL, V8, P843, DOI 10.1111/j.1365-2958.1993.tb01631.x; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Soulat D, 2006, J BIOL CHEM, V281, P14048, DOI 10.1074/jbc.M513600200; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; Tudela CM, 2012, OBSTET GYNECOL, V119, P626, DOI 10.1097/AOG.0b013e31824532f6; van den Biggelaar AHJ, 2013, VACCINE, V31, P2525, DOI 10.1016/j.vaccine.2012.06.019; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; WESSELS MR, 1990, J CLIN INVEST, V86, P1428, DOI 10.1172/JCI114858; Whitfield C, 2003, CARBOHYD RES, V338, P2491, DOI 10.1016/j.carres.2003.08.010; Yamamoto S, 1999, J BACTERIOL, V181, P5176, DOI 10.1128/JB.181.17.5176-5184.1999; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944	38	30	33	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9521	9532		10.1074/jbc.M114.631499	http://dx.doi.org/10.1074/jbc.M114.631499			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25666613	hybrid, Green Published			2022-12-28	WOS:000352729400019
J	Hara, T; Mizuguchi, M; Fujii, M; Nakamura, M				Hara, Toshifumi; Mizuguchi, Mariko; Fujii, Masahiro; Nakamura, Masataka			Kruppel-like Factor 2 Represses Transcription of the Telomerase Catalytic Subunit Human Telomerase Reverse Transcriptase (hTERT) in Human T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED EXPRESSION; HUMAN-LYMPHOCYTES; UP-REGULATION; GENE; TRAFFICKING; QUIESCENCE; ACTIVATION; GROWTH; KLF2	In normal human T cells, telomerase activity is strictly regulated. T cells are thought to express telomerase to avoid replicative senescence, unlike most normal somatic cells with definite replicative lifespan. T cells in blood and tissues are usually in a state of quiescence without expression of the limiting catalytic subunit of telomerase, human telomerase reverse transcriptase (hTERT). In contrast to activation, repression of hTERT transcription has not been studied well. Our previous studies have found an hTERT promoter element with repressive function. Here we identified KLF2, which represses hTERT transcription by binding to the putative promoter element. KLF2 and hTERT exhibited reciprocal mRNA expression patterns in primary human T cells. In activated T cells, KLF2 binding to the hTERT promoter was eliminated, relieving the repression of hTERT transcription found in resting T cells. Our results suggest that KLF2 is involved in strict repression of hTERT expression through binding to the promoter in primary human T cells.	[Hara, Toshifumi; Mizuguchi, Mariko; Nakamura, Masataka] Tokyo Med & Dent Univ, Human Gene Sci Ctr, Tokyo 1138510, Japan; [Hara, Toshifumi; Fujii, Masahiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Virol, Niigata 9518510, Japan	Tokyo Medical & Dental University (TMDU); Niigata University	Nakamura, M (corresponding author), Tokyo Med & Dent Univ, Human Gene Sci Ctr, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	naka.gene@tmd.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Japan Society for Promotion of Science.	Akbar AN, 2007, J IMMUNOL, V178, P6689, DOI 10.4049/jimmunol.178.11.6689; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Buchkovich KJ, 1996, MOL BIOL CELL, V7, P1443, DOI 10.1091/mbc.7.9.1443; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Ducrest AL, 2002, ONCOGENE, V21, P541, DOI 10.1038/sj.onc.1205081; Funato N, 2001, MOL CELL BIOL, V21, P7416, DOI 10.1128/MCB.21.21.7416-7428.2001; Hara T, 2008, CANCER SCI, V99, P1155, DOI 10.1111/j.1349-7006.2008.00798.x; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Hodes RJ, 2002, NAT REV IMMUNOL, V2, P699, DOI 10.1038/nri890; Horikawa L, 2005, P NATL ACAD SCI USA, V102, P18437, DOI 10.1073/pnas.0508964102; Janknecht R, 2004, FEBS LETT, V564, P9, DOI 10.1016/S0014-5793(04)00356-4; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kawauchi K, 2005, J IMMUNOL, V174, P5261, DOI 10.4049/jimmunol.174.9.5261; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Liu KB, 1999, P NATL ACAD SCI USA, V96, P5147, DOI 10.1073/pnas.96.9.5147; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; Odumade OA, 2010, J IMMUNOL, V184, P6060, DOI 10.4049/jimmunol.1000511; Poole JC, 2001, GENE, V269, P1, DOI 10.1016/S0378-1119(01)00440-1; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Takada K, 2011, J IMMUNOL, V186, P775, DOI 10.4049/jimmunol.1000094; Weng NP, 1996, J EXP MED, V183, P2471, DOI 10.1084/jem.183.6.2471; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; Zhang XL, 2004, BIOCHEM BIOPH RES CO, V316, P139, DOI 10.1016/j.bbrc.2004.02.033; Zhao YJ, 2014, NUCLEIC ACIDS RES, V42, P10385, DOI 10.1093/nar/gku721	28	5	5	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8758	8763		10.1074/jbc.M114.610386	http://dx.doi.org/10.1074/jbc.M114.610386			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25694435	hybrid, Green Published			2022-12-28	WOS:000352207100007
J	Abou-Hamdan, A; Ceccaldi, P; Lebrette, H; Gutierrez-Sanz, O; Richaud, P; Cournac, L; Guigliarelli, B; De Lacey, AL; Leger, C; Volbeda, A; Burlat, B; Dementin, S				Abou-Hamdan, Abbas; Ceccaldi, Pierre; Lebrette, Hugo; Gutierrez-Sanz, Oscar; Richaud, Pierre; Cournac, Laurent; Guigliarelli, Bruno; De lacey, Antonio L.; Leger, Christophe; Volbeda, Anne; Burlat, Benedicte; Dementin, Sebastien			A Threonine Stabilizes the NiC and NiR Catalytic Intermediates of [NiFe]-hydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON TRANSPORT PATHWAYS; UNREADY OXIDIZED STATES; NIFE HYDROGENASE; ACTIVE-SITE; DESULFOVIBRIO-GIGAS; ELECTRON TRANSFERS; ESCHERICHIA-COLI; ACTIVATION; CLUSTER; CYCLE	The heterodimeric [NiFe] hydrogenase from Desulfovibrio fructosovorans catalyzes the reversible oxidation of H-2 into protons and electrons. The catalytic intermediates have been attributed to forms of the active site (NiSI, NiR, and NiC) detected using spectroscopic methods under potentiometric but noncatalytic conditions. Here, we produced variants by replacing the conserved Thr-18 residue in the small subunit with Ser, Val, Gln, Gly, or Asp, and we analyzed the effects of these mutations on the kinetic (H-2 oxidation, H-2 production, and H/D exchange), spectroscopic (IR, EPR), and structural properties of the enzyme. The mutations disrupt the H-bond network in the crystals and have a strong effect on H-2 oxidation and H-2 production turnover rates. However, the absence of correlation between activity and rate of H/D exchange in the series of variants suggests that the alcoholic group of Thr-18 is not necessarily a proton relay. Instead, the correlation between H-2 oxidation and production activity and the detection of the NiC species in reduced samples confirms that NiC is a catalytic intermediate and suggests that Thr-18 is important to stabilize the local protein structure of the active site ensuring fast NiSI-NiC-NiR interconversions during H-2 oxidation/production.	[Abou-Hamdan, Abbas; Ceccaldi, Pierre; Guigliarelli, Bruno; Leger, Christophe; Burlat, Benedicte; Dementin, Sebastien] Aix Marseille Univ, Lab Bioenergt & Ingn Proteines, Inst Microbiol Mediterranee, CNRS,UMR 7281, F-13402 Marseille 20, France; [Lebrette, Hugo; Volbeda, Anne] Univ Grenoble 1, Metalloproteins Unit, Inst Biol Struct, UMR Commissariat Energie Atom 5075,CNRS, F-38000 Grenoble, France; [Gutierrez-Sanz, Oscar; De lacey, Antonio L.] Inst Catalisis & Petroleoquim, Consejo Super Invest Cientif, Madrid 28049, Spain; [Richaud, Pierre; Cournac, Laurent] Inst Biol Environm & Biotechnol, Lab Bioenerget & Biotechnol Bacteries & Microalgu, Commissariat Energie Atom, Direct Sci Vivant, F-13108 St Paul Les Durance, France; [Richaud, Pierre; Cournac, Laurent] CNRS, UMR Biol Vegetale & Microbiol Environm BVME 7265, F-13108 St Paul Les Durance, France; Aix Marseille Univ, BVME UMR7265, F-13284 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite	Dementin, S (corresponding author), Aix Marseille Univ, Lab Bioenergt & Ingn Proteines, Inst Microbiol Mediterranee, CNRS,UMR 7281, 31 Chemin J Aiguier, F-13402 Marseille 20, France.	dementin@imm.cnrs.fr	HAMDAN, Abbas ABOU/N-6783-2014; Léger, Christophe/C-7230-2016; Ceccaldi, Pierre/AAH-3860-2020; Cournac, Laurent/G-2564-2010; De Lacey, Antonio L/H-3311-2015	HAMDAN, Abbas ABOU/0000-0001-6703-772X; Léger, Christophe/0000-0002-8871-6059; De Lacey, Antonio L/0000-0002-9347-0452; Ceccaldi, Pierre/0000-0001-8156-5035; Cournac, Laurent/0000-0003-0371-938X; Dementin, Sebastien/0000-0001-6168-5371; Volbeda, Anne/0000-0002-6038-0979; Gutierrez-Sanz, Oscar/0000-0001-7559-9204; Lebrette, Hugo/0000-0002-8081-181X	Pole de Competitivite Capenergies; FrenchBIC research network	Pole de Competitivite Capenergies; FrenchBIC research network	We thank the Pole de Competitivite Capenergies and the FrenchBIC research network for support. We thank the staff at the used SLS and ESRF beamlines for assistance with x-ray data collections. We acknowledge the Aix-Marseille EPR spectroscopy Facility Center (national TGE-RENARD network, FR3443) and the HelioBiotec platform (Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)).	Abou Hamdan A, 2013, NAT CHEM BIOL, V9, P15, DOI [10.1038/nchembio.1110, 10.1038/NCHEMBIO.1110]; Abou Hamdan A, 2012, J AM CHEM SOC, V134, P8368, DOI 10.1021/ja301802r; Bleijlevens B, 2004, J BIOL INORG CHEM, V9, P743, DOI 10.1007/s00775-004-0570-z; Bruschi M, 2014, J AM CHEM SOC, V136, P1803, DOI 10.1021/ja408511y; Cammack R., 2001, HYDROGEN FUEL LEARNI, P77; Cornish AJ, 2011, J BIOL CHEM, V286, P38341, DOI 10.1074/jbc.M111.254664; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; deLacey AL, 1997, J AM CHEM SOC, V119, P7181, DOI 10.1021/ja963802w; Dementin S, 2006, J AM CHEM SOC, V128, P5209, DOI 10.1021/ja060233b; Dementin S, 2004, J BIOL CHEM, V279, P10508, DOI 10.1074/jbc.M312716200; Dementin S, 2011, J AM CHEM SOC, V133, P10211, DOI 10.1021/ja202615a; Dementin S, 2009, J AM CHEM SOC, V131, P10156, DOI 10.1021/ja9018258; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fourmond V, 2013, CHEM COMMUN, V49, P6840, DOI 10.1039/c3cc43297a; Galvan IF, 2008, PROTEINS, V73, P195, DOI 10.1002/prot.22045; Gebler A, 2007, FEBS J, V274, P74, DOI 10.1111/j.1742-4658.2006.05565.x; Ginovska-Pangovska B, 2014, BBA-BIOENERGETICS, V1837, P131, DOI 10.1016/j.bbabio.2013.08.004; Greco C, 2014, ENERG ENVIRON SCI, V7, P3543, DOI 10.1039/c4ee01848f; GUIGLIARELLI B, 1995, BIOCHEMISTRY-US, V34, P4781, DOI 10.1021/bi00014a036; HATCHIKIAN CE, 1990, EUR J BIOCHEM, V187, P635, DOI 10.1111/j.1432-1033.1990.tb15347.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Leger C, 2004, J AM CHEM SOC, V126, P12162, DOI 10.1021/ja046548d; Leroux F, 2008, P NATL ACAD SCI USA, V105, P11188, DOI 10.1073/pnas.0803689105; Liebgott PP, 2011, J AM CHEM SOC, V133, P986, DOI 10.1021/ja108787s; Liebgott PP, 2010, NAT CHEM BIOL, V6, P63, DOI [10.1038/NCHEMBIO.276, 10.1038/nchembio.276]; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Pardo A, 2006, J BIOL INORG CHEM, V11, P286, DOI 10.1007/s00775-005-0076-3; Roessler MM, 2012, J AM CHEM SOC, V134, P15581, DOI 10.1021/ja307117y; Rousset M, 1998, P NATL ACAD SCI USA, V95, P11625, DOI 10.1073/pnas.95.20.11625; Shafaat HS, 2013, BBA-BIOENERGETICS, V1827, P986, DOI 10.1016/j.bbabio.2013.01.015; Sumner I, 2012, J PHYS CHEM B, V116, P2917, DOI 10.1021/jp208512y; Szori-Doroghazi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034666; Teixeira VH, 2008, PROTEINS, V70, P1010, DOI 10.1002/prot.21588; Vernede X, 1999, J APPL CRYSTALLOGR, V32, P505, DOI 10.1107/S0021889899002678; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; Volbeda A, 2015, J BIOL INORG CHEM, V20, P11, DOI 10.1007/s00775-014-1203-9; Volbeda A, 2012, P NATL ACAD SCI USA, V109, P5305, DOI 10.1073/pnas.1119806109; Yagi T, 2014, INT J HYDROGEN ENERG, V39, P18543, DOI 10.1016/j.ijhydene.2013.12.174; Yagi T, 2013, P JPN ACAD B-PHYS, V89, P16, DOI 10.2183/pjab.89.16	45	15	15	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8550	8558		10.1074/jbc.M114.630491	http://dx.doi.org/10.1074/jbc.M114.630491			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25666617	Green Published, hybrid			2022-12-28	WOS:000351662600045
J	Hedgepeth, SC; Garcia, MI; Wagner, LE; Rodriguez, AM; Chintapalli, SV; Snyder, RR; Hankins, GDV; Henderson, BR; Brodie, KM; Yule, DI; van Rossum, DB; Boehning, D				Hedgepeth, Serena C.; Garcia, M. Iveth; Wagner, Larry E., II; Rodriguez, Ana M.; Chintapalli, Sree V.; Snyder, Russell R.; Hankins, Gary D. V.; Henderson, Beric R.; Brodie, Kirsty M.; Yule, David I.; van Rossum, Damian B.; Boehning, Darren			The BRCA1 Tumor Suppressor Binds to Inositol 1,4,5-Trisphosphate Receptors to Stimulate Apoptotic Calcium Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID-BINDING; SPORADIC BREAST-CANCER; ENDOPLASMIC-RETICULUM; CA2+ OSCILLATIONS; HELA-CELLS; IDENTIFICATION; MITOCHONDRIA; EXPRESSION; PROTEINS; TYPE-1	The inositol 1,4,5-trisphosphate receptor (IP3R) is a ubiquitously expressed endoplasmic reticulum (ER)-resident calcium channel. Calcium release mediated by IP(3)Rs influences many signaling pathways, including those regulating apoptosis. IP3R activity is regulated by protein-protein interactions, including binding to proto-oncogenes and tumor suppressors to regulate cell death. Here we show that the IP3R binds to the tumor suppressor BRCA1. BRCA1 binding directly sensitizes the IP3R to its ligand, IP3. BRCA1 is recruited to the ER during apoptosis in an IP3R-dependent manner, and, in addition, a pool of BRCA1 protein is constitutively associated with the ER under non-apoptotic conditions. This is likely mediated by a novel lipid binding activity of the first BRCA1 C terminus domain of BRCA1 These findings provide a mechanistic explanation by which BRCA1 can act as a proapoptotic protein.	[Hedgepeth, Serena C.; Garcia, M. Iveth; Boehning, Darren] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Hedgepeth, Serena C.; Garcia, M. Iveth] Univ Texas Med Branch, Cell Biol Grad Program, Galveston, TX 77555 USA; [Rodriguez, Ana M.; Snyder, Russell R.; Hankins, Gary D. V.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Wagner, Larry E., II; Yule, David I.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Chintapalli, Sree V.; van Rossum, Damian B.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Henderson, Beric R.; Brodie, Kirsty M.] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Ctr Canc Res, Westmead, NSW 2145, Australia	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Rochester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Sydney; Westmead Institute for Medical Research	Boehning, D (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, 6431 Fannin St,MSB Suite 6-161, Houston, TX 77030 USA.	Darren.F.Boehning@uth.tmc.edu	; Boehning, Darren/I-8539-2015	van Rossum, Damian/0000-0003-1011-2586; Boehning, Darren/0000-0001-7920-6922	National Institutes of Health [GM081685, DE014756]; Department of Obstetrics and Gynecology, University of Texas Medical Branch (Galveston, TX); Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston (Houston, TX); Cancer Institute of New South Wales, Australia [12/CDF/2-12]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014756, R01DE019245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE014756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Obstetrics and Gynecology, University of Texas Medical Branch (Galveston, TX); Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston (Houston, TX); Cancer Institute of New South Wales, Australia; Pennsylvania Department of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM081685 (to D. B.) and by National Institutes of Health Grant DE014756 (to D. I. Y.). This work was also supported by seed funds provided by the Department of Obstetrics and Gynecology, University of Texas Medical Branch (Galveston, TX) and startup funds provided by the Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston (Houston, TX) (to D. B.); by Cancer Institute of New South Wales, Australia Grant 12/CDF/2-12 (to B. R. H.); and by a grant from the Pennsylvania Department of Health using tobacco settlement funds (to D. V. R.).	Akimzhanov AM, 2013, CELL CALCIUM, V53, P152, DOI 10.1016/j.ceca.2012.10.002; Akl H, 2013, BBA-REV CANCER, V1835, P180, DOI 10.1016/j.bbcan.2012.12.001; BERNIER I, 1987, BIOCHIMIE, V69, P1127, DOI 10.1016/0300-9084(87)90140-4; Betzenhauser MJ, 2008, METHODS, V46, P177, DOI 10.1016/j.ymeth.2008.09.014; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Bootman M, 1997, J PHYSIOL-LONDON, V499, P307, DOI 10.1113/jphysiol.1997.sp021928; Borahay MA, 2014, J BIOL CHEM, V289, P35075, DOI 10.1074/jbc.M114.583575; Chen CF, 1996, J BIOL CHEM, V271, P32863, DOI 10.1074/jbc.271.51.32863; Churchill GC, 1999, AM J PHYSIOL-CELL PH, V276, pC426, DOI 10.1152/ajpcell.1999.276.2.C426; Clark SL, 2012, COMPUT STRUCT BIOTEC, V1, DOI 10.5936/csbj.201204005; Coene ED, 2005, MOL BIOL CELL, V16, P997, DOI 10.1091/mbc.E04-10-0895; Decuypere JP, 2011, BBA-MOL CELL RES, V1813, P1003, DOI 10.1016/j.bbamcr.2010.11.023; DIARRA A, 1994, PFLUG ARCH EUR J PHY, V426, P129, DOI 10.1007/BF00374680; Fabbro M, 2004, EXP CELL RES, V298, P661, DOI 10.1016/j.yexcr.2004.05.004; Fabbro M, 2002, J BIOL CHEM, V277, P21315, DOI 10.1074/jbc.M200769200; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; GLATZ JFC, 1990, MOL CELL BIOCHEM, V98, P237, DOI 10.1007/BF00231390; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Henderson BR, 2012, SCIENTIFICA, V2012, P1; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hong Y., 2011, J INTEGR OMICS, V1, P88; Hong Yoojin, 2009, J Proteomics Bioinform, V2, P139; Jones JA, 2005, BIOCHEMISTRY-US, V44, P13235, DOI 10.1021/bi0505159; Kennedy RD, 2004, JNCI-J NATL CANCER I, V96, P1659, DOI 10.1093/jnci/djh312; Ko KD, 2011, IEEE INT C BIO BIO W, P374, DOI 10.1109/BIBMW.2011.6112401; Lee LF, 1998, J BIOL CHEM, V273, P28253, DOI 10.1074/jbc.273.43.28253; Liu LY, 2002, IN VITRO CELL DEV-AN, V38, P582; Magdinier F, 1998, ONCOGENE, V17, P3169, DOI 10.1038/sj.onc.1202248; Michaud M, 2011, INT J ONCOL, V38, P169, DOI 10.3892/ijo_00000836; Milner R, 2013, VIRCHOWS ARCH, V462, P269, DOI 10.1007/s00428-012-1368-y; Mylona E, 2014, PATHOL RES PRACT, V210, P533, DOI 10.1016/j.prp.2014.05.009; OCKNER RK, 1990, MOL CELL BIOCHEM, V98, P3; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Quinn JE, 2003, CANCER RES, V63, P6221; Rodriguez JA, 2000, J BIOL CHEM, V275, P38589, DOI 10.1074/jbc.M003851200; Rodriguez JA, 2004, EXP CELL RES, V293, P14, DOI 10.1016/j.yexcr.2003.09.027; Rong YP, 2009, BBA-MOL CELL RES, V1793, P971, DOI 10.1016/j.bbamcr.2008.10.015; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; SAUVE R, 1991, CELL CALCIUM, V12, P165, DOI 10.1016/0143-4160(91)90018-A; Scully R, 1996, SCIENCE, V272, P123, DOI 10.1126/science.272.5258.123; Shao NS, 1996, ONCOGENE, V13, P1; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Tembe V, 2007, J BIOL CHEM, V282, P20513, DOI 10.1074/jbc.M702627200; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Wagner LE, 2012, J PHYSIOL-LONDON, V590, P3245, DOI 10.1113/jphysiol.2012.228320; Wozniak AL, 2006, J CELL BIOL, V175, P709, DOI 10.1083/jcb.200608035; ZANOTTI G, 1992, J BIOL CHEM, V267, P18541	51	49	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7304	7313		10.1074/jbc.M114.611186	http://dx.doi.org/10.1074/jbc.M114.611186			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25645916	hybrid, Green Published			2022-12-28	WOS:000350991500058
J	Edukulla, R; Singh, B; Jegga, AG; Sontake, V; Dillon, SR; Madala, SK				Edukulla, Ramakrishna; Singh, Brijendra; Jegga, Anil G.; Sontake, Vishwaraj; Dillon, Stacey R.; Madala, Satish K.			Th2 Cytokines Augment IL-31/IL-31RA Interactions via STAT6-dependent IL-31RA Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; EPIDERMAL-KERATINOCYTES; SCRATCHING BEHAVIOR; SIGNAL-TRANSDUCTION; IL-4 RECEPTOR; NC/NGA MICE; INTERLEUKIN-31; STAT6; ACTIVATION; RESPONSIVENESS	Interleukin 31 receptor alpha(IL-31RA) is a novel Type I cytokine receptor that pairs with oncostatin M receptor to mediate IL-31 signaling. Binding of IL-31 to its receptor results in the phosphorylation and activation of STATs, MAPK, and JNK signaling pathways. IL-31 plays a pathogenic role in tissue inflammation, particularly in allergic diseases. Recent studies demonstrate IL-31RA expression and signaling in non-hematopoietic cells, but this receptor is poorly studied in immune cells. Macrophages are key immune-effector cells that play a critical role in Th2-cytokine-mediated allergic diseases. Here, we demonstrate that Th2 cytokines IL-4 and IL-13 are capable of up-regulating IL-31RA expression on both peritoneal and bone marrow-derived macrophages from mice. Our data also demonstrate that IL-4R alpha-driven IL-31RA expression is STAT6 dependent in macrophages. Notably, the inflammation-associated genes Fizz1 and serum amyloid A (SAA) are significantly up-regulated in M2 macrophages stimulated with IL-31, but not in IL-4 receptor-deficient macrophages. Furthermore, the absence of Type II IL-4 receptor signaling is sufficient to attenuate the expression of IL-31RA in vivo during allergic asthma induced by soluble egg antigen, which may suggest a role for IL-31 signaling in Th2 cytokine-driven inflammation and allergic responses. Our study reveals an important counter-regulatory role between Th2 cytokine and IL-31 signaling involved in allergic diseases.	[Edukulla, Ramakrishna; Singh, Brijendra; Sontake, Vishwaraj; Madala, Satish K.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Cincinnati, OH 45229 USA; [Jegga, Anil G.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Madala, Satish K.] ZymoGenetics Inc, Seattle, WA 98102 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Zymogenet Inc.	Madala, SK (corresponding author), MLC 2021 3333 Burnet Ave, Cincinnati, OH 45229 USA.	satish.madala@cchmc.org	Singh, Brijendra/AAQ-2550-2020; Jegga, Anil/H-6140-2011; Sontake, Vishwaraj/ABD-7278-2020; Regan, Clinton/E-6250-2012	Jegga, Anil/0000-0002-4881-7752; Sontake, Vishwaraj/0000-0002-8532-7680; Singh, Brijendra/0000-0002-0113-4831	National Institutes of Health [1R03AR062832]; Parker B. Francis Fellowship; American Heart Association [12SDG9130040]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR062832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R03AR062832 (to S. K. M.), a Parker B. Francis Fellowship (to S. K. M.), and American Heart Association Grant 12SDG9130040 (to S. K. M.). S. R. Dillon is an employee and stockholder of Bristol-Myers Squibb. None of the remaining authors have a financial relationship with a commercial entity that has an interest in the subject of this manuscript.	[Anonymous], 2005, APPL PHYS REV, V97, P1; Bilsborough J, 2006, J ALLERGY CLIN IMMUN, V117, P418, DOI 10.1016/j.jaci.2005.10.046; Bilsborough J, 2010, J IMMUNOL, V185, P6023, DOI 10.4049/jimmunol.0902769; Brandt Eric B, 2011, J Clin Cell Immunol, V2; Chattopadhyay S, 2007, J BIOL CHEM, V282, P3014, DOI 10.1074/jbc.M609655200; Cheung PFY, 2010, INT IMMUNOL, V22, P453, DOI 10.1093/intimm/dxq027; Cornelissen C, 2012, EUR J CELL BIOL, V91, P552, DOI 10.1016/j.ejcb.2011.07.006; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Gonzales AJ, 2013, VET DERMATOL, V24, P48, DOI 10.1111/j.1365-3164.2012.01098.x; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Grimstad O, 2009, EXP DERMATOL, V18, P35, DOI 10.1111/j.1600-0625.2008.00766.x; Heise R, 2009, J INVEST DERMATOL, V129, P240, DOI 10.1038/jid.2008.183; Heller NM, 2004, AM J RESP CELL MOL, V31, P573, DOI 10.1165/rcmb.2004-0195OC; Horejs-Hoeck J, 2012, J IMMUNOL, V188, P5319, DOI 10.4049/jimmunol.1101044; Ip WK, 2007, IMMUNOLOGY, V122, P532, DOI 10.1111/j.1365-2567.2007.02668.x; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kasraie S, 2010, ALLERGY, V65, P712, DOI 10.1111/j.1398-9995.2009.02255.x; Kawakami K, 2001, BLOOD, V97, P2673, DOI 10.1182/blood.V97.9.2673; Kuperman DA, 2005, J IMMUNOL, V175, P3746, DOI 10.4049/jimmunol.175.6.3746; Madala SK, 2010, J IMMUNOL, V184, P3955, DOI 10.4049/jimmunol.0903008; Maier E, 2014, TLS-TIMES LIT SUPPL, P6; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Moynihan BJ, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-84; Munitz A, 2008, P NATL ACAD SCI USA, V105, P7240, DOI 10.1073/pnas.0802465105; Neis MM, 2006, J ALLERGY CLIN IMMUN, V118, P930, DOI 10.1016/j.jaci.2006.07.015; Nobbe S, 2012, ACTA DERM-VENEREOL, V92, P24, DOI 10.2340/00015555-1191; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Rabenhorst A, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0423-y; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Takaoka A, 2006, EXP DERMATOL, V15, P161, DOI 10.1111/j.1600-0625.2006.00405.x; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Thompson RW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000023; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wilson MS, 2008, J IMMUNOL, V181, P6942, DOI 10.4049/jimmunol.181.10.6942; Wilson MS, 2007, J CLIN INVEST, V117, P2941, DOI 10.1172/JCI31546; Zhang Q, 2008, CYTOKINE GROWTH F R, V19, P347, DOI 10.1016/j.cytogfr.2008.08.003	40	28	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13510	13520		10.1074/jbc.M114.622126	http://dx.doi.org/10.1074/jbc.M114.622126			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847241	Green Published, hybrid			2022-12-28	WOS:000354975700045
J	Carrara, G; Saraiva, N; Parsons, M; Byrne, B; Prole, DL; Taylor, CW; Smith, GL				Carrara, Guia; Saraiva, Nuno; Parsons, Maddy; Byrne, Bernadette; Prole, David L.; Taylor, Colin W.; Smith, Geoffrey L.			Golgi Anti-apoptotic Proteins Are Highly Conserved Ion Channels That Affect Apoptosis and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE CALCIUM LEAK; BAX INHIBITOR-1; VACCINIA VIRUS; K+ CHANNELS; P7 PROTEIN; I-TASSER; EXPRESSION; CANCER; RECEPTOR; FORMS	Golgi anti-apoptotic proteins (GAAPs) are multitransmembrane proteins that are expressed in the Golgi apparatus and are able to homo-oligomerize. They are highly conserved throughout eukaryotes and are present in some prokaryotes and orthopoxviruses. Within eukaryotes, GAAPs regulate the Ca2+ content of intracellular stores, inhibit apoptosis, and promote cell adhesion and migration. Data presented here demonstrate that purified viral GAAPs (vGAAPs) and human Bax inhibitor 1 form ion channels and that vGAAP from camelpox virus is selective for cations. Mutagenesis of vGAAP, including some residues conserved in the recently solved structure of a related bacterial protein, BsYetJ, altered the conductance (E207Q and D219N) and ion selectivity (E207Q) of the channel. Mutation of residue Glu-207 or -178 reduced the effects of GAAP on cell migration and adhesion without affecting protection from apoptosis. In contrast, mutation of Asp-219 abrogated the anti-apoptotic activity of GAAP but not its effects on cell migration and adhesion. These results demonstrate that GAAPs are ion channels and define residues that contribute to the ion-conducting pore and affect apoptosis, cell adhesion, and migration independently.	[Carrara, Guia; Saraiva, Nuno; Smith, Geoffrey L.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Prole, David L.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Byrne, Bernadette] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of Cambridge; University of Cambridge; Imperial College London; University of London; King's College London	Prole, DL (corresponding author), Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England.	dp350@cam.ac.uk; cwt1000@cam.ac.uk; gls37@cam.ac.uk	Saraiva, Nuno/I-9299-2019; Parsons, Maddy/B-2203-2013; Taylor, Colin/G-2447-2010	Saraiva, Nuno/0000-0003-1333-9137; Parsons, Maddy/0000-0002-2021-8379; Prole, David/0000-0003-2782-6665; Taylor, Colin/0000-0001-7771-1044; Byrne, Bernadette/0000-0001-9598-9832; Smith, Geoffrey L/0000-0002-3730-9955	United Kingdom Medical Research Council; Biotechnology and Biological Sciences Research Council; Wellcome Trust; BBSRC [BB/L000075/1] Funding Source: UKRI; MRC [G0900224] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L000075/1] Funding Source: researchfish; Medical Research Council [G0900224] Funding Source: researchfish; Wellcome Trust [101844/Z/13/Z] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the United Kingdom Medical Research Council, the Biotechnology and Biological Sciences Research Council, and the Wellcome Trust.	Ahn T, 2009, FEBS J, V276, P2285, DOI 10.1111/j.1742-4658.2009.06956.x; ALCAMI A, 1995, J VIROL, V69, P4633; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Brelidze TI, 2003, P NATL ACAD SCI USA, V100, P9017, DOI 10.1073/pnas.1532257100; Bruggemann A, 2003, ASSAY DRUG DEV TECHN, V1, P665, DOI 10.1089/154065803770381020; Bultynck G, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005764; Bultynck G, 2012, J BIOL CHEM, V287, P2544, DOI 10.1074/jbc.M111.275354; Carrara G, 2012, J BIOL CHEM, V287, P15896, DOI 10.1074/jbc.M111.336149; Chang YQ, 2014, SCIENCE, V344, P1131, DOI 10.1126/science.1252043; Chen QR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105393; Chizhmakov IV, 1996, J PHYSIOL-LONDON, V494, P329, DOI 10.1113/jphysiol.1996.sp021495; Cohen A, 2009, EUR BIOPHYS J BIOPHY, V39, P61, DOI 10.1007/s00249-009-0457-6; de Mattia F, 2009, MOL BIOL CELL, V20, P3638, DOI 10.1091/mbc.E09-05-0385; Denning EJ, 2010, PROTEINS, V78, P1105, DOI 10.1002/prot.22632; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Fertig N, 2002, APPL PHYS LETT, V81, P4865, DOI 10.1063/1.1531228; Gonzalez C, 2012, COMPR PHYSIOL, V2, P2087, DOI 10.1002/cphy.c110047; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Grzmil M, 2006, J PATHOL, V208, P340, DOI 10.1002/path.1902; Gubser C, 2002, J GEN VIROL, V83, P855, DOI 10.1099/0022-1317-83-4-855; Gubser C, 2007, PLOS PATHOG, V3, P246, DOI 10.1371/journal.ppat.0030017; Hu L, 2009, APOPTOSIS, V14, P1255, DOI 10.1007/s10495-009-0402-2; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kew J., 2010, ION CHANNELS STRUCTU, P20; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; Kiviluoto S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.103; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee GH, 2010, ONCOGENE, V29, P2130, DOI 10.1038/onc.2009.491; Lee GH, 2010, MOL CELL BIOL, V30, P1800, DOI 10.1128/MCB.01357-09; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; Li XY, 2010, CELL BIOL INT, V34, P1099, DOI 10.1042/CBI20090400; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; Mariotti M, 2014, J HUM GENET, V59, P288, DOI 10.1038/jhg.2014.6; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; MOORE JB, 1992, EMBO J, V11, P1973, DOI 10.1002/j.1460-2075.1992.tb05251.x; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; OuYang B, 2014, BBA-BIOMEMBRANES, V1838, P1058, DOI 10.1016/j.bbamem.2013.09.004; Parker AKT, 2004, J BIOL CHEM, V279, P23797, DOI 10.1074/jbc.M402098200; Pavlovic D, 2003, P NATL ACAD SCI USA, V100, P6104, DOI 10.1073/pnas.1031527100; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Reimers K, 2008, CURR MOL MED, V8, P148, DOI 10.2174/156652408783769562; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saraiva N, 2013, J CELL BIOL, V202, P699, DOI 10.1083/jcb.201301016; Saraiva N, 2013, J BIOL CHEM, V288, P13057, DOI 10.1074/jbc.M112.414367; Schmits R, 2002, INT J CANCER, V98, P73, DOI 10.1002/ijc.10170; Singh S, 2010, PROTEIN EXPRES PURIF, V74, P80, DOI 10.1016/j.pep.2010.04.018; SMITH GL, 1991, J GEN VIROL, V72, P511, DOI 10.1099/0022-1317-72-3-511; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Wang K, 2011, BBA-BIOMEMBRANES, V1808, P510, DOI 10.1016/j.bbamem.2010.05.006; Welsh JB, 2001, CANCER RES, V61, P5974; Wolgien MDGM, 2005, EUR J GYNAECOL ONCOL, V26, P501; Wu XF, 2013, CANCER RES, V73, P4028, DOI 10.1158/0008-5472.CAN-12-4033; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Yun CH, 2012, J PHARM SCI-US, V101, P1314, DOI 10.1002/jps.23007; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	60	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11785	11801		10.1074/jbc.M115.637306	http://dx.doi.org/10.1074/jbc.M115.637306			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25713081	Green Published, hybrid			2022-12-28	WOS:000353719400050
J	Heidrich, E; Carattino, MD; Hughey, RP; Pilewski, JM; Kleyman, TR; Myerburg, MM				Heidrich, Elisa; Carattino, Marcelo D.; Hughey, Rebecca P.; Pilewski, Joseph M.; Kleyman, Thomas R.; Myerburg, Mike M.			Intracellular Na+ Regulates Epithelial Na+ Channel Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCONVENTIONAL PROTEIN SECRETION; SODIUM-CHANNEL; CYSTIC-FIBROSIS; FEEDBACK INHIBITION; CYTOSOLIC NA+; GAMMA-SUBUNIT; MEMBRANE; TRAFFICKING; CELLS	Epithelial Na+ channel (ENaC) function is regulated by the intracellular Na+ concentration ([Na+](i)) through a process known as Na+ feedback inhibition. Although this process is known to decrease the expression of proteolytically processed active channels on the cell surface, it is unknown how [Na+](i) alters ENaC cleavage. We show here that [Na+](i) regulates the posttranslational processing of ENaC subunits during channel biogenesis. At times when [Na+](i) is low, ENaC subunits develop mature N-glycans and are processed by proteases. Conversely, glycan maturation and sensitivity to proteolysis are reduced when [Na+](i) is relatively high. Surface channels with immature N-glycans were not processed by endogenous channel activating proteases, nor were they sensitive to cleavage by exogenous trypsin. Biotin chase experiments revealed that the immature surface channels were not converted into mature cleaved channels following a reduction in [Na+](i). The hypothesis that [Na+](i) regulates ENaC maturation within the biosynthetic pathways is further supported by the finding that Brefeldin A prevented the accumulation of processed surface channels following a reduction in [Na+](i). Therefore, increased [Na+](i) interferes with ENaC N-glycan maturation and prevents the channel from entering a state that allows proteolytic processing.	[Heidrich, Elisa; Hughey, Rebecca P.; Pilewski, Joseph M.; Myerburg, Mike M.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Carattino, Marcelo D.; Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Renal Electrolyte Div, Pittsburgh, PA 15213 USA; [Carattino, Marcelo D.; Pilewski, Joseph M.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Myerburg, MM (corresponding author), NW628 Montefiore Hosp, Div Pulm Allergy & Crit Care Med, 3459 Fifth Ave, Pittsburgh, PA 15213 USA.	myerburgm@upmc.edu	Pilewski, Joseph/AAF-5149-2021; Regan, Clinton/E-6250-2012		National Institutes of Health [K08 HL087932, R01 HL112863, R01 DK051391, P30 DK079307, P30 DK072506]; Cystic Fibrosis Foundation [MYERBU07Q0, RDP]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL087932, R01HL112863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051391, R37DK051391, P30DK072506, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 HL087932, R01 HL112863, R01 DK051391, P30 DK079307, and P30 DK072506. This work was also supported by Cystic Fibrosis Foundation Grants MYERBU07Q0 and RDP (to The University of Pittsburgh).	Abriel H, 1999, J PHYSIOL-LONDON, V516, P31, DOI 10.1111/j.1469-7793.1999.031aa.x; Anantharam A, 2006, J PHYSIOL-LONDON, V574, P333, DOI 10.1113/jphysiol.2006.109173; Awayda MS, 1999, AM J PHYSIOL-CELL PH, V277, pC216, DOI 10.1152/ajpcell.1999.277.2.C216; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; Dinudom A, 1998, P NATL ACAD SCI USA, V95, P7169, DOI 10.1073/pnas.95.12.7169; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Farinha CM, 2013, FEBS J, V280, P4396, DOI 10.1111/febs.12392; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Kashlan OB, 2012, EXP CELL RES, V318, P1011, DOI 10.1016/j.yexcr.2012.02.024; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Komwatana P, 1996, P NATL ACAD SCI USA, V93, P8107, DOI 10.1073/pnas.93.15.8107; Myerburg M. M., 2010, AM J RESP CELL MOL B, V45, P592; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Patel AB, 2013, AM J PHYSIOL-RENAL, V304, pF222, DOI 10.1152/ajprenal.00596.2012; Rabouille C, 2012, J CELL SCI, V125, P5251, DOI 10.1242/jcs.103630; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Tong ZY, 2004, AM J PHYSIOL-LUNG C, V287, pL928, DOI 10.1152/ajplung.00160.2004; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200	27	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11569	11577		10.1074/jbc.M115.640763	http://dx.doi.org/10.1074/jbc.M115.640763			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25767115	hybrid, Green Published			2022-12-28	WOS:000353719400032
J	Morey, TM; Roufayel, R; Johnston, DS; Fletcher, AS; Mosser, DD				Morey, Trevor M.; Roufayel, Rabih; Johnston, Donald S.; Fletcher, Andrew S.; Mosser, Dick D.			Heat Shock Inhibition of CDK5 Increases NOXA Levels through miR-23a Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; RNA-POLYMERASE-II; INDUCED APOPTOSIS; SELICICLIB CYC202; NEURONAL SURVIVAL; MULTIPLE-MYELOMA; DOWN-REGULATION; STRESSED CELLS; R-ROSCOVITINE; C-JUN	Hyperthermia is a proteotoxic stress that is lethal when exposure is extreme but also cytoprotective in that sublethal exposure leads to the synthesis of heat shock proteins, including HSP70, which are able to inhibit stress-induced apoptosis. CDK5 is an atypical cyclin-dependent kinase family member that regulates many cellular functions including motility and survival. Here we show that exposure of a human lymphoid cell line to hyperthermia causes CDK5 insolubilization and loss of tyrosine-15 phosphorylation, both of which were prevented in cells overexpressing HSP70. Inhibition of CDK5 activity with roscovitine-sensitized cells to heat induced apoptosis indicating a protective role for CDK5 in inhibiting heat-induced apoptosis. Both roscovitine and heat shock treatment caused increased accumulation of NOXA a pro-apoptotic BH3-only member of the BCL2 family. The increased abundance of NOXA by CDK5 inhibition was not a result of changes in NOXA protein turnover. Instead, CDK5 inhibition increased NOXA mRNA and protein levels by decreasing the expression of miR-23a, whereas overexpressing the CDK5 activator p35 attenuated both of these effects on NOXA and miR-23a expression. Lastly, overexpression of miR-23a prevented apoptosis under conditions in which CDK5 activity was inhibited. These results demonstrate that CDK5 activity provides resistance to heat-induced apoptosis through the expression of miR-23a and subsequent suppression of NOXA synthesis. Additionally, they indicate that hyperthermia induces apoptosis through the insolubilization and inhibition of CDK5 activity.	[Morey, Trevor M.; Roufayel, Rabih; Johnston, Donald S.; Fletcher, Andrew S.; Mosser, Dick D.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Mosser, DD (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rmosser@uoguelph.ca	Roufayel, Rabih/AAX-5552-2021; Mosser, Dick D/A-7391-2008	Roufayel, Rabih/0000-0002-4595-1104; Mosser, Richard/0000-0002-9183-2288	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC).	Arif A, 2012, BIOCHEM PHARMACOL, V84, P985, DOI 10.1016/j.bcp.2012.06.027; Brinkkoetter PT, 2010, KIDNEY INT, V77, P690, DOI 10.1038/ki.2009.548; BUKH A, 1990, J IMMUNOL, V144, P4835; Chen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.92; Cheung ZH, 2008, J NEUROSCI, V28, P4872, DOI 10.1523/JNEUROSCI.0689-08.2008; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Contreras-Vallejos E, 2012, CELL SIGNAL, V24, P44, DOI 10.1016/j.cellsig.2011.08.022; Demange L, 2013, BIOORG MED CHEM LETT, V23, P125, DOI 10.1016/j.bmcl.2012.10.141; Fabre C, 2014, CANCER CHEMOTH PHARM, V74, P1057, DOI 10.1007/s00280-014-2583-9; Fitzgerald JC, 2012, CELL DEATH DIFFER, V19, P257, DOI 10.1038/cdd.2011.90; Gao C, 2001, J CELL SCI, V114, P1145; Gautam S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079352; Hernandez-Torres F, 2014, BBA-GENE REGUL MECH, V1839, P885, DOI 10.1016/j.bbagrm.2014.07.009; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Jain SK, 2000, LEUKEMIA, V14, P845, DOI 10.1038/sj.leu.2401759; Kennedy D, 2014, IUBMB LIFE, V66, P327, DOI 10.1002/iub.1274; Kobayashi H, 2014, J BIOL CHEM, V289, P19627, DOI 10.1074/jbc.M113.501148; Lachapelle G, 2007, APOPTOSIS, V12, P1479, DOI 10.1007/s10495-007-0068-6; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li XN, 2013, J BIOL CHEM, V288, P18121, DOI 10.1074/jbc.M113.478560; Liebl J, 2011, CELL SIGNAL, V23, P1698, DOI 10.1016/j.cellsig.2011.06.020; Lima RT, 2011, EUR J CANCER, V47, P163, DOI 10.1016/j.ejca.2010.11.005; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Liu JL, 2011, MED ONCOL, V28, P673, DOI 10.1007/s12032-010-9510-7; Liu R, 2008, P NATL ACAD SCI USA, V105, P7570, DOI 10.1073/pnas.0712306105; Lopes JP, 2011, PROG NEUROBIOL, V94, P49, DOI 10.1016/j.pneurobio.2011.03.006; Lowman XH, 2010, MOL CELL, V40, P823, DOI 10.1016/j.molcel.2010.11.035; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Mao JQ, 2014, EXP MOL PATHOL, V97, P23, DOI 10.1016/j.yexmp.2013.11.005; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Meriin AB, 1999, MOL CELL BIOL, V19, P2547; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; MOSSER DD, 1992, J CELL PHYSIOL, V151, P561, DOI 10.1002/jcp.1041510316; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Place RF, 2014, CELL STRESS CHAPERON, V19, P159, DOI 10.1007/s12192-013-0456-5; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; RAVID Z, 1980, INT J CANCER, V25, P705, DOI 10.1002/ijc.2910250604; Rockett JC, 2001, BIOL REPROD, V65, P229, DOI 10.1095/biolreprod65.1.229; Roufayel R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.484; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Shah K, 2014, J CELL SCI, V127, P2391, DOI 10.1242/jcs.147553; Simard JP, 2011, J CELL SCI, V124, P2367, DOI 10.1242/jcs.081745; Stankiewicz AR, 2009, CELL DEATH DIFFER, V16, P638, DOI 10.1038/cdd.2008.189; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Stephenson JJ, 2014, LUNG CANCER, V83, P219, DOI 10.1016/j.lungcan.2013.11.020; Tan XC, 2012, P NATL ACAD SCI USA, V109, P15805, DOI 10.1073/pnas.1207787109; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Yaglom J, 2003, MOL CELL BIOL, V23, P3813, DOI 10.1128/MCB.23.11.3813-3824.2003; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	52	10	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11443	11454		10.1074/jbc.M114.625988	http://dx.doi.org/10.1074/jbc.M114.625988			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25829494	Green Published, hybrid			2022-12-28	WOS:000353719400021
J	Akopian, T; Kandror, O; Tsu, C; Lai, JH; Wu, WG; Liu, YX; Zhao, P; Park, A; Wolf, L; Dick, LR; Rubin, EJ; Bachovchin, W; Goldberg, AL				Akopian, Tatos; Kandror, Olga; Tsu, Christopher; Lai, Jack H.; Wu, Wengen; Liu, Yuxin; Zhao, Peng; Park, Annie; Wolf, Lisa; Dick, Lawrence R.; Rubin, Eric J.; Bachovchin, William; Goldberg, Alfred L.			Cleavage Specificity of Mycobacterium tuberculosis ClpP1P2 Protease and Identification of Novel Peptide Substrates and Boronate Inhibitors with Anti-bacterial Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; ESCHERICHIA-COLI; CLP PROTEASE; PROCESSIVE DEGRADATION; PROTEINS; DISTINCT; TRANSLOCATION; TETRADECAMER; COMPONENT; CONTAINS	The ClpP1P2 protease complex is essential for viability in Mycobacteria tuberculosis and is an attractive drug target. Using a fluorogenic tripeptide library (Ac-X3X2X1-aminomethylcoumarin) and by determining specificity constants (k(cat)/K-m), we show that ClpP1P2 prefers Met >> Leu > Phe > Ala in the X-1 position, basic residues or Trp in the X-2 position, and Pro >> Ala > Trp in the X-3 position. We identified peptide substrates that are hydrolyzed up to 1000 times faster than the standard ClpP substrate. These positional preferences were consistent with cleavage sites in the protein GFPssrA by ClpXP1P2. Studies of ClpP1P2 with inactive ClpP1 or ClpP2 indicated that ClpP1 was responsible for nearly all the peptidase activity, whereas both ClpP1 and ClpP2 contributed to protein degradation. Substrate-based peptide boronates were synthesized that inhibit ClpP1P2 peptidase activity in the submicromolar range. Some of them inhibited the growth of Mtb cells in the low micromolar range indicating that cleavage specificity of Mtb ClpP1P2 can be used to design novel anti-bacterial agents.	[Akopian, Tatos; Kandror, Olga; Wolf, Lisa; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Tsu, Christopher; Dick, Lawrence R.] Takeda Pharmaceut Int Co, Dept Biochem, Cambridge, MA 02139 USA; [Lai, Jack H.; Wu, Wengen; Liu, Yuxin; Zhao, Peng; Bachovchin, William] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02711 USA; [Park, Annie; Rubin, Eric J.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.; Tufts University; Harvard University; Harvard T.H. Chan School of Public Health	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	Alfred_Goldberg@hms.harvard.edu	liu, yuxin/GRY-3592-2022; Dick, Lawrence/ABA-8831-2021; william.bachovchin@tufts.edu/AAA-3538-2022	Dick, Larry/0000-0002-6880-0405	National Institutes of Health [R01GM051923-17A1]; Harvard Catalyst Grant; Roche Applied Science; Bill and Melinda Gates Foundation [OPP1024065]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst Grant; Roche Applied Science; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM051923-17A1. This work was also supported by a Harvard Catalyst Grant, a grant from Roche Applied Science (to A. L. G.), and by Bill and Melinda Gates Foundation Grant OPP1024065 (to E. J. R.).	Akopian T, 2012, EMBO J, V31, P1529, DOI 10.1038/emboj.2012.5; Akopian TN, 1997, J BIOL CHEM, V272, P1791, DOI 10.1074/jbc.272.3.1791; Andersson FI, 2009, J BIOL CHEM, V284, P13519, DOI 10.1074/jbc.M809588200; Bachovchin DA, 2014, NAT CHEM BIOL, V10, P656, DOI [10.1038/NCHEMBIO.1578, 10.1038/nchembio.1578]; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Butler SM, 2006, MOL MICROBIOL, V60, P553, DOI 10.1111/j.1365-2958.2006.05128.x; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Coutts SJ, 1996, J MED CHEM, V39, P2087, DOI 10.1021/jm950732f; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; FLANAGAN JM, 1995, BIOCHEMISTRY-US, V34, P10910, DOI 10.1021/bi00034a025; Frase H, 2007, BIOCHEMISTRY-US, V46, P6647, DOI 10.1021/bi7002789; Gavrish E, 2014, CHEM BIOL, V21, P509, DOI 10.1016/j.chembiol.2014.01.014; Geiger SR, 2011, ANGEW CHEM INT EDIT, V50, P5748, DOI 10.1002/anie.201100666; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077; Hoskins JR, 1998, P NATL ACAD SCI USA, V95, P12135, DOI 10.1073/pnas.95.21.12135; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; HWANG BJ, 1988, J BIOL CHEM, V263, P8727; HWANG BJ, 1987, P NATL ACAD SCI USA, V84, P5550, DOI 10.1073/pnas.84.16.5550; Ingallinella P, 2000, BIOCHEMISTRY-US, V39, P12898, DOI 10.1021/bi001590g; Ishikawa T, 2001, P NATL ACAD SCI USA, V98, P4328, DOI 10.1073/pnas.081543698; Kang SG, 2005, J BIOL CHEM, V280, P35424, DOI 10.1074/jbc.M507240200; KATAYAMAFUJIMURA Y, 1987, J BIOL CHEM, V262, P4477; Kress W, 2009, RES MICROBIOL, V160, P618, DOI 10.1016/j.resmic.2009.08.006; Lin G, 2008, J BIOL CHEM, V283, P34423, DOI 10.1074/jbc.M805324200; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MAURIZI MR, 1990, J BIOL CHEM, V265, P12536; MAURIZI MR, 1991, BIOCHEM SOC T, V19, P719, DOI 10.1042/bst0190719; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Raju RM, 2012, NAT REV DRUG DISCOV, V11, P777, DOI 10.1038/nrd3846; Raju RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002511; Reid BG, 2001, P NATL ACAD SCI USA, V98, P3768, DOI 10.1073/pnas.071043698; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schmitt EK, 2011, ANGEW CHEM INT EDIT, V50, P5889, DOI 10.1002/anie.201101740; Schmitz KR, 2014, MOL MICROBIOL, V93, P617, DOI 10.1111/mmi.12694; Sheppeck JE, 2000, BIOORG MED CHEM LETT, V10, P2639, DOI 10.1016/S0960-894X(00)00545-X; Smoum R, 2012, CHEM REV, V112, P4156, DOI 10.1021/cr608202m; THOMPSON MW, 1994, J BIOL CHEM, V269, P18209; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Zeiler E, 2013, P NATL ACAD SCI USA, V110, P11302, DOI 10.1073/pnas.1219125110	45	37	37	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11008	11020		10.1074/jbc.M114.625640	http://dx.doi.org/10.1074/jbc.M114.625640			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25759383	hybrid, Green Published			2022-12-28	WOS:000353404500037
J	Li, ZX; Moniz, H; Wang, S; Ramiah, A; Zhang, FM; Moremen, KW; Linhardt, RJ; Sharp, JS				Li, Zixuan; Moniz, Heather; Wang, Shuo; Ramiah, Annapoorani; Zhang, Fuming; Moremen, Kelley W.; Linhardt, Robert J.; Sharp, Joshua S.			High Structural Resolution Hydroxyl Radical Protein Footprinting Reveals an Extended Robo1-Heparin Binding Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; MASS-SPECTROMETRY; AXON GUIDANCE; PHOTOCHEMICAL OXIDATION; SLIT; ROBO; ROUNDABOUT; RECEPTORS; MIDLINE; MORPHOGENESIS	Interaction of transmembrane receptors of the Robo family and the secreted protein Slit provides important signals in the development of the central nervous system and regulation of axonal midline crossing. Heparan sulfate, a sulfated linear polysaccharide modified in a complex variety of ways, serves as an essential co-receptor in Slit-Robo signaling. Previous studies have shown that closely related heparin octasaccharides bind to Drosophila Robo directly, and surface plasmon resonance analysis revealed that Robo1 binds more tightly to full-length unfractionated heparin. For the first time, we utilized electron transfer dissociation-based high spatial resolution hydroxyl radical protein footprinting to identify two separate binding sites for heparin interaction with Robo1: one binding site at the previously identified site for heparin dp8 and a second binding site at the N terminus of Robo1 that is disordered in the x-ray crystal structure. Mutagenesis of the identified N-terminal binding site exhibited a decrease in binding affinity as measured by surface plasmon resonance and heparin affinity chromatography. Footprinting also indicated that heparin binding induces a minor change in the conformation and/or dynamics of the Ig2 domain, but no major conformational changes were detected. These results indicate a second low affinity binding site in the Robo-Slit complex as well as suggesting the role of the Ig2 domain of Robo1 in heparin-mediated signal transduction. This study also marks the first use of electron transfer dissociation-based high spatial resolution hydroxyl radical protein footprinting, which shows great utility for the characterization of protein-carbohydrate complexes.	[Li, Zixuan; Moniz, Heather; Wang, Shuo; Ramiah, Annapoorani; Moremen, Kelley W.; Sharp, Joshua S.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, Troy, NY 12180 USA	University System of Georgia; University of Georgia; Rensselaer Polytechnic Institute	Sharp, JS (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	jsharp@ccrc.uga.edu	Moremen, Kelley/AAD-4661-2019		National Institutes of Health, NIGMS as part of the Research Resource for Integrated Glycotechnology [P41GM103390]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS as part of the Research Resource for Integrated Glycotechnology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant P41GM103390 as part of the Research Resource for Integrated Glycotechnology.	Aye TT, 2005, ANAL CHEM, V77, P5814, DOI 10.1021/ac050353m; Barb AW, 2012, BIOCHEMISTRY-US, V51, P4618, DOI 10.1021/bi300319q; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chance MR, 2001, BIOCHEM BIOPH RES CO, V287, P614, DOI 10.1006/bbrc.2001.5628; Charvatova O, 2008, J AM SOC MASS SPECTR, V19, P1692, DOI 10.1016/j.jasms.2008.07.013; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Englund C, 2002, DEVELOPMENT, V129, P4941; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Evans TA, 2012, DEV BIOL, V363, P266, DOI 10.1016/j.ydbio.2011.12.046; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Fukuhara N, 2008, J BIOL CHEM, V283, P16226, DOI 10.1074/jbc.M800688200; Garbe DS, 2004, CRIT REV BIOCHEM MOL, V39, P319, DOI 10.1080/10409230490906797; Gau BC, 2009, ANAL CHEM, V81, P6563, DOI 10.1021/ac901054w; Gibson DA, 2014, NEURON, V81, P1040, DOI 10.1016/j.neuron.2014.01.009; Goldsmith SC, 2001, J BIOMOL STRUCT DYN, V19, P405, DOI 10.1080/07391102.2001.10506750; Hambly DM, 2005, J AM SOC MASS SPECTR, V16, P2057, DOI 10.1016/j.jasms.2005.09.008; Hernaiz M, 2000, BIOCHEM BIOPH RES CO, V276, P292, DOI 10.1006/bbrc.2000.3453; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; Hussain SA, 2006, J BIOL CHEM, V281, P39693, DOI 10.1074/jbc.M609384200; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Jumper CC, 2012, ANAL CHEM, V84, P4411, DOI 10.1021/ac300120z; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Konermann L, 2010, ANAL CHEM, V82, P6667, DOI 10.1021/ac101326f; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Li XY, 2013, J AM SOC MASS SPECTR, V24, P1767, DOI 10.1007/s13361-013-0719-5; Maleknia SD, 1999, ANAL CHEM, V71, P3965, DOI 10.1021/ac990500e; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Sharp JS, 2004, ANAL CHEM, V76, P672, DOI 10.1021/ac0302004; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Watson C, 2009, ANAL CHEM, V81, P2496, DOI 10.1021/ac802252y; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Zhang FM, 2013, BIOCHIMIE, V95, P2345, DOI 10.1016/j.biochi.2013.08.018	40	42	42	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10729	10740		10.1074/jbc.M115.648410	http://dx.doi.org/10.1074/jbc.M115.648410			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25752613	Green Published, hybrid			2022-12-28	WOS:000353404500015
J	Li, JY; Yue, YY; Dong, XH; Jia, WS; Li, K; Liang, D; Dong, ZJ; Wang, XX; Nan, XX; Zhang, QX; Zhao, QS				Li, Jingyun; Yue, Yunyun; Dong, Xiaohua; Jia, Wenshuang; Li, Kui; Liang, Dong; Dong, Zhangji; Wang, Xiaoxiao; Nan, Xiaoxi; Zhang, Qinxin; Zhao, Qingshun			Zebrafish foxc1a Plays a Crucial Role in Early Somitogenesis by Restricting the Expression of aldh1a2 Directly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fibroblast Growth Factor (FGF); MyoD; Retinoic Acid; Transcription Activator-like Effector Nuclease (TALEN); Zebrafish; aldh1a2; deltaC; foxc1a; Paraxial Mesoderm; Somitogenesis	HELIX TRANSCRIPTION FACTORS; RETINOIC ACID CONTROLS; ONE-EYED PINHEAD; SEGMENTATION CLOCK; SOMITE FORMATION; NO TAIL; EMBRYONIC-DEVELOPMENT; WILD-TYPE; IN-VIVO; GENE	Foxc1a is a member of the forkhead transcription factors. It plays an essential role in zebrafish somitogenesis. However, little is known about the molecular mechanisms underlying its controlling somitogenesis. To uncover how foxc1a regulates zebrafish somitogenesis, we generated foxc1a knock-out zebrafish using TALEN (transcription activator-like effector nuclease) technology. The foxc1a null embryos exhibited defective somites at early development. Analyses on the expressions of the key genes that control processes of somitogenesis revealed that foxc1a controlled early somitogenesis by regulating the expression of myod1. In the somites of foxc1a knock-out embryos, expressions of fgf8a and deltaC were abolished, whereas the expression of aldh1a2 (responsible for providing retinoic acid signaling) was significantly increased. Once the increased retinoic acid level in the foxc1a null embryos was reduced by knocking down aldh1a2, the reduced expression of myod1 was partially rescued by resuming expressions of fgf8a and deltaC in the somites of the mutant embryos. Moreover, a chromatin immunoprecipitation assay on zebrafish embryos revealed that Foxc1a bound aldh1a2 promoter directly. On the other hand, neither knocking down fgf8a nor inhibiting Notch signaling affected the expression of aldh1a2, although knocking down fgf8a reduced expression of deltaC in the somites of zebrafish embryos at early somitogenesis and vice versa. Taken together, our results demonstrate that foxc1a plays an essential role in early somitogenesis by controlling Fgf and Notch signaling through restricting the expression of aldh1a2 in paraxial mesoderm directly.	[Li, Jingyun; Yue, Yunyun; Dong, Xiaohua; Jia, Wenshuang; Li, Kui; Liang, Dong; Dong, Zhangji; Wang, Xiaoxiao; Nan, Xiaoxi; Zhang, Qinxin; Zhao, Qingshun] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; [Li, Jingyun] Nanjing Med Univ, Maternal & Child Hlth Med Inst, Nanjing Maternal & Child Hlth Care Hosp, Nanjing 210004, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University	Zhao, QS (corresponding author), Nanjing Univ, Model Anim Res Ctr, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	qingshun@nju.edu.cn			Ministry of Science and Technology of China [2011CB943804]; National Natural Science Foundation of China [31171434]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) Grant [20130091110051]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) Grant(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by Ministry of Science and Technology of China Grant 2011CB943804, National Natural Science Foundation of China Grant 31171434, and Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) Grant 20130091110051.	Araki I, 2001, GENESIS, V30, P157, DOI 10.1002/gene.1054; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Bajard L, 2014, DEVELOPMENT, V141, P1381, DOI 10.1242/dev.093435; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Begemann G, 2001, DEVELOPMENT, V128, P3081; Bessarab DA, 2008, DEV BIOL, V323, P216, DOI 10.1016/j.ydbio.2008.08.015; Brend Tim, 2009, J Vis Exp, DOI 10.3791/1229; Buckingham M, 2009, CURR OPIN GENET DEV, V19, P444, DOI 10.1016/j.gde.2009.08.001; Cao Y, 2004, DEV BIOL, V271, P130, DOI 10.1016/j.ydbio.2004.03.032; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Choorapoikayil S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039073; Coutelle O, 2001, DEV BIOL, V236, P136, DOI 10.1006/dbio.2001.0193; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Dong ZJ, 2014, ZEBRAFISH, V11, P265, DOI 10.1089/zeb.2014.0974; Dong ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028897; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Echeverri K, 2007, DEV BIOL, V301, P388, DOI 10.1016/j.ydbio.2006.10.003; Ferjentsik Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000662; Fujii T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023491; Griffin KJP, 2002, NAT CELL BIOL, V4, P821, DOI 10.1038/ncb862; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Hamade A, 2006, DEV BIOL, V289, P127, DOI 10.1016/j.ydbio.2005.10.019; Hammond CL, 2007, DEV BIOL, V302, P504, DOI 10.1016/j.ydbio.2006.10.009; Herrgen L, 2010, CURR BIOL, V20, P1244, DOI 10.1016/j.cub.2010.06.034; Holley SA, 2007, DEV DYNAM, V236, P1422, DOI 10.1002/dvdy.21162; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Jackson HE, 2013, MECH DEVELOP, V130, P447, DOI 10.1016/j.mod.2013.06.001; Julich D, 2005, DEV CELL, V8, P575, DOI 10.1016/j.devcel.2005.01.016; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Kumar S, 2014, DEVELOPMENT, V141, P2972, DOI 10.1242/dev.112367; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Li JY, 2012, ANAT REC, V295, P268, DOI 10.1002/ar.21520; Liang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030865; Maroto M, 2012, DEVELOPMENT, V139, P2453, DOI 10.1242/dev.069310; Mathieu J, 2004, DEVELOPMENT, V131, P629, DOI 10.1242/dev.00964; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; O'Brien LL, 2011, DEV BIOL, V358, P318, DOI 10.1016/j.ydbio.2011.08.005; Oates AC, 2002, DEVELOPMENT, V129, P2929; Ochi H, 2007, DEV GROWTH DIFFER, V49, P1, DOI 10.1111/j.1440-169x.2007.00905.x; Ozbudak EM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040015; Palencia-Desai S, 2011, DEVELOPMENT, V138, P4721, DOI 10.1242/dev.064998; Porazzi P, 2012, ENDOCRINOLOGY, V153, P5645, DOI 10.1210/en.2011-1888; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Reifers F, 1998, DEVELOPMENT, V125, P2381; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Sawada A, 2000, DEVELOPMENT, V127, P1691; Sawada A, 2001, DEVELOPMENT, V128, P4873; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P843; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Shanmugalingam S, 1998, MECH DEVELOP, V78, P85, DOI 10.1016/S0925-4773(98)00150-6; Smithers L, 2000, MECH DEVELOP, V90, P119, DOI 10.1016/S0925-4773(99)00231-2; Sun L, 2005, MATRIX BIOL, V24, P69, DOI 10.1016/j.matbio.2004.12.002; Takke C, 1999, DEVELOPMENT, V126, P3005; Topczewska JM, 2001, MECH DEVELOP, V100, P343, DOI 10.1016/S0925-4773(00)00534-7; Topczewska JM, 2001, GENE DEV, V15, P2483, DOI 10.1101/gad.907401; Veldman MB, 2012, CIRC RES, V110, P220, DOI 10.1161/CIRCRESAHA.111.251298; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488; Warga RA, 2003, DEV BIOL, V261, P391, DOI 10.1016/S0012-1606(03)00328-2; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Wilm B, 2004, DEV BIOL, V271, P176, DOI 10.1016/j.ydbio.2004.03.034; Xu F, 2009, MECH DEVELOP, V126, P771, DOI 10.1016/j.mod.2009.09.001; Xu YF, 2000, DEV DYNAM, V219, P201, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1043>3.3.CO;2-9; Zhao QS, 2005, GENE EXPR PATTERNS, V5, P363, DOI 10.1016/j.modgep.2004.09.011	70	23	23	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10216	10228		10.1074/jbc.M114.612572	http://dx.doi.org/10.1074/jbc.M114.612572			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25724646	Green Published, hybrid			2022-12-28	WOS:000353241100028
J	Meabon, JS; De Laat, R; Leguchi, K; Wiley, JC; Hudson, MP; Bothwell, M				Meabon, James S.; De Laat, Rian; Leguchi, Katsuaki; Wiley, Jesse C.; Hudson, Mark P.; Bothwell, Mark			LINGO-1 Protein Interacts with the p75 Neurotrophin Receptor in Intracellular Membrane Compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; OLIGODENDROCYTE DIFFERENTIATION; AXONAL REGENERATION; SURFACE EXPRESSION; FAMILY-MEMBER; NOGO RECEPTOR; INHIBITION; WNK4; COTRANSPORTER; RELEASE	Axon outgrowth inhibition in response to trauma is thought to be mediated via the binding of myelin-associated inhibitory factors (e.g. Nogo-66, myelin-associated glycoprotein, oligodendrocyte myelin glycoprotein, and myelin basic protein) to a putative tripartite LINGO-1-p75(NTR).Nogo-66 receptor (NgR) complex at the cell surface. We found that endogenous LINGO-1 expression in neurons in the cortex and cerebellum is intracellular. Mutation or truncation of the highly conserved LINGO-1 C terminus altered this intracellular localization, causing poor intracellular retention and increased plasma membrane expression. p75(NTR) associated predominantly with natively expressed LINGO-1 containing immature N-glycans, characteristic of protein that has not completed trans-Golgi-mediated processing, whereas mutant forms of LINGO-1 with enhanced plasma membrane expression did not associate with p75(NTR). Co-immunoprecipitation experiments demonstrated that LINGO-1 and NgR competed for binding to p75(NTR) a manner that is difficult to reconcile with the existence of a LINGO-1.p75(NTR).NgR ternary complex. These findings contradict models postulating functional LINGO-1.p75(NTR).NgR complexes in the plasma membrane.	[Meabon, James S.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98109 USA; [Wiley, Jesse C.] Univ Washington, Dept Comparat Med, Seattle, WA 98109 USA; [Hudson, Mark P.; Bothwell, Mark] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98109 USA; [Meabon, James S.] Vet Affairs Med Ctr, Mental Illness Res Educ & Clin Ctr, Seattle, WA 98108 USA; [De Laat, Rian] Immusoft, Seattle, WA 98103 USA; [Leguchi, Katsuaki] Tokyo Womens Med Univ, Dept Pharmacol, Tokyo 1628666, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Tokyo Women's Medical University	Bothwell, M (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98109 USA.	mab@uw.edu			National Institutes of Health [NS47348]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS47348 (to M. B.).	Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Bandtlow Christine, 2004, Sci STKE, V2004, ppe24, DOI 10.1126/stke.2352004pe24; Carim-Todd L, 2003, EUR J NEUROSCI, V18, P3167, DOI 10.1111/j.1460-9568.2003.03003.x; Cope G, 2006, J AM SOC NEPHROL, V17, P1867, DOI 10.1681/ASN.2005111224; Dilly KW, 2006, J PHYSIOL-LONDON, V572, P227, DOI 10.1113/jphysiol.2005.102020; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Escudero CA, 2014, J CELL SCI, V127, P1966, DOI 10.1242/jcs.141754; Fang L, 2009, J CLIN INVEST, V119, P3278, DOI 10.1172/JCI37950; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Golbang AP, 2006, AM J PHYSIOL-RENAL, V291, pF1369, DOI 10.1152/ajprenal.00468.2005; Gonzalez A, 2009, FEBS LETT, V583, P3784, DOI 10.1016/j.febslet.2009.10.050; Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104; Jepson S, 2012, J BIOL CHEM, V287, P22184, DOI 10.1074/jbc.M112.366179; Jiang Y, 2008, BIOCHEM BIOPH RES CO, V375, P225, DOI 10.1016/j.bbrc.2008.08.010; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Lee BH, 2004, MOL CELL, V15, P741, DOI 10.1016/j.molcel.2004.07.018; Lee X, 2007, J NEUROSCI, V27, P220, DOI 10.1523/JNEUROSCI.4175-06.2007; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029771; Mandai K, 2009, NEURON, V63, P614, DOI 10.1016/j.neuron.2009.07.031; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mosyak L, 2006, J BIOL CHEM, V281, P36378, DOI 10.1074/jbc.M607314200; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Rubin C, 2005, CELL RES, V15, P66, DOI 10.1038/sj.cr.7290268; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; Urra S, 2007, J BIOL CHEM, V282, P7606, DOI 10.1074/jbc.M610458200; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Zhang ZH, 2009, J BIOL CHEM, V284, P15717, DOI 10.1074/jbc.M808751200; Zhong XT, 2009, FEBS LETT, V583, P1034, DOI 10.1016/j.febslet.2009.02.034	32	16	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9511	9520		10.1074/jbc.M114.608018	http://dx.doi.org/10.1074/jbc.M114.608018			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25666623	Green Published, hybrid			2022-12-28	WOS:000352729400018
J	Wu, KR; Fukuda, K; Xing, F; Zhang, YY; Sharma, S; Liu, Y; Chan, MD; Zhou, XB; Qasem, SA; Pochampally, R; Mo, YY; Watabe, K				Wu, Kerui; Fukuda, Koji; Xing, Fei; Zhang, Yingyu; Sharma, Sambad; Liu, Yin; Chan, Michael D.; Zhou, Xiaobo; Qasem, Shadi A.; Pochampally, Radhika; Mo, Yin-Yuan; Watabe, Kounosuke			Roles of the Cyclooxygenase 2 Matrix Metalloproteinase 1 Pathway in Brain Metastasis of Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT-JUNCTION PROTEINS; CAPILLARY ENDOTHELIAL-CELLS; NERVOUS-SYSTEM LEUKEMIA; TUMOR MICROENVIRONMENT; POOR-PROGNOSIS; BARRIER; EXPRESSION; PERMEABILITY; OCCLUDIN; GROWTH	Brain is one of the major sites of metastasis in breast cancer; however, the pathological mechanism of brain metastasis is poorly understood. One of the critical rate-limiting steps of brain metastasis is the breaching of blood-brain barrier, which acts as a selective interface between the circulation and the central nervous system, and this process is considered to involve tumor-secreted proteinases. We analyzed clinical significance of 21 matrix metalloproteinases on brain metastasis-free survival of breast cancer followed by verification in brain metastatic cell lines and found that only matrix metalloproteinase 1 (MMP1) is significantly correlated with brain metastasis. We have shown that MMP1 is highly expressed in brain metastatic cells and is capable of degrading Claudin and Occludin but not Zo-1, which are key components of blood-brain barrier. Knockdown of MMP1 in brain metastatic cells significantly suppressed their ability of brain metastasis in vivo, whereas ectopic expression of MMP1 significantly increased the brain metastatic ability of the cells that are not brain metastatic. We also found that COX2 was highly up-regulated in brain metastatic cells and that COX2-induced prostaglandins were directly able to promote the expression of MMP1 followed by augmenting brain metastasis. Furthermore, we found that COX2 and prostaglandin were able to activate astrocytes to release chemokine (C-C motif) ligand 7 (CCL7), which in turn promoted self-renewal of tumor-initiating cells in the brain and that knockdown of COX2 significantly reduced the brain metastatic ability of tumor cells. Our results suggest the COX2-MMP1/CCL7 axis as a novel therapeutic target for brain metastasis.	[Wu, Kerui; Xing, Fei; Sharma, Sambad; Liu, Yin; Chan, Michael D.; Zhou, Xiaobo; Qasem, Shadi A.; Watabe, Kounosuke] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA; [Zhang, Yingyu; Pochampally, Radhika; Mo, Yin-Yuan] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA; [Fukuda, Koji] Kanazawa Univ, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan	Wake Forest University; Wake Forest Baptist Medical Center; University of Mississippi; University of Mississippi Medical Center; Kanazawa University	Watabe, K (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	kwatabe@wakehealth.edu	Mo, Yin-Yuan/R-8255-2019	Pochampally, Radhika/0000-0002-4263-0364	Comprehensive Cancer Center of Wake Forest University NCI, National Institutes of Health [CCSG P30CA012197]; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA124650, R01CA151851, R01CA129000, U01CA166886, R01CA173499] Funding Source: NIH RePORTER	Comprehensive Cancer Center of Wake Forest University NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Tumor Tissue Core is supported by the Comprehensive Cancer Center of Wake Forest University NCI, National Institutes of Health Grant CCSG P30CA012197.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Benson CS, 2013, DIS MARKERS, V34, P395, DOI [10.3233/DMA-130986, 10.1155/2013/420914]; Bertucci F, 2002, HUM MOL GENET, V11, P863, DOI 10.1093/hmg/11.8.863; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Broek IV, 2003, BRIT J CANCER, V88, P855, DOI 10.1038/sj.bjc.6600833; Cheng X, 2007, CANCER METAST REV, V26, P635, DOI 10.1007/s10555-007-9083-x; Cunnea P, 2010, ACTA NEUROPATHOL, V119, P601, DOI 10.1007/s00401-009-0618-9; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fedwick JP, 2005, INFECT IMMUN, V73, P7844, DOI 10.1128/IAI.73.12.7844-7852.2005; Feng S, 2011, MED HYPOTHESES, V76, P618, DOI 10.1016/j.mehy.2010.12.001; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Giebel SJ, 2005, LAB INVEST, V85, P597, DOI 10.1038/labinvest.3700251; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Greenwald RA, 1999, ANN NY ACAD SCI, V878, P413, DOI 10.1111/j.1749-6632.1999.tb07699.x; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gurney KJ, 2006, NEUROBIOL DIS, V23, P87, DOI 10.1016/j.nbd.2006.02.006; Heinecke JL, 2014, P NATL ACAD SCI USA, V111, P6323, DOI 10.1073/pnas.1401799111; Hirase T, 1997, J CELL SCI, V110, P1603; HONN KV, 1981, PROSTAG OTH LIPID M, V21, P833, DOI 10.1016/0090-6980(81)90240-9; Hwang TL, 2012, WORLD J GASTROENTERO, V18, P1249, DOI 10.3748/wjg.v18.i11.1249; Ichikawa Y, 2006, ONCOL REP, V15, P311; Ii M, 2006, EXP BIOL MED, V231, P20; Jung DW, 2010, INT J CANCER, V127, P332, DOI 10.1002/ijc.25060; Laningham FH, 2007, NEURORADIOLOGY, V49, P873, DOI 10.1007/s00234-007-0300-7; Latorre IJ, 2005, J CELL SCI, V118, P4283, DOI 10.1242/jcs.02560; Lee KY, 2011, ANTICANCER RES, V31, P4307; Li HJ, 2012, CANCER DISCOV, V2, P840, DOI 10.1158/2159-8290.CD-12-0101; Liebner S, 2000, EUR J CELL BIOL, V79, P707, DOI 10.1078/0171-9335-00101; Liu H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-583; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Liu SL, 2012, J MAMMARY GLAND BIOL, V17, P15, DOI 10.1007/s10911-012-9242-8; Louie E, 2013, ONCOGENE, V32, P4064, DOI 10.1038/onc.2012.417; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Mendes O, 2007, CLIN EXP METASTAS, V24, P341, DOI 10.1007/s10585-007-9071-0; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moss LAS, 2012, AM J PATHOL, V181, P1895, DOI 10.1016/j.ajpath.2012.08.044; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ohtsuki S, 2008, J NEUROCHEM, V104, P147, DOI 10.1111/j.1471-4159.2007.05008.x; Ohtsuki S, 2007, J CELL PHYSIOL, V210, P81, DOI 10.1002/jcp.20823; Ong VH, 2009, EXP CELL RES, V315, P151, DOI 10.1016/j.yexcr.2008.11.001; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Poola I, 2005, NAT MED, V11, P481, DOI 10.1038/nm1243; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rajaram M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003789; Reel B, 2011, BRIT J PHARMACOL, V163, P1679, DOI 10.1111/j.1476-5381.2011.01298.x; Romero IA, 2003, NEUROSCI LETT, V344, P112, DOI 10.1016/S0304-3940(03)00348-3; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Wachtel M, 1999, J CELL SCI, V112, P4347; Xing F, 2013, EMBO MOL MED, V5, P384, DOI 10.1002/emmm.201201623; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	59	76	82	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9842	9854		10.1074/jbc.M114.602185	http://dx.doi.org/10.1074/jbc.M114.602185			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25691572	hybrid, Green Published			2022-12-28	WOS:000352729400043
J	Liu, Y; Yang, YF; Fan, JL; He, RN; Luo, M; Zheng, XF				Liu, Yong; Yang, Yongfeng; Fan, Jialin; He, Ruina; Luo, Ming; Zheng, Xiaofeng			The Crystal Structure of the PB2 Cap-binding Domain of Influenza B Virus Reveals a Novel Cap Recognition Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN EIF4E; POLYMERASE; ENDONUCLEASE; 1ST-IN-CLASS; TRANSLATION; INFECTIONS; INHIBITOR; VX-787	The influenza RNA-dependent RNA polymerase is a core enzyme required for both transcription and replication of the virus RNA genome, making it a potential drug target for the influenza virus. To detect the feature of cap-dependent transcription of influenza B virus (FluB) polymerase, we determined the crystal structures of the wild-type FluB polymerase PB2 subunit cap-binding domain (PB2(cap)) with bound GDP and the mutant FluB Q325F PB2(cap) with bound m(7)GDP or GDP. These structures revealed that, distinct from influenza A virus (FluA) PB2(cap), the guanine and ribose moieties of substrates invert in FluB PB2(caps). Moreover, we characterized the substrate specificity and affinity of the PB2(caps) using isothermal titration calorimetry. FluB PB2(cap) has a weaker affinity for m(7)GDP than FluA PB2(cap). Unlike FluA PB2(cap) that has a preference for m(7)GDP in comparison with GDP, FluB PB2(cap) shows an analogous affinity for both substrates. Replacement of FluB PB2 Glu(325) by Phe, the corresponding residue of FluA PB2, increased the binding affinity of FluB PB2(cap) for m(7)GDP to a level approximate to that of FluA PB2(cap) and caused a significant higher affinity to GDP. This study indicated that FluB PB2(cap) has a unique cap recognition mechanism compared with FluA PB2(cap), providing molecular insight into inhibitor design targeting FluB PB2(cap).	[Liu, Yong; Yang, Yongfeng; Fan, Jialin; He, Ruina; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Liu, Yong; Yang, Yongfeng; Fan, Jialin; He, Ruina; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Luo, Ming] Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA	Peking University; Peking University; University System of Georgia; Georgia State University	Zheng, XF (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	xiaofengz@pku.edu.cn	Fan, Jialin/GRY-1253-2022		Beijing Natural Science Foundation [5152012]; National Science Foundation of China [31470754, 31170709]; Ministry of Education of China [20130001130003]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by Beijing Natural Science Foundation Grant 5152012, National Science Foundation of China Grants 31470754 and 31170709, and Doctoral Fund Grant 20130001130003 of the Ministry of Education of China.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanton Lenee, 2011, Morbidity and Mortality Weekly Report, V60, P1233; Bodewes R, 2013, EMERG INFECT DIS, V19, P511, DOI 10.3201/eid1903.120965; BOULOY M, 1980, P NATL ACAD SCI-BIOL, V77, P3952, DOI 10.1073/pnas.77.7.3952; Byrn RA, 2015, ANTIMICROB AGENTS CH, V59, P1574, DOI 10.1128/AAC.04623-14; Clark MP, 2014, J MED CHEM, V57, P6668, DOI 10.1021/jm5007275; Culjkovic B, 2007, CELL CYCLE, V6, P65, DOI 10.4161/cc.6.1.3688; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Graff JR, 2003, CLIN EXP METASTAS, V20, P265, DOI 10.1023/A:1022943419011; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Kinkelin K, 2012, RNA, V18, P1624, DOI 10.1261/rna.033639.112; Liu Y, 2013, J BIOL CHEM, V288, P11013, DOI 10.1074/jbc.M112.392878; Liu Y, 2013, ACTA CRYSTALLOGR F, V69, P280, DOI 10.1107/S1744309113002388; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Mazza C, 2002, EMBO J, V21, P5548, DOI 10.1093/emboj/cdf538; McCullers JA, 2012, J INFECT DIS, V205, P870, DOI 10.1093/infdis/jir865; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Mukherjee TR, 2013, INFECT GENET EVOL, V16, P419, DOI 10.1016/j.meegid.2013.02.014; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Osborne MJ, 2013, P NATL ACAD SCI USA, V110, P3877, DOI 10.1073/pnas.1216862110; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; Paddock CD, 2012, J INFECT DIS, V205, P895, DOI 10.1093/infdis/jir861; Pautus S, 2013, J MED CHEM, V56, P8915, DOI 10.1021/jm401369y; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rosettani P, 2007, J MOL BIOL, V368, P691, DOI 10.1016/j.jmb.2007.02.019; Taylor NR, 1998, J MED CHEM, V41, P798, DOI 10.1021/jm9703754; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tsurumura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082020; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; Wakai C, 2011, J VIROL, V85, P7504, DOI 10.1128/JVI.02375-10; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	37	13	15	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9141	9149		10.1074/jbc.M115.636464	http://dx.doi.org/10.1074/jbc.M115.636464			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25691568	Green Published, hybrid			2022-12-28	WOS:000352207100037
J	Ithychanda, SS; Fang, XY; Mohan, ML; Zhu, L; Tirupula, KC; Prasad, SVN; Wang, YX; Karnik, SS; Qin, J				Ithychanda, Sujay Subbayya; Fang, Xianyang; Mohan, Maradumane L.; Zhu, Liang; Tirupula, Kalyan C.; Prasad, Sathyamangla V. Naga; Wang, Yun-Xing; Karnik, Sadashiva S.; Qin, Jun			A Mechanism of Global Shape-dependent Recognition and Phosphorylation of Filamin by Protein Kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING PROTEIN; SMALL-ANGLE SCATTERING; POSTTRANSLATIONAL MODIFICATIONS; BIOLOGICAL MACROMOLECULES; SUBSTRATE-SPECIFICITY; CONSENSUS SEQUENCES; STRUCTURAL BASIS; LIGAND-BINDING; LINEAR MOTIFS; ACTIVATION	Protein phosphorylation mediates essentially all aspects of cellular life. In humans, this is achieved by similar to 500 kinases, each recognizing a specific consensus motif (CM) in the substrates. The majority of CMs are surface-exposed and are thought to be accessible to kinases for phosphorylation. Here we investigated the archetypical protein kinase A (PKA)-mediated phosphorylation of filamin, a major cytoskeletal protein that can adopt an autoinhibited conformation. Surprisingly, autoinhibited filamin is refractory to phosphorylation by PKA on a known Ser(2152) site despite itsCMbeing exposed and the corresponding isolated peptide being readily phosphorylated. Structural analysis revealed that although the CM fits into the PKA active site its surrounding regions sterically clash with the kinase. However, upon ligand binding, filamin undergoes a conformational adjustment, allowing rapid phosphorylation on Ser(2152). These data uncover a novel ligand-induced conformational switch to trigger filamin phosphorylation. They further suggest a substrate shape-dependent filtering mechanism that channels specific exposed CM/kinase recognition in diverse signaling responses.	[Ithychanda, Sujay Subbayya; Mohan, Maradumane L.; Zhu, Liang; Tirupula, Kalyan C.; Prasad, Sathyamangla V. Naga; Karnik, Sadashiva S.; Qin, Jun] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Fang, Xianyang; Wang, Yun-Xing] NCI, NIH, Protein Nucle Acid Interact Sect, Struct Biophys Lab, Frederick, MD 21702 USA; [Zhu, Liang; Qin, Jun] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Case Western Reserve University	Qin, J (corresponding author), Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Mail Code NB20,9500 Euclid Ave, Cleveland, OH 44195 USA.	qinj@ccf.org	Zhu, Liang/GMX-3125-2022; Ithychanda, Sujay Subbayya/C-7792-2011; Karnik, Sadashiva/Y-2477-2019	Ithychanda, Sujay Subbayya/0000-0001-8979-246X; Karnik, Sadashiva/0000-0003-0746-2753; Fang, Xianyang/0000-0001-9432-9736; Qin, Jun/0000-0002-2647-9270	National Institutes of Health [GM062823, HL057470, HL089473]; NATIONAL CANCER INSTITUTE [ZICBC011535] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089473, R01HL115964, R01HL057470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM062823, HL057470, and HL089473 (to J.Q., S.S.K., and S.V.N.P.).	Aksaas Anne Kristin, 2011, Genes Cancer, V2, P841, DOI 10.1177/1947601911430226; Bedolla RG, 2009, CLIN CANCER RES, V15, P788, DOI 10.1158/1078-0432.CCR-08-1402; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; CARROLL RC, 1982, BLOOD, V59, P466; Changeux Jean-Pierre, 2011, F1000 Biol Rep, V3, P19, DOI 10.3410/B3-19; Chen D., 1999, MOL CELL BIOL, V19, P1002; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eisenhaber B, 2007, CURR PROTEIN PEPT SC, V8, P197, DOI 10.2174/138920307780363424; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Evans GJO, 2001, J BIOL CHEM, V276, P47877, DOI 10.1074/jbc.M108186200; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; Hammes GG, 2011, BIOCHEMISTRY-US, V50, P10422, DOI 10.1021/bi201486f; Hastie LE, 1997, J CELL PHYSIOL, V172, P373, DOI 10.1002/(SICI)1097-4652(199709)172:3<373::AID-JCP11>3.0.CO;2-7; Heikkinen O, 2009, BIOMOL NMR ASSIGN, V3, P53, DOI 10.1007/s12104-008-9140-6; Heikkinen OK, 2009, J BIOL CHEM, V284, P25450, DOI 10.1074/jbc.M109.019661; Hoffman L, 2011, EMBO J, V30, P1251, DOI 10.1038/emboj.2011.40; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hou SH, 2003, J BIOL CHEM, V278, P45994, DOI 10.1074/jbc.M307971200; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Ithychanda SS, 2011, BIOCHEMISTRY-US, V50, P4229, DOI 10.1021/bi2003229; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Jay D, 2004, MOL CELL BIOCHEM, V260, P49, DOI 10.1023/B:MCBI.0000026052.76418.55; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Levene PA, 1906, J BIOL CHEM, V2, P127; Li M, 2000, MOL PHARMACOL, V57, P446, DOI 10.1124/mol.57.3.446; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; MADHUSUDAN, 1994, PROTEIN SCI, V3, P176; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marazita MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035638; Masterson LR, 2011, J MOL BIOL, V412, P155, DOI 10.1016/j.jmb.2011.06.041; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Ren S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S26; ROCHETTEEGLY C, 1995, MOL ENDOCRINOL, V9, P860, DOI 10.1210/me.9.7.860; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Simon EJ, 2010, NEUROCHEM RES, V35, P1859, DOI 10.1007/s11064-010-0261-9; SPARKS JW, 1986, INT J BIOCHEM, V18, P497, DOI 10.1016/0020-711X(86)90159-X; Steichen JM, 2012, J BIOL CHEM, V287, P14672, DOI 10.1074/jbc.M111.335091; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tyanova S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002842; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Vandermarliere E, 2013, PROTEOMICS, V13, P1028, DOI 10.1002/pmic.201200232; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wu JM, 2002, J BIOL CHEM, V277, P42669, DOI 10.1074/jbc.M205501200; Zhang JP, 2012, J NEUROSCI, V32, P12619, DOI 10.1523/JNEUROSCI.1063-12.2012; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	77	13	14	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8527	8538		10.1074/jbc.M114.633446	http://dx.doi.org/10.1074/jbc.M114.633446			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25666618	hybrid, Green Published			2022-12-28	WOS:000351662600043
J	Shaw, JJ; Berbasova, T; Sasaki, T; Jefferson-George, K; Spakowicz, DJ; Dunican, BF; Portero, CE; Narvaez-Trujillo, A; Strobel, SA				Shaw, Jeffrey J.; Berbasova, Tetyana; Sasaki, Tomoaki; Jefferson-George, Kyra; Spakowicz, Daniel J.; Dunican, Brian F.; Portero, Carolina E.; Narvaez-Trujillo, Alexandra; Strobel, Scott A.			Identification of a Fungal 1,8-Cineole Synthase from Hypoxylon sp with Specificity Determinants in Common with the Plant Synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE RESIDUE SWITCH; ACTIVE-SITE RESIDUES; ARISTOLOCHENE SYNTHASE; ESCHERICHIA-COLI; TRICHODIENE SYNTHASE; MECHANISTIC INSIGHTS; CRYSTAL-STRUCTURE; BIOSYNTHESIS; EVOLUTION; GENE	Terpenes are an important and diverse class of secondary metabolites widely produced by fungi. Volatile compound screening of a fungal endophyte collection revealed a number of isolates in the family Xylariaceae, producing a series of terpene molecules, including 1,8-cineole. This compound is a commercially important component of eucalyptus oil used in pharmaceutical applications and has been explored as a potential biofuel additive. The genes that produce terpene molecules, such as 1,8-cineole, have been little explored in fungi, providing an opportunity to explore the biosynthetic origin of these compounds. Through genome sequencing of cineole-producing isolate E7406B, we were able to identify 11 new terpene synthase genes. Expressing a subset of these genes in Escherichia coli allowed identification of the hyp3 gene, responsible for 1,8-cineole biosynthesis, the first monoterpene synthase discovered in fungi. In a striking example of convergent evolution, mutational analysis of this terpene synthase revealed an active site asparagine critical for water capture and specificity during cineole synthesis, the same mechanism used in an unrelated plant homologue. These studies have provided insight into the evolutionary relationship of fungal terpene synthases to those in plants and bacteria and further established fungi as a relatively untapped source of this important and diverse class of compounds.	[Shaw, Jeffrey J.; Berbasova, Tetyana; Sasaki, Tomoaki; Spakowicz, Daniel J.; Dunican, Brian F.; Strobel, Scott A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Jefferson-George, Kyra] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Portero, Carolina E.; Narvaez-Trujillo, Alexandra] Pontificia Univ Catolica Ecuador, Lab Biotecnol Vegetal, Quito 17012184, Ecuador	Yale University; University of Pennsylvania; Pennsylvania Medicine; Pontificia Universidad Catolica del Ecuador	Strobel, SA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 260 Whitney Ave, New Haven, CT 06520 USA.	scott.strobel@yale.edu	Spakowicz, Dan/E-5233-2012	Spakowicz, Dan/0000-0003-2314-6435	Office of Assistant Secretary of Defense for Research and Engineering NSSEFF [N00244-09-1-0070]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007056] Funding Source: NIH RePORTER	Office of Assistant Secretary of Defense for Research and Engineering NSSEFF; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by Office of Assistant Secretary of Defense for Research and Engineering NSSEFF Grant N00244-09-1-0070 and a Howard Hughes Medical Institute Professorship (to S.A.S.).	Agger S, 2009, MOL MICROBIOL, V72, P1181, DOI 10.1111/j.1365-2958.2009.06717.x; Alonso-Gutierrez J, 2013, METAB ENG, V19, P33, DOI 10.1016/j.ymben.2013.05.004; Aubourg S, 2002, MOL GENET GENOMICS, V267, P730, DOI 10.1007/s00438-002-0709-y; BARTON AFM, 1989, FUEL, V68, P11, DOI 10.1016/0016-2361(89)90004-5; BENEDICT CR, 1995, PHYTOCHEMISTRY, V39, P327, DOI 10.1016/0031-9422(95)00066-G; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Cane DE, 2012, ACCOUNTS CHEM RES, V45, P463, DOI 10.1021/ar200198d; CANE DE, 1995, BIOCHEMISTRY-US, V34, P2480, DOI 10.1021/bi00008a011; Carter OA, 2003, PHYTOCHEMISTRY, V64, P425, DOI 10.1016/S0031-9422(03)00204-8; Chen MB, 2013, BIOCHEMISTRY-US, V52, P5441, DOI 10.1021/bi400691v; Chen XY, 1995, ARCH BIOCHEM BIOPHYS, V324, P255, DOI 10.1006/abbi.1995.0038; Christianson DW, 2008, CURR OPIN CHEM BIOL, V12, P141, DOI 10.1016/j.cbpa.2007.12.008; CROTEAU R, 1994, ARCH BIOCHEM BIOPHYS, V309, P184, DOI 10.1006/abbi.1994.1101; Davis EM, 2000, TOP CURR CHEM, V209, P53; Degenhardt J, 2000, PLANTA, V210, P815, DOI 10.1007/s004250050684; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Engels B, 2011, J BIOL CHEM, V286, P6871, DOI 10.1074/jbc.M110.165845; Ezra D, 2004, MICROBIOL-SGM, V150, P4023, DOI 10.1099/mic.0.27334-0; Fahnrich A, 2012, PLANT MOL BIOL, V79, P537, DOI 10.1007/s11103-012-9933-y; Fahnrich A, 2011, MOL PLANT, V4, P965, DOI 10.1093/mp/ssr021; Felicetti B, 2004, J AM CHEM SOC, V126, P7212, DOI 10.1021/ja0499593; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fortman JL, 2008, TRENDS BIOTECHNOL, V26, P375, DOI 10.1016/j.tibtech.2008.03.008; Gianoulis TA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002558; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Greenhagen BT, 2006, P NATL ACAD SCI USA, V103, P9826, DOI 10.1073/pnas.0601605103; Griffin MA, 2010, MICROBIOL-SGM, V156, P3814, DOI 10.1099/mic.0.041327-0; Harvey BG, 2010, ENERG FUEL, V24, P267, DOI 10.1021/ef900799c; Haynes RK, 2001, CURR OPIN INFECT DIS, V14, P719, DOI 10.1097/00001432-200112000-00010; HOHN TM, 1989, GENE, V79, P131, DOI 10.1016/0378-1119(89)90098-X; HOHN TM, 1989, ARCH BIOCHEM BIOPHYS, V272, P137, DOI 10.1016/0003-9861(89)90204-X; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hsieh HM, 2005, MYCOLOGIA, V97, P844, DOI 10.3852/mycologia.97.4.844; Inoue Y, 2004, FEMS MICROBIOL LETT, V237, P325, DOI 10.1016/j.femsle.2004.06.049; Jennewein S, 2001, APPL MICROBIOL BIOT, V57, P13; Kampranis SC, 2007, PLANT CELL, V19, P1994, DOI 10.1105/tpc.106.047779; Katoh S, 2004, ARCH BIOCHEM BIOPHYS, V425, P65, DOI 10.1016/j.abb.2004.02.015; Keeling CI, 2008, P NATL ACAD SCI USA, V105, P1085, DOI 10.1073/pnas.0709466105; KLOCKE JA, 1987, J CHEM ECOL, V13, P2131, DOI 10.1007/BF01012562; Kollner TG, 2008, PLANT CELL, V20, P482, DOI 10.1105/tpc.107.051672; Kumeta Y, 2010, PLANT PHYSIOL, V154, P1998, DOI 10.1104/pp.110.161828; Lauchli R, 2013, ANGEW CHEM INT EDIT, V52, P5571, DOI 10.1002/anie.201301362; Leita BA, 2011, CATAL TODAY, V178, P98, DOI 10.1016/j.cattod.2011.05.037; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Mends M. T., 2012, J PET ENV BIOTECHNOL, V3, P117, DOI [10.4172, DOI 10.4172/2157-7463.1000117]; Nakano C, 2011, CHEMBIOCHEM, V12, P1988, DOI 10.1002/cbic.201100330; Newman JD, 2006, BIOTECHNOL BIOENG, V95, P684, DOI 10.1002/bit.21017; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Peralta-Yahya PP, 2010, BIOTECHNOL J, V5, P147, DOI 10.1002/biot.200900220; Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6; Pinedo C, 2008, ACS CHEM BIOL, V3, P791, DOI 10.1021/cb800225v; Redding-Johanson AM, 2011, METAB ENG, V13, P194, DOI 10.1016/j.ymben.2010.12.005; Riyaz-Ul-Hassan S, 2013, J MICROBIOL BIOTECHN, V23, P29, DOI 10.4014/jmb.1208.04062; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schulz B, 2002, MYCOL RES, V106, P996, DOI 10.1017/S0953756202006342; Sharkey TD, 2005, PLANT PHYSIOL, V137, P700, DOI 10.1104/pp.104.054445; Shaw JJ, 2015, APPL MICROBIOL BIOT, V99, P3715, DOI 10.1007/s00253-014-6206-5; Shishova EY, 2007, BIOCHEMISTRY-US, V46, P1941, DOI 10.1021/bi0622524; Silvestre AJD, 2000, IND CROP PROD, V12, P53, DOI 10.1016/S0926-6690(99)00067-9; Silvestre AJD, 1999, MONATSH CHEM, V130, P589, DOI 10.1007/s007060050218; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Strobel GA, 2008, MICROBIOL-SGM, V154, P3319, DOI 10.1099/mic.0.2008/022186-0; Suwannasai N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054529; Tomsheck AR, 2010, MICROB ECOL, V60, P903, DOI 10.1007/s00248-010-9759-6; Trombetta D, 2005, ANTIMICROB AGENTS CH, V49, P2474, DOI 10.1128/AAC.49.6.2474-2478.2005; TURNER WB, 1983, FUNGAL METABOLITES; van Zeijl CMJ, 1998, J BIOTECHNOL, V59, P221, DOI 10.1016/S0168-1656(97)00170-3; Vedula LS, 2008, ARCH BIOCHEM BIOPHYS, V469, P184, DOI 10.1016/j.abb.2007.10.015; Wang JL, 2009, NAT PROD RES, V23, P1080, DOI 10.1080/14786410802267759; Wawrzyn GT, 2012, METHOD ENZYMOL, V515, P83, DOI 10.1016/B978-0-12-394290-6.00005-7; Wawrzyn GT, 2012, CHEM BIOL, V19, P772, DOI 10.1016/j.chembiol.2012.05.012; White T.J., 1990, PCR PROTOCOLS GUIDE, P315; Wilderman PR, 2007, J AM CHEM SOC, V129, P15736, DOI 10.1021/ja074977g; Xu MM, 2007, P NATL ACAD SCI USA, V104, P7397, DOI 10.1073/pnas.0611454104; Yang JM, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-60; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607	81	52	59	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8511	8526		10.1074/jbc.M114.636159	http://dx.doi.org/10.1074/jbc.M114.636159			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25648891	Green Published, hybrid			2022-12-28	WOS:000351662600042
J	Mayor, R; Izquierdo-Bouldstridge, A; Millan-Arino, L; Bustillos, A; Sampaio, C; Luque, N; Jordan, A				Mayor, Regina; Izquierdo-Bouldstridge, Andrea; Millan-Arino, Lluis; Bustillos, Alberto; Sampaio, Cristina; Luque, Neus; Jordan, Albert			Genome Distribution of Replication-independent Histone H1 Variants Shows H1.0 Associated with Nucleolar Domains and H1X Associated with RNA Polymerase II-enriched Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; Epigenetics; Histone; Nucleolus; RNA Polymerase II; H1; 0; H1X; Histone H1; Variants	NUCLEAR LAMINA INTERACTIONS; DNA METHYLATION; GENE-EXPRESSION; BREAST-CANCER; CHROMOSOME TERRITORIES; CHROMATIN-STRUCTURE; HUMAN-CELLS; IN-VIVO; TRANSCRIPTION; PHOSPHORYLATION	Background: There are seven histone H1 variants in somatic mammalian cells, two of which are replication-independent, H1.0 and H1X. Results: In breast cancer cells, H1.0 is enriched at nucleolus-associated domains, whereas H1X is associated with RNA polymerase II-enriched regions. Conclusion: Most H1 variants show great redundancy across the genome, but there is also some specificity. Significance: Some H1 variants may have specific functions. Unlike core histones, the linker histone H1 family is more evolutionarily diverse, and many organisms have multiple H1 variants or subtypes. In mammals, the H1 family includes seven somatic H1 variants; H1.1 to H1.5 are expressed in a replication-dependent manner, whereas H1.0 and H1X are replication-independent. Using ChIP-sequencing data and cell fractionation, we have compared the genomic distribution of H1.0 and H1X in human breast cancer cells, in which we previously observed differential distribution of H1.2 compared with the other subtypes. We have found H1.0 to be enriched at nucleolus-associated DNA repeats and chromatin domains, whereas H1X is associated with coding regions, RNA polymerase II-enriched regions, and hypomethylated CpG islands. Further, H1X accumulates within constitutive or included exons and retained introns and toward the 3 end of expressed genes. Inducible H1X knockdown does not affect cell proliferation but dysregulates a subset of genes related to cell movement and transport. In H1X-depleted cells, the promoters of up-regulated genes are not occupied specifically by this variant, have a lower than average H1 content, and, unexpectedly, do not form an H1 valley upon induction. We conclude that H1 variants are not distributed evenly across the genome and may participate with some specificity in chromatin domain organization or gene regulation.	[Mayor, Regina; Izquierdo-Bouldstridge, Andrea; Millan-Arino, Lluis; Bustillos, Alberto; Sampaio, Cristina; Luque, Neus; Jordan, Albert] CSIC, IBMB, E-08028 Barcelona, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Jordan, A (corresponding author), CSIC, IBMB, C Baldiri Reixac 4, E-08028 Barcelona, Catalonia, Spain.	albert.jordan@ibmb.csic.es	jordan, albert/ABC-8229-2020; jordan, albert/K-4678-2014; Bustillos, Alberto/AAQ-5390-2021	jordan, albert/0000-0002-3970-8693; jordan, albert/0000-0002-3970-8693; Bustillos, Alberto/0000-0002-4409-8113; Izquierdo Bouldstridge, Andrea/0000-0001-6169-936X; Sampaio, Cristina/0000-0002-2974-210X	Spanish Ministry of Science and Innovation (MICINN); European Regional Development Fund [BFU2011-23057]; Generalitat de Catalunya [2009-SGR-1222]; Consejo Superior de Investigaciones Cientificas-MICINN; MICINN	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); Generalitat de Catalunya(Generalitat de Catalunya); Consejo Superior de Investigaciones Cientificas-MICINN; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This work was supported by funding from the Spanish Ministry of Science and Innovation (MICINN), European Regional Development Fund Grant BFU2011-23057, and Generalitat de Catalunya Grant 2009-SGR-1222.; Recipient of a Tecnico de Apoyo contract from Consejo Superior de Investigaciones Cientificas-MICINN.; Recipient of a Formacion de Personal Universitario predoctoral fellowship from MICINN.	Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Ballare C, 2013, MOL CELL, V49, P67, DOI 10.1016/j.molcel.2012.10.019; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Cao Kaixiang, 2013, PLoS Genet, V9, pe1003417, DOI 10.1371/journal.pgen.1003417; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Acuna LIG, 2013, WIRES RNA, V4, P77, DOI 10.1002/wrna.1142; GORKA C, 1993, EXP CELL RES, V205, P152, DOI 10.1006/excr.1993.1069; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hale TK, 2006, MOL CELL, V22, P693, DOI 10.1016/j.molcel.2006.04.016; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Happel N, 2005, BIOL CHEM, V386, P541, DOI 10.1515/BC.2005.064; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Hergeth SP, 2011, J CELL SCI, V124, P1623, DOI 10.1242/jcs.084947; Hnilicova J, 2011, NUCLEUS-PHILA, V2, P182, DOI 10.4161/nucl.2.3.15876; Hodl M, 2012, CURR BIOL, V22, P2253, DOI 10.1016/j.cub.2012.10.008; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Izzo A, 2013, CELL REP, V3, P2142, DOI 10.1016/j.celrep.2013.05.003; Jarboui MA, 2011, MOL IMMUNOL, V49, P441, DOI 10.1016/j.molimm.2011.09.005; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kalashnikova AA, 2013, NUCLEIC ACIDS RES, V41, P4026, DOI 10.1093/nar/gkt104; Kamieniarz K, 2012, GENE DEV, V26, P797, DOI 10.1101/gad.182014.111; Kim K, 2012, ONCOGENE, V31, P4290, DOI 10.1038/onc.2011.605; Kim KJ, 2013, BIOMIMETIC ROBOTIC ARTIFICIAL MUSCLES, P1; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; LENNOX RW, 1983, J BIOL CHEM, V258, P262; Lin QC, 2004, J BIOL CHEM, V279, P23525, DOI 10.1074/jbc.M400925200; Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Medrzycki M, 2012, FRONT BIOSCI-LANDMRK, V17, P396, DOI 10.2741/3934; Meergans T, 1997, DNA CELL BIOL, V16, P1041, DOI 10.1089/dna.1997.16.1041; Millan-Arino L, 2014, NUCLEIC ACIDS RES, V42, P4474, DOI 10.1093/nar/gku079; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Nemeth A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000889; Orthaus S, 2009, NUCLEIC ACIDS RES, V37, P3391, DOI 10.1093/nar/gkp199; Parseghian MH, 2000, CHROMOSOME RES, V8, P405, DOI 10.1023/A:1009262819961; Parseghian MH, 2001, BIOCHEM CELL BIOL, V79, P289; PENNINGS S, 1994, P NATL ACAD SCI USA, V91, P10275, DOI 10.1073/pnas.91.22.10275; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; PINA B, 1987, EUR J BIOCHEM, V164, P71, DOI 10.1111/j.1432-1033.1987.tb10994.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Sato S, 2012, PATHOL INT, V62, P84, DOI 10.1111/j.1440-1827.2011.02755.x; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stoldt S, 2007, BIOL CELL, V99, P541, DOI 10.1042/BC20060117; Takata H, 2007, FEBS LETT, V581, P3783, DOI 10.1016/j.febslet.2007.06.076; Telu KH, 2013, J PROTEOME RES, V12, P3317, DOI 10.1021/pr400143x; Terme JM, 2014, FEBS LETT, V588, P2353, DOI 10.1016/j.febslet.2014.05.035; Terme JM, 2011, J BIOL CHEM, V286, P35347, DOI 10.1074/jbc.M111.281923; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x; van Koningsbruggen S, 2010, MOL BIOL CELL, V21, P3735, DOI 10.1091/mbc.E10-06-0508; VanderKraats ND, 2013, NUCLEIC ACIDS RES, V41, P6816, DOI 10.1093/nar/gkt482; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Weiss T, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-7; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yamamoto T, 1996, GENE, V173, P281, DOI 10.1016/0378-1119(96)00020-0; Yang SM, 2013, P NATL ACAD SCI USA, V110, P1708, DOI 10.1073/pnas.1213266110; Zentner GE, 2011, NUCLEIC ACIDS RES, V39, P4949, DOI 10.1093/nar/gkq1326; Zhang HS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004202; Zhang YZ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002691; Zheng YP, 2010, J CELL BIOL, V189, P407, DOI 10.1083/jcb.201001148	78	45	45	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7474	7491		10.1074/jbc.M114.617324	http://dx.doi.org/10.1074/jbc.M114.617324			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25645921	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000351613600016
J	Sliepen, K; van Montfort, T; Melchers, M; Isik, G; Sanders, RW				Sliepen, Kwinten; van Montfort, Thijs; Melchers, Mark; Isik, Goezde; Sanders, Rogier W.			Immunosilencing a Highly Immunogenic Protein Trimerization Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); humoral response; influenza; protein engineering; vaccine	ENVELOPE GLYCOPROTEIN TRIMERS; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSE; CELL RESPONSES; COILED-COIL; CD40 LIGAND; ANTIGENICITY; POTENT; HEMAGGLUTININ; GLYCOSYLATION	Background: Trimerization domains are commonly used to stabilize trimeric protein vaccines and therapeutics. Results: The GCN4-based isoleucine zipper domain induces strong antibody responses in vivo but this can be overcome by introducing glycans. Conclusion: Appropriately positioned glycans can effectively immunosilence the GCN4-based trimerization domain. Significance: Immunosilencing trimerization domains could be important for the exploitation of trimerization domains in protein vaccines and therapeutics. Many therapeutic proteins and protein subunit vaccines contain heterologous trimerization domains, such as the widely used GCN4-based isoleucine zipper (IZ) and the T4 bacteriophage fibritin foldon (Fd) trimerization domains. We found that these domains induced potent anti-IZ or anti-Fd antibody responses in animals when fused to an HIV-1 envelope glycoprotein (Env) immunogen. To dampen IZ-induced responses, we constructed an IZ domain containing four N-linked glycans (IZN4) to shield the underlying protein surface. When fused to two different vaccine antigens, HIV-1 Env and influenza hemagglutinin (HA), IZN4 strongly reduced the antibody responses against the IZ, but did not affect the antibody titers against Env or HA. Silencing of immunogenic multimerization domains with glycans might be relevant for therapeutic proteins and protein vaccines.	[Sliepen, Kwinten; van Montfort, Thijs; Melchers, Mark; Isik, Goezde; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Sanders, Rogier W.] Cornell Univ, Weill Med Coll, New York, NY 10065 USA	University of Amsterdam; Academic Medical Center Amsterdam; Cornell University	Sanders, RW (corresponding author), Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	rws2002@med.cornell.edu		Isik, Gozde/0000-0002-1329-6782	Aids fonds Netherlands [2009012]; Vidi fellowship from the Netherlands Organization for Scientific Research; European Research Council [ERC-StG-2011-280829-SHEV]	Aids fonds Netherlands; Vidi fellowship from the Netherlands Organization for Scientific Research; European Research Council(European Research Council (ERC)European Commission)	This work was supported by Aids fonds Netherlands, Grant 2009012.; Recipient of a Vidi fellowship from the Netherlands Organization for Scientific Research and a Starting Investigator Grant from the European Research Council (ERC-StG-2011-280829-SHEV).	Baker Matthew P, 2010, Self Nonself, V1, P314, DOI 10.4161/self.1.4.13904; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Bosch BJ, 2010, J VIROL, V84, P10366, DOI 10.1128/JVI.01035-10; Chakrabarti BK, 2013, J VIROL, V87, P13239, DOI 10.1128/JVI.01247-13; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; Depetris RS, 2012, J BIOL CHEM, V287, P24239, DOI 10.1074/jbc.M112.371898; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Du LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016555; Du SX, 2009, VIROLOGY, V395, P33, DOI 10.1016/j.virol.2009.07.042; Eggink D, 2014, J VIROL, V88, P699, DOI 10.1128/JVI.02608-13; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Forsell MNE, 2013, J IMMUNOL, V191, P44, DOI 10.4049/jimmunol.1203087; Forsell MNE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000171; Garrity RR, 1997, J IMMUNOL, V159, P279; Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hemmer B, 2005, LANCET NEUROL, V4, P403, DOI 10.1016/S1474-4422(05)70117-4; Isik G, 2014, J IMMUNOL, V192, P4628, DOI 10.4049/jimmunol.1303401; Jain A, 2011, BLOOD, V118, P3811, DOI 10.1182/blood-2011-04-351254; KASTURI L, 1995, J BIOL CHEM, V270, P14756, DOI 10.1074/jbc.270.24.14756; King C, 2014, P NATL ACAD SCI USA, V111, P8577, DOI 10.1073/pnas.1321126111; Kovacs JM, 2014, P NATL ACAD SCI USA, V111, P18542, DOI 10.1073/pnas.1422269112; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Loeffen WLA, 2011, VACCINE, V29, P1545, DOI 10.1016/j.vaccine.2010.12.096; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; Melchers M, 2012, J VIROL, V86, P2488, DOI 10.1128/JVI.06259-11; Melchers M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-48; Morris AE, 1999, J BIOL CHEM, V274, P418, DOI 10.1074/jbc.274.1.418; Morris NP, 2007, MOL IMMUNOL, V44, P3112, DOI 10.1016/j.molimm.2007.02.004; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Onda M, 2008, P NATL ACAD SCI USA, V105, P11311, DOI 10.1073/pnas.0804851105; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Rigter A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071072; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rozanov DV, 2009, MOL CANCER THER, V8, P1515, DOI 10.1158/1535-7163.MCT-09-0202; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Selvarajah S, 2005, J VIROL, V79, P12148, DOI 10.1128/JVI.79.19.12148-12163.2005; Sundling C, 2010, J EXP MED, V207, P2003, DOI 10.1084/jem.20100025; Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5; Tobin GJ, 2008, VACCINE, V26, P6189, DOI 10.1016/j.vaccine.2008.09.080; van der Laken CJ, 2007, ANN RHEUM DIS, V66, P253, DOI 10.1136/ard.2006.057406; Van Montfort T, 2011, J BIOL CHEM, V286, P22250, DOI 10.1074/jbc.M111.229625; Vonderheide RH, 2001, J CLIN ONCOL, V19, P3280, DOI 10.1200/JCO.2001.19.13.3280; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Weldon WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012466; Wu XF, 2001, MOL THER, V3, P368, DOI 10.1006/mthe.2001.0280; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001	51	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7436	7442		10.1074/jbc.M114.620534	http://dx.doi.org/10.1074/jbc.M114.620534			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25635058	Green Published, hybrid			2022-12-28	WOS:000351613600012
J	Banerjee, A; Adolph, RS; Gopalakrishnapai, J; Kleinboelting, S; Emmerich, C; Steegborn, C; Visweswariah, SS				Banerjee, Arka; Adolph, Ramona S.; Gopalakrishnapai, Jayashree; Kleinboelting, Silke; Emmerich, Christiane; Steegborn, Clemens; Visweswariah, Sandhya S.			A Universal Stress Protein (USP) in Mycobacteria Binds cAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; RECEPTOR PROTEIN; MOLECULAR-REPLACEMENT; NUCLEOTIDE CYCLASES; TUBERCULOSIS H37RV; ADENYLYL CYCLASES; GAF DOMAINS; IDENTIFICATION; SMEGMATIS; TOOLS	Mycobacteria are endowed with rich and diverse machinery for the synthesis, utilization, and degradation of cAMP. The actions of cyclic nucleotides are generally mediated by binding of cAMP to conserved and well characterized cyclic nucleotide binding domains or structurally distinct cGMP-specific and -regulated cyclic nucleotide phosphodiesterase, adenylyl cyclase, and E. coli transcription factor FhlA (GAF) domain-containing proteins. Proteins with cyclic nucleotide binding and GAF domains can be identified in the genome of mycobacterial species, and some of them have been characterized. Here, we show that a significant fraction of intracellular cAMP is bound to protein in mycobacterial species, and by using affinity chromatography techniques, we identify specific universal stress proteins (USP) as abundantly expressed cAMP-binding proteins in slow growing as well as fast growing mycobacteria. We have characterized the biochemical and thermodynamic parameters for binding of cAMP, and we show that these USPs bind cAMP with a higher affinity than ATP, an established ligand for other USPs. We determined the structure of the USP MSMEG_3811 bound to cAMP, and we confirmed through structure-guided mutagenesis, the residues important for cAMP binding. This family of USPs is conserved in all mycobacteria, and we suggest that they serve as "sinks" for cAMP, making this second messenger available for downstream effectors as and when ATP levels are altered in the cell.	[Banerjee, Arka; Gopalakrishnapai, Jayashree; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Adolph, Ramona S.; Kleinboelting, Silke; Emmerich, Christiane; Steegborn, Clemens] Univ Bayreuth, Dept Biochem, D-95440 Bayreuth, Germany	Indian Institute of Science (IISC) - Bangalore; University of Bayreuth	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	sandhya@mrdg.iisc.ernet.in	Visweswariah, Sandhya/Q-7500-2019; Banerjee, Arka/ABE-7498-2020	Visweswariah, Sandhya/0000-0003-2786-7344; Banerjee, Arka/0000-0001-8387-1271; Adolph, Ramona S./0000-0001-5143-5977	Council for Scientific and Industrial Research, Government of India; Deutsche Forschungsgemeinschaft [STE1701/11-1]; Department of Biotechnology, an Intensive Research in High Priority Areas grant; JC Bose Fellowship from the Department of Science	Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Department of Biotechnology, an Intensive Research in High Priority Areas grant; JC Bose Fellowship from the Department of Science	Supported by a senior research fellowship from the Council for Scientific and Industrial Research, Government of India.; Supported by Grant STE1701/11-1 from the Deutsche Forschungsgemeinschaft.; Supported by the Department of Biotechnology, an Intensive Research in High Priority Areas grant, and a JC Bose Fellowship from the Department of Science.	Antoni FA, 2000, FRONT NEUROENDOCRIN, V21, P103, DOI 10.1006/frne.1999.0193; Aravind L, 2002, PROTEINS, V48, P1, DOI 10.1002/prot.10064; Bahk YY, 2004, PROTEOMICS, V4, P3299, DOI 10.1002/pmic.200400980; Bai G, 2011, CELL MICROBIOL, V13, P349, DOI 10.1111/j.1462-5822.2010.01562.x; Bai GC, 2009, FEMS IMMUNOL MED MIC, V55, P68, DOI 10.1111/j.1574-695X.2008.00500.x; Bertinetti Daniela, 2009, BMC Chem Biol, V9, P3, DOI 10.1186/1472-6769-9-3; Biswas KH, 2008, BIOCHEMISTRY-US, V47, P3534, DOI 10.1021/bi702025w; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Borland G, 2009, BRIT J PHARMACOL, V158, P70, DOI 10.1111/j.1476-5381.2008.00087.x; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Dass BKM, 2008, J BACTERIOL, V190, P3824, DOI 10.1128/JB.00138-08; de Souza GA, 2011, J PROTEOMICS, V75, P502, DOI 10.1016/j.jprot.2011.08.016; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FSIHI H, 1995, MOL MICROBIOL, V16, P909, DOI 10.1111/j.1365-2958.1995.tb02317.x; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; Gu S, 2003, MOL CELL PROTEOMICS, V2, P1284, DOI 10.1074/mcp.M300060-MCP200; Harman JG, 2001, BBA-PROTEIN STRUCT M, V1547, P1, DOI 10.1016/S0167-4838(01)00187-X; Heikaus CC, 2009, STRUCTURE, V17, P1551, DOI 10.1016/j.str.2009.07.019; Hingley-Wilson SM, 2010, TUBERCULOSIS, V90, P236, DOI 10.1016/j.tube.2010.03.013; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kannan N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r264; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Laxman S, 2007, MOL INTERV, V7, P203, DOI 10.1124/mi.7.4.7; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; LOWRIE DB, 1975, NATURE, V254, P600, DOI 10.1038/254600a0; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Martinez Sergio E, 2002, Mol Interv, V2, P317, DOI 10.1124/mi.2.5.317; Mattow J, 2003, ELECTROPHORESIS, V24, P3405, DOI 10.1002/elps.200305601; McCue LA, 2000, GENOME RES, V10, P204, DOI 10.1101/gr.10.2.204; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nambi S, 2013, J BIOL CHEM, V288, P14114, DOI 10.1074/jbc.M113.463992; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; Ntolosi BA, 2001, TUBERCULOSIS, V81, P279, DOI 10.1054/tube.2001.0302; O'Toole R, 2003, RES MICROBIOL, V154, P387, DOI 10.1016/S0923-2508(03)00081-0; PADH H, 1976, INDIAN J BIOCHEM BIO, V13, P413; Podobnik M, 2014, J BIOL CHEM, V289, P16588, DOI 10.1074/jbc.M114.560086; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Rosenkrands I, 2000, ELECTROPHORESIS, V21, P935, DOI 10.1002/(SICI)1522-2683(20000301)21:5<935::AID-ELPS935>3.3.CO;2-G; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; SCHOMAKER V, 1968, ACTA CRYSTALL B-STRU, VB 24, P63, DOI 10.1107/S0567740868001718; Schubert OT, 2013, CELL HOST MICROBE, V13, P602, DOI 10.1016/j.chom.2013.04.008; SHAH S, 1991, J BACTERIOL, V173, P3238, DOI 10.1128/JB.173.10.3238-3242.1991; Sharma R, 2014, BIOCHEMISTRY-US, V53, P7765, DOI 10.1021/bi500924v; Shenoy AR, 2004, COMP FUNCT GENOM, V5, P17, DOI 10.1002/cfg.349; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Shenoy AR, 2006, FEBS LETT, V580, P3344, DOI 10.1016/j.febslet.2006.05.034; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Stapleton M, 2010, J BIOL CHEM, V285, P7016, DOI 10.1074/jbc.M109.047720; Steegborn C, 2014, BBA-MOL BASIS DIS, V1842, P2535, DOI 10.1016/j.bbadis.2014.08.012; Stivala A, 2011, BIOINFORMATICS, V27, P3315, DOI 10.1093/bioinformatics/btr575; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Tkaczuk KL, 2013, EVOL APPL, V6, P434, DOI 10.1111/eva.12057; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weiglmeier PR, 2010, TOXINS, V2, P2213, DOI 10.3390/toxins2092213; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zarembinski TI, 1998, P NATL ACAD SCI USA, V95, P15189, DOI 10.1073/pnas.95.26.15189; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267	65	20	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12731	12743		10.1074/jbc.M115.644856	http://dx.doi.org/10.1074/jbc.M115.644856			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25802331	hybrid, Green Published			2022-12-28	WOS:000354569000025
J	Whitney, JC; Whitfield, GB; Marmont, LS; Yip, P; Neculai, AM; Lobsanov, YD; Robinson, H; Ohman, DE; Howell, PL				Whitney, John C.; Whitfield, Gregory B.; Marmont, Lindsey S.; Yip, Patrick; Neculai, A. Mirela; Lobsanov, Yuri D.; Robinson, Howard; Ohman, Dennis E.; Howell, P. Lynne			Dimeric c-di-GMP Is Required for Post-translational Regulation of Alginate Production in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CELLULOSE SYNTHASE; PILZ DOMAIN PROTEINS; CYCLIC DIGUANYLATE; ALLOSTERIC CONTROL; STRUCTURAL BASIS; EAL DOMAIN; RECEPTOR; MOTILITY; POLYSACCHARIDES; BIOSYNTHESIS	Pseudomonas aeruginosa is an opportunistic human pathogen that secretes the exopolysaccharide alginate during infection of the respiratory tract of individuals afflicted with cystic fibrosis and chronic obstructive pulmonary disease. Among the proteins required for alginate production, Alg44 has been identified as an inner membrane protein whose bis-(3',5')-cyclic dimeric guanosine monophosphate (c-di-GMP) binding activity post-translationally regulates alginate secretion. In this study, we report the 1.8 angstrom crystal structure of the cytoplasmic region of Alg44 in complex with dimeric self-intercalated c-di-GMP and characterize its dinucleotide-binding site using mutational analysis. The structure shows that the c-di-GMP binding region of Alg44 adopts a PilZ domain fold with a dimerization mode not previously observed for this family of proteins. Calorimetric binding analysis of residues in the c-di-GMP binding site demonstrate that mutation of Arg-17 and Arg-95 alters the binding stoichiometry between c-di-GMP and Alg44 from 2:1 to 1:1. Introduction of these mutant alleles on the P. aeruginosa chromosome show that the residues required for binding of dimeric c-di-GMP in vitro are also required for efficient alginate production in vivo. These results suggest that the dimeric form of c-di-GMP represents the biologically active signaling molecule needed for the secretion of an important virulence factor produced by P. aeruginosa.	[Whitney, John C.; Whitfield, Gregory B.; Marmont, Lindsey S.; Yip, Patrick; Neculai, A. Mirela; Lobsanov, Yuri D.; Howell, P. Lynne] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 0A4, Canada; [Whitney, John C.; Whitfield, Gregory B.; Marmont, Lindsey S.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Robinson, Howard] Brookhaven Natl Lab, Photon Sci Div, Upton, NY 11973 USA; [Ohman, Dennis E.] Virginia Commonwealth Univ, Med Ctr, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Ohman, Dennis E.] McGuire Vet Affairs Med Ctr, Richmond, VA 23298 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; United States Department of Energy (DOE); Brookhaven National Laboratory; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center	Howell, PL (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Mol Struct & Funct, 686 Bay St, Toronto, ON M5G 0A4, Canada.	howell@sickkids.ca			National Institutes of Health, NIAID [AI-19146]; Canadian Institutes of Health Research [MT13337]; Veterans Administration Medical Research Grant [IO1BX000477]; Natural Sciences and Engineering Research Council of Canada (NSERC); Cystic Fibrosis Canada (CFC); Ontario Graduate Scholarship (OGS) Program; Hospital for Sick Children (SickKids) Foundation Student Scholarship Program; NSERC; CFC; OGS and SickKids Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019146, R56AI019146] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000477] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Veterans Administration Medical Research Grant; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cystic Fibrosis Canada (CFC); Ontario Graduate Scholarship (OGS) Program(Ontario Graduate Scholarship); Hospital for Sick Children (SickKids) Foundation Student Scholarship Program; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CFC; OGS and SickKids Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant AI-19146 (to D. E. O.). This work was also supported by Canadian Institutes of Health Research Grant MT13337 (to P. L. H.) and Veterans Administration Medical Research Grant IO1BX000477 (to D. E. O.). Beam line X29 at the National Synchrotron Light Source is supported by the United States Department of Energy and the National Institutes of Health National Center for Research Resources.; Supported by graduate scholarships from the Natural Sciences and Engineering Research Council of Canada (NSERC), Cystic Fibrosis Canada (CFC), the Ontario Graduate Scholarship (OGS) Program, and the Hospital for Sick Children (SickKids) Foundation Student Scholarship Program. Present address: Dept. of Microbiology, University of Washington, Seattle, WA 98195.; Supported by a graduate scholarship from NSERC.; Supported in part by an undergraduate summer studentship from CFC and graduate scholarships from NSERC and the OGS and SickKids Foundation Student scholarship programs.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chin KH, 2012, ACTA CRYSTALLOGR D, V68, P1380, DOI 10.1107/S0907444912030594; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Colvin KM, 2012, ENVIRON MICROBIOL, V14, P1913, DOI 10.1111/j.1462-2920.2011.02657.x; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Fujiwara T, 2013, BIOCHEM BIOPH RES CO, V431, P802, DOI 10.1016/j.bbrc.2012.12.103; Gentner M, 2012, J AM CHEM SOC, V134, P1019, DOI 10.1021/ja207742q; Habazettl J, 2011, J BIOL CHEM, V286, P14304, DOI 10.1074/jbc.M110.209007; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Hogardt M, 2013, CURR TOP MICROBIOL, V358, P91, DOI 10.1007/82_2011_199; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003; Jain R, 2012, J BACTERIOL, V194, P4285, DOI 10.1128/JB.00803-12; KNUTSON CA, 1968, ANAL BIOCHEM, V24, P470, DOI 10.1016/0003-2697(68)90154-1; Ko J, 2010, J MOL BIOL, V398, P97, DOI 10.1016/j.jmb.2010.03.007; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Mills E, 2011, CELL MICROBIOL, V13, P1122, DOI 10.1111/j.1462-5822.2011.01619.x; Morgan JLW, 2014, NAT STRUCT MOL BIOL, V21, P489, DOI 10.1038/nsmb.2803; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Murray TS, 2007, CURR OPIN PEDIATR, V19, P83, DOI 10.1097/MOP.0b013e3280123a5d; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; Oglesby LL, 2008, MICROBIOL-SGM, V154, P1605, DOI 10.1099/mic.0.2007/015305-0; Pratt JT, 2007, J BIOL CHEM, V282, P12860, DOI 10.1074/jbc.M611593200; Pultz IS, 2012, MOL MICROBIOL, V86, P1424, DOI 10.1111/mmi.12066; Ramsey DM, 2005, MOL MICROBIOL, V56, P309, DOI 10.1111/j.1365-2958.2005.04552.x; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; SALAMITOU S, 1994, J BACTERIOL, V176, P2828, DOI 10.1128/JB.176.10.2828-2834.1994; Steiner S, 2013, EMBO J, V32, P354, DOI 10.1038/emboj.2012.315; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Weinhouse H, 1997, FEBS LETT, V416, P207, DOI 10.1016/S0014-5793(97)01202-7; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001; Whitney JC, 2012, J BIOL CHEM, V287, P23582, DOI 10.1074/jbc.M112.375378; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Wozniak DJ, 2003, P NATL ACAD SCI USA, V100, P7907, DOI 10.1073/pnas.1231792100; Yang L, 2012, FEMS IMMUNOL MED MIC, V65, P366, DOI 10.1111/j.1574-695X.2012.00936.x	51	55	58	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12451	12462		10.1074/jbc.M115.645051	http://dx.doi.org/10.1074/jbc.M115.645051			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25817996	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000354569000002
J	Bastiaansen, KC; van Ulsen, P; Wijtmans, M; Bitter, W; Llamas, MA				Bastiaansen, Karlijn C.; van Ulsen, Peter; Wijtmans, Maikel; Bitter, Wilbert; Llamas, Maria A.			Self-cleavage of the Pseudomonas aeruginosa Cell-surface Signaling Anti-sigma Factor FoxR Occurs through an N-O Acyl Rearrangement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Gene Regulation; Iron; Post-translational Modification (PTM); Proteolysis; Pseudomonas aeruginosa (P; aeruginosa); Siderophore; Signal Transduction	CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; IRON TRANSPORT; PROTEIN; SIDEROPHORES; GLYCOSYLASPARAGINASE; FRAMEWORK; RESPONSES; RECEPTOR	Background: Many transmembrane anti-sigma factors, including P. aeruginosa FoxR, undergo periplasmic self-cleavage by an unknown mechanism. Results: Presence of an OH or SH group at +1 of the cleavage site is essential for FoxR self-cleavage. Conclusion: FoxR self-cleavage is mediated by an N-O acyl rearrangement. Significance: The complex proteolytic network that modulates alternative sigma factor activity in Gram-negative bacteria also includes an enzyme-independent step. The Fox system of Pseudomonas aeruginosa is a cell-surface signaling (CSS) pathway employed by the bacterium to sense and respond to the presence of the heterologous siderophore ferrioxamine in the environment. This regulatory pathway controls the transcription of the foxA ferrioxamine receptor gene through the extracytoplasmic function sigma factor sigma(FoxI). In the absence of ferrioxamine, the activity of sigma(FoxI) is inhibited by the transmembrane anti-sigma factor FoxR. Upon binding of ferrioxamine by the FoxA receptor, FoxR is processed by a complex proteolytic cascade leading to the release and activation of sigma(FoxI). Interestingly, we have recently shown that FoxR undergoes self-cleavage between the periplasmic Gly-191 and Thr-192 residues independent of the perception of ferrioxamine. This autoproteolytic event, which is widespread among CSS anti-sigma factors, produces two distinct domains that interact and function together to transduce the presence of the signal. In this work, we provide evidence that the self-cleavage of FoxR is not an enzyme-dependent process but is induced by an N-O acyl rearrangement. Mutation analysis showed that the nucleophilic side chain of the Thr-192 residue at +1 of the cleavage site is required for an attack on the preceding Gly-191, after which the resulting ester bond is likely hydrolyzed. Because the cleavage site is well preserved and the hydrolysis of periplasmic CSS anti-sigma factors is widely observed, we hypothesize that cleavage via an N-O acyl rearrangement is a conserved feature of these proteins.	[Bastiaansen, Karlijn C.; Llamas, Maria A.] CSIC, Environm Protect Dept, Estn Expt Zaidin, E-18008 Granada, Spain; [Bastiaansen, Karlijn C.; van Ulsen, Peter; Bitter, Wilbert] Vrije Univ, Sect Mol Microbiol, Dept Mol Cell Biol, NL-1081 HV Amsterdam, Netherlands; [Wijtmans, Maikel] Vrije Univ, Div Med Chem, Dept Chem & Pharmaceut Sci, NL-1081 HV Amsterdam, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Llamas, MA (corresponding author), CSIC, Environm Protect Dept, Estn Expt Zaidin, C Prof Albareda 1, E-18008 Granada, Spain.	marian.llamas@eez.csic.es	Bitter, Wilbert/AAA-6872-2019; Bitter, W/CAJ-5778-2022; Bitter, Wilbert/ABG-3726-2020; Llamas, María A/M-1669-2014	Bitter, Wilbert/0000-0001-8347-6511; Llamas, María A/0000-0002-9499-0492; van Ulsen, Peter/0000-0002-2164-1611	Netherlands Organization for Scientific Research through ECHO [2951201]; European Union [3038130]; Spanish Ministry of Economy [RYC2011-08874, SAF2012-31919]	Netherlands Organization for Scientific Research through ECHO; European Union(European Commission); Spanish Ministry of Economy(Spanish Government)	This work was supported by Netherlands Organization for Scientific Research through ECHO Grant 2951201 (to K. C. B.), Marie Curie Career Integration Grant (CIG) 3038130 from the European Union, and Ramon&Cajal Grant RYC2011-08874 and Plan Nacional Grant SAF2012-31919 from the Spanish Ministry of Economy (to M. A. L.).	Bastiaansen KC, 2015, ENVIRON MICROBIOL, V17, P3263, DOI 10.1111/1462-2920.12776; Bastiaansen KC, 2014, ENVIRON MICROBIOL, V16, P2433, DOI 10.1111/1462-2920.12371; Bastiaansen KC, 2012, BACTERIAL REGULATORY NETWORKS, P59; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Braun V, 2006, BIOMETALS, V19, P103, DOI 10.1007/s10534-005-8253-y; Braun V, 2003, CURR OPIN MICROBIOL, V6, P173, DOI 10.1016/S1369-5274(03)00022-5; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Campbell EA, 2007, MOL CELL, V27, P793, DOI 10.1016/j.molcel.2007.07.009; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Dembek M, 2012, J BIOL CHEM, V287, P1538, DOI 10.1074/jbc.M111.302463; Ditzel L, 1998, J MOL BIOL, V279, P1187, DOI 10.1006/jmbi.1998.1818; Draper RC, 2011, MOL MICROBIOL, V82, P1444, DOI 10.1111/j.1365-2958.2011.07901.x; Du ZM, 2009, J AM CHEM SOC, V131, P11581, DOI 10.1021/ja904318w; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Ferguson AD, 2007, P NATL ACAD SCI USA, V104, P513, DOI 10.1073/pnas.0609887104; FINNEN RL, 1992, J BACTERIOL, V174, P4977, DOI 10.1128/JB.174.15.4977-4985.1992; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Garcia-Herrero A, 2005, MOL MICROBIOL, V58, P1226, DOI 10.1111/j.1365-2958.2005.04889.x; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guan C, 1998, J BIOL CHEM, V273, P9695, DOI 10.1074/jbc.273.16.9695; Guan CD, 1996, J BIOL CHEM, V271, P1732, DOI 10.1074/jbc.271.3.1732; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Johansson DGA, 2009, J AM CHEM SOC, V131, P9475, DOI 10.1021/ja9010817; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; KOSTER M, 1993, MOL MICROBIOL, V8, P591, DOI 10.1111/j.1365-2958.1993.tb01603.x; Llamas MA, 2014, FEMS MICROBIOL REV, V38, P569, DOI 10.1111/1574-6976.12078; Maillard AP, 2014, J MOL BIOL, V426, P2313, DOI 10.1016/j.jmb.2014.04.003; Malki I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089502; Mettrick KA, 2009, MOL MICROBIOL, V74, P1257, DOI 10.1111/j.1365-2958.2009.06932.x; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; OINONEN C, 1995, NAT STRUCT BIOL, V2, P1102, DOI 10.1038/nsb1295-1102; Paulus H, 1998, CHEM SOC REV, V27, P375, DOI 10.1039/a827375z; Perler FB, 1997, CURR OPIN CHEM BIOL, V1, P292, DOI 10.1016/S1367-5931(97)80065-8; Poole K, 2003, FRONT BIOSCI-LANDMRK, V8, pD661, DOI 10.2741/1051; Qian XF, 2003, STRUCTURE, V11, P997, DOI 10.1016/S0969-2126(03)00150-3; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schalk IJ, 2004, MOL MICROBIOL, V54, P14, DOI 10.1111/j.1365-2958.2004.04241.x; Schalk IJ, 2009, BIOMETALS, V22, P671, DOI 10.1007/s10534-008-9203-2; Shao Y, 1996, BIOCHEMISTRY-US, V35, P3810, DOI 10.1021/bi952592h; Shukla J, 2014, ACTA CRYSTALLOGR D, V70, P1026, DOI 10.1107/S1399004714000121; Starokadomskyy PL, 2007, MOL BIOL+, V41, P278, DOI 10.1134/S0026893307020094; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Xu QA, 1999, CELL, V98, P651, DOI 10.1016/S0092-8674(00)80052-5	53	14	14	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12237	12246		10.1074/jbc.M115.643098	http://dx.doi.org/10.1074/jbc.M115.643098			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25809487	Green Published, hybrid			2022-12-28	WOS:000354388600034
J	Hsieh, LS; Su, WM; Han, GS; Carman, GM				Hsieh, Lu-Sheng; Su, Wen-Min; Han, Gil-Soo; Carman, George M.			Phosphorylation Regulates the Ubiquitin-independent Degradation of Yeast Pah1 Phosphatidate Phosphatase by the 20S Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDP-DIACYLGLYCEROL SYNTHASE; NUCLEAR-MEMBRANE GROWTH; PROTEIN-KINASE-A; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; LIPID-METABOLISM; MEDIATED REGULATION; ORTHOLOGUE PAH1P; ACID; BIOSYNTHESIS	Saccharomyces cerevisiae Pah1 phosphatidate phosphatase, which catalyzes the conversion of phosphatidate to diacylglycerol for triacylglycerol synthesis and simultaneously controls phosphatidate levels for phospholipid synthesis, is subject to the proteasome-mediated degradation in the stationary phase of growth. In this study, we examined the mechanism for its degradation using purified Pah1 and isolated proteasomes. Pah1 expressed in S. cerevisiae or Escherichia coli was not degraded by the 26S proteasome, but by its catalytic 20S core particle, indicating that its degradation is ubiquitin-independent. The degradation of Pah1 by the 20S proteasome was dependent on time and proteasome concentration at the pH optimum of 7.0. The 20S proteasomal degradation was conserved for human lipin 1 phosphatidate phosphatase. The degradation analysis using Pah1 truncations and its fusion with GFP indicated that proteolysis initiates at the N- and C-terminal unfolded regions. The folded region of Pah1, in particular the haloacid dehalogenase-like domain containing the DIDGT catalytic sequence, was resistant to the proteasomal degradation. The structural change of Pah1, as reflected by electrophoretic mobility shift, occurs through its phosphorylation by Pho85-Pho80, and the phosphorylation sites are located within its N-and C-terminal unfolded regions. Phosphorylation of Pah1 by Pho85-Pho80 inhibited its degradation, extending its half-life by similar to 2-fold. The dephosphorylation of endogenously phosphorylated Pah1 by the Nem1-Spo7 protein phosphatase, which is highly specific for the sites phosphorylated by Pho85-Pho80, stimulated the 20S proteasomal degradation and reduced its half-life by 2.6-fold. These results indicate that the proteolysis of Pah1 by the 20S proteasome is controlled by its phosphorylation state.	Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu	Lu-Sheng, Hsieh/AAZ-9188-2020; Regan, Clinton/E-6250-2012	Lu-Sheng, Hsieh/0000-0001-7555-759X; Su, Wen-Min/0000-0002-1861-6335	National Institutes of Health [GM028140, GM050679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R01GM050679, R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM028140 and GM050679.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; CARTER JR, 1966, J LIPID RES, V7, P678; CHEN P, 1995, EMBO J, V14, P2620, DOI 10.1002/j.1460-2075.1995.tb07260.x; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; CHIRALA SS, 1994, NUCLEIC ACIDS RES, V22, P412, DOI 10.1093/nar/22.3.412; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; De Virgilio C, 2012, FEMS MICROBIOL REV, V36, P306, DOI 10.1111/j.1574-6976.2011.00287.x; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Grkovich A, 2009, ADV ENZYME REGUL, V49, P114, DOI 10.1016/j.advenzreg.2009.01.005; HAID A, 1983, METHOD ENZYMOL, V96, P192; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2009, CHEM REV, V109, P1479, DOI 10.1021/cr900054t; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Laporte D, 2011, J CELL BIOL, V192, P949, DOI 10.1083/jcb.201009028; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Leggett David S., 2005, V301, P57; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIN YP, 1989, J BIOL CHEM, V264, P8641; LIN YP, 1990, J BIOL CHEM, V265, P166; Lindegaard B, 2007, INT J OBESITY, V31, P449, DOI 10.1038/sj.ijo.0803434; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lussier M, 1997, GENETICS, V147, P435; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Michot C, 2013, BBA-MOL BASIS DIS, V1832, P2103, DOI 10.1016/j.bbadis.2013.07.021; Mul JD, 2011, J BIOL CHEM, V286, P26781, DOI 10.1074/jbc.M110.197947; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nadra K, 2012, MOL CELL BIOL, V32, P4794, DOI 10.1128/MCB.00512-12; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Orij R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r80; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peters LZ, 2013, J CELL BIOL, V201, P663, DOI 10.1083/jcb.201211146; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Pickering AM, 2012, PROG MOL BIOL TRANSL, V109, P227, DOI 10.1016/B978-0-12-397863-9.00006-7; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Ruiz C, 1999, YEAST, V15, P1001; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Shen HF, 1996, J BIOL CHEM, V271, P789, DOI 10.1074/jbc.271.2.789; Siniossoglou S, 2000, J BIOL CHEM, V275, P19352, DOI 10.1074/jbc.M001314200; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; SMITH SW, 1957, J BIOL CHEM, V228, P915; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Tamura Y, 2013, CELL METAB, V17, P709, DOI 10.1016/j.cmet.2013.03.018; TANAKA K, 1986, J BIOL CHEM, V261, P5197; Tar K, 2014, J BIOL CHEM, V289, P12145, DOI 10.1074/jbc.M114.554105; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003	101	41	43	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11467	11478		10.1074/jbc.M115.648659	http://dx.doi.org/10.1074/jbc.M115.648659			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25809482	Green Published, hybrid			2022-12-28	WOS:000353719400023
J	Wu, YD; Gunst, SJ				Wu, Yidi; Gunst, Susan J.			Vasodilator-stimulated Phosphoprotein (VASP) Regulates Actin Polymerization and Contraction in Airway Smooth Muscle by a Vinculin-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FOCAL-ADHESION; FILAMENT ELONGATION; TENSION DEVELOPMENT; PROXIMITY LIGATION; ENA/VASP PROTEINS; HUMAN PLATELETS; ARP2/3 COMPLEX; CELL-MIGRATION; BARBED END	Vasodilator-stimulated phosphoprotein (VASP) can catalyze actin polymerization by elongating actin filaments. The elongation mechanism involves VASP oligomerization and its binding to profilin, a G-actin chaperone. Actin polymerization is required for tension generation during the contraction of airway smooth muscle (ASM); however, the role of VASP in regulating actin dynamics in ASM is not known. We stimulated ASM cells and tissues with the contractile agonist acetylcholine (ACh) or the adenylyl cyclase activator, forskolin (FSK), a dilatory agent. ACh and FSK stimulated VASP Ser(157) phosphorylation by different kinases. Inhibition of VASP Ser(157) phosphorylation by expression of the mutant VASP S157A in ASM tissues suppressed VASP phosphorylation and membrane localization in response to ACh, and also inhibited contraction and actin polymerization. ACh but not FSK triggered the formation of VASPVASP complexes as well as VASP-vinculin and VASP-profilin complexes at membrane sites. VASP-VASP complex formation and the interaction of VASP with vinculin and profilin were inhibited by expression of the inactive vinculin mutant, vinculin Y1065F, but VASP phosphorylation and membrane localization were unaffected. We conclude that VASP phosphorylation at Ser(157) mediates its localization at the membrane, but that VASP Ser(157) phosphorylation and membrane localization are not sufficient to activate its actin catalytic activity. The interaction of VASP with activated vinculin at membrane adhesion sites is a necessary prerequisite for VASP-mediated molecular processes necessary for actin polymerization. Our results show that VASP is a critical regulator of actin dynamics and tension generation during the contractile activation of ASM.	[Wu, Yidi; Gunst, Susan J.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Gunst, SJ (corresponding author), 635 Barnhill Dr, Indianapolis, IN 46202 USA.	sgunst@iupui.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 HL29289, HL074099, R01HL109629]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109629, R01HL048522, R01HL029289, R01HL074099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL29289, HL074099, and R01HL109629.	Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Benz PM, 2009, J CELL SCI, V122, P3954, DOI 10.1242/jcs.044537; Blume C, 2007, J BIOL CHEM, V282, P4601, DOI 10.1074/jbc.M608866200; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Breitsprecher D, 2011, EMBO J, V30, P456, DOI 10.1038/emboj.2010.348; Brindle NPJ, 1996, BIOCHEM J, V318, P753, DOI 10.1042/bj3180753; BUTT E, 1994, J BIOL CHEM, V269, P14509; Chitaley K, 2004, FEBS LETT, V556, P211, DOI 10.1016/S0014-5793(03)01435-2; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Doppler H, 2013, CELL ADHES MIGR, V7, P482, DOI 10.4161/cam.27351; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Ferron F, 2007, EMBO J, V26, P4597, DOI 10.1038/sj.emboj.7601874; Freyer AM, 2004, AM J RESP CELL MOL, V31, P440, DOI 10.1165/rcmb.2003-0241OC; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Goncharova EA, 2012, AM J RESP CELL MOL, V46, P48, DOI 10.1165/rcmb.2011-0217OC; Gunst SJ, 2003, RESP PHYSIOL NEUROBI, V137, P151, DOI 10.1016/S1569-9048(03)00144-7; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; HAFFNER C, 1995, EMBO J, V14, P19, DOI 10.1002/j.1460-2075.1995.tb06971.x; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; HATHAWAY DR, 1985, AM J PHYSIOL, V249, pC345; Herrera AM, 2004, AM J PHYSIOL-LUNG C, V286, pL1161, DOI 10.1152/ajplung.00298.2003; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; Huang YL, 2014, J BIOL CHEM, V289, P3677, DOI 10.1074/jbc.M113.508077; Huang YL, 2011, J BIOL CHEM, V286, P3630, DOI 10.1074/jbc.M110.139923; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Huttelmaier S, 1998, CURR BIOL, V8, P479, DOI 10.1016/S0960-9822(98)70199-X; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kim HR, 2010, AM J PHYSIOL-CELL PH, V298, pC559, DOI 10.1152/ajpcell.00431.2009; Kuhnel K, 2004, P NATL ACAD SCI USA, V101, P17027, DOI 10.1073/pnas.0403069101; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Quinlan MP, 2004, J CELL PHYSIOL, V200, P277, DOI 10.1002/jcp.20009; Reinhard M, 1996, FEBS LETT, V399, P103, DOI 10.1016/S0014-5793(96)01295-1; Saez AO, 2004, AM J PHYSIOL-CELL PH, V286, pC433, DOI 10.1152/ajpcell.00030.2003; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tang DD, 2003, J PHYSIOL-LONDON, V553, P21, DOI 10.1113/jphysiol.2003.045047; Wentworth JKI, 2006, BIOCHEM J, V393, P555, DOI 10.1042/BJ20050796; Zhang Wenwu, 2008, Proc Am Thorac Soc, V5, P32, DOI 10.1513/pats.200704-048VS; Zhang WW, 2006, J PHYSIOL-LONDON, V572, P659, DOI 10.1113/jphysiol.2006.106518; Zhang WW, 2012, J BIOL CHEM, V287, P33996, DOI 10.1074/jbc.M112.369603; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zimmermann J, 2002, BIOCHEMISTRY-US, V41, P11143, DOI 10.1021/bi020379x	46	18	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11403	11416		10.1074/jbc.M115.645788	http://dx.doi.org/10.1074/jbc.M115.645788			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25759389	Green Published, hybrid			2022-12-28	WOS:000353719400017
J	Xie, J; Owen, T; Xia, K; Singh, AV; Tou, E; Li, LY; Arduini, B; Li, HM; Wan, LQ; Callahan, B; Wang, CY				Xie, Jian; Owen, Timothy; Xia, Ke; Singh, Ajay Vikram; Tou, Emiley; Li, Lingyun; Arduini, Brigitte; Li, Hongmin; Wan, Leo Q.; Callahan, Brian; Wang, Chunyu			Zinc Inhibits Hedgehog Autoprocessing LINKING ZINC DEFICIENCY WITH HEDGEHOG ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC-HEDGEHOG; SIGNALING PATHWAY; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; TRACE-ELEMENTS; SPECTRUM; AUTISM; GENE; TRANSPORTER; ASTROCYTES	Zinc is an essential trace element with wide-ranging biological functions, whereas the Hedgehog (Hh) signaling pathway plays crucial roles in both development and disease. Here we show that there is a mechanistic link between zinc and Hh signaling. The upstream activator of Hh signaling, the Hh ligand, originates from Hh autoprocessing, which converts the Hh precursor protein to the Hh ligand. In an in vitro Hh autoprocessing assay we show that zinc inhibits Hh autoprocessing with a K-i of 2 mu M. We then demonstrate that zinc inhibits Hh autoprocessing in a cellular environment with experiments in primary rat astrocyte culture. Solution NMR reveals that zinc binds the active site residues of the Hh autoprocessing domain to inhibit autoprocessing, and isothermal titration calorimetry provided the thermodynamics of the binding. In normal physiology, zinc likely acts as a negative regulator of Hh autoprocessing and inhibits the generation of Hh ligand and Hh signaling. In many diseases, zinc deficiency and elevated level of Hh ligand co-exist, including prostate cancer, lung cancer, ovarian cancer, and autism. Our data suggest a causal relationship between zinc deficiency and the overproduction of Hh ligand.	[Xie, Jian; Wang, Chunyu] Rensselaer Polytech Inst, Biochem & Biophys Grad Program, Troy, NY 12180 USA; [Xia, Ke; Li, Lingyun; Wang, Chunyu] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Singh, Ajay Vikram; Wan, Leo Q.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Tou, Emiley; Wang, Chunyu] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA; [Xie, Jian; Arduini, Brigitte; Wan, Leo Q.; Wang, Chunyu] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Owen, Timothy; Callahan, Brian] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA; [Li, Hongmin] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; Wadsworth Center	Wang, CY (corresponding author), Rensselaer Polytech Inst, Biochem & Biophys Grad Program, Dept Chem & Chem Biol, 110 8th St, Troy, NY 12180 USA.	wangc5@rpi.edu	Singh, Ajay/AAF-4414-2020; Wang, Chunyu/AAH-5952-2019; Li, Hongmin/ABI-2439-2020; Wan, Leo/D-7634-2016	Li, Hongmin/0000-0002-8684-5308; xia, ke/0000-0001-9699-9901; Wang, Chunyu/0000-0001-5165-7959; Wan, Leo/0000-0001-8371-5623; Arduini, Brigitte/0000-0002-8587-3518; Callahan, Brian/0000-0003-4826-0162; Tou, Emiley/0000-0003-2992-4269	National Institutes of Health (NIGMS) [R01GM081408]; Department of Defense [W81XWH-14-1-0155]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081408] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM081408 (NIGMS; to C. W.). This work was also supported in part through Department of Defense Grant W81XWH-14-1-0155 (to B. C.).	Abramoff MD., 2004, BIOPHOTONICS INT, V2004, P1; Al-Ayadhi LY, 2012, NEUROCHEM RES, V37, P394, DOI 10.1007/s11064-011-0624-x; Atwood SX, 2014, CANCER CELL, V25, P133, DOI 10.1016/j.ccr.2014.01.027; Bellomo EA, 2011, J BIOL CHEM, V286, P25778, DOI 10.1074/jbc.M111.246082; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Bishop GM, 2007, FREE RADICAL BIO MED, V42, P1222, DOI 10.1016/j.freeradbiomed.2007.01.022; Bjorklund G, 2013, ACTA NEUROBIOL EXP, V73, P225; Blnur N., 1986, CLIN CHEM, V32, P101; Blumberg Stephen J, 2013, Natl Health Stat Report, P1; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Cai C, 2008, STEM CELLS, V26, P1097, DOI 10.1634/stemcells.2007-0684; Carvalho ML, 2007, SPECTROCHIM ACTA B, V62, P1004, DOI 10.1016/j.sab.2007.03.030; Chabosseau P, 2014, ACS CHEM BIOL, V9, P2111, DOI 10.1021/cb5004064; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen XJ, 2007, CANCER SCI, V98, P68, DOI 10.1111/j.1349-7006.2006.00353.x; Chen X, 2011, J CELL BIOL, V192, P825, DOI 10.1083/jcb.201008090; Costello LC, 2011, J BIOL INORG CHEM, V16, P3, DOI 10.1007/s00775-010-0736-9; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P50142, DOI 10.1074/jbc.M304163200; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Elder LM, 2008, J AUTISM DEV DISORD, V38, P1104, DOI 10.1007/s10803-007-0495-9; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Grabrucker Andreas M, 2012, Front Psychiatry, V3, P118, DOI 10.3389/fpsyt.2012.00118; Gumulec J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099790; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hessels AM, 2015, METALLOMICS, V7, P258, DOI 10.1039/c4mt00179f; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kolenko V, 2013, NAT REV UROL, V10, P219, DOI 10.1038/nrurol.2013.43; Kubala-Kukus A, 1999, NUCL INSTRUM METH B, V150, P193, DOI 10.1016/S0168-583X(98)01057-X; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Maity T, 2005, P NATL ACAD SCI USA, V102, P17026, DOI 10.1073/pnas.0507848102; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; McGinnis WR, 2005, ALTERN THER HEALTH M, V11, P19; Memon AUR, 2007, CLIN CHIM ACTA, V379, P66, DOI 10.1016/j.cca.2006.12.009; Mongin AA, 2011, AM J PHYSIOL-CELL PH, V301, pC814, DOI 10.1152/ajpcell.00035.2011; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Nolte C, 2004, GLIA, V48, P145, DOI 10.1002/glia.20065; Owen TS, 2015, CHEMBIOCHEM, V16, P55, DOI 10.1002/cbic.201402421; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Priya MDL, 2011, BIOL TRACE ELEM RES, V142, P148, DOI 10.1007/s12011-010-8766-2; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Roessler E, 1997, HUM MOL GENET, V6, P1847, DOI 10.1093/hmg/6.11.1847; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Segawa S, 2014, LIFE SCI, V94, P137, DOI 10.1016/j.lfs.2013.11.007; Sheng T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-29; Szewczyk B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00033; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Velcheti V, 2007, J THORAC ONCOL, V2, P7, DOI 10.1097/JTO.0b013e31802c0276; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/nmeth.1368, 10.1038/NMETH.1368]; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; White S, 2009, NEUROPSYCHOLOGIA, V47, P1274, DOI 10.1016/j.neuropsychologia.2009.01.012; Xia YP, 2012, NEUROSCIENCE, V209, P1, DOI 10.1016/j.neuroscience.2012.02.019; Xie J, 2014, BIOMOL NMR ASSIGN, V8, P279, DOI 10.1007/s12104-013-9500-8; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhang LL, 2012, BIOL TRACE ELEM RES, V148, P7, DOI 10.1007/s12011-012-9336-6; Zhang LY, 2009, MOL BIOSYST, V5, P644, DOI 10.1039/b903144h; Zuidema JM, 2014, BIOMATERIALS, V35, P1439, DOI 10.1016/j.biomaterials.2013.10.079	64	13	13	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11591	11600		10.1074/jbc.M114.623264	http://dx.doi.org/10.1074/jbc.M114.623264			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25787080	Green Published, hybrid			2022-12-28	WOS:000353719400034
J	Ramesh, M; Krishnan, N; Muthuswamy, SK; Tonks, NK				Ramesh, Mathangi; Krishnan, Navasona; Muthuswamy, Senthil K.; Tonks, Nicholas K.			A Novel Phosphatidic Acid-Protein-tyrosine Phosphatase D2 Axis Is Essential for ERBB2 Signaling in Mammary Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTATIC BREAST-CANCER; PHOSPHOLIPASE-D; KINASE; 1B; TUMORIGENESIS; ACTIVATION; RECEPTOR; SURVIVAL; SRC; PHOSPHORYLATION	We used a loss-of-function screen to investigate the role of classical protein-tyrosine phosphatases (PTPs) in three-dimensional mammary epithelial cell morphogenesis and ERBB2 signaling. The study revealed a novel role for PTPD2 as a positive regulator of ERBB2 signaling. Suppression of PT PD2 attenuated the ERBB2-induced multiacinar phenotype in three-dimensional cultures specifically by inhibiting ERBB2-mediated loss of polarity and lumen filling. In contrast, overexpression of PTPD2 enhanced the ERBB2 phenotype. We also found that a lipid second messenger, phosphatidic acid, bound PTPD2 in vitro and enhanced its catalytic activity. Small molecule inhibitors of phospholipase D (PLD), an enzyme that produces phosphatidic acid in cells, also attenuated the ERBB2 phenotype. Exogenously added phosphatidic acid rescued the PLD-inhibition phenotype, but only when PTPD2 was present. These findings illustrate a novel pathway involving PTPD2 and the lipid second messenger phosphatidic acid that promotes ERBB2 function.	[Ramesh, Mathangi; Krishnan, Navasona; Muthuswamy, Senthil K.; Tonks, Nicholas K.] Cold Spring Harbor Lab, One Bungtown Rd, Cold Spring Harbor, NY 11724 USA; [Ramesh, Mathangi] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA; [Muthuswamy, Senthil K.] Univ Toronto, Campbell Family Inst Breast Canc Res, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Tonks, NK (corresponding author), Cold Spring Harbor Lab, One Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	tonks@cshl.edu	Muthuswamy, Senthil K/AGY-2834-2022	Muthuswamy, Senthil K/0000-0001-6564-9634	National Institutes of Health [CA53840]; Cold Spring Harbor Laboratory Cancer Center [CA45508]; Gladowsky Breast Cancer Foundation; Don Monti Memorial Research Foundation; Hansen Memorial Foundation; West Islip Breast Cancer Coalition for Long Island; Glen Cove CARES; Find a Cure Today (FACT); Constance Silveri; Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE [R01CA053840, P30CA045508, R37CA053840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cold Spring Harbor Laboratory Cancer Center; Gladowsky Breast Cancer Foundation; Don Monti Memorial Research Foundation; Hansen Memorial Foundation; West Islip Breast Cancer Coalition for Long Island; Glen Cove CARES; Find a Cure Today (FACT); Constance Silveri; Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA53840 and Cold Spring Harbor Laboratory Cancer Center Support Grant CA45508 (to N. K. T.).r Supported by the Gladowsky Breast Cancer Foundation, the Don Monti Memorial Research Foundation, Hansen Memorial Foundation, West Islip Breast Cancer Coalition for Long Island, Glen Cove CARES, Find a Cure Today (FACT), Constance Silveri, Robertson Research Fund, and the Masthead Cove Yacht Club Carol Marcincuk Fund. To whom correspondence should be addressed: Cold Spring Harbor Laboratory, One Bungtown Road, Cold Spring Harbor, NY 11724. Tel.: 516-367-8815; E-mail: tonks@cshl.edu.	Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Arias-Romero LE, 2009, CANCER RES, V69, P4582, DOI 10.1158/0008-5472.CAN-08-4001; Barr AJ, 2006, PROTEINS, V63, P1132, DOI 10.1002/prot.20958; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Boivin B, 2013, J BIOL CHEM, V288, P36926, DOI 10.1074/jbc.M113.527564; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Fan GF, 2013, J BIOL CHEM, V288, P24923, DOI 10.1074/jbc.M113.482737; Fiucci G, 2000, INT J CANCER, V85, P882, DOI 10.1002/(SICI)1097-0215(20000315)85:6<882::AID-IJC24>3.0.CO;2-E; Frank C, 1999, BIOCHEMISTRY-US, V38, P11993, DOI 10.1021/bi982586w; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ghosh S, 1997, BIOCHEM SOC T, V25, P561, DOI 10.1042/bst0250561; Grassian AR, 2011, COLD SH Q B, V76, P313, DOI 10.1101/sqb.2011.76.010967; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Huang JM, 2013, ONCOGENE, V32, P2220, DOI 10.1038/onc.2012.231; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; Krishnan N, 2014, NAT CHEM BIOL, V10, P558, DOI [10.1038/NCHEMBIO.1528, 10.1038/nchembio.1528]; Lavieri R, 2009, BIOORG MED CHEM LETT, V19, P2240, DOI 10.1016/j.bmcl.2009.02.125; Lavieri RR, 2010, J MED CHEM, V53, P6706, DOI 10.1021/jm100814g; Lin G, 2011, GENE DEV, V25, P1412, DOI 10.1101/gad.2018911; LISCOVITCH M, 1994, CELL, V77, P329, DOI 10.1016/0092-8674(94)90148-1; Liu X, 2013, ONCOGENE, V32, P1266, DOI 10.1038/onc.2012.147; Meng TC, 2005, METHODS, V35, P28, DOI 10.1016/j.ymeth.2004.07.005; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; MUTHUSWAMY SK, 1994, MOL CELL BIOL, V14, P735, DOI 10.1128/MCB.14.1.735; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nemoz G, 1997, MOL PHARMACOL, V51, P242, DOI 10.1124/mol.51.2.242; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Slaaby R, 1998, J BIOL CHEM, V273, P33722, DOI 10.1074/jbc.273.50.33722; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; TONKS NK, 1988, J BIOL CHEM, V263, P6722; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wang WQ, 2012, GENE DEV, V26, P1959, DOI 10.1101/gad.192955.112; WELSH CJ, 1994, BIOCHEM BIOPH RES CO, V202, P211, DOI 10.1006/bbrc.1994.1914; Wyatt L, 2007, J CELL BIOL, V178, P1223, DOI 10.1083/jcb.200705035; Yang WT, 2013, NATURE, V499, P491, DOI 10.1038/nature12396; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zhao RX, 2003, J BIOL CHEM, V278, P22609, DOI 10.1074/jbc.M301560200	53	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9646	9659		10.1074/jbc.M114.627968	http://dx.doi.org/10.1074/jbc.M114.627968			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25681440	hybrid, Green Published			2022-12-28	WOS:000352729400028
J	Heim, KP; Sullan, RMA; Crowley, PJ; El-Kirat-Chatel, S; Beaussart, A; Tang, WX; Besingi, R; Dufrene, YF; Brady, LJ				Heim, Kyle P.; Sullan, Ruby May A.; Crowley, Paula J.; El-Kirat-Chatel, Sofiane; Beaussart, Audrey; Tang, Wenxing; Besingi, Richard; Dufrene, Yves F.; Brady, L. Jeannine			Identification of a Supramolecular Functional Architecture of Streptococcus mutans Adhesin P1 on the Bacterial Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE FORCE SPECTROSCOPY; GRAM-POSITIVE BACTERIA; ANTIGEN-BINDING FORCES; RICH REPEAT DOMAIN; SALIVARY AGGLUTININ; PROTEIN ANTIGEN; SEROTYPE-C; MONOCLONAL-ANTIBODIES; DENTAL-CARIES; PORPHYROMONAS-GINGIVALIS	P1 (antigen I/II) is a sucrose-independent adhesin of Streptococcus mutans whose functional architecture on the cell surface is not fully understood. S. mutans cells subjected to mechanical extraction were significantly diminished in adherence to immobilized salivary agglutinin but remained immunoreactive and were readily aggregated by fluid-phase salivary agglutinin. Bacterial adherence was restored by incubation of postextracted cells with P1 fragments that contain each of the two known adhesive domains. In contrast to untreated cells, glutaraldehyde-treated bacteria gained reactivity with anti-C-terminal monoclonal antibodies (mAbs), whereas epitopes recognized by mAbs against other portions of the molecule were masked. Surface plasmon resonance experiments demonstrated the ability of apical and C-terminal fragments of P1 to interact. Binding of several different anti-P1 mAbs to unfixed cells triggered release of a C-terminal fragment from the bacterial surface, suggesting a novel mechanism of action of certain adherence-inhibiting antibodies. We also used atomic force microscopy-based single molecule force spectroscopy with tips bearing various mAbs to elucidate the spatial organization and orientation of P1 on living bacteria. The similar rupture lengths detected using mAbs against the head and C-terminal regions, which are widely separated in the tertiary structure, suggest a higher order architecture in which these domains are in close proximity on the cell surface. Taken together, our results suggest a supramolecular organization in which additional P1 polypeptides, including the C-terminal segment originally identified as antigen II, associate with covalently attached P1 to form the functional adhesive layer.	[Heim, Kyle P.; Crowley, Paula J.; Tang, Wenxing; Besingi, Richard; Brady, L. Jeannine] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; [Sullan, Ruby May A.; El-Kirat-Chatel, Sofiane; Beaussart, Audrey; Dufrene, Yves F.] Catholic Univ Louvain, Inst Life Sci, B-1348 Louvain La Neuve, Belgium	State University System of Florida; University of Florida; Universite Catholique Louvain	Dufrene, YF (corresponding author), Catholic Univ Louvain, Inst Life Sci, Croix Sud 1,Bte L7-04-01, B-1348 Louvain La Neuve, Belgium.	Yves.Dufrene@uclouvain.be; jbrady@dental.ufl.edu	Brady, L. Jeannine/P-5059-2019; Beaussart, Audrey/N-5645-2016; El-Kirat-Chatel, Sofiane/H-7728-2016; Sullan, Ruby May A./L-7511-2016	Beaussart, Audrey/0000-0002-4602-3019; El-Kirat-Chatel, Sofiane/0000-0001-5877-5640; Sullan, Ruby May A./0000-0002-8927-2605; Brady, Jeannine/0000-0001-8952-086X; Dufrene, Yves/0000-0002-7289-4248	National Institutes of Health from the NIDCR [R01DE08007, R01DE21789]; University of Florida Alumni; National Foundation for Scientific Research (FNRS); Universite catholique de Louvain (Fondation Louvain-Prix De Merre); Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Program); Research Department of the Communaute francaise de Belgique (Concerted Research Action);  [T90 DE021990-03]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021990, R01DE008007, R01DE021789] Funding Source: NIH RePORTER	National Institutes of Health from the NIDCR; University of Florida Alumni(University of Florida); National Foundation for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite catholique de Louvain (Fondation Louvain-Prix De Merre); Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Program); Research Department of the Communaute francaise de Belgique (Concerted Research Action); ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE08007 and R01DE21789 from the NIDCR and Predoctoral Fellowship T90 DE021990-03. This work was also supported by a University of Florida Alumni fellowship; the National Foundation for Scientific Research (FNRS); the Universite catholique de Louvain (Fondation Louvain-Prix De Merre); the Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Program); and the Research Department of the Communaute francaise de Belgique (Concerted Research Action).	Allen S, 1997, BIOCHEMISTRY-US, V36, P7457, DOI 10.1021/bi962531z; Alsteens D, 2010, P NATL ACAD SCI USA, V107, P20744, DOI 10.1073/pnas.1013893107; Andre G, 2008, J BACTERIOL, V190, P7079, DOI 10.1128/JB.00519-08; AYAKAWA GY, 1987, INFECT IMMUN, V55, P2759, DOI 10.1128/IAI.55.11.2759-2767.1987; Beg AM, 2002, BIOCHEM BIOPH RES CO, V298, P75, DOI 10.1016/S0006-291X(02)02390-2; Berquand A, 2005, LANGMUIR, V21, P5517, DOI 10.1021/la050162e; Bikker FJ, 2004, J BIOL CHEM, V279, P47699, DOI 10.1074/jbc.M406095200; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; BLEIWEIS AS, 1992, ADV EXP MED BIOL, V327, P229; Brady LJ, 2010, MOL MICROBIOL, V77, P276, DOI 10.1111/j.1365-2958.2010.07212.x; BRADY LJ, 1992, INFECT IMMUN, V60, P1008, DOI 10.1128/IAI.60.3.1008-1017.1992; Brady LJ, 1998, INFECT IMMUN, V66, P4274; BRADY LJ, 1991, INFECT IMMUN, V59, P1803, DOI 10.1128/IAI.59.5.1803-1810.1991; BRADY LJ, 1991, INFECT IMMUN, V59, P4425, DOI 10.1128/IAI.59.12.4425-4435.1991; CRAIG RA, 1979, INFECT IMMUN, V26, P1177, DOI 10.1128/IAI.26.3.1177-1185.1979; Crowley PJ, 2008, INFECT IMMUN, V76, P2456, DOI 10.1128/IAI.01315-07; CROWLEY PJ, 1993, INFECT IMMUN, V61, P1547, DOI 10.1128/IAI.61.4.1547-1552.1993; Crowley PJ, 1999, INFECT IMMUN, V67, P1201, DOI 10.1128/IAI.67.3.1201-1206.1999; Dupres V, 2005, NAT METHODS, V2, P515, DOI 10.1038/NMETH769; Ebner A, 2007, BIOCONJUGATE CHEM, V18, P1176, DOI 10.1021/bc070030s; ERICSON T, 1983, EUR J BIOCHEM, V133, P255, DOI 10.1111/j.1432-1033.1983.tb07456.x; Francius G, 2009, NAT PROTOC, V4, P939, DOI 10.1038/nprot.2009.65; Gauduchon V, 2001, CLIN MICROBIOL INFEC, V7, P36, DOI 10.1046/j.1469-0691.2001.00197.x; Gilbert Y, 2007, NANO LETT, V7, P796, DOI 10.1021/nl0700853; HAJISHENGALLIS G, 1992, INFECT IMMUN, V60, P5057, DOI 10.1128/IAI.60.12.5057-5064.1992; HAJISHENGALLIS G, 1994, J DENT RES, V73, P1493, DOI 10.1177/00220345940730090301; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; HANDLEY PS, 1987, J GEN MICROBIOL, V133, P3207; HARRINGTON DJ, 1993, J BACTERIOL, V175, P5925, DOI 10.1128/JB.175.18.5925-5933.1993; Heim KP, 2014, P NATL ACAD SCI USA, V111, P15746, DOI 10.1073/pnas.1413018111; Heim KP, 2013, J BIOL CHEM, V288, P13762, DOI 10.1074/jbc.M113.459974; Homonylo-McGavin MK, 1999, CAN J MICROBIOL, V45, P536, DOI 10.1139/cjm-45-6-536; HomonyloMcGavin MK, 1996, J BACTERIOL, V178, P801, DOI 10.1128/jb.178.3.801-807.1996; Hu P, 2008, ARCH ORAL BIOL, V53, P150, DOI 10.1016/j.archoralbio.2007.08.008; Isoda R, 2007, FEMS IMMUNOL MED MIC, V51, P102, DOI 10.1111/j.1574-695X.2007.00279.x; Jakubovics NS, 2005, MOL MICROBIOL, V55, P1591, DOI 10.1111/j.1365-2958.2005.04495.x; Jenkinson HF, 1997, MOL MICROBIOL, V23, P183, DOI 10.1046/j.1365-2958.1997.2021577.x; KELLY C, 1989, FEBS LETT, V258, P127, DOI 10.1016/0014-5793(89)81632-1; Kesavalu L, 2012, J DENT RES, V91, P255, DOI 10.1177/0022034511435101; KISHIMOTO E, 1989, INFECT IMMUN, V57, P3702, DOI 10.1128/IAI.57.12.3702-3707.1989; Knox K W, 1978, Adv Exp Med Biol, V107, P629; LAMONT RJ, 1992, ORAL MICROBIOL IMMUN, V7, P193, DOI 10.1111/j.1399-302X.1992.tb00024.x; Lamont RJ, 2002, MICROBIOL-SGM, V148, P1627, DOI 10.1099/00221287-148-6-1627; Larson MR, 2011, J BIOL CHEM, V286, P21657, DOI 10.1074/jbc.M111.231100; Larson MR, 2010, P NATL ACAD SCI USA, V107, P5983, DOI 10.1073/pnas.0912293107; Lee SF, 2000, CAN J MICROBIOL, V46, P584, DOI 10.1139/cjm-46-6-584; Lee SF, 2003, INFECT IMMUN, V71, P676, DOI 10.1128/IAI.71.2.676-681.2003; LEE SF, 1989, INFECT IMMUN, V57, P3306, DOI 10.1128/IAI.57.11.3306-3313.1989; LEE SF, 1995, INFECT IMMUN, V63, P1940, DOI 10.1128/IAI.63.5.1940-1946.1995; Lee SG, 2002, J BIOL CHEM, V277, P46912, DOI 10.1074/jbc.M208660200; LEHNER T, 1980, LANCET, V1, P995; Liu BH, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/27/275401; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; McArthur WP, 2007, FEMS IMMUNOL MED MIC, V50, P342, DOI 10.1111/j.1574-695X.2007.00260.x; MORO I, 1983, INFECT IMMUN, V41, P410, DOI 10.1128/IAI.41.1.410-413.1983; MUNRO GH, 1993, INFECT IMMUN, V61, P4590, DOI 10.1128/IAI.61.11.4590-4598.1993; Murakami Y, 1997, INFECT IMMUN, V65, P794, DOI 10.1128/IAI.65.2.794-797.1997; Murakami Y, 1997, INFECT IMMUN, V65, P1531, DOI 10.1128/IAI.65.4.1531-1535.1997; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Nylander A, 2011, ACTA CRYSTALLOGR F, V67, P23, DOI 10.1107/S174430911004443X; Oho T, 1998, INFECT IMMUN, V66, P115, DOI 10.1128/IAI.66.1.115-121.1998; OKAHASHI N, 1993, INFECT IMMUN, V61, P1301, DOI 10.1128/IAI.61.4.1301-1306.1993; OKAHASHI N, 1989, MOL MICROBIOL, V3, P673, DOI 10.1111/j.1365-2958.1989.tb00215.x; Oli MW, 2012, MICROBIOL-SGM, V158, P2903, DOI 10.1099/mic.0.060855-0; Oli MW, 2006, J MICROBIOL METH, V65, P503, DOI 10.1016/j.mimet.2005.09.011; Petersen FC, 2002, INFECT IMMUN, V70, P249, DOI 10.1128/IAI.70.1.249-256.2002; Prakobphol A, 2000, J BIOL CHEM, V275, P39860, DOI 10.1074/jbc.M006928200; Purushotham S, 2014, J BIOL CHEM, V289, P21877, DOI 10.1074/jbc.M114.565507; Ray CA, 1999, CLIN DIAGN LAB IMMUN, V6, P400, DOI 10.1128/CDLI.6.3.400-404.1999; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rhodin NR, 2004, INFECT IMMUN, V72, P13, DOI 10.1128/IAI.72.1.13-21.2004; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Robinette RA, 2014, VACCINE, V32, P375, DOI 10.1016/j.vaccine.2013.11.023; Robinette RA, 2009, J IMMUNOL, V183, P4628, DOI 10.4049/jimmunol.0803300; Ros R, 1998, P NATL ACAD SCI USA, V95, P7402, DOI 10.1073/pnas.95.13.7402; RUSSELL MW, 1980, INFECT IMMUN, V29, P999; RUSSELL MW, 1980, INFECT IMMUN, V28, P486; RUSSELL MW, 1978, ARCH ORAL BIOL, V23, P7, DOI 10.1016/0003-9969(78)90047-X; RUSSELL MW, 1989, ORAL MICROBIOL IMMUN, V4, P106, DOI 10.1111/j.1399-302X.1989.tb00107.x; RUSSELL RRB, 1979, J GEN MICROBIOL, V114, P109, DOI 10.1099/00221287-114-1-109; SCHOLLER M, 1981, INFECT IMMUN, V31, P52; Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972; Seifert TB, 2004, INFECT IMMUN, V72, P4699, DOI 10.1128/IAI.72.8.4699-4706.2004; Shanmugam KT, 2013, J CLIN DIAGN RES, V7, P1250, DOI 10.7860/JCDR/2013/5246.3053; Sivanathan V, 2012, GENE DEV, V26, P2659, DOI 10.1101/gad.205310.112; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Troffer-Charlier N, 2002, J MOL BIOL, V318, P179, DOI 10.1016/S0022-2836(02)00025-6; ULLMAN RF, 1988, HEART LUNG, V17, P209; van Dolleweerd CJ, 2004, J BIOL CHEM, V279, P22198, DOI 10.1074/jbc.M400820200; Verbelen C, 2009, LANGMUIR, V25, P4324, DOI 10.1021/la900302a; Xu QA, 2011, INFECT IMMUN, V79, P3792, DOI 10.1128/IAI.05338-11; Zhang S, 2006, INFECT IMMUN, V74, P4200, DOI 10.1128/IAI.00493-06; Zhang S, 2013, CURR PHARM BIOTECHNO, V14, P960; Zhao WW, 2014, CLIN VACCINE IMMUNOL, V21, P74, DOI 10.1128/CVI.00452-13	96	26	28	3	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9002	9019		10.1074/jbc.M114.626663	http://dx.doi.org/10.1074/jbc.M114.626663			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25666624	hybrid, Green Published			2022-12-28	WOS:000352207100026
J	Clowez, S; Godaux, D; Cardol, P; Wollman, FA; Rappaport, F				Clowez, Sophie; Godaux, Damien; Cardol, Pierre; Wollman, Francis-Andre; Rappaport, Fabrice			The Involvement of Hydrogen-producing and ATP-dependent NADPH-consuming Pathways in Setting the Redox Poise in the Chloroplast of Chlamydomonas reinhardtii in Anoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ELECTRON FLOW; STATE TRANSITIONS; PHOTOSYSTEM-II; GENE-EXPRESSION; OXYGEN EVOLUTION; MUTANTS; PHOTOSYNTHESIS; METABOLISM; TRANSPORT; DARK	Photosynthetic microalgae are exposed to changing environmental conditions. In particular, microbes found in ponds or soils often face hypoxia or even anoxia, and this severely impacts their physiology. Chlamydomonas reinhardtii is one among such photosynthetic microorganisms recognized for its unusual wealth of fermentative pathways and the extensive remodeling of its metabolism upon the switch to anaerobic conditions. As regards the photosynthetic electron transfer, this remodeling encompasses a strong limitation of the electron flow downstream of photosystem I. Here, we further characterize the origin of this limitation. We show that it stems from the strong reducing pressure that builds up upon the onset of anoxia, and this pressure can be relieved either by the light-induced synthesis of ATP, which promotes the consumption of reducing equivalents, or by the progressive activation of the hydrogenase pathway, which provides an electron transfer pathway alternative to the CO2 fixation cycle.	[Clowez, Sophie; Wollman, Francis-Andre; Rappaport, Fabrice] Inst Biol Phys Chim, UMR CNRS UPMC 7141, F-75005 Paris, France; [Godaux, Damien; Cardol, Pierre] Univ Liege, Lab Genet & Physiol Microalgues Phyosyst, Dept Life Sci, Inst Bot, B-4000 Liege, Belgium	UDICE-French Research Universities; Sorbonne Universite; University of Liege	Rappaport, F (corresponding author), Inst Biol Phys Chim, UMR CNRS UPMC 7141, 13 Rue P&M Curie, F-75005 Paris, France.	Fabrice.Rappaport@ibpc.fr	Cardol, Pierre/AAA-3090-2019	Cardol, Pierre/0000-0001-9799-0546	Universite Pierre et Marie Curie; CNRS; "Initiative d'Excellence" Program from French State Grant "DYNAMO" [ANR-11-LABX-0011-01]; Belgian Fonds de la Recherche Scientifique-Fonds National de la Recherche Fondamentale Collective Grant [2.4597.11]; Mandat d'Impulsion Scientifique [F.4520]	Universite Pierre et Marie Curie; CNRS(Centre National de la Recherche Scientifique (CNRS)); "Initiative d'Excellence" Program from French State Grant "DYNAMO"; Belgian Fonds de la Recherche Scientifique-Fonds National de la Recherche Fondamentale Collective Grant(Fonds de la Recherche Scientifique - FNRS); Mandat d'Impulsion Scientifique	Recipient of a Ph.D. fellowship from Universite Pierre et Marie Curie.; Supported by CNRS and the "Initiative d'Excellence" Program from French State Grant "DYNAMO," ANR-11-LABX-0011-01.; Supported by the Belgian Fonds de la Recherche Scientifique-Fonds National de la Recherche Fondamentale Collective Grant 2.4597.11 and Mandat d'Impulsion Scientifique Grant F.4520.	Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; Alric J, 2014, BBA-BIOENERGETICS, V1837, P825, DOI 10.1016/j.bbabio.2014.01.024; Alric J, 2010, PHOTOSYNTH RES, V106, P47, DOI 10.1007/s11120-010-9566-4; Alric J, 2010, BBA-BIOENERGETICS, V1797, P44, DOI 10.1016/j.bbabio.2009.07.009; Antal TK, 2013, PHOTOSYNTH RES, V117, P1, DOI 10.1007/s11120-013-9945-8; Armbruster U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6439; Baker NR, 2007, PLANT CELL ENVIRON, V30, P1107, DOI 10.1111/j.1365-3040.2007.01680.x; BASSHAM JA, 1950, J BIOL CHEM, V185, P781; BENDALL DS, 1995, BBA-BIOENERGETICS, V1229, P23, DOI 10.1016/0005-2728(94)00195-B; BOHME H, 1978, EUR J BIOCHEM, V83, P137, DOI 10.1111/j.1432-1033.1978.tb12077.x; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; Brettel K, 1997, BBA-BIOENERGETICS, V1318, P322, DOI 10.1016/S0005-2728(96)00112-0; BULTE L, 1990, BIOCHIM BIOPHYS ACTA, V1020, P72, DOI 10.1016/0005-2728(90)90095-L; CAMMACK R, 1977, BIOCHEM J, V168, P205, DOI 10.1042/bj1680205; Cardol P, 2003, PLANT PHYSIOL, V133, P2010, DOI 10.1104/pp.103.028076; Carraretto L, 2013, SCIENCE, V342, P114, DOI 10.1126/science.1242113; Cassan N, 2005, J BIOL CHEM, V280, P25960, DOI 10.1074/jbc.M503742200; Catalanotti C, 2012, PLANT CELL, V24, P692, DOI 10.1105/tpc.111.093146; de Lavalette AD, 2009, J BIOL CHEM, V284, P20822, DOI 10.1074/jbc.M109.016709; Del Campo JA, 2004, METHOD ENZYMOL, V381, P604; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; Dubini A, 2009, J BIOL CHEM, V284, P7201, DOI 10.1074/jbc.M803917200; Finazzi G, 1998, BIOCHEMISTRY-US, V37, P9999, DOI 10.1021/bi980320j; Finazzi G, 1997, BIOCHEMISTRY-US, V36, P2867, DOI 10.1021/bi962717y; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; Forestier M, 2003, EUR J BIOCHEM, V270, P2750, DOI 10.1046/j.1432-1033.2003.03656; Ghysels B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064161; Godaux D, 2013, INT J HYDROGEN ENERG, V38, P1826, DOI 10.1016/j.ijhydene.2012.11.081; Grossman AR, 2007, CURR OPIN PLANT BIOL, V10, P190, DOI 10.1016/j.pbi.2007.01.012; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; Hemschemeier A, 2005, BIOCHEM SOC T, V33, P39, DOI 10.1042/BST0330039; Hemschemeier A, 2011, BBA-BIOENERGETICS, V1807, P919, DOI 10.1016/j.bbabio.2011.02.010; Hemschemeier A, 2009, PHOTOSYNTH RES, V102, P523, DOI 10.1007/s11120-009-9415-5; HIYAMA T, 1971, ARCH BIOCHEM BIOPHYS, V147, P99, DOI 10.1016/0003-9861(71)90314-6; Houille-Vernes L, 2011, P NATL ACAD SCI USA, V108, P20820, DOI 10.1073/pnas.1110518109; Iwai M, 2010, NATURE, V464, P1210, DOI 10.1038/nature08885; Iwai M, 2010, P NATL ACAD SCI USA, V107, P2337, DOI 10.1073/pnas.0908808107; Jans F, 2008, P NATL ACAD SCI USA, V105, P20546, DOI 10.1073/pnas.0806896105; Johnson X, 2012, J BIOL CHEM, V287, P26445, DOI 10.1074/jbc.M112.370205; Johnson X, 2010, PLANT CELL, V22, P234, DOI 10.1105/tpc.109.066266; Joliot P, 2005, P NATL ACAD SCI USA, V102, P4913, DOI 10.1073/pnas.0501268102; Joliot P, 2004, BBA-BIOENERGETICS, V1656, P166, DOI 10.1016/j.bbabio.2004.03.010; JOLIOT P, 1985, BIOCHIM BIOPHYS ACTA, V806, P398, DOI 10.1016/0005-2728(85)90247-6; JUNGE W, 1968, Z NATURFORSCH PT B, VB 23, P244, DOI 10.1515/znb-1968-0222; KLUGHAMMER C, 1994, PLANTA, V192, P261, DOI 10.1007/BF01089043; Kramer DM, 2011, PLANT PHYSIOL, V155, P70, DOI 10.1104/pp.110.166652; KRAMER DM, 1993, BIOCHIM BIOPHYS ACTA, V1183, P72, DOI 10.1016/0005-2728(93)90006-2; Kuchenreuther JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045850; Leister D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00161; LEMAIRE C, 1989, J BIOL CHEM, V264, P10235; Lucker B, 2013, PHOTOSYNTH RES, V117, P449, DOI 10.1007/s11120-013-9932-0; Maughan SC, 2010, P NATL ACAD SCI USA, V107, P2331, DOI 10.1073/pnas.0913689107; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; MILLER AG, 1989, PLANT PHYSIOL, V91, P1044, DOI 10.1104/pp.91.3.1044; Miyake C, 2010, PLANT CELL PHYSIOL, V51, P1951, DOI 10.1093/pcp/pcq173; Moal G, 2012, BBA-BIOENERGETICS, V1817, P1635, DOI 10.1016/j.bbabio.2012.05.015; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; Nagy G, 2014, P NATL ACAD SCI USA, V111, P5042, DOI 10.1073/pnas.1322494111; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; QUINN J, 1993, J BIOL CHEM, V268, P7832; Quinn JM, 2002, PLANT PHYSIOL, V128, P463, DOI 10.1104/pp.010694; Rimbault B, 2000, MOL GEN GENET, V264, P486, DOI 10.1007/s004380000332; Roach T, 2014, CURR PROTEIN PEPT SC, V15, P351, DOI 10.2174/1389203715666140327105143; Sacksteder CA, 2000, PHOTOSYNTH RES, V66, P145, DOI 10.1023/A:1010785912271; Schottler MA, 2004, PLANT PHYSIOL, V136, P4265, DOI 10.1104/pp.104.052324; Steunou AS, 2008, ISME J, V2, P364, DOI 10.1038/ismej.2007.117; Subramanian V, 2014, J PROTEOME RES, V13, P5431, DOI 10.1021/pr500342j; Takahashi H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2954; Takahashi S, 2005, BBA-BIOENERGETICS, V1708, P352, DOI 10.1016/j.bbabio.2005.04.003; Terashima M, 2012, P NATL ACAD SCI USA, V109, P17717, DOI 10.1073/pnas.1207118109; Terashima M, 2010, MOL CELL PROTEOMICS, V9, P1514, DOI 10.1074/mcp.M900421-MCP200; Tikkanen M, 2014, TRENDS PLANT SCI, V19, P10, DOI 10.1016/j.tplants.2013.09.003; Unlu C, 2014, P NATL ACAD SCI USA, V111, P3460, DOI 10.1073/pnas.1319164111; VALLON O, 1991, P NATL ACAD SCI USA, V88, P8262, DOI 10.1073/pnas.88.18.8262; WOESSNER JP, 1984, PLANT MOL BIOL, V3, P177, DOI 10.1007/BF00016065; WOLLMAN FA, 1989, ENER BIOMAS, V5, P198; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; WOLLMAN FA, 1988, BIOCHIM BIOPHYS ACTA, V933, P85, DOI 10.1016/0005-2728(88)90058-8; Yang WQ, 2014, PLANT CELL, V26, P4499, DOI 10.1105/tpc.114.129965; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	81	21	21	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8666	8676		10.1074/jbc.M114.632588	http://dx.doi.org/10.1074/jbc.M114.632588			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25691575	hybrid, Green Published			2022-12-28	WOS:000351662600056
J	Crichton, PG; Lee, Y; Ruprecht, JJ; Cerson, E; Thangaratnarajah, C; King, MS; Kunji, ERS				Crichton, Paul G.; Lee, Yang; Ruprecht, Jonathan J.; Cerson, Elizabeth; Thangaratnarajah, Chancievan; King, Martin S.; Kunji, Edmund R. S.			Trends in Thermostability Provide Information on the Nature of Substrate, Inhibitor, and Lipid Interactions with Mitochondrial Carriers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOSE-TISSUE; UNCOUPLING PROTEIN-1 UCP1; ADP/ATP CARRIER; MEMBRANE-PROTEINS; NUCLEOTIDE-BINDING; CYANIDIOSCHYZON-MEROLAE; TRANSPORT ACTIVITY; FAT MITOCHONDRIA; MECHANISM; YEAST	Mitochondrial carriers, including uncoupling proteins, are unstable in detergents, which hampers structural and mechanistic studies. To investigate carrier stability, we have purified ligand-free carriers and assessed their stability with a fluorescence- based thermostability assay that monitors protein unfolding with a thiol-reactive dye. We find that mitochondrial carriers from both mesophilic and thermophilic organisms exhibit poor stability in mild detergents, indicating that instability is inherent to the protein family. Trends in the thermostability of yeast ADP/ATP carrier AAC2 and ovine uncoupling protein UCP1 allow optimal conditions for stability in detergents to be established but also provide mechanistic insights into the interactions of lipids, substrates, and inhibitors with these proteins. Both proteins exhibit similar stability profiles across various detergents, where stability increases with the size of the associated detergent micelle. Detailed analysis shows that lipids stabilize carriers indirectly by increasing the associated detergent micelle size, but cardiolipin stabilizes by direct interactions as well. Cardiolipin reverses destabilizing effects of ADP and bongkrekic acid on AAC2 and enhances large stabilizing effects of carboxyatractyloside, revealing that this lipid interacts in the m-state and possibly other states of the transport cycle, despite being in a dynamic interface. Fatty acid activators destabilize UCP1 in a similar way, which can also be prevented by cardiolipin, indicating that they interact like transport substrates. Our controls show that carriers can be soluble but unfolded in some commonly used detergents, such as the zwitterionic Fos-choline-12, which emphasizes the need for simple validation assays like the one used here.	[Crichton, Paul G.; Lee, Yang; Ruprecht, Jonathan J.; Cerson, Elizabeth; Thangaratnarajah, Chancievan; King, Martin S.; Kunji, Edmund R. S.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England		Kunji, ERS (corresponding author), MRC, Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England.	ek@mrc-mbu.cam.ac.uk	Kunji, Edmund/AAH-2362-2020; King, Martin S/B-6361-2012	Kunji, Edmund/0000-0002-0610-4500; Ruprecht, Jonathan/0000-0002-1838-7245; Thangaratnarajah, Chancievan/0000-0002-0279-6642; King, Martin/0000-0001-6030-5154; Crichton, Paul/0000-0003-3786-8359; Lee, Yang/0000-0002-8040-3648	European Drug Initiative on Channels and Transporters [HEALTH-F4-2007-201924]; Medical Research Council; MRC [MC_U105663139] Funding Source: UKRI; Medical Research Council [MC_U105663139] Funding Source: researchfish	European Drug Initiative on Channels and Transporters; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Drug Initiative on Channels and Transporters via contract HEALTH-F4-2007-201924 (EDICT) and the Medical Research Council.	Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; AQUILA H, 1987, FEBS LETT, V212, P1, DOI 10.1016/0014-5793(87)81546-6; Bamber L, 2006, P NATL ACAD SCI USA, V103, P16224, DOI 10.1073/pnas.0607640103; Barbier G, 2005, PLANT PHYSIOL, V137, P460, DOI 10.1104/pp.104.051169; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Blesneac I, 2012, BBA-BIOMEMBRANES, V1818, P798, DOI 10.1016/j.bbamem.2011.12.016; Cannon B, 1979, Methods Enzymol, V55, P65; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Crichton PG, 2013, J BIOL CHEM, V288, P22163, DOI 10.1074/jbc.M113.484329; Dehez F, 2008, J AM CHEM SOC, V130, P12725, DOI 10.1021/ja8033087; Divakaruni AS, 2012, J BIOL CHEM, V287, P36845, DOI 10.1074/jbc.M112.381780; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Douette P, 2004, BIOCHEM J, V380, P139, DOI 10.1042/BJ20031957; Echtay KS, 1997, BIOCHEMISTRY-US, V36, P8253, DOI 10.1021/bi970513r; Echtay KS, 1999, FEBS LETT, V450, P8, DOI 10.1016/S0014-5793(99)00460-3; ECKERSKORN C, 1987, FEBS LETT, V226, P166, DOI 10.1016/0014-5793(87)80572-0; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Garlid KD, 1998, FEBS LETT, V438, P10, DOI 10.1016/S0014-5793(98)01246-0; Hashimoto M, 1999, BBA-BIOENERGETICS, V1409, P113, DOI 10.1016/S0005-2728(98)00155-8; Hoang T, 2013, J BIOL CHEM, V288, P36244, DOI 10.1074/jbc.M113.509935; Hoang T, 2012, BIOCHEMISTRY-US, V51, P4004, DOI 10.1021/bi3003378; Ivanova MV, 2010, BIOCHEMISTRY-US, V49, P512, DOI 10.1021/bi901742g; Jelokhani-Niaraki M, 2008, BIOCHEM J, V411, P593, DOI 10.1042/bj20071326; KLINGENBERG M, 1988, BIOCHEMISTRY-US, V27, P781, DOI 10.1021/bi00402a044; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; KLINGENBERG M, 1989, EUR J BIOCHEM, V180, P123, DOI 10.1111/j.1432-1033.1989.tb14622.x; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; KRAMER R, 1989, BIOCHIM BIOPHYS ACTA, V974, P1, DOI 10.1016/S0005-2728(89)80160-4; Kunji ERS, 2010, BBA-BIOENERGETICS, V1797, P817, DOI 10.1016/j.bbabio.2010.03.023; Kunji ERS, 2008, METHODS, V46, P62, DOI 10.1016/j.ymeth.2008.10.020; Kunji ERS, 2003, J BIOL CHEM, V278, P36985, DOI 10.1074/jbc.C300304200; LIN CS, 1982, BIOCHEMISTRY-US, V21, P2950, DOI 10.1021/bi00541a023; Maheshwari R, 2000, MICROBIOL MOL BIOL R, V64, P461, DOI 10.1128/MMBR.64.3.461-488.2000; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Monne M, 2012, J BIOL CHEM, V287, P7925, DOI 10.1074/jbc.M111.324855; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Nury H, 2005, FEBS LETT, V579, P6031, DOI 10.1016/j.febslet.2005.09.061; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; RICCIO P, 1975, FEBS LETT, V56, P133, DOI 10.1016/0014-5793(75)80127-X; Riccio P, 1975, FEBS Lett, V56, P192; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Ruprecht JJ, 2014, P NATL ACAD SCI USA, V111, pE426, DOI 10.1073/pnas.1320692111; SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0; Shabalina IG, 2004, J BIOL CHEM, V279, P38236, DOI 10.1074/jbc.M402375200; Stuart JA, 2001, BIOCHEM J, V356, P779, DOI 10.1042/0264-6021:3560779; Thangaratnarajah C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6491; VIGNAIS PV, 1973, BIOCHEMISTRY-US, V12, P1508, DOI 10.1021/bi00732a007; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Wang Y, 2008, P NATL ACAD SCI USA, V105, P9598, DOI 10.1073/pnas.0801786105; Zoonens M, 2013, J AM CHEM SOC, V135, P15174, DOI 10.1021/ja407424v	58	51	51	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8206	8217		10.1074/jbc.M114.616607	http://dx.doi.org/10.1074/jbc.M114.616607			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25653283	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000351662600018
J	Malhotra, V; Agrawal, R; Duncan, TR; Saini, DK; Clark-Curtiss, JE				Malhotra, Vandana; Agrawal, Ruchi; Duncan, Tammi R.; Saini, Deepak. K.; Clark-Curtiss, Josephine E.			Mycobacterium tuberculosis Response Regulators, DevR and NarL, Interact in Vivo and Co-regulate Gene Expression during Aerobic Nitrate Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT SYSTEM; NITRIC-OXIDE; HYPOXIC RESPONSE; CARBON-MONOXIDE; PROTEIN-KINASE; DOSR; ADAPTATION; TRANSDUCTION; OPERON; ACTIVATION	Mycobacterium tuberculosis genes Rv0844c/Rv0845 encoding the NarL response regulator and NarS histidine kinase are hypothesized to constitute a two-component system involved in the regulation of nitrate metabolism. However, there is no experimental evidence to support this. In this study, we established M. tuberculosis NarL/NarS as a functional two-component system and identified His(241) and Asp(61) as conserved phosphorylation sites in NarS and NarL, respectively. Transcriptional profiling between M. tuberculosis H37Rv and Delta narL mutant strain during exponential growth in broth cultures with or without nitrate defined an similar to 30-gene NarL regulon that exhibited significant overlap with DevR-regulated genes, thereby implicating a role for the DevR response regulator in the regulation of nitrate metabolism. Notably, expression analysis of a subset of genes common to NarL and DevR regulons in M. tuberculosis Delta devR, Delta devS Delta dosT, and Delta narL mutant strains revealed that in response to nitrite produced during aerobic nitrate metabolism, the DevRS/DosT regulatory system plays a primary role that is augmented by NarL. Specifically, NarL itself was unable to bind to the narK2, acg, and Rv3130c promoters in phosphorylated or unphosphorylated form; however, its interaction with DevR similar to P resulted in cooperative binding, thereby enabling co-regulation of these genes. These findings support the role of physiologically derived nitrite as a metabolic signal in mycobacteria. We propose NarL-DevR binding, possibly as a heterodimer, as a novel mechanism for co-regulation of gene expression by the DevRS/DosT and NarL/NarS regulatory systems.	[Malhotra, Vandana; Duncan, Tammi R.; Clark-Curtiss, Josephine E.] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; [Duncan, Tammi R.; Clark-Curtiss, Josephine E.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Agrawal, Ruchi; Saini, Deepak. K.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Indian Institute of Science (IISC) - Bangalore	Malhotra, V (corresponding author), Univ Delhi, Dept Biochem, Sri Venkateswara Coll, New Delhi 110021, India.	vmal71@gmail.com; deepak@mrdg.iisc.ernet.in	Agrawal, Ruchi/D-7230-2015; agrawal, ruchi/AAE-6860-2022	Agrawal, Ruchi/0000-0003-0168-6000; agrawal, ruchi/0000-0003-0168-6000	National Institutes of Health [AI46428]; Department of Biotechnology, India [BT/PR15001/BRB/10/897]; Council of Scientific and Industrial Research, India [37 (1435) 10-EMR-II]; Arizona State University; Arizona State University PREP program for Biomedical Research; National Institutes of Health Public Health Service [GM071798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM071798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Arizona State University; Arizona State University PREP program for Biomedical Research; National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI46428. This research was also supported by Department of Biotechnology, India, Grant BT/PR15001/BRB/10/897; Council of Scientific and Industrial Research, India, Grant-in-aid 37 (1435) 10-EMR-II (to D. K. S.); and Arizona State University start-up funding (to J. E. C.-C.).; Supported by a research fellowship from the Council of Scientific and Industrial Research, India.; Supported by the Arizona State University PREP program for Biomedical Research and National Institutes of Health Public Health Service Grant GM071798.	Agrawal R., 2014, BIOCHEM BIOPH RES CO, V446, P1172; Al-Bassam MM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004554; Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; Bagchi G, 2005, MICROBIOL-SGM, V151, P4045, DOI 10.1099/mic.0.28333-0; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Bhattacharya M, 2010, BIOCHIMIE, V92, P263, DOI 10.1016/j.biochi.2009.11.009; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bretl DJ, 2012, INFECT IMMUN, V80, P3018, DOI 10.1128/IAI.00520-12; Bretl DJ, 2011, MICROBIOL MOL BIOL R, V75, P566, DOI 10.1128/MMBR.05004-11; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; Chakraborti PK, 2011, TUBERCULOSIS, V91, P432, DOI 10.1016/j.tube.2011.04.005; Chao JD, 2010, J BIOL CHEM, V285, P29239, DOI 10.1074/jbc.M110.132894; Chauhan S, 2008, J BACTERIOL, V190, P4301, DOI 10.1128/JB.01308-07; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Cho HY, 2014, BIOCHEM BIOPH RES CO, V444, P651, DOI 10.1016/j.bbrc.2014.01.128; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cunningham-Bussel A, 2013, P NATL ACAD SCI USA, V110, pE4256, DOI 10.1073/pnas.1316894110; Gao R, 2008, MOL MICROBIOL, V69, P1358, DOI 10.1111/j.1365-2958.2008.06355.x; Gautam US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016500; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Haydel SE, 2004, FEMS MICROBIOL LETT, V236, P341, DOI 10.1016/j.femsle.2004.06.010; Haydel SE, 2012, J BACTERIOL, V194, P354, DOI 10.1128/JB.06258-11; He HJ, 2011, J BACTERIOL, V193, P5105, DOI 10.1128/JB.05562-11; HEDGECOCK LW, 1962, J BACTERIOL, V84, P195, DOI 10.1128/JB.84.2.195-205.1962; Khan A, 2008, MICROB PATHOGENESIS, V44, P71, DOI 10.1016/j.micpath.2007.08.006; Khan A, 2012, MICROBIOL-SGM, V158, P301, DOI 10.1099/mic.0.054759-0; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Laub MT, 2007, METHOD ENZYMOL, V423, P531, DOI 10.1016/S0076-6879(07)23026-5; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; LI J, 1994, J MOL BIOL, V241, P150, DOI 10.1006/jmbi.1994.1485; Loebel RO, 1933, J BACTERIOL, V26, P167, DOI 10.1128/JB.26.2.167-200.1933; Malhotra V, 2012, J BACTERIOL, V194, P4184, DOI 10.1128/JB.00585-12; Malhotra V, 2009, TUBERCULOSIS, V89, P169, DOI 10.1016/j.tube.2008.12.003; Malm S, 2009, MICROBIOL-SGM, V155, P1332, DOI 10.1099/mic.0.023275-0; Pang XH, 2007, MICROBIOL-SGM, V153, P1229, DOI 10.1099/mic.0.29281-0; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; RABIN RS, 1993, J BACTERIOL, V175, P3259, DOI 10.1128/jb.175.11.3259-3268.1993; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Saini DK, 2004, FEBS LETT, V565, P75, DOI 10.1016/j.febslet.2004.02.092; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Saini DK, 2002, PROTEIN EXPRES PURIF, V25, P203, DOI 10.1006/prep.2002.1628; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Shiva S, 2013, REDOX BIOL, V1, P40, DOI 10.1016/j.redox.2012.11.005; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; Sohaskey CD, 2008, J BACTERIOL, V190, P2981, DOI 10.1128/JB.01857-07; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tan W, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012924, 10.1371/journal.pone.0013356]; Taneja NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010860; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Wisedchaisri G, 2005, J MOL BIOL, V354, P630, DOI 10.1016/j.jmb.2005.09.048; Wisedchaisri G, 2008, J MOL BIOL, V378, P227, DOI 10.1016/j.jmb.2008.02.029; Zahrt TC, 2000, J BACTERIOL, V182, P3832, DOI 10.1128/JB.182.13.3832-3838.2000; Zhang Z, 1998, BIOCHEM BIOPH RES CO, V249, P767, DOI 10.1006/bbrc.1998.9226	62	23	25	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8294	8309		10.1074/jbc.M114.591800	http://dx.doi.org/10.1074/jbc.M114.591800			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25659431	Green Published, hybrid			2022-12-28	WOS:000351662600025
J	Ma, Y; Keil, V; Sun, JJ				Ma, Yue; Keil, Verena; Sun, Jianjun			Characterization of Mycobacterium tuberculosis EsxA Membrane Insertion ROLES OF N- AND C-TERMINAL FLEXIBLE ARMS AND CENTRAL HELIX-TURN-HELIX MOTIF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTHRAX PROTECTIVE ANTIGEN; T-CELL ANTIGEN; COMPLEX-FORMATION; ESAT-6-CFP-10 COMPLEX; CALMETTE-GUERIN; PORE FORMATION; BOVIS BCG; ESAT-6; VIRULENCE; SECRETION	EsxA (LSAT-6), an important virulence factor of Mycobacterium tuberculosis, plays an essential role in phagosome rupture and bacterial cytosolic translocation within host macrophages. Our previous study showed that EsxA exhibits a unique membrane-interacting activity that is not found in its ortholog from nonpathogenic Mycobacterium smegmatis. However, the molecular mechanism of EsxA membrane insertion remains unknown. In this study, we generated truncated EsxA proteins with deletions of the N- and/or C-terminal flexible arm. Using a fluorescence-based liposome leakage assay, we found that both the N- and C-terminal arms were required for membrane disruption. Moreover, we found that, upon acidification, EsxA converted into a more organized structure with increased a-helical content, which was evidenced by CD analysis and intrinsic tryptophan fluorescence. Finally, using an environmentally sensitive fluorescent dye, we obtained direct evidence that the central helix-turn-helix motif of EsxA inserted into the membranes and formed a membrane-spanning pore. A model of EsxA membrane insertion is proposed and discussed.	[Sun, Jianjun] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Sun, Jianjun] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso	Sun, JJ (corresponding author), Univ Texas El Paso, Dept Biol Sci, 500 West Univ Ave, El Paso, TX 79968 USA.	jsun@utep.edu			National Institutes of Health from the National Center for Research Resources [5G12RR008124]; NIMHD [G12MD007592]; University of Texas at El Paso new faculty startup funds; German Academic Exchange Service (DAAD) Research Internships in Science and Engineering; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); University of Texas at El Paso new faculty startup funds; German Academic Exchange Service (DAAD) Research Internships in Science and Engineering(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health Grant 5G12RR008124 from the National Center for Research Resources and Grant G12MD007592 from NIMHD. This work was also supported by University of Texas at El Paso new faculty startup funds (to J. S.) and German Academic Exchange Service (DAAD) Research Internships in Science and Engineering (to V. K.).	Aguilo JI, 2013, CELL MICROBIOL, V15, P1994, DOI 10.1111/cmi.12169; ANDERSEN P, 1995, J IMMUNOL, V154, P3359; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Brodin P, 2005, J BIOL CHEM, V280, P33953, DOI 10.1074/jbc.M503515200; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; De Leon J, 2012, J BIOL CHEM, V287, P44184, DOI 10.1074/jbc.M112.420869; DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Jacquez P, 2014, PROTEIN EXPRES PURIF, V95, P149, DOI 10.1016/j.pep.2013.12.010; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Lakowicz R, 1983, PRINCIPLES FLUORESCE; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Lightbody KL, 2008, J BIOL CHEM, V283, P17681, DOI 10.1074/jbc.M800123200; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Medie FM, 2014, INFECT IMMUN, V82, P4572, DOI 10.1128/IAI.02153-14; Meher AK, 2006, FEBS J, V273, P1445, DOI 10.1111/j.1742-4658.2006.05166.x; Okkels LM, 2004, PROTEOMICS, V4, P2954, DOI 10.1002/pmic.200400906; Orme I, 2004, CURR OPIN MICROBIOL, V7, P58, DOI 10.1016/j.mib.2003.11.002; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Poulsen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089313; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Sun J, 2008, P NATL ACAD SCI USA, V105, P4346, DOI 10.1073/pnas.0800701105; Sun JJ, 2007, J BIOL CHEM, V282, P1059, DOI 10.1074/jbc.M609869200; Sun JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010553; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Wards BJ, 2000, TUBERCLE LUNG DIS, V80, P185, DOI 10.1054/tuld.2000.0244	38	42	43	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7314	7322		10.1074/jbc.M114.622076	http://dx.doi.org/10.1074/jbc.M114.622076			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25645924	hybrid, Green Published			2022-12-28	WOS:000350991500059
J	Hughes, MLR; Liu, BN; Halls, ML; Wagstaff, KM; Patil, R; Velkov, T; Jans, DA; Bunnett, NW; Scanlon, MJ; Porter, CJH				Hughes, Maria L. R.; Liu, Bonan; Halls, Michelle L.; Wagstaff, Kylie M.; Patil, Rahul; Velkov, Tony; Jans, David A.; Bunnett, Nigel W.; Scanlon, Martin J.; Porter, Christopher J. H.			Fatty Acid-binding Proteins 1 and 2 Differentially Modulate the Activation of Peroxisome Proliferator-activated Receptor alpha in a Ligand-selective Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID; STRUCTURAL BASIS; GENE-EXPRESSION; HUMAN PROTEOME; LIVING CELLS; PPAR-GAMMA; LOCALIZATION; PATHWAYS; NUCLEUS; TARGETS	Nuclear hormone receptors (NHRs) regulate the expression of proteins that control aspects of reproduction, development and metabolism, and are major therapeutic targets. However, NHRs are ubiquitous and participate in multiple physiological processes. Drugs that act at NHRs are therefore commonly restricted by toxicity, often at nontarget organs. For endogenous NHR ligands, intracellular lipid-binding proteins, including the fatty acid-binding proteins (FABPs), can chaperone ligands to the nucleus and promote NHR activation. Drugs also bind FABPs, raising the possibility that FABPs similarly regulate drug activity at the NHRs. Here, we investigate the ability of FABP1 and FABP2 (intracellular lipid-binding proteins that are highly expressed in tissues involved in lipid metabolism, including the liver and intestine) to influence drug-mediated activation of the lipid regulator peroxisome proliferator-activated receptor (PPAR) alpha. We show by quantitative fluorescence imaging and gene reporter assays that drug binding to FABP1 and FABP2 promotes nuclear localization and PPAR alpha activation in a drug-and FABP-dependent manner. We further show that nuclear accumulation of FABP1 and FABP2 is dependent on the presence of PPAR alpha. Nuclear accumulation of FABP on drug binding is driven largely by reduced nuclear egress rather than an increased rate of nuclear entry. Importin binding assays indicate that nuclear access occurs via an importin-independent mechanism. Together, the data suggest that specific drug-FABP complexes can interact with PPAR alpha to effect nuclear accumulation of FABP and NHR activation. Because FABPs are expressed in a regionally selective manner, this may provide a means to tailor the patterns of NHR drug activation in a tissue-specific manner.	[Hughes, Maria L. R.; Liu, Bonan; Velkov, Tony; Porter, Christopher J. H.] Monash Univ, Drug Delivery Disposit & Dynam, Parkville, Vic 3052, Australia; [Halls, Michelle L.; Bunnett, Nigel W.] Monash Univ, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Patil, Rahul; Scanlon, Martin J.] Monash Univ, Med Chem, Parkville, Vic 3052, Australia; [Bunnett, Nigel W.; Porter, Christopher J. H.] Monash Univ, ARC Ctr Excellence Convergent Bionano Sci & Techn, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Wagstaff, Kylie M.; Jans, David A.] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Bunnett, Nigel W.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia	Monash University; Monash University; Monash University; Monash University; Monash University; University of Melbourne	Bunnett, NW (corresponding author), Monash Inst Pharmaceut Sci, Drug Discovery Biol, 381 Royal Parade, Parkville, Vic 3052, Australia.	nigel.bunnett@monash.edu; martin.scanlon@monash.edu; chris.porter@monash.edu	Porter, Christopher JH/C-6333-2011	Porter, Christopher JH/0000-0003-3474-7551; Wagstaff, Kylie/0000-0003-4791-1410; Halls, Michelle/0000-0001-8555-8959; Scanlon, Martin/0000-0002-9230-7506; Jans, David/0000-0001-5115-4745; velkov, tony/0000-0002-0017-7952; Bunnett, Nigel W./0000-0003-3367-0644	ARC [DP120102930]; ARC Centres of Excellence for Coherent X-ray Science and Convergent Bio-Nano Science and Technology; National Health and Medical Research Council [63303, 1049682, 1031886]; Monash University	ARC(Australian Research Council); ARC Centres of Excellence for Coherent X-ray Science and Convergent Bio-Nano Science and Technology(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University)	This work was supported by ARC Grant DP120102930 and the ARC Centres of Excellence for Coherent X-ray Science and Convergent Bio-Nano Science and Technology, National Health and Medical Research Council Grants 63303, 1049682, and 1031886, and Monash University.	Armstrong EH, 2014, J BIOL CHEM, V289, P14941, DOI 10.1074/jbc.M113.514646; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Bernlohr DA, 1997, ANNU REV NUTR, V17, P277, DOI 10.1146/annurev.nutr.17.1.277; Bishop-Bailey D, 2003, PROSTAG OTH LIPID M, V71, P1, DOI 10.1016/S0090-6980(03)00003-0; Budhu A, 2001, J MOL BIOL, V305, P939, DOI 10.1006/jmbi.2000.4340; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Huang H, 2002, J BIOL CHEM, V277, P29139, DOI 10.1074/jbc.M202923200; Huang H, 2004, BIOCHEMISTRY-US, V43, P2484, DOI 10.1021/bi0352318; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Kuusisto HV, 2012, FASEB J, V26, P1181, DOI 10.1096/fj.11-191585; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Patil R, 2014, ACS CHEM BIOL, V9, P2526, DOI 10.1021/cb5005178; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; Schoonjans K, 1996, J LIPID RES, V37, P907; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Smith AJ, 2004, J BIOL CHEM, V279, P52399, DOI 10.1074/jbc.M410301200; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storch J, 2010, J BIOL CHEM, V285, P32679, DOI 10.1074/jbc.R110.135210; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Umemoto T, 2012, GENES CELLS, V17, P576, DOI 10.1111/j.1365-2443.2012.01607.x; Veerkamp JH, 1999, MOL CELL BIOCHEM, V192, P137, DOI 10.1023/A:1006866119264; Velkov T, 2005, J BIOL CHEM, V280, P17769, DOI 10.1074/jbc.M410193200; Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wolfrum C, 2000, BIOCHEMISTRY-US, V39, P14363, DOI 10.1021/bi0051187; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898	33	36	36	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13895	13906		10.1074/jbc.M114.605998	http://dx.doi.org/10.1074/jbc.M114.605998			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25847235	Green Published, hybrid			2022-12-28	WOS:000355313000022
J	Yang, G; Geng, XR; Liu, ZQ; Liu, JQ; Liu, XY; Xu, LZ; Zhang, HP; Sun, YX; Liu, ZG; Yang, PC				Yang, Gui; Geng, Xiao-Rui; Liu, Zhi-Qiang; Liu, Jiang-Qi; Liu, Xiao-Yu; Xu, Ling-Zhi; Zhang, Huan-Ping; Sun, Ying-Xue; Liu, Zhi-Gang; Yang, Ping-Chang			Thrombospondin-1 (TSP1)-producing B Cells Restore Antigen (Ag)-specific Immune Tolerance in an Allergic Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; FOOD ALLERGY; DENDRITIC CELLS; INDUCTION; BETA; INFLAMMATION; DISEASE; PLAYS	Restoration of the antigen (Ag)-specific immune tolerance in an allergic environment is refractory. B cells are involved in immune regulation. Whether B cells facilitate the generation of Ag-specific immune tolerance in an allergic environment requires further investigation. This paper aims to elucidate the mechanism by which B cells restore the Ag-specific immune tolerance in an allergic environment. In this study, a B cell-deficient mouse model was created by injecting an anti-CD20 antibody. The frequency of tolerogenic dendritic cell (TolDC) was assessed by flow cytometry. The levels of cytokines were determined by enzyme-linked immunosorbent assay. The expression of thrombospondin-1 (TSP1) was assessed by quantitative real-time RT-PCR, Western blotting, and methylation-specific PCR. The results showed that B cells were required in the generation of the TGF-beta-producing TolDCs in mice. B cell-derived TSP1 converted the latent TGF-beta to the active TGF-beta in DCs, which generated TGF-beta-producing TolDCs. Exposure to IL-13 inhibited the expression of TSP1 in B cells by enhancing the TSP1 gene DNA methylation. Treating food allergy mice with Ag-specific immunotherapy and IL-13 antagonists restored the generation of TolDCs and enhanced the effect of specific immunotherapy. In conclusion, B cells play a critical role in the restoration of specific immune tolerance in an allergic environment. Blocking IL-13 in an allergic environment facilitated the generation of TolDCs and enhanced the therapeutic effect of immunotherapy.	[Yang, Gui; Geng, Xiao-Rui; Liu, Zhi-Qiang; Liu, Jiang-Qi; Liu, Xiao-Yu; Xu, Ling-Zhi; Liu, Zhi-Gang; Yang, Ping-Chang] Shenzhen Univ, Sch Med, Shenzhen Key Lab Allergy & Immunol, ENT Inst, Shenzhen 518060, Peoples R China; [Yang, Gui; Geng, Xiao-Rui; Liu, Zhi-Qiang; Liu, Jiang-Qi; Liu, Xiao-Yu; Xu, Ling-Zhi; Liu, Zhi-Gang; Yang, Ping-Chang] Shenzhen Univ, State Key Lab Resp Dis Allergy, Shenzhen 518060, Peoples R China; [Yang, Gui; Geng, Xiao-Rui; Liu, Zhi-Qiang; Liu, Jiang-Qi; Zhang, Huan-Ping; Sun, Ying-Xue; Yang, Ping-Chang] McMaster Univ, Brain Body Inst, Hamilton, ON L8N 4A6, Canada; [Yang, Gui; Geng, Xiao-Rui; Liu, Zhi-Qiang; Liu, Jiang-Qi] Longgang Cent Hosp, Shenzhen 518116, Peoples R China	Shenzhen University; Shenzhen University; State Key Laboratory of Respiratory Disease; McMaster University	Liu, ZG (corresponding author), Med Sch Bldg Rm 722,3688 Nanhai Ave, Shenzhen 518060, Peoples R China.	lzg@szu.edu.cn; pcy2356@szu.edu.cn	Yang, Ping-Chang/K-4669-2019		Natural Science Foundation of SZU [000004]; Shenzhen Innovation of Science and Technology Commission [JCYJ20140418095735538, JCYJ20140411150916749]; Natural Science Foundation of China [81373176, 31400856]	Natural Science Foundation of SZU; Shenzhen Innovation of Science and Technology Commission; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Natural Science Foundation of SZU (000004), the Shenzhen Innovation of Science and Technology Commission (JCYJ20140418095735538 and JCYJ20140411150916749), and the Natural Science Foundation of China (81373176 and 31400856).	Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen X, 2011, ALLERGY, V66, P1038, DOI 10.1111/j.1398-9995.2011.02585.x; Chen X, 2011, J LEUKOCYTE BIOL, V90, P751, DOI 10.1189/jlb.1210696; Gilbert RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027501; Grimbert P, 2006, J IMMUNOL, V177, P3534, DOI 10.4049/jimmunol.177.6.3534; Hayashi H, 2012, HEPATOLOGY, V55, P1562, DOI 10.1002/hep.24800; He SH, 2011, GASTROENTEROLOGY, V141, P249, DOI 10.1053/j.gastro.2011.04.006; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Horn M, 2012, J THROMB HAEMOST, V10, P647, DOI 10.1111/j.1538-7836.2012.04640.x; JAFFE E, 1990, GENOMICS, V7, P123, DOI 10.1016/0888-7543(90)90528-3; Kim JS, 2012, CURR OPIN GASTROEN, V28, P99, DOI 10.1097/MOG.0b013e32834e7b60; Kushwah R, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-20; Leonard SA, 2012, J ALLERGY CLIN IMMUN, V129, P1579, DOI 10.1016/j.jaci.2012.04.009; Liu ZQ, 2013, ALLERGY, V68, P1241, DOI 10.1111/all.12218; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Lo-Man R, 2011, IMMUNOTHERAPY-UK, V3, P19, DOI [10.2217/IMT.11.34, 10.2217/imt.11.34]; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Mayer CT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00183; Okada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044338; Ooi AT, 2012, AM J TRANSL RES, V4, P219; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Seidel-Guyenot W, 2004, EUR J IMMUNOL, V34, P3082, DOI 10.1002/eji.200425402; Sid B, 2004, CRIT REV ONCOL HEMAT, V49, P245, DOI 10.1016/j.critrevonc.2003.09.009; Smits HH, 2012, AUTOIMMUNITY, V45, P415, DOI 10.3109/08916934.2012.665525; Tang MX, 2011, MOL CELL BIOCHEM, V346, P49, DOI 10.1007/s11010-010-0590-7; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Wu ZQ, 2013, CELL IMMUNOL, V283, P75, DOI 10.1016/j.cellimm.2013.06.014; Zhang HP, 2013, SCI REP-UK, V3, DOI 10.1038/srep03345; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183	31	21	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12858	12867		10.1074/jbc.M114.623421	http://dx.doi.org/10.1074/jbc.M114.623421			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25839231	hybrid, Green Published			2022-12-28	WOS:000354569000036
J	Kumari, S; Chaurasia, SN; Nayak, MK; Mallick, RL; Dash, D				Kumari, Sharda; Chaurasia, Susheel N.; Nayak, Manasa K.; Mallick, Ram L.; Dash, Debabrata			Sirtuin Inhibition Induces Apoptosis-like Changes in Platelets and Thrombocytopenia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; histone deacetylase (HDAC); platelet; sirtuin; thrombosis	CANCER-CELLS; LYSINE ACETYLATION; LIFE-SPAN; ACTIVATION; DEATH; SIRTINOL; RECEPTOR; PROTEIN; BAX; PROTEASOME	Background: The role of sirtuins in regulating platelet aging is largely unexplored. Results: Sirtuin inhibitors induced apoptosis-like changes in blood platelets, associated with a rise in active Bax and a significant drop in platelet count. Conclusion: Sirtuins act as a central player in the determination of platelet aging. Significance: This study refocuses attention on the potential side effect of sirtuin inhibition in delimiting platelet life span and management of thrombosis. Sirtuins are evolutionarily conserved NAD(+)-dependent acetyl-lysine deacetylases that belong to class III type histone deacetylases. In humans, seven sirtuin isoforms (Sirt1 to Sirt7) have been identified. Sirtinol, a cell-permeable lactone ring derived from naphthol, is a dual Sirt1/Sirt2 inhibitor of low potency, whereas EX-527 is a potent and selective Sirt1 inhibitor. Here we demonstrate that Sirt1, Sirt2, and Sirt3 are expressed in enucleate platelets. Both sirtinol and EX-527 induced apoptosis-like changes in platelets, as revealed by enhanced annexin V binding, reactive oxygen species production, and drop in mitochondrial transmembrane potential. These changes were associated with increased phagocytic clearance of the platelets by macrophages. Expression of acetylated p53 and the conformationally active form of Bax were found to be significantly higher in both sirtinol- and EX-527-treated platelets, implicating the p53-Bax axis in apoptosis induced by sirtuin inhibitors. Administration of either sirtinol or EX-527 in mice led to a reduction in both platelet count and the number of reticulated platelets. Our results, for the first time, implicate sirtuins as a central player in the determination of platelet aging. Because sirtuin inhibitors are being evaluated for their antitumor activity, this study refocuses attention on the potential side effect of sirtuin inhibition in delimiting platelet life span and management of thrombosis.	[Kumari, Sharda; Chaurasia, Susheel N.; Nayak, Manasa K.; Mallick, Ram L.; Dash, Debabrata] Banaras Hindu Univ, Inst Med Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Dash, D (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India.	ddash.biochem@gmail.com	kumari, sharda/AAO-5300-2020; DASH, DEBABRATA/AAF-1837-2020; Nayak, Manasa/AAZ-9439-2021	kumari, sharda/0000-0001-5864-5475; Nayak, Manasa/0000-0001-6461-0543	Department of Biotechnology, Government of India; Department of Science and Technology, Government of India; DST-FIST Program; Indian Council of Medical Research; Council of Scientific and Industrial Research; Tata innovation fellowship grant from DBT	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); DST-FIST Program(Department of Science & Technology (India)); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Tata innovation fellowship grant from DBT	This work was supported by grants from the Department of Biotechnology and the Department of Science and Technology, Government of India; the DST-FIST Program; the Indian Council of Medical Research; and the Council of Scientific and Industrial Research, and a Tata innovation fellowship grant from the DBT (to D. D.).	Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Balcerczyk A, 2010, BIOFACTORS, V36, P383, DOI 10.1002/biof.112; Bishton MJ, 2011, BLOOD, V117, P3658, DOI 10.1182/blood-2010-11-318055; Borradaile NM, 2009, CURR PHARM DESIGN, V15, P110, DOI 10.2174/138161209787185742; Brown SB, 2000, J BIOL CHEM, V275, P5987, DOI 10.1074/jbc.275.8.5987; Chiu SM, 2003, BRIT J CANCER, V89, P1590, DOI 10.1038/sj.bjc.6601298; Cho MS, 2012, BLOOD, V120, P4869, DOI 10.1182/blood-2012-06-438598; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cregan SP, 1999, J NEUROSCI, V19, P7860; Juan ME, 2008, J AGR FOOD CHEM, V56, P4813, DOI 10.1021/jf800175a; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Gertz M, 2013, P NATL ACAD SCI USA, V110, pE2772, DOI 10.1073/pnas.1303628110; Gil-Parrado S, 2002, J BIOL CHEM, V277, P27217, DOI 10.1074/jbc.M202945200; Jung-Hynes B, 2009, J BIOL CHEM, V284, P3823, DOI 10.1074/jbc.M807869200; Kodama T, 2011, J BIOL CHEM, V286, P13905, DOI 10.1074/jbc.M110.195370; Kozako T, 2012, INT J CANCER, V131, P2044, DOI 10.1002/ijc.27481; Kraemer BF, 2012, BLOOD, V120, P5014, DOI 10.1182/blood-2012-04-420661; Kumari S, 2011, FEBS LETT, V585, P2345, DOI 10.1016/j.febslet.2011.05.067; Li CY, 2010, J BIOL CHEM, V285, P16096, DOI 10.1074/jbc.M109.072694; Lin KH, 2009, CARDIOVASC RES, V83, P575, DOI 10.1093/cvr/cvp139; Liu FC, 2009, BIOCHEM PHARMACOL, V77, P1364, DOI 10.1016/j.bcp.2009.01.011; Lopez JJ, 2007, J THROMB HAEMOST, V5, P1283, DOI 10.1111/j.1538-7836.2007.02505.x; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Nayak MK, 2013, J BIOL CHEM, V288, P6826, DOI 10.1074/jbc.M112.403154; Ostrowska JK, 2004, THROMB HAEMOSTASIS, V92, P171, DOI 10.1160/TH03-11-0707; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Pereira J, 1999, THROMB HAEMOSTASIS, V82, P1318; Sadoul K, 2012, BLOOD, V120, P4215, DOI 10.1182/blood-2012-05-428011; Sadoul K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/970382; Sebastian C, 2012, J BIOL CHEM, V287, P42444, DOI 10.1074/jbc.R112.402768; van Leeuwen I, 2009, ADV CANCER RES, V102, P171, DOI 10.1016/S0065-230X(09)02005-3; Wadhawan V, 2004, ARCH BIOCHEM BIOPHYS, V422, P183, DOI 10.1016/j.abb.2003.12.024; Wang J, 2012, INT J ONCOL, V41, P1101, DOI 10.3892/ijo.2012.1534; Yamaguchi H, 2004, J BIOL CHEM, V279, P39431, DOI 10.1074/jbc.M401530200; Yamaguchi H, 2009, J BIOL CHEM, V284, P11171, DOI 10.1074/jbc.M809268200; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	38	30	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12290	12299		10.1074/jbc.M114.615948	http://dx.doi.org/10.1074/jbc.M114.615948			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25829495	Green Published, hybrid			2022-12-28	WOS:000354388600039
J	Ma, N; Shan, YL; Liao, BJ; Kong, GY; Wang, C; Huang, K; Zhang, H; Cai, XJ; Chen, SB; Pei, DQ; Chen, NS; Pan, GJ				Ma, Ning; Shan, Yongli; Liao, Baojian; Kong, Guanyi; Wang, Cheng; Huang, Ke; Zhang, Hui; Cai, Xiujuan; Chen, Shubin; Pei, Duanqing; Chen, Nansheng; Pan, Guangjin			Factor-induced Reprogramming and Zinc Finger Nuclease-aided Gene Targeting Cause Different Genome Instability in -Thalassemia Induced Pluripotent Stem Cells (iPSCs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Therapy; Genomic Instability; Genomics; Induced Pluripotent Stem Cell (iPS Cell) (iPSC); Reprogramming	COPY NUMBER; MUTATIONS; CLONES; SKIN	Background: Genome alterations need to be investigated before clinical application of iPS cells. Results: Reprogramming and gene targeting can generate substantial but different genomic variations. Conclusion: Stringent genomic monitoring and selection are needed both at the time of iPSC derivation and after gene targeting. Significance: This study examined the genome instability during iPSC generation and subsequent gene correction and revealed different genome alterations at each step. The generation of personalized induced pluripotent stem cells (iPSCs) followed by targeted genome editing provides an opportunity for developing customized effective cellular therapies for genetic disorders. However, it is critical to ascertain whether edited iPSCs harbor unfavorable genomic variations before their clinical application. To examine the mutation status of the edited iPSC genome and trace the origin of possible mutations at different steps, we have generated virus-free iPSCs from amniotic cells carrying homozygous point mutations in -hemoglobin gene (HBB) that cause severe -thalassemia (-Thal), corrected the mutations in both HBB alleles by zinc finger nuclease-aided gene targeting, and obtained the final HBB gene-corrected iPSCs by excising the exogenous drug resistance gene with Cre recombinase. Through comparative genomic hybridization and whole-exome sequencing, we uncovered seven copy number variations, five small insertions/deletions, and 64 single nucleotide variations (SNVs) in -Thal iPSCs before the gene targeting step and found a single small copy number variation, 19 insertions/deletions, and 340 single nucleotide variations in the final gene-corrected -Thal iPSCs. Our data revealed that substantial but different genomic variations occurred at factor-induced somatic cell reprogramming and zinc finger nuclease-aided gene targeting steps, suggesting that stringent genomic monitoring and selection are needed both at the time of iPSC derivation and after gene targeting.	[Ma, Ning; Shan, Yongli; Liao, Baojian; Huang, Ke; Zhang, Hui; Cai, Xiujuan; Chen, Shubin; Pei, Duanqing; Pan, Guangjin] Chinese Acad Sci, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Peoples R China; [Kong, Guanyi; Wang, Cheng] Wuhan Frasergen Bioinformat Co Ltd, Wuhan 430075, Peoples R China; [Chen, Nansheng] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Simon Fraser University	Chen, NS (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	chenn@sfu.ca; pan_guangjin@gibh.ac.cn	Liao, Baojian/AAI-6286-2021	Pan, Guangjin/0000-0002-2378-7198	National Basic Research Program of China; 973 Program of China [2012CB966503]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA01020202]; National Scientific and Technological Major Special Project on Major New Drug Innovation [2011ZX09102-010]; National Natural Science Foundation of China [31200970]; "Hundred Talents Program" of the Chinese Academy of Sciences; "Youth Innovation Promotion Association of the Chinese Academy of Sciences"; "Pearl River Nova program"; Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN/328095-2014]; International Science and Technology Cooperation Program of China [2014DFA30180]	National Basic Research Program of China(National Basic Research Program of China); 973 Program of China(National Basic Research Program of China); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Scientific and Technological Major Special Project on Major New Drug Innovation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Hundred Talents Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); "Youth Innovation Promotion Association of the Chinese Academy of Sciences"; "Pearl River Nova program"; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); International Science and Technology Cooperation Program of China	This work was supported by the National Basic Research Program of China, 973 Program of China (Grant 2012CB966503), "Strategic Priority Research Program" of the Chinese Academy of Sciences (Grant XDA01020202), National Scientific and Technological Major Special Project on Major New Drug Innovation (Grant 2011ZX09102-010), National Natural Science Foundation of China (Grant 31200970), "Hundred Talents Program" of the Chinese Academy of Sciences (to G. P.), "Youth Innovation Promotion Association of the Chinese Academy of Sciences," "Pearl River Nova program" (to B. L.), Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant (RGPIN/328095-2014, to N. C.), and International Science and Technology Cooperation Program of China (Grant 2014DFA30180).	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Cai JL, 2010, J BIOL CHEM, V285, P11227, DOI 10.1074/jbc.M109.086389; Chen YL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-79; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Choi KD, 2012, CELL REP, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Ma N, 2013, J BIOL CHEM, V288, P34671, DOI 10.1074/jbc.M113.496174; Martin A, 2013, PEDIATR CLIN N AM, V60, P1383, DOI 10.1016/j.pcl.2013.08.008; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Olivieri NF, 1999, NEW ENGL J MED, V341, P99, DOI 10.1056/NEJM199907083410207; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Tsai SQ, 2014, CELL STEM CELL, V15, P3, DOI 10.1016/j.stem.2014.06.017; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wang YX, 2012, CELL RES, V22, P637, DOI 10.1038/cr.2012.23; Xue YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070573	25	22	22	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12079	12089		10.1074/jbc.M114.624999	http://dx.doi.org/10.1074/jbc.M114.624999			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25795783	hybrid, Green Published			2022-12-28	WOS:000354388600023
J	Tanida, T; Matsuda, KI; Yamada, S; Hashimoto, T; Kawata, M				Tanida, Takashi; Matsuda, Ken Ichi; Yamada, Shunji; Hashimoto, Takashi; Kawata, Mitsuhiro			Estrogen-related Receptor Reduces the Subnuclear Mobility of Estrogen Receptor and Suppresses Estrogen-dependent Cellular Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Estrogen Receptor; Fluorescence Recovery after Photobleaching (FRAP); Fluorescence Resonance Energy Transfer (FRET); Transcription; Estrogen-related Receptor (ERR); Live-cell Imaging	ORPHAN NUCLEAR RECEPTORS; STEROID-HORMONE RECEPTOR; BREAST-CANCER CELLS; ALPHA ERR-ALPHA; INTRANUCLEAR MOBILITY; TRANSCRIPTIONAL REGULATION; GLUCOCORTICOID-RECEPTOR; ANDROGEN RECEPTOR; BINDING DOMAIN; LIVING CELLS	Background: The role of orphan nuclear receptor ERR in estrogen-related pathophysiology is poorly understood. Results: ERR repressed the transactivity of ER and proliferation of MCF-7 breast carcinoma cells through reduction of the intranuclear mobility of ER. Conclusion: ERR affects ER dynamics and function. Significance: Regulation of ERR will provide a potential therapeutic approach for estrogen-related cancer. Estrogen-related receptor (ERR) is a member of the nuclear receptor superfamily that has strong homology with estrogen receptor (ER) . ERR has three subtypes (, , and ) expressed in estrogen-sensitive organs, including ovary, breast, and brain. No endogenous ligands of ERRs have been identified, but these receptors share a common DNA element with ER and control estrogen-mediated gene transcription. Recent evidence suggests a role of ERRs in estrogen-related pathophysiology, but the detailed mechanisms of ERR functions in estrogen-related tissues are unclear. Using live-cell imaging with fluorescent protein labeling, we found that only ERR among the ERRs exhibits a punctate intranuclear pattern overlapping with ER following 17-estradiol (E-2)-stimulation. Fluorescence recovery after photobleaching showed significant reduction of the mobility of ligand-activated ER with co-expression of ERR. Fluorescence resonance energy transfer revealed that ERR directly interacts with ER. The N-terminal domain of ERR was identified as the region that interacts with ER. We also found a correlation between punctate cluster formation of ER and interaction between the receptors. Expression of ERR significantly repressed ER-mediated transactivity, whereas that of other ERR subtypes had no effect on the transactivity of ER. Consistent with this finding, E-2-stimulated proliferation of MCF-7 breast carcinoma cells and bcl-2 expression was significantly inhibited by expression of ERR. These results provide strong evidence for a suppressive effect of ERR on estrogen signaling through reduction of the intranuclear mobility of ER. The findings further suggest a unique inhibitory role for ERR in estrogen-dependent cellular function such as cancer cell proliferation.	[Tanida, Takashi; Matsuda, Ken Ichi; Yamada, Shunji; Hashimoto, Takashi; Kawata, Mitsuhiro] Kyoto Prefectural Univ Med, Dept Anat & Neurobiol, Kamigyo Ku, Kyoto 6028566, Japan	Kyoto Prefectural University of Medicine	Tanida, T (corresponding author), Kyoto Prefectural Univ Med, Dept Anat & Neurobiol, Kamigyo Ku, 465 Kajii Cho,Kawara Machi Hirokoji, Kyoto 6028566, Japan.	t-tanida@koto.kpu-m.ac.jp		Tanida, Takashi/0000-0002-0864-2433	Ministry of Education, Culture, Sports, Science and Technology of Japan [24791116, 26860852, 24300128]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Young Scientists (B) 24791116 and 26860852 (to T. T.) and for Scientific Research (B) 24300128 (to M. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; ALEXANDER RB, 1987, ENDOCRINOLOGY, V120, P1851, DOI 10.1210/endo-120-5-1851; Ariazi EA, 2002, CANCER RES, V62, P6510; Barbieri RL, 2008, J CLIN ENDOCR METAB, V93, P2439, DOI 10.1210/jc.2008-0752; BARRACK ER, 1987, J STEROID BIOCHEM, V27, P115, DOI 10.1016/0022-4731(87)90302-5; Beato M, 1996, STEROIDS, V61, P240, DOI 10.1016/0039-128X(96)00030-X; Bombail V, 2010, MOL CELL ENDOCRINOL, V314, P53, DOI 10.1016/j.mce.2009.09.007; Bombail V, 2008, HUM REPROD, V23, P2782, DOI 10.1093/humrep/den298; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Brazda P, 2011, J CELL SCI, V124, P3631, DOI 10.1242/jcs.086082; Chen S, 2001, J BIOL CHEM, V276, P28465, DOI 10.1074/jbc.M102638200; Deblois G, 2013, NAT REV CANCER, V13, P27, DOI 10.1038/nrc3396; Dong S, 2004, MOL CELL BIOL, V24, P4465, DOI 10.1128/MCB.24.10.4465-4475.2004; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Eudy JD, 1998, GENOMICS, V50, P382, DOI 10.1006/geno.1998.5345; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Hashimoto T, 2012, J CELL BIOCHEM, V113, P3039, DOI 10.1002/jcb.24182; Heckler MM, 2015, CELL CYCLE, V14, P31, DOI 10.4161/15384101.2014.972886; Heery DM, 2001, J BIOL CHEM, V276, P6695, DOI 10.1074/jbc.M009404200; Hentschke M, 2002, EUR J BIOCHEM, V269, P4086, DOI 10.1046/j.1432-1033.2002.03102.x; Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618; Horard B, 2004, J MOL ENDOCRINOL, V33, P493, DOI 10.1677/jme.1.01538; Htun H, 1999, MOL BIOL CELL, V10, P471, DOI 10.1091/mbc.10.2.471; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Ijichi N, 2011, J STEROID BIOCHEM, V123, P1, DOI 10.1016/j.jsbmb.2010.09.002; Kaku N, 2008, ENDOCRINOLOGY, V149, P3960, DOI 10.1210/en.2008-0137; Kanaujiya JK, 2013, PROTEOMICS, V13, P2100, DOI 10.1002/pmic.201200534; Karimi P, 2013, CANCER INVEST, V31, P600, DOI 10.3109/07357907.2013.845672; Kawata M, 1995, NEUROSCI RES, V24, P1, DOI 10.1016/0168-0102(96)81278-8; Knower KC, 2013, BREAST CANCER RES TR, V142, P211, DOI 10.1007/s10549-013-2716-6; Kuiper GGJM, 1997, FEBS LETT, V410, P87, DOI 10.1016/S0014-5793(97)00413-4; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; LaBarge S, 2014, FASEB J, V28, P1082, DOI 10.1096/fj.13-229211; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lim CS, 1999, MOL ENDOCRINOL, V13, P366, DOI 10.1210/me.13.3.366; Lin CC, 2006, CARCINOGENESIS, V27, P131, DOI 10.1093/carcin/bgi199; Lu DS, 2001, CANCER RES, V61, P6755; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; Maruyama K, 1998, BIOCHEM BIOPH RES CO, V246, P142, DOI 10.1006/bbrc.1998.8590; Matsuda K, 2008, J CELL BIOCHEM, V103, P136, DOI 10.1002/jcb.21393; Matsuda KI, 2002, MOL ENDOCRINOL, V16, P2215, DOI 10.1210/me.2002-0110; Mohseni M, 2014, P NATL ACAD SCI USA, V111, P17606, DOI 10.1073/pnas.1408650111; Monroe DG, 2005, MOL ENDOCRINOL, V19, P1555, DOI 10.1210/me.2004-0381; Muyan M, 2012, J MOL ENDOCRINOL, V49, P249, DOI 10.1530/JME-12-0097; Nishi M, 1999, EUR J NEUROSCI, V11, P1927, DOI 10.1046/j.1460-9568.1999.00616.x; Nishi M, 2004, J NEUROSCI, V24, P4918, DOI 10.1523/JNEUROSCI.5495-03.2004; Ochiai I, 2004, MOL ENDOCRINOL, V18, P26, DOI 10.1210/me.2002-0262; Oftedal BE, 2005, ANN NY ACAD SCI, V1040, P420, DOI 10.1196/annals.1327.079; Pettersson K, 1996, MECH DEVELOP, V54, P211, DOI 10.1016/0925-4773(95)00479-3; Pfaff DW, 1997, P NATL ACAD SCI USA, V94, P14213, DOI 10.1073/pnas.94.26.14213; Powell E, 2008, P NATL ACAD SCI USA, V105, P19012, DOI 10.1073/pnas.0807274105; Prufer K, 2008, EXP CELL RES, V314, P2652, DOI 10.1016/j.yexcr.2008.05.005; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; SEKIGUCHI M, 1979, BIOMEDICINE, V30, P245; Sem DS, 1997, J BIOL CHEM, V272, P18038, DOI 10.1074/jbc.272.29.18038; Sengupta D, 2014, BRIT J CANCER, V110, P2144, DOI 10.1038/bjc.2014.53; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Stenoien DL, 2000, MOL ENDOCRINOL, V14, P518, DOI 10.1210/me.14.4.518; Sun PM, 2005, J MOL MED, V83, P457, DOI 10.1007/s00109-005-0639-3; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Tremblay GB, 2001, GENE DEV, V15, P833, DOI 10.1101/gad.873401; Watanabe A, 2006, J CLIN ENDOCR METAB, V91, P1573, DOI 10.1210/jc.2005-1990; Yoo YA, 2008, BBA-MOL CELL RES, V1783, P438, DOI 10.1016/j.bbamcr.2007.12.001; Yu S, 2008, ONCOGENE, V27, P3313, DOI 10.1038/sj.onc.1210986; Zhang X, 1998, MOL ENDOCRINOL, V12, P513, DOI 10.1210/me.12.4.513; Zhou W, 2006, J CLIN ENDOCR METAB, V91, P569, DOI 10.1210/jc.2004-1957	70	30	30	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12332	12345		10.1074/jbc.M114.619098	http://dx.doi.org/10.1074/jbc.M114.619098			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25805499	hybrid, Green Published			2022-12-28	WOS:000354388600042
J	Blumer-Schuette, SE; Alahuhta, M; Conway, JM; Lee, LL; Zurawski, JV; Giannone, RJ; Hettich, RL; Lunin, VV; Himmel, ME; Kelly, RM				Blumer-Schuette, Sara E.; Alahuhta, Markus; Conway, Jonathan M.; Lee, Laura L.; Zurawski, Jeffrey V.; Giannone, Richard J.; Hettich, Robert L.; Lunin, Vladimir V.; Himmel, Michael E.; Kelly, Robert M.			Discrete and Structurally Unique Proteins (Tapirins) Mediate Attachment of Extremely Thermophilic Caldicellulosiruptor Species to Cellulose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; BACTERIUM RUMINOCOCCUS-ALBUS; IN-SITU PROTEOLYSIS; FIBROBACTER-SUCCINOGENES; SURFACE DISPLAY; ADHESION; YEAST; REVEALS; FAMILY; DOMAIN	A variety of catalytic and noncatalytic protein domains are deployed by select microorganisms to deconstruct lignocellulose. These extracellular proteins are used to attach to, modify, and hydrolyze the complex polysaccharides present in plant cell walls. Cellulolytic enzymes, often containing carbohydrate-binding modules, are key to this process; however, these enzymes are not solely responsible for attachment. Few mechanisms of attachment have been discovered among bacteria that do not form large polypeptide structures, called cellulosomes, to deconstruct biomass. In this study, bioinformatics and proteomics analyses identified unique, discrete, hypothetical proteins ("tapirins," origin from Maori: to join), not directly associated with cellulases, that mediate attachment to cellulose by species in the noncellulosomal, extremely thermophilic bacterial genus Caldicellulosiruptor. Two tapirin genes are located directly downstream of a type IV pilus operon in strongly cellulolytic members of the genus, whereas homologs are absent from the weakly cellulolytic Caldicellulosiruptor species. Based on their amino acid sequence, tapirins are specific to these extreme thermophiles. Tapirins are also unusual in that they share no detectable protein domain signatures with known polysaccharide-binding proteins. Adsorption isotherm and trans vivo analyses demonstrated the carbohydrate-binding module-like affinity of the tapirins for cellulose. Crystallization of a cellulose-binding truncation from one tapirin indicated that these proteins form a long beta-helix core with a shielded hydro-phobic face. Furthermore, they are structurally unique and define a new class of polysaccharide adhesins. Strongly cellulolytic Caldicellulosiruptor species employ tapirins to complement substrate-binding proteins from the ATP-binding cassette transporters and multidomain extracellular and S-layer-associated glycoside hydrolases to process the carbohydrate content of lignocellulose.	[Blumer-Schuette, Sara E.; Conway, Jonathan M.; Lee, Laura L.; Zurawski, Jeffrey V.; Kelly, Robert M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Alahuhta, Markus; Lunin, Vladimir V.; Himmel, Michael E.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Giannone, Richard J.; Hettich, Robert L.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA	University of North Carolina; North Carolina State University; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); Oak Ridge National Laboratory	Kelly, RM (corresponding author), N Carolina State Univ, Dept Chem & Biomol Engn, EB-1,911 Partners Way, Raleigh, NC 27695 USA.	rmkelly@ncsu.edu	Hettich, Robert L/N-1458-2016; Alahuhta, Markus/E-9344-2012; Blumer-Schuette, Sara/H-4081-2019; Giannone, Richard/ABC-8247-2020	Hettich, Robert L/0000-0001-7708-786X; Alahuhta, Markus/0000-0001-9375-778X; Blumer-Schuette, Sara/0000-0001-9522-4266; Giannone, Richard/0000-0001-8551-0138; Conway, Jonathan/0000-0002-2715-2149; Kelly, Robert/0000-0002-0639-3592	BioEnergy Science Center; Oak Ridge National Laboratory, a United States Department of Energy Bioenergy Research Center - Office of Biological and Environmental Research in the Department of Energy Bioenergy Office of Science	BioEnergy Science Center; Oak Ridge National Laboratory, a United States Department of Energy Bioenergy Research Center - Office of Biological and Environmental Research in the Department of Energy Bioenergy Office of Science(United States Department of Energy (DOE))	This work was supported by the BioEnergy Science Center and the Oak Ridge National Laboratory, a United States Department of Energy Bioenergy Research Center funded by the Office of Biological and Environmental Research in the Department of Energy Bioenergy Office of Science.	Baek SH, 2012, ENZYME MICROB TECH, V51, P366, DOI 10.1016/j.enzmictec.2012.08.005; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Blumer-Schuette SE, 2014, FEMS MICROBIOL REV, V38, P393, DOI 10.1111/1574-6976.12044; Blumer-Schuette SE, 2012, J BACTERIOL, V194, P4015, DOI 10.1128/JB.00266-12; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Clantin B, 2004, P NATL ACAD SCI USA, V101, P6194, DOI 10.1073/pnas.0400291101; Close DW, 2014, ACTA CRYSTALLOGR D, V70, P2583, DOI 10.1107/S1399004714015934; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Ezer A, 2008, J BACTERIOL, V190, P8220, DOI 10.1128/JB.00609-08; Fan LH, 2012, P NATL ACAD SCI USA, V109, P13260, DOI 10.1073/pnas.1209856109; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Gera N, 2011, J MOL BIOL, V409, P601, DOI 10.1016/j.jmb.2011.04.020; GIBBS MD, 1992, APPL ENVIRON MICROB, V58, P3864, DOI 10.1128/AEM.58.12.3864-3867.1992; Gibbs MD, 2000, CURR MICROBIOL, V40, P333, DOI 10.1007/s002849910066; GILKES NR, 1988, J BIOL CHEM, V263, P10401; Gong JH, 1996, CAN J MICROBIOL, V42, P453, DOI 10.1139/m96-062; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Ito J, 2004, BIOTECHNOL PROGR, V20, P688, DOI 10.1021/bp034332u; Jager G, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-33; Jun HS, 2007, J BACTERIOL, V189, P6806, DOI 10.1128/JB.00560-07; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Linder M, 1996, J BIOL CHEM, V271, P21268, DOI 10.1074/jbc.271.35.21268; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; Mello LV, 2010, FEBS LETT, V584, P2421, DOI 10.1016/j.febslet.2010.04.045; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Mosoni P, 2001, ARCH MICROBIOL, V176, P52, DOI 10.1007/s002030100292; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nam JM, 2002, J MOL CATAL B-ENZYM, V17, P197, DOI 10.1016/S1381-1177(02)00028-0; Onyenwoke RU, 2006, INT J SYST EVOL MICR, V56, P1391, DOI 10.1099/ijs.0.63723-0; Ozdemir I, 2012, APPL ENVIRON MICROB, V78, P768, DOI 10.1128/AEM.07031-11; Pegden RS, 1998, J BACTERIOL, V180, P5921, DOI 10.1128/JB.180.22.5921-5927.1998; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rakotoarivonina H, 2002, MICROBIOL-SGM, V148, P1871, DOI 10.1099/00221287-148-6-1871; Rakotoarivonina H, 2005, MICROBIOL-SGM, V151, P1291, DOI 10.1099/mic.0.27735-0; Riedel K, 1998, FEMS MICROBIOL LETT, V164, P261, DOI 10.1016/S0378-1097(98)00223-7; Rigden DJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-196; Skubak P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3777; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEO VSJ, 1995, APPL MICROBIOL BIOT, V43, P291, DOI 10.1007/s002530050405; Tomme P, 1998, J CHROMATOGR B, V715, P283, DOI 10.1016/S0378-4347(98)00053-X; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Tsai SL, 2010, APPL ENVIRON MICROB, V76, P7514, DOI 10.1128/AEM.01777-10; VanFossen AL, 2008, ANN NY ACAD SCI, V1125, P322, DOI 10.1196/annals.1419.017; VanFossen AL, 2011, BIOTECHNOL BIOENG, V108, P1559, DOI 10.1002/bit.23093; VanFossen AL, 2009, APPL ENVIRON MICROB, V75, P7718, DOI 10.1128/AEM.01959-09; Vodovnik M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065333; Wang ZW, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-30; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wen F, 2010, APPL ENVIRON MICROB, V76, P1251, DOI 10.1128/AEM.01687-09; Wernimont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005094; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu Q, 2004, FEBS LETT, V566, P11, DOI 10.1016/j.febslet.2004.04.005; Yeo HJ, 2007, J BIOL CHEM, V282, P31076, DOI 10.1074/jbc.M705750200; Yokoyama H, 2014, J BACTERIOL, V196, P3784, DOI 10.1128/JB.01897-14; Young J, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0142-6	73	20	21	0	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10645	10656		10.1074/jbc.M115.641480	http://dx.doi.org/10.1074/jbc.M115.641480			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25720489	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000353404500008
J	Nakai, T; Ito, H; Kobayashi, K; Takahashi, Y; Hori, H; Tsubaki, M; Tanizawa, K; Okajima, T				Nakai, Tadashi; Ito, Hiroto; Kobayashi, Kazuo; Takahashi, Yasuhiro; Hori, Hiroshi; Tsubaki, Motonari; Tanizawa, Katsuyuki; Okajima, Toshihide			The Radical S-Adenosyl-L-methionine Enzyme QhpD Catalyzes Sequential Formation of Intra-protein Sulfur-to-Methylene Carbon Thioether Bonds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUINOHEMOPROTEIN AMINE DEHYDROGENASE; 4FE-4S CLUSTERS; PARACOCCUS-DENITRIFICANS; PSEUDOMONAS-PUTIDA; POSTTRANSLATIONAL MODIFICATION; BIOTIN SYNTHASE; IRON; BIOSYNTHESIS; BIOGENESIS; COFACTOR	The bacterial enzyme designated QhpD belongs to the radical S-adenosyl-L-methionine (SAM) superfamily of enzymes and participates in the post-translational processing of quinohemoprotein amine dehydrogenase. QhpD is essential for the formation of intra-protein thioether bonds within the small subunit (maturated QhpC) of quinohemoprotein amine dehydrogenase. We overproduced QhpD from Paracoccus denitrificans as a stable complex with its substrate QhpC, carrying the 28-residue leader peptide that is essential for the complex formation. Absorption and electron paramagnetic resonance spectra together with the analyses of iron and sulfur contents suggested the presence of multiple (likely three) [4Fe-4S] clusters in the purified and reconstituted QhpD. In the presence of a reducing agent (sodium dithionite), QhpD catalyzed the multiple-turnover reaction of reductive cleavage of SAM into methionine and 5'-deoxyadenosine and also the single-turnover reaction of intra-protein sulfur-to-methylene carbon thioether bond formation in QhpC bound to QhpD, producing a multiknotted structure of the polypeptide chain. Homology modeling and mutagenic analysis revealed several conserved residues indispensable for both in vivo and in vitro activities of QhpD. Our findings uncover another challenging reaction catalyzed by a radical SAM enzyme acting on a ribosomally translated protein substrate.	[Nakai, Tadashi; Ito, Hiroto; Kobayashi, Kazuo; Tanizawa, Katsuyuki; Okajima, Toshihide] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; [Takahashi, Yasuhiro] Saitama Univ, Div Life Sci, Grad Sch Sci & Engn, Saitama 3388570, Japan; [Hori, Hiroshi; Tsubaki, Motonari] Kobe Univ, Grad Sch Sci, Dept Chem, Kobe, Hyogo 6578501, Japan; [Tanizawa, Katsuyuki] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Olomouc 78371, Czech Republic	Osaka University; Saitama University; Kobe University; Palacky University Olomouc	Okajima, T (corresponding author), Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan.	tokajima@sanken.osaka-u.ac.jp	Kobayashi, Kazuo/H-9279-2012; Nakai, Tadashi/F-8047-2010; Takahashi, Yasuhiro/F-1119-2011	Kobayashi, Kazuo/0000-0002-5586-9112; Nakai, Tadashi/0000-0001-9770-8168; Takahashi, Yasuhiro/0000-0002-0588-6045; Okajima, Toshihide/0000-0003-1733-9580	Japan Society for the Promotion of Science [24658288, 23570135]; Operational Program Education for Competitiveness-European Social Fund [CZ.1.07/2.3.00/20.0165]; Network Joint Research Center for Materials and Devices	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Operational Program Education for Competitiveness-European Social Fund(European Social Fund (ESF)); Network Joint Research Center for Materials and Devices	This work was supported by Japan Society for the Promotion of Science Grants-in-aid for Scientific Research, Challenging Exploratory Research 24658288 (to T. O.) and Category C 23570135 (to T. N.), the Operational Program Education for Competitiveness-European Social Fund Project CZ.1.07/2.3.00/20.0165) (to K. T.), and by Network Joint Research Center for Materials and Devices.	Adachi O, 1998, BIOSCI BIOTECH BIOCH, V62, P469, DOI 10.1271/bbb.62.469; Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Benjdia A, 2010, FEBS J, V277, P1906, DOI 10.1111/j.1742-4658.2010.07613.x; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chang CH, 1996, BIOCHEMISTRY-US, V35, P11081, DOI 10.1021/bi960850k; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Datta S, 2001, P NATL ACAD SCI USA, V98, P14268, DOI 10.1073/pnas.241429098; Dowling DP, 2012, BBA-PROTEINS PROTEOM, V1824, P1178, DOI 10.1016/j.bbapap.2012.04.006; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Dyballa Nadine, 2009, J Vis Exp, DOI 10.3791/1431; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Fluhe L, 2013, CURR OPIN CHEM BIOL, V17, P605, DOI 10.1016/j.cbpa.2013.06.031; Fluhe L, 2013, J AM CHEM SOC, V135, P959, DOI 10.1021/ja310542g; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P8519, DOI 10.1073/pnas.1302417110; Grove TL, 2008, BIOCHEMISTRY-US, V47, P7523, DOI 10.1021/bi8004297; Haft DH, 2011, J BACTERIOL, V193, P2745, DOI 10.1128/JB.00040-11; Haft DH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-21; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hanzelmann P, 2004, J BIOL CHEM, V279, P34721, DOI 10.1074/jbc.M313398200; Kawulka KE, 2004, BIOCHEMISTRY-US, V43, P3385, DOI 10.1021/bi0359527; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lanz ND, 2012, METHOD ENZYMOL, V516, P125, DOI 10.1016/B978-0-12-394291-3.00030-7; Lees NS, 2009, J AM CHEM SOC, V131, P9184, DOI 10.1021/ja903978u; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moore BN, 2012, PHYS CHEM CHEM PHYS, V14, P3148, DOI 10.1039/c2cp23443b; Nakai T, 2014, BIOCHEMISTRY-US, V53, P895, DOI 10.1021/bi401625m; Nakai T, 2012, J BIOL CHEM, V287, P6530, DOI 10.1074/jbc.M111.324756; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; Nicolet Y, 2004, NUCLEIC ACIDS RES, V32, P4015, DOI 10.1093/nar/gkh728; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Ono K, 2006, J BIOL CHEM, V281, P13672, DOI 10.1074/jbc.M600029200; Roach PL, 2011, CURR OPIN CHEM BIOL, V15, P267, DOI 10.1016/j.cbpa.2010.11.015; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Satoh A, 2002, J BIOL CHEM, V277, P2830, DOI 10.1074/jbc.M109090200; Takagi K, 1999, BIOCHEMISTRY-US, V38, P6935, DOI 10.1021/bi9828268; Takagi K, 2001, EUR J BIOCHEM, V268, P470, DOI 10.1046/j.1432-1033.2001.01912.x; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ugulava NB, 2000, BIOCHEMISTRY-US, V39, P5206, DOI 10.1021/bi9926227; Ugulava NB, 2001, BIOCHEMISTRY-US, V40, P8343, DOI 10.1021/bi0104625; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Vandenberghe I, 2001, J BIOL CHEM, V276, P42923, DOI 10.1074/jbc.M107164200; VANSPANNING RJM, 1991, J BACTERIOL, V173, P6962, DOI 10.1128/jb.173.21.6962-6970.1991; Wang JR, 2014, ACS CHEM BIOL, V9, P1929, DOI 10.1021/cb5004674; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b	55	34	34	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11144	11166		10.1074/jbc.M115.638320	http://dx.doi.org/10.1074/jbc.M115.638320			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25778402	Green Published, hybrid			2022-12-28	WOS:000353404500048
J	Basudhar, D; Madrona, Y; Kandel, S; Lampe, JN; Nishida, CR; de Montellano, PRO				Basudhar, Debashree; Madrona, Yarrow; Kandel, Sylvie; Lampe, Jed N.; Nishida, Clinton R.; de Montellano, Paul R. Ortiz			Analysis of Cytochrome P450 CYP119 Ligand-dependent Conformational Dynamics by Two-dimensional NMR and X-ray Crystallography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Conformational Change; Cytochrome P450; Molecular Dynamics; Nuclear Magnetic Resonance (NMR); X-ray Crystallography	CRYSTAL-STRUCTURE; THERMOPHILIC CYTOCHROME-P450; MYCOBACTERIUM-TUBERCULOSIS; ACTIVE-SITE; SUBSTRATE; BINDING; COMPLEX; RESOLUTION; P450CAM; STATE	Defining the conformational states of cytochrome P450 active sites is critical for the design of agents that minimize drug-drug interactions, the development of isoform-specific P450 inhibitors, and the engineering of novel oxidative catalysts. We used two-dimensional H-1,N-15 HSQC chemical shift perturbation mapping of N-15-labeled Phe residues and x-ray crystallography to examine the ligand-dependent conformational dynamics of CYP119. Active site Phe residues were most affected by the binding of azole inhibitors and fatty acid substrates, in agreement with active site localization of the conformational changes. This was supported by crystallography, which revealed movement of the F-G loop with various azoles. Nevertheless, the NMR chemical shift perturbations caused by azoles and substrates were distinguishable. The absence of significant chemical shift perturbations with several azoles revealed binding of ligands to an open conformation similar to that of the ligand-free state. In contrast, 4-phenylimidazole caused pronounced NMR changes involving Phe-87, Phe-144, and Phe-153 that support the closed conformation found in the crystal structure. The same closed conformation is observed by NMR and crystallography with a para-fluoro substituent on the 4-phenylimidazole, but a para-chloro or bromo substituent engendered a second closed conformation. An open conformation is thus favored in solution with many azole ligands, but para-substituted phenylimidazoles give rise to two closed conformations that depend on the size of the para-substituent. The results suggest that ligands selectively stabilize discrete cytochrome P450 conformational states.	[Basudhar, Debashree; Madrona, Yarrow; Nishida, Clinton R.; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Kandel, Sylvie] XenoTech LLC, Lenexa, KS 66219 USA; [Lampe, Jed N.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	University of California System; University of California San Francisco; University of Kansas; University of Kansas Medical Center	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 600 16th St, San Francisco, CA 94158 USA.	Ortiz@cgl.ucsf.edu	Lampe, Jed N./J-8930-2019	Lampe, Jed N./0000-0003-0794-2263; Kandel, Sylvie/0000-0002-8059-8035	United States Department of Energy [DE-ACO2-05CH11231, DE-ACO2-76SF00515]; Department of Energy Office of Biological and Environmental Research; National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM025515, R37GM025515] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Christopher Waddling, manager of the X-ray Structure Facility (University of California at San Francisco), and Dr. James Holton and George Meigs of the Advance Light Source beamline (8.3.1), for their help. The Advanced Light Source is supported by Contract DE-ACO2-05CH11231 and the Stanford Synchrotron Radiation Light Source by Contract DE-ACO2-76SF00515, both from the United States Department of Energy. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and National Institutes of Health Grant P41GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahuja S, 2013, J BIOL CHEM, V288, P22080, DOI 10.1074/jbc.M112.448225; Asciutto EK, 2012, BIOCHEMISTRY-US, V51, P3383, DOI 10.1021/bi300007r; Ball A, 2013, ENVIRON SCI POLLUT R, V20, P4311, DOI 10.1007/s11356-013-1620-2; BANCI L, 1994, J AM CHEM SOC, V116, P4866, DOI 10.1021/ja00090a035; BANCI L, 1993, BIOPHYS J, V65, P806, DOI 10.1016/S0006-3495(93)81122-6; Benedetti MS, 1999, DRUG METAB REV, V31, P665, DOI 10.1081/DMR-100101941; Brandman R, 2011, ARCH BIOCHEM BIOPHYS, V509, P127, DOI 10.1016/j.abb.2011.02.020; Cupp-Vickery JR, 2001, J MOL BIOL, V311, P101, DOI 10.1006/jmbi.2001.4803; Dunn AR, 2001, P NATL ACAD SCI USA, V98, P12420, DOI 10.1073/pnas.221297998; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Fraser JS, 2011, P NATL ACAD SCI USA, V108, P16247, DOI 10.1073/pnas.1111325108; Harford-Cross CF, 2000, PROTEIN ENG, V13, P121, DOI 10.1093/protein/13.2.121; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Ingelman-Sundberg M, 2004, TRENDS PHARMACOL SCI, V25, P193, DOI 10.1016/j.tips.2004.02.007; Jakesz R, 2005, LANCET, V366, P455, DOI 10.1016/S0140-6736(05)67059-6; Jaudzems K, 2010, ACTA CRYSTALLOGR F, V66, P1367, DOI 10.1107/S1744309110005890; Jiang YY, 2009, ANGEW CHEM INT EDIT, V48, P7193, DOI 10.1002/anie.200901485; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keating GM, 2005, DRUGS, V65, P1553, DOI 10.2165/00003495-200565110-00007; Koo LS, 2000, J BIOL CHEM, V275, P14112, DOI 10.1074/jbc.275.19.14112; Lacroix C, 2005, BRIT J DERMATOL, V152, P1067, DOI 10.1111/j.1365-2133.2005.06534.x; Lampe JN, 2010, J BIOL CHEM, V285, P9594, DOI 10.1074/jbc.M109.087593; Lampe JN, 2008, J AM CHEM SOC, V130, P16168, DOI 10.1021/ja8071463; Lee YT, 2011, BIOCHEMISTRY-US, V50, P693, DOI 10.1021/bi101726d; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; LOOSE DS, 1983, J CLIN INVEST, V71, P1495, DOI 10.1172/JCI110903; Martinez CA, 2013, CURR TOP MED CHEM, V13, P1470; McLean MA, 1998, BIOCHEM BIOPH RES CO, V252, P166, DOI 10.1006/bbrc.1998.9584; Mohanty B, 2010, ACTA CRYSTALLOGR F, V66, P1381, DOI 10.1107/S1744309110020956; Muralidhara BK, 2006, J BIOL CHEM, V281, P8051, DOI 10.1074/jbc.M509696200; MURRAY M, 1983, CHEM-BIOL INTERACT, V43, P341, DOI 10.1016/0009-2797(83)90117-5; Nazor J, 2008, PROTEIN ENG DES SEL, V21, P29, DOI 10.1093/protein/gzm074; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nishida CR, 2005, BIOCHEM BIOPH RES CO, V338, P437, DOI 10.1016/j.bbrc.2005.08.093; Olieric V, 2007, ACTA CRYSTALLOGR D, V63, P759, DOI 10.1107/S0907444907019580; Ouellet H, 2008, J BIOL CHEM, V283, P5069, DOI 10.1074/jbc.M708734200; Park SY, 2002, J INORG BIOCHEM, V91, P491, DOI 10.1016/S0162-0134(02)00446-4; Park SY, 2000, ACTA CRYSTALLOGR D, V56, P1173, DOI 10.1107/S0907444900008234; Pochapsky SS, 2003, BIOCHEMISTRY-US, V42, P5649, DOI 10.1021/bi034263s; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 1985, J BIOL CHEM, V260, P6122; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; Puchkaev AV, 2003, ARCH BIOCHEM BIOPHYS, V409, P52, DOI 10.1016/S0003-9861(02)00402-2; RAAG R, 1991, BIOCHEMISTRY-US, V30, P2674, DOI 10.1021/bi00224a016; Roberts AG, 2006, BIOCHEMISTRY-US, V45, P1673, DOI 10.1021/bi0518895; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Serrano P, 2010, ACTA CRYSTALLOGR F, V66, P1393, DOI 10.1107/S1744309110033658; Shah MB, 2013, J PHARMACOL EXP THER, V346, P113, DOI 10.1124/jpet.113.204776; Stoll S, 2012, P NATL ACAD SCI USA, V109, P12888, DOI 10.1073/pnas.1207123109; Vallurupalli P, 2008, P NATL ACAD SCI USA, V105, P11766, DOI 10.1073/pnas.0804221105; Venkatakrishnan K, 2000, CLIN PHARMACOKINET, V38, P111, DOI 10.2165/00003088-200038020-00002; Vidakovic M, 1998, BIOCHEMISTRY-US, V37, P9211, DOI 10.1021/bi980189f; Wackett LP, 1998, ANN NY ACAD SCI, V864, P142, DOI 10.1111/j.1749-6632.1998.tb10297.x; Weik M, 2010, ACTA CRYSTALLOGR D, V66, P437, DOI 10.1107/S0907444910002702; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamamoto K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02538; Yano JK, 2000, J BIOL CHEM, V275, P31086, DOI 10.1074/jbc.M004281200	64	23	23	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10000	10017		10.1074/jbc.M114.627935	http://dx.doi.org/10.1074/jbc.M114.627935			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25670859	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000353241100009
J	Pesch, YY; Riedel, D; Behr, M				Pesch, Yanina-Yasmin; Riedel, Dietmar; Behr, Matthias			Obstructor A Organizes Matrix Assembly at the Apical Cell Surface to Promote Enzymatic Cuticle Maturation in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chitin; Drosophila; Epidermis; Extracellular Matrix; Functional Genomics; Membrane; Molecular Genetics; Cuticle	PHYLOGENETIC ANALYSIS; EXTRACELLULAR-MATRIX; DOMAIN ORGANIZATION; CHITIN SYNTHASES; AIRWAY CLEARANCE; PROTEINS; FAMILY; SECRETION; KNICKKOPF; GROWTH	Assembly and maturation of the apical extracellular matrix (aECM) is crucial for protecting organisms, but underlying molecular mechanisms remain poorly understood. Epidermal cells secrete proteins and enzymes that assemble at the apical cell surface to provide epithelial integrity and stability during developmental growth and upon tissue damage. We analyzed molecular mechanisms of aECM assembly and identified the conserved chitin-binding protein Obst-A (Obstructor A) as an essential regulator. We show in Drosophila that Obst-A is required to coordinate protein and chitin matrix packaging at the apical cell surface during development. Secreted by epidermal cells, the Obst-A protein is specifically enriched in the apical assembly zone where matrix components are packaged into their highly ordered architecture. In obst-A null mutant larvae, the assembly zone is strongly diminished, resulting in severe disturbance of matrix scaffold organization and impaired aECM integrity. Furthermore, enzymes that support aECM stability are mislocalized. As a biological consequence, cuticle architecture, integrity, and function are disturbed in obst-A mutants, finally resulting in immediate lethality upon wounding. Our studies identify a new core organizing center, the assembly zone that controls aECM assembly at the apical cell surface. We propose a genetically conserved molecular mechanism by which Obst-A forms a matrix scaffold to coordinate trafficking and localization of proteins and enzymes in the newly deposited aECM. This mechanism is essential for maturation and stabilization of the aECM in a growing and remodeling epithelial tissue as an outermost barrier.	[Pesch, Yanina-Yasmin; Behr, Matthias] Univ Bonn, Dept Mol Dev Biol, Life & Med Sci Inst LIMES, D-53115 Bonn, Germany; [Pesch, Yanina-Yasmin; Behr, Matthias] Univ Leipzig, Dept Cell Dev Biol, Translat Ctr Regenerat Med TRM, D-04103 Leipzig, Germany; [Riedel, Dietmar] Max Planck Inst Biophys Chem, Electron Microscopy Grp, D-37077 Gottingen, Germany	University of Bonn; Leipzig University; Max Planck Society	Behr, M (corresponding author), Univ Bonn, Dept Mol Dev Biol, Life & Med Sci Inst LIMES, D-53115 Bonn, Germany.	matthias.behr@uni-leipzig.de	Behr, Matthias/K-6505-2019	Behr, Matthias/0000-0001-9869-1257	Deutsche Forschungsgemeinschaft [SFB645-C5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB645-C5 (to M. B.).	Arakane Y, 2012, PLOS GENET, V8, P612, DOI 10.1371/journal.pgen.1002682; Arakane Y, 2010, CELL MOL LIFE SCI, V67, P201, DOI 10.1007/s00018-009-0161-9; Arakane Y, 2009, INSECT BIOCHEM MOLEC, V39, P355, DOI 10.1016/j.ibmb.2009.02.002; Barry MK, 1999, INSECT BIOCHEM MOLEC, V29, P319, DOI 10.1016/S0965-1748(99)00004-1; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Behr M, 2005, FEBS LETT, V579, P6827, DOI 10.1016/j.febslet.2005.11.021; Behr M, 2007, NAT CELL BIOL, V9, P847, DOI 10.1038/ncb1611; Bokel C, 2005, J CELL SCI, V118, P633, DOI 10.1242/jcs.01619; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chaudhari SS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004537; Chaudhari SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003268; Chaudhari SS, 2011, P NATL ACAD SCI USA, V108, P17028, DOI 10.1073/pnas.1112288108; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; Hsiao YC, 2013, ACTA BIOMATER, V9, P8214, DOI 10.1016/j.actbio.2013.06.002; Jasrapuria S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049844; Jasrapuria S, 2010, INSECT BIOCHEM MOLEC, V40, P214, DOI 10.1016/j.ibmb.2010.01.011; Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049; KAZNOWSKI CE, 1985, J INSECT PHYSIOL, V31, P801, DOI 10.1016/0022-1910(85)90073-3; Kramer K. J., 2005, COMPREHENSIVE MOL IN, P11; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Moussian B, 2007, MATRIX BIOL, V26, P337, DOI 10.1016/j.matbio.2007.02.001; Moussian B, 2010, INSECT BIOCHEM MOLEC, V40, P363, DOI 10.1016/j.ibmb.2010.03.003; Nisole A, 2010, J INSECT PHYSIOL, V56, P1427, DOI 10.1016/j.jinsphys.2009.12.006; Noh MY, 2014, INSECT BIOCHEM MOLEC, V53, P22, DOI 10.1016/j.ibmb.2014.07.005; PETERS W, 1986, HISTOCHEMISTRY, V84, P155, DOI 10.1007/BF00499827; Petkau G, 2012, J BIOL CHEM, V287, P21396, DOI 10.1074/jbc.M112.359984; Shaik KS, 2012, EUR J CELL BIOL, V91, P204, DOI 10.1016/j.ejcb.2011.11.005; Stumpges B, 2011, FEBS LETT, V585, P3316, DOI 10.1016/j.febslet.2011.09.018; Tiklova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067415; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; WOLFGANG WJ, 1986, DEV BIOL, V113, P305, DOI 10.1016/0012-1606(86)90166-1; WOLFGANG WJ, 1987, TISSUE CELL, V19, P827, DOI 10.1016/0040-8166(87)90023-1; Yang TL, 2011, INT J MOL SCI, V12, P1936, DOI 10.3390/ijms12031936; Zhu QS, 2008, INSECT BIOCHEM MOLEC, V38, P452, DOI 10.1016/j.ibmb.2007.06.010	40	45	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10071	10082		10.1074/jbc.M114.614933	http://dx.doi.org/10.1074/jbc.M114.614933			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25737451	hybrid, Green Published			2022-12-28	WOS:000353241100014
J	Plitzko, B; Havemeyer, A; Kunze, T; Clement, B				Plitzko, Birte; Havemeyer, Antje; Kunze, Thomas; Clement, Bernd			The Pivotal Role of the Mitochondrial Amidoxime Reducing Component 2 in Protecting Human Cells against Apoptotic Effects of the Base Analog N-6-Hydroxylaminopurine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cell metabolism; flow cytometry; nucleoside; nucleotide analogue; RNA interference (RNAi); MOSC; N-reduction; N-6-hydroxyadenosine; N-6-hydroxylaminopurine; mARC	ESCHERICHIA-COLI; CYTOCHROME B(5); MOLYBDENUM; ADENOSINE; MARC; 6-N-HYDROXYLAMINOPURINE; INVOLVEMENT; REDUCTION; ADENINE; SYSTEM	Background:In vitro the mARC-system catalyzes reductions of N-hydroxylated compounds as for instance N-hydroxylated base analogs. Results: mARC2 knockdown increases N-6-hydroxylaminopurine sensitivity of HeLa cells but N-6-hydroxyadenosine detoxication is more effectively catalyzed by adenosine deaminase. Conclusion: mARC2 plays a critical role in detoxication of N-6-hydroxylaminopurine in HeLa cells. Significance: Detoxication of mutagenic N-hydroxylated base analogs may constitute a physiological function of the mARC-system. N-Hydroxylated nucleobases and nucleosides as N-hydroxylaminopurine (HAP) or N-hydroxyadenosine (HAPR) may be generated endogenously in the course of cell metabolism by cytochrome P450, by oxidative stress or by a deviating nucleotide biosynthesis. These compounds have shown to be toxic and mutagenic for procaryotic and eucaryotic cells. For DNA replication fidelity it is therefore of great importance that organisms exhibit effective mechanisms to remove such non-canonical base analogs from DNA precursor pools. In vitro, the molybdoenzymes mitochondrial amidoxime reducing component 1 and 2 (mARC1 and mARC2) have shown to be capable of reducing N-hydroxylated base analogs and nucleoside analogs to the corresponding canonical nucleobases and nucleosides upon reconstitution with the electron transport proteins cytochrome b(5) and NADH-cytochrome b(5) reductase. By RNAi-mediated down-regulation of mARC in human cell lines the mARC-dependent N-reductive detoxication of HAP in cell metabolism could be demonstrated. For HAPR, on the other hand, the reduction to adenosine seems to be of less significance in the detoxication pathway of human cells as HAPR is primarily metabolized to inosine by direct dehydroxylamination catalyzed by adenosine deaminase. Furthermore, the effect of mARC knockdown on sensitivity of human cells to HAP was examined by flow cytometric quantification of apoptotic cell death and detection of poly (ADP-ribose) polymerase (PARP) cleavage. mARC2 was shown to protect HeLa cells against the apoptotic effects of the base analog, whereas the involvement of mARC1 in reductive detoxication of HAP does not seem to be pivotal.	[Plitzko, Birte; Havemeyer, Antje; Kunze, Thomas; Clement, Bernd] Univ Kiel, Dept Pharmaceut & Med Chem, Inst Pharmaceut, D-24118 Kiel, Germany	University of Kiel	Clement, B (corresponding author), Univ Kiel, Dept Pharmaceut & Med Chem, Inst Pharmaceut, Gutenbergstr 76, D-24118 Kiel, Germany.	bclement@pharmazie.uni-kiel.de			Deutsche Forschungsgemeinschaft (DFG) [CL56/9-1, ME 1266/24-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, Grant Number CL56/9-1, ME 1266/24-1).	ABDULMASIH MT, 1986, J BIOL CHEM, V261, P2020; Anantharaman V, 2002, FEMS MICROBIOL LETT, V207, P55, DOI 10.1016/S0378-1097(01)00515-8; BARRETT JC, 1981, P NATL ACAD SCI-BIOL, V78, P5685, DOI 10.1073/pnas.78.9.5685; BUNAG RD, 1964, CIRC RES, V15, P83, DOI 10.1161/01.RES.15.1.83; BURCHENAL JH, 1967, BIOCHEM PHARMACOL, V16, P423, DOI 10.1016/0006-2952(67)90089-5; Burgis NE, 2003, J BACTERIOL, V185, P3101, DOI 10.1128/JB.185.10.3101-3110.2003; CLEMENT B, 1990, BIOCHEM PHARMACOL, V39, P925, DOI 10.1016/0006-2952(90)90209-4; CRISTALLI G, 1991, J MED CHEM, V34, P2226, DOI 10.1021/jm00111a044; DIVE C, 1992, BIOCHIM BIOPHYS ACTA, V1133, P275, DOI 10.1016/0167-4889(92)90048-G; DOLLINGER MR, 1975, CLIN PHARMACOL THER, V17, P57; Feng JDZ, 2000, THER DRUG MONIT, V22, P177, DOI 10.1097/00007691-200004000-00007; FREESE E, 1959, J MOL BIOL, V1, P87, DOI 10.1016/S0022-2836(59)80038-3; Froriep D, 2013, XENOBIOTICA, V43, P780, DOI 10.3109/00498254.2013.767481; Gruenewald S, 2008, J MED CHEM, V51, P8173, DOI 10.1021/jm8010417; Haghdoost S, 2006, FREE RADICAL BIO MED, V41, P620, DOI 10.1016/j.freeradbiomed.2006.05.003; Havemeyer A, 2006, J BIOL CHEM, V281, P34796, DOI 10.1074/jbc.M607697200; Havemeyer A, 2011, DRUG METAB REV, V43, P524, DOI 10.3109/03602532.2011.608682; Havemeyer A, 2010, DRUG METAB DISPOS, V38, P1917, DOI 10.1124/dmd.110.032813; Islinger M, 2007, J BIOL CHEM, V282, P23055, DOI 10.1074/jbc.M610910200; Jakobs HH, 2014, CHEMMEDCHEM, V9, P2381, DOI 10.1002/cmdc.201402127; Jakobs HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105371; KhromovBorisov NN, 1997, MUTAT RES-FUND MOL M, V379, P95, DOI 10.1016/S0027-5107(97)00112-7; Kotthaus J, 2011, BIOCHEM J, V433, P383, DOI 10.1042/BJ20100960; Kozmin SG, 1998, MUTAT RES-FUND MOL M, V402, P41, DOI 10.1016/S0027-5107(97)00280-7; Kozmin SG, 2008, MOL MICROBIOL, V68, P51, DOI 10.1111/j.1365-2958.2008.06128.x; KRENITSKY TA, 1969, J BIOL CHEM, V244, P4779; Krompholz N, 2012, CHEM RES TOXICOL, V25, P2443, DOI 10.1021/tx300298m; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIEBERMAN I, 1956, J BIOL CHEM, V223, P327; Malik AN, 2007, BIOCHEM BIOPH RES CO, V357, P237, DOI 10.1016/j.bbrc.2007.03.132; Mendel RR, 2012, BBA-MOL CELL RES, V1823, P1568, DOI 10.1016/j.bbamcr.2012.02.007; Menezes MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032313; Mikula M, 2011, FUNCT INTEGR GENOMIC, V11, P215, DOI 10.1007/s10142-010-0200-5; NEGISHI K, 1994, MUTAT RES-REV GENET, V318, P227, DOI 10.1016/0165-1110(94)90016-7; Neve EPA, 2012, J BIOL CHEM, V287, P6307, DOI 10.1074/jbc.M111.328237; Newton BW, 2011, J PROTEOME RES, V10, P4692, DOI 10.1021/pr200491h; ORMEROD MG, 1993, ACTA ONCOL, V32, P417, DOI 10.3109/02841869309093620; Pavlov YI, 1996, MUTAT RES-FUND MOL M, V357, P1, DOI 10.1016/0027-5107(96)00060-7; PFLEGER K, 1969, N-S ARCH PHARMAKOL, V265, P118, DOI 10.1007/BF00997145; Plitzko B, 2013, J BIOL CHEM, V288, P20228, DOI 10.1074/jbc.M113.474916; ROCKWELL M, 1966, MOL PHARMACOL, V2, P574; Simandan T, 1998, BIOCHEM J, V335, P233, DOI 10.1042/bj3350233; Sparacino-Watkins CE, 2014, J BIOL CHEM, V289, P10345, DOI 10.1074/jbc.M114.555177; STAFFORD A, 1966, BRIT J PHARM CHEMOTH, V28, P218, DOI 10.1111/j.1476-5381.1966.tb01888.x; Tone S, 2007, EXP CELL RES, V313, P3635, DOI 10.1016/j.yexcr.2007.06.018; Wahl B, 2010, J BIOL CHEM, V285, P37847, DOI 10.1074/jbc.M110.169532; Waisertreiger ISR, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/872180; White RH, 2010, J BACTERIOL, V192, P2023, DOI 10.1128/JB.00087-10; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200	49	15	15	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10126	10135		10.1074/jbc.M115.640052	http://dx.doi.org/10.1074/jbc.M115.640052			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25713076	hybrid, Green Published			2022-12-28	WOS:000353241100019
J	Setiaputra, D; Ross, JD; Lu, S; Cheng, DT; Dong, MQ; Yip, CK				Setiaputra, Dheva; Ross, James D.; Lu, Shan; Cheng, Derrick T.; Dong, Meng-Qiu; Yip, Calvin K.			Conformational Flexibility and Subunit Arrangement of the Modular Yeast Spt-Ada-Gcn5 Acetyltransferase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyltransferase; Chromatin Modification; Deubiquitylation (Deubiquitination); Electron Microscopy (EM); Mass Spectrometry (MS); Protein Cross-linking; Structural Biology; Yeast; Macromolecular Assembly	SAGA COACTIVATOR COMPLEX; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; MOLECULAR ARCHITECTURE; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HEAT REPEATS; TRANSCRIPTION; ACETYLATION	The Spt-Ada-Gcn5 acetyltransferase (SAGA) complex is a highly conserved, 19-subunit histone acetyltransferase complex that activates transcription through acetylation and deubiquitination of nucleosomal histones in Saccharomyces cerevisiae. Because SAGA has been shown to display conformational variability, we applied gradient fixation to stabilize purified SAGA and systematically analyzed this flexibility using single-particle EM. Our two- and three-dimensional studies show that SAGA adopts three major conformations, and mutations of specific subunits affect the distribution among these. We also located the four functional modules of SAGA using electron microscopy-based labeling and transcriptional activator binding analyses and show that the acetyltransferase module is localized in the most mobile region of the complex. We further comprehensively mapped the subunit interconnectivity of SAGA using cross-linking mass spectrometry, revealing that the Spt and Taf subunits form the structural core of the complex. These results provide the necessary restraints for us to generate a model of the spatial arrangement of all SAGA subunits. According to this model, the chromatin-binding domains of SAGA are all clustered in one face of the complex that is highly flexible. Our results relate information of overall SAGA structure with detailed subunit level interactions, improving our understanding of its architecture and flexibility.	[Setiaputra, Dheva; Ross, James D.; Cheng, Derrick T.; Yip, Calvin K.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Lu, Shan; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China	University of British Columbia; National Institute of Biological Sciences, Beijing	Yip, CK (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	calvin.yip@ubc.ca	Lu, Shan/ABI-5830-2020	Lu, Shan/0000-0003-4740-0610; Yip, Calvin/0000-0003-1779-9501; Setiaputra, Dheva/0000-0003-2956-6422	Natural Sciences and Engineering Research Council of Canada Discovery Grant [418157]; Michael Smith Foundation for Health Research Career Investigator Award; Canadian Institutes of Health Research New Investigator Award; Canadian Foundation for Innovation; University of British Columbia	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research Career Investigator Award(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); University of British Columbia	This work was supported by Natural Sciences and Engineering Research Council of Canada Discovery Grant 418157, a Michael Smith Foundation for Health Research Career Investigator Award, a Canadian Institutes of Health Research New Investigator Award, an infrastructure grant from the Canadian Foundation for Innovation, and startup funds from the University of British Columbia.	Barbaric S, 2003, MOL CELL BIOL, V23, P3468, DOI 10.1128/MCB.23.10.3468-3476.2003; Belotserkovskaya R, 2000, MOL CELL BIOL, V20, P634, DOI 10.1128/MCB.20.2.634-647.2000; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; Bonnet J, 2014, GENE DEV, V28, P1999, DOI 10.1101/gad.250225.114; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Chittuluru JR, 2011, NAT STRUCT MOL BIOL, V18, P1196, DOI 10.1038/nsmb.2128; Cianfrocco MA, 2013, CELL, V152, P120, DOI 10.1016/j.cell.2012.12.005; Durand A, 2014, STRUCTURE, V22, P1553, DOI 10.1016/j.str.2014.07.017; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gangloff YG, 2000, MOL CELL BIOL, V20, P340, DOI 10.1128/MCB.20.1.340-351.2000; Gangloff YG, 2001, MOL CELL BIOL, V21, P1841, DOI 10.1128/MCB.21.5.1841-1853.2001; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Han Y, 2014, EMBO J, V33, P2534, DOI 10.15252/embj.201488638; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Herbig E, 2010, MOL CELL BIOL, V30, P2376, DOI 10.1128/MCB.01046-09; Knutson BA, 2011, MOL CELL BIOL, V31, P818, DOI 10.1128/MCB.00687-10; Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026; Koutelou E, 2010, CURR OPIN CELL BIOL, V22, P374, DOI 10.1016/j.ceb.2010.03.005; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee KK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.40; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Leschziner AE, 2007, P NATL ACAD SCI USA, V104, P4913, DOI 10.1073/pnas.0700706104; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Looke M, 2011, BIOTECHNIQUES, V50, P325, DOI 10.2144/000113672; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; Taylor DW, 2013, NAT STRUCT MOL BIOL, V20, P662, DOI 10.1038/nsmb.2564; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005; Wu PYJ, 2002, MOL CELL BIOL, V22, P5367, DOI 10.1128/MCB.22.15.5367-5379.2002; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yip CK, 2010, NAT STRUCT MOL BIOL, V17, P1298, DOI 10.1038/nsmb.1914	49	41	41	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10057	10070		10.1074/jbc.M114.624684	http://dx.doi.org/10.1074/jbc.M114.624684			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25713136	Green Published, hybrid			2022-12-28	WOS:000353241100013
J	Foley, PL; Hsieh, PK; Luciano, DJ; Belasco, JG				Foley, Patricia L.; Hsieh, Ping-kun; Luciano, Daniel J.; Belasco, Joel G.			Specificity and Evolutionary Conservation of the Escherichia coil RNA Pyrophosphohydrolase RppH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; BACILLUS-SUBTILIS; DEGRADATION; COLI; ENZYME; DECAY; INITIATION; STABILITY; HYDROLASE; REMOVAL	Bacterial RNA degradation often begins with conversion of the 5'-terminal triphosphate to a monophosphate by the RNA pyrophosphohydrolase RppH, an event that triggers rapid ribonucleolytic attack. Besides its role as the master regulator of 5'-end-dependent mRNA decay, RppH is important for the ability of pathogenic bacteria to invade host cells, yet little is known about how it chooses its targets. Here, we show that Escherichia call RppH (EcRppH) requires at least two unpaired nucleotides at the RNA 5' end and prefers three or more such nucleotides, It can tolerate any nucleotide at the first three positions but has a modest preference for A at the 5' terminus and either a G or A at the second position. Mutational analysis has identified EcRppH residues crucial for substrate recognition or catalysis. The promiscuity of EcRppH differentiates it from its Bacillus subtilis counterpart, which has a strict RNA sequence requirement. EcRppH orthologs likely to share its relaxed sequence specificity are widespread in all classes of Proteobacteria, except Deltaproteobacteria, and in flowering plants. By contrast, the phylogenetic range of recognizable B. subtilis RppH orthologs appears to be restricted to the order Bacillales. These findings help to explain the selective influence of RppH on bacterial mRNA decay and show that RppH-dependent degradation has diversified significantly during the course of evolution.	NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA; NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; New York University	Belasco, JG (corresponding author), NYU, Sch Med, Skirball Inst, 540 First Ave, New York, NY 10016 USA.	joel.belasco@med.nyu.edu			National Institutes of Health Research [R01GM035769]; National Institutes of Health Fellowship [T32AI007180]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035769] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant R01GM035769 (to J. G. B).r Supported by National Institutes of Health Fellowship T32AI007180.	Arnold TE, 1998, RNA, V4, P319; Badger JL, 2000, MOL MICROBIOL, V36, P174, DOI 10.1046/j.1365-2958.2000.01840.x; Baker KE, 2003, MOL MICROBIOL, V47, P75, DOI 10.1046/j.1365-2958.2003.03292.x; Bi YC, 2009, BIOMOL NMR ASSIGN, V3, P149, DOI 10.1007/s12104-009-9162-8; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Celesnik H, 2008, METHOD ENZYMOL, V447, P83, DOI 10.1016/S0076-6879(08)02205-2; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Dorleans A, 2011, STRUCTURE, V19, P1252, DOI 10.1016/j.str.2011.06.018; EMORY SA, 1992, GENE DEV, V6, P135, DOI 10.1101/gad.6.1.135; Gabelli SB, 2004, STRUCTURE, V12, P927, DOI 10.1016/j.str.2004.03.028; Heck C, 1996, MOL MICROBIOL, V20, P1165, DOI 10.1111/j.1365-2958.1996.tb02637.x; Hsieh PK, 2013, P NATL ACAD SCI USA, V110, P8864, DOI 10.1073/pnas.1222670110; Laalami S, 2014, CELL MOL LIFE SCI, V71, P1799, DOI 10.1007/s00018-013-1472-4; Liu H, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00013; Luciano DJ, 2012, J BACTERIOL, V194, P6233, DOI 10.1128/JB.01223-12; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Maksel D, 2001, BIOCHEM J, V357, P399, DOI 10.1042/0264-6021:3570399; Messing SAJ, 2009, STRUCTURE, V17, P472, DOI 10.1016/j.str.2008.12.022; MITCHELL SJ, 1995, INFECT IMMUN, V63, P1552, DOI 10.1128/IAI.63.4.1552-1562.1995; Piton J, 2013, P NATL ACAD SCI USA, V110, P8858, DOI 10.1073/pnas.1221510110; Ramirez-Pena E, 2010, MOL MICROBIOL, V78, P1332, DOI 10.1111/j.1365-2958.2010.07427.x; Richards J, 2011, MOL CELL, V43, P940, DOI 10.1016/j.molcel.2011.07.023; Unniraman S, 2002, NUCLEIC ACIDS RES, V30, P5376, DOI 10.1093/nar/gkf697; Vasilyev N, 2015, J BIOL CHEM, V290, P9487, DOI 10.1074/jbc.M114.634824	24	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9478	9486		10.1074/jbc.M114.634659	http://dx.doi.org/10.1074/jbc.M114.634659			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25657006	Green Published, hybrid			2022-12-28	WOS:000352729400015
J	Maganti, AV; Maier, B; Tersey, SA; Sampley, ML; Mosley, AL; Ozcan, S; Pachaiyappan, B; Woster, PM; Hunter, CS; Stein, R; Mirmira, RG				Maganti, Aarthi V.; Maier, Bernhard; Tersey, Sarah A.; Sampley, Megan L.; Mosley, Amber L.; Oezcan, Sabire; Pachaiyappan, Boobalan; Woster, Patrick M.; Hunter, Chad S.; Stein, Roland; Mirmira, Raghavendra G.			Transcriptional Activity of the Islet beta Cell Factor Pdx1 Is Augmented by Lysine Methylation Catalyzed by the Methyltransferase Set7/9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; INSULIN GENE; PROTEIN STABILITY; DEMETHYLASE LSD1; DNA-BINDING; MICE; PROMOTER; MAINTENANCE; ACTIVATION; MECHANISM	The transcription factor Pdx1 is crucial to islet beta cell function and regulates target genes in part through interaction with coregulatory factors. Set7/9 is a Lys methyltransferase that interacts with Pdx1. Here we tested the hypothesis that Lys methylation of Pdx1 by Set7/9 augments Pdx1 transcriptional activity. Using mass spectrometry and mutational analysis of purified proteins, we found that Set7/9 methylates the N-terminal residues Lys-123 and Lys-131 of Pdx1. Methylation of these residues occurred only in the context of intact, full-length Pdx1, suggesting a specific requirement of secondary and/or tertiary structural elements for catalysis by Set7/9. Immunoprecipitation assays and mass spectrometric analysis using beta cells verified Lys methylation of endogenous Pdx1. Cell-based luciferase reporter assays using wild-type and mutant transgenes revealed a requirement of Pdx1 residue Lys-131, but not Lys-123, for transcriptional augmentation by Set7/9. Lys-131 was not required for high-affinity interactions with DNA in vitro, suggesting that its methylation likely enhances post-DNA binding events. To define the role of Set7/9 in beta cell function, we generated mutant mice in which the gene encoding Set7/9 was conditionally deleted in beta cells (Set(Delta)beta). Set(Delta)beta mice exhibited glucose intolerance similar to Pdx1-deficient mice, and their isolated islets showed impaired glucose-stimulated insulin secretion with reductions in expression of Pdx1 target genes. Our results suggest a previously unappreciated role for Set7/9-mediated methylation in the maintenance of Pdx1 activity and beta cell function.	[Maganti, Aarthi V.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Maier, Bernhard; Tersey, Sarah A.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Maier, Bernhard; Tersey, Sarah A.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Mosley, Amber L.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Sampley, Megan L.; Oezcan, Sabire] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Pachaiyappan, Boobalan; Woster, Patrick M.] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Hunter, Chad S.; Stein, Roland] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Kentucky; Medical University of South Carolina; Vanderbilt University	Mirmira, RG (corresponding author), 635 Barnhill Dr,MS2031B, Indianapolis, IN 46202 USA.	rmirmira@iu.edu	Mirmira, Raghavendra G/AAD-7592-2020; Woster, Patrick M/A-5604-2010; Vijaykumar, Aarthi Maganti/AAC-6844-2019	Mirmira, Raghavendra G/0000-0002-5013-6075; Woster, Patrick M/0000-0002-9471-1916; Tersey, Sarah/0000-0003-0667-2361; Hunter, Chad/0000-0002-1644-447X	National Institutes of Health [R01 DK083583, R01 DK060581, R01 CA149095]; American Diabetes Association; NATIONAL CANCER INSTITUTE [R01CA149095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060581, R01DK083583, P30DK097512, R56DK050203, R01DK050203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK083583 and R01 DK060581 (to R. G. M.) and R01 CA149095 (to P. M. W.). This work was also supported by an American Diabetes Association junior faculty award (to S. A. T.).	An R, 2010, BIOCHEM BIOPH RES CO, V399, P155, DOI 10.1016/j.bbrc.2010.07.035; Babu DA, 2008, J BIOL CHEM, V283, P8164, DOI 10.1074/jbc.M800336200; Babu DA, 2007, MOL GENET METAB, V92, P43, DOI 10.1016/j.ymgme.2007.06.008; Boucher MJ, 2006, J BIOL CHEM, V281, P6395, DOI 10.1074/jbc.M511597200; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Chakrabarti SK, 2003, J BIOL CHEM, V278, P23617, DOI 10.1074/jbc.M303423200; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Claiborn KC, 2010, J CLIN INVEST, V120, P3713, DOI 10.1172/JCI40440; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Dhayalan A, 2011, CHEM BIOL, V18, P111, DOI 10.1016/j.chembiol.2010.11.014; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Ferrannini E, 2005, J CLIN ENDOCR METAB, V90, P493, DOI 10.1210/jc.2004-1133; Ferrannini E, 2010, DIABETES, V59, P679, DOI 10.2337/db09-1378; Francis J., 2005, J BIOL CHEM, V280; Frogne T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035233; GERMAN MS, 1992, MOL CELL BIOL, V12, P1777, DOI 10.1128/MCB.12.4.1777; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Keating ST, 2014, CELL MOL LIFE SCI, V71, P4471, DOI 10.1007/s00018-014-1651-y; Kebede M, 2012, P NATL ACAD SCI USA, V109, P2376, DOI 10.1073/pnas.1114350109; Khoo C, 2012, MOL ENDOCRINOL, V26, P521, DOI 10.1210/me.2011-1231; Kishi A, 2003, AM J PHYSIOL-ENDOC M, V284, pE830, DOI 10.1152/ajpendo.00390.2002; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Kwon T, 2003, EMBO J, V22, P292, DOI 10.1093/emboj/cdg025; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Mirmira RG, 2000, J BIOL CHEM, V275, P14743, DOI 10.1074/jbc.275.19.14743; Mosley AL, 2004, MOL ENDOCRINOL, V18, P2279, DOI 10.1210/me.2003-0463; Mosley Amber L, 2003, Methods Mol Med, V83, P73; Mosley AL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000687; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Offield MF, 1996, DEVELOPMENT, V122, P983; Ohneda K, 2000, MOL CELL BIOL, V20, P900, DOI 10.1128/MCB.20.3.900-911.2000; Robbins RD, 2010, J BIOL CHEM, V285, P39943, DOI 10.1074/jbc.M110.170142; Sakane N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002184; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Semache M, 2013, J BIOL CHEM, V288, P24825, DOI 10.1074/jbc.M113.495945; Sharma SK, 2010, J MED CHEM, V53, P5197, DOI 10.1021/jm100217a; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Stull ND, 2012, JOVE-J VIS EXP, DOI 10.3791/4137; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Tamarina NA, 2014, ISLETS, V6, DOI 10.4161/isl.27685; Taylor DG, 2005, BIOCHEMISTRY-US, V44, P11269, DOI 10.1021/bi050821m; Verlinden BK, 2011, J MED CHEM, V54, P6624, DOI 10.1021/jm200463z; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55	55	31	32	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9812	9822		10.1074/jbc.M114.616219	http://dx.doi.org/10.1074/jbc.M114.616219			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713082	Green Published, hybrid			2022-12-28	WOS:000352729400041
J	Shi, XZ; Zirbes, KM; Rasnnussen, TL; Ferdous, A; Garry, MG; Koyano-Nakagawa, N; Garry, DJ				Shi, Xiaozhong; Zirbes, Katie M.; Rasnnussen, Tara L.; Ferdous, Anwarul; Garry, Mary G.; Koyano-Nakagawa, Naoko; Garry, Daniel J.			The Transcription Factor Mesp1 Interacts with cAMP-responsive Element Binding Protein 1 (Creb1) and Coactivates Ets Variant 2 (Etv2) Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE CASSETTE EXCHANGE; GENOME-WIDE ANALYSIS; MICE LACKING; PROGENITOR SPECIFICATION; MYOGENIC PROGENITORS; CELL DEVELOPMENT; ACTS DOWNSTREAM; EMBRYONIC STEM; YOLK-SAC; BLOOD	Mesoderm posterior 1 (Mesp1) is well recognized for its role in cardiac development, although it is expressed broadly in mesodermal lineages. We have previously demonstrated important roles for Mesp land Ets variant 2 (Etv2) during lineage specification, but their relationship has not been defined. This study reveals that Mesp1 binds to the proximal promoter and transactivates Etv2 gene expression via the CRE motif. We also demonstrate the protein-protein interaction between Mesp 1 and cAMP-responsive element binding protein 1 (Creb1) in vitro and in vivo. Utilizing transgenesis, lineage tracing, flow cytometry, and immunostaining technologies, we define the lineage relationship between Mesp1- and Etv2-expressing cell populations. We observe that the majority of Etv2-EYFP+ cells are derived from Mesp1-Cre(+) cells in both the embryo and yolk sac. Furthermore, we observe that the conditional deletion of Etv2, using a Mesp1-Cre transgenic strategy, results in vascular and hematopoietic detects similar to those observed in the global deletion of Etv2 and that it has embryonic lethality by embryonic day 9.5. In summary, our study supports the hypothesis that Mesp1 is a direct upstream transactivator of Etv2 during embryogenesis and that Creb1 is an important cofactor of Mesp1 in the transcriptional regulation of Etv2 gene expression.	[Shi, Xiaozhong; Zirbes, Katie M.; Rasnnussen, Tara L.; Garry, Mary G.; Koyano-Nakagawa, Naoko; Garry, Daniel J.] Univ Minnesota, Lillehei Heart Inst, Sch Med, Minneapolis, MN 55455 USA; [Ferdous, Anwarul] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Southwestern Medical Center Dallas	Garry, DJ (corresponding author), Univ Minnesota, Lillehei Heart Inst, 22316th St SE,4-146 CCRB, Minneapolis, MN 55455 USA.	garry@umn.edu			National Institutes of Health [U01 HL100407, R01 HL122576]; American Heart Association [0970499N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100407, R01HL122576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants U01 HL100407 and R01 HL122576 (to D. J. G.). This work was also supported by the American Heart Association (Jon Holden DeHaan Four) dation Grant 0970499N) (to D. J. G.).	Abedin MJ, 2014, CIRC RES, V114, P1690, DOI 10.1161/CIRCRESAHA.1134303145; Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Behrens AN, 2014, STEM CELLS DEV, V23, P2004, DOI 10.1089/scd.2013.0525; BENBROOK DM, 1994, NUCLEIC ACIDS RES, V22, P1463, DOI 10.1093/nar/22.8.1463; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Bondue A, 2010, CIRC RES, V107, P1414, DOI 10.1161/CIRCRESAHA.110.227058; Bowlin KM, 2013, DIFFERENTIATION, V86, P184, DOI 10.1016/j.diff.2013.08.002; Chan SSK, 2013, CELL STEM CELL, V12, P587, DOI 10.1016/j.stem.2013.03.004; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Ferdous A, 2009, P NATL ACAD SCI USA, V106, P814, DOI 10.1073/pnas.0807583106; Ferkowicz MJ, 2005, EXP HEMATOL, V33, P1041, DOI 10.1016/j.exphem.2005.06.006; Fujii Y, 2000, NAT STRUCT BIOL, V7, P889; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; Iacovino M, 2014, METHODS MOL BIOL, V1101, P339, DOI 10.1007/978-1-62703-721-1_16; Iacovino M, 2011, STEM CELLS, V29, P1580, DOI 10.1002/stem.715; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Keller G, 1999, EXP HEMATOL, V27, P777, DOI 10.1016/S0301-472X(99)00024-7; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Koyano-Nakagawa N, 2012, STEM CELLS, V30, P1611, DOI 10.1002/stem.1131; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Li WM, 2005, STEM CELLS DEV, V14, P44, DOI 10.1089/scd.2005.14.44; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Magenta A, 2003, MOL CELL BIOL, V23, P2893, DOI 10.1128/MCB.23.8.2893-2906.2003; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Matsuo N, 2006, J BIOL CHEM, V281, P5445, DOI 10.1074/jbc.M509923200; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Moignard V, 2013, BLOOD CELL MOL DIS, V51, P239, DOI 10.1016/j.bcmd.2013.07.007; Muir T, 2008, MOL REPROD DEV, V75, P1637, DOI 10.1002/mrd.20902; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Palencia-Desai S, 2011, DEVELOPMENT, V138, P4721, DOI 10.1242/dev.064998; Rasmussen TL, 2013, GENESIS, V51, P471, DOI 10.1002/dvg.22396; Rasmussen TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050103; Rasmussen TL, 2011, DEVELOPMENT, V138, P4801, DOI 10.1242/dev.070912; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1996, DEVELOPMENT, V122, P2769; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Schupp MO, 2014, DEV BIOL, V393, P71, DOI 10.1016/j.ydbio.2014.06.019; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shi XZ, 2014, DEV BIOL, V389, P208, DOI 10.1016/j.ydbio.2014.02.018; Shi XZ, 2012, BIOCHEM J, V446, P349, DOI 10.1042/BJ20120563; Shi XZ, 2010, BIOCHEM J, V428, P213, DOI 10.1042/BJ20091906; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; van Bueren KL, 2012, CURR OPIN HEMATOL, V19, P199, DOI 10.1097/MOH.0b013e3283523e07; Veldman MB, 2012, CIRC RES, V110, P220, DOI 10.1161/CIRCRESAHA.111.251298; Wareing S, 2012, DEV DYNAM, V241, P1454, DOI 10.1002/dvdy.23825; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yamamizu K, 2012, STEM CELLS, V30, P687, DOI 10.1002/stem.1041; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhao L, 2009, J BONE MINER RES, V24, P826, DOI [10.1359/JBMR.081236, 10.1359/jbmr.081236]	55	22	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9614	9625		10.1074/jbc.M114.614628	http://dx.doi.org/10.1074/jbc.M114.614628			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25694434	Green Published, hybrid			2022-12-28	WOS:000352729400026
J	Stanicka, J; Russell, EG; Woolley, JF; Cotter, TG				Stanicka, Joanna; Russell, Eileen G.; Woolley, John F.; Cotter, Thomas G.			NADPH Oxidase-generated Hydrogen Peroxide Induces DNA Damage in Mutant FLT3-expressing Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; GENOMIC INSTABILITY; OXIDATIVE STRESS; CONSTITUTIVE ACTIVATION; FLT3 INHIBITORS; ROS; REPAIR; NOX4; MUTATIONS	Internal tandem duplication of the FMS-like tyrosine kinase (FLT3-ITD) receptor is present in 20% of acute myeloid leukemia (AML) patients and it has been associated with an aggressive AML phenotype. FLT3-ITD expressing cell lines have been shown to generate increased levels of reactive oxygen species (ROS) and DNA double strand breaks (DSBs). However, the molecular basis of how FLT3-ITD-driven ROS leads to the aggressive form of AML is not clearly understood. Our group has previously reported that inhibition of FLT3-ITD signaling results in post-translational down-regulation of p22(Phox), a small membrane-bound subunit of the NADPH oxidase (NOX) complex. Here we demonstrated that 32D cells, a myeloblast-like cell line transfected with FLT3-ITD, have a higher protein level of p22(Phox) and p22(Phox)-interacting NOX isoforms than 32D cells transfected with the wild type FIT 3 receptor (ITT3-WT). The inhibition of NOX proteins, p22(phox), and NOX protein knockdowns caused a reduction in ROS, as measured with a hydrogen peroxide (H2O2)-specific dye, peroxy orange 1 (PO1), and nuclear H2O2, as measured with nuclear peroxy emerald 1 (NucPE1). These reductions in the level of H2O2 following the NOX knockdowns were accompanied by a decrease in the number of DNA DS Bs. We showed that 32D cells that express FLT3-ITD have a higher level of both oxidized DNA and DNA DSBs than their wild type counterparts. We also observed that NOX4 and p22(phox) localize to the nuclear membrane in MV4-11 cells expressing FLT3-LTD. Taken together these data indicate that NOX and p22(phox) mediate the ROS production from FLT3-ITD that signal to the nucleus causing genomic instability.	[Stanicka, Joanna; Russell, Eileen G.; Woolley, John F.; Cotter, Thomas G.] Natl Univ Ireland Univ Coll Cork, Sch Biochem & Cell Biol, Tumour Biol Lab, Biosci Res Inst, Cork, Ireland	University College Cork	Cotter, TG (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Biochem & Cell Biol, Tumour Biol Lab, Biosci Res Inst, Cork, Ireland.	t.cotter@ucc.ie		Woolley, John/0000-0001-7885-8515; Cotter, Thomas/0000-0003-4626-5613	Irish Cancer Society Research Scholarship Award [CRS11STA]	Irish Cancer Society Research Scholarship Award	This work was supported by Irish Cancer Society Research Scholarship Award CRS11STA.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Anilkumar N, 2013, ARTERIOSCL THROM VAS, V33, pE104, DOI 10.1161/ATVBAHA.112.300956; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block K, 2012, NAT REV CANCER, V12, P627, DOI 10.1038/nrc3339; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Brandts CH, 2005, CANCER RES, V65, P9643, DOI 10.1158/0008-5472.CAN-05-0422; Case AJ, 2013, AM J PHYSIOL-HEART C, V305, pH19, DOI 10.1152/ajpheart.00974.2012; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Dickinson BC, 2011, CHEM BIOL, V18, P943, DOI 10.1016/j.chembiol.2011.07.005; Edderkaoui M, 2011, J BIOL CHEM, V286, P7779, DOI 10.1074/jbc.M110.200063; Fan JS, 2010, BLOOD, V116, P5298, DOI 10.1182/blood-2010-03-272591; Gilliland DG, 2002, CURR OPIN HEMATOL, V9, P274, DOI 10.1097/00062752-200207000-00003; Godfrey R, 2012, BLOOD, V119, P4499, DOI 10.1182/blood-2011-02-336446; Grunwald MR, 2013, INT J HEMATOL, V97, P683, DOI 10.1007/s12185-013-1334-8; Hajas G, 2013, FREE RADICAL BIO MED, V61, P384, DOI 10.1016/j.freeradbiomed.2013.04.011; Hayakawa F, 2000, ONCOGENE, V19, P624, DOI 10.1038/sj.onc.1203354; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI [10.1089/ars.2008.2383, 10.1089/ARS.2008.2383]; Hole PS, 2011, BLOOD, V117, P5816, DOI 10.1182/blood-2011-01-326025; Irwin ME, 2013, ANTIOXID REDOX SIGN, V18, P1349, DOI 10.1089/ars.2011.4258; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; Kiyoi H, 1998, LEUKEMIA, V12, P1333, DOI 10.1038/sj.leu.2401130; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Landry WD, 2013, LEUKEMIA RES, V37, P183, DOI 10.1016/j.leukres.2012.11.003; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Lu AL, 2001, CELL BIOCHEM BIOPHYS, V35, P141, DOI 10.1385/CBB:35:2:141; Matsushima S, 2013, CIRC RES, V112, P651, DOI 10.1161/CIRCRESAHA.112.279760; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08; Nakao M, 1996, LEUKEMIA, V10, P1911; Naughton R, 2009, LEUKEMIA, V23, P1432, DOI 10.1038/leu.2009.49; Nowicki MO, 2004, BLOOD, V104, P3746, DOI 10.1182/blood-2004-05-1941; Pazhanisamy SK, 2011, MUTAGENESIS, V26, P431, DOI 10.1093/mutage/ger001; Piloto O, 2007, BLOOD, V109, P1643, DOI 10.1182/blood-2006-05-023804; Rassool FV, 2007, CANCER RES, V67, P8762, DOI 10.1158/0008-5472.CAN-06-4807; Reddy MM, 2011, LEUKEMIA, V25, P281, DOI 10.1038/leu.2010.263; Sallmyr A, 2008, CANCER LETT, V270, P1, DOI 10.1016/j.canlet.2008.03.036; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Sato T, 2011, BLOOD, V117, P3286, DOI 10.1182/blood-2010-01-266742; Seedhouse CH, 2006, LEUKEMIA, V20, P2130, DOI 10.1038/sj.leu.2404439; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Spencer NY, 2011, J BIOL CHEM, V286, P8977, DOI 10.1074/jbc.M110.193821; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Weyemi U, 2012, MUTAT RES-REV MUTAT, V751, P77, DOI 10.1016/j.mrrev.2012.04.002; Woolley JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034050; Zhang LL, 2011, BIOCHIMIE, V93, P457, DOI 10.1016/j.biochi.2010.11.001; Zhou FL, 2010, J BIOL CHEM, V285, P15010, DOI 10.1074/jbc.M110.103713; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	55	55	56	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9348	9361		10.1074/jbc.M113.510495	http://dx.doi.org/10.1074/jbc.M113.510495			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25697362	hybrid, Green Published			2022-12-28	WOS:000352729400004
J	Bao, X; Johnson, JL; Rao, H				Bao, Xin; Johnson, Jill L.; Rao, Hai			Rad25 Protein Is Targeted for Degradation by the Ubc4-Ufd4 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; UBIQUITIN; REPLICATION; SUMO	Proteasome-mediated proteolysis provides dynamic spatial and temporal modulation of protein concentration in response to various intrinsic and extrinsic challenges. To gain a better understanding of the role of the proteasome in DNA repair, we systematically monitored the stability of 26 proteins involved in nucleotide excision repair (NER) under normal growth conditions. Among six NER factors found to be regulated by the proteasome, we further delineated the specific pathway involved in the degradation of Rad25, a subunit of TFIIH. We demonstrate that Rad25 turnover requires the ubiquitin-conjugating enzyme Ubc4 and the ubiquitin ligase Ufd4. Interestingly, the deletion of UFD4 specifically suppresses the rad25 mutant defective in transcription. Our results reveal a novel function of the Ufd4 pathway and another tie between the proteasome and NER regulators.	[Bao, Xin; Rao, Hai] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Johnson, Jill L.] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA	University of Texas System; University of Texas Health San Antonio; Idaho; University of Idaho	Bao, X (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	baox@livemail.uthscsa.edu; raoh@uthscsa.edu		RAO, HAI/0000-0002-4235-2210	National Institutes of Health [GM 078085]; Department of Defense [W911NF-11-10466]; Welch Foundation [AQ 1747]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grant GM 078085, by Department of Defense Grant W911NF-11-10466, and by Welch Foundation Grant AQ 1747. To whom correspondence may be addressed: Dept. of Molecular Medicine, University of Texas Health Science Center, 7703 Floyd Curl Dr., San Antonio, TX 78229. Tel.: 210-562-4149; Fax: 210-562-4161; E-mail: raoh@uthscsa.edu.	Baek G.H., 2013, J AMINO ACIDS, V2013, DOI DOI 10.1155/2013/183421; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Compe E, 2012, NAT REV MOL CELL BIO, V13, P343, DOI 10.1038/nrm3350; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; den Dulk B, 2006, DNA REPAIR, V5, P683, DOI 10.1016/j.dnarep.2006.02.002; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Flom G, 2005, CURR GENET, V47, P368, DOI 10.1007/s00294-005-0580-6; Furuchi T, 2004, BIOCHEM BIOPH RES CO, V314, P844, DOI 10.1016/j.bbrc.2003.12.160; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Krzeszinski JY, 2014, MOL BIOL CELL, V25, P213, DOI 10.1091/mbc.E13-05-0293; Li Y, 2010, MOL BIOL CELL, V21, P177, DOI 10.1091/mbc.E09-04-0305; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; Silver HR, 2011, DNA REPAIR, V10, P1243, DOI 10.1016/j.dnarep.2011.09.013; Skoneczna A, 2007, J MOL BIOL, V366, P1074, DOI 10.1016/j.jmb.2006.11.093; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Ulrich HD, 2012, J CELL SCI, V125, P249, DOI 10.1242/jcs.091801; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Westmoreland TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005830	22	2	2	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8606	8612		10.1074/jbc.M114.618793	http://dx.doi.org/10.1074/jbc.M114.618793			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25670855	Green Published, hybrid			2022-12-28	WOS:000351662600050
J	Huang, W; Shang, YF; Chen, PL; Cen, K; Wang, CS				Huang, Wei; Shang, Yanfang; Chen, Peilin; Cen, Kai; Wang, Chengshu			Basic Leucine Zipper (bZIP) Domain Transcription Factor MBZ1 Regulates Cell Wall Integrity, Spore Adherence, and Virulence in Metarhizium robertsii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGAL BIOCONTROL AGENTS; SACCHAROMYCES-CEREVISIAE; ENTOMOPATHOGENIC FUNGUS; CANDIDA-ALBICANS; STRESS RESPONSES; FULL VIRULENCE; GENE; PROTEINS; ADHESION; REVEALS	Transcription factors (TFs) containing the basic leucine zipper (bZIP) domain are widely distributed in eukaryotes and display an array of distinct functions. In this study, a bZIP-type TF gene (MBZ1) was deleted and functionally characterized in the insect pathogenic fungus Metarhizium robertsii. The deletion mutant (Delta MBZ1) showed defects in cell wall integrity, adhesion to hydrophobic surfaces, and topical infection of insects. Relative to the WT, Delta MBZ1 was also impaired in growth and conidiogenesis. Examination of putative target gene expression indicated that the genes involved in chitin biosynthesis were differentially transcribed in Delta MBZ1 compared with the WT, which led to the accumulation of a higher level of chitin in mutant cell walls. MBZ1 exhibited negative regulation of subtilisin proteases, but positive control of an adhesin gene, which is consistent with the observation of effects on cell autolysis and a reduction in spore adherence to hydrophobic surfaces in Delta MBZ1. Promoter binding assays indicated thatMBZ1can bind to different target genes and suggested the possibility of heterodimer formation to increase the diversity of the MBZ1 regulatory network. The results of this study advance our understanding of the divergence of bZIP-type TFs at both intra-and interspecific levels.	[Huang, Wei; Shang, Yanfang; Chen, Peilin; Cen, Kai; Wang, Chengshu] Chinese Acad Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, CS (corresponding author), Chinese Acad Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China.	cswang@sibs.ac.cn	Wang, Chengshu/A-1656-2011	Wang, Chengshu/0000-0003-1477-1466	National Natural Science Foundation of China [31225023]; Chinese Academy of Sciences Strategic Priority Research Program [XDB11030100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Strategic Priority Research Program	This work was supported by National Natural Science Foundation of China Grant 31225023 and Chinese Academy of Sciences Strategic Priority Research Program Grant XDB11030100.	Alberti-Segui C, 2004, YEAST, V21, P285, DOI 10.1002/yea.1061; Amoutzias GD, 2007, MOL BIOL EVOL, V24, P827, DOI 10.1093/molbev/msl211; Boomsma JJ, 2014, ANNU REV ENTOMOL, V59, P467, DOI 10.1146/annurev-ento-011613-162054; Cabib E, 2008, J BIOL CHEM, V283, P29859, DOI 10.1074/jbc.M804274200; Calderon J, 2010, MICROBIOL-SGM, V156, P2484, DOI 10.1099/mic.0.038000-0; Chen L, 2014, FUNGAL GENET BIOL, V63, P42, DOI 10.1016/j.fgb.2013.12.001; Chen YX, 2015, FUNGAL GENET BIOL, V81, P142, DOI 10.1016/j.fgb.2014.10.018; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Duan ZB, 2013, AUTOPHAGY, V9, P538, DOI 10.4161/auto.23575; Duan ZB, 2009, ENVIRON MICROBIOL, V11, P2351, DOI 10.1111/j.1462-2920.2009.01961.x; Emri T, 2008, APPL BIOCHEM BIOTECH, V151, P211, DOI 10.1007/s12010-008-8174-7; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Gao Q, 2013, APPL ENVIRON MICROB, V79, P7646, DOI 10.1128/AEM.02905-13; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Guo M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001302; Guo M, 2010, MOL PLANT MICROBE IN, V23, P1053, DOI 10.1094/MPMI-23-8-1053; Hu X, 2014, P NATL ACAD SCI USA, V111, P16796, DOI 10.1073/pnas.1412662111; Huang W, 2015, ENVIRON MICROBIOL, V17, P994, DOI 10.1111/1462-2920.12451; Jiang C, 2015, ENVIRON MICROBIOL, V17, P1245, DOI 10.1111/1462-2920.12561; Lagorce A, 2002, EUR J BIOCHEM, V269, P1697, DOI 10.1046/j.1432-1327.2002.02814.x; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Llorca CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00169; Lu DD, 2008, APPL MICROBIOL BIOT, V81, P515, DOI 10.1007/s00253-008-1695-8; Montibus M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083377; MOYEROWLEY WS, 1989, GENE DEV, V3, P283, DOI 10.1101/gad.3.3.283; Orlean P., 1997, MOL CELLULAR BIOL YE, V21, P229; Polley SD, 1996, FEBS LETT, V388, P200, DOI 10.1016/0014-5793(96)00541-8; Ragni E, 2007, YEAST, V24, P297, DOI 10.1002/yea.1473; Ramana KV, 2013, AM J INFECT DIS MICR, V1, P64, DOI DOI 10.12691/AJIDM-1-4-2; Selvaggini S, 2004, MICROBIOL-SGM, V150, P921, DOI 10.1099/mic.0.26661-0; Spode I, 2002, J MOL BIOL, V319, P407, DOI 10.1016/S0022-2836(02)00322-4; St Leger RJ, 2010, APPL MICROBIOL BIOT, V85, P901, DOI 10.1007/s00253-009-2306-z; StLeger RJ, 1996, P NATL ACAD SCI USA, V93, P6349, DOI 10.1073/pnas.93.13.6349; STLEGER RJ, 1994, ARCH BIOCHEM BIOPHYS, V313, P1, DOI 10.1006/abbi.1994.1350; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang W, 2015, ENVIRON MICROBIOL, V17, P1377, DOI 10.1111/1462-2920.12618; Tian CG, 2011, MICROBIOL-SGM, V157, P747, DOI 10.1099/mic.0.045468-0; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; Wanchoo A, 2009, MICROBIOL-SGM, V155, P3121, DOI 10.1099/mic.0.029157-0; Wang B, 2012, P NATL ACAD SCI USA, V109, P1287, DOI 10.1073/pnas.1115983109; Wang CS, 2007, EUKARYOT CELL, V6, P808, DOI 10.1128/EC.00409-06; Wang CS, 2014, BIOL CONTROL, V68, P129, DOI 10.1016/j.biocontrol.2013.06.017; Wang CS, 2005, FUNGAL GENET BIOL, V42, P704, DOI 10.1016/j.fgb.2005.04.006; Wang CS, 2004, J INVERTEBR PATHOL, V85, P168, DOI 10.1016/j.jip.2004.02.008; Wang CS, 2002, FEMS MICROBIOL LETT, V213, P251, DOI 10.1111/j.1574-6968.2002.tb11314.x; Wang JC, 2013, J EXP BOT, V64, P3453, DOI 10.1093/jxb/ert187; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; Xiao Guohua, 2012, Sci Rep, V2, P483, DOI 10.1038/srep00483; Yago JI, 2011, MOL PLANT PATHOL, V12, P653, DOI [10.1111/j.1364-3703.2010.00701.x, 10.1111/J.1364-3703.2010.00701.X]; Yin WB, 2013, MICROBIOL-SGM, V159, P77, DOI 10.1099/mic.0.063370-0; Zhang SZ, 2011, MOL MICROBIOL, V80, P811, DOI 10.1111/j.1365-2958.2011.07613.x; Zheng P, 2013, APPL MICROBIOL BIOT, V97, P2797, DOI 10.1007/s00253-013-4771-7; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116	56	31	36	2	33	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8218	8231		10.1074/jbc.M114.630939	http://dx.doi.org/10.1074/jbc.M114.630939			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25673695	Green Published, hybrid			2022-12-28	WOS:000351662600019
J	Hudson, DM; Joeng, KS; Werther, R; Rajagopal, A; Weis, M; Lee, BH; Eyre, DR				Hudson, David M.; Joeng, Kyu Sang; Werther, Rachel; Rajagopal, Abbhirami; Weis, MaryAnn; Lee, Brendan H.; Eyre, David R.			Post-translationally Abnormal Collagens of Prolyl 3-Hydroxylase-2 Null Mice Offer a Pathobiological Mechanism for the High Myopia Linked to Human LEPREL1 Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE; CYCLOPHILIN-B; I COLLAGEN; 3-HYDROXYPROLINE; DEFICIENCY; EXPRESSION; PROTEIN; SCLERA; CRTAP; FORM	Myopia, the leading cause of visual impairment worldwide, results from an increase in the axial length of the eyeball. Mutations in LEPREL1, the gene encoding prolyl 3-hydroxylase-2 (P3H2), have recently been identified in individuals with recessively inherited nonsyndromic severe myopia. P3H2 is a member of a family of genes that includes three isoenzymes of prolyl 3-hydroxylase (P3H), P3H1, P3H2, and P3H3. Fundamentally, it is understood that P3H1 is responsible for converting proline to 3-hydroxyproline. This limited additional knowledge also suggests that each isoenzyme has evolved different collagen sequence-preferred substrate specificities. In this study, differences in prolyl 3-hydroxylation were screened in eye tissues from P3h2-null (P3h2(n/n)) and wild-type mice to seek tissue-specific effects due the lack of P3H2 activity on post-translational collagen chemistry that could explain myopia. The mice were viable and had no gross musculoskeletal phenotypes. Tissues from sclera and cornea(type I collagen) and lens capsule (type IV collagen) were dissected from mouse eyes, and multiple sites of prolyl 3-hydroxylation were identified by mass spectrometry. The level of prolyl 3-hydroxylation at multiple substrate sites from type I collagen chains was high in sclera, similar to tendon. Almost every known site of prolyl 3-hydroxylation in types I and IV collagen from P3h2(n/n) mouse eye tissues was significantly under-hydroxylated compared with their wild-type littermates. We conclude that altered collagen prolyl 3-hydroxylationis caused by loss of P3H2. We hypothesize that this leads to structural abnormalities in multiple eye tissues, but particularly sclera, causing progressive myopia.	[Hudson, David M.; Werther, Rachel; Weis, MaryAnn; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Joeng, Kyu Sang; Rajagopal, Abbhirami; Lee, Brendan H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Washington; University of Washington Seattle; Baylor College of Medicine	Eyre, DR (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	deyre@u.washington.edu			National Institutes of Health from NIAMS [AR37694, AR37318, AR063616]; National Institutes of Health from NICHD [HD22657, HD070394]; National Institutes of Health from the Eunice Kennedy Shriver NICHD [P30 HD024064, AI036211, P30 CA125123, RR024574]; Ernest M. Burgess Endowed Chair research program of the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, P01HD070394, U54HD083092] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036794, F32AR063616, R01AR037318, R37AR037318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060445] Funding Source: NIH RePORTER	National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health from NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health from the Eunice Kennedy Shriver NICHD; Ernest M. Burgess Endowed Chair research program of the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AR37694 and AR37318 from NIAMS (to D. R. E.), HD22657 and HD070394 from NICHD (to B. H. L. and D. R. E.), AR063616 from NIAMS (to K. S. J.), P30 HD024064 from the Eunice Kennedy Shriver NICHD (to the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center), and AI036211, P30 CA125123, and RR024574 (to the Baylor College of Medicine Advanced Technology Cores). This work was also supported by the Ernest M. Burgess Endowed Chair research program of the University of Washington.	Aldahmesh MA, 2013, AM J HUM GENET, V93, P313, DOI 10.1016/j.ajhg.2013.06.002; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; DEAN DC, 1983, J BIOL CHEM, V258, P590; EYRE D, 1987, METHOD ENZYMOL, V144, P115; Eyre DR, 2011, J BIOL CHEM, V286, P7732, DOI 10.1074/jbc.C110.195768; Fernandes RJ, 2011, J BIOL CHEM, V286, P30662, DOI 10.1074/jbc.M111.267906; Gentle A, 2003, J BIOL CHEM, V278, P16587, DOI 10.1074/jbc.M300970200; Guo H, 2014, CLIN GENET, V86, P575, DOI 10.1111/cge.12309; Guo H, 2014, J MED GENET, V51, P518, DOI 10.1136/jmedgenet-2014-102351; Halfter W, 2006, INVEST OPHTH VIS SCI, V47, P3586, DOI 10.1167/iovs.05-1480; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; HENKEL W, 1976, EUR J BIOCHEM, V69, P223, DOI 10.1111/j.1432-1033.1976.tb10877.x; Hornbeak DM, 2009, CURR OPIN OPHTHALMOL, V20, P356, DOI 10.1097/ICU.0b013e32832f8040; Hudson DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093467; Hudson DM, 2013, CONNECT TISSUE RES, V54, P245, DOI 10.3109/03008207.2013.800867; Hudson DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019336; Ishikawa Y, 2012, J BIOL CHEM, V287, P22253, DOI 10.1074/jbc.M111.333336; Jarnum S, 2004, BIOCHEM BIOPH RES CO, V317, P342, DOI 10.1016/j.bbrc.2004.03.060; Kaufman RM, 2001, BLOOD, V98, P65, DOI 10.1182/blood.V98.1.65; Liu HH, 2010, INVEST OPHTH VIS SCI, V51, P2865, DOI 10.1167/iovs.09-4322; Marini JC, 2010, CELL TISSUE RES, V339, P59, DOI 10.1007/s00441-009-0872-0; McBrien NA, 2000, INVEST OPHTH VIS SCI, V41, P3713; McBrien NA, 2001, INVEST OPHTH VIS SCI, V42, P2179; McBrien NA, 2009, OPTOMETRY VISION SCI, V86, P23, DOI 10.1097/OPX.0b013e3181940669; Mordechai S, 2011, AM J HUM GENET, V89, P438, DOI 10.1016/j.ajhg.2011.08.003; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; OGLE JD, 1962, J BIOL CHEM, V237, P3667; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; PHILLIPS JR, 1995, OPHTHAL PHYSL OPT, V15, P357, DOI 10.1016/0275-5408(95)00062-I; Pokidysheva E, 2014, P NATL ACAD SCI USA, V111, P161, DOI 10.1073/pnas.1307597111; Pokidysheva E, 2013, J BIOL CHEM, V288, P24742, DOI 10.1074/jbc.M113.464156; Ren SY, 2002, DEV DYNAM, V225, P305, DOI 10.1002/dvdy.10171; RISTELI J, 1980, EUR J BIOCHEM, V108, P239, DOI 10.1111/j.1432-1033.1980.tb04717.x; Shi Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002084; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; Tran-Viet KN, 2013, AM J HUM GENET, V92, P820, DOI 10.1016/j.ajhg.2013.04.005; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka J, 2009, CELL STRUCT FUNCT, V34, P97, DOI 10.1247/csf.09002; Vranka JA, 2010, J BIOL CHEM, V285, P17253, DOI 10.1074/jbc.M110.102228; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Young TL, 1998, AM J HUM GENET, V63, P109, DOI 10.1086/301907	45	27	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8613	8622		10.1074/jbc.M114.634915	http://dx.doi.org/10.1074/jbc.M114.634915			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25645914	Green Published, hybrid			2022-12-28	WOS:000351662600051
J	Hung, ME; Leonard, JN				Hung, Michelle E.; Leonard, Joshua N.			Stabilization of Exosome-targeting Peptides via Engineered Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-DELIVERY SYSTEMS; EXTRACELLULAR VESICLES; CELLS; ELECTROPORATION; LIPOSOME; SIRNA	Exosomes are secreted extracellular vesicles that mediate intercellular transfer of cellular contents and are attractive vehicles for therapeutic delivery of bimolecular cargo such as nucleic acids, proteins, and even drugs. Efficient exosome-mediated delivery in vivo requires targeting vesicles for uptake by specific recipient cells. Although exosomes have been successfully targeted to several cellular receptors by displaying peptides on the surface of the exosomes, identifying effective exosome-targeting peptides for other receptors has proven challenging. Furthermore, the biophysical rules governing targeting peptide success remain poorly understood. To evaluate one factor potentially limiting exosome delivery, we investigated whether peptides displayed on the exosome surface are degraded during exosome biogenesis, for example by endosomal proteases. Indeed, peptides fused to theNterminus of exosome-associated transmembrane protein Lamp2b were cleaved in samples derived from both cells and exosomes. To suppress peptide loss, we engineered targeting peptide-Lamp2b fusion proteins to include a glycosylation motif at various positions. Introduction of this glycosylation motif both protected the peptide from degradation and led to an increase in overall Lamp2b fusion protein expression in both cells and exosomes. Moreover, glycosylationstabilized peptides enhanced targeted delivery of exosomes to neuroblastoma cells, demonstrating that such glycosylation does not ablate peptide-target interactions. Thus, we have identified a strategy for achieving robust display of targeting peptides on the surface of exosomes, which should facilitate the evaluation and development of new exosome-based therapeutics.	[Hung, Michelle E.] Northwestern Univ, Interdisciplinary Biol Sci Program, Evanston, IL 60208 USA; [Leonard, Joshua N.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Leonard, Joshua N.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA; [Leonard, Joshua N.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Leonard, JN (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd,Rm E136, Evanston, IL 60208 USA.	j-leonard@northwestern.edu	Leonard, Joshua/B-7649-2009; Hung, Michelle/J-3336-2014	Leonard, Joshua/0000-0003-4359-6126; Hung, Michelle/0000-0002-1909-8162	Northwestern University Office for Research; National Center for Research Resources [1S10RR025092]; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL CANCER INSTITUTE [P50CA090386, P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008449] Funding Source: NIH RePORTER	Northwestern University Office for Research; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Charlene Wilke for assistance with transmission electron microscopy, as well as Myrick Dennis and Dr. Arabela Grigorescu for assistance with NanoSight analysis. We thank the laboratory of Richard Morimoto for Neuro2A cells. NanoSight analysis was performed at the Northwestern University Keck Biophysics Facility. TEM was performed at the Northwestern University Biological Imaging Facility on a JEOL 3200 FETEM supported by the Northwestern University Office for Research and National Center for Research Resources Grant 1S10RR025092. Traditional sequencing services were performed at the Northwestern University Genomics Core Facility. BCA assays were performed at the Northwestern University High Throughput Analysis Lab, which is supported by the Chicago Biomedical Consortium and The Searle Funds at The Chicago Community Trust.	Akao Y, 2011, MOL THER, V19, P395, DOI 10.1038/mt.2010.254; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Bano-Polo M, 2011, PROTEIN SCI, V20, P179, DOI 10.1002/pro.551; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Gyorgy B, 2015, ANNU REV PHARMACOL, V55, P439, DOI 10.1146/annurev-pharmtox-010814-124630; Hood JL, 2014, ANAL BIOCHEM, V448, P41, DOI 10.1016/j.ab.2013.12.001; Kooijmans SAA, 2013, J CONTROL RELEASE, V172, P229, DOI 10.1016/j.jconrel.2013.08.014; Kraft JC, 2014, J PHARM SCI-US, V103, P29, DOI 10.1002/jps.23773; Kundra R, 1999, J BIOL CHEM, V274, P31039, DOI 10.1074/jbc.274.43.31039; Lai CP, 2014, ACS NANO, V8, P483, DOI 10.1021/nn404945r; LEE N, 1990, J BIOL CHEM, V265, P20476; Li X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044045; Liang YX, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.606269; Marcus ME, 2013, PHARMACEUTICALS-BASE, V6, P659, DOI 10.3390/ph6050659; Mizrak A, 2013, MOL THER, V21, P101, DOI 10.1038/mt.2012.161; Montecalvo A, 2008, J IMMUNOL, V180, P3081, DOI 10.4049/jimmunol.180.5.3081; Neefjes J, 2013, NAT CHEM BIOL, V9, P769, DOI [10.1038/NCHEMBIO.1391, 10.1038/nchembio.1391]; Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180; Sun DM, 2010, MOL THER, V18, P1606, DOI 10.1038/mt.2010.105; Tian YH, 2014, BIOMATERIALS, V35, P2383, DOI 10.1016/j.biomaterials.2013.11.083; van der Meel R, 2014, J CONTROL RELEASE, V195, P72, DOI 10.1016/j.jconrel.2014.07.049; van der Vlist EJ, 2012, NAT PROTOC, V7, P1311, DOI 10.1038/nprot.2012.065; Veron P, 2005, BLOOD CELL MOL DIS, V35, P81, DOI 10.1016/j.bcmd.2005.05.001; Zeelenberg IS, 2008, CANCER RES, V68, P1228, DOI 10.1158/0008-5472.CAN-07-3163	24	179	189	8	97	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8166	8172		10.1074/jbc.M114.621383	http://dx.doi.org/10.1074/jbc.M114.621383			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25657008	Green Published, hybrid			2022-12-28	WOS:000351662600014
J	Morais, MAB; Giuseppe, PO; Souza, TACB; Alegria, TGP; Oliveira, MA; Netto, LES; Murakami, MT				Morais, Mariana A. B.; Giuseppe, Priscila O.; Souza, Tatiana A. C. B.; Alegria, Thiago G. P.; Oliveira, Marcos A.; Netto, Luis E. S.; Murakami, Mario T.			How pH Modulates the Dimer-Decamer Interconversion of 2-Cys Peroxiredoxins from the Prx1 Subfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE FUNCTION; STABLE OXIDIZED DECAMER; OXIDATIVE STRESS; MITOCHONDRIAL PEROXIREDOXIN; PLASMODIUM-FALCIPARUM; STRUCTURE REFINEMENT; ANTIOXIDANT DEFENSE; LEISHMANIA-INFANTUM; CRYSTAL-STRUCTURE; OLIGOMERIC STATE	2-Cys peroxiredoxins belonging to the Prx1 subfamily are Cys-based peroxidases that control the intracellular levels of H2O2 and seem to assume a chaperone function under oxidative stress conditions. The regulation of their peroxidase activity as well as the observed functional switch from peroxidase to chaperone involves changes in their quaternary structure. Multiple factors can modulate the oligomeric transitions of 2-Cys peroxiredoxins such as redox state, post-translational modifications, and pH. However, the molecular basis for the pH influence on the oligomeric state of these enzymes is still elusive. Herein, we solved the crystal structure of a typical 2-Cys peroxiredoxin from Leishmania in the dimeric (pH 8.5) and decameric (pH 4.4) forms, showing that conformational changes in the catalytic loop are associated with the pH-induced decamerization. Mutagenesis and biophysical studies revealed that a highly conserved histidine (His(113)) functions as a pH sensor that, at acidic conditions, becomes protonated and forms an electrostatic pair with Asp(76) from the catalytic loop, triggering the decamerization. In these 2-Cys peroxiredoxins, decamer formation is important for the catalytic efficiency and has been associated with an enhanced sensitivity to oxidative inactivation by overoxidation of the peroxidatic cysteine. In eukaryotic cells, exposure to high levels of H2O2 can trigger intracellular pH variations, suggesting that pH changes might act cooperatively with H2O2 and other oligomerization-modulator factors to regulate the structure and function of typical 2-Cys peroxiredoxins in response to oxidative stress.	[Morais, Mariana A. B.; Giuseppe, Priscila O.; Murakami, Mario T.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, BR-13083970 Campinas, SP, Brazil; [Souza, Tatiana A. C. B.] Inst Carlos Chagas, Lab Proteom & Engn Proteinas, BR-81350010 Curitiba, Parana, Brazil; [Alegria, Thiago G. P.; Netto, Luis E. S.] Univ Sao Paulo, Dept Genet & Biol Evolutiva, Inst Biociencias, BR-05508900 Sao Paulo, SP, Brazil; [Oliveira, Marcos A.] Univ Estadual Paulista, Dept Biol, BR-11330900 Sao Vicente, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista	Murakami, MT (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, BR-13083970 Campinas, SP, Brazil.	mario.murakami@lnbio.cnpem.br	Murakami, Mario T/C-2087-2012; Oliveira de Giuseppe, Priscila/GLR-1319-2022; Murakami, Mario T/F-5640-2016; Netto, Luis/A-3783-2008; de Oliveira, Marcos A/K-5746-2015	Oliveira de Giuseppe, Priscila/0000-0003-2094-7325; Murakami, Mario T/0000-0002-0405-8010; Netto, Luis/0000-0002-4250-9177; de Oliveira, Marcos A/0000-0002-1192-7296; Morais, Mariana Abrahao Bueno de/0000-0003-1012-1394; Alegria, Thiago Geronimo Pires/0000-0002-3086-4059	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/51730-0, 2011/10248-4, 2012/24134-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 2010/51730-0, 2011/10248-4, and 2012/24134-3, the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aran M, 2009, FEBS J, V276, P2478, DOI 10.1111/j.1742-4658.2009.06984.x; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Bernier-Villamor L, 2004, J EXP BOT, V55, P2191, DOI 10.1093/jxb/erh238; Boucher IW, 2006, MOL MICROBIOL, V61, P948, DOI 10.1111/j.1365-2958.2006.05303.x; de Morais MAB, 2013, ACTA CRYSTALLOGR F, V69, P408, DOI 10.1107/S1744309113003989; Cao Z, 2007, J MOL BIOL, V372, P1022, DOI 10.1016/j.jmb.2007.07.018; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; Carnielli JBT, 2014, J PROTEOMICS, V108, P198, DOI 10.1016/j.jprot.2014.05.010; Castro H, 2002, FREE RADICAL BIO MED, V33, P1552, DOI 10.1016/S0891-5849(02)01089-4; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chuang MH, 2006, P NATL ACAD SCI USA, V103, P2552, DOI 10.1073/pnas.0510770103; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelman R, 2013, J BIOL CHEM, V288, P11312, DOI 10.1074/jbc.M112.433755; Gretes MC, 2012, ANTIOXID REDOX SIGN, V17, P608, DOI 10.1089/ars.2011.4404; Guimaraes BG, 2005, J BIOL CHEM, V280, P25735, DOI 10.1074/jbc.M503076200; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Harder S, 2006, EUKARYOT CELL, V5, P861, DOI 10.1128/EC.5.5.861-870.2006; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kitano K, 1999, J BIOCHEM, V126, P313, DOI 10.1093/oxfordjournals.jbchem.a022451; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristensen P, 1999, BIOCHEM BIOPH RES CO, V262, P127, DOI 10.1006/bbrc.1999.1107; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson KJ, 2011, PROTEINS, V79, P947, DOI 10.1002/prot.22936; Nguyen JB, 2013, CHEM BIOL, V20, P991, DOI 10.1016/j.chembiol.2013.06.011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Park JW, 2011, BIOCHEMISTRY-US, V50, P3204, DOI 10.1021/bi101373h; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Santo-Domingo J, 2012, J GEN PHYSIOL, V139, P415, DOI 10.1085/jgp.201110767; Sarma GN, 2005, J MOL BIOL, V346, P1021, DOI 10.1016/j.jmb.2004.12.022; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WERDAN K, 1975, BIOCHIM BIOPHYS ACTA, V396, P276, DOI 10.1016/0005-2728(75)90041-9; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	50	33	33	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8582	8590		10.1074/jbc.M114.619205	http://dx.doi.org/10.1074/jbc.M114.619205			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25666622	Green Published, hybrid			2022-12-28	WOS:000351662600048
J	Dayer, C; Stamenkovic, I				Dayer, Cynthia; Stamenkovic, Ivan			Recruitment of Matrix Metalloproteinase-9 (MMP-9) to the Fibroblast Cell Surface by Lysyl Hydroxylase 3 (LH3) Triggers Transforming Growth Factor-beta (TGF-beta) Activation and Fibroblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; TUMOR INVASION; LYSYL-HYDROXYLASE-3 LH3; EXTRACELLULAR-SPACE; IV COLLAGENASE; CANCER; BINDING; CARCINOGENESIS; ANGIOGENESIS; LOCALIZATION	Solid tumor growth triggers a wound healing response. Similar to wound healing, fibroblasts in the tumor stroma differentiate into myofibroblasts (also referred to as cancer-associated fibroblasts) primarily, but not exclusively, in response to transforming growth factor-beta (TGF-beta). Myofibroblasts in turn enhance tumor progression by remodeling the stroma. Among proteases implicated in stroma remodeling, matrix metalloproteinases (MMPs), including MMP-9, play a prominent role. Recent evidence indicates that MMP-9 recruitment to the tumor cell surface enhances tumor growth and invasion. In the present work, we addressed the potential relevance of MMP-9 recruitment to and activity at the surface of fibroblasts. We show that recruitment of MMP-9 to the fibroblast cell surface occurs through its fibronectin-like (FN) domain and that the molecule responsible for the recruitment is lysyl hydroxylase 3 (LH3). Functional assays suggest that both pro-and active MMP-9 trigger alpha-smooth muscle actin expression in cultured fibroblasts, reflecting myofibroblast differentiation, possibly as a result of TGF-beta activation. Moreover, the recombinant FN domain inhibited both MMP-9-induced TGF-beta activation and alpha-smooth muscle actin expression by displacing MMP-9 from the fibroblast cell surface. Together our results uncover LH3 as a new docking receptor of MMP-9 on the fibroblast cell surface and demonstrate that the MMP-9 FN domain is essential for the interaction. They also show that the recombinant FN domain inhibits MMP-9-induced TGF-beta activation and fibroblast differentiation, providing a potentially attractive therapeutic reagent toward attenuating tumor progression where MMP-9 activity is strongly implicated.	[Dayer, Cynthia; Stamenkovic, Ivan] Univ Lausanne, Fac Biol & Med, CHUV, Div Expt Pathol,Inst Pathol, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Stamenkovic, I (corresponding author), Univ Lausanne, Fac Biol & Med, CHUV, Div Expt Pathol,Inst Pathol, Rue Bugnon 25, CH-1011 Lausanne, Switzerland.	Ivan.Stamenkovic@chuv.ch			Swiss National Science Foundation (FNS) [310030_150024]; Swiss Institute for Experimental Cancer Research (ISREC) Foundation	Swiss National Science Foundation (FNS)(Swiss National Science Foundation (SNSF)); Swiss Institute for Experimental Cancer Research (ISREC) Foundation	This work was supported by Swiss National Science Foundation (FNS) Grant 310030_150024 and a grant from the Swiss Institute for Experimental Cancer Research (ISREC) Foundation.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Behrendt N, 2004, BIOL CHEM, V385, P103, DOI 10.1515/BC.2004.031; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dufour A, 2011, CANCER RES, V71, P4977, DOI 10.1158/0008-5472.CAN-10-4552; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Lauer-Fields JL, 2008, J BIOL CHEM, V283, P20087, DOI 10.1074/jbc.M801438200; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Malla N, 2008, CONNECT TISSUE RES, V49, P180, DOI 10.1080/03008200802151755; Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Roomi MW, 2009, ONCOL REP, V21, P1323, DOI 10.3892/or_00000358; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; Toth M, 2003, BIOCHEM BIOPH RES CO, V308, P386, DOI 10.1016/S0006-291X(03)01405-0; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Wang CG, 2009, J CELL MOL MED, V13, P508, DOI 10.1111/j.1582-4934.2008.00286.x; Xu XP, 2005, BIOCHEM J, V392, P127, DOI 10.1042/BJ20050650; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu Q, 2000, GENE DEV, V14, P163	36	67	68	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13763	13778		10.1074/jbc.M114.622274	http://dx.doi.org/10.1074/jbc.M114.622274			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25825495	Green Published, hybrid			2022-12-28	WOS:000355313000012
J	Arnaouteli, S; Giastas, P; Andreou, A; Tzanodaskalaki, M; Aldridge, C; Tzartos, SJ; Vollmer, W; Eliopoulos, E; Bouriotis, V				Arnaouteli, Sofia; Giastas, Petros; Andreou, Athina; Tzanodaskalaki, Mary; Aldridge, Christine; Tzartos, Socrates J.; Vollmer, Waldemar; Eliopoulos, Elias; Bouriotis, Vassilis			Two Putative Polysaccharide Deacetylases Are Required for Osmotic Stability and Cell Shape Maintenance in Bacillus anthracis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; N-ACETYLGLUCOSAMINE DEACETYLASES; CARBOHYDRATE ESTERASE; ESCHERICHIA-COLI; SPORE GERMINATION; GENE-EXPRESSION; PEPTIDOGLYCAN; WALL; PROTEINS; VIRULENCE	Membrane-anchored lipoproteins have a broad range of functions and play key roles in several cellular processes in Gram-positive bacteria. BA0330 and BA0331 are the only lipoproteins among the 11 known or putative polysaccharide deacetylases of Bacillus anthracis. We found that both lipoproteins exhibit unique characteristics. BA0330 and BA0331 interact with peptidoglycan, and BA0330 is important for the adaptation of the bacterium to grow in the presence of a high concentration of salt, whereas BA0331 contributes to the maintenance of a uniform cell shape. They appear not to alter the peptidoglycan structure and do not contribute to lysozyme resistance. The high resolution x-ray structure of BA0330 revealed a C-terminal domain with the typical fold of a carbohydrate esterase 4 and an N-terminal domain unique for this family, composed of a two-layered (4 + 3) beta-sandwich with structural similarity to fibronectin type 3 domains. Our data suggest that BA0330 and BA0331 have a structural role in stabilizing the cell wall of B. anthracis.	[Arnaouteli, Sofia; Bouriotis, Vassilis] Univ Crete, Dept Biol, Enzyme Biotechnol Grp, Iraklion 70013, Crete, Greece; [Giastas, Petros; Tzartos, Socrates J.] Hellenic Pasteur Inst, Dept Neurobiol, Athens 11521, Greece; [Andreou, Athina; Eliopoulos, Elias] Agr Univ Athens, Genet Lab, Dept Biotechnol, GR-11855 Athens, Greece; [Tzanodaskalaki, Mary; Bouriotis, Vassilis] Univ Crete, Inst Mol Biol & Biotechnol, Iraklion 70013, Crete, Greece; [Aldridge, Christine; Vollmer, Waldemar] Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Tzartos, Socrates J.] Univ Patras, Dept Pharm, Patras 26504, Greece	University of Crete; University of Crete; Newcastle University - UK; University of Patras	Bouriotis, V (corresponding author), Univ Crete, Dept Biol, Enzyme Biotechnol Grp, POB 2208, Iraklion 70013, Crete, Greece.	bouriotis@biology.uoc.gr	Giastas, Petros/AAD-8770-2021	Andreou, Athena/0000-0003-4683-8071; Giastas, Petros/0000-0002-3490-8223; Eliopoulos, Elias/0000-0002-0919-0571	Project "IRAKLITOS II-University of Crete" of the National Strategic Reference Framework, "Thalis"; European Union (European Social Fund); BioStruct-X Contract [283570/3521]; National Resources; Biotechnology and Biological Sciences Research Council [BB/G015902/1]; BBSRC [BB/G015902/1] Funding Source: UKRI	Project "IRAKLITOS II-University of Crete" of the National Strategic Reference Framework, "Thalis"; European Union (European Social Fund)(European Social Fund (ESF)); BioStruct-X Contract; National Resources; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Project "IRAKLITOS II-University of Crete" of the National Strategic Reference Framework (2007-2013), "Thalis," which is co-funded by the European Union (European Social Fund), BioStruct-X Contract 283570/3521, and National Resources.; Supported by Biotechnology and Biological Sciences Research Council Grant BB/G015902/1.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Antelmann H, 2005, PROTEOMICS, V5, P3684, DOI 10.1002/pmic.200401218; ARAKI Y, 1980, J BIOCHEM-TOKYO, V88, P469, DOI 10.1093/oxfordjournals.jbchem.a132994; Balomenou S, 2013, MOL MICROBIOL, V87, P867, DOI 10.1111/mmi.12137; Barendt SM, 2011, J BACTERIOL, V193, P2290, DOI 10.1128/JB.01555-10; Benachour A, 2012, J BACTERIOL, V194, P6066, DOI 10.1128/JB.00981-12; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; BRAUN V, 1994, N COMP BIOC, V27, P319, DOI DOI 10.1016/S0167-7306(08)60417-2; Browne N, 2001, J APPL MICROBIOL, V91, P1085, DOI 10.1046/j.1365-2672.2001.01478.x; Bui NK, 2012, ANAL BIOCHEM, V421, P657, DOI 10.1016/j.ab.2011.11.026; Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205; CAMPBELL ID, 1994, STRUCTURE, V2, P333, DOI 10.1016/S0969-2126(00)00034-4; Candela T, 2014, MICROB DRUG RESIST, V20, P222, DOI 10.1089/mdr.2014.0063; Caufrier F, 2003, CARBOHYD RES, V338, P687, DOI 10.1016/S0008-6215(03)00002-8; Chen YH, 2004, ANTIMICROB AGENTS CH, V48, P4873, DOI 10.1128/AAC.48.12.4873-4877.2004; Chen Y, 2009, J AM CHEM SOC, V131, P14345, DOI 10.1021/ja903773f; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Cossart P, 2000, P NATL ACAD SCI USA, V97, P5013, DOI 10.1073/pnas.97.10.5013; Deng DM, 2009, J BACTERIOL, V191, P394, DOI 10.1128/JB.00838-08; Dramsi S, 2008, FEMS MICROBIOL REV, V32, P307, DOI 10.1111/j.1574-6976.2008.00102.x; EKWUNIFE FS, 1991, FEMS MICROBIOL LETT, V82, P257; El Hidri D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/648141; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ETIENNETOUMELIN I, 1995, J BACTERIOL, V177, P614, DOI 10.1128/jb.177.3.614-620.1995; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fadouloglou VE, 2013, ACTA CRYSTALLOGR D, V69, P276, DOI 10.1107/S0907444912045829; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; Fortineau N, 2000, RES MICROBIOL, V151, P353, DOI 10.1016/S0923-2508(00)00158-3; Fouet A, 2009, MOL ASPECTS MED, V30, P374, DOI 10.1016/j.mam.2009.07.001; Frirdich E, 2014, J BIOL CHEM, V289, P8007, DOI 10.1074/jbc.M113.491829; Hoffmaster AR, 1997, INFECT IMMUN, V65, P3091, DOI 10.1128/IAI.65.8.3091-3099.1997; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hoyland CN, 2014, STRUCTURE, V22, P949, DOI 10.1016/j.str.2014.04.015; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Janulczyk R, 2001, INFECT IMMUN, V69, P4019, DOI 10.1128/IAI.69.6.4019-4026.2001; JOLLIFFE LK, 1981, CELL, V25, P753, DOI 10.1016/0092-8674(81)90183-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAFETZOPOULOS D, 1993, P NATL ACAD SCI USA, V90, P2564, DOI 10.1073/pnas.90.7.2564; Kataeva IA, 2002, APPL ENVIRON MICROB, V68, P4292, DOI 10.1128/AEM.68.9.4292-4300.2002; Little DJ, 2012, J BIOL CHEM, V287, P31126, DOI 10.1074/jbc.M112.390005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Palomino MM, 2009, RES MICROBIOL, V160, P117, DOI 10.1016/j.resmic.2008.10.011; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; MURPHY E, 1985, MOL GEN GENET, V200, P33, DOI 10.1007/BF00383309; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Nelson DE, 2002, J BACTERIOL, V184, P3630, DOI 10.1128/JB.184.13.3630-3639.2002; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oberbarnscheidt L, 2007, PROTEINS, V66, P250, DOI 10.1002/prot.21217; Okugawa S, 2012, MOL MICROBIOL, V83, P96, DOI 10.1111/j.1365-2958.2011.07915.x; Piuri M, 2005, J APPL MICROBIOL, V98, P84, DOI 10.1111/j.1365-2672.2004.02428.x; Pokrovskaya V, 2013, BIOCHEMISTRY-US, V52, P5463, DOI 10.1021/bi400836g; Psylinakis E, 2005, J BIOL CHEM, V280, P30856, DOI 10.1074/jbc.M407426200; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; RYGUS T, 1991, APPL MICROBIOL BIOT, V35, P594; Senior A, 2008, J BACTERIOL, V190, P6148, DOI 10.1128/JB.00789-08; Strunk RJ, 2014, ACTA CRYSTALLOGR F, V70, P156, DOI 10.1107/S2053230X13034262; SUTCLIFFE IC, 1995, J BACTERIOL, V177, P1123, DOI 10.1128/jb.177.5.1123-1128.1995; Sycuro LK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002603; Taylor EJ, 2006, J BIOL CHEM, V281, P10968, DOI 10.1074/jbc.M513066200; Tsigos I, 2000, TRENDS BIOTECHNOL, V18, P305, DOI 10.1016/S0167-7799(00)01462-1; Uehara T, 2010, EMBO J, V29, P1412, DOI 10.1038/emboj.2010.36; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	65	21	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13465	13478		10.1074/jbc.M115.640029	http://dx.doi.org/10.1074/jbc.M115.640029			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25825488	hybrid, Green Published			2022-12-28	WOS:000354975700041
J	Greenough, L; Kelman, Z; Gardner, AF				Greenough, Lucia; Kelman, Zvi; Gardner, Andrew F.			The Roles of Family B and D DNA Polymerases in Thermococcus Species 9 degrees N Okazaki Fragment Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION; ARCHAEON; PCNA	During replication, Okazaki fragment maturation is a fundamental process that joins discontinuously synthesized DNA fragments into a contiguous lagging strand. Efficient maturation prevents repeat sequence expansions, small duplications, and generation of double-stranded DNA breaks. To address the components required for the process in Thermococcus, Okazaki fragment maturation was reconstituted in vitro using purified proteins from Thermococcus species 9 degrees N or cell extracts. A dual color fluorescence assay was developed to monitor reaction substrates, intermediates, and products. DNA polymerase D (polD) was proposed to function as the replicative polymerase in Thermococcus replicating both the leading and the lagging strands. It is shown here, however, that it stops before the previous Okazaki fragments, failing to rapidly process them. Instead, Family B DNA polymerase (polB) was observed to rapidly fill the gaps left by polD and displaces the downstream Okazaki fragment to create a flap structure. This flap structure was cleaved by flap endonuclease 1 (Fen1) and the resultant nick was ligated by DNA ligase to form a mature lagging strand. The similarities to both bacterial and eukaryotic systems and evolutionary implications of archaeal Okazaki fragment maturation are discussed.	[Greenough, Lucia; Gardner, Andrew F.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Kelman, Zvi] NIST, Rockville, MD 20850 USA	New England Biolabs; National Institute of Standards & Technology (NIST) - USA	Gardner, AF (corresponding author), 240 Cty Rd, Ipswich, MA 01938 USA.	gardner@neb.com			New England Biolabs, Inc.	New England Biolabs, Inc.	This work was supported by New England Biolabs, Inc.	Balakrishnan L, 2010, METHODS, V51, P347, DOI 10.1016/j.ymeth.2010.02.017; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Beattie TR, 2012, EMBO J, V31, P1556, DOI 10.1038/emboj.2012.12; Berquist BR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-31; Cubonova L, 2013, J BACTERIOL, V195, P2322, DOI 10.1128/JB.02037-12; Greenough L, 2014, EXTREMOPHILES, V18, P653, DOI 10.1007/s00792-014-0646-9; Henneke G, 2005, J MOL BIOL, V350, P53, DOI 10.1016/j.jmb.2005.04.042; Henneke G, 2012, BIOCHEM J, V447, P271, DOI 10.1042/BJ20120959; Jozwiakowski SK, 2014, NUCLEIC ACIDS RES, V42, P9949, DOI 10.1093/nar/gku683; Kelman LM, 2014, ANNU REV GENET, V48, P71, DOI 10.1146/annurev-genet-120213-092148; KORNBERG A, 1988, J BIOL CHEM, V263, P1; Kurth I, 2013, TRENDS BIOCHEM SCI, V38, P195, DOI 10.1016/j.tibs.2012.10.003; Li Z, 2011, NUCLEIC ACIDS RES, V39, P6114, DOI 10.1093/nar/gkr181; Li Z, 2010, MBIO, V1, DOI 10.1128/mBio.00221-10; Makarova KS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00354; Matsunaga F, 2003, EMBO REP, V4, P154, DOI 10.1038/sj.embor.embor732; Prokhorova TA, 2003, P NATL ACAD SCI USA, V100, P13241, DOI 10.1073/pnas.2336104100; Rangarajan S, 1999, P NATL ACAD SCI USA, V96, P9224, DOI 10.1073/pnas.96.16.9224; Rouillon C, 2007, J MOL BIOL, V369, P343, DOI 10.1016/j.jmb.2007.03.054; Sarmiento F, 2013, P NATL ACAD SCI USA, V110, P4726, DOI 10.1073/pnas.1220225110	20	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12514	12522		10.1074/jbc.M115.638130	http://dx.doi.org/10.1074/jbc.M115.638130			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25814667	Green Published, hybrid			2022-12-28	WOS:000354569000008
J	Yan, W; Ye, Q; Tan, M; Chen, X; Eriani, G; Wang, ED				Yan, Wei; Ye, Qing; Tan, Min; Chen, Xi; Eriani, Gilbert; Wang, En-Duo			Modulation of Aminoacylation and Editing Properties of Leucyl-tRNA Synthetase by a Conserved Structural Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA Synthetase; enzyme; evolution; protein synthesis; transfer RNA (tRNA); aminoacylation; editing; stem contact fold	PROOFREADING FUNCTIONAL CYCLE; ESCHERICHIA-COLI TRNA(LEU); ANGSTROM CRYSTAL-STRUCTURE; QUALITY-CONTROL; BINDING DOMAIN; GENETIC-CODE; RECOGNITION; DYNAMICS; REVEALS; COMPLEX	Background: A structural module following the KMSKS catalytic loop is conserved in most class I synthetases. Results: This module contributes to aminoacylation and editing of leucyl-tRNA synthetases (LeuRS). Conclusion: This module affects the activities of LeuRS in both a structure- and sequence-dependent manner. Significance: This work further extends the function of stem-contact fold in LeuRS. A conserved structural module following the KMSKS catalytic loop exhibits --- topology in class Ia and Ib aminoacyl-tRNA synthetases. However, the function of this domain has received little attention. Here, we describe the effect this module has on the aminoacylation and editing capacities of leucyl-tRNA synthetases (LeuRSs) by characterizing the key residues from various species. Mutation of highly conserved basic residues on the third -helix of this domain impairs the affinity of LeuRS for the anticodon stem of tRNA(Leu), which decreases both aminoacylation and editing activities. Two glycine residues on this -helix contribute to flexibility, leucine activation, and editing of LeuRS from Escherichia coli (EcLeuRS). Acidic residues on the -strand enhance the editing activity of EcLeuRS and sense the size of the tRNA(Leu) D-loop. Incorporation of these residues stimulates the tRNA-dependent editing activity of the chimeric minimalist enzyme Mycoplasma mobile LeuRS fused to the connective polypeptide 1 editing domain and leucine-specific domain from EcLeuRS. Together, these results reveal the stem contact-fold to be a functional as well as a structural linker between the catalytic site and the tRNA binding domain. Sequence comparison of the EcLeuRS stem contact-fold domain with editing-deficient enzymes suggests that key residues of this module have evolved an adaptive strategy to follow the editing functions of LeuRS.	[Yan, Wei; Ye, Qing; Tan, Min; Wang, En-Duo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Wang, En-Duo] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; [Eriani, Gilbert] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & Reactiv ARN, F-67084 Strasbourg, France; [Chen, Xi] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hunan, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Wuhan University	Wang, ED (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	edwang@sibcb.ac.cn	Tan, Min/K-1780-2016	Eriani, Gilbert/0000-0002-8518-4675; Chen, Xi/0000-0003-2894-0363; Yan, Wei/0000-0003-3978-7675	National Key Basic Research Foundation of China [2012CB911000]; Natural Science Foundation of China [31130064]; Committee of Science and Technology in Shanghai Grant [12JC1409700]	National Key Basic Research Foundation of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology in Shanghai Grant	This work was supported by National Key Basic Research Foundation of China Grant 2012CB911000, Natural Science Foundation of China Grant 31130064, and Committee of Science and Technology in Shanghai Grant 12JC1409700.	BURBAUM JJ, 1991, J BIOL CHEM, V266, P16965; Casina VC, 2011, BIOCHEMISTRY-US, V50, P763, DOI 10.1021/bi101375d; Cavarelli J, 1998, EMBO J, V17, P5438, DOI 10.1093/emboj/17.18.5438; Chen X, 2011, NUCLEIC ACIDS RES, V39, P235, DOI 10.1093/nar/gkq763; CROTHERS DM, 1972, P NATL ACAD SCI USA, V69, P3063, DOI 10.1073/pnas.69.10.3063; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; Du X, 2003, NUCLEIC ACIDS RES, V31, P2865, DOI 10.1093/nar/gkg382; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Fukunaga R, 2005, J MOL BIOL, V346, P57, DOI 10.1016/j.jmb.2004.11.060; Gomes AC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r206; Guijarro JI, 2002, STRUCTURE, V10, P311, DOI 10.1016/S0969-2126(02)00699-8; Hu QH, 2013, NUCLEIC ACIDS RES, V41, P1859, DOI 10.1093/nar/gks1307; Huang Q, 2012, NUCLEIC ACIDS RES, V40, P10463, DOI 10.1093/nar/gks783; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Li L, 2013, P NATL ACAD SCI USA, V110, P3817, DOI 10.1073/pnas.1218374110; Li L, 2011, P NATL ACAD SCI USA, V108, P9378, DOI 10.1073/pnas.1016460108; Li Y, 1998, SCI CHINA SER C, V41, P225, DOI 10.1007/BF02895095; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v; MCCLAIN WH, 1993, J MOL BIOL, V234, P257, DOI 10.1006/jmbi.1993.1582; Michel SLJ, 2003, BIOCHEMISTRY-US, V42, P4626, DOI 10.1021/bi034073h; Nordin BE, 1999, J BIOL CHEM, V274, P6835, DOI 10.1074/jbc.274.11.6835; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; Rogers HH, 2014, RNA, V20, P269, DOI 10.1261/rna.041681.113; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Sugiura I, 2000, STRUCTURE, V8, P197, DOI 10.1016/S0969-2126(00)00095-2; Tan M, 2012, BIOCHEM J, V443, P477, DOI 10.1042/BJ20111925; Tan M, 2010, J BIOL CHEM, V285, P3235, DOI 10.1074/jbc.M109.060616; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Yan W, 2013, NUCLEIC ACIDS RES, V41, P4988, DOI 10.1093/nar/gkt185; Yao P, 2008, J BIOL CHEM, V283, P22591, DOI 10.1074/jbc.M801181200; YARUS M, 1970, ANAL BIOCHEM, V35, P450, DOI 10.1016/0003-2697(70)90207-1; Zhou XL, 2011, NUCLEIC ACIDS RES, V39, P8857, DOI 10.1093/nar/gkr595; Zhou XL, 2010, BIOCHEM J, V429, P505, DOI 10.1042/BJ20100235; Zhu B, 2009, J BIOL CHEM, V284, P3418, DOI 10.1074/jbc.M806717200	39	3	6	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12256	12267		10.1074/jbc.M115.639492	http://dx.doi.org/10.1074/jbc.M115.639492			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25817995	Green Published, hybrid			2022-12-28	WOS:000354388600036
J	Johjima, A; Noi, K; Nishikori, S; Ogi, H; Esaki, M; Ogura, T				Johjima, Ai; Noi, Kentaro; Nishikori, Shingo; Ogi, Hirotsugu; Esaki, Masatoshi; Ogura, Teru			Microtubule Severing by Katanin p60 AAA+ ATPase Requires the C-terminal Acidic Tails of Both alpha- and beta-Tubulins and Basic Amino Acid Residues in the AAA plus Ring Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUARTZ-CRYSTAL MICROBALANCE; SPASTIC PARAPLEGIA PROTEIN; RECOGNITION; ENZYME; IDENTIFICATION; DEPOLYMERASE; SENSITIVITY; DIVERSITY; MACHINERY; FIDGETIN	The microtubule (MT) network is highly dynamic and undergoes dramatic reorganizations during the cell cycle. Dimers of alpha- and beta-tubulins rapidly polymerize to and depolymerize from the end of MT fibrils in an intrinsic GTP-dependent manner. MT severing by ATP-driven enzymes such as katanin and spastin contributes significantly to microtubule dynamics, and it has been shown that katanin p60, a AAA+ family protein, has ATPase and MT-severing activities. The mechanism of MT severing by katanin p60 is poorly understood, and the residues in katanin p60 and tubulins important for severing activity were therefore explored in this study. MT-severing activity, but not ATPase activity, was inhibited by mutations of the conserved aromatic residue and the flanking basic residues in the pore region of the katanin p60 hexameric ring. When the acidic residue-rich C-terminal unstructured segment of either alpha- or beta-tubulin was removed, polymerized MTs were resistant to katanin p60 treatment. Interactions between katanin p60 and the mutant MTs, on the other hand, were unaffected. Taken together, these findings led us to propose that the interactions between the positively charged residues of katanin p60 and the acidic tails of both tubulins are essential for efficient severing of MTs.	[Johjima, Ai; Noi, Kentaro; Nishikori, Shingo; Esaki, Masatoshi; Ogura, Teru] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Mol Cell Biol, Kumamoto 8600811, Japan; [Noi, Kentaro; Esaki, Masatoshi; Ogura, Teru] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020076, Japan; [Noi, Kentaro; Ogi, Hirotsugu] Osaka Univ, Grad Sch Engn Sci, Osaka 5608531, Japan	Kumamoto University; Japan Science & Technology Agency (JST); Osaka University	Esaki, M (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Mol Cell Biol, Kumamoto 8600811, Japan.	esaki@kumamoto-u.ac.jp; ogura@gpo.kumamoto-u.ac.jp	Esaki, Masatoshi/L-6591-2017; Esaki, Masatoshi/ABS-6645-2022	Ogura, Teru/0000-0003-3784-0970	Japan Society for the Promotion of Science; MEXT of Japan; CREST program of JST	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST program of JST(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by grants-in-aid from Japan Society for the Promotion of Science, from MEXT of Japan, and from the CREST program of JST.	Ando T, 2014, CURR OPIN STRUC BIOL, V28, P63, DOI 10.1016/j.sbi.2014.07.011; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; Davis LJ, 2002, BIOPHYS J, V82, P2916, DOI 10.1016/S0006-3495(02)75632-4; Diaz-Valencia J. D., 2011, BIOPHYS J, V100, P2440; Downing KH, 1998, CURR OPIN CELL BIOL, V10, P16, DOI 10.1016/S0955-0674(98)80082-3; Dymek EE, 2012, J CELL SCI, V125, P3357, DOI 10.1242/jcs.096941; Eckert T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050161; Gupta ML, 2003, P NATL ACAD SCI USA, V100, P6394, DOI 10.1073/pnas.1131967100; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; HEUSELE C, 1987, EUR J BIOCHEM, V165, P613, DOI 10.1111/j.1432-1033.1987.tb11484.x; Iwaya N, 2012, FEBS J, V279, P1339, DOI 10.1111/j.1742-4658.2012.08528.x; Iwaya N, 2010, J BIOL CHEM, V285, P16822, DOI 10.1074/jbc.M110.108365; Kannegaard E, 2014, MOL BIOL CELL, V25, P3686, DOI 10.1091/mbc.E14-06-1116; Llorca O, 2000, EMBO J, V19, P5971, DOI 10.1093/emboj/19.22.5971; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; MARYA PK, 1994, J CELL SCI, V107, P339; Matsushita-Ishiodori Y, 2007, BIOCHEM BIOPH RES CO, V359, P157, DOI 10.1016/j.bbrc.2007.05.086; Matsushita-Ishiodori Y, 2009, GENES CELLS, V14, P925, DOI 10.1111/j.1365-2443.2009.01320.x; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; McNally KP, 2000, J CELL SCI, V113, P1623; Mukherjee S, 2012, CELL CYCLE, V11, P2359, DOI 10.4161/cc.20849; Ogi H, 2008, ANAL CHEM, V80, P5494, DOI 10.1021/ac800459g; Ogi H, 2009, ANAL CHEM, V81, P4015, DOI 10.1021/ac9004524; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Onitake A, 2012, J STRUCT BIOL, V179, P143, DOI 10.1016/j.jsb.2012.04.022; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Sharma N, 2007, J CELL BIOL, V178, P1065, DOI 10.1083/jcb.200704021; Sharp DJ, 2012, J CELL SCI, V125, P2561, DOI 10.1242/jcs.101139; SHIINA N, 1995, TRENDS CELL BIOL, V5, P283, DOI 10.1016/S0962-8924(00)89040-6; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; Srayko M, 2000, GENE DEV, V14, P1072; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uchimura S, 2006, EMBO J, V25, P5932, DOI 10.1038/sj.emboj.7601442; Walczak CE, 2000, CURR OPIN CELL BIOL, V12, P52, DOI 10.1016/S0955-0674(99)00056-3; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Widlund PO, 2012, MOL BIOL CELL, V23, P4393, DOI 10.1091/mbc.E12-06-0444; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878; Yu WQ, 2005, J NEUROSCI, V25, P5573, DOI 10.1523/JNEUROSCI.0834-05.2005; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011; Zhang D, 2011, NAT CELL BIOL, V13, P361, DOI 10.1038/ncb2206	50	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11762	11770		10.1074/jbc.M114.614768	http://dx.doi.org/10.1074/jbc.M114.614768			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25805498	Green Published, hybrid			2022-12-28	WOS:000353719400048
J	Orabi, AI; Sah, S; Javed, TA; Lemon, KL; Good, ML; Guo, P; Xiao, XW; Prasadan, K; Gittes, GK; Jin, SQ; Husain, SZ				Orabi, Abrahim I.; Sah, Swati; Javed, Tanveer A.; Lemon, Kathryn L.; Good, Misty L.; Guo, Ping; Xiao, Xiangwei; Prasadan, Krishna; Gittes, George K.; Jin, Shunqian; Husain, Sohail Z.			Dynamic Imaging of Pancreatic Nuclear Factor kappa B (NF-kappa B) Activation in Live Mice Using Adeno-associated Virus (AAV) Infusion and Bioluminescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; TRANSGENIC MICE; TRYPSINOGEN ACTIVATION; MOUSE MODEL; LUCIFERASE; KINASE; CELLS; GENE; EXPRESSION; CERULEIN	Nuclear factor kappa B (NF-kappa B) is an important signaling molecule that plays a critical role in the development of acute pancreatitis. Current methods for examining NF-kappa B activation involve infection of an adenoviral NF-kappa B-luciferase reporter into cell lines or electrophoretic mobility shift assay of lysate. The use of adeno-associated viruses (AAVs) has proven to be an effective method of transfecting whole organs in live animals. We examined whether intrapancreatic duct infusion of AAV containing an NF-kappa B-luciferase reporter (AAV-NF-kappa B-luciferase) can reliably measure pancreatic NF-kappa B activation. We confirmed the infectivity of the AAV-NF-kappa B-luciferase reporter in HEK293 cells using a traditional luciferase readout. Mice were infused with AAV-NF-kappa B-luciferase 5 weeks before induction of pancreatitis (caerulein, 50 mu g/kg). Unlike transgenic mice that globally express NF-kappa B-luciferase, AAV-infused mice showed a 15-fold increase in pancreas-specific NF-kappa B bioluminescence following 12 h of caerulein compared with baseline luminescence (p < 0.05). The specificity of the NF-kappa B-luciferase signal to the pancreas was confirmed by isolating the pancreas and adjacent organs and observing a predominant bioluminescent signal in the pancreas compared with liver, spleen, and stomach. A complementary mouse model of post-ERCP-pancreatitis also induced pancreatic NF-kappa B signals. Taken together these data provide the first demonstration that NF-kappa B activation can be examined in a live, dynamic fashion during pancreatic inflammation. Webelieve this technique offers a valuable tool to study real-time activation of NF-kappa B in vivo.	[Orabi, Abrahim I.; Sah, Swati; Javed, Tanveer A.; Lemon, Kathryn L.; Good, Misty L.; Jin, Shunqian; Husain, Sohail Z.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA; [Guo, Ping; Xiao, Xiangwei; Prasadan, Krishna; Gittes, George K.] UPMC, Childrens Hosp Pittsburgh, Dept Surg, Pittsburgh, PA 15224 USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Husain, SZ (corresponding author), Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	sohail.husain@chp.edu	Good, Misty/AAI-6192-2020; Regan, Clinton/E-6250-2012	Good, Misty/0000-0002-0264-5721; Xiao, Xiangwei/0000-0003-0890-9203; Husain, Sohail Z/0000-0003-3012-1308	National Institutes of Health [DK083327, DK093491, DK03002]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103002, R01DK093491, R01DK083327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK083327, DK093491, and DK03002 (to S. Z. H.).	Andriulli A, 2007, AM J GASTROENTEROL, V102, P1781, DOI 10.1111/j.1572-0241.2007.01279.x; [Anonymous], 2006, GASTROINTEST ENDOSC, V63, P361, DOI 10.1016/j.gie.2006.01.010; Badr CE, 2009, MOL IMAGING, V8, P278, DOI 10.2310/7290.2009.00026; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Chen XQ, 2002, GASTROENTEROLOGY, V122, P448, DOI 10.1053/gast.2002.31060; Contag CH, 2000, NEOPLASIA, V2, P41, DOI 10.1038/sj.neo.7900079; D Frank C, 2006, NAT CLIN PRACT GASTR, V3, P680, DOI 10.1038/ncpgasthep0654; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Ding SP, 2003, WORLD J GASTROENTERO, V9, P584, DOI 10.3748/wjg.v9.i3.584; Dohlen G, 2005, PEDIATR RES, V58, P941, DOI 10.1203/01.PDR.0000182595.62545.EE; Ethridge RT, 2002, J AM COLL SURGEONS, V195, P497, DOI 10.1016/S1072-7515(02)01222-X; Gray KD, 2003, J SURG RES, V110, P310, DOI 10.1016/S0022-4804(03)00024-6; Gukovsky I, 1998, AM J PHYSIOL-GASTR L, V275, pG1402, DOI 10.1152/ajpgi.1998.275.6.G1402; Gukovsky I, 2013, GASTROENTEROLOGY, V144, P26, DOI 10.1053/j.gastro.2012.11.016; Guo P, 2013, LAB INVEST, V93, P1241, DOI 10.1038/labinvest.2013.113; Guo P, 2012, J VIROL METHODS, V183, P139, DOI 10.1016/j.jviromet.2012.04.004; Haridas V, 1999, ONCOGENE, V18, P6496, DOI 10.1038/sj.onc.1203059; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hietaranta AJ, 2001, BIOCHEM BIOPH RES CO, V280, P388, DOI 10.1006/bbrc.2000.4120; Houbracken I, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-74; Huang HJ, 2013, GASTROENTEROLOGY, V144, P202, DOI 10.1053/j.gastro.2012.09.059; Hyoudou K, 2007, MOL PHARMACOL, V71, P446, DOI 10.1124/mol.106.027169; Jamal MM, 2007, AM J GASTROENTEROL, V102, P966, DOI 10.1111/j.1572-0241.2007.01127.x; Kang R, 2014, GASTROENTEROLOGY, V146, P1097, DOI 10.1053/j.gastro.2013.12.015; LAMPEL M, 1977, VIRCHOWS ARCH A, V373, P97, DOI 10.1007/BF00432156; Le TM, 2015, PANCREAS, V44, P493, DOI 10.1097/MPA.0000000000000285; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; LORENZ WW, 1991, P NATL ACAD SCI USA, V88, P4438, DOI 10.1073/pnas.88.10.4438; Magness ST, 2004, J IMMUNOL, V173, P1561, DOI 10.4049/jimmunol.173.3.1561; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Muili KA, 2013, J BIOL CHEM, V288, P21065, DOI 10.1074/jbc.M113.471425; Nakajima Y, 2004, BIOSCI BIOTECH BIOCH, V68, P565, DOI 10.1271/bbb.68.565; Neuhofer P, 2013, GASTROENTEROLOGY, V144, P192, DOI 10.1053/j.gastro.2012.09.058; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1192, DOI 10.1016/S0016-5085(85)80079-2; Niu G, 2013, THERANOSTICS, V3, P190, DOI 10.7150/thno.5825; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Perides G, 2010, NAT PROTOC, V5, P335, DOI 10.1038/nprot.2009.243; Rakonczay Z, 2008, GUT, V57, P259, DOI 10.1136/gut.2007.124115; Sadikot Ruxana T, 2005, Proc Am Thorac Soc, V2, P537, DOI 10.1513/pats.200507-067DS; Sah RP, 2013, CURR OPIN GASTROEN, V29, P523, DOI 10.1097/MOG.0b013e328363e399; SchmidtUllrich R, 1996, DEVELOPMENT, V122, P2117; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tando Y, 2002, DIGESTION, V66, P237, DOI 10.1159/000068364; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Xiao XW, 2014, NAT PROTOC, V9, P2719, DOI 10.1038/nprot.2014.183; Zangani M, 2009, AM J PATHOL, V174, P1358, DOI 10.2353/ajpath.2009.080700; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhang N, 2003, J IMMUNOL, V170, P6307, DOI 10.4049/jimmunol.170.12.6307; Zhang N, 2005, J IMMUNOL, V174, P8125, DOI 10.4049/jimmunol.174.12.8125; Zhang WS, 2001, TRANSGENIC RES, V10, P423, DOI 10.1023/A:1012042506002	54	12	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11309	11320		10.1074/jbc.M115.647933	http://dx.doi.org/10.1074/jbc.M115.647933			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25802340	hybrid, Green Published			2022-12-28	WOS:000353719400009
J	Richardson, SL; Mao, YF; Zhang, G; Hanjra, P; Peterson, DL; Huang, R				Richardson, Stacie L.; Mao, Yunfei; Zhang, Gang; Hanjra, Pahul; Peterson, Darrell L.; Huang, Rong			Kinetic Mechanism of Protein N-terminal Methyltransferase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLATION; DNA; IDENTIFICATION; SPECIFICITY; CHROMATIN; PEPTIDES; BINDING; ASSAY; NRMT; RCC1	The protein N-terminal methyltransferase 1 (NTMT1) catalyzes the transfer of the methyl group from the S-adenosyl-L-methionine to the protein alpha-amine, resulting in formation of S-adenosyl-L-homocysteine and alpha-N-methylated proteins. NTMT1 is an interesting potential anticancer target because it is overexpressed in gastrointestinal cancers and plays an important role in cell mitosis. To gain insight into the biochemical mechanism of NTMT1, we have characterized the kinetic mechanism of recombinant NTMT1 using a fluorescence assay and mass spectrometry. The results of initial velocity, product, and dead-end inhibition studies indicate that methylation by NTMT1 proceeds via a random sequential Bi Bi mechanism. In addition, our processivity studies demonstrate that NTMT1 proceeds via a distributive mechanism for multiple methylations. Together, our studies provide new knowledge about the kinetic mechanism of NTMT1 and lay the foundation for the development of mechanism-based inhibitors.	[Richardson, Stacie L.; Mao, Yunfei; Zhang, Gang; Hanjra, Pahul; Huang, Rong] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23219 USA; [Richardson, Stacie L.; Mao, Yunfei; Zhang, Gang; Hanjra, Pahul; Peterson, Darrell L.; Huang, Rong] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23219 USA; [Peterson, Darrell L.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23219 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Huang, R (corresponding author), Inst Struct Biol & Drug Discovery, Dept Med Chem, 800 East Leigh St,Suite 212, Richmond, VA 23219 USA.	rhuang@vcu.edu	Zhang, Gang/J-3328-2019; Huang, Rong/AAL-3276-2020; Zhang, Gang/A-3292-2016	Zhang, Gang/0000-0003-0774-5710; Huang, Rong/0000-0002-1477-3165; Zhang, Gang/0000-0003-0774-5710	National Institutes of Health, National Center for Advancing Translational Sciences [UL1TR000058]; Virginia Commonwealth University School of Pharmacy; A. D. Williams Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Advancing Translational Sciences; Virginia Commonwealth University School of Pharmacy; A. D. Williams Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health, National Center for Advancing Translational Sciences, Grant UL1TR000058 (to the Virginia Commonwealth University Center for Clinical and Translational Research). This work was also supported by the startup funds from the Virginia Commonwealth University School of Pharmacy and the A. D. Williams Fund.	Bailey AO, 2013, P NATL ACAD SCI USA, V110, P11827, DOI 10.1073/pnas.1300325110; Biron E, 2006, J PEPT SCI, V12, P213, DOI 10.1002/psc.711; BORCH RF, 1971, J AM CHEM SOC, V93, P2897, DOI 10.1021/ja00741a013; Cai Q, 2014, J BIOL CHEM, V289, P16046, DOI 10.1074/jbc.M114.558510; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Collazo E, 2005, ANAL BIOCHEM, V342, P86, DOI 10.1016/j.ab.2005.04.007; Copeland R.A., 2000, ENZYMES PRACTICAL IN, P352; Copeland RA, 2010, CURR OPIN CHEM BIOL, V14, P505, DOI 10.1016/j.cbpa.2010.06.174; Ctrnacta V, 2007, FEMS MICROBIOL LETT, V273, P87, DOI 10.1111/j.1574-6968.2007.00795.x; Dai XX, 2013, J PROTEOME RES, V12, P4167, DOI 10.1021/pr400498y; Dorgan KM, 2006, ANAL BIOCHEM, V350, P249, DOI 10.1016/j.ab.2006.01.004; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Petkowski JJ, 2013, BIOCHEM J, V456, P453, DOI 10.1042/BJ20131163; Petkowski JJ, 2012, BIOCHEMISTRY-US, V51, P5942, DOI 10.1021/bi300278f; Pu D, 2008, RAPID COMMUN MASS SP, V22, P91, DOI 10.1002/rcm.3337; Rechthaler J, 2013, J AM SOC MASS SPECTR, V24, P701, DOI 10.1007/s13361-013-0614-0; Reid GE, 2000, J AM SOC MASS SPECTR, V11, P1047, DOI 10.1016/S1044-0305(00)00189-6; Santhiya D, 2009, LANGMUIR, V25, P13770, DOI 10.1021/la901546t; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9; Tooley CES, 2010, NATURE, V466, P1125, DOI 10.1038/nature09343; Villar-Garea A, 2012, NUCLEIC ACIDS RES, V40, P1536, DOI 10.1093/nar/gkr935; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Yost Julianne M, 2011, Curr Chem Genomics, V5, P72, DOI 10.2174/1875397301005010072; Zhu Xiangping, 2003, J Biomol Tech, V14, P298	27	26	26	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11601	11610		10.1074/jbc.M114.626846	http://dx.doi.org/10.1074/jbc.M114.626846			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25771539	Green Published, hybrid			2022-12-28	WOS:000353719400035
J	Li, LY; Homan, KT; Vishnivetskiy, SA; Manglik, A; Tesmer, JJG; Gurevich, VV; Gurevich, EV				Li, Lingyong; Homan, Kristoff T.; Vishnivetskiy, Sergey A.; Manglik, Aashish; Tesmer, John J. G.; Gurevich, Vsevolod V.; Gurevich, Eugenia V.			G Protein-coupled Receptor Kinases of the GRK4 Protein Subfamily Phosphorylate Inactive G Protein-coupled Receptors (GPCRs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; LIGHT-DEPENDENT PHOSPHORYLATION; RHODOPSIN KINASE; BETA(2)-ADRENERGIC RECEPTOR; VISUAL ARRESTIN; CONSTITUTIVE ACTIVITY; DIFFERENTIALLY AFFECT; VASOPRESSIN RECEPTOR; NONVISUAL ARRESTINS; SIGNALING PATHWAYS	G protein-coupled receptor (GPCR) kinases (GRKs) play a key role in homologous desensitization of GPCRs. It is widely assumed that most GRKs selectively phosphorylate only active GPCRs. Here, we show that although this seems to be the case for the GRK2/3 subfamily, GRK5/6 effectively phosphorylate inactive forms of several GPCRs, including beta 2-adrenergic and M2 muscarinic receptors, which are commonly used as representative models for GPCRs. Agonist-independent GPCR phosphorylation cannot be explained by constitutive activity of the receptor or membrane association of the GRK, suggesting that it is an inherent ability of GRK5/6. Importantly, phosphorylation of the inactive beta(2)-adrenergic receptor enhanced its interactions with arrestins. Arrestin-3 was able to discriminate between phosphorylation of the same receptor by GRK2 and GRK5, demonstrating preference for the latter. Arrestin recruitment to inactive phosphorylated GPCRs suggests that not only agonist activation but also the complement of GRKs in the cell regulate formation of the arrestin-receptor complex and thereby G protein-independent signaling.	[Li, Lingyong; Vishnivetskiy, Sergey A.; Gurevich, Vsevolod V.; Gurevich, Eugenia V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Homan, Kristoff T.; Tesmer, John J. G.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Manglik, Aashish] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Vanderbilt University; University of Michigan System; University of Michigan; Stanford University	Gurevich, EV (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Preston Res Bldg,Rm 454, Nashville, TN 37232 USA.	Eugenia.Gurevich@vanderbilt.edu	Vishnivetskiy, Sergey/AAJ-8661-2020; Li, Lingyong/D-7493-2016; Regan, Clinton/E-6250-2012; Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351; Tesmer, John/0000-0003-1125-3727	National Institutes of Health [NS065868, R21DA030103, GM077561, EY011500, HL071818, HL086865]; American Heart Association [N014938]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818, R01HL086865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109955, R01GM077561, T32GM008294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS065868 and R21DA030103 (to E V. G.), GM077561 and EY011500 (to V. V. G.), and HL071818 and HL086865 (to J. J. G. T.). This work was also supported by American Heart Association Grant N014938 (to K. T. H.).	Ahmed MR, 2008, J NEUROCHEM, V104, P1622, DOI 10.1111/j.1471-4159.2007.05104.x; Ahmed MR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000664; Ahmed MR, 2008, J PHARMACOL EXP THER, V325, P276, DOI 10.1124/jpet.107.131987; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Baameur F, 2010, MOL PHARMACOL, V77, P405, DOI 10.1124/mol.109.058115; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; BENOVIC JL, 1988, J BIOL CHEM, V263, P3893; BENOVIC JL, 1987, J BIOL CHEM, V262, P9026; BENOVIC JL, 1986, NATURE, V321, P869, DOI 10.1038/321869a0; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BINDER BM, 1990, J BIOL CHEM, V265, P15333; Binder BM, 1996, J BIOL CHEM, V271, P19826, DOI 10.1074/jbc.271.33.19826; Boguth CA, 2010, EMBO J, V29, P3249, DOI 10.1038/emboj.2010.206; BOWNDS D, 1972, NATURE-NEW BIOL, V237, P125, DOI 10.1038/newbio237125a0; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Bychkov ER, 2008, NEUROBIOL AGING, V29, P379, DOI 10.1016/j.neurobiolaging.2006.10.012; Bychkov ER, 2011, NEUROBIOL DIS, V44, P248, DOI 10.1016/j.nbd.2011.07.009; Bychkov E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048912; Bychkov E, 2011, INT J NEUROPSYCHOPH, V14, P1, DOI 10.1017/S1461145710000118; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Chanrion B, 2008, MOL PHARMACOL, V73, P748, DOI 10.1124/mol.107.041574; CHEN CY, 1993, J BIOL CHEM, V268, P7825; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Daaka Y, 1997, P NATL ACAD SCI USA, V94, P2180, DOI 10.1073/pnas.94.6.2180; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; Fryxell KJ, 1996, TRENDS GENET, V12, P364, DOI 10.1016/S0168-9525(96)80020-5; Gimenez LE, 2014, CELL SIGNAL, V26, P1523, DOI 10.1016/j.cellsig.2014.03.019; Gimenez LE, 2012, J BIOL CHEM, V287, P29495, DOI 10.1074/jbc.M112.366674; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Gurevich VV, 2014, CURR OPIN CELL BIOL, V27, P1, DOI 10.1016/j.ceb.2013.10.007; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Hisatomi O, 1998, FEBS LETT, V424, P159, DOI 10.1016/S0014-5793(98)00162-8; Homan KT, 2014, CURR OPIN CELL BIOL, V27, P25, DOI 10.1016/j.ceb.2013.10.009; Huang CC, 2011, BIOCHEMISTRY-US, V50, P1940, DOI 10.1021/bi101606e; Huang CC, 2011, J BIOL CHEM, V286, P7715, DOI 10.1074/jbc.R109.051847; Huang CC, 2009, J BIOL CHEM, V284, P17206, DOI 10.1074/jbc.M809544200; KIM CM, 1993, J BIOL CHEM, V268, P15412; KIM CM, 1993, RECEPTOR, V3, P39; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; KUHN H, 1972, FEBS LETT, V20, P1, DOI 10.1016/0014-5793(72)80002-4; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lau EK, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001748; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; LORENZ W, 1991, P NATL ACAD SCI USA, V88, P8715, DOI 10.1073/pnas.88.19.8715; Loudon RP, 1997, J BIOL CHEM, V272, P27422, DOI 10.1074/jbc.272.43.27422; Mushegian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033806; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; OHTA T, 1991, J MOL EVOL, V33, P34, DOI 10.1007/BF02100193; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; Pitcher JA, 1999, J BIOL CHEM, V274, P34531, DOI 10.1074/jbc.274.49.34531; Premont RT, 1999, J BIOL CHEM, V274, P29381, DOI 10.1074/jbc.274.41.29381; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Rankin ML, 2006, MOL PHARMACOL, V69, P759, DOI 10.1124/mol.105.019901; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; STOFFEL RH, 1994, J BIOL CHEM, V269, P27791; Stoffel RH, 1998, BIOCHEMISTRY-US, V37, P16053, DOI 10.1021/bi981432d; Tesmer JJG, 2012, ACTA CRYSTALLOGR F, V68, P622, DOI 10.1107/S1744309112017435; Tesmer JJG, 2010, J MED CHEM, V53, P1867, DOI 10.1021/jm9017515; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Thiyagarajan MM, 2004, J BIOL CHEM, V279, P17989, DOI 10.1074/jbc.M310738200; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2013, J BIOL CHEM, V288, P3394, DOI 10.1074/jbc.M112.445437; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Walther C, 2010, J BIOL CHEM, V285, P41578, DOI 10.1074/jbc.M110.162156; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Woollard Alison, 2005, WormBook, P1, DOI 10.1895/wormbook.1.2.1; Yang P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082072; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034	95	40	40	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10775	10790		10.1074/jbc.M115.644773	http://dx.doi.org/10.1074/jbc.M115.644773			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25770216	Green Published, hybrid			2022-12-28	WOS:000353404500019
J	Mannangatti, P; NarasimhaNaidu, K; Damaj, MI; Ramamoorthy, S; Jayanthi, LD				Mannangatti, Padmanabhan; NarasimhaNaidu, Kamalakkannan; Damaj, Mohamad Imad; Ramamoorthy, Sammanda; Jayanthi, Lankupalle Damodara			A Role for p38 Mitogen-activated Protein Kinase-mediated Threonine 30-dependent Norepinephrine Transporter Regulation in Cocaine Sensitization and Conditioned Place Preference	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-OPIOID RECEPTOR; INSENSITIVE DOPAMINE TRANSPORTER; EXTRACELLULAR DOPAMINE; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; SURFACE EXPRESSION; SUBCELLULAR-LOCALIZATION; SEROTONIN TRANSPORTERS; INDUCED REINSTATEMENT	The noradrenergic and p38 mitogen-activated protein kinase (p38 MAPK) systems are implicated in cocaine-elicited behaviors. Previously, we demonstrated a role for p38 MAPK-mediated norepinephrine transporter (NET) Thr(30) phosphorylation in cocaine-induced NET up-regulation (Mannangatti, P., Arapulisamy, O., Shippenberg, T. S., Ramamoorthy, S., and Jayanthi, L. D. (2011) J. Biol. Chem. 286, 20239-20250). The present study explored the functional interaction between p38 MAPK-mediated NET regulation and cocaine-induced behaviors. In vitro cocaine treatment of mouse prefrontal cortex synaptosomes resulted in enhanced NET function, surface expression, and phosphorylation. Pretreatment with PD169316, a p38 MAPK inhibitor, completely blocked cocaine-mediated NET up-regulation and phosphorylation. In mice, in vivo administration of p38 MAPK inhibitor SB203580 completely blocked cocaine-induced NET up-regulation and p38 MAPK activation in the prefrontal cortex and nucleus accumbens. When tested for cocaine-induced locomotor sensitization and conditioned place preference (CPP), mice receiving SB203580 on cocaine challenge day or on postconditioning test day exhibited significantly reduced cocaine sensitization and CPP. A transactivator of transcription (TAT) peptide strategy was utilized to test the involvement of the NET-Thr(30) motif. In vitro treatment of synaptosomes with TAT-NET-Thr(30) (wild-type peptide) completely blocked cocaine-mediated NET up-regulation and phosphorylation. In vivo administration of TAT-NET-Thr(30) peptide but not TAT-NET-T30A (mutant peptide) completely blocked cocaine-mediated NET up-regulation and phosphorylation. In the cocaine CPP paradigm, mice receiving TAT-NET-Thr30 but not TAT-NET-T30A on postconditioning test day exhibited significantly reduced cocaine CPP. Following extinction, TAT-NET-Thr(30) when given prior to cocaine challenge significantly reduced reinstatement of cocaine CPP. These results demonstrate that the direct inhibition of p38 MAPK or the manipulation of NET-Thr(30) motif/phosphorylation via a TAT peptide strategy prevents cocaine-induced NET up-regulation, locomotor sensitization, and CPP, suggesting a role for Thr(30)-linked NET regulation in cocaine-elicited behaviors.	[Mannangatti, Padmanabhan; NarasimhaNaidu, Kamalakkannan; Damaj, Mohamad Imad; Ramamoorthy, Sammanda; Jayanthi, Lankupalle Damodara] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA	Virginia Commonwealth University	Jayanthi, LD (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	ljayanthi@vcu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01-GM081054, R01-MH083928]; Virginia Commonwealth University; department of Pharmacology and Toxicology, Virginia Commonwealth University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University; department of Pharmacology and Toxicology, Virginia Commonwealth University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM081054 (to L. D. J.) and R01-MH083928 (to S. R.). This work was also supported by start-up funds from Virginia Commonwealth University (to L. D. J. and S. R.).; Recipient of postdoctoral support from the department of Pharmacology and Toxicology, Virginia Commonwealth University.	AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Apparsundaram S, 1998, J PHARMACOL EXP THER, V287, P733; Arai A, 2008, SYNAPSE, V62, P632, DOI 10.1002/syn.20535; Arapulisamy O, 2013, J BIOL CHEM, V288, P28599, DOI 10.1074/jbc.M113.472878; ASTIER B, 1990, NEUROSCI LETT, V118, P141, DOI 10.1016/0304-3940(90)90612-D; Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; AXELROD J, 1971, SCIENCE, V173, P598, DOI 10.1126/science.173.3997.598; Barker Eric L., 1995, P321; Borgkvist A, 2011, NEURON, V70, P803, DOI 10.1016/j.neuron.2011.05.024; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Bruss M, 1999, J NEURAL TRANSM, V106, P657, DOI 10.1007/s007020050187; CAO CJ, 1990, BIOCHEM PHARMACOL, V39, pR9, DOI 10.1016/0006-2952(90)90275-P; Carboni E, 2006, J NEUROCHEM, V96, P473, DOI 10.1111/j.1471-4159.2005.03556.x; CARBONI E, 1990, J NEUROCHEM, V55, P1067, DOI 10.1111/j.1471-4159.1990.tb04599.x; Chen H, 2009, NEUROSCI LETT, V452, P258, DOI 10.1016/j.neulet.2009.01.078; Chen R, 2006, P NATL ACAD SCI USA, V103, P9333, DOI 10.1073/pnas.0600905103; Choe ES, 2002, NEUROREPORT, V13, P1013, DOI 10.1097/00001756-200206120-00006; Conrad KL, 2013, PSYCHOPHARMACOLOGY, V227, P109, DOI 10.1007/s00213-012-2944-1; Cornish JL, 2001, J ADDICT DIS, V20, P43, DOI 10.1300/J069v20n03_05; Daws LC, 2002, BIOCHEM BIOPH RES CO, V290, P1545, DOI 10.1006/bbrc.2002.6384; Devoto P, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-31; Ding YS, 2010, SYNAPSE, V64, P30, DOI 10.1002/syn.20696; Doucet EL, 2013, BIOL PSYCHIAT, V74, P90, DOI 10.1016/j.biopsych.2012.11.029; Fan L, 2009, J PHARMACOL EXP THER, V328, P99, DOI 10.1124/jpet.108.145201; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Fritz JD, 1998, J NEUROCHEM, V70, P2241; Fujita Y, 2012, PHARMACOL BIOCHEM BE, V101, P303, DOI 10.1016/j.pbb.2012.01.005; Gurguis GNM, 1999, PSYCHIAT RES, V89, P73, DOI 10.1016/S0165-1781(99)00103-1; Hall FS, 2002, NEUROSCIENCE, V115, P153, DOI 10.1016/S0306-4522(02)00379-2; Ignatowska-Jankowska BM, 2013, PSYCHOPHARMACOLOGY, V229, P591, DOI 10.1007/s00213-013-3117-6; Itzhak Y, 2012, ADDICT BIOL, V17, P706, DOI 10.1111/j.1369-1600.2011.00334.x; Jackson KJ, 2013, PSYCHOPHARMACOLOGY, V226, P763, DOI 10.1007/s00213-012-2716-y; Jackson KJ, 2012, GENES BRAIN BEHAV, V11, P993, DOI 10.1111/j.1601-183X.2012.00827.x; Jackson KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051154; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Jeannotte AM, 2009, NEUROSCI LETT, V467, P86, DOI 10.1016/j.neulet.2009.10.010; Kalivas PW, 2011, MOL PSYCHIATR, V16, P974, DOI 10.1038/mp.2011.46; Kalivas PW, 2007, AM J ADDICTION, V16, P71, DOI 10.1080/10550490601184142; Kaye DM, 1997, AM J PHYSIOL-HEART C, V272, pH875, DOI 10.1152/ajpheart.1997.272.2.H875; Kivell B, 2014, NEUROPHARMACOLOGY, V86, P228, DOI 10.1016/j.neuropharm.2014.07.016; KLEVEN MS, 1990, PSYCHOPHARMACOLOGY, V101, P208, DOI 10.1007/BF02244128; Kota D, 2007, J PHARMACOL EXP THER, V322, P399, DOI 10.1124/jpet.107.121616; Li GH, 2005, J PHARMACOL EXP THER, V312, P112, DOI 10.1124/jpet.104.073494; Malhotra A, 2005, AM J PHYSIOL-HEART C, V289, pH1343, DOI 10.1152/ajpheart.01200.2004; Mannangatti P, 2011, J BIOL CHEM, V286, P20239, DOI 10.1074/jbc.M111.226811; Marquez P, 2013, EUR J PHARMACOL, V707, P41, DOI 10.1016/j.ejphar.2013.03.021; Matthies HJG, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-65; MELLO NK, 1990, DRUG ALCOHOL DEPEN, V26, P103, DOI 10.1016/0376-8716(90)90117-W; Moron JA, 2003, J NEUROSCI, V23, P8480; Murphy Stephen, 2005, Cardiol Rev, V13, P3; Nestler EJ, 1996, MOL PSYCHIATR, V1, P190; O'Neill B, 2014, NEUROPHARMACOLOGY, V79, P626, DOI 10.1016/j.neuropharm.2013.12.023; Olive MF, 2005, MOL PHARMACOL, V67, P349, DOI 10.1124/mol.104.003319; Olive MF, 2004, MOL NEUROBIOL, V29, P139, DOI 10.1385/MN:29:2:139; Platt DM, 2007, J PHARMACOL EXP THER, V322, P894, DOI 10.1124/jpet.107.121806; Pum ME, 2008, PSYCHOPHARMACOLOGY, V201, P391, DOI 10.1007/s00213-008-1296-3; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Ramamoorthy S, 2011, PHARMACOL THERAPEUT, V129, P220, DOI 10.1016/j.pharmthera.2010.09.009; Rickhag M, 2013, J BIOL CHEM, V288, P27534, DOI 10.1074/jbc.M112.441295; Samuvel DJ, 2008, J PHARMACOL EXP THER, V325, P293, DOI 10.1124/jpet.107.130534; Samuvel DJ, 2005, J NEUROSCI, V25, P29, DOI 10.1523/JNEUROSCI.3754-04.2005; SHIMADA S, 1991, SCIENCE, V254, P576, DOI 10.1126/science.1948034; Siuta MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000393; Smith JS, 2012, J NEUROSCI, V32, P1488, DOI 10.1523/JNEUROSCI.2980-11.2012; Smith RJ, 2013, CURR OPIN NEUROBIOL, V23, P546, DOI 10.1016/j.conb.2013.01.026; Sorg BA, 1997, J PHARMACOL EXP THER, V281, P54; Steinkellner T, 2014, NEUROPSYCHOPHARMACOL, V39, P2681, DOI 10.1038/npp.2014.124; Tejeda HA, 2013, NEUROPSYCHOPHARMACOL, V38, P1770, DOI 10.1038/npp.2013.76; TELLA SR, 1995, PHARMACOL BIOCHEM BE, V51, P687, DOI 10.1016/0091-3057(94)00438-O; Tzschentke TM, 1998, BEHAV BRAIN RES, V97, P115, DOI 10.1016/S0166-4328(98)00034-5; Tzschentke TM, 1999, EUR J NEUROSCI, V11, P4099, DOI 10.1046/j.1460-9568.1999.00834.x; Valentini V, 2004, J NEUROCHEM, V88, P917, DOI 10.1046/j.1471-4159.2003.02238.x; Valjent E, 2005, M S-MED SCI, V21, P453, DOI 10.1051/medsci/2005215453; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Volkow ND, 2011, P NATL ACAD SCI USA, V108, P15037, DOI 10.1073/pnas.1010654108; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; Yamamoto BK, 1998, J NEUROCHEM, V71, P274; Zhang L, 1998, MOL BRAIN RES, V59, P66, DOI 10.1016/S0169-328X(98)00138-7; Zhu CB, 2010, NEUROPSYCHOPHARMACOL, V35, P2510, DOI 10.1038/npp.2010.116	79	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10814	10827		10.1074/jbc.M114.612192	http://dx.doi.org/10.1074/jbc.M114.612192			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	CG6IX	25724654	Green Published, hybrid			2022-12-28	WOS:000353404500022
J	Pena-Munzenmayer, G; Catalan, MA; Kondo, Y; Jaramillo, Y; Liu, F; Shull, GE; Melvin, JE				Pena-Muenzenmayer, Gaspar; Catalan, Marcelo A.; Kondo, Yusuke; Jaramillo, Yasna; Liu, Frances; Shull, Gary E.; Melvin, James E.			Ae4 (Slc4a9) Anion Exchanger Drives Cl- Uptake-dependent Fluid Secretion by Mouse Submandibular Gland Acinar Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CL-/HCO3-EXCHANGER; SALIVARY-GLAND; UP-REGULATION; TARGETED DISRUPTION; INTERCALATED CELLS; INTRACELLULAR PH; ION-TRANSPORT; MICE LACKING; COTRANSPORTER; HCO3	Transcellular Cl- movement across acinar cells is the rate-limiting step for salivary gland fluid secretion. Basolateral Nkcc1 Na+-K+-2Cl(-) cotransporters play a critical role in fluid secretion by promoting the intracellular accumulation of Cl- above its equilibrium potential. However, salivation is only partially abolished in the absence of Nkcc1 cotransporter activity, suggesting that another Cl- uptake pathway concentrates Cl- ions in acinar cells. To identify alternative molecular mechanisms, we studied mice lacking Ae2 and Ae4 Cl-/HCO3- exchangers. We found that salivation stimulated by muscarinic and beta-adrenergic receptor agonists was normal in the submandibular glands of Ae2(-/-) mice. In contrast, saliva secretion was reduced by 35% in Ae4(-/-) mice. The decrease in salivation was not related to loss of Na+-K+-2Cl(-) cotransporter or Na+/H+ exchanger activity in Ae4(-/-) mice but correlated with reduced Cl- uptake during beta-adrenergic receptor activation of cAMP signaling. Direct measurements of Cl-/HCO3- exchanger activity revealed that HCO3--dependent Cl- uptake was reduced in the acinar cells of Ae2(-/-) and Ae4(-/-) mice. Moreover, Cl-/HCO3- exchanger activity was nearly abolished in double Ae4/Ae2 knock-out mice, suggesting that most of the Cl-/HCO3- exchanger activity in submandibular acinar cells depends on Ae2 and Ae4 expression. In conclusion, both Ae2 and Ae4 anion exchangers are functionally expressed in submandibular acinar cells; however, only Ae4 expression appears to be important for cAMP-dependent regulation of fluid secretion.	[Pena-Muenzenmayer, Gaspar; Catalan, Marcelo A.; Kondo, Yusuke; Jaramillo, Yasna; Liu, Frances; Melvin, James E.] NIDCR, Secretory Mech & Dysfunct Sect, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Shull, Gary E.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Coll Med, Cincinnati, OH 45267 USA; [Kondo, Yusuke] Kyushu Dent Univ, Dept Oral Reconstruct & Rehabil, Kitakyushu, Fukuoka, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University System of Ohio; University of Cincinnati; Kyushu Dental University	Melvin, JE (corresponding author), NIDCR, Secretory Mech & Dysfunct Sect, Div Intramural Res, NIH, Bethesda, MD 20892 USA.	james.melvin@nih.gov	Catalan, Marcelo/ABE-7044-2021; Pena-Munzenmayer, Gaspar/ABD-2296-2021; Catalan, Marcelo/AAW-3848-2020; Regan, Clinton/E-6250-2012	Pena-Munzenmayer, Gaspar/0000-0001-6633-0545; Catalan, Marcelo/0000-0003-3544-2821; Kondo, Yusuke/0000-0002-1975-3796	National Institutes of Health (NIH), NIDCR, Division of Intramural Research; NIH [DK050594]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIEDE000727, ZIADE000738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK050594, R01DK050594] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIDCR, Division of Intramural Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health (NIH), NIDCR, Division of Intramural Research (to the Secretory Mechanisms and Dysfunction Section) and NIH Grant DK050594 (to G. E. S.).	ATKINSON JC, 1994, J AM DENT ASSOC, V125, P409, DOI 10.14219/jada.archive.1994.0059; CASE RM, 1982, J PHYSIOL-LONDON, V322, P273, DOI 10.1113/jphysiol.1982.sp014037; Catalan MA, 2014, CELL CALCIUM, V55, P362, DOI 10.1016/j.ceca.2014.01.005; Catalan MA, 2010, J PHYSIOL-LONDON, V588, P713, DOI 10.1113/jphysiol.2009.183541; Chambrey R, 2013, P NATL ACAD SCI USA, V110, P7928, DOI 10.1073/pnas.1221496110; CHAO AC, 1989, BIOPHYS J, V56, P1071, DOI 10.1016/S0006-3495(89)82755-9; Coury F, 2013, P NATL ACAD SCI USA, V110, P2163, DOI 10.1073/pnas.1206392110; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Evans RL, 1999, J BIOL CHEM, V274, P29025, DOI 10.1074/jbc.274.41.29025; Evans RL, 2000, J BIOL CHEM, V275, P26720; Evans RL, 1997, J PHYSIOL-LONDON, V499, P351, DOI 10.1113/jphysiol.1997.sp021932; FAELLI A, 1984, PHARMACOL RES COMMUN, V16, P339, DOI 10.1016/S0031-6989(84)80002-8; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Flodby P, 2010, AM J RESP CELL MOL, V43, P173, DOI 10.1165/rcmb.2009-0226OC; Gawenis LR, 2010, AM J PHYSIOL-GASTR L, V298, pG493, DOI 10.1152/ajpgi.00178.2009; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; Gonzalez-Begne M, 2007, J BIOL CHEM, V282, P35125, DOI 10.1074/jbc.M707266200; Grubb BR, 2000, AM J PHYSIOL-GASTR L, V279, pG707, DOI 10.1152/ajpgi.2000.279.4.G707; Grubb BR, 2001, AM J PHYSIOL-CELL PH, V281, pC615, DOI 10.1152/ajpcell.2001.281.2.C615; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kleinboelting S, 2014, P NATL ACAD SCI USA, V111, P3727, DOI 10.1073/pnas.1322778111; Ko SBH, 2002, AM J PHYSIOL-CELL PH, V283, pC1206, DOI 10.1152/ajpcell.00512.2001; KOEFOEDJOHNSEN V, 1958, ACTA PHYSIOL SCAND, V42, P298, DOI 10.1111/j.1748-1716.1958.tb01563.x; Krane CM, 2001, J BIOL CHEM, V276, P23413, DOI 10.1074/jbc.M008760200; Lee MG, 2008, GUT, V57, P1037, DOI 10.1136/gut.2008.150961; Lee MG, 2012, PHYSIOL REV, V92, P39, DOI 10.1152/physrev.00011.2011; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; MELVIN JE, 1992, AM J PHYSIOL, V262, pG393, DOI 10.1152/ajpgi.1992.262.3.G393; Nakamoto T, 2007, AM J PHYSIOL-REG I, V292, pR2380, DOI 10.1152/ajpregu.00591.2006; Nakamoto T, 2009, J BIOL CHEM, V284, P4815, DOI 10.1074/jbc.M808597200; NAUNTOFTE B, 1992, AM J PHYSIOL, V263, pG823, DOI 10.1152/ajpgi.1992.263.6.G823; Nguyen HV, 2004, AM J PHYSIOL-GASTR L, V286, pG312, DOI 10.1152/ajpgi.00158.2003; Nguyen HV, 2000, J PHYSIOL-LONDON, V523, P139, DOI 10.1111/j.1469-7793.2000.t01-2-00139.x; NOVAK I, 1986, PFLUG ARCH EUR J PHY, V407, P649, DOI 10.1007/BF00582647; Park K, 2000, J KOREAN MED SCI, V15, pS5, DOI 10.3346/jkms.2000.15.S.S5; Parker MD, 2013, PHYSIOL REV, V93, P803, DOI 10.1152/physrev.00023.2012; Parker MD, 2002, FASEB J, V16, pA796; PAULAIS M, 1992, J CLIN INVEST, V89, P1142, DOI 10.1172/JCI115695; PIRANI D, 1987, PFLUG ARCH EUR J PHY, V408, P178, DOI 10.1007/BF00581349; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; QUINTON PM, 1999, PHYSIOL REV, V79, P3; Reuss L, 2001, J MEMBRANE BIOL, V184, P211, DOI 10.1007/s00232-001-0096-z; Reynolds A, 2007, J PHYSIOL-LONDON, V582, P507, DOI 10.1113/jphysiol.2007.129718; Romanenko VG, 2008, AM J PHYSIOL-GASTR L, V295, pG1058, DOI 10.1152/ajpgi.90384.2008; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Romero MF, 2013, MOL ASPECTS MED, V34, P159, DOI 10.1016/j.mam.2012.10.008; Seidler U, 2001, JOP, V2, P247; Sekler I, 1996, CELL, V86, P929, DOI 10.1016/S0092-8674(00)80168-3; Shahidullah M, 2013, AM J PHYSIOL-CELL PH, V305, pC492, DOI 10.1152/ajpcell.00057.2013; Simpson JE, 2007, AM J PHYSIOL-GASTR L, V292, pG1079, DOI 10.1152/ajpgi.00354.2006; Suzuki M, 2006, CELL MOL LIFE SCI, V63, P12, DOI 10.1007/s00018-005-5336-4; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Tsuganezawa H, 2001, J BIOL CHEM, V276, P8180, DOI 10.1074/jbc.M004513200; VEGA FV, 1988, ACTA PHYSIOL SCAND, V134, P543, DOI 10.1111/j.1365-201X.1988.tb10633.x; Walker NM, 2002, GASTROENTEROLOGY, V123, P531, DOI 10.1053/gast.2002.34757; Xu J, 2003, AM J PHYSIOL-GASTR L, V285, pG1225, DOI 10.1152/ajpgi.00236.2003	58	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10677	10688		10.1074/jbc.M114.612895	http://dx.doi.org/10.1074/jbc.M114.612895			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25745107	Green Published, hybrid			2022-12-28	WOS:000353404500011
J	Tomizuka, J; Tachibanaki, S; Kawamura, S				Tomizuka, Junko; Tachibanaki, Shuji; Kawamura, Satoru			Phosphorylation-independent Suppression of Light-activated Visual Pigment by Arrestin in Carp Rods and Cones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHODIESTERASE ACTIVATION; FUNCTIONAL-CHARACTERIZATION; 48-KDA PROTEIN; MOUSE RODS; IN-VIVO; RHODOPSIN; PHOTORECEPTORS; EXPRESSION; PHOTOTRANSDUCTION; PHOTORESPONSES	Visual pigment in photoreceptors is activated by light. Activated visual pigment (R*) is believed to be inactivated by phosphorylation of R* with subsequent binding of arrestin. There are two types of photoreceptors, rods and cones, in the vertebrate retina, and they express different subtypes of arrestin, rod and cone type. To understand the difference in the function between rod- and cone-type arrestin, we first identified the subtype of arrestins expressed in rods and cones in carp retina. We found that two rod-type arrestins, rArr1 and rArr2, are co-expressed in a rod and that a cone-type arrestin, cArr1, is expressed in blue- and UV-sensitive cones; the other cone-type arrestin, cArr2, is expressed in red- and green-sensitive cones. We quantified each arrestin subtype and estimated its concentration in the outer segment of a rod or a cone in the dark; they were similar to 0.25 mM (rArr1 plus rArr2) in a rod and 0.6-0.8 mm (cArr1 or cArr2) in a cone. The effect of each arrestin was examined. In contrast to previous studies, both rod and cone arrestins suppressed the activation of transducin in the absence of visual pigment phosphorylation, and all of the arrestins examined (rArr1, rArr2, and cArr2) bound transiently to most probably nonphosphorylated R*. One rod arrestin, rArr2, bound firmly to phosphorylated pigment, and the other two, rArr1 and cArr2, once bound to phosphorylated R* but dissociated from it during incubation. Our results suggested a novel mechanism of arrestin effect on the suppression of the R* activity in both rods and cones.	[Tomizuka, Junko; Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Grad Sch Frontier Biosci, Yamada Oka 1-3, Suita, Osaka 5650871, Japan; [Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Dept Biol Sci, Grad Sch Sci, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Kawamura, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Yamada Oka 1-3, Suita, Osaka 5650871, Japan.	kawamura@fbs.osaka-u.ac.jp			Japan Society for the Promotion of Science [23227002, 24570085]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science Grants 23227002 (to S. K.) and 24570085 (to S. T.).	Arinobu D, 2010, J NEUROCHEM, V115, P259, DOI 10.1111/j.1471-4159.2010.06925.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burns ME, 2006, J NEUROSCI, V26, P1036, DOI 10.1523/JNEUROSCI.3301-05.2006; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; CRAFT CM, 1994, J BIOL CHEM, V269, P4613; Fein A., 1982, PHOTORECEPTORS THEIR, P33; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Golobokova EY, 2006, VISION RES, V46, P2287, DOI 10.1016/j.visres.2005.12.017; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; Imanishi Y, 1999, FEBS LETT, V462, P31, DOI 10.1016/S0014-5793(99)01483-0; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Kennedy MJ, 2004, NEURON, V41, P915, DOI 10.1016/S0896-6273(04)00086-8; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; KIMURA N, 1983, J BIOL CHEM, V258, P2278; Koshitani Y, 2014, J BIOL CHEM, V289, P2651, DOI 10.1074/jbc.M113.495325; KUHN H, 1984, FEBS LETT, V176, P473, DOI 10.1016/0014-5793(84)81221-1; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; MCKECHNIE NM, 1986, EXP EYE RES, V42, P479, DOI 10.1016/0014-4835(86)90007-2; MORRISON WR, 1964, ANAL BIOCHEM, V7, P218, DOI 10.1016/0003-2697(64)90231-3; Nikonov SS, 2008, NEURON, V59, P462, DOI 10.1016/j.neuron.2008.06.011; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; Renninger SL, 2011, EUR J NEUROSCI, V33, P658, DOI 10.1111/j.1460-9568.2010.07574.x; Sakuma H, 1996, FEBS LETT, V382, P105, DOI 10.1016/0014-5793(96)00163-9; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; Shimauchi-Matsukawa Y, 2005, MOL VIS, V11, P1220; Shimauchi-Matsukawa Y, 2008, MOL VIS, V14, P358; Smith WC, 2000, INVEST OPHTH VIS SCI, V41, P2445; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Zhang HB, 2003, INVEST OPHTH VIS SCI, V44, P2858, DOI 10.1167/iovs.03-0072; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003; Zhu XM, 2002, MOL VIS, V8, P462	40	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9399	9411		10.1074/jbc.M114.634543	http://dx.doi.org/10.1074/jbc.M114.634543			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713141	Green Published, hybrid			2022-12-28	WOS:000352729400009
J	Etoh, K; Fukuda, M				Etoh, Kan; Fukuda, Mitsunori			Structure-Function Analyses of the Small GTPase Rab35 and Its Effector Protein Centaurin-beta 2/ACAP2 during Neurite Outgrowth of PC12 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUCCESSFUL CYTOKINESIS; RECYCLING ENDOSOMES; MEMBRANE IDENTITY; BINDING PROTEINS; ARF6; RECRUITMENT; DOMAIN; FAMILY; ACAP2; GAPS	The small GTPase Rab35 is a molecular switch for membrane trafficking that regulates a variety of cellular events. We previously showed that Rab35 promotes neurite outgrowth of nerve growth factor-stimulated PC12 cells through interaction with centaurin-beta 2 (also called ACAP2). Centaurin-beta 2 is the only Rab35-binding protein reported thus far that exclusively recognizes Rab35 and does not recognize any of the other 59 Rabs identified in mammals, but the molecular basis for the exclusive specificity of centaurin-beta 2 for Rab35 has remained completely unknown. In this study, we performed deletion and mutation analyses and succeeded in identifying the residues of Rab35 and centaurin-beta 2 that are crucial for formation of a Rab35 center dot centaurin-beta 2 complex. We found that two threonine residues (Thr-76 and Thr-81) in the switch II region of Rab35 are responsible for binding centaurin-beta 2 and that the same residues are dispensable for Rab35 recognition by other Rab35-binding proteins. We also determined the minimal Rab35-binding site of centaurin-beta 2 and identified two asparagine residues (Asn-610 and Asn-691) in the Rab35-binding site as key residues for its specific Rab35 recognition. We further showed by knockdown-rescue approaches that neither a centaurin-beta 2 binding-deficient Rab35(T76S/T81A) mutant nor a Rab35 binding-deficient centaurin-beta 2(N610A/N691A) mutant supported neurite outgrowth of PC12 cells, thereby demonstrating the functional significance of the Rab35/centaurin-beta 2 interaction during neurite outgrowth of PC12 cells.	[Etoh, Kan; Fukuda, Mitsunori] Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Fukuda, M (corresponding author), Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853	Ministry of Education, Culture, Sports, and Technology of Japan	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, and Technology of Japan (to M. F.).	Allaire PD, 2013, J CELL SCI, V126, P722, DOI 10.1242/jcs.112375; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Barr FA, 2013, J CELL BIOL, V202, P191, DOI 10.1083/jcb.201306010; Chesneau L, 2012, CURR BIOL, V22, P147, DOI 10.1016/j.cub.2011.11.058; Chevallier J, 2009, FEBS LETT, V583, P1096, DOI 10.1016/j.febslet.2009.03.012; Dambournet D, 2011, NAT CELL BIOL, V13, P981, DOI 10.1038/ncb2279; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Egami Y, 2011, J CELL SCI, V124, P3557, DOI 10.1242/jcs.083881; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2005, METHOD ENZYMOL, V403, P445, DOI 10.1016/S0076-6879(05)03039-9; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2002, J BIOL CHEM, V277, P40118, DOI 10.1074/jbc.M205765200; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hesketh GG, 2014, DEV CELL, V29, P591, DOI 10.1016/j.devcel.2014.04.010; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Jackson TR, 2000, J CELL BIOL, V151, P627, DOI 10.1083/jcb.151.3.627; James P, 1996, GENETICS, V144, P1425; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Kobayashi H, 2014, BIOL OPEN, V3, P803, DOI 10.1242/bio.20148771; Kobayashi H, 2013, J CELL SCI, V126, P2424, DOI 10.1242/jcs.117846; Kobayashi H, 2012, J CELL SCI, V125, P2235, DOI 10.1242/jcs.098657; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Kukimoto-Niino M, 2008, STRUCTURE, V16, P1478, DOI 10.1016/j.str.2008.07.014; Matsui T, 2012, J BIOL CHEM, V287, P28619, DOI 10.1074/jbc.M112.370544; Miyamotoa Y, 2014, MOL BIOL CELL, V25, P1532, DOI 10.1091/mbc.E13-10-0600; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Rahajeng J, 2012, TRAFFIC, V13, P82, DOI 10.1111/j.1600-0854.2011.01294.x; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Shim J, 2010, MOL CELL BIOL, V30, P1421, DOI 10.1128/MCB.01463-09; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921; Zhu YC, 2013, CELL SIGNAL, V25, P1075, DOI 10.1016/j.cellsig.2013.01.015	43	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9064	9074		10.1074/jbc.M114.611301	http://dx.doi.org/10.1074/jbc.M114.611301			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25694427	Green Published, hybrid			2022-12-28	WOS:000352207100030
J	Kaur, PJ; Strawn, R; Bai, HY; Xu, K; Ordas, G; Matsui, H; Xu, YJ				Kaur, Parminder Jeet; Strawn, Rebecca; Bai, Hanying; Xu, Ke; Ordas, Gabriel; Matsui, Hiroshi; Xu, Yujia			The Self-assembly of a Mini-fibril with Axial Periodicity from a Designed Collagen-mimetic Triple Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE-AMPHIPHILE NANOFIBERS; HIGHER-ORDER STRUCTURES; AMINO-ACID-SEQUENCE; CRYSTAL-STRUCTURE; I COLLAGEN; HYDROXYPROLINE; STABILIZATION; TROPOCOLLAGEN; RECOGNITION; ASSOCIATION	In this work we describe the self-assembly of a collagen-like periodic mini-fibril from a recombinant triple helix. The triple helix, designated Col108, is expressed in Escherichia coli using an artificial gene and consists of a 378-residue triple helix domain organized into three pseudo-repeating sequence units. The peptide forms a stable triple helix with a melting temperature of 41 degrees C. Upon increases of pH and temperature, Col108 self-assembles in solution into smooth mini-fibrils with the cross-striated banding pattern typical of fibrillar collagens. The banding pattern is characterized by an axially repeating feature of similar to 35nmas observed by transmission electron microscopy and atomic force microscopy. Both the negatively stained and the positively stained transmission electron microscopy patterns of the Col108 mini-fibrils are consistent with a staggered arrangement of triple helices having a staggering value of 123 residues, a value closely connected to the size of one repeat sequence unit. A mechanism is proposed for the mini-fibril formation of Col108 in which the axial periodicity is instigated by the built-in sequence periodicity and stabilized by the optimized interactions between the triple helices in a 1-unit staggered arrangement. Lacking hydroxyproline residues and telopeptides, two factors implicated in the fibrillogenesis of native collagen, the Col108 mini-fibrils demonstrate that sequence features of the triple helical domain alone are sufficient to "code" for axially repeating periodicity of fibrils. To our knowledge, Col108 is the first designed triple helix to self-assemble into periodic fibrils and offers a unique opportunity to unravel the specific molecular interactions of collagen fibrillogenesis.	[Kaur, Parminder Jeet; Strawn, Rebecca; Bai, Hanying; Xu, Ke; Ordas, Gabriel; Matsui, Hiroshi; Xu, Yujia] CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Xu, YJ (corresponding author), CUNY Hunter Coll, Dept Chem, 695 Pk Ave, New York, NY 10065 USA.	Yujia.xu@hunter.cuny.edu			National Science Foundation [CHE 1022120]; National Institutes of Health [RR003037]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003037] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007599] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Science Foundation Grant CHE 1022120 (to Y. X.). This work was also supported in part by National Institutes of Health Grant RR003037.	BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439; Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5; Cejas MA, 2007, J AM CHEM SOC, V129, P2202, DOI 10.1021/ja066986f; COMPER WD, 1977, BIOPOLYMERS, V16, P2113, DOI 10.1002/bip.1977.360161004; DOYLE BB, 1974, PROC R SOC SER B-BIO, V187, P37, DOI 10.1098/rspb.1974.0059; DRAKE MP, 1966, BIOCHEMISTRY-US, V5, P301, DOI 10.1021/bi00865a039; Feng YB, 1996, J AM CHEM SOC, V118, P10351, DOI 10.1021/ja961260c; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; GHOSH SK, 1975, BIOCHIM BIOPHYS ACTA, V405, P340, DOI 10.1016/0005-2795(75)90099-9; GUSTAVSON KH, 1955, NATURE, V175, P70, DOI 10.1038/175070a0; HEIDEMANN E, 1982, ADV POLYM SCI, V43, P143; HELSETH DL, 1981, J BIOL CHEM, V256, P7118; Hodge A, 1963, ASPECTS PROTEIN STRU, P289; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; HULMES DJS, 1977, BIOCHEM BIOPH RES CO, V77, P574, DOI 10.1016/S0006-291X(77)80017-X; HULMES DJS, 1973, J MOL BIOL, V79, P137, DOI 10.1016/0022-2836(73)90275-1; Kadler KE, 1996, BIOCHEM J, V316, P1; KADLER KE, 1987, J BIOL CHEM, V262, P15696; Kar K, 2006, J BIOL CHEM, V281, P33283, DOI 10.1074/jbc.M605747200; Kar K, 2009, BIOCHEMISTRY-US, V48, P7959, DOI 10.1021/bi900496m; Kielty Cay M., 1993, P103; Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103; Kuznetsova N, 1999, J BIOL CHEM, V274, P36083, DOI 10.1074/jbc.274.51.36083; LEIBOVICH SJ, 1970, BIOCHIM BIOPHYS ACTA, V214, P445, DOI 10.1016/0005-2795(70)90303-X; Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532; Olsen DR, 2001, J BIOL CHEM, V276, P24038, DOI 10.1074/jbc.M101613200; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Paramonov SE, 2006, BIOMACROMOLECULES, V7, P24, DOI 10.1021/bm050798k; Paramonov SE, 2006, J AM CHEM SOC, V128, P7291, DOI 10.1021/ja060573x; Perret S, 2001, J BIOL CHEM, V276, P43693, DOI 10.1074/jbc.M105507200; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; PIEZ K A, 1974, Journal of Supramolecular Structure, V2, P121, DOI 10.1002/jss.400020207; PROCKOP DJ, 1969, J BIOL CHEM, V244, P4838; Prockop DJ, 1998, J STRUCT BIOL, V122, P111, DOI 10.1006/jsbi.1998.3976; Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598; Rele S, 2007, J AM CHEM SOC, V129, P14780, DOI 10.1021/ja0758990; Stetefeld J, 2003, STRUCTURE, V11, P339, DOI 10.1016/S0969-2126(03)00025-X; Xu K, 2008, J BIOL CHEM, V283, P34337, DOI 10.1074/jbc.M805485200; Xu YJ, 2004, BIOPHYS CHEM, V108, P141, DOI 10.1016/j.bpc.2003.10.015	41	13	13	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9251	9261		10.1074/jbc.M113.542241	http://dx.doi.org/10.1074/jbc.M113.542241			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25673694	Green Published, hybrid			2022-12-28	WOS:000352207100046
J	Perry, MM; Durham, AL; Austin, PJ; Adcock, IM; Chung, KF				Perry, Mark M.; Durham, Andrew L.; Austin, Philip J.; Adcock, Ian M.; Chung, Kian Fan			BET Bromodomains Regulate Transforming Growth Factor-beta-induced Proliferation and Cytokine Release in Asthmatic Airway Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELATIVE CORTICOSTEROID INSENSITIVITY; ALVEOLAR MACROPHAGES; SELECTIVE-INHIBITION; PAUSE RELEASE; RAPID CHANGES; INFLAMMATION; EXPRESSION; CELLS; PROTEIN; MECHANISMS	Airway smooth muscle (ASM) mass is increased in asthma, and ASM cells from patients with asthma are hyperproliferative and release more IL-6 and CXCL8. The BET (bromo- and extra-terminal) family of proteins (Brd2, Brd3, and Brd4) govern the assembly of histone acetylation-dependent chromatin complexes. We have examined whether they modulate proliferation and cytokine expression in asthmatic ASM cells by studying the effect of BET bromodomain mimics JQ1/SGCBD01 and I-BET762. ASM cells from healthy individuals and nonsevere and severe asthmatics were pretreated with JQ1/SGCBD01 and I-BET762 prior to stimulation with FCS and TGF-beta. Proliferation was measured by BrdU incorporation. IL-6 and CXCL8 release was measured by ELISA, and mRNA expression was measured by quantitative RT-PCR. ChIP using a specific anti-Brd4 antibody and PCR primers directed against the transcriptional start site of IL-6 and CXCL8 gene promoters was performed. Neither JQ1/SGCBD01 nor I-BET762 had any effect on ASM cell viability. JQ1/SGCBD01 and I-BET762 inhibited FCS + TGF-beta-induced ASM cell proliferation and IL-6 and CXCL8 release in healthy individuals (>= 30 nM) and in nonsevere and severe asthma patients (>= 100 nM), with the latter requiring higher concentrations of these mimics. JQ1/SGCBD01 reduced Brd4 binding to IL8 and IL6 promoters induced by FCS + TGF-beta. Mimics of BET bromodomains inhibit aberrant ASM cell proliferation and inflammation with lesser efficiency in those from asthmatic patients. They may be effective in reducing airway remodeling in asthma.	Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Expt Studies, London SW3 6LY, England; Royal Brompton Natl Inst Hlth Res, Biomed Res Unit, London SW3 6LY, England	Imperial College London	Perry, MM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dovehouse St, London SW3 6LY, England.	m.perry@imperial.ac.uk	Chung, Kian Fan/B-1872-2012; Adcock, Ian/L-3217-2019	Chung, Kian Fan/0000-0001-7101-1426; Durham, Andrew/0000-0003-2372-4688; Adcock, Ian/0000-0003-2101-8843; Austin, Philip/0000-0002-8855-220X; Perry, Mark/0000-0002-8145-8042	Asthma UK [08/041]; Wellcome Trust [085935]; National Institute for Health Research Respiratory Disease Biomedical Research Unit at the Royal Brompton National Health Service Foundation Trust and Imperial College London; Innovative Medicines Initiative; Medical Research Council [G1000758] Funding Source: researchfish; Asthma UK [10/066] Funding Source: researchfish	Asthma UK; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Respiratory Disease Biomedical Research Unit at the Royal Brompton National Health Service Foundation Trust and Imperial College London; Innovative Medicines Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	This work was supported by Asthma UK Grant 08/041 and Wellcome Trust Grant 085935 (to K. F. C.). It was also supported by the National Institute for Health Research Respiratory Disease Biomedical Research Unit at the Royal Brompton National Health Service Foundation Trust and Imperial College London and the Innovative Medicines Initiative.	Adcock IM, 2008, CURR ALLERGY ASTHM R, V8, P171, DOI 10.1007/s11882-008-0028-4; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Anand P, 2013, CELL, V154, P569, DOI 10.1016/j.cell.2013.07.013; [Anonymous], 2000, AM J RESP CRIT CARE, V162, P2341; Bandukwala HS, 2012, P NATL ACAD SCI USA, V109, P14532, DOI 10.1073/pnas.1212264109; Belkina AC, 2013, J IMMUNOL, V190, P3670, DOI 10.4049/jimmunol.1202838; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Boardman C, 2014, PULM PHARMACOL THER, V29, P129, DOI 10.1016/j.pupt.2014.08.008; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Chang PJ, 2012, J ALLERGY CLIN IMMUN, V130, P877, DOI 10.1016/j.jaci.2012.07.017; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Chung KF, 1999, EUR RESPIR J, V13, P1198; Chung Kian Fan, 2007, Expert Rev Respir Med, V1, P209, DOI 10.1586/17476348.1.2.209; Cosio BG, 2004, AM J RESP CRIT CARE, V170, P141, DOI 10.1164/rccm.200305-659OC; Denis GV, 2010, DISCOV MED, V10, P489; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Durham AL, 2011, BBA-GEN SUBJECTS, V1810, P1103, DOI 10.1016/j.bbagen.2011.03.006; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Goupille O, 2012, BIOCHEM BIOPH RES CO, V429, P1, DOI 10.1016/j.bbrc.2012.10.112; Halayko AJ, 2003, RESP PHYSIOL NEUROBI, V137, P209, DOI 10.1016/S1569-9048(03)00148-4; Hassan M, 2010, J ALLERGY CLIN IMMUN, V125, P1037, DOI 10.1016/j.jaci.2010.02.031; Hew M, 2006, AM J RESP CRIT CARE, V174, P134, DOI 10.1164/rccm.200512-1930OC; Hewings DS, 2012, J MED CHEM, V55, P9393, DOI 10.1021/jm300915b; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Larner-Svensson HM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-68; Li J, 2011, CURR OPIN GENET DEV, V21, P231, DOI 10.1016/j.gde.2011.01.010; Macedo P, 2009, CLIN EXP ALLERGY, V39, P1668, DOI 10.1111/j.1365-2222.2009.03319.x; Meng S, 2014, J DENT RES, V93, P657, DOI 10.1177/0022034514534261; Michaeloudes C, 2011, AM J RESP CRIT CARE, V184, P894, DOI 10.1164/rccm.201011-1780OC; Michaeloudes C, 2011, AM J PHYSIOL-LUNG C, V300, pL295, DOI 10.1152/ajplung.00134.2010; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Oliver SS, 2011, CHEMBIOCHEM, V12, P299, DOI 10.1002/cbic.201000474; Patel MC, 2013, MOL CELL BIOL, V33, P2497, DOI 10.1128/MCB.01180-12; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; Perry MM, 2014, AM J RESP CELL MOL, V50, P7, DOI 10.1165/rcmb.2013-0067OC; Perry MM, 2011, AM J RESP CELL MOL, V45, P746, DOI 10.1165/rcmb.2010-0304OC; Rohn J, 2012, NAT BIOTECHNOL, V30, P305, DOI 10.1038/nbt0412-305; Shimamura T, 2013, CLIN CANCER RES, V19, P6183, DOI 10.1158/1078-0432.CCR-12-3904; Tang XY, 2013, MOL PHARMACOL, V83, P283, DOI 10.1124/mol.112.081661; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; Zirath H, 2013, P NATL ACAD SCI USA, V110, P10258, DOI 10.1073/pnas.1222404110; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	47	46	50	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9111	9121		10.1074/jbc.M114.612671	http://dx.doi.org/10.1074/jbc.M114.612671			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25697361	hybrid, Green Published			2022-12-28	WOS:000352207100034
J	Sarbeng, EB; Liu, QD; Tian, XL; Yang, J; Li, HT; Wong, JL; Zhou, L; Liu, QL				Sarbeng, Evans Boateng; Liu, Qingdai; Tian, Xueli; Yang, Jiao; Li, Hongtao; Wong, Jennifer Li; Zhou, Lei; Liu, Qinglian			A Functional DnaK Dimer Is Essential for the Efficient Interaction with Hsp40 Heat Shock Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE DNAK; NUCLEOTIDE EXCHANGE FACTOR; ESCHERICHIA-COLI; HSP70 CHAPERONES; SUBSTRATE-BINDING; PEPTIDE-BINDING; MITOCHONDRIAL HSP70; CRYSTAL-STRUCTURE; ALLOSTERIC REGULATION; INTERDOMAIN LINKER	Highly conserved molecular chaperone Hsp70 heat shock proteins play a key role in maintaining protein homeostasis (proteostasis). DnaK, a major Hsp70 in Escherichia coli, has been widely used as a paradigm for studying Hsp70s. In the absence of ATP, purified DnaK forms low-ordered oligomer, whereas ATP binding shifts the equilibrium toward the monomer. Recently, we solved the crystal structure of DnaK in complex with ATP. There are two molecules of DnaK-ATP in the asymmetric unit. Interestingly, the interfaces between the two molecules of DnaK are large with good surface complementarity, suggesting functional importance of this crystallographic dimer. Biochemical analyses of DnaK protein supported the formation of dimer in solution. Furthermore, our cross-linking experiment based on the DnaK-ATP structure confirmed that DnaK forms specific dimer in an ATP-dependent manner. To understand the physiological function of the dimer, we mutated five residues on the dimer interface. Four mutations, R56A, T301A, N537A, and D540A, resulted in loss of chaperone activity and compromised the formation of dimer, indicating the functional importance of the dimer. Surprisingly, neither the intrinsic biochemical activities, the ATP-induced allosteric coupling, nor GrpE co-chaperone interaction is affected appreciably in all of the mutations except for R56A. Unexpectedly, the interaction with co-chaperone Hsp40 is significantly compromised. In summary, this study suggests that DnaK forms a transient dimer upon ATP binding, and this dimer is essential for the efficient interaction of DnaK with Hsp40.	[Sarbeng, Evans Boateng; Liu, Qingdai; Tian, Xueli; Yang, Jiao; Li, Hongtao; Wong, Jennifer Li; Zhou, Lei; Liu, Qinglian] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University	Liu, QL (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.	qliu3@vcu.edu		Yang, Jiao/0000-0002-0518-1475	National Institutes of Health [1R01GM098592, 1RO1GM109193]; Virginia Commonwealth University School of Medicine; New Scholar Award in Aging from the Ellison Medical Foundation [AG-NS-0587-09]; American Heart Association [11GRNT7460003]; National Natural Science Foundation of China [31271676, 30900339]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109193, R01GM098592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University School of Medicine; New Scholar Award in Aging from the Ellison Medical Foundation; American Heart Association(American Heart Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM098592 (to Qinglian Liu). This work was also supported by startup funds from the Virginia Commonwealth University School of Medicine (to Qinglian Liu), New Scholar Award in Aging Grant AG-NS-0587-09 from the Ellison Medical Foundation (to Qinglian Liu), and Grant-in-aid Award 11GRNT7460003 from the American Heart Association (to Qinglian Liu).; Supported in part by Grants 31271676 and 30900339 from National Natural Science Foundation of China.; Supported in part by National Institutes of Health Grant 1RO1GM109193.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BENAROUDJ N, 1995, BIOCHEMISTRY-US, V34, P15282, DOI 10.1021/bi00046a037; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burkholder WF, 1996, P NATL ACAD SCI USA, V93, P10632, DOI 10.1073/pnas.93.20.10632; CARLINO A, 1992, P NATL ACAD SCI USA, V89, P2081, DOI 10.1073/pnas.89.6.2081; Chang YW, 2008, J BIOL CHEM, V283, P15502, DOI 10.1074/jbc.M708992200; CRAIG EA, 1985, CRC CR REV BIOCH MOL, V18, P239, DOI 10.3109/10409238509085135; Davis JE, 1999, P NATL ACAD SCI USA, V96, P9269, DOI 10.1073/pnas.96.16.9269; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Fernandez-Saiz V, 2006, J BIOL CHEM, V281, P7479, DOI 10.1074/jbc.M512744200; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; GEORGOPOULOS C, 1982, J BACTERIOL, V149, P1175, DOI 10.1128/JB.149.3.1175-1177.1982; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hendrickson WA, 2008, STRUCTURE, V16, P1153, DOI 10.1016/j.str.2008.07.002; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Jiang RF, 1997, J BIOL CHEM, V272, P6141, DOI 10.1074/jbc.272.10.6141; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Kumar DP, 2011, J MOL BIOL, V411, P1099, DOI 10.1016/j.jmb.2011.07.001; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Li JZ, 2009, PROTEIN PEPTIDE LETT, V16, P606, DOI 10.2174/092986609788490159; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; Miao BJ, 1997, J MOL BIOL, V265, P541, DOI 10.1006/jmbi.1996.0762; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; OSIPIUK J, 1993, J BIOL CHEM, V268, P4821; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Saibil HR, 2008, CURR OPIN STRUC BIOL, V18, P35, DOI 10.1016/j.sbi.2007.11.006; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SCHONFELD HJ, 1995, J BIOL CHEM, V270, P2183, DOI 10.1074/jbc.270.5.2183; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Thompson AD, 2012, CELL STRESS CHAPERON, V17, P313, DOI 10.1007/s12192-011-0307-1; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Wisen S, 2010, ACS CHEM BIOL, V5, P611, DOI 10.1021/cb1000422; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	71	54	55	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8849	8862		10.1074/jbc.M114.596288	http://dx.doi.org/10.1074/jbc.M114.596288			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25635056	Green Published, hybrid			2022-12-28	WOS:000352207100014
J	Zhao, GP; Lu, HY; Li, C				Zhao, Guoping; Lu, Huayi; Li, Chi			Proapoptotic Activities of Protein Disulfide Isomerase (PDI) and PDIA3 Protein, a Role of the Bcl-2 Protein Bak	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; INDUCED APOPTOSIS; MEDIATED APOPTOSIS; CELL-DEATH; CYTOCHROME-C; ER STRESS; X-L; FAMILY; MITOCHONDRIA; INHIBITION	Protein disulfide isomerase (PDI) family proteins are classified as enzymatic chaperones for reconstructing misfolded proteins. Previous studies have shown that several PDI members possess potential proapoptotic functions. However, the detailed molecular mechanisms of PDI-mediated apoptosis are not completely known. In this study, we investigated how two members of PDI family, PDI and PDIA3, modulate apoptotic signaling. Inhibiting PDI and PDIA3 activities pharmacologically alleviates apoptosis induced by various apoptotic stimuli. Although a decrease of PDIA3 expression alleviates apoptotic responses, overexpression of PDIA3 exacerbates apoptotic signaling. Importantly, Bak, but not Bax, is essential for PDIA3-induced proapoptotic signaling. Furthermore, both purified PDI and PDIA3 proteins induce Bak-dependent, but not Bax-dependent, mitochondrial outer membrane permeabilization in vitro, probably through triggering Bak oligomerization on mitochondria. Our results suggest that both of PDI and PDIA3 possess Bak-dependent proapoptotic function through inducing mitochondrial outer membrane permeabilization, which provides a new mechanism linking ER chaperone proteins and apoptotic signaling.	[Zhao, Guoping; Li, Chi] Univ Louisville, Mol Targets Program, Dept Med, Louisville, KY 40202 USA; [Zhao, Guoping; Li, Chi] Univ Louisville, Mol Targets Program, Dept Pharmacol, Louisville, KY 40202 USA; [Zhao, Guoping; Li, Chi] Univ Louisville, Mol Targets Program, Dept Toxicol, Louisville, KY 40202 USA; [Lu, Huayi] Jilin Univ, Hosp 2, Changchun 130041, Jilin Province, Peoples R China	University of Louisville; University of Louisville; University of Louisville; Jilin University	Li, C (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Clinical & Translat Res Bldg,Rm 418, Louisville, KY 40202 USA.	chi.li@louisville.edu			National Institutes of Health [CA106599, CA175003, RR018733]; National Natural Science Foundation of China [81300769]; James Graham Brown Cancer Center; University of Louisville School of Medicine Research Committee; NATIONAL CANCER INSTITUTE [K01CA106599, R01CA175003] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); James Graham Brown Cancer Center; University of Louisville School of Medicine Research Committee; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA106599, CA175003, and RR018733 (to C. L.). This work was also supported by National Natural Science Foundation of China Grant 81300769 (to H. L.), the James Graham Brown Cancer Center, and the University of Louisville School of Medicine Research Committee (to C. L.).	Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Cartron PF, 2003, MOL CELL BIOL, V23, P4701, DOI 10.1128/MCB.23.13.4701-4712.2003; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Coe H, 2010, INT J BIOCHEM CELL B, V42, P796, DOI 10.1016/j.biocel.2010.01.009; Corazzari M, 2007, BRIT J CANCER, V96, P1062, DOI 10.1038/sj.bjc.6603672; Dickerhof N, 2011, FEBS J, V278, P2034, DOI 10.1111/j.1742-4658.2011.08119.x; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Eno CO, 2012, BIOCHEM J, V444, P69, DOI 10.1042/BJ20112023; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Galligan JJ, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-6; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Huber-Ruano I, 2010, J CELL PHYSIOL, V225, P620, DOI 10.1002/jcp.22254; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kepp O, 2007, EMBO J, V26, P825, DOI 10.1038/sj.emboj.7601533; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lindenboim L, 2005, CELL DEATH DIFFER, V12, P713, DOI 10.1038/sj.cdd.4401638; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Lovat PE, 2008, CANCER RES, V68, P5363, DOI 10.1158/0008-5472.CAN-08-0035; Madesh M, 2009, MOL CELL BIOL, V29, P3099, DOI 10.1128/MCB.01845-08; Mossuto M. F., 2013, INT J CELL BIOL, V2013; Muller C, 2013, ANTIOXID REDOX SIGN, V18, P731, DOI 10.1089/ars.2012.4577; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Renault TT, 2014, CHEM BIOL, V21, P114, DOI 10.1016/j.chembiol.2013.10.009; Roberson EC, 2012, AM J RESP CELL MOL, V46, P573, DOI 10.1165/rcmb.2010-0460OC; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; Sliskovic I, 2006, FEBS LETT, V580, P2233, DOI 10.1016/j.febslet.2006.03.031; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wang C, 2012, ONCOGENE, V31, P3177, DOI 10.1038/onc.2011.497; Wang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038221; Wang X, 2011, CELL DEATH DIFFER, V18, P38, DOI 10.1038/cdd.2010.68; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Xu D, 2009, AM J PHYSIOL-LUNG C, V297, pL44, DOI 10.1152/ajplung.90626.2008; Zhao GP, 2014, MOL CELL BIOL, V34, P1198, DOI 10.1128/MCB.00996-13	47	36	38	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8949	8963		10.1074/jbc.M114.619353	http://dx.doi.org/10.1074/jbc.M114.619353			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25697356	Green Published, hybrid			2022-12-28	WOS:000352207100022
J	Tsai, YL; Zhang, Y; Tseng, CC; Stanciauskas, R; Pinaud, F; Lee, AS				Tsai, Yuan-Li; Zhang, Yi; Tseng, Chun-Chih; Stanciauskas, Ramunas; Pinaud, Fabien; Lee, Amy S.			Characterization and Mechanism of Stress-induced Translocation of 78-Kilodalton Glucose-regulated Protein (GRP78) to the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM CHAPERONE; MONOCLONAL-ANTIBODY; MEMBRANE-PROTEIN; LIVING CELLS; CANCER-CELLS; ATP BINDING; BREFELDIN-A; ER; RECEPTOR; BIP	Glucose-regulated protein (GRP78)/BiP, a major chaperone in the endoplasmic reticulum, is recently discovered to be preferably expressed on the surface of stressed cancer cells, where it regulates critical oncogenic signaling pathways and is emerging as a target for anti-cancer therapy while sparing normal organs. However, because GRP78 does not contain classical transmembrane domains, its mechanism of transport and its anchoring at the cell surface are poorly understood. Using a combination of biochemical, mutational, FACS, and single molecule super-resolution imaging approaches, we discovered that GRP78 majorly exists as a peripheral protein on plasma membrane via interaction with other cell surface proteins including glycosylphosphatidylinositol-anchored proteins. Moreover, cell surface GRP78 expression requires its substrate binding activity but is independent of ATP binding or a membrane insertion motif conserved with HSP70. Unexpectedly, different cancer cell lines rely on different mechanisms for GRP78 cell surface translocation, implying that the process is cell context-dependent.	[Tsai, Yuan-Li; Zhang, Yi; Tseng, Chun-Chih; Lee, Amy S.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Stanciauskas, Ramunas; Pinaud, Fabien] Univ So Calif, Dana & David Dornsife Coll Letters Arts & Sci, Dept Biol Sci, Los Angeles, CA 90089 USA; [Pinaud, Fabien] Univ So Calif, Dana & David Dornsife Coll Letters Arts & Sci, Dept Chem, Los Angeles, CA 90089 USA; [Pinaud, Fabien] Univ So Calif, Dana & David Dornsife Coll Letters Arts & Sci, Dept Phys & Astron, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Lee, AS (corresponding author), USC Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, 1441 Eastlake Ave,Rm 5308, Los Angeles, CA 90089 USA.	amylee@usc.edu	Tseng, Chun-Chih/AAS-3712-2020	Tseng, Chun-Chih/0000-0001-9285-0712; Pinaud, Fabien/0000-0002-4272-3616; Lee, Amy/0000-0002-0378-5443	National Cancer Institute Cancer Center Shared Grant [P30 CA014089]; USC Provost Office, Dean's Development Funds, Keck School of Medicine; NATIONAL CANCER INSTITUTE [R21CA179273, P30CA014089, R01CA027607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG034906] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center Shared Grant; USC Provost Office, Dean's Development Funds, Keck School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. Parkash Gill and Ren Liu for the gift of antibodies and reagents and James Ou, Tobias Ulmer, Erik Snapp, and Linda Hendershot for helpful discussions. Flow cytometry was performed in the USC Flow Cytometry Core Facility supported in part by the National Cancer Institute Cancer Center Shared Grant P30 CA014089 and the USC Provost Office, Dean's Development Funds, Keck School of Medicine.	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Al-Hashimi AA, 2010, J BIOL CHEM, V285, P28912, DOI 10.1074/jbc.M110.119107; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Awad W, 2008, P NATL ACAD SCI USA, V105, P1164, DOI 10.1073/pnas.0702132105; Bellani S, 2014, CELL DEATH DIFFER, V21, P1971, DOI 10.1038/cdd.2014.111; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bhattacharjee G, 2005, ARTERIOSCL THROM VAS, V25, P1737, DOI 10.1161/01.ATV.0000173419.31242.56; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; de Ridder GG, 2012, MELANOMA RES, V22, P225, DOI 10.1097/CMR.0b013e32835312fd; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/nmeth.1768, 10.1038/NMETH.1768]; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Gray PC, 2012, FEBS LETT, V586, P1836, DOI 10.1016/j.febslet.2012.01.051; Guo F, 2013, J CELL SCI, V126, P1429, DOI 10.1242/jcs.118182; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Kepes F, 1996, J MOL BIOL, V262, P77, DOI 10.1006/jmbi.1996.0500; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; LIU ES, 1992, J BIOL CHEM, V267, P7128; Liu R, 2013, CLIN CANCER RES, V19, P6802, DOI 10.1158/1078-0432.CCR-13-1106; Liu R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-269; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Mahalka AK, 2014, BBA-BIOMEMBRANES, V1838, P1344, DOI 10.1016/j.bbamem.2014.01.022; Miao YR, 2013, CLIN CANCER RES, V19, P2107, DOI 10.1158/1078-0432.CCR-12-2991; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Nakayama H, 2012, MOL BIOL CELL, V23, P1964, DOI 10.1091/mbc.E11-08-0683; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Obeid M, 2007, CANCER RES, V67, P7941, DOI 10.1158/0008-5472.CAN-07-1622; Okamoto T, 2001, Curr Protoc Cell Biol, VChapter 5, DOI 10.1002/0471143030.cb0101s05; Patlolla JMR, 2004, ONCOL REP, V11, P957; Pinaud F, 2011, P NATL ACAD SCI USA, V108, pE201, DOI 10.1073/pnas.1101929108; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rasche L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063414; Ray R, 2012, J BIOL CHEM, V287, P32755, DOI 10.1074/jbc.M112.399808; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sato M, 2010, ADV GENET, V69, P97, DOI 10.1016/S0065-2660(10)69006-2; Satpute-Krishnan P, 2014, CELL, V158, P522, DOI 10.1016/j.cell.2014.06.026; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Spike BT, 2014, STEM CELL REP, V2, P427, DOI 10.1016/j.stemcr.2014.02.010; Tamilselvam B, 2008, J IMMUNOL, V180, P8262, DOI 10.4049/jimmunol.180.12.8262; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Wolter S, 2012, NAT METHODS, V9, P1040, DOI 10.1038/nmeth.2224; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080071; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	56	105	108	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8049	8064		10.1074/jbc.M114.618736	http://dx.doi.org/10.1074/jbc.M114.618736			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25673690	hybrid, Green Published			2022-12-28	WOS:000351662600004
J	Apellaniz, B; Rujas, E; Serrano, S; Morante, K; Tsumoto, K; Caaveiro, JMM; Jimenez, MA; Nieva, JL				Apellaniz, Beatriz; Rujas, Edurne; Serrano, Soraya; Morante, Koldo; Tsumoto, Kouhei; Caaveiro, Jose M. M.; Angeles Jimenez, M.; Nieva, Jose L.			The Atomic Structure of the HIV-1 gp41 Transmembrane Domain and Its Connection to the Immunogenic Membrane-proximal External Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; SPANNING DOMAIN; SECONDARY STRUCTURE; CHEMICAL-SHIFT; NMR STRUCTURE; FUSION; ANTIBODY; EPITOPE; SEQUENCE	The membrane-proximal external region (MPER) C-terminal segment and the transmembrane domain (TMD) of gp41 are involved in HIV-1 envelope glycoprotein-mediated fusion and modulation of immune responses during viral infection. However, the atomic structure of this functional region remains unsolved. Here, based on the high resolution NMR data obtained for peptides spanning the C-terminal segment of MPER and the TMD, we report two main findings: (i) the conformational variability of the TMD helix at a membrane-buried position; and (ii) the existence of an uninterrupted alpha-helix spanning MPER and the N-terminal region of the TMD. Thus, our structural data provide evidence for the bipartite organization of TMD predicted by previous molecular dynamics simulations and functional studies, but they do not support the breaking of the helix at Lys-683, as was suggested by some models to mark the initiation of the TMD anchor. Antibody binding energetics examined with isothermal titration calorimetry and humoral responses elicited in rabbits by peptide-based vaccines further support the relevance of a continuous MPER-TMD helix for immune recognition. We conclude that the transmembrane anchor of HIV-1 envelope is composed of two distinct subdomains: 1) an immunogenic helix at the N terminus also involved in promoting membrane fusion; and 2) an immunosuppressive helix at the C terminus, which might also contribute to the late stages of the fusion process. The unprecedented high resolution structural data reported here may guide future vaccine and inhibitor developments.	[Apellaniz, Beatriz; Rujas, Edurne; Nieva, Jose L.] Univ Basque Country UPV EHU, UPV EHU, CSIC, Biophys Unit, Bilbao 48080, Spain; [Apellaniz, Beatriz; Rujas, Edurne; Nieva, Jose L.] Univ Basque Country UPV EHU, Dept Biochem & Mol Biol, Bilbao 48080, Spain; [Rujas, Edurne; Morante, Koldo; Tsumoto, Kouhei; Caaveiro, Jose M. M.] Univ Tokyo, Dept Bioengn, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Serrano, Soraya; Angeles Jimenez, M.] CSIC, Inst Phys Chem Rocasolano, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; University of Tokyo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Caaveiro, JMM (corresponding author), Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan.	jose@bioeng.t.u-tokyo.ac.jp; majimenez@iqfr.csic.es; joseluis.nieva@ehu.es	Rujas, Edurne/AGV-1475-2022; Caaveiro, Jose/J-2790-2013; Apellaniz, Beatriz/E-9291-2012; Rujas, Edurne/GXG-7368-2022; Rujas, Edurne/P-1969-2018; Nieva, Jose L/Q-2063-2019; Jimenez, M. Angeles/C-7193-2008	Caaveiro, Jose/0000-0001-5568-2369; Nieva, Jose L/0000-0001-6446-5649; Jimenez, M. Angeles/0000-0001-6835-5850; Rujas, Edurne/0000-0002-4465-5071; APELLANIZ, BEATRIZ/0000-0003-1573-5440; Morante, Koldo/0000-0002-9877-9168	National Institutes of Health [R01 AI097051]; Canadian Institutes of Health Research [MOP-114941]; Spanish MINECO [CTQ2011-22514]; Basque Government [IT838-13]; Japan Society for the Promotion of Science [25249115]; Platform for Drug Discovery, Informatics, and Structural Life Science (Ministry of Education, Culture, Sports, Science and Technology) from Japan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Spanish MINECO(Spanish Government); Basque Government(Basque Government); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Platform for Drug Discovery, Informatics, and Structural Life Science (Ministry of Education, Culture, Sports, Science and Technology) from Japan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI097051 (to J. L. N.). This work was also supported by Canadian Institutes of Health Research Grant MOP-114941 (to J. L. N.), Spanish MINECO Grant CTQ2011-22514 (to M. A. J.), Basque Government Grant IT838-13 (to J. L. N.), and Japan Society for the Promotion of Science Project 25249115 (to K. T. and J. M. M. C.).; Recipient of a predoctoral fellowship from the Basque Government.; Recipient of a predoctoral fellowship from the Spanish MINECO.; Supported in part by the Platform for Drug Discovery, Informatics, and Structural Life Science (Ministry of Education, Culture, Sports, Science and Technology) from Japan.	Alving CR, 2012, EXPERT REV VACCINES, V11, P733, DOI [10.1586/ERV.12.35, 10.1586/erv.12.35]; Apellaniz B, 2014, J VIROL, V88, P13367, DOI 10.1128/JVI.02151-14; Apellaniz B, 2009, BIOCHEMISTRY-US, V48, P5320, DOI 10.1021/bi900504t; Ashkenazi A, 2013, TRENDS BIOCHEM SCI, V38, P345, DOI 10.1016/j.tibs.2013.04.003; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Baker MK, 2014, BBA-BIOMEMBRANES, V1838, P1396, DOI 10.1016/j.bbamem.2014.01.009; Bird GH, 2014, NAT STRUCT MOL BIOL, V21, P1058, DOI 10.1038/nsmb.2922; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; Cardoso RMF, 2007, J MOL BIOL, V365, P1533, DOI 10.1016/j.jmb.2006.10.088; Cohen T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001085; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Dennison SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027824; Dennison SM, 2009, J VIROL, V83, P10211, DOI 10.1128/JVI.00571-09; DREESMAN GR, 1982, NATURE, V295, P158, DOI 10.1038/295158a0; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gangupomu VK, 2010, BIOPHYS J, V99, P3438, DOI 10.1016/j.bpj.2010.09.054; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HAFFAR OK, 1988, J CELL BIOL, V107, P1677, DOI 10.1083/jcb.107.5.1677; HELSETH E, 1990, J VIROL, V64, P6314, DOI 10.1128/JVI.64.12.6314-6318.1990; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huarte N, 2008, J VIROL, V82, P8986, DOI 10.1128/JVI.00846-08; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Khayat R, 2013, J VIROL, V87, P9865, DOI 10.1128/JVI.01222-13; Kim JH, 2009, BBA-BIOMEMBRANES, V1788, P1804, DOI 10.1016/j.bbamem.2009.06.011; Kim M, 2013, J BIOL CHEM, V288, P31888, DOI 10.1074/jbc.M113.494609; Klasse PJ, 2013, J VIROL, V87, P9873, DOI 10.1128/JVI.01226-13; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Litowski JR, 2002, J BIOL CHEM, V277, P37272, DOI 10.1074/jbc.M204257200; Liu SJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-100; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Maeso R, 2011, AIDS RES HUM RETROV, V27, P863, DOI [10.1089/AID.2010.0265, 10.1089/aid.2010.0265]; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melikyan GB, 2011, CURR TOP MEMBR, V68, P81, DOI 10.1016/B978-0-12-385891-7.00004-0; Mirassou Y, 2009, CHEMBIOCHEM, V10, P902, DOI 10.1002/cbic.200800834; Miyauchi K, 2005, J VIROL, V79, P4720, DOI 10.1128/JVI.79.8.4720-4729.2005; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Montero M, 2012, J VIROL, V86, P2930, DOI 10.1128/JVI.06349-11; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OWENS RJ, 1994, J VIROL, V68, P570, DOI 10.1128/JVI.68.1.570-574.1994; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Reardon PN, 2014, P NATL ACAD SCI USA, V111, P1391, DOI 10.1073/pnas.1309842111; Reuven EM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004248; Reuven EM, 2012, BIOCHEMISTRY-US, V51, P2867, DOI 10.1021/bi201721r; Saez-Cirion A, 2002, J BIOL CHEM, V277, P21776, DOI 10.1074/jbc.M202255200; Saez-Cirion A, 2003, BIOPHYS J, V85, P3769, DOI 10.1016/S0006-3495(03)74792-4; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Sanders RW, 2014, NATURE, V514, P437, DOI 10.1038/nature13926; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; Serrano S, 2014, J BIOL CHEM, V289, P6565, DOI 10.1074/jbc.M113.527747; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Suarez T, 2000, J VIROL, V74, P8038, DOI 10.1128/JVI.74.17.8038-8047.2000; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Sun ZYJ, 2014, J MOL BIOL, V426, P1095, DOI 10.1016/j.jmb.2013.09.030; Trkola A, 2008, J VIROL, V82, P1591, DOI 10.1128/JVI.01792-07; van Gils MJ, 2014, TRENDS MICROBIOL, V22, P550, DOI 10.1016/j.tim.2014.08.006; Venditto VJ, 2013, CLIN VACCINE IMMUNOL, V20, P39, DOI 10.1128/CVI.00615-12; Vila R, 2000, PROTEIN SCI, V9, P627; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WUTHRICH K, 1984, J MOL BIOL, V180, P715, DOI 10.1016/0022-2836(84)90034-2; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Yue L, 2009, J VIROL, V83, P11588, DOI 10.1128/JVI.00914-09; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	78	37	37	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					12999	13015		10.1074/jbc.M115.644351	http://dx.doi.org/10.1074/jbc.M115.644351			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25787074	Green Published, hybrid			2022-12-28	WOS:000354975700003
J	Anand, A; LeDoyt, M; Karanian, C; Luthra, A; Koszelak-Rosenblum, M; Malkowski, MG; Puthenveetil, R; Vinogradova, O; Radolf, JD				Anand, Arvind; LeDoyt, Morgan; Karanian, Carson; Luthra, Amit; Koszelak-Rosenblum, Mary; Malkowski, Michael G.; Puthenveetil, Robbins; Vinogradova, Olga; Radolf, Justin D.			Bipartite Topology of Treponema pallidum Repeat Proteins C/D and I: OUTER MEMBRANE INSERTION, TRIMERIZATION, AND PORIN FUNCTION REQUIRE A C-TERMINAL -BARREL DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electron Microscopy (EM); Microbial Pathogenesis; Outer Membrane; Small Angle X-ray Scattering (SAXS); X-ray Scattering; beta-Barrel; Syphilis; Treponema pallidum; Outer Membrane Proteins; Porins	SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; PHOSPHOLIPID-BILAYER NANODISCS; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; OMPA PROTEIN; SYPHILIS SPIROCHETE; MOLECULAR ARCHITECTURE; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURES	Background:Treponema pallidum contains a paucity of outer membrane proteins. Results: The C-terminal domains of TprC/D and TprI are -barrels with porin function; their N-terminal domains provide periplasmic anchors for the -barrels. Conclusion: Full-length TprC subfamily proteins possess a dual domain topology. Significance: TprC/D are bona fide rare outer membrane proteins and a new class of dual function, bipartite, bacterial outer membrane protein. We previously identified Treponemapallidumrepeat proteins TprC/D, TprF, and TprI as candidate outer membrane proteins (OMPs) and subsequently demonstrated that TprC is not only a rare OMP but also forms trimers and has porin activity. We also reported that TprC contains N- and C-terminal domains (TprC(N) and TprC(C)) orthologous to regions in the major outer sheath protein (MOSPN and MOSPC) of Treponema denticola and that TprC(C) is solely responsible for -barrel formation, trimerization, and porin function by the full-length protein. Herein, we show that TprI also possesses bipartite architecture, trimeric structure, and porin function and that the MOSPC-like domains of native TprC and TprI are surface-exposed in T. pallidum, whereas their MOSPN-like domains are tethered within the periplasm. TprF, which does not contain a MOSPC-like domain, lacks amphiphilicity and porin activity, adopts an extended inflexible structure, and, in T. pallidum, is tightly bound to the protoplasmic cylinder. By thermal denaturation, the MOSPN and MOSPC-like domains of TprC and TprI are highly thermostable, endowing the full-length proteins with impressive conformational stability. When expressed in Escherichia coli with PelB signal sequences, TprC and TprI localize to the outer membrane, adopting bipartite topologies, whereas TprF is periplasmic. We propose that the MOSPN-like domains enhance the structural integrity of the cell envelope by anchoring the -barrels within the periplasm. In addition to being bona fide T. pallidum rare outer membrane proteins, TprC/D and TprI represent a new class of dual function, bipartite bacterial OMP.	[Anand, Arvind; LeDoyt, Morgan; Luthra, Amit; Radolf, Justin D.] Univ Connecticut, Dept Med, Ctr Hlth, Farmington, CT 06030 USA; [Karanian, Carson; Radolf, Justin D.] Univ Connecticut, Dept Pediat, Ctr Hlth, Farmington, CT 06030 USA; [Radolf, Justin D.] Univ Connecticut, Dept Mol Biol & Biophys, Ctr Hlth, Farmington, CT 06030 USA; [Radolf, Justin D.] Univ Connecticut, Dept Genet & Genom Sci, Ctr Hlth, Farmington, CT 06030 USA; [Radolf, Justin D.] Univ Connecticut, Dept Immunol, Ctr Hlth, Farmington, CT 06030 USA; [Koszelak-Rosenblum, Mary; Malkowski, Michael G.] SUNY Buffalo, Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA; [Puthenveetil, Robbins] Univ Connecticut, Dept Mol Cell Biol, Storrs, CT 06269 USA; [Vinogradova, Olga] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Connecticut; University of Connecticut	Radolf, JD (corresponding author), Univ Connecticut, Dept Med, Ctr Hlth, 263 Farmington Ave, Farmington, CT 06030 USA.	JRadolf@uchc.edu	Puthenveetil, Robbins/H-8949-2019; Vinogradova, Olga/ABE-8367-2020	Puthenveetil, Robbins/0000-0003-4958-6295; Vinogradova, Olga/0000-0001-5101-7361; Malkowski, Michael/0000-0002-1203-7463	National Institutes of Health (NIH) Public Health Service Grant [AI-26756]; NIH PSI: Biology Grant [U54 GM094611]; Connecticut Children's Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI026756, R01AI026756, R37AI026756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094611] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Public Health Service Grant; NIH PSI: Biology Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Children's Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Public Health Service Grant AI-26756 (to J. D. R.) and NIH PSI: Biology Grant U54 GM094611 (to M. G. M.). This work was also supported by research funds from Connecticut Children's Medical Center.	Allaire M, 2011, J SYNCHROTRON RADIAT, V18, P41, DOI 10.1107/S0909049510036022; Anand A, 2013, J BACTERIOL, V195, P2060, DOI 10.1128/JB.00078-13; Anand A, 2012, J BACTERIOL, V194, P2321, DOI 10.1128/JB.00101-12; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; BEHER MG, 1980, J BACTERIOL, V143, P906, DOI 10.1128/JB.143.2.906-913.1980; Bennion D, 2010, MOL MICROBIOL, V77, P1153, DOI 10.1111/j.1365-2958.2010.07280.x; Blanco DR, 1997, EMERG INFECT DIS, V3, P11, DOI 10.3201/eid0301.970102; Blanco DR, 1996, J BACTERIOL, V178, P6685, DOI 10.1128/jb.178.23.6685-6692.1996; BLANCO DR, 1995, J BACTERIOL, V177, P3556, DOI 10.1128/jb.177.12.3556-3562.1995; BOURELL KW, 1994, J BACTERIOL, V176, P1598, DOI 10.1128/jb.176.6.1598-1608.1994; BRUSCA JS, 1994, METHOD ENZYMOL, V228, P182; Cameron CE, 2006, PATHOGENIC TREPONEMA : MOLECULAR AND CELLULAR BIOLOGY, P237; Cameron CE, 2014, VACCINE, V32, P1602, DOI 10.1016/j.vaccine.2013.09.053; Centurion-Lara A, 1999, J EXP MED, V189, P647, DOI 10.1084/jem.189.4.647; COWAN SW, 1995, STRUCTURE, V3, P1041, DOI 10.1016/S0969-2126(01)00240-4; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Cox DL, 2010, INFECT IMMUN, V78, P5178, DOI 10.1128/IAI.00834-10; COX DL, 1995, MOL MICROBIOL, V15, P1151, DOI 10.1111/j.1365-2958.1995.tb02288.x; COX DL, 1992, INFECT IMMUN, V60, P1076, DOI 10.1128/IAI.60.3.1076-1083.1992; Cox DL, 2001, MICROBIOL-SGM, V147, P1161, DOI 10.1099/00221287-147-5-1161; COX DL, 1994, METHOD ENZYMOL, V236, P390; Cullen PA, 2006, EXPERT REV VACCINES, V5, P67, DOI 10.1586/14760584.5.1.67; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Desrosiers DC, 2011, MOL MICROBIOL, V80, P1496, DOI 10.1111/j.1365-2958.2011.07662.x; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; EGLI C, 1993, INFECT IMMUN, V61, P1694, DOI 10.1128/IAI.61.5.1694-1699.1993; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Galvao TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056463; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Hazlett KRO, 2005, J BACTERIOL, V187, P6499, DOI 10.1128/JB.187.18.6499-6508.2005; Hazlett KRO, 2001, J EXP MED, V193, P1015, DOI 10.1084/jem.193.9.1015; Heinz E, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00370; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Ho EL, 2011, J CLIN INVEST, V121, P4584, DOI 10.1172/JCI57173; Hook EW, 2004, NEW ENGL J MED, V351, P122, DOI 10.1056/NEJMp048126; Izard J, 2009, J BACTERIOL, V191, P7566, DOI 10.1128/JB.01031-09; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Klausner JD, 2013, B WORLD HEALTH ORGAN, V91, P158, DOI 10.2471/BLT.13.118604; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kumar S, 2001, BIOCHEMISTRY-US, V40, P14152, DOI 10.1021/bi0106383; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Liu J, 2010, J MOL BIOL, V403, P546, DOI 10.1016/j.jmb.2010.09.020; LUKEHART SA, 1978, J IMMUNOL, V121, P2014; Luthra A, 2011, J BIOL CHEM, V286, P41656, DOI 10.1074/jbc.M111.305284; Magnuson Harold J., 1948, AMER JOUR SYPHILIS GONORRHEA AND VENEREAL DIS, V32, P1; Marcoux J, 2014, STRUCTURE, V22, P781, DOI 10.1016/j.str.2014.03.004; Mitchell J. C., 2011, THERMOSTABLE PROTEIN; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Nicolay T, 2015, CRIT REV MICROBIOL, V41, P109, DOI 10.3109/1040841X.2013.804032; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noinaj N, 2014, STRUCTURE, V22, P1055, DOI 10.1016/j.str.2014.05.008; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Norris SJ, 2001, J MOL MICROB BIOTECH, V3, P37; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Park JS, 2012, FASEB J, V26, P219, DOI 10.1096/fj.11-188425; Pascual-Montano A, 2001, J STRUCT BIOL, V133, P233, DOI 10.1006/jsbi.2001.4369; Paster BJ, 2006, PATHOGENIC TREPONEMA : MOLECULAR AND CELLULAR BIOLOGY, P9; Patton ME, 2014, MMWR-MORBID MORTAL W, V63, P402; Pauw BR, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/38/383201; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Perez J, 2012, CURR OPIN STRUC BIOL, V22, P670, DOI 10.1016/j.sbi.2012.07.014; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Phale PS, 1998, BIOCHEMISTRY-US, V37, P15663, DOI 10.1021/bi981215c; Phale PS, 2001, BIOCHEMISTRY-US, V40, P6319, DOI 10.1021/bi010046k; RADOLF JD, 1989, P NATL ACAD SCI USA, V86, P2051, DOI 10.1073/pnas.86.6.2051; RADOLF JD, 1995, INFECT IMMUN, V63, P4244, DOI 10.1128/IAI.63.11.4244-4252.1995; RADOLF JD, 1995, MOL MICROBIOL, V16, P1067, DOI 10.1111/j.1365-2958.1995.tb02332.x; Radolf JD, 2006, PATHOGENIC TREPONEMA : MOLECULAR AND CELLULAR BIOLOGY, P285; Radolf JD, 2006, PATHOGENIC TREPONEMA : MOLECULAR AND CELLULAR BIOLOGY, P197; Radolf JD, 2009, MOL MICROBIOL, V72, P1081, DOI 10.1111/j.1365-2958.2009.06711.x; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Salazar JC, 2002, MICROBES INFECT, V4, P1133, DOI 10.1016/S1286-4579(02)01638-6; Selkrig J, 2014, BBA-MOL CELL RES, V1843, P1542, DOI 10.1016/j.bbamcr.2013.10.009; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F; SUGAWARA E, 1994, J BIOL CHEM, V269, P17981; SUGAWARA E, 1992, J BIOL CHEM, V267, P2507; Sun ES, 2004, MICROBES INFECT, V6, P725, DOI 10.1016/j.micinf.2004.04.001; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thein M, 2010, J PROTEOME RES, V9, P6135, DOI 10.1021/pr1002438; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; Ulrich T, 2014, J BIOL CHEM, V289, P29457, DOI 10.1074/jbc.M114.565655; Ulrich T, 2012, J BIOL CHEM, V287, P27467, DOI 10.1074/jbc.M112.382093; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Visudtiphole V, 2005, BIOCHEM J, V392, P375, DOI 10.1042/BJ20051257; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WALFIELD AM, 1982, SCIENCE, V216, P522, DOI 10.1126/science.7041257; WALKER EM, 1989, J BACTERIOL, V171, P5005, DOI 10.1128/jb.171.9.5005-5011.1989; Walton TA, 2009, P NATL ACAD SCI USA, V106, P1772, DOI 10.1073/pnas.0809275106; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Yamashita E, 2008, EMBO J, V27, P2171, DOI 10.1038/emboj.2008.137; Yildiz O, 2006, EMBO J, V25, P3702, DOI 10.1038/sj.emboj.7601237	109	21	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12313	12331		10.1074/jbc.M114.629188	http://dx.doi.org/10.1074/jbc.M114.629188			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25805501	Green Published, hybrid			2022-12-28	WOS:000354388600041
J	Curran, J; Musa, H; Kline, CF; Makara, MA; Little, SC; Higgins, JD; Hund, TJ; Band, H; Mohler, PJ				Curran, Jerry; Musa, Hassan; Kline, Crystal F.; Makara, Michael A.; Little, Sean C.; Higgins, John D.; Hund, Thomas J.; Band, Hamid; Mohler, Peter J.			Eps15 Homology Domain-containing Protein 3 Regulates Cardiac T-type Ca2+ Channel Targeting and Function in the Atria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytoskeleton; endosome; heart; ion channel; membrane trafficking; ankyrin; arrhythmia	EH-DOMAIN; ANKYRIN-B; CALCIUM CURRENT; PATHOPHYSIOLOGICAL SIGNIFICANCE; VENTRICULAR MYOCYTES; TRAFFICKING; MICE; EXPRESSION; HEARTS; CELLS	Background: Endosome-based protein trafficking in the heart is poorly understood. Results: Functional targeting and expression of the T-type Ca2+ channel (TTCC) in the atria requires the endosomal protein, EHD3. Conclusion: Impaired endosomal transport leads to cardiac rhythm and conduction disorders. Significance: Understanding endosome-based protein trafficking in the heart may provide new therapeutic targets for cardiovascular disease. Proper trafficking of membrane-bound ion channels and transporters is requisite for normal cardiac function. Endosome-based protein trafficking of membrane-bound ion channels and transporters in the heart is poorly understood, particularly in vivo. In fact, for select cardiac cell types such as atrial myocytes, virtually nothing is known regarding endosomal transport. We previously linked the C-terminal Eps15 homology domain-containing protein 3 (EHD3) with endosome-based protein trafficking in ventricular cardiomyocytes. Here we sought to define the roles and membrane protein targets for EHD3 in atria. We identify the voltage-gated T-type Ca2+ channels (Ca(V)3.1, Ca(V)3.2) as substrates for EHD3-dependent trafficking in atria. Mice selectively lacking EHD3 in heart display reduced expression and targeting of both Ca(v)3.1 and Ca(V)3.2 in the atria. Furthermore, functional experiments identify a significant loss of T-type-mediated Ca2+ current in EHD3-deficient atrial myocytes. Moreover, EHD3 associates with both Ca(V)3.1 and Ca(V)3.2 in co-immunoprecipitation experiments. T-type Ca2+ channel function is critical for proper electrical conduction through the atria. Consistent with these roles, EHD3-deficient mice demonstrate heart rate variability, sinus pause, and atrioventricular conduction block. In summary, our findings identify Ca(V)3.1 and Ca(V)3.2 as substrates for EHD3-dependent protein trafficking in heart, provide in vivo data on endosome-based trafficking pathways in atria, and implicate EHD3 as a key player in the regulation of atrial myocyte excitability and cardiac conduction.	[Curran, Jerry; Musa, Hassan; Kline, Crystal F.; Makara, Michael A.; Little, Sean C.; Higgins, John D.; Hund, Thomas J.; Mohler, Peter J.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Curran, Jerry; Musa, Hassan; Kline, Crystal F.; Makara, Michael A.; Little, Sean C.; Higgins, John D.; Mohler, Peter J.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Dept Med, Columbus, OH 43210 USA; [Hund, Thomas J.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Band, Hamid] Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska Med Ctr, UNMC Eppley Canc Ctr, Omaha, NE 68198 USA	Ohio State University; Ohio State University; Ohio State University; Ohio State University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Curran, J (corresponding author), 473 W 12th Ave, Columbus, OH 43210 USA.	jerry.curran@osumc.edu	Hund, Thomas/C-9222-2012; Band, Hamid/AAF-4701-2020; Regan, Clinton/E-6250-2012; Musa, Hassan/AAQ-1548-2021		National Institutes of Health [HL114252, HL084583, HL083422, HL114893, CA105489, CA87986, CA99163, CA116552]; NATIONAL CANCER INSTITUTE [R01CA087986, R01CA105489, R01CA099163, R01CA116552] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084583, R01HL114893, R01HL083422, F32HL114252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL114252 (to J. C.), HL084583, HL083422, and HL114893 (to P. J. M.), and CA105489, CA87986, CA99163, and CA116552 (to H. B.).	Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Alvarez JL, 1996, J PHYSIOL-LONDON, V491, P321, DOI 10.1113/jphysiol.1996.sp021218; Bar M, 2014, PLANT MOL BIOL, V84, P509, DOI 10.1007/s11103-013-0148-7; Benoist M, 2006, J PHYSIOL-PARIS, V99, P146, DOI 10.1016/j.jphysparis.2005.12.006; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers Donald M., 2002, Basic Research in Cardiology, V97; Chiang CS, 2009, CIRC RES, V104, P522, DOI 10.1161/CIRCRESAHA.108.184051; Chukkapalli S, 2014, CARCINOGENESIS, V35, P877, DOI 10.1093/carcin/bgt399; Cunha SR, 2008, J BIOL CHEM, V283, P31968, DOI 10.1074/jbc.M806050200; Curran J, 2014, CIRC RES, V115, P68, DOI 10.1161/CIRCRESAHA.115.304149; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; DeGrande S, 2012, HEART RHYTHM, V9, P2034, DOI 10.1016/j.hrthm.2012.08.026; Dobrev D, 2009, J MOL CELL CARDIOL, V46, P448, DOI 10.1016/j.yjmcc.2008.12.004; Fei H, 2008, TRAFFIC, V9, P1425, DOI 10.1111/j.1600-0854.2008.00771.x; Galperin E, 2002, TRAFFIC, V3, P575, DOI 10.1034/j.1600-0854.2002.30807.x; George M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017838; Giordanetto F, 2011, EXPERT OPIN THER PAT, V21, P85, DOI 10.1517/13543776.2011.536532; Goonasekera SA, 2012, J CLIN INVEST, V122, P280, DOI 10.1172/JCI58227; Gordon A, 2007, ANN APPL STAT, V1, P179, DOI 10.1214/07-AOAS102; Gudmundsson H, 2012, J MOL CELL CARDIOL, V52, P1183, DOI 10.1016/j.yjmcc.2012.02.008; Gudmundsson H, 2010, CIRC RES, V107, P84, DOI 10.1161/CIRCRESAHA.110.216713; Guilherme A, 2004, J BIOL CHEM, V279, P40062, DOI 10.1074/jbc.M401918200; Han W, 2001, CIRCULATION, V104, P2095, DOI 10.1161/hc4201.097134; Heubach JF, 1999, CARDIOVASC RES, V42, P173, DOI 10.1016/S0008-6363(98)00262-4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Izumi T, 2003, CIRCULATION, V108, P2530, DOI 10.1161/01.CIR.0000096484.03318.AB; Jaleel N, 2008, CIRC RES, V103, P1109, DOI 10.1161/CIRCRESAHA.108.185611; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Kamens AJ, 2014, BIOCHEMISTRY-US, V53, P4758, DOI 10.1021/bi500744q; Kinoshita H, 2009, CIRCULATION, V120, P743, DOI 10.1161/CIRCULATIONAHA.109.857011; Kline CF, 2009, P NATL ACAD SCI USA, V106, P16669, DOI 10.1073/pnas.0907138106; Kobayashi H, 2013, J CELL SCI, V126, P2424, DOI 10.1242/jcs.117846; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Le Quang K, 2011, CARDIOVASC RES, V91, P420, DOI 10.1093/cvr/cvr082; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; Mesirca P, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00019; Mesirca P, 2014, PFLUG ARCH EUR J PHY, V466, P791, DOI 10.1007/s00424-014-1482-6; Miliaras NB, 2004, CELL BIOCHEM BIOPHYS, V41, P295, DOI 10.1385/CBB:41:2:295; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Nakayama H, 2009, J CLIN INVEST, V119, P3787, DOI 10.1172/JCI39724; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Naslavsky N, 2009, J CELL SCI, V122, P389, DOI 10.1242/jcs.037051; Niwa N, 2004, AM J PHYSIOL-HEART C, V286, pH2257, DOI 10.1152/ajpheart.01043.2003; Ono K, 2005, J PHARMACOL SCI, V99, P197, DOI 10.1254/jphs.FMJ05002X2; Ono K, 2010, J MOL CELL CARDIOL, V48, P65, DOI 10.1016/j.yjmcc.2009.08.021; Periasamy M, 2008, CARDIOVASC RES, V77, P265, DOI 10.1093/cvr/cvm056; Picciano JA, 2003, AM J PHYSIOL-CELL PH, V285, pC1009, DOI 10.1152/ajpcell.00140.2003; Pohl U, 2000, GENOMICS, V63, P255, DOI 10.1006/geno.1999.6087; Posey AD, 2014, DEV BIOL, V387, P179, DOI 10.1016/j.ydbio.2014.01.004; Pott C, 2005, CIRC RES, V97, P1288, DOI 10.1161/01.RES.0000196563.84231.21; Roca TP, 1996, PEDIATR RES, V40, P462, DOI 10.1203/00006450-199609000-00016; Sandmann S, 2000, VIRCHOWS ARCH, V436, P147, DOI 10.1007/PL00008215; Sharma Mahak, 2010, Commun Integr Biol, V3, P181; Stenmark H, 2001, GENOME BIOL, V2; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tsai CT, 2008, J AM COLL CARDIOL, V52, P241, DOI 10.1016/j.jacc.2008.02.072; Vaidyanathan R, 2013, HEART RHYTHM, V10, P80, DOI 10.1016/j.hrthm.2012.10.002; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Wei SH, 2010, MOL CELL NEUROSCI, V45, P418, DOI 10.1016/j.mcn.2010.07.014; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Yasui K, 2005, J PHARMACOL SCI, V99, P205, DOI 10.1254/jphs.FMJ05002X3	68	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12210	12221		10.1074/jbc.M115.646893	http://dx.doi.org/10.1074/jbc.M115.646893			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25825486	Green Published, hybrid			2022-12-28	WOS:000354388600032
J	Janda, A; Eryilmaz, E; Nakouzi, A; Pohl, MA; Bowen, A; Casadevall, A				Janda, Alena; Eryilmaz, Ertan; Nakouzi, Antonio; Pohl, Mary Ann; Bowen, Anthony; Casadevall, Arturo			Variable Region Identical IgA and IgE to Cryptococcus neoformans Capsular Polysaccharide Manifest Specificity Differences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody; Antigen; Immunoglobulin A (IgA); Immunoglobulin E (IgE); Nuclear Magnetic Resonance (NMR); Peptides; Isotype	IMMUNOGLOBULIN CONSTANT; ANTIGEN-BINDING; FINE SPECIFICITY; ANTIBODIES; ISOTYPE; AFFINITY; MURINE; NMR; SPECTROSCOPY; CONTRIBUTES	Background: Ig , , and constant regions can affect Ag specificity, but this is unknown for IgE. Results: IgE and IgA variable regions differ in specificity and cleavage rates compared with each other and IgG subclasses. Conclusion: Like IgG subclasses, the IgA and IgE constant regions can affect Ag binding specificities. Significance: These results extend the principle that the constant region can affect variable region specificity to IgE. In recent years several groups have shown that isotype switching from IgM to IgG to IgA can affect the affinity and specificity of antibodies sharing identical variable (V) regions. However, whether the same applies to IgE is unknown. In this study we compared the fine specificity of V region-identical IgE and IgA to Cryptococcus neoformans capsular polysaccharide and found that these differed in specificity from each other. The IgE and IgA paratopes were probed by nuclear magnetic resonance spectroscopy with N-15-labeled peptide mimetics of cryptococcal polysaccharide antigen (Ag). IgE was found to cleave the peptide at a much faster rate than V region-identical IgG subclasses and IgA, consistent with an altered paratope. Both IgE and IgA were opsonic for C. neoformans and protected against infection in mice. In summary, V-region expression in the context of the E constant (C) region results in specificity changes that are greater than observed for comparable IgG subclasses. These results raise the possibility that expression of certain V regions in the context of and E C regions affects their function and contributes to the special properties of those isotypes.	[Janda, Alena; Nakouzi, Antonio; Pohl, Mary Ann; Bowen, Anthony; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Eryilmaz, Ertan] Boehringer Ingelheim Pharmaceut Inc, Biotherapeut, Ridgefield, CT 06877 USA	Yeshiva University; Albert Einstein College of Medicine; Boehringer Ingelheim	Casadevall, A (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	arturo.casadevall@einstein.yu.edu	Regan, Clinton/E-6250-2012; Bowen, Anthony/O-4982-2015; Markmann, Alena Janda/AAD-7310-2019	Bowen, Anthony/0000-0003-1064-8372; Markmann, Alena Janda/0000-0003-3656-9322	National Institutes of Health [HL059842, AI033774, AI052733, AI033142, T32-GM007288, R37-AI033142]; Institutional AIDS Training Grant [T32-AI007501]; Medical Scientist Training Program Training Grant [T32-GM007288]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033142, R01AI033774, T32AI007501, R37AI033142, R01AI052733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional AIDS Training Grant; Medical Scientist Training Program Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL059842, AI033774, AI052733, and AI033142.; Supported by Institutional AIDS Training Grant T32-AI007501 and the Medical Scientist Training Program Training Grant T32-GM007288.; Supported by National Institutes of Health Awards T32-GM007288 and R37-AI033142.	[Anonymous], 2013, MOL OP ENV MOE VERS; [Anonymous], 2008, AMBER 10; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; CASADEVALL A, 1992, J IMMUNOL METHODS, V154, P27, DOI 10.1016/0022-1759(92)90209-C; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; Casadevall A, 2012, P NATL ACAD SCI USA, V109, P12272, DOI 10.1073/pnas.1209750109; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; COOPER LJN, 1994, MOL IMMUNOL, V31, P577, DOI 10.1016/0161-5890(94)90165-1; COOPER LJN, 1993, J IMMUNOL, V150, P2231; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Eryilmaz E, 2013, MOL IMMUNOL, V56, P588, DOI 10.1016/j.molimm.2013.06.006; Feldmesser Marta, 1998, Frontiers in Bioscience, V3, pD136; GREENSPAN NS, 1993, SPRINGER SEMIN IMMUN, V15, P275; Janda A, 2012, J BIOL CHEM, V287, P35409, DOI 10.1074/jbc.M112.404483; Janda A, 2010, MOL IMMUNOL, V47, P1421, DOI 10.1016/j.molimm.2010.02.018; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Karagiannis SN, 2012, CANCER IMMUNOL IMMUN, V61, P1547, DOI 10.1007/s00262-011-1162-8; KATO K, 1991, BIOCHEMISTRY-US, V30, P6604, DOI 10.1021/bi00240a033; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341; McLean GR, 2002, J IMMUNOL, V169, P1379, DOI 10.4049/jimmunol.169.3.1379; MUKHERJEE J, 1992, INFECT IMMUN, V60, P4534, DOI 10.1128/IAI.60.11.4534-4541.1992; Mukherjee S, 1996, J INFECT DIS, V173, P1222, DOI 10.1093/infdis/173.5.1222; MUKHERJEE S, 1995, INFECT IMMUN, V63, P573, DOI 10.1128/IAI.63.2.573-579.1995; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; Pritsch O, 2000, EUR J IMMUNOL, V30, P3387, DOI 10.1002/1521-4141(2000012)30:12<3387::AID-IMMU3387>3.0.CO;2-K; Reitan SK, 2002, P NATL ACAD SCI USA, V99, P7588, DOI 10.1073/pnas.052150899; REITAN SK, 1995, EUR J IMMUNOL, V25, P1601, DOI 10.1002/eji.1830250620; ROBERTSON MW, 1988, MOL IMMUNOL, V25, P103, DOI 10.1016/0161-5890(88)90057-0; ROUZER CA, 1982, P NATL ACAD SCI-BIOL, V79, P5656, DOI 10.1073/pnas.79.18.5656; Sapparapu G, 2012, J BIOL CHEM, V287, P36096, DOI 10.1074/jbc.M112.401075; Spira G, 1996, CLIN EXP IMMUNOL, V105, P436, DOI 10.1046/j.1365-2249.1996.d01-786.x; Taborda CP, 2002, IMMUNITY, V16, P791, DOI 10.1016/S1074-7613(02)00328-X; Torres M, 2005, J IMMUNOL, V174, P2132, DOI 10.4049/jimmunol.174.4.2132; Torres M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001310; Torres M, 2008, TRENDS IMMUNOL, V29, P91, DOI 10.1016/j.it.2007.11.004; Torres M, 2007, J BIOL CHEM, V282, P13917, DOI 10.1074/jbc.M700661200; Tudor D, 2012, P NATL ACAD SCI USA, V109, P12680, DOI 10.1073/pnas.1200024109; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; Xia YM, 2012, J AUTOIMMUN, V39, P398, DOI 10.1016/j.jaut.2012.06.005; Young ACM, 1997, J MOL BIOL, V274, P622, DOI 10.1006/jmbi.1997.1407	44	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12090	12100		10.1074/jbc.M114.618975	http://dx.doi.org/10.1074/jbc.M114.618975			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25778397	Green Published, hybrid			2022-12-28	WOS:000354388600024
J	Rowland, LA; Bal, NC; Kozak, LP; Periasamy, M				Rowland, Leslie A.; Bal, Naresh C.; Kozak, Leslie P.; Periasamy, Muthu			Uncoupling Protein 1 and Sarcolipin Are Required to Maintain Optimal Thermogenesis, and Loss of Both Systems Compromises Survival of Mice under Cold Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose tissue; calcium ATPase; muscle physiology; sarcoplasmic reticulum (SR); skeletal muscle; skeletal muscle metabolism; uncoupling protein; sarcolipin; thermogenesis	BROWN ADIPOSE-TISSUE; SKELETAL-MUSCLE MITOCHONDRIA; NONSHIVERING THERMOGENESIS; HEAT-PRODUCTION; MESSENGER-RNA; CA2+; UCP1; FAT; CA2+-ATPASE; EXPRESSION	Background: The mechanisms underlying UCP1-independent thermogenesis are not well understood. Results: Loss of both SLN and UCP1 results in compromised thermogenic ability and severe sensitivity to acute cold. Conclusion: Sarcolipin-mediated thermogenesis is required for optimal thermogenesis and is up-regulated in the absence of UCP1. Significance: Sarcolipin is a crucial contributor to thermogenesis and energy expenditure. The importance of brown adipose tissue as a site of nonshivering thermogenesis has been well documented. Emerging studies suggest that skeletal muscle is also an important site of thermogenesis especially when brown adipose tissue function is lacking. We recently showed that sarcolipin (SLN), an uncoupler of the sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) pump, could contribute to heat production in skeletal muscle. In this study, we sought to understand how loss of UCP1 or SLN is compensated during cold exposure and whether they are both necessary for thermogenesis. Toward this goal, we generated a UCP1;SLN double knock-out (DKO) mouse model and challenged the single and DKO mice to acute and long-term cold exposures. Results from this study show that there is up-regulation of SLN expression in UCP1-KO mice, and loss of SLN is compensated by increased expression of UCP1 and browning of white adipose tissue. We found that the DKO mice were viable when reared at thermoneutrality. When challenged to acute cold, the DKO were extremely cold-sensitive and became hypothermic. Paradoxically, the DKO mice were able to survive gradual cold challenge, but these mice lost significant weight and depleted their fat stores, despite having higher caloric intake. These studies suggest that UCP1 and SLN are required to maintain optimal thermogenesis and that loss of both systems compromises survival of mice under cold stress.	[Rowland, Leslie A.; Bal, Naresh C.; Periasamy, Muthu] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Kozak, Leslie P.] Polish Acad Sci, Inst Anim Reprod & Food Res, PL-10748 Olsztyn, Poland	University System of Ohio; Ohio State University; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Periasamy, M (corresponding author), Ohio State Univ, 013 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	periasamy.1@osu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01-HL088555, R01-DK098240-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL088555 and R01-DK098240-01.	Anunciado-Koza RP, 2011, J BIOL CHEM, V286, P11659, DOI 10.1074/jbc.M110.203000; ARJAMAA O, 1979, J THERM BIOL, V4, P35, DOI 10.1016/0306-4565(79)90043-3; Arruda AP, 2008, ENDOCRINOLOGY, V149, P6262, DOI 10.1210/en.2008-0564; Aydin J, 2008, FASEB J, V22, P3919, DOI 10.1096/fj.08-113712; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bicudo JEPW, 2001, BIOSCIENCE REP, V21, P181, DOI 10.1023/A:1013648208428; BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535; Bombardier E, 2013, FASEB J, V27, P3871, DOI 10.1096/fj.13-230631; Bruton JD, 2010, J PHYSIOL-LONDON, V588, P4275, DOI 10.1113/jphysiol.2010.198598; BRYANT DM, 1975, COMP BIOCHEM PHYSIOL, V50, P99, DOI 10.1016/S0010-406X(75)80208-8; Cambon B, 1998, MOL CELL ENDOCRINOL, V146, P49, DOI 10.1016/S0303-7207(98)00200-7; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CASTEILLA L, 1989, BIOCHEM J, V257, P665, DOI 10.1042/bj2570665; CHAFFEE RRJ, 1971, ANNU REV PHYSIOL, V33, P155, DOI 10.1146/annurev.ph.33.030171.001103; Clarke SD, 2012, AM J PHYSIOL-REG I, V303, pR1071, DOI 10.1152/ajpregu.00036.2012; DAVIS TRA, 1967, AM J PHYSIOL, V213, P1423, DOI 10.1152/ajplegacy.1967.213.6.1423; DUCHAMP C, 1991, AM J PHYSIOL, V261, pR1438, DOI 10.1152/ajpregu.1991.261.6.R1438; DUCHAMP C, 1993, AM J PHYSIOL, V265, pR1076, DOI 10.1152/ajpregu.1993.265.5.R1076; DUMONTEIL E, 1993, AM J PHYSIOL, V265, pC507, DOI 10.1152/ajpcell.1993.265.2.C507; DUMONTEIL E, 1994, J PHYSIOL-LONDON, V479, P29, DOI 10.1113/jphysiol.1994.sp020275; DUMONTEIL E, 1995, AM J PHYSIOL-CELL PH, V269, pC955, DOI 10.1152/ajpcell.1995.269.4.C955; Eldershaw TPD, 1997, COMP BIOCHEM PHYS A, V117, P545, DOI 10.1016/S0300-9629(96)00401-X; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Golozoubova V, 2004, MOL ENDOCRINOL, V18, P384, DOI 10.1210/me.2003-0267; Golozoubova V, 2006, AM J PHYSIOL-ENDOC M, V291, pE350, DOI 10.1152/ajpendo.00387.2005; LANDSBERG L, 1984, AM J PHYSIOL, V247, pE181, DOI 10.1152/ajpendo.1984.247.2.E181; LEAN MEJ, 1986, CLIN SCI, V71, P291, DOI 10.1042/cs0710291; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; Maurya SK, 2015, J BIOL CHEM, V290, P10840, DOI 10.1074/jbc.M115.636878; Meyer CW, 2010, AM J PHYSIOL-REG I, V299, pR1396, DOI 10.1152/ajpregu.00021.2009; Rose RW, 1999, PHYSIOL BIOCHEM ZOOL, V72, P699, DOI 10.1086/316709; ROTHWELL NJ, 1985, COMP BIOCHEM PHYS A, V82, P745, DOI 10.1016/0300-9629(85)90477-3; Rowland LA, 2015, BIOL REV, V90, P1279, DOI 10.1111/brv.12157; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Shabalina IG, 2010, BBA-BIOENERGETICS, V1797, P968, DOI 10.1016/j.bbabio.2010.02.033; Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277; Solinas G, 2004, FEBS LETT, V577, P539, DOI 10.1016/j.febslet.2004.10.066; Sopariwala DH, 2015, J APPL PHYSIOL, V118, P1050, DOI 10.1152/japplphysiol.01066.2014; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Ukropec J, 2006, ENDOCRINOLOGY, V147, P2468, DOI 10.1210/en.2005-1216; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200	46	72	73	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12282	12289		10.1074/jbc.M115.637603	http://dx.doi.org/10.1074/jbc.M115.637603			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25825499	hybrid, Green Published			2022-12-28	WOS:000354388600038
J	Kuusk, S; Sorlie, M; Valjamae, P				Kuusk, Silja; Sorlie, Morten; Valjamae, Priit			The Predominant Molecular State of Bound Enzyme Determines the Strength and Type of Product Inhibition in the Hydrolysis of Recalcitrant Polysaccharides by Processive Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI CELLOBIOHYDROLASE; FAMILY 18 CHITINASE; SERRATIA-MARCESCENS; CRYSTALLINE CELLULOSE; INSOLUBLE CELLULOSE; AROMATIC RESIDUES; KINETIC-MODEL; SUBSTRATE; BINDING; CELLULASES	Processive enzymes are major components of the efficient enzyme systems that are responsible for the degradation of the recalcitrant polysaccharides cellulose and chitin. Despite intensive research, there is no consensus on which step is rate-limiting for these enzymes. Here, we performed a comparative study of two well characterized enzymes, the cellobiohydrolase Cel7A from Hypocrea jecorina and the chitinase ChiA from Serratia marcescens. Both enzymes were inhibited by their disaccharide product, namely chitobiose for ChiA and cellobiose for Cel7A. The products behaved as noncompetitive inhibitors according to studies using the C-14-labeled crystalline polymeric substrates C-14 chitin nanowhiskers and C-14-labeled bacterial microcrystalline cellulose for ChiA and Cel7A, respectively. The resulting observed K-i(obs) values were 0.45 +/- 0.08 mM for ChiA and 0.17 +/- 0.02 mM for Cel7A. However, in contrast to ChiA, the K-i(obs) of Cel7A was an order of magnitude higher than the true K-i value governed by the thermodynamic stability of the enzyme-inhibitor complex. Theoretical analysis of product inhibition suggested that the inhibition strength and pattern can be accounted for by assuming different rate-limiting steps for ChiA and Cel7A. Measuring the population of enzymes whose active site was occupied by a polymer chain revealed that Cel7A was bound predominantly via its active site. Conversely, the active-site-mediated binding of ChiA was slow, and most ChiA exhibited a free active site, even when the substrate concentration was saturating for the activity. Collectively, our data suggest that complexation with the polymer chain is rate-limiting for ChiA, whereas Cel7A is limited by dissociation.	[Kuusk, Silja; Valjamae, Priit] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Sorlie, Morten] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	University of Tartu; Norwegian University of Life Sciences	Valjamae, P (corresponding author), Riia 23b-202, EE-51010 Tartu, Estonia.	priit.valjamae@ut.ee	Väljamäe, Priit/O-6468-2018	Väljamäe, Priit/0000-0002-1035-9493	Norwegian Financial Mechanism Grant [EMP171]; Estonian Science Foundation [9227]	Norwegian Financial Mechanism Grant; Estonian Science Foundation	This work was supported by Norwegian Financial Mechanism Grant EMP171 and Estonian Science Foundation Grant 9227.	Aronson NN, 2003, BIOCHEM J, V376, P87, DOI 10.1042/bj20030273; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Baumann MJ, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-45; Beckham GT, 2014, CURR OPIN BIOTECH, V27, P96, DOI 10.1016/j.copbio.2013.12.002; BHIKHABHAI R, 1984, Journal of Applied Biochemistry, V6, P336; BRURBERG MB, 1994, FEMS MICROBIOL LETT, V124, P399, DOI 10.1016/0378-1097(94)00462-5; Brurberg MB, 1996, MICROBIOL-SGM, V142, P1581, DOI 10.1099/13500872-142-7-1581; Bu LT, 2012, J BIOL CHEM, V287, P24807, DOI 10.1074/jbc.M112.365510; Chen L, 2014, J BIOL CHEM, V289, P17932, DOI 10.1074/jbc.M114.564534; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; CLAEYSSENS M, 1989, BIOCHEM J, V261, P819, DOI 10.1042/bj2610819; Colussi F, 2015, J BIOL CHEM, V290, P2444, DOI 10.1074/jbc.M114.624163; Cruys-Bagger N, 2014, ANAL BIOCHEM, V447, P162, DOI 10.1016/j.ab.2013.11.024; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; Dybvik AI, 2011, ANAL CHEM, V83, P4030, DOI 10.1021/ac1031308; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gao DH, 2013, P NATL ACAD SCI USA, V110, P10922, DOI 10.1073/pnas.1213426110; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Hamre AG, 2014, FEBS LETT, V588, P4620, DOI 10.1016/j.febslet.2014.10.034; HOLTZAPPLE M, 1990, BIOTECHNOL BIOENG, V36, P275, DOI 10.1002/bit.260360310; Honda Y, 2003, J BIOCHEM, V133, P253, DOI 10.1093/jb/mvg031; HORMANN H, 1962, LIEBIGS ANN CHEM, V655, P178; Horn SJ, 2004, CARBOHYD POLYM, V56, P35, DOI 10.1016/j.carbpol.2003.11.011; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Igarashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4975; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jalak J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108181; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jung J, 2013, J BIOL CHEM, V288, P24164, DOI 10.1074/jbc.M113.455758; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Knott BC, 2014, J AM CHEM SOC, V136, P8810, DOI 10.1021/ja504074g; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; Kont R, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-135; Kostylev M, 2013, BIOCHEMISTRY-US, V52, P5656, DOI 10.1021/bi400358v; Kostylev M, 2012, BIOTECHNOL BIOENG, V109, P295, DOI 10.1002/bit.23299; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Macdonald JM, 2010, ANGEW CHEM INT EDIT, V49, P2599, DOI 10.1002/anie.200906644; Murphy L, 2013, ENZYME MICROB TECH, V52, P163, DOI 10.1016/j.enzmictec.2013.01.002; Murphy L, 2012, J BIOL CHEM, V287, P1252, DOI 10.1074/jbc.M111.276485; Nakamura A, 2014, J AM CHEM SOC, V136, P4584, DOI 10.1021/ja4119994; Nelson N, 1944, J BIOL CHEM, V153, P375; Norberg AL, 2011, FEBS LETT, V585, P2339, DOI 10.1016/j.febslet.2011.06.002; Papanikolau Y, 2001, BIOCHEMISTRY-US, V40, P11338, DOI 10.1021/bi010505h; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; Pereira AGB, 2014, CARBOHYD POLYM, V107, P158, DOI 10.1016/j.carbpol.2014.02.046; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Qi F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-238; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Sammond DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048615; Shang BZ, 2014, ACS CATAL, V4, P2216, DOI 10.1021/cs500126q; Shang BZ, 2013, J BIOL CHEM, V288, P29081, DOI 10.1074/jbc.M113.497412; Shibafuji Y, 2014, J BIOL CHEM, V289, P14056, DOI 10.1074/jbc.M113.546085; Sikorski P, 2006, BIOCHEMISTRY-US, V45, P9566, DOI 10.1021/bi060370l; Sipos B, 2010, APPL BIOCHEM BIOTECH, V161, P347, DOI 10.1007/s12010-009-8824-4; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; Teugjas H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-104; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; Valjamae P, 2003, BIOTECHNOL BIOENG, V84, P254, DOI 10.1002/bit.10775; Valjamae P, 1999, EUR J BIOCHEM, V266, P327, DOI 10.1046/j.1432-1327.1999.00853.x; Velleste R, 2010, CELLULOSE, V17, P125, DOI 10.1007/s10570-009-9356-3; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Voutilainen SP, 2008, BIOTECHNOL BIOENG, V101, P515, DOI 10.1002/bit.21940; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zakariassen H, 2010, CARBOHYD POLYM, V82, P779, DOI 10.1016/j.carbpol.2010.05.051; Zakariassen H, 2010, CARBOHYD POLYM, V81, P14, DOI 10.1016/j.carbpol.2010.01.048; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j	75	38	38	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11678	11691		10.1074/jbc.M114.635631	http://dx.doi.org/10.1074/jbc.M114.635631			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25767120	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000353719400041
J	Novoa, EM; Vargas-Rodriguez, O; Lange, S; Goto, Y; Suga, H; Musier-Forsyth, K; de Pouplana, LR				Maria Novoa, Eva; Vargas-Rodriguez, Oscar; Lange, Stefanie; Goto, Yuki; Suga, Hiroaki; Musier-Forsyth, Karin; Ribas de Pouplana, Lluis			Ancestral AlaX Editing Enzymes for Control of Genetic Code Fidelity Are Not tRNA-specific	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aminoacyl tRNA Synthetase; phylogenetics; Protein Evolution; RNA Editing; tRNA; AlaX; Genetic Code; Mistranslation; Proofreading	ESCHERICHIA-COLI; QUALITY-CONTROL; IN-VIVO; SYNTHETASE; DOMAIN; AMINOACYLATION; MISTRANSLATION; RECOGNITION; PROTEIN; MECHANISM	Background: Both AlaRS editing domains and their free-standing editing forms, AlaX, are thought to exclusively deacylate mischarged tRNA(Ala). Results: Contrary to this belief, we find that AlaX-S deacylates Ser-tRNA(Ala) and Ser-tRNA(Thr). Conclusion: AlaX-S is likely to be the ancestor of AlaX, AlaRS editing, and bacterial-like ThrRS editing domains. Significance: The biochemical activities of AlaX-S link, for the first time, the activities of the AlaRS and ThrRS editing domains. Accurate protein synthesis requires the hydrolytic editing of tRNAs incorrectly aminoacylated by aminoacyl-tRNA synthetases (ARSs). Recognition of cognate tRNAs by ARS is less error-prone than amino acid recognition, and, consequently, editing domains are generally believed to act only on the tRNAs cognate to their related ARSs. For example, the AlaX family of editing domains, including the editing domain of alanyl-tRNA synthetase and the related free-standing trans-editing AlaX enzymes, are thought to specifically act on tRNA(Ala), whereas the editing domains of threonyl-tRNA synthetases are specific for tRNA(Thr). Here we show that, contrary to this belief, AlaX-S, the smallest of the extant AlaX enzymes, deacylates Ser-tRNA(Thr) in addition to Ser-tRNA(Ala) and that a single residue is important to determine this behavior. Our data indicate that promiscuous forms of AlaX are ancestral to tRNA-specific AlaXs. We propose that former AlaX domains were used to maintain translational fidelity in earlier stages of genetic code evolution when mis-serylation of several tRNAs was possible.	[Maria Novoa, Eva; Lange, Stefanie; Ribas de Pouplana, Lluis] Inst Res Biomed, Barcelona 08028, Catalonia, Spain; [Vargas-Rodriguez, Oscar; Musier-Forsyth, Karin] Ohio State Univ, Dept Chem & Biochem, Ctr RNA Biol, Columbus, OH 43210 USA; [Goto, Yuki; Suga, Hiroaki] Univ Tokyo, Grad Sch Sci, Dept Chem, Tokyo 1130033, Japan; [Ribas de Pouplana, Lluis] Catalan Inst Res & Adv Studies, Barcelona 08010, Catalonia, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University System of Ohio; Ohio State University; University of Tokyo; ICREA	de Pouplana, LR (corresponding author), Inst Res Biomed, C Baldiri Reixac 10, Barcelona 08028, Catalonia, Spain.	lluis.ribas@irbbarcelona.org	de Pouplana, Lluis Ribas/AAA-4738-2019; Novoa, Eva Maria/B-1004-2015; Novoa, Eva Maria/B-1004-2015	de Pouplana, Lluis Ribas/0000-0002-2087-0359; Novoa, Eva Maria/0000-0002-9367-6311; Vargas-Rodriguez, Oscar/0000-0002-2301-2800; Novoa, Eva Maria/0000-0001-5567-1299	National Institutes of Health [R01 GM049928]; Spanish Ministry of Education and Science [BIO2009-09776]; La Caixa/IRB international Ph.D. program fellowship; EMBO long-term postdoctoral fellowship; HFSP postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113656, R01GM049928] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Education and Science(Spanish Government); La Caixa/IRB international Ph.D. program fellowship; EMBO long-term postdoctoral fellowship(European Molecular Biology Organization (EMBO)); HFSP postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM049928 (to K. M. F.). This work was also supported by Grant BIO2009-09776 (to L. R. d. P.) from the Spanish Ministry of Education and Science.; Supported by a La Caixa/IRB international Ph.D. program fellowship, an EMBO long-term postdoctoral fellowship, and an HFSP postdoctoral fellowship.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Ahel I, 2002, J BIOL CHEM, V277, P34743, DOI 10.1074/jbc.M206928200; Amirnovin R, 1997, J MOL EVOL, V44, P473, DOI 10.1007/PL00006170; An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; Beebe K, 2004, P NATL ACAD SCI USA, V101, P5958, DOI 10.1073/pnas.0401530101; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beebe K, 2008, NATURE, V451, P90, DOI 10.1038/nature06454; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chong YE, 2008, J BIOL CHEM, V283, P30073, DOI 10.1074/jbc.M805943200; Cvetesic N, 2014, EMBO J, V33, P1639, DOI 10.15252/embj.201488199; Das M, 2014, NUCLEIC ACIDS RES, V42, P3943, DOI 10.1093/nar/gkt1332; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; Eddy Sean R, 2009, Genome Inform, V23, P205; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Fukunaga R, 2007, ACTA CRYSTALLOGR D, V63, P390, DOI 10.1107/S090744490605640X; Geslain R, 2004, TRENDS GENET, V20, P604, DOI 10.1016/j.tig.2004.09.012; Geslain R, 2006, J BIOL CHEM, V281, P38217, DOI 10.1074/jbc.M607862200; Gomes AC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r206; Goto Y, 2011, NAT PROTOC, V6, P779, DOI 10.1038/nprot.2011.331; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Guo M, 2009, SCIENCE, V325, P744, DOI 10.1126/science.1174343; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; Huang Q, 2012, NUCLEIC ACIDS RES, V40, P10463, DOI 10.1093/nar/gks783; Hussain T, 2006, EMBO J, V25, P4152, DOI 10.1038/sj.emboj.7601278; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ishijima J, 2006, PROTEINS, V62, P1133, DOI 10.1002/prot.20760; Jones TE, 2011, P NATL ACAD SCI USA, V108, P6933, DOI 10.1073/pnas.1019033108; Karkhanis VA, 2007, J BACTERIOL, V189, P8765, DOI 10.1128/JB.01215-07; Korencic D, 2004, P NATL ACAD SCI USA, V101, P10260, DOI 10.1073/pnas.0403926101; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; MCCLAIN WH, 1988, SCIENCE, V240, P793, DOI 10.1126/science.2452483; Murakami Hiroshi, 2006, Nucleic Acids Symp Ser (Oxf), P35, DOI 10.1093/nass/nrl018; Naganuma M, 2014, NATURE, V510, P507, DOI 10.1038/nature13440; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Nordin BE, 2002, J BIOL CHEM, V277, P20510, DOI 10.1074/jbc.M202023200; Page Roderic D M, 2002, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0602s01; Pan T, 2013, ANNU REV GENET, V47, P121, DOI 10.1146/annurev-genet-111212-133522; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; de Pouplana LR, 2014, TRENDS BIOCHEM SCI, V39, P355, DOI 10.1016/j.tibs.2014.06.002; Ronneberg TA, 2000, P NATL ACAD SCI USA, V97, P13690, DOI 10.1073/pnas.250403097; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; SANTOS MAS, 1995, NUCLEIC ACIDS RES, V23, P1481, DOI 10.1093/nar/23.9.1481; Schimmel P, 2000, TRENDS BIOCHEM SCI, V25, P207, DOI 10.1016/S0968-0004(00)01553-X; Schimmel P, 2001, COLD SPRING HARB SYM, V66, P161, DOI 10.1101/sqb.2001.66.161; Schimmel P, 2011, PHILOS T R SOC B, V366, P2965, DOI 10.1098/rstb.2011.0158; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; Torres-Larios A, 2002, NAT STRUCT BIOL, V9, P343, DOI 10.1038/nsb789; Vargas-Rodriguez O, 2013, J BIOL CHEM, V288, P14391, DOI 10.1074/jbc.M113.467795; Wiltrout E, 2012, NUCLEIC ACIDS RES, V40, P10494, DOI 10.1093/nar/gks805; WOESE CR, 1965, P NATL ACAD SCI USA, V54, P1546, DOI 10.1073/pnas.54.6.1546; Yao P, 2008, NUCLEIC ACIDS RES, V36, P2728, DOI 10.1093/nar/gkn028	58	11	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10495	10503		10.1074/jbc.M115.640060	http://dx.doi.org/10.1074/jbc.M115.640060			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25724653	Green Published, hybrid			2022-12-28	WOS:000353241100048
J	Melero, R; Moro, F; Perez-Calvo, MA; Perales-Calvo, J; Quintana-Gallardo, L; Llorca, O; Muga, A; Valpuesta, JM				Melero, Roberto; Moro, Fernando; Angeles Perez-Calvo, Maria; Perales-Calvo, Judit; Quintana-Gallardo, Lucia; Llorca, Oscar; Muga, Arturo; Maria Valpuesta, Jose			Modulation of the Chaperone DnaK Allosterism by the Nucleotide Exchange Factor GrpE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-Kilodalton Heat Shock Protein (Hsp70); Chaperone; Chaperone DnaK (DnaK); Electron Microscopy (EM); Protein Folding; GrpE; Nucleotide Exchange Factor	ELECTRON-MICROSCOPY; HSP70 CHAPERONES; ATPASE DOMAIN; CELLULAR FUNCTIONS; CRYSTAL-STRUCTURE; BINDING; SUBSTRATE; CONFORMATION; SYSTEM; COMMUNICATION	Hsp70 chaperones comprise two domains, the nucleotide-binding domain (Hsp70(NBD)), responsible for structural and functional changes in the chaperone, and the substrate-binding domain (Hsp70(SBD)), involved in substrate interaction. Substrate binding and release in Hsp70 is controlled by the nucleotide state of DnaK(NBD), with ATP inducing the open, substrate-receptive DnaK(SBD) conformation, whereas ADP forces its closure. DnaK cycles between the two conformations through interaction with two cofactors, the Hsp40 co-chaperones (DnaJ in Escherichia coli) induce the ADP state, and the nucleotide exchange factors (GrpE in E. coli) induce the ATP state. X-ray crystallography showed that the GrpE dimer is a nucleotide exchange factor that works by interaction of one of its monomers with DnaK(NBD). DnaK(SBD) location in this complex is debated; there is evidence that it interacts with the GrpE N-terminal disordered region, far from DnaK(NBD). Although we confirmed this interaction using biochemical and biophysical techniques, our EM-based three-dimensional reconstruction of the DnaK-GrpE complex located DnaK(SBD) near DnaK(NBD). This apparent discrepancy between the functional and structural results is explained by our finding that the tail region of the GrpE dimer in the DnaK-GrpE complex bends and its tip contacts DnaK(SBD), whereas the DnaK(NBD)-DnaK(SBD) linker contacts the GrpE helical region. We suggest that these interactions define a more complex role for GrpE in the control of DnaK function.	[Melero, Roberto; Llorca, Oscar] Ctr Invest Biol CIB CSIC, Madrid 28040, Spain; [Moro, Fernando; Perales-Calvo, Judit; Muga, Arturo] Univ Basque Country, Fac Ciencias & Tecnol, Unidad Biofis CSIC UPV EHU, E-48080 Bilbao, Spain; [Moro, Fernando; Perales-Calvo, Judit; Muga, Arturo] Univ Basque Country, Fac Ciencias & Tecnol, Dept Bioquim & Biol Mol, E-48080 Bilbao, Spain; [Angeles Perez-Calvo, Maria; Quintana-Gallardo, Lucia; Maria Valpuesta, Jose] Ctr Nacl Biotecnol CNB CSIC, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Llorca, O (corresponding author), Ramiro de Maeztu 9, Madrid 28040, Spain.	ollorca@cib.csic.es; arturo.muga@ehu.es; jmv@cnb.csic.es	Llorca, Oscar/K-1144-2014; Valpuesta, Jose M/AAA-6002-2019; Moro Pérez, Fernando/P-3891-2015; Valpuesta, José M/T-1977-2017; Muga, Arturo/N-1174-2014; Llorca, Oscar/P-2784-2019; Melero, Roberto/J-8780-2014	Llorca, Oscar/0000-0001-5705-0699; Moro Pérez, Fernando/0000-0002-3568-3388; Valpuesta, José M/0000-0001-7468-8053; Muga, Arturo/0000-0003-0345-6882; Llorca, Oscar/0000-0001-5705-0699; Melero, Roberto/0000-0001-9467-9381	Spanish Ministry of Economy and Innovation [BFU2013-44202, SAF2011-22988, BFU2013-47059]; Madrid Regional Government [S2013/MIT-2807, S2010/BMD-2316]; Basque Government [IT709-13]; Juan de la Cierva contract [JCI-2011-09536]	Spanish Ministry of Economy and Innovation(Spanish Government); Madrid Regional Government; Basque Government(Basque Government); Juan de la Cierva contract	This work was supported in part by Spanish Ministry of Economy and Innovation Grants BFU2013-44202 (to J. M. V.), SAF2011-22988 (to O. L.), and BFU2013-47059 (to A. M.), Madrid Regional Government Grants S2013/MIT-2807 (to J. M. V.) and S2010/BMD-2316 (to O. L.), and Basque Government Grant IT709-13 (to A. M.).; Recipient of Juan de la Cierva contract JCI-2011-09536.	Alberti S, 2003, CELL STRESS CHAPERON, V8, P225, DOI 10.1379/1466-1268(2003)008<0225:BNEFOH>2.0.CO;2; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Brehmer D, 2004, J BIOL CHEM, V279, P27957, DOI 10.1074/jbc.M403558200; BUCHBERGER A, 1994, NAT STRUCT BIOL, V1, P95, DOI 10.1038/nsb0294-95; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chesnokova LS, 2003, BIOCHEMISTRY-US, V42, P9028, DOI 10.1021/bi0346493; Gelinas AD, 2003, BIOCHEMISTRY-US, V42, P9050, DOI 10.1021/bi034416b; Grimshaw JPA, 2001, J BIOL CHEM, V276, P6098, DOI 10.1074/jbc.M009290200; Groemping Y, 2001, J MOL BIOL, V305, P1173, DOI 10.1006/jmbi.2000.4373; Han WJ, 2003, BIOCHEM J, V369, P627, DOI 10.1042/BJ20020943; Harrison C, 2003, CELL STRESS CHAPERON, V8, P218, DOI 10.1379/1466-1268(2003)008<0218:GANEFF>2.0.CO;2; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Horst M, 1996, PROTEIN SCI, V5, P759; Kabani M, 2009, PROTEIN PEPTIDE LETT, V16, P623, DOI 10.2174/092986609788490186; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marabini R, 1996, J STRUCT BIOL, V116, P237, DOI 10.1006/jsbi.1996.0036; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McLellan CA, 2003, J BIOL CHEM, V278, P19017, DOI 10.1074/jbc.M301109200; Mehl AF, 2001, BIOCHEM BIOPH RES CO, V282, P562, DOI 10.1006/bbrc.2001.4567; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moro F, 2007, J MOL BIOL, V374, P1054, DOI 10.1016/j.jmb.2007.10.002; Muga A, 2008, CURR PROTEIN PEPT SC, V9, P552, DOI 10.2174/138920308786733903; Nakamura A, 2010, J MOL BIOL, V396, P1000, DOI 10.1016/j.jmb.2009.12.028; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Lopez-Blanco JR, 2013, J STRUCT BIOL, V184, P261, DOI 10.1016/j.jsb.2013.08.010; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2009, J STRUCT BIOL, V166, P234, DOI 10.1016/j.jsb.2009.02.007; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Taneva SG, 2010, BIOCHEMISTRY-US, V49, P1338, DOI 10.1021/bi901847q; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Wu CC, 2012, J BIOL CHEM, V287, P21461, DOI 10.1074/jbc.M112.344358; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zahn M, 2013, J MOL BIOL, V425, P2463, DOI 10.1016/j.jmb.2013.03.041	42	18	18	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10083	10092		10.1074/jbc.M114.623371	http://dx.doi.org/10.1074/jbc.M114.623371			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25739641	hybrid, Green Published			2022-12-28	WOS:000353241100015
J	Choi, SW; Song, JK; Yim, YS; Yun, HG; Chun, KH				Choi, Seung-Won; Song, Jun-Kyu; Yim, Ye-Seal; Yun, Ho-Geun; Chun, Kyung-Hee			Glucose Deprivation Triggers Protein Kinase C-dependent beta-Catenin Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-CANCER; COLON-CARCINOMA; MELANOMA-CELLS; BREAST-CANCER; PATHWAY; AUTOPHAGY; WNT; INACTIVATION; SENESCENCE; EXPRESSION	Autophagy is a conserved process that contributes to cell homeostasis. It is well known that induction mainly occurs in response to nutrient starvation, such as starvation of amino acids and insulin, and its mechanisms have been extensively characterized. However, the mechanisms behind cellular glucose deprivation-induced autophagy are as of now poorly understood. In the present study, we determined a mechanism by which glucose deprivation induced the PKC-dependent proteasomal degradation of beta-catenin, leading to autophagy. Glucose deprivation was shown to cause a sub-G(1) transition and enhancement of the LC3-II protein levels, whereas beta-catenin protein underwent degradation in a proteasome-dependent manner. Moreover, the inhibition of GSK3 beta was unable to abolish the glucose deprivation-mediated beta-catenin degradation or up-regulation of LC3-II protein levels, which suggested GSK3 beta-independent protein degradation. Intriguingly, the inhibition of PKC beta using a pharmacological inhibitor and transfection of siRNA for PKC alpha was observed to effectively block glucose deprivation- induced beta-catenin degradation as well as the increase in LC3-II levels and the accumulation of a sub-G(1) population. Together, our results demonstrated a molecular mechanism by which glucose deprivation can induce the GSK3 beta-independent protein degradation of beta-catenin, leading to autophagy.	[Choi, Seung-Won; Song, Jun-Kyu; Yim, Ye-Seal; Yun, Ho-Geun; Chun, Kyung-Hee] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, 50 Yonsei Ro, Seoul 120752, South Korea; [Song, Jun-Kyu; Yim, Ye-Seal; Yun, Ho-Geun; Chun, Kyung-Hee] Yonsei Univ, Brain Korea Plus Project Med Sci 21, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System; Yonsei University	Chun, KH (corresponding author), Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, 50 Yonsei Ro, Seoul 120752, South Korea.	khchun@yuhs.ac			National Research Foundation of Korea (NRF) - Korean government (Ministry of Science, ICT and Future Planning) [NRF-2014R1A2A1A11050600, NRF-2011-0030086]; Korea Health Technology RAMP;D Project, Ministry of Health and Welfare [A121982]	National Research Foundation of Korea (NRF) - Korean government (Ministry of Science, ICT and Future Planning); Korea Health Technology RAMP;D Project, Ministry of Health and Welfare	This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (Ministry of Science, ICT and Future Planning) (Grants NRF-2014R1A2A1A11050600 and NRF-2011-0030086) and by the Korea Health Technology R&D Project, Ministry of Health and Welfare, Grant A121982.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ahn YH, 2012, CLIN EXP METASTAS, V29, P359, DOI 10.1007/s10585-012-9458-4; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Bikkavilli Rama Kamesh, 2009, Commun Integr Biol, V2, P46; Chang HW, 2013, CELL SIGNAL, V25, P839, DOI 10.1016/j.cellsig.2012.12.020; Cheong TC, 2010, CANCER SCI, V101, P94, DOI 10.1111/j.1349-7006.2009.01364.x; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; de Candia P, 2011, AM J PATHOL, V178, P1814, DOI 10.1016/j.ajpath.2010.12.047; Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Flentke GR, 2014, J NEUROCHEM, V128, P523, DOI 10.1111/jnc.12464; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gwak J, 2006, J CELL SCI, V119, P4702, DOI 10.1242/jcs.03256; Jelluma N, 2006, MOL CANCER RES, V4, P319, DOI 10.1158/1541-7786.MCR-05-0061; Jiang HB, 2010, BIOCHEM BIOPH RES CO, V395, P471, DOI 10.1016/j.bbrc.2010.04.030; Kim SJ, 2014, CELL DEATH DIFFER, V21, P1769, DOI 10.1038/cdd.2014.88; Kim Sangsoo, 2011, Genomics & Informatics, V9, P1; Kim SJ, 2013, ONCOTARGET, V4, P1461, DOI 10.18632/oncotarget.1219; Kim SJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3098; Kim SJ, 2011, J CONTROL RELEASE, V155, P427, DOI 10.1016/j.jconrel.2011.06.026; Kim YM, 2010, ANN NY ACAD SCI, V1201, P65, DOI 10.1111/j.1749-6632.2010.05617.x; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Knecht E, 2009, CELL MOL LIFE SCI, V66, P2427, DOI 10.1007/s00018-009-0030-6; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee EH, 2012, IEEE PHOTONIC TECH L, V24, P3, DOI 10.1109/LPT.2011.2178738; Lee HW, 2014, BMB REP, V47, P697, DOI 10.5483/BMBRep.2014.47.12.069; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lin NY, 2013, ANN RHEUM DIS, V72, P761, DOI 10.1136/annrheumdis-2012-201671; Ma L, 2007, J BIOL CHEM, V282, P28980, DOI 10.1074/jbc.M702840200; Ma L, 2006, J BIOL CHEM, V281, P30990, DOI 10.1074/jbc.M603603200; Munoz-Pinedo C, 2003, J BIOL CHEM, V278, P12759, DOI 10.1074/jbc.M212392200; Petherick KJ, 2013, EMBO J, V32, P1903, DOI 10.1038/emboj.2013.123; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Sadot E, 2002, J CELL SCI, V115, P2771; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Wang YG, 2012, EXP MOL MED, V44, P387, DOI 10.3858/emm.2012.44.6.044; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601	50	18	20	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9863	9873		10.1074/jbc.M114.606756	http://dx.doi.org/10.1074/jbc.M114.606756			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25691573	Green Published, hybrid			2022-12-28	WOS:000352729400045
J	Maruyama, K; Fukasaka, M; Uematsu, S; Takeuchi, O; Kondo, T; Saitoh, T; Martino, MM; Akira, S				Maruyama, Kenta; Fukasaka, Masahiro; Uematsu, Satoshi; Takeuchi, Osamu; Kondo, Takeshi; Saitoh, Tatsuya; Martino, Mikael M.; Akira, Shizuo			5-Azacytidine-induced Protein 2 (AZI2) Regulates Bone Mass by Fine-tuning Osteoclast Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY ALVEOLAR PROTEINOSIS; NF-KAPPA-B; COLONY-STIMULATING FACTOR; T-CELLS NFAT; TRANSCRIPTION FACTOR; C-FOS; NEGATIVE REGULATOR; NUCLEAR FACTOR; TNF-ALPHA; DIFFERENTIATION	5-Azacytidine-induced protein 2 (AZI2) is a TNF receptor (TNFR)-associated factor family member-associated NF-kappa B activator-binding kinase 1-binding protein that regulates the production of IFNs. A previous in vitro study showed that AZI2 is involved in dendritic cell differentiation. However, the roles of AZI2 in immunity and its pleiotropic functions are unknown in vivo. Here we report that AZI2 knock-out mice exhibit normal dendritic cell differentiation in vivo. However, we found that adult AZI2 knock-out mice have severe osteoporosis due to increased osteoclast longevity. We revealed that the higher longevity of AZI2-deficient osteodasts is due to an augmented activation of proto-oncogene tyrosine-protein kinase Src (c-Src), which is a critical player in osteoclast survival. We found that AZI2 inhibits c-Src activity by regulating the activation of heat shock protein 90 (Hsp90), a chaperone involved in c-Src dephosphorylation. Furthermore, we demonstrated that AZI2 indirectly inhibits c-Src by interacting with the Hsp90 co-chaperone Cdc37. Strikingly, administration of a c-Src inhibitor markedly prevented bone loss in AZI2 knock-out mice. Together, these findings indicate that AZI2 regulates bone mass by fine-tuning osteoclast survival.	[Maruyama, Kenta; Fukasaka, Masahiro; Kondo, Takeshi; Saitoh, Tatsuya; Martino, Mikael M.; Akira, Shizuo] Osaka Univ, Host Def Lab, WPI Immunol Frontier Res Ctr IFReC, Suita, Osaka 5650871, Japan; [Uematsu, Satoshi] Univ Tokyo, Div Innate Immune Regulat, Int Res & Dev Ctr Mucosal Vaccine, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Fukasaka, Masahiro] Nitto Denko Corp, Corp R&D Dev Div, Life Sci Res Ctr, Ibaraki, Osaka 5678680, Japan; [Takeuchi, Osamu] Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Sakyo Ku, Kyoto 6068507, Japan	Osaka University; University of Tokyo; Osaka University; Nitto Denko Corporation; Kyoto University	Maruyama, K (corresponding author), Osaka Univ, Host Def Lab, WPI Immunol Frontier Res Ctr, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	maruyama@biken.osaka-u.ac.jp; sakira@biken.osaka-u.ac.jp	Takeuchi, Osamu/AAG-9359-2019; Akira, Shizuo/C-3134-2009; Martino, Mikaël M/N-9345-2013; KONDO, Takeshi/AGV-4963-2022	Takeuchi, Osamu/0000-0002-1260-6232; Martino, Mikaël M/0000-0002-5012-4605; 	Japan Society for the Promotion of Science (JSPS); JSPS KAKENHI; Osaka University MEET project; Astellas Foundation for Research on Metabolic Disorders; Naito Foundation; SENSHIN Medical Research Foundation; Japan Intractable Disease Research Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [25670027] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Osaka University MEET project; Astellas Foundation for Research on Metabolic Disorders; Naito Foundation(Naito Memorial Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Japan Intractable Disease Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a research fellowship from the Japan Society for the Promotion of Science (JSPS) for the Promotion of Science for Young Scientists, JSPS KAKENHI for a grant-in-aid for challenging exploratory research, a grant from the Osaka University MEET project, a grant from the Astellas Foundation for Research on Metabolic Disorders, a grant from the Naito Foundation, a grant from the SENSHIN Medical Research Foundation, a grant from the Japan Intractable Disease Research Foundation, and a visionary research grant from Takeda Science Foundation (to K. M.).	Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Fukasaka M, 2013, J IMMUNOL, V190, P5702, DOI 10.4049/jimmunol.1203155; Gao BX, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2081; Glantschnig H, 2003, CELL DEATH DIFFER, V10, P1165, DOI 10.1038/sj.cdd.4401285; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kawaida R, 2003, J EXP MED, V197, P1029, DOI 10.1084/jem.20021321; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Lee SE, 2001, J BIOL CHEM, V276, P49343, DOI 10.1074/jbc.M103642200; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Maruyama K, 2006, J IMMUNOL, V177, P3799, DOI 10.4049/jimmunol.177.6.3799; Maruyama K, 2012, IMMUNITY, V37, P1024, DOI 10.1016/j.immuni.2012.08.022; Maruyama K, 2012, J BIOL CHEM, V287, P29114, DOI 10.1074/jbc.M112.347799; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; ROSEN SH, 1958, NEW ENGL J MED, V258, P1123, DOI 10.1056/NEJM195806052582301; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanabe N, 2011, J BIOL CHEM, V286, P39871, DOI 10.1074/jbc.M111.295048; Thomassen MJ, 2007, J LIPID RES, V48, P2762, DOI 10.1194/jlr.P700022-JLR200; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Xing LP, 2001, GENE DEV, V15, P241, DOI 10.1101/gad.840301; Yano A, 2008, P NATL ACAD SCI USA, V105, P15541, DOI 10.1073/pnas.0805354105; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	30	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9377	9386		10.1074/jbc.M114.631374	http://dx.doi.org/10.1074/jbc.M114.631374			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25691576	hybrid, Green Published			2022-12-28	WOS:000352729400007
J	Jaitovich, A; Angulo, M; Lecuona, E; Dada, LA; Welch, LC; Cheng, Y; Gusarova, G; Ceco, E; Liu, C; Shigemura, M; Barreiro, E; Patterson, C; Nader, GA; Sznajder, JI				Jaitovich, Ariel; Angulo, Martin; Lecuona, Emilia; Dada, Laura A.; Welch, Lynn C.; Cheng, Yuan; Gusarova, Galina; Ceco, Ermelinda; Liu, Chang; Shigemura, Masahiko; Barreiro, Esther; Patterson, Cam; Nader, Gustavo A.; Sznajder, Jacob I.			High CO2 Levels Cause Skeletal Muscle Atrophy via AMP-activated Kinase (AMPK), FoxO3a Protein, and Muscle-specific Ring Finger Protein 1 (MuRF1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; ENERGY SENSOR; UBIQUITIN-PROTEASOME; HYPERCAPNIC ACIDOSIS; MUSCULAR-DYSTROPHY; OXIDATIVE STRESS; HYPERTROPHY; DYSFUNCTION; EXPRESSION; RNA	Patients with chronic obstructive pulmonary disease, acute lung injury, and critical care illness may develop hypercapnia. Many of these patients often have muscle dysfunction which increases morbidity and impairs their quality of life. Here, we investigated whether hypercapnia leads to skeletal muscle atrophy. Mice exposed to high CO2 had decreased skeletal muscle wet weight, fiber diameter, and strength. Cultured myotubes exposed to high CO2 had reduced fiber diameter, protein/DNA ratios, and anabolic capacity. High CO2 induced the expression of MuRF1 in vivo and in vitro, whereas MuRF1(-/-) mice exposed to high CO2 did not develop muscle atrophy. AMP-activated kinase AMPK), a metabolic sensor, was activated in myotubes exposed to high CO2, and loss-of-function studies showed that the AMPK alpha 2 isoform is necessary for muscle-specific ring finger protein 1 MuRF1) up-regulation and myofiber size reduction. High CO2 induced AMPK alpha 2 activation, triggering the phosphorylation and nuclear translocation of FoxO3a, and leading to an increase in MuRF1 expression and myotube atrophy. Accordingly, we provide evidence that high CO2 activates skeletal muscle atrophy via AMPK alpha 2-FoxO3a-MuRF1, which is of biological and potentially clinical significance in patients with lung diseases and hypercapnia.	[Jaitovich, Ariel; Angulo, Martin; Lecuona, Emilia; Dada, Laura A.; Welch, Lynn C.; Cheng, Yuan; Gusarova, Galina; Ceco, Ermelinda; Shigemura, Masahiko; Sznajder, Jacob I.] Northwestern Univ, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Angulo, Martin] Univ Republica, Fac Med, Dept Fisiopatol, Montevideo, Uruguay; [Liu, Chang; Nader, Gustavo A.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Barreiro, Esther] Univ Pompeu Fabra, Mol Mech Lung Canc Predisposit Res Grp IMIM, Muscle & Resp Syst Res Unit, Pulmonol Dept,Hosp del Mar,IMIM,Dept Expt & Hlth, Barcelona, Spain; [Barreiro, Esther] Inst Salud Carlos III, Ctr Invest Red Enfermedades Resp CIBERES, Madrid, Spain; [Patterson, Cam] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA	Northwestern University; Universidad de la Republica, Uruguay; Karolinska Institutet; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of North Carolina; University of North Carolina Chapel Hill	Sznajder, JI (corresponding author), Northwestern Univ, Div Pulm & Crit Care Med, Chicago, IL 60611 USA.	j-sznajder@northwestern.edu	Shigemura, Masahiko/AAL-3185-2020	Shigemura, Masahiko/0000-0001-7767-6584; Angulo, Martin/0000-0002-3326-5764	National Institutes of Health [CA060553, HL-85534, HL-71643, HL-T32-76139]; Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES); Instituto de Salud Carlos III, Spain [FIS 11/02029, FIS 12/02534]; Ministry of Competitiveness, Spain [SAF-2011-26908]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076139, P01HL071643, R01HL085534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Ministry of Competitiveness, Spain; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants CA060553 (to the Robert H. Lurie Comprehensive Cancer Center Cores: Center for Advanced Microscopy Center, Genomics Core, and Mouse Phenotyping and Histology Laboratory), HL-85534, HL-71643, and HL-T32-76139. This work was also supported by Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES) and Grants FIS 11/02029 and FIS 12/02534 (Instituto de Salud Carlos III), Spain and SAF-2011-26908 from Ministry of Competitiveness, Spain.	Baehr LM, 2011, J PHYSIOL-LONDON, V589, P4759, DOI 10.1113/jphysiol.2011.212845; Barreiro E, 2005, AM J RESP CRIT CARE, V171, P1116, DOI 10.1164/rccm.200407-887OC; Barreiro E, 2013, J APPL PHYSIOL, V114, P1220, DOI 10.1152/japplphysiol.00162.2013; Batt J, 2014, AM J RESP CELL MOL, V50, P74, DOI 10.1165/rcmb.2012-0506OC; Batt J, 2013, AM J RESP CRIT CARE, V187, P238, DOI 10.1164/rccm.201205-0954SO; Belkin RA, 2006, AM J RESP CRIT CARE, V173, P659, DOI 10.1164/rccm.200410-1369OC; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Caples SM, 2009, AM J PHYSIOL-LUNG C, V296, pL140, DOI 10.1152/ajplung.90339.2008; Ceco E, 2013, FEBS J, V280, P4198, DOI 10.1111/febs.12266; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cummins EP, 2014, CELL MOL LIFE SCI, V71, P831, DOI 10.1007/s00018-013-1470-6; Dick CR, 1997, AM J RESP CRIT CARE, V155, P609, DOI 10.1164/ajrccm.155.2.9032202; Doerr CH, 2005, AM J RESP CRIT CARE, V171, P1371, DOI 10.1164/rccm.200309-1223OC; Doucet M, 2007, AM J RESP CRIT CARE, V176, P261, DOI 10.1164/rccm.200605-704OC; ENGELEN MPKJ, 1994, EUR RESPIR J, V7, P1793, DOI 10.1183/09031936.94.07101793; Fermoselle C, 2012, EUR RESPIR J, V40, P851, DOI 10.1183/09031936.00137211; Files DC, 2012, AM J RESP CRIT CARE, V185, P825, DOI 10.1164/rccm.201106-1150OC; Gajic O, 2003, AM J RESP CRIT CARE, V167, P1057, DOI 10.1164/rccm.200208-889OC; Gates KL, 2013, AM J RESP CELL MOL, V49, P821, DOI 10.1165/rcmb.2012-0487OC; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Gowans GJ, 2014, BIOCHEM SOC T, V42, P71, DOI 10.1042/BST20130244; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Guo YT, 2013, AM J RESP CRIT CARE, V188, P1313, DOI 10.1164/rccm.201304-0732OC; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hayward LJ, 2008, J CLIN INVEST, V118, P1437, DOI 10.1172/JCI32638; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Helenius IT, 2009, P NATL ACAD SCI USA, V106, P18710, DOI 10.1073/pnas.0905925106; Hoppe S, 2009, P NATL ACAD SCI USA, V106, P17781, DOI 10.1073/pnas.0909873106; Kok MO, 2012, EUR ADDICT RES, V18, P70, DOI 10.1159/000333600; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Machida M, 2012, J CELL PHYSIOL, V227, P1569, DOI 10.1002/jcp.22871; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; MOSS T, 1995, PROG NUCLEIC ACID RE, V50, P25, DOI 10.1016/S0079-6603(08)60810-7; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Nystrom G, 2009, METABOLISM, V58, P787, DOI 10.1016/j.metabol.2009.01.015; Nystrom GJ, 2008, INT J CLIN EXP MED, V1, P50; Plant PJ, 2010, AM J RESP CELL MOL, V42, P461, DOI 10.1165/rcmb.2008-0382OC; Puhan M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005305.pub2; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schols AMWJ, 1998, AM J RESP CRIT CARE, V157, P1791, DOI 10.1164/ajrccm.157.6.9705017; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Vadasz I, 2012, AM J RESP CELL MOL, V46, P417, DOI 10.1165/rcmb.2011-0395PS; Vohwinkel CU, 2011, J BIOL CHEM, V286, P37067, DOI 10.1074/jbc.M111.290056; von Walden F, 2012, AM J PHYSIOL-CELL PH, V302, pC1523, DOI 10.1152/ajpcell.00460.2011; Wang NZ, 2010, FASEB J, V24, P2178, DOI 10.1096/fj.09-136895; Weathington NM, 2013, AM J RESP CRIT CARE, V188, P530, DOI 10.1164/rccm.201304-0754PP; WEINBERGER SE, 1989, NEW ENGL J MED, V321, P1223; Williamson DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE304, DOI 10.1152/ajpendo.91007.2008; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32	60	85	87	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9183	9194		10.1074/jbc.M114.625715	http://dx.doi.org/10.1074/jbc.M114.625715			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25691571	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000352207100041
J	Simpson, MA; Bradley, WD; Harburger, D; Parsons, M; Calderwood, DA; Koleske, AJ				Simpson, Mark A.; Bradley, William D.; Harburger, David; Parsons, Maddy; Calderwood, David A.; Koleske, Anthony J.			Direct Interactions with the Integrin beta 1 Cytoplasmic Tail Activate the Abl2/Arg Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABL TYROSINE KINASE; CELL EDGE PROTRUSION; C-ABL; FAMILY KINASES; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; N-WASP; ARG; PHOSPHORYLATION; ADHESION	Integrins are heterodimeric alpha/beta extracellular matrix adhesion receptors that couple physically to the actin cytoskeleton and regulate kinase signaling pathways to control cytoskeletal remodeling and adhesion complex formation and disassembly. beta 1 integrins signal through the Abl2/Arg ( Abl-related gene) nonreceptor tyrosine kinase to control fibroblast cell motility, neuronal dendrite morphogenesis and stability, and cancer cell invasiveness, but the molecular mechanisms by which integrin beta 1 activates Arg are unknown. We report here that the Arg kinase domain interacts directly with a lysine-rich membraneproximal segment in the integrin beta 1 cytoplasmic tail, that Arg phosphorylates the membrane-proximal Tyr-783 in the beta 1 tail, and that the Arg Src homology domain then engages this phosphorylated region in the tail. We show that these interactions mediate direct binding between integrin beta 1 and Arg in vitro and in cells and activate Arg kinase activity. These findings provide a model for understanding how beta 1-containing integrins interact with and activate Abl family kinases.	[Simpson, Mark A.; Bradley, William D.; Koleske, Anthony J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Harburger, David; Calderwood, David A.] Yale Univ, Dept Pharmacol, New Haven, CT 06510 USA; [Calderwood, David A.] Yale Univ, Dept Cell Biol, New Haven, CT 06510 USA; [Koleske, Anthony J.] Yale Univ, Dept Neurobiol, New Haven, CT 06510 USA; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	Yale University; Yale University; Yale University; Yale University; University of London; King's College London	Koleske, AJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 208024, New Haven, CT 06520 USA.	anthony.koleske@yale.edu	Calderwood, David A/AAC-6954-2019; Parsons, Maddy/B-2203-2013	Calderwood, David A/0000-0002-0791-4142; Parsons, Maddy/0000-0002-2021-8379	National Institutes of Health [CA133346, GM100411, RO1 GM068600]; NIGMS, National Institutes of Health [T32GM007223-40]; American Heart Association Founders Affiliate Predoctoral Fellowship Award [12PRE12080140]; Royal Society; NATIONAL CANCER INSTITUTE [R01CA133346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100411, R01GM068600, T32GM007223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association Founders Affiliate Predoctoral Fellowship Award(American Heart Association); Royal Society(Royal Society of London); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA133346 and GM100411 (to A. J. K.).; Supported by T32GM007223-40 from NIGMS, National Institutes of Health and American Heart Association Founders Affiliate Predoctoral Fellowship Award #12PRE12080140.; Supported by the Royal Society.; Supported by National Institutes of Health Grant RO1 GM068600.	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arias-Salgado EG, 2005, J BIOL CHEM, V280, P29699, DOI 10.1074/jbc.M503508200; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Beaty BT, 2013, MOL BIOL CELL, V24, P1661, DOI 10.1091/mbc.E12-12-0908; Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; Boyle SN, 2007, BIOCHEMISTRY-US, V46, P11614, DOI 10.1021/bi701119s; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Campbell DH, 1999, CANCER RES, V59, P5376; Campbell ID, 2011, COLD SPRING HARB PER, V1, P3, DOI DOI 10.1101/CSHPERSPECT; Cao XQ, 2008, J BIOL CHEM, V283, P31401, DOI 10.1074/jbc.M804002200; FOX JEB, 1993, J BIOL CHEM, V268, P25973; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gifford SM, 2014, J BIOL CHEM, V289, P19704, DOI 10.1074/jbc.M114.556480; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Harrison SC, 2003, CELL, V112, P737, DOI 10.1016/S0092-8674(03)00196-X; Hernandez SE, 2004, CURR BIOL, V14, P691, DOI 10.1016/j.cub.2004.03.062; Kerrisk ME, 2013, J NEUROSCI, V33, P6742, DOI 10.1523/JNEUROSCI.0528-13.2013; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Lapetina S, 2009, J CELL BIOL, V185, P503, DOI 10.1083/jcb.200809085; Lewis JM, 1998, J BIOL CHEM, V273, P14225, DOI 10.1074/jbc.273.23.14225; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Li R, 2011, CURR BIOL, V21, P1534, DOI 10.1016/j.cub.2011.08.023; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; Miller MM, 2010, BIOCHEMISTRY-US, V49, P2227, DOI 10.1021/bi901721u; Moresco EMY, 2005, J NEUROSCI, V25, P6105, DOI 10.1523/JNEUROSCI.1432-05.2005; Morse EM, 2014, BIOCHEMISTRY-US, V53, P810, DOI 10.1021/bi401596q; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Peacock JG, 2007, MOL BIOL CELL, V18, P3860, DOI 10.1091/mbc.E07-01-0075; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; Warren MS, 2012, J NEUROSCI, V32, P2824, DOI 10.1523/JNEUROSCI.3942-11.2012; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013	41	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8360	8372		10.1074/jbc.M115.638874	http://dx.doi.org/10.1074/jbc.M115.638874			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25694433	Green Published, hybrid			2022-12-28	WOS:000351662600030
J	Vitvitsky, V; Yadav, PK; Kurthen, A; Banerjee, R				Vitvitsky, Victor; Yadav, Pramod K.; Kurthen, Angelika; Banerjee, Ruma			Sulfide Oxidation by a Noncanonical Pathway in Red Blood Cells Generates Thiosulfate and Polysulfides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE BETA-SYNTHASE; HYDROGEN-SULFIDE; GAMMA-CYSTATHIONASE; H2S; REACTIVITY; MECHANISM; ASSAY	A cardioprotectant at low concentrations, H2S is a toxin at high concentrations and inhibits cytochrome c oxidase. A conundrum in H2S homeostasis is its fate in red blood cells (RBCs), which produce H2S but lack the canonical mitochondrial sulfide oxidation pathway for its clearance. The sheer abundance of RBCs in circulation enhances the metabolic significance of their clearance strategy for H2S, necessary to avoid systemic toxicity. In this study, we demonstrate that H2S generation by RBCs is catalyzed by mercaptopyruvate sulfurtransferase. Furthermore, we have discovered the locus of sulfide oxidation in RBCs and describe a new role for an old protein, hemoglobin, which in the ferric or methemoglobin state binds H2S and oxidizes it to a mixture of thiosulfate and hydropolysulfides. Our study reveals a previously undescribed route for the biogenesis of hydropolysulfides, which are increasingly considered important for H2S-based signaling, but their origin in mammalian cells is unknown. An NADPH/ flavoprotein oxidoreductase system restores polysulfide-carrying hemoglobin derivatives to ferrous hemoglobin, thus completing the methemoglobin- dependent sulfide oxidation cycle. Methemoglobindependent sulfide oxidation in mammals is complex and has similarities to chemistry reported for the dissolution of iron oxides in sulfidic waters and during bioleaching of metal sulfides. The catalytic oxidation of H2S by hemoglobin explains how RBCs maintain low steady-state H2S levels in circulation, and suggests that additional hemeproteins might be involved in sulfide homeostasis in other tissues.	[Vitvitsky, Victor; Yadav, Pramod K.; Kurthen, Angelika; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Yadav, Pramod K./A-6166-2010; Vitvitsky, Victor/ABA-2967-2021	Yadav, Pramod K./0000-0003-0026-1684; Vitvitsky, Victor/0000-0001-6251-6115	National Institutes of Health [GM112455]; American Heart Association [14POST18760003]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM112455 (to R. B.). This work was also supported by American Heart Association Grant 14POST18760003 (to P. K. Y.).	Carballal S, 2011, FREE RADICAL BIO MED, V50, P196, DOI 10.1016/j.freeradbiomed.2010.10.705; CHEN KY, 1972, ENVIRON SCI TECHNOL, V6, P529, DOI 10.1021/es60065a008; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Cuevasanta E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034562; Das TN, 1999, J PHYS CHEM A, V103, P5221, DOI 10.1021/jp9907544; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Hoppe-Seyler F., 1983, ZENTBL MED WISS, V1, P433; Kabil O, 2014, ANNU REV NUTR, V34, P171, DOI 10.1146/annurev-nutr-071813-105654; Kabil O, 2014, BBA-PROTEINS PROTEOM, V1844, P1355, DOI 10.1016/j.bbapap.2014.01.002; Kabil O, 2014, ANTIOXID REDOX SIGN, V20, P770, DOI 10.1089/ars.2013.5339; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Keilin D, 1933, P R SOC LOND B-CONTA, V113, P393, DOI 10.1098/rspb.1933.0056; Kimura H, 2015, ANTIOXID REDOX SIGN, V22, P347, DOI 10.1089/ars.2014.6082; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; King AL, 2014, P NATL ACAD SCI USA, V111, P3182, DOI 10.1073/pnas.1321871111; KRAUS DW, 1990, J BIOL CHEM, V265, P16054; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; NICHOL AW, 1968, BIOCHIM BIOPHYS ACTA, V156, P97, DOI 10.1016/0304-4165(68)90108-6; NICHOLLS P, 1982, CAN J BIOCHEM CELL B, V60, P613, DOI 10.1139/o82-076; Ogasawara Y, 2002, J BIOCHEM BIOPH METH, V51, P139, DOI 10.1016/S0165-022X(02)00010-6; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; Pavlik JW, 2010, INORG CHEM, V49, P1017, DOI 10.1021/ic901853p; Pietri R, 2011, ANTIOXID REDOX SIGN, V15, P393, DOI 10.1089/ars.2010.3698; Pietri R, 2009, BIOCHEMISTRY-US, V48, P4881, DOI 10.1021/bi801738j; Riahi S, 2014, J AM CHEM SOC, V136, P15111, DOI 10.1021/ja508063s; Sakaguchi M, 2014, ANESTHESIOLOGY, V121, P1248, DOI 10.1097/ALN.0000000000000456; Schippers A, 1999, APPL ENVIRON MICROB, V65, P319; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; SMITH RP, 1966, TOXICOL APPL PHARM, V8, P159, DOI 10.1016/0041-008X(66)90112-8; Snijder P. M., 2014, BRIT J PHARMACOL, V172, P1494; SORBO B, 1956, BIOCHIM BIOPHYS ACTA, V21, P393, DOI 10.1016/0006-3002(56)90034-8; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Theissen U, 2003, MOL BIOL EVOL, V20, P1564, DOI 10.1093/molbev/msg174; VALENTINE WN, 1974, CLIN CHIM ACTA, V51, P205, DOI 10.1016/0009-8981(74)90031-X; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; WOOD JL, 1987, METHOD ENZYMOL, V143, P25; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Yao WS, 1996, MAR CHEM, V52, P1, DOI 10.1016/0304-4203(95)00072-0; Zhong FF, 2014, P NATL ACAD SCI USA, V111, pE306, DOI 10.1073/pnas.1317173111	39	110	114	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8310	8320		10.1074/jbc.M115.639831	http://dx.doi.org/10.1074/jbc.M115.639831			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25688092	Green Published, hybrid			2022-12-28	WOS:000351662600026
J	Dhingra, N; Bruck, I; Smith, S; Ning, BT; Kaplan, DL				Dhingra, Nalini; Bruck, Irina; Smith, Skye; Ning, Boting; Kaplan, Daniel L.			Dpb11 Protein Helps Control Assembly of the Cdc45 center dot Mcm2-7 center dot GINS Replication Fork Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Cyclin-dependent Kinase (CDK); DNA; DNA Helicase; DNA Replication	EUKARYOTIC DNA-REPLICATION; SINGLE-STRANDED-DNA; S-PHASE PROGRESSION; BUDDING YEAST; IN-VITRO; SACCHAROMYCES-CEREVISIAE; MCM2-7 HELICASE; ACTIVE-SITES; ORIGIN DNA; CDC45	Background: Dpb11 is required for the initiation of DNA replication. The replication fork helicase is composed of Cdc45, Mcm2-7, and GINS. Results: Dpb11 recruits Cdc45 to Mcm2-7, and Dpb11 blocks GINS interaction with Mcm2-7. Dpb11 also binds to ssDNA, and this interaction releases Dpb11 from Mcm2-7. Conclusion: Dpb11 helps control assembly of the replication fork helicase. Significance: A mechanism for Dpb11 function is described. Dpb11 is required for the initiation of DNA replication in budding yeast. Dpb11 binds to S-phase cyclin-dependent kinase-phosphorylated Sld2 and Sld3 to form a ternary complex during S phase. The replication fork helicase in eukaryotes is composed of Cdc45, Mcm2-7, and GINS. We show here, using purified proteins from budding yeast, that Dpb11 alone binds to Mcm2-7 and that Dpb11 also competes with GINS for binding to Mcm2-7. Furthermore, Dpb11 binds directly to single-stranded DNA (ssDNA), and ssDNA inhibits the Dpb11 interaction with Mcm2-7. We also found that Dpb11 can recruit Cdc45 to Mcm2-7. We identified a mutant of the BRCT4 motif of Dpb11 that remains bound to Mcm2-7 in the presence of ssDNA (dpb11-m1,m2,m3,m5), and this mutant exhibits a DNA replication defect when expressed in budding yeast cells. Expression of this mutant results in increased interaction between Dpb11 and Mcm2-7 during S phase, impaired GINS interaction with Mcm2-7 during S phase, and decreased replication protein A (RPA) interaction with origin DNA during S phase. We propose a model in which Dpb11 first recruits Cdc45 to Mcm2-7. Dpb11, although bound to Cdc45.Mcm2-7, can block the interaction between GINS and Mcm2-7. Upon extrusion of ssDNA from the central channel of Mcm2-7, Dpb11 dissociates from Mcm2-7, and Dpb11 binds to ssDNA, thereby allowing GINS to bind to Cdc45.Mcm2-7. Finally, we propose that Dpb11 functions with Sld2 and Sld3 to help control the assembly of the replication fork helicase.	[Dhingra, Nalini; Ning, Boting] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Bruck, Irina; Smith, Skye; Kaplan, Daniel L.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	Vanderbilt University; State University System of Florida; Florida State University	Kaplan, DL (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	Daniel.Kaplan@med.fsu.edu		Dhingra, Nalini/0000-0003-0949-883X; Kaplan, Daniel/0000-0003-2760-7745	National Science Foundation [1265431]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant 1265431 (to D. L. K.).	ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bochman ML, 2010, NUCLEIC ACIDS RES, V38, P6078, DOI 10.1093/nar/gkq422; Bruck I, 2015, J BIOL CHEM, V290, P1210, DOI 10.1074/jbc.M114.608232; Bruck I, 2014, J BIOL CHEM, V289, P1948, DOI 10.1074/jbc.M113.532085; Bruck I, 2013, J BIOL CHEM, V288, P7550, DOI 10.1074/jbc.M112.440941; Bruck I, 2011, J BIOL CHEM, V286, P36414, DOI 10.1074/jbc.M111.282822; Bruck I, 2011, J BIOL CHEM, V286, P18602, DOI 10.1074/jbc.M111.226332; Bruck I, 2011, J BIOL CHEM, V286, P14157, DOI 10.1074/jbc.M111.218305; Costa A, 2014, ELIFE, V3, DOI 10.7554/eLife.03273; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Geraghty DS, 2000, J BIOL CHEM, V275, P18011, DOI 10.1074/jbc.M909787199; Gros J, 2014, EMBO J, V33, P621, DOI 10.1002/embj.201387278; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kanter DM, 2011, NUCLEIC ACIDS RES, V39, P2580, DOI 10.1093/nar/gkq1222; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; On KF, 2014, EMBO J, V33, P605, DOI 10.1002/embj.201387369; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Samel SA, 2014, GENE DEV, V28, P1653, DOI 10.1101/gad.242404.114; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Sun JC, 2014, GENE DEV, V28, P2291, DOI 10.1101/gad.242313.114; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka S, 2013, MOL CELL BIOL, V33, P2614, DOI 10.1128/MCB.00431-13; Tanaka S, 2011, CURR BIOL, V21, P2055, DOI 10.1016/j.cub.2011.11.038; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	43	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7586	7601		10.1074/jbc.M115.640383	http://dx.doi.org/10.1074/jbc.M115.640383			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25659432	hybrid, Green Published			2022-12-28	WOS:000351613600023
J	Burmeister, BT; Wang, L; Gold, MG; Skidgel, RA; O'Bryan, JP; Carnegie, GK				Burmeister, Brian T.; Wang, Li; Gold, Matthew G.; Skidgel, Randal A.; O'Bryan, John P.; Carnegie, Graeme K.			Protein Kinase A (PKA) Phosphorylation of Shp2 Protein Inhibits Its Phosphatase Activity and Modulates Ligand Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						A-kinase Anchoring Protein (AKAP); Cardiac Hypertrophy; PKA; Signal Transduction; Tyrosine-protein Phosphatase (Tyrosine Phosphatase)	D-DEPENDENT ACTIVATION; CARDIAC-HYPERTROPHY; ANCHORING PROTEINS; NOONAN-SYNDROME; CARDIOMYOCYTE HYPERTROPHY; SIGNALING PATHWAYS; LEOPARD-SYNDROME; PTPN11 SHP2; KAPPA-B; HEART	Background: The AKAP-Lbc scaffold coordinates cardiac hypertrophic signaling. Results: PKA phosphorylation of Shp2 at Thr-73/Ser-189 inhibits tyrosine-phosphorylated ligand binding and PTP activity. Conclusion: AKAP-Lbc integrates PKA and Shp2 signaling, and AKAP-Lbc-associated Shp2 activity is reduced in hypertrophic hearts following chronic -adrenergic stimulation. Significance: PKA inhibition of AKAP-Lbc-anchored Shp2 activity is a previously unrecognized mechanism that may promote cardiac hypertrophy. Pathological cardiac hypertrophy (an increase in cardiac mass resulting from stress-induced cardiac myocyte growth) is a major factor underlying heart failure. Src homology 2 domain-containing phosphatase (Shp2) is critical for cardiac function because mutations resulting in loss of Shp2 catalytic activity are associated with congenital cardiac defects and hypertrophy. We identified a novel mechanism of Shp2 inhibition that may promote cardiac hypertrophy. We demonstrate that Shp2 is a component of the protein kinase A anchoring protein (AKAP)-Lbc complex. AKAP-Lbc facilitates PKA phosphorylation of Shp2, which inhibits Shp2 phosphatase activity. We identified two key amino acids in Shp2 that are phosphorylated by PKA. Thr-73 contributes a helix cap to helix B within the N-terminal SH2 domain of Shp2, whereas Ser-189 occupies an equivalent position within the C-terminal SH2 domain. Utilizing double mutant PKA phosphodeficient (T73A/S189A) and phosphomimetic (T73D/S189D) constructs, in vitro binding assays, and phosphatase activity assays, we demonstrate that phosphorylation of these residues disrupts Shp2 interaction with tyrosine-phosphorylated ligands and inhibits its protein-tyrosine phosphatase activity. Overall, our data indicate that AKAP-Lbc integrates PKA and Shp2 signaling in the heart and that AKAP-Lbc-associated Shp2 activity is reduced in hypertrophic hearts in response to chronic -adrenergic stimulation and PKA activation. Therefore, although induction of cardiac hypertrophy is a multifaceted process, inhibition of Shp2 activity through AKAP-Lbc-anchored PKA is a previously unrecognized mechanism that may promote this compensatory response.	[Burmeister, Brian T.; Wang, Li; Skidgel, Randal A.; O'Bryan, John P.; Carnegie, Graeme K.] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; [O'Bryan, John P.] Univ Illinois, Ctr Canc, Coll Med, Chicago, IL 60612 USA; [O'Bryan, John P.] Univ Illinois, Cardiovasc Res Ctr, Coll Med, Chicago, IL 60612 USA; [Gold, Matthew G.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [O'Bryan, John P.] Jessie Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of London; University College London; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	O'Bryan, JP (corresponding author), Univ Illinois, Dept Pharmacol, E403 MSB,835 S Wolcott Ave, Chicago, IL 60612 USA.	obryanj@uic.edu	Regan, Clinton/E-6250-2012; Gold, Matthew/AAL-2546-2021	Gold, Matthew/0000-0002-1281-0815; O'Bryan, John/0000-0001-5386-1080	American Heart Association [11SDG5230003, 14PRE18830077]; Center for Clinical and Translational Science at UIC from National Institutes of Health National Center for Advancing Translational Sciences [UL1TR000050]; University of Illinois at Chicago; Veterans Administration MERIT Award [1I01BX002095]; National Institutes of Health [RO1CA116708]; NATIONAL CANCER INSTITUTE [R01CA116708] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000050] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002095] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Center for Clinical and Translational Science at UIC from National Institutes of Health National Center for Advancing Translational Sciences; University of Illinois at Chicago; Veterans Administration MERIT Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Veterans Affairs(US Department of Veterans Affairs)	Deceased. Supported by American Heart Association Scientist Development Grant 11SDG5230003, by the Center for Clinical and Translational Science at UIC through Grant UL1TR000050 from the National Institutes of Health National Center for Advancing Translational Sciences, and by startup funds from the University of Illinois at Chicago.; Supported by American Heart Association Predoctoral Fellowship 14PRE18830077.; Supported by Veterans Administration MERIT Award 1I01BX002095 and by National Institutes of Health Award RO1CA116708. To whom correspondence should be addressed: Dept. of Pharmacology, University of Illinois at Chicago, E403 MSB, 835 S. Wolcott Ave., Chicago, IL 60612. Tel.: 312-996-6221; Fax: 312-996-1225; E-mail: obryanj@uic.edu.	Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Aye TT, 2012, J MOL CELL CARDIOL, V52, P511, DOI 10.1016/j.yjmcc.2011.06.003; Burmeister BT, 2012, J BIOL CHEM, V287, P40535, DOI 10.1074/jbc.M112.385641; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Carnegie GK, 2011, J CARDIOVASC PHARM, V58, P451, DOI 10.1097/FJC.0b013e31821c0220; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2008, CURR OPIN PHARMACOL, V8, P166, DOI 10.1016/j.coph.2007.11.001; Doppler H, 2007, J BIOL CHEM, V282, P31873, DOI 10.1074/jbc.M703584200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enns Linda C, 2010, BMC Res Notes, V3, P307, DOI 10.1186/1756-0500-3-307; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Kontaridis MI, 2008, CIRCULATION, V117, P1423, DOI 10.1161/CIRCULATIONAHA.107.728865; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Kratz CP, 2005, BLOOD, V106, P2183, DOI 10.1182/blood-2005-02-0531; Krenz M, 2008, P NATL ACAD SCI USA, V105, P18930, DOI 10.1073/pnas.0806556105; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; Nakamura T, 2007, J CLIN INVEST, V117, P2123, DOI 10.1172/JCI30756; Nakamura T, 2009, P NATL ACAD SCI USA, V106, P15436, DOI 10.1073/pnas.0903302106; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Stewart RA, 2010, DEV CELL, V18, P750, DOI [10.1016/j.devcel.2010.03.009, 10.1016/j.devce1.2010.03.009]; Storz P, 2004, MOL PHARMACOL, V66, P870, DOI 10.1124/mol.104.000687; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Wang L, 2015, CELL SIGNAL, V27, P908, DOI 10.1016/j.cellsig.2015.02.003; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	37	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12058	12067		10.1074/jbc.M115.642983	http://dx.doi.org/10.1074/jbc.M115.642983			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25802336	hybrid, Green Published			2022-12-28	WOS:000354388600021
J	Chen, XQ; Kim, IK; Honaker, Y; Paudyal, SC; Koh, WK; Sparks, M; Li, S; Piwnica-Worms, H; Ellenberger, T; You, ZS				Chen, Xiaoqing; Kim, In-Kwon; Honaker, Yuchi; Paudyal, Sharad C.; Koh, Won Kyun; Sparks, Melanie; Li, Shan; Piwnica-Worms, Helen; Ellenberger, Tom; You, Zhongsheng			14-3-3 Proteins Restrain the Exo1 Nuclease to Prevent Overresection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						14-3-3 protein; checkpoint control; DNA damage response; DNA repair; proliferating cell nuclear antigen (PCNA); DNA resection; Exo1	DNA END RESECTION; HUMAN EXONUCLEASE 1; DAMAGE RESPONSE; REPAIR DEFECTS; FUNCTIONAL MRX; CANCER; ATR; PHOSPHORYLATION; RECOMBINATION; REPLICATION	Background: Proper regulation of DSB resection is key to genome maintenance. Results: 14-3-3s bind to Exo1 and restrain its damage association and resection activity by counteracting the function of PCNA. Conclusion: Exo1 activity is controlled by both positive and negative regulators to ensure a proper level of DNA end resection. Significance: Our data reveal a key mechanism that controls the DNA end resection process. The DNA end resection process dictates the cellular response to DNA double strand break damage and is essential for genome maintenance. Although insufficient DNA resection hinders homology-directed repair and ATR (ataxia telangiectasia and Rad3 related)-dependent checkpoint activation, overresection produces excessive single-stranded DNA that could lead to genomic instability. However, the mechanisms controlling DNA end resection are poorly understood. Here we show that the major resection nuclease Exo1 is regulated both positively and negatively by protein-protein interactions to ensure a proper level of DNA resection. We have shown previously that the sliding DNA clamp proliferating cell nuclear antigen (PCNA) associates with the C-terminal domain of Exo1 and promotes Exo1 damage association and DNA resection. In this report, we show that 14-3-3 proteins interact with a central region of Exo1 and negatively regulate Exo1 damage recruitment and subsequent resection. 14-3-3s limit Exo1 damage association, at least in part, by suppressing its association with PCNA. Disruption of the Exo1 interaction with 14-3-3 proteins results in elevated sensitivity of cells to DNA damage. Unlike Exo1, the Dna2 resection pathway is apparently not regulated by PCNA and 14-3-3s. Our results provide critical insights into the mechanism and regulation of the DNA end resection process and may have implications for cancer treatment.	[Chen, Xiaoqing; Honaker, Yuchi; Paudyal, Sharad C.; Koh, Won Kyun; Sparks, Melanie; Li, Shan; Piwnica-Worms, Helen; You, Zhongsheng] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Kim, In-Kwon; Ellenberger, Tom] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Piwnica-Worms, Helen] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77230 USA	Washington University (WUSTL); Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center	You, ZS (corresponding author), Washington Univ, Sch Med, Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	zyou@wustl.edu	chen, xia/GXM-5435-2022; Regan, Clinton/E-6250-2012; chen, xi/GXH-3653-2022; Classen, Scott/AAY-8176-2020; chen, xia/GYR-3948-2022	You, Zhongsheng/0000-0002-9719-8791; Koh, Won Kyun/0000-0001-8068-7348; Paudyal, Sharad/0000-0002-1658-6400	National Institutes of Health [R01GM098535, P01CA92584]; American Cancer Society [RSG-13-212-01-DMC]; Washington University; NATIONAL CANCER INSTITUTE [P01CA092584, T32CA113275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098535] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Washington University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM098535 (to Z. Y.) and P01CA92584 (to T. E.). This work was also supported by American Cancer Society Research Scholar Grant RSG-13-212-01-DMC (to Z. Y.) and a Washington University Siteman Career Award in Breast Cancer Research (to Z. Y.).	Adkins NL, 2013, NAT STRUCT MOL BIOL, V20, P836, DOI 10.1038/nsmb.2585; Andersen SD, 2012, DNA REPAIR, V11, P267, DOI 10.1016/j.dnarep.2011.11.007; Bardwell PD, 2004, NAT IMMUNOL, V5, P224, DOI 10.1038/ni1031; Bertuch AA, 2004, GENETICS, V166, P1651, DOI 10.1534/genetics.166.4.1651; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Bonetti D, 2015, EMBO REP, V16, P351, DOI 10.15252/embr.201439764; Cannavo E, 2013, P NATL ACAD SCI USA, V110, pE1661, DOI 10.1073/pnas.1305166110; Chen H, 2013, MOL CELL, V50, P589, DOI 10.1016/j.molcel.2013.04.032; Chen XQ, 2013, NUCLEIC ACIDS RES, V41, P9325, DOI 10.1093/nar/gkt672; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Costanzo V, 2004, METH MOL B, V241, P255; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Eid W, 2010, EMBO REP, V11, P962, DOI 10.1038/embor.2010.157; El-Shemerly M, 2008, NUCLEIC ACIDS RES, V36, P511, DOI 10.1093/nar/gkm1052; Engels K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001367; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Karanja KK, 2014, CELL CYCLE, V13, P1540, DOI 10.4161/cc.28476; Karras GI, 2013, MOL CELL, V49, P536, DOI 10.1016/j.molcel.2012.11.016; Kim IK, 2012, NAT STRUCT MOL BIOL, V19, P653, DOI 10.1038/nsmb.2305; Knipscheer Puck, 2012, Methods Mol Biol, V920, P221, DOI 10.1007/978-1-61779-998-3_16; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; Liao SR, 2011, NUCLEIC ACIDS RES, V39, P5967, DOI 10.1093/nar/gkr216; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Maringele L, 2004, GENE DEV, V18, P2663, DOI 10.1101/gad.316504; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Morin I, 2008, EMBO J, V27, P2400, DOI 10.1038/emboj.2008.171; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Ngo GHP, 2014, NUCLEIC ACIDS RES, V42, P10516, DOI 10.1093/nar/gku746; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Rossiello F, 2014, CURR OPIN GENET DEV, V26, P89, DOI 10.1016/j.gde.2014.06.009; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Schaetzlein S, 2013, P NATL ACAD SCI USA, V110, pE2470, DOI 10.1073/pnas.1308512110; Segurado M, 2008, GENE DEV, V22, P1816, DOI 10.1101/gad.477208; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Shiotani B, 2013, CELL REP, V3, P1651, DOI 10.1016/j.celrep.2013.04.018; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Stracker Travis H., 2013, Frontiers in Genetics, V4, P37, DOI 10.3389/fgene.2013.00037; Sun J, 2012, J BIOL CHEM, V287, P4936, DOI 10.1074/jbc.M111.306167; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Tomimatsu N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4561; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Tsutakawa SE, 2014, DNA REPAIR, V19, P95, DOI 10.1016/j.dnarep.2014.03.022; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Xu ZM, 2010, NAT STRUCT MOL BIOL, V17, P1124, DOI 10.1038/nsmb.1884; Yang SH, 2013, EMBO J, V32, P126, DOI 10.1038/emboj.2012.314; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Zhang JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001946; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	71	18	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12300	12312		10.1074/jbc.M115.644005	http://dx.doi.org/10.1074/jbc.M115.644005			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25833945	Green Published, hybrid			2022-12-28	WOS:000354388600040
J	Juarez, JF; Liu, HX; Zamarro, MT; McMahon, S; Liu, HT; Naismith, JH; Eberlein, C; Boll, M; Carmona, M; Diaz, E				Juarez, Javier F.; Liu, Huixiang; Zamarro, Maria T.; McMahon, Stephen; Liu, Huanting; Naismith, James H.; Eberlein, Christian; Boll, Matthias; Carmona, Manuel; Diaz, Eduardo			Unraveling the Specific Regulation of the Central Pathway for Anaerobic Degradation of 3-Methylbenzoate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Transcription; Gene Expression; Microbiology; Protein-DNA Interaction; Transcription Regulation; 3-Methylbenzoate; Azoarcus; Anaerobic Degradation	AROMATIC-COMPOUNDS; TRANSCRIPTIONAL REGULATOR; ESCHERICHIA-COLI; TETR FAMILY; COENZYME-A; M-XYLENE; RHODOPSEUDOMONAS-PALUSTRIS; BENZOATE METABOLISM; TOLUENE METABOLISM; CATABOLIC GENES	Background: The specific transcriptional regulation of the mbd pathway for anaerobic 3-methylbenzoate degradation is unknown. Results: The MbdR/3-methylbenzoyl-CoA couple controls the induction of the mbd genes. Conclusion: MbdR is the regulator of the mbd pathway in Azoarcus sp. CIB. Significance: This work highlights the importance of the regulatory systems in the evolution and adaptation of bacteria to the anaerobic degradation of aromatic compounds. The mbd cluster encodes the anaerobic degradation of 3-methylbenzoate in the -proteobacterium Azoarcus sp. CIB. The specific transcriptional regulation circuit that controls the expression of the mbd genes was investigated. The P-O, P-B1, and P-3R promoters responsible for the expression of the mbd genes, their cognate MbdR transcriptional repressor, as well as the MbdR operator regions (ATACN(10)GTAT) have been characterized. The three-dimensional structure of MbdR has been solved revealing a conformation similar to that of other TetR family transcriptional regulators. The first intermediate of the catabolic pathway, i.e. 3-methylbenzoyl-CoA, was shown to act as the inducer molecule. An additional MbdR-dependent promoter, P-A, which contributes to the expression of the CoA ligase that activates 3-methylbenzoate to 3-methylbenzoyl-CoA, was shown to be necessary for an efficient induction of the mbd genes. Our results suggest that the mbd cluster recruited a regulatory system based on the MbdR regulator and its target promoters to evolve a distinct central catabolic pathway that is only expressed for the anaerobic degradation of aromatic compounds that generate 3-methylbenzoyl-CoA as the central metabolite. All these results highlight the importance of the regulatory systems in the evolution and adaptation of bacteria to the anaerobic degradation of aromatic compounds.	[Juarez, Javier F.; Zamarro, Maria T.; Carmona, Manuel; Diaz, Eduardo] CSIC, Dept Environm Biol, Ctr Invest Biol, Madrid 28040, Spain; [Liu, Huixiang; McMahon, Stephen; Liu, Huanting; Naismith, James H.] Univ St Andrews, St Andrews KY16 9ST, Scotland; [Eberlein, Christian; Boll, Matthias] Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of St Andrews; University of Freiburg	Diaz, E (corresponding author), CSIC, Dept Environm Biol, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	ediaz@cib.csic.es	Naismith, James Henderson/H-3408-2012; Naismith, James Henderson/AAB-8614-2020; Eberlein, Christian/AAL-8874-2021; Diaz, Eduardo/F-8605-2016	Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Diaz, Eduardo/0000-0002-9731-6524; Fernandez Juarez, Javier/0000-0002-1958-9906; Carmona, Manuel/0000-0002-1591-7618	Ministry of Economy and Competitiveness of Spain [BIO2009-10438, BIO2012-39501, CSD2007-00005]; European Union [311815]; Biotechnology and Biological Sciences Research Council; Wellcome Trust; Comunidad Autonoma de Madrid; Biotechnology and Biological Sciences Research Council [BB/K015508/1] Funding Source: researchfish; BBSRC [BB/K015508/1] Funding Source: UKRI	Ministry of Economy and Competitiveness of Spain(Spanish Government); European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Comunidad Autonoma de Madrid(Comunidad de Madrid); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Ministry of Economy and Competitiveness of Spain Grants BIO2009-10438, BIO2012-39501, and CSD2007-00005 and European Union FP7 Grant 311815. Crystallography was supported by a Biotechnology and Biological Sciences Research Council grant and a Wellcome Trust award.; Supported by a predoctoral fellowship from the Comunidad Autonoma de Madrid. Present address: Dept. of Genetics, Harvard Medical School, 77 Louis Pasteur Ave., Boston, MA 02155.	Achong GR, 2001, J BACTERIOL, V183, P6763, DOI 10.1128/JB.183.23.6763-6770.2001; Agari Y, 2012, J BACTERIOL, V194, P4630, DOI 10.1128/JB.00668-12; Agari Y, 2011, MICROBIOL-SGM, V157, P1589, DOI 10.1099/mic.0.048017-0; Valderrama JA, 2014, J BIOL CHEM, V289, P1892, DOI 10.1074/jbc.M113.517714; Valderrama JA, 2012, J BIOL CHEM, V287, P10494, DOI 10.1074/jbc.M111.309005; Barragan MJL, 2005, J BIOL CHEM, V280, P10683, DOI 10.1074/jbc.M412259200; Barragan MJL, 2004, J BACTERIOL, V186, P5762, DOI 10.1128/JB.186.17.5762-5774.2004; Boll M, 2014, ENVIRON MICROBIOL, V16, P612, DOI 10.1111/1462-2920.12328; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bugg TDH, 2011, NAT PROD REP, V28, P1883, DOI 10.1039/c1np00042j; Calisti C, 2008, APPL MICROBIOL BIOT, V80, P475, DOI 10.1007/s00253-008-1557-4; Carmona M, 1996, J MOL BIOL, V261, P348, DOI 10.1006/jmbi.1996.0468; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chen DW, 2014, APPL ENVIRON MICROB, V80, P4051, DOI 10.1128/AEM.01146-14; Coschigano PW, 2004, FEMS MICROBIOL LETT, V231, P261, DOI 10.1016/S0378-1097(04)00005-9; Coschigano PW, 1997, APPL ENVIRON MICROB, V63, P652, DOI 10.1128/AEM.63.2.652-660.1997; de Lorenzo Victor, 2011, Bioeng Bugs, V2, P3, DOI 10.4161/bbug.2.1.13388; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Diaz E, 2013, CURR OPIN BIOTECH, V24, P431, DOI 10.1016/j.copbio.2012.10.010; Durante-Rodriguez G, 2006, J BACTERIOL, V188, P2343, DOI 10.1128/JB.188.7.2343-2354.2006; Durante-Rodriguez G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057518; Durante-Rodriguez G, 2010, J BIOL CHEM, V285, P35694, DOI 10.1074/jbc.M110.143503; Egland PG, 1999, J BACTERIOL, V181, P2102, DOI 10.1128/JB.181.7.2102-2109.1999; Egland PG, 2000, J BACTERIOL, V182, P100, DOI 10.1128/JB.182.1.100-106.2000; FERNANDEZ S, 1995, MOL MICROBIOL, V16, P205, DOI 10.1111/j.1365-2958.1995.tb02293.x; Ferrandez A, 1998, J BIOL CHEM, V273, P25974, DOI 10.1074/jbc.273.40.25974; Fuchs G, 2008, ANN NY ACAD SCI, V1125, P82, DOI 10.1196/annals.1419.010; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; Fujihashi M, 2014, PROTEINS, V82, P1301, DOI 10.1002/prot.24496; Grkovic S, 2001, J BACTERIOL, V183, P7102, DOI 10.1128/JB.183.24.7102-7109.2001; GROSS GG, 1966, Z NATURFORSCH PT B, VB 21, P683; Herrmann S, 2009, ENV MICROBIOL REP, V1, P535, DOI 10.1111/j.1758-2229.2009.00076.x; Hirakawa H, 2012, J BACTERIOL, V194, P1960, DOI 10.1128/JB.06817-11; Juarez JF, 2013, ENVIRON MICROBIOL, V15, P148, DOI 10.1111/j.1462-2920.2012.02818.x; Juarez JF, 2010, APPL ENVIRON MICROB, V76, P383, DOI 10.1128/AEM.02255-09; Kasai D, 2012, FEMS MICROBIOL LETT, V332, P68, DOI 10.1111/j.1574-6968.2012.02576.x; Krieger CJ, 1999, J BACTERIOL, V181, P6403, DOI 10.1128/JB.181.20.6403-6410.1999; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; Leuthner B, 1998, FEMS MICROBIOL LETT, V166, P35, DOI 10.1111/j.1574-6968.1998.tb13180.x; Liu HT, 2009, PROTEIN EXPRES PURIF, V63, P102, DOI 10.1016/j.pep.2008.09.008; Lovley DR, 2003, NAT REV MICROBIOL, V1, P35, DOI 10.1038/nrmicro731; Marschall C, 1998, J MOL BIOL, V276, P339, DOI 10.1006/jmbi.1997.1533; Maxam A M, 1980, Methods Enzymol, V65, P499; Meckenstock RU, 2011, CURR OPIN BIOTECH, V22, P406, DOI 10.1016/j.copbio.2011.02.009; Morasch B, 2004, ARCH MICROBIOL, V181, P407, DOI 10.1007/s00203-004-0672-6; Moreno-Ruiz E, 2003, J BACTERIOL, V185, P2026, DOI 10.1128/JB.185.6.2026-2030.2003; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Parke D, 2003, APPL ENVIRON MICROB, V69, P5398, DOI 10.1128/AEM.69.9.5398-5409.2003; Peres CM, 2006, J BACTERIOL, V188, P8662, DOI 10.1128/JB.01312-06; Peters KM, 2008, BIOCHEMISTRY-US, V47, P8122, DOI 10.1021/bi8008246; Philipp B, 2012, ENV MICROBIOL REP, V4, P469, DOI 10.1111/j.1758-2229.2011.00304.x; Rabus R, 2014, APPL MICROBIOL BIOT, V98, P3371, DOI 10.1007/s00253-013-5466-9; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rieger PG, 2002, J BIOTECHNOL, V94, P101, DOI 10.1016/S0168-1656(01)00422-9; Sakamoto K, 2011, J BACTERIOL, V193, P4388, DOI 10.1128/JB.05203-11; Sambrook J., 2001, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueki T, 2011, APPL ENVIRON MICROB, V77, P7058, DOI 10.1128/AEM.05516-11; Vilchez-Vargas R, 2010, ENVIRON MICROBIOL, V12, P3089, DOI 10.1111/j.1462-2920.2010.02340.x; Willems AR, 2008, J MOL BIOL, V376, P1377, DOI 10.1016/j.jmb.2007.12.061; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu Z, 2010, J MOL BIOL, V400, P847, DOI 10.1016/j.jmb.2010.05.062	71	7	7	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12165	12183		10.1074/jbc.M115.637074	http://dx.doi.org/10.1074/jbc.M115.637074			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25795774	Green Published, hybrid			2022-12-28	WOS:000354388600029
J	Liu, C; Tan, FCK; Xiao, ZC; Dawe, GS				Liu, Chao; Tan, Francis Chee Kuan; Xiao, Zhi-Cheng; Dawe, Gavin S.			Amyloid Precursor Protein Enhances Nav1.6 Sodium Channel Cell Surface Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid Precursor Protein (APP); JNK; G Protein; Membrane Protein; Sodium Channel; Trafficking; Duolink; G(o) Protein; Nav1; 6 Sodium Channels; Cell Surface Expression	N-TERMINAL KINASE; CYTOPLASMIC DOMAIN; EPILEPTIC ENCEPHALOPATHY; SCN8A; NA(V)1.6; PHOSPHORYLATION; NEURONS; MUTATION; MICE; G(O)	Background: Loss-of-function amyloid precursor protein (APP) and Nav1.6 transgenic mice share similar phenotypes. Results: APP interacts with Nav1.6 and enhances its cell surface expression through a G(o)-coupled JNK pathway. Conclusion: APP regulates Nav1.6 function, likely through a G(o)-coupled JNK pathway. Significance: This finding advances the current understanding of APP functions and has implications for novel therapies for neurodegenerative disorders. Amyloid precursor protein (APP) is commonly associated with Alzheimer disease, but its physiological function remains unknown. Nav1.6 is a key determinant of neuronal excitability in vivo. Because mouse models of gain of function and loss of function of APP and Nav1.6 share some similar phenotypes, we hypothesized that APP might be a candidate molecule for sodium channel modulation. Here we report that APP colocalized and interacted with Nav1.6 in mouse cortical neurons. Knocking down APP decreased Nav1.6 sodium channel currents and cell surface expression. APP-induced increases in Nav1.6 cell surface expression were G(o) protein-dependent, enhanced by a constitutively active G(o) protein mutant, and blocked by a dominant negative G(o) protein mutant. APP also regulated JNK activity in a G(o) protein-dependent manner. JNK inhibition attenuated increases in cell surface expression of Nav1.6 sodium channels induced by overexpression of APP. JNK, in turn, phosphorylated APP. Nav1.6 sodium channel surface expression was increased by T668E and decreased by T668A, mutations of APP695 mimicking and preventing Thr-668 phosphorylation, respectively. Phosphorylation of APP695 at Thr-668 enhanced its interaction with Nav1.6. Therefore, we show that APP enhances Nav1.6 sodium channel cell surface expression through a G(o)-coupled JNK pathway.	[Liu, Chao; Tan, Francis Chee Kuan; Dawe, Gavin S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Liu, Chao; Tan, Francis Chee Kuan; Dawe, Gavin S.] Natl Univ Singapore, Neurobiol & Ageing Programme, Inst Life Sci, Singapore 117456, Singapore; [Liu, Chao; Tan, Francis Chee Kuan; Dawe, Gavin S.] Natl Univ Singapore, Singapore Inst Neurotechnol SINAPSE, Ctr Life Sci, Singapore 117456, Singapore; [Xiao, Zhi-Cheng] Kunming Med Coll, Inst Mol & Clin Med, Key Lab Stem Cell & Regenerat Med, Kunming 650031, Peoples R China; [Xiao, Zhi-Cheng] Monash Univ, Dept Anat & Dev Biol, Shunxi Monash Immune Regenerat & Neurosci Lab, Melbourne, Vic 3800, Australia	National University of Singapore; National University of Singapore; National University of Singapore; Kunming Medical University; Monash University	Xiao, ZC (corresponding author), Kunming Med Coll, Inst Mol & Clin Med, Key Lab Stem Cell & Regenerat Med, Kunming 650031, Peoples R China.	zhicheng.xiao@monash.edu; gavindawe@nus.edu.sg	Liu, Chao/AAL-6454-2021	Dawe, Gavin/0000-0001-6119-701X; xiao, zhicheng/0000-0001-5172-762X; Tan, Francis Chee Kuan/0000-0002-5272-9990	National Medical Research Council, Ministry of Health, Singapore; NMRC NUHS Centre Grant-Memory, Aging, and Cognition Centre [NMRC/CG/013/2013]; Monash University, Australia; Talent Program of Yunnan Province, China;  [NMRC/1059/2006]	National Medical Research Council, Ministry of Health, Singapore(National Medical Research Council, Singapore); NMRC NUHS Centre Grant-Memory, Aging, and Cognition Centre; Monash University, Australia(Monash University); Talent Program of Yunnan Province, China; 	This work was supported by the National Medical Research Council, Ministry of Health, Singapore with NMRC NUHS Centre Grant-Memory, Aging, and Cognition Centre Seed Funding, NMRC/CG/013/2013 (to G. S. D.) and in collaboration with Z. C. X. (Grant NMRC/1059/2006). This work was also supported by grants from the Professorial Fellowship of Monash University, Australia, and by the Talent Program of Yunnan Province, China (to Z. C. X.).	Aman TK, 2007, BIOPHYS J, V92, P1938, DOI 10.1529/biophysj.106.093500; Aplin AE, 1996, J NEUROCHEM, V67, P699; Biffi E, 2012, BIOTECHNOL BIOENG, V109, P166, DOI 10.1002/bit.23310; Black JA, 2012, EXP NEUROL, V234, P302, DOI 10.1016/j.expneurol.2011.09.030; Black JA, 2009, GLIA, V57, P1072, DOI 10.1002/glia.20830; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Brouillet E, 1999, J NEUROSCI, V19, P1717; Burbidge SA, 2002, MOL BRAIN RES, V103, P80, DOI 10.1016/S0169-328X(02)00188-2; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Cousins SL, 2009, J NEUROCHEM, V111, P1501, DOI 10.1111/j.1471-4159.2009.06424.x; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Gullberg M., 2010, NAT METHODS, DOI [10.1038/nmeth.f.1306, DOI 10.1038/NMETH.F.1306]; Guo QX, 2012, J BIOL CHEM, V287, P2437, DOI 10.1074/jbc.M111.315051; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Hashimoto Y, 2003, J NEUROCHEM, V84, P864, DOI 10.1046/j.1471-4159.2003.01585.x; Hoe HS, 2009, J BIOL CHEM, V284, P8495, DOI 10.1074/jbc.M900141200; ICHIKAWA M, 1993, NEUROSCI RES, V16, P95, DOI 10.1016/0168-0102(93)90076-3; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; Komwatana P, 1996, P NATL ACAD SCI USA, V93, P8107, DOI 10.1073/pnas.93.15.8107; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; LANG J, 1995, EMBO J, V14, P3635, DOI 10.1002/j.1460-2075.1995.tb00033.x; Lee A, 2009, CHANNELS, V3, P171, DOI 10.4161/chan.3.3.8854; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Liu C, 2010, TRAFFIC, V11, P405, DOI 10.1111/j.1600-0854.2009.01027.x; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Lu T, 1999, J PHYSIOL-LONDON, V518, P371, DOI 10.1111/j.1469-7793.1999.0371p.x; Ma JY, 1997, NEURON, V19, P443, DOI 10.1016/S0896-6273(00)80952-6; McKinney BC, 2008, GENES BRAIN BEHAV, V7, P629, DOI 10.1111/j.1601-183X.2008.00399.x; Meisler MH, 2004, GENETICA, V122, P37, DOI 10.1007/s10709-004-1441-9; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; O'Brien Janelle E., 2013, Frontiers in Genetics, V4, P213, DOI 10.3389/fgene.2013.00213; O'Brien JE, 2012, J BIOL CHEM, V287, P18459, DOI 10.1074/jbc.M111.336024; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; Sharkey LM, 2009, J NEUROSCI, V29, P2733, DOI 10.1523/JNEUROSCI.6026-08.2009; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Standen CL, 2001, J NEUROCHEM, V76, P316, DOI 10.1046/j.1471-4159.2001.00102.x; Thakur A, 2007, J NEUROSCI RES, V85, P1668, DOI 10.1002/jnr.21298; Trudeau MM, 2006, J MED GENET, V43, P527, DOI 10.1136/jmg.2005.035667; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Van Wart A, 2006, J NEUROSCI, V26, P7172, DOI 10.1523/JNEUROSCI.1101-06.2006; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Veeramah KR, 2012, AM J HUM GENET, V90, P502, DOI 10.1016/j.ajhg.2012.01.006; Veeraraghavalu K, 2014, J NEUROSCI, V34, P3668, DOI 10.1523/JNEUROSCI.5079-13.2014; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Xu DE, 2014, CELL ADHES MIGR, V8, P396, DOI 10.4161/cam.28802; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	61	18	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12048	12057		10.1074/jbc.M114.617092	http://dx.doi.org/10.1074/jbc.M114.617092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25767117	Green Published, hybrid			2022-12-28	WOS:000354388600020
J	Moon, C; Zhang, WQ; Ren, AX; Arora, K; Sinha, C; Yarlagadda, S; Woodrooffe, K; Schuetz, JD; Valasani, KR; de Jonge, HR; Shanmukhappa, SK; Shata, MTM; Buddington, RK; Parthasarathi, K; Naren, AP				Moon, Changsuk; Zhang, Weiqiang; Ren, Aixia; Arora, Kavisha; Sinha, Chandrima; Yarlagadda, Sunitha; Woodrooffe, Koryse; Schuetz, John D.; Valasani, Koteswara Rao; de Jonge, Hugo R.; Shanmukhappa, Shiva Kumar; Shata, Mohamed Tarek M.; Buddington, Randal K.; Parthasarathi, Kaushik; Naren, Anjaparavanda P.			Compartmentalized Accumulation of cAMP near Complexes of Multidrug Resistance Protein 4 (MRP4) and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Contributes to Drug-induced Diarrhea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; IN-VITRO; CONFERS RESISTANCE; SMALL-INTESTINE; IRINOTECAN; CAMPTOTHECINS; MECHANISMS; TRANSPORT; CULTURES; EFFLUX	Diarrhea is one of the most common adverse side effects observed in similar to 7% of individuals consuming Food and Drug Administration (FDA)-approved drugs. The mechanism of how these drugs alter fluid secretion in the gut and induce diarrhea is not clearly understood. Several drugs are either substrates or inhibitors of multidrug resistance protein 4 (MRP4), such as the anti-colon cancer drug irinotecan and an anti-retroviral used to treat HIV infection, 3'-azido-3'-deoxythymidine (AZT). These drugs activate cystic fibrosis transmembrane conductance regulator (CFTR)-mediated fluid secretion by inhibiting MRP4-mediated cAMP efflux. Binding of drugs to MRP4 augments the formation of MRP4-CFTR-containing macromolecular complexes that is mediated via scaffolding protein PDZK1. Importantly, HIV patients on AZT treatment demonstrate augmented MRP4-CFTR complex formation in the colon, which defines a novel paradigm of drug-induced diarrhea.	[Moon, Changsuk; Arora, Kavisha; Yarlagadda, Sunitha; Woodrooffe, Koryse; Shanmukhappa, Shiva Kumar; Naren, Anjaparavanda P.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Moon, Changsuk; Zhang, Weiqiang; Ren, Aixia; Arora, Kavisha; Sinha, Chandrima; Yarlagadda, Sunitha; Parthasarathi, Kaushik; Naren, Anjaparavanda P.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Zhang, Weiqiang] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN 38163 USA; [Ren, Aixia] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA; [Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Valasani, Koteswara Rao] Univ Kansas, Dept Pharmacol & Toxicol, Sch Pharm, Lawrence, KS 66047 USA; [Valasani, Koteswara Rao] Univ Kansas, Higuchi Biosci Ctr, Sch Pharm, Lawrence, KS 66047 USA; [de Jonge, Hugo R.] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, NL-3000 CA Rotterdam, Netherlands; [Shata, Mohamed Tarek M.] Univ Cincinnati, Med Ctr, Div Digest Dis, Cincinnati, OH 45267 USA; [Buddington, Randal K.] Univ Memphis, Dept Hlth & Sport Sci, Memphis, TN 38152 USA	Cincinnati Children's Hospital Medical Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Kansas; University of Kansas; Erasmus University Rotterdam; Erasmus MC; University System of Ohio; University of Cincinnati; University of Memphis	Naren, AP (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, 3333 Burnet Ave,S-6322, Cincinnati, OH 45229 USA.	anaren@cchmc.org	Buddington, Randal/ABH-2011-2021; Regan, Clinton/E-6250-2012; Schuetz, John D/N-2692-2018; Shata, Mohamed/ABB-3392-2021	Shata, Mohamed Tarek/0000-0003-1907-0570; Buddington, Randal/0000-0001-5790-0593	National Institutes of Health [DK080834, DK093045, GM060904]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392, R01DK080834, R01DK093045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060904, R56GM060904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health Grants DK080834 and DK093045 (to A. P. N.) and GM060904 (to J. D. S.).	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blake M, 2000, CLIN INFECT DIS, V30, pS96, DOI 10.1086/313859; Blandizzi C, 2001, TOXICOL APPL PHARM, V177, P149, DOI 10.1006/taap.2001.9293; Blandizzi C, 2001, BRIT J PHARMACOL, V132, P73, DOI 10.1038/sj.bjp.0703766; Chassany O, 2000, DRUG SAFETY, V22, P53, DOI 10.2165/00002018-200022010-00005; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Dallas S, 2004, J PHARMACOL EXP THER, V309, P1221, DOI 10.1124/jpet.103.063966; Damu AG, 1998, PHYTOCHEMISTRY, V49, P1811, DOI 10.1016/S0031-9422(98)00342-2; Kool M, 1997, CANCER RES, V57, P3537; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Li CY, 2010, INTEGR BIOL-UK, V2, P161, DOI [10.1039/B924455G, 10.1039/b924455g]; Liu JH, 2012, AM J PHYSIOL-CELL PH, V302, pC1492, DOI 10.1152/ajpcell.00392.2011; Maroun J A, 2007, Curr Oncol, V14, P13, DOI 10.3747/co.2007.96; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; Nieto N, 2000, DIGEST DIS SCI, V45, P2044, DOI 10.1023/A:1005603019800; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; PAVLOV O G, 1987, Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova, V73, P517; Penmatsa H, 2010, MOL BIOL CELL, V21, P1097, DOI 10.1091/mbc.E09-08-0655; Pizzolato JF, 2003, LANCET, V361, P2235, DOI 10.1016/S0140-6736(03)13780-4; Ratnaike RN, 1998, DRUG AGING, V13, P245, DOI 10.2165/00002512-199813030-00007; Ren AX, 2012, DIGEST DIS SCI, V57, P99, DOI 10.1007/s10620-011-1821-9; Riedl KM, 2001, J AGR FOOD CHEM, V49, P4917, DOI 10.1021/jf010683h; Sager G, 2009, MINI-REV MED CHEM, V9, P1009, DOI 10.2174/138955709788681654; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schaaf LJ, 2006, CLIN CANCER RES, V12, P3782, DOI 10.1158/1078-0432.CCR-05-2152; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; Seidler U, 2009, ANN NY ACAD SCI, V1165, P249, DOI 10.1111/j.1749-6632.2009.04046.x; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sparreboom A, 1998, CLIN CANCER RES, V4, P2747; Stein Alexander, 2010, Ther Adv Med Oncol, V2, P51, DOI 10.1177/1758834009355164; Stelzner M, 2012, AM J PHYSIOL-GASTR L, V302, pG1359, DOI 10.1152/ajpgi.00493.2011; Tian Q, 2005, PHARM RES-DORDR, V22, P1837, DOI 10.1007/s11095-005-7595-z; Vilar S, 2008, J COMPUT CHEM, V29, P2613, DOI 10.1002/jcc.21016; Vilar S, 2008, CURR TOP MED CHEM, V8, P1555, DOI 10.2174/156802608786786624; Zeng WZ, 1997, AM J PHYSIOL-CELL PH, V273, pC442, DOI 10.1152/ajpcell.1997.273.2.C442	40	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11246	11257		10.1074/jbc.M114.605410	http://dx.doi.org/10.1074/jbc.M114.605410			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25762723	Green Published, hybrid			2022-12-28	WOS:000353719400004
J	Li, PY; Chen, XL; Ji, P; Li, CY; Wang, P; Zhang, Y; Xie, BB; Qin, QL; Su, HN; Zhou, BC; Zhang, YZ; Zhang, XY				Li, Ping-Yi; Chen, Xiu-Lan; Ji, Peng; Li, Chun-Yang; Wang, Peng; Zhang, Yi; Xie, Bin-Bin; Qin, Qi-Long; Su, Hai-Nan; Zhou, Bai-Cheng; Zhang, Yu-Zhong; Zhang, Xi-Ying			Interdomain Hydrophobic Interactions Modulate the Thermostability of Microbial Esterases from the Hormone-Sensitive Lipase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; THERMOPHILIC ESTERASE; SEQUENCE SIMILARITY; FUNCTIONAL-ANALYSIS; BACTERIAL HOMOLOG; SUBFAMILY; CARBOXYLESTERASE; ACIDOCALDARIUS; STABILITY; RESIDUES	Microbial hormone-sensitive lipases (HSLs) contain a CAP domain and a catalytic domain. However, it remains unclear how the CAP domain interacts with the catalytic domain to maintain the stability of microbial HSLs. Here, we isolated an HSL esterase, E40, from a marine sedimental metagenomic library. E40 exhibited the maximal activity at 45 degrees C and was quite thermolabile, with a half-life of only 2 min at 40 degrees C, which may be an adaptation of E40 to the permanently cold sediment environment. The structure of E40 was solved to study its thermolability. Structural analysis showed that E40 lacks the interdomain hydrophobic interactions between loop 1 of the CAP domain and alpha 7 of the catalytic domain compared with its thermostable homologs. Mutational analysis showed that the introduction of hydrophobic residues Trp(202) and Phe(203) in alpha 7 significantly improved E40 stability and that a further introduction of hydrophobic residues in loop 1 made E40 more thermostable because of the formation of interdomain hydrophobic interactions. Altogether, the results indicate that the absence of interdomain hydrophobic interactions between loop 1 and alpha 7 leads to the thermolability of E40. In addition, a comparative analysis of the structures of E40 and other thermolabile and thermostable HSLs suggests that the interdomain hydrophobic interactions between loop 1 and alpha 7 are a key element for the thermostability of microbial HSLs. Therefore, this study not only illustrates the structural element leading to the thermolability of E40 but also reveals a structural determinant for HSL thermostability.	[Li, Ping-Yi; Chen, Xiu-Lan; Ji, Peng; Li, Chun-Yang; Wang, Peng; Zhang, Yi; Xie, Bin-Bin; Qin, Qi-Long; Su, Hai-Nan; Zhou, Bai-Cheng; Zhang, Yu-Zhong; Zhang, Xi-Ying] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Li, Ping-Yi; Chen, Xiu-Lan; Ji, Peng; Li, Chun-Yang; Wang, Peng; Zhang, Yi; Xie, Bin-Bin; Qin, Qi-Long; Su, Hai-Nan; Zhou, Bai-Cheng; Zhang, Yu-Zhong; Zhang, Xi-Ying] Shandong Univ, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Zhang, XY (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangxiying@sdu.edu.cn	WANG, Peng/GSN-5263-2022	Li, Chun-Yang/0000-0002-1151-4897; Zhang, Yu-Zhong/0000-0002-2017-1005	National Natural Science Foundation of China [91228210, 31290230, 31290231, 31170055, 91328208]; Hi-Tech Research and Development Program of China [2012AA092103]; China Ocean Mineral Resources R&D Association Special Foundation [DY125-15-T-05]; Fundamental Research Funds of Shandong University [2014QY006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); China Ocean Mineral Resources R&D Association Special Foundation; Fundamental Research Funds of Shandong University	This work was supported by National Natural Science Foundation of China Grants 91228210, 31290230, 31290231, 31170055, and 91328208; Hi-Tech Research and Development Program of China Grant 2012AA092103; China Ocean Mineral Resources R&D Association Special Foundation Grant DY125-15-T-05; and Fundamental Research Funds of Shandong University Grant 2014QY006.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Angkawidjaja C, 2012, FEBS J, V279, P3071, DOI 10.1111/j.1742-4658.2012.08687.x; Benavente R, 2013, FEBS J, V280, P6658, DOI 10.1111/febs.12569; Byun JS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-47; De Simone G, 2000, J MOL BIOL, V303, P761, DOI 10.1006/jmbi.2000.4195; De Simone G, 2004, J BIOL CHEM, V279, P6815, DOI 10.1074/jbc.M307738200; De Simone G, 2001, J MOL BIOL, V314, P507, DOI 10.1006/jmbi.2001.5152; Dou S, 2014, BIOCHEM BIOPH RES CO, V446, P1145, DOI 10.1016/j.bbrc.2014.03.072; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Jensen LH, 1997, METHOD ENZYMOL, V277, P353, DOI 10.1016/S0076-6879(97)77020-4; Jeon JH, 2012, APPL MICROBIOL BIOT, V93, P623, DOI 10.1007/s00253-011-3433-x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; Li PY, 2014, J BIOL CHEM, V289, P19031, DOI 10.1074/jbc.M114.574913; Li PY, 2012, ENVIRON MICROBIOL, V14, P467, DOI 10.1111/j.1462-2920.2011.02637.x; Ma BD, 2013, BIORESOURCE TECHNOL, V133, P354, DOI 10.1016/j.biortech.2013.01.089; Manco G, 2000, ARCH BIOCHEM BIOPHYS, V373, P182, DOI 10.1006/abbi.1999.1497; Manco G, 1998, BIOCHEM J, V332, P203, DOI 10.1042/bj3320203; Manco G, 2001, J BIOL CHEM, V276, P37482, DOI 10.1074/jbc.M103017200; Mandrich L, 2005, J MOL BIOL, V345, P501, DOI 10.1016/j.jmb.2004.10.035; Mandrich L, 2008, PROTEINS, V71, P1721, DOI 10.1002/prot.21877; Nam KH, 2009, PROTEINS, V74, P1036, DOI 10.1002/prot.22313; Nam KH, 2009, BIOCHEM BIOPH RES CO, V379, P553, DOI 10.1016/j.bbrc.2008.12.085; Ngo TD, 2013, ACTA CRYSTALLOGR D, V69, P1726, DOI 10.1107/S0907444913013425; Ohara K, 2014, J BIOL CHEM, V289, P24499, DOI 10.1074/jbc.M113.521856; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Palm GJ, 2011, APPL MICROBIOL BIOT, V91, P1061, DOI 10.1007/s00253-011-3337-9; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pezzullo M, 2013, PROTEIN ENG DES SEL, V26, P47, DOI 10.1093/protein/gzs066; Rhee JK, 2006, APPL ENVIRON MICROB, V72, P3021, DOI 10.1128/AEM.72.4.3021-3025.2006; Suzuki Y, 2004, FEMS MICROBIOL LETT, V236, P97, DOI 10.1016/j.femsle.2004.05.026; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Wei YY, 1999, NAT STRUCT BIOL, V6, P340; Xia YZ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1189; Zhu XY, 2003, J BIOL CHEM, V278, P2008, DOI 10.1074/jbc.M210103200	37	51	51	0	35	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11188	11198		10.1074/jbc.M115.646182	http://dx.doi.org/10.1074/jbc.M115.646182			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25771540	hybrid, Green Published			2022-12-28	WOS:000353404500051
J	Li, TL; Su, L; Lei, YJ; Liu, XF; Zhang, YJ; Liu, XG				Li, Tianliang; Su, Ling; Lei, Yuanjiu; Liu, Xianfang; Zhang, Yajing; Liu, Xiangguo			DDIT3 and KAT2A Proteins Regulate TNFRSF10A and TNFRSF10B Expression in Endoplasmic Reticulum Stress-mediated Apoptosis in Human Lung Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEATH RECEPTOR 5; NF-KAPPA-B; CCAAT/ENHANCER-BINDING PROTEIN; TRAIL-INDUCED APOPTOSIS; HOMOLOGOUS PROTEIN; CARCINOMA-CELLS; UP-REGULATION; DR5 EXPRESSION; CHOP; TRANSCRIPTION	TNFRSF10A and TNFRSF10B are cell surface receptors that bind to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and mediate the extrinsic pathway of apoptosis. However, the mechanisms of transcriptional regulation of TNFRSF10A and TNFRSF10B remain largely uncharacterized. In this study, two putative DDIT3 binding sites (-1636/-1625; -374/-364) and a putative AP-1 binding site (-304/-298) were identified in the TNFRSF10A promoter region. We found that DDIT3 interacts with phospho-JUN, and the DDIT3-phospho-JUN complex binds to the AP-1 binding site (-304/-298) within the TNFRSF10A promoter region. In addition, we confirmed that KAT2A physically interacts with the N-terminal region (amino acids 1-26) of DDIT3. Importantly, knockdown of KAT2A down-regulated TNFRSF10A and TNFRSF10B and dramatically decreased promoter activity of cells transfected with luciferase reporter plasmid containing the AP-1 binding site (-304/-298) of the TNFRSF10A promoter, as well as cells transfected with luciferase reporter plasmid containing DDIT3 binding site (-276/- 264) of the TNFRSF10B promoter. ChIP results suggest that KAT2 A may participate in a KAT2A center dot DDIT3 center dot phospho-JUN complex, or may participate in a KAT2A center dot DDIT3 complex and acetylate H3K9/K14, respectively. Moreover, we verified that TNFRSF10A mediates apoptosis triggered by endoplasmic reticulum stress in human lung cancer cells. Collectively, we demonstrate that DDIT3 and KAT2A cooperatively up-regulate TNFRSF10A and TNFRSF10B. Our findings highlight novel mechanisms underlying endoplasmic reticulum stress-induced TNFRSF10A and TNFRSF10B expressions and apoptosis. These findings will be helpful for elucidating mechanisms related to anticancer drugs in mediating apoptosis.	[Li, Tianliang; Su, Ling; Lei, Yuanjiu; Liu, Xianfang; Zhang, Yajing; Liu, Xiangguo] Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China	Shandong University	Liu, XG (corresponding author), Shandong Univ, Sch Life Sci, Rm 103,South Bldg,27 Shanda South Rd, Jinan 250100, Peoples R China.	xgliu@sdu.edu.cn	Liu, Xiangguo/G-1091-2010	Liu, Xiangguo/0000-0002-1879-3817; Lei, Yuanjiu/0000-0002-7486-4261; Su, Ling/0000-0001-7008-0550	National Natural Science Foundation of China [31371402, 31171332, 81472686, 30971479]; National Key Basic Research Program of China [2013CB910900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (31371402, 31171332, 81472686, 30971479), National Key Basic Research Program of China (2013CB910900, project 3).	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Baritaki S, 2007, J IMMUNOL, V179, P5441, DOI 10.4049/jimmunol.179.8.5441; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Cherasse Y, 2007, NUCLEIC ACIDS RES, V35, P5954, DOI 10.1093/nar/gkm642; Downey M, 2013, CURR BIOL, V23, P1638, DOI 10.1016/j.cub.2013.06.050; Elrod HA, 2008, CANCER BIOL THER, V7, P163, DOI 10.4161/cbt.7.2.5335; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Guan BX, 2002, ONCOGENE, V21, P3121, DOI 10.1038/sj.onc.1205430; Gunderson FQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000682; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Jin XH, 2007, J UROLOGY, V177, P1894, DOI 10.1016/j.juro.2007.01.018; Johnsson A, 2009, EMBO REP, V10, P1009, DOI 10.1038/embor.2009.127; Kimberley FC, 2004, CELL RES, V14, P359, DOI 10.1038/sj.cr.7290236; Lee BS, 2013, ENDOCR-RELAT CANCER, V20, P283, DOI 10.1530/ERC-12-0405; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lim JH, 2009, CARCINOGENESIS, V30, P729, DOI 10.1093/carcin/bgn265; Liu GB, 2012, J CELL MOL MED, V16, P1618, DOI 10.1111/j.1582-4934.2011.01401.x; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Liu XG, 2004, CANCER RES, V64, P5078, DOI 10.1158/0008-5472.CAN-04-1195; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Marmorstein R, 2001, J MOL BIOL, V311, P433, DOI 10.1006/jmbi.2001.4859; Marmorstein R, 2001, CURR OPIN GENET DEV, V11, P155, DOI 10.1016/S0959-437X(00)00173-8; Mendoza FJ, 2008, APOPTOSIS, V13, P756, DOI 10.1007/s10495-008-0210-0; Miyagi Satoru, 2011, Rinsho Ketsueki, V52, P490; Ohoka N, 2007, J BIOL CHEM, V282, P35687, DOI 10.1074/jbc.M703735200; Pino SC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005468; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shetty S, 2005, MOL CELL BIOL, V25, P5404, DOI 10.1128/MCB.25.13.5404-5416.2005; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Sun SY, 2007, J BIOL CHEM, V282, P18800, DOI 10.1074/jbc.M611438200; Sun SY, 2005, APOPTOSIS, V10, P1203, DOI 10.1007/s10495-005-2274-4; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Tsai JY, 2010, ONCOL REP, V24, P1169, DOI 10.3892/or_00000969; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Verfaillie T, 2013, CANCER LETT, V332, P249, DOI 10.1016/j.canlet.2010.07.016; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Yoshida T, 2007, ONCOL REP, V18, P1239; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	51	61	62	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11108	11118		10.1074/jbc.M115.645333	http://dx.doi.org/10.1074/jbc.M115.645333			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25770212	Green Published, hybrid			2022-12-28	WOS:000353404500045
J	Liang, J; Suhandynata, RT; Zhou, HL				Liang, Jason; Suhandynata, Raymond T.; Zhou, Huilin			Phosphorylation of Sae2 Mediates Forkhead-associated (FHA) Domain-specific Interaction and Regulates Its DNA Repair Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; BUDDING YEAST SAE2; SACCHAROMYCES-CEREVISIAE; DAMAGE CHECKPOINT; GENOME REARRANGEMENTS; END RESECTION; ATM; PROTEIN; RAD53; MEC1	Saccharomyces cerevisiae Sae2 and its ortholog CtIP in higher eukaryotes have a conserved role in the initial processing of DNA lesions and influencing their subsequent repair pathways. Sae2 is phosphorylated by the ATR/ATM family kinases Mec1 and Tel1 in response to DNA damage. Among the Mec1/Tel1 consensus phosphorylation sites of Sae2, we found that mutations of Thr-90 and Thr-279 of Sae2 into alanine caused a persistent Rad53 activation in response to a transient DNA damage, similar to the loss of Sae2. To gain insight into the function of this phosphorylation of Sae2, we performed a quantitative proteomics analysis to identify its associated proteins. We found that phosphorylation of Thr-90 of Sae2 mediates its interaction with Rad53, Dun1, Xrs2, Dma1, and Dma2, whereas Rad53 and Dun1 additionally interact with phosphorylated Thr-279 of Sae2. Mutations of the ligand-binding residues of Forkhead-associated (FHA) domains of Rad53, Dun1, Xrs2, Dma1, and Dma2 abolished their interactions with Sae2, revealing the involvement of FHA-specific interactions. Mutations of Thr-90 and Thr-279 of Sae2 caused a synergistic defect when combined with sgs1 Delta and exo1 Delta and elevated gross chromosomal rearrangements. Likewise, mutations of RAD53 and DUN1 caused a synthetic growth defect with sgs1 Delta and elevated gross chromosomal rearrangements. These findings suggest that threonine-specific phosphorylation of Sae2 by Mec1 and Tel1 contributes to DNA repair and genome maintenance via its interactions with Rad53 and Dun1.	[Liang, Jason; Suhandynata, Raymond T.; Zhou, Huilin] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Liang, Jason; Zhou, Huilin] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhou, HL (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr,CMM East 2055, La Jolla, CA 92093 USA.	huzhou@ucsd.edu	Regan, Clinton/E-6250-2012	Liang, Jason/0000-0001-8742-8824; Zhou, Huilin/0000-0002-1350-4430	National Institutes of Health [GM080469]; Ludwig Cancer Research; National Institutes of Health, NCI [T32 CA009523]; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Cancer Research; National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080469 (to H. Z. and R. S.). This work was also supported by Ludwig Cancer Research (to H. Z. and R. S.).; Supported by National Institutes of Health, NCI, Training Grant T32 CA009523.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Baroni E, 2004, MOL CELL BIOL, V24, P4151, DOI 10.1128/MCB.24.10.4151-4165.2004; Bashkirov VI, 2003, MOL CELL BIOL, V23, P1441, DOI 10.1128/MCB.23.4.1441-1452.2003; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Cartagena-Lirola H, 2006, CELL CYCLE, V5, P1549, DOI 10.4161/cc.5.14.2916; Chen SH, 2007, J BIOL CHEM, V282, P986, DOI 10.1074/jbc.M609322200; Chen SH, 2010, J BIOL CHEM, V285, P12803, DOI 10.1074/jbc.M110.106989; Clerici M, 2006, EMBO REP, V7, P212, DOI 10.1038/sj.embor.7400593; Craven RJ, 2002, GENETICS, V161, P493; Deng CC, 2005, GENETICS, V170, P591, DOI 10.1534/genetics.104.028795; Dodson GE, 2010, CELL CYCLE, V9, P1516, DOI 10.4161/cc.9.8.11260; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Fu Q, 2014, MOL CELL BIOL, V34, P778, DOI 10.1128/MCB.00963-13; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Lee K, 2008, NATURE, V454, P543, DOI 10.1038/nature07054; Li S, 2000, NATURE, V406, P210, DOI 10.1038/35018134; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Palmbos PL, 2008, GENETICS, V180, P1809, DOI 10.1534/genetics.108.095539; Pennaneach V, 2004, NAT GENET, V36, P612, DOI 10.1038/ng1359; Peterson SE, 2013, MOL CELL, V49, P657, DOI 10.1016/j.molcel.2012.11.020; Putnam CD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004277; Putnam Christopher D, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5492; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Smolka MB, 2006, J CELL BIOL, V175, P743, DOI 10.1083/jcb.200605081; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; Wang HL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003277; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	44	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10751	10763		10.1074/jbc.M114.625293	http://dx.doi.org/10.1074/jbc.M114.625293			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25762720	hybrid, Green Published			2022-12-28	WOS:000353404500017
J	Gonzalez-Garcia, VA; Pulido-Cid, M; Garcia-Doval, C; Bocanegra, R; van Raaij, MJ; Martin-Benito, J; Cuervo, A; Carrascosa, JL				Gonzalez-Garcia, Veronica A.; Pulido-Cid, Mar; Garcia-Doval, Carmela; Bocanegra, Rebeca; van Raaij, Mark J.; Martin-Benito, Jaime; Cuervo, Ana; Carrascosa, Jose L.			Conformational Changes Leading to T7 DNA Delivery upon Interaction with the Bacterial Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteriophage; DNA Viruses; Electron Microscopy (EM); Protein Complex; Virus Entry; Virus Structure	ELECTRON-MICROSCOPY; BACTERIOPHAGE SPP1; STRUCTURAL-CHANGES; IN-VITRO; TERMINAL DOMAIN; GENOME; HOST; EJECTION; MECHANISM; INFECTION	The majority of bacteriophages protect their genetic material by packaging the nucleic acid in concentric layers to an almost crystalline concentration inside protein shells (capsid). This highly condensed genome also has to be efficiently injected into the host bacterium in a process named ejection. Most phages use a specialized complex (often a tail) to deliver the genome without disrupting cell integrity. Bacteriophage T7 belongs to the Podoviridae family and has a short, non-contractile tail formed by a tubular structure surrounded by fibers. Here we characterize the kinetics and structure of bacteriophage T7 DNA delivery process. We show that T7 recognizes lipopolysaccharides (LPS) from Escherichia coli rough strains through the fibers. Rough LPS acts as the main phage receptor and drives DNA ejection in vitro. The structural characterization of the phage tail after ejection using cryo-electron microscopy (cryo-EM) and single particle reconstruction methods revealed the major conformational changes needed for DNA delivery at low resolution. Interaction with the receptor causes fiber tilting and opening of the internal tail channel by untwisting the nozzle domain, allowing release of DNA and probably of the internal head proteins.	[Gonzalez-Garcia, Veronica A.; Pulido-Cid, Mar; Garcia-Doval, Carmela; Bocanegra, Rebeca; van Raaij, Mark J.; Martin-Benito, Jaime; Cuervo, Ana; Carrascosa, Jose L.] CSIC, Ctr Nacl Biotecnol, Struct Macromol Dept, E-28049 Madrid, Spain; [Carrascosa, Jose L.] IMDEA Nanociencia, Inst Madrileno Estudios Avanzados Nanociencia, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); IMDEA Nanociencia	Cuervo, A (corresponding author), Ctr Nacl Biotecnol, CSIC C Darwin 3,Cantoblanco, Madrid 28049, Spain.	acuervo@cnb.csic.es; jlcarras@cnb.csic.es	van Raaij, Mark J/B-3678-2009; Bocanegra, Rebeca/AAO-3887-2020; Cuervo, Ana/AAB-1464-2020	van Raaij, Mark J/0000-0002-4781-1375; Bocanegra, Rebeca/0000-0002-9024-9365; Martin-Benito Romero, Jaime/0000-0002-8541-4709; Garcia Doval, Carmela/0000-0002-3422-9490; Cuervo, Ana/0000-0001-9414-503X	Spanish Ministry of Economy and Competitiveness [BFU2011-29038, BFU2011-25090, BFU2011-24843]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness Grants BFU2011-29038 (to J. L. C.), BFU2011-25090 (to J. M.-B.), and BFU2011-24843 (to M. J. v. R.).	Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840; Andres D, 2012, MOL MICROBIOL, V83, P1244, DOI 10.1111/j.1365-2958.2012.08006.x; Andres D, 2010, J BIOL CHEM, V285, P36768, DOI 10.1074/jbc.M110.169003; Bertin A, 2011, CURR OPIN MICROBIOL, V14, P492, DOI 10.1016/j.mib.2011.07.010; Bhardwaj A, 2014, CURR OPIN STRUC BIOL, V25, P1, DOI 10.1016/j.sbi.2013.10.005; Casjens SR, 2012, ADV EXP MED BIOL, V726, P143, DOI 10.1007/978-1-4614-0980-9_7; Chang CY, 2010, VIROLOGY, V398, P176, DOI 10.1016/j.virol.2009.12.002; Chang JT, 2010, J MOL BIOL, V402, P731, DOI 10.1016/j.jmb.2010.07.058; Chiaruttini N, 2010, BIOPHYS J, V99, P447, DOI 10.1016/j.bpj.2010.04.048; Cuervo A., 2013, BACTERIOPHAGE, DOI [10.4161/bact.27011, DOI 10.4161/BACT.27011]; Cuervo A, 2013, J BIOL CHEM, V288, P26290, DOI 10.1074/jbc.M113.491209; Cuervo Ana, 2013, Subcell Biochem, V68, P361, DOI 10.1007/978-94-007-6552-8_12; Cuervo A, 2012, CURR OPIN BIOTECH, V23, P529, DOI 10.1016/j.copbio.2011.11.029; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Garcia-Doval C, 2012, P NATL ACAD SCI USA, V109, P9390, DOI 10.1073/pnas.1119719109; Garcia-Doval C, 2012, ACTA CRYSTALLOGR F, V68, P166, DOI 10.1107/S1744309111051049; HERSHEY AD, 1952, J GEN PHYSIOL, V36, P39, DOI 10.1085/jgp.36.1.39; Hu B, 2013, SCIENCE, V339, P576, DOI 10.1126/science.1231887; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; Kemp P, 2005, VIROLOGY, V340, P307, DOI 10.1016/j.virol.2005.06.039; KOIKE M, 1971, J BACTERIOL, V108, P1402, DOI 10.1128/JB.108.3.1402-1411.1971; Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975; KRUGER DH, 1981, MICROBIOL REV, V45, P9; Leiman PG, 2007, J MOL BIOL, V371, P836, DOI 10.1016/j.jmb.2007.05.083; Lhuillier S, 2009, P NATL ACAD SCI USA, V106, P8507, DOI 10.1073/pnas.0812407106; LINDBERG AA, 1973, ANNU REV MICROBIOL, V27, P205, DOI 10.1146/annurev.mi.27.100173.001225; Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Molineux IJ, 2013, NAT REV MICROBIOL, V11, P194, DOI 10.1038/nrmicro2988; Molineux IJ, 2001, MOL MICROBIOL, V40, P1, DOI 10.1046/j.1365-2958.2001.02357.x; Oliveira L, 2005, J MOL BIOL, V353, P529, DOI 10.1016/j.jmb.2005.08.063; Parent KN, 2014, MOL MICROBIOL, V92, P47, DOI 10.1111/mmi.12536; Peralta B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001667; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Qimron U, 2006, P NATL ACAD SCI USA, V103, P19039, DOI 10.1073/pnas.0609428103; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Sun L, 2014, NATURE, V505, P432, DOI 10.1038/nature12816; Veesler D, 2011, MICROBIOL MOL BIOL R, V75, P423, DOI 10.1128/MMBR.00014-11; Vinga I., 2006, MODERN BACTERIOPHAGE, P167; Xiang Y, 2006, EMBO J, V25, P5229, DOI 10.1038/sj.emboj.7601386; Zhao XN, 2013, J VIROL, V87, P12260, DOI 10.1128/JVI.01948-13	46	38	39	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10038	10044		10.1074/jbc.M114.614222	http://dx.doi.org/10.1074/jbc.M114.614222			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25697363	Green Published, hybrid			2022-12-28	WOS:000353241100011
J	Wang, YB; Tan, B; Mu, R; Chang, Y; Wu, M; Tu, HQ; Zhang, YC; Guo, SS; Qin, XH; Li, T; Li, WH; Li, AL; Zhang, XM; Li, HY				Wang, Yu-Bo; Tan, Bo; Mu, Rui; Chang, Yan; Wu, Min; Tu, Hai-Qing; Zhang, Yu-Cheng; Guo, Sai-Sai; Qin, Xuan-He; Li, Tao; Li, Wei-Hua; Li, Ai-Ling; Zhang, Xue-Min; Li, Hui-Yan			Ubiquitin-associated Domain-containing Ubiquitin Regulatory X (UBX) Protein UBXN1 Is a Negative Regulator of Nuclear Factor kappa B (NF-kappa B) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; NF-B; Polyubiquitin Chain; Signal Transduction; Tumor Necrosis Factor (TNF); UBXN1; cIAPs	IKK ACTIVATION; KINASE IKK; AAA-ATPASE; CANCER; INFLAMMATION; PATHWAY; SYSTEM; NEMO; P47	Excessive nuclear factor B (NF-B) activation should be precisely controlled as it contributes to multiple immune and inflammatory diseases. However, the negative regulatory mechanisms of NF-B activation still need to be elucidated. Various types of polyubiquitin chains have proved to be involved in the process of NF-B activation. Many negative regulators linked to ubiquitination, such as A20 and CYLD, inhibit IB kinase activation in the NF-B signaling pathway. To find new NF-B signaling regulators linked to ubiquitination, we used a small scale siRNA library against 51 ubiquitin-associated domain-containing proteins and screened out UBXN1, which contained both ubiquitin-associated and ubiquitin regulatory X (UBX) domains as a negative regulator of TNF-triggered NF-B activation. Overexpression of UBXN1 inhibited TNF-triggered NF-B activation, although knockdown of UBXN1 had the opposite effect. UBX domain-containing proteins usually act as valosin-containing protein (VCP)/p97 cofactors. However, knockdown of VCP/p97 barely affected UBXN1-mediated NF-B inhibition. At the same time, we found that UBXN1 interacted with cellular inhibitors of apoptosis proteins (cIAPs), E3 ubiquitin ligases of RIP1 in the TNF receptor complex. UBXN1 competitively bound to cIAP1, blocked cIAP1 recruitment to TNFR1, and sequentially inhibited RIP1 polyubiquitination in response to TNF. Therefore, our findings demonstrate that UBXN1 is an important negative regulator of the TNF-triggered NF-B signaling pathway by mediating cIAP recruitment independent of VCP/p97.	[Wang, Yu-Bo; Tan, Bo; Mu, Rui; Chang, Yan; Wu, Min; Tu, Hai-Qing; Zhang, Yu-Cheng; Guo, Sai-Sai; Qin, Xuan-He; Li, Tao; Li, Wei-Hua; Li, Ai-Ling; Zhang, Xue-Min; Li, Hui-Yan] Natl Ctr Biomed Anal, Inst Basic Med Sci, Beijing 100850, Peoples R China		Li, HY (corresponding author), Natl Ctr Biomed Anal, Inst Basic Med Sci, Beijing 100850, Peoples R China.	hyli@ncba.ac.cn		Li, Tao/0000-0002-0746-8322	National Basic Research Program of China [2013CB910302, 2012CB910701, 2012CB910801]; National Natural Science Foundation of China [81325014, 81130037, 31370761, 81221004, 81025010]; National Science and Technology Major Projects for "Major New Drugs Innovation and Development" [2012ZX09301003-001-001]; International S&T Corporation Program of China [2013DFA31710]; National Science and Technology Support Program [2012BAK25B00]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects for "Major New Drugs Innovation and Development"; International S&T Corporation Program of China; National Science and Technology Support Program	This work was supported by National Basic Research Program of China Grants 2013CB910302, 2012CB910701, and 2012CB910801, National Natural Science Foundation of China Grants 81325014, 81130037, 31370761, 81221004, and 81025010, National Science and Technology Major Projects for "Major New Drugs Innovation and Development" Grant 2012ZX09301003-001-001, International S&T Corporation Program of China Grant 2013DFA31710, and National Science and Technology Support Program Grant 2012BAK25B00.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Chernorudskiy AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004251; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Ghosh S, 2012, IMMUNOL REV, V246, P5, DOI 10.1111/j.1600-065X.2012.01111.x; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Park MY, 2007, J BIOL CHEM, V282, P27572, DOI 10.1074/jbc.C700106200; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Shibata Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2068; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang PH, 2013, CELL REP, V3, P1057, DOI 10.1016/j.celrep.2013.02.027; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu-Baer F, 2010, MOL CELL BIOL, V30, P2787, DOI 10.1128/MCB.01056-09	24	20	20	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10395	10405		10.1074/jbc.M114.631689	http://dx.doi.org/10.1074/jbc.M114.631689			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25681446	Green Published, hybrid			2022-12-28	WOS:000353241100040
J	Haering, C; Kanageswaran, N; Bouvain, P; Scholz, P; Altmuller, J; Becker, C; Gisselmann, G; Waring-Bischof, J; Hatt, H				Haering, Claudia; Kanageswaran, Ninthujah; Bouvain, Pascal; Scholz, Paul; Altmueller, Janine; Becker, Christian; Gisselmann, Guenter; Waering-Bischof, Janine; Hatt, Hanns			Ion Transporter NKCC1, Modulator of Neurogenesis in Murine Olfactory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING NKCC1; SENSORY NEURONS; RNA-SEQ; NA-K-2CL COTRANSPORTER; CHLORIDE ACCUMULATION; EXPRESSION ANALYSIS; MULTIGENE FAMILY; CL-COTRANSPORTER; RECEPTOR NEURONS; PARIETAL-CELLS	Olfaction is one of the most crucial senses for vertebrates regarding foraging and social behavior. Therefore, it is of particular interest to investigate the sense of smell, its function on a molecular level, the signaling proteins involved in the process and the mechanism of required ion transport. In recent years, the precise role of the ion transporter NKCC1 in olfactory sensory neuron (OSN) chloride accumulation has been a controversial subject. NKCC1 is expressed in OSNs and is involved in chloride accumulation of dissociated neurons, but it had not been shown to play a role in mouse odorant sensation. Here, we present electro-olfactogram recordings (EOG) demonstrating that NKCC1-deficient mice exhibit significant defects in perception of a complex odorant mixture (Henkel100) in both air-phase and submerged approaches. Using next generation sequencing (NG'S) and RT-PCR experiments of NKCC1-deficient and wild type mouse transcriptomes, we confirmed the absence of a highly expressed ion transporter that could compensate for NKCC1. Additional histological investigations demonstrated a reduced number of cells in the olfactory epithelium (OE), resulting in a thinner neuronal layer. Therefore, we conclude that NKCC1 is an important transporter involved in chloride ion accumulation in the olfactory epithelium, but it is also involved in OSN neurogenesis.	[Haering, Claudia; Kanageswaran, Ninthujah; Bouvain, Pascal; Scholz, Paul; Gisselmann, Guenter; Waering-Bischof, Janine; Hatt, Hanns] Ruhr Univ Bochum, Cell Physiol, Univ Str 150, D-44780 Bochum, Germany; [Altmueller, Janine; Becker, Christian] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany	Ruhr University Bochum; University of Cologne	Haering, C (corresponding author), Ruhr Univ Bochum, Cell Physiol, Univ Str 150, D-44780 Bochum, Germany.	Claudia.Haering@rub.de		Altmuller, Janine/0000-0003-4372-1521	International Max Planck Research School in Chemical and Molecular Biology (IMPRS-CMB) [SFB 642]; Ruhr-University Bochum Research School	International Max Planck Research School in Chemical and Molecular Biology (IMPRS-CMB); Ruhr-University Bochum Research School	This work was supported by the SFB 642, the International Max Planck Research School in Chemical and Molecular Biology (IMPRS-CMB), and the Ruhr-University Bochum Research School.	Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Altimimi HF, 2007, J BIOL CHEM, V282, P3720, DOI 10.1074/jbc.M609285200; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Bicho A, 2005, BIOPHYS J, V89, P211, DOI 10.1529/biophysj.105.061002; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Bouyer PG, 2013, AM J PHYSIOL-GASTR L, V304, pG142, DOI 10.1152/ajpgi.00483.2011; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chen H, 2005, NEUROL RES, V27, P280, DOI 10.1179/016164105X25243; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; DeMaria S, 2010, J CELL BIOL, V191, P443, DOI 10.1083/jcb.201008163; Fenton RA, 2002, AM J PHYSIOL-RENAL, V282, pF630, DOI 10.1152/ajprenal.00264.2001; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Gonzalez-Silva C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069295; Goode S, 1997, GENE DEV, V11, P2532, DOI 10.1101/gad.11.19.2532; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Hu S, 2003, PHYSIOL GENOMICS, V15, P191, DOI 10.1152/physiolgenomics.00110.2003; Huard JMT, 1998, J COMP NEUROL, V400, P469; Ikeda M, 2003, BRAIN RES, V984, P149, DOI 10.1016/S0006-8993(03)03126-3; Kakigi A, 2009, AURIS NASUS LARYNX, V36, P135, DOI 10.1016/j.anl.2008.04.012; Kanageswaran N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113170; Kaplan MR, 1996, J CLIN INVEST, V98, P723, DOI 10.1172/JCI118844; Karpova NN, 2011, SCIENCE, V334, P1731, DOI 10.1126/science.1214592; Kim KH, 2005, J BIOL CHEM, V280, P6463, DOI 10.1074/jbc.M409162200; Kosiek O, 2007, PFLUG ARCH EUR J PHY, V454, P989, DOI 10.1007/s00424-007-0254-y; Kurschat CE, 2008, EXP PHYSIOL, V93, P458, DOI 10.1113/expphysiol.2007.040931; Kurtenbach S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077509; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LERMA J, 1992, MOL PHARMACOL, V41, P217; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XF, 2002, J BIOL CHEM, V277, P48410, DOI 10.1074/jbc.M210011200; Liu Q, 2012, NEUROSCIENCE, V210, P1, DOI 10.1016/j.neuroscience.2012.03.018; Loo DDF, 2000, J BIOL CHEM, V275, P37414, DOI 10.1074/jbc.M007241200; Lopez F, 2014, J NEUROSCI, V34, P3268, DOI 10.1523/JNEUROSCI.4903-13.2014; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; LOWE G, 1989, P NATL ACAD SCI USA, V86, P5641, DOI 10.1073/pnas.86.14.5641; Lu K. T., 2014, PFLUGERS ARCH; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Nakajima K, 2007, BIOCHEM BIOPH RES CO, V359, P604, DOI 10.1016/j.bbrc.2007.05.133; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Nickell WT, 2007, J PHYSIOL-LONDON, V583, P1005, DOI 10.1113/jphysiol.2007.129601; Nickell WT, 2006, J NEUROPHYSIOL, V95, P2003, DOI 10.1152/jn.00962.2005; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Panet R, 2000, J CELL PHYSIOL, V182, P109, DOI 10.1002/(SICI)1097-4652(200001)182:1<109::AID-JCP12>3.0.CO;2-A; Panet R, 2002, J CELL PHYSIOL, V190, P227, DOI 10.1002/JCP.10055; Petrovic S, 2003, AM J PHYSIOL-GASTR L, V284, pG1093, DOI 10.1152/ajpgi.00454.2002; Pieraut S, 2007, J NEUROSCI, V27, P6751, DOI 10.1523/JNEUROSCI.1337-07.2007; Piirsoo M, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-10; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; RAMAMOORTHY S, 1994, BIOCHEM J, V300, P893, DOI 10.1042/bj3000893; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Roberts S, 2012, FEBS J, V279, P3549, DOI 10.1111/j.1742-4658.2012.08729.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schobel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048005; Smith DW, 2008, PHYSIOL BEHAV, V93, P44, DOI 10.1016/j.physbeh.2007.07.011; Spehr M, 2002, NEURON, V33, P731, DOI 10.1016/S0896-6273(02)00610-4; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Sun L, 2012, EUR J NEUROSCI, V35, P661, DOI 10.1111/j.1460-9568.2012.08007.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Zhong X, 2013, J CANCER RES CLIN, V139, P485, DOI 10.1007/s00432-012-1353-5	66	10	10	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9767	9779		10.1074/jbc.M115.640656	http://dx.doi.org/10.1074/jbc.M115.640656			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713142	Green Published, hybrid			2022-12-28	WOS:000352729400037
J	Bailey, JK; Fields, AT; Cheng, KJ; Lee, A; Wagenaar, E; Lagrois, R; Schmidt, B; Xia, B; Ma, D				Bailey, Jeffrey K.; Fields, Alexander T.; Cheng, Kaijian; Lee, Albert; Wagenaar, Eric; Lagrois, Remy; Schmidt, Bailey; Xia, Bin; Ma, Dzwokai			WD Repeat-containing Protein 5 (WDR5) Localizes to the Midbody and Regulates Abscission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIXED LINEAGE LEUKEMIA; HISTONE H3 LYSINE-4; STRUCTURAL BASIS; ESCRT-III; MOLECULAR RECOGNITION; SHOTGUN PROTEOMICS; SET1 FAMILY; CYTOKINESIS; METHYLATION; COMPLEX	Cytokinesis partitions the cytoplasm of a parent cell into two daughter cells and is essential for the completion of cell division. The final step of cytokinesis in animal cells is abscission, which is a process leading to the physical separation of two daughter cells. Abscission requires membrane traffic and microtubule disassembly at a specific midbody region called the secondary ingression. Here, we report that WD repeat-containing protein 5 (WDR5), a core subunit of COMPASS/MLL family histone H3 lysine 4 methyltransferase (H3K4MT) complexes, resides at the midbody and associates with a subset of midbody regulatory proteins, including PRC1 and CYK4/MKLP1. Knockdown of WDR5 impairs abscission and increases the incidence of multinucleated cells. Further investigation revealed that the abscission delay is primarily due to slower formation of secondary ingressions in WDR5 knockdown cells. Consistent with these defects, midbody microtubules in WDR5 knockdown cells also display enhanced resistance to depolymerization by nocodazole. Recruitment of WDR5 to the midbody dark zone appears to require integrity of the WDR5 central arginine-binding cavity, as mutations that disrupt histone H3 and MLL1 binding to this pocket also abolish the midbody localization of WDR5. Taken together, these data suggest that WDR5 is specifically targeted to the midbody in the absence of chromatin and that it promotes abscission, perhaps by facilitating midbody microtubule disassembly.	[Bailey, Jeffrey K.; Fields, Alexander T.; Cheng, Kaijian; Lee, Albert; Wagenaar, Eric; Lagrois, Remy; Schmidt, Bailey; Xia, Bin; Ma, Dzwokai] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Bailey, Jeffrey K.; Fields, Alexander T.; Cheng, Kaijian; Lee, Albert; Wagenaar, Eric; Lagrois, Remy; Schmidt, Bailey; Xia, Bin; Ma, Dzwokai] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Ma, D (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Bldg 571,Rm 6129, Santa Barbara, CA 93106 USA.	ma@lifesci.ucsb.edu		/0000-0002-6129-2938	Office of The Director, National Institutes of Health Award [S10OD010610]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086853] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010610] Funding Source: NIH RePORTER	Office of The Director, National Institutes of Health Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to M. Cosgrove for the WDR5 S91K and F133A constructs, W. I. Sundquist for the CHMP1B anti-body, L. Johnson for the hTERT-RPE-1 cell line, and to the many undergraduates whose technical assistance contributed to this work. We also thank M. Glotzer for helpful suggestions, C. A. Vandenberg and K. R. Foltz for critically reading this manuscript, T. E. Kippin and K. K. Szumlinski for statistical advice, and Jennifer Knappe for editing assistance. We acknowledge the use of the NRI-MCDB Microscopy Facility and the Spectral Laser Scanning Confocal supported by the Office of The Director, National Institutes of Health Award S10OD010610.	Ali A, 2014, NUCLEIC ACIDS RES, V42, P7611, DOI 10.1093/nar/gku458; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bonner MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020489; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dharmarajan V, 2012, J BIOL CHEM, V287, P27275, DOI 10.1074/jbc.M112.364125; Dias J, 2014, GENE DEV, V28, P929, DOI 10.1101/gad.240200.114; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Ernst P, 2012, BRIEF FUNCT GENOMICS, V11, P217, DOI 10.1093/bfgp/els017; Estey MP, 2010, J CELL BIOL, V191, P741, DOI 10.1083/jcb.201006031; EUTENEUER U, 1980, J CELL BIOL, V87, P509, DOI 10.1083/jcb.87.2.509; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Florindo C, 2012, J CELL SCI, V125, P3085, DOI 10.1242/jcs.097147; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Goldsworthy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061870; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Karatas H, 2013, J AM CHEM SOC, V135, P669, DOI 10.1021/ja306028q; Lacroix B, 2012, J PATHOL, V226, P338, DOI 10.1002/path.3013; Lafaurie-Janvore J, 2013, SCIENCE, V339, P1625, DOI 10.1126/science.1233866; Lee KY, 2012, J CELL SCI, V125, P3495, DOI 10.1242/jcs.094672; Li DW, 2005, CELL RES, V15, P120, DOI 10.1038/sj.cr.7290276; Li MM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2863; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Martz MK, 2013, MOL BIOL CELL, V24, P2785, DOI 10.1091/mbc.E12-07-0533; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Morgan MA, 2013, MOL CELL BIOL, V33, P1698, DOI 10.1128/MCB.00203-13; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Nakagawa T, 2011, MOL CELL, V43, P381, DOI 10.1016/j.molcel.2011.05.033; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng SS, 2009, CELL MOL LIFE SCI, V66, P407, DOI 10.1007/s00018-008-8303-z; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Odho Z, 2010, J BIOL CHEM, V285, P32967, DOI 10.1074/jbc.M110.159921; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Qin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4952; Rinaldo C, 2012, MOL CELL, V47, P87, DOI 10.1016/j.molcel.2012.04.029; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schiel JA, 2013, CURR OPIN CELL BIOL, V25, P92, DOI 10.1016/j.ceb.2012.10.012; Schiel JA, 2012, NAT CELL BIOL, V14, P1068, DOI 10.1038/ncb2577; Schiel JA, 2011, J CELL SCI, V124, P1411, DOI 10.1242/jcs.081448; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/NMETH.1855, 10.1038/nmeth.1855]; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Shinsky SA, 2014, J MOL BIOL, V426, P2283, DOI 10.1016/j.jmb.2014.03.011; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Swaney DL, 2008, NAT METHODS, V5, P959, DOI 10.1038/nmeth.1260; Thoresen SB, 2014, NAT CELL BIOL, V16, P547, DOI 10.1038/ncb2959; Tomas A, 2004, J CELL BIOL, V165, P813, DOI 10.1083/jcb.200311054; Townsend E., 2012, THESIS U MICHIGAN; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; van Nuland R, 2013, MOL CELL BIOL, V33, P2067, DOI 10.1128/MCB.01742-12; Wang YY, 2010, P NATL ACAD SCI USA, V107, P815, DOI 10.1073/pnas.0908967107; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; White EA, 2012, CYTOSKELETON, V69, P882, DOI 10.1002/cm.21065; Xu ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009725; Xu ZJ, 2009, J CELL BIOL, V186, P343, DOI 10.1083/jcb.200902146; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Zhang P, 2012, NUCLEIC ACIDS RES, V40, P4237, DOI 10.1093/nar/gkr1235; Zhou H, 2008, MOL CELL BIOCHEM, V311, P45, DOI 10.1007/s11010-007-9692-2	82	23	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8987	9001		10.1074/jbc.M114.623611	http://dx.doi.org/10.1074/jbc.M114.623611			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25666610	hybrid, Green Published			2022-12-28	WOS:000352207100025
J	Brown, NE; Goswami, D; Branch, MR; Ramineni, S; Ortlund, EA; Griffin, PR; Hepler, JR				Brown, Nicole E.; Goswami, Devrishi; Branch, Mary Rose; Ramineni, Suneela; Ortlund, Eric A.; Griffin, Patrick R.; Hepler, John R.			Integration of G Protein alpha (G alpha) Signaling by the Regulator of G Protein Signaling 14 (RGS14)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; DISSOCIATION INHIBITOR; DOMAIN; COMPLEX; BINDING	RGS14 contains distinct binding sites for both active (GTP-bound) and inactive (GDP-bound) forms of G alpha subunits. The N-terminal regulator of G protein signaling (RGS) domain binds active G alpha(i/o)-GTP, whereas the C-terminal G protein regulatory (GPR) motif binds inactive G alpha(i1/3)-GDP. The molecular basis for how RGS14 binds different activation states of G alpha proteins to integrate G protein signaling is unknown. Here we explored the intramolecular communication between the GPR motif and the RGS domain upon G protein binding and examined whether RGS14 can functionally interact with two distinct forms of G alpha subunits simultaneously. Using complementary cellular and biochemical approaches, we demonstrate that RGS14 forms a stable complex with inactive G alpha(i1)-GDP at the plasma membrane and that free cytosolic RGS14 is recruited to the plasma membrane by activated G alpha(o)-AlF4-. Bioluminescence resonance energy transfer studies showed that RGS14 adopts different conformations in live cells when bound to G alpha in different activation states. Hydrogen/deuterium exchange mass spectrometry revealed that RGS14 is a very dynamic protein that undergoes allosteric conformational changes when inactive G alpha(i1)-GDP binds the GPR motif. Pure RGS14 forms a ternary complex with G alpha(o)-AlF4- and an AlF4--insensitive mutant (G42R) of G alpha(i1)-GDP, as observed by size exclusion chromatography and differential hydrogen/deuterium exchange. Finally, a preformed RGS14 center dot G alpha(i1)-GDP complex exhibits full capacity to stimulate the GTPase activity of G alpha(o)-GTP, demonstrating that RGS14 can functionally engage two distinct forms of G alpha subunits simultaneously. Based on these findings, we propose a working model for how RGS14 integrates multiple G protein signals in host CA2 hippocampal neurons to modulate synaptic plasticity.	[Brown, Nicole E.; Branch, Mary Rose; Ramineni, Suneela; Hepler, John R.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Ortlund, Eric A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Goswami, Devrishi; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	Emory University; Emory University; Scripps Research Institute	Hepler, JR (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd,Rollins Res Ctr Suite G205, Atlanta, GA 30322 USA.	jhepler@emory.edu	Ortlund, Eric Anthony/F-4672-2014; Ortlund, Eric Anthony/P-3121-2019	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029; Brown, Nicole/0000-0002-3184-0550	National Institutes of Health [5R01NS037112, 5R21NS074975]; National Institutes of Health Pharmacological Sciences Predoctoral Research Training Grant [T32M008602]; Emory URC grant; American Heart Association [14PRE18850017, 14GRNT20460124]; Emory University Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS, National Institutes of Health [P30NS055077]; National Institute of Mental Health [U54MH074404]; National Institutes of Health, NIDDK [R01DK095750]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602, R01GM084041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH074404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037112, R21NS074975, P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Pharmacological Sciences Predoctoral Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory URC grant; American Heart Association(American Heart Association); Emory University Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS, National Institutes of Health; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01NS037112 and 5R21NS074975 (to J. R. H.) and National Institutes of Health Pharmacological Sciences Predoctoral Research Training Grant T32M008602 (to Emory University in support of N. E. B.). Additional support was provided by an Emory URC grant (to J. R. H.) and American Heart Association Predoctoral Grant 14PRE18850017 (to N. E. B.). This project was also supported in part by the Emory University Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS, National Institutes of Health, Core Facilities Grant P30NS055077.; Supported by National Institute of Mental Health Grant U54MH074404.; Supported by National Institutes of Health, NIDDK, Grant R01DK095750 and American Heart Association Grant-in-aid 14GRNT20460124.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Blumer JB, 2014, MOL PHARMACOL, V85, P388, DOI 10.1124/mol.113.090068; Bosch DE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002553; Bosch DE, 2011, J BIOL CHEM, V286, P3351, DOI 10.1074/jbc.M110.190496; Chen CK, 1996, P NATL ACAD SCI USA, V93, P12885, DOI 10.1073/pnas.93.23.12885; Cho H, 2000, MOL PHARMACOL, V58, P569, DOI 10.1124/mol.58.3.569; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Evans P. R., 2012, 42 ANN M SOC NEUR NE; Evans PR, 2014, J COMP NEUROL, V522, P186, DOI 10.1002/cne.23395; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goswami D, 2014, STRUCTURE, V22, P961, DOI 10.1016/j.str.2014.04.013; Goswami D, 2013, J AM SOC MASS SPECTR, V24, P1584, DOI 10.1007/s13361-013-0669-y; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hollinger S, 2003, BIOCHEMISTRY-US, V42, P811, DOI 10.1021/bi026664y; Hollinger S, 2001, J NEUROCHEM, V79, P941, DOI 10.1046/j.1471-4159.2001.00629.x; Hollinger Susanne, 2003, V237, P205; Ishii M, 2005, BIOCHEM J, V385, P65, DOI 10.1042/BJ20040404; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kiel C, 2005, J MOL BIOL, V348, P759, DOI 10.1016/j.jmb.2005.02.046; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Landgraf RR, 2013, STRUCTURE, V21, P1942, DOI 10.1016/j.str.2013.08.023; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Marciano DP, 2014, CURR OPIN STRUC BIOL, V28, P105, DOI 10.1016/j.sbi.2014.08.007; Mittal V, 2006, BIOCHEM J, V394, P309, DOI 10.1042/BJ20051086; Mittal V, 2004, J BIOL CHEM, V279, P46772, DOI 10.1074/jbc.M407409200; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Oner SS, 2010, J BIOL CHEM, V285, P33949, DOI 10.1074/jbc.M110.138073; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Panja D, 2014, NEUROPHARMACOLOGY, V76, P664, DOI 10.1016/j.neuropharm.2013.06.024; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Popov SG, 2000, J BIOL CHEM, V275, P18962, DOI 10.1074/jbc.M001128200; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tesmer JJG, 2009, PROG MOL BIOL TRANSL, V86, P75, DOI 10.1016/S1877-1173(09)86004-3; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; Traver S, 2004, BIOCHEM J, V379, P627, DOI 10.1042/BJ20031889; Tu YP, 1999, J BIOL CHEM, V274, P38260, DOI 10.1074/jbc.274.53.38260; Vellano CP, 2013, J BIOL CHEM, V288, P3620, DOI 10.1074/jbc.M112.440057; Vellano CP, 2011, J BIOL CHEM, V286, P38659, DOI 10.1074/jbc.M111.274928; Vellano CP, 2011, TRENDS PHARMACOL SCI, V32, P666, DOI 10.1016/j.tips.2011.07.005; Vellano CP, 2011, BIOCHEMISTRY-US, V50, P752, DOI 10.1021/bi101910n; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Willard FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004884	55	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9037	9049		10.1074/jbc.M114.634329	http://dx.doi.org/10.1074/jbc.M114.634329			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25666614	Green Published, hybrid			2022-12-28	WOS:000352207100028
J	Gerganova, V; Maurer, S; Stoliar, L; Japaridze, A; Dietler, G; Nasser, W; Kutateladze, T; Travers, A; Muskhelishvili, G				Gerganova, Veneta; Maurer, Sebastian; Stoliar, Liubov; Japaridze, Aleksandre; Dietler, Giovanni; Nasser, William; Kutateladze, Tamara; Travers, Andrew; Muskhelishvili, Georgi			Upstream Binding of Idling RNA Polymerase Modulates Transcription Initiation from a Nearby Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-RECEPTOR PROTEIN; COLI-FIS PROMOTER; ESCHERICHIA-COLI; STRINGENT CONTROL; ALPHA-SUBUNIT; BIDIRECTIONAL PROMOTERS; DIVERGENT TRANSCRIPTION; BACTERIAL PROMOTERS; MULTIPLE PROMOTERS; DNA-BINDING	The bacterial gene regulatory regions often demonstrate distinctly organized arrays of RNA polymerase binding sites of illdefined function. Previously we observed a module of closely spaced polymerase binding sites upstream of the canonical promoter of the Escherichia coli fis operon. FIS is an abundant nucleoid- associated protein involved in adjusting the chromosomal DNA topology to changing cellular physiology. Here we show that simultaneous binding of the polymerase at the canonical fis promoter and an upstream transcriptionally inactive site stabilizes a RNAP oligomeric complex in vitro. Wefurther show that modulation of the upstream binding of RNA polymerase affects the fis promoter activity both in vivo and in vitro. The effect of the upstream RNA polymerase binding on the fis promoter activity depends on the spatial arrangement of polymerase binding sites and DNA supercoiling. Our data suggest that a specific DNA geometry of the nucleoprotein complex stabilized on concomitant binding of RNA polymerase molecules at the fis promoter and the upstream region acts as a topological device regulating the fis transcription. We propose that transcriptionally inactive RNA polymerase molecules can act as accessory factors regulating the transcription initiation from a nearby promoter.	Jacobs Univ Bremen, D-28759 Bremen, Germany; [Japaridze, Aleksandre; Dietler, Giovanni] Ecole Polytech Fed Lausanne, Lab Phys Living Matter, CH-1015 Lausanne, Switzerland; [Nasser, William] Univ Lyon, UCB, INSA, UMR5240,CNRS, F-69003 Villeurbanne, France; [Nasser, William] INSA Lyon, F-69621 Villeurbanne, France; [Kutateladze, Tamara] Ivane Beritashvili Ctr Expt Biomed, Tbilisi, Georgia; [Travers, Andrew] MRC, Mol Biol Lab, Cambridge CB2 QH, England; [Gerganova, Veneta; Maurer, Sebastian; Stoliar, Liubov; Muskhelishvili, Georgi] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany	Jacobs University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Jacobs University	Muskhelishvili, G (corresponding author), Jacobs Univ Bremen, Campus Ring 1, D-28759 Bremen, Germany.	g.muskhelishvili@jacobs-university.de	Japaridze, Aleksandre/AAK-5062-2020; NASSER, William/C-9611-2019; Maurer, Sebastian P/D-4727-2009	Japaridze, Aleksandre/0000-0002-9581-9128; NASSER, William/0000-0001-9848-3597; Maurer, Sebastian P/0000-0003-4532-1994; Gerganova, Veneta/0000-0002-1491-1249	Deutsche Forschungsgemeinschaft; Medical Research Council [MC_U105178783] Funding Source: researchfish; MRC [MC_U105178783] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (to G. M.).	Auner H, 2003, J MOL BIOL, V331, P331, DOI 10.1016/S0022-2836(03)00727-7; Bae JY, 2008, APPL BIOCHEM BIOTECH, V145, P69, DOI 10.1007/s12010-007-8076-0; BALL CA, 1992, J BACTERIOL, V174, P8043, DOI 10.1128/JB.174.24.8043-8056.1992; Biswas T, 2005, NATURE, V435, P1059, DOI 10.1038/nature03657; Blot N, 2006, EMBO REP, V7, P710, DOI 10.1038/sj.embor.7400729; Bordes P, 2003, MOL MICROBIOL, V48, P561, DOI 10.1046/j.1365-2958.2003.03461.x; Cameron ADS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084382; CHAMBERL.M, 1970, NATURE, V228, P227, DOI 10.1038/228227a0; Crozat E, 2010, MOL BIOL EVOL, V27, P2113, DOI 10.1093/molbev/msq099; El-Robh MS, 2002, BIOCHEM J, V368, P835, DOI 10.1042/BJ20021003; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Geertz M, 2011, MBIO, V2, DOI 10.1128/mBio.00034-11; Gonzalez-Gil G, 1998, EMBO J, V17, P2877, DOI 10.1093/emboj/17.10.2877; GonzalezGil G, 1996, MOL MICROBIOL, V22, P21, DOI 10.1111/j.1365-2958.1996.tb02652.x; GOODRICH JA, 1991, TRENDS BIOCHEM SCI, V16, P394, DOI 10.1016/0968-0004(91)90162-O; Govantes F, 2000, MOL MICROBIOL, V38, P1061, DOI 10.1046/j.1365-2958.2000.02215.x; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; Guerin M, 1996, EMBO J, V15, P5397, DOI 10.1002/j.1460-2075.1996.tb00923.x; HANAMURA A, 1991, NUCLEIC ACIDS RES, V19, P4413, DOI 10.1093/nar/19.16.4413; Hu HY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-457; Huerta AM, 2006, PLOS GENET, V2, P1740, DOI 10.1371/journal.pgen.0020185; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Ishihama A, 2012, P JPN ACAD B-PHYS, V88, P485, DOI 10.2183/pjab.88.485; Jauregui R, 2003, NUCLEIC ACIDS RES, V31, P6770, DOI 10.1093/nar/gkg882; Kansara SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018990; Kelly A, 2004, MICROBIOL-SGM, V150, P2037, DOI 10.1099/mic.0.27209-0; Kolmsee T, 2011, MICROBIOL-SGM, V157, P2871, DOI 10.1099/mic.0.052357-0; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; LEGRICE SFJ, 1982, J MOL BIOL, V162, P551, DOI 10.1016/0022-2836(82)90388-6; Lepoivre C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-914; LESLEY SA, 1990, J BACTERIOL, V172, P6871, DOI 10.1128/jb.172.12.6871-6874.1990; Li MJ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-19; LIEBIG B, 1995, MOL GEN GENET, V249, P328, DOI 10.1007/BF00290534; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Mallik P, 2004, J BACTERIOL, V186, P122, DOI 10.1128/JB.186.1.122-135.2004; Marinello J, 2013, NUCLEIC ACIDS RES, V41, P10110, DOI 10.1093/nar/gkt778; Maurer S, 2006, EMBO J, V25, P3784, DOI 10.1038/sj.emboj.7601261; Mechold U, 2013, NUCLEIC ACIDS RES, V41, P6175, DOI 10.1093/nar/gkt302; MENENDEZ M, 1987, EMBO J, V6, P4227, DOI 10.1002/j.1460-2075.1987.tb02771.x; Meng WM, 2001, NUCLEIC ACIDS RES, V29, P4166, DOI 10.1093/nar/29.20.4166; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Murakami KS, 2013, J BIOL CHEM, V288, P9126, DOI 10.1074/jbc.M112.430900; Murley LL, 1998, CELL, V95, P553, DOI 10.1016/S0092-8674(00)81622-0; MUSKHELISHVILI G, 1995, EMBO J, V14, P1446, DOI 10.1002/j.1460-2075.1995.tb07131.x; Muskhelishvili G, 2010, BACTERIAL CHROMATIN, P323, DOI 10.1007/978-90-481-3473-1_14; Muskhelishvili G, 2010, MOL BIOSYST, V6, P662, DOI 10.1039/b909192k; Nafissi M, 2012, J BACTERIOL, V194, P2458, DOI 10.1128/JB.00053-12; Nakagawa H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001484; Nasser W, 2002, EMBO J, V21, P715, DOI 10.1093/emboj/21.4.715; Nasser W, 2001, J BIOL CHEM, V276, P17878, DOI 10.1074/jbc.M100632200; Naughton C, 2013, TRANSCR-AUSTIN, V4, P162, DOI 10.4161/trns.25554; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; NILSSON L, 1992, J BACTERIOL, V174, P921, DOI 10.1128/jb.174.3.921-929.1992; NILSSON L, 1992, FEMS MICROBIOL LETT, V99, P85; NINNEMANN O, 1992, EMBO J, V11, P1075, DOI 10.1002/j.1460-2075.1992.tb05146.x; Opel ML, 2001, MOL MICROBIOL, V39, P191, DOI 10.1046/j.1365-2958.2001.02249.x; Ozoline ON, 1999, NUCLEIC ACIDS RES, V27, P4768, DOI 10.1093/nar/27.24.4768; Palmer AC, 2009, MOL CELL, V34, P545, DOI 10.1016/j.molcel.2009.04.018; Pratt TS, 1997, J BACTERIOL, V179, P6367, DOI 10.1128/jb.179.20.6367-6377.1997; Qi HY, 1997, J MOL BIOL, V267, P481, DOI 10.1006/jmbi.1997.0901; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Rice PA, 2010, BIOCHEM SOC T, V38, P384, DOI 10.1042/BST0380384; RICHARDS.JP, 1966, P NATL ACAD SCI USA, V55, P1616, DOI 10.1073/pnas.55.6.1616; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; Rivetti C, 1999, EMBO J, V18, P4464, DOI 10.1093/emboj/18.16.4464; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Ross W, 2001, GENE DEV, V15, P491, DOI 10.1101/gad.870001; SAVOCHKINA L P, 1979, Molekulyarnaya Biologiya (Moscow), V13, P509; Schneider R, 1999, MOL MICROBIOL, V34, P953, DOI 10.1046/j.1365-2958.1999.01656.x; Schneider R, 2000, MOL MICROBIOL, V38, P167, DOI 10.1046/j.1365-2958.2000.02129.x; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; SHANER SL, 1982, BIOCHEMISTRY-US, V21, P5539, DOI 10.1021/bi00265a025; Shavkunov KS, 2009, NUCLEIC ACIDS RES, V37, P4919, DOI 10.1093/nar/gkp490; Strainic MG, 2000, J BACTERIOL, V182, P216, DOI 10.1128/JB.182.1.216-220.2000; Tichopad A, 2002, BIOTECHNOL LETT, V24, P2053, DOI 10.1023/A:1021319421153; Travers AA, 2012, PHILOS T R SOC A, V370, P2960, DOI 10.1098/rsta.2011.0231; TSEDINH YC, 1988, J MOL BIOL, V202, P735, DOI 10.1016/0022-2836(88)90554-2; Uesaka M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-35; Valle F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.158105; Wade JT, 2014, NAT REV MICROBIOL, V12, P647, DOI 10.1038/nrmicro3316; Walker KA, 2004, J BIOL CHEM, V279, P50818, DOI 10.1074/jbc.M406285200; Yamada M, 2003, J MOL MICROB BIOTECH, V6, P206, DOI 10.1159/000077251; Zhang XY, 1996, J MOL BIOL, V259, P27, DOI 10.1006/jmbi.1996.0299	84	11	11	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8095	8109		10.1074/jbc.M114.628131	http://dx.doi.org/10.1074/jbc.M114.628131			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25648898	Green Published, hybrid			2022-12-28	WOS:000351662600008
J	Guo, EZ; Xu, ZH				Guo, Emily Z.; Xu, Zhaohui			Distinct Mechanisms of Recognizing Endosomal Sorting Complex Required for Transport III (ESCRT-III) Protein IST1 by Different Microtubule Interacting and Trafficking (MIT) Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; MEMBRANE-TRAFFICKING; TROYER-SYNDROME; VPS4; RECOGNITION; SPARTIN; VTA1; CYTOKINESIS; SCISSION; SPASTIN	The endosomal sorting complex required for transport (ESCRT) machinery is responsible for membrane remodeling in a number of biological processes including multivesicular body biogenesis, cytokinesis, and enveloped virus budding. In mammalian cells, efficient abscission during cytokinesis requires proper function of the ESCRT-III protein IST1, which binds to the microtubule interacting and trafficking (MIT) domains of VPS4, LIP5, and Spartin via its C-terminal MIT-interacting motif (MIM). Here, we studied the molecular interactions between IST1 and the three MIT domain-containing proteins to understand the structural basis that governs pairwiseMIT-MIM interaction. Crystal structures of the three molecular complexes revealed that IST1 binds to the MIT domains of VPS4, LIP5, and Spartin using two different mechanisms (MIM1 mode versus MIM3 mode). Structural comparison revealed that structural features in both MIT andMIMcontribute to determine the specific binding mechanism. Within the IST1 MIM sequence, two phenylalanine residues were shown to be important in discriminating MIM1 versus MIM3 binding. These observations enabled us to deduce a preliminary binding code, which we applied to provide CHMP2A, a protein that normally only binds the MIT domain in the MIM1 mode, the additional ability to bind the MIT domain of Spartin in the MIM3 mode.	[Guo, Emily Z.; Xu, Zhaohui] Univ Michigan, Inst Life Sci, Sch Med, Ann Arbor, MI 48109 USA; [Xu, Zhaohui] Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, ZH (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	zhaohui@umich.edu			United States DOE [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095769] Funding Source: NIH RePORTER	United States DOE(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advanced Photon Source Sector 21 (21-ID-F) for access and help with data collection. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor (Grant 085P1000817). We thank C. Vild and Y. Li for helpful discussion and K. Chinnaswamy and B. Wanfor access and help for ITC experiments.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Eastman SW, 2009, J CELL BIOL, V184, P881, DOI 10.1083/jcb.200808041; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujita H, 2003, J CELL SCI, V116, P401, DOI 10.1242/jcs.00213; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hurley JH, 2008, DEV CELL, V14, P6, DOI 10.1016/j.devcel.2007.12.013; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Nickerson DP, 2010, MOL BIOL CELL, V21, P1023, DOI 10.1091/mbc.E09-09-0776; Norgan AP, 2013, J BIOL CHEM, V288, P26147, DOI 10.1074/jbc.M113.494112; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937; Renvoise B, 2012, HUM MOL GENET, V21, P3604, DOI 10.1093/hmg/dds191; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Skalicky JJ, 2012, J BIOL CHEM, V287, P43910, DOI 10.1074/jbc.M112.417899; Solomons J, 2011, STRUCTURE, V19, P1149, DOI 10.1016/j.str.2011.05.011; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Vild CJ, 2014, J BIOL CHEM, V289, P10378, DOI 10.1074/jbc.M113.532960; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xiao JY, 2008, DEV CELL, V14, P37, DOI 10.1016/j.devcel.2007.10.013; Xiao JY, 2009, MOL BIOL CELL, V20, P3514, DOI 10.1091/mbc.E09-05-0403; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Yang ZZ, 2012, J BIOL CHEM, V287, P43899, DOI 10.1074/jbc.M112.390724; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	54	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8396	8408		10.1074/jbc.M114.607903	http://dx.doi.org/10.1074/jbc.M114.607903			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25657007	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000351662600033
J	Hansen, DB; Garrido-Comas, N; Salter, M; Fern, R				Hansen, Daniel Bloch; Garrido-Comas, Nestor; Salter, Mike; Fern, Robert			HCO3--independent pH Regulation in Astrocytes in Situ Is Dominated by V-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT OPTIC-NERVE; CULTURED ASTROCYTES; WHITE-MATTER; H+-ATPASE; CELLS; GLIOGENESIS; HIPPOCAMPUS; COTRANSPORT; EXPRESSION; CAPACITY	The mechanisms of HCO3--independent intracellular pH (pH(i)) regulation were examined in fibrous astrocytes within isolated neonatal rat optic nerve (RON) and in cultured cortical astrocytes. In agreement with previous studies, resting pHi in cultured astrocytes was 6.82 +/- 0.06 and inhibition of the V-ATPase H+ pump by Cl- removal or via the selective inhibitor bafilomycin had only a small effect upon resting pHi and recovery following an acid load. In contrast, resting pH(i) in RON astrocytes was 7.10 +/- 0.04, significantly less acidic than that in cultured cells (p < 0.001), and responded to inhibition of V-ATPase with profound acidification to the 6.3-6.5 range. Fluorescent immuno-staining and immuno-gold labeling confirmed the presence V-ATPase in the cell membrane of RON astrocyte processes and somata. Using ammonia pulse recovery, pHi recovery in RON astrocyte was achieved largely via V-ATPase with sodium-proton exchange (NHE) playing a minor role. The findings indicate that astrocytes in a whole-mount preparation such as the optic nerve rely to a greater degree upon V-ATPase for HCO3--independent pHi regulation than do cultured astrocytes, with important functional consequences for the regulation of pH in the CNS.	[Hansen, Daniel Bloch; Fern, Robert] Univ Plymouth, Peninsula Sch Med, Plymouth PL6 8BU, Devon, England; [Hansen, Daniel Bloch; Fern, Robert] Univ Plymouth, Peninsula Sch Dent, Plymouth PL6 8BU, Devon, England; [Garrido-Comas, Nestor] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 7RH, Leics, England; [Salter, Mike] Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	University of Plymouth; University of Plymouth; University of Leicester; University of Leeds	Fern, R (corresponding author), Univ Plymouth, Peninsula Sch Med & Dent, John Bull Bldg,Res Way, Plymouth PL6 8BU, Devon, England.	robert.fern@plymouth.ac.uk		fern, robert/0000-0002-0625-3434; Hansen, Daniel Bloch/0000-0002-1250-4754	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J016969/1]; BBSRC [BB/J016969/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J016969/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/J016969/1 (to R.F.).	Alix JJP, 2008, J PHYSIOL-LONDON, V586, P4069, DOI 10.1113/jphysiol.2008.155077; Amos BJ, 1998, J NEUROPHYSIOL, V79, P695, DOI 10.1152/jn.1998.79.2.695; Bevensee MO, 1997, J GEN PHYSIOL, V110, P453, DOI 10.1085/jgp.110.4.453; Bevensee MO, 1997, J GEN PHYSIOL, V110, P467, DOI 10.1085/jgp.110.4.467; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Boron WF, 2004, ADV PHYSIOL EDUC, V28, P160, DOI 10.1152/advan.00045.2004; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; BOYARSKY G, 1993, GLIA, V8, P241, DOI 10.1002/glia.440080404; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Cengiz P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084294; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; Erlichman JS, 2004, AM J PHYSIOL-REG I, V286, pR289, DOI 10.1152/ajpregu.00245.2003; Fern R, 1998, J NEUROSCI, V18, P7232; Fernandez R, 1998, J MEMBRANE BIOL, V163, P137, DOI 10.1007/s002329900378; FOSTER RE, 1982, DEV BRAIN RES, V3, P371, DOI 10.1016/0165-3806(82)90005-0; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Howard BM, 2008, NEUROSCIENTIST, V14, P459, DOI 10.1177/1073858407313512; JEAN T, 1985, J BIOL CHEM, V260, P9678; KATSURA K, 1993, BRAIN RES, V618, P283, DOI 10.1016/0006-8993(93)91277-Y; KAUNITZ JD, 1985, J BIOL CHEM, V260, P1567; Kirischuk S, 2012, TRENDS NEUROSCI, V35, P497, DOI 10.1016/j.tins.2012.04.003; Malnic G, 2000, J MEMBRANE BIOL, V178, P115, DOI 10.1007/s002320010019; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McLean LA, 2000, AM J PHYSIOL-CELL PH, V278, pC676, DOI 10.1152/ajpcell.2000.278.4.C676; Mi HY, 1999, J NEUROSCI, V19, P1049; MINTURN JE, 1992, GLIA, V6, P19, DOI 10.1002/glia.440060104; NACHSHEN DA, 1988, J GEN PHYSIOL, V91, P289, DOI 10.1085/jgp.91.2.289; Newman EA, 1999, GLIA, V26, P302, DOI 10.1002/(SICI)1098-1136(199906)26:4<302::AID-GLIA4>3.0.CO;2-A; PAPPAS CA, 1994, J NEUROPHYSIOL, V72, P2816, DOI 10.1152/jn.1994.72.6.2816; PAPPAS CA, 1993, GLIA, V9, P280, DOI 10.1002/glia.440090406; Philippe JM, 2002, GLIA, V37, P365, DOI 10.1002/glia.10041; Pizzonia JH, 1996, J NEUROSCI RES, V44, P191, DOI 10.1002/(SICI)1097-4547(19960415)44:2<191::AID-JNR12>3.0.CO;2-9; RANSOM BR, 1985, J NEUROSCI, V5, P532; Ransom BR, 1997, GLIA, V21, P134; Roberts EL, 1998, BRAIN RES, V779, P271, DOI 10.1016/S0006-8993(97)01120-7; ROESSMANN U, 1986, ACTA NEUROPATHOL, V70, P308, DOI 10.1007/BF00686089; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SHRODE LD, 1994, GLIA, V12, P196, DOI 10.1002/glia.440120305; SKOFF RP, 1976, J COMP NEUROL, V169, P313, DOI 10.1002/cne.901690304; STURROCK RR, 1975, J ANAT, V119, P223; TAKASHIMA S, 1983, ARCH NEUROL-CHICAGO, V40, P14, DOI 10.1001/archneur.1983.04050010034008; Thomas R, 2004, J NEUROPATH EXP NEUR, V63, P856, DOI 10.1093/jnen/63.8.856; TRAYNELIS SF, 1991, J PHYSIOL-LONDON, V433, P727, DOI 10.1113/jphysiol.1991.sp018453; VAUGHN JE, 1969, Z ZELLFORSCH MIK ANA, V94, P293, DOI 10.1007/BF00319179; Voipio J., 1994, MICROELECTRODE TECHN, V2, P275; WierzbaBobrowicz T, 1997, FOLIA NEUROPATHOL, V35, P29	48	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8039	8047		10.1074/jbc.M115.636597	http://dx.doi.org/10.1074/jbc.M115.636597			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25666621	Green Published, hybrid			2022-12-28	WOS:000351662600003
J	Ma, D; Fang, Q; Wang, P; Gao, R; Wu, WB; Lu, TS; Cao, L; Hu, XY; Wang, JS				Ma, Dan; Fang, Qin; Wang, Ping; Gao, Rui; Wu, Weibing; Lu, Tangsheng; Cao, Lu; Hu, Xiuying; Wang, Jishi			Induction of Heme Oxygenase-1 by Na+-H+ Exchanger 1 Protein Plays a Crucial Role in Imatinib-resistant Chronic Myeloid Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE INHIBITORS; BCR-ABL; ACTIVATION; PATHWAY; APOPTOSIS; THERAPY; EXPRESSION; MUTATIONS; FREQUENCY; SURVIVAL	Resistance toward imatinib (IM) and other BCR/ABL tyrosine kinase inhibitors remains troublesome in the treatment of advanced stage chronic myeloid leukemia (CML). The aim of this study was to estimate the reversal effects of down-regulation of Na+/H+ exchanger 1 (NHE1) on the chemoresistance of BCR-ABL-positive leukemia patients' cells and cell lines. After treatment with the specific NHE1 inhibitor cariporide to decrease intracellular pH (pH(i)), the heme oxygenase-1 (HO-1) levels of the K562R cell line and cells from IM-insensitive CML patients decreased. HO-1, as a Bcr/Abl-dependent survival molecule in CML cells, is important for the resistance to tyrosine kinase inhibitors in patients with newly diagnosed CML or IM-resistant CML. Silencing PKC-beta and Nrf-2 or treatment with inhibitors of p38 pathways obviously blocked NHE1-induced HO-1 expression. Furthermore, treatment with HO-1 or p38 inhibitor plus IM increased the apoptosis of the K562R cell line and IM-insensitive CML patients' cells. Inhibiting HO-1 enhanced the activation of caspase-3 and poly(ADP-ribose) polymerase-1. Hence, the results support the anti-apoptotic role of HO-1 induced by NHE1 in the K562R cell line and IM-insensitive CML patients and provide a mechanism by which inducing HO-1 expression via the PKC-beta/p38-MAPK pathway may promote tumor resistance to oxidative stress.	[Ma, Dan; Wang, Ping; Gao, Rui; Wu, Weibing; Hu, Xiuying; Wang, Jishi] Guiyang Med Coll, Affiliated Hosp, Dept Hematol, Guiyang 550004, Guizhou, Peoples R China; [Wang, Ping; Gao, Rui; Wu, Weibing; Hu, Xiuying; Wang, Jishi] Guizhou Prov Hematopoiet Stem Cell Transplantat C, Guiyang 550004, Peoples R China; [Wang, Ping; Gao, Rui; Wu, Weibing; Hu, Xiuying; Wang, Jishi] Hematol Dis Diagnost & Treatment Ctr, Key Lab, Guiyang 550004, Peoples R China; [Ma, Dan; Fang, Qin] Guiyang Med Univ, Affiliated BaiYun Hosp, Dept Pharm, Guiyang 550014, Peoples R China; [Fang, Qin] Guiyang Med Univ, Affiliated Hosp, Dept Pharm, Guiyang 550004, Peoples R China; [Lu, Tangsheng; Cao, Lu] Guiyang Med Univ, Sch Pharm, Guiyang 550004, Peoples R China	Guizhou Medical University; Guizhou Medical University; Guizhou Medical University; Guizhou Medical University	Wang, JS (corresponding author), Guiyang Med Coll, Affiliated Hosp, Dept Hematol, 28 Guiyi St, Guiyang 550004, Guizhou, Peoples R China.	wangjishi9646@163.com	fang, qin/GQA-8223-2022		National Natural Science Foundation of China [81070444, 81270636, 81360501, 81470006]; International Cooperation Project of GuiZhou Province [2011-7010]; Social Project of GuiZhou Province [2011-3012]; Provincial Governor Special Fund of GuiZhou Province [2010-84]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Project of GuiZhou Province; Social Project of GuiZhou Province; Provincial Governor Special Fund of GuiZhou Province	This work was supported by in part, by the National Natural Science Foundation of China (Grants 81070444, 81270636, 81360501, and 81470006), International Cooperation Project of GuiZhou Province (Grant 2011-7010), Social Project of GuiZhou Province (Grant 2011-3012), and Provincial Governor Special Fund of GuiZhou Province (Grant 2010-84).	Akagi R, 2005, CONTRIB NEPHROL, V148, P70, DOI 10.1159/000086044; Baccarani M, 2014, MEDITERR J HEMATOL I, V6, DOI 10.4084/MJHID.2014.005; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Breccia M, 2014, CANCER LETT, V347, P22, DOI 10.1016/j.canlet.2014.01.033; Almeida Maria Helena de, 2014, Rev. Bras. Hematol. Hemoter., V36, P54, DOI 10.5581/1516-8484.20140014; Du YS, 1997, P NATL ACAD SCI USA, V94, P11657, DOI 10.1073/pnas.94.21.11657; Elias MH, 2014, LEUKEMIA RES, V38, P454, DOI 10.1016/j.leukres.2013.12.025; Hwang YP, 2008, FEBS LETT, V582, P2655, DOI 10.1016/j.febslet.2008.06.045; Jabbour EJ, 2013, CL LYMPH MYELOM LEUK, V13, P515, DOI 10.1016/j.clml.2013.03.018; Kantarjian H, 2012, BLOOD, V119, P1981, DOI 10.1182/blood-2011-08-358135; Katayama K, 2007, MOL CANCER THER, V6, P2092, DOI 10.1158/1535-7163.MCT-07-0148; Kawajiri C, 2014, INT J HEMATOL, V99, P513, DOI 10.1007/s12185-014-1531-0; Kim D, 2012, INT J HEMATOL, V96, P47, DOI 10.1007/s12185-012-1093-y; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Lee BK, 2014, CELL SIGNAL, V26, P697, DOI 10.1016/j.cellsig.2013.12.011; Lin TK, 2014, INT J MOL SCI, V15, P1625, DOI 10.3390/ijms15011625; Liu M, 2007, J BIOL CHEM, V282, P17581, DOI 10.1074/jbc.M702206200; Lutzny G, 2013, CANCER CELL, V23, P77, DOI 10.1016/j.ccr.2012.12.003; Marin D, 2014, J CLIN ONCOL, V32, P379, DOI 10.1200/JCO.2013.52.9230; Mayerhofer M, 2008, BLOOD, V111, P2200, DOI 10.1182/blood-2006-11-055723; Miyake M, 2011, ONCOL REP, V25, P653, DOI 10.3892/or.2010.1125; Oriente F, 2013, DIABETOLOGIA, V56, P2713, DOI 10.1007/s00125-013-3053-3; Ozkan P, 2002, BBA-GEN SUBJECTS, V1572, P143, DOI 10.1016/S0304-4165(02)00303-3; Randle LE, 2008, TOXICOLOGY, V243, P249, DOI 10.1016/j.tox.2007.10.011; Ruvolo PP, 2011, J CELL BIOCHEM, V112, P1696, DOI 10.1002/jcb.23090; Saba NS, 2012, J INVEST MED, V60, P29, DOI 10.2310/JIM.0b013e318237eb55; Sacha T, 2014, MEDITERR J HEMATOL I, V6, DOI 10.4084/MJHID.2014.007; Sass G, 2008, INT J CANCER, V123, P1269, DOI 10.1002/ijc.23695; Savona MR, 2013, ACTA HAEMATOL-BASEL, V130, P268, DOI 10.1159/000353163; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Snabaitis AK, 2008, CIRC RES, V103, P881, DOI 10.1161/CIRCRESAHA.108.175877; Tibullo D, 2013, CURR PHARM DESIGN, V19, P2765, DOI 10.2174/1381612811319150012; Trela E., 2014, ISRN ONCOL, V2014; Ursu ON, 2014, CELL PHYSIOL BIOCHEM, V33, P52, DOI 10.1159/000356649; Voss J, 2000, ONCOGENE, V19, P1684, DOI 10.1038/sj.onc.1203467; Wang GW, 2010, CIRCULATION, V121, P1912, DOI 10.1161/CIRCULATIONAHA.109.905471; Wegiel B, 2013, CANCER RES, V73, P7009, DOI 10.1158/0008-5472.CAN-13-1075; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Xenaki D, 2004, CELL SIGNAL, V16, P145, DOI 10.1016/S0898-6568(03)00101-3; Xu HL, 2014, MOL BIOSYST, V10, P1524, DOI 10.1039/c3mb70577c; Yun SM, 2014, CANCER LETT, V348, P50, DOI 10.1016/j.canlet.2014.03.012; Zhou J, 2006, CANCER RES, V66, P445, DOI 10.1158/0008-5472.CAN-05-1779	44	35	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12558	12571		10.1074/jbc.M114.626960	http://dx.doi.org/10.1074/jbc.M114.626960			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25802333	Green Published, hybrid			2022-12-28	WOS:000354569000012
J	Moller, MS; Vester-Christensen, MB; Jensen, JM; Abou Hachem, M; Henriksen, A; Svensson, B				Moller, Marie S.; Vester-Christensen, Malene B.; Jensen, Johanne M.; Abou Hachem, Maher; Henriksen, Anette; Svensson, Birte			Crystal Structure of Barley Limit Dextrinase-Limit Dextrinase Inhibitor (LD-LDI) Complex Reveals Insights into Mechanism and Diversity of Cereal Type Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STARCH-DEBRANCHING ENZYME; ALPHA-AMYLASE INHIBITOR; BIFUNCTIONAL INHIBITOR; WHEAT KERNEL; RAGI SEEDS; GENE; PURIFICATION; EXPRESSION; BINDING; SEQUENCE	Molecular details underlying regulation of starch mobilization in cereal seed endosperm remain unknown despite the paramount role of this process in plant growth. The structure of the complex between the starch debranching enzyme barley limit dextrinase (LD), hydrolyzing alpha-1,6-glucosidic linkages, and its endogenous inhibitor (LDI) was solved at 2.7 angstrom. The structure reveals an entirely new and unexpected binding mode of LDI as compared with previously solved complex structures of related cereal type family inhibitors (CTIs) bound to glycoside hydrolases but is structurally analogous to binding of dual specificity CTIs to proteases. Site-directed mutagenesis establishes that a hydrophobic cluster flanked by ionic interactions in the protein-protein interface is vital for the picomolar affinity of LDI to LD as assessed by analysis of binding by using surface plasmon resonance and also supported by LDI inhibition of the enzyme activity. A phylogenetic analysis identified four LDI-like proteins in cereals among the 45 sequences from monocot databases that could be classified as unique CTI sequences. The unprecedented binding mechanism shown here for LDI has likely evolved in cereals from a need for effective inhibition of debranching enzymes having characteristic open active site architecture. The findings give a mechanistic rationale for the potency of LD activity regulation and provide a molecular understanding of the debranching events associated with optimal starch mobilization and utilization during germination. This study unveils a hitherto not recognized structural basis for the features endowing diversity to CTIs.	[Moller, Marie S.; Vester-Christensen, Malene B.; Jensen, Johanne M.; Abou Hachem, Maher; Svensson, Birte] Tech Univ Denmark, Dept Syst Biol, Enzyme & Prot Chem, DK-2800 Lyngby, Denmark; [Moller, Marie S.; Vester-Christensen, Malene B.; Jensen, Johanne M.; Henriksen, Anette] Carlsberg Lab, Prot Chem Grp, DK-1799 Copenhagen V, Denmark	Technical University of Denmark	Henriksen, A (corresponding author), Novo Nordisk AS, Dept Prot Biophys & Formulat, Global Res Unit, Novo Nordisk Pk, DK-2760 Malov, Denmark.	athx@novonordisk.com; bis@bio.dtu.dk	Abou Hachem, Maher/M-4772-2019; Møller, Marie Sofie/AAH-2568-2021; Møller, Marie Sofie/GRE-9135-2022	Abou Hachem, Maher/0000-0001-8250-1842; Møller, Marie Sofie/0000-0001-9017-3367; Svensson, Birte/0000-0002-2993-8196; Henriksen, Anette/0000-0003-4051-5079	Carlsberg Foundation; Danish Council for Independent Research, Natural Sciences; Technical University of Denmark; Oticon Foundation	Carlsberg Foundation(Carlsberg Foundation); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Technical University of Denmark; Oticon Foundation	This work was supported by the Carlsberg Foundation, the Danish Council for Independent Research, Natural Sciences, Technical University of Denmark Ph.D. stipends (to M. B. V.- C. and M. S. M.), and an Oticon Foundation M.Sc. scholarship (to J. M. J.).	Behnke CA, 1998, BIOCHEMISTRY-US, V37, P15277, DOI 10.1021/bi9812266; Burton RA, 1999, PLANT PHYSIOL, V119, P859, DOI 10.1104/pp.119.3.859; Carbonero P, 1999, SEED PROTEINS, P617; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dinges JR, 2003, PLANT CELL, V15, P666, DOI 10.1105/tpc.007575; DUNN G, 1975, CARBOHYD RES, V39, P283, DOI 10.1016/S0008-6215(00)86138-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finnie C, 2011, PROTEOMICS, V11, P1595, DOI 10.1002/pmic.201000656; Fujita N, 2009, J EXP BOT, V60, P1009, DOI 10.1093/jxb/ern349; Gilding EK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2450; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gourinath S, 2000, ACTA CRYSTALLOGR D, V56, P287, DOI 10.1107/S0907444999016601; Jensen JM, 2011, PROTEIN EXPRES PURIF, V79, P217, DOI 10.1016/j.pep.2011.04.009; Jose-Estanyol M, 2004, PLANT PHYSIOL BIOCH, V42, P355, DOI 10.1016/j.plaphy.2004.03.009; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristensen M, 1999, BBA-PROTEIN STRUCT M, V1431, P538, DOI 10.1016/S0167-4838(99)00077-1; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; LI B, 1992, PLANT PHYSIOL, V98, P1277, DOI 10.1104/pp.98.4.1277; Li QF, 2009, PLANT PHYSIOL BIOCH, V47, P351, DOI 10.1016/j.plaphy.2009.02.001; LONGSTAFF MA, 1993, PLANT PHYSIOL, V101, P881, DOI 10.1104/pp.101.3.881; LUDWIG I, 1984, PLANT PHYSIOL, V74, P856, DOI 10.1104/pp.74.4.856; MacGregor A. W., 1995, P EUR BREW CONV C BR, P185; MacGregor AW, 2003, J CEREAL SCI, V37, P357, DOI 10.1006/jcrs.2002.0500; MACGREGOR AW, 1994, J CEREAL SCI, V20, P33, DOI 10.1006/jcrs.1994.1042; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Moller MS, 2015, J MOL BIOL, V427, P1263, DOI 10.1016/j.jmb.2014.12.019; Moller MS, 2012, ACTA CRYSTALLOGR F, V68, P1008, DOI 10.1107/S1744309112031004; Morinaga K, 1997, PHYSIOL PLANTARUM, V101, P519, DOI 10.1111/j.1399-3054.1997.tb01032.x; Myszka DG, 1998, BIOPHYS J, V75, P583, DOI 10.1016/S0006-3495(98)77549-6; Oda Y, 1997, BIOCHEMISTRY-US, V36, P13503, DOI 10.1021/bi971307m; Oneda H, 2004, J BIOCHEM, V135, P421, DOI 10.1093/jb/mvh050; Ostergaard O, 2004, PROTEOMICS, V4, P2437, DOI 10.1002/pmic.200300753; Payan F, 2004, BBA-PROTEINS PROTEOM, V1696, P171, DOI 10.1016/j.bbapap.2003.10.012; Repellin A, 2008, J CEREAL SCI, V47, P302, DOI 10.1016/j.jcs.2007.04.015; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schroeder SW, 1998, J AM SOC BREW CHEM, V56, P32; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Stahl Y, 2007, PLANT SCI, V172, P452, DOI 10.1016/j.plantsci.2006.10.008; Stahl Y, 2004, PLANT J, V39, P599, DOI 10.1111/j.1365-313X.2004.02159.x; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Strobl S, 1998, STRUCTURE, V6, P911, DOI 10.1016/S0969-2126(98)00092-6; STROBL S, 1995, BIOCHEMISTRY-US, V34, P8281, DOI 10.1021/bi00026a009; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Svensson B, 2004, BBA-PROTEINS PROTEOM, V1696, P145, DOI 10.1016/j.bbapap.2003.07.004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tester RF, 2004, J CEREAL SCI, V39, P151, DOI 10.1016/j.jcs.2003.12.001; Vester-Christensen MB, 2010, J MOL BIOL, V403, P739, DOI 10.1016/j.jmb.2010.09.031; Vester-Christensen MB, 2010, PROTEIN EXPRES PURIF, V69, P112, DOI 10.1016/j.pep.2009.08.016; Wattebled F, 2008, PLANT PHYSIOL, V148, P1309, DOI 10.1104/pp.108.129379; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YAMADA J, 1981, AGR BIOL CHEM TOKYO, V45, P1013, DOI 10.1080/00021369.1981.10864644; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zhu ZP, 1998, PLANT PHYSIOL, V118, P581, DOI 10.1104/pp.118.2.581	54	15	15	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12614	12629		10.1074/jbc.M115.642777	http://dx.doi.org/10.1074/jbc.M115.642777			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25792743	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000354569000017
J	Peterson, DA; Planer, JD; Guruge, JL; Xue, L; Downey-Virgin, W; Goodman, AL; Seedorf, H; Gordon, JI				Peterson, Daniel A.; Planer, Joseph D.; Guruge, Janaki L.; Xue, Lai; Downey-Virgin, Whitt; Goodman, Andrew L.; Seedorf, Henning; Gordon, Jeffrey I.			Characterizing the Interactions between a Naturally Primed Immunoglobulin A and Its Conserved Bacteroides thetaiotaomicron Species-specific Epitope in Gnotobiotic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GUT; SYMBIOTIC BACTERIA; IN-VIVO; RESPONSES; CELLS; HOST; MICROBIOME; DIVERSITY; ANTIBODY; DEFENSE	The adaptive immune response to the human gut microbiota consists of a complex repertoire of antibodies interacting with a broad range of taxa. Fusing intestinal lamina propria lymphocytes from mice monocolonized with Bacteroides thetaiotaomicron to a myeloma fusion partner allowed us to recover hybridomas that captured naturally primed, antigen-specific antibody responses representing multiple isotypes, including IgA. One of these hybridomas, 260.8, produced a monoclonal antibody that recognizes an epitope specific for B. thetaiotaomicron isolates in a large panel of hospital-and community-acquired Bacteroides. Whole genome transposon mutagenesis revealed a 19-gene locus, involved in LPS O-antigen polysaccharide synthesis and conserved among multiple B. thetaiotaomicron isolates, that is required for 260.8 epitope expression. Mutants in this locus exhibited marked fitness defects in vitro during growth in rich medium and in gnotobiotic mice colonized with defined communities of human gut symbionts. Expression of the 260.8 epitope was sustained during 10 months of daily passage in vitro and during 14 months of monocolonization of gnotobiotic wild-type, Rag1(-/-), or Myd88(-/-) mice. Comparison of gnotobiotic Rag1(-/-) mice with and without subcutaneous 260.8 hybridomas disclosed that this IgA did not affect B. thetaiotaomicron population density or suppress 260.8 epitope production but did affect bacterial gene expression in ways emblematic of a diminished host innate immune response. Our study illustrates an approach for (i) generating diagnostic antibodies, (ii) characterizing IgA responses along a continuum of specificity/degeneracy that defines the IgA repertoire to gut symbionts, and (iii) identifying immunogenic epitopes that affect competitiveness and help maintain host-microbe mutualism.	[Peterson, Daniel A.; Planer, Joseph D.; Guruge, Janaki L.; Xue, Lai; Downey-Virgin, Whitt; Goodman, Andrew L.; Seedorf, Henning; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Peterson, Daniel A.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA	Washington University (WUSTL); Johns Hopkins University	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, 4444 Forest Pk Ave, St Louis, MO 63108 USA.	jgordon@wustl.edu	Regan, Clinton/E-6250-2012; Seedorf, Henning/AAW-6023-2020	Seedorf, Henning/0000-0002-5763-0236	National Institutes of Health [DK30292, DK078669, K08-AI07660902, GM007200]; Washington University Medical Scientist Training Program; National Science Foundation [EF-0333284]; Crohn's and Colitis Association of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669, R37DK030292, R01DK030292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Medical Scientist Training Program; National Science Foundation(National Science Foundation (NSF)); Crohn's and Colitis Association of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK30292, DK078669, K08-AI07660902, and GM007200, a Washington University Medical Scientist Training Program grant (to J. P.). This work was also supported by National Science Foundation Grant EF-0333284 and the Crohn's and Colitis Association of America. J. I. G is co-founder of Matatu, Inc., a company characterizing the role of diet-by-microbiota interactions in animal health.	Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Blumberg R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004184; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; GALFRE G, 1979, NATURE, V277, P131, DOI 10.1038/277131a0; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens EC, 2009, J BIOL CHEM, V284, P18445, DOI 10.1074/jbc.M109.008094; Mirpuri J, 2014, GUT MICROBES, V5, P28, DOI 10.4161/gmic.26489; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; Salyers AA, 2000, METHODS, V20, P35, DOI 10.1006/meth.1999.0903; Shimoda M, 1999, IMMUNOLOGY, V97, P9, DOI 10.1046/j.1365-2567.1999.00755.x; SHOEMAKER NB, 1986, J BACTERIOL, V165, P929, DOI 10.1128/jb.165.3.929-936.1986; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Simmon KE, 2008, J CLIN MICROBIOL, V46, P1596, DOI 10.1128/JCM.02469-07; Snydman DR, 2007, ANTIMICROB AGENTS CH, V51, P1649, DOI 10.1128/AAC.01435-06; Sommer F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085254; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Stoel M, 2005, J IMMUNOL, V174, P1046, DOI 10.4049/jimmunol.174.2.1046; Suzuki K, 2008, TRENDS IMMUNOL, V29, P523, DOI 10.1016/j.it.2008.08.001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Yang Y, 2012, P NATL ACAD SCI USA, V109, P5388, DOI 10.1073/pnas.1121627109; Yang Y, 2012, P NATL ACAD SCI USA, V109, P5382, DOI 10.1073/pnas.1121631109	44	39	40	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12630	12649		10.1074/jbc.M114.633800	http://dx.doi.org/10.1074/jbc.M114.633800			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25795776	hybrid, Green Published			2022-12-28	WOS:000354569000018
J	Ward, RJ; Pediani, JD; Godin, AG; Milligan, G				Ward, Richard J.; Pediani, John D.; Godin, Antoine G.; Milligan, Graeme			Regulation of Oligomeric Organization of the Serotonin 5-Hydroxytryptamine 2C (5-HT2C) Receptor Observed by Spatial Intensity Distribution Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIME-RESOLVED FRET; FLUORESCENCE CORRELATION SPECTROSCOPY; MUSCARINIC ACETYLCHOLINE-RECEPTORS; DISTRIBUTION ANALYSIS SPIDA; TYROSINE KINASE ACTIVATION; G-PROTEIN; GPCR OLIGOMERIZATION; PLASMA-MEMBRANE; LIVE CELLS; LIGAND	The questions of whether G protein-coupled receptors exist as monomers, dimers, and/or oligomers and if these species interconvert in a ligand-dependent manner are among the most contentious current issues in biology. When employing spatial intensity distribution analysis to laser scanning confocal microscope images of cells stably expressing either a plasma membrane-associated form of monomeric enhanced green fluorescent protein (eGFP) or a tandem version of this fluorophore, the eGFP tandem was identified as a dimer. Similar studies on cells stably expressing an eGFP-tagged form of the epidermal growth factor receptor demonstrated that, although largely a monomer in the basal state, this receptor rapidly became predominantly dimeric upon the addition of its ligand epidermal growth factor. In cells induced to express an eGFP-tagged form of the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor, global analysis of construct quantal brightness was consistent with the predominant form of the receptor being dimeric. However, detailed spatial intensity distribution analysis demonstrated the presence of multiple forms ranging from monomers to higher-order oligomers. Furthermore, treatment with chemically distinct 5-HT2C receptor antagonists resulted in a time-dependent change in the quaternary organization to one in which there was a preponderance of receptor monomers. This antagonist-mediated effect was reversible, because washout of the ligand resulted in the regeneration of many of the oligomeric forms of the receptor.	[Ward, Richard J.; Pediani, John D.; Milligan, Graeme] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Godin, Antoine G.] Univ Bordeaux, LP2N, UMR 5298, F-33405 Talence, France; [Godin, Antoine G.] Grad Sch, Inst Opt, F-33405 Talence, France; [Godin, Antoine G.] CNRS, LP2N, UMR 5298, F-33405 Talence, France	University of Glasgow; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite de Bordeaux; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite de Bordeaux; Universite Paris Saclay	Milligan, G (corresponding author), Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk	Pediani, John/F-2708-2019	Pediani, John/0000-0001-6615-537X; Godin, Antoine/0000-0003-2417-2563	Medical Research Council [MR/L023806/1, G0900050]; MRC [G0900050, MR/L023806/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grants MR/L023806/1 and G0900050.	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/NCHEMBIO.396, 10.1038/nchembio.396]; Alvarez-Curto E, 2010, J BIOL CHEM, V285, P23316, DOI 10.1074/jbc.M110.122184; Aronne L, 2014, POSTGRAD MED, V126, P7, DOI 10.3810/pgm.2014.10.2817; Barbeau A, 2013, METHOD CELL BIOL, V117, P1, DOI 10.1016/B978-0-12-408143-7.00001-3; Barbeau A, 2013, METHOD ENZYMOL, V522, P109, DOI 10.1016/B978-0-12-407865-9.00007-8; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Chakraborty H, 2015, ACS CHEM NEUROSCI, V6, P199, DOI 10.1021/cn500231d; Comps-Agrar L, 2012, FASEB J, V26, P3430, DOI 10.1096/fj.12-203646; Comps-Agrar L, 2011, METHODS MOL BIOL, V756, P201, DOI 10.1007/978-1-61779-160-4_10; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Gavalas A, 2013, MOL PHARMACOL, V84, P346, DOI 10.1124/mol.113.086868; Godin AG, 2011, P NATL ACAD SCI USA, V108, P7010, DOI 10.1073/pnas.1018658108; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; Herrick-Davis K, 2015, MOL PHARMACOL, V87, P660, DOI 10.1124/mol.114.096636; Herrick-Davis K, 2013, MOL PHARMACOL, V84, P630, DOI 10.1124/mol.113.087072; Herrick-Davis K, 2012, J BIOL CHEM, V287, P23604, DOI 10.1074/jbc.M112.350249; Kaczor AA, 2011, CURR MED CHEM, V18, P4606, DOI 10.2174/092986711797379285; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Lambert NA, 2014, J PHYSIOL-LONDON, V592, P2443, DOI 10.1113/jphysiol.2014.272997; Lambert NA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115pe12; Lane JR, 2014, NAT CHEM BIOL, V10, P745, DOI [10.1038/nchembio.1593, 10.1038/NCHEMBIO.1593]; Leppanen VM, 2013, P NATL ACAD SCI USA, V110, P12960, DOI 10.1073/pnas.1301415110; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Macdonald-Obermann JL, 2014, J BIOL CHEM, V289, P26178, DOI 10.1074/jbc.M114.586826; Mancia F, 2008, EMBO REP, V9, P363, DOI 10.1038/embor.2008.27; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Milligan G, 2013, MOL PHARMACOL, V84, P158, DOI 10.1124/mol.113.084780; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Moreno JL, 2012, J BIOL CHEM, V287, P44301, DOI 10.1074/jbc.M112.413161; Nenasheva TA, 2013, J MOL CELL CARDIOL, V57, P129, DOI 10.1016/j.yjmcc.2013.01.009; Patowary S, 2013, BIOCHEM J, V452, P303, DOI 10.1042/BJ20121902; Rivero-Muller A, 2013, PROG MOL BIOL TRANSL, V117, P163, DOI 10.1016/B978-0-12-386931-9.00007-6; Stahl SM, 2013, CURR DRUG TARGETS, V14, P578; Sun XL, 2014, EUR J MED CHEM, V88, P34, DOI 10.1016/j.ejmech.2014.07.041; Swift JL, 2011, P NATL ACAD SCI USA, V108, P7016, DOI 10.1073/pnas.1018280108; van Rijn RM, 2008, BIOCHEM J, V414, P121, DOI 10.1042/BJ20071583; Varela Liste M. J., 2015, MOL PHARM, DOI [10.1124/mol.114.096925, DOI 10.1124/M0L.114.096925]; von Stetten D, 2012, ACTA CRYSTALLOGR F, V68, P878, DOI 10.1107/S1744309112028667; Ward RJ, 2013, METHOD ENZYMOL, V521, P69, DOI 10.1016/B978-0-12-391862-8.00004-1; Ward RJ, 2011, BRIT J PHARMACOL, V162, P1439, DOI 10.1111/j.1476-5381.2010.01156.x; Youker RT, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.9.090801; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zakrys L, 2014, BIOCHEM J, V461, P61, DOI 10.1042/BJ20140190	49	48	48	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12844	12857		10.1074/jbc.M115.644724	http://dx.doi.org/10.1074/jbc.M115.644724			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25825490	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000354569000035
J	Muramatsu, R; Kuroda, M; Matoba, K; Lin, HY; Takahashi, C; Koyama, Y; Yamashita, T				Muramatsu, Rieko; Kuroda, Mariko; Matoba, Ken; Lin, Hsiaoyun; Takahashi, Chisato; Koyama, Yoshihisa; Yamashita, Toshihide			Prostacyclin Prevents Pericyte Loss and Demyelination Induced by Lysophosphatidylcholine in the Central Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; SPINAL-CORD DEMYELINATION; NEURONAL DAMAGE; CELLS; REMYELINATION; RECRUITMENT; DISRUPTION; INTEGRITY; RECOVERY; DISEASE	Pericytes play pivotal roles in physiological and pathophysiological conditions in the central nervous system. As pericytes prevent vascular leakage, they can halt neuronal damage stemming from a compromised blood-brain barrier. Therefore, pericytes may be a good target for the treatment of neurodegenerative disorders, although evidence is lacking. In this study, we show that prostacyclin attenuates lysophosphatidylcholine (LPC)-mediated vascular dysfunction through pericyte protection in the adult mouse spinal cord. LPC decreased the number of pericytes in an in vitro blood-brain barrier model, and this decrease was prevented by iloprost treatment, a prostacyclin analog. Intrathecal administration of iloprost attenuated vascular barrier disruption after LPC injection in the mouse spinal cord. Furthermore, iloprost treatment diminished demyelination and motor function deficits in mice injected with LPC. These results support the notion that prostacyclin acts on pericytes to maintain vascular barrier integrity.	[Muramatsu, Rieko; Kuroda, Mariko; Matoba, Ken; Lin, Hsiaoyun; Takahashi, Chisato; Koyama, Yoshihisa; Yamashita, Toshihide] Osaka Univ, Dept Mol Neurosci, Grad Sch Med, Suita, Osaka 5650871, Japan; [Muramatsu, Rieko; Kuroda, Mariko; Matoba, Ken; Lin, Hsiaoyun; Takahashi, Chisato; Koyama, Yoshihisa; Yamashita, Toshihide] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan; [Muramatsu, Rieko] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Muramatsu, R (corresponding author), Osaka Univ, Dept Mol Neurosci, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	muramatsu@molneu.med.osaka-u.ac.jp; yamashita@molneu.med.osaka-u.ac.jp		Yamashita, Toshihide/0000-0003-4559-7018	Ministry of Health, Labour and Welfare; Japan Society for the Promotion of Science [25221309]	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid from the Ministry of Health, Labour and Welfare (to R. M.) and Grant-in-aid for Scientific Research (S) 25221309 from Japan Society for the Promotion of Science (to T. Y.).	Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Birukova AA, 2013, EUR RESPIR J, V41, P165, DOI 10.1183/09031936.00148311; Cui YL, 1999, BIOCHEM BIOPH RES CO, V265, P301, DOI 10.1006/bbrc.1999.1671; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Fortin D, 2012, CURR CANCER DRUG TAR, V12, P247, DOI 10.2174/156800912799277511; Garbuzova-Davis S., 2014, FRONT CELL NEUROSCI, V8, P21; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Hsieh CC, 2000, ATHEROSCLEROSIS, V151, P481, DOI 10.1016/S0021-9150(00)00453-6; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Jeffery ND, 1997, BRAIN, V120, P27, DOI 10.1093/brain/120.1.27; Karow M, 2012, CELL STEM CELL, V11, P471, DOI 10.1016/j.stem.2012.07.007; Koizumi S, 2010, NEUROSCIENCE, V168, P219, DOI 10.1016/j.neuroscience.2010.03.056; Mozafari S, 2010, BRAIN RES, V1351, P50, DOI 10.1016/j.brainres.2010.07.026; Muramatsu R, 2012, NAT MED, V18, P1658, DOI 10.1038/nm.2943; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ousman SS, 2000, GLIA, V30, P92, DOI 10.1002/(SICI)1098-1136(200003)30:1<92::AID-GLIA10>3.0.CO;2-W; Ousman SS, 2001, J NEUROSCI, V21, P4649, DOI 10.1523/JNEUROSCI.21-13-04649.2001; Qiao J, 2006, AM J PHYSIOL-LUNG C, V291, pL91, DOI 10.1152/ajplung.00508.2005; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Takahashi C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.335; Takamatsu H, 2002, BRAIN RES, V925, P176, DOI 10.1016/S0006-8993(01)03280-2; TERAWAKI T, 1988, EUR J PHARMACOL, V152, P63, DOI 10.1016/0014-2999(88)90836-9; Tigges U, 2012, MICROVASC RES, V84, P74, DOI 10.1016/j.mvr.2012.03.008; Vane J. R., 1995, AM J CARDIOL, V75, p3A; Winkler EA, 2012, J CEREBR BLOOD F MET, V32, P1841, DOI 10.1038/jcbfm.2012.113; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946	36	36	36	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11515	11525		10.1074/jbc.M114.587253	http://dx.doi.org/10.1074/jbc.M114.587253			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25795781	hybrid, Green Published			2022-12-28	WOS:000353719400027
J	Omoto, S; Guo, HY; Talekar, GR; Roback, L; Kaiser, WJ; Mocarski, ES				Omoto, Shinya; Guo, Hongyan; Talekar, Ganesh R.; Roback, Linda; Kaiser, William J.; Mocarski, Edward S.			Suppression of RIP3-dependent Necroptosis by Human Cytomegalovirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-INTERACTING PROTEIN; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; MIXED LINEAGE KINASE; MITOCHONDRIA-LOCALIZED INHIBITOR; RIBONUCLEOTIDE REDUCTASE HOMOLOG; VIRION-ASSOCIATED PROTEIN; PROGRAMMED CELL-DEATH; DOMAIN-LIKE PROTEIN; MURINE CYTOMEGALOVIRUS	Necroptosis is an alternate programmed cell death pathway that is unleashed by caspase-8 compromise and mediated by receptor-interacting protein kinase 3 (RIP3). Murine cytomegalovirus (CMV) and herpes simplex virus (HSV) encode caspase-8 inhibitors that prevent apoptosis together with competitors of RIP homotypic interaction motif (RHIM)-dependent signal transduction to interrupt the necroptosis. Here, we show that pro-necrotic murine CMV M45 mutant virus drives virus-induced necroptosis during nonproductive infection of RIP3-expressing human fibroblasts, whereas WT virus does not. Thus, M45-encoded RHIM competitor, viral inhibitor of RIP activation, sustains viability of human cells like it is known to function in infected mouse cells. Importantly, human CMV is shown to block necroptosis induced by either TNF or M45 mutant murine CMV in RIP3-expressing human cells. Human CMV blocks TNF-induced necroptosis after RIP3 activation and phosphorylation of the mixed lineage kinase domain-like (MLKL) pseudokinase. An early, IE1-regulated viral gene product acts on a necroptosis step that follows MLKL phosphorylation prior to membrane leakage. This suppression strategy is distinct from RHIM signaling competition by murine CMV or HSV and interrupts an execution process that has not yet been fully elaborated.	[Omoto, Shinya; Guo, Hongyan; Talekar, Ganesh R.; Roback, Linda; Kaiser, William J.; Mocarski, Edward S.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Emory University	Mocarski, ES (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, 1462 Clifton Rd,Suite 429, Atlanta, GA 30322 USA.	mocarski@emory.edu	Mocarski, Edward/ABC-2893-2020	Omoto, Shinya/0000-0002-2730-3912	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118853, R01AI020211] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012198] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI118853, R01 AI020211] Funding Source: Medline; NIH HHS [DP5 OD012198] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Antonopoulos C, 2013, J IMMUNOL, V191, P4789, DOI 10.4049/jimmunol.1300645; Baillie J, 2003, J VIROL, V77, P7007, DOI 10.1128/JVI.77.12.7007-7016.2003; Berger AK, 2013, MBIO, V4, DOI 10.1128/mBio.00178-13; Brune W, 2001, SCIENCE, V291, P303, DOI 10.1126/science.291.5502.303; Brune W, 2011, VIRUS RES, V157, P144, DOI 10.1016/j.virusres.2010.10.012; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Cam M, 2010, CELL DEATH DIFFER, V17, P655, DOI 10.1038/cdd.2009.147; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cicin-Sain L, 2008, J VIROL, V82, P2056, DOI 10.1128/JVI.01803-07; Crosby LN, 2013, VIROLOGY, V436, P274, DOI 10.1016/j.virol.2012.12.002; Daley-Bauer LP, 2013, CYTOMEGALOVIRUSES: FROM MOLECULAR PATHOGENESIS TO INTERVENTION, VOL I, P363; DeFilippis VR, 2010, J VIROL, V84, P585, DOI 10.1128/JVI.01748-09; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dufour F, 2011, APOPTOSIS, V16, P256, DOI 10.1007/s10495-010-0560-2; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Feoktistova M, 2012, CELL CYCLE, V11, P460, DOI 10.4161/cc.11.3.19060; Fleming P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003192; Fliss PM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002517; Goldmacher VS, 1999, P NATL ACAD SCI USA, V96, P12536, DOI 10.1073/pnas.96.22.12536; Greaves RF, 1998, J VIROL, V72, P366, DOI 10.1128/JVI.72.1.366-379.1998; Green DR, 2012, TRENDS CELL BIOL, V22, P555, DOI 10.1016/j.tcb.2012.08.008; Guo HY, 2015, CELL HOST MICROBE, V17, P243, DOI 10.1016/j.chom.2015.01.003; Hahn G, 2002, J VIROL, V76, P9551, DOI 10.1128/JVI.76.18.9551-9555.2002; Handke W, 2013, J VIROL, V87, P3592, DOI 10.1128/JVI.02657-12; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hedrick SM, 2010, IMMUNOL REV, V236, P41, DOI 10.1111/j.1600-065X.2010.00918.x; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Huang Z, 2015, CELL HOST MICROBE, V17, P229, DOI 10.1016/j.chom.2015.01.002; Jurak I, 2006, EMBO J, V25, P2634, DOI 10.1038/sj.emboj.7601133; Kaarbo M, 2011, MITOCHONDRION, V11, P935, DOI 10.1016/j.mito.2011.08.008; Kaiser WJ, 2008, J IMMUNOL, V181, P6427, DOI 10.4049/jimmunol.181.9.6427; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2013, CURR OPIN VIROL, V3, P296, DOI 10.1016/j.coviro.2013.05.019; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Krause E, 2014, J VIROL, V88, P9963, DOI 10.1128/JVI.00684-14; LAFEMINA RL, 1988, J GEN VIROL, V69, P355, DOI 10.1099/0022-1317-69-2-355; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Lembo D, 2004, J VIROL, V78, P4278, DOI 10.1128/JVI.78.8.4278-4288.2004; Lembo D, 2009, TRENDS BIOCHEM SCI, V34, P25, DOI 10.1016/j.tibs.2008.09.008; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li M, 2000, J VIROL, V74, P7470, DOI 10.1128/JVI.74.16.7470-7477.2000; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Mack C, 2008, P NATL ACAD SCI USA, V105, P3094, DOI 10.1073/pnas.0800168105; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Manning WC, 1998, J VIROL METHODS, V73, P31, DOI 10.1016/S0166-0934(98)00034-2; Manzur M, 2009, CELL DEATH DIFFER, V16, P312, DOI 10.1038/cdd.2008.152; Marchini A, 2001, J VIROL, V75, P1870, DOI 10.1128/JVI.75.4.1870-1878.2001; McCormick AL, 2008, CURR TOP MICROBIOL, V325, P281; McCormick AL, 2013, CYTOMEGALOVIRUSES: FROM MOLECULAR PATHOGENESIS TO INTERVENTION, VOL I, P264; McCormick AL, 2013, VIROLOGY, V435, P250, DOI 10.1016/j.virol.2012.08.042; McCormick AL, 2010, J VIROL, V84, P5108, DOI 10.1128/JVI.01345-09; McCormick AL, 2003, VIROLOGY, V316, P221, DOI 10.1016/j.virol.2003.07.003; Menard C, 2003, J VIROL, V77, P5557, DOI 10.1128/JVI.77.10.5557-5570.2003; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mocarski ES, 2014, J IMMUNOL, V192, P2019, DOI 10.4049/jimmunol.1302426; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Montag C, 2011, J VIROL, V85, P11409, DOI 10.1128/JVI.05028-11; Moquin D, 2010, TRENDS BIOCHEM SCI, V35, P434, DOI 10.1016/j.tibs.2010.03.001; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Muller-Sienerth N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021556; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Omoto S, 2013, J VIROL, V87, P8651, DOI 10.1128/JVI.01052-13; Patrone M, 2003, J GEN VIROL, V84, P3359, DOI 10.1099/vir.0.19452-0; Paulus C, 2009, VIRUSES-BASEL, V1, P760, DOI 10.3390/v1030760; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seirafian S, 2014, J GEN VIROL, V95, P933, DOI 10.1099/vir.0.058313-0; Skaletskaya A, 2001, P NATL ACAD SCI USA, V98, P7829, DOI 10.1073/pnas.141108798; Smith W, 2013, CELL HOST MICROBE, V13, P324, DOI 10.1016/j.chom.2013.02.003; Sridharan H, 2014, TRENDS MICROBIOL, V22, P199, DOI 10.1016/j.tim.2014.01.005; Stinski MF, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P241; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; Upton JW, 2008, J BIOL CHEM, V283, P16966, DOI 10.1074/jbc.C800051200; Upton JW, 2014, MOL CELL, V54, P273, DOI 10.1016/j.molcel.2014.01.027; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; WALKER D, 1987, ARCH VIROL, V92, P103, DOI 10.1007/BF01310066; Wang X, 2014, P NATL ACAD SCI USA, V111, P15438, DOI 10.1073/pnas.1412767111; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Xie T, 2013, CELL REP, V5, P70, DOI 10.1016/j.celrep.2013.08.044; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109; ZHU H, 1995, J VIROL, V69, P7960, DOI 10.1128/JVI.69.12.7960-7970.1995	99	96	97	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11635	11648		10.1074/jbc.M115.646042	http://dx.doi.org/10.1074/jbc.M115.646042			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25778401	Green Published, hybrid			2022-12-28	WOS:000353719400038
J	Plessner, M; Melak, M; Chinchilla, P; Baarlink, C; Grosse, R				Plessner, Matthias; Melak, Michael; Chinchilla, Pilar; Baarlink, Christian; Grosse, Robert			Nuclear F-actin Formation and Reorganization upon Cell Spreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORCE TRANSMISSION; TRANSCRIPTION; DYNAMICS; FILAMENTS; SRF; MECHANOTRANSDUCTION; CYTOSKELETON; COMPLEXES; PROTEINS; NETWORK	We recently discovered signal-regulated nuclear actin network assembly. However, in contrast to cytoplasmic actin regulation, polymeric nuclear actin structures and functions remain only poorly understood. Here we describe a novel molecular tool to visualize real-time nuclear actin dynamics by targeting the Actin-Chromobody-TagGFP to the nucleus, thus establishing a nuclear Actin-Chromobody. Interestingly, we observe nuclear actin polymerization into dynamic filaments upon cell spreading and fibronectin stimulation, both of which appear to be triggered by integrin signaling. Furthermore, we show that nucleoskeletal proteins such as the LINC (linker of nucleoskeleton and cytoskeleton) complex and components of the nuclear lamina couple cell spreading or integrin activation by fibronectin to nuclear actin polymerization. Spreading-induced nuclear actin polymerization results in serum response factor (SRF)-mediated transcription through nuclear retention of myocardin-related transcription factor A (MRTF-A). Our results reveal a signaling pathway, which links integrin activation by extracellular matrix interaction to nuclear actin polymerization through the LINC complex, and therefore suggest a role for nuclear actin polymerization in the context of cellular adhesion and mechanosensing.	[Plessner, Matthias; Melak, Michael; Chinchilla, Pilar; Baarlink, Christian; Grosse, Robert] Univ Marburg, Inst Pharmacol, BPC, D-35043 Marburg, Germany	Philipps University Marburg	Grosse, R (corresponding author), Univ Marburg, Inst Pharmacol, BPC, Karl von Frisch Str 1, D-35043 Marburg, Germany.	robert.grosse@staff.uni-marburg.de		Grosse, Robert/0000-0002-3380-5273	Deutsche Forschungsgemeinschaft (DFG) [GR 2111/7-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (GR 2111/7-1).	Baarlink C, 2014, NUCLEUS-PHILA, V5, P15, DOI 10.4161/nucl.28066; Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Belin BJ, 2013, MOL BIOL CELL, V24, P982, DOI 10.1091/mbc.E12-09-0685; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; de Lanerolle P, 2011, NAT CELL BIOL, V13, P1282, DOI 10.1038/ncb2364; Dopie J, 2012, P NATL ACAD SCI USA, V109, pE544, DOI 10.1073/pnas.1118880109; Fedorchak GR, 2014, PROG BIOPHYS MOL BIO, V115, P76, DOI 10.1016/j.pbiomolbio.2014.06.009; Floch AG, 2014, METHOD CELL BIOL, V122, P1, DOI 10.1016/B978-0-12-417160-2.00001-1; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; Grosse R, 2013, NAT REV MOL CELL BIO, V14, P693, DOI 10.1038/nrm3681; Gundersen GG, 2013, CELL, V152, P1376, DOI 10.1016/j.cell.2013.02.031; Hendzel MJ, 2014, CURR OPIN CELL BIOL, V28, P84, DOI 10.1016/j.ceb.2014.04.003; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kaminski A, 2014, PROG MOL BIOL TRANSL, V126, P157, DOI 10.1016/B978-0-12-394624-9.00007-5; Kapoor P, 2014, TRENDS CELL BIOL, V24, P238, DOI 10.1016/j.tcb.2013.10.007; Lombardi ML, 2011, BIOCHEM SOC T, V39, P1729, DOI 10.1042/BST20110686; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Munsie LN, 2009, NAT METHODS, V6, P317, DOI 10.1038/nmeth0509-317; NISHIDA E, 1987, P NATL ACAD SCI USA, V84, P5262, DOI 10.1073/pnas.84.15.5262; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Rocchetti A, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-12; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Skarp KP, 2010, CYTOSKELETON, V67, P487, DOI 10.1002/cm.20464; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Treisman R, 2013, TRENDS BIOCHEM SCI, V38, P376, DOI 10.1016/j.tibs.2013.06.004; Vartiainen MK, 2008, FEBS LETT, V582, P2033, DOI 10.1016/j.febslet.2008.04.010; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Weston L, 2012, J CELL SCI, V125, P3519, DOI 10.1242/jcs.099523	32	151	154	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11209	11216		10.1074/jbc.M114.627166	http://dx.doi.org/10.1074/jbc.M114.627166			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25759381	Green Published, hybrid			2022-12-28	WOS:000353719400001
J	Scheerer, P; Zhang, F; Kalms, J; von Stetten, D; Krauss, N; Oberpichler, I; Lamparter, T				Scheerer, Patrick; Zhang, Fan; Kalms, Jacqueline; von Stetten, David; Krauss, Norbert; Oberpichler, Inga; Lamparter, Tilman			The Class III Cyclobutane Pyrimidine Dimer Photolyase Structure Reveals a New Antenna Chromophore Binding Site and Alternative Photoreduction Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BLUE-LIGHT PHOTORECEPTORS; DNA PHOTOLYASE; CRYSTAL-STRUCTURE; ARABIDOPSIS-THALIANA; MACROMOLECULAR CRYSTALLOGRAPHY; ELECTRON-TRANSFER; CRYPTOCHROME; REPAIR; TRYPTOPHAN	Photolyases are proteins with an FAD chromophore that repair UV-induced pyrimidine dimers on the DNA in a light-dependent manner. The cyclobutane pyrimidine dimer class III photolyases are structurally unknown but closely related to plant cryptochromes, which serve as blue-light photoreceptors. Here we present the crystal structure of a class III photolyase termed photolyase-related protein A (PhrA) of Agrobacterium tumefaciens at 1.67-angstrom resolution. PhrA contains 5,10-methenyltetrahydrofolate (MTHF) as an antenna chromophore with a unique binding site and mode. Two Trp residues play pivotal roles for stabilizing MTHF by a double pi-stacking sandwich. Plant cryptochrome I forms a pocket at the same site that could accommodate MTHF or a similar molecule. The PhrA structure and mutant studies showed that electrons flow during FAD photoreduction proceeds via two Trp triads. The structural studies on PhrA give a clearer picture on the evolutionary transition from photolyase to photoreceptor.	[Scheerer, Patrick; Kalms, Jacqueline] Univ Med Berlin, Inst Med Phys & Biophys CC2, AG Prot Xray Crystallog & Signal Transduct, Charite, D-10117 Berlin, Germany; [Zhang, Fan; Oberpichler, Inga; Lamparter, Tilman] Karlsruhe Inst Technol, Inst Bot, D-76131 Karlsruhe, Germany; [von Stetten, David] European Synchroton Radiat Facil, Struct Biol Grp, F-38043 Grenoble 9, France; [Krauss, Norbert] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Karlsruhe Institute of Technology; European Synchrotron Radiation Facility (ESRF); University of London; Queen Mary University London	Scheerer, P (corresponding author), Univ Med Berlin, Inst Med Phys & Biophys CC2, AG Prot Xray Crystallog & Signal Transduct, Charite, Charitepl 1, D-10117 Berlin, Germany.	patrick.scheerer@charite.de; oberpichler@gsl.uni-luebeck.de; tilman.lamparter@kit.edu	; Lamparter, Tilman/E-4421-2013	von Stetten, David/0000-0001-7906-9788; Lamparter, Tilman/0000-0003-4327-9737; Scheerer, Patrick/0000-0001-5028-2075; Krauss, Norbert/0000-0002-7128-4632	Deutsche Forschungsgemeinschaft (DFG) [799/8-1, SFB 740-B6, SFB 1078-B6]; China Scholarship Council; Karlsruhe House of Young Scientists; DFG Cluster of Excellence "Unifying Concepts in Catalysis" Research Field [D3/E3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council); Karlsruhe House of Young Scientists; DFG Cluster of Excellence "Unifying Concepts in Catalysis" Research Field(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant 799/8-1 (to T. L.), and SFB 740-B6 and SFB 1078-B6 (to P. S.), and grants from the China Scholarship Council (to F. Z.), Karlsruhe House of Young Scientists (to F. Z.), and DFG Cluster of Excellence "Unifying Concepts in Catalysis" Research Field D3/E3-1 (to P. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aubert C, 1999, P NATL ACAD SCI USA, V96, P5423, DOI 10.1073/pnas.96.10.5423; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balland V, 2009, J AM CHEM SOC, V131, P426, DOI 10.1021/ja806540j; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Biskup T, 2013, J BIOL CHEM, V288, P9249, DOI 10.1074/jbc.M112.417725; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Burney S, 2012, ANGEW CHEM INT EDIT, V51, P9356, DOI 10.1002/anie.201203476; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Cowtan K, 2011, ACTA CRYSTALLOGR D, V67, P233, DOI 10.1107/S0907444911007578; de Sanctis D, 2012, J SYNCHROTRON RADIAT, V19, P455, DOI 10.1107/S0909049512009715; DeLano W.L, PYMOL MOL GRAPHICS S; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujihashi M, 2007, J MOL BIOL, V365, P903, DOI 10.1016/j.jmb.2006.10.012; Geisselbrecht Y, 2012, EMBO REP, V13, P223, DOI 10.1038/embor.2012.2; Glas AF, 2009, CHEM-EUR J, V15, P10387, DOI 10.1002/chem.200901004; Hitomi K, 2012, J BIOL CHEM, V287, P12060, DOI 10.1074/jbc.M111.244020; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Hoang N, 2008, MOL PLANT, V1, P68, DOI 10.1093/mp/ssm008; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huang YH, 2006, P NATL ACAD SCI USA, V103, P17701, DOI 10.1073/pnas.0608554103; Juhas M, 2014, FEBS J, V281, P2299, DOI 10.1111/febs.12782; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiontke S, 2011, EMBO J, V30, P4437, DOI 10.1038/emboj.2011.313; Klar T, 2007, J MOL BIOL, V366, P954, DOI 10.1016/j.jmb.2006.11.066; Klar T, 2006, CHEMBIOCHEM, V7, P1798, DOI 10.1002/cbic.200600206; Komori H, 2001, P NATL ACAD SCI USA, V98, P13560, DOI 10.1073/pnas.241371398; Kort R, 2004, ACTA CRYSTALLOGR D, V60, P1205, DOI 10.1107/S0907444904009321; Kottke T, 2006, BIOCHEMISTRY-US, V45, P2472, DOI 10.1021/bi051964b; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li X, 2011, P NATL ACAD SCI USA, V108, P20844, DOI 10.1073/pnas.1114579108; LI YF, 1991, BIOCHEMISTRY-US, V30, P6322, DOI 10.1021/bi00239a034; Liu B, 2010, CURR OPIN PLANT BIOL, V13, P578, DOI 10.1016/j.pbi.2010.09.005; Liu ZY, 2013, P NATL ACAD SCI USA, V110, P12966, DOI 10.1073/pnas.1311073110; Liu ZY, 2011, P NATL ACAD SCI USA, V108, P14831, DOI 10.1073/pnas.1110927108; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MALHOTRA K, 1995, BIOCHEMISTRY-US, V34, P6892, DOI 10.1021/bi00020a037; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Oberpichler I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026775; Ozturk N, 2008, BIOCHEMISTRY-US, V47, P10255, DOI 10.1021/bi801085a; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; PAYNE G, 1990, BIOCHEMISTRY-US, V29, P7715, DOI 10.1021/bi00485a021; Pokorny R, 2008, P NATL ACAD SCI USA, V105, P21023, DOI 10.1073/pnas.0805830106; Royant A, 2007, J APPL CRYSTALLOGR, V40, P1105, DOI 10.1107/S0021889807044196; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Selby CP, 2012, BIOCHEMISTRY-US, V51, P167, DOI 10.1021/bi201536w; Tamada T, 1997, NAT STRUCT BIOL, V4, P887, DOI 10.1038/nsb1197-887; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhang F, 2013, P NATL ACAD SCI USA, V110, P7217, DOI 10.1073/pnas.1302377110	67	36	36	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11504	11514		10.1074/jbc.M115.637868	http://dx.doi.org/10.1074/jbc.M115.637868			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25784552	Green Published, hybrid			2022-12-28	WOS:000353719400026
J	Barbour, SE; Nguyen, PT; Park, M; Emani, B; Lei, XY; Kambalapalli, M; Shultz, JC; Wijesinghe, D; Chalfant, CE; Ramanadham, S				Barbour, Suzanne E.; Nguyen, Phuong T.; Park, Margaret; Emani, Bhargavi; Lei, Xiaoyong; Kambalapalli, Mamatha; Shultz, Jacqueline C.; Wijesinghe, Dayanjan; Chalfant, Charles E.; Ramanadham, Sasanka			Group VIA Phospholipase A(2) (iPLA(2)beta) Modulates Bcl-x 5 '-Splice Site Selection and Suppresses Anti-apoptotic Bcl-x(L) in beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; PRE-MESSENGER-RNA; ARACHIDONIC-ACID METABOLISM; INSULIN-SECRETING CELLS; HUMAN PANCREATIC-ISLETS; ER STRESS; CERAMIDE GENERATION; PROTEIN; EXPRESSION; 12-LIPOXYGENASE	Diabetes is a consequence of reduced beta-cell function and mass, due to beta-cell apoptosis. Endoplasmic reticulum (ER) stress is induced during beta-cell apoptosis due to various stimuli, and our work indicates that group VIA phospholipase A(2)beta (iPLA(2)beta) participates in this process. Delineation of underlying mechanism(s) reveals that ER stress reduces the anti-apoptotic Bcl-x(L) protein in INS-1 cells. The Bcl-x pre-mRNA undergoes alternative pre-mRNA splicing to generate Bcl-x(L) or Bcl-x(S) mature mRNA. We show that both thapsigargin-induced and spontaneous ER stress are associated with reductions in the ratio of Bcl-x(L)/Bcl-x(S) mRNA in INS-1 and islet beta-cells. However, chemical inactivation or knockdown of iPLA(2)beta augments the Bcl-x(L)/Bcl-x(S) ratio. Furthermore, the ratio is lower in islets from islet-specific RIP-iPLA(2)beta transgenic mice, whereas islets from global iPLA(2)beta(-/-) mice exhibit the opposite phenotype. In view of our earlier reports that iPLA(2)beta induces ceramide accumulation through neutral sphingomyelinase 2 and that ceramides shift the Bcl-x 5'-splice site (5'SS) selection in favor of Bcl-x(S), we investigated the potential link between Bcl-x splicing and the iPLA(2)beta/ceramide axis. Exogenous C-6-ceramide did not alter Bcl-x 5'SS selection in INS-1 cells, and neutral sphingomyelinase 2 inactivation only partially prevented the ER stress-induced shift in Bcl-x splicing. In contrast, 5(S)-hydroxytetraenoic acid augmented the ratio of Bcl-x(L)/Bcl-x(S) by 15.5-fold. Taken together, these data indicate that beta-cell apoptosis is, in part, attributable to the modulation of 5'SS selection in the Bcl-x pre-mRNA by bioactive lipids modulated by iPLA(2)beta.	[Barbour, Suzanne E.; Nguyen, Phuong T.; Park, Margaret; Emani, Bhargavi; Kambalapalli, Mamatha; Shultz, Jacqueline C.; Wijesinghe, Dayanjan; Chalfant, Charles E.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Lei, Xiaoyong; Ramanadham, Sasanka] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Lei, Xiaoyong; Ramanadham, Sasanka] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA; [Wijesinghe, Dayanjan; Chalfant, Charles E.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA 23249 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Reanimat Engn Sci Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; Virginia Commonwealth University	Ramanadham, S (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.	sramvem@uab.edu			National Institutes of Health from NIDDK [DK-69455]; National Institutes of Health from NHLBI [HL91388]; National Institutes of Health from NCI Cancer Center [HL072925, CA154314, NH1C06-RR17393, P30 CA016059]; American Diabetes Association; National Science Foundation [MCB 0544068]; Virginia Commonwealth University Presidential Research Incentive Program; Veterans Affairs Merit Award [BX001792]; Research Career Scientist Award; United States Israel Bi-National Science Foundation [2011380]; NATIONAL CANCER INSTITUTE [R01CA154314, P30CA016059] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058, KL2TR000057] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017393] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072925, R01HL125353, R21HL091388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069455] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010641] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001792] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health from NCI Cancer Center; American Diabetes Association(American Diabetes Association); National Science Foundation(National Science Foundation (NSF)); Virginia Commonwealth University Presidential Research Incentive Program; Veterans Affairs Merit Award(US Department of Veterans Affairs); Research Career Scientist Award(US Department of Veterans Affairs); United States Israel Bi-National Science Foundation(US-Israel Binational Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant DK-69455 from NIDDK (to S. R.), Grant HL91388 from NHLBI (to S. E. B.), Grants HL072925 (to C. E C.), CA154314 (to C. E. C.), and NH1C06-RR17393 (to Virginia Commonwealth University), and P30 CA016059 from NCI Cancer Center. This work was also supported by the American Diabetes Association (to S. R.), National Science Foundation Grant MCB 0544068 (to S. E. B.), Virginia Commonwealth University Presidential Research Incentive Program (to S. E. B.), Veterans Affairs Merit Award BX001792 (to C. E. C.), a Research Career Scientist Award (to C. E. C.), and Grant BSF#2011380 from the United States Israel Bi-National Science Foundation (to C. E. C.).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Bao S, 2008, AM J PHYSIOL-ENDOC M, V294, pE217, DOI 10.1152/ajpendo.00474.2007; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Bauman JA, 2010, NUCLEIC ACIDS RES, V38, P8348, DOI 10.1093/nar/gkq731; Bleich D, 1999, J CLIN INVEST, V103, P1431, DOI 10.1172/JCI5241; Bone RN, 2015, DIABETES, V64, P541, DOI 10.2337/db14-0097; Braun T, 2003, MOL CANCER RES, V1, P186; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Carrington EM, 2009, DIABETES, V58, P2316, DOI 10.2337/db08-1602; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Cloutier P, 2008, J BIOL CHEM, V283, P21315, DOI 10.1074/jbc.M800353200; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Ealovega MW, 1996, CANCER RES, V56, P1965; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Gijon MA, 1997, SEMIN CELL DEV BIOL, V8, P297, DOI 10.1006/scdb.1997.0151; Green-Mitchell SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056763; GROSS RW, 1993, BIOCHEMISTRY-US, V32, P327, DOI 10.1021/bi00052a041; Han JS, 1998, SPRINGER SEMIN IMMUN, V19, P279, DOI 10.1007/BF00787225; Holohan C, 2008, J CELL MOL MED, V12, P591, DOI 10.1111/j.1582-4934.2007.00191.x; HUGHES JH, 1989, DIABETES, V38, P1251, DOI 10.2337/diabetes.38.10.1251; Hui HX, 2005, DIABETES, V54, P424, DOI 10.2337/diabetes.54.2.424; Iwawaki T, 2013, SEMIN IMMUNOPATHOL, V35, P333, DOI 10.1007/s00281-013-0369-5; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kayo T, 1998, J CLIN INVEST, V101, P2112, DOI 10.1172/JCI1842; Klein D, 2004, BIOCHEM BIOPH RES CO, V323, P473, DOI 10.1016/j.bbrc.2004.08.116; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Lei XY, 2014, ENDOCRINOLOGY, V155, P3352, DOI 10.1210/en.2013-2134; Lei XY, 2013, ISLETS, V5, P29, DOI 10.4161/isl.23758; Lei XY, 2012, AM J PHYSIOL-ENDOC M, V303, pE1386, DOI 10.1152/ajpendo.00234.2012; Lei XY, 2010, BIOCHIMIE, V92, P627, DOI 10.1016/j.biochi.2010.01.005; Lei XY, 2010, J BIOL CHEM, V285, P6693, DOI 10.1074/jbc.M109.084293; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Leu S, 2012, J CELL SCI, V125, P3164, DOI 10.1242/jcs.100859; Ma K, 2010, J CLIN ENDOCR METAB, V95, P887, DOI 10.1210/jc.2009-1102; Ma ZM, 2001, J BIOL CHEM, V276, P13198, DOI 10.1074/jbc.M010423200; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; Massiello A, 2004, J BIOL CHEM, V279, P15799, DOI 10.1074/jbc.M313950200; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Mercatante DR, 2001, J BIOL CHEM, V276, P16411, DOI 10.1074/jbc.M009256200; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Michels J., 2013, INT J CELL BIOL, V2013; Minn AJ, 1996, J BIOL CHEM, V271, P6306, DOI 10.1074/jbc.271.11.6306; Mitra RS, 2001, NEOPLASIA, V3, P437, DOI 10.1038/sj.neo.7900181; Nowatzke W, 1998, ENDOCRINOLOGY, V139, P4073, DOI 10.1210/en.139.10.4073; Nozaki J, 2004, GENES CELLS, V9, P261, DOI 10.1111/j.1356-9597.2004.00721.x; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Persaud SJ, 2007, DIABETES, V56, P197, DOI 10.2337/db06-0490; Prasad KMR, 2003, BIOCHEM BIOPH RES CO, V308, P427, DOI 10.1016/S0006-291X(03)01418-9; Rabinovitch A, 1998, BIOCHEM PHARMACOL, V55, P1139, DOI 10.1016/S0006-2952(97)00492-9; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P5339, DOI 10.1021/bi00071a009; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P13499, DOI 10.1021/bi00212a015; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P337, DOI 10.1021/bi00052a042; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; RAMANADHAM S, 1994, BIOCHEMISTRY-US, V33, P7442, DOI 10.1021/bi00189a052; Revil T, 2009, J BIOL CHEM, V284, P21458, DOI 10.1074/jbc.M109.019711; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Sesti G, 2002, ANN MED, V34, P444, DOI 10.1080/078538902321012397; Simanshu DK, 2013, NATURE, V500, P463, DOI 10.1038/nature12332; Socha L, 2003, ANN NY ACAD SCI, V1005, P178, DOI 10.1196/annals.1288.022; Tao HM, 2002, J BIOL CHEM, V277, P31270, DOI 10.1074/jbc.M203196200; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; TURK J, 1988, DIABETES, V37, P992, DOI 10.2337/diabetes.37.7.992; TURK J, 1992, BIOCHIM BIOPHYS ACTA, V1125, P280, DOI 10.1016/0005-2760(92)90057-3; Vannuvel K, 2013, J CELL PHYSIOL, V228, P1802, DOI 10.1002/jcp.24360; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Weaver JR, 2012, MOL CELL ENDOCRINOL, V358, P88, DOI 10.1016/j.mce.2012.03.004; Wijesinghe DS, 2014, J LIPID RES, V55, P1298, DOI 10.1194/jlr.M048207; Xiao QL, 2012, J NEUROSCI, V32, P13587, DOI 10.1523/JNEUROSCI.2617-12.2012; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; Yang HP, 2004, HEPATOLOGY, V40, P221, DOI 10.1002/hep.20274; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x; Zhou YP, 1998, J CLIN INVEST, V101, P1623, DOI 10.1172/JCI1245; Zhou YP, 2000, AM J PHYSIOL-ENDOC M, V278, pE340, DOI 10.1152/ajpendo.2000.278.2.E340	81	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11021	11031		10.1074/jbc.M115.648956	http://dx.doi.org/10.1074/jbc.M115.648956			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25762722	hybrid, Green Published			2022-12-28	WOS:000353404500038
J	Huang, HY; Zhang, WT; Jiang, WY; Chen, SZ; Liu, Y; Ge, X; Li, X; Dang, YJ; Wen, B; Liu, XH; Lu, HJ; Tang, QQ				Huang, Hai-Yan; Zhang, Wen-Ting; Jiang, Wen-Yan; Chen, Su-Zhen; Liu, Yang; Ge, Xin; Li, Xi; Dang, Yong-Jun; Wen, Bo; Liu, Xiao-Hui; Lu, Hao-Jie; Tang, Qi-Qun			RhoGDI beta Inhibits Bone Morphogenetic Protein 4 (BMP4)-induced Adipocyte Lineage Commitment and Favors Smooth Muscle-like Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; PLAYS OPPOSING ROLES; ACTIN STRESS FIBERS; ADIPOSE-TISSUE; COMMITTED PREADIPOCYTES; FAMILY GTPASES; LYSYL OXIDASE; 10T1/2 CELLS; MARROW; EXPRESSION	The integration of signals involved in deciding the fate of mesenchymal stem cells is largely unknown. We used proteomics profiling to identify RhoGDI beta, an inhibitor of the small G-protein Rho family, as a component that regulates commitment of C3H10T1/2 mesenchymal stem cells to the adipocyte or smooth muscle cell lineage in response to bone morphogenetic protein 4 (BMP4). RhoGDI beta is notably down-regulated during BMP4-induced adipocytic lineage commitment of C3H10T1/2 mesenchymal stem cells, and this involves the cytoskeleton-associated protein lysyl oxidase. Excess RhoGDI beta completely prevents BMP4-induced commitment to the adipocyte lineage and simultaneously stimulates smooth muscle cell commitment by suppressing the activation of Rac1. Overexpression of RhoGDI beta induces stress fibers of F-actin by a process involving phosphomyosin light chain, indicating that cytoskeletal tension regulated by RhoGDI beta contributes to determining adipocyte versus myocyte commitment. Furthermore, the overexpression of RacV12 (constitutively active form of Rac1) totally rescues the inhibition of adipocyte commitment by RhoGDI beta, simultaneously preventing formation of the smooth muscle-like phenotype and disrupting the stress fibers in cells overexpressing RhoGDI beta. Collectively, these results indicate that RhoGDI beta functions as a novel BMP4 signaling target that regulates adipogenesis and myogensis.	[Huang, Hai-Yan; Zhang, Wen-Ting; Jiang, Wen-Yan; Chen, Su-Zhen; Liu, Yang; Ge, Xin; Li, Xi; Dang, Yong-Jun; Wen, Bo; Tang, Qi-Qun] Fudan Univ, Shanghai Med Coll, Key Lab Metab & Mol Med, Minist Educ,Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China; [Liu, Xiao-Hui; Lu, Hao-Jie] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Huang, HY (corresponding author), Fudan Univ, Minist Educ, Key Lab Metab & Mol Med, Shanghai 200032, Peoples R China.	haiyanhuang@shmu.edu.cn; qqtang@shmu.edu.cn	Lu, Hao/GQH-3203-2022; Wen, Bo/P-5332-2019; dang, yongjun/M-6531-2016	Wen, Bo/0000-0003-0394-7366; dang, yongjun/0000-0001-7237-1132	National Key Basic Research Project [2011CB910201]; National Natural Science Foundation [31030048C 120114, 81390350, 31271489, 81170781]; Shanghai Leading Academic Discipline Project [B110]	National Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported in part by National Key Basic Research Project Grant 2011CB910201, the State Key Program of National Natural Science Foundation Grant 31030048C 120114, and National Natural Science Foundation Grant 81390350 (to Q. Q. T.) and Grants 31271489 and 81170781 (to H. H.). The Department of Biochemistry is supported by Shanghai Leading Academic Discipline Project, Project number B110.	BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Bjorntorp P, 1974, Horm Metab Res, VSuppl 4, P77; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429; Chen BH, 2002, J BIOL CHEM, V277, P33857, DOI 10.1074/jbc.M204429200; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FAUST IM, 1978, AM J PHYSIOL, V235, pE279, DOI 10.1152/ajpendo.1978.235.3.E279; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Huang HY, 2013, STEM CELL RES, V10, P278, DOI 10.1016/j.scr.2012.12.005; Huang HY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002691; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; JOHNSON PR, 1978, METABOLISM, V27, P1941, DOI 10.1016/S0026-0495(78)80011-0; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Payne SL, 2006, J CELL BIOCHEM, V98, P827, DOI 10.1002/jcb.20792; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; PINNEY DF, 1989, ENVIRON HEALTH PERSP, V80, P221, DOI 10.2307/3430747; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rivero F, 2002, EMBO J, V21, P4539, DOI 10.1093/emboj/cdf449; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Smith JR, 2004, STEM CELLS, V22, P823, DOI 10.1634/stemcells.22-5-823; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Sun JJ, 2004, J BIOL CHEM, V279, P42936, DOI 10.1074/jbc.M406493200; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Theodorescu D, 2004, CLIN CANCER RES, V10, P3800, DOI 10.1158/1078-0432.CCR-03-0653; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang SS, 2013, INT J BIOCHEM CELL B, V45, P1825, DOI 10.1016/j.biocel.2013.06.003; Yin JW, 2012, GENE DEV, V26, P2192, DOI 10.1101/gad.192666.112; YOUNG HE, 1995, DEV DYNAM, V202, P137, DOI 10.1002/aja.1002020205; Yu ZK, 1997, OBES RES, V5, P9, DOI 10.1002/j.1550-8528.1997.tb00277.x	47	13	13	4	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11119	11129		10.1074/jbc.M114.608075	http://dx.doi.org/10.1074/jbc.M114.608075			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25778399	Green Published, hybrid			2022-12-28	WOS:000353404500046
J	Tokarski, JS; Zupa-Fernandez, A; Tredup, JA; Pike, K; Chang, CY; Xie, DL; Cheng, LH; Pedicord, D; Muckelbauer, J; Johnson, SR; Wu, S; Edavettal, SC; Hong, Y; Witmer, MR; Elkin, LL; Blat, Y; Pitts, WJ; Weinstein, DS; Burke, JR				Tokarski, John S.; Zupa-Fernandez, Adriana; Tredup, Jeffrey A.; Pike, Kristen; Chang, ChiehYing; Xie, Dianlin; Cheng, Lihong; Pedicord, Donna; Muckelbauer, Jodi; Johnson, Stephen R.; Wu, Sophie; Edavettal, Suzanne C.; Hong, Yang; Witmer, Mark R.; Elkin, Lisa L.; Blat, Yuval; Pitts, William J.; Weinstein, David S.; Burke, James R.			Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V617F JAK2; TYK2; ACTIVATION; INHIBITOR; MUTATION; EFFICACY; SAFETY; ANTIBODY; THERAPY; PLACEBO	Inhibition of signal transduction downstream of the IL-23 receptor represents an intriguing approach to the treatment of autoimmunity. Using a chemogenomics approach marrying kinome-wide inhibitory profiles of a compound library with the cellular activity against an IL-23-stimulated transcriptional response in T lymphocytes, a class of inhibitors was identified that bind to and stabilize the pseudokinase domain of the Janus kinase tyrosine kinase 2 (Tyk2), resulting in blockade of receptor-mediated activation of the adjacent catalytic domain. These Tyk2 pseudokinase domain stabilizers were also shown to inhibit Tyk2-dependent signaling through the Type I interferon receptor but not Tyk2-independent signaling and transcriptional cellular assays, including stimulation through the receptors for IL-2 (JAK1- and JAK3-dependent) and thrombopoietin (JAK2-dependent), demonstrating the high functional selectivity of this approach. A crystal structure of the pseudokinase domain liganded with a representative example showed the compound bound to a site analogous to the ATP-binding site in catalytic kinases with features consistent with high ligand selectivity. The results support a model where the pseudokinase domain regulates activation of the catalytic domain by forming receptor-regulated inhibitory interactions. Tyk2 pseudokinase stabilizers, therefore, represent a novel approach to the design of potent and selective agents for the treatment of autoimmunity.	[Tokarski, John S.; Chang, ChiehYing; Muckelbauer, Jodi; Johnson, Stephen R.] Bristol Myers Squibb Res & Dev, Dept Mol Struct & Design, Princeton, NJ 08543 USA; [Zupa-Fernandez, Adriana; Cheng, Lihong; Burke, James R.] Bristol Myers Squibb Res & Dev, Dept Immunosci Biol, Princeton, NJ 08543 USA; [Tredup, Jeffrey A.; Xie, Dianlin; Wu, Sophie; Edavettal, Suzanne C.; Witmer, Mark R.] Bristol Myers Squibb Res & Dev, Dept Prot Sci, Princeton, NJ 08543 USA; [Pedicord, Donna; Blat, Yuval] Bristol Myers Squibb Res & Dev, Dept Leads Discovery & Optimizat, Princeton, NJ 08543 USA; [Hong, Yang; Pitts, William J.; Weinstein, David S.] Bristol Myers Squibb Res & Dev, Dept Discovery Chem, Princeton, NJ 08543 USA; [Pike, Kristen; Elkin, Lisa L.] Bristol Myers Squibb Res & Dev, Dept Leads Discovery & Optimizat, Wallingford, CT 06492 USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Burke, JR (corresponding author), Bristol Myers Squibb Res & Dev, Immunosci Biol, Mail Stop K24-03,POB 4000, Princeton, NJ 08543 USA.	james.burke@bms.com		Pitts, William/0000-0002-1034-6043				Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Bandaranayake RM, 2012, NAT STRUCT MOL BIOL, V19, P754, DOI 10.1038/nsmb.2348; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Bricogne G., 2011, BUSTER; Constantinescu SN, 2013, BIOCHEM SOC T, V41, P1048, DOI 10.1042/BST20130084; Couturier N, 2011, BRAIN, V134, P693, DOI 10.1093/brain/awr010; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Doyle ML, 1995, METHOD ENZYMOL, V259, P183; Dyckman A., 2008, United States Patent, Patent No. 7456194; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Freire E, 2008, DRUG DISCOV TODAY, V13, P869, DOI 10.1016/j.drudis.2008.07.005; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Gillooly KM, 2009, J PHARMACOL EXP THER, V331, P349, DOI 10.1124/jpet.109.156018; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; Kempson J, 2009, J MED CHEM, V52, P1994, DOI 10.1021/jm8015816; Liang J, 2013, J MED CHEM, V56, P4521, DOI 10.1021/jm400266t; Longbrake EE, 2009, EXPERT REV NEUROTHER, V9, P319, DOI 10.1586/14737175.9.3.319; Lupardus PJ, 2014, P NATL ACAD SCI USA, V111, P8025, DOI 10.1073/pnas.1401180111; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Norman P, 2012, EXPERT OPIN THER PAT, V22, P1233, DOI 10.1517/13543776.2012.723693; Ortmann R, 2001, J IMMUNOL, V166, P5712, DOI 10.4049/jimmunol.166.9.5712; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyamada A, 2009, J IMMUNOL, V183, P7539, DOI 10.4049/jimmunol.0902740; Percy MJ, 2005, HEMATOL ONCOL, V23, P91, DOI 10.1002/hon.761; Pieri L, 2009, HAEMATOL-HEMATOL J, V94, P1537, DOI 10.3324/haematol.2009.007047; Posy SL, 2011, J MED CHEM, V54, P54, DOI 10.1021/jm101195a; Purandare AV, 2012, LEUKEMIA, V26, P280, DOI 10.1038/leu.2011.292; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Shide K, 2007, LEUKEMIA RES, V31, P1077, DOI 10.1016/j.leukres.2006.08.018; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Strober BE, 2011, BRIT J DERMATOL, V165, P661, DOI 10.1111/j.1365-2133.2011.10419.x; Toms AV, 2013, NAT STRUCT MOL BIOL, V20, P1221, DOI 10.1038/nsmb.2673; Vincenti F, 2012, AM J TRANSPLANT, V12, P2446, DOI 10.1111/j.1600-6143.2012.04127.x; Vollmer TL, 2011, MULT SCLER J, V17, P181, DOI 10.1177/1352458510384496; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001	44	64	64	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11061	11074		10.1074/jbc.M114.619502	http://dx.doi.org/10.1074/jbc.M114.619502			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25762719	Green Published, hybrid			2022-12-28	WOS:000353404500042
J	Moradi, S; Berry, R; Pymm, P; Hitchen, C; Beckham, SA; Wilce, MCJ; Walpole, NG; Clements, CS; Reid, HH; Perugini, MA; Brooks, AG; Rossjohn, J; Vivian, JP				Moradi, Shoeib; Berry, Richard; Pymm, Phillip; Hitchen, Corinne; Beckham, Simone A.; Wilce, Matthew C. J.; Walpole, Nicholas G.; Clements, Craig S.; Reid, Hugh H.; Perugini, Matthew A.; Brooks, Andrew G.; Rossjohn, Jamie; Vivian, Julian P.			The Structure of the Atypical Killer Cell Immunoglobulin-like Receptor, KIR2DL4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Immunoglobulin Fold; Natural Killer Cells (NK Cells); Protein Structure; Receptor Structure-Function; Small Angle X-ray Scattering (SAXS)	SIZE-DISTRIBUTION ANALYSIS; CRYSTAL-STRUCTURE; HLA-G; ACTIVATING RECEPTOR; CUTTING EDGE; NK CELLS; RECOGNITION; CD158D; EXPRESSION; ULTRACENTRIFUGATION	Background: KIR2DL4 is an important natural killer cell receptor with properties distinct from other KIRs. Results: The D0 domain of KIR2DL4 drove self-association of the receptor. Conclusion: Among KIRs, the self-association of KIR2DL4 is unique and a result of discrete differences in its D0 domain. Significance: The self-association of KIR2DL4 has implications for its unique signaling and function. The engagement of natural killer cell immunoglobulin-like receptors (KIRs) with their target ligands, human leukocyte antigen (HLA) molecules, is a critical component of innate immunity. Structurally, KIRs typically have either two (D1-D2) or three (D0-D1-D2) extracellular immunoglobulin domains, with the D1 and D2 domain recognizing the 1 and 2 helices of HLA, respectively, whereas the D0 domain of the KIR3DLs binds a loop region flanking the 1 helix of the HLA molecule. KIR2DL4 is distinct from other KIRs (except KIR2DL5) in that it does not contain a D1 domain and instead has a D0-D2 arrangement. Functionally, KIR2DL4 is also atypical in that, unlike all other KIRs, KIR2DL4 has both activating and inhibitory signaling domains. Here, we determined the 2.8 angstrom crystal structure of the extracellular domains of KIR2DL4. Structurally, KIR2DL4 is reminiscent of other KIR2DL receptors, with the D0 and D2 adopting the C2-type immunoglobulin fold arranged with an acute elbow angle. However, KIR2DL4 self-associated via the D0 domain in a concentration-dependent manner and was observed as a tetramer in the crystal lattice by size exclusion chromatography, dynamic light scattering, analytical ultracentrifugation, and small angle x-ray scattering experiments. The assignment of residues in the D0 domain to forming the KIR2DL4 tetramer precludes an interaction with HLA akin to that observed for KIR3DL1. Accordingly, no interaction was observed to HLA by direct binding studies. Our data suggest that the unique functional properties of KIR2DL4 may be mediated by self-association of the receptor.	[Moradi, Shoeib; Berry, Richard; Pymm, Phillip; Hitchen, Corinne; Beckham, Simone A.; Wilce, Matthew C. J.; Walpole, Nicholas G.; Clements, Craig S.; Reid, Hugh H.; Rossjohn, Jamie; Vivian, Julian P.] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Berry, Richard; Rossjohn, Jamie; Vivian, Julian P.] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Perugini, Matthew A.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic 3086, Australia; [Brooks, Andrew G.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales	Monash University; Monash University; La Trobe University; University of Melbourne; Cardiff University	Rossjohn, J (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	Jamie.rossjohn@monash.edu; Julian.vivian@monash.edu	Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; berry, richard/0000-0001-7043-0469; Moradi, Shoeib/0000-0003-2808-4579; Pymm, Phillip/0000-0003-2722-4621; Vivian, Julian/0000-0002-9400-4437; Brooks, Andrew/0000-0002-4085-9683	Australian Research Council (ARC) [DE130101504]; National Health and Medical Research Council (NHMRC) of Australia [1046685]; NHMRC Peter Doherty Fellowship [GNT1035636]; NHMRC Australia Fellowship; ARC DECRA Fellowship	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Peter Doherty Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); ARC DECRA Fellowship(Australian Research Council)	This work was supported by Australian Research Council (ARC) Grant DE130101504 and by National Health and Medical Research Council (NHMRC) of Australia Grant 1046685.; Supported by NHMRC Peter Doherty Fellowship GNT1035636.; Supported by an NHMRC Australia Fellowship. To whom correspondence may be addressed. E-mail: Jamie.rossjohn@monash.edu.; Supported by an ARC DECRA Fellowship. To whom correspondence may be addressed. E-mail: Julian.vivian@monash.edu.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bloushtain N, 2004, J IMMUNOL, V173, P2392, DOI 10.4049/jimmunol.173.4.2392; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Boyson JE, 2002, P NATL ACAD SCI USA, V99, P16180, DOI 10.1073/pnas.212643199; Brown PH, 2007, BIOMACROMOLECULES, V8, P2011, DOI 10.1021/bm070193j; Brusilovsky M, 2013, J IMMUNOL, V191, P5256, DOI 10.4049/jimmunol.1302079; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Cantoni C, 1998, EUR J IMMUNOL, V28, P1980, DOI 10.1002/(SICI)1521-4141(199806)28:06<1980::AID-IMMU1980>3.0.CO;2-F; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clements CS, 2006, ACTA CRYSTALLOGR F, V62, P70, DOI 10.1107/S1744309105041473; Clements CS, 2005, P NATL ACAD SCI USA, V102, P3360, DOI 10.1073/pnas.0409676102; Costello RT, 2002, BLOOD, V99, P3661, DOI 10.1182/blood.V99.10.3661; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Faure M, 2002, J IMMUNOL, V168, P6208, DOI 10.4049/jimmunol.168.12.6208; Finton KA, 2012, IMMUNOL REV, V250, P239, DOI 10.1111/j.1600-065X.2012.01168.x; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Goding J.W., 1996, MONOCLONAL ANTIBODIE, Vthird, P234; Goodridge JP, 2003, J IMMUNOL, V171, P1768, DOI 10.4049/jimmunol.171.4.1768; Graef T, 2009, J EXP MED, V206, P2557, DOI 10.1084/jem.20091010; Gumperz JE, 1997, J IMMUNOL, V158, P5237; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hansasuta P, 2004, EUR J IMMUNOL, V34, P1673, DOI 10.1002/eji.200425089; Hecht ML, 2009, J PROTEOME RES, V8, P712, DOI 10.1021/pr800747c; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Kikuchi-Maki A, 2005, J IMMUNOL, V174, P3859, DOI 10.4049/jimmunol.174.7.3859; Kikuchi-Maki A, 2003, J IMMUNOL, V171, P3415, DOI 10.4049/jimmunol.171.7.3415; Laue T. M., 1991, ANAL ULTRACENTRIFUGA, P90; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Le Page MEL, 2014, J IMMUNOL, V192, P732, DOI 10.4049/jimmunol.1301748; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Liu JX, 2014, P NATL ACAD SCI USA, V111, P2662, DOI 10.1073/pnas.1322052111; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McVicar D W, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.75.re1; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; O'Connor GM, 2014, J IMMUNOL, V192, P2875, DOI 10.4049/jimmunol.1303142; PARHAM P, 1979, J IMMUNOL, V123, P342; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Raffaghello L, 2004, NEOPLASIA, V6, P558, DOI 10.1593/neo.04316; Rajagopalan S, 2006, PLOS BIOL, V4, P70, DOI 10.1371/journal.pbio.0040009; Rajagopalan S, 2001, J IMMUNOL, V167, P1877, DOI 10.4049/jimmunol.167.4.1877; Rajagopalan S, 2014, CELL MOL IMMUNOL, V11, P460, DOI 10.1038/cmi.2014.53; Rajagopalan S, 2012, P NATL ACAD SCI USA, V109, P20596, DOI 10.1073/pnas.1208248109; Rajagopalan S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00258; Rajagopalan S, 2010, TRAFFIC, V11, P1381, DOI 10.1111/j.1600-0854.2010.01112.x; Saulquin X, 2003, J EXP MED, V197, P933, DOI 10.1084/jem.20021624; Saunders PM, 2015, J IMMUNOL, V194, P781, DOI 10.4049/jimmunol.1402542; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Sivori S, 2010, BLOOD, V116, P1637, DOI 10.1182/blood-2009-12-256586; Stifter SA, 2014, PROTEIN EXPRES PURIF, V94, P7, DOI 10.1016/j.pep.2013.10.019; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517	58	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10460	10471		10.1074/jbc.M114.612291	http://dx.doi.org/10.1074/jbc.M114.612291			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25759384	Green Published, hybrid			2022-12-28	WOS:000353241100045
J	Holm, R; Einholm, AP; Andersen, JP; Vilsen, B				Holm, Rikke; Einholm, Anja P.; Andersen, Jens P.; Vilsen, Bente			Rescue of Na+ Affinity in Aspartate 928 Mutants of Na+,K+-ATPase by Secondary Mutation of Glutamate 314	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONSET DYSTONIA-PARKINSONISM; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; ALTERNATING HEMIPLEGIA; K+-ATPASE; SODIUM; ATP1A3; EXCHANGE; PUMP	The Na+,K+-ATPase binds Na+ at three transport sites denoted I, II, and III, of which site III is Na+-specific and suggested to be the first occupied in the cooperative binding process activating phosphorylation from ATP. Here we demonstrate that the asparagine substitution of the aspartate associated with site III found in patients with rapid-onset dystonia parkinsonism or alternating hemiplegia of childhood causes a dramatic reduction of Na+ affinity in the alpha 1-, alpha 2-, and alpha 3-iso-forms of Na+,K+-ATPase, whereas other substitutions of this aspartate are much less disruptive. This is likely due to interference by the amide function of the asparagine side chain with Na+-coordinating residues in site III. Remarkably, the Na+ affinity of site III aspartate to asparagine and alanine mutants is rescued by second-site mutation of a glutamate in the extracellular part of the fourth transmembrane helix, distant to site III. This gain-of-function mutation works without recovery of the lost cooperativity and selectivity of Na+ binding and does not affect the E-1-E-2 conformational equilibrium or the maximum phosphorylation rate. Hence, the rescue of Na+ affinity is likely intrinsic to the Na+ binding pocket, and the underlying mechanism could be a tightening of Na+ binding at Na+ site II, possibly via movement of transmembrane helix four. The second-site mutation also improves Na+,K+ pump function in intact cells. Rescue of Na+ affinity and Na+ and Kt transport by second-site mutation is unique in the history of Na+,K+-ATPase and points to new possibilities for treatment of neurological patients carrying Na+,K+-ATPase mutations.	[Holm, Rikke; Einholm, Anja P.; Andersen, Jens P.; Vilsen, Bente] Aarhus Univ, Dept Biomed, Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark	Aarhus University	Vilsen, B (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark.	bv@biomed.au.dk		Andersen, Jens Peter/0000-0003-0654-4300; Vilsen, Bente/0000-0002-4727-9382	Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation; L'Oreal Denmark; Lundbeck Foundation [R118-2012-11726] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0013409] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); L'Oreal Denmark(L'Oreal Group); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported in part by grants from the Danish Medical Research Council, the Novo Nordisk Foundation, the Lundbeck Foundation, and L'Oreal Denmark.	ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Anselm IA, 2009, NEUROLOGY, V73, P400, DOI 10.1212/WNL.0b013e3181b04acd; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; DECARVALHO A, 2004, NEURON, V43, P169, DOI [DOI 10.1016/J.NEUR0N.2004.06.028, 10.1016/j.neuron.2004.06.028]; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; Heinzen EL, 2014, LANCET NEUROL, V13, P503, DOI 10.1016/S1474-4422(14)70011-0; JORGENSEN PL, 1982, BIOCHIM BIOPHYS ACTA, V705, P38, DOI 10.1016/0167-4838(82)90333-8; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; KAPLAN JH, 1980, NATURE, V288, P587, DOI 10.1038/288587a0; LEE KH, 1980, NATURE, V285, P338, DOI 10.1038/285338a0; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; POST RL, 1972, J BIOL CHEM, V247, P6530; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Roubergue A, 2013, MOVEMENT DISORD, V28, P1457, DOI 10.1002/mds.25396; Sasaki M, 2014, NEUROLOGY, V82, P482, DOI 10.1212/WNL.0000000000000102; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Toustrup-Jensen MS, 2014, J BIOL CHEM, V289, P3186, DOI 10.1074/jbc.M113.543272; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Toustrup-lensen M., 2001, BIOCHEMISTRY-US, V40, P5521; Vedovato N, 2014, J GEN PHYSIOL, V143, P449, DOI 10.1085/jgp.201311148; VILSEN B, 1992, FEBS LETT, V314, P301, DOI 10.1016/0014-5793(92)81494-7	24	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9801	9811		10.1074/jbc.M114.625509	http://dx.doi.org/10.1074/jbc.M114.625509			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713066	hybrid, Green Published			2022-12-28	WOS:000352729400040
J	Llavero, F; Urzelai, B; Osinalde, N; Galvez, P; Lacerda, HM; Parada, LA; Zugaza, JL				Llavero, Francisco; Urzelai, Bakarne; Osinalde, Nerea; Galvez, Patricia; Lacerda, Hadriano M.; Parada, Luis A.; Zugaza, Jose L.			Guanine Nucleotide Exchange Factor alpha PIX Leads to Activation of the Rac 1 GTPase/Glycogen Phosphorylase Pathway in Interleukin (IL)-2-stimulated T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PKC-THETA; GLYCOGEN-PHOSPHORYLASE; GDP/GTP EXCHANGE; DEPENDENT ACTIVATION; SIGNALING PATHWAY; RHO GTPASES; FAMILY; IL-2; TIAM1	Recently, we have reported that the active form of Rac 1 GTPase binds to the glycogen phosphorylase muscle isoform (PYGM) and modulates its enzymatic activity leading to T cell proliferation. In the lymphoid system, Rac 1 and in general other small GTPases of the Rho family participate in the signaling cascades that are activated after engagement of the T cell antigen receptor. However, little is known about the IL-2-dependent Rac 1 activator molecules. For the first time, a signaling pathway leading to the activation of Rac 1/PYGM in response to IL-2-stimulated T cell proliferation is described. More specifically, alpha PIX, a known guanine nucleotide exchange factor for the small GTPases of the Rho family, preferentially Rac 1, mediates PYGM activation in Kit 225 T cells stimulated with IL-2. Using directed mutagenesis, phosphorylation of alpha PIX Rho-GEF serines 225 and 488 is required for activation of the Rac 1/PYGM pathway. IL-2-stimulated serine phosphorylation was corroborated in Kit 225 T cells cultures. A parallel pharmacological and genetic approach identified PKC theta as the serine/threonine kinase responsible for alpha PIX serine phosphorylation. The phosphorylated state of alpha PIX was required to activate first Rac 1 and subsequently PYGM. These results demonstrate that the IL-2 receptor activation, among other early events, leads to activation of PKC theta. To activate Rac 1 and consequently PYGM, PKC theta phosphorylates alpha PIX in T cells. The biological significance of this PKC theta/alpha PIX/Rac 1 GTPase/PYGM signaling pathway seems to be the control of different cellular responses such as migration and proliferation.	[Llavero, Francisco; Urzelai, Bakarne; Zugaza, Jose L.] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Leioa 48940, Spain; [Llavero, Francisco; Zugaza, Jose L.] Achucarro Basque Ctr Neurosci, Zamudio 48170, Spain; [Osinalde, Nerea] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Galvez, Patricia] Technol Pk Hlth Sci, Pharmasci Div, Granada 18100, Spain; [Lacerda, Hadriano M.] Univ Turin, Dept Biomed Sci & Human Oncol, Canc Epidemiol Unit, I-10124 Turin, Italy; [Parada, Luis A.] Univ Nacl Salta, Inst Patol Expt, RA-4400 Salta, Argentina; [Zugaza, Jose L.] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain	University of Basque Country; University of Southern Denmark; University of Turin; Basque Foundation for Science	Zugaza, JL (corresponding author), Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Barrio Sarriena S-N, Leioa 48940, Spain.	joseluis.zugaza@ehu.es	Bustelo, Xose R./A-9526-2010	Bustelo, Xose R./0000-0001-9398-6072; ZUGAZA GURRUCHAGA, JOSE LUIS/0000-0003-2287-6671; Osinalde, Nerea/0000-0001-8850-7794	Dept. of Industry of the Basque Government [S-PE11UN018, S-PE13UN028]; University of the Basque Country [EHU11/08, UFI 11/20]; Dept. of Education, Basque Government [BFI-2010-184]	Dept. of Industry of the Basque Government(Basque Government); University of the Basque Country; Dept. of Education, Basque Government	Supported by Dept. of Education, Basque Government Grant BFI-2010-184.; Supported by Dept. of Industry of the Basque Government Grants S-PE11UN018 and S-PE13UN028 and University of the Basque Country Grants EHU11/08 and UFI 11/20.	Andersen B, 2002, BIOCHEM J, V367, P443, DOI 10.1042/BJ20020153; Arendt CW, 2002, CURR OPIN IMMUNOL, V14, P323, DOI 10.1016/S0952-7915(02)00346-1; Arnaud M, 2004, BIOCHEM J, V382, P545, DOI 10.1042/BJ20040103; Arrieumerlou C, 1998, EUR J IMMUNOL, V28, P1877, DOI 10.1002/(SICI)1521-4141(199806)28:06<1877::AID-IMMU1877>3.3.CO;2-9; Arrizabalaga O, 2012, J BIOL CHEM, V287, P11878, DOI 10.1074/jbc.M111.297804; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Beier I, 2008, ATHEROSCLEROSIS, V196, P92, DOI 10.1016/j.atherosclerosis.2007.02.003; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Brockdorff J, 2000, EUR CYTOKINE NETW, V11, P225; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Caloca MJ, 2008, J BIOL CHEM, V283, P36454, DOI 10.1074/jbc.M803814200; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; Cannon JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078940; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Chiariello M, 2010, METHODS MOL BIOL, V661, P137, DOI 10.1007/978-1-60761-795-2_8; Collard JG, 1996, CURR TOP MICROBIOL, V213, P253; Cordey M, 2006, J NEUROCHEM, V96, P204, DOI 10.1111/j.1471-4159.2005.03545.x; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; EVANS GA, 1993, BIOCHEM J, V294, P339, DOI 10.1042/bj2940339; Feng QY, 2004, EMBO J, V23, P3492, DOI 10.1038/sj.emboj.7600331; Fleming IN, 1997, J BIOL CHEM, V272, P33105, DOI 10.1074/jbc.272.52.33105; Freeley M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00227; Gerard A, 2009, BLOOD, V113, P6138, DOI 10.1182/blood-2008-07-167668; Gomez J, 1997, J IMMUNOL, V158, P1516; Goto A, 2011, MOL BIOL CELL, V22, P1780, DOI 10.1091/mbc.E10-09-0783; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; HORI T, 1987, BLOOD, V70, P1069; Isakov N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00273; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Lan RY, 2008, J AUTOIMMUN, V31, P7, DOI 10.1016/j.jaut.2008.03.002; Letschka T, 2008, BLOOD, V112, P4617, DOI 10.1182/blood-2007-11-121111; Llorca O, 2005, EMBO J, V24, P1330, DOI 10.1038/sj.emboj.7600617; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Manicassamy S, 2006, CELL MOL IMMUNOL, V3, P263; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Manterola L, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.147; Matsuo N, 2002, J BIOL CHEM, V277, P2860, DOI 10.1074/jbc.M106186200; McInerney M, 2002, BBA-GEN SUBJECTS, V1570, P53, DOI 10.1016/S0304-4165(02)00154-X; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Nishizuka Y, 2001, ALCOHOL CLIN EXP RES, V25, p3S, DOI 10.1111/j.1530-0277.2001.tb02367.x; Obermeier A, 1998, EMBO J, V17, P4328, DOI 10.1093/emboj/17.15.4328; Osinalde N, 2011, J PROTEOMICS, V75, P177, DOI 10.1016/j.jprot.2011.06.007; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; Pelletier S, 2003, MOL CELL BIOL, V23, P1316, DOI 10.1128/MCB.23.4.1316-1333.2003; Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]; Poppe D, 2006, J IMMUNOL, V176, P640, DOI 10.4049/jimmunol.176.1.640; Ravichandran KS, 1996, P NATL ACAD SCI USA, V93, P5275, DOI 10.1073/pnas.93.11.5275; Ravichandran KS, 1995, ANN NY ACAD SCI, V766, P202, DOI 10.1111/j.1749-6632.1995.tb26663.x; Shiromizu T, 2013, J PROTEOME RES, V12, P2414, DOI 10.1021/pr300825v; SMITH KA, 1988, IMMUNOL TODAY, V9, P36, DOI 10.1016/0167-5699(88)91255-8; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; Villalba M, 1999, J IMMUNOL, V163, P5813; von Essen MR, 2013, EUR J IMMUNOL, V43, P1659, DOI 10.1002/eji.201243140; Wang XH, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00197; Weber C, 2012, J PROTEOMICS, V75, P1343, DOI 10.1016/j.jprot.2011.11.004; Wery-Zennaro S, 2000, ONCOGENE, V19, P1596, DOI 10.1038/sj.onc.1203458; Yang Yong Ryoul, 2013, Advances in Biological Regulation, V53, P232, DOI 10.1016/j.jbior.2013.08.003; Yoshii S, 1999, ONCOGENE, V18, P5680, DOI 10.1038/sj.onc.1202936; Zaldua N, 2007, FEBS LETT, V581, P5814, DOI 10.1016/j.febslet.2007.11.053; Zugaza JL, 2004, ONCOGENE, V23, P5823, DOI 10.1038/sj.onc.1207768	63	15	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9171	9182		10.1074/jbc.M114.608414	http://dx.doi.org/10.1074/jbc.M114.608414			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25694429	Green Published, hybrid			2022-12-28	WOS:000352207100040
J	Broniowska, KA; Oleson, BJ; McGraw, J; Naatz, A; Mathews, CE; Corbett, JA				Broniowska, Katarzyna A.; Oleson, Bryndon J.; McGraw, Jennifer; Naatz, Aaron; Mathews, Clayton E.; Corbett, John A.			How the Location of Superoxide Generation Influences the beta-Cell Response to Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta Cell (B-cell); Cytokine; Diabetes; Nitric Oxide; Oxidative Stress; Peroxynitrite; Type 1 Diabetes	CYTOKINE-INDUCED DESTRUCTION; INSULIN-SECRETION; REACTIVE OXYGEN; PANCREATIC-ISLETS; ALR/LT MICE; PEROXYNITRITE; DEATH; ACTIVATION; SYNTHASE; INTERLEUKIN-1-BETA	Background: Although nitric oxide inhibits -cell function, the impact of superoxide on nitric oxide signaling remains unknown. Results: Superoxide produced within -cells inhibits nitric oxide-dependent responses, whereas extracellular generation does not. Conclusion: The reaction of nitric oxide with superoxide regulates the -cell response to nitric oxide. Significance: The location of radical generation dictates the functional response of -cells to reactive species. Cytokines impair the function and decrease the viability of insulin-producing -cells by a pathway that requires the expression of inducible nitric oxide synthase (iNOS) and generation of high levels of nitric oxide. In addition to nitric oxide, excessive formation of reactive oxygen species, such as superoxide and hydrogen peroxide, has been shown to cause -cell damage. Although the reaction of nitric oxide with superoxide results in the formation of peroxynitrite, we have shown that -cells do not have the capacity to produce this powerful oxidant in response to cytokines. When -cells are forced to generate peroxynitrite using nitric oxide donors and superoxide-generating redox cycling agents, superoxide scavenges nitric oxide and prevents the inhibitory and destructive actions of nitric oxide on mitochondrial oxidative metabolism and -cell viability. In this study, we show that the -cell response to nitric oxide is regulated by the location of superoxide generation. Nitric oxide freely diffuses through cell membranes, and it reacts with superoxide produced within cells and in the extracellular space, generating peroxynitrite. However, only when it is produced within cells does superoxide attenuate nitric oxide-induced mitochondrial dysfunction, gene expression, and toxicity. These findings suggest that the location of radical generation and the site of radical reactions are key determinants in the functional response of -cells to reactive oxygen species and reactive nitrogen species. Although nitric oxide is freely diffusible, its biological function can be controlled by the local generation of superoxide, such that when this reaction occurs within -cells, superoxide protects -cells by scavenging nitric oxide.	[Broniowska, Katarzyna A.; Oleson, Bryndon J.; McGraw, Jennifer; Naatz, Aaron; Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Mathews, Clayton E.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA	Medical College of Wisconsin; State University System of Florida; University of Florida	Broniowska, KA (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	kbroniow@mcw.edu; jcorbett@mcw.edu		Broniowska, Katarzyna/0000-0002-8000-9093	National Institutes of Health [DK-052194, AI-44458, DK-074656]; American Diabetes Association; American Heart Association [13POST16940076, 14PRE20380585]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI042288, R01AI044458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK074656, R01DK052194, UC4DK104194, R01DK074656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-052194 and AI-44458 (to J. A. C) and DK-074656 (to C. E. M.) This work was also supported by a grant from the American Diabetes Association (to C. E. M.); American Heart Association Postdoctoral Fellowship 13POST16940076 (to K. A. B); American Heart Association Predoctoral Fellowship 14PRE20380585 (to B. J. O.); and a gift from the Forest County Potawatomi Foundation.	Andreone T, 2012, AM J PHYSIOL-ENDOC M, V303, pE172, DOI 10.1152/ajpendo.00055.2012; Bensellam M, 2009, DIABETOLOGIA, V52, P463, DOI 10.1007/s00125-008-1245-z; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broniowska KA, 2013, J BIOL CHEM, V288, P36567, DOI 10.1074/jbc.M113.522243; Broniowska KA, 2013, BIOCHEMISTRY-US, V52, P4364, DOI 10.1021/bi400342t; BRUNMARK A, 1989, FREE RADICAL BIO MED, V7, P435, DOI 10.1016/0891-5849(89)90126-3; Chambers KT, 2008, DIABETES, V57, P124, DOI 10.2337/db07-0944; Chambers KT, 2007, AM J PHYSIOL-ENDOC M, V292, pE1052, DOI 10.1152/ajpendo.00274.2006; Chiara F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.184; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; CORBETT JA, 1994, BIOCHEM J, V299, P719, DOI 10.1042/bj2990719; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; Delaney CA, 1996, FEBS LETT, V394, P300, DOI 10.1016/0014-5793(96)00977-5; EIZIRIK DL, 1993, FEBS LETT, V317, P62, DOI 10.1016/0014-5793(93)81492-I; Godoy JR, 2011, BBA-GEN SUBJECTS, V1810, P2, DOI 10.1016/j.bbagen.2010.05.006; Gusdon AM, 2007, J BIOL CHEM, V282, P5171, DOI 10.1074/jbc.M609367200; Huang S, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-38; Hughes KJ, 2011, J BIOL CHEM, V286, P8338, DOI 10.1074/jbc.M110.204768; Hughes KJ, 2009, J BIOL CHEM, V284, P27402, DOI 10.1074/jbc.M109.046912; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Khan P, 2014, APPL BIOCHEM BIOTECH, V173, P333, DOI 10.1007/s12010-014-0850-1; Klotz LO, 2000, BIOCHEM J, V352, P219, DOI 10.1042/0264-6021:3520219; Lakey JRT, 2001, LAB INVEST, V81, P1683, DOI 10.1038/labinvest.3780381; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Liu DB, 2000, DIABETES, V49, P1116, DOI 10.2337/diabetes.49.7.1116; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; Mathews CE, 2005, J IMMUNOL, V175, P1248, DOI 10.4049/jimmunol.175.2.1248; Mathews CE, 2002, FREE RADICAL BIO MED, V32, P744, DOI 10.1016/S0891-5849(02)00747-5; Mathews CE, 1999, FREE RADICAL BIO MED, V27, P449, DOI 10.1016/S0891-5849(99)00084-2; Meares GP, 2013, AM J PHYSIOL-ENDOC M, V304, pE614, DOI 10.1152/ajpendo.00424.2012; Meares GP, 2011, EXP CELL RES, V317, P1621, DOI 10.1016/j.yexcr.2011.02.012; Newsholme P, 2012, ADV EXP MED BIOL, V942, P235, DOI 10.1007/978-94-007-2869-1_10; Oliveira HR, 2003, DIABETES, V52, P1457, DOI 10.2337/diabetes.52.6.1457; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Scarim AL, 1997, ENDOCRINOLOGY, V138, P5301, DOI 10.1210/en.138.12.5301; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SCHWIZER RW, 1984, TRANSPLANTATION, V37, P539, DOI 10.1097/00007890-198406000-00002; Son YO, 2013, TOXICOL APPL PHARM, V271, P239, DOI 10.1016/j.taap.2013.04.036; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; STOCCHI V, 1987, ANAL BIOCHEM, V167, P181, DOI 10.1016/0003-2697(87)90150-3; SuarezPinzon WL, 1997, DIABETES, V46, P907, DOI 10.2337/diabetes.46.5.907; SUMOSKI W, 1989, DIABETOLOGIA, V32, P792; Syed I, 2011, DIABETES, V60, P2843, DOI 10.2337/db11-0809; Thayer TC, 2011, DIABETES, V60, P2144, DOI 10.2337/db10-1222; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	57	17	17	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7952	7960		10.1074/jbc.M114.627869	http://dx.doi.org/10.1074/jbc.M114.627869			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25648890	hybrid, Green Published			2022-12-28	WOS:000351613600052
J	Chatterjee, S; Prados-Rosales, R; Itin, B; Casadevall, A; Stark, RE				Chatterjee, Subhasish; Prados-Rosales, Rafael; Itin, Boris; Casadevall, Arturo; Stark, Ruth E.			Solid-state NMR Reveals the Carbon-based Molecular Architecture of Cryptococcus neoformans Fungal Eumelanins in the Cell Wall	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSISTED ROTATIONAL RESONANCE; NUCLEAR-MAGNETIC-RESONANCE; HIGH-RESOLUTION; C-13 NMR; SIGNAL ENHANCEMENT; CROSS-POLARIZATION; SPINNING C-13; MELANIN; SPECTROSCOPY; CHITIN	Melanin pigments protect against both ionizing radiation and free radicals and have potential soil remediation capabilities. Eumelanins produced by pathogenic Cryptococcus neoformans fungi are virulence factors that render the fungal cells resistant to host defenses and certain antifungal drugs. Because of their insoluble and amorphous characteristics, neither the pigment bonding framework nor the cellular interactions underlying melanization of C. neoformans have yielded to comprehensive molecular-scale investigation. This study used the C. neoformans requirement of exogenous obligatory catecholamine precursors for melanization to produce isotopically enriched pigment "ghosts" and applied 2D C-13-C-13 correlation solid-state NMR to reveal the carbon-based architecture of intact natural eumelanin assemblies in fungal cells. We demonstrated that the aliphatic moieties of solid C. neoformans melanin ghosts include cell-wall components derived from polysaccharides and/or chitin that are associated proximally with lipid membrane constituents. Prior to development of the mature aromatic fungal pigment, these aliphatic moieties form a chemically resistant framework that could serve as the scaffold for melanin synthesis. The indole-based core aromatic moieties show interconnections that are consistent with proposed melanin structures consisting of stacked planar assemblies, which are associated spatially with the aliphatic scaffold. The pyrrole aromatic carbons of the pigments bind covalently to the aliphatic framework via glycoside or glyceride functional groups. These findings establish that the structure of the pigment assembly changes with time and provide the first biophysical information on the mechanism by which melanin is assembled in the fungal cell wall, offering vital insights that can advance the design of bio-inspired conductive nanomaterials and novel therapeutics.	[Chatterjee, Subhasish; Stark, Ruth E.] CUNY City Coll, Dept Chem, Grad Ctr, New York, NY 10031 USA; [Chatterjee, Subhasish; Stark, Ruth E.] CUNY, Inst Macromol Assemblies, New York, NY 10031 USA; [Prados-Rosales, Rafael; Casadevall, Arturo] Yeshiva Univ, Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Itin, Boris] New York Struct Biol Ctr, New York, NY 10027 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; Yeshiva University; Albert Einstein College of Medicine	Chatterjee, S (corresponding author), CUNY City Coll, Dept Chem, Grad Ctr, New York, NY 10031 USA.	stark@sci.ccny.cuny.edu	Prados-Rosales, Rafael/D-5840-2019; Chatterjee, Subhasish/AAT-6069-2020; Prados-Rosales, Rafael/B-1240-2016	Prados-Rosales, Rafael/0000-0001-5964-0166; Chatterjee, Subhasish/0000-0003-1351-3537; 	National Institutes of Health from the National Institute on Minority Health and Health Disparities [8G12 MD007603-29]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052733, R37AI033142] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute on Minority Health and Health Disparities; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The 600 MHz NMR facilities used in this work are operated by City College and the City University of New York Institute for Macromolecular Assemblies, with additional infrastructural support provided by National Institutes of Health Grant 8G12 MD007603-29 from the National Institute on Minority Health and Health Disparities. We thank Dr. Hsin Wang for technical support and the reviewers for helpful suggestions related to 2D NMR interpretation and literature citations.	Adhyaru BB, 2003, MAGN RESON CHEM, V41, P466, DOI 10.1002/mrc.1193; ATALLA RH, 1980, J AM CHEM SOC, V102, P3249, DOI 10.1021/ja00529a063; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Cabib E, 2001, J BIOL CHEM, V276, P19679, DOI 10.1074/jbc.R000031200; Chatterjee S, 2014, ORG BIOMOL CHEM, V12, P6730, DOI 10.1039/c4ob01066c; Chatterjee S, 2012, BIOCHEMISTRY-US, V51, P6080, DOI 10.1021/bi300325m; Chen LL, 2006, J AM CHEM SOC, V128, P9992, DOI 10.1021/ja062347t; CHENG J, 1994, PIGM CELL RES, V7, P263, DOI 10.1111/j.1600-0749.1994.tb00061.x; Coelho C, 2014, ADV APPL MICROBIOL, V87, P1, DOI 10.1016/B978-0-12-800261-2.00001-3; CRESCENZI O, 1994, LIEBIGS ANN CHEM, P563; Crocker E, 2004, J BIOMOL NMR, V29, P11, DOI 10.1023/B:JNMR.0000019521.79321.3c; d'Ischia M, 2013, PIGM CELL MELANOMA R, V26, P616, DOI 10.1111/pcmr.12121; d'Ischia M, 2009, ANGEW CHEM INT EDIT, V48, P3914, DOI 10.1002/anie.200803786; Della Vecchia NF, 2013, ADV FUNCT MATER, V23, P1331, DOI 10.1002/adfm.201202127; Dick-Perez M, 2011, BIOCHEMISTRY-US, V50, P989, DOI 10.1021/bi101795q; DUFF GA, 1988, BIOCHEMISTRY-US, V27, P7112, DOI 10.1021/bi00418a067; EARL WL, 1980, J AM CHEM SOC, V102, P3251, DOI 10.1021/ja00529a064; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; Eisenman HC, 2009, MICROBIOL-SGM, V155, P3860, DOI 10.1099/mic.0.032854-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; FUKAMIZO T, 1986, ARCH BIOCHEM BIOPHYS, V249, P15, DOI 10.1016/0003-9861(86)90555-2; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; GARBOW JR, 1989, PLANT PHYSIOL, V90, P783, DOI 10.1104/pp.90.3.783; Garcia-Rivera J, 2005, FUNGAL GENET BIOL, V42, P989, DOI 10.1016/j.fgb.2005.09.003; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Hwang DS, 2013, ACTA BIOMATER, V9, P8110, DOI 10.1016/j.actbio.2013.06.015; Ito S, 2003, PIGM CELL RES, V16, P230, DOI 10.1034/j.1600-0749.2003.00037.x; Johnson RL, 2014, J MAGN RESON, V239, P44, DOI 10.1016/j.jmr.2013.11.009; Johnson RL, 2013, J MAGN RESON, V234, P112, DOI 10.1016/j.jmr.2013.06.006; Kao PF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/673764; Kim SJ, 2008, BIOCHEMISTRY-US, V47, P10155, DOI 10.1021/bi800838c; Kim SJ, 2013, BIOCHEMISTRY-US, V52, P3651, DOI 10.1021/bi4005039; Lee D, 2009, PHYS CHEM CHEM PHYS, V11, P3547, DOI 10.1039/b818867j; LI KL, 1993, BIOCHEMISTRY-US, V32, P9926, DOI 10.1021/bi00089a008; Meng S, 2008, BIOPHYS J, V94, P2095, DOI 10.1529/biophysj.107.121087; Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x; METZ G, 1994, J MAGN RESON SER A, V110, P219, DOI 10.1006/jmra.1994.1208; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; NETO CP, 1995, SOLID STATE NUCL MAG, V4, P143, DOI 10.1016/0926-2040(94)00039-F; Nosanchuk JD, 2003, MICROBIOL-SGM, V149, P1945, DOI 10.1099/mic.0.26333-0; PERKINS SJ, 1977, CARBOHYD RES, V59, P19, DOI 10.1016/S0008-6215(00)83289-9; Pihet M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-177; Renault M, 2010, ANGEW CHEM INT EDIT, V49, P8346, DOI 10.1002/anie.201002823; Rosas AL, 2000, INFECT IMMUN, V68, P2845, DOI 10.1128/IAI.68.5.2845-2853.2000; SCHNITZER M, 1986, SOIL SCI SOC AM J, V50, P67, DOI 10.2136/sssaj1986.03615995005000010013x; Serra O, 2014, BIOMACROMOLECULES, V15, P799, DOI 10.1021/bm401620d; Simon JD, 2010, ACCOUNTS CHEM RES, V43, P1452, DOI 10.1021/ar100079y; Stark RE, 2013, EMAGRES, V2, P377, DOI 10.1002/9780470034590.emrstm1340; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Stavenga DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049743; Takahashi H, 2013, J AM CHEM SOC, V135, P5105, DOI 10.1021/ja312501d; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Thureau P, 2012, CHEM-EUR J, V18, P10689, DOI 10.1002/chem.201200277; Tian S., 2003, BIOCHEMISTRY-US, V42, P8105; Tran ML, 2006, BIOPHYS J, V90, P743, DOI 10.1529/biophysj.105.069096; Walker CA, 2010, EUKARYOT CELL, V9, P1329, DOI 10.1128/EC.00051-10; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; Wang YL, 1996, INFECT IMMUN, V64, P2420, DOI 10.1128/IAI.64.7.2420-2424.1996; ZAJAC GW, 1994, BBA-GEN SUBJECTS, V1199, P271, DOI 10.1016/0304-4165(94)90006-X; Zhong JY, 2008, BIOCHEMISTRY-US, V47, P4701, DOI 10.1021/bi702093r	64	43	43	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13779	13790		10.1074/jbc.M114.618389	http://dx.doi.org/10.1074/jbc.M114.618389			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25825492	Green Published, hybrid			2022-12-28	WOS:000355313000013
J	Sen, A; Sun, R; Krahn, MP				Sen, Arnab; Sun, Rui; Krahn, Michael P.			Localization and Function of Pals1-associated Tight Junction Protein in Drosophila Is Regulated by Two Distinct Apical Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN EPITHELIAL-CELLS; RHO-ASSOCIATED KINASE; PHOTORECEPTOR MORPHOGENESIS; E-CADHERIN; POLARITY COMPLEXES; CRUMBS COMPLEX; BASAL POLARITY; DOMAIN; PATJ; BAZOOKA	The transmembrane protein Crumbs (Crb) and its intracellular adaptor protein Pals1 (Stardust, Sdt in Drosophila) play a crucial role in the establishment and maintenance of apical-basal polarity in epithelial cells in various organisms. In contrast, the multiple PDZ domain-containing protein Pals1-associated tight junction protein (PATJ), which has been described to form a complex with Crb/Sdt, is not essential for apical basal polarity or for the stability of the Crb/Sdt complex in the Drosophila epidermis. Here we show that, in the embryonic epidermis, Sdt is essential for the correct subcellular localization of PATJ in differentiated epithelial cells but not during cellularization. Consistently, the L27 domain of PATJ is crucial for the correct localization and function of the protein. Our data further indicate that the four PDZ domains of PATJ function, to a large extent, in redundancy, regulating the function of the protein. Interestingly, the PATJ-Sdt heterodimer is not only recruited to the apical cell-cell contacts by binding to Crb but depends on functional Bazooka (Baz). However, biochemical experiments show that PATJ associates with both complexes, the Baz-Sdt and the Crb-Sdt complex, in the mature epithelium of the embryonic epidermis, suggesting a role of these two complexes for the function of PATJ during the development of Drosophila.	[Sen, Arnab; Sun, Rui; Krahn, Michael P.] Univ Regensburg, Inst Mol & Cellular Anat, D-93053 Regensburg, Germany	University of Regensburg	Krahn, MP (corresponding author), Univ Regensburg, Inst Mol & Cellular Anat, Univ Str 31, D-93053 Regensburg, Germany.	Michael.Krahn@vkl.uni-Regensburg.de	Krahn, Michael/AAD-4476-2022	Krahn, Michael/0000-0001-7718-9890	Deutsche Forschungsgemeinschaft [DFG3901/1-1, DFG3901/2-1];  [SFB699]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by Deutsche Forschungsgemeinschaft Grants DFG3901/1-1 and DFG3901/2-1 (to M. P. K.) and by SFB699.	Adachi M, 2009, MOL CELL BIOL, V29, P2372, DOI 10.1128/MCB.01505-08; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; Berger S, 2007, GENETICS, V176, P2189, DOI 10.1534/genetics.107.071449; Bulgakova NA, 2013, J CELL BIOL, V201, P887, DOI 10.1083/jcb.201211159; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Desai R, 2013, NAT CELL BIOL, V15, P261, DOI 10.1038/ncb2685; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Feng W, 2005, P NATL ACAD SCI USA, V102, P6861, DOI 10.1073/pnas.0409346102; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; Kempkens O, 2006, EUR J CELL BIOL, V85, P753, DOI 10.1016/j.ejcb.2006.03.003; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Klose S, 2013, G3-GENES GENOM GENET, V3, P153, DOI 10.1534/g3.112.005074; Krahn MP, 2010, J CELL BIOL, V190, P751, DOI 10.1083/jcb.201006029; Krahn MP, 2010, CURR BIOL, V20, P636, DOI 10.1016/j.cub.2010.01.065; Krahn MP, 2009, DEV CELL, V16, P901, DOI 10.1016/j.devcel.2009.04.011; Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001; Lemmers C, 2004, MOL BIOL CELL, V15, P1324, DOI 10.1091/mbc.E03-04-0235; Li YH, 2004, EMBO J, V23, P2723, DOI 10.1038/sj.emboj.7600294; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Makarova O, 2003, GENE, V302, P21, DOI 10.1016/S0378111902010843; McKim KS, 1996, GENETICS, V144, P215; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; Michel D, 2005, J CELL SCI, V118, P4049, DOI 10.1242/jcs.02528; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; Nakajima H, 2011, J CELL BIOL, V195, P245, DOI 10.1083/jcb.201104118; Nam SC, 2006, DEV DYNAM, V235, P1501, DOI 10.1002/dvdy.20726; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Penalva C, 2012, DEVELOPMENT, V139, P4549, DOI 10.1242/dev.085449; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Richard M, 2006, DEV DYNAM, V235, P895, DOI 10.1002/dvdy.20595; Roh MH, 2003, J CELL SCI, V116, P2895, DOI 10.1242/jcs.00500; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Roignot J., 2013, COLD SPRING HARB PER, V5; Sen A, 2012, J CELL BIOL, V199, P685, DOI 10.1083/jcb.201206064; Shahab J., 2015, BIOL OPEN; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Shin K, 2005, J CELL BIOL, V168, P705, DOI 10.1083/jcb.200408064; Shin K, 2007, EMBO REP, V8, P158, DOI 10.1038/sj.embor.7400890; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Straight SW, 2004, MOL BIOL CELL, V15, P1981, DOI 10.1091/mbc.E03-08-0620; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Wang Q, 2004, J BIOL CHEM, V279, P30715, DOI 10.1074/jbc.M401930200; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Zhou WK, 2012, DEVELOPMENT, V139, P2891, DOI 10.1242/dev.083162	58	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13224	13233		10.1074/jbc.M114.629014	http://dx.doi.org/10.1074/jbc.M114.629014			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847234	hybrid, Green Published			2022-12-28	WOS:000354975700024
J	Chi, X; Shetty, SK; Shows, HW; Hjelmaas, AJ; Malcolm, EK; Davies, BSJ				Chi, Xun; Shetty, Shwetha K.; Shows, Hannah W.; Hjelmaas, Alexander J.; Malcolm, Emily K.; Davies, Brandon S. J.			Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelial Cell; Lipase; Lipolysis; Lipoprotein Metabolism; Triglyceride	ACTIVATED RECEPTOR-GAMMA; ADIPOSE-TISSUE; IN-VIVO; RICH LIPOPROTEINS; TARGET GENE; PROTEINS 3; ANGPTL4; PLASMA; CHYLOMICRONEMIA; INCREASES	Background: Lipoprotein lipase (LPL) function is modified by interactions with its transporter GPIHBP1 and the inhibitor angiopoietin-like 4 (ANGPTL4). Results: ANGPTL4 inactivated GPIHBP1-bound LPL. Inactivated LPL could not bind GPIHBP1. Conclusion: ANGPTL4 inactivation of LPL reduces the affinity of LPL for GPIHBP1 causing dissociation. Significance: Understanding ANGPTL4's interactions with LPL in a physiological context is vital to clarifying ANGPTL4's role in triglyceride metabolism. The release of fatty acids from plasma triglycerides for tissue uptake is critically dependent on the enzyme lipoprotein lipase (LPL). Hydrolysis of plasma triglycerides by LPL can be disrupted by the protein angiopoietin-like 4 (ANGPTL4), and ANGPTL4 has been shown to inactivate LPL in vitro. However, in vivo LPL is often complexed to glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) on the surface of capillary endothelial cells. GPIHBP1 is responsible for trafficking LPL across capillary endothelial cells and anchors LPL to the capillary wall during lipolysis. How ANGPTL4 interacts with LPL in this context is not known. In this study, we investigated the interactions of ANGPTL4 with LPL-GPIHBP1 complexes on the surface of endothelial cells. We show that ANGPTL4 was capable of binding and inactivating LPL complexed to GPIHBP1 on the surface of endothelial cells. Once inactivated, LPL dissociated from GPIHBP1. We also show that ANGPTL4-inactivated LPL was incapable of binding GPIHBP1. ANGPTL4 was capable of binding, but not inactivating, LPL at 4 degrees C, suggesting that binding alone was not sufficient for ANGPTL4's inhibitory activity. We observed that although the N-terminal coiled-coil domain of ANGPTL4 by itself and full-length ANGPTL4 both bound with similar affinities to LPL, the N-terminal fragment was more potent in inactivating both free and GPIHBP1-bound LPL. These results led us to conclude that ANGPTL4 can both bind and inactivate LPL complexed to GPIHBP1 and that inactivation of LPL by ANGPTL4 greatly reduces the affinity of LPL for GPIHBP1.	Univ Iowa, Dept Biochem, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; Univ Iowa, Obes Res & Educ Initiat, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Davies, BSJ (corresponding author), Univ Iowa, Dept Biochem, 169 Newton Rd,PBDB 3326, Iowa City, IA 52242 USA.	Brandon-davies@uiowa.edu		Shetty, Shwetha Kumari/0000-0003-1762-8040; Davies, Brandon/0000-0002-7168-8522; Cushing, Emily/0000-0002-9495-802X	American Heart Association	American Heart Association(American Heart Association)	This work was supported by a grant from the American Heart Association Scientist Development (to B. S. J. D.).	Adhikary T, 2013, ONCOGENE, V32, P5241, DOI 10.1038/onc.2012.549; Basu D, 2011, J LIPID RES, V52, P826, DOI 10.1194/jlr.D010744; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Beigneux AP, 2009, J BIOL CHEM, V284, P30240, DOI 10.1074/jbc.M109.046391; Beigneux AP, 2009, ARTERIOSCL THROM VAS, V29, P956, DOI 10.1161/ATVBAHA.109.186577; Ben-Zeev O, 2002, J BIOL CHEM, V277, P10727, DOI 10.1074/jbc.M108128200; Bergo M, 1996, BIOCHEM J, V313, P893, DOI 10.1042/bj3130893; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Charriere S, 2011, J CLIN ENDOCR METAB, V96, pE1675, DOI 10.1210/jc.2011-1444; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; Coca-Prieto I, 2011, J INTERN MED, V270, P224, DOI 10.1111/j.1365-2796.2011.02361.x; Davies BSJ, 2008, MOL ENDOCRINOL, V22, P2496, DOI 10.1210/me.2008-0146; Davies BSJ, 2012, J LIPID RES, V53, P2690, DOI 10.1194/jlr.M031559; Davies BSJ, 2012, CURR OPIN LIPIDOL, V23, P35, DOI 10.1097/MOL.0b013e32834d0b33; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; Dijk W, 2014, TRENDS ENDOCRIN MET, V25, P146, DOI 10.1016/j.tem.2013.12.005; Franssen R, 2010, CIRC-CARDIOVASC GENE, V3, P169, DOI 10.1161/CIRCGENETICS.109.908905; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Gin P, 2011, ARTERIOSCL THROM VAS, V31, P176, DOI 10.1161/ATVBAHA.110.214718; Goulbourne CN, 2014, CELL METAB, V19, P849, DOI 10.1016/j.cmet.2014.01.017; Jonker JT, 2013, AM J CLIN NUTR, V97, P255, DOI 10.3945/ajcn.112.043687; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Kroupa Olessia, 2012, BMC Physiology, V12, P13, DOI 10.1186/1472-6793-12-13; Lafferty MJ, 2013, J BIOL CHEM, V288, P28524, DOI 10.1074/jbc.M113.497602; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Mehta N, 2014, ARTERIOSCL THROM VAS, V34, P1057, DOI 10.1161/ATVBAHA.113.302802; Merkel M, 1998, P NATL ACAD SCI USA, V95, P13841, DOI 10.1073/pnas.95.23.13841; Merkel M, 2002, J BIOL CHEM, V277, P7405, DOI 10.1074/jbc.M107914200; Mitrou P, 2010, INT J OBESITY, V34, P770, DOI 10.1038/ijo.2009.293; Nilsson SK, 2012, BBA-MOL CELL BIOL L, V1821, P1370, DOI 10.1016/j.bbalip.2012.06.003; OLIVECRONA G, 1995, CURR OPIN LIPIDOL, V6, P291, DOI 10.1097/00041433-199510000-00009; Olivecrona G, 2010, J LIPID RES, V51, P1535, DOI 10.1194/jlr.M002717; Olivecrona T, 2009, CELLULAR LIPID METABOLISM, P315, DOI 10.1007/978-3-642-00300-4_13; REINA M, 1992, J LIPID RES, V33, P1823; Rios JJ, 2012, J INHERIT METAB DIS, V35, P531, DOI 10.1007/s10545-011-9406-5; Robciuc MR, 2010, J LIPID RES, V51, P824, DOI 10.1194/jlr.M002618; Smart-Halajko MC, 2010, ARTERIOSCL THROM VAS, V30, P2277, DOI 10.1161/ATVBAHA.110.212209; Sonnenburg WK, 2009, J LIPID RES, V50, P2421, DOI 10.1194/jlr.M900145-JLR200; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; TAYLOR KG, 1979, DIABETOLOGIA, V16, P313, DOI 10.1007/BF01223620; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang Y, 2011, DIABETES, V60, P2041, DOI 10.2337/db11-0042; Weinstein MM, 2010, ARTERIOSCL THROM VAS, V30, P2106, DOI 10.1161/ATVBAHA.110.214403; Yin W, 2009, J BIOL CHEM, V284, P13213, DOI 10.1074/jbc.M900553200; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	50	44	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11865	11877		10.1074/jbc.M114.623769	http://dx.doi.org/10.1074/jbc.M114.623769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25809481	Green Published, hybrid			2022-12-28	WOS:000354388600006
J	Pfister, AS; Keil, M; Kuhl, M				Pfister, Astrid S.; Keil, Marina; Kuehl, Michael			The Wnt Target Protein Peter Pan Defines a Novel p53-independent Nucleolar Stress-Response Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME BIOGENESIS; DOWN-REGULATION; TRANSCRIPTION; APOPTOSIS; P53; NUCLEOPHOSMIN; BCL-2; BAX; DNA; SUPERFAMILY	Proper ribosome formation is a prerequisite for cell growth and proliferation. Failure of this process results in nucleolar stress and p53-mediated apoptosis. The Wnt target Peter Pan (PPAN) is required for 45 S rRNA maturation. So far, the role of PPAN in nucleolar stress response has remained elusive. We demonstrate that PPAN localizes to mitochondria in addition to its nucleolar localization and inhibits the mitochondrial apoptosis pathway in a p53-independent manner. Loss of PPAN induces BAX stabilization, depolarization of mitochondria, and release of cytochrome c, demonstrating its important role as an anti-apoptotic factor. Staurosporine-induced nucleolar stress and apoptosis disrupt nucleolar PPAN localization and induce its accumulation in the cytoplasm. This is accompanied by phosphorylation and subsequent cleavage of PPAN by caspases. Moreover, we show that PPAN is a novel interaction partner of the anti-apoptotic protein nucleophosmin (NPM). PPAN depletion induces NPM and upstream-binding factor (UBF) degradation, which is independent of caspases. In summary, we provide evidence for a novel nucleolar stress-response pathway involving PPAN, NPM, and BAX to guarantee cell survival in a p53 independent manner.	[Pfister, Astrid S.; Keil, Marina; Kuehl, Michael] Univ Ulm, Inst Biochem & Mol Biol, D-89081 Ulm, Germany	Ulm University	Kuhl, M (corresponding author), Univ Ulm, Inst Biochem & Mol Biol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	michael.kuehl@uni-ulm.de			German Federal Ministry of Research and Technology within SyStaR Grant [BMF0315894A]; State of Baden-Wurttemberg Perspektivforderung; Medical Faculty of Ulm University Baustein [3.2, LSBN0101]	German Federal Ministry of Research and Technology within SyStaR Grant; State of Baden-Wurttemberg Perspektivforderung; Medical Faculty of Ulm University Baustein	This work was supported by German Federal Ministry of Research and Technology within SyStaR Grant BMF0315894A (to M. Kuhl), State of Baden-Wurttemberg Perspektivforderung (to M. Kuhl), and Medical Faculty of Ulm University Baustein 3.2, LSBN0101 (to A. S. P.).	Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bogengruber E, 2003, FEMS YEAST RES, V3, P35, DOI 10.1111/j.1567-1364.2003.tb00136.x; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bugner V, 2011, DEVELOPMENT, V138, P2369, DOI 10.1242/dev.060160; Burger K, 2013, BIOL CHEM, V394, P1133, DOI 10.1515/hsz-2013-0153; Cain K, 2003, DRUG METAB REV, V35, P337, DOI 10.1081/DMR-120026497; Casiano CA, 1996, J EXP MED, V184, P765, DOI 10.1084/jem.184.2.765; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Chou CC, 2001, MOL PHARMACOL, V59, P38, DOI 10.1124/mol.59.1.38; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donati G, 2011, J CELL SCI, V124, P3017, DOI 10.1242/jcs.086074; Fang H, 2011, CLIN CANCER RES, V17, P7093, DOI 10.1158/1078-0432.CCR-11-0578; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Geng Y, 2010, J HISTOCHEM CYTOCHEM, V58, P265, DOI 10.1369/jhc.2009.954024; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Hirsch T, 1998, J IMMUNOL, V161, P35; Holmberg Olausson Karl, 2012, Cells, V1, P774, DOI 10.3390/cells1040774; Hoye AT, 2008, ACCOUNTS CHEM RES, V41, P87, DOI 10.1021/ar700135m; James A, 2014, NUCLEUS-PHILA, V5, P402, DOI 10.4161/nucl.32235; Kanellis D. C., 2014, ONCOGENE, DOI [10.1038/onc.2014.183, DOI 10.1038/0NC.2014.183]; Kim J, 1998, GENETICS, V149, P795; Lindenboim L, 2011, BBA-MOL CELL RES, V1813, P584, DOI 10.1016/j.bbamcr.2010.11.016; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Liu ML, 2007, J CELL BIOCHEM, V100, P1154, DOI 10.1002/jcb.21103; Lo SJ, 2013, HEPATOLOGY, V57, P1893, DOI 10.1002/hep.26209; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marquez-Lona EM, 2012, BIOCHEM BIOPH RES CO, V417, P514, DOI 10.1016/j.bbrc.2011.11.152; Migeon JC, 1999, MOL BIOL CELL, V10, P1733, DOI 10.1091/mbc.10.6.1733; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pfister AS, 2012, J BIOL CHEM, V287, P1734, DOI 10.1074/jbc.M111.308650; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Stepczynska A, 2001, ONCOGENE, V20, P1193, DOI 10.1038/sj.onc.1204221; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suzuki A, 2012, CANCER SCI, V103, P632, DOI 10.1111/j.1349-7006.2012.02219.x; Torres-Montaner A, 2000, J HISTOCHEM CYTOCHEM, V48, P1521, DOI 10.1177/002215540004801109; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; Wehner KA, 2002, MOL CELL, V9, P329, DOI 10.1016/S1097-2765(02)00438-0; Westphal D, 2014, CELL DEATH DIFFER, V21, P196, DOI 10.1038/cdd.2013.139; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042253; Zhang JH, 2009, ACTA BIOCH BIOPH SIN, V41, P991, DOI 10.1093/abbs/gmp096; Zhu JB, 2007, CELL RES, V17, P441, DOI 10.1038/cr.2007.36	51	31	32	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10905	10918		10.1074/jbc.M114.634246	http://dx.doi.org/10.1074/jbc.M114.634246			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25759387	hybrid, Green Published			2022-12-28	WOS:000353404500029
J	Han, JY; Kang, MJ; Kim, KH; Han, PL; Kim, HS; Ha, JY; Son, JH				Han, Ji-Young; Kang, Min-Ji; Kim, Kyung-Hee; Han, Pyung-Lim; Kim, Hyun-Seok; Ha, Ji-Young; Son, Jin H.			Nitric Oxide Induction of Parkin Translocation in PTEN-induced Putative Kinase 1 (PINK1) Deficiency FUNCTIONAL ROLE OF NEURONAL NITRIC OXIDE SYNTHASE DURING MITOPHAGY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitophagy; Nitric Oxide; Parkin; Parkinson Disease; PTEN-induced Putative Kinase 1 (PINK1); nNOS	MITOCHONDRIAL QUALITY-CONTROL; UBIQUITIN LIGASE ACTIVITY; COMPLEX I ACTIVITY; RESPIRATORY-CHAIN; S-NITROSYLATION; PINK1/PARKIN-MEDIATED MITOPHAGY; OXIDATIVE STRESS; ACTIVATE PARKIN; DISEASE; PHOSPHORYLATION	The failure to trigger mitophagy is implicated in the pathogenesis of familial Parkinson disease that is caused by PINK1 or Parkin mutations. According to the prevailing PINK1-Parkin signaling model, mitophagy is promoted by the mitochondrial translocation of Parkin, an essential PINK1-dependent step that occurs via a previously unknown mechanism. Here we determined that critical concentrations of NO was sufficient to induce the mitochondrial translocation of Parkin even in PINK1 deficiency, with apparent increased interaction of full-length PINK1 accumulated during mitophagy, with neuronal nitric oxide synthase (nNOS). Specifically, optimum levels of NO enabled PINK1-null dopaminergic neuronal cells to regain the mitochondrial translocation of Parkin, which appeared to be significantly suppressed by nNOS-null mutation. Moreover, nNOS-null mutation resulted in the same mitochondrial electron transport chain (ETC) enzyme deficits as PINK1-null mutation. The involvement of mitochondrial nNOS activation in mitophagy was further confirmed by the greatly increased interactions of full-length PINK1 with nNOS, accompanied by mitochondrial accumulation of phospho-nNOS (Ser(1412)) during mitophagy. Of great interest is that the L347P PINK1 mutant failed to bind to nNOS. The loss of nNOS phosphorylation and Parkin accumulation on PINK1-deficient mitochondria could be reversed in a PINK1-dependent manner. Finally, non-toxic levels of NO treatment aided in the recovery of PINK1-null dopaminergic neuronal cells from mitochondrial ETC enzyme deficits. In summary, we demonstrated the full-length PINK1-dependent recruitment of nNOS, its activation in the induction of Parkin translocation, and the feasibility of NO-based pharmacotherapy for defective mitophagy and ETC enzyme deficits in Parkinson disease.	[Han, Ji-Young; Kim, Kyung-Hee; Han, Pyung-Lim; Son, Jin H.] Ewha Womans Univ, Dept Brain & Cognit Sci, Brain Dis Res Inst, Seoul 120750, South Korea; [Kang, Min-Ji; Ha, Ji-Young; Son, Jin H.] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, Seoul 120750, South Korea; [Kim, Hyun-Seok] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Son, JH (corresponding author), Ewha Womans Univ, Dept Brain & Cognit Sci, Sci Bldg C,Rm C307, Seoul 120750, South Korea.	hjson@ewha.ac.kr	Kim, Hyung-Kwan/R-8375-2019	Han, Pyung-Lim/0000-0002-1735-6746	NRF, Republic of Korea [2013-008773]	NRF, Republic of Korea	This research was supported by Grant 2013-008773 from NRF, Republic of Korea.	Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878; Amo T, 2014, NEUROSCI LETT, V580, P37, DOI 10.1016/j.neulet.2014.07.045; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gomez-Sanchez R, 2014, NEUROBIOL DIS, V62, P426, DOI 10.1016/j.nbd.2013.10.021; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Ha JY, 2014, NEUROSCI LETT, V561, P101, DOI 10.1016/j.neulet.2013.12.064; Hendgen-Cotta UB, 2008, P NATL ACAD SCI USA, V105, P10256, DOI 10.1073/pnas.0801336105; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Khoo NKH, 2014, FREE RADICAL BIO MED, V70, P45, DOI 10.1016/j.freeradbiomed.2014.02.009; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; McCoy MK, 2012, ANTIOXID REDOX SIGN, V16, P869, DOI [10.1089/ars.2011.4019, 10.1089/ars.2011.4074]; Miller MW, 2013, AM J PHYSIOL-HEART C, V304, pH1624, DOI 10.1152/ajpheart.00987.2012; Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Moriwaki Y, 2008, NEUROSCI RES, V61, P43, DOI 10.1016/j.neures.2008.01.006; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Ozawa K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02202; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schapira AHV, 2012, ANTIOXID REDOX SIGN, V16, P965, DOI 10.1089/ars.2011.4419; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Shim JH, 2011, MITOCHONDRION, V11, P707, DOI 10.1016/j.mito.2011.05.013; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107; SUGDEN PH, 1975, BIOCHEM J, V150, P105, DOI 10.1042/bj1500105; Thomas B, 2010, MOVEMENT DISORD, V25, pS155, DOI 10.1002/mds.22781; Van Humbeeck C, 2011, J NEUROSCI, V31, P10249, DOI 10.1523/JNEUROSCI.1917-11.2011; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhu JH, 2013, AUTOPHAGY, V9, P1663, DOI 10.4161/auto.24135	54	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10325	10335		10.1074/jbc.M114.624767	http://dx.doi.org/10.1074/jbc.M114.624767			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25716315	Green Published, hybrid			2022-12-28	WOS:000353241100035
J	Howard, AE; Fox, JC; Slep, KC				Howard, Amy E.; Fox, Jaime C.; Slep, Kevin C.			Drosophila melanogaster Mini Spindles TOG3 Utilizes Unique Structural Elements to Promote Domain Stability and Maintain a TOG1-and TOG2-like Tubulin-binding Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Division; Crystal Structure; Microtubule; Microtubule-associated Protein; Structural Biology; Tubulin; Msps; TOG; XMAP215; Microtubule Dynamics	ALPHA-BETA-TUBULIN; PLUS-END-TRACKING; MICROTUBULE-ASSOCIATED PROTEIN; MITOTIC SPINDLE; XMAP215; DYNAMICS; STU2P; HOMOLOG; LATTICE; FAMILY	Microtubule-associated proteins regulate microtubule (MT) dynamics spatially and temporally, which is essential for proper formation of the bipolar mitotic spindle. The XMAP215 family is comprised of conserved microtubule-associated proteins that use an array of tubulin-binding tumor overexpressed gene (TOG) domains, consisting of six (A-F) Huntingtin, elongation factor 3, protein phosphatase 2A, target of rapamycin (HEAT) repeats, to robustly increase MT plus-end polymerization rates. Recent work showed that TOG domains have differentially conserved architectures across the array, with implications for position-dependent TOG domain tubulin binding activities and function within the XMAP215 MT polymerization mechanism. Although TOG domains 1, 2, and 4 are well described, structural and mechanistic information characterizing TOG domains 3 and 5 is outstanding. Here, we present the structure and characterization of Drosophila melanogaster Mini spindles (Msps) TOG3. Msps TOG3 has two unique features as follows: the first is a C-terminal tail that stabilizes the ultimate four HEAT repeats (HRs), and the second is a unique architecture in HR B. Structural alignments of TOG3 with other TOG domain structures show that the architecture of TOG3 is most similar to TOG domains 1 and 2 and diverges from TOG4. Docking TOG3 onto recently solved Stu2 TOG1 and TOG2tubulin complex structures suggests that TOG3 uses similarly conserved tubulin-binding intra-HEAT loop residues to engage - and -tubulin. This indicates that TOG3 has maintained a TOG1- and TOG2-like TOG-tubulin binding mode despite structural divergence. The similarity of TOG domains 1-3 and the divergence of TOG4 suggest that a TOG domain array with polarized structural diversity may play a key mechanistic role in XMAP215-dependent MT polymerization activity.	[Howard, Amy E.; Fox, Jaime C.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Howard, Amy E.; Fox, Jaime C.] Univ N Carolina, Program Mol & Cellular Biophys, Chapel Hill, NC 27599 USA; [Slep, Kevin C.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Slep, KC (corresponding author), Univ N Carolina, Dept Biol, Fordham Hall,Campus Box 3280, Chapel Hill, NC 27599 USA.	kslep@bio.unc.edu			National Institutes of Health [T32GM008570, R01GM094415]; March of Dimes [FY14-247]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094415, T32GM008570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32GM008570 (to the Program in Molecular and Cellular Biophysics, University of North Carolina at Chapel Hill) and Grant R01GM094415. This work was also supported by March of Dimes Grant FY14-247 (to K. C. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akhmanova A, 2011, CURR BIOL, V21, pR283, DOI 10.1016/j.cub.2011.03.023; Al-Bassam J, 2006, J CELL BIOL, V172, P1009, DOI 10.1083/jcb.200511010; Al-Bassam J, 2007, STRUCTURE, V15, P355, DOI 10.1016/j.str.2007.01.012; Al-Bassam J, 2012, MOL BIOL CELL, V23, P2878, DOI 10.1091/mbc.E12-03-0205; Al-Bassam J, 2011, TRENDS CELL BIOL, V21, P604, DOI 10.1016/j.tcb.2011.06.007; Al-Bassam J, 2010, DEV CELL, V19, P245, DOI 10.1016/j.devcel.2010.07.016; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Ayaz P, 2014, ELIFE, V3, DOI 10.7554/eLife.03069; Ayaz P, 2012, SCIENCE, V337, P857, DOI 10.1126/science.1221698; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bratman SV, 2007, DEV CELL, V13, P812, DOI 10.1016/j.devcel.2007.10.015; Brittle AL, 2005, EMBO J, V24, P1387, DOI 10.1038/sj.emboj.7600629; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Brouhard GJ, 2014, J CELL BIOL, V207, P323, DOI 10.1083/jcb.201407095; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Cassimeris L, 2001, J CELL SCI, V114, P3025; Cassimeris L, 2009, CELL MOTIL CYTOSKEL, V66, P535, DOI 10.1002/cm.20359; Charrasse S, 1998, J CELL SCI, V111, P1371; CHARRASSE S, 1995, EUR J BIOCHEM, V234, P406, DOI 10.1111/j.1432-1033.1995.406_b.x; Cullen CF, 1999, J CELL BIOL, V146, P1005, DOI 10.1083/jcb.146.5.1005; Currie JD, 2011, MOL BIOL CELL, V22, P4343, DOI 10.1091/mbc.E11-06-0520; De la Mora-Rey T, 2013, ACTA CRYSTALLOGR F, V69, P723, DOI 10.1107/S1744309113015182; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fox JC, 2014, MOL BIOL CELL, V25, P2375, DOI 10.1091/mbc.E13-08-0501; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gard DL, 2004, INT REV CYTOL, V239, P179, DOI 10.1016/S0074-7696(04)39004-2; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; GELFAND VI, 1991, ANNU REV CELL BIOL, V7, P93, DOI 10.1146/annurev.cb.07.110191.000521; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hestermann A, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-24; Kawamura E, 2008, J CELL SCI, V121, P4114, DOI 10.1242/jcs.039065; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kosco KA, 2001, MOL BIOL CELL, V12, P2870, DOI 10.1091/mbc.12.9.2870; Kronja I, 2009, MOL BIOL CELL, V20, P2684, DOI 10.1091/mbc.E08-10-1051; LEAHY DJ, 1994, PROTEINS, V19, P48, DOI 10.1002/prot.340190107; Leano JB, 2013, STRUCTURE, V21, P939, DOI 10.1016/j.str.2013.04.018; Lechner B, 2012, J CELL SCI, V125, P4812, DOI 10.1242/jcs.107045; Lee MJ, 2001, NAT CELL BIOL, V3, P643, DOI 10.1038/35083033; Li WJ, 2012, J CELL BIOL, V199, P849, DOI 10.1083/jcb.201206101; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Nakamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051442; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pecqueur L, 2012, P NATL ACAD SCI USA, V109, P12011, DOI 10.1073/pnas.1204129109; Popov AV, 2002, CURR BIOL, V12, P1326, DOI 10.1016/S0960-9822(02)01033-3; Reber SB, 2013, NAT CELL BIOL, V15, P1116, DOI 10.1038/ncb2834; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Severin F, 2001, J CELL BIOL, V153, P435, DOI 10.1083/jcb.153.2.435; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Slep KC, 2009, BIOCHEM SOC T, V37, P1002, DOI 10.1042/BST0371002; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; van Breugel M, 2003, J CELL BIOL, V161, P359, DOI 10.1083/jcb.200211097; van der Vaart B, 2011, J CELL BIOL, V193, P1083, DOI 10.1083/jcb.201012179; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; Widlund PO, 2011, P NATL ACAD SCI USA, V108, P2741, DOI 10.1073/pnas.1016498108; Zanic M, 2013, NAT CELL BIOL, V15, P688, DOI 10.1038/ncb2744	69	7	8	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10149	10162		10.1074/jbc.M114.633826	http://dx.doi.org/10.1074/jbc.M114.633826			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25720490	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000353241100022
J	Kurteva-Yaneva, N; Zahn, M; Weichler, MT; Starke, R; Harms, H; Muller, RH; Strater, N; Rohwerder, T				Kurteva-Yaneva, Nadya; Zahn, Michael; Weichler, M. -Teresa; Starke, Robert; Harms, Hauke; Mueller, Roland H.; Straeter, Norbert; Rohwerder, Thore			Structural Basis of the Stereospecificity of Bacterial B-12-dependent 2-Hydroxyisobutyryl-CoA Mutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLMALONYL-COENZYME-A; COA MUTASE; CRYSTAL-STRUCTURE; ACID; COBALAMIN; CLONING	Bacterial coenzyme B-12-dependent 2-hydroxyisobutyryl-CoA mutase (HCM) is a radical enzyme catalyzing the stereospecific interconversion of (S)-3-hydroxybutyryl- and 2-hydroxyisobutyryl-CoA. It consists of two subunits, HcmA and HcmB. To characterize the determinants of substrate specificity, we have analyzed the crystal structure of HCM from Aquincola tertiaricarbonis in complex with coenzyme B-12 and the substrates (S)-3-hydroxybutyryl- and 2-hydroxyisobutyryl-CoA in alternative binding. When compared with the well studied structure of bacterial and mitochondrial B-12-dependent methylmalonyl-CoA mutase (MCM), HCM has a highly conserved domain architecture. However, inspection of the substrate binding site identified amino acid residues not present in MCM, namely HcmA He-A90 and Asp(A117). Asp(A117) determines the orientation of the hydroxyl group of the acyl-CoA esters by H-bond formation, thus determining stereospecificity of catalysis. Accordingly, HcmA D117A and D117V mutations resulted in significantly increased activity toward (R)-3-hydroxybutyryl-CoA. Besides interconversion of hydroxylated acyl-CoA esters, wild-type HCM as well as HcmA I90V and I90A mutant enzymes could also isomerize pivalyl- and isovaleryl-CoA, albeit at >10 times lower rates than the favorite substrate (S)-3-hydroxybutyryl-CoA. The nonconservative mutation HcmA D117V, however, resulted in an enzyme showing high activity toward pivalyl-CoA. Structural requirements for binding and isomerization of highly branched acyl-CoA substrates such as 2-hydroxyisobutyryl- and pivalyl-CoA, possessing tertiary and quaternary carbon atoms, respectively, are discussed.	[Kurteva-Yaneva, Nadya; Weichler, M. -Teresa; Starke, Robert; Harms, Hauke; Mueller, Roland H.; Rohwerder, Thore] UFZ Helmholtz Ctr Environm Res, Dept Environm Microbiol, D-04318 Leipzig, Germany; [Zahn, Michael; Straeter, Norbert] Univ Leipzig, Fac Chem & Mineral, Inst Bioanalyt Chem, Ctr Biotechnol & Biomed, D-04103 Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University	Strater, N (corresponding author), Univ Leipzig, Fac Chem & Mineral, Inst Bioanalyt Chem, Ctr Biotechnol & Biomed, D-04103 Leipzig, Germany.	strater@bbz.uni-leipzig.de; thore.rohwerder@ufz.de	Starke, Robert/M-7451-2019; Rohde, Maria-Teresa/E-7214-2015; Starke, Robert/E-6166-2016; Harms, Hauke/I-4406-2012; Starke, Robert/E-2714-2019; Strater, Norbert/P-4856-2018	Starke, Robert/0000-0003-3020-4605; Rohde, Maria-Teresa/0000-0001-6378-2562; Harms, Hauke/0000-0002-7316-7341; Starke, Robert/0000-0003-3020-4605; Rohwerder, Thore/0000-0001-7877-8953; Strater, Norbert/0000-0002-2001-0500; Zahn, Michael/0000-0002-5709-8665				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; BIRCH A, 1993, J BACTERIOL, V175, P3511, DOI 10.1128/jb.175.11.3511-3519.1993; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cracan V, 2012, BIOCHEMISTRY-US, V51, P6039, DOI 10.1021/bi300827v; Cracan V, 2012, J BIOL CHEM, V287, P3723, DOI 10.1074/jbc.M111.320051; Cracan V, 2010, J BIOL CHEM, V285, P655, DOI 10.1074/jbc.M109.062182; Dai LZ, 2014, NAT CHEM BIOL, V10, P365, DOI [10.1038/NCHEMBIO.1497, 10.1038/nchembio.1497]; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Froese DS, 2010, J BIOL CHEM, V285, P38204, DOI 10.1074/jbc.M110.177717; Han YJ, 2012, APPL ENVIRON MICROB, V78, P6194, DOI 10.1128/AEM.01312-12; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kumps A, 2002, CLIN CHEM, V48, P708; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Mancia F, 1999, BIOCHEMISTRY-US, V38, P7999, DOI 10.1021/bi9903852; PADMAKUMAR R, 1993, ANAL BIOCHEM, V214, P318, DOI 10.1006/abio.1993.1494; Probian C, 2003, APPL ENVIRON MICROB, V69, P1866, DOI 10.1128/AEM.69.3.1866-1870.2003; Przybylski D, 2015, APPL MICROBIOL BIOT, V99, P2131, DOI 10.1007/s00253-014-6266-6; Przybylski D, 2013, APPL MICROBIOL BIOT, V97, P8875, DOI 10.1007/s00253-013-5064-x; Ratnatilleke A, 1999, J BIOL CHEM, V274, P31679, DOI 10.1074/jbc.274.44.31679; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROHWERDER T, 2007, VITAMIN B NEW RES, P81; Rohwerder T, 2006, APPL ENVIRON MICROB, V72, P4128, DOI 10.1128/AEM.00080-06; Rohwerder T, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-13; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIMON EJ, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a522; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vlasie MD, 2004, BIOCHEMISTRY-US, V43, P8410, DOI 10.1021/bi036299q; Vlasie MD, 2003, J AM CHEM SOC, V125, P5431, DOI 10.1021/ja029420+; Yabuta Y, 2015, BIOSCI BIOTECH BIOCH, V79, P710, DOI 10.1080/09168451.2014.993353; Yaneva N, 2012, J BIOL CHEM, V287, P15502, DOI 10.1074/jbc.M111.314690	36	15	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9727	9737		10.1074/jbc.M115.645689	http://dx.doi.org/10.1074/jbc.M115.645689			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25720495	Green Published, hybrid			2022-12-28	WOS:000352729400034
J	Braiterman, LT; Gupta, A; Chaerkady, R; Cole, RN; Hubbard, AL				Braiterman, Lelita T.; Gupta, Arnab; Chaerkady, Raghothama; Cole, Robert N.; Hubbard, Ann L.			Communication between the N and C Termini Is Required for Copper-stimulated Ser/Thr Phosphorylation of Cu(I)-ATPase (ATP7B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSONS-DISEASE PROTEIN; TANDEM MASS-SPECTROMETRY; POLARIZED HEPATIC CELLS; TRANS-GOLGI NETWORK; ATPASE ATP7B; TRANSPORTING ATPASE; CATALYTIC-ACTIVITY; STATISTICAL-MODEL; BINDING SITES; TRAFFICKING	The Wilson disease protein ATP7B exhibits copper-dependent trafficking. In high copper, ATP7B exits the trans-Golgi network and moves to the apical domain of hepatocytes where it facilitates elimination of excess copper through the bile. Copper levels also affect ATP7B phosphorylation. ATP7B is basally phosphorylated in low copper and becomes more phosphorylated ("hyperphosphorylated") in elevated copper. The functional significance of hyperphosphorylation remains unclear. We showed that hyperphosphorylation occurs even when ATP7B is restricted to the trans-Golgi network. We performed comprehensive phosphoproteomics of ATP7B in low versus high copper, which revealed that 24 Ser/Thr residues in ATP7B could be phosphorylated, and only four of these were copper-responsive. Most of the phosphorylated sites were found in the N- and C-terminal cytoplasmic domains. Using truncation and mutagenesis, we showed that inactivation or elimination of all six N-terminal metal binding domains did not block copper-dependent, reversible, apical trafficking but did block hyperphosphorylation in hepatic cells. We showed that nine of 15 Ser/Thr residues in the C-terminal domain were phosphorylated. Inactivation of 13 C-terminal phosphorylation sites reduced basal phosphorylation and eliminated hyperphosphorylation, suggesting that copper binding at the N terminus propagates to the ATP7B C-terminal region. C-terminal mutants with either inactivating or phosphomimetic substitutions showed little effect upon copper-stimulated trafficking, indicating that trafficking does not depend on phosphorylation at these sites. Thus, our studies revealed that copper-dependent conformational changes in the N-terminal region lead to hyperphosphorylation at C-terminal sites, which seem not to affect trafficking and may instead fine-tune copper sequestration.	[Braiterman, Lelita T.; Gupta, Arnab; Hubbard, Ann L.] Johns Hopkins Univ, Dept Cell Biol, Sch Med, Baltimore, MD 21205 USA; [Chaerkady, Raghothama; Cole, Robert N.] Johns Hopkins Univ, Mass Spectrometry & Prote Facil, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Braiterman, LT (corresponding author), Johns Hopkins Univ, Dept Cell Biol, Sch Med, 725 N Wolfe St, Baltimore, MD 21205 USA.	lbraite1@jhmi.edu			National Institutes of Health [P01 DK-072084, P01 GM-067166]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 DK-072084 and P01 GM-067166.	Arshavsky VY, 2002, TRENDS NEUROSCI, V25, P124, DOI 10.1016/S0166-2236(00)02094-4; Baek H, 2011, SEMIN CELL DEV BIOL, V22, P153, DOI 10.1016/j.semcdb.2010.09.009; Banci L, 2008, BIOCHEMISTRY-US, V47, P7423, DOI 10.1021/bi8004736; Bartee MY, 2009, BIOCHEMISTRY-US, V48, P5573, DOI 10.1021/bi900325k; Bastaki M, 2002, MOL BIOL CELL, V13, P225, DOI 10.1091/mbc.01-07-0376; Borjigin J, 1999, J NEUROSCI, V19, P1018; Brady DC, 2014, NATURE, V509, P492, DOI 10.1038/nature13180; Braiterman L, 2011, AM J PHYSIOL-GASTR L, V301, pG69, DOI 10.1152/ajpgi.00038.2011; Braiterman L, 2009, AM J PHYSIOL-GASTR L, V296, pG433, DOI 10.1152/ajpgi.90489.2008; Braiterman LT, 2014, P NATL ACAD SCI USA, V111, pE1364, DOI 10.1073/pnas.1314161111; Cardoso LHD, 2014, INT J BIOCHEM CELL B, V54, P60, DOI 10.1016/j.biocel.2014.06.019; Cater MA, 2007, BIOCHEM J, V401, P143, DOI 10.1042/BJ20061055; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Ferenci P, 2006, HUM GENET, V120, P151, DOI 10.1007/s00439-006-0202-5; GRIFFITHS G, 1989, J CELL BIOL, V108, P277, DOI 10.1083/jcb.108.2.277; Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Gupta A, 2011, P NATL ACAD SCI USA, V108, P5390, DOI 10.1073/pnas.1014959108; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hasan NM, 2012, J BIOL CHEM, V287, P36041, DOI 10.1074/jbc.M112.370403; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huster D, 2003, J BIOL CHEM, V278, P32212, DOI 10.1074/jbc.M305408200; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; IHRKE G, 1993, J CELL BIOL, V123, P1761, DOI 10.1083/jcb.123.6.1761; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Ladinsky MS, 2002, MOL BIOL CELL, V13, P2810, DOI 10.1091/mbc.01-12-0593; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nyasae LK, 2014, TRAFFIC, V15, P1344, DOI 10.1111/tra.12229; Pilankatta Rajendra, 2011, J Biol Chem, V286, P7389, DOI 10.1074/jbc.M110.171454; Pilankatta R, 2009, J BIOL CHEM, V284, P21307, DOI 10.1074/jbc.M109.023341; Polishchuk R, 2013, HISTOCHEM CELL BIOL, V140, P285, DOI 10.1007/s00418-013-1123-8; Shevchenko A, 1996, BIOCHEM SOC T, V24, P893, DOI 10.1042/bst0240893; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; Turski ML, 2012, MOL CELL BIOL, V32, P1284, DOI 10.1128/MCB.05722-11; Valverde RHF, 2011, J BIOL CHEM, V286, P6879, DOI 10.1074/jbc.M110.207704; van den Berghe PVE, 2010, J BIOL INORG CHEM, V15, P37, DOI 10.1007/s00775-009-0592-7; Vanderwerf SM, 2002, BIOCHEM SOC T, V30, P739, DOI 10.1042/bst0300739; Vanderwerf SM, 2001, J BIOL CHEM, V276, P36289, DOI 10.1074/jbc.M102055200; Weiss Karl Heinz, 2012, Curr Gastroenterol Rep, V14, P1, DOI 10.1007/s11894-011-0227-3; Wilson-Grady JT, 2013, METHODS, V61, P277, DOI 10.1016/j.ymeth.2013.03.031; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k	45	21	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8803	8819		10.1074/jbc.M114.627414	http://dx.doi.org/10.1074/jbc.M114.627414			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25666620	Green Published, hybrid			2022-12-28	WOS:000352207100011
J	Mills, RD; Mita, M; Nakagawa, J; Shoji, M; Sutherland, C; Walsh, MP				Mills, Ryan D.; Mita, Mitsuo; Nakagawa, Jun-ichi; Shoji, Masaru; Sutherland, Cindy; Walsh, Michael P.			A Role for the Tyrosine Kinase Pyk2 in Depolarization-induced Contraction of Vascular Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; RHO-ASSOCIATED KINASE; CA2+ SENSITIZATION; MYOSIN PHOSPHATASE; PHOSPHORYLATION; INHIBITOR; TRANSLOCATION; SUBUNIT; GROWTH; THR850	Depolarization of the vascular smooth muscle cell membrane evokes a rapid (phasic) contractile response followed by a sustained (tonic) contraction. We showed previously that the sustained contraction involves genistein-sensitive tyrosine phosphorylation upstream of the RhoA/Rho-associated kinase (ROK) pathway leading to phosphorylation of MYPT1(the myosin-targeting subunit of myosin light chain phosphatase (MLCP)) and myosin regulatory light chains (LC20). In this study, we addressed the hypothesis that membrane depolarization elicits activation of the Ca2+-dependent tyrosine kinase Pyk2 (proline-rich tyrosine kinase 2). Pyk2 was identified as the major tyrosine-phosphorylated protein in response to membrane depolarization. The tonic phase of K+-induced contraction was inhibited by the Pyk2 inhibitor sodium salicylate, which abolished the sustained elevation of LC20 phosphorylation. Membrane depolarization induced autophosphorylation (activation) of Pyk2 with a time course that correlated with the sustained contractile response. The Pyk2/focal adhesion kinase (FAK) inhibitor PF-431396 inhibited both phasic and tonic components of the contractile response to K+, Pyk2 autophosphorylation, and LC20 phosphorylation but had no effect on the calyculin A (MLCP inhibitor)-induced contraction. Ionomycin, in the presence of extracellular Ca2+, elicited a slow, sustained contraction and Pyk2 autophosphorylation, which were blocked by pre-treatment with PF-431396. Furthermore, the Ca2+ channel blocker nifedipine inhibited peak and sustained K+-induced force and Pyk2 autophosphorylation. Inhibition of Pyk2 abolished the K+-induced translocation of RhoA to the particulate fraction and the phosphorylation of MYPT1 at Thr-697 and Thr-855. We conclude that depolarization-induced entry of Ca2+ activates Pyk2 upstream of the RhoA/ROK pathway, leading to MYPT1 phosphorylation and MLCP inhibition. The resulting sustained elevation of LC20 phosphorylation then accounts for the tonic contractile response to membrane depolarization.	[Mills, Ryan D.; Sutherland, Cindy; Walsh, Michael P.] Univ Calgary, Libin Cardiovasc Inst, Dept Biochem & Mol Biol, Smooth Muscle Res Grp, Calgary, AB T2N 4N1, Canada; [Mills, Ryan D.; Sutherland, Cindy; Walsh, Michael P.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Mita, Mitsuo; Nakagawa, Jun-ichi; Shoji, Masaru] Meiji Pharmaceut Univ, Dept Pharmacodynam, Tokyo 2048588, Japan	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; Meiji Pharmaceutical University	Walsh, MP (corresponding author), Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	walsh@ucalgary.ca			Canadian Institutes of Health Research [CIHR MOP-111262]; High-Tech Research Center Project, the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [S0801043]; Kertland Family Postdoctoral Fellowship in Vascular Biology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); High-Tech Research Center Project, the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kertland Family Postdoctoral Fellowship in Vascular Biology	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR MOP-111262) (to M. P. W.) and a grant from the High-Tech Research Center Project, the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (S0801043) (to M. S.).; Recipient of a Kertland Family Postdoctoral Fellowship in Vascular Biology.	ALLEN BG, 1994, TRENDS BIOCHEM SCI, V19, P362, DOI 10.1016/0968-0004(94)90112-0; Allen JG, 2010, J MED CHEM, V53, P4332, DOI 10.1021/jm9018756; Bhattachariya A, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12080; Bolton TB, 1999, ANNU REV PHYSIOL, V61, P85, DOI 10.1146/annurev.physiol.61.1.85; Dao P, 2013, BIOORG MED CHEM LETT, V23, P4552, DOI 10.1016/j.bmcl.2013.06.038; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Gong MC, 1997, J BIOL CHEM, V272, P10704; Han S, 2009, J BIOL CHEM, V284, P13193, DOI 10.1074/jbc.M809038200; Kanda T, 2005, FASEB J, V19, P169, DOI 10.1096/fj.05-4197fje; Kohno T, 2008, BIOCHEM J, V410, P513, DOI 10.1042/BJ20070665; Lipinski CA, 2010, EXPERT OPIN THER TAR, V14, P95, DOI 10.1517/14728220903473194; Liu TJ, 2007, MOL CANCER THER, V6, P1357, DOI 10.1158/1535-7163.MCT-06-0476; Mita M, 2002, BIOCHEM J, V364, P431, DOI 10.1042/BJ20020191; Mita Mitsuo, 2013, J Smooth Muscle Res, V49, P26; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Ratz PH, 2005, AM J PHYSIOL-CELL PH, V288, pC769, DOI 10.1152/ajpcell.00529.2004; SHIMADA T, 1986, BLOOD VESSELS, V23, P113; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Sutherland C, 2012, J BIOL CHEM, V287, P24064, DOI 10.1074/jbc.M112.371609; Takeya K, 2008, AM J PHYSIOL-RENAL, V294, pF1487, DOI 10.1152/ajprenal.00060.2008; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Urban NH, 2003, AM J PHYSIOL-CELL PH, V285, pC1377, DOI 10.1152/ajpcell.00501.2002; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Walker DP, 2008, BIOORG MED CHEM LETT, V18, P6071, DOI 10.1016/j.bmcl.2008.10.030; WALSH MP, 1983, METHOD ENZYMOL, V99, P279; Wang ZY, 2001, HYPERTENSION, V37, P148, DOI 10.1161/01.HYP.37.1.148; Ying ZK, 2009, ARTERIOSCL THROM VAS, V29, P1657, DOI 10.1161/ATVBAHA.109.190892; Ying ZK, 2009, CARDIOVASC RES, V83, P155, DOI 10.1093/cvr/cvp084	29	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8677	8692		10.1074/jbc.M114.633107	http://dx.doi.org/10.1074/jbc.M114.633107			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25713079	Green Published, hybrid			2022-12-28	WOS:000352207100001
J	Muller, HM; Steringer, JP; Wegehingel, S; Bleicken, S; Munster, M; Dimou, E; Unger, S; Weidmann, G; Andreas, H; Garcia-Saez, AJ; Wild, K; Sinning, I; Nickel, W				Mueller, Hans-Michael; Steringer, Julia P.; Wegehingel, Sabine; Bleicken, Stephanie; Muenster, Maximilian; Dimou, Eleni; Unger, Sebastian; Weidmann, Georg; Andreas, Helena; Garcia-Saez, Ana J.; Wild, Klemens; Sinning, Irmgard; Nickel, Walter			Formation of Disulfide Bridges Drives Oligomerization, Membrane Pore Formation, and Translocation of Fibroblast Growth Factor 2 to Cell Surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCONVENTIONAL PROTEIN SECRETION; HEPARAN-SULFATE PROTEOGLYCANS; FGF-2; FIBROBLAST-GROWTH-FACTOR-2; MECHANISMS; EXPORT; GLUTAREDOXINS; MACHINERY; PATHWAY; CANCER	Fibroblast growth factor 2 (FGF2) is a key signaling molecule in tumor-induced angiogenesis. FGF2 is secreted by an unconventional secretory mechanism that involves phosphatidylinositol 4,5-bisphosphate-dependent insertion of FGF2 oligomers into the plasma membrane. This process is regulated by Tec kinase-mediated tyrosine phosphorylation of FGF2. Molecular interactions driving FGF2 monomers into membrane-inserted FGF2 oligomers are unknown. Here we identify two surface cysteines that are critical for efficient unconventional secretion of FGF2. They represent unique features of FGF2 as they are absent from all signal-peptide-containing members of the FGF protein family. We show that phosphatidylinositol 4,5-bisphosphate-dependent FGF2 oligomerization concomitant with the generation of membrane pores depends on FGF2 surface cysteines as either chemical alkylation or substitution with alanines impairs these processes. We further demonstrate that the FGF2 variant forms lacking the two surface cysteines are not secreted from cells. These findings were corroborated by experiments redirecting a signal-peptide-containing FGF family member from the endoplasmic reticulum/Golgi-dependent secretory pathway into the unconventional secretory pathway of FGF2. Cis elements known to be required for unconventional secretion of FGF2, including the two surface cysteines, were transplanted into a variant form of FGF4 without signal peptide. The resulting FGF4/2 hybrid protein was secreted by unconventional means. We propose that the formation of disulfide bridges drives membrane insertion of FGF2 oligomers as intermediates in unconventional secretion of FGF2.	[Mueller, Hans-Michael; Steringer, Julia P.; Wegehingel, Sabine; Muenster, Maximilian; Dimou, Eleni; Unger, Sebastian; Weidmann, Georg; Andreas, Helena; Wild, Klemens; Sinning, Irmgard; Nickel, Walter] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany; [Bleicken, Stephanie; Garcia-Saez, Ana J.] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Bleicken, Stephanie; Garcia-Saez, Ana J.] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany	Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Max Planck Society	Nickel, W (corresponding author), Heidelberg Univ, Biochem Ctr BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	walter.nickel@bzh.uni-heidelberg.de	Saez, Ana J. Garcia/U-1611-2019	Bleicken, Stephanie/0000-0002-4789-0974; Muller, Hans-Michael/0000-0002-2384-7285; Dimou, Eleni/0000-0003-4885-135X	German Research Council [DFG-SFB 638, DFG-SFB/TRR 83, DFG-GRK1188]; AID-NET program of the Federal Ministry for Education and Research of Germany; Deutsche Forschungsgemeinschaft cluster of excellence CellNetworks	German Research Council(German Research Foundation (DFG)); AID-NET program of the Federal Ministry for Education and Research of Germany; Deutsche Forschungsgemeinschaft cluster of excellence CellNetworks	This work was supported by the German Research Council (DFG-SFB 638, DFG-SFB/TRR 83, and DFG-GRK1188), the AID-NET program of the Federal Ministry for Education and Research of Germany, and the Deutsche Forschungsgemeinschaft cluster of excellence CellNetworks.	Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Backhaus R, 2004, J CELL SCI, V117, P1727, DOI 10.1242/jcs.01027; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Ebert AD, 2010, TRAFFIC, V11, P813, DOI 10.1111/j.1600-0854.2010.01059.x; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; Garcia-Saez AJ, 2008, METHODS, V46, P116, DOI 10.1016/j.ymeth.2008.06.011; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Lillig CH, 2013, ANTIOXID REDOX SIGN, V18, P1654, DOI 10.1089/ars.2012.5007; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2007, J CELL SCI, V120, P2295, DOI 10.1242/jcs.011080; Nickel W, 2011, TRAFFIC, V12, P799, DOI 10.1111/j.1600-0854.2011.01187.x; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Rabouille C, 2012, J CELL SCI, V125, P5251, DOI 10.1242/jcs.103630; REISFELD RA, 1962, NATURE, V195, P281, DOI 10.1038/195281a0; Steringer JP, 2015, J MOL BIOL, V427, P1202, DOI 10.1016/j.jmb.2014.07.012; Steringer JP, 2012, J BIOL CHEM, V287, P27659, DOI 10.1074/jbc.M112.381939; Temmerman K, 2008, TRAFFIC, V9, P1204, DOI 10.1111/j.1600-0854.2008.00749.x; Temmerman K, 2009, J LIPID RES, V50, P1245, DOI 10.1194/jlr.D800043-JLR200; Torrado LC, 2009, J CELL SCI, V122, P3322, DOI 10.1242/jcs.049791; Wegehingel S, 2008, FEBS LETT, V582, P2387, DOI 10.1016/j.febslet.2008.05.042; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103; Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740	29	35	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8925	8937		10.1074/jbc.M114.622456	http://dx.doi.org/10.1074/jbc.M114.622456			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25694424	hybrid, Green Published			2022-12-28	WOS:000352207100020
J	Holkar, SS; Kamerkar, SC; Pucadyil, TJ				Holkar, Sachin S.; Kamerkar, Sukrut C.; Pucadyil, Thomas J.			Spatial Control of Epsin-induced Clathrin Assembly by Membrane Curvature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK COGNATE PROTEIN; MEDIATED ENDOCYTOSIS; AMPHIPATHIC HELICES; VESICLE FORMATION; BAR DOMAINS; MECHANISM; BINDING; AP180; CARGO; INTERNALIZATION	Epsins belong to the family of highly conserved clathrin-associated sorting proteins that are indispensable for clathrin-mediated endocytosis, but their precise functions remain unclear. We have developed an assay system of budded supported membrane tubes displaying planar and highly curved membrane surfaces to analyze intrinsic membrane curvature preference shown by clathrin-associated sorting proteins. Using real-time fluorescence microscopy, we find that epsin preferentially partitions to and assembles clathrin on highly curved membrane surfaces. Sorting of epsin to regions of high curvature strictly depends on binding to phosphatidylinositol 4,5-bisphosphate. Fluorescently labeled clathrins rapidly assemble as foci, which in turn cluster epsin, while maintaining tube integrity. Clathrin foci grow in intensity with a typical time constant of similar to 75 s, similar to the time scales for coated pit formation seen in cells. Epsin therefore effectively senses membrane curvature to spatially control clathrin assembly. Our results highlight the potential role of membrane curvature in orchestrating the myriad molecular interactions necessary for the success of clathrin-mediated membrane budding.	[Holkar, Sachin S.; Kamerkar, Sukrut C.; Pucadyil, Thomas J.] Indian Inst Sci Educ & Res, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune	Pucadyil, TJ (corresponding author), Indian Inst Sci Educ & Res, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India.	pucadyil@iiserpune.ac.in	Pucadyil, Thomas/AAJ-3974-2020	Pucadyil, Thomas/0000-0002-2907-9889; KAMERKAR, SUKRUT/0000-0003-2848-7132	Indian Institute of Science Education and Research; Wellcome Trust-Department of Biotechnology (DBT) India Alliance; Council for Scientific and Industrial Research (CSIR)	Indian Institute of Science Education and Research; Wellcome Trust-Department of Biotechnology (DBT) India Alliance(Wellcome Trust DBT India Alliance); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by intramural funds from the Indian Institute of Science Education and Research and the Wellcome Trust-Department of Biotechnology (DBT) India Alliance.r Supported by graduate research fellowships from the Council for Scientific and Industrial Research (CSIR).	Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Bhatia VK, 2010, SEMIN CELL DEV BIOL, V21, P381, DOI 10.1016/j.semcdb.2009.12.004; Bocking T, 2011, NAT STRUCT MOL BIOL, V18, P295, DOI 10.1038/nsmb.1985; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; CAMPBELL C, 1984, BIOCHEMISTRY-US, V23, P4420, DOI 10.1021/bi00314a028; Capraro BR, 2010, J AM CHEM SOC, V132, P1200, DOI 10.1021/ja907936c; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Dannhauser PN, 2015, TRAFFIC, V16, P519, DOI 10.1111/tra.12263; Dannhauser PN, 2012, NAT CELL BIOL, V14, P634, DOI 10.1038/ncb2478; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Ha JH, 1997, J BIOL CHEM, V272, P27796, DOI 10.1074/jbc.272.44.27796; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hom RA, 2007, J MOL BIOL, V373, P412, DOI 10.1016/j.jmb.2007.08.016; Hsieh WT, 2012, LANGMUIR, V28, P12838, DOI 10.1021/la302205b; Jakobsson J, 2008, P NATL ACAD SCI USA, V105, P6445, DOI 10.1073/pnas.0710267105; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; Kelly BT, 2014, SCIENCE, V345, P459, DOI 10.1126/science.1254836; Kunding AH, 2008, BIOPHYS J, V95, P1176, DOI 10.1529/biophysj.108.128819; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Messa M, 2014, ELIFE, V3, DOI 10.7554/eLife.03311; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Neumann S, 2013, J BIOL CHEM, V288, P25119, DOI 10.1074/jbc.M113.490474; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Pucadyil TJ, 2010, BIOPHYS J, V99, P517, DOI 10.1016/j.bpj.2010.04.036; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Rosenthal JA, 1999, J BIOL CHEM, V274, P33959, DOI 10.1074/jbc.274.48.33959; Rothnie A, 2011, P NATL ACAD SCI USA, V108, P6927, DOI 10.1073/pnas.1018845108; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Saleem M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7249; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Turner DK, 2013, APPL SPECTROSC, V67, P692, DOI 10.1366/12-06848; Yoon Y, 2010, J BIOL CHEM, V285, P531, DOI 10.1074/jbc.M109.068015	39	18	18	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14267	14276		10.1074/jbc.M115.653394	http://dx.doi.org/10.1074/jbc.M115.653394			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25837255	Green Published, hybrid			2022-12-28	WOS:000355754600001
J	Orlandi, C; Xie, KQ; Masuho, I; Fajardo-Serrano, A; Lujan, R; Martemyanov, KA				Orlandi, Cesare; Xie, Keqiang; Masuho, Ikuo; Fajardo-Serrano, Ana; Lujan, Rafael; Martemyanov, Kirill A.			Orphan Receptor GPR158 Is an Allosteric Modulator of RGS7 Catalytic Activity with an Essential Role in Dictating Its Expression and Localization in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACCELERATING PROTEIN; HETEROTRIMERIC G-PROTEINS; MUSCARINIC M3 RECEPTOR; MEMBRANE ANCHOR; SIGNALING RGS; PROTEOLYTIC STABILITY; LIGHT RESPONSE; DEP DOMAIN; COMPLEX; R7BP	Regulators of G protein signaling control the duration and extent of signaling via G protein-coupled receptor (GPCR) pathways by accelerating the GTP hydrolysis on G protein alpha subunits thereby promoting termination of GPCR signaling. A member of this family, RGS7, plays a critical role in the nervous system where it regulates multiple neurotransmitter GPCRs that mediate vision, memory, and the action of addictive drugs. Previous studies have established that in vivo RGS7 forms mutually exclusive complexes with the membrane protein RGS7-binding protein or the orphan receptor GPR158. In this study, we examine the impact of GPR158 on RGS7 in the brain. We report that knock-out of GPR158 in mice results in marked post-transcriptional destabilization of RGS7 and substantial loss of its association with membranes in several brain regions. We further identified the RGS7-binding site in the C terminus of GPR158 and found that it shares significant homology with the RGS7-binding protein. The proximal portion of the GPR158 C terminus additionally contained a conserved sequence that was capable of enhancing RGS7 GTPase-activating protein activity in solution by an allosteric mechanism acting in conjunction with the regulators of the G protein signaling-binding domain. The distal portion of the GPR158 C terminus contained several phosphodiesterase E gamma-like motifs and selectively recruited G proteins in their activated state. The results of this study establish GPR158 as an essential regulator of RGS7 in the native nervous system with a critical role in controlling its expression, membrane localization, and catalytic activity.	[Orlandi, Cesare; Xie, Keqiang; Masuho, Ikuo; Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Fajardo-Serrano, Ana; Lujan, Rafael] Univ Castilla La Mancha, Fac Med, Dept Ciencias Med, Inst Invest Descapacidades Neuronales IDINE, Albacete 02006, Spain	Scripps Research Institute; Universidad de Castilla-La Mancha	Martemyanov, KA (corresponding author), Scripps Res Inst Florida, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA.	kirill@scripps.edu	Lujan, Rafael/G-2555-2015; Xie, Keqiang/J-9668-2012; Fajardo-Serrano, Ana/AAB-4166-2021; Regan, Clinton/E-6250-2012; Orlandi, Cesare/O-4332-2015; Orlandi, Cesare/AAK-3180-2020	Fajardo-Serrano, Ana/0000-0003-0645-8808; Orlandi, Cesare/0000-0002-4992-9350; Lujan Miras, Rafael/0000-0003-2001-9545	National Institutes of Health [DA036082, DA036596]; Spanish Ministry of Education and Science [BFU-2012-38348]; Junta de Comunidades de Castilla-La Mancha [PPII11-0284-9301]; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026405, R01DA036596, R21DA036082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Education and Science(Spanish Government); Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA036082 and DA036596 (to K. A. M.). This work was also supported by Spanish Ministry of Education and Science Grant BFU-2012-38348 and Junta de Comunidades de Castilla-La Mancha Grant PPII11-0284-9301 (to R. L.).	Anderson GR, 2007, J NEUROSCI, V27, P14117, DOI 10.1523/JNEUROSCI.3884-07.2007; Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Anderson GR, 2009, MOL CELL BIOL, V29, P3033, DOI 10.1128/MCB.01449-08; Audo I, 2012, AM J HUM GENET, V90, P321, DOI 10.1016/j.ajhg.2011.12.007; Baker SA, 2006, BIOCHEMISTRY-US, V45, P10690, DOI 10.1021/bi060376a; Benzing T, 1999, NAT MED, V5, P913, DOI 10.1038/11354; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Cao Y, 2008, J NEUROSCI, V28, P10443, DOI 10.1523/JNEUROSCI.3282-08.2008; Cao Y, 2012, P NATL ACAD SCI USA, V109, P7905, DOI 10.1073/pnas.1202332109; Cao Y, 2010, J NEUROSCI, V30, P13784, DOI 10.1523/JNEUROSCI.1191-10.2010; Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Cowan CW, 2001, PROG NUCLEIC ACID RE, V65, P341; Cowan CW, 2000, METHOD ENZYMOL, V315, P524; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drenan RM, 2006, J BIOL CHEM, V281, P28222, DOI 10.1074/jbc.M604428200; Gold SJ, 1997, J NEUROSCI, V17, P8024; Grabowska D, 2008, NEUROSCIENCE, V151, P969, DOI 10.1016/j.neuroscience.2007.11.045; Grant JE, 2006, J BIOL CHEM, V281, P6194, DOI 10.1074/jbc.M509511200; Hausmann ON, 2002, EUR J NEUROSCI, V15, P602, DOI 10.1046/j.1460-9568.2002.01916.x; He W, 2000, J BIOL CHEM, V275, P37093, DOI 10.1074/jbc.M006982200; Holden NS, 2014, J PHARMACOL EXP THER, V348, P12, DOI 10.1124/jpet.113.204586; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hu G, 2003, J BIOL CHEM, V278, P14550, DOI 10.1074/jbc.M212046200; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Ingi T, 1998, J NEUROSCI, V18, P7178; Jayaraman M, 2009, TRENDS PHARMACOL SCI, V30, P17, DOI 10.1016/j.tips.2008.10.002; Jeffrey BG, 2010, VISUAL NEUROSCI, V27, P9, DOI 10.1017/S0952523809990319; Kach J, 2012, AM J PHYSIOL-HEART C, V303, pH19, DOI 10.1152/ajpheart.00764.2011; Karpinsky-Semper D, 2015, BIOCHEMISTRY-US, V54, P1077, DOI 10.1021/bi500980d; Keresztes G, 2004, J BIOL CHEM, V279, P1581, DOI 10.1074/jbc.C300456200; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; Lishko PV, 2002, J BIOL CHEM, V277, P24376, DOI 10.1074/jbc.M203237200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Martemyanov KA, 2003, NEURON, V38, P857, DOI 10.1016/S0896-6273(03)00320-9; Masuho I, 2013, J BIOL CHEM, V288, P25129, DOI 10.1074/jbc.M113.462283; Masuho I, 2011, J BIOL CHEM, V286, P21806, DOI 10.1074/jbc.M111.241513; Masuho I, 2010, J BIOL CHEM, V285, P4781, DOI 10.1074/jbc.M109.058511; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Orlandi C, 2013, INVEST OPHTH VIS SCI, V54, P7153, DOI 10.1167/iovs.13-12907; Orlandi C, 2012, J CELL BIOL, V197, P711, DOI 10.1083/jcb.201202123; Ostrovskaya O, 2014, ELIFE, V3, DOI 10.7554/eLife.02053; Panicker LM, 2010, J NEUROCHEM, V113, P1101, DOI 10.1111/j.1471-4159.2010.06616.x; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Patel N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057843; Peachey NS, 2012, AM J HUM GENET, V90, P331, DOI 10.1016/j.ajhg.2011.12.006; Porter MY, 2010, J BIOL CHEM, V285, P41100, DOI 10.1074/jbc.M110.163600; Ray TA, 2014, J NEUROSCI, V34, P6334, DOI 10.1523/JNEUROSCI.4044-13.2014; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Seeman P, 2007, SYNAPSE, V61, P303, DOI 10.1002/syn.20368; SELF AJ, 1995, METHOD ENZYMOL, V256, P67; Singh RK, 2007, J PHARMACOL EXP THER, V322, P133, DOI 10.1124/jpet.107.120386; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; Skiba NP, 2001, J BIOL CHEM, V276, P37365, DOI 10.1074/jbc.M106431200; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SLEPAK VZ, 1995, J BIOL CHEM, V270, P14319, DOI 10.1074/jbc.270.24.14319; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Song JH, 2006, J BIOL CHEM, V281, P15361, DOI 10.1074/jbc.M600749200; Terzi D, 2012, NEUROPSYCHOPHARMACOL, V37, P1005, DOI 10.1038/npp.2011.284; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhang JM, 2010, INVEST OPHTH VIS SCI, V51, P1121, DOI 10.1167/iovs.09-4163; Zhou H, 2012, P NATL ACAD SCI USA, V109, P19977, DOI 10.1073/pnas.1214337109	77	40	41	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13622	13639		10.1074/jbc.M115.645374	http://dx.doi.org/10.1074/jbc.M115.645374			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25792749	Green Published, hybrid			2022-12-28	WOS:000355313000001
J	Chen, AA; Akhshi, TK; Lavoie, BD; Wilde, A				Chen, Anan; Akhshi, Tara K.; Lavoie, Brigitte D.; Wilde, Andrew			Importin beta 2 Mediates the Spatio-temporal Regulation of Anillin through a Noncanonical Nuclear Localization Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE RING; GTPASE RAN; AURORA-A; PROTEIN; CYTOKINESIS; BINDING; ACTIN; TPX2; ORGANIZATION; MYOSIN	The compartmentalization of cell cycle regulators is a common mechanism to ensure the precise temporal control of key cell cycle events. For instance, many mitotic spindle assembly factors are known to be sequestered in the nucleus prior to mitotic onset. Similarly, the essential cytokinetic factor anillin, which functions at the cell membrane to promote the physical separation of daughter cells at the end of mitosis, is sequestered in the nucleus during interphase. To address the mechanism and role of anillin targeting to the nucleus in interphase, we identified the nuclear targeting motif. Here, we show that anillin is targeted to the nucleus by importin beta 2 in a Ran-dependent manner through an atypical basic patch PY nuclear localization signal motif. We show that although importin beta 2 binding does not regulate anillin's function in mitosis, it is required to prevent the cytosolic accumulation of anillin, which disrupts cellular architecture during interphase. The nuclear sequestration of anillin during interphase serves to restrict anillin's function at the cell membrane to mitosis and allows anillin to be rapidly available when the nuclear envelope breaks down to remodel the cellular architecture necessary for successful cell division.	[Chen, Anan; Akhshi, Tara K.; Wilde, Andrew] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Lavoie, Brigitte D.; Wilde, Andrew] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Wilde, A (corresponding author), Univ Toronto, Dept Mol Genet, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	andrew.wilde@utoronto.ca		Wilde, Andrew/0000-0002-9812-3847	Canadian Cancer Society Research Institute Grant [700741]	Canadian Cancer Society Research Institute Grant	Supported by Canadian Cancer Society Research Institute Grant 700741.	Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Desmond CR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412379; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Field CM, 2005, DEVELOPMENT, V132, P2849, DOI 10.1242/dev.01843; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Fox JD, 2003, FEBS LETT, V537, P53, DOI 10.1016/S0014-5793(03)00070-X; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Kechad A, 2012, CURR BIOL, V22, P197, DOI 10.1016/j.cub.2011.11.062; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Lagana A, 2010, NAT CELL BIOL, V12, P1186, DOI 10.1038/ncb2129; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Liu JH, 2012, CURR BIOL, V22, P64, DOI 10.1016/j.cub.2011.11.040; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Monzo P, 2005, MOL BIOL CELL, V16, P2891, DOI 10.1091/mbc.E04-09-0773; Moss DK, 2009, J CELL SCI, V122, P644, DOI 10.1242/jcs.037259; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Neumayer G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110994; Neumayer G, 2014, CELL MOL LIFE SCI, V71, P3027, DOI 10.1007/s00018-014-1582-7; Oegema K, 2000, J CELL BIOL, V150, P539, DOI 10.1083/jcb.150.3.539; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Piekny AJ, 2010, SEMIN CELL DEV BIOL, V21, P881, DOI 10.1016/j.semcdb.2010.08.002; Renshaw MJ, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130190; Silverman-Gavrila RV, 2008, MOL BIOL CELL, V19, P3735, DOI 10.1091/mbc.E08-01-0049; Soniat Michael, 2013, Journal of Structural and Functional Genomics, V14, P31, DOI 10.1007/s10969-013-9150-1; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Trieselmann N, 2003, J CELL SCI, V116, P4791, DOI 10.1242/jcs.00798; Triplet CV, 2014, J CELL SCI, V127, P3699, DOI 10.1242/jcs.147504; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Watanabe S, 2010, MOL BIOL CELL, V21, P3193, DOI 10.1091/mbc.E10-04-0324; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Zhang ZC, 2011, MOL BIOL CELL, V22, P4657, DOI 10.1091/mbc.E11-03-0222	39	14	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13500	13509		10.1074/jbc.M115.649160	http://dx.doi.org/10.1074/jbc.M115.649160			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25829492	Green Published, hybrid			2022-12-28	WOS:000354975700044
J	Law, C; Cheung, P				Law, Cindy; Cheung, Peter			Expression of Non-acetylatable H2A.Z in Myoblast Cells Blocks Myoblast Differentiation through Disruption of MyoD Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE VARIANT H2A.Z; NUCLEOSOME SURFACE; VERTEBRATE H2A.Z; GENES; PROMOTERS; HETEROCHROMATIN; TRANSCRIPTION; RECRUITMENT; ACTIVATION; ENHANCERS	H2A.Z is a histone H2A variant that is essential for viability in Tetrahymena and Drosophila and also during embryonic development of mice. Although implicated in diverse cellular processes, including transcriptional regulation, chromosome segregation, and heterochromatin formation, its essential function in cells remains unknown. Cellular differentiation is part of the developmental process of multicellular organisms. To elucidate the roles of H2A.Z and H2A.Z acetylation in cellular differentiation, we examined the effects of expressing wild type (WT) or a non-acetylatable form of H2A.Z in the growth and differentiation of the myoblast C2C12 cell line. Ectopic expression of wild type or mutant H2A.Z resulted in distinct phenotypes in the differentiation of the C2C12 cells and the formation of myotubes. Most strikingly, expression of the H2A.Z non-acetylatable mutant (H2A. Z-Ac-mut) resulted in a complete block of myoblast differentiation. We determined that this phenotype is caused by a loss of MyoD expression in the Ac-mut-expressing cells prior to and after induction of differentiation. Moreover, chromatin accessibility assays showed that the promoter region of MyoD is less accessible in the differentiation-defective cells. Altogether, these new findings show that expression of the Ac-mut form of H2A.Z resulted in a dominant phenotype that blocked differentiation due to chromatin changes at the MyoD promoter.	[Law, Cindy; Cheung, Peter] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Cheung, Peter] York Univ, Dept Biol, N York, ON M3J 1P3, Canada	University of Toronto; York University - Canada	Cheung, P (corresponding author), York Univ, Dept Biol, Life Sci Bldg,Rm 331A, N York, ON M3J 1P3, Canada.	pmcheung@yorku.ca			Canadian Research Chair program; Canadian Cancer Society Research Institute operating grant; National Sciences and Engineering Research Council of Canada	Canadian Research Chair program(Canada Research Chairs); Canadian Cancer Society Research Institute operating grant; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by the Canadian Research Chair program and by a Canadian Cancer Society Research Institute operating grant (to P. C.).; Supported in part by a National Sciences and Engineering Research Council of Canada postgraduate scholarship.	Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bernacchioni C, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-15; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Brunk BP, 1996, DEV BIOL, V177, P490, DOI 10.1006/dbio.1996.0180; Chen JCJ, 2002, DEV BIOL, V245, P213, DOI 10.1006/dbio.2002.0638; Chen Jennifer C J, 2003, Reprod Biol Endocrinol, V1, P101, DOI 10.1186/1477-7827-1-101; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cuadrado A, 2010, EMBO J, V29, P2014, DOI 10.1038/emboj.2010.85; Dhillon N, 2006, MOL CELL BIOL, V26, P489, DOI 10.1128/MCB.26.2.489-501.2006; Draker R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003047; Draker R, 2011, NUCLEIC ACIDS RES, V39, P3529, DOI 10.1093/nar/gkq1352; Draker R, 2009, BIOCHEM CELL BIOL, V87, P19, DOI 10.1139/O08-117; Dryhurst D, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-86; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Filigheddu N, 2007, MOL BIOL CELL, V18, P986, DOI 10.1091/mbc.E06-05-0402; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; GOLDHAMER DJ, 1992, SCIENCE, V256, P538, DOI 10.1126/science.1315077; Greaves IK, 2006, MOL CELL BIOL, V26, P5394, DOI 10.1128/MCB.00519-06; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; GUO K, 1995, MOL CELL BIOL, V15, P3823; Harada A, 2012, EMBO J, V31, P2994, DOI 10.1038/emboj.2012.136; Ishibashi T, 2009, BIOCHEMISTRY-US, V48, P5007, DOI 10.1021/bi900196c; Jackson JD, 2000, NUCLEIC ACIDS RES, V28, P3811, DOI 10.1093/nar/28.19.3811; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Ku MC, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R85, 10.1186/gb-2012-13-10-r85]; Kucharczuk KL, 1999, DEVELOPMENT, V126, P1957; L'honore A, 2003, MOL BIOL CELL, V14, P2151, DOI 10.1091/mbc.e02-07-0451; Larochelle M, 2003, EMBO J, V22, P4512, DOI 10.1093/emboj/cdg427; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Liu XW, 1996, MOL CELL BIOL, V16, P4305; Matsuda R, 2010, NUCLEIC ACIDS RES, V38, P4263, DOI 10.1093/nar/gkq171; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rangasamy D, 2004, NAT STRUCT MOL BIOL, V11, P650, DOI 10.1038/nsmb786; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Ridgway P, 2004, J BIOL CHEM, V279, P43815, DOI 10.1074/jbc.M408409200; Sarcinella E, 2007, MOL CELL BIOL, V27, P6457, DOI 10.1128/MCB.00241-07; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P174, DOI 10.1093/nar/22.2.174; Updike DL, 2006, PLOS GENET, V2, P1500, DOI 10.1371/journal.pgen.0020161; VANDAAL A, 1992, MOL BIOL CELL, V3, P593, DOI 10.1091/mbc.3.6.593; Wan YK, 2009, MOL CELL BIOL, V29, P2346, DOI 10.1128/MCB.01233-08; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang JH, 2011, P NATL ACAD SCI USA, V108, P85, DOI 10.1073/pnas.1009830108; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506	54	16	16	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13234	13249		10.1074/jbc.M114.595462	http://dx.doi.org/10.1074/jbc.M114.595462			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25839232	Green Published, hybrid			2022-12-28	WOS:000354975700025
J	Zhang, M; Huang, R; Im, SC; Waskell, L; Ramamoorthy, A				Zhang, Meng; Huang, Rui; Im, Sang-Choul; Waskell, Lucy; Ramamoorthy, Ayyalusamy			Effects of Membrane Mimetics on Cytochrome P450-Cytochrome b(5) Interactions Characterized by NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; TRANSIENT ENCOUNTER COMPLEXES; PROTEIN SECONDARY STRUCTURE; MICROSOMAL CYTOCHROME-P450; ESCHERICHIA-COLI; NADPH-CYTOCHROME-P450 REDUCTASE; OMEGA-HYDROXYLATION; NH2-TERMINAL REGION; CATALYTIC-ACTIVITY; HEMOPROTEIN P-450	Mammalian cytochrome P450 (P450) is a membrane-bound monooxygenase whose catalytic activities require two electrons to be sequentially delivered from its redox partners: cytochrome b(5) (cytb(5)) and cytochrome P450 reductase, both of which are membrane proteins. Although P450 functional activities are known to be affected by lipids, experimental evidence to reveal the effect of membrane on P450-cytb(5) interactions is still lacking. Here, we present evidence for the influence of phospholipid bilayers on complex formation between rabbit P450 2B4 (CYP2B4) and rabbit cytb(5) at the atomic level, utilizing NMR techniques. General line broadening and modest chemical shift perturbations of cytb(5) resonances characterize CYP2B4-cytb(5) interactions on the intermediate time scale. More significant intensity attenuation and a more specific protein-protein binding interface are observed in bicelles as compared with lipid-free solution, highlighting the importance of the lipid bilayer in stabilizing stronger and more specific interactions between CYP2B4 and cytb(5), which may lead to a more efficient electron transfer. Similar results observed for the interactions between CYP2B4 lacking the transmembrane domain (tr-CYP2B4) and cytb(5) imply interactions between tr-CYP2B4 and the membrane surface, which might assist in CYP2B4-cytb(5) complex formation by orienting tr-CYP2B4 for efficient contact with cytb(5). Furthermore, the observation of weak and nonspecific interactions between CYP2B4 and cytb(5) in micelles suggests that lipid bilayer structures and low curvature membrane surface are preferable for CYP2B4-cytb(5) complex formation. Results presented in this study provide structural insights into the mechanism behind the important role that the lipid bilayer plays in the interactions between P450s and their redox partners.	[Zhang, Meng; Huang, Rui; Ramamoorthy, Ayyalusamy] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA; [Im, Sang-Choul; Waskell, Lucy] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48105 USA; [Im, Sang-Choul; Waskell, Lucy] Vet Affairs Med Ctr, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ramamoorthy, A (corresponding author), Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA.	ramamoor@umich.edu	Regan, Clinton/E-6250-2012; Huang, Rui/N-4022-2017; Zhang, Meng/P-6278-2017	Huang, Rui/0000-0002-4064-6397; Ramamoorthy, Ayyalusamy/0000-0003-1964-1900; Zhang, Meng/0000-0003-4497-3253	National Institutes of Health [GM084018, GM095640, GM35533]; VA Merit grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035533, R01GM084018, R01GM095640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM084018 and GM095640 (to A. R.) and GM35533 (to L. W.). This work was also supported by a VA Merit grant (to L. W.).	Ahuja S, 2013, J BIOL CHEM, V288, P22080, DOI 10.1074/jbc.M112.448225; [Anonymous], 1976, STRUCTURAL BASIS MEM; Arora A, 2001, CURR OPIN STRUC BIOL, V11, P540, DOI 10.1016/S0959-440X(00)00246-3; Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; Baylon JL, 2013, J AM CHEM SOC, V135, P8542, DOI 10.1021/ja4003525; BLANCK J, 1984, EUR J BIOCHEM, V144, P509, DOI 10.1111/j.1432-1033.1984.tb08495.x; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; CANOVADAVIS E, 1985, BIOCHEM PHARMACOL, V34, P1907, DOI 10.1016/0006-2952(85)90307-7; CLARK BJ, 1991, J BIOL CHEM, V266, P5898; COLEMAN R, 1973, BIOCHIM BIOPHYS ACTA, V300, P1, DOI 10.1016/0304-4157(73)90010-5; CULLIN C, 1992, BIOCHEM BIOPH RES CO, V184, P1490, DOI 10.1016/S0006-291X(05)80051-8; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; de Montellano PRO, 2010, CHEM REV, V110, P932, DOI 10.1021/cr9002193; DEPIERRE JW, 1975, BIOCHIM BIOPHYS ACTA, V415, P411, DOI 10.1016/0304-4157(75)90006-4; DEPIERRE JW, 1977, ANNU REV BIOCHEM, V46, P201, DOI 10.1146/annurev.bi.46.070177.001221; Durr UHN, 2012, CHEM REV, V112, P6054, DOI 10.1021/cr300061w; Durr UHN, 2007, BBA-BIOMEMBRANES, V1768, P3235, DOI 10.1016/j.bbamem.2007.08.007; Durr UHN, 2007, J AM CHEM SOC, V129, P6670, DOI 10.1021/ja069028m; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Finn RD, 2008, J BIOL CHEM, V283, P31385, DOI 10.1074/jbc.M803496200; FRENCH JS, 1980, J BIOL CHEM, V255, P4112; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; GRUENKE LD, 1995, J BIOL CHEM, V270, P24707, DOI 10.1074/jbc.270.42.24707; Guengerich F Peter, 2003, Mol Interv, V3, P194, DOI 10.1124/mi.3.4.194; Guengerich FP, 2006, AAPS J, V8, pE101, DOI 10.1208/aapsj080112; Guengerich FP, 2005, BIOCHEM BIOPH RES CO, V338, P465, DOI 10.1016/j.bbrc.2005.08.079; Im SC, 2011, ARCH BIOCHEM BIOPHYS, V507, P144, DOI 10.1016/j.abb.2010.10.023; INGELMANSUNDBERG M, 1977, FEBS LETT, V78, P72, DOI 10.1016/0014-5793(77)80275-5; KAWATO S, 1982, J BIOL CHEM, V257, P7023; KNELLER DG, 1993, J CELL BIOCHEM, P254; Koberova M, 2013, INT J ELECTROCHEM SC, V8, P125; KOMINAMI S, 1992, J STEROID BIOCHEM, V42, P57, DOI 10.1016/0960-0760(92)90011-7; LARSON JR, 1991, J BIOL CHEM, V266, P7321; Lee D, 2008, J AM CHEM SOC, V130, P13822, DOI 10.1021/ja803686p; LU AYH, 1969, J BIOL CHEM, V244, P3714; LU AYH, 1970, MOL PHARMACOL, V6, P213; LU AYH, 1969, BIOCHEM BIOPH RES CO, V36, P545, DOI 10.1016/0006-291X(69)90339-8; LU AYH, 1968, J BIOL CHEM, V243, P1331; Matthews EE, 2006, CELL, V127, P447, DOI 10.1016/j.cell.2006.10.016; MIWA GT, 1981, ARCH BIOCHEM BIOPHYS, V211, P454, DOI 10.1016/0003-9861(81)90477-X; MORGAN ET, 1984, DRUG METAB DISPOS, V12, P358; MULLERENOCH D, 1984, J BIOL CHEM, V259, P8174; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Nelson DR, 2003, ARCH BIOCHEM BIOPHYS, V409, P18, DOI 10.1016/S0003-9861(02)00553-2; OHTA Y, 1994, J BIOL CHEM, V269, P15597; PERNECKY SJ, 1993, P NATL ACAD SCI USA, V90, P2651, DOI 10.1073/pnas.90.7.2651; PERNECKY SJ, 1995, ARCH BIOCHEM BIOPHYS, V318, P446, DOI 10.1006/abbi.1995.1253; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Prudencio M, 2004, J MOL RECOGNIT, V17, P524, DOI 10.1002/jmr.686; SAGARA Y, 1993, ARCH BIOCHEM BIOPHYS, V304, P272, DOI 10.1006/abbi.1993.1349; SANDERS CR, 1995, BIOCHEMISTRY-US, V34, P4030, DOI 10.1021/bi00012a022; Saribas AS, 2001, PROTEIN EXPRES PURIF, V21, P303, DOI 10.1006/prep.2000.1377; Scott EE, 2001, ARCH BIOCHEM BIOPHYS, V395, P57, DOI 10.1006/abbi.2001.2574; Shank-Retzlaff ML, 1998, ARCH BIOCHEM BIOPHYS, V359, P82, DOI 10.1006/abbi.1998.0889; Shimada T, 2005, ARCH BIOCHEM BIOPHYS, V435, P207, DOI 10.1016/j.abb.2004.12.008; STROBEL HW, 1970, J BIOL CHEM, V245, P4851; Suh JY, 2007, J AM CHEM SOC, V129, P12954, DOI 10.1021/ja0760978; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; VANDERHO.TA, 1974, J BIOL CHEM, V249, P6302; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Volkov AN, 2010, J BIOMOL NMR, V48, P225, DOI 10.1007/s10858-010-9452-6; Volkov AN, 2005, PROTEIN SCI, V14, P799, DOI 10.1110/ps.041150205; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; Yamamoto K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02556; Yamamoto K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02538; YANG CS, 1977, J BIOL CHEM, V252, P293; Zhang HM, 2008, J BIOL CHEM, V283, P5217, DOI 10.1074/jbc.M709094200; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200	71	25	25	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12705	12718		10.1074/jbc.M114.597096	http://dx.doi.org/10.1074/jbc.M114.597096			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25795780	Green Published, hybrid			2022-12-28	WOS:000354569000023
J	Zhang, C; Nygaard, M; Haxholm, GW; Boutillon, F; Bernadet, M; Hoos, S; England, P; Broutin, I; Kragelund, BB; Goffin, V				Zhang, Chi; Nygaard, Mads; Haxholm, Gitte W.; Boutillon, Florence; Bernadet, Marie; Hoos, Sylviane; England, Patrick; Broutin, Isabelle; Kragelund, Birthe B.; Goffin, Vincent			A Residue Quartet in the Extracellular Domain of the Prolactin Receptor Selectively Controls Mitogen-activated Protein Kinase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Cell Surface Receptor; Cytokine; Extracellular Signal-regulated Kinase (ERK); Nuclear Magnetic Resonance (NMR); STAT Transcription Factor	GROWTH-HORMONE; CYTOKINE RECEPTORS; BREAST-CANCER; WSXWS MOTIF; DIMERIZATION; AFFINITY; PATHWAY; ERYTHROPOIETIN; IDENTIFICATION; VARIANTS	Cytokine receptors elicit several signaling pathways, but it is poorly understood how they select and discriminate between them. We have scrutinized the prolactin receptor as an archetype model of homodimeric cytokine receptors to address the role of the extracellular membrane proximal domain in signal transfer and pathway selection. Structure-guided manipulation of residues involved in the receptor dimerization interface identified one residue (position 170) that in cell-based assays profoundly altered pathway selectivity and species-specific bio-characteristics. Subsequent in vitro spectroscopic and nuclear magnetic resonance analyses revealed that this residue was part of a residue quartet responsible for specific local structural changes underlying these effects. This included alteration of a novel aromatic T-stack within the membrane proximal domain, which promoted selective signaling affecting primarily the MAPK (ERK1/2) pathway. Importantly, activation of the MAPK pathway correlated with in vitro stabilities of ternary ligandreceptor complexes, suggesting a threshold mean lifetime of the complex necessary to achieve maximal activation. No such dependence was observed for STAT5 signaling. Thus, this study establishes a residue quartet in the extracellular membrane proximal domain of homodimeric cytokine receptors as a key regulator of intracellular signaling discrimination.	[Zhang, Chi; Boutillon, Florence; Bernadet, Marie; Goffin, Vincent] INSERM, U1151, Inst Necker Enfants Malad, Equipe Physiopathol Hormones PRL GH, F-75993 Paris 14, France; [Zhang, Chi; Boutillon, Florence; Bernadet, Marie; Broutin, Isabelle; Goffin, Vincent] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Nygaard, Mads; Haxholm, Gitte W.; Kragelund, Birthe B.] Univ Copenhagen, Dept Biol, Struct Biol & NMR Lab, DK-2200 Copenhagen, Denmark; [Hoos, Sylviane; England, Patrick] Inst Pasteur, Dept Biol Struct & Chim, Plateforme Biophys Macromol & Ieurs Interact, F-75015 Paris, France; [Broutin, Isabelle] CNRS, UMR 8015, Lab Cristallog & RMN Biol, F-75006 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Goffin, V (corresponding author), INSERM, U1151, INEM, Equipe PRL GH Pathophysiol Translat Approache,Fac, Batiment Leriche Porte 9, F-75993 Paris 14, France.	vincent.goffin@inserm.fr	Broutin, Isabelle/A-2003-2017; GOFFIN, Vincent/G-3322-2013; Kragelund, Birthe/M-3927-2014	GOFFIN, Vincent/0000-0002-8021-3086; Kragelund, Birthe/0000-0002-7454-1761; Broutin, isabelle/0000-0001-9862-1232; Nygaard, Mads Morup/0000-0003-1642-4724; ENGLAND, Patrick/0000-0001-6410-5918	Danish Cancer Society; Danish Research Councils for Health and Disease [09-072179, 12-125862]; Novo Nordic Foundation; Ligue Contre le Cancer Grant [RS11/75-26]; University Paris Descartes Grant [990 UMRS 845/2011/02]; Agence Nationale de la Recherche [ANR-07-PCVI-0029]; Ministere de l'Education Nationale de la Recherche et de la Technologie; Fondation ARC	Danish Cancer Society(Danish Cancer Society); Danish Research Councils for Health and Disease; Novo Nordic Foundation(Novo Nordisk Foundation); Ligue Contre le Cancer Grant; University Paris Descartes Grant; Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de l'Education Nationale de la Recherche et de la Technologie; Fondation ARC	This work was supported by the Danish Cancer Society grants (to B. B. K.), Danish Research Councils for Health and Disease Grants 09-072179 and 12-125862 (to B. B. K.), the Novo Nordic Foundation (to B. B. K.), Ligue Contre le Cancer Grant RS11/75-26 (to I. B.), University Paris Descartes Grant 990 UMRS 845/2011/02 (to V. G. and I. B.), and the Agence Nationale de la Recherche Grant ANR-07-PCVI-0029 (to V. G.).; Recipient of fellowships from the Ministere de l'Education Nationale de la Recherche et de la Technologie and from the Fondation ARC.	Aksamitiene E, 2011, CELL SIGNAL, V23, P1794, DOI 10.1016/j.cellsig.2011.06.014; Atanasova M, 2012, CRIT REV BIOCHEM MOL, V47, P502, DOI 10.3109/10409238.2012.729561; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BAZAN JF, 1989, BIOCHEM BIOPH RES CO, V164, P788, DOI 10.1016/0006-291X(89)91528-3; Bernat B, 2003, P NATL ACAD SCI USA, V100, P952, DOI 10.1073/pnas.0235023100; Bernichtein S, 2003, J BIOL CHEM, V278, P35988, DOI 10.1074/jbc.M305687200; Bernichtein S, 2003, ENDOCRINE, V20, P177, DOI 10.1385/ENDO:20:1-2:177; Bogorad RL, 2008, P NATL ACAD SCI USA, V105, P14533, DOI 10.1073/pnas.0800685105; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Broutin I, 2010, J BIOL CHEM, V285, P8422, DOI 10.1074/jbc.M109.089128; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chen CM, 1997, J BIOL CHEM, V272, P5133, DOI 10.1074/jbc.272.8.5133; Courtillot C, 2010, J CLIN ENDOCR METAB, V95, P271, DOI 10.1210/jc.2009-1494; Dagil R, 2012, STRUCTURE, V20, P270, DOI 10.1016/j.str.2011.12.010; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gadd SL, 2006, MOL ENDOCRINOL, V20, P2734, DOI 10.1210/me.2006-0114; Gertler A, 2002, MOL GENET METAB, V75, P189, DOI 10.1006/mgme.2002.3303; Goffin V, 1996, J BIOL CHEM, V271, P16573, DOI 10.1074/jbc.271.28.16573; Goffin V, 2010, METHOD ENZYMOL, V484, P329, DOI [10.1016/S0076-6879(10)84017-0, 10.1016/B978-0-12-381298-8.00017-4]; Hansen MJK, 2011, J MOL RECOGNIT, V24, P533, DOI 10.1002/jmr.1064; Helman D, 2001, J ENDOCRINOL, V169, P43, DOI 10.1677/joe.0.1690043; Jomain JB, 2007, J BIOL CHEM, V282, P33118, DOI 10.1074/jbc.M704364200; KARNITZ LM, 1995, CURR OPIN IMMUNOL, V7, P320, DOI 10.1016/0952-7915(95)80105-7; Keeler C, 2007, BIOCHEMISTRY-US, V46, P2398, DOI 10.1021/bi061958v; Kulkarni MV, 2010, J BIOL CHEM, V285, P38524, DOI 10.1074/jbc.M110.172072; LEBRUN JJ, 1995, P NATL ACAD SCI USA, V92, P4031, DOI 10.1073/pnas.92.9.4031; LEBRUN JJ, 1994, J BIOL CHEM, V269, P14021; Li W, 2013, MOL CELL ENDOCRINOL, V376, P51, DOI 10.1016/j.mce.2013.06.008; Li Y, 2005, J MOL ENDOCRINOL, V35, P411, DOI 10.1677/jme.1.01798; Liu ZH, 2007, BLOOD, V110, P2408, DOI 10.1182/blood-2007-04-083998; Maxwell KL, 2005, PROTEIN SCI, V14, P602, DOI 10.1110/ps.041205405; Millot GA, 2004, CELL SIGNAL, V16, P355, DOI 10.1016/j.cellsig.2003.08.010; Moucadel V, 2005, J BIOL CHEM, V280, P13364, DOI 10.1074/jbc.M407326200; Olsen JG, 2014, CYTOKINE GROWTH F R, V25, P337, DOI 10.1016/j.cytogfr.2014.04.007; Pearce KH, 1999, BIOCHEMISTRY-US, V38, P81, DOI 10.1021/bi9817008; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Rowlinson SW, 2008, NAT CELL BIOL, V10, P740, DOI 10.1038/ncb1737; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Tallet Estelle, 2011, Front Endocrinol (Lausanne), V2, P29, DOI 10.3389/fendo.2011.00029; Teilum K, 2005, J MOL BIOL, V351, P810, DOI 10.1016/j.jmb.2005.06.042; van Agthoven J, 2010, J MOL BIOL, V404, P112, DOI 10.1016/j.jmb.2010.09.036; Wan Y, 2004, J BIOL CHEM, V279, P44775, DOI 10.1074/jbc.M406092200; Yang N, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3467; Zhang C, 2015, MOL CELL ENDOCRINOL, V401, P173, DOI 10.1016/j.mce.2014.12.006	45	3	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11890	11904		10.1074/jbc.M115.639096	http://dx.doi.org/10.1074/jbc.M115.639096			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25784554	Green Published, hybrid			2022-12-28	WOS:000354388600008
J	Bottinger, L; Oeljeklaus, S; Guiard, B; Rospert, S; Warscheid, B; Becker, T				Boettinger, Lena; Oeljeklaus, Silke; Guiard, Bernard; Rospert, Sabine; Warscheid, Bettina; Becker, Thomas			Mitochondrial Heat Shock Protein (Hsp) 70 and Hsp10 Cooperate in the Formation of Hsp60 Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER MEMBRANE; IMPORT MOTOR; YEAST MITOCHONDRIA; PREPROTEIN TRANSLOCASE; MOLECULAR CHAPERONES; SEQUENTIAL ACTION; ATP HYDROLYSIS; MATRIX HSP70; IN-VIVO; HOMOLOG	Mitochondrial Hsp70 (mtHsp70) mediates essential functions for mitochondrial biogenesis, like import and folding of proteins. In these processes, the chaperone cooperates with cochaperones, the presequence translocase, and other chaperone systems. The chaperonin Hsp60, together with its cofactor Hsp10, catalyzes folding of a subset of mtHsp70 client proteins. Hsp60 forms heptameric ring structures that provide a cavity for protein folding. How the Hsp60 rings are assembled is poorly understood. In a comprehensive interaction study, we found that mtHsp70 associates with Hsp60 and Hsp10. Surprisingly, mtHsp70 interacts with Hsp10 independently of Hsp60. The mtHsp70-Hsp10 complex binds to the unassembled Hsp60 precursor to promote its assembly into mature Hsp60 complexes. Weconclude that coupling to Hsp10 recruits mtHsp70 to mediate the biogenesis of the heptameric Hsp60 rings.	[Boettinger, Lena; Rospert, Sabine; Becker, Thomas] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany; [Boettinger, Lena; Becker, Thomas] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Oeljeklaus, Silke; Warscheid, Bettina] Univ Freiburg, Inst Biol 2, Abt Biochem & Funkt Prote, D-79104 Freiburg, Germany; [Oeljeklaus, Silke; Rospert, Sabine; Warscheid, Bettina; Becker, Thomas] CNRS, BIOSS Ctr Biol Signalling Studies, F-91190 Gif Sur Yvette, France; [Guiard, Bernard] CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France	University of Freiburg; University of Freiburg; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Becker, T (corresponding author), Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany.	thomas.becker@biochemie.uni-freiburg.de	Becker, Thomas/AAS-9404-2020	Warscheid, Bettina/0000-0001-5096-1975; Rospert, Sabine/0000-0002-3089-9614	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 746]; Excellence Initiative of the German Federal and State Governments [EXC 294 BIOSS]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 746 and the Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS).	Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Becker T, 2008, J BIOL CHEM, V283, P120, DOI 10.1074/jbc.M706997200; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; Blamowska M, 2012, J CELL BIOL, V199, P125, DOI 10.1083/jcb.201205012; Bottinger L, 2013, MOL BIOL CELL, V24, P2609, DOI 10.1091/mbc.E13-02-0106; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burri L, 2004, J BIOL CHEM, V279, P50243, DOI 10.1074/jbc.M409194200; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; CHENG MY, 1990, NATURE, V348, P455, DOI 10.1038/348455a0; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CRAIG EA, 1987, P NATL ACAD SCI USA, V84, P4156, DOI 10.1073/pnas.84.12.4156; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Dubaquie Y, 1997, P NATL ACAD SCI USA, V94, P9011, DOI 10.1073/pnas.94.17.9011; Dubaquie Y, 1998, EMBO J, V17, P5868, DOI 10.1093/emboj/17.20.5868; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; HALLBERG EM, 1993, MOL CELL BIOL, V13, P3050, DOI 10.1128/MCB.13.5.3050; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HERRMANN JM, 1994, J CELL BIOL, V127, P893, DOI 10.1083/jcb.127.4.893; HOHFELD J, 1994, J CELL BIOL, V126, P305, DOI 10.1083/jcb.126.2.305; Horst M, 1997, EMBO J, V16, P1842, DOI 10.1093/emboj/16.8.1842; HUTCHINSON EG, 1989, EMBO J, V8, P1485, DOI 10.1002/j.1460-2075.1989.tb03532.x; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; LALORAYA S, 1994, P NATL ACAD SCI USA, V91, P6481, DOI 10.1073/pnas.91.14.6481; LALORAYA S, 1995, MOL CELL BIOL, V15, P7098; Levy-Rimler G, 2001, EUR J BIOCHEM, V268, P3465, DOI 10.1046/j.1432-1327.2001.02243.x; Lewrenz I, 2013, J BIOL CHEM, V288, P30931, DOI 10.1074/jbc.M113.465997; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Lytovchenko O, 2014, EMBO J, V33, P1624, DOI 10.15252/embj.201488076; MANNINGKRIEG UC, 1991, EMBO J, V10, P3273, DOI 10.1002/j.1460-2075.1991.tb04891.x; Mapa K, 2010, MOL CELL, V38, P89, DOI 10.1016/j.molcel.2010.03.010; MOCZKO M, 1995, J MOL BIOL, V254, P538, DOI 10.1006/jmbi.1995.0636; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; NAKAI M, 1994, BIOCHEM BIOPH RES CO, V200, P435, DOI 10.1006/bbrc.1994.1468; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nielsen KL, 1998, MOL CELL, V2, P93, DOI 10.1016/S1097-2765(00)80117-3; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; Qiu J, 2013, CELL, V154, P596, DOI 10.1016/j.cell.2013.06.033; RASSOW J, 1994, J CELL BIOL, V127, P1547, DOI 10.1083/jcb.127.6.1547; ROSPERT S, 1993, P NATL ACAD SCI USA, V90, P10967, DOI 10.1073/pnas.90.23.10967; ROWLEY N, 1994, CELL, V77, P249, DOI 10.1016/0092-8674(94)90317-4; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; RYAN MT, 1995, J BIOL CHEM, V270, P22037, DOI 10.1074/jbc.270.37.22037; SCHMITT M, 1995, EMBO J, V14, P3434, DOI 10.1002/j.1460-2075.1995.tb07349.x; Schneider HC, 1996, EMBO J, V15, P5796, DOI 10.1002/j.1460-2075.1996.tb00966.x; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Schulz C, 2015, TRENDS CELL BIOL, V25, P265, DOI 10.1016/j.tcb.2014.12.001; Sichting M, 2005, EMBO J, V24, P1046, DOI 10.1038/sj.emboj.7600580; Slutsky-Leiderman O, 2007, J BIOL CHEM, V282, P33935, DOI 10.1074/jbc.M704435200; Sokol AM, 2014, FEBS LETT, V588, P2484, DOI 10.1016/j.febslet.2014.05.028; Szklarz LKS, 2005, J MOL BIOL, V351, P206, DOI 10.1016/j.jmb.2005.05.068; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; VIITANEN PV, 1992, J BIOL CHEM, V267, P695; VOOS W, 1994, MOL CELL BIOL, V14, P6627, DOI 10.1128/MCB.14.10.6627; Voos W, 2013, BBA-MOL CELL RES, V1833, P388, DOI 10.1016/j.bbamcr.2012.06.005; Wenz LS, 2014, EMBO REP, V15, P678, DOI 10.1002/embr.201338144; WESTERMANN B, 1995, EMBO J, V14, P3452, DOI 10.1002/j.1460-2075.1995.tb07351.x; Westermann B, 1996, MOL CELL BIOL, V16, P7063; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200; Yamamoto H, 2005, FEBS LETT, V579, P507, DOI 10.1016/j.febslet.2004.12.018	68	48	50	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11611	11622		10.1074/jbc.M115.642017	http://dx.doi.org/10.1074/jbc.M115.642017			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792736	hybrid, Green Published			2022-12-28	WOS:000353719400036
J	Islam, Z; Kumar, A; Singh, S; Salmon, L; Karthikeyan, S				Islam, Zeyaul; Kumar, Adarsh; Singh, Suruchi; Salmon, Laurent; Karthikeyan, Subramanian			Structural Basis for Competitive Inhibition of 3,4-Dihydroxy-2-butanone-4-phosphate Synthase from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP CYCLOHYDROLASE-II; 4-PHOSPHATE SYNTHASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; RIBOFLAVIN; BIOSYNTHESIS; MECHANISM; PROTEIN; 6,7-DIMETHYL-8-RIBITYLLUMAZINE; DEAMINASE	The riboflavin biosynthesis pathway has been shown to be essential in many pathogens and is absent in humans. Therefore, enzymes involved in riboflavin synthesis are considered as potential antibacterial drug targets. The enzyme 3,4-dihydroxy-2-butanone-4-phosphate synthase (DHBPS) catalyzes one of the two committed steps in the riboflavin pathway and converts D-ribulose 5-phosphate (Ru5P) to L-3,4-dihydroxy-2-butanone 4-phosphate and formate. Moreover, DHBPS is shown to be indispensable for Mycobacterium, Salmonella, and Helicobacter species. Despite the essentiality of this enzyme in bacteria, no inhibitor has been identified hitherto. Here, we describe kinetic and crystal structure characterization of DHBPS from Vibrio cholerae (vDHBPS) with a competitive inhibitor 4-phospho-D-erythronohydroxamic acid (4PEH) at 1.86 angstrom resolution. In addition, we also report the structural characterization of vDHBPS in its apo form and in complex with its substrate and substrate plus metal ions at 1.96-, 1.59-, and 2.04 angstrom resolution, respectively. Comparison of these crystal structures suggests that 4PEH inhibits the catalytic activity of DHBPS as it is unable to form a proposed intermediate that is crucial for DHBPS activity. Furthermore, vDHBPS structures complexed with substrate and metal ions reveal that, unlike Candida albicans, binding of substrate to vDHBPS induces a conformational change from an open to closed conformation. Interestingly, the position of second metal ion, which is different from that of Methanococcus jannaschii, strongly supports an active role in the catalytic mechanism. Thus, the kinetic and structural characterization of vDHBPS reveals the molecular mechanism of inhibition shown by 4PEH and that it can be explored further for designing novel antibiotics.	[Islam, Zeyaul; Kumar, Adarsh; Singh, Suruchi; Karthikeyan, Subramanian] CSIR, Inst Microbial Technol, Chandigarh 160036, India; [Salmon, Laurent] Univ Paris 11, CNRS UMR8182, Lab Chim Bioorgan & Bioinorgan, Inst Chim Mol & Mat Orsay, F-91405 Orsay, France	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Karthikeyan, S (corresponding author), CSIR, Inst Microbial Technol, Sect 39-A, Chandigarh 160036, India.	skarthik@imtech.res.in	Islam, Zeyaul/AAZ-5625-2020; Singh, Suruchi/AFZ-0966-2022; Salmon, Laurent/T-5179-2018	Islam, Zeyaul/0000-0002-5444-3910; Singh, Suruchi/0000-0002-4306-9345; Salmon, Laurent/0000-0003-1946-8458; Kumar, Adarsh/0000-0002-8219-0332	CSIR Network [BSC-210, BSC-104]; Department of Biotechnology, Government of India; CSIR, Government of India; University Grant Commission Government of India	CSIR Network(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission Government of India(University Grants Commission, India)	This work was supported in part by CSIR Network Projects BSC-210 and BSC-104 and by the Department of Biotechnology, Government of India (for synchrotron data collection in France).; Supported by the CSIR, Government of India.; Supported by University Grant Commission Government of India doctoral fellowships.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; Bacher A, 1997, METHOD ENZYMOL, V280, P382; Bacher A., 1991, CHEM BIOCH FLAVOENZY, P349; Bacher A., 1996, ESCHERICHIA COLI SAL, V1, P657; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BURROWS RB, 1978, J BACTERIOL, V136, P657, DOI 10.1128/JB.136.2.657-667.1978; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; DeLano WL, 2010, PYMOL MOL GRAPH SYST; Echt S, 2004, J MOL BIOL, V341, P1085, DOI 10.1016/j.jmb.2004.06.053; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fassbinder F, 2000, FEMS MICROBIOL LETT, V191, P191, DOI 10.1111/j.1574-6968.2000.tb09339.x; Fischer M, 2008, ARCH BIOCHEM BIOPHYS, V474, P252, DOI 10.1016/j.abb.2008.02.008; FOOR F, 1975, J BIOL CHEM, V250, P3545; Foor F, 1980, Methods Enzymol, V66, P303; Frago S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-160; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Herguedas B, 2010, J MOL BIOL, V400, P218, DOI 10.1016/j.jmb.2010.05.018; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jin L, 2013, PROTEIN EXPRES PURIF, V91, P161, DOI 10.1016/j.pep.2013.07.007; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kelly MJS, 2001, P NATL ACAD SCI USA, V98, P13025, DOI 10.1073/pnas.231323598; KIS K, 1995, J BIOL CHEM, V270, P16788, DOI 10.1074/jbc.270.28.16788; KIS K, 1995, BIOCHEMISTRY-US, V34, P2883, DOI 10.1021/bi00009a019; KLEYWEGT GJ, 1995, STRUCTURE, V3, P535, DOI 10.1016/S0969-2126(01)00187-3; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar P, 2010, PROTEINS, V78, P3292, DOI 10.1002/prot.22837; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liao DI, 2002, BIOCHEMISTRY-US, V41, P1795, DOI 10.1021/bi015652u; Liao DI, 2001, STRUCTURE, V9, P11, DOI 10.1016/S0969-2126(00)00550-5; Long QX, 2010, CHEM BIOL DRUG DES, V75, P339, DOI 10.1111/j.1747-0285.2010.00946.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Philipp WJ, 1996, P NATL ACAD SCI USA, V93, P3132, DOI 10.1073/pnas.93.7.3132; Picollelli MA, 2000, ANAL BIOCHEM, V287, P347, DOI 10.1006/abio.2000.4867; PLAUT GWE, 1960, J BIOL CHEM, V235, pPC41; PLAUT GWE, 1970, BIOCHEMISTRY-US, V9, P771, DOI 10.1021/bi00806a010; Ren J, 2005, J BIOL CHEM, V280, P36912, DOI 10.1074/jbc.M507725200; RICHTER G, 1993, J BACTERIOL, V175, P4045, DOI 10.1128/JB.175.13.4045-4051.1993; RICHTER G, 1992, J BACTERIOL, V174, P4050, DOI 10.1128/jb.174.12.4050-4056.1992; Richter G, 1997, J BACTERIOL, V179, P2022, DOI 10.1128/jb.179.6.2022-2028.1997; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rollenhagen C, 2006, INFECT IMMUN, V74, P1649, DOI 10.1128/IAI.74.3.1649-1660.2006; Roos AK, 2005, J BIOL CHEM, V280, P6416, DOI 10.1074/jbc.M412018200; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh M, 2013, ACTA CRYSTALLOGR D, V69, P1633, DOI 10.1107/S0907444913011402; Singh M, 2011, J STRUCT BIOL, V174, P374, DOI 10.1016/j.jsb.2011.01.013; Steinbacher S, 2003, J BIOL CHEM, V278, P42256, DOI 10.1074/jbc.M307301200; TENG TY, 1990, J APPL CRYSTALLOGR, V23, P387, DOI 10.1107/S0021889890005568; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; VOLK R, 1990, J BIOL CHEM, V265, P19479; VOLK R, 1991, J BIOL CHEM, V266, P20610; Wang WR, 2003, PROTEINS, V52, P633, DOI 10.1002/prot.10353; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	62	10	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11293	11308		10.1074/jbc.M114.611830	http://dx.doi.org/10.1074/jbc.M114.611830			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792735	hybrid, Green Published			2022-12-28	WOS:000353719400008
J	Romagnuolo, R; Scipione, CA; Boffa, MB; Marcovina, SM; Seidah, NG; Koschinsky, ML				Romagnuolo, Rocco; Scipione, Corey A.; Boffa, Michael B.; Marcovina, Santica M.; Seidah, Nabil G.; Koschinsky, Marlys L.			Lipoprotein(a) Catabolism Is Regulated by Proprotein Convertase Subtilisin/Kexin Type 9 through the Low Density Lipoprotein Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE-BINDING SITES; EVOLOCUMAB AMG 145; LDL RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; MONOCLONAL-ANTIBODY; HUMAN APOLIPOPROTEIN(A); PLASMINOGEN ACTIVATION; REDUCES LIPOPROTEIN(A); CARDIOVASCULAR RISK; LP(A) LIPOPROTEIN	Elevated levels of lipoprotein(a) (Lp(a)) have been identified as an independent risk factor for coronary heart disease. Plasma Lp(a) levels are reduced by monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9 (PCSK9). However, the mechanism of Lp(a) catabolism in vivo and the role of PCSK9 in this process are unknown. We report that Lp(a) internalization by hepatic HepG2 cells and primary human fibroblasts was effectively reduced by PCSK9. Overexpression of the low density lipoprotein (LDL) receptor (LDLR) in HepG2 cells dramatically increased the internalization of Lp(a). Internalization of Lp(a) was markedly reduced following treatment of HepG2 cells with a function-blocking monoclonal antibody against the LDLR or the use of primary human fibroblasts from an individual with familial hypercholesterolemia; in both cases, Lp(a) internalization was not affected by PCSK9. Optimal Lp(a) internalization in both hepatic and primary human fibroblasts was dependent on the LDL rather than the apolipoprotein(a) component of Lp(a). Lp(a) internalization was also dependent on clathrin-coated pits, and Lp(a) was targeted for lysosomal and not proteasomal degradation. Our data provide strong evidence that the LDLR plays a role in Lp(a) catabolism and that this process can be modulated by PCSK9. These results provide a direct mechanism underlying the therapeutic potential of PCSK9 in effectively lowering Lp(a) levels.	[Romagnuolo, Rocco; Scipione, Corey A.; Boffa, Michael B.; Koschinsky, Marlys L.] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada; [Marcovina, Santica M.] Univ Washington, Northwest Lipid Metab & Diabet Res Labs, Seattle, WA 98109 USA; [Seidah, Nabil G.] Inst Rech Clin Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	University of Windsor; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Koschinsky, ML (corresponding author), Univ Windsor, Dept Chem & Biochem, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	mlk@uwindsor.ca	Seidah, Nabil/I-3596-2013; Boffa, Michael/N-6539-2019; Scipione, Corey A/AAH-2200-2019	Seidah, Nabil/0000-0001-6503-9342; Boffa, Michael/0000-0003-1211-3064; Scipione, Corey A/0000-0002-0052-8038; Koschinsky, Marlys/0000-0002-2643-2288	Canadian Institutes of Health Research [126076, 102741]; Heart and Stroke Foundation of Canada [G-13-0003091]; Canada Foundation for Innovation/Ontario Ministry of Research and Innovation; Canada Research Chair Program [216684]; Leducq Foundation [13 CVD 03]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Foundation for Innovation/Ontario Ministry of Research and Innovation; Canada Research Chair Program(Canada Research Chairs); Leducq Foundation(Leducq Foundation)	This work was supported by Canadian Institutes of Health Research Grants 126076 (to M. L. K. and M. B. B.) and 102741 (to N. G. S.), Heart and Stroke Foundation of Canada Grant G-13-0003091 (to M. L. K.), the Canada Foundation for Innovation/Ontario Ministry of Research and Innovation (to M. L. K. and M. B. B.), Canada Research Chair Program Grant 216684 (to N. G. S.), and Leducq Foundation Grant 13 CVD 03 (to N. G. S.). S. M. M. and M. L. K. are members of an advisory board to Sanofi SA.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2009, HUM MUTAT, V30, P520, DOI 10.1002/humu.20882; Alonso R, 2014, J AM COLL CARDIOL, V63, P1983, DOI 10.1016/j.jacc.2014.01.063; Argraves KM, 1997, J CLIN INVEST, V100, P2170, DOI 10.1172/JCI119753; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Bea AM, 2014, CLIN INVEST ARTERIOS, V26, P176, DOI 10.1016/j.arteri.2014.01.001; Becker L, 2004, J BIOL CHEM, V279, P2679, DOI 10.1074/jbc.M309414200; Becker L, 2003, J BIOL CHEM, V278, P14074, DOI 10.1074/jbc.M212855200; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Boffa MB, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0360-6; Cain WJ, 2005, J LIPID RES, V46, P2681, DOI 10.1194/jlr.M500249-JLR200; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Desai NR, 2013, CIRCULATION, V128, P962, DOI 10.1161/CIRCULATIONAHA.113.001969; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; ERNST A, 1995, J BIOL CHEM, V270, P6227, DOI 10.1074/jbc.270.11.6227; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; FLOREN CH, 1981, BIOCHEM BIOPH RES CO, V102, P636, DOI 10.1016/S0006-291X(81)80179-9; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; GABEL BR, 1995, BIOCHEMISTRY-US, V34, P15777, DOI 10.1021/bi00048a023; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Gaudet D, 2014, AM J CARDIOL, V114, P711, DOI 10.1016/j.amjcard.2014.05.060; GHISELLI G, 1992, METABOLISM, V41, P833, DOI 10.1016/0026-0495(92)90163-5; Gonbert S, 2002, ATHEROSCLEROSIS, V164, P305, DOI 10.1016/S0021-9150(02)00072-2; Hancock MA, 2003, J BIOL CHEM, V278, P23260, DOI 10.1074/jbc.M302780200; HAVEKES L, 1981, FEBS LETT, V132, P169, DOI 10.1016/0014-5793(81)81153-2; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; HOFMANN SL, 1990, J CLIN INVEST, V85, P1542, DOI 10.1172/JCI114602; KOSCHINSKY ML, 1993, J BIOL CHEM, V268, P19819; Kosenko T, 2013, J BIOL CHEM, V288, P8279, DOI 10.1074/jbc.M112.421370; Kraft HG, 2000, ARTERIOSCL THROM VAS, V20, P522, DOI 10.1161/01.ATV.20.2.522; KREMPLER F, 1983, J CLIN INVEST, V71, P1431, DOI 10.1172/JCI110896; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Marcovina SM, 1996, J LIPID RES, V37, P2569; MARCOVINA SM, 1995, CLIN CHEM, V41, P246; MARZ W, 1993, FEBS LETT, V325, P271, DOI 10.1016/0014-5793(93)81087-G; McKenney JM, 2012, J AM COLL CARDIOL, V59, P2344, DOI 10.1016/j.jacc.2012.03.007; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; MILES LA, 1995, THROMB HAEMOSTASIS, V73, P458; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Nguyen AT, 2006, J LIPID RES, V47, P1399, DOI 10.1194/jlr.M600130-JLR200; Niemeier A, 1999, ARTERIOSCL THROM VAS, V19, P552, DOI 10.1161/01.ATV.19.3.552; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Raal FJ, 2014, J AM COLL CARDIOL, V63, P1278, DOI 10.1016/j.jacc.2014.01.006; RADER DJ, 1994, J CLIN INVEST, V93, P2758, DOI 10.1172/JCI117292; RADER DJ, 1995, J CLIN INVEST, V95, P1403, DOI 10.1172/JCI117794; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Romagnuolo R, 2014, J LIPID RES, V55, P625, DOI 10.1194/jlr.M036566; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; SOUTAR AK, 1991, J CLIN INVEST, V88, P483, DOI 10.1172/JCI115329; Stein EA, 2014, EUR HEART J, V35, P2249, DOI 10.1093/eurheartj/ehu085; Strom TB, 2010, MOL GENET METAB, V101, P76, DOI 10.1016/j.ymgme.2010.05.003; Tam SP, 1996, J LIPID RES, V37, P518; Theuerle J. D., 2009, THESIS QUEENS U KING; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P716, DOI 10.1016/j.jacc.2012.04.038; Tziomalos K, 2009, CURR OPIN CARDIOL, V24, P351, DOI 10.1097/HCO.0b013e32832ac21a; van Wissen S, 2003, HEART, V89, P893, DOI 10.1136/heart.89.8.893; Wang Y, 2012, J LIPID RES, V53, P1932, DOI 10.1194/jlr.M028563; White AL, 1997, J BIOL CHEM, V272, P5048, DOI 10.1074/jbc.272.8.5048; Yang XP, 2013, J LIPID RES, V54, P2450, DOI 10.1194/jlr.M038877; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	65	142	156	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11649	11662		10.1074/jbc.M114.611988	http://dx.doi.org/10.1074/jbc.M114.611988			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25778403	Green Published, hybrid			2022-12-28	WOS:000353719400039
J	Cheung, KG; Cole, LK; Xiang, B; Chen, KY; Ma, XL; Myal, Y; Hatch, GM; Tong, Q; Dolinsky, VW				Cheung, Kyle G.; Cole, Laura K.; Xiang, Bo; Chen, Keyun; Ma, Xiuli; Myal, Yvonne; Hatch, Grant M.; Tong, Qiang; Dolinsky, Vernon W.			Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRIAMYCIN-INDUCED CARDIOMYOPATHY; MANGANESE SUPEROXIDE-DISMUTASE; AEROBIC EXERCISE; BREAST-CANCER; RAT-HEART; ELECTRON-TRANSPORT; SKELETAL-MUSCLE; COMPLEX-I; ANTHRACYCLINE; DEACETYLASE	Doxorubicin (DOX) is a chemotherapeutic agent effective in the treatment of many cancers. However, cardiac dysfunction caused by DOX limits its clinical use. DOX is believed to be harmful to cardiomyocytes by interfering with the mitochondrial phospholipid cardiolipin and causing inefficient electron transfer resulting in the production of reactive oxygen species (ROS). Sirtuin-3 (SIRT3) is a class III lysine deacetylase that is localized to the mitochondria and regulates mitochondrial respiration and oxidative stress resistance enzymes such as superoxide dismutase-2 (SOD2). The purpose of this study was to determine whether SIRT3 prevents DOX-induced mitochondrial ROS production. Administration of DOX to mice suppressed cardiac SIRT3 expression, and DOX induced a dose-dependent decrease in SIRT3 and SOD2 expression in H9c2 cardiomyocytes. SIRT3-null mouse embryonic fibroblasts produced significantly more ROS in the presence of DOX compared with wild-type cells. Overexpression of wildtype SIRT3 increased cardiolipin levels and rescued mitochondrial respiration and SOD2 expression in DOX-treated H9c2 cardiomyocytes and attenuated the amount of ROS produced following DOX treatment. These effects were absent when a deacetylase-deficient SIRT3 was expressed in H9c2 cells. Our results suggest that overexpression of SIRT3 attenuates DOX-induced ROS production, and this may involve increased SOD2 expression and improved mitochondrial bioenergetics. SIRT3 activation could be a potential therapy for DOX-induced cardiac dysfunction.	[Cheung, Kyle G.; Cole, Laura K.; Xiang, Bo; Ma, Xiuli; Hatch, Grant M.; Dolinsky, Vernon W.] Univ Manitoba, Dept Pharmacol & Therapeut, Winnipeg, MB R3E 3P4, Canada; [Cheung, Kyle G.; Cole, Laura K.; Xiang, Bo; Ma, Xiuli; Hatch, Grant M.; Dolinsky, Vernon W.] Univ Manitoba, Diabet Res Envisioned & Accomplished Manitoba DRE, Winnipeg, MB R3E 3P4, Canada; [Cheung, Kyle G.; Cole, Laura K.; Xiang, Bo; Ma, Xiuli; Hatch, Grant M.; Dolinsky, Vernon W.] Univ Manitoba, Childrens Hosp Res Inst Manitoba, Winnipeg, MB R3E 3P4, Canada; [Myal, Yvonne] Univ Manitoba, Dept Pathol, Winnipeg, MB R3E 3P4, Canada; [Chen, Keyun; Tong, Qiang] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA	University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Baylor College of Medicine	Dolinsky, VW (corresponding author), Univ Manitoba, 601 John Buhler Res Ctr,715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada.	vdolinsky@chrim.ca			Heart and Stroke Foundation [000402]; Manitoba Health Research Council; Canadian Breast Cancer Foundation; American Heart Association [0665162Y]; United States Department of Agriculture [6250-51000-055]; Canadian Institutes of Health Research/Heart and Stroke Foundation of Canada Integrated and Mentored Pulmonary and Cardiovascular Training (IMPACT) fellowship	Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Manitoba Health Research Council; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); American Heart Association(American Heart Association); United States Department of Agriculture(United States Department of Agriculture (USDA)); Canadian Institutes of Health Research/Heart and Stroke Foundation of Canada Integrated and Mentored Pulmonary and Cardiovascular Training (IMPACT) fellowship	This work was supported in part by the Heart and Stroke Foundation Grant 000402 and a research grant the Manitoba Health Research Council (to V. W. D.), a Canadian Breast Cancer Foundation grant (to Y. M.), a Heart and Stroke Foundation grant (to G. M. H.), and American Heart Association Grant 0665162Y and United States Department of Agriculture Grant 6250-51000-055 (to Q. T.).; Recipient of a Canadian Institutes of Health Research/Heart and Stroke Foundation of Canada Integrated and Mentored Pulmonary and Cardiovascular Training (IMPACT) fellowship.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Ascensao A, 2011, CLIN SCI, V120, P37, DOI 10.1042/CS20100254; Bao JJ, 2010, J CELL BIOCHEM, V110, P238, DOI 10.1002/jcb.22531; BARTLETT GR, 1959, J BIOL CHEM, V234, P469; BIANCHI C, 1987, EXP MOL PATHOL, V46, P123, DOI 10.1016/0014-4800(87)90036-0; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Danz EDB, 2009, FREE RADICAL BIO MED, V46, P1589, DOI 10.1016/j.freeradbiomed.2009.03.011; Dolinsky VW, 2014, MOLECULES, V19, P14919, DOI 10.3390/molecules190914919; Dolinsky VW, 2013, AM J PHYSIOL-ENDOC M, V305, pE243, DOI 10.1152/ajpendo.00044.2013; Dolinsky VW, 2012, J PHYSIOL-LONDON, V590, P2783, DOI 10.1113/jphysiol.2012.230490; DOROSHOW JH, 1983, CANCER RES, V43, P460; Eidenschink AB, 2000, CARDIOL YOUNG, V10, P610; Ewer MS, 2005, J CLIN ONCOL, V23, P2900, DOI 10.1200/JCO.2005.05.827; GOORMAGHTIGH E, 1983, BIOCHEM PHARMACOL, V32, P889, DOI 10.1016/0006-2952(83)90593-2; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Haykowsky MJ, 2009, CLIN CANCER RES, V15, P4963, DOI 10.1158/1078-0432.CCR-09-0628; Hequet O, 2004, J CLIN ONCOL, V22, P1864, DOI 10.1200/JCO.2004.06.033; Hostetler K. Y., 1982, PHOSPHOLIPIDS, V4, P215; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Jones LW, 2007, J AM COLL CARDIOL, V50, P1435, DOI 10.1016/j.jacc.2007.06.037; Kawamura Y, 2010, J CLIN INVEST, V120, P2817, DOI 10.1172/JCI42020; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Kuznetsov AV, 2011, BBA-MOL CELL RES, V1813, P1144, DOI 10.1016/j.bbamcr.2011.03.002; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; Law IKM, 2009, PROTEOMICS, V9, P2444, DOI 10.1002/pmic.200800738; Marques-Aleixo I, 2015, MITOCHONDRION, V20, P22, DOI 10.1016/j.mito.2014.10.008; MUHAMMED H, 1983, BIOCHIM BIOPHYS ACTA, V722, P43, DOI 10.1016/0005-2728(83)90155-X; Mutter T, 2000, BIOCHEM J, V346, P403, DOI 10.1042/0264-6021:3460403; Ohkura K, 2003, MOL CELL BIOCHEM, V248, P203, DOI 10.1023/A:1024161024231; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Pereira GC, 2011, CURR PHARM DESIGN, V17, P2113; Pinder MC, 2007, J CLIN ONCOL, V25, P3808, DOI 10.1200/JCO.2006.10.4976; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Sack MN, 2011, AM J PHYSIOL-HEART C, V301, pH2191, DOI 10.1152/ajpheart.00199.2011; Samant SA, 2014, MOL CELL BIOL, V34, P807, DOI 10.1128/MCB.01483-13; Scott JM, 2011, CIRCULATION, V124, P642, DOI 10.1161/CIRCULATIONAHA.111.021774; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang YJ, 2010, J CELL BIOCHEM, V111, P1051, DOI 10.1002/jcb.22795; Yen HC, 1999, ARCH BIOCHEM BIOPHYS, V362, P59, DOI 10.1006/abbi.1998.1011; Zhang C, 2011, CARDIOVASC RES, V90, P538, DOI 10.1093/cvr/cvr022	49	113	117	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10981	10993		10.1074/jbc.M114.607960	http://dx.doi.org/10.1074/jbc.M114.607960			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25759382	Green Published, hybrid			2022-12-28	WOS:000353404500035
J	Silva, KAS; Dong, JL; Dong, YJ; Dong, YL; Schor, N; Tweardy, DJ; Zhang, LP; Mitch, WE				Santos Silva, Kleiton Augusto; Dong, Jiangling; Dong, Yanjun; Dong, Yanlan; Schor, Nestor; Tweardy, David J.; Zhang, Liping; Mitch, William E.			Inhibition of Stat3 Activation Suppresses Caspase-3 and the Ubiquitin-Proteasome System, Leading to Preservation of Muscle Mass in Cancer Cachexia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; PROTEIN-DEGRADATION; TRANSCRIPTION FACTORS; CATABOLIC CONDITIONS; MYOSTATIN GENE; UP-REGULATION; KAPPA-B; PATHWAY; EXPRESSION; ATROPHY	Cachexia occurs in patients with advanced cancers. Despite the adverse clinical impact of cancer-induced muscle wasting, pathways causing cachexia are controversial, and clinically reliable therapies are not available. A trigger of muscle protein loss is the Jak/Stat pathway, and indeed, we found that conditioned medium from C26 colon carcinoma (C26) or Lewis lung carcinoma cells activates Stat3 (p-Stat3) in C2C12 myotubes. We identified two proteolytic pathways that are activated in muscle by p-Stat3; one is activation of caspase-3, and the other is p-Stat3 to myostatin, MAFbx/Atrogin-1, and MuRF-1 via CAAT/enhancer-binding protein delta (C/EBP delta). Using sequential deletions of the caspase-3 promoter and CHIP assays, we determined that Stat3 activation increases caspase-3 expression in C2C12 cells. Caspase-3 expression and proteolytic activity were stimulated by p-Stat3 in muscles of tumor-bearing mice. In mice with cachexia caused by Lewis lung carcinoma or C26 tumors, knock-out of p-Stat3 in muscle or with a small chemical inhibitor of p-Stat3 suppressed muscle mass losses, improved protein synthesis and degradation in muscle, and increased body weight and grip strength. Activation of p-Stat3 stimulates a pathway from C/EBP delta to myostatin and expression of MAFbx/Atrogin-1 and increases the ubiquitin-proteasome system. Indeed, C/EBP delta KO decreases the expression of MAFbx/Atrogin-1 and myostatin, while increasing muscle mass and grip strength. In conclusion, cancer stimulates p-Stat3 in muscle, activating protein loss by stimulating caspase-3, myostatin, and the ubiquitin-proteasome system. These results could lead to novel strategies for preventing cancer-induced muscle wasting.	[Santos Silva, Kleiton Augusto; Dong, Jiangling; Dong, Yanjun; Dong, Yanlan; Zhang, Liping; Mitch, William E.] Baylor Coll Med, Div Nephrol, Dept Med, Houston, TX 77030 USA; [Tweardy, David J.] Baylor Coll Med, Dept Med, Sect Infect Dis, Houston, TX 77030 USA; [Tweardy, David J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Tweardy, David J.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Santos Silva, Kleiton Augusto; Schor, Nestor] Univ Fed Sao Paulo, Dept Med, Div Nephrol, BR-04023900 Sao Paulo, Brazil; [Dong, Jiangling] Sichuan Univ, Coll Life Sci, Chengdu 610065, Peoples R China; [Dong, Yanjun] Capital Med Univ, An Zhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Universidade Federal de Sao Paulo (UNIFESP); Sichuan University; Capital Medical University	Zhang, LP (corresponding author), Baylor Coll Med, Div Nephrol, Dept Med, One Baylor Plaza,M-S BCM 395,ABBR R705, Houston, TX 77030 USA.	lipingz@bcm.edu	Tweardy, David/L-3929-2019; dong, jiangling/GYJ-4337-2022	Silva, Kleiton/0000-0001-8230-0012; Dong, Yanjun/0000-0001-6396-8949; Dong, Jiangling/0000-0001-9742-2469	Satellite Health; American Diabetic Association [1-11-BS-194]; Diabetes Research Center at Baylor College of Medicine [P30-DK079638]; National Institutes of Health [R37 DK37175, P50 CA058183, P50 CA097007, R21 CA149783]; Cancer Prevention and Research Institute of Texas [RP100421]; Alkek Foundation; Dan L. Duncan Cancer Center; Sao Paulo Research Foundation [FAPESP 2012/03142-8]; NATIONAL CANCER INSTITUTE [R21CA149783, P50CA097007, P50CA058183] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638, R01DK037175, R37DK037175] Funding Source: NIH RePORTER	Satellite Health; American Diabetic Association(American Diabetes Association); Diabetes Research Center at Baylor College of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Alkek Foundation; Dan L. Duncan Cancer Center; Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project was supported by the generous support of Dr. and Mrs. Harold Selzman, the Norman S. Coplon extramural research grants from Satellite Health, American Diabetic Association (1-11-BS-194), and the Pilot/Feasibility award of the Diabetes Research Center (P30-DK079638) at Baylor College of Medicine (to L. Z.). This work was also supported by National Institutes of Health Grants R37 DK37175 (to W. E. M.) and P50 CA058183, P50 CA097007, and R21 CA149783, Cancer Prevention and Research Institute of Texas Grant RP100421, and Grants from the Alkek Foundation and the Dan L. Duncan Cancer Center (to D. T.), and by a fellowship from the Sao Paulo Research Foundation (FAPESP 2012/03142-8) (to K. A. S. S.).	Allen DL, 2007, AM J PHYSIOL-CELL PH, V292, pC188, DOI 10.1152/ajpcell.00542.2005; ALVESTRAND A, 1983, CLIN NEPHROL, V19, P67; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonetto A, 2012, AM J PHYSIOL-ENDOC M, V303, pE410, DOI 10.1152/ajpendo.00039.2012; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Carlson CJ, 1999, AM J PHYSIOL-REG I, V277, pR601, DOI 10.1152/ajpregu.1999.277.2.R601; CLARK AS, 1983, BIOCHEM J, V212, P649, DOI 10.1042/bj2120649; den Kamp CMO, 2013, AM J CLIN NUTR, V98, P738, DOI 10.3945/ajcn.113.058388; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; FUJIMOTOOUCHI K, 1995, INT J CANCER, V61, P522, DOI 10.1002/ijc.2910610416; Gilabert M, 2014, J CELL PHYSIOL, V229, P1437, DOI 10.1002/jcp.24580; Glass DJ, 2007, J CLIN INVEST, V117, P2388, DOI 10.1172/JCI33379; GOODMAN MN, 1991, AM J PHYSIOL, V260, pE727, DOI 10.1152/ajpendo.1991.260.5.E727; GOODMAN MN, 1994, P SOC EXP BIOL MED, V205, P182; Han HQ, 2013, INT J BIOCHEM CELL B, V45, P2333, DOI 10.1016/j.biocel.2013.05.019; Hebenstreit D, 2005, DRUG NEWS PERSPECT, V18, P243, DOI 10.1358/dnp.2005.18.4.908658; Jeschke MG, 2008, ANN SURG, V248, P387, DOI 10.1097/SLA.0b013e3181856241; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Ma K, 2003, AM J PHYSIOL-ENDOC M, V285, pE363, DOI 10.1152/ajpendo.00487.2002; Ma K, 2001, AM J PHYSIOL-ENDOC M, V281, pE1128, DOI 10.1152/ajpendo.2001.281.6.E1128; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; MORRISON SD, 1976, PHYSIOL BEHAV, V17, P705, DOI 10.1016/0031-9384(76)90173-6; Puppa MJ, 2014, FASEB J, V28, P998, DOI 10.1096/fj.13-240580; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Staiger J, 2009, CARCINOGENESIS, V30, P832, DOI 10.1093/carcin/bgn273; Thomas S. S., 2013, KIDNEY INT; Tisdale M J, 1998, Curr Opin Clin Nutr Metab Care, V1, P253, DOI 10.1097/00075197-199805000-00003; Tisdale MJ, 2010, CELL, V142, P511, DOI 10.1016/j.cell.2010.08.004; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Todorov P, 1996, NATURE, V379, P739, DOI 10.1038/379739a0; Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398; Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251; Wang XNH, 2010, J BIOL CHEM, V285, P21249, DOI 10.1074/jbc.M109.041707; Watchorn TM, 2005, INT J ONCOL, V27, P1105; Weil WM, 2007, BULL HOSP JT DIS, V65, P72; White J, 2012, ITE J, V82, P14; Workeneh BT, 2006, J AM SOC NEPHROL, V17, P3233, DOI 10.1681/ASN.2006020131; Xu XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004783; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292; Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012; Zhang LP, 2011, FASEB J, V25, P1653, DOI 10.1096/fj.10-176917; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	50	131	139	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11177	11187		10.1074/jbc.M115.641514	http://dx.doi.org/10.1074/jbc.M115.641514			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25787076	hybrid, Green Published			2022-12-28	WOS:000353404500050
J	Artamonov, MV; Jin, L; Franke, AS; Momotani, K; Ho, RY; Dong, XR; Majesky, MW; Somlyo, AV				Artamonov, Mykhaylo V.; Jin, Li; Franke, Aaron S.; Momotani, Ko; Ho, Ruoya; Dong, Xiu Rong; Majesky, Mark W.; Somlyo, Avril V.			Signaling Pathways That Control Rho Kinase Activity Maintain the Embryonic Epicardial Progenitor State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiovascular; Guanine Nucleotide Exchange Factor (GEF); Ras Homolog Gene Family; Member A (RhoA); Signal Transduction; Transformation; Epac; Rnds; Epicardial Cells; Epithelial to Mesenchymal Transformation; p190RhoGAP	VASCULAR SMOOTH-MUSCLE; NUCLEOTIDE EXCHANGE FACTOR; CA2+ SENSITIZATION; RND PROTEINS; PROEPICARDIAL CELLS; GENE-EXPRESSION; AVIAN HEART; TGF-BETA; IN-VIVO; DIFFERENTIATION	This study identifies signaling pathways that play key roles in the formation and maintenance of epicardial cells, a source of progenitors for coronary smooth muscle cells (SMCs). After epithelial to mesenchymal transition (EMT), mesenchymal cells invade the myocardium to form coronary SMCs. RhoA/Rho kinase activity is required for EMT and for differentiation into coronary SMCs, whereas cAMP activity is known to inhibit EMT in epithelial cells by an unknown mechanism. We use outgrowth of epicardial cells from E9.5 isolated mouse proepicardium (PE) explants, wild type and Epac1 null E12.5 mouse heart explants, adult rat epicardial cells, and immortalized mouse embryonic epicardial cells as model systems to identify signaling pathways that regulate RhoA activity to maintain the epicardial progenitor state. We demonstrate that RhoA activity is suppressed in the epicardial progenitor state, that the cAMP-dependent Rap1 GTP exchange factor (GEF), Epac, known to down-regulate RhoA activity through activation of Rap1 GTPase activity increased, that Rap1 activity increased, and that expression of the RhoA antagonistic Rnd proteins known to activate p190RhoGAP increased and associated with p190RhoGAP. Finally, EMT is associated with increased p63RhoGEF and RhoGEF-H1 protein expression, increased GEF-H1 activity, with a trend in increased p63RhoGEF activity. EMT is suppressed by partial silencing of p63RhoGEF and GEF-H1. In conclusion, we have identified new signaling molecules that act together to control RhoA activity and play critical roles in the maintenance of coronary smooth muscle progenitor cells in the embryonic epicardium. We suggest that their eventual manipulation could promote revascularization after myocardial injury.	[Artamonov, Mykhaylo V.; Jin, Li; Franke, Aaron S.; Momotani, Ko; Ho, Ruoya; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Dong, Xiu Rong; Majesky, Mark W.] Seattle Childrens Res Inst, Seattle, WA 98101 USA	University of Virginia; Seattle Children's Hospital	Somlyo, AV (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	avs5u@virginia.edu	Artamonov, Mykhaylo/AAD-3488-2021	Artamonov, Mykhaylo/0000-0002-0848-2054; Majesky, Mark/0000-0003-4267-6220	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086457] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL123650] Funding Source: Medline; NIGMS NIH HHS [R01 GM086457] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artamonov MV, 2013, J BIOL CHEM, V288, P34030, DOI 10.1074/jbc.M113.514596; Austin AF, 2008, DEV DYNAM, V237, P366, DOI 10.1002/dvdy.21421; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Birukova AA, 2008, J CELL PHYSIOL, V215, P715, DOI 10.1002/jcp.21354; Bregeon J, 2009, AM J PHYSIOL-CELL PH, V297, pC1062, DOI 10.1152/ajpcell.00174.2009; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cario-Toumaniantz C, 2003, J PHYSIOL-LONDON, V552, P403, DOI 10.1113/jphysiol.2003.047738; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Dokic D, 2006, DEV BIOL, V299, P489, DOI 10.1016/j.ydbio.2006.08.054; Dunkerley HA, 2002, MOL PHARMACOL, V61, P1033, DOI 10.1124/mol.61.5.1033; Foster R, 1996, MOL CELL BIOL, V16, P2689; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Goh LL, 2012, J BIOL CHEM, V287, P31311, DOI 10.1074/jbc.M111.327056; Gong MC, 1997, J BIOL CHEM, V272, P10704; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Kolosionek E, 2009, MOL BIOL CELL, V20, P4751, DOI 10.1091/mbc.E09-01-0019; Landerholm TE, 1999, DEVELOPMENT, V126, P2053; Lonjedo M, 2013, J BIOL CHEM, V288, P30872, DOI 10.1074/jbc.M113.511105; Lu J, 2001, DEV BIOL, V240, P404, DOI 10.1006/dbio.2001.0403; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Mack CP, 1999, CIRC RES, V84, P852; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Momotani K, 2008, BIOCHEM J, V412, P265, DOI 10.1042/BJ20071501; Momotani K, 2012, TRENDS CARDIOVAS MED, V22, P122, DOI 10.1016/j.tcm.2012.07.007; Momotani K, 2011, CIRC RES, V109, P993, DOI 10.1161/CIRCRESAHA.111.248898; Morabito CJ, 2001, DEV BIOL, V234, P204, DOI 10.1006/dbio.2001.0254; Mori K, 2009, J BIOL CHEM, V284, P5067, DOI 10.1074/jbc.M806853200; Munoz-Chapuli R, 2002, TEX HEART I J, V29, P243; Neppl RL, 2009, J BIOL CHEM, V284, P6348, DOI 10.1074/jbc.M807040200; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Patel TB, 2004, PHARMACOL REV, V56, P371, DOI 10.1124/pr.56.3.4; PerezPomares JM, 1997, DEV DYNAM, V210, P96, DOI 10.1002/(SICI)1097-0177(199710)210:2<96::AID-AJA3>3.0.CO;2-4; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; Roscioni SS, 2011, J CELL MOL MED, V15, P1551, DOI 10.1111/j.1582-4934.2010.01150.x; Rossman KL, 2003, J BIOL CHEM, V278, P18393, DOI 10.1074/jbc.M300127200; Santibanez JF, 2003, INT J CANCER, V107, P715, DOI 10.1002/ijc.11457; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; Shankaranarayanan A, 2010, CELL SIGNAL, V22, P1114, DOI 10.1016/j.cellsig.2010.03.006; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Tang XL, 2010, CIRC J, V74, P390, DOI 10.1253/circj.CJ-09-0923; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; Tsapara A, 2010, MOL BIOL CELL, V21, P860, DOI 10.1091/mbc.E09-07-0567; van Triest Miranda, 2004, Methods Mol Biol, V250, P97; Wada AM, 2003, CIRC RES, V92, P525, DOI 10.1161/01.RES.0000060484.11032.0B; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Winter EM, 2007, CELL MOL LIFE SCI, V64, P692, DOI 10.1007/s00018-007-6522-3; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Wuertz CM, 2010, FASEB J, V24, P4865, DOI 10.1096/fj.10-155499; Yamada T, 2005, J BIOL CHEM, V280, P33026, DOI 10.1074/jbc.M504587200; Zhang AH, 2006, AM J PHYSIOL-RENAL, V291, pF1332, DOI 10.1152/ajprenal.00131.2006; Zhou B, 2008, REGEN MED, V3, P633, DOI 10.2217/17460751.3.5.633; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zieba BJ, 2011, J BIOL CHEM, V286, P16681, DOI 10.1074/jbc.M110.205062	65	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10353	10367		10.1074/jbc.M114.613190	http://dx.doi.org/10.1074/jbc.M114.613190			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25733666	Green Published, hybrid			2022-12-28	WOS:000353241100037
J	Chen, GY; Arginteanu, DFJ; Hancock, WO				Chen, Geng-Yuan; Arginteanu, David F. J.; Hancock, William O.			Processivity of the Kinesin-2 KIF3A Results from Rear Head Gating and Not Front Head Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Kinesin; Microtubule; Intracellular Trafficking; Enzyme Kinetics; Single-molecule Biophysics; Molecular Motor; Cilia	STIMULATED ATP HYDROLYSIS; MOTOR PROTEIN; INTRACELLULAR-TRANSPORT; SUPERFAMILY PROTEIN; MICROTUBULE; MECHANISM; DOMAIN; FORCE; KINETICS; COORDINATION	The kinesin-2 family motor KIF3A/B works together with dynein to bidirectionally transport intraflagellar particles, melanosomes, and neuronal vesicles. Compared with kinesin-1, kinesin-2 is less processive, and its processivity is more sensitive to load, suggesting that processivity may be controlled by different gating mechanisms. We used stopped-flow and steady-state kinetics experiments, along with single-molecule and multimotor assays to characterize the entire kinetic cycle of a KIF3A homodimer that exhibits motility similar to that of full-length KIF3A/B. Upon first encounter with a microtubule, the motor rapidly exchanges both mADP and mATP. When adenosine 5-[(,)-imido]triphosphate was used to entrap the motor in a two-head-bound state, exchange kinetics were unchanged, indicating that rearward strain in the two-head-bound state does not alter nucleotide binding to the front head. A similar lack of front head gating was found when intramolecular strain was enhanced by shortening the neck linker domain from 17 to 14 residues. In single-molecule assays in ADP, the motor dissociates at 2.1 s(-1), 20-fold slower than the stepping rate, demonstrating the presence of rear head gating. In microtubule pelleting assays, the K<sub arrange="stack">D<sup arrange="stack">Mt is similar in ADP and ATP. The data and accompanying simulations suggest that, rather than KIF3A processivity resulting from strain-dependent regulation of nucleotide binding (front head gating), the motor spends a significant fraction of its hydrolysis cycle in a low affinity state but dissociates only slowly from this state. This work provides a mechanism to explain differences in the load-dependent properties of kinesin-1 and kinesin-2.	[Chen, Geng-Yuan; Arginteanu, David F. J.; Hancock, William O.] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hancock, WO (corresponding author), Penn State Univ, Dept Biomed Engn, 205 Hallowell Bldg, University Pk, PA 16802 USA.	wohbio@engr.psu.edu	Hancock, William/E-7653-2016	Hancock, William/0000-0001-5547-8755	National Institutes of Health [R01 GM076476]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM076476 (to W. O. H.).	Albracht CD, 2014, J BIOL CHEM, V289, P27836, DOI 10.1074/jbc.M114.583914; Andreasson J. O., 2015, CURR BIOL IN PRESS; Arpag G, 2014, BIOPHYS J, V107, P1896, DOI 10.1016/j.bpj.2014.09.009; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Brunnbauer M, 2012, MOL CELL, V46, P147, DOI 10.1016/j.molcel.2012.04.005; Brunnbauer M, 2010, P NATL ACAD SCI USA, V107, P10460, DOI 10.1073/pnas.1005177107; Cheng JQ, 1998, BIOCHEMISTRY-US, V37, P5288, DOI 10.1021/bi972742j; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cole DG, 1999, CELL MOL LIFE SCI, V56, P217, DOI 10.1007/s000180050423; Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; DIVITA G, 1993, J BIOL CHEM, V268, P13178; GILBERT SP, 1994, BIOCHEMISTRY-US, V33, P1951, DOI 10.1021/bi00173a044; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hackney DD, 2005, P NATL ACAD SCI USA, V102, P18338, DOI 10.1073/pnas.0505288102; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; HACKNEY DD, 1994, J BIOL CHEM, V269, P16508; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; Hancock WO, 2014, NAT REV MOL CELL BIO, V15, P615, DOI 10.1038/nrm3853; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Hancock WO, 1999, P NATL ACAD SCI USA, V96, P13147, DOI 10.1073/pnas.96.23.13147; Haraguchi K, 2006, J BIOL CHEM, V281, P4094, DOI 10.1074/jbc.M507028200; Hariharan V, 2009, CELL MOL BIOENG, V2, P177, DOI 10.1007/s12195-009-0059-5; Hendricks AG, 2012, CURR BIOL, V22, pR1053, DOI 10.1016/j.cub.2012.11.009; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Hoeprich GJ, 2014, BIOPHYS J, V106, P1691, DOI 10.1016/j.bpj.2014.02.034; HOWARD J, 1995, BIOPHYS J, V68, pS245; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; MA YZ, 1995, BIOCHEMISTRY-US, V34, P13242, DOI 10.1021/bi00040a040; Ma YZ, 1997, J BIOL CHEM, V272, P717, DOI 10.1074/jbc.272.2.717; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; MEYHOFER E, 1995, P NATL ACAD SCI USA, V92, P574, DOI 10.1073/pnas.92.2.574; Milic B, 2014, P NATL ACAD SCI USA, V111, P14136, DOI 10.1073/pnas.1410943111; Moffitt JR, 2010, METHOD ENZYMOL, V475, P221, DOI 10.1016/S0076-6879(10)75010-2; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Muthukrishnan G, 2009, CURR BIOL, V19, P442, DOI 10.1016/j.cub.2009.01.058; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Romberg L, 1998, J CELL BIOL, V140, P1407, DOI 10.1083/jcb.140.6.1407; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; SCHNAPP BJ, 1990, P NATL ACAD SCI USA, V87, P10053, DOI 10.1073/pnas.87.24.10053; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Schroeder HW, 2012, BIOPHYS J, V103, P48, DOI 10.1016/j.bpj.2012.05.037; Shastry S, 2011, P NATL ACAD SCI USA, V108, P16253, DOI 10.1073/pnas.1102628108; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; Soppina V, 2014, P NATL ACAD SCI USA, V111, P5562, DOI 10.1073/pnas.1400759111; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; SVOBODA K, 1994, P NATL ACAD SCI USA, V91, P11782, DOI 10.1073/pnas.91.25.11782; Toprak E, 2009, P NATL ACAD SCI USA, V106, P12717, DOI 10.1073/pnas.0808396106; Uemura S, 2003, NAT STRUCT BIOL, V10, P308, DOI 10.1038/nsb911; Uppalapati M., 2009, METHODS BIOENGINEERI, P311; Uyeda K, 1997, J BIOL CHEM, V272, P7867, DOI 10.1074/jbc.272.12.7867; Vertommen D, 1996, J BIOL CHEM, V271, P17875, DOI 10.1074/jbc.271.30.17875; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; WOODWARD SKA, 1991, BIOCHEMISTRY-US, V30, P422, DOI 10.1021/bi00216a017; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	67	27	27	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10274	10294		10.1074/jbc.M114.628032	http://dx.doi.org/10.1074/jbc.M114.628032			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25657001	hybrid, Green Published			2022-12-28	WOS:000353241100032
J	Hayes, ML; Dang, KN; Diaz, MF; Mulligan, RM				Hayes, Michael L.; Dang, Kim N.; Diaz, Michael F.; Mulligan, R. Michael			A Conserved Glutamate Residue in the C-terminal Deaminase Domain of Pentatricopeptide Repeat Proteins Is Required for RNA Editing Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytidine Deaminase; Metalloenzyme; RNA-binding Protein; RNA Editing; RNA Metabolism; Chloroplasts; Zinc; DYW Deaminase Domain	CYTIDINE DEAMINASE; PPR PROTEINS; PHYSCOMITRELLA-PATENS; ARABIDOPSIS; SITE; MITOCHONDRIA; ZINC; IDENTIFICATION; TRANSCRIPTS; SUBSTRATE	Background: Pentatricopeptide repeat (PPR) proteins that are required for RNA editing frequently include a C-terminal DYW deaminase domain. Results: Mutagenesis of a glutamate residue in the conserved deaminase HXE motif results in loss of editing activity. Conclusion: The glutamate residue is required for editing. Significance: The DYW deaminase domain of PPR proteins has the molecular characteristics of a deaminase. Many transcripts expressed from plant organelle genomes are modified by C-to-U RNA editing. Nuclear encoded pentatricopeptide repeat (PPR) proteins include an RNA binding domain that provides site specificity. In addition, many PPR proteins include a C-terminal DYW deaminase domain with characteristic zinc binding motifs (CXXC, HXE) and has recently been shown to bind zinc ions. The glutamate residue of the HXE motif is catalytically required in the reaction catalyzed by cytidine deaminase. In this work, we examine the activity of the DYW deaminase domain through truncation or mutagenesis of the HXE motif. OTP84 is required for editing three chloroplast sites, and transgenes expressing OTP84 with C-terminal truncations were capable of editing only one of the three cognate sites at high efficiency. These results suggest that the deaminase domain of OTP84 is required for editing two of the sites, but another deaminase is able to supply the deamination activity for the third site. OTP84 and CREF7 transgenes were mutagenized to replace the glutamate residue of the HXE motif, and transgenic plants expressing OTP84-E824A and CREF7-E554A were unable to efficiently edit the cognate editing sites for these genes. In addition, plants expressing CREF7-E554A exhibited substantially reduced capacity to edit a non-cognate site, rpoA C200. These results indicate that the DYW deaminase domains of PPR proteins are involved in editing their cognate editing sites, and in some cases may participate in editing additional sites in the chloroplast.	[Hayes, Michael L.; Dang, Kim N.; Diaz, Michael F.; Mulligan, R. Michael] Univ Calif Irvine, Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Mulligan, RM (corresponding author), Univ Calif Irvine, 5217 McGaugh Hall, Irvine, CA 92697 USA.	rmmullig@uci.edu			National Science Foundation [MCB-0929423, DGE-1321846]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0929423 (to R. M. M.). In addition, this material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant DGE-1321846 (to M. F. D.).	Andres C, 2007, PHYSIOL PLANTARUM, V129, P14, DOI 10.1111/j.1399-3054.2006.00766.x; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bentolila S, 2008, GENETICS, V178, P1693, DOI 10.1534/genetics.107.073585; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Boussardon C, 2014, NEW PHYTOL, V203, P1090, DOI 10.1111/nph.12928; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Bransteitter R, 2009, CELL MOL LIFE SCI, V66, P3137, DOI 10.1007/s00018-009-0070-y; Carlow DC, 1998, BIOCHEMISTRY-US, V37, P1199, DOI 10.1021/bi971731n; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COVELLO PS, 1989, NATURE, V341, P662, DOI 10.1038/341662a0; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Fraley R. T., 1985, NAT BIOTECHNOL, DOI [10.1038/nbt0785-62, DOI 10.1038/NBT0785-62]; Goodman RA, 2012, CURR TOP MICROBIOL, V353, P1, DOI 10.1007/82_2011_144; GUALBERTO JM, 1989, NATURE, V341, P660, DOI 10.1038/341660a0; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Hayes ML, 2007, METHOD ENZYMOL, V424, P459, DOI 10.1016/S0076-6879(07)24021-2; Hayes ML, 2013, J BIOL CHEM, V288, P36519, DOI 10.1074/jbc.M113.485755; Hegeman CE, 2005, PLANT J, V42, P124, DOI 10.1111/j.1365-313X.2005.02360.x; Hirose T, 2001, EMBO J, V20, P1144, DOI 10.1093/emboj/20.5.1144; Iyer LM, 2011, NUCLEIC ACIDS RES, V39, P9473, DOI 10.1093/nar/gkr691; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Nakajima Y, 2005, J PLANT PHYSIOL, V162, P1347, DOI 10.1016/j.jplph.2005.02.009; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Okuda K, 2014, PLANT J, V80, P870, DOI 10.1111/tpj.12687; Okuda K, 2010, PLANT J, V61, P339, DOI 10.1111/j.1365-313X.2009.04059.x; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; RAJASEKHAR VK, 1993, PLANT CELL, V5, P1843, DOI 10.2307/3869699; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Roberson LM, 2006, RNA, V12, P1907, DOI 10.1261/rna.166906; Rudinger M, 2011, PLANT J, V67, P370, DOI 10.1111/j.1365-313X.2011.04600.x; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Spears JL, 2011, J BIOL CHEM, V286, P20366, DOI 10.1074/jbc.M111.243568; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tseng CC, 2010, PLANT MOL BIOL, V73, P309, DOI 10.1007/s11103-010-9616-5; Uchida M, 2011, FEBS LETT, V585, P2367, DOI 10.1016/j.febslet.2011.06.009; Verbitskiy D, 2010, PLANT SIGNAL BEHAV, V5, P558, DOI 10.4161/psb.11095; Wagoner JA, 2015, J BIOL CHEM, V290, P2957, DOI 10.1074/jbc.M114.622084; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101; Yagi Y, 2013, RNA BIOL, V10, P1419, DOI 10.4161/rna.24908; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; YU W, 1995, J BIOL CHEM, V270, P18227, DOI 10.1074/jbc.270.31.18227; Zehrmann A, 2011, RNA BIOL, V8, P67, DOI 10.4161/rna.8.1.14298	50	51	52	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10136	10142		10.1074/jbc.M114.631630	http://dx.doi.org/10.1074/jbc.M114.631630			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25739442	Green Published, hybrid			2022-12-28	WOS:000353241100020
J	Stojanoski, V; Chow, DC; Hu, LY; Sankaran, B; Gilbert, HF; Prasad, BVV; Palzkill, T				Stojanoski, Vlatko; Chow, Dar-Chone; Hu, Liya; Sankaran, Banumathi; Gilbert, Hiram F.; Prasad, B. V. Venkataram; Palzkill, Timothy			A Triple Mutant in the Omega-loop of TEM-1 beta-Lactamase Changes the Substrate Profile via a Large Conformational Change and an Altered General Base for Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotic Resistance; Enzyme Catalysis; Enzyme Kinetics; Enzyme Structure; Protein Stability; Protein Structure; X-ray Crystallography; Beta-Lactamase; Enzyme Evolution	SITE-DIRECTED MUTAGENESIS; ACYL-ENZYME INTERMEDIATE; ESCHERICHIA-COLI; STRUCTURAL-CHARACTERIZATION; ANTIBIOTIC-RESISTANCE; CRYSTAL-STRUCTURE; EVOLUTION; HYDROLYSIS; MECHANISM; SUBSTITUTIONS	beta-Lactamases are bacterial enzymes that hydrolyze -lactam antibiotics. TEM-1 is a prevalent plasmid-encoded -lactamase in Gram-negative bacteria that efficiently catalyzes the hydrolysis of penicillins and early cephalosporins but not oxyimino-cephalosporins. A previous random mutagenesis study identified a W165Y/E166Y/P167G triple mutant that displays greatly altered substrate specificity with increased activity for the oxyimino-cephalosporin, ceftazidime, and decreased activity toward all other -lactams tested. Surprisingly, this mutant lacks the conserved Glu-166 residue critical for enzyme function. Ceftazidime contains a large, bulky side chain that does not fit optimally in the wild-type TEM-1 active site. Therefore, it was hypothesized that the substitutions in the mutant expand the binding site in the enzyme. To investigate structural changes and address whether there is an enlargement in the active site, the crystal structure of the triple mutant was solved to 1.44 angstrom. The structure reveals a large conformational change of the active site -loop structure to create additional space for the ceftazidime side chain. The position of the hydroxyl group of Tyr-166 and an observed shift in the pH profile of the triple mutant suggests that Tyr-166 participates in the hydrolytic mechanism of the enzyme. These findings indicate that the highly conserved Glu-166 residue can be substituted in the mechanism of serine -lactamases. The results reveal that the robustness of the overall -lactamase fold coupled with the plasticity of an active site loop facilitates the evolution of enzyme specificity and mechanism.	[Stojanoski, Vlatko; Hu, Liya; Gilbert, Hiram F.; Prasad, B. V. Venkataram; Palzkill, Timothy] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Stojanoski, Vlatko; Chow, Dar-Chone; Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Sankaran, Banumathi] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Adv Light Source, Berkeley, CA 94720 USA	Baylor College of Medicine; Baylor College of Medicine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Palzkill, T (corresponding author), Baylor Coll Med, Dept Pharmacol, One Baylor Plaza, Houston, TX 77030 USA.	timothyp@bcm.edu		Prasad, B.V.Venkataram/0000-0002-1172-2071	National Institutes of Health [AI32956]; NIGMS, National Institutes of Health; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy [DE-AC02-05CH11231]; NIH [T32 AI55449]; Robert Welch Foundation [Q1279]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI032956, R01AI032956, R37AI032956, T32AI055449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI32956 (to T. P.). This work was also supported by funds from NIGMS, National Institutes of Health and the Howard Hughes Medical Institute (to Berkeley Center for Structural Biology) and Contract DE-AC02-05CH11231 from the Director of the Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy (to Advanced Light Source). V. S. was supported by NIH training Grant T32 AI55449.; Supported by Robert Welch Foundation Grant Q1279.	ADACHI H, 1991, J BIOL CHEM, V266, P3186; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Antunes NT, 2011, BIOCHEMISTRY-US, V50, P6387, DOI 10.1021/bi200403e; Atanasov BP, 2000, P NATL ACAD SCI USA, V97, P3160, DOI 10.1073/pnas.060027897; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BOWDEN GA, 1991, BIO-TECHNOL, V9, P725, DOI 10.1038/nbt0891-725; Brown NG, 2009, J BIOL CHEM, V284, P33703, DOI 10.1074/jbc.M109.053819; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Cantu C, 1997, J BIOL CHEM, V272, P29144, DOI 10.1074/jbc.272.46.29144; CHARNAS RL, 1981, BIOCHEMISTRY-US, V20, P2732, DOI 10.1021/bi00513a005; Chen CCH, 1999, PROTEIN ENG, V12, P573, DOI 10.1093/protein/12.7.573; CITRI N, 1976, P NATL ACAD SCI USA, V73, P1048, DOI 10.1073/pnas.73.4.1048; DELAIRE M, 1991, PROTEIN ENG, V4, P805, DOI 10.1093/protein/4.7.805; Dubus A, 1996, PROTEINS, V25, P473, DOI 10.1002/prot.7; DUBUS A, 1994, BIOCHEMISTRY-US, V33, P8577, DOI 10.1021/bi00194a024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESCOBAR WA, 1994, BIOCHEMISTRY-US, V33, P7619, DOI 10.1021/bi00190a015; ESCOBAR WA, 1991, BIOCHEMISTRY-US, V30, P10783, DOI 10.1021/bi00108a025; Fisette O, 2010, BIOPHYS J, V98, P637, DOI 10.1016/j.bpj.2009.08.061; Fisher JF, 2009, CURR PROTEIN PEPT SC, V10, P401, DOI 10.2174/138920309789351967; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; FRERE JM, 1981, BIOCHEM PHARMACOL, V30, P549, DOI 10.1016/0006-2952(81)90124-6; Golemi-Kotra D, 2004, J BIOL CHEM, V279, P34665, DOI 10.1074/jbc.M313143200; Hata M, 2005, J PHYS CHEM B, V109, P16153, DOI 10.1021/jp045403q; Hata M, 2006, BIOL PHARM BULL, V29, P2151, DOI 10.1248/bpb.29.2151; Huang WZ, 1997, P NATL ACAD SCI USA, V94, P8801, DOI 10.1073/pnas.94.16.8801; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; KIENER PA, 1980, EUR J BIOCHEM, V109, P575, DOI 10.1111/j.1432-1033.1980.tb04830.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lipski A, 2013, ACTA CRYSTALLOGR D, V69, P298, DOI 10.1107/S0907444912045532; Marciano DC, 2008, J MOL BIOL, V384, P151, DOI 10.1016/j.jmb.2008.09.009; Massova I, 1998, ANTIMICROB AGENTS CH, V42, P1; Maveyraud L, 1996, J BIOL CHEM, V271, P10482, DOI 10.1074/jbc.271.18.10482; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Page MGP, 2008, CLIN MICROBIOL INFEC, V14, P63, DOI 10.1111/j.1469-0691.2007.01863.x; Page MI, 1999, CURR PHARM DESIGN, V5, P895; PALZKILL T, 1994, MOL MICROBIOL, V12, P217, DOI 10.1111/j.1365-2958.1994.tb01011.x; PERSAUD KC, 1986, BIOCHEM J, V237, P723, DOI 10.1042/bj2370723; Petrosino JF, 1996, J BACTERIOL, V178, P1821, DOI 10.1128/jb.178.7.1821-1828.1996; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Phillips Kevin, 2011, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1028s94; Pimenta AC, 2014, MINI-REV MED CHEM, V14, P111, DOI 10.2174/1389557514666140123145809; RAQUET X, 1994, J MOL BIOL, V244, P625, DOI 10.1006/jmbi.1994.1756; Salverda MLM, 2010, FEMS MICROBIOL REV, V34, P1015, DOI 10.1111/j.1574-6976.2010.00222.x; Sideraki V, 2001, P NATL ACAD SCI USA, V98, P283, DOI 10.1073/pnas.011454198; Sosa-Peinado A, 2000, PROTEIN EXPRES PURIF, V19, P235, DOI 10.1006/prep.2000.1243; SOWEK JA, 1991, BIOCHEMISTRY-US, V30, P3179, DOI 10.1021/bi00227a004; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vakulenko SB, 1999, J BIOL CHEM, V274, P23052, DOI 10.1074/jbc.274.33.23052; Vanhove M, 1996, PROTEINS, V25, P104, DOI 10.1002/(SICI)1097-0134(199605)25:1<104::AID-PROT8>3.3.CO;2-H; WAHL RC, 1994, ANAL BIOCHEM, V219, P383, DOI 10.1006/abio.1994.1284; WALEY SG, 1991, BIOCHEM J, V279, P87, DOI 10.1042/bj2790087; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zawadzke LE, 1996, BIOCHEMISTRY-US, V35, P16475, DOI 10.1021/bi962242a	62	36	40	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10382	10394		10.1074/jbc.M114.633438	http://dx.doi.org/10.1074/jbc.M114.633438			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25713062	hybrid, Green Published			2022-12-28	WOS:000353241100039
J	Ho, CY; Choy, CH; Wattson, CA; Johnson, DE; Botelho, RJ				Ho, Cheuk Y.; Choy, Christopher H.; Wattson, Christina A.; Johnson, Danielle E.; Botelho, Roberto J.			The Fab1/PIKfyve Phosphoinositide Phosphate Kinase Is Not Necessary to Maintain the pH of Lysosomes and of the Yeast Vacuole	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID KINASE; PIKFYVE; PROTEIN; COMPLEX; STRESS; MECHANISM; DEGRADATION; ENDOCYTOSIS; TRAFFICKING; CHLOROQUINE	Lysosomes and the yeast vacuole are degradative and acidic organelles. Phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5) P-2), a master architect of endolysosome and vacuole identity, is thought to be necessary for vacuolar acidification in yeast. There is also evidence that PtdIns(3,5) P-2 may play a role in lysosomal acidification in higher eukaryotes. Nevertheless, these conclusions rely on qualitative assays of lysosome/vacuole pH. For example, quinacrine, an acidotropic fluorescent base, does not accumulate in the vacuoles of fab1 Delta yeast. Fab1, along with its mammalian ortholog PIKfyve, is the lipid kinase responsible for synthesizing PtdIns(3,5) P-2. In this study, we employed several assays that quantitatively assessed the lysosomal and vacuolar pH in PtdIns(3,5) P-2-depleted cells. Using ratiometric imaging, we conclude that lysosomes retain apH< 5 in PIKfyve-inhibited mammalian cells. In addition, quantitative fluorescence microscopy of vacuole-targeted pHluorin, a pH-sensitive GFP variant, indicates that fab1 Delta vacuoles are as acidic as wild-type yeast. Importantly, we also employed fluorimetry of vacuoles loaded with cDCFDA, a pH-sensitive dye, to show that both wild-type and fab1 Delta vacuoles have a pH < 5.0. In comparison, the vacuolar pH of the V-ATPase mutant vph1 Delta or vph1 Delta fab1 Delta double mutant was 6.1. Although the steady-state vacuolar pH is not affected by PtdIns(3,5) P-2 depletion, it may have a role in stabilizing the vacuolar pH during salt shock. Overall, we propose a model in which PtdIns(3,5) P-2 does not govern the steady-state pH of vacuoles or lysosomes.	[Ho, Cheuk Y.; Choy, Christopher H.; Wattson, Christina A.; Botelho, Roberto J.] Ryerson Univ, Dept Biol & Chem, 350 Victoria St, Toronto, ON M5B 2K3, Canada; [Ho, Cheuk Y.; Choy, Christopher H.; Botelho, Roberto J.] Ryerson Univ, Mol Sci Program, Toronto, ON M5B 2K3, Canada; [Johnson, Danielle E.; Botelho, Roberto J.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada	Toronto Metropolitan University; Toronto Metropolitan University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Botelho, RJ (corresponding author), Ryerson Univ, Dept Biol & Chem, 350 Victoria St, Toronto, ON M5B 2K3, Canada.	rbotelho@ryerson.ca	Botelho, Roberto J/B-9145-2013	Botelho, Roberto J/0000-0002-7820-0999; Ho, Shannon/0000-0001-9301-3430	Natural Sciences and Engineering Research Council of Canada; Ontario Government	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Government	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (to R. J. B.).r Supported by a graduate scholarship from the Ontario Government.	Alghamdi TA, 2013, J BIOL CHEM, V288, P9363, DOI 10.1074/jbc.M113.453712; Babich V, 2013, FASEB J, V27, P4646, DOI 10.1096/fj.12-225466; BENZ R, 1983, BIOPHYS J, V41, P381, DOI 10.1016/S0006-3495(83)84449-X; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Bonangelino CJ, 1997, MOL CELL BIOL, V17, P6847, DOI 10.1128/MCB.17.12.6847; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Botelho RJ, 2000, J BIOL CHEM, V275, P15717, DOI 10.1074/jbc.M910068199; Botelho RJ, 2008, MOL BIOL CELL, V19, P4273, DOI 10.1091/mbc.E08-04-0405; Cai XM, 2014, J IMMUNOL, V192, P3383, DOI 10.4049/jimmunol.1302411; Cai XM, 2013, CHEM BIOL, V20, P912, DOI 10.1016/j.chembiol.2013.05.010; Cao Q, 2014, J BIOL CHEM, V289, P23189, DOI 10.1074/jbc.M114.567107; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; de Lartigue J, 2009, TRAFFIC, V10, P883, DOI 10.1111/j.1600-0854.2009.00915.x; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Graham LA, 2000, J EXP BIOL, V203, P61; Guha S, 2014, EXP EYE RES, V126, P68, DOI 10.1016/j.exer.2014.05.013; Harrison TS, 2002, MED MYCOL, V40, P329, DOI 10.1080/mmy.40.3.329.332; Hayashi H, 2002, J BIOL CHEM, V277, P11090, DOI 10.1074/jbc.M111868200; Hazeki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073894; Ho CY, 2012, TRAFFIC, V13, P1, DOI 10.1111/j.1600-0854.2011.01246.x; HO MN, 1993, J BIOL CHEM, V268, P18286; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Ikonomov NC, 2007, EXP CELL RES, V313, P2404, DOI 10.1016/j.yexcr.2007.03.024; Ikonomov OC, 2003, MOL BIOL CELL, V14, P4581, DOI 10.1091/mbc.E03-04-0222; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; KASIANOWICZ J, 1984, J MEMBRANE BIOL, V82, P179, DOI 10.1007/BF01868942; Kim GHE, 2014, TRAFFIC, V15, P1143, DOI 10.1111/tra.12199; Kiselyov K, 2011, CELL CALCIUM, V50, P288, DOI 10.1016/j.ceca.2011.04.009; KLIONSKY DJ, 1992, J BIOL CHEM, V267, P3416; KROGSTAD DJ, 1985, J CELL BIOL, V101, P2302, DOI 10.1083/jcb.101.6.2302; Lamb TM, 2001, J BIOL CHEM, V276, P1850, DOI 10.1074/jbc.M008381200; Leng XH, 1998, J BIOL CHEM, V273, P6717, DOI 10.1074/jbc.273.12.6717; Li SC, 2014, MOL BIOL CELL, V25, P1251, DOI 10.1091/mbc.E13-10-0563; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LullmannRauch R, 1996, TOXICOLOGY, V110, P27, DOI 10.1016/0300-483X(96)03319-7; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; Marshansky V, 2007, BIOCHEM SOC T, V35, P1092, DOI 10.1042/BST0351092; McCartney AJ, 2014, BIOESSAYS, V36, P52, DOI 10.1002/bies.201300012; Menant A, 2006, EMBO J, V25, P4436, DOI 10.1038/sj.emboj.7601330; Miseta A, 1999, FEBS LETT, V451, P132, DOI 10.1016/S0014-5793(99)00519-0; Nicot AS, 2006, MOL BIOL CELL, V17, P3062, DOI 10.1091/mbc.e05-12-1120; Obara K, 2012, J BIOL CHEM, V287, P38473, DOI 10.1074/jbc.M112.394205; Prosser DC, 2010, TRAFFIC, V11, P1141, DOI 10.1111/j.1600-0854.2010.01088.x; Ruivo R, 2009, BBA-MOL CELL RES, V1793, P636, DOI 10.1016/j.bbamcr.2008.12.008; Russnak R, 2001, J BIOL CHEM, V276, P23849, DOI 10.1074/jbc.M008028200; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Sambade M, 2005, GENETICS, V170, P1539, DOI 10.1534/genetics.105.042812; Schneider L, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-14; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Tanabe M, 2001, J BIOL CHEM, V276, P15269, DOI 10.1074/jbc.M100289200; VIK SB, 1994, J BIOL CHEM, V269, P30364; ZHANG JM, 1992, J BIOL CHEM, V267, P9773	62	34	36	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9919	9928		10.1074/jbc.M114.613984	http://dx.doi.org/10.1074/jbc.M114.613984			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713145	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000352729400050
J	Kuwabara, N; Minami, R; Yokota, N; Matsumoto, H; Senda, T; Kawahara, H; Kato, R				Kuwabara, Naoyuki; Minami, Ryosuke; Yokota, Naoto; Matsumoto, Hirofumi; Senda, Toshiya; Kawahara, Hiroyuki; Kato, Ryuichi			Structure of a BAG6 (Bcl-2-associated Athanogene 6)-Ubl4a (Ubiquitin-like Protein 4a) Complex Reveals a Novel Binding Interface That Functions in Tail-anchored Protein Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; CIRCULAR-DICHROISM; GET4/GET5 COMPLEX; MEMBRANE-PROTEINS; DOMAIN; CHAPERONE; PROTEASOME; SCYTHE; GET3	BAG6 is an essential protein that functions in two distinct biological pathways, ubiquitin-mediated protein degradation of defective polypeptides and tail-anchored (TA) transmembrane protein biogenesis in mammals, although its structural and functional properties remain unknown. We solved a crystal structure of the C-terminal heterodimerization domains of BAG6 and Ubl4a and characterized their interaction biochemically. Unexpectedly, the specificity and structure of the C terminus of BAG6, which was previously classified as a BAG domain, were completely distinct from those of the canonical BAG domain. Furthermore, the tight association of BAG6 and Ubl4a resulted in modulation of Ubl4a protein stability in cells. Therefore, we propose to designate the Ubl4a-binding region of BAG6 as the novel BAG-similar (BAGS) domain. The structure of Ubl4a, which interacts with BAG6, is similar to the yeast homologue Get 5, which forms a homodimer. These observations indicate that the BAGS domain of BAG6 promotes the TA protein biogenesis pathway in mammals by the interaction with Ubl4a.	[Kuwabara, Naoyuki; Senda, Toshiya; Kato, Ryuichi] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, Photon Factory, Struct Biol Res Ctr, Tsukuba, Ibaraki 3050801, Japan; [Minami, Ryosuke; Yokota, Naoto; Matsumoto, Hirofumi; Kawahara, Hiroyuki] Tokyo Metropolitan Univ, Dept Biol Sci, 7-1 Minami Osawa, Hachioji, Tokyo 7920397, Japan	High Energy Accelerator Research Organization (KEK); Tokyo Metropolitan University	Kawahara, H (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, 7-1 Minami Osawa, Hachioji, Tokyo 7920397, Japan.	hkawa@tmu.ac.jp; ryuichi.kato@kek.jp		Kuwabara, Naoyuki/0000-0002-1659-323X; Kato, Ryuichi/0000-0003-2087-2896; Senda, Toshiya/0000-0002-5153-928X	Ministry of Education, Culture, Science, and Technology of Japan; Uehara Memorial Foundation; Naito Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [25840038, 26840029] Funding Source: KAKEN	Ministry of Education, Culture, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants (Ubiquitin Neobiology) from the Ministry of Education, Culture, Science, and Technology of Japan, the Uehara Memorial Foundation, and the Naito Foundation. This work was also supported by the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	BANERJI J, 1990, P NATL ACAD SCI USA, V87, P2374, DOI 10.1073/pnas.87.6.2374; Binici J, 2014, CELL MOL LIFE SCI, V71, P1829, DOI 10.1007/s00018-013-1522-y; Briknarova K, 2002, J BIOL CHEM, V277, P31172, DOI 10.1074/jbc.M202792200; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2012, CELL REP, V2, P1620, DOI 10.1016/j.celrep.2012.10.010; Chartron JW, 2012, CURR OPIN STRUC BIOL, V22, P217, DOI 10.1016/j.sbi.2012.03.001; Chartron JW, 2012, J BIOL CHEM, V287, P8310, DOI 10.1074/jbc.M111.333252; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Claessen JHL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028542; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Corduan A, 2009, CELL MOL LIFE SCI, V66, P1998, DOI 10.1007/s00018-009-9198-z; Darby JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113281; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hammersley A. P., 1997, ESRF97HA02T; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Hiraki M, 2006, ACTA CRYSTALLOGR D, V62, P1058, DOI 10.1107/S0907444906023821; Johnson N, 2013, BBA-MOL CELL RES, V1833, P2403, DOI 10.1016/j.bbamcr.2012.12.008; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawahara H, 2013, J BIOCHEM, V153, P147, DOI 10.1093/jb/mvs149; Kikukawa Y, 2005, FEBS J, V272, P6373, DOI 10.1111/j.1742-4658.2005.05032.x; Lee JG, 2013, BIOESSAYS, V35, P377, DOI 10.1002/bies.201200159; Leznicki P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059590; Leznicki P, 2012, P NATL ACAD SCI USA, V109, P19214, DOI 10.1073/pnas.1209997109; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Liou ST, 2007, CELL STRESS CHAPERON, V12, P59, DOI 10.1379/CSC-220R.1; Liu YF, 2014, ELIFE, V3, DOI 10.7554/eLife.01369; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Minami R, 2007, BIOCHEM J, V405, P495, DOI 10.1042/BJ20061886; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Mock JY, 2015, P NATL ACAD SCI USA, V112, P106, DOI 10.1073/pnas.1402745112; Simpson PJ, 2010, STRUCTURE, V18, P897, DOI 10.1016/j.str.2010.07.003; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; Thress K, 2001, EMBO J, V20, P1033, DOI 10.1093/emboj/20.5.1033; TONIOLO D, 1988, P NATL ACAD SCI USA, V85, P851, DOI 10.1073/pnas.85.3.851; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Xu Y, 2013, J BIOL CHEM, V288, P18068, DOI 10.1074/jbc.M112.449199; Xu Y, 2012, CELL REP, V2, P1633, DOI 10.1016/j.celrep.2012.11.010	48	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9387	9398		10.1074/jbc.M114.631804	http://dx.doi.org/10.1074/jbc.M114.631804			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713138	hybrid, Green Published			2022-12-28	WOS:000352729400008
J	Pelletan, LE; Suhaiman, L; Vaquer, CC; Bustos, MA; De Blas, GA; Vitale, N; Mayorga, LS; Belmonte, SA				Pelletan, Leonardo E.; Suhaiman, Laila; Vaquer, Cintia C.; Bustos, Matias A.; De Blas, Gerardo A.; Vitale, Nicolas; Mayorga, Luis S.; Belmonte, Silvia A.			ADP Ribosylation Factor 6 (ARF6) Promotes Acrosomal Exocytosis by Modulating Lipid Turnover and Rab3A Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; CALCIUM-REGULATED EXOCYTOSIS; PHOSPHOLIPASE C-EPSILON; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; HUMAN SPERM; MOUSE SPERM; HUMAN SPERMATOZOA; CHROMAFFIN CELLS; NEUROENDOCRINE CELLS	Regulated secretion is a central issue for the specific function of many cells; for instance, mammalian sperm acrosomal exocytosis is essential for egg fertilization. ARF6 (ADP-ribosylation factor 6) is a small GTPase implicated in exocytosis, but its downstream effectors remain elusive in this process. We combined biochemical, functional, and microscopy-based methods to show that ARF6 is present in human sperm, localizes to the acrosomal region, and is required for calcium and diacylglycerol-induced exocytosis. Results from pulldown assays show that ARF6 exchanges GDP for GTP in sperm challenged with different exocytic stimuli. Myristoylated and guanosine 5'-3-O(thio) triphosphate (GTP gamma S)-loaded ARF6 (active form) added to permeabilized sperm induces acrosome exocytosis even in the absence of extracellular calcium. We explore the ARF6 signaling cascade that promotes secretion. We demonstrate that ARF6 stimulates a sperm phospholipase D activity to produce phosphatidic acid and boosts the synthesis of phosphatidylinositol 4,5-bisphosphate. We present direct evidence showing that active ARF6 increases phospholipase C activity, causing phosphatidylinositol 4,5-bisphosphate hydrolysis and inositol 1,4,5-trisphosphate-dependent intra-acrosomal calcium release. We show that active ARF6 increases the exchange of GDP for GTP on Rab3A, a prerequisite for secretion. We propose that exocytic stimuli activate ARF6, which is required for acrosomal calcium efflux and the assembly of the membrane fusion machinery. This report highlights the physiological importance of ARF6 as a key factor for human sperm exocytosis and fertilization.	[Pelletan, Leonardo E.; Suhaiman, Laila; Vaquer, Cintia C.; Bustos, Matias A.; De Blas, Gerardo A.; Mayorga, Luis S.; Belmonte, Silvia A.] Univ Nacl Cuyo, Fac Ciencias Med, Inst Histol & Embriol, CONICET, RA-5500 Mendoza, Argentina; [Vitale, Nicolas] CNRS, Inst Neurosci Cellulaires & Integrat, UPR 3212, Dept Neurotransmiss & Secret Neuroendocrine, F-67084 Strasbourg, France; [Vitale, Nicolas] Univ Strasbourg, F-67084 Strasbourg, France	University Nacional Cuyo Mendoza; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Belmonte, SA (corresponding author), Univ Nacl Cuyo, Fac Ciencias Med, Inst Histol & Embriol, CC56, RA-5500 Mendoza, Argentina.	sbelmont@fcm.uncu.edu.ar	Belmonte, Silvia Alejandra Alejandra/AAW-5131-2021; Vitale, Nicolas/G-5967-2014	Vitale, Nicolas/0000-0002-4752-4907; Mayorga, Luis S/0000-0002-5995-0671; Bustos, Matias A./0000-0001-9625-1127	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 0628]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2010-1789, PICT-2011-2310]; Secretaria de Ciencia y Tecnica; Universidad Nacional de Cuyo [06/J353]; Ministerio de CienciaMinisterio de Ciencia, Tecnologia e Innovacion Productiva de la Republica Argentina; ECOS-Sud France; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina; Agence Nationale de la Recherche [ANR-09-BLAN-0264-01]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Secretaria de Ciencia y Tecnica(Secretaria de Ciencia y Tecnologia (SECYT)); Universidad Nacional de Cuyo; Ministerio de CienciaMinisterio de Ciencia, Tecnologia e Innovacion Productiva de la Republica Argentina; ECOS-Sud France; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported in part by Consejo Nacional de Investigaciones Cientificas y Tecnicas Grant PIP 0628 (to S. A. B.), Agencia Nacional de Promocion Cientifica y Tecnologica Grants PICT-2010-1789 (to S. A. B.) and PICT-2011-2310 (to L. S. M.), Secretaria de Ciencia y Tecnica, Universidad Nacional de Cuyo Grant 06/J353 (to S. A. B.), and Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Republica Argentina and ECOS-Sud France grants (to S. A. B. and N. V.).r Recipients of a fellowship from Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina.r Supported by Grant ANR-09-BLAN-0264-01 from the Agence Nationale de la Recherche.	Ackermann F, 2009, J CELL SCI, V122, P4547, DOI 10.1242/jcs.058263; Arora DK, 2012, ISLETS, V4, P354, DOI 10.4161/isl.22538; Bader MF, 2009, BBA-MOL CELL BIOL L, V1791, P936, DOI 10.1016/j.bbalip.2009.02.016; Baker MA, 2008, PROTEOMICS, V8, P1720, DOI 10.1002/pmic.200701020; Baker MA, 2013, PROTEOMICS, V13, P61, DOI 10.1002/pmic.201200350; Begle A, 2009, J BIOL CHEM, V284, P4836, DOI 10.1074/jbc.M806894200; Bello OD, 2012, EXP CELL RES, V318, P478, DOI 10.1016/j.yexcr.2012.01.002; Belmonte SA, 2005, DEV BIOL, V285, P393, DOI 10.1016/j.ydbio.2005.07.001; Belmonte Silvia A, 2012, Methods Mol Biol, V874, P99, DOI 10.1007/978-1-61779-800-9_9; Bohring C, 1999, ELECTROPHORESIS, V20, P971, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<971::AID-ELPS971>3.0.CO;2-6; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Bustos MA, 2012, P NATL ACAD SCI USA, V109, pE2057, DOI 10.1073/pnas.1121173109; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Caumon AS, 2000, J BIOL CHEM, V275, P15637, DOI 10.1074/jbc.M908347199; Caumont AS, 1998, J BIOL CHEM, V273, P1373, DOI 10.1074/jbc.273.3.1373; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Coppola T, 2002, BIOCHEM J, V362, P273, DOI 10.1042/0264-6021:3620273; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; CROSS NL, 1989, BIOL REPROD, V41, P635, DOI 10.1095/biolreprod41.4.635; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Darszon A, 2005, INT REV CYTOL, V243, P79, DOI 10.1016/S0074-7696(05)43002-8; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Diaz A, 1996, ANDROLOGIA, V28, P21; Donaldson JG, 2005, BIOCHEM SOC T, V33, P1276, DOI 10.1042/BST0331276; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Dong N, 2012, CELL, V150, P1029, DOI 10.1016/j.cell.2012.06.050; Dyer N, 2007, DEVELOPMENT, V134, P4437, DOI 10.1242/dev.010983; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Falkenburger BH, 2013, J GEN PHYSIOL, V141, P537, DOI 10.1085/jgp.201210887; Fukaya M, 2014, J NEUROCHEM, V129, P21, DOI 10.1111/jnc.12524; Funakoshi Y, 2011, J CELL PHYSIOL, V226, P888, DOI 10.1002/jcp.22482; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Guo XJ, 2010, J PROTEOME RES, V9, P1246, DOI 10.1021/pr900735k; Hafez I, 2003, J BIOL CHEM, V278, P44921, DOI 10.1074/jbc.M306013200; Herrick SB, 2005, J CELL PHYSIOL, V202, P663, DOI 10.1002/jcp.20172; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Hu TH, 2011, J CELL MOL MED, V15, P647, DOI 10.1111/j.1582-4934.2010.01035.x; Jungnickel MK, 2007, DEV BIOL, V304, P116, DOI 10.1016/j.ydbio.2006.12.023; Kassas N, 2012, METHOD CELL BIOL, V108, P445, DOI 10.1016/B978-0-12-386487-1.00020-1; Klein S, 2006, J BIOL CHEM, V281, P12352, DOI 10.1074/jbc.M601021200; Lawrence JTR, 2003, P NATL ACAD SCI USA, V100, P13320, DOI 10.1073/pnas.2232129100; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; Lopez CI, 2012, BBA-MOL CELL BIOL L, V1821, P1186, DOI 10.1016/j.bbalip.2012.05.001; Macia E, 2008, J BIOL CHEM, V283, P19836, DOI 10.1074/jbc.M800781200; Zoppino FCM, 2012, FERTIL STERIL, V97, P1309, DOI 10.1016/j.fertnstert.2012.03.002; MASSENBURG D, 1994, P NATL ACAD SCI USA, V91, P11718, DOI 10.1073/pnas.91.24.11718; Mayorga LS, 2007, IUBMB LIFE, V59, P286, DOI 10.1080/15216540701222872; MENDOZA C, 1992, J REPROD FERTIL, V95, P755; Menetrey J, 2000, NAT STRUCT BIOL, V7, P466; Meyer MZ, 2006, J BIOL CHEM, V281, P7919, DOI 10.1074/jbc.M600081200; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Nomikos M, 2005, J BIOL CHEM, V280, P31011, DOI 10.1074/jbc.M500629200; Nomikos M, 2011, BIOCHEM J, V438, P427, DOI 10.1042/BJ20110953; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Powelka AM, 2001, FEBS LETT, V501, P47; POWIS G, 1994, CANCER METAST REV, V13, P91, DOI 10.1007/BF00690420; Randazzo P. A., 2000, SCI STKE; RHEE SG, 1991, TRENDS BIOCHEM SCI, V16, P297, DOI 10.1016/0968-0004(91)90122-C; Roggero CM, 2007, J BIOL CHEM, V282, P26335, DOI 10.1074/jbc.M700854200; Roggero CM, 2005, DEV BIOL, V285, P422, DOI 10.1016/j.ydbio.2005.07.007; Sakagami H, 2008, TOHOKU J EXP MED, V214, P191, DOI 10.1620/tjem.214.191; Sakurai A, 2011, J BIOL CHEM, V286, P34335, DOI 10.1074/jbc.M111.259499; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Schafer DA, 2000, TRAFFIC, V1, P892; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; Schweitzer JK, 2002, J BIOL CHEM, V277, P27210, DOI 10.1074/jbc.M201569200; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; Suhaiman L, 2010, J BIOL CHEM, V285, P16302, DOI 10.1074/jbc.M109.072439; Suzuki R, 2009, J MOL HISTOL, V40, P77, DOI 10.1007/s10735-008-9207-9; Tomes Claudia Nora, 2007, Soc Reprod Fertil Suppl, V65, P275; Tomes CN, 1996, MOL REPROD DEV, V43, P196, DOI 10.1002/(SICI)1098-2795(199602)43:2&lt;196::AID-MRD9&gt;3.0.CO;2-M; Tomes CN, 2005, MOL HUM REPROD, V11, P43, DOI 10.1093/molehr/gah126; Vitale N, 2002, J CELL BIOL, V159, P79, DOI 10.1083/jcb.200203027; Vitale N, 2010, BIOCHEM SOC T, V38, P167, DOI 10.1042/BST0380167; Wang GG, 2013, J PROTEOMICS, V79, P114, DOI 10.1016/j.jprot.2012.12.008; Wang L, 2005, J BIOL CHEM, V280, P16522, DOI 10.1074/jbc.M413263200; Yanagimachi R., 1994, P189; Yoon SY, 2012, HUM REPROD, V27, P1768, DOI 10.1093/humrep/des092; Yunes R, 2000, BIOL REPROD, V62, P1084, DOI 10.1095/biolreprod62.4.1084; Zanetti SR, 2010, BIOCHIMIE, V92, P1778, DOI 10.1016/j.biochi.2010.08.012; Zanetti SR, 2010, BIOCHIMIE, V92, P1886, DOI 10.1016/j.biochi.2010.08.015; Zheng Q, 2005, J NEUROCHEM, V92, P442, DOI 10.1111/j.1471-4159.2004.02897.x; Zheng Q, 2004, NEUROCHEM INT, V45, P633, DOI 10.1016/j.neuint.2004.03.028	92	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9823	9841		10.1074/jbc.M114.629006	http://dx.doi.org/10.1074/jbc.M114.629006			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713146	Green Published, hybrid			2022-12-28	WOS:000352729400042
J	Elmes, MW; Kaczocha, M; Berger, WT; Leung, K; Ralph, BP; Wang, LQ; Sweeney, JM; Miyauchi, JT; Tsirka, SE; Ojima, I; Deutsch, DG				Elmes, Matthew W.; Kaczocha, Martin; Berger, William T.; Leung, KwanNok; Ralph, Brian P.; Wang, Liqun; Sweeney, Joseph M.; Miyauchi, Jeremy T.; Tsirka, Stella E.; Ojima, Iwao; Deutsch, Dale G.			Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Delta(9)-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; PLANT CANNABINOIDS; AMIDE HYDROLASE; CRYSTAL-STRUCTURE; NEUROPATHIC PAIN; CELLULAR UPTAKE; FREE-ENERGIES; DOUBLE-BLIND; ANANDAMIDE; RECEPTORS	Delta(9)-Tetrahydrocannabinol (THC) and cannabidiol (CBD) occur naturally in marijuana (Cannabis) and may be formulated, individually or in combination in pharmaceuticals such as Marinol or Sativex. Although it is known that these hydrophobic compounds can be transported in blood by albumin or lipoproteins, the intracellular carrier has not been identified. Recent reports suggest that CBD and THC elevate the levels of the endocannabinoid anandamide (AEA) when administered to humans, suggesting that phytocannabinoids target cellular proteins involved in endocannabinoid clearance. Fatty acid-binding proteins (FABPs) are intracellular proteins that mediate AEA transport to its catabolic enzyme fatty acid amide hydrolase (FAAH). By computational analysis and ligand displacement assays, we show that at least three human FABPs bind THC and CBD and demonstrate that THC and CBD inhibit the cellular uptake and catabolism of AEA by targeting FABPs. Furthermore, we show that in contrast to rodent FAAH, CBD does not inhibit the enzymatic actions of human FAAH, and thus FAAH inhibition cannot account for the observed increase in circulating AEA in humans following CBD consumption. Using computational molecular docking and site-directed mutagenesis we identify key residues within the active site of FAAH that confer the species-specific sensitivity to inhibition by CBD. Competition for FABPs may in part or wholly explain the increased circulating levels of endocannabinoids reported after consumption of cannabinoids. These data shed light on the mechanism of action of CBD in modulating the endocannabinoid tone in vivo and may explain, in part, its reported efficacy toward epilepsy and other neurological disorders.	[Elmes, Matthew W.; Kaczocha, Martin; Leung, KwanNok; Ralph, Brian P.; Wang, Liqun; Sweeney, Joseph M.; Deutsch, Dale G.] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Dept Biochem & Cell Biol, Stony Brook, NY 11795 USA; [Kaczocha, Martin] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Dept Anesthesiol, Stony Brook, NY 11795 USA; [Berger, William T.; Ojima, Iwao] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Dept Chem, Stony Brook, NY 11795 USA; [Miyauchi, Jeremy T.; Tsirka, Stella E.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11795 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Deutsch, DG (corresponding author), SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Dept Biochem & Cell Biol, Stony Brook, NY 11795 USA.	Dale.Deutsch@Stonybrook.edu	Tsirka, Stella/AAD-4018-2019	Ojima, Iwao/0000-0002-3628-1161; Kaczocha, Martin/0000-0002-2527-1398	National Institutes of Health [DA032232, DA035923, DA035949, DA016419, DA026593, GM007518, GM008444, NS042168]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008468, T32GM007518, T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016419, R01DA035923, R21DA032232, R01DA035949, R03DA026593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA032232, DA035923, DA035949, DA016419, DA026593, GM007518, GM008444, and NS042168.	Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002829; ALOZIE SO, 1980, PHARMACOL BIOCHEM BE, V12, P217, DOI 10.1016/0091-3057(80)90359-7; Balendiran GK, 2000, J BIOL CHEM, V275, P27045; Balius TE, 2011, J COMPUT CHEM, V32, P2273, DOI 10.1002/jcc.21814; Balius TE, 2009, BIOCHEMISTRY-US, V48, P8435, DOI 10.1021/bi900729a; Basavarajappa BS, 2007, CURR NEUROPHARMACOL, V5, P81, DOI 10.2174/157015907780866910; Ben-Shabat S, 1998, EUR J PHARMACOL, V353, P23, DOI 10.1016/S0014-2999(98)00392-6; Bergamaschi MM, 2013, ANAL BIOANAL CHEM, V405, P4679, DOI 10.1007/s00216-013-6837-x; Berger WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050968; Bisogno T, 2001, BRIT J PHARMACOL, V134, P845, DOI 10.1038/sj.bjp.0704327; Bjorklund E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103479; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Case D. A., 2012, AMBER 12; CASE DA, 2004, AMBER8; Collin C, 2007, EUR J NEUROL, V14, P290, DOI 10.1111/j.1468-1331.2006.01639.x; Costa B, 2008, PAIN, V139, P541, DOI 10.1016/j.pain.2008.06.003; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; De Petrocellis L, 2011, BRIT J PHARMACOL, V163, P1479, DOI 10.1111/j.1476-5381.2010.01166.x; Garcia MD, 2009, EUR J PHARMACOL, V610, P75, DOI 10.1016/j.ejphar.2009.03.021; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; Devinsky O, 2014, EPILEPSIA, V55, P791, DOI 10.1111/epi.12631; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Fanali G, 2011, IUBMB LIFE, V63, P446, DOI 10.1002/iub.466; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gomes FV, 2011, PSYCHOPHARMACOLOGY, V213, P465, DOI 10.1007/s00213-010-2036-z; Happyana N, 2013, PHYTOCHEMISTRY, V87, P51, DOI 10.1016/j.phytochem.2012.11.001; Hayakawa K, 2007, NEUROPHARMACOLOGY, V52, P1079, DOI 10.1016/j.neuropharm.2006.11.005; Hohoff C, 1999, BIOCHEMISTRY-US, V38, P12229, DOI 10.1021/bi990305u; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Howlett AC, 2011, BRIT J PHARMACOL, V163, P1329, DOI 10.1111/j.1476-5381.2011.01364.x; Huang YL, 2012, BIOCHEMISTRY-US, V51, P2390, DOI 10.1021/bi2016553; Huestis MA, 2005, HANDB EXP PHARMACOL, V168, P657; Huestis MA, 2007, CHEM BIODIVERS, V4, P1770, DOI 10.1002/cbdv.200790152; HUNT CA, 1981, J PHARMACOKINET BIOP, V9, P245, DOI 10.1007/BF01059266; Iskedjian M, 2007, CURR MED RES OPIN, V23, P17, DOI 10.1185/030079906X158066; Izzo AA, 2009, TRENDS PHARMACOL SCI, V30, P515, DOI 10.1016/j.tips.2009.07.006; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaczocha M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094200; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kaczocha M, 2010, J BIOL CHEM, V285, P2796, DOI 10.1074/jbc.M109.058461; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Langford RM, 2013, J NEUROL, V260, P984, DOI 10.1007/s00415-012-6739-4; Leweke FM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.15; Ligresti A, 2006, J PHARMACOL EXP THER, V318, P1375, DOI 10.1124/jpet.106.105247; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; McArdle K, 2001, TOXICOLOGY, V168, P133; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Meiri E, 2007, CURR MED RES OPIN, V23, P533, DOI 10.1185/030079907X167525; Mileni M, 2008, P NATL ACAD SCI USA, V105, P12820, DOI 10.1073/pnas.0806121105; Mileni M, 2009, J AM CHEM SOC, V131, P10497, DOI 10.1021/ja902694n; Min XS, 2011, P NATL ACAD SCI USA, V108, P7379, DOI 10.1073/pnas.1016167108; Mukherjee S, 2010, J CHEM INF MODEL, V50, P1986, DOI 10.1021/ci1001982; Nadulski T, 2005, THER DRUG MONIT, V27, P799, DOI 10.1097/01.ftd.0000177223.19294.5c; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanson B, 2014, ACTA CRYSTALLOGR D, V70, P290, DOI 10.1107/S1399004713026795; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Tomida I, 2006, J GLAUCOMA, V15, P349, DOI 10.1097/01.ijg.0000212260.04488.60; Walter C, 2013, J CLIN PSYCHOPHARM, V33, P699, DOI 10.1097/JCP.0b013e3182984015; Yu SL, 2014, J BIOL CHEM, V289, P12748, DOI 10.1074/jbc.M114.559062; Zanelati TV, 2010, BRIT J PHARMACOL, V159, P122, DOI 10.1111/j.1476-5381.2009.00521.x	73	160	164	1	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8711	8721		10.1074/jbc.M114.618447	http://dx.doi.org/10.1074/jbc.M114.618447			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25666611	Green Published, hybrid			2022-12-28	WOS:000352207100003
J	Patra, A; Zhang, QQ; Lei, L; Su, Y; Egli, M; Guengerich, FP				Patra, Amritaj; Zhang, Qianqian; Lei, Li; Su, Yan; Egli, Martin; Guengerich, F. Peter			Structural and Kinetic Analysis of Nucleoside Triphosphate Incorporation Opposite an Abasic Site by Human Translesion DNA Polymerase eta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-RULE; DEOXYRIBONUCLEIC-ACID; APYRIMIDINIC SITES; CRYSTAL-STRUCTURES; LESION BYPASS; REPLICATION; MECHANISM; SPECIFICITY; MUTAGENESIS; SNAPSHOTS	The most common lesion in DNA is an abasic site resulting from glycolytic cleavage of a base. In a number of cellular studies, abasic sites preferentially code for dATP insertion (the "A rule"). In some cases frameshifts are also common. X-ray structures with abasic sites in oligonucleotides have been reported for several microbial and human DNA polymerases (pols), e.g. Dpo4, RB69, KlenTaq, yeast pol iota, human (h) pol iota, and human pol beta. Wereported previously that hpol eta is a major pol involved in abasic site bypass (Choi, J.-Y., Lim, S., Kim, E. J., Jo, A., and Guengerich, F.P. (2010 J. Mol. Biol. 404, 34-44). hpol eta inserted all four dNTPs in steady-state and pre-steady-state assays, preferentially inserting A and G. In LC-MS analysis of primer-template pairs, A and G were inserted but little C or T was inserted. Frameshifts were observed when an appropriate pyrimidine was positioned 5' to the abasic site in the template. In x-ray structures of hpol eta with a non-hydrolyzable analog of dATP or dGTP opposite an abasic site, H-bonding was observed between the phosphate 5' to the abasic site and water H-bonded to N1 and N6 of A and N1 and O6 of G nucleoside triphosphate analogs, offering an explanation for what appears to be a "purine rule." A structure was also obtained for an A inserted and bonded in the primer opposite the abasic site, but it did not pair with a 5' T in the template. We conclude that hpol eta, a major copying enzyme with abasic sites, follows a purine rule, which can also lead to frameshifts. The phenomenon can be explained with H-bonds.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Egli, M (corresponding author), Vanderbilt Univ, Dept Biochem, 868A Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	martin.egli@vanderbilt.edu; f.guengerich@vanderbilt.edu			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375, P30ES000267] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We are grateful to K. Trisler for assistance in the preparation of this manuscript. Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team at Sector 21 of the Advanced Photon Source, Argonne, IL. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beard WA, 2009, J BIOL CHEM, V284, P31680, DOI 10.1074/jbc.M109.029843; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; BOITEUX S, 1982, BIOCHEMISTRY-US, V21, P6746, DOI 10.1021/bi00269a020; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Choi JY, 2010, J MOL BIOL, V404, P34, DOI 10.1016/j.jmb.2010.09.015; Christov PP, 2009, CHEM RES TOXICOL, V22, P1086, DOI 10.1021/tx900047c; Correll CC, 1997, CELL, V91, P705, DOI 10.1016/S0092-8674(00)80457-2; Efrati E, 1997, J BIOL CHEM, V272, P2559; Fiala KA, 2007, J BIOL CHEM, V282, P8188, DOI 10.1074/jbc.M610718200; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Gibbs PEM, 2005, GENETICS, V169, P575, DOI 10.1534/genetics.104.034611; Haracska L, 2001, J BIOL CHEM, V276, P6861, DOI 10.1074/jbc.M008021200; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; JUCKER FM, 1995, RNA, V1, P219; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Nair DT, 2011, J MOL BIOL, V406, P18, DOI 10.1016/j.jmb.2010.12.016; Nair DT, 2009, STRUCTURE, V17, P530, DOI 10.1016/j.str.2009.02.015; O'Flaherty D. K., 2014, NUCL ACID CHEM, V59; Obeid S, 2010, EMBO J, V29, P1738, DOI 10.1038/emboj.2010.64; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SAGHER D, 1985, NUCLEIC ACIDS RES, V13, P4285, DOI 10.1093/nar/13.12.4285; SAGHER D, 1983, BIOCHEMISTRY-US, V22, P4518, DOI 10.1021/bi00288a026; SCHAAPER RM, 1982, MUTAT RES, V106, P1, DOI 10.1016/0027-5107(82)90186-5; Strauss BS, 2002, DNA REPAIR, V1, P125, DOI 10.1016/S1568-7864(01)00014-3; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yuan FH, 2000, J BIOL CHEM, V275, P8233, DOI 10.1074/jbc.275.11.8233; Zahn KE, 2007, BIOCHEMISTRY-US, V46, P10551, DOI 10.1021/bi7008807; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhao B, 2004, NUCLEIC ACIDS RES, V32, P3984, DOI 10.1093/nar/gkh710	37	39	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8028	8038		10.1074/jbc.M115.637561	http://dx.doi.org/10.1074/jbc.M115.637561			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25666608	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000351662600002
J	Kudalkar, SN; Nikas, SP; Kingsley, PJ; Xu, S; Galligan, JJ; Rouzer, CA; Banerjee, S; Ji, LP; Eno, MR; Makriyannis, A; Marnett, LJ				Kudalkar, Shalley N.; Nikas, Spyros P.; Kingsley, Philip J.; Xu, Shu; Galligan, James J.; Rouzer, Carol A.; Banerjee, Surajit; Ji, Lipin; Eno, Marsha R.; Makriyannis, Alexandros; Marnett, Lawrence J.			13-Methylarachidonic Acid Is a Positive Allosteric Modulator of Endocannabinoid Oxygenation by Cyclooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Cyclooxygenase (COX); Endocannabinoid; Enzyme Kinetics; Site-directed Mutagenesis	COX-2 OXIDATIVE METABOLITE; PROSTAGLANDIN-H SYNTHASE; SYNAPTIC-TRANSMISSION; ARACHIDONIC-ACID; STRUCTURAL BASIS; GLYCEROL ESTER; CROSS-TALK; INHIBITION; 2-ARACHIDONOYLGLYCEROL; STOICHIOMETRY	Background: The structurally identical monomers of cyclooxygenase-2 act as distinct catalytic and allosteric subunits. Results: 13-Methylarachidonic acid strongly potentiates cyclooxygenase-2-mediated endocannabinoid oxygenation without affecting arachidonic acid oxygenation. Conclusion: 13-Methylarachidonic acid is a substrate-selective allosteric potentiator of cyclooxygenase-2-mediated endocannabinoid oxygenation. Significance: 13-Methylarachidonic acid is a valuable tool for probing cyclooxygenase-dependent endocannabinoid oxygenation. Cyclooxygenase-2 (COX-2) oxygenates arachidonic acid (AA) and the endocannabinoids 2-arachidonoylglycerol (2-AG) and arachidonylethanolamide to prostaglandins, prostaglandin glyceryl esters, and prostaglandin ethanolamides, respectively. A structural homodimer, COX-2 acts as a conformational heterodimer with a catalytic and an allosteric monomer. Prior studies have demonstrated substrate-selective negative allosteric regulation of 2-AG oxygenation. Here we describe AM-8138 (13(S)-methylarachidonic acid), a substrate-selective allosteric potentiator that augments 2-AG oxygenation by up to 3.5-fold with no effect on AA oxygenation. In the crystal structure of an AM-8138.COX-2 complex, AM-8138 adopts a conformation similar to the unproductive conformation of AA in the substrate binding site. Kinetic analysis suggests that binding of AM-8138 to the allosteric monomer of COX-2 increases 2-AG oxygenation by increasing k(cat) and preventing inhibitory binding of 2-AG. AM-8138 restored the activity of COX-2 mutants that exhibited very poor 2-AG oxygenating activity and increased the activity of COX-1 toward 2-AG. Competition of AM-8138 for the allosteric site prevented the inhibition of COX-2-dependent 2-AG oxygenation by substrate-selective inhibitors and blocked the inhibition of AA or 2-AG oxygenation by nonselective time-dependent inhibitors. AM-8138 selectively enhanced 2-AG oxygenation in intact RAW264.7 macrophage-like cells. Thus, AM-8138 is an important new tool compound for the exploration of allosteric modulation of COX enzymes and their role in endocannabinoid metabolism.	[Kudalkar, Shalley N.; Kingsley, Philip J.; Xu, Shu; Galligan, James J.; Rouzer, Carol A.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA; [Kudalkar, Shalley N.; Kingsley, Philip J.; Xu, Shu; Galligan, James J.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37232 USA; [Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Rouzer, Carol A.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Ctr Mol Toxicol, Nashville, TN 37232 USA; [Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; [Nikas, Spyros P.; Ji, Lipin; Eno, Marsha R.; Makriyannis, Alexandros] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Banerjee, Surajit] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Banerjee, Surajit] Argonne Natl Lab, Northeastern Collaborat Access Team, Argonne, IL 60439 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Northeastern University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu	Xu, Shu/O-6667-2019; Ji, Lipin/AAG-3845-2022; Makriyannis, Alexandros/GRF-1518-2022; Ji, Lipin/AFK-5292-2022	Xu, Shu/0000-0002-6876-7991; Ji, Lipin/0000-0001-9956-3855; Makriyannis, Alexandros/0000-0003-3272-3687; Ji, Lipin/0000-0001-9956-3855; Rouzer, Carol/0000-0001-6827-1534; Kudalkar, Shalley/0000-0001-9377-335X; Banerjee, Surajit/0000-0002-9414-7163	National Institutes of Health from the NIGMS [P41 GM103403]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA089450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, P01GM015431, P50GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009158, R37DA003801, R01DA007215, R01DA003801] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank James A. Wepy for valuable input in developing the AM-8138 potentiation scheme. We also thank William N. Beavers for helpful discussions and suggestions. This work is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by National Institutes of Health Grant P41 GM103403 from the NIGMS. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; Beavers WN, 2014, J AM CHEM SOC, V136, P11529, DOI 10.1021/ja506038v; Blankman JL, 2013, PHARMACOL REV, V65, P849, DOI 10.1124/pr.112.006387; COPELAND RA, 1994, P NATL ACAD SCI USA, V91, P11202, DOI 10.1073/pnas.91.23.11202; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dong L, 2013, J BIOL CHEM, V288, P28641, DOI 10.1074/jbc.M113.505503; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hermanson DJ, 2014, TRENDS PHARMACOL SCI, V35, P358, DOI 10.1016/j.tips.2014.04.006; Hermanson DJ, 2013, NAT NEUROSCI, V16, P1291, DOI 10.1038/nn.3480; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2001, J BIOL CHEM, V276, P30072, DOI 10.1074/jbc.M104467200; Kozak KR, 2001, J BIOL CHEM, V276, P36993, DOI 10.1074/jbc.M105854200; KULMACZ RJ, 1984, J BIOL CHEM, V259, P6358; KULMACZ RJ, 1985, J BIOL CHEM, V260, P2572; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Nirodi CS, 2004, P NATL ACAD SCI USA, V101, P1840, DOI 10.1073/pnas.0303950101; ODENWALLER R, 1990, METHOD ENZYMOL, V187, P479; PERCIVAL MD, 1994, ARCH BIOCHEM BIOPHYS, V315, P111, DOI 10.1006/abbi.1994.1478; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Sang N, 2007, J NEUROCHEM, V102, P1966, DOI 10.1111/j.1471-4159.2007.04668.x; Sang N, 2006, J PHYSIOL-LONDON, V572, P735, DOI 10.1113/jphysiol.2006.105569; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Valdeolivas S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.387; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; Vane J. R., 1998, AM J MED, V104, p2S, DOI [DOI 10.1016/S0002-9343(97)00203-9, 10.1016/S0002-9343(97)00203-9]; Vecchio AJ, 2011, J BIOL CHEM, V286, P20736, DOI 10.1074/jbc.M111.230367; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Vecchio AJ, 2011, FASEB J, V25; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu S, 2014, J BIOL CHEM, V289, P6799, DOI 10.1074/jbc.M113.517987; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200; Zou HC, 2012, J LIPID RES, V53, P1336, DOI 10.1194/jlr.M026856	47	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7897	7909		10.1074/jbc.M114.634014	http://dx.doi.org/10.1074/jbc.M114.634014			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25648895	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000351613600047
J	Vild, CJ; Li, Y; Guo, EZ; Liu, Y; Xu, ZH				Vild, Cody J.; Li, Yan; Guo, Emily Z.; Liu, Yuan; Xu, Zhaohui			A Novel Mechanism of Regulating the ATPase VPS4 by Its Cofactor LIP5 and the Endosomal Sorting Complex Required for Transport (ESCRT)-III Protein CHMP5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCRT-III; STRUCTURAL BASIS; MEMBRANE SCISSION; PLASMA-MEMBRANE; VTA1; RECOGNITION; BINDING; ACTIVATION; DYNAMICS; MODEL	Disassembly of the endosomal sorting complex required for transport (ESCRT) machinery from biological membranes is a critical final step in cellular processes that require the ESCRT function. This reaction is catalyzed by VPS4, an AAA-ATPase whose activity is tightly regulated by a host of proteins, including LIP5 and the ESCRT-III proteins. Here, we present structural and functional analyses of molecular interactions between human VPS4, LIP5, and the ESCRT-III proteins. The N-terminal domain of LIP5 (LIP5NTD) is required for LIP5-mediated stimulation of VPS4, and the ESCRT-III protein CHMP5 strongly inhibits the stimulation. Both of these observations are distinct from what was previously described for homologous yeast proteins. The, crystal structure of LIP5NTD in complex with the MIT (microtubule-interacting and transport)-interacting motifs of CHMP5 and a second ESCRT-III protein, CHMP1B, was determined at 1 A resolution. It reveals an ESCRT-III binding induced moderate conformational change in LIP5NTD, which results from insertion of a conserved CHMP5 tyrosine residue (Tyr(182)) at the core of LIP5NTD structure. Mutation of Tyr(182) partially relieves the inhibition displayed by CHMP5. Together, these results suggest a novel mechanism of VPS4 regulation in metazoans, where CHMP5 functions as a negative allosteric switch to control LIPS-mediated stimulation of VPS4.	[Vild, Cody J.; Li, Yan; Guo, Emily Z.; Liu, Yuan; Xu, Zhaohui] Univ Michigan, Inst Life Sci, Sch Med, Ann Arbor, MI 48109 USA; [Vild, Cody J.; Xu, Zhaohui] Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, ZH (corresponding author), Univ Michigan, Life Sci Inst 3163B, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	zhaohui@umich.edu		LIU, YUAN/0000-0001-9452-0442	National Institutes of Health [GM095769]; United States Department of Energy [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor [085P1000817]; Michigan Economic Development Corporation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor; Michigan Economic Development Corporation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM095769 (to Z. X.). Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adell MAY, 2014, J CELL BIOL, V205, P33, DOI 10.1083/jcb.201310114; Adell MAY, 2011, FEBS LETT, V585, P3191, DOI 10.1016/j.febslet.2011.09.001; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Bricogne G., 2011, BUSTER VERSION 2 10; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Davies BA, 2014, J BIOL CHEM, V289, P28707, DOI 10.1074/jbc.M114.580696; Davies BA, 2010, MOL BIOL CELL, V21, P3396, DOI 10.1091/mbc.E10-06-0512; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Elia N, 2012, BIOPHYS J, V102, P2309, DOI 10.1016/j.bpj.2012.04.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Gonciarz MD, 2008, J MOL BIOL, V384, P878, DOI 10.1016/j.jmb.2008.09.066; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Henne WM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016766; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Jouvenet N, 2011, NAT CELL BIOL, V13, P394, DOI 10.1038/ncb2207; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Lata S, 2009, BIOCHEM SOC T, V37, P156, DOI 10.1042/BST0370156; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Monroe N, 2014, J MOL BIOL, V426, P510, DOI 10.1016/j.jmb.2013.09.043; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Nickerson DP, 2010, MOL BIOL CELL, V21, P1023, DOI 10.1091/mbc.E09-09-0776; Norgan AP, 2013, J BIOL CHEM, V288, P26147, DOI 10.1074/jbc.M113.494112; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Schuh AL, 2014, CRIT REV BIOCHEM MOL, V49, P242, DOI 10.3109/10409238.2014.881777; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Skalicky JJ, 2012, J BIOL CHEM, V287, P43910, DOI 10.1074/jbc.M112.417899; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Vild CJ, 2014, J BIOL CHEM, V289, P10378, DOI 10.1074/jbc.M113.532960; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Wemmer M, 2011, J CELL BIOL, V192, P295, DOI 10.1083/jcb.201007018; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xiao JY, 2008, DEV CELL, V14, P37, DOI 10.1016/j.devcel.2007.10.013; Xiao JY, 2007, J MOL BIOL, V374, P655, DOI 10.1016/j.jmb.2007.09.067; Yang ZZ, 2012, J BIOL CHEM, V287, P43899, DOI 10.1074/jbc.M112.390724	53	24	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7291	7303		10.1074/jbc.M114.616730	http://dx.doi.org/10.1074/jbc.M114.616730			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25637630	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000350991500057
J	Evelyn, CR; Biesiada, J; Duan, X; Tang, H; Shang, X; Papoian, R; Seibel, WL; Nelson, S; Meller, J; Zheng, Y				Evelyn, Chris R.; Biesiada, Jacek; Duan, Xin; Tang, Hong; Shang, Xun; Papoian, Ruben; Seibel, William L.; Nelson, Sandra; Meller, Jaroslaw; Zheng, Yi			Combined Rational Design and a High Throughput Screening Platform for Identifying Chemical Inhibitors of a Ras-activating Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; SMALL-MOLECULE INHIBITORS; MICROSCALE THERMOPHORESIS; NOONAN-SYNDROME; BINDING-SITES; ONCOGENIC RAS; RHO-GTPASES; WEB SERVER; K-RAS; SOS	The Ras family small GTPases regulate multiple cellular processes, including cell growth, survival, movement, and gene expression, and are intimately involved in cancer pathogenesis. Activation of these small GTPases is catalyzed by a special class of enzymes, termed guanine nucleotide exchange factors (GEFs). Herein, we developed a small molecule screening platform for identifying lead hits targeting a Ras GEF enzyme, SOS1. We employed an ensemble structure-based virtual screening approach in combination with a multiple tier high throughput experimental screen utilizing two complementary fluorescent guanine nucleotide exchange assays to identify small molecule inhibitors of GEF catalytic activity toward Ras. From a library of 350,000 compounds, we selected a set of 418 candidate compounds predicted to disrupt the GEF-Ras interaction, of which dual wavelength GDP dissociation and GTP-loading experimental screening identified two chemically distinct small molecule inhibitors. Subsequent biochemical validations indicate that they are capable of dose-dependently inhibiting GEF catalytic activity, binding to SOS1 with micromolar affinity, and disrupting GEF-Ras interaction. Mutagenesis studies in conjunction with structure-activity relationship studies mapped both compounds to different sites in the catalytic pocket, and both inhibited Ras signaling in cells. The unique screening platform established here for targeting Ras GEF enzymes could be broadly useful for identifying lead inhibitors for a variety of small GTPase-activating GEF reactions.	[Evelyn, Chris R.; Duan, Xin; Shang, Xun; Zheng, Yi] Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Biesiada, Jacek; Meller, Jaroslaw] Childrens Hosp Res Fdn, Div Biomed Informat, Cincinnati, OH 45229 USA; [Tang, Hong] Childrens Hosp Res Fdn, Div Immunobiol, Cincinnati, OH 45229 USA; [Seibel, William L.] Childrens Hosp Res Fdn, Div Oncol, Cincinnati, OH 45229 USA; [Papoian, Ruben; Seibel, William L.; Nelson, Sandra] Univ Cincinnati, Ctr Drug Discovery, Cincinnati, OH 45267 USA; [Papoian, Ruben] Univ Cincinnati, Dept Neurol, Cincinnati, OH 45267 USA; [Meller, Jaroslaw] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45267 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Zheng, Y (corresponding author), Div Expt Hematol & Canc Biol, 3333 Burnet Ave,R7567, Cincinnati, OH 45229 USA.	Yi.Zheng@cchmc.org	Meller, Jaroslaw/A-1971-2011; Regan, Clinton/E-6250-2012; Zheng, Yi/J-7235-2015; Biesiada, Jacek/I-2844-2018	Meller, Jaroslaw/0000-0002-1162-8253; Zheng, Yi/0000-0001-7089-6074; Biesiada, Jacek/0000-0003-0435-2225	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by the National Institutes of Health.	Appels NMGM, 2005, ONCOLOGIST, V10, P565, DOI 10.1634/theoncologist.10-8-565; Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; Biesiada Jacek, 2011, Hum Genomics, V5, P497; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Burns MC, 2014, P NATL ACAD SCI USA, V111, P3401, DOI 10.1073/pnas.1315798111; Cox Adrienne D, 2010, Small GTPases, V1, P2; Epifano F, 2007, BIOORG MED CHEM LETT, V17, P2639, DOI 10.1016/j.bmcl.2007.01.097; Evelyn CR, 2014, CHEM BIOL, V21, P1618, DOI 10.1016/j.chembiol.2014.09.018; Evelyn CR, 2009, J BIOMOL SCREEN, V14, P161, DOI 10.1177/1087057108328761; Field LA, 2012, CANCER-AM CANCER SOC, V118, P1334, DOI 10.1002/cncr.26405; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Grabocka E, 2014, CANCER CELL, V25, P243, DOI 10.1016/j.ccr.2014.01.005; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; HARA M, 1993, P NATL ACAD SCI USA, V90, P2281, DOI 10.1073/pnas.90.6.2281; Hocker HJ, 2013, P NATL ACAD SCI USA, V110, P10201, DOI 10.1073/pnas.1300016110; Hong L, 2013, J BIOL CHEM, V288, P8531, DOI 10.1074/jbc.M112.435941; Jeng HH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2173; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Konc J, 2014, NUCLEIC ACIDS RES, V42, pW215, DOI 10.1093/nar/gku460; Konc J, 2012, NUCLEIC ACIDS RES, V40, pW214, DOI 10.1093/nar/gks435; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; McEwen DP, 2002, METHOD ENZYMOL, V344, P403; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Patgiri A, 2011, NAT CHEM BIOL, V7, P585, DOI [10.1038/NCHEMBIO.612, 10.1038/nchembio.612]; Peterson YK, 2006, J BIOL CHEM, V281, P12445, DOI 10.1074/jbc.M600168200; Peterson YK, 2009, J MED CHEM, V52, P4210, DOI 10.1021/jm8013772; Pierre S, 2011, BIOCHEM PHARMACOL, V82, P1049, DOI 10.1016/j.bcp.2011.07.072; Porollo A, 2010, NUCLEIC ACIDS RES, V38, pW662, DOI 10.1093/nar/gkq445; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Roman DL, 2007, MOL PHARMACOL, V71, P169, DOI 10.1124/mol.106.028670; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schopel M, 2013, J MED CHEM, V56, P9664, DOI 10.1021/jm401291q; Shang X, 2012, CHEM BIOL, V19, P699, DOI 10.1016/j.chembiol.2012.05.009; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Spiegel J, 2014, NAT CHEM BIOL, V10, P613, DOI 10.1038/nchembio.1560; Stengel KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037317; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Tanizaki R, 2008, INT J HEMATOL, V88, P460, DOI 10.1007/s12185-008-0185-1; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Timofeeva OA, 2009, INT J ONCOL, V35, P751, DOI 10.3892/ijo_00000388; van der Meel R, 2011, DRUG DISCOV TODAY, V16, P219, DOI 10.1016/j.drudis.2011.01.005; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	52	20	21	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12879	12898		10.1074/jbc.M114.634493	http://dx.doi.org/10.1074/jbc.M114.634493			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25825487	Green Published, hybrid			2022-12-28	WOS:000354569000038
J	Lee, HJ; Feliers, D; Mariappan, MM; Sataranatarajan, K; Choudhury, GG; Gorin, Y; Kasinath, BS				Lee, Hak Joo; Feliers, Denis; Mariappan, Meenalakshmi M.; Sataranatarajan, Kavithalakshmi; Choudhury, Goutam Ghosh; Gorin, Yves; Kasinath, Balakuntalam S.			Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in Podocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); diabetes; fibrosis; kidney; mammalian target of rapamycin (mTOR)	CYSTATHIONINE-GAMMA-LYASE; MESSENGER-RNA TRANSLATION; DIABETIC-NEPHROPATHY; PHOSPHODIESTERASE-5 INHIBITOR; RENAL ISCHEMIA/REPERFUSION; SPECIFICITY PROTEIN-1; CELL-PROLIFERATION; HIGH INSULIN; SYNTHASE; SILDENAFIL	Background: The mechanism underlying tadalafil regulation of diabetes-induced matrix synthesis in the kidney is unknown. Results: In podocytes, tadalafil stimulated inducible nitric-oxide synthase to generate hydrogen sulfide and inhibit high glucose-induced matrix protein synthesis. Conclusion: Tadalafil recruits nitric oxide and hydrogen sulfide to inhibit high glucose-induced matrix protein synthesis. Significance: Tadalafil may be tested for treating diabetic kidney disease. Diabetes-induced kidney cell injury involves an increase in matrix protein expression that is only partly alleviated by current treatment, prompting a search for new modalities. We have previously shown that hydrogen sulfide (H2S) inhibits high glucose-induced protein synthesis in kidney podocytes. We tested whether tadalafil, a phosphodiesterase 5 inhibitor used to treat erectile dysfunction, ameliorates high glucose stimulation of matrix proteins by generating H2S in podocytes. Tadalafil abrogated high glucose stimulation of global protein synthesis and matrix protein laminin 1. Tadalafil inhibited high glucose-induced activation of mechanistic target of rapamycin complex 1 and laminin 1 accumulation in an AMP-activated protein kinase (AMPK)-dependent manner. Tadalafil increased AMPK phosphorylation by stimulating calcium-calmodulin kinase kinase . Tadalafil rapidly increased the expression and activity of the H2S-generating enzyme cystathionine -lyase (CSE) by promoting its translation. dl-Propargylglycine, a CSE inhibitor, and siRNA against CSE inhibited tadalafil-induced AMPK phosphorylation and abrogated the tadalafil effect on high glucose stimulation of laminin 1. In tadalafil-treated podocytes, we examined the interaction between H2S and nitric oxide (NO). N-Nitro-l-arginine methyl ester and 1H-[1,2,4]-oxadiazolo-[4,3-a]-quinoxalin-1-one, inhibitors of NO synthase (NOS) and soluble guanylyl cyclase, respectively, abolished tadalafil induction of H2S and AMPK phosphorylation. Tadalafil rapidly augmented inducible NOS (iNOS) expression by increasing its mRNA, and siRNA for iNOS and 1400W, an iNOS blocker, inhibited tadalafil stimulation of CSE expression and AMPK phosphorylation. We conclude that tadalafil amelioration of high glucose stimulation of synthesis of proteins including matrix proteins in podocytes requires integration of the NO-H2S-AMPK axis leading to the inhibition of high glucose-induced mechanistic target of rapamycin complex 1 activity and mRNA translation.	[Lee, Hak Joo; Feliers, Denis; Mariappan, Meenalakshmi M.; Sataranatarajan, Kavithalakshmi; Choudhury, Goutam Ghosh; Gorin, Yves; Kasinath, Balakuntalam S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Lee, Hak Joo; Mariappan, Meenalakshmi M.; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.] South Texas Vet Healthcare Syst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Kasinath, BS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, MC7882,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	Kasinath@uthscsa.edu		Feliers, Denis/0000-0003-1952-1386	National Institutes of Health from National Cancer Institute [P30 CA54174]; National Institutes of Health from National Institute on Aging [P01AG19316]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190, R01DK079996, R29DK050190, R01DK077295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019316, RC2AG036613] Funding Source: NIH RePORTER	National Institutes of Health from National Cancer Institute; National Institutes of Health from National Institute on Aging; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Dan Riley for critical reading of the manuscript and Dr. Doug Yoon Lee for helpful suggestions. Images were generated in the Core Optical Imaging Facility, which is supported by the University of Texas Health Science Center at San Antonio (UTHSCSA) and National Institutes of Health Grants P30 CA54174 from the National Cancer Institute (to the Cancer Therapy and Research Center at UTHSCSA) and P01AG19316 from the National Institute on Aging.	Abe K, 1996, J NEUROSCI, V16, P1066; Aktug H, 2012, TURK J MED SCI, V42, P830, DOI 10.3906/sag-1104-38; Altaany Z, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005478; Ang SF, 2011, J IMMUNOL, V187, P4778, DOI 10.4049/jimmunol.1101559; Blattler SM, 2007, P NATL ACAD SCI USA, V104, P1045, DOI 10.1073/pnas.0610216104; Blount MA, 2004, MOL PHARMACOL, V66, P144, DOI 10.1124/mol.66.1.144; Bos EM, 2013, J AM SOC NEPHROL, V24, P759, DOI 10.1681/ASN.2012030268; Chrysant SG, 2013, CURR HYPERTENS REP, V15, P475, DOI 10.1007/s11906-013-0377-9; Coletta C, 2012, P NATL ACAD SCI USA, V109, P9161, DOI 10.1073/pnas.1202916109; COURTOY PJ, 1982, J HISTOCHEM CYTOCHEM, V30, P874, DOI 10.1177/30.9.7130672; d'Andon MF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002664; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Fan K, 2014, CELL SIGNAL, V26, P2801, DOI 10.1016/j.cellsig.2014.08.023; Fang L, 2013, NEPHROL DIAL TRANSPL, V28, P1751, DOI 10.1093/ndt/gfs391; Feliers D, 2001, KIDNEY INT, V60, P495, DOI 10.1046/j.1523-1755.2001.060002495.x; Fonseca BD, 2014, SEMIN CELL DEV BIOL, V36, P102, DOI 10.1016/j.semcdb.2014.09.014; Francescato HD, 2011, NEPHROL DIAL TRANSPL, V26, P479, DOI 10.1093/ndt/gfq447; Gharavi N, 2003, J PHARM PHARM SCI, V6, P302; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Hohenstein B, 2008, NEPHROL DIAL TRANSPL, V23, P3427, DOI 10.1093/ndt/gfn319; Holwerda KM, 2014, J AM SOC NEPHROL, V25, P717, DOI 10.1681/ASN.2013030291; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Jeong KH, 2009, AM J NEPHROL, V29, P274, DOI 10.1159/000158635; Jerums G, 2006, CONTEMP DIAB, P59; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kasinath BS, 2006, J AM SOC NEPHROL, V17, P3281, DOI 10.1681/ASN.2006050488; Kasinath BS, 2014, KIDNEY INT, V85, P1255, DOI 10.1038/ki.2013.529; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kim KO, 2008, EXP MOL MED, V40, P286, DOI 10.3858/emm.2008.40.3.286; Kondo K, 2013, CIRCULATION, V127, P1116, DOI 10.1161/CIRCULATIONAHA.112.000855; Kotera J, 2000, J HISTOCHEM CYTOCHEM, V48, P685, DOI 10.1177/002215540004800512; Kuno Y, 2011, BRIT J PHARMACOL, V162, P1389, DOI 10.1111/j.1476-5381.2010.01149.x; Lee HJ, 2012, J BIOL CHEM, V287, P4451, DOI 10.1074/jbc.M111.278325; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Lee MJ, 2010, CELL SIGNAL, V22, P65, DOI 10.1016/j.cellsig.2009.09.011; Liu XM, 2012, BIOCHEM PHARMACOL, V84, P1045, DOI 10.1016/j.bcp.2012.07.023; Lu M, 2010, J AM SOC NEPHROL, V21, P993, DOI 10.1681/ASN.2009090949; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Mariappan MM, 2012, EXP DIABETES RES, DOI 10.1155/2012/749812; Matousovic K, 1997, J LAB CLIN MED, V130, P487, DOI 10.1016/S0022-2143(97)90125-6; Mok YYP, 2004, BRIT J PHARMACOL, V143, P881, DOI 10.1038/sj.bjp.0706014; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Poon BY, 2003, CIRCULATION, V108, P1107, DOI 10.1161/01.CIR.0000086321.04702.AC; Redpath NT, 1996, EMBO J, V15, P2291, DOI 10.1002/j.1460-2075.1996.tb00582.x; Salloum F, 2003, CIRC RES, V92, P595, DOI 10.1161/01.RES.0000066853.09821.98; Salloum FN, 2009, CIRCULATION, V120, pS31, DOI 10.1161/CIRCULATIONAHA.108.843979; Sanchez AP, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001057; Sataranatarajan K, 2012, AGING CELL, V11, P1065, DOI 10.1111/acel.12008; Sen U, 2009, AM J PHYSIOL-RENAL, V297, pF410, DOI 10.1152/ajprenal.00145.2009; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Shue EH, 2014, J PEDIATR SURG, V49, P39, DOI 10.1016/j.jpedsurg.2013.09.024; Si JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107832; Song K, 2014, KIDNEY INT, V85, P1318, DOI 10.1038/ki.2013.449; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Sun WX, 2014, FREE RADICAL BIO MED, V68, P22, DOI 10.1016/j.freeradbiomed.2013.11.015; Suzuki K, 2011, P NATL ACAD SCI USA, V108, P13829, DOI 10.1073/pnas.1105121108; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Trachtman H, 2002, PEDIATR NEPHROL, V17, P20, DOI 10.1007/s004670200004; Tripatara P, 2008, LAB INVEST, V88, P1038, DOI 10.1038/labinvest.2008.73; Wang R, 2012, P NATL ACAD SCI USA, V109, P8801, DOI 10.1073/pnas.1206646109; Wangsiripaisan A, 1999, KIDNEY INT, V55, P2281, DOI 10.1046/j.1523-1755.1999.00484.x; Yamamoto J, 2013, CLIN EXP NEPHROL, V17, P32, DOI 10.1007/s10157-012-0670-y; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2012, J CELL PHYSIOL, V227, P3192, DOI 10.1002/jcp.24006; Yang GD, 2011, AM J PATHOL, V179, P869, DOI 10.1016/j.ajpath.2011.04.028; Yang GD, 2011, J BIOL CHEM, V286, P26450, DOI 10.1074/jbc.M111.266643; Yuan P, 2011, NEPHROL DIAL TRANSPL, V26, P2119, DOI 10.1093/ndt/gfq749; Zdychova J, 2008, PHYSIOL RES, V57, P709, DOI 10.33549/physiolres.931337; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798; Zhao SQ, 2011, INT IMMUNOPHARMACOL, V11, P468, DOI 10.1016/j.intimp.2010.12.017	78	34	34	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12014	12026		10.1074/jbc.M114.615377	http://dx.doi.org/10.1074/jbc.M114.615377			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25752605	Green Published, hybrid			2022-12-28	WOS:000354388600017
J	Zhu, SC; Jing, RQ; Yang, YW; Huang, YT; Wang, X; Leng, Y; Xi, JJ; Wang, GY; Jia, WW; Kang, JH				Zhu, Songcheng; Jing, Ruiqi; Yang, Yiwei; Huang, Yitong; Wang, Xin; Leng, Ye; Xi, Jiajie; Wang, Guiying; Jia, Wenwen; Kang, Jiuhong			A Motif from Lys(216) to Lys(222) in Human BUB3 Protein Is a Nuclear Localization Signal and Critical for BUB3 Function in Mitotic Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; ACCURATE CHROMOSOME SEGREGATION; CENP-A; KINETOCHORE FUNCTION; AURORA-B; MOUSE OOCYTE; MPS1; PHOSPHORYLATION; RECRUITMENT; CELLS	Human BUB3 is a key mitotic checkpoint factor that recognizes centromeric components and recruits other mitotic checkpoint molecules to the unattached kinetochore. The key amino acid residues responsible for its localization are not yet defined. In this study, we identified a motif from Lys(216) to Lys(222) in BUB3 as its nuclear localization signal. A BUB3 mutant with deletion of this motif (Del216-222) was found to localize to both the cytoplasm and the nucleus, distinct from the exclusively nuclear distribution of wild-type BUB3. Further analysis revealed that residues Glu(213), Lys(216), Lys(217), Lys(218), Tyr(219), and Phe(221), but not Lys(222), contribute to nuclear localization. Interestingly, the nuclear localization signal was also critical for the kinetochore localization of BUB3. The deletion mutant Del216-222 and a subtle mutant with four residue changes in this region (E213Q/(KE)-E-216/(KE)-E-217/(KE)-E-218 (QE)) did not localize to the kinetochore efficiently or mediate mitotic checkpoint arrest. Protein interaction data suggested that the QE mutant was able to interact with BUB1, MAD2, and BubR1 but that its association with the centromeric components CENP-A and KNL1 was impaired. Amotif from Leu(61) to Leu(65) in CENP-A was found to be involved in the association of BUB3 and CENP-A in cells; however, further assays suggested that CENP-A does not physically interact with BUB3 and does not affect BUB3 localization. Our findings help to dissect the mechanisms of BUB3 in mitotic checkpoint signaling.	[Zhu, Songcheng; Jing, Ruiqi; Yang, Yiwei; Huang, Yitong; Wang, Xin; Leng, Ye; Xi, Jiajie; Wang, Guiying; Jia, Wenwen; Kang, Jiuhong] Tongji Univ, Shanghai Matern & Infant Hosp 1, Shanghai Key Lab Signaling & Dis Res, Clin & Translat Res Ctr,Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Tongji University	Zhu, SC (corresponding author), Tongji Univ, Shanghai Matern & Infant Hosp 1, Shanghai Key Lab Signaling & Dis Res, Clin & Translat Res Ctr,Sch Life Sci & Technol, 1239 Si Ping Rd, Shanghai 200092, Peoples R China.	zhusongcheng@tongji.edu.cn; jhkang@tongji.edu.cn			National Natural Science Foundation of China; Ministry of Science and Technology [31171432, 2011CBA01100, 91219305, 31210103905, 31371510, 31101061, 81170499, 31201107, 31301208, 81201599, 2011CB965100, 2012CB966603, 2013CB967600]; Science and Technology Commission of Shanghai Municipality [11ZR1438500, 12ZR1450900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from the National Natural Science Foundation of China and the Ministry of Science and Technology (Grants 31171432, 2011CBA01100, 91219305, 31210103905, 31371510, 31101061, 81170499, 31201107, 31301208, 81201599, 2011CB965100, 2012CB966603, and 2013CB967600) and the Science and Technology Commission of Shanghai Municipality (Grants 11ZR1438500 and 12ZR1450900).	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Christophe D, 2000, CELL SIGNAL, V12, P337, DOI 10.1016/S0898-6568(00)00077-2; da Silva SM, 2013, J CELL BIOL, V201, P385, DOI 10.1083/jcb.201210018; de Voer RM, 2013, GASTROENTEROLOGY, V145, P544, DOI 10.1053/j.gastro.2013.06.001; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Goutte-Gattat D, 2013, P NATL ACAD SCI USA, V110, P8579, DOI 10.1073/pnas.1302955110; Handyside AH, 2012, BBA-MOL BASIS DIS, V1822, P1913, DOI 10.1016/j.bbadis.2012.07.007; Hauf S, 2013, BIOCHEM SOC T, V41, P1755, DOI 10.1042/BST20130240; Hori T, 2003, J CELL SCI, V116, P3347, DOI 10.1242/jcs.00645; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Jiang H, 2014, DEV CELL, V28, P268, DOI 10.1016/j.devcel.2013.12.013; Kops GJPL, 2008, FRONT BIOSCI-LANDMRK, V13, P3606, DOI 10.2741/2953; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Larsen NA, 2004, J MOL BIOL, V344, P885, DOI 10.1016/j.jmb.2004.09.094; Lermontova I, 2011, PLANT J, V68, P40, DOI 10.1111/j.1365-313X.2011.04664.x; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017794; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; McGregor M, 2014, CELL CYCLE, V13, P739, DOI 10.4161/cc.27549; Niikura Y, 2010, CELL DEATH DIFFER, V17, P1011, DOI 10.1038/cdd.2009.207; Nijenhuis W, 2013, J CELL BIOL, V201, P217, DOI 10.1083/jcb.201210033; Okaz E, 2012, CELL, V151, P603, DOI 10.1016/j.cell.2012.08.044; Primorac I, 2013, ELIFE, V2, DOI 10.7554/eLife.01030; Quimby BB, 2005, EUKARYOT CELL, V4, P274, DOI 10.1128/EC.4.2.274-280.2005; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Shepperd LA, 2012, CURR BIOL, V22, P891, DOI 10.1016/j.cub.2012.03.051; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Slattery SD, 2008, CELL CYCLE, V7, P787, DOI 10.4161/cc.7.6.5563; Sun TT, 2010, J BIOL CHEM, V285, P38730, DOI 10.1074/jbc.M110.177642; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Toledo CM, 2014, DEV CELL, V28, P282, DOI 10.1016/j.devcel.2013.12.014; Topham CH, 2013, CURR OPIN CELL BIOL, V25, P780, DOI 10.1016/j.ceb.2013.07.003; Vleugel M, 2013, J CELL BIOL, V203, P943, DOI 10.1083/jcb.201307016; Wang YC, 2014, CELL CYCLE, V13, DOI 10.4161/cc.29027; Weaver BAA, 2009, J CELL BIOL, V185, P934, DOI 10.1083/jcb.200905098; Wei L, 2010, CELL CYCLE, V9, P1112, DOI 10.4161/cc.9.6.10957; Wilson DK, 2005, J BIOL CHEM, V280, P13944, DOI 10.1074/jbc.M412919200; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yan HL, 2012, CELL SIGNAL, V24, P961, DOI 10.1016/j.cellsig.2011.12.019; Zhang G, 2014, J CELL SCI, V127, P871, DOI 10.1242/jcs.139725; Zhang XJ, 2011, CELL CYCLE, V10, P2742, DOI 10.4161/cc.10.16.15927; Zhu SC, 2007, J BIOL CHEM, V282, P18327, DOI 10.1074/jbc.M700636200	44	5	5	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11282	11292		10.1074/jbc.M114.598029	http://dx.doi.org/10.1074/jbc.M114.598029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25814666	hybrid, Green Published			2022-12-28	WOS:000353719400007
J	Ryvkin, V; Rashel, M; Gaddapara, T; Ghazizadeh, S				Ryvkin, Vladislav; Rashel, Mohammad; Gaddapara, Trivikram; Ghazizadeh, Soosan			Opposing Growth Regulatory Roles of Protein Kinase D Isoforms in Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; P63; DIFFERENTIATION; PROLIFERATION; EXPRESSION; PKD3; COMMITMENT; TRANSPORT; FAMILY; CELLS	PKD is a family of three serine/threonine kinases (PKD-1, -2, and -3) involved in the regulation of diverse biological processes including proliferation, migration, secretion, and cell survival. We have previously shown that despite expression of all three isoforms in mouse epidermis, PKD1 plays a unique and critical role in wound healing, phorbol ester-induced hyperplasia, and tumor development. In translating our findings to the human, we discovered that PKD1 is not expressed in human keratinocytes (KCs) and there is a divergence in the expression and function of other PKD isoforms. Contrary to mouse KCs, treatment of cultured human KCs with pharmacological inhibitors of PKDs resulted in growth arrest. We found that PKD2 and PKD3 are expressed differentially in proliferating and differentiating human KCs, with the former uniformly present in both compartments whereas the latter is predominantly expressed in the proliferating compartment. Knockdown of individual PKD isoforms in human KCs revealed contrasting growth regulatory roles for PKD2 and PKD3. Loss of PKD2 enhanced KC proliferative potential while loss of PKD3 resulted in a progressive proliferation defect, loss of clonogenicity and diminished tissue regenerative ability. This proliferation defect was correlated with up-regulation of CDK4/6 inhibitor p15(INK4B) and induction of a p53-independent G1 cell cycle arrest. Simultaneous silencing of PKD isoforms resulted in a more pronounced proliferation defect consistent with a predominant role for PKD3 in proliferating KCs. These data underline the importance and complexity of PKD signaling in human epidermis and suggest a central role for PKD3 signaling in maintaining human epidermal homeostasis.	[Ryvkin, Vladislav; Ghazizadeh, Soosan] SUNY Stony Brook, Grad Program Mol & Cell Biol, Stony Brook, NY 11794 USA; [Rashel, Mohammad; Gaddapara, Trivikram; Ghazizadeh, Soosan] SUNY Stony Brook, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ghazizadeh, S (corresponding author), SUNY Stony Brook, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA.	soosan.ghazizadeh@stonybrook.edu			National Institutes of Health [R21AR056013]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21AR056013 (to S. G.).	Alani RM, 1998, MOL CARCINOGEN, V23, P226, DOI 10.1002/(SICI)1098-2744(199812)23:4<226::AID-MC5>3.0.CO;2-N; Anderson G, 2005, CELL SIGNAL, V17, P1397, DOI 10.1016/j.cellsig.2005.02.007; Arun SN, 2011, ONCOGENE, V30, P1586, DOI 10.1038/onc.2010.540; Borges S, 2013, EXPERT REV ANTICANC, V13, P895, DOI 10.1586/14737140.2013.816460; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Carlson M. W., 2001, CURRENT PROTOCOLS CE; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Dodd ME, 2005, J INVEST DERMATOL, V125, P294, DOI 10.1111/j.0022-202X.2005.23780.x; Egles C, 2010, METHODS MOL BIOL, V585, P345, DOI 10.1007/978-1-60761-380-0_24; Ellwanger K, 2013, IUBMB LIFE, V65, P98, DOI 10.1002/iub.1116; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Galli F, 2010, J CELL SCI, V123, P2423, DOI 10.1242/jcs.061010; Ghazizadeh S, 2004, J INVEST DERM SYMP P, V9, P269, DOI 10.1111/j.1087-0024.2004.09302.x; Guha S, 2010, BIOCHEM PHARMACOL, V80, P1946, DOI 10.1016/j.bcp.2010.07.002; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hao Q, 2013, ANTICANCER RES, V33, P393; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Ivanova P, 2008, ARCH DERMATOL RES, V300, P139, DOI 10.1007/s00403-008-0832-7; Jadali A, 2010, J BIOL CHEM, V285, P23385, DOI 10.1074/jbc.M110.105619; LaValle CR, 2012, MOL CANCER THER, V11, P1389, DOI 10.1158/1535-7163.MCT-11-0887; LaValle CR, 2010, BBA-REV CANCER, V1806, P183, DOI 10.1016/j.bbcan.2010.05.003; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Li CH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/175721; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Rashel M, 2014, J INVEST DERMATOL, V134, P902, DOI 10.1038/jid.2013.474; Rennecke J, 1999, INT J CANCER, V80, P98, DOI 10.1002/(SICI)1097-0215(19990105)80:1<98::AID-IJC19>3.3.CO;2-4; Rey O, 2006, J BIOL CHEM, V281, P5149, DOI 10.1074/jbc.M508014200; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Ristich VL, 2006, BRIT J DERMATOL, V154, P586, DOI 10.1111/j.1365-2133.2005.07073.x; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shin S, 2012, AM J PHYSIOL-CELL PH, V303, pC743, DOI 10.1152/ajpcell.00442.2011; Steinberg SF, 2012, MOL PHARMACOL, V81, P284, DOI 10.1124/mol.111.075986; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Watt FM, 2014, SCIENCE, V346, P937, DOI 10.1126/science.1253734; Wille Christoph, 2014, Bioarchitecture, V4, P111, DOI 10.4161/bioa.29273; Wu N, 2012, J BIOL CHEM, V287, P5627, DOI 10.1074/jbc.M111.328120; WU YJ, 1982, CELL, V31, P693, DOI 10.1016/0092-8674(82)90324-5; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zou ZP, 2012, J CELL SCI, V125, P4800, DOI 10.1242/jcs.106542	45	7	9	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11199	11208		10.1074/jbc.M115.643742	http://dx.doi.org/10.1074/jbc.M115.643742			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25802335	Green Published, hybrid			2022-12-28	WOS:000353404500052
J	Driver, J; Weber, CE; Callaci, JJ; Kothari, AN; Zapf, MA; Roper, PM; Borys, D; Franzen, CA; Gupta, GN; Wai, PY; Zhang, JW; Denning, MF; Kuo, PC; Mi, ZY				Driver, Joseph; Weber, Cynthia E.; Callaci, John J.; Kothari, Anai N.; Zapf, Matthew A.; Roper, Philip M.; Borys, Dariusz; Franzen, Carrie A.; Gupta, Gopal N.; Wai, Philip Y.; Zhang, Jiwang; Denning, Mitchell F.; Kuo, Paul C.; Mi, Zhiyong			Alcohol Inhibits Osteopontin-dependent Transforming Growth Factor-beta 1 Expression in Human Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Expression; Gene Transcription; Mesenchymal Stem Cells (MSCs); Osteopontin; Promoter; Protein Kinase A (PKA); Transforming Growth Factor (TGF-); Zinc Finger; Alcohol (EtOH)	GROWTH-FACTOR; FRACTURE REPAIR; MESSENGER-RNA; BONE; MIGRATION; DIFFERENTIATION; PROLIFERATION; PROTEIN; MODEL; RAT	Alcohol (EtOH) intoxication is a risk factor for increased morbidity and mortality with traumatic injuries, in part through inhibition of bone fracture healing. Animal models have shown that EtOH decreases fracture callus volume, diameter, and biomechanical strength. Transforming growth factor 1 (TGF-1) and osteopontin (OPN) play important roles in bone remodeling and fracture healing. Mesenchymal stem cells (MSC) reside in bone and are recruited to fracture sites for the healing process. Resident MSC are critical for fracture healing and function as a source of TGF-1 induced by local OPN, which acts through the transcription factor myeloid zinc finger 1 (MZF1). The molecular mechanisms responsible for the effect of EtOH on fracture healing are still incompletely understood, and this study investigated the role of EtOH in affecting OPN-dependent TGF-1 expression in MSC. We have demonstrated that EtOH inhibits OPN-induced TGF-1 protein expression, decreases MZF1-dependent TGF-1 transcription and MZF1 transcription, and blocks OPN-induced MZF1 phosphorylation. We also found that PKA signaling enhances OPN-induced TGF-1 expression. Last, we showed that EtOH exposure reduces the TGF-1 protein levels in mouse fracture callus. We conclude that EtOH acts in a novel mechanism by interfering directly with the OPN-MZF1-TGF-1 signaling pathway in MSC.	[Driver, Joseph; Weber, Cynthia E.; Kothari, Anai N.; Zapf, Matthew A.; Wai, Philip Y.; Kuo, Paul C.; Mi, Zhiyong] Loyola Univ, Med Ctr, Dept Surg, Maywood, IL 60130 USA; [Callaci, John J.; Roper, Philip M.] Loyola Univ, Med Ctr, Dept Orthopaed Surg, Maywood, IL 60130 USA; [Borys, Dariusz; Zhang, Jiwang; Denning, Mitchell F.] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60130 USA; [Franzen, Carrie A.; Gupta, Gopal N.] Loyola Univ, Med Ctr, Dept Urol, Maywood, IL 60130 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Kuo, PC (corresponding author), 2160 S First Ave, Maywood, IL USA.	pkuo@lumc.edu	Zhang, Jiwang/AAG-2706-2021; Zapf, Matthew/GRS-0086-2022	Franzen, Carrie/0000-0002-1127-8599; Zapf, Matthew/0000-0001-5544-8900	NIAAA NIH HHS [R21 AA021225] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA021225] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Blum Arnon, 2012, Am J Orthop (Belle Mead NJ), V41, P87; Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247; Chakkalakal D., 2011, OPEN BONE J, V3, P1, DOI [10.2174/1876525401103010001, DOI 10.2174/1876525401103010001]; Chakkalakal DA, 2005, ALCOHOL, V36, P201, DOI 10.1016/j.alcohol.2005.08.001; Chakkalakal DA, 1999, BONE, V25, P321, DOI 10.1016/S8756-3282(99)00167-2; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Demetriades D, 2004, J AM COLL SURGEONS, V199, P687, DOI 10.1016/j.jamcollsurg.2004.07.017; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; DOSTMANN WRG, 1990, J BIOL CHEM, V265, P10484; Duvall CL, 2007, J BONE MINER RES, V22, P286, DOI 10.1359/JBMR.061103; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; Gaboli M, 2001, GENE DEV, V15, P1625, DOI 10.1101/gad.902301; Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6; Gong ZD, 2004, ALCOHOL CLIN EXP RES, V28, P468, DOI 10.1097/01.ALC.0000118315.58404.C1; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; HIRAKAWA K, 1994, J BONE MINER RES, V9, P1551; Lauing KL, 2012, ALCOHOL CLIN EXP RES, V36, P2095, DOI 10.1111/j.1530-0277.2012.01830.x; Levy RS, 1996, J ORTHOP TRAUMA, V10, P21, DOI 10.1097/00005131-199601000-00004; Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022; LIND M, 1993, ACTA ORTHOP SCAND, V64, P553, DOI 10.3109/17453679308993691; Mi ZY, 2009, MOL THER, V17, P153, DOI 10.1038/mt.2008.235; Nyquist F, 1997, ALCOHOL ALCOHOLISM, V32, P91; Obermeyer TS, 2012, J ORTHOP TRAUMA, V26, P712, DOI 10.1097/BOT.0b013e3182724298; Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019; RIVARA FP, 1993, ARCH SURG-CHICAGO, V128, P907; Saadeh PB, 1999, AM J PHYSIOL-CELL PH, V277, pC628, DOI 10.1152/ajpcell.1999.277.4.C628; Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1; Standal T, 2004, EXP ONCOL, V26, P179; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; TONNESEN H, 1991, J BONE JOINT SURG BR, V73, P511, DOI 10.1302/0301-620X.73B3.1670461; Volkmer DL, 2011, J ORTHOP TRAUMA, V25, P516, DOI 10.1097/BOT.0b013e31821f65cc; Weber CE, 2015, ONCOGENE, V34, P4821, DOI 10.1038/onc.2014.410; Wezeman FH, 2004, ALCOHOL CLIN EXP RES, V28, P1091, DOI 10.1097/01.ALC.0000130808.49262.F5; Yang DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001540; Yoo JU, 1998, CLIN ORTHOP RELAT R, pS73	35	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					9959	9973		10.1074/jbc.M114.616888	http://dx.doi.org/10.1074/jbc.M114.616888			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25713073	Green Published, hybrid			2022-12-28	WOS:000353241100006
J	Han, XB; Xiao, ZS; Quarles, LD				Han, Xiaobin; Xiao, Zhousheng; Quarles, L. Darryl			Membrane and Integrative Nuclear Fibroblastic Growth Factor Receptor (FGFR) Regulation of FGF-23	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcineurin; Cyclic AMP (cAMP); Fibroblast Growth Factor (FGF); Fibroblast Growth Factor Receptor (FGFR); Osteoblast	VITAMIN-D METABOLISM; HYPOPHOSPHATEMIC RICKETS; GENE-EXPRESSION; PHOSPHATE HOMEOSTASIS; TRANSCRIPTION FACTORS; SIGNALING MODULE; BONE; CELLS; KLOTHO; MICE	Background: Mechanisms whereby local bone-derived factors regulate FGF-23 are unclear. Results: Low and high molecular weight FGF-2 stimulated FGF-23 promoter activity in osteoblasts through membrane FGFR-mediated PLC and MAPK activation of NFAT and Ets1 and integrative nuclear FGFR1 signaling involving cAMP/CBP/CREB signaling pathways, respectively. Conclusion: Membrane FGFR and intranucelar FGFR/CBP pathways regulate FGF-23 transcription. Significance: Paracrine/autocrine FGFs control hormonal FGF-23. Fibroblastic growth factor receptor 1 (FGFR1) signaling pathways are implicated in the regulation of FGF-23 gene transcription, but the molecular pathways remain poorly defined. We used low molecular weight (LMW, 18 kDa) FGF-2 and high molecular weight (HMW) FGF-2 isoforms, which, respectively, activate cell surface FGF receptors and intranuclear FGFR1, to determine the roles of membrane FGFRs and integrative nuclear FGFR1 signaling (INFS) in the regulation of FGF-23 gene transcription in osteoblasts. We found that LMW-FGF-2 induced NFAT and Ets1 binding to conserved cis-elements in the proximal FGF-23 promoter and stimulated FGF-23 promoter activity through PLC/calcineurin/NFAT and MAPK pathways in SaOS-2 and MC3T3-E1 osteoblasts. In contrast, HMW-FGF-2 stimulated FGF-23 promoter activity in osteoblasts through a cAMP-dependent binding of FGFR1 and cAMP-response element-binding protein (CREB) to a conserved cAMP response element (CRE) contiguous with the NFAT binding site in the FGF-23 promoter. Mutagenesis of the NFAT and CRE binding sites, respectively, inhibited the effects of LMW-FGF-2 and HMW-FGF-23 to stimulate FGF-23 promoter activity. FGF-2 activation of both membrane FGFRs and INFS-dependent FGFR1 pathways may provide a means to integrate systemic and local regulation of FGF-23 transcription under diverse physiological and pathological conditions.	[Han, Xiaobin; Xiao, Zhousheng; Quarles, L. Darryl] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Quarles, LD (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coleman Bldg,Suite B216,956 Court Ave, Memphis, TN 38163 USA.	dquarles@uthsc.edu		Quarles, L. Darryl/0000-0002-5082-7896; xiao, zhousheng/0000-0002-3363-5673	National Institutes of Health [5R01AR045955]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01AR045955 (to L. D. Q.).	Avitan-Hersh E, 2014, J CLIN ENDOCR METAB, V99, pE132, DOI 10.1210/jc.2013-2813; Baron O, 2012, J BIOL CHEM, V287, P19827, DOI 10.1074/jbc.M112.347831; Beckman MJ, 1996, BIOCHEMISTRY-US, V35, P8465, DOI 10.1021/bi960658i; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Brown WW, 2009, J CLIN ENDOCR METAB, V94, P17, DOI 10.1210/jc.2008-0220; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; David V, 2013, ENDOCRINOLOGY, V154, P4469, DOI 10.1210/en.2013-1627; Degnin CR, 2010, J CELL BIOCHEM, V110, P1046, DOI 10.1002/jcb.22629; Delrieu I, 2000, FEBS LETT, V468, P6, DOI 10.1016/S0014-5793(00)01189-3; Du X, 2012, J CELL PHYSL, V227, P3731, DOI DOI 10.1002/JCP.24083; Dunham-Ems SM, 2009, MOL BIOL CELL, V20, P2401, DOI 10.1091/mbc.E08-06-0600; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Gee K, 2007, J IMMUNOL, V178, P798, DOI 10.4049/jimmunol.178.2.798; Hoenderop JGJ, 2004, KIDNEY INT, V65, P531, DOI 10.1111/j.1523-1755.2004.00402.x; Homer-Bouthiette C, 2014, J BIOL CHEM, V289, P36303, DOI 10.1074/jbc.M114.619569; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; Kawata T, 2007, J AM SOC NEPHROL, V18, P2683, DOI 10.1681/ASN.2006070783; Kolek OI, 2005, AM J PHYSIOL-GASTR L, V289, pG1036, DOI 10.1152/ajpgi.00243.2005; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Liang K, 1999, ENDOCRINOLOGY, V140, P5780; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Liu SG, 2009, MOL ENDOCRINOL, V23, P1505, DOI 10.1210/me.2009-0085; Liu SG, 2008, J AM SOC NEPHROL, V19, P2342, DOI 10.1681/ASN.2007121301; Marie PJ, 2012, GENE, V498, P1, DOI 10.1016/j.gene.2012.01.086; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Meir T, 2014, KIDNEY INT, V86, P1106, DOI 10.1038/ki.2014.215; Mendoza FA, 2012, CLIN J AM SOC NEPHRO, V7, P1155, DOI 10.2215/CJN.13281211; Miraoui H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146re9; Nauman EA, 2003, CALCIFIED TISSUE INT, V73, P147, DOI 10.1007/s00223-002-1033-6; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Peng H, 2002, J NEUROCHEM, V81, P506, DOI 10.1046/j.1471-4159.2002.00833.x; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Saini RK, 2013, CALCIFIED TISSUE INT, V92, P339, DOI 10.1007/s00223-012-9683-5; Samadfam R, 2009, ENDOCRINOLOGY, V150, P4835, DOI 10.1210/en.2009-0472; Sato T, 2004, AM J KIDNEY DIS, V44, P481, DOI 10.1053/j.ajkd.2004.05.026; Shalhoub V, 2011, CALCIFIED TISSUE INT, V89, P140, DOI 10.1007/s00223-011-9501-5; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shimada T, 2005, AM J PHYSIOL-RENAL, V289, pF1088, DOI 10.1152/ajprenal.00474.2004; Stachowiak MK, 2015, J CELL PHYSIOL, V230, P989, DOI 10.1002/jcp.24879; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Stevens DA, 2003, MOL ENDOCRINOL, V17, P1751, DOI 10.1210/me.2003-0137; Tomiyama K, 2010, P NATL ACAD SCI USA, V107, P1666, DOI 10.1073/pnas.0913986107; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Valtink M, 2012, INVEST OPHTH VIS SCI, V53, P3207, DOI 10.1167/iovs.12-9423; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Wesseling-Perry K, 2013, PEDIATR NEPHROL, V28, P2207, DOI 10.1007/s00467-013-2547-z; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; Wohrle S, 2013, J BONE MINER RES, V28, P899, DOI 10.1002/jbmr.1810; Wohrle S, 2011, J BONE MINER RES, V26, P2486, DOI 10.1002/jbmr.478; Wu AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057322; Xiao LP, 2013, J BONE MINER RES, V28, P35, DOI 10.1002/jbmr.1721; Xiao LP, 2010, J BIOL CHEM, V285, P2834, DOI 10.1074/jbc.M109.030577; Xiao Z., 2014, PLOS ONE, V9; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491	63	39	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10447	10459		10.1074/jbc.M114.609230	http://dx.doi.org/10.1074/jbc.M114.609230			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25752607	hybrid, Green Published			2022-12-28	WOS:000353241100044
J	Li, YL; Pierce, BG; Wang, Q; Keck, ZY; Fuerst, TR; Foung, SKH; Mariuzza, RA				Li, Yili; Pierce, Brian G.; Wang, Qian; Keck, Zhen-Yong; Fuerst, Thomas R.; Foung, Steven K. H.; Mariuzza, Roy A.			Structural Basis for Penetration of the Glycan Shield of Hepatitis C Virus E2 Glycoprotein by a Broadly Neutralizing Human Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody; Crystal Structure; Glycosylation; Hepatitis C Virus (HCV); Vaccine; Neutralization	HUMAN MONOCLONAL-ANTIBODIES; ENVELOPE GLYCOPROTEIN; AMINO-TERMINUS; PROTEIN; BINDING; INFECTION; GLYCOSYLATION; EPITOPES; ENTRY; CD81	Hepatitis C virus (HCV) is a major cause of liver cirrhosis and hepatocellular carcinoma. A challenge for HCV vaccine development is to identify conserved epitopes able to elicit protective antibodies against this highly diverse virus. Glycan shielding is a mechanism by which HCV masks such epitopes on its E2 envelope glycoprotein. Antibodies to the E2 region comprising residues 412-423 (E2(412-423)) have broadly neutralizing activities. However, an adaptive mutation in this linear epitope, N417S, is associated with a glycosylation shift from Asn-417 to Asn-415 that enables HCV to escape neutralization by mAbs such as HCV1 and AP33. By contrast, the human mAb HC33.1 can neutralize virus bearing the N417S mutation. To understand how HC33.1 penetrates the glycan shield created by the glycosylation shift to Asn-415, we determined the structure of this broadly neutralizing mAb in complex with its E2(412-423) epitope to 2.0 resolution. The conformation of E2(412-423) bound to HC33.1 is distinct from the -hairpin conformation of this peptide bound to HCV1 or AP33, because of disruption of the -hairpin through interactions with the unusually long complementarity-determining region 3 of the HC33.1 heavy chain. Whereas Asn-415 is buried by HCV1 and AP33, it is solvent-exposed in the HC33.1-E2(412-423) complex, such that glycosylation of Asn-415 would not prevent antibody binding. Furthermore, our results highlight the structural flexibility of the E2(412-423) epitope, which may serve as an immune evasion strategy to impede induction of antibodies targeting this site by reducing its antigenicity.	[Li, Yili; Pierce, Brian G.; Wang, Qian; Fuerst, Thomas R.; Mariuzza, Roy A.] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [Li, Yili; Wang, Qian; Fuerst, Thomas R.; Mariuzza, Roy A.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Keck, Zhen-Yong; Foung, Steven K. H.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94304 USA	University System of Maryland; University of Maryland College Park; Stanford University	Mariuzza, RA (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	rmariuzz@umd.edu	Pierce, Brian/AAB-8965-2022	Pierce, Brian/0000-0003-4821-0368; Foung, Steven/0000-0001-7149-6160	National Institutes of Health [AI036900]; MPower Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036900, R37AI036900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MPower Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI036900 (to R. A. M.). This work was also supported by MPower Maryland.	Angus AGN, 2011, FUTURE MICROBIOL, V6, P279, DOI [10.2217/fmb.11.9, 10.2217/FMB.11.9]; [Anonymous], 2013, HEP C; Bankwitz D, 2010, J VIROL, V84, P5751, DOI 10.1128/JVI.02200-09; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Broering TJ, 2009, J VIROL, V83, P12473, DOI 10.1128/JVI.01138-09; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chung RT, 2013, AM J TRANSPLANT, V13, P1047, DOI 10.1111/ajt.12083; Deng L, 2014, P NATL ACAD SCI USA, V111, P10690, DOI 10.1073/pnas.1411317111; Dhillon S, 2010, J VIROL, V84, P5494, DOI 10.1128/JVI.02153-09; Dowd KA, 2009, GASTROENTEROLOGY, V136, P2377, DOI 10.1053/j.gastro.2009.02.080; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Falkowska E, 2007, J VIROL, V81, P8072, DOI 10.1128/JVI.00459-07; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Goffard A, 2005, J VIROL, V79, P8400, DOI 10.1128/JVI.79.13.8400-8409.2005; Goffard A, 2003, BIOCHIMIE, V85, P295, DOI 10.1016/S0300-9084(03)00004-X; Hadlock KG, 2000, J VIROL, V74, P10407, DOI 10.1128/JVI.74.22.10407-10416.2000; Helle F, 2007, J VIROL, V81, P8101, DOI 10.1128/JVI.00127-07; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Hwang WC, 2006, J BIOL CHEM, V281, P34610, DOI 10.1074/jbc.M603275200; Iacob RE, 2008, J AM SOC MASS SPECTR, V19, P428, DOI 10.1016/j.jasms.2007.11.022; IMPERIALI B, 1995, P NATL ACAD SCI USA, V92, P97, DOI 10.1073/pnas.92.1.97; Julien JP, 2012, IMMUNOL REV, V250, P180, DOI 10.1111/imr.12005; KATO N, 1993, J VIROL, V67, P3923, DOI 10.1128/JVI.67.7.3923-3930.1993; Keck ZY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004297; Keck ZY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002653; Keck Z, 2013, J VIROL, V87, P37, DOI 10.1128/JVI.01941-12; Keck ZY, 2005, J VIROL, V79, P13199, DOI 10.1128/JVI.79.21.13199-13208.2005; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Khan AG, 2014, NATURE, V509, P381, DOI 10.1038/nature13117; Kolawole AO, 2014, J VIROL, V88, P4543, DOI 10.1128/JVI.03685-13; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; Kong L, 2012, J VIROL, V86, P13085, DOI 10.1128/JVI.01939-12; Kong L, 2012, P NATL ACAD SCI USA, V109, P9499, DOI 10.1073/pnas.1202924109; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Meola A, 2015, J VIROL, V89, P2170, DOI 10.1128/JVI.02190-14; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Owsianka A, 2005, J VIROL, V79, P11095, DOI 10.1128/JVI.79.17.11095-11104.2005; Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pantua H, 2013, J MOL BIOL, V425, P1899, DOI 10.1016/j.jmb.2013.02.025; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Potter JA, 2012, J VIROL, V86, P12923, DOI 10.1128/JVI.02052-12; Robin G, 2014, J MOL BIOL, V426, P3729, DOI 10.1016/j.jmb.2014.08.013; Sabo MC, 2011, J VIROL, V85, P7005, DOI 10.1128/JVI.00586-11; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423; Schulz BL, 2012, GLYCOSYLATION, P21, DOI 10.5772/50260; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tarr AW, 2007, J GEN VIROL, V88, P2991, DOI 10.1099/vir.0.83065-0; Tarr AW, 2012, J VIROL, V86, P2739, DOI 10.1128/JVI.06492-11; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008	60	55	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10117	10125		10.1074/jbc.M115.643528	http://dx.doi.org/10.1074/jbc.M115.643528			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25737449	Green Published, hybrid			2022-12-28	WOS:000353241100018
J	Stoppini, M; Bellotti, V				Stoppini, Monica; Bellotti, Vittorio			Systemic Amyloidosis: Lessons from beta(2)-Microglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Amyloid; Atomic Force Microscopy (AFM); Protein Aggregation; Protein Misfolding; Protein Structure; 2-Microglobulin; Fibrillogenesis in Vitro; Genetic Variant Asp76Asn; Mechanism of Amyloidogenesis	EXTRACELLULAR CHAPERONE; PHYSIOLOGICAL CONDITIONS; FIBRIL FORMATION; NATIVE-STATE; NEUTRAL PH; BETA-2-MICROGLOBULIN; AGGREGATION; PROTEIN; ROLES; NMR	beta (2)-Microglobulin is responsible for systemic amyloidosis affecting patients undergoing long-term hemodialysis. Its genetic variant D76N causes a very rare form of familial systemic amyloidosis. These two types of amyloidoses differ significantly in terms of the tissue localization of deposits and for major pathological features. Considering how the amyloidogenesis of the (2)-microglobulin mechanism has been scrutinized in depth for the last three decades, the comparative analysis of molecular and pathological properties of wild type (2)-microglobulin and of the D76N variant offers a unique opportunity to critically reconsider the current understanding of the relation between the protein's structural properties and its pathologic behavior.	[Stoppini, Monica; Bellotti, Vittorio] Univ Pavia, Dept Mol Med, Inst Biochem, I-27100 Pavia, Italy; [Bellotti, Vittorio] UCL, Wolfson Drug Discovery Unit, Div Med, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England	University of Pavia; University of London; University College London	Bellotti, V (corresponding author), UCL, Wolfson Drug Discovery Unit, Div Med, Ctr Amyloidosis & Acute Phase Prot, Rowland Hill St, London NW3 2PF, England.	v.bellotti@ucl.ac.uk	Bellotti, Vittorio/A-6201-2014	Bellotti, Vittorio/0000-0001-8678-662X	Medical Research Council [MR/K000187/1]; University College London (UCL) Amyloidosis Research Fund; UCL Wolfson Drug Discovery Unit Funds; Cariplo Foundation [2011-2096, 2013-0964]; Telethon [GG14127]; MRC [MR/K000187/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University College London (UCL) Amyloidosis Research Fund; UCL Wolfson Drug Discovery Unit Funds; Cariplo Foundation(Fondazione Cariplo); Telethon(Fondazione Telethon); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by Medical Research Council Grant MR/K000187/1 (to V. B.); the University College London (UCL) Amyloidosis Research Fund and UCL Wolfson Drug Discovery Unit Funds; the Cariplo Foundation Projects 2011-2096 (to V. B.) and 2013-0964 (to M. S.); and Telethon Grant GG14127 (to V. B.).	Agwuh KN, 2006, J ANTIMICROB CHEMOTH, V58, P256, DOI 10.1093/jac/dkl224; Barbet-Massin E, 2010, J AM CHEM SOC, V132, P5556, DOI 10.1021/ja1002839; BARDIN T, 1987, AM J MED, V83, P419, DOI 10.1016/0002-9343(87)90750-9; Bekard IB, 2011, BIOPOLYMERS, V95, P733, DOI 10.1002/bip.21646; Bellotti V, 1998, EUR J BIOCHEM, V258, P61, DOI 10.1046/j.1432-1327.1998.2580061.x; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Campistol JM, 1996, NEPHROL DIAL TRANSPL, V11, P142; CAMPISTOL JM, 1992, KIDNEY INT, V42, P915, DOI 10.1038/ki.1992.368; Chiti F, 2001, J BIOL CHEM, V276, P46714, DOI 10.1074/jbc.M107040200; Chiti F, 2001, J MOL BIOL, V307, P379, DOI 10.1006/jmbi.2000.4478; CONNORS LH, 1985, BIOCHEM BIOPH RES CO, V131, P1063, DOI 10.1016/0006-291X(85)90198-6; Domanska K, 2011, P NATL ACAD SCI USA, V108, P1314, DOI 10.1073/pnas.1008560108; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Esposito G, 2008, J MOL BIOL, V378, P887, DOI 10.1016/j.jmb.2008.03.002; Esposito G, 2013, J BIOL CHEM, V288, P17844, DOI 10.1074/jbc.M112.448639; Fabian H, 2013, BIOPHYS CHEM, V179, P35, DOI 10.1016/j.bpc.2013.05.001; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Giorgetti S, 2005, PROTEIN SCI, V14, P696, DOI 10.1110/ps.041194005; Giorgetti S, 2011, J BIOL CHEM, V286, P2121, DOI 10.1074/jbc.M110.178376; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOREVIC PD, 1986, P NATL ACAD SCI USA, V83, P7908, DOI 10.1073/pnas.83.20.7908; GOREVIC PD, 1985, J CLIN INVEST, V76, P2425, DOI 10.1172/JCI112257; Gumral D, 2013, MAGN RESON CHEM, V51, P795, DOI 10.1002/mrc.4018; Hatters DM, 2002, EUR J BIOCHEM, V269, P2789, DOI 10.1046/j.1432-1033.2002.02957.x; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Ihse E, 2013, AMYLOID, V20, P142, DOI 10.3109/13506129.2013.797890; Ikenoue T, 2014, P NATL ACAD SCI USA, V111, P6654, DOI 10.1073/pnas.1322602111; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Kelly JW, 1997, ADV PROTEIN CHEM, V50, P161, DOI 10.1016/S0065-3233(08)60321-6; Kolstoe SE, 2010, P NATL ACAD SCI USA, V107, P20483, DOI 10.1073/pnas.1008255107; Kumita JR, 2007, J MOL BIOL, V369, P157, DOI 10.1016/j.jmb.2007.02.095; LINKE RP, 1989, KIDNEY INT, V36, P675, DOI 10.1038/ki.1989.245; Magalhaes J, 2011, J NEUROPATH EXP NEUR, V70, P1097, DOI 10.1097/NEN.0b013e31823a44f4; Mangione PP, 2014, P NATL ACAD SCI USA, V111, P1539, DOI 10.1073/pnas.1317488111; Mangione PP, 2013, J BIOL CHEM, V288, P30917, DOI 10.1074/jbc.M113.498857; McParland VJ, 2002, NAT STRUCT BIOL, V9, P326, DOI 10.1038/nsb791; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Montagna G, 2013, AMYLOID, V20, P173, DOI 10.3109/13506129.2013.803463; Motomiya Y, 2003, KIDNEY INT, V64, P2244, DOI 10.1046/j.1523-1755.2003.00315.x; Mukaiyama A, 2013, J MOL BIOL, V425, P257, DOI 10.1016/j.jmb.2012.11.004; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; NELSON SR, 1991, BIOCHEM J, V275, P67, DOI 10.1042/bj2750067; Ohhashi Y, 2002, J BIOCHEM, V131, P45, DOI 10.1093/oxfordjournals.jbchem.a003076; Ozawa D, 2011, J BIOL CHEM, V286, P9668, DOI 10.1074/jbc.M110.167965; Piazza R, 2006, EUR BIOPHYS J BIOPHY, V35, P439, DOI 10.1007/s00249-006-0051-0; Raimondi S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-159; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Sasahara K, 2008, BIOCHEMISTRY-US, V47, P2650, DOI 10.1021/bi701968g; Stoppini M, 2005, BBA-PROTEINS PROTEOM, V1753, P23, DOI 10.1016/j.bbapap.2005.07.019; Su YC, 2014, J AM CHEM SOC, V136, P6313, DOI 10.1021/ja4126092; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Vanderhaegen S, 2013, PROTEIN SCI, V22, P1349, DOI 10.1002/pro.2321; Wyatt AR, 2012, J MOL BIOL, V421, P499, DOI 10.1016/j.jmb.2012.01.004; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com	61	61	64	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					9951	9958		10.1074/jbc.R115.639799	http://dx.doi.org/10.1074/jbc.R115.639799			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25750126	Green Published, hybrid			2022-12-28	WOS:000353241100005
J	Choi, JS; Maity, A; Gray, T; Berdis, AJ				Choi, Jung-Suk; Maity, Ayan; Gray, Thomas; Berdis, Anthony J.			A Metal-containing Nucleoside That Possesses Both Therapeutic and Diagnostic Activity against Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; PYRIMIDINE NUCLEOSIDES; IRIDIUM(III) COMPLEXES; MULTIDRUG-RESISTANCE; TRANSPORTER PROTEINS; ANALOGS; PURINE; APOPTOSIS; ROLES; PHARMACOKINETICS	Nucleoside transport is an essential process that helps maintain the hyperproliferative state of most cancer cells. As such, it represents an important target for developing diagnostic and therapeutic agents that can effectively detect and treat cancer, respectively. This report describes the development of a metal-containing nucleoside designated Ir(III)-PPY nucleoside that displays both therapeutic and diagnostic properties against the human epidermal carcinoma cell line KB3-1. The cytotoxic effects of Ir(III)-PPY nucleoside are both time- and dose-dependent. Flow cytometry analyses validate that the nucleoside analog causes apoptosis by blocking cell cycle progression at G(2)/M. Fluorescent microscopy studies show rapid accumulation in the cytoplasm within 4 h. However, more significant accumulation is observed in the nucleus and mitochondria after 24 h. This localization is consistent with the ability of the metal-containing nucleoside to influence cell cycle progression at G(2)/M. Mitochondrial depletion is also observed after longer incubations (Delta t similar to 48 h), and this effect may produce additional cytotoxic effects. siRNA knockdown experiments demonstrate that the nucleoside transporter, hENT1, plays a key role in the cellular entry of Ir(III)-PPY nucleoside. Collectively, these data provide evidence for the development of a metal-containing nucleoside that functions as a combined therapeutic and diagnostic agent against cancer.	[Choi, Jung-Suk; Berdis, Anthony J.] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Choi, Jung-Suk; Berdis, Anthony J.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA; [Maity, Ayan; Gray, Thomas] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University; Case Western Reserve University	Berdis, AJ (corresponding author), Cleveland State Univ, 2351 Euclid Ave, Cleveland, OH 44115 USA.	a.berdis@csuohio.edu	MAITY, AYAN/P-7450-2015		National Science Foundation [CBET-1066107]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by National Science Foundation Grant CBET-1066107 to A. J. B. and T. G.).	Alexander RL, 2005, CANCER CHEMOTH PHARM, V56, P15, DOI 10.1007/s00280-004-0949-0; Baldwin SA, 1999, MOL MED TODAY, V5, P216, DOI 10.1016/S1357-4310(99)01459-8; Berdis AJ, 2008, BIOCHEMISTRY-US, V47, P8253, DOI 10.1021/bi801179f; Bereiter-Hahn J, 2010, INT REV CEL MOL BIO, V284, P1, DOI 10.1016/S1937-6448(10)84001-8; CAPIZZI RL, 1983, J CLIN ONCOL, V1, P763, DOI 10.1200/JCO.1983.1.12.763; Chang C, 2004, MOL PHARMACOL, V65, P558, DOI 10.1124/mol.65.3.558; Craig S, 2012, J MED CHEM, V55, P2437, DOI 10.1021/jm2005942; Crawford S, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00068; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Fernandez-Moreira V, 2010, CHEM COMMUN, V46, P186, DOI 10.1039/b917757d; Fukunaga M, 2001, GYNECOL ONCOL, V81, P67, DOI 10.1006/gyno.2000.6100; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Hedskog L, 2012, ANTIOXID REDOX SIGN, V16, P1476, DOI 10.1089/ars.2011.4259; HO DHW, 1971, CLIN PHARMACOL THER, V12, P944; Hopper-Borge E, 2009, CANCER RES, V69, P178, DOI 10.1158/0008-5472.CAN-08-1420; Hunter AL, 2005, METH MOLEC MED, V112, P277; Krude T, 1999, EXP CELL RES, V247, P148, DOI 10.1006/excr.1998.4342; Liu Z, 2014, ORGANOMETALLICS, V33, P5324, DOI 10.1021/om500644f; Loffler M, 2007, ARTERIOSCL THROM VAS, V27, P1004, DOI 10.1161/ATVBAHA.106.126714; Lopez-Guerra M, 2008, HAEMATOL-HEMATOL J, V93, P1843, DOI 10.3324/haematol.13186; Mackey JR, 1999, JNCI-J NATL CANCER I, V91, P1876, DOI 10.1093/jnci/91.21.1876; Maity A, 2013, CHEM-EUR J, V19, P15924, DOI 10.1002/chem.201301776; Molina-Arcas M, 2008, NUCLEOS NUCLEOT NUCL, V27, P769, DOI 10.1080/15257770802145819; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Parker WB, 2009, CHEM REV, V109, P2880, DOI 10.1021/cr900028p; Pastor-Anglada M, 2008, XENOBIOTICA, V38, P972, DOI 10.1080/00498250802069096 ; Patra M, 2012, CHEMBIOCHEM, V13, P1232, DOI 10.1002/cbic.201200159; Ritzel MWL, 1998, MOL MEMBR BIOL, V15, P203; Ritzel MWL, 2001, MOL MEMBR BIOL, V18, P65, DOI 10.1080/09687680010026313; Sakumura T, 2000, CELL PROLIFERAT, V33, P19, DOI 10.1046/j.1365-2184.2000.00145.x; Seve Pascal, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P73, DOI 10.2174/1568011053352604; Shabaik YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054346; Shavaleev NM, 2012, INORG CHEM, V51, P2263, DOI 10.1021/ic202297h; Shi Z, 2001, CANCER RES, V61, P1065; Sigmond J, 2005, NUCLEOS NUCLEOT NUCL, V24, P1997, DOI 10.1080/15257770500269556; Slugoski MD, 2008, J BIOL CHEM, V283, P8496, DOI 10.1074/jbc.M710433200; Spratlin J, 2004, CLIN CANCER RES, V10, P6956, DOI 10.1158/1078-0432.CCR-04-0224; Su CH, 2012, EUR J CANCER, V48, P3465, DOI 10.1016/j.ejca.2012.04.015; THAMPY KG, 1983, J NEUROCHEM, V40, P874, DOI 10.1111/j.1471-4159.1983.tb08061.x; Tiwari KN, 2003, NUCLEOS NUCLEOT NUCL, V22, P2161, DOI 10.1081/NCN-120026872; Vagnarelli P, 2012, EXP CELL RES, V318, P1435, DOI 10.1016/j.yexcr.2012.03.017; Vickers MF, 2002, BIOCHEM CELL BIOL, V80, P639, DOI 10.1139/O02-148; Wang MJ, 2004, ONCOL REP, V12, P193; Wang QA, 2011, BIOCHEM PHARMACOL, V81, P848, DOI 10.1016/j.bcp.2011.01.001; WEINSTEIN HJ, 1982, BLOOD, V59, P1351; Wheate NJ, 2007, MINI-REV MED CHEM, V7, P627; Wiebe LI, 1999, NUCLEOS NUCLEOT, V18, P1065, DOI 10.1080/15257779908041646; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Yu MX, 2008, CHEM COMMUN, P2115, DOI 10.1039/b800939b; Zhang J, 2006, BIOCHEMISTRY-US, V45, P1087, DOI 10.1021/bi0520535; Zhang J, 2007, CANCER METAST REV, V26, P85, DOI 10.1007/s10555-007-9044-4; Zhu HR, 2012, EUR J PHARMACOL, V696, P43, DOI 10.1016/j.ejphar.2012.09.046	52	6	6	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9714	9726		10.1074/jbc.M114.620294	http://dx.doi.org/10.1074/jbc.M114.620294			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713072	Green Published, hybrid			2022-12-28	WOS:000352729400033
J	Park, ES; Choi, S; Shin, B; Yu, J; Yu, J; Hwang, JM; Yun, H; Chung, YH; Choi, JS; Choi, Y; Rho, J				Park, Eui-Soon; Choi, Seunga; Shin, Bongjin; Yu, Jungeun; Yu, Jiyeon; Hwang, Jung-Me; Yun, Hyeongseok; Chung, Young-Ho; Choi, Jong-Soon; Choi, Yongwon; Rho, Jaerang			Tumor Necrosis Factor (TNF) Receptor-associated Factor (TRAF)-interacting Protein (TRIP) Negatively Regulates the TRAF2 Ubiquitin-dependent Pathway by Suppressing the TRAF2-Sphingosine 1-Phosphate (S1P) Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SIGNALING COMPLEXES; IKK ACTIVATION; LIGASE; GENE; DIFFERENTIATION; ALPHA; DEGRADATION; EXPRESSION; DROSOPHILA	The signaling pathway downstream of TNF receptor (TNFR) is involved in the induction of a wide range of cellular processes, including cell proliferation, activation, differentiation, and apoptosis. TNFR-associated factor 2 (TRAF2) is a key adaptor molecule in TNFR signaling complexes that promotes downstream signaling cascades, such as nuclear factor-kappa B (NF-kappa B) and mitogen-activated protein kinase activation. TRAF-interacting protein (TRIP) is a known cellular binding partner of TRAF2 and inhibits TNF-induced NF-kappa B activation. Recent findings that TRIP plays a multifunctional role in antiviral response, cell proliferation, apoptosis, and embryonic development have increased our interest in exploring how TRIP can affect the TNFR-signaling pathway on a molecular level. In our current study, we demonstrated that TRIP is negatively involved in the TNF-induced inflammatory response through the down-regulation of proinflammatory cytokine production. Here, we demonstrated that the TRAF2-TRIP interaction inhibits Lys(63)-linked TRAF2 ubiquitination by inhibiting TRAF2 E3 ubiquitin (Ub) ligase activity. The TRAF2-TRIP interaction inhibited the binding of sphingosine 1-phosphate, which is a cofactor of TRAF2 E3 Ub ligase, to the TRAF2 RING domain. Finally, we demonstrated that TRIP functions as a negative regulator of proinflammatory cytokine production by inhibiting TNF-induced NF-kappa B activation. These results indicate that TRIP is an important cellular regulator of the TNF-induced inflammatory response.	[Park, Eui-Soon; Choi, Seunga; Shin, Bongjin; Yu, Jungeun; Yu, Jiyeon; Hwang, Jung-Me; Yun, Hyeongseok; Choi, Jong-Soon; Rho, Jaerang] Chungnam Natl Univ, Dept Microbiol & Mol Biol, Taejon 305764, South Korea; [Chung, Young-Ho] Korea Basic Sci Inst, Div Life Sci, Taejon 305333, South Korea; [Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Chungnam National University; Korea Basic Science Institute (KBSI); University of Pennsylvania	Rho, J (corresponding author), Chungnam Natl Univ, Dept Microbiol & Mol Biol, Taejon 305764, South Korea.	jrrho@cnu.ac.kr		Rho, Jaerang/0000-0002-0019-4939	Basic Science Research Program through National Research Foundation of Korea (NRF); Ministry of Education [NRF-2011-0021771]; Korea Basic Science Institute [D33400]; Chungnam National University; Ministry of National Defense Foundation [ADD: 14-01-06-06]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064909] Funding Source: NIH RePORTER	Basic Science Research Program through National Research Foundation of Korea (NRF); Ministry of Education; Korea Basic Science Institute; Chungnam National University; Ministry of National Defense Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) and was funded by Ministry of Education Grant NRF-2011-0021771, Korea Basic Science Institute Grant D33400 (to J. S. C.), the research fund of Chungnam National University, and Ministry of National Defense Foundation Grant ADD: 14-01-06-06.	Almeida S, 2011, J INVEST DERMATOL, V131, P349, DOI 10.1038/jid.2010.329; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bertrand MJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022356; Besse A, 2007, BIOCHEM BIOPH RES CO, V359, P660, DOI 10.1016/j.bbrc.2007.05.149; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chapard C, 2012, EXP DERMATOL, V21, P321, DOI 10.1111/j.1600-0625.2012.01477.x; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; Ha Hyunil, 2009, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1109ds87; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Krishnan S, 2009, P NATL ACAD SCI USA, V106, P16692, DOI 10.1073/pnas.0906293106; Lee SH, 2008, BIOCHEM BIOPH RES CO, V369, P320, DOI 10.1016/j.bbrc.2008.01.168; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lee SY, 1997, J EXP MED, V185, P1275, DOI 10.1084/jem.185.7.1275; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Ma XJ, 2012, CELL RES, V22, P425, DOI 10.1038/cr.2011.135; Merkle JA, 2009, DEVELOPMENT, V136, P449, DOI 10.1242/dev.027599; Murano K, 2008, MOL CELL BIOL, V28, P3114, DOI 10.1128/MCB.02078-07; Park ES, 2007, BIOCHEM BIOPH RES CO, V363, P971, DOI 10.1016/j.bbrc.2007.09.103; Regamey A, 2003, J EXP MED, V198, P1959, DOI 10.1084/jem.20031187; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; Shembade N, 2007, J VIROL, V81, P13735, DOI 10.1128/JVI.01790-07; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Tse AKW, 2005, BIOCHEM PHARMACOL, V70, P1443, DOI 10.1016/j.bcp.2005.08.011; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Xia Zong-Ping, 2005, Sci STKE, V2005, ppe7, DOI 10.1126/stke.2722005pe7; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Yang YL, 2000, CELL RES, V10, P169, DOI 10.1038/sj.cr.7290046; Yu J, 2012, J CLIN IMMUNOL, V32, P1360, DOI 10.1007/s10875-012-9722-z; Yu J, 2010, BIOCHEM BIOPH RES CO, V391, P322, DOI 10.1016/j.bbrc.2009.11.057; Zhang LQ, 2010, J MOL BIOL, V396, P528, DOI 10.1016/j.jmb.2010.01.008; Zhang M, 2012, J EXP MED, V209, P1703, DOI 10.1084/jem.20120024; Zhou Q, 2009, ONCOGENE, V28, P1348, DOI 10.1038/onc.2008.493	43	45	46	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9660	9673		10.1074/jbc.M114.609685	http://dx.doi.org/10.1074/jbc.M114.609685			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25716317	hybrid, Green Published			2022-12-28	WOS:000352729400029
J	Tamura, A; Yui, N				Tamura, Atsushi; Yui, Nobuhiko			beta-Cyclodextrin-threaded Biocleavable Polyrotaxanes Ameliorate Impaired Autophagic Flux in Niemann-Pick Type C Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL ACCUMULATION; STORAGE; DYSFUNCTION; MATURATION; CLATHRIN; FUSION; NEURODEGENERATION; TRAFFICKING; ACTIVATION; PROTEINASE	Niemann-Pick type C (NPC) disease is characterized by the lysosomal accumulation of cholesterols and impaired autophagic flux due to the inhibited fusion of autophagosomes to lysosornes. We have recently developed beta-cydodextrin (beta-CD)-threaded biocleavable polyrotaxanes (PRXs), which can release threaded beta-CDs in response to intracellular environments as a therapeutic for NPC disease. The biocleavable PRXs exhibited effective cholesterol reduction ability and negligible toxic effect compared with hydroxypropyl-beta-CD (HP-beta-CD). In this study, we investigated the effect of biodeavable PRX and HP-beta-CD on the impaired autophagy in NPC disease. The NPC patient-derived fibroblasts (NPC1 fibroblasts) showed an increase in the number of LC3-positive puncta compared with normal fibroblasts, even in the basal conditions; the HP-beta-CD treatment markedly increased the number of LC3-positive puncta and the levels of p62 in NPC1 fibroblasts, indicating that autophagic flux was further perturbed. In sharp contrast, the biocleavable PRX reduced the number of LC3-positive puncta and the levels of p62 in NPC1 fibroblasts through an mTOR-independent mechanism. The mRFP-GFP-LC3 reporter gene expression experiments revealed that the biocleavable PRX facilitated the formation of autolysosomes to allow for autophagic protein degradation. Therefore, the beta-CD-threaded biocleavable PRXs may be promising therapeutics for ameliorating not only cholesterol accumulation but also autophagy impairment in NPC disease.	[Tamura, Atsushi; Yui, Nobuhiko] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Organ Biomat, Tokyo 1010062, Japan	Tokyo Medical & Dental University (TMDU)	Yui, N (corresponding author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Organ Biomat, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.	yui.org@tmd.ac.jp		Tamura, Atsushi/0000-0003-0235-7364	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [23107004]; MEXT of Japan [26750155]; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research	This work was supported by Grant-in-aid for Scientific Research 23107004 on Innovative Areas "Nanomedicine Molecular Science" (to N. Y.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Grant-in-Aid for Young Scientists (B) 26750155 (to A. T.) from MEXT of Japan; and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to A. T.).	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chang TY, 2005, J BIOL CHEM, V280, P20917, DOI 10.1074/jbc.R400040200; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Cheng JL, 2006, BIOCHEM BIOPH RES CO, V351, P246, DOI 10.1016/j.bbrc.2006.10.042; Chevrier M, 2010, AUTOPHAGY, V6, P589, DOI 10.4161/auto.6.5.11943; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Elrick MJ, 2012, HUM MOL GENET, V21, P4876, DOI 10.1093/hmg/dds324; Fraldi A, 2010, EMBO J, V29, P3607, DOI 10.1038/emboj.2010.237; Furuta N, 2010, MOL BIOL CELL, V21, P1001, DOI 10.1091/mbc.E09-08-0693; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gabande-Rodriguez E, 2014, CELL DEATH DIFFER, V21, P864, DOI 10.1038/cdd.2014.4; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harada A, 2009, CHEM REV, V109, P5974, DOI 10.1021/cr9000622; Ishibashi S, 2009, J CLIN NEUROSCI, V16, P954, DOI 10.1016/j.jocn.2008.09.020; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Lieberman AP, 2012, AUTOPHAGY, V8, P719, DOI 10.4161/auto.19469; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; MACH L, 1994, J BIOL CHEM, V269, P13030; Matsuo M, 2013, MOL GENET METAB, V108, P76, DOI 10.1016/j.ymgme.2012.11.005; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Motoyama K, 2006, EUR J PHARM SCI, V29, P111, DOI 10.1016/j.ejps.2006.06.002; Motoyama K, 2009, EUR J PHARM SCI, V38, P249, DOI 10.1016/j.ejps.2009.07.010; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Onodera R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04417; Ordonez MP, 2012, HUM MOL GENET, V21, P2651, DOI 10.1093/hmg/dds090; Pacheco CD, 2007, HUM MOL GENET, V16, P1495, DOI 10.1093/hmg/ddm100; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Platt FM, 2012, J CELL BIOL, V199, P723, DOI 10.1083/jcb.201208152; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Punturieri A, 2000, J EXP MED, V192, P789, DOI 10.1084/jem.192.6.789; Reverter M, 2014, CELL REP, V7, P883, DOI 10.1016/j.celrep.2014.03.043; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rong YG, 2012, NAT CELL BIOL, V14, P924, DOI 10.1038/ncb2557; Sarkar S, 2013, CELL REP, V5, P1302, DOI 10.1016/j.celrep.2013.10.042; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Song WS, 2014, J BIOL CHEM, V289, P10211, DOI 10.1074/jbc.M113.506246; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Takamura A, 2008, BIOCHEM BIOPH RES CO, V367, P616, DOI 10.1016/j.bbrc.2007.12.187; Tamura A, 2014, CHEM COMMUN, V50, P13433, DOI 10.1039/c4cc03709j; Tamura A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04356; Tamura A, 2013, BIOMATERIALS, V34, P2480, DOI 10.1016/j.biomaterials.2012.12.006; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x	60	40	44	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9442	9454		10.1074/jbc.M115.636803	http://dx.doi.org/10.1074/jbc.M115.636803			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713067	hybrid, Green Published			2022-12-28	WOS:000352729400012
J	Daringer, NM; Schwarz, KA; Leonard, JN				Daringer, Nichole M.; Schwarz, Kelly A.; Leonard, Joshua N.			Contributions of Unique Intracellular Domains to Switchlike Biosensing by Toll-like Receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE REGULATION; IMMUNE-RESPONSES; CELL-ACTIVATION; PLASMA-MEMBRANE; PROTEIN TMED7; TLR4; TOLL-LIKE-RECEPTOR-4; COMPLEX; INNATE; DIMERIZATION	Toll-like receptors (TLRs) mediate immune recognition of both microbial infections and tissue damage. Aberrant TLR signaling promotes disease; thus, understanding the regulation of TLR signaling is of medical relevance. Although downstream mediators of TLR signaling have been identified, the detailed mechanism by which ligand binding-mediated dimerization induces downstream signaling remains poorly understood. Here, we investigate this question for TLR4, which mediates responsiveness to bacterial LPS and drives inflammatory disease. TLR4 exhibits structural and functional features that are unique among TLRs, including responsiveness to a wide variety of ligands. However, the connection between these structural features and the regulation of signaling is not clear. Here, we investigated how the unique intracellular structures of TLR4 contribute to receptor signaling. Key conclusions include the following. 1) The unique intracellular linker of TLR4 is important for achieving LPS-inducible signaling via Toll/IL-1 receptor (TIR) domain-containing adapter-inducing interferon-beta (TRIF) but less so for signaling via myeloid differentiation primary response 88 (MyD88). 2) Membrane-bound TLR4 TIR domains were sufficient to induce signaling. However, introducing long, flexible intracellular linkers neither induced constitutive signaling nor ablated LPS-inducible signaling. Thus, the initiation of TLR4 signaling is regulated by a mechanism that does not require tight geometric constraints. Together, these observations necessitate refining the model of TLR4 signal initiation. We hypothesize that TLR4 may interact with an inhibitory partner in the absence of ligand, via both TIR and extracellular domains of TLR4. In this speculative model, ligand binding induces dissociation of the inhibitory partner, triggering spontaneous, switchlike TIR domain homodimerization to initiate downstream signaling.	[Daringer, Nichole M.; Schwarz, Kelly A.; Leonard, Joshua N.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Leonard, Joshua N.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA; [Leonard, Joshua N.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Leonard, JN (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd,Rm E136, Evanston, IL 60208 USA.	j-leonard@northwestern.edu	Leonard, Joshua/B-7649-2009	Leonard, Joshua/0000-0003-4359-6126	National Institutes of Health, NCI, Cancer Center Support Grant [CA060553]; Defense Advanced Research Projects Agency [W911NF-11-2-0066]; National Academies Keck Futures Initiative [NAKFI-SB6]; National Institutes of Health T32 Training Grant through Northwestern University's Biotechnology Training Program [GM 008449]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008449] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Cancer Center Support Grant; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Academies Keck Futures Initiative; National Institutes of Health T32 Training Grant through Northwestern University's Biotechnology Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Cancer Center Support Grant CA060553. This work was also supported by Defense Advanced Research Projects Agency Award W911NF-11-2-0066 and by the National Academies Keck Futures Initiative (NAKFI-SB6).; Supported in part by National Institutes of Health T32 Training Grant GM 008449 through Northwestern University's Biotechnology Training Program.	Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Daringer NM, 2014, ACS SYNTH BIOL, V3, P892, DOI 10.1021/sb400128g; Divanovic S, 2005, J ENDOTOXIN RES, V11, P363, DOI 10.1179/096805105X67300; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Doyle SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1706; Fekonja O, 2012, CURR PROTEIN PEPT SC, V13, P776, DOI 10.2174/138920312804871148; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Godfroy JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048875; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Kim S, 2013, MOL MED, V19, P88, DOI 10.2119/molmed.2012.00306; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Liaunardy-Jopeace A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00473; Liaunardy-Jopeace A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005275; Marr N, 2012, INNATE IMMUN-LONDON, V18, P856, DOI 10.1177/1753425912444479; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nishiya T, 2006, BIOCHEM BIOPH RES CO, V341, P1128, DOI 10.1016/j.bbrc.2006.01.074; Panter G, 2011, J BIOL CHEM, V286, P23334, DOI 10.1074/jbc.M110.205419; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Raghavan B, 2012, EMBO REP, V13, P1109, DOI 10.1038/embor.2012.155; Reuven EM, 2014, BBA-BIOMEMBRANES, V1838, P1586, DOI 10.1016/j.bbamem.2014.01.020; Savva A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00387; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Treeby M, 2009, BIOCHEM BIOPH RES CO, V381, P65, DOI 10.1016/j.bbrc.2009.02.017; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Visintin A, 2006, J LEUKOCYTE BIOL, V80, P1584, DOI 10.1189/jlb.0606388; Wang D, 2010, P NATL ACAD SCI USA, V107, P13806, DOI 10.1073/pnas.1009428107; Wang JQ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00367; Zhang HF, 2002, FEBS LETT, V532, P171, DOI 10.1016/S0014-5793(02)03669-4	44	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8764	8777		10.1074/jbc.M114.610063	http://dx.doi.org/10.1074/jbc.M114.610063			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25694428	Green Published, hybrid			2022-12-28	WOS:000352207100008
J	Monaco, G; Decrock, E; Arbel, N; van Vliet, AR; La Rovere, RM; De Smedt, H; Parys, JB; Agostinis, P; Leybaert, L; Shoshan-Barmatz, V; Bultynck, G				Monaco, Giovanni; Decrock, Elke; Arbel, Nir; van Vliet, Alexander R.; La Rovere, Rita M.; De Smedt, Humbert; Parys, Jan B.; Agostinis, Patrizia; Leybaert, Luc; Shoshan-Barmatz, Varda; Bultynck, Geert			The BH4 Domain of Anti-apoptotic Bcl-XL, but Not That of the Related Bcl-2, Limits the Voltage-dependent Anion Channel 1 (VDAC1)-mediated Transfer of Pro-apoptotic Ca2+ Signals to Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE; ENDOPLASMIC-RETICULUM; CALCIUM-RELEASE; CELL-DEATH; VDAC; MEMBRANE; PROTEIN; ER; BCL-X(L); MODULATION	Excessive Ca2+ fluxes from the endoplasmic reticulum to the mitochondria result in apoptotic cell death. Bcl-2 and Bcl-XL proteins exert part of their anti-apoptotic function by directly targeting Ca2+-transport systems, like the endoplasmic reticulum-localized inositol 1,4,5-trisphosphate receptors (IP(3)Rs) and the voltage-dependent anion channel 1 (VDAC1) at the outer mitochondrial membranes. We previously demonstrated that the Bcl-2 homology 4 (BH4) domain of Bcl-2 protects against Ca2+-dependent apoptosis by binding and inhibiting IP(3)Rs, although the BH4 domain of Bcl-XL was protective independently of binding IP(3)Rs. Here, we report that in contrast to the BH4 domain of Bcl-2, the BH4 domain of Bcl-XL binds and inhibits VDAC1. In intact cells, delivery of the BH4-Bcl-XL peptide via electroporation limits agonist-induced mitochondrial Ca2+ uptake and protects against staurosporine-induced apoptosis, in line with the results obtained with VDAC1(-/-) cells. Moreover, the delivery of the N-terminal domain of VDAC1 as a synthetic peptide (VDAC1-NP) abolishes the ability of BH4-Bcl-XL to suppress mitochondrial Ca2+ uptake and to protect against apoptosis. Importantly, VDAC1-NP did not affect the ability of BH4-Bcl-2 to suppress agonist-induced Ca2+ release in the cytosol or to prevent apoptosis, as done instead by an IP3R-derived peptide. In conclusion, our data indicate that the BH4 domain of Bcl-XL, but not that of Bcl-2, selectively targets VDAC1 and inhibits apoptosis by decreasing VDAC1-mediated Ca2+ uptake into the mitochondria.	[Monaco, Giovanni; La Rovere, Rita M.; De Smedt, Humbert; Parys, Jan B.; Bultynck, Geert] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Mol & Cellular Signaling, B-3000 Leuven, Belgium; [van Vliet, Alexander R.; Agostinis, Patrizia] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Cell Death Res & Therapy, B-3000 Leuven, Belgium; [Decrock, Elke; Leybaert, Luc] Univ Ghent, Fac Med & Hlth Sci, Dept Basic Med Sci, Physiol Grp, B-9000 Ghent, Belgium; [Arbel, Nir; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Arbel, Nir; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [La Rovere, Rita M.] Univ G DAnnunzio, Fac Pharm, Dept Neurosci Imaging & Clin Sci, Lab Cellular Physiol, I-66013 Chieti, Italy	KU Leuven; KU Leuven; Ghent University; Ben Gurion University; Ben Gurion University; G d'Annunzio University of Chieti-Pescara	Monaco, G (corresponding author), Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Mol & Cellular Signaling, Campus Gasthuisberg,Herestr 49,O&N1,Bus 802, B-3000 Leuven, Belgium.	giovanni.monaco@med.kuleuven.be; geert.bultynck@med.kuleuven.be	van Vliet, Alexander R/G-8588-2016; Agostinis, Patrizia/ABI-1177-2020; Leybaert, Luc/F-4079-2015; Monaco, Giovanni/J-2957-2019; Agostinis, Patrizia/AAO-2468-2020	van Vliet, Alexander R/0000-0003-4729-4379; Agostinis, Patrizia/0000-0003-1314-2115; Leybaert, Luc/0000-0001-6452-6982; Monaco, Giovanni/0000-0001-5209-4326; Parys, Jan/0000-0002-3591-4967; Bultynck, Geert/0000-0002-5968-4828	Research Foundation-Flanders [6.057.12, G.0134.09N]; Research Council of the KU Leuven [STRT1/10/044, OT/14/101]; Interuniversity Attraction Poles Program, Belgian Science Policy [P7/13]; Israel Science Foundation [649/09, 307/13]; Research Foundation-Flanders; Innovation by Science and Technology (IWT) Vlaanderen	Research Foundation-Flanders(FWO); Research Council of the KU Leuven(KU Leuven); Interuniversity Attraction Poles Program, Belgian Science Policy(Belgian Federal Science Policy Office); Israel Science Foundation(Israel Science Foundation); Research Foundation-Flanders(FWO); Innovation by Science and Technology (IWT) Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported in part by Research Foundation-Flanders Grants 6.057.12 (to G. B. and L. L.) and G.0134.09N (to L. L.), Research Council of the KU Leuven Grants STRT1/10/044 and OT/14/101 (to G. B.), Interuniversity Attraction Poles Program, Belgian Science Policy P7/13 (to G. B. and J. B. P.), and Israel Science Foundation Grants 649/09 and 307/13 (to V. S.-B. and N. A.).; Supported by postdoctoral fellowships provided by the Research Foundation-Flanders.; Recipient of a fellowship from Innovation by Science and Technology (IWT) Vlaanderen.	Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Arbel N, 2012, J BIOL CHEM, V287, P23152, DOI 10.1074/jbc.M112.345918; Arbel N, 2010, J BIOL CHEM, V285, P6053, DOI 10.1074/jbc.M109.082990; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bultynck G, 2004, BIOCHEM J, V381, P87, DOI 10.1042/BJ20040072; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; De Stefani D, 2012, CELL DEATH DIFFER, V19, P267, DOI 10.1038/cdd.2011.92; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138; Decrock E., 2014, CALCIUM TECHNIQUES L, P93; Decuypere JP, 2011, BBA-MOL CELL RES, V1813, P1003, DOI 10.1016/j.bbamcr.2010.11.023; Deniaud A, 2007, LANGMUIR, V23, P3898, DOI 10.1021/la063105+; Distelhorst CW, 2011, CELL CALCIUM, V50, P234, DOI 10.1016/j.ceca.2011.05.011; Eckenrode EF, 2010, J BIOL CHEM, V285, P13678, DOI 10.1074/jbc.M109.096040; Eno CO, 2012, MOL BIOL CELL, V23, P2605, DOI 10.1091/mbc.E12-02-0090; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Gunter TE, 1998, BBA-BIOENERGETICS, V1366, P5, DOI 10.1016/S0005-2728(98)00117-0; Harr MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005579; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Huang H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.419; Huang HY, 2013, J BIOL CHEM, V288, P19870, DOI 10.1074/jbc.M112.448290; Ivanova H, 2014, BBA-MOL CELL RES, V1843, P2164, DOI 10.1016/j.bbamcr.2014.03.007; Jonas EA, 2004, P NATL ACAD SCI USA, V101, P13590, DOI 10.1073/pnas.0401372101; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kerner J, 2012, BBA-BIOMEMBRANES, V1818, P1520, DOI 10.1016/j.bbamem.2011.11.013; Kutuk O, 2008, CURR MOL MED, V8, P102; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Lemeshko VV, 2006, EUR BIOPHYS J BIOPHY, V36, P57, DOI 10.1007/s00249-006-0101-7; Lewis A, 2014, J BIOENERG BIOMEMBR, V46, P1, DOI 10.1007/s10863-013-9527-7; Liu YQ, 2011, BIOCHEM BIOPH RES CO, V404, P364, DOI 10.1016/j.bbrc.2010.11.124; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; McNally MA, 2013, MITOCHONDRION, V13, P119, DOI 10.1016/j.mito.2013.01.004; Mertins B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047938; Meunier J, 2010, J PHARMACOL EXP THER, V332, P388, DOI 10.1124/jpet.109.160960; Michels Judith, 2013, Int J Cell Biol, V2013, P705294, DOI 10.1155/2013/705294; Monaco G, 2012, CELL DEATH DIFFER, V19, P295, DOI 10.1038/cdd.2011.97; Monaco G, 2013, CELL MOL LIFE SCI, V70, P1171, DOI 10.1007/s00018-012-1118-y; Monaco G, 2012, BIOCHEM BIOPH RES CO, V428, P31, DOI 10.1016/j.bbrc.2012.10.002; Naon D, 2014, BBA-MOL CELL RES, V1843, P2184, DOI 10.1016/j.bbamcr.2014.05.011; Pastorino JG, 2003, CURR MED CHEM, V10, P1535, DOI 10.2174/0929867033457269; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Putt KS, 2006, NAT CHEM BIOL, V2, P543, DOI 10.1038/nchembio814; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Sabirov RZ, 2006, J BIOL CHEM, V281, P1897, DOI 10.1074/jbc.M509482200; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shoshan-Barmatz V, 2004, BBA-BIOENERGETICS, V1657, P105, DOI 10.1016/j.bbabio.2004.02.009; Shoshan-Barmatz V, 2012, CURR MED CHEM, V19, P714, DOI 10.2174/092986712798992110; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63; Tan WZ, 2007, BBA-BIOMEMBRANES, V1768, P2510, DOI 10.1016/j.bbamem.2007.06.002; Thinnes FP, 2012, MOL GENET METAB, V106, P253, DOI 10.1016/j.ymgme.2012.04.008; Tornero D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020423; Van Moorhem M, 2010, CELL CALCIUM, V47, P287, DOI 10.1016/j.ceca.2010.01.001; Vander Heiden MG, 1999, MOL CELL, V3, P159; Villinger S, 2014, J BIOL CHEM, V289, P13397, DOI 10.1074/jbc.M113.524173; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Yehezkel G, 2006, J BIOL CHEM, V281, P5938, DOI 10.1074/jbc.M510104200; Yuan SP, 2008, FASEB J, V22, P2809, DOI 10.1096/fj.08-107417; Zachariae U, 2012, STRUCTURE, V20, P1540, DOI 10.1016/j.str.2012.06.015; ZIZI M, 1994, J BIOL CHEM, V269, P1614	77	95	100	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9150	9161		10.1074/jbc.M114.622514	http://dx.doi.org/10.1074/jbc.M114.622514			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25681439	hybrid, Green Published			2022-12-28	WOS:000352207100038
J	Wang, RJ; Li, JW; Bao, BH; Wu, HC; Du, ZH; Su, JL; Zhang, MH; Liang, HQ				Wang, Ren-jie; Li, Jian-wei; Bao, Bu-he; Wu, Huan-cheng; Du, Zhen-hua; Su, Jing-liang; Zhang, Ming-hua; Liang, Hai-qian			MicroRNA-873 (MiRNA-873) Inhibits Glioblastoma Tumorigenesis and Metastasis by Suppressing the Expression of IGF2BP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC; GLIOMA; GROWTH; RNA; BRAIN; PROLIFERATION; PROTEINS; CANCER; TUMORS; CELLS	Glioblastoma multiforme (GBM) is known as a highly malignant brain tumor with a poor prognosis, despite intensive research and clinical efforts. In this study, we observed that microRNA-873 (miR-873) was expressed at low levels in GBM and that the overexpression of miR-873 dramatically reduced the cell proliferation, migration, and invasion of GBM cells. Our further investigations of the inhibition mechanism indicated that miR-873 negatively affected the carcinogenesis and metastasis of GBM by down-regulating the expression of IGF2BP1, which stabilizes the mRNA transcripts of its target genes. These results demonstrate that miR-873 may constitute a potential target for GBM therapy.	[Wang, Ren-jie; Bao, Bu-he; Du, Zhen-hua; Zhang, Ming-hua] Logist Coll Armed Police Forces, Pingjin Hosp, Dept Clin Lab, Tianjin 300162, Peoples R China; [Li, Jian-wei; Wu, Huan-cheng; Su, Jing-liang; Liang, Hai-qian] Logist Coll Armed Police Forces, Pingjin Hosp, Dept Neurosurg, Tianjin 300162, Peoples R China		Liang, HQ (corresponding author), Logist Coll Armed Police Forces, Pingjin Hosp, Dept Neurosurg, 220 Chenglin Rd, Tianjin 300162, Peoples R China.	lianghaiqian711@163.com	li, jian/GSE-0245-2022; LI, JIAN/GRY-2197-2022					Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568; Gladson CL, 2010, ANNU REV PATHOL-MECH, V5, P33, DOI 10.1146/annurev-pathol-121808-102109; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Guessous F, 2013, J NEURO-ONCOL, V112, P153, DOI 10.1007/s11060-013-1047-0; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Gutschner T, 2014, HEPATOLOGY, V59, P1900, DOI 10.1002/hep.26997; Hui Wang, 2013, PLoS One, V8, pe54932, DOI 10.1371/journal.pone.0054932; Kang MK, 2007, STEM CELLS DEV, V16, P837, DOI 10.1089/scd.2007.0006; Kanu OO, 2009, CLIN MED INSIGHTS-ON, V3, P39; Kobel M, 2007, ONCOGENE, V26, P7584, DOI 10.1038/sj.onc.1210563; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Ostrom QT, 2011, CURR NEUROL NEUROSCI, V11, P329, DOI 10.1007/s11910-011-0189-8; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Sotgia F, 2002, MOL CELL BIOL, V22, P3905, DOI 10.1128/MCB.22.11.3905-3926.2002; Sparanese D, 2007, NUCLEIC ACIDS RES, V35, P1209, DOI 10.1093/nar/gkl1148; Stohr N, 2012, GENE DEV, V26, P176, DOI 10.1101/gad.177642.111; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun G, 2013, CANCER BIOTHER RADIO, V28, P327, DOI 10.1089/cbr.2012.1380; TRENT J, 1986, P NATL ACAD SCI USA, V83, P470, DOI 10.1073/pnas.83.2.470; Tu YY, 2013, CANCER RES, V73, P6046, DOI 10.1158/0008-5472.CAN-13-0358; Vainer G, 2008, J PATHOL, V215, P445, DOI 10.1002/path.2376; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Yang TQ, 2014, CANCER SCI, V105, P265, DOI 10.1111/cas.12351; Yaniv K, 2002, GENE, V287, P49, DOI 10.1016/S0378-1119(01)00866-6; Yue Q, 2005, DEVELOPMENT, V132, P3281, DOI 10.1242/dev.01891; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126	38	81	84	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8938	8948		10.1074/jbc.M114.624700	http://dx.doi.org/10.1074/jbc.M114.624700			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25670861	hybrid, Green Published			2022-12-28	WOS:000352207100021
J	Zhang, Y; Ying, JQ; Jiang, DS; Chang, ZG; Li, H; Zhang, GQ; Gong, S; Jiang, XH; Tao, J				Zhang, Yuan; Ying, Jiaoqian; Jiang, Dongsheng; Chang, Zhigang; Li, Hua; Zhang, Guoqiang; Gong, Shan; Jiang, Xinghong; Tao, Jin			Urotensin-II Receptor Stimulation of Cardiac L-type Ca2+ Channels Requires the beta gamma Subunits of G(i/o)-protein and Phosphatidylinositol 3-Kinase-dependent Protein Kinase C beta 1 Isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE 3-KINASE GAMMA; CAV1.2 CALCIUM-CHANNELS; HEART-FAILURE; ACTIVATION; INHIBITION; MODULATION; CURRENTS; REGION; ALPHA; CELLS	Recent studies have demonstrated that urotensin-II (U-II) plays important roles in cardiovascular actions including cardiac positive inotropic effects and increasing cardiac output. However, the mechanisms underlying these effects of U-II in cardiomyocytes still remain unknown. We show by electrophysiological studies that U-II dose-dependently potentiates L-type Ca2+ currents (I-Ca,I- L) in adult rat ventricular myocytes. This effect was U-II receptor (U-IIR)-dependent and was associated with a depolarizing shift in the voltage dependence of inactivation. Intracellular application of guanosine-5'-O-(2-thiodiphosphate) and pertussis toxin pretreatment both abolished the stimulatory effects of U-II. Dialysis of cells with the QEHA peptide, but not scrambled peptide SKEE, blocked the U-II-induced response. The phosphatidylinositol 3-kinase (PI3K) inhibitor wortmannin as well as the class I PI3K antagonist CH132799 blocked the U-II-induced I-Ca,I- L response. Protein kinase C antagonists calphostin C and chelerythrine chloride as well as dialysis of cells with 1,2bis(2aminophenoxy)-ethaneN, N,N',N'-tetraacetic acid abolished the U-II-induced responses, whereas PKC beta inhibition or PKA blockade had no effect. Exposure of ventricular myocytes to U-II markedly increased membrane PKC beta(1) expression, whereas inhibition of PKC beta(1) pharmacologically or by shRNA targeting abolished the U-II-induced I-Ca,I- L response. Functionally, we observed a significant increase in the amplitude of sarcomere shortening induced by U-II; blockade of U-IIR as well as PKC beta inhibition abolished this effect, whereas Bay K8644 mimicked the U-II response. Taken together, our results indicate that U-II potentiates I-Ca,I- L through the beta gamma subunits of G(i/o)-protein and downstream activation of the class I PI3K-dependent PKC beta(1) isoform. This occurred via the activation of U-IIR and contributes to the positive inotropic effect on cardiomyocytes.	[Zhang, Yuan; Ying, Jiaoqian; Jiang, Dongsheng; Chang, Zhigang; Li, Hua; Gong, Shan; Jiang, Xinghong; Tao, Jin] Soochow Univ, Dept Physiol & Neurobiol, Coll Med, Suzhou 215123, Peoples R China; [Zhang, Yuan] Soochow Univ, Dept Geriatr, Suzhou 215004, Peoples R China; [Zhang, Yuan] Soochow Univ, Inst Neurosci, Affiliated Hosp 2, Suzhou 215004, Peoples R China; [Ying, Jiaoqian; Zhang, Guoqiang] China Japan Friendship Hosp, Dept Emergency Med, Beijing 100029, Peoples R China; [Jiang, Dongsheng] Univ Ulm, Dept Dermatol & Allerg Dis, D-89081 Ulm, Germany; [Li, Hua] Natl Shanghai Ctr New Drug Safety Evaluat & Res, Shanghai 201203, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; China-Japan Friendship Hospital; Ulm University	Tao, J (corresponding author), Soochow Univ, Dept Physiol & Neurobiol, Coll Med, 199 Ren Ai Rd, Suzhou 215123, Peoples R China.	taoj@suda.edu.cn	Jiang, Dongsheng/AAG-1284-2020	Jiang, Dongsheng/0000-0003-0961-2671; Tao, Jin/0000-0002-8481-3732	National Natural Science Foundation of China [81171056, 31271258, 81200852, 81371229]; National Natural Science Foundation of China-CNRS Joint Program [81311130114]; Natural Science Funding of Jiangsu Province [BK2011293]; Natural Science Funding for Colleges and Universities in Jiangsu Province [12KJB320010]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry; Soochow University; National University Student Innovation Programs; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China-CNRS Joint Program; Natural Science Funding of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Funding for Colleges and Universities in Jiangsu Province; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Soochow University; National University Student Innovation Programs; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China Grants 81171056, 31271258, 81200852, and 81371229; National Natural Science Foundation of China-CNRS Joint Program Grant 81311130114; Natural Science Funding of Jiangsu Province Grant BK2011293; Natural Science Funding for Colleges and Universities in Jiangsu Province Grant 12KJB320010; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry (to J. T.); Dong-Wu Scholar Funding of Soochow University (to J. T.); National University Student Innovation Programs (to Hong Jin); and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Alden KJ, 2002, AM J PHYSIOL-CELL PH, V282, pC768, DOI 10.1152/ajpcell.00494.2001; Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Blumenstein Y, 2002, J BIOL CHEM, V277, P3419, DOI 10.1074/jbc.C100642200; Bonneau B, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004480; Bousette N, 2006, CURR HYPERTENS REP, V8, P479, DOI 10.1007/s11906-006-0026-7; Callaghan B, 2004, CIRC RES, V94, P626, DOI 10.1161/01.RES.0000118248.17466.B7; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003936; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Diaz-Flores E, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004125; Douglas SA, 2002, LANCET, V359, P1990, DOI 10.1016/S0140-6736(02)08831-1; El Khoury N, 2014, J BIOL CHEM, V289, P21896, DOI 10.1074/jbc.M114.549642; Er EE, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004015; Farren MR, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004656; Ferreira JCB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033175; Gartlon J, 2001, PSYCHOPHARMACOLOGY, V155, P426, DOI 10.1007/s002130100715; Gui PC, 2006, J BIOL CHEM, V281, P14015, DOI 10.1074/jbc.M600433200; Herold CL, 2003, BRIT J PHARMACOL, V139, P203, DOI 10.1038/sj.bjp.0705251; Hoddah H, 2009, CELL CALCIUM, V46, P303, DOI 10.1016/j.ceca.2009.08.007; Hofmann F, 2014, PHYSIOL REV, V94, P303, DOI 10.1152/physrev.00016.2013; Hu CL, 2009, J BIOL CHEM, V284, P7465, DOI 10.1074/jbc.M808049200; Huitron-Resendiz S, 2005, J NEUROSCI, V25, P5465, DOI 10.1523/JNEUROSCI.4501-04.2005; IRISAWA H, 1993, PHYSIOL REV, V73, P197, DOI 10.1152/physrev.1993.73.1.197; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Jian Z, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005046; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kho C, 2012, NAT REV CARDIOL, V9, P717, DOI 10.1038/nrcardio.2012.145; Kotla S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004214; Kusne Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005196; Lao QZ, 2008, J BIOL CHEM, V283, P15577, DOI 10.1074/jbc.M802035200; Liao P, 2004, J BIOL CHEM, V279, P50329, DOI 10.1074/jbc.M409436200; Liao P, 2007, J BIOL CHEM, V282, P35133, DOI 10.1074/jbc.M705478200; Lin YZ, 2003, HYPERTENS RES, V26, P839, DOI 10.1291/hypres.26.839; Maeno-Hikichi Y, 2003, NAT NEUROSCI, V6, P468, DOI 10.1038/nn1041; Mohan ML, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003308; Ng LL, 2002, CIRCULATION, V106, P2877, DOI 10.1161/01.CIR.0000044388.19119.02; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Niepel M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004379; PEARSON D, 1980, P NATL ACAD SCI-BIOL, V77, P5021, DOI 10.1073/pnas.77.8.5021; Perez-Garci E, 2013, J PHYSIOL-LONDON, V591, P1599, DOI 10.1113/jphysiol.2012.245464; Poole AAW, 2004, TRENDS PHARMACOL SCI, V25, P528, DOI 10.1016/j.tips.2004.08.006; Richards AM, 2004, PEPTIDES, V25, P1795, DOI 10.1016/j.peptides.2004.04.017; Russell FD, 2001, BRIT J PHARMACOL, V132, P5, DOI 10.1038/sj.bjp.0703811; Russell FD, 2008, VASC HEALTH RISK MAN, V4, P775, DOI 10.2147/VHRM.S1983; Sainsily X, 2014, BIOCHEM PHARMACOL, V92, P280, DOI 10.1016/j.bcp.2014.08.023; Sardesai N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004518; Shaw RM, 2013, CARDIOVASC RES, V98, P177, DOI 10.1093/cvr/cvt021; Sirenko S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003391; Sonkusare SK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005052; Stebbins EG, 2001, J BIOL CHEM, V276, P29644, DOI 10.1074/jbc.M101044200; Tao J, 2004, PHARMACOL RES, V50, P471, DOI 10.1016/j.phrs.2004.05.006; Tao JJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005125; Tao J, 2008, MOL PHARMACOL, V73, P1596, DOI 10.1124/mol.107.043612; TSENG GN, 1991, AM J PHYSIOL, V261, pH364, DOI 10.1152/ajpheart.1991.261.2.H364; Vaudry H, 2010, ANN NY ACAD SCI, V1200, P53, DOI 10.1111/j.1749-6632.2010.05514.x; Viard P, 1999, FASEB J, V13, P685, DOI 10.1096/fasebj.13.6.685; Viard P, 2001, BRIT J PHARMACOL, V132, P669, DOI 10.1038/sj.bjp.0703864; WALSH KB, 1988, SCIENCE, V242, P67, DOI 10.1126/science.2845575; Wang H, 2014, ENDOCRINOLOGY, V155, P168, DOI 10.1210/en.2013-1559; Wang XX, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005147; Wang YX, 1999, J BIOL CHEM, V274, P13859, DOI 10.1074/jbc.274.20.13859; Wu BN, 2009, VASC PHARMACOL, V51, P65, DOI 10.1016/j.vph.2009.03.001; Yang L, 2005, J BIOL CHEM, V280, P207, DOI 10.1074/jbc.M410509200; Zhang HY, 2010, BRIT J PHARMACOL, V160, P1631, DOI 10.1111/j.1476-5381.2010.00798.x; Zhang YM, 2012, J BIOL CHEM, V287, P18562, DOI 10.1074/jbc.M111.322271; Zhang YA, 2010, CELL SIGNAL, V22, P1660, DOI 10.1016/j.cellsig.2010.06.006; Zhang ZH, 1997, CIRC RES, V80, P720, DOI 10.1161/01.RES.80.5.720	68	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8644	8655		10.1074/jbc.M114.615021	http://dx.doi.org/10.1074/jbc.M114.615021			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25678708	hybrid, Green Published			2022-12-28	WOS:000351662600054
J	Crack, JC; Munnoch, J; Dodd, EL; Knowles, F; Al Bassam, MM; Kamali, S; Holland, AA; Cramer, SP; Hamilton, CJ; Johnson, MK; Thomson, AJ; Hutchings, MI; Le Brun, NE				Crack, Jason C.; Munnoch, John; Dodd, Erin L.; Knowles, Felicity; Al Bassam, Mahmoud M.; Kamali, Saeed; Holland, Ashley A.; Cramer, Stephen P.; Hamilton, Chris J.; Johnson, Michael K.; Thomson, Andrew J.; Hutchings, Matthew I.; Le Brun, Nick E.			NsrR from Streptomyces coelicolor Is a Nitric Oxide-sensing [4Fe-4S] Cluster Protein with a Specialized Regulatory Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; PYROCOCCUS-FURIOSUS FERREDOXIN; ESCHERICHIA-COLI; TRANSCRIPTION FACTOR; SPECTROSCOPIC CHARACTERIZATION; NEISSERIA-MENINGITIDIS; NITROSATIVE STRESS; S-NITROSYLATION; IDENTIFICATION; EXPRESSION	The Rrf2 family transcription factor NsrR controls expression of genes in a wide range of bacteria in response to nitric oxide (NO). The precise form of the NO-sensing module of NsrR is the subject of controversy because NsrR proteins containing either [2Fe-2S] or [4Fe-4S] clusters have been observed previously. Optical, Mossbauer, resonance Raman spectroscopies and native mass spectrometry demonstrate that Streptomyces coelicolor NsrR (ScNsrR), previously reported to contain a [2Fe-2S] cluster, can be isolated containing a [4Fe-4S] cluster. ChIP-seq experiments indicated that the ScNsrR regulon is small, consisting of only hmpA1, hmpA2, and nsrR itself. The hmpA genes encode NO-detoxifying flavohemoglobins, indicating that ScNsrR has a specialized regulatory function focused on NO detoxification and is not a global regulator like some NsrR orthologues. EMSAs and DNase I footprinting showed that the [4Fe-4S] form of ScNsrR binds specifically and tightly to an 11-bp inverted repeat sequence in the promoter regions of the identified target genes and that DNA binding is abolished following reaction with NO. Resonance Raman data were consistent with cluster coordination by three Cys residues and one oxygen-containing residue, and analysis of ScNsrR variants suggested that highly conserved Glu-85 may be the fourth ligand. Finally, we demonstrate that some low molecular weight thiols, but importantly not physiologically relevant thiols, such as cysteine and an analogue of mycothiol, bind weakly to the [4Fe-4S] cluster, and exposure of this bound form to O-2 results in cluster conversion to the [2Fe-2S] form, which does not bind to DNA. These data help to account for the observation of [2Fe-2S] forms of NsrR.	[Crack, Jason C.; Dodd, Erin L.; Thomson, Andrew J.; Le Brun, Nick E.] Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England; [Munnoch, John; Knowles, Felicity; Al Bassam, Mahmoud M.; Hutchings, Matthew I.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Hamilton, Chris J.] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England; [Kamali, Saeed; Cramer, Stephen P.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Holland, Ashley A.; Johnson, Michael K.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Holland, Ashley A.; Johnson, Michael K.] Univ Georgia, Ctr Metalloenzyme Studies, Athens, GA 30602 USA	University of East Anglia; University of East Anglia; University of East Anglia; University of California System; University of California Davis; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Hutchings, MI (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	m.hutchings@uea.ac.uk; n.le-brun@uea.ac.uk	Regan, Clinton/E-6250-2012; hamilton, chris/C-5651-2009; Hutchings, Matthew/D-1923-2009	Le Brun, Nick/0000-0001-9780-4061; Dodd, Erin/0000-0002-9870-2398; Munnoch, John Tyson/0000-0002-9018-6026; Hutchings, Matthew/0000-0001-6628-5940; Crack, Jason C./0000-0002-4979-1910	National Institutes of Health [GM62524, GM65440]; Biotechnology and Biological Sciences Research Council [BB/J003247/1, BB/K02115X/1]; Natural Environment Research Council; Biotechnology and Biological Sciences Research Council [BB/L007673/1] Funding Source: researchfish; Natural Environment Research Council [1090758] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062524, R01GM062524, R01GM065440] Funding Source: NIH RePORTER; BBSRC [BB/L007673/1, BB/J003247/1, BB/K02115X/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62524 (to M. K. J.) and GM65440 (to S. P. C.). This work was also supported by Biotechnology and Biological Sciences Research Council Grants BB/J003247/1 (to N. L. B., M. I. H., and A. J. T.) and BB/K02115X/1 (to N. L. B.) and a Natural Environment Research Council Ph.D. studentship (to J. M.).	Al-Bassam MM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004554; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Branchu P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003874; Brereton PS, 1999, BIOCHEMISTRY-US, V38, P10594, DOI 10.1021/bi990671d; Bruckdorfer Richard, 2005, Molecular Aspects of Medicine, V26, P3, DOI 10.1016/j.mam.2004.09.002; CALZOLAI L, 1995, BIOCHEMISTRY-US, V34, P11373, DOI 10.1021/bi00036a010; Cervantes S, 2014, AUTOPHAGY, V10, P80, DOI 10.4161/auto.26743; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P11770, DOI 10.1021/bi0488505; CONOVER RC, 1990, J BIOL CHEM, V265, P8533; Crack JC, 2008, J AM CHEM SOC, V130, P1749, DOI 10.1021/ja077455+; Crack JC, 2014, METHODS MOL BIOL, V1122, P33, DOI 10.1007/978-1-62703-794-5_4; Crack JC, 2013, J BIOL CHEM, V288, P11492, DOI 10.1074/jbc.M112.439901; Crack JC, 2012, CURR OPIN CHEM BIOL, V16, P35, DOI 10.1016/j.cbpa.2012.02.009; Crack JC, 2011, J AM CHEM SOC, V133, P1112, DOI 10.1021/ja109581t; Crack JC, 2009, BIOCHEMISTRY-US, V48, P12252, DOI 10.1021/bi901498v; CZERNUSZEWICZ RS, 1987, J AM CHEM SOC, V109, P7178, DOI 10.1021/ja00257a045; D'Autreaux B, 2005, NATURE, V437, P769, DOI 10.1038/nature03953; Demple B, 2002, MOL CELL BIOCHEM, V234, P11, DOI 10.1023/A:1015933216079; Dickson D. P. E., 1974, J PHYS-PARIS, DOI 10.1051/jphyscol:1974659; Fernandez-Martinez LT, 2011, ANTON LEEUW INT J G, V99, P515, DOI 10.1007/s10482-010-9518-1; Fleischhacker AS, 2012, BIOCHEMISTRY-US, V51, P4453, DOI 10.1021/bi3003204; GEORGE SJ, 1989, BIOCHEM J, V264, P275, DOI 10.1042/bj2640275; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Gruner I, 2011, J BIOL CHEM, V286, P2017, DOI 10.1074/jbc.M110.191940; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Heurlier K, 2008, J BACTERIOL, V190, P2488, DOI 10.1128/JB.01869-07; Hutchings MI, 2002, J BACTERIOL, V184, P4640, DOI 10.1128/JB.184.16.4640-4643.2002; Hutchings MI, 2002, J BACTERIOL, V184, P503, DOI 10.1128/JB.184.2.503-508.2002; Isabella VM, 2009, MOL MICROBIOL, V71, P227, DOI 10.1111/j.1365-2958.2008.06522.x; Jothivasan VK, 2008, NAT PROD REP, V25, P1091, DOI 10.1039/b616489g; Karlinsey JE, 2012, MOL MICROBIOL, V85, P1179, DOI 10.1111/j.1365-2958.2012.08167.x; Kers JA, 2004, NATURE, V429, P79, DOI 10.1038/nature02504; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kieser T., 2000, PRACTICAL STREPTOMYC, P412; Kommineni S, 2010, MOL MICROBIOL, V78, P1280, DOI 10.1111/j.1365-2958.2010.07407.x; Kwon YM, 2009, J BACTERIOL, V191, P5369, DOI 10.1128/JB.00586-09; Moir JW, 2011, BIOCHEM SOC T, V39, P1890, DOI 10.1042/BST20110735; Nakano MM, 2006, J BACTERIOL, V188, P5878, DOI 10.1128/JB.00486-06; NEWTON GL, 1995, EUR J BIOCHEM, V230, P821; NEWTON GL, 1993, J BACTERIOL, V175, P2734, DOI 10.1128/JB.175.9.2734-2742.1993; Partridge JD, 2009, MOL MICROBIOL, V73, P680, DOI 10.1111/j.1365-2958.2009.06799.x; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Rancourt D.C., 1998, RECOIL MOSSBAUER SPE; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STEPHENS PJ, 1978, BIOCHEMISTRY-US, V17, P4770, DOI 10.1021/bi00615a026; Stevanin TM, 2007, GENE, V398, P62, DOI 10.1016/j.gene.2007.03.021; Stewart MJG, 2008, ORG BIOMOL CHEM, V6, P385, DOI 10.1039/b716380k; Sudhamsu J, 2009, TRENDS MICROBIOL, V17, P212, DOI 10.1016/j.tim.2009.02.003; Tucker NP, 2010, TRENDS MICROBIOL, V18, P149, DOI 10.1016/j.tim.2009.12.009; Tucker NP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003623; Vine CE, 2011, FEMS MICROBIOL LETT, V325, P99, DOI 10.1111/j.1574-6968.2011.02425.x; Weiss B, 2006, J BACTERIOL, V188, P829, DOI 10.1128/JB.188.3.829-833.2006; Yuki ET, 2008, BIOCHEMISTRY-US, V47, P13084, DOI 10.1021/bi801342x; Zhang B, 2012, P NATL ACAD SCI USA, V109, P15734, DOI 10.1073/pnas.1208787109	61	63	63	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12689	12704		10.1074/jbc.M115.643072	http://dx.doi.org/10.1074/jbc.M115.643072			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25771538	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000354569000022
J	Mortenson, JB; Heppler, LN; Banks, CJ; Weerasekara, VK; Whited, MD; Piccolo, SR; Johnson, WE; Thompson, JW; Andersen, JL				Mortenson, Jeffrey B.; Heppler, Lisa N.; Banks, Courtney J.; Weerasekara, Vajira K.; Whited, Matthew D.; Piccolo, Stephen R.; Johnson, William E.; Thompson, J. Will; Andersen, Joshua L.			Histone Deacetylase 6 (HDAC6) Promotes the Pro-survival Activity of 14-3-3 zeta via Deacetylation of Lysines within the 14-3-3 zeta Binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; MULTIPLE-MYELOMA; CELL-SURVIVAL; PROTEIN-TAU; PHOSPHORYLATION; BAD; INHIBITOR; APOPTOSIS; TARGETS; DEPHOSPHORYLATION	The phospho-binding protein 14-3-3 zeta acts as a signaling hub controlling a network of interacting partners and oncogenic pathways. We show here that lysines within the 14-3-3 zeta binding pocket and protein-protein interface can be modified by acetylation. The positive charge on two of these lysines, Lys(49) and Lys(120), is critical for coordinating 14-3-3 zeta -phosphoprotein interactions. Through screening, we identified HDAC6 as the Lys(49)/Lys(120) deacetylase. Inhibition of HDAC6 blocks 14-3-3 zeta interactions with two well described interacting partners, Bad and AS160, which triggers their dephosphorylation at Ser(112) and Thr(642), respectively. Expression of an acetylation-refractory K49R/K120R mutant of 14-3-3 zeta rescues both the HDAC6 inhibitor-induced loss of interaction and Ser(112)/Thr(642) phosphorylation. Furthermore, expression of the K49R/K120R mutant of 14-3-3 zeta inhibits the cytotoxicity of HDAC6 inhibition. These data demonstrate a novel role for HDAC6 in controlling 14-3-3 zeta binding activity.	[Mortenson, Jeffrey B.; Heppler, Lisa N.; Banks, Courtney J.; Weerasekara, Vajira K.; Whited, Matthew D.; Andersen, Joshua L.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; [Piccolo, Stephen R.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Johnson, William E.] Boston Univ, Sch Med, Div Computat Biomed, Boston, MA 02215 USA; [Thompson, J. Will] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA	Brigham Young University; Brigham Young University; Boston University; Duke University	Andersen, JL (corresponding author), Brigham Young Univ, E111 BNSN,685 E Univ Pkwy, Provo, UT 84602 USA.	jandersen@chem.byu.edu		Johnson, W. Evan/0000-0002-6247-6595	Elsa U. Pardee Foundation; Simmons Center for Cancer Research Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005692] Funding Source: NIH RePORTER	Elsa U. Pardee Foundation; Simmons Center for Cancer Research Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by funding from the Elsa U. Pardee Foundation (to J. L. A.) and a Simmons Center for Cancer Research Award (to L. N. H. and J. L. A.).	Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Andersen JL, 2011, MOL CELL, V43, P834, DOI 10.1016/j.molcel.2011.07.028; Bergamaschi A, 2013, BREAST CANCER RES TR, V137, P689, DOI 10.1007/s10549-012-2390-0; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Chen S, 2011, TRENDS ENDOCRIN MET, V22, P429, DOI 10.1016/j.tem.2011.07.005; Cheng JC, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-14; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x; Du YH, 2013, ASSAY DRUG DEV TECHN, V11, P367, DOI 10.1089/adt.2013.507; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Garrido P, 2015, J CELL PHYSIOL, V230, P191, DOI 10.1002/jcp.24698; Ge F, 2010, J PROTEOME RES, V9, P5848, DOI 10.1021/pr100616g; Goto H, 2007, NAT PROTOC, V2, P2574, DOI 10.1038/nprot.2007.374; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Lin MT, 2009, INT J CANCER, V125, P603, DOI 10.1002/ijc.24346; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Matta A, 2012, EXPERT OPIN THER TAR, V16, P515, DOI 10.1517/14728222.2012.668185; Maxwell SA, 2009, J BIOL CHEM, V284, P22379, DOI 10.1074/jbc.M109.022418; McBrayer SK, 2012, BLOOD, V119, P4686, DOI 10.1182/blood-2011-09-377846; Molzan M, 2013, ACS CHEM BIOL, V8, P1869, DOI 10.1021/cb4003464; Namdar M, 2010, P NATL ACAD SCI USA, V107, P20003, DOI 10.1073/pnas.1013754107; Neal CL, 2010, EXPERT OPIN THER TAR, V14, P1343, DOI 10.1517/14728222.2010.531011; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Pozuelo-Rubio M, 2010, FEBS J, V277, P3321, DOI 10.1111/j.1742-4658.2010.07730.x; Qureshi HY, 2013, BIOCHEMISTRY-US, V52, P6445, DOI 10.1021/bi400442d; Santo L, 2012, BLOOD, V119, P2579, DOI 10.1182/blood-2011-10-387365; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044265; Weerasekara VK, 2014, MOL CELL BIOL, V34, P4379, DOI 10.1128/MCB.00740-14; Williams KA, 2013, J BIOL CHEM, V288, P33156, DOI 10.1074/jbc.M113.472506; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Xu Z, 2013, J CELL SCI, V126, P4173, DOI 10.1242/jcs.126102; Yan J, 2014, DNA CELL BIOL, V33, P567, DOI 10.1089/dna.2013.2300; Yang PH, 2013, DRUG DISCOV THER, V7, P233, DOI 10.5582/ddt.2013.v7.6.233; Yang X, 2012, CANCER GENE THER, V19, P153, DOI 10.1038/cgt.2011.85; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang M, 2014, MOL CELL, V55, P31, DOI 10.1016/j.molcel.2014.04.028; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhao J, 2011, SEMIN CELL DEV BIOL, V22, P705, DOI 10.1016/j.semcdb.2011.09.012	53	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12487	12496		10.1074/jbc.M114.607580	http://dx.doi.org/10.1074/jbc.M114.607580			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25770209	Green Published, hybrid			2022-12-28	WOS:000354569000005
J	Manne, BK; Badolia, R; Dangelmaier, C; Eble, JA; Ellmeier, W; Kahn, M; Kunapuli, SP				Manne, Bhanu Kanth; Badolia, Rachit; Dangelmaier, Carol; Eble, Johannes A.; Ellmeier, Wilfried; Kahn, Mark; Kunapuli, Satya P.			Distinct Pathways Regulate Syk Protein Activation Downstream of Immune Tyrosine Activation Motif (ITAM) and hemITAM Receptors in Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; X-LINKED AGAMMAGLOBULINEMIA; GLYCOPROTEIN-IB-IX; SRC-FAMILY KINASE; IN-VIVO ROLES; GAMMA-CHAIN; B-CELL; PHOSPHOINOSITIDE 3-KINASE; COLLAGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE	Tyrosine kinase pathways are known to play an important role in the activation of platelets. In particular, the GPVI and CLEC-2 receptors are known to activate Syk upon tyrosine phosphorylation of an immune tyrosine activation motif (ITAM) and hemITAM, respectively. However, unlike GPVI, the CLEC-2 receptor contains only one tyrosine motif in the intracellular domain. The mechanisms by which this receptor activates Syk are not completely understood. In this study, we identified a novel signaling mechanism in CLEC-2-mediated Syk activation. CLEC-2-mediated, but not GPVI-mediated, platelet activation and Syk phosphorylation were abolished by inhibition of PI3K, which demonstrates that PI3K regulates Syk downstream of CLEC-2. Ibrutinib, a Tec family kinase inhibitor, also completely abolished CLEC-2-mediated aggregation and Syk phosphorylation in human and murine platelets. Furthermore, embryos lacking both Btk and Tec exhibited cutaneous edema associated with blood-filled vessels in a typical lymphatic pattern similar to CLEC-2 or Syk-deficient embryos. Thus, our data show, for the first time, that PI3K and Tec family kinases play a crucial role in the regulation of platelet activation and Syk phosphorylation downstream of the CLEC-2 receptor.	[Manne, Bhanu Kanth; Badolia, Rachit; Dangelmaier, Carol; Kunapuli, Satya P.] Temple Univ, Dept Physiol, Sch Med, Philadelphia, PA 19140 USA; [Manne, Bhanu Kanth; Badolia, Rachit; Dangelmaier, Carol; Kunapuli, Satya P.] Temple Univ, Dept Physiol, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Eble, Johannes A.] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Ellmeier, Wilfried] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Div Immunobiol, Inst Immunol, A-1090 Vienna, Austria; [Kahn, Mark] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Kahn, Mark] Univ Penn, Div Cardiol, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Munster; Medical University of Vienna; University of Pennsylvania; University of Pennsylvania	Kunapuli, SP (corresponding author), Temple Univ, Dept Physiol, Rm 403 MRB,3420 N Broad St, Philadelphia, PA 19140 USA.	spk@temple.edu	Regan, Clinton/E-6250-2012	Ellmeier, Wilfried/0000-0001-8192-8481	National Institutes of Health [HL93231, HL118593]; Deutsche Forschungsgemeinschaft [SFB1009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118593, R01HL093231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL93231 and HL118593 (to S. P. K.).; Supported by the Deutsche Forschungsgemeinschaft Grant SFB1009 Project A09.	Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-59; Asazuma N, 1997, BLOOD, V90, P4789, DOI 10.1182/blood.V90.12.4789.4789_4789_4798; Atkinson BT, 2003, BLOOD, V102, P3592, DOI 10.1182/blood-2003-04-1142; Benezech C, 2014, BLOOD, V123, P3200, DOI 10.1182/blood-2013-03-489286; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Bhavaraju K, 2008, EUR J PHARMACOL, V580, P285, DOI 10.1016/j.ejphar.2007.11.009; Blair TA, 2014, ARTERIOSCL THROM VAS, V34, P1681, DOI 10.1161/ATVBAHA.114.303954; Bobe R, 2001, BLOOD, V97, P678, DOI 10.1182/blood.V97.3.678; Brass L, 2010, HEMATOL-AM SOC HEMAT, P387, DOI 10.1182/asheducation-2010.1.387; Cancro MP, 2001, INT IMMUNOL, V13, P1501, DOI 10.1093/intimm/13.12.1501; CHENG GH, 1994, P NATL ACAD SCI USA, V91, P8152, DOI 10.1073/pnas.91.17.8152; Clemetson KJ, 2011, HAMOSTASEOLOGIE, V31, P264, DOI 10.5482/ha-1152; Corken A, 2014, ARTERIOSCL THROM VAS, V34, P996, DOI 10.1161/ATVBAHA.113.303113; Dubovsky JA, 2013, BLOOD, V122, P2539, DOI 10.1182/blood-2013-06-507947; Ellmeier W, 2000, J EXP MED, V192, P1611, DOI 10.1084/jem.192.11.1611; Falet H, 2000, BLOOD, V96, P3786, DOI 10.1182/blood.V96.12.3786.h8003786_3786_3792; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Garcia A, 2010, BIOCHEM J, V429, P369, DOI 10.1042/BJ20100166; Gardiner EE, 2013, J INFECT DIS, V208, P871, DOI 10.1093/infdis/jit305; Getz TM, 2011, J THROMB HAEMOST, V9, P608, DOI 10.1111/j.1538-7836.2011.04192.x; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; Gibbins JM, 1997, FEBS LETT, V413, P255, DOI 10.1016/S0014-5793(97)00926-5; Gitz E, 2014, BLOOD, V124, P2262, DOI 10.1182/blood-2014-05-572818; Giurisato E, 2007, MOL CELL BIOL, V27, P8583, DOI 10.1128/MCB.01477-07; Glassford J, 2003, ONCOGENE, V22, P2248, DOI 10.1038/sj.onc.1206425; Hamman BD, 2002, J BIOMOL SCREEN, V7, P45, DOI 10.1089/108705702753520332; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Hess PR, 2014, J CLIN INVEST, V124, P273, DOI 10.1172/JCI70422; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Humphries LA, 2004, J BIOL CHEM, V279, P37651, DOI 10.1074/jbc.M311985200; Jung SM, 2008, ADV EXP MED BIOL, V640, P53, DOI 10.1007/978-0-387-09789-3_5; KARNITZ LM, 1994, J EXP MED, V179, P1799, DOI 10.1084/jem.179.6.1799; Kim S, 2009, J BIOL CHEM, V284, P33763, DOI 10.1074/jbc.M109.048553; Krajewski S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038455; Laffargue M, 1999, FEBS LETT, V443, P66, DOI 10.1016/S0014-5793(98)01680-9; Levade M, 2014, BLOOD, V124, P3991, DOI 10.1182/blood-2014-06-583294; Manne BK, 2013, J BIOL CHEM, V288, P7717, DOI 10.1074/jbc.M112.424473; Mano H, 1999, CYTOKINE GROWTH F R, V10, P267, DOI 10.1016/S1359-6101(99)00019-2; Menter DG, 2014, CANCER METAST REV, V33, P231, DOI 10.1007/s10555-014-9498-0; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; Nonoyama S, 1998, J IMMUNOL, V161, P3925; Noordzij JG, 2002, PEDIATR RES, V51, P159, DOI 10.1203/00006450-200202000-00007; Oda A, 2000, BLOOD, V95, P1663; Okoh MP, 1999, BIOCHEM BIOPH RES CO, V265, P151, DOI 10.1006/bbrc.1999.1407; PACKHAM MA, 1994, CAN J PHYSIOL PHARM, V72, P278, DOI 10.1139/y94-043; Page C, 2014, CLIN EXP ALLERGY, V44, P901, DOI 10.1111/cea.12322; Pasquet JM, 2000, EMBO J, V19, P2793, DOI 10.1093/emboj/19.12.2793; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Quek LS, 1998, CURR BIOL, V8, P1137, DOI 10.1016/S0960-9822(98)70471-3; Quek LS, 2000, BLOOD, V96, P4246; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; Riedl J, 2014, HAMOSTASEOLOGIE, V34, P54, DOI 10.5482/HAMO-13-10-0054; Schwarzbich MA, 2014, RECENT RESULTS CANC, V201, P259, DOI 10.1007/978-3-642-54490-3_17; Severin S, 2011, J BIOL CHEM, V286, P4107, DOI 10.1074/jbc.M110.167502; Strijbis K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003446; Susa M, 1996, BIOCHEM BIOPH RES CO, V220, P729, DOI 10.1006/bbrc.1996.0472; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2004, BIOCHEM J, V378, P1023, DOI 10.1042/BJ20031430; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2011, J BIOCHEM, V150, P127, DOI 10.1093/jb/mvr079; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Vihinen M, 2000, FRONT BIOSCI-LANDMRK, V5, pD917, DOI 10.2741/vihinen; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Watanabe N, 2003, BLOOD, V102, P541, DOI 10.1182/blood-2002-11-3327; Watson SP, 2010, J THROMB HAEMOST, V8, P1457, DOI 10.1111/j.1538-7836.2010.03875.x; Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5; YANAGA F, 1995, BIOCHEM J, V311, P471, DOI 10.1042/bj3110471	73	51	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11557	11568		10.1074/jbc.M114.629527	http://dx.doi.org/10.1074/jbc.M114.629527			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25767114	Green Published, hybrid			2022-12-28	WOS:000353719400031
J	Deng, XD; Walker, RG; Morris, J; Davidson, WS; Thompson, TB				Deng, Xiaodi; Walker, Ryan G.; Morris, Jamie; Davidson, W. Sean; Thompson, Thomas B.			Role of Conserved Proline Residues in Human Apolipoprotein A-IV Structure and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEINS; CROSS-LINKING; EXCHANGEABLE APOLIPOPROTEINS; CRYSTAL-STRUCTURE; N-TERMINI; DOMAIN; CONFORMATION; REVEALS; HDL; SCATTERING	Apolipoprotein (apo)A-IV is a lipid emulsifying protein linked to a range of protective roles in obesity, diabetes, and cardiovascular disease. It exists in several states in plasma including lipid-bound in HDL and chylomicrons and as monomeric and dimeric lipid-free/poor forms. Our recent x-ray crystal structure of the central domain of apoA-IV shows that it adopts an elongated helical structure that dimerizes via two long reciprocating helices. A striking feature is the alignment of conserved proline residues across the dimer interface. We speculated that this plays important roles in the structure of the lipid-free protein and its ability to bind lipid. Here we show that the systematic conversion of these prolines to alanine increased the thermodynamic stability of apoA-IV and its propensity to oligomerize. Despite the structural stabilization, we noted an increase in the ability to bind and reorganize lipids and to promote cholesterol efflux from cells. The novel properties of these mutants allowed us to isolate the first trimeric form of an exchangeable apolipoprotein and characterize it by small-angle x-ray scattering and chemical cross-linking. The results suggest that the reciprocating helix interaction is a common feature of all apoA-IV oligomers. We propose a model of how self-association of apoA-IV can result in spherical lipoprotein particles, a model that may have broader applications to other exchangeable apolipoprotein family members.	[Deng, Xiaodi; Walker, Ryan G.; Thompson, Thomas B.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45237 USA; [Morris, Jamie; Davidson, W. Sean; Thompson, Thomas B.] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Davidson, WS (corresponding author), Univ Cincinnati, Dept Pathol & Lab Med, 2120 Galbraith Rd, Cincinnati, OH 45237 USA.	Sean.Davidson@UC.edu; Tom.Thompson@uc.edu	Regan, Clinton/E-6250-2012	Thompson, Thomas/0000-0002-7041-5047; Davidson, William/0000-0003-2756-2989; Walker, Ryan/0000-0001-6160-8026	National Institutes of Health [GM098458, HL67093]; National Institutes of Health Training Grant [T32 HL007382]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067093, T32HL007382, R01HL082734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health R01 Grants GM098458 (to T. B. T. and W. S. D.) and HL67093 (to W. S. D.) and by National Institutes of Health Training Grant T32 HL007382 (to X. D.).	Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Deng XD, 2013, J BIOL CHEM, V288, P4854, DOI 10.1074/jbc.M112.436709; Deng XD, 2012, STRUCTURE, V20, P767, DOI 10.1016/j.str.2012.02.020; ELSHOURBAGY NA, 1986, J BIOL CHEM, V261, P1998; Garai K, 2010, BIOCHEMISTRY-US, V49, P9533, DOI 10.1021/bi101407m; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; HIGUCHI K, 1986, FEBS LETT, V207, P23, DOI 10.1016/0014-5793(86)80006-0; Huang R, 2011, NAT STRUCT MOL BIOL, V18, P416, DOI 10.1038/nsmb.2028; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koppaka V, 1999, J BIOL CHEM, V274, P14541, DOI 10.1074/jbc.274.21.14541; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Li XM, 2014, J BIOL CHEM, V289, P2396, DOI 10.1074/jbc.M113.511766; Luo B, 2008, AM J NEPHROL, V28, P347, DOI 10.1159/000111828; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Miller M, 1998, ARTERIOSCL THROM VAS, V18, P1242, DOI 10.1161/01.ATV.18.8.1242; Mitani A, 2011, J ATHEROSCLER THROMB, V18, P531, DOI 10.5551/jat.7377; Murphy CL, 2004, AM J KIDNEY DIS, V44, P1103, DOI 10.1053/j.ajkd.2004.08.033; Oikawa S, 1997, J AM SOC NEPHROL, V8, P820; Pearson K, 2005, J BIOL CHEM, V280, P38576, DOI 10.1074/jbc.M506802200; Pearson K, 2004, BIOCHEMISTRY-US, V43, P10719, DOI 10.1021/bi048978m; Phillips JC, 1997, BIOPHYS J, V73, P2337, DOI 10.1016/S0006-3495(97)78264-X; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; SEGREST JP, 1992, J LIPID RES, V33, P141; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tabet F, 2009, CLIN SCI, V116, P87, DOI 10.1042/CS20080106; Tso P, 2004, PHYSIOL BEHAV, V83, P631, DOI 10.1016/j.physbeh.2004.07.032; Tubb MR, 2008, J BIOL CHEM, V283, P17314, DOI 10.1074/jbc.M800036200; Tubb MR, 2007, J BIOL CHEM, V282, P28385, DOI 10.1074/jbc.M704070200; UTERMANN G, 1984, EUR J BIOCHEM, V144, P325, DOI 10.1111/j.1432-1033.1984.tb08467.x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Walker RG, 2014, J BIOL CHEM, V289, P5596, DOI 10.1074/jbc.M113.541037; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	43	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10689	10702		10.1074/jbc.M115.637058	http://dx.doi.org/10.1074/jbc.M115.637058			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25733664	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000353404500012
J	Huang, X; Zhou, J; Zhou, AW; Olson, ST				Huang, Xin; Zhou, Jian; Zhou, Aiwu; Olson, Steven T.			Thermodynamic and Kinetic Characterization of the Protein Z-dependent Protease Inhibitor (ZPI)-Protein Z Interaction Reveals an Unexpected Role for ZPI Lys-239	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR XA; PROTHROMBOTIC PHENOTYPE; CANCER TISSUE; Z DEFICIENCY; COAGULATION; COMPLEX; BINDING; PLASMA; HEPARIN; SERPIN	The anticoagulant serpin, protein Z-dependent protease inhibitor (ZPI), circulates in blood as a tight complex with its cofactor, protein Z (PZ), enabling it to function as a rapid inhibitor of membrane-associated factor Xa. Here, we show that N, N'-dimethyl-N-(acetyl)-N'-(7-nitrobenz-3-oxa-1,3-diazol-4yl) ethylenediamine (NBD)-fluorophore-labeled K239C ZPI is a sensitive, moderately perturbing reporter of the ZPI-PZ interaction and utilize the labeled ZPI to characterize in-depth the thermodynamics and kinetics of wild-type and variant ZPI-PZ interactions. NBD-labeled K239C ZPI bound PZ with similar to 3nM K-D and similar to 400% fluorescence enhancement at physiologic pH and ionic strength. The NBD-ZPI-PZ interaction was markedly sensitive to ionic strength and pH but minimally affected by temperature, consistent with the importance of charged interactions. NBD-ZPI-PZ affinity was reduced similar to 5-fold by physiologic calcium levels to resemble NBD-ZPI affinity for gamma-carboxyglutamic acid/EGF1-domainless PZ. Competitive binding studies with ZPI variants revealed that in addition to previously identified Asp-293 and Tyr-240 hot spot residues, Met-71, Asp-74, and Asp-238 made significant contributions to PZ binding, whereas Lys-239 antagonized binding. Rapid kinetic studies indicated a multistep binding mechanism with diffusion-limited association and slow complex dissociation. ZPI complexation with factor Xa or cleavage decreased ZPI-PZ affinity 2-7-fold by increasing the rate of PZ dissociation. Acatalytic role for PZ was supported by the correlation between a decreased rate of PZ dissociation from the K239A ZPI-PZ complex and an impaired ability of PZ to catalyze the K239A ZPI-factor Xa reaction. Together, these results reveal the energetic basis of the ZPI-PZ interaction and suggest an important role for ZPI Lys-239 in PZ catalytic action.	[Huang, Xin; Zhou, Jian; Olson, Steven T.] Univ Illinois, Ctr Mol Biol Oral Dis, 801 S Paulina St,MC 860, Chicago, IL 60612 USA; [Huang, Xin; Zhou, Jian; Olson, Steven T.] Univ Illinois, Dept Periodont, Chicago, IL 60612 USA; [Zhou, Aiwu] Shanghai Jiao Tong Univ, Sch Med, Minist Educ China, Key Lab Cell Differentiat & Apoptosis, Shanghai 200025, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Ministry of Education, China; Shanghai Jiao Tong University	Huang, X (corresponding author), Univ Illinois, Ctr Mol Biol Oral Dis, 801 S Paulina St,MC 860, Chicago, IL 60612 USA.	xinhuang@uic.edu		ZHOU, Aiwu/0000-0002-2555-5091; Huang, Xin/0000-0002-4730-9318	National Institutes of Health [R37 HL39888]; American Heart Association Scientist Development Grant [SDG 48880022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 HL39888 (to S. T. O.). This work was also supported by American Heart Association Scientist Development Grant SDG 48880022 (to X. H.).	Bafunno V, 2011, THROMB RES, V128, P508, DOI 10.1016/j.thromres.2011.08.007; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Girard TJ, 2013, J THROMB HAEMOST, V11, P375, DOI 10.1111/jth.12084; Han X, 1999, BIOCHEMISTRY-US, V38, P11073, DOI 10.1021/bi990641a; Han X, 2000, BLOOD, V96, P3049; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; Huang X, 2008, J BIOL CHEM, V283, P29770, DOI 10.1074/jbc.M805214200; Huang X, 2011, J BIOL CHEM, V286, P8740, DOI 10.1074/jbc.M110.188375; Huang X, 2010, J BIOL CHEM, V285, P20399, DOI 10.1074/jbc.M110.112748; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kemkes-Matthes B, 2002, THROMB RES, V106, P183, DOI 10.1016/S0049-3848(02)00181-0; LEWIS SD, 1985, J BIOL CHEM, V260, P192; LINDAHL P, 1991, BIOCHEM J, V276, P387, DOI 10.1042/bj2760387; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160; MILETICH JP, 1987, BLOOD, V69, P1580; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; Rezaie AR, 1998, J BIOL CHEM, V273, P16824, DOI 10.1074/jbc.273.27.16824; SEJIMA H, 1990, BIOCHEM BIOPH RES CO, V171, P661, DOI 10.1016/0006-291X(90)91197-Z; Sierko E, 2012, THROMB RES, V129, pE112, DOI 10.1016/j.thromres.2011.10.027; Sierko E, 2010, THROMB HAEMOSTASIS, V104, P183, DOI 10.1160/TH09-09-0666; STONE SR, 1989, BIOCHEMISTRY-US, V28, P6857, DOI 10.1021/bi00443a012; Swanson R, 2007, J BIOL CHEM, V282, P2305, DOI 10.1074/jbc.M609546200; Tabatabai A, 2001, THROMB HAEMOSTASIS, V85, P655, DOI 10.1055/s-0037-1615649; Vasse M, 2011, HAMOSTASEOLOGIE, V31, P155, DOI 10.5482/ha-1161; Wei ZQ, 2009, BLOOD, V114, P3662, DOI 10.1182/blood-2009-04-210021; Yin ZF, 2000, P NATL ACAD SCI USA, V97, P6734, DOI 10.1073/pnas.120081897; Zhang J, 2008, BLOOD, V111, P4973, DOI 10.1182/blood-2007-12-126391	27	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9906	9918		10.1074/jbc.M114.633479	http://dx.doi.org/10.1074/jbc.M114.633479			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713144	Green Published, hybrid			2022-12-28	WOS:000352729400049
J	Vasilyev, N; Serganov, A				Vasilyev, Nikita; Serganov, Alexander			Structures of RNA Complexes with the Escherichia coli RNA Pyrophosphohydrolase RppH Unveil the Basis for Specific 5 '-End-dependent mRNA Decay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUDIX HYDROLASE; COLORIMETRIC DETERMINATION; PROTEIN; RECOGNITION; DEGRADATION; PYROPHOSPHATE; MECHANISM; INSIGHTS; K1	5'-End-dependent RNA degradation impacts virulence, stress responses, and DNA repair in bacteria by controlling the decay of hundreds of mRNAs. The RNA pyrophosphohydrolase RppH, a member of the Nudix hydrolase superfamily, triggers this degradation pathway by removing pyrophosphate from the triphosphorylated RNA 5' terminus Here, we report the x-ray structures of Escherichia call RppH (EcRppH) in apo- and RNA-bound forms. These structures show distinct conformations of EcRppH.RNA complexes on the catalytic pathway and suggest a common catalytic mechanism for Nudix hydrolases. EcRppH interacts with RNA by a bipartite mechanism involving specific recognition of the 5'-terminal triphosphate and the second nucleotide, thus enabling discrimination against mononudeotides as substrates. The structures also reveal the molecular basis for the preference of the enzyme for RNA substrates bearing guanine in the second position by identifying a protein cleft in which guanine interacts with EcRppH side chains via cation-pi contacts and hydrogen bonds. These interactions explain the modest specificity of EcRppH at the 5' terminus and distinguish the enzyme from the highly selective RppH present in Bacillus subtilis. The divergent means by which RNA is recognized by these two functionally and structurally analogous enzymes have important implications for mRNA decay and the regulation of protein biosynthesis in bacteria.	[Vasilyev, Nikita; Serganov, Alexander] NYU, Sch Med, Dept Biochem & Mol Pharmacol, 550 First Ave, New York, NY 10016 USA	New York University	Serganov, A (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, 550 First Ave, New York, NY 10016 USA.	alexander.serganov@nyumc.org		Serganov, Alexander/0000-0001-8328-9310	New York University	New York University	This work was supported by New York University start-up funds (to A. S.).	Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al Mamun AM, 2012, SCIENCE, V338, P1344, DOI 10.1126/science.1226683; Badger JL, 2000, MOL MICROBIOL, V36, P174, DOI 10.1046/j.1365-2958.2000.01840.x; Bailey S, 2002, STRUCTURE, V10, P589, DOI 10.1016/S0969-2126(02)00746-3; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; Bessman MJ, 2001, J BIOL CHEM, V276, P37834; Bi YC, 2009, BIOMOL NMR ASSIGN, V3, P149, DOI 10.1007/s12104-009-9162-8; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Derewenda ZS, 2006, ACTA CRYSTALLOGR D, V62, P116, DOI 10.1107/S0907444905035237; Derewenda ZS, 2004, STRUCTURE, V12, P529, DOI 10.1016/j.str.2004.03.008; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Fletcher JI, 2002, STRUCTURE, V10, P205, DOI 10.1016/S0969-2126(02)00696-2; Foley PL, 2015, J BIOL CHEM, V290, P9478, DOI 10.1074/jbc.M114.634659; Gabelli SB, 2002, BIOCHEMISTRY-US, V41, P9279, DOI 10.1021/bi0259296; HEINONEN JK, 1981, ANAL BIOCHEM, V117, P293, DOI 10.1016/0003-2697(81)90725-9; Hsieh PK, 2013, P NATL ACAD SCI USA, V110, P8864, DOI 10.1073/pnas.1222670110; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang LW, 2003, STRUCTURE, V11, P1015, DOI 10.1016/S0969-2126(03)00154-0; Leung DW, 2012, CURR OPIN STRUC BIOL, V22, P297, DOI 10.1016/j.sbi.2012.03.011; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luciano DJ, 2012, J BACTERIOL, V194, P6233, DOI 10.1128/JB.01223-12; Lundin A, 2003, J BIOL CHEM, V278, P12574, DOI 10.1074/jbc.M212542200; Lusty CJ, 1999, J APPL CRYSTALLOGR, V32, P106, DOI 10.1107/S002188989801053X; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; McLennan AG, 2013, CELL MOL LIFE SCI, V70, P373, DOI 10.1007/s00018-012-1210-3; Messing SAJ, 2009, STRUCTURE, V17, P472, DOI 10.1016/j.str.2008.12.022; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Miyazaki K, 2002, BIOTECHNIQUES, V33, P1033, DOI 10.2144/02335st03; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Piton J, 2013, P NATL ACAD SCI USA, V110, P8858, DOI 10.1073/pnas.1221510110; PUTNINS RF, 1975, ANAL BIOCHEM, V68, P185, DOI 10.1016/0003-2697(75)90693-4; Richards J, 2011, MOL CELL, V43, P940, DOI 10.1016/j.molcel.2011.07.023; Scarsdale JN, 2006, STRUCTURE, V14, P331, DOI 10.1016/j.str.2005.11.010; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wintjens R, 2000, J MOL BIOL, V302, P395, DOI 10.1006/jmbi.2000.4040	44	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9487	9499		10.1074/jbc.M114.634824	http://dx.doi.org/10.1074/jbc.M114.634824			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25657011	hybrid, Green Published			2022-12-28	WOS:000352729400016
J	Zhangsun, DT; Zhu, XP; Wu, Y; Hu, YY; Kaas, Q; Craik, DJ; McIntosh, JM; Luo, SL				Zhangsun, Dongting; Zhu, Xiaopeng; Wu, Yong; Hu, Yuanyan; Kaas, Quentin; Craik, David J.; McIntosh, J. Michael; Luo, Sulan			Key Residues in the Nicotinic Acetylcholine Receptor beta 2 Subunit Contribute to alpha-Conotoxin LvIA Binding*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERMINANTS; TARGETS; PROLIFERATION; SELECTIVITY; CIRCUITS; PEPTIDE; SYSTEM; PROBES; BUIA	alpha-Conotoxin LvIA (alpha-CTx LvIA) is a small peptide from the venom of the carnivorous marine gastropod Conus lividus and is the most selective inhibitor of alpha 3 beta 2 nicotinic acetylcholine receptors (nAChRs) known to date. It can distinguish the alpha 3 beta 2 nAChR subtype from the alpha 6 beta 2* (*indicates the other subunit) and alpha 3 beta 4 nAChR subtypes. In this study, we performed mutational studies to assess the influence of residues of the beta 2 subunit versus those of the beta 4 subunit on the binding of alpha-CTx LvIA. Although two beta 2 mutations, alpha 3 beta 2[F119Q] and alpha 3 beta 2[T59K], strongly enhanced the affinity of LvIA, the beta 2 mutation alpha 3 beta 2[V111I] substantially reduced the binding of LvIA. Increased activity of LvIA was also observed when the beta 2-T59L mutant was combined with the alpha 3 subunit. There were no significant difference in inhibition of alpha 3 beta 2[T59I], alpha 3 beta 2[Q34A], and alpha 3 beta 2[K79A] nAChRs when compared with wild-type alpha 3 beta 2 nAChR. alpha-CTx LvIA displayed slower off-rate kinetics at alpha 3 beta 2[F119Q] and alpha 3 beta 2[T59K] than at the wild-type receptor, with the latter mutant having the most pronounced effect. Taken together, these data provide evidence that the beta 2 subunit contributes to alpha-CTx LvIA binding and selectivity. The results demonstrate that Val(111) is critical and facilitates LvIA binding; this position has not previously been identified as important to binding of other 4/7 framework alpha-conotoxins. Thr(59) and Phe(119) of the beta 2 subunit appear to interfere with LvIA binding, and their replacement by the corresponding residues of the beta 4 subunit leads to increased affinity.	[Zhangsun, Dongting; Zhu, Xiaopeng; Wu, Yong; Hu, Yuanyan; Luo, Sulan] Hainan Univ, Key Lab Marine Drugs Haikou, Key Lab Trop Biol Resources, Minist Educ, Haikou 570228, Hainan, Peoples R China; [Kaas, Quentin; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [McIntosh, J. Michael] Univ Utah, George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT 84112 USA; [McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA	Hainan University; University of Queensland; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Luo, SL (corresponding author), Hainan Univ, Key Lab Marine Drugs Haikou, Key Lab Trop Biol Resources, Minist Educ, Haikou 570228, Hainan, Peoples R China.	luosulan2003@163.com	Craik, David/B-1695-2010; Kaas, Quentin/J-8727-2014	Craik, David/0000-0003-0007-6796; Kaas, Quentin/0000-0001-9988-6152	National Natural Science Foundation of China [81420108028, 41366002]; State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China [2012AA021706]; Program for International Science and Technology Cooperation Program of China [2011DFR31210]; Changjiang Scholars and Innovative Research Team in University Grant PCSIRT [IRT1123]; National Institutes of Health [GM48677, GM103801]; University of Queensland Early Career Research Grant [2013002338]; Australian Research Council [1093115]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103801, P01GM048677] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China; Program for International Science and Technology Cooperation Program of China; Changjiang Scholars and Innovative Research Team in University Grant PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Queensland Early Career Research Grant; Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by the National Natural Science Foundation of China (Grants 81420108028 and 41366002), State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China Grant 2012AA021706, Program for International Science and Technology Cooperation Program of China Grant 2011DFR31210, Changjiang Scholars and Innovative Research Team in University Grant PCSIRT, IRT1123. This work was also supported by National Institutes of Health Grants GM48677 and GM103801, University of Queensland Early Career Research Grant (2013002338), and Australian Research Council Grant 1093115.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; Armishaw CJ, 2010, TOXINS, V2, P1471, DOI 10.3390/toxins2061471; Arredondo J, 2005, AM J PATHOL, V166, P597, DOI 10.1016/S0002-9440(10)62281-X; Azam L, 2005, J BIOL CHEM, V280, P80, DOI 10.1074/jbc.M406281200; Azam L, 2009, ACTA PHARMACOL SIN, V30, P771, DOI 10.1038/aps.2009.47; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; D'hoedt D, 2009, EXPERT OPIN THER TAR, V13, P395, DOI [10.1517/14728220902841045 , 10.1517/14728220902841045]; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P7142, DOI 10.1021/bi00243a015; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Dutertre S, 2004, EUR J BIOCHEM, V271, P2327, DOI 10.1111/j.1432-1033.2004.04147.x; Garza A, 2009, NEUROSCIENCE, V158, P1521, DOI 10.1016/j.neuroscience.2008.11.027; Harvey SC, 1997, MOL PHARMACOL, V51, P336, DOI 10.1124/mol.51.2.336; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Lebbe EKM, 2014, MAR DRUGS, V12, P2970, DOI 10.3390/md12052970; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Luo S, 1999, BIOCHEMISTRY-US, V38, P14542, DOI 10.1021/bi991252j; Luo SL, 2014, FASEB J, V28, P1842, DOI 10.1096/fj.13-244103; Luo SL, 2010, J BIOL CHEM, V285, P12355, DOI 10.1074/jbc.M109.079012; Muttenthaler M, 2011, CURR PHARM DESIGN, V17, P4226, DOI 10.2174/138161211798999384; Poorthuis RB, 2013, BIOCHEM PHARMACOL, V86, P1089, DOI 10.1016/j.bcp.2013.07.003; Posadas I, 2013, CURR NEUROPHARMACOL, V11, P298, DOI 10.2174/1570159X11311030005; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Quik M, 2005, MOL PHARMACOL, V67, P32, DOI 10.1124/mol.104.006015; Rahman S, 2013, CNS NEUROL DISORD-DR, V12, P633; Rossman Amanda C, 2011, AANA J, V79, P433; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schaal C, 2014, MOL CANCER RES, V12, P14, DOI 10.1158/1541-7786.MCR-13-0541; Shen JX, 2013, CURR MOL MED, V13, P1455; Shiembob DL, 2006, BIOCHEMISTRY-US, V45, P11200, DOI 10.1021/bi0611715; Somm E, 2014, ARCH IMMUNOL THER EX, V62, P87, DOI 10.1007/s00005-013-0266-6; TSUNEKI H, 1995, NEUROSCI LETT, V196, P13, DOI 10.1016/0304-3940(95)11824-G; Wallace TL, 2013, BIOCHEM PHARMACOL, V85, P1713, DOI 10.1016/j.bcp.2013.04.001; Yakel JL, 2013, PFLUG ARCH EUR J PHY, V465, P441, DOI 10.1007/s00424-012-1200-1; Yu RL, 2013, J MED CHEM, V56, P3557, DOI 10.1021/jm400041h; Yu RL, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002011	40	17	19	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9855	9862		10.1074/jbc.M114.632646	http://dx.doi.org/10.1074/jbc.M114.632646			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713061	Green Published, hybrid			2022-12-28	WOS:000352729400044
J	Priya, RS; Veena, M; Kalisz, I; Whitney, S; Priyanka, D; LaBranche, CC; Teja, MS; Montefiori, DC; Pal, R; Mahalingam, S; Kalyanaraman, VS				Priya, Rangasamy Sneha; Veena, Menon; Kalisz, Irene; Whitney, Stephen; Priyanka, Dhopeshwarkar; LaBranche, Celia C.; Teja, Mullapudi Sri; Montefiori, David C.; Pal, Ranajit; Mahalingam, Sundarasamy; Kalyanaraman, Vaniambadi S.			Antigenicity and Immunogenicity of a Trimeric Envelope Protein from an Indian Clade C HIV-1 Isolate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; CROSS-CLADE; SUBTYPE-C; NEUTRALIZING ANTIBODIES; CHIMERIC VIRUS; ENV CLONES; VACCINE; RESPONSES; GLYCOPROTEIN	Human immunodeficiency virus type 1 (HIV-1) isolates from India mainly belong to clade C and are quite distinct from clade C isolates from Africa in terms of their phylogenetic makeup, serotype, and sensitivity to known human broadly neutralizing monoclonal antibodies. Because many of these properties are associated with the envelope proteins of HIV-1, it is of interest to study the envelope proteins of Indian clade C isolates as part of the ongoing efforts to develop a vaccine against HIV-1. To this end, we purified trimeric uncleaved gp145 of a CCR5 tropic Indian clade C HIV-1 (93IN101) from the conditioned medium of 293 cells. The purified protein was shown to be properly folded with stable structure by circular dichroism. Conformational integrity was further demonstrated by its high affinity binding to soluble CD4, CD4 binding site antibodies such as b12 and VRC01, quaternary epitope-specific antibody PG9, and CD4-induced epitope-specific antibody 17b. Sera from rabbits immunized with gp145 elicited high titer antibodies to various domains of gp120 and neutralized a broad spectrum of cladeBand clade C HIV-1 isolates. Similar to other clade B and clade C envelope immunogens, most of the Tier 1 neutralizing activity could be absorbed with the V3-specific peptide. Subsequent boosting of these rabbits with a clade B HIV-1 Bal gp145 resulted in an expanded breadth of neutralization of HIV-1 isolates. The present study strongly supports the inclusion of envelopes from Indian isolates in a future mixture of HIV-1 vaccines.	[Priya, Rangasamy Sneha; Teja, Mullapudi Sri; Mahalingam, Sundarasamy] Indian Inst Technol, Lab Mol Virol & Cell Biol, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Chennai 600036, Tamil Nadu, India; [Veena, Menon; Kalisz, Irene; Whitney, Stephen; Priyanka, Dhopeshwarkar; Pal, Ranajit; Kalyanaraman, Vaniambadi S.] Adv Biosci Labs Inc, Rockville, MD 20850 USA; [LaBranche, Celia C.; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Duke University	Mahalingam, S (corresponding author), Indian Inst Technol, Lab Mol Virol & Cell Biol, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Chennai 600036, Tamil Nadu, India.	mahalingam@iitm.ac.in		Mahalingam, Sundarasamy/0000-0003-4460-3949	Department of Science and Technology, Government of India [DST/TSG/ME/2010/50(G)]; Ministry of Human Resource and Development, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Ministry of Human Resource and Development, Government of India(Ministry of Human Resource Development (MHRD), Government of India)	This work was supported in part by Grant DST/TSG/ME/2010/50(G) from the Department of Science and Technology, Government of India (to S. M.) and a fellowship from the Ministry of Human Resource and Development, Government of India (to R. S. P.).	Amara RR, 2005, VIROLOGY, V334, P124; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Bhattacharyya S, 2010, J BIOL CHEM, V285, P27100, DOI 10.1074/jbc.M110.152272; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bontjer I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067484; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Chen B, 2000, J BIOL CHEM, V275, P34946, DOI 10.1074/jbc.M004905200; Chung HK, 2010, VIRUS RES, V151, P229, DOI 10.1016/j.virusres.2010.04.006; Davenport TM, 2011, J VIROL, V85, P7095, DOI 10.1128/JVI.00411-11; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Derdeyn CA, 2014, CURR OPIN HIV AIDS, V9, P210, DOI 10.1097/COH.0000000000000057; DIETRICH U, 1993, AIDS, V7, P23, DOI 10.1097/00002030-199301000-00003; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Feng Y, 2012, J BIOL CHEM, V287, P5673, DOI 10.1074/jbc.M111.317776; Gharu L, 2011, VIRUS RES, V158, P216, DOI 10.1016/j.virusres.2011.04.003; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Kang Y, 2009, VACCINE, V27, P5120, DOI 10.1016/j.vaccine.2009.06.037; Kim M, 2005, AIDS RES HUM RETROV, V21, P58, DOI 10.1089/aid.2005.21.58; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kong Leopold, 2012, J AIDS Clin Res, VS8, P3; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kraus MH, 2010, VIROLOGY, V397, P346, DOI 10.1016/j.virol.2009.11.019; Kulkarni SS, 2009, VIROLOGY, V385, P505, DOI 10.1016/j.virol.2008.12.032; Kwong PD, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007278; Liao HX, 2013, J VIROL, V87, P4185, DOI 10.1128/JVI.02297-12; Mascola JR, 2003, CURR MOL MED, V3, P209, DOI 10.2174/1566524033479799; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Matano T, 2004, J EXP MED, V199, P1709, DOI 10.1084/jem.20040432; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Mochizuki N, 1999, AIDS RES HUM RETROV, V15, P1321, DOI 10.1089/088922299310223; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Polonis V, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S2-P323; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ringe R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-76; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Sellhorn G, 2012, J VIROL, V86, P128, DOI 10.1128/JVI.06363-11; Selvarajah S, 2005, J VIROL, V79, P12148, DOI 10.1128/JVI.79.19.12148-12163.2005; Shen CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025956; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Smith DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012076; Srivastava IK, 2008, VIROLOGY, V372, P273, DOI 10.1016/j.virol.2007.10.022; Stamatatos L, 2000, AIDS RES HUM RETROV, V16, P981, DOI 10.1089/08892220050058407; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; THALI M, 1991, J VIROL, V65, P6188, DOI 10.1128/JVI.65.11.6188-6193.1991; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tong T, 2014, VIROLOGY, V456, P55, DOI 10.1016/j.virol.2014.03.015; Vaine M, 2008, J VIROL, V82, P7369, DOI 10.1128/JVI.00562-08; VANCOTT TC, 1995, J IMMUNOL METHODS, V183, P103, DOI 10.1016/0022-1759(95)00038-C; Visciano ML, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-165; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	67	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9195	9208		10.1074/jbc.M114.621185	http://dx.doi.org/10.1074/jbc.M114.621185			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25691567	Green Published, hybrid			2022-12-28	WOS:000352207100042
J	Dong, AW; Wodziak, D; Lowe, AW				Dong, Aiwen; Wodziak, Dariusz; Lowe, Anson W.			Epidermal Growth Factor Receptor (EGFR) Signaling Requires a Specific Endoplasmic Reticulum Thioredoxin for the Post-translational Control of Receptor Presentation to the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE-ISOMERASE FAMILY; ANTERIOR GRADIENT 2; AGR2 EXPRESSION; PROTEIN-KINASE; ESTROGEN-RECEPTOR; PLASMA-MEMBRANE; CARCINOMA-CELLS; LIVING CELLS; LUNG-CANCER; GENE	The epidermal growth factor receptor (EGFR) is a well characterized receptor-tyrosine kinase that functions in development and serves a vital role in many human cancers. Understanding EGFR regulatory mechanisms, and hence approaches for clinical intervention, has focused on ligand-receptor interactions and tyrosine kinase activity. Here, we show using the NCI-H460 lung and A431 epidermoid human cancer cell lines that EGFR binding to anterior gradient homolog 2 (AGR2) in the endoplasmic reticulum is required for receptor delivery to the plasma membrane and thus EGFR signaling. Reduced AGR2 protein levels or mutation of an essential cysteine in the active site result in decreased cell surface EGFR and a concomitant decrease in signaling as reflected by AREG, EGR1, and FOS expression. Similar to previously described EGFR nulls, an AGR2 null also resulted in embryonic lethality. Consistent with its role in regulating EGFR-mediated signaling, AGR2 expression is also enhanced in many human cancers and promotes the transformed phenotype. Furthermore, EGFR-mediated signaling in NCI-H460 cells, which are resistant to the tyrosine kinase inhibitor AG1478, is also disrupted with reduced AGR2 expression. The results provide insights into why cancer prognosis or response to therapy often does not correlate with EGFR protein or RNA levels because they do not reflect delivery to the cell surface where signaling is initiated. AGR2, therefore, represents a novel post-translational regulator of EGFR-mediated signaling and a promising target for treating human cancers.	[Dong, Aiwen; Wodziak, Dariusz; Lowe, Anson W.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Stanford University	Lowe, AW (corresponding author), Alway Bldg,Rm M211,300 Pasteur Dr, Stanford, CA 94305 USA.	lowe@stanford.edu			NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NCI NIH HHS [P30CA124435, P30 CA124435] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Armes JE, 2013, PATHOLOGY, V45, P49, DOI 10.1097/PAT.0b013e32835bd561; Arteaga CL, 2002, ONCOLOGIST, V7, P31; Bergstrom JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104186; Brankatschk B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002351; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034408; Chen YT, 2013, CANCER LETT, V339, P270, DOI 10.1016/j.canlet.2013.06.025; COHEN S, 1982, J BIOL CHEM, V257, P1523; COHEN S, 1982, P NATL ACAD SCI-BIOL, V79, P6237, DOI 10.1073/pnas.79.20.6237; COHEN S, 1980, J BIOL CHEM, V255, P4834; Di Maro G, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-160; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Feige MJ, 2011, CURR OPIN CELL BIOL, V23, P167, DOI 10.1016/j.ceb.2010.10.012; FISCH TM, 1987, MOL CELL BIOL, V7, P3490, DOI 10.1128/MCB.7.10.3490; Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740; Fritzsche FR, 2007, HISTOL HISTOPATHOL, V22, P703, DOI 10.14670/HH-22.703; Gupta A, 2013, J BIOL CHEM, V288, P4321, DOI 10.1074/jbc.M112.433086; Gupta A, 2012, J BIOL CHEM, V287, P4773, DOI 10.1074/jbc.M111.301531; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; Hong XY, 2013, CELL BIOCHEM BIOPHYS, V67, P1487, DOI 10.1007/s12013-013-9650-4; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Johns TG, 2005, FASEB J, V19, P780, DOI 10.1096/fj.04-1766fje; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; Koziel K, 2009, INT J BIOCHEM CELL B, V41, P2440, DOI 10.1016/j.biocel.2009.07.003; Li YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092081; Llorens F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-326; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; LYALL RM, 1989, J BIOL CHEM, V264, P14503; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Persson S, 2005, MOL PHYLOGENET EVOL, V36, P734, DOI 10.1016/j.ympev.2005.04.002; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Rutkevich LA, 2010, MOL BIOL CELL, V21, P3093, DOI 10.1091/mbc.E10-04-0356; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; SLIEKER LJ, 1985, J BIOL CHEM, V260, P687; SOULE HD, 1990, CANCER RES, V50, P6075; Sousa LP, 2012, P NATL ACAD SCI USA, V109, P4419, DOI 10.1073/pnas.1200164109; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; WUNDERLICH M, 1995, J MOL BIOL, V247, P28, DOI 10.1006/jmbi.1995.0119; YARDEN Y, 1985, J BIOL CHEM, V260, P315; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zhang JS, 2005, GENE CHROMOSOME CANC, V43, P249, DOI 10.1002/gcc.20188; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008; Zhu H, 2007, CANCER LETT, V245, P303, DOI 10.1016/j.canlet.2006.01.020	54	25	26	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8016	8027		10.1074/jbc.M114.623207	http://dx.doi.org/10.1074/jbc.M114.623207			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25666625	Green Published, hybrid			2022-12-28	WOS:000351662600001
J	Kim, JS; Saint-Andre, C; Lim, HS; Hwang, CS; Egly, JM; Cho, Y				Kim, Jin Seok; Saint-Andre, Charlotte; Lim, Hye Seong; Hwang, Cheol-Sang; Egly, Jean Marc; Cho, Yunje			Crystal Structure of the Rad3/XPD Regulatory Domain of Ssl1/p44	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; NUCLEOTIDE EXCISION-REPAIR; XERODERMA-PIGMENTOSUM; XPD HELICASE; CANCER RISK; TRANSCRIPTION; COMPLEX; TFIIH; DNA; MUTATIONS	The Ssl1/p44 subunit is a core component of the yeast/mammalian general transcription factor TFIIH, which is involved in transcription and DNA repair. Ssl1/p44 binds to and stimulates the Rad3/XPD helicase activity of TFIIH. To understand the helicase stimulatory mechanism of Ssl1/p44, we determined the crystal structure of the N-terminal regulatory domain of Ssl1 from Saccharomyces cerevisiae. Ssl1 forms a von Willebrand factor A fold in which a central six-stranded beta-sheet is sandwiched between three alpha helices on both sides. Structural and biochemical analyses of Ssl1/p44 revealed that the beta 4-alpha 5 loop, which is frequently found at the interface between von Willebrand factor A family proteins and cellular counterparts, is critical for the stimulation of Rad3/XPD. Yeast genetics analyses showed that double mutation of Leu-239 and Ser-240 in the beta 4-alpha 5 loop of Ssl1 leads to lethality of a yeast strain, demonstrating the importance of the Rad3-Ssl1 interactions to cell viability. Here, we provide a structural model for the Rad3/XPD-Ssl1/p44 complex and insights into how the binding of Ssl1/p44 contributes to the helicase activity of Rad3/XPD and cell viability.	[Kim, Jin Seok; Lim, Hye Seong; Hwang, Cheol-Sang; Cho, Yunje] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Saint-Andre, Charlotte; Egly, Jean Marc] CNRS INSERM UdS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, Cu Strasbourg, France	Pohang University of Science & Technology (POSTECH); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Egly, JM (corresponding author), CNRS INSERM UdS, Inst Genet & Biol Mol & Cellulaire, BP163, F-67404 Illkirch Graffenstaden, Cu Strasbourg, France.	jean-marc.egly@igbmc.fr; yunje@postech.ac.kr	Hwang, Cheol-Sang/Q-7391-2019	Hwang, Cheol-Sang/0000-0002-0105-5957	National R&D Program for Cancer Control, Ministry for Health and Welfare [1020280]; National Research Foundation of Korea - Korea government (Ministry of Education, Science and Technology; MEST) [2012R1A2A1A01004028, 2013M3A6A4044580, 2010-0019706]; Pohang University of Science and Technology rising star program; Ministry of Education BK21 Program; European Research Council; European Research Council Advanced Scientists; Agence Nationale de la Recherche [ANR-08-MIEN-022-03, ANR-10-BLANC-1231-02]; Association de la Recherche contre le Cancer [SL220100601335]	National R&D Program for Cancer Control, Ministry for Health and Welfare; National Research Foundation of Korea - Korea government (Ministry of Education, Science and Technology; MEST)(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); Pohang University of Science and Technology rising star program; Ministry of Education BK21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); European Research Council(European Research Council (ERC)European Commission); European Research Council Advanced Scientists; Agence Nationale de la Recherche(French National Research Agency (ANR)); Association de la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by National R&D Program for Cancer Control, Ministry for Health and Welfare Grant 1020280; National Research Foundation of Korea Grants 2012R1A2A1A01004028, 2013M3A6A4044580, and 2010-0019706 funded by the Korea government (Ministry of Education, Science and Technology; MEST); the Pohang University of Science and Technology rising star program; the Ministry of Education BK21 Program (to Y. C.); and a European Research Council advanced grant (to J. M. E.). This work was also supported by grants from the European Research Council Advanced Scientists; Agence Nationale de la Recherche Grants ANR-08-MIEN-022-03, ANR-10-BLANC-1231-02, and FRETNET; and Association de la Recherche contre le Cancer Grant SL220100601335.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BARDWELL L, 1994, P NATL ACAD SCI USA, V91, P3926, DOI 10.1073/pnas.91.9.3926; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Cleaver JE, 1999, HUM MUTAT, V14, P9, DOI 10.1002/(SICI)1098-1004(1999)14:1<9::AID-HUMU2>3.3.CO;2-Y; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Compe E, 2012, NAT REV MOL CELL BIO, V13, P343, DOI 10.1038/nrm3350; Ding DP, 2012, MOL BIOL REP, V39, P2533, DOI 10.1007/s11033-011-1005-x; Dubaele S, 2003, MOL CELL, V11, P1635, DOI 10.1016/S1097-2765(03)00182-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Fribourg S, 2000, J BIOL CHEM, V275, P31963, DOI 10.1074/jbc.M004960200; Gibbons BJ, 2012, P NATL ACAD SCI USA, V109, P1949, DOI 10.1073/pnas.1105266109; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kuper J, 2012, EMBO J, V31, P494, DOI 10.1038/emboj.2011.374; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Maines S, 1998, GENETICS, V150, P963; MATSUI P, 1995, NUCLEIC ACIDS RES, V23, P767, DOI 10.1093/nar/23.5.767; Murakami K, 2013, SCIENCE, V342, P709, DOI 10.1126/science.1238724; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pabalan N, 2010, BREAST CANCER RES TR, V124, P531, DOI 10.1007/s10549-010-0863-6; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Riedinger C, 2010, J BIOL CHEM, V285, P33992, DOI 10.1074/jbc.M110.134510; Sandrock B, 2001, J BIOL CHEM, V276, P35328, DOI 10.1074/jbc.M105570200; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Schmitt DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102389; Schultz P, 2000, CELL, V102, P599, DOI 10.1016/S0092-8674(00)00082-9; SERIZAWA H, 1993, NATURE, V363, P371, DOI 10.1038/363371a0; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Takagi Y, 2005, MOL CELL, V18, P237, DOI 10.1016/j.molcel.2005.03.007; Taylor EM, 1997, P NATL ACAD SCI USA, V94, P8658, DOI 10.1073/pnas.94.16.8658; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Tremeau-Bravard A, 2001, J BIOL CHEM, V276, P27693, DOI 10.1074/jbc.M102457200; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang ML, 2009, J TOXICOL ENV HEAL A, V72, P698, DOI 10.1080/15287390902841029; WANG ZG, 1995, MOL CELL BIOL, V15, P2288; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Xue HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043431; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; YOON H, 1992, GENE DEV, V6, P2463, DOI 10.1101/gad.6.12b.2463; Zhang Y, 2011, INT J COLORECTAL DIS, V26, P1257, DOI 10.1007/s00384-011-1222-8; Zhu JQ, 2010, BLOOD, V116, P5050, DOI 10.1182/blood-2010-04-281154	49	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8321	8330		10.1074/jbc.M115.636514	http://dx.doi.org/10.1074/jbc.M115.636514			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25681444	hybrid, Green Published			2022-12-28	WOS:000351662600027
J	Rayner, LE; Hui, GK; Gor, J; Heenan, RK; Dalby, PA; Perkins, SJ				Rayner, Lucy E.; Hui, Gar Kay; Gor, Jayesh; Heenan, Richard K.; Dalby, Paul A.; Perkins, Stephen J.			The Solution Structures of Two Human IgG1 Antibodies Show Conformational Stability and Accommodate Their C1q and Fc gamma R Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; COMPLEMENT ACTIVATION; HUMAN-IMMUNOGLOBULIN; NEUTRON-SCATTERING; EFFECTOR FUNCTIONS; CRYSTAL-STRUCTURE; CRYSTALLOGRAPHIC REFINEMENT; HYDRODYNAMIC PROPERTIES; 3-DIMENSIONAL STRUCTURE; MONOCLONAL-ANTIBODY	The human IgG1 antibody subclass shows distinct properties compared with the IgG2, IgG3, and IgG4 subclasses and is the most exploited subclass in therapeutic antibodies. It is the most abundant subclass, has a half-life as long as that of IgG2 and IgG4, binds the Fc gamma R receptor, and activates complement. There is limited structural information on full-length human IgG1 because of the challenges of crystallization. To rectify this, we have studied the solution structures of two human IgG1 6a and 19a monoclonal antibodies in different buffers at different temperatures. Analytical ultracentrifugation showed that both antibodies were predominantly monomeric, with sedimentation coefficients s(20,w)(0) of 6.3-6.4 S. Only a minor dimer peak was observed, and the amount was not dependent on buffer conditions. Solution scattering showed that the x-ray radius of gyration R-g increased with salt concentration, whereas the neutron R-g values remained unchanged with temperature. The x-ray and neutron distance distribution curves P(r) revealed two peaks, M1 and M2, whose positions were unchanged in different buffers to indicate conformational stability. Constrained atomistic scattering modeling revealed predominantly asymmetric solution structures for both antibodies with extended hinge structures. Both structures were similar to the only known crystal structure of full-length human IgG1. The Fab conformations in both structures were suitably positioned to permit the Fc region to bind readily to its Fc gamma R and C1q ligands without steric clashes, unlike human IgG4. Our molecular models for human IgG1 explain its immune activities, and we discuss its stability and function for therapeutic applications.	[Rayner, Lucy E.; Hui, Gar Kay; Gor, Jayesh; Perkins, Stephen J.] UCL, Dept Struct & Mol Biol, Div Biosci, London WC1E 6BT, England; [Heenan, Richard K.] Rutherford Appleton Lab, ISIS Facil, Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England; [Dalby, Paul A.] UCL, Div Engn, Dept Biochem Engn, London WC1E 7JE, England	University of London; University College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of London; University College London	Perkins, SJ (corresponding author), UCL, Dept Struct & Mol Biol, Div Biosci, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@ucl.ac.uk	Dalby, Paul A/C-1639-2008	Dalby, Paul A/0000-0002-0980-8167	Biotechnology and Biological Sciences Research Council; CCP-SAS project; Engineering and Physical Sciences Research Council [EP/K039121/1]; National Science Foundation [CHE-1265821]; BBSRC [BB/K021354/1, BB/I017119/1] Funding Source: UKRI; EPSRC [EP/K039121/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I017119/1, BB/K021354/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CCP-SAS project; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Science Foundation(National Science Foundation (NSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council. Support for this work was also provided in part by the CCP-SAS project, a joint Engineering and Physical Sciences Research Council (EP/K039121/1) and National Science Foundation (CHE-1265821) grant.	Abe Y, 2010, BIOCHEM J, V432, P101, DOI 10.1042/BJ20100641; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Ashish, 2010, BIOCHEM BIOPH RES CO, V391, P947, DOI 10.1016/j.bbrc.2009.11.170; Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; Boehm MK, 1999, J MOL BIOL, V286, P1421, DOI 10.1006/jmbi.1998.2556; BREKKE OH, 1995, IMMUNOL TODAY, V16, P85, DOI 10.1016/0167-5699(95)80094-8; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; CALMETTES P, 1991, ARCH BIOCHEM BIOPHYS, V291, P277, DOI 10.1016/0003-9861(91)90135-6; Collins AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00235; Dall'Acqua WF, 2006, J IMMUNOL, V177, P1129, DOI 10.4049/jimmunol.177.2.1129; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; Davies AM, 2014, J MOL BIOL, V426, P630, DOI 10.1016/j.jmb.2013.10.039; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DELATORRE JG, 1994, BIOPHYS J, V67, P530, DOI 10.1016/S0006-3495(94)80512-0; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; DORAI H, 1992, MOL IMMUNOL, V29, P1487, DOI 10.1016/0161-5890(92)90222-J; FEINSTEIN A, 1986, IMMUNOL TODAY, V7, P169, DOI 10.1016/0167-5699(86)90168-4; Furtado PB, 2004, J MOL BIOL, V338, P921, DOI 10.1016/j.jmb.2004.03.007; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Glatter O., 1982, SMALL ANGLE XRAY SCA, P17; GREGORY L, 1987, MOL IMMUNOL, V24, P821, DOI 10.1016/0161-5890(87)90184-2; GUDDAT LW, 1993, P NATL ACAD SCI USA, V90, P4271, DOI 10.1073/pnas.90.9.4271; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamilton R.G., 2001, HUMAN IGG SUBCLASSES; Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; Heenan R. K., 2011, NEUTRON NEWS, V22, P19, DOI DOI 10.1080/10448632.2011.569531; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; HUGHESJONES NC, 1979, MOL IMMUNOL, V16, P697, DOI 10.1016/0161-5890(79)90010-5; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; ISENMAN DE, 1975, J IMMUNOL, V114, P1726; Iwura T, 2014, J BIOCHEM, V155, P63, DOI 10.1093/jb/mvt095; Jefferis R, 2009, MABS, V1, P332, DOI 10.4161/mabs.1.4.9122; KILAR F, 1985, EUR J BIOCHEM, V147, P17, DOI 10.1111/j.1432-1033.1985.tb08712.x; KLEIN M, 1981, P NATL ACAD SCI-BIOL, V78, P524, DOI 10.1073/pnas.78.1.524; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lilyestrom WG, 2012, J PHYS CHEM B, V116, P9611, DOI 10.1021/jp303839t; LUND J, 1991, J IMMUNOL, V147, P2657; Luo Y, 2009, MABS-AUSTIN, V1, P491, DOI 10.4161/mabs.1.5.9631; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; MARQUART M, 1980, J MOL BIOL, V141, P369, DOI 10.1016/0022-2836(80)90252-1; Michaelsen TE, 2006, EUR J IMMUNOL, V36, P129, DOI 10.1002/eji.200535178; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; PERKINS SJ, 1991, J MOL BIOL, V221, P1345; Perkins SJ, 2001, BIOPHYS CHEM, V93, P129, DOI 10.1016/S0301-4622(01)00216-2; Perkins SJ, 2009, J R SOC INTERFACE, V6, pS679, DOI 10.1098/rsif.2009.0164.focus; PHILLIPS ML, 1994, MOL IMMUNOL, V31, P1201, DOI 10.1016/0161-5890(94)90034-5; PILZ I, 1973, BIOCHEMISTRY-US, V12, P4998, DOI 10.1021/bi00748a028; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Radaev S, 2002, MOL IMMUNOL, V38, P1073, DOI 10.1016/S0161-5890(02)00036-6; Rayner LE, 2014, J BIOL CHEM, V289, P20740, DOI 10.1074/jbc.M114.572404; Rayner LE, 2013, J MOL BIOL, V425, P506, DOI 10.1016/j.jmb.2012.11.019; Remmele RL, 2006, J PHARM SCI-US, V95, P126, DOI 10.1002/jps.20515; Richardson J. S., 1989, PREDICTION PROTEIN S, P1; Roux KH, 1997, J IMMUNOL, V159, P3372; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; SARMA R, 1982, J APPL CRYSTALLOGR, V15, P476, DOI 10.1107/S002188988201245X; Schneider S, 2012, MOL IMMUNOL, V51, P66, DOI 10.1016/j.molimm.2012.02.111; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Strohl WR, 2012, WOODH PUB SER BIOMED, P1, DOI 10.1533/9781908818096; Sun Z, 2005, J MOL BIOL, V353, P155, DOI 10.1016/j.jmb.2005.07.072; Tamm A, 1997, Int Rev Immunol, V16, P57, DOI 10.3109/08830189709045703; TAO MH, 1993, J EXP MED, V178, P661, DOI 10.1084/jem.178.2.661; Thommesen JE, 2000, MOL IMMUNOL, V37, P995, DOI 10.1016/S0161-5890(01)00010-4; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727; Yang J, 2014, MOL IMMUNOL, V58, P108, DOI 10.1016/j.molimm.2013.11.011	74	27	29	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8420	8438		10.1074/jbc.M114.631002	http://dx.doi.org/10.1074/jbc.M114.631002			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25659433	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000351662600035
J	Devaraneni, PK; Martin, GM; Olson, EM; Zhou, Q; Shyng, SL				Devaraneni, Prasanna K.; Martin, Gregory M.; Olson, Erik M.; Zhou, Qing; Shyng, Show-Ling			Structurally Distinct Ligands Rescue Biogenesis Defects of the K-ATP Channel Complex via a Converging Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-binding Cassette Transporter Subfamily C Member 8 (ABCC8); Chaperone; Potassium Channel; Protein Assembly; Protein Cross-linking; Carbamazepine; Glibenclamide; Pharmacological Chaperone; Sulfonylurea Receptor 1; Unnatural Amino Acid	SENSITIVE POTASSIUM CHANNELS; SULFONYLUREA RECEPTOR SUR1; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; CORRECT TRAFFICKING DEFECTS; PHARMACOLOGICAL CHAPERONES; CONGENITAL HYPERINSULINISM; INSULIN-SECRETION; HIGH-AFFINITY; N-TERMINUS; CROSS-LINKERS	Background: Carbamazepine and glibenclamide correct K-ATP channel trafficking defects. Results: Carbamazepine and glibenclamide share a binding pocket in the channel and enhance cross-linking of Kir6.2 to SUR1. Conclusion: The two structurally distinct drugs correct K-ATP channel biogenesis defects caused by mutations in SUR1 and Kir6.2 by promoting interactions between the two channel subunits. Significance: The heteromeric subunit interface is an important target for pharmacological chaperones. Small molecules that correct protein misfolding and misprocessing defects offer a potential therapy for numerous human diseases. However, mechanisms underlying pharmacological correction of such defects, especially in heteromeric complexes with structurally diverse constituent proteins, are not well understood. Here we investigate how two chemically distinct compounds, glibenclamide and carbamazepine, correct biogenesis defects in ATP-sensitive potassium (K-ATP) channels composed of sulfonylurea receptor 1 (SUR1) and Kir6.2. We present evidence that despite structural differences, carbamazepine and glibenclamide compete for binding to K-ATP channels, and both drugs share a binding pocket in SUR1 to exert their effects. Moreover, both compounds engage Kir6.2, in particular the distal N terminus of Kir6.2, which is involved in normal channel biogenesis, for their chaperoning effects on SUR1 mutants. Conversely, both drugs can correct channel biogenesis defects caused by Kir6.2 mutations in a SUR1-dependent manner. Using an unnatural, photocross-linkable amino acid, azidophenylalanine, genetically encoded in Kir6.2, we demonstrate in living cells that both drugs promote interactions between the distal N terminus of Kir6.2 and SUR1. These findings reveal a converging pharmacological chaperoning mechanism wherein glibenclamide and carbamazepine stabilize the heteromeric subunit interface critical for channel biogenesis to overcome defective biogenesis caused by mutations in individual subunits.	[Devaraneni, Prasanna K.; Martin, Gregory M.; Olson, Erik M.; Zhou, Qing; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Devaraneni, PK (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	devarane@ohsu.edu; shyngs@ohsu.edu			National Institutes of Health [DK57699, DK066485, T32 DK007680]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007680, R01DK066485, R01DK057699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57699 (to S.-L. S.), DK066485 (S.-L. S.), and T32 DK007680 (to G. M. M.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Ashfield R, 1999, DIABETES, V48, P1341, DOI 10.2337/diabetes.48.6.1341; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Babenko AP, 1999, BIOCHEM BIOPH RES CO, V255, P231, DOI 10.1006/bbrc.1999.0172; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; Bessadok A, 2011, J BIOL CHEM, V286, P3552, DOI 10.1074/jbc.M110.155200; Bruederle CE, 2011, TRAFFIC, V12, P1242, DOI 10.1111/j.1600-0854.2011.01227.x; Bryan J, 2004, DIABETES, V53, pS104, DOI 10.2337/diabetes.53.suppl_3.S104; Carlile GW, 2007, CHEMBIOCHEM, V8, P1012, DOI 10.1002/cbic.200700027; Cartier EA, 2003, J BIOL CHEM, V278, P7081, DOI 10.1074/jbc.M211395200; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; Chen PC, 2013, J BIOL CHEM, V288, P34098, DOI 10.1074/jbc.M113.516880; Chen PC, 2013, J BIOL CHEM, V288, P20942, DOI 10.1074/jbc.M113.470948; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Conti LR, 2001, J BIOL CHEM, V276, P41270, DOI 10.1074/jbc.M106555200; Crane A, 2004, J BIOL CHEM, V279, P9080, DOI 10.1074/jbc.M311079200; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Gopalakrishnan M, 2000, BRIT J PHARMACOL, V129, P1323, DOI 10.1038/sj.bjp.0703181; Grell W, 1998, J MED CHEM, V41, P5219, DOI 10.1021/jm9810349; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; Grunbeck A, 2013, METHOD ENZYMOL, V520, P307, DOI 10.1016/B978-0-12-391861-1.00014-9; Grunbeck A, 2012, ACS CHEM BIOL, V7, P967, DOI 10.1021/cb300059z; Hambrock A, 2002, BRIT J PHARMACOL, V136, P995, DOI 10.1038/sj.bjp.0704801; Hambrock A, 2001, MOL PHARMACOL, V60, P190, DOI 10.1124/mol.60.1.190; Hanrahan JW, 2013, TRENDS PHARMACOL SCI, V34, P119, DOI 10.1016/j.tips.2012.11.006; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Hu SL, 2000, J PHARMACOL EXP THER, V293, P444; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; INAGAKI N, 1995, J BIOL CHEM, V270, P5691, DOI 10.1074/jbc.270.11.5691; Kobayashi H, 2009, TRAFFIC, V10, P1019, DOI 10.1111/j.1600-0854.2009.00932.x; Koster JC, 1999, J GEN PHYSIOL, V114, P203, DOI 10.1085/jgp.114.2.203; Koster JC, 1999, J PHYSIOL-LONDON, V515, P19, DOI 10.1111/j.1469-7793.1999.019ad.x; Kuhner P, 2012, N-S ARCH PHARMACOL, V385, P299, DOI 10.1007/s00210-011-0709-8; Lavoie H, 2013, NAT CHEM BIOL, V9, P428, DOI [10.1038/NCHEMBIO.1257, 10.1038/nchembio.1257]; Li LX, 2013, CURR ALZHEIMER RES, V10, P433, DOI 10.2174/1567205011310040008; Lin CW, 2006, DIABETES, V55, P1738, DOI 10.2337/db05-1571; Lin CW, 2005, DIABETES, V54, P2852, DOI 10.2337/diabetes.54.10.2852; Lin YW, 2008, J BIOL CHEM, V283, P9146, DOI 10.1074/jbc.M708798200; Lin YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063758; Martin GM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00386; Mecozzi VJ, 2014, NAT CHEM BIOL, V10, P443, DOI [10.1038/NCHEMBIO.1508, 10.1038/nchembio.1508]; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nichols CG, 2013, CIRC RES, V112, P1059, DOI 10.1161/CIRCRESAHA.112.300514; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Pratt EB, 2012, J GEN PHYSIOL, V140, P175, DOI 10.1085/jgp.201210803; Proks P, 2007, HUM MOL GENET, V16, P2011, DOI 10.1093/hmg/ddm149; Reimann F, 1999, J PHYSIOL-LONDON, V518, P325, DOI 10.1111/j.1469-7793.1999.0325p.x; Ringe Dagmar, 2009, J Biol, V8, P80, DOI 10.1186/jbiol186; Sampson HM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-11; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Snider KE, 2013, J CLIN ENDOCR METAB, V98, pE355, DOI 10.1210/jc.2012-2169; Srinivasan R, 2014, PHARMACOL RES, V83, P20, DOI 10.1016/j.phrs.2014.02.005; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Vila-Carriles WH, 2007, FASEB J, V21, P18, DOI 10.1096/fj.06-6730hyp; Winkler M, 2012, N-S ARCH PHARMACOL, V385, P287, DOI 10.1007/s00210-011-0708-9; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150; Yan FF, 2006, J BIOL CHEM, V281, P33403, DOI 10.1074/jbc.M605195200; Yan FF, 2010, MOL BIOL CELL, V21, P1945, DOI 10.1091/mbc.E10-02-0116; Yan FF, 2004, J BIOL CHEM, V279, P11096, DOI 10.1074/jbc.M312810200; Yu W, 2011, J BIOL CHEM, V286, P24714, DOI 10.1074/jbc.M111.239699; Yuriev E, 2004, EUR J MED CHEM, V39, P835, DOI 10.1016/j.ejmech.2004.06.004; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhou Q, 2014, CHANNELS, V8, P376, DOI 10.4161/chan.29117; Zhou Q, 2013, CHANNELS, V7, P313, DOI 10.4161/chan.25003; Zhou Q, 2010, J CLIN ENDOCR METAB, V95, pE473, DOI 10.1210/jc.2010-1231; Zhou SF, 2008, CURR MED CHEM, V15, P1981, DOI 10.2174/092986708785132870	70	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7980	7991		10.1074/jbc.M114.634576	http://dx.doi.org/10.1074/jbc.M114.634576			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25637631	Green Published, hybrid			2022-12-28	WOS:000351613600055
J	Lin, L; Jin, Y; Hu, KB				Lin, Ling; Jin, Yang; Hu, Kebin			Tissue-type Plasminogen Activator (tPA) Promotes M1 Macrophage Survival through p90 Ribosomal S6 Kinase (RSK) and p38 Mitogen-activated Protein Kinase (MAPK) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cell Signaling; Macrophage; Serine Protease; Tissue Plasminogen Activator (tPA)	RECEPTOR-RELATED PROTEIN; NF-KAPPA-B; IN-VIVO; MICE; POLARIZATION; KIDNEY; INJURY; FAMILY; INFLAMMATION; EXPRESSION	Background: Macrophages become resistant to apoptosis in response to pathogenic cues. Results: Tissue-type plasminogen activator (tPA) protects the classically activated macrophages from apoptosis. Conclusion: tPA is an endogenous factor that promotes macrophage survival. Significance: tPA modulates inflammation by promoting the survival of polarized macrophages through a new signaling cascade. Macrophage accumulation is one of the hallmarks of progressive kidney disease. Resting macrophages have a finite lifespan, but become resistant to apoptosis in response to pathogenic cues, whereas the underlying mechanism remains unknown. Tissue-type plasminogen activator (tPA), a protease up-regulated in the kidneys with chronic injury, has been shown to promote macrophage accumulation and renal inflammation. We hypothesized that tPA may be the endogenous factor that promotes macrophage survival and extends their lifespan that leads to their accumulation in the injured kidneys. We examined the role of tPA in macrophage survival, and found that tPA protected macrophages from both staurosporine and H2O2-induced apoptosis. tPA promoted the survival of both resting and lipopolysaccharide- or interferon--induced M1 macrophages, but failed to do so in the interleukin 4 (IL4)-induced M2 macrophages. In the kidneys with unilateral ureteral obstruction, there were significantly more apoptotic M1 macrophages in tPA-deficient mice than their wild-type counterparts, and obstruction-induced M1 macrophages accumulation and M1 chemokine expression were markedly reduced in these knock-out mice. The cytoprotective effect of tPA required its receptor, LDL receptor-related protein-1 (LRP-1). tPA induced the phosphorylation of Erk1/2, p90 ribosomal S6 kinase (RSK), and p38 in a temporal order. The tPA-mediated macrophage survival was eliminated by PD98059, BI-D1870, or sc68376, the specific inhibitors for Erk1/2, p90RSK, or p38, respectively. Thus, it is clear that tPA promoted M1 macrophage survival through its receptor LRP-1-mediated novel signaling cascade involving Erk1/2, p90RSK, and p38, which leads to the accumulation of these cells in the injured kidneys.	[Lin, Ling; Hu, Kebin] Penn State Univ, Coll Med, Dept Med, Div Nephrol, Hershey, PA 17033 USA; [Jin, Yang] Harvard Univ, Brigham & Womens Hosp, Div Pulm & Crit Care Med, Dept Med,Med Sch, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Hu, KB (corresponding author), Penn State Univ, Coll Med, Dept Med, Mail Code H040,500 Univ Dr, Hershey, PA 17033 USA.	kebinhu@hmc.psu.edu	Hu, Kebin/AAT-7840-2021	Lin, Ling/0000-0001-5527-0575; Hu, Kebin/0000-0002-0829-4256	National Institutes of Health [DK102624]; American Heart Association [14GRNT20380289, 10SDG3900029]; Barsumian Trust [157904]; Kidney Foundation of Central Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Barsumian Trust; Kidney Foundation of Central Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK102624, American Heart Association Grants 14GRNT20380289 and 10SDG3900029, Barsumian Trust Grant 157904, and the Kidney Foundation of Central Pennsylvania (to K. H.).	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Higazi AA, 2008, CLIN EXP IMMUNOL, V152, P163, DOI 10.1111/j.1365-2249.2008.03606.x; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; Hu K, 2008, FRONT BIOSCI, V13, P5174, DOI 10.2741/3073; Hu KB, 2008, J AM SOC NEPHROL, V19, P503, DOI 10.1681/ASN.2007030300; Hu K, 2007, J CLIN INVEST, V117, P3821, DOI 10.1172/JCI32301; Hu L, 2006, ARTERIOSCL THROM VAS, V26, P2710, DOI 10.1161/01.ATV.0000249641.96896.e6; Iwata Y, 2012, J IMMUNOL, V188, P4568, DOI 10.4049/jimmunol.1102154; Lange-Sperandio B, 2007, AM J PATHOL, V171, P861, DOI 10.2353/ajpath.2007.061199; Lin L, 2014, INT J MOL SCI, V15, P22887, DOI 10.3390/ijms151222887; Lin L, 2014, AM J PATHOL, V184, P2757, DOI 10.1016/j.ajpath.2014.06.013; Lin L, 2014, AM J CLIN EXP IMMUNO, V3, P30; Lin L, 2012, J AM SOC NEPHROL, V23, P1329, DOI 10.1681/ASN.2011111123; Lin L, 2010, AM J PATHOL, V177, P1687, DOI 10.2353/ajpath.2010.100213; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; Marriott HM, 2005, J CLIN INVEST, V115, P359, DOI 10.1172/JCI200521766; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nguyen TL, 2008, ANTI-CANCER AGENT ME, V8, P710, DOI 10.2174/187152008785914770; Overton CD, 2007, CIRC RES, V100, P670, DOI 10.1161/01.RES.0000260204.40510.aa; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Roelofs JJTH, 2006, J AM SOC NEPHROL, V17, P131, DOI 10.1681/ASN.2005010089; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Steinberg BE, 2008, J CLIN INVEST, V118, P2002, DOI 10.1172/JCI35433; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Wang YP, 2011, J AM SOC NEPHROL, V22, P21, DOI 10.1681/ASN.2010030269; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Zhang BZ, 2008, J AM SOC NEPHROL, V19, P923, DOI 10.1681/ASN.2007090982; Zhang C, 2009, AM J PATHOL, V174, P586, DOI 10.2353/ajpath.2009.080661; Zhang MZ, 2012, J CLIN INVEST, V122, P4519, DOI 10.1172/JCI60363	42	20	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7910	7917		10.1074/jbc.M114.599688	http://dx.doi.org/10.1074/jbc.M114.599688			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25670857	Green Published, hybrid			2022-12-28	WOS:000351613600048
J	Wang, WS; Han, WJ; Cai, XY; Zheng, XY; Sugahara, K; Li, FC				Wang, Wenshuang; Han, Wenjun; Cai, Xingya; Zheng, Xiaoyu; Sugahara, Kazuyuki; Li, Fuchuan			Cloning and Characterization of a Novel Chondroitin Sulfate/Dermatan Sulfate 4-O-Endosulfatase from a Marine Bacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondroitin Sulfate; Dermatan Sulfate; Glycosaminoglycan; Oligosaccharide; Polysaccharide; Endosulfatase; Marine Bacterium; Sulfated Polysaccharide	SIMPLEX-VIRUS INFECTIVITY; DERMATAN SULFATE; NEURITE OUTGROWTH; GLUCURONIC-ACID; GROWTH-FACTORS; HYBRID CHAINS; GLYCOSAMINOGLYCANS; BINDING; BIOSYNTHESIS; EXPRESSION	Background: To date, few glycosaminoglycan (GAG) endosulfatases have been identified. Results: A novel chondroitin sulfate/dermatan sulfate (CS/DS) endosulfatase was identified for the first time from a marine bacterium. Conclusion: The endosulfatase has low homology to the conventional GAG sulfatases and can specifically remove 4-O-sulfate from CS/DS chains. Significance: The endosulfatase will be a useful tool for CS/DS-related research and applications. Sulfatases are potentially useful tools for structure-function studies of glycosaminoglycans (GAGs). To date, various GAG exosulfatases have been identified in eukaryotes and prokaryotes. However, endosulfatases that act on GAGs have rarely been reported. Recently, a novel HA and CS lyase (HCLase) was identified for the first time from a marine bacterium (Han, W., Wang, W., Zhao, M., Sugahara, K., and Li, F. (2014) J. Biol. Chem. 289, 27886-27898). In this study, a putative sulfatase gene, closely linked to the hclase gene in the genome, was recombinantly expressed and characterized in detail. The recombinant protein showed a specific N-acetylgalactosamine-4-O-sulfatase activity that removes 4-O-sulfate from both disaccharides and polysaccharides of chondroitin sulfate (CS)/dermatan sulfate (DS), suggesting that this sulfatase represents a novel endosulfatase. The novel endosulfatase exhibited maximal reaction rate in a phosphate buffer (pH 8.0) at 30 degrees C and effectively removed 17-65% of 4-O-sulfates from various CS and DS and thus significantly inhibited the interactions of CS and DS with a positively supercharged fluorescent protein. Moreover, this endosulfatase significantly promoted the digestion of CS by HCLase, suggesting that it enhances the digestion of CS/DS by the bacterium. Therefore, this endosulfatase is a potential tool for use in CS/DS-related studies and applications.	[Wang, Wenshuang; Han, Wenjun; Cai, Xingya; Zheng, Xiaoyu; Li, Fuchuan] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China; [Wang, Wenshuang; Han, Wenjun; Cai, Xingya; Zheng, Xiaoyu; Li, Fuchuan] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Proteoglycan Signaling & Therapeut Res Grp, Fac Adv Life Sci, Sapporo, Hokkaido 0070021, Japan	Shandong University; Shandong University; Hokkaido University	Li, FC (corresponding author), Shandong Univ, Natl Glycoengn Res Ctr, 27 South Shanda Rd, Jinan 250100, Peoples R China.	fuchuanli@sdu.edu.cn			Major State Basic Research Development Program of China [2012CB822102]; National High Technology Research and Development Program of China [2012AA021504]; Shandong Province Science and Technology Development Plan [2013GSF12106]; National Natural Science Foundation of China [31300664]; Japan Society for the Promotion of Science [25670018]	Major State Basic Research Development Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shandong Province Science and Technology Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Major State Basic Research Development Program of China Grant 2012CB822102, National High Technology Research and Development Program of China Grant 2012AA021504, Shandong Province Science and Technology Development Plan Grant 2013GSF12106, and National Natural Science Foundation of China Grant 31300664. This study was also supported in part by Grant-in-aid for Challenging Exploratory Research 25670018 from the Japan Society for the Promotion of Science.	Bergefall K, 2005, J BIOL CHEM, V280, P32193, DOI 10.1074/jbc.M503645200; BIELICKI J, 1995, BIOCHEM J, V311, P333, DOI 10.1042/bj3110333; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; BRAMHALL S, 1969, ANAL BIOCHEM, V31, P146, DOI 10.1016/0003-2697(69)90251-6; CHENG F, 1994, GLYCOBIOLOGY, V4, P685, DOI 10.1093/glycob/4.5.685; Clement AM, 1998, J BIOL CHEM, V273, P28444, DOI 10.1074/jbc.273.43.28444; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Han WJ, 2014, J BIOL CHEM, V289, P27886, DOI 10.1074/jbc.M114.590752; Hanson SR, 2004, ANGEW CHEM INT EDIT, V43, P5736, DOI 10.1002/anie.200300632; Hsiao JC, 1999, J VIROL, V73, P8750, DOI 10.1128/JVI.73.10.8750-8761.1999; Izumikawa T, 2004, J BIOL CHEM, V279, P53755, DOI 10.1074/jbc.M409615200; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; LAFONT F, 1992, DEVELOPMENT, V114, P17; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Li FC, 2008, GLYCOCONJUGATE J, V25, P603, DOI 10.1007/s10719-008-9124-x; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Maeda N, 2006, J BIOL CHEM, V281, P4894, DOI 10.1074/jbc.M507750200; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Mizumoto S, 2012, J BIOL CHEM, V287, P18985, DOI 10.1074/jbc.M111.313437; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Narita K, 2007, J BIOL CHEM, V282, P14413, DOI 10.1074/jbc.M611395200; SAITO H, 1968, J BIOL CHEM, V243, P1536; Sambrook J, 2001, MOL CLONING LAB MANU; Seffouh A, 2013, FASEB J, V27, P2431, DOI 10.1096/fj.12-226373; SHAKLEE PN, 1985, J BIOL CHEM, V260, P9146; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 1996, EUR J BIOCHEM, V239, P865, DOI 10.1111/j.1432-1033.1996.0865u.x; Sugahara K, 2000, TRENDS GLYCOSCI GLYC, V12, P321, DOI 10.4052/tigg.12.321; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Trowbridge JM, 2002, J BIOL CHEM, V277, P42815, DOI 10.1074/jbc.M204959200; Ulmer JE, 2014, J BIOL CHEM, V289, P24289, DOI 10.1074/jbc.M114.573303; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Williams RK, 1997, J VIROL, V71, P1375, DOI 10.1128/JVI.71.2.1375-1380.1997; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523	43	17	17	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7823	7832		10.1074/jbc.M114.629154	http://dx.doi.org/10.1074/jbc.M114.629154			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25648894	Green Published, hybrid			2022-12-28	WOS:000351613600040
J	Zhang, YY; Huang, Y; He, QZ; Luo, J; Zhu, L; Lu, SS; Liu, JY; Huang, PF; Zeng, XZ; Liang, SP				Zhang, Yi-Ya; Huang, Yong; He, Quan-Ze; Luo, Ji; Zhu, Li; Lu, Shan-Shan; Liu, Jin-Yan; Huang, Peng-Fei; Zeng, Xiong-Zhi; Liang, Song-Ping			Structural and Functional Diversity of Peptide Toxins from Tarantula Haplopelma hainanum (Ornithoctonus hainana) Venom Revealed by Transcriptomic, Peptidomic, and Patch Clamp Approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIDER SELENOCOSMIA-HUWENA; CHINESE BIRD SPIDER; FUNNEL-WEB SPIDER; MOLECULAR DIVERSIFICATION; GLAND TRANSCRIPTOME; HUWENTOXIN-V; NEUROTOXINS; PURIFICATION; FAMILY; DISCOVERY	Spider venom is a complex mixture of bioactive peptides to subdue their prey. Early estimates suggested that over 400 venom peptides are produced per species. In order to investigate the mechanisms responsible for this impressive diversity, transcriptomics based on second generation high throughput sequencing was combined with peptidomic assays to characterize the venom of the tarantula Haplopelma hainanum. The genes expressed in the venom glands were identified, and the bioactivity of their protein products was analyzed using the patch clamp technique. A total of 1,136 potential toxin precursors were identified that clustered into 90 toxin groups, of which 72 were novel. The toxin peptides clustered into 20 cysteine scaffolds that included between 4 and 12 cysteines, and 14 of these groups were newly identified in this spider. Highly abundant toxin peptide transcripts were present and resulted from hypermutation and/or fragment insertion/deletion. In combination with variable post-translational modifications, this genetic variability explained how a limited set of genes can generate hundreds of toxin peptides in venom glands. Furthermore, the intraspecies venom variability illustrated the dynamic nature of spider venom and revealed how complex components work together to generate diverse bioactivities that facilitate adaptation to changing environments, types of prey, and milking regimes in captivity.	[Zhang, Yi-Ya; He, Quan-Ze; Luo, Ji; Zhu, Li; Lu, Shan-Shan; Liu, Jin-Yan; Huang, Peng-Fei; Zeng, Xiong-Zhi; Liang, Song-Ping] Hunan Normal Univ, Coll Life Sci, Key Lab Prot Chem & Dev Biol, Minist Educ, Changsha 410081, Hunan, Peoples R China; [Huang, Yong] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China	Hunan Normal University; Beijing Institute of Microbiology & Epidemiology	Zeng, XZ (corresponding author), Hunan Normal Univ, Coll Life Sci, Key Lab Prot Chem & Dev Biol, Minist Educ, Changsha 410081, Hunan, Peoples R China.	xiongzhizeng@gmail.com; liangsp@hunnu.edu.cn		Zhang, Yiya/0000-0003-3644-3500	National Basic Research Program of China [2010CB529801]; Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province [20134486]	National Basic Research Program of China(National Basic Research Program of China); Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province	This work was supported by National Basic Research Program of China (973) Grant 2010CB529801 and by Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province Grant 20134486.	Adams ME, 2004, TOXICON, V43, P509, DOI 10.1016/j.toxicon.2004.02.004; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BINDOKAS VP, 1991, J NEUROPHYSIOL, V66, P590, DOI 10.1152/jn.1991.66.2.590; Binford GJ, 2009, MOL BIOL EVOL, V26, P547, DOI 10.1093/molbev/msn274; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Chen JJ, 2008, TOXICON, V52, P794, DOI 10.1016/j.toxicon.2008.08.003; Choi SJ, 2004, FEBS LETT, V572, P109, DOI 10.1016/j.febslet.2004.07.019; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conticello SG, 2001, MOL BIOL EVOL, V18, P120, DOI 10.1093/oxfordjournals.molbev.a003786; CORDEIRO MD, 1993, TOXICON, V31, P35, DOI 10.1016/0041-0101(93)90354-L; Corzo G, 2003, CELL MOL LIFE SCI, V60, P2409, DOI 10.1007/s00018-003-3108-6; Deng MC, 2008, EUR J PHARMACOL, V582, P12, DOI 10.1016/j.ejphar.2007.12.014; Diao JB, 2003, TOXICON, V42, P715, DOI 10.1016/j.toxicon.2003.08.007; Diochot S, 1999, BRIT J PHARMACOL, V126, P251, DOI 10.1038/sj.bjp.0702283; Duan D, 2011, ACTA NEUROCHIR, V153, P2085, DOI 10.1007/s00701-011-0955-z; Durban J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-259; Dutertre S, 2013, MOL CELL PROTEOMICS, V12, P312, DOI 10.1074/mcp.M112.021469; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Escoubas P, 2006, MOL DIVERS, V10, P545, DOI 10.1007/s11030-006-9050-4; Fernandes-Pedrosa MD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-279; Grishin E, 1999, EUR J BIOCHEM, V264, P276, DOI 10.1046/j.1432-1327.1999.00622.x; Huang RH, 2003, ACTA BIOCH BIOPH SIN, V35, P976; Ingrao F, 2013, DEV COMP IMMUNOL, V41, P429, DOI 10.1016/j.dci.2013.03.017; Jiang LP, 2008, TOXICON, V51, P1479, DOI 10.1016/j.toxicon.2008.03.024; Jiang LP, 2010, COMP BIOCHEM PHYS D, V5, P81, DOI 10.1016/j.cbd.2010.01.001; KAISER II, 1994, TOXICON, V32, P1083, DOI 10.1016/0041-0101(94)90392-1; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kuzmenkov AI, 2013, BBA-BIOMEMBRANES, V1828, P724, DOI 10.1016/j.bbamem.2012.10.014; Li DL, 2004, J BIOL CHEM, V279, P37734, DOI 10.1074/jbc.M405765200; Li ZH, 2006, J BIOL CHEM, V281, P8628, DOI 10.1074/jbc.M513542200; Liang S, 2008, EXPERT REV PROTEOMIC, V5, P731, DOI 10.1586/14789450.5.5.731; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Liao Z, 2007, PROTEOMICS, V7, P1892, DOI 10.1002/pmic.200600785; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Lluisma AO, 2012, MAR GENOM, V5, P43, DOI 10.1016/j.margen.2011.09.002; Lu SY, 1999, J PROTEIN CHEM, V18, P609, DOI 10.1023/A:1020663619657; Miranda DM, 2001, BRAIN RES BULL, V54, P533, DOI 10.1016/S0361-9230(01)00443-9; Morgenstern D, 2011, TOXICON, V57, P695, DOI 10.1016/j.toxicon.2011.02.001; Naamati G, 2009, NUCLEIC ACIDS RES, V37, pW363, DOI 10.1093/nar/gkp299; Oswald RE, 2002, J BIOL CHEM, V277, P34443, DOI 10.1074/jbc.M202715200; Park S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-50; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Pimentel C, 2006, PROTEIN SCI, V15, P628, DOI 10.1110/ps.051860606; Prosdocimi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021634; Rash LD, 2002, TOXICON, V40, P225, DOI 10.1016/S0041-0101(01)00199-4; Rokyta DR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-312; Rong MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065984; SAVELNIEMANN A, 1989, BIOL CHEM H-S, V370, P485, DOI 10.1515/bchm3.1989.370.1.485; SKINNER WS, 1989, J BIOL CHEM, V264, P2150; STAPLETON A, 1990, J BIOL CHEM, V265, P2054; Tang X, 2010, J PROTEOME RES, V9, P2550, DOI 10.1021/pr1000016; Terrat Y, 2012, TOXICON, V59, P34, DOI 10.1016/j.toxicon.2011.10.001; Urbarova I, 2012, MAR DRUGS, V10, P2265, DOI 10.3390/md10102265; Violette A, 2012, J PROTEOMICS, V75, P5215, DOI 10.1016/j.jprot.2012.06.001; Wen SP, 2005, PEPTIDES, V26, P2412, DOI 10.1016/j.peptides.2005.05.012; Wong ESW, 2012, GENE, V496, P1, DOI 10.1016/j.gene.2012.01.009; Xiao XC, 2003, EUR J PHARMACOL, V477, P1, DOI 10.1016/S0014-2999(03)02190-3; Yuan CH, 2007, J PROTEOME RES, V6, P2792, DOI 10.1021/pr0700192; Zelanis A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001554; ZHANG DG, 1993, J PROTEIN CHEM, V12, P735, DOI 10.1007/BF01024931; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003; Zhang PF, 2003, TOXICON, V42, P15, DOI 10.1016/S0041-0101(03)00095-3; Zhang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100682; Zhang YQ, 2010, ZOOLOGY, V113, P10, DOI 10.1016/j.zool.2009.04.001; Zheng Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-453	66	13	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14192	14207		10.1074/jbc.M114.635458	http://dx.doi.org/10.1074/jbc.M114.635458			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25770214	Green Published, hybrid			2022-12-28	WOS:000355313000046
J	Onguka, O; Calzada, E; Ogunbona, OB; Claypool, SM				Onguka, Ouma; Calzada, Elizabeth; Ogunbona, Oluwaseun B.; Claypool, Steven M.			Phosphatidylserine Decarboxylase 1 Autocatalysis and Function Does Not Require a Mitochondrial-specific Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; PHOSPHOLIPID-SYNTHESIS; STRUCTURAL GENE; OUTER-MEMBRANE; INNER MEMBRANE; EMBL-EBI; PHOSPHATIDYLETHANOLAMINE; CARDIOLIPIN; IDENTIFICATION	Phosphatidylethanolamine (PE) is a major cellular phospholipid that can be made by four separate pathways, one of which resides in the mitochondrion. The mitochondrial enzyme that generates PE is phosphatidylserine decarboxylase 1 (Psd1p). The pool of PE produced by Psd1p, which cannot be compensated for by the other cellular PE metabolic pathways, is important for numerous mitochondrial functions, including oxidative phosphorylation and mitochondrial dynamics and morphology, and is essential for murine development. To become catalytically active, Psd1p undergoes an autocatalytic processing step involving a conserved LGST motif that separates the enzyme into alpha and beta subunits that remain non-covalently attached and are anchored to the inner membrane by virtue of the membrane-embedded beta subunit. It was speculated that Psd1p autocatalysis requires a mitochondrial-specific factor and that for Psd1p to function in vivo, it had to be embedded with the correct topology in the mitochondrial inner membrane. However, the identity of the mitochondrial factor required for Psd1p autocatalysis has not been identified. With the goal of defining molecular requirements for Psd1p autocatalysis, we demonstrate that: 1) despite the conservation of the LGST motif from bacteria to humans, only the serine residue is absolutely required for Psd1p autocatalysis and function; 2) yeast Psd1p does not require its substrate phosphatidylserine for autocatalysis; and 3) contrary to a prior report, yeast Psd1p autocatalysis does not require mitochondrial-specific phospholipids, proteins, or co-factors, because Psd1p re-directed to the secretory pathway undergoes autocatalysis normally and is fully functional in vivo.	[Onguka, Ouma; Calzada, Elizabeth; Ogunbona, Oluwaseun B.; Claypool, Steven M.] Johns Hopkins Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Claypool, SM (corresponding author), 725 N Wolfe St, Baltimore, MD 21205 USA.	sclaypo1@jhmi.edu	Ogunbona, Oluwaseun/ABG-1189-2020; Regan, Clinton/E-6250-2012; Ogunbona, Oluwaseun B/J-1039-2017	Ogunbona, Oluwaseun/0000-0001-5116-7204; Ogunbona, Oluwaseun B/0000-0001-5116-7204; Calzada, Elizabeth/0000-0003-1322-7303; Claypool, Steven/0000-0001-5316-1623	National Institutes of Health [R01GM111548]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM111548 (to S. M. C.).	ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733; Baile MG, 2013, MOL BIOL CELL, V24, P2008, DOI 10.1091/mbc.E13-03-0121; Becker T, 2013, J BIOL CHEM, V288, P16451, DOI 10.1074/jbc.M112.442392; Birner R, 2003, MOL BIOL CELL, V14, P370, DOI 10.1091/mbc.E02-05-0263; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Bottinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Choi JY, 2015, J BIOL CHEM, V290, P10972, DOI 10.1074/jbc.M115.642413; Choi JY, 2012, J BIOL CHEM, V287, P222, DOI 10.1074/jbc.M111.313676; Choi JY, 2004, J BIOL CHEM, V279, P42321, DOI 10.1074/jbc.M405074200; Claypool SM, 2002, J BIOL CHEM, V277, P28038, DOI 10.1074/jbc.M202367200; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Claypool SM, 2011, J CELL BIOL, V192, P447, DOI 10.1083/jcb.201008177; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; CUI Z, 1993, J BIOL CHEM, V268, P16655; DOWHAN W, 1974, J BIOL CHEM, V249, P3079; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gulshan K, 2008, MOL CELL BIOL, V28, P5851, DOI 10.1128/MCB.00405-08; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Horvath SE, 2012, J BIOL CHEM, V287, P36744, DOI 10.1074/jbc.M112.398107; HOVIUS R, 1992, J BIOL CHEM, V267, P16790; JOHNSON LM, 1987, CELL, V48, P875, DOI 10.1016/0092-8674(87)90084-5; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; KOHLWEIN SD, 1988, J BACTERIOL, V170, P3778, DOI 10.1128/jb.170.8.3778-3781.1988; Kuge O, 1996, BIOCHEM J, V319, P33, DOI 10.1042/bj3190033; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; LETTS VA, 1983, P NATL ACAD SCI-BIOL, V80, P7279, DOI 10.1073/pnas.80.23.7279; LI QX, 1988, J BIOL CHEM, V263, P11516; LI QX, 1990, J BIOL CHEM, V265, P4111; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; RIEZMAN H, 1983, EMBO J, V2, P1105, DOI 10.1002/j.1460-2075.1983.tb01553.x; SATRE M, 1978, J BIOL CHEM, V253, P479; Schuiki I, 2009, IUBMB LIFE, V61, P151, DOI 10.1002/iub.159; SHIAO YJ, 1995, J BIOL CHEM, V270, P11190, DOI 10.1074/jbc.270.19.11190; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; SUMMERS EF, 1988, GENETICS, V120, P909; Tamura Y, 2012, J BIOL CHEM, V287, P43961, DOI 10.1074/jbc.M112.390997; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WAECHTER CJ, 1973, ARCH BIOCHEM BIOPHYS, V158, P401, DOI 10.1016/0003-9861(73)90637-1; Whited K, 2013, HUM MOL GENET, V22, P483, DOI 10.1093/hmg/dds447; ZBOROWSKI J, 1983, FEBS LETT, V157, P179, DOI 10.1016/0014-5793(83)81141-7; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	56	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12744	12752		10.1074/jbc.M115.641118	http://dx.doi.org/10.1074/jbc.M115.641118			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25829489	Green Published, hybrid			2022-12-28	WOS:000354569000026
J	Ariestanti, DM; Ando, H; Hirose, S; Nakamura, N				Ariestanti, Donna Maretta; Ando, Hikaru; Hirose, Shigehisa; Nakamura, Nobuhiro			Targeted Disruption of Ig-Hepta/Gpr116 Causes Emphysema-like Symptoms That Are Associated with Alveolar Macrophage Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SURFACTANT PROTEIN-D; SMOKE-INDUCED EMPHYSEMA; LUNG INFLAMMATION; REDOX REGULATION; MATRIX METALLOPROTEINASES; NADPH OXIDASE; II CELLS; OXIDATIVE STRESS; GENE-EXPRESSION	Ig-Hepta/GPR116 is a member of the G protein-coupled receptor family predominantly expressed in the alveolar type II epithelial cells of the lung. Previous studies have shown that Ig-Hepta is essential for lung surfactant homeostasis, and loss of its function results in high accumulation of surfactant lipids and proteins in the alveolar space. Ig-Hepta knock-out (Ig-Hepta(-/-) mice also exhibit emphysema-like symptoms, including accumulation of foamy alveolar macrophages (AMs), but its pathogenic mechanism is unknown. Here, we show that the bronchoalveolar lavage fluid obtained from Ig-Hepta(-/-) mice contains high levels of inflammatory mediators, lipid hydroperoxides, and matrix metalloproteinases (MMPs), which are produced by AMs. Accumulation of reactive oxygen species was observed in the AMs of Ig-Hepta(-/-) mice in an age-dependent manner. In addition, nuclear factor-kappa B (NF-kappa B) is activated and translocated into the nuclei of the AMs of Ig-Hepta(-/-) mice. Release of MMP-2 and MMP-9 from the AMs was strongly inhibited by treatment with inhibitors of oxidants and NF-kappa B. We also found that the level of monocyte chemotactic protein-1 is increased in the embryonic lungs of Ig-Hepta(-/-) mice at 18.5 days postcoitum, when AMs are not accumulated and activated. These results suggest that Ig-Hepta plays an important role in regulating macrophage immune responses, and its deficiency leads to local inflammation in the lung, where AMs produce excessive amounts of reactive oxygen species and up-regulate MMPs through the NF-kappa B signaling pathway.	[Ariestanti, Donna Maretta; Ando, Hikaru; Hirose, Shigehisa; Nakamura, Nobuhiro] Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Nakamura, N (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, 4259-B13 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	nnakamur@bio.titech.ac.jp	Nakamura, Nobuhiro/C-4265-2015	Nakamura, Nobuhiro/0000-0002-0249-2665	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan [21026010, 24117707, 22770123]; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid for scientific research 21026010, 24117707, and 22770123 from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan and the Japan Society for the Promotion of Science.	Abe J, 1999, J BIOL CHEM, V274, P19957, DOI 10.1074/jbc.274.28.19957; Amano H, 2004, J IMMUNOL, V172, P398, DOI 10.4049/jimmunol.172.1.398; Andersson S, 1999, LUNG, V177, P179, DOI 10.1007/PL00007639; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baraldo S, 2007, CHEST, V132, P1733, DOI 10.1378/chest.06-2819; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Besnard V, 2010, AM J PHYSIOL-LUNG C, V298, pL646, DOI 10.1152/ajplung.00409.2009; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; Braun OO, 2010, J MOL CELL CARDIOL, V49, P362, DOI 10.1016/j.yjmcc.2010.05.001; Bridges JP, 2013, AM J RESP CELL MOL, V49, P348, DOI 10.1165/rcmb.2012-0439OC; Chakrabarti S, 2005, EXP LUNG RES, V31, P599, DOI 10.1080/019021490944232; Churg A, 2004, AM J RESP CRIT CARE, V170, P492, DOI 10.1164/rccm.200404-511OC; Churg A, 2008, AM J PHYSIOL-LUNG C, V294, pL612, DOI 10.1152/ajplung.00390.2007; Churg A, 2007, THORAX, V62, P706, DOI 10.1136/thx.2006.068353; Corbel M, 2000, BRAZ J MED BIOL RES, V33, P749, DOI 10.1590/S0100-879X2000000700004; Deacu M, 2012, ROM J MORPHOL EMBRYO, V53, P173; DOELMAN CJA, 1990, FREE RADICAL BIO MED, V9, P381, DOI 10.1016/0891-5849(90)90015-B; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Foronjy R, 2008, AM J PHYSIOL-LUNG C, V294, pL1149, DOI 10.1152/ajplung.00481.2007; Fukuzawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069451; GILLIARD N, 1994, J CLIN INVEST, V93, P2608, DOI 10.1172/JCI117273; Glasser SW, 2003, J BIOL CHEM, V278, P14291, DOI 10.1074/jbc.M210909200; Haugen TS, 1999, EUR RESPIR J, V14, P1100, DOI 10.1183/09031936.99.14511009; Hirama N, 2007, RESPIROLOGY, V12, P191, DOI 10.1111/j.1440-1843.2006.01009.x; Ikegami M, 2000, AM J PHYSIOL-LUNG C, V279, pL468, DOI 10.1152/ajplung.2000.279.3.L468; Kannan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004891; Kim MJ, 2013, TOXICOL APPL PHARM, V273, P77, DOI 10.1016/j.taap.2013.08.005; KINNULA VL, 1991, AM J PHYSIOL, V261, pL84, DOI 10.1152/ajplung.1991.261.2.L84; Kruse R, 2014, PURINERG SIGNAL, V10, P499, DOI 10.1007/s11302-014-9414-7; Lavigne MC, 2005, BIOCHEM BIOPH RES CO, V330, P194, DOI 10.1016/j.bbrc.2005.02.144; Lee SJ, 2007, FEBS LETT, V581, P4189, DOI 10.1016/j.febslet.2007.07.058; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Loffek S, 2011, EUR RESPIR J, V38, P191, DOI 10.1183/09031936.00146510; MACKAY AR, 1990, J BIOL CHEM, V265, P21929; Maguire JA, 2011, AM J RESP CELL MOL, V44, P404, DOI 10.1165/rcmb.2009-0382OC; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mechri M, 2010, PEDIATR PULM, V45, P1021, DOI 10.1002/ppul.21289; Molet S, 2005, INFLAMM RES, V54, P31, DOI 10.1007/s00011-004-1319-4; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Muller B, 1998, EUR J CLIN INVEST, V28, P762; Munaut C, 1999, J BIOL CHEM, V274, P5588, DOI 10.1074/jbc.274.9.5588; Ohnishi K, 1998, LAB INVEST, V78, P1077; Perez-Rial S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072975; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; ROONEY SA, 1994, FASEB J, V8, P957, DOI 10.1096/fasebj.8.12.8088461; Schuchardt M, 2011, J MOL MED, V89, P799, DOI 10.1007/s00109-011-0750-6; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Shapiro SD, 2002, BIOCHEM SOC T, V30, P98, DOI 10.1042/BST0300098; Stokes L, 2007, J IMMUNOL, V179, P6016, DOI 10.4049/jimmunol.179.9.6016; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; van Zoelen MAD, 2011, MOL IMMUNOL, V48, P1468, DOI 10.1016/j.molimm.2011.04.001; Vernooy JHJ, 2004, CHEST, V126, P1802, DOI 10.1378/chest.126.6.1802; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wert SE, 2000, P NATL ACAD SCI USA, V97, P5972, DOI 10.1073/pnas.100448997; Wright JL, 2007, AM J PHYSIOL-LUNG C, V292, pL125, DOI 10.1152/ajplung.00539.2005; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Yang MY, 2013, CELL REP, V3, P1457, DOI 10.1016/j.celrep.2013.04.019; Yao H, 2007, BIOCHEM SOC T, V35, P1151, DOI 10.1042/BST0351151; Yao HW, 2008, AM J PATHOL, V172, P1222, DOI 10.2353/ajpath.2008.070765; Yoshida M, 2001, J IMMUNOL, V166, P7514, DOI 10.4049/jimmunol.166.12.7514	63	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11032	11040		10.1074/jbc.M115.648311	http://dx.doi.org/10.1074/jbc.M115.648311			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25778400	Green Published, hybrid			2022-12-28	WOS:000353404500039
J	Burkinshaw, BJ; Deng, WY; Lameignere, E; Wasney, GA; Zhu, HZ; Worrall, LJ; Finlay, BB; Strynadka, NCJ				Burkinshaw, Brianne J.; Deng, Wanyin; Lameignere, Emilie; Wasney, Gregory A.; Zhu, Haizhong; Worrall, Liam J.; Finlay, B. Brett; Strynadka, Natalie C. J.			Structural Analysis of a Specialized Type III Secretion System Peptidoglycan-cleaving Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Cell Wall; Peptidoglycan; Type III Secretion System (T3SS); X-ray Crystallography	ENTEROPATHOGENIC ESCHERICHIA-COLI; LYTIC TRANSGLYCOSYLASES; MACROMOLECULAR STRUCTURES; PROTEIN CRYSTALLIZATION; NEEDLE COMPLEX; FLGJ; TRANSLOCATION; LOCUS; CELLS; RESOLUTION	Background: Bacterial virulence-associated type III secretion system (T3SS) assembly requires a dedicated enzyme to penetrate peptidoglycan (PG). Results: We structurally characterized a T3SS PG-lytic enzyme, identified catalytically important residues, and characterized its activity. Conclusion: The active site is similar to lysozymes and lytic transglycosylases and interaction with the T3SS enhances activity. Significance: Structural information is critical for development of drugs targeting T3SS PG-lytic enzymes. The Gram-negative bacterium enteropathogenic Escherichia coli uses a syringe-like type III secretion system (T3SS) to inject virulence or effector proteins into the cytoplasm of host intestinal epithelial cells. To assemble, the T3SS must traverse both bacterial membranes, as well as the peptidoglycan layer. Peptidoglycan is made of repeating N-acetylmuramic acid and N-acetylglucosamine disaccharides cross-linked by pentapeptides to form a tight mesh barrier. Assembly of many macromolecular machines requires a dedicated peptidoglycan lytic enzyme (PG-lytic enzyme) to locally clear peptidoglycan. Here we have solved the first structure of a T3SS-associated PG-lytic enzyme, EtgA from enteropathogenic E. coli. Unexpectedly, the active site of EtgA has features in common with both lytic transglycosylases and hen egg white lysozyme. Most notably, the -hairpin region resembles that of lysozyme and contains an aspartate that aligns with lysozyme Asp-52 (a residue critical for catalysis), a conservation not observed in other previously characterized lytic transglycosylase families to which the conserved T3SS enzymes had been presumed to belong. Mutation of the EtgA catalytic glutamate, Glu-42, conserved across lytic transglycosylases and hen egg white lysozyme, and this differentiating aspartate diminishes type III secretion in vivo, supporting its essential role in clearing the peptidoglycan for T3SS assembly. Finally, we show that EtgA forms a 1:1 complex with the building block of the polymerized T3SS inner rod component, EscI, and that this interaction enhances PG-lytic activity of EtgA in vitro, collectively providing the necessary strict localization and regulation of the lytic activity to prevent overall cell lysis.	[Burkinshaw, Brianne J.; Lameignere, Emilie; Wasney, Gregory A.; Zhu, Haizhong; Worrall, Liam J.; Finlay, B. Brett; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Burkinshaw, Brianne J.; Lameignere, Emilie; Wasney, Gregory A.; Zhu, Haizhong; Worrall, Liam J.; Finlay, B. Brett; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Deng, Wanyin; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z3, Canada; [Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	ncjs@mail.ubc.ca			CIHR; HHMI International Scholar program; University of British Columbia Centre for Blood Research graduate student fellowship; Cystic Fibrosis Canada Fellowship	CIHR(Canadian Institutes of Health Research (CIHR)); HHMI International Scholar program; University of British Columbia Centre for Blood Research graduate student fellowship; Cystic Fibrosis Canada Fellowship	This work was funded by CIHR operating grants to NCJS and BBF and operating funding from the HHMI International Scholar program to NCJS.; Supported by a University of British Columbia Centre for Blood Research graduate student fellowship.; Supported by a Cystic Fibrosis Canada Fellowship.	Abby SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002983; ALLAOUI A, 1993, INFECT IMMUN, V61, P1707, DOI 10.1128/IAI.61.5.1707-1714.1993; Baron Christian, 2007, Infectious Disorders - Drug Targets, V7, P19, DOI 10.2174/187152607780090685; Blackburn NT, 2002, BIOCHEMISTRY-US, V41, P1001, DOI 10.1021/bi011833k; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Creasey EA, 2003, MICROBIOL-SGM, V149, P2093, DOI 10.1099/mic.0.26355-0; Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x; Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Dijkstra AJ, 1996, J BACTERIOL, V178, P5555, DOI 10.1128/jb.178.19.5555-5562.1996; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia-Gomez E, 2011, MICROBIOL-SGM, V157, P1145, DOI 10.1099/mic.0.045617-0; Hashimoto W, 2009, BIOCHEM BIOPH RES CO, V381, P16, DOI 10.1016/j.bbrc.2009.01.186; Herlihey FA, 2014, J BIOL CHEM, V289, P31029, DOI 10.1074/jbc.M114.603944; Hirano T, 2001, J MOL BIOL, V312, P359, DOI 10.1006/jmbi.2001.4963; Hoppner C, 2005, MICROBIOL-SGM, V151, P3469, DOI 10.1099/mic.0.28326-0; Ide T, 2001, CELL MICROBIOL, V3, P669, DOI 10.1046/j.1462-5822.2001.00146.x; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166; Koraimann G, 2003, CELL MOL LIFE SCI, V60, P2371, DOI 10.1007/s00018-003-3056-1; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nambu T, 1999, J BACTERIOL, V181, P1555, DOI 10.1128/JB.181.5.1555-1561.1999; Oh HS, 2007, J BACTERIOL, V189, P8277, DOI 10.1128/JB.00998-07; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pucciarelli MG, 2003, MOL MICROBIOL, V48, P573, DOI 10.1046/j.1365-2958.2003.03469.x; Rosenshine I, 1996, EMBO J, V15, P2613, DOI 10.1002/j.1460-2075.1996.tb00621.x; Roure S, 2012, MOL MICROBIOL, V86, P845, DOI 10.1111/mmi.12019; Sal-Man N, 2012, BIOCHEM J, V442, P119, DOI 10.1042/BJ20111620; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Scheurwater EM, 2011, FEMS MICROBIOL LETT, V318, P1, DOI 10.1111/j.1574-6968.2011.02228.x; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; STRYNADKA NCJ, 1991, J MOL BIOL, V220, P401, DOI 10.1016/0022-2836(91)90021-W; TAYLOR CJ, 1986, J PEDIATR GASTR NUTR, V5, P70, DOI 10.1097/00005176-198601000-00013; THUNNISSEN AMWH, 1994, NATURE, V367, P750, DOI 10.1038/367750a0; THUNNISSEN AMWH, 1995, BIOCHEMISTRY-US, V34, P12729, DOI 10.1021/bi00039a032; Uehara T, 2005, J BACTERIOL, V187, P3643, DOI 10.1128/JB.187.11.3643-3649.2005; van Asselt EJ, 1999, J MOL BIOL, V291, P877, DOI 10.1006/jmbi.1999.3013; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang YA, 2006, STRUCTURE, V14, P1189, DOI 10.1016/j.str.2006.05.018; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554; Yip CK, 2005, NAT STRUCT MOL BIOL, V12, P75, DOI 10.1038/nsmb879; Yu YC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-52; Zahrl D, 2005, MICROBIOL-SGM, V151, P3455, DOI 10.1099/mic.0.28141-0; Zhong DL, 2012, J BIOL CHEM, V287, P25303, DOI 10.1074/jbc.M112.381574	59	31	32	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10406	10417		10.1074/jbc.M115.639013	http://dx.doi.org/10.1074/jbc.M115.639013			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25678709	Green Published, hybrid			2022-12-28	WOS:000353241100041
J	Singh, D; Gawel, D; Itsko, M; Hochkoeppler, A; Krahn, JM; London, RE; Schaaper, RM				Singh, Deepa; Gawel, Damian; Itsko, Mark; Hochkoeppler, Alejandro; Krahn, Juno M.; London, Robert E.; Schaaper, Roel M.			Structure of Escherichia coli dGTP Triphosphohydrolase A HEXAMERIC ENZYME WITH DNA EFFECTOR MOLECULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Cooperativity; Crystal Structure; DNA-binding Protein; Escherichia coli (E; coli); dGTPase; Mutator Phenotype	DEOXYGUANOSINE TRIPHOSPHATE TRIPHOSPHOHYDROLASE; RESTRICTION FACTOR SAMHD1; GENE 1.2 PROTEIN; DNTP TRIPHOSPHOHYDROLASE; ALLOSTERIC ACTIVATION; INHIBITION; INSIGHT; SYSTEM; GROWTH; DOMAIN	Background: The Escherichia coli Dgt enzyme hydrolyzes the important DNA building block dGTP, but the cellular role of this activity is still unclear. Results: The enzyme is shown to be a hexameric structure containing regulatory DNA molecules. Conclusion: DNA mediates the regulation of dGTPase activity in the cell. Significance: This is the first demonstration of regulation of dNTPase by DNA. The Escherichia coli dgt gene encodes a dGTP triphosphohydrolase whose detailed role still remains to be determined. Deletion of dgt creates a mutator phenotype, indicating that the dGTPase has a fidelity role, possibly by affecting the cellular dNTP pool. In the present study, we have investigated the structure of the Dgt protein at 3.1- resolution. One of the obtained structures revealed a protein hexamer that contained two molecules of single-stranded DNA. The presence of DNA caused significant conformational changes in the enzyme, including in the catalytic site of the enzyme. Dgt preparations lacking DNA were able to bind single-stranded DNA with high affinity (K-d approximate to 50 nm). DNA binding positively affected the activity of the enzyme: dGTPase activity displayed sigmoidal (cooperative) behavior without DNA but hyperbolic (Michaelis-Menten) kinetics in its presence, consistent with a specific lowering of the apparent K-m for dGTP. A mutant Dgt enzyme was also created containing residue changes in the DNA binding cleft. This mutant enzyme, whereas still active, was incapable of DNA binding and could no longer be stimulated by addition of DNA. We also created an E. coli strain containing the mutant dgt gene on the chromosome replacing the wild-type gene. The mutant also displayed a mutator phenotype. Our results provide insight into the allosteric regulation of the enzyme and support a physiologically important role of DNA binding.	[Singh, Deepa; Itsko, Mark; Krahn, Juno M.; London, Robert E.; Schaaper, Roel M.] NIEHS, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Gawel, Damian] Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, PL-01813 Warsaw, Poland; [Hochkoeppler, Alejandro] Univ Bologna, Dept Ind Chem, I-40136 Bologna, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Centre of Postgraduate Medical Education - Poland; University of Bologna	Schaaper, RM (corresponding author), POB 12233, Res Triangle Pk, NC 27709 USA.	schaaper@niehs.nih.gov	Schaaper, Roel M/E-6680-2019; Gawel, Damian/U-4218-2019; London, Robert E/F-7990-2019; Hochkoeppler, Alejandro/HGA-5916-2022	Schaaper, Roel M/0000-0003-1344-3196; Gawel, Damian/0000-0002-1270-5505; London, Robert E/0000-0001-9108-8463; 	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101905, ZIAES101905] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Drs. K. Bebenek and L. Pedersen, NIEHS, for helpful comments on the manuscript. Crystallographic data were collected at the Southeast Regional Collaborative Access Team 22-ID beam line at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amie SM, 2013, J BIOL CHEM, V288, P25001, DOI 10.1074/jbc.C113.493619; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; BEAUCHAMP BB, 1988, P NATL ACAD SCI USA, V85, P2563, DOI 10.1073/pnas.85.8.2563; Benson RW, 2011, J MICROBIOL METH, V84, P479, DOI 10.1016/j.mimet.2010.12.020; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COHEN SS, 1954, P NATL ACAD SCI USA, V40, P885, DOI 10.1073/pnas.40.10.885; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Gawel D, 2008, J BACTERIOL, V190, P6931, DOI 10.1128/JB.00935-08; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; HUBER HE, 1988, J BIOL CHEM, V263, P13549; Itsko M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004310; Itsko M, 2011, MOL MICROBIOL, V81, P1221, DOI 10.1111/j.1365-2958.2011.07756.x; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kleywegt GJ, 1997, STRUCTURE, V5, P1557, DOI 10.1016/S0969-2126(97)00305-5; Kondo N, 2004, J BIOCHEM, V136, P221, DOI 10.1093/jb/mvh115; Kondo N, 2007, ACTA CRYSTALLOGR D, V63, P230, DOI 10.1107/S0907444906049262; KORNBERG SR, 1958, J BIOL CHEM, V233, P159; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Mega R, 2009, FEBS J, V276, P3211, DOI 10.1111/j.1742-4658.2009.07035.x; MYERS JA, 1987, J BIOL CHEM, V262, P5288; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; QUIRK S, 1989, MOL MICROBIOL, V3, P1391, DOI 10.1111/j.1365-2958.1989.tb00121.x; QUIRK S, 1990, GENE, V89, P13, DOI 10.1016/0378-1119(90)90200-B; SAITO H, 1981, J VIROL, V37, P343, DOI 10.1128/JVI.37.1.343-351.1981; SETO D, 1988, J BIOL CHEM, V263, P1494; Tungler V, 2013, J MOL MED, V91, P759, DOI 10.1007/s00109-013-0995-3; Vorontsov II, 2014, J BIOL CHEM, V289, P2815, DOI 10.1074/jbc.M113.524207; Vorontsov II, 2011, J BIOL CHEM, V286, P33158, DOI 10.1074/jbc.M111.250456; WILLIAMS KR, 1983, J BIOL CHEM, V258, P3346; WURGLER SM, 1993, J BIOL CHEM, V268, P20046; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	40	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10418	10429		10.1074/jbc.M115.636936	http://dx.doi.org/10.1074/jbc.M115.636936			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25694425	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000353241100042
J	Vanacloig-Pedros, E; Bets-Plasencia, C; Pascual-Ahuir, A; Proft, M				Vanacloig-Pedros, Elena; Bets-Plasencia, Carolina; Pascual-Ahuir, Amparo; Proft, Markus			Coordinated Gene Regulation in the Initial Phase of Salt Stress Adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Expression; Glycerol; Saccharomyces cerevisiae; Stress Response; Transcription Regulation; Vacuolar ATPase; Hog1; Osmotic Stress	VACUOLAR H+-ATPASE; RNA POL-II; SACCHAROMYCES-CEREVISIAE; OSMOTIC-STRESS; MAP KINASE; 2 ISOENZYMES; HOG PATHWAY; EXPRESSION; YEAST; GLYCEROL	Stress triggers complex transcriptional responses, which include both gene activation and repression. We used time-resolved reporter assays in living yeast cells to gain insights into the coordination of positive and negative control of gene expression upon salt stress. We found that the repression of housekeeping genes coincides with the transient activation of defense genes and that the timing of this expression pattern depends on the severity of the stress. Moreover, we identified mutants that caused an alteration in the kinetics of this transcriptional control. Loss of function of the vacuolar H+-ATPase (vma1) or a defect in the biosynthesis of the osmolyte glycerol (gpd1) caused a prolonged repression of housekeeping genes and a delay in gene activation at inducible loci. Both mutants have a defect in the relocation of RNA polymerase II complexes at stress defense genes. Accordingly salt-activated transcription is delayed and less efficient upon partially respiratory growth conditions in which glycerol production is significantly reduced. Furthermore, the loss of Hog1 MAP kinase function aggravates the loss of RNA polymerase II from housekeeping loci, which apparently do not accumulate at inducible genes. Additionally the Def1 RNA polymerase II degradation factor, but not a high pool of nuclear polymerase II complexes, is needed for efficient stress-induced gene activation. The data presented here indicate that the finely tuned transcriptional control upon salt stress is dependent on physiological functions of the cell, such as the intracellular ion balance, the protective accumulation of osmolyte molecules, and the RNA polymerase II turnover.	[Proft, Markus] Univ Politecn Valencia, Dept Mech Plant Stress Responses, Consejo Super Invest Cient, Valencia 46022, Spain; [Vanacloig-Pedros, Elena; Bets-Plasencia, Carolina; Pascual-Ahuir, Amparo] Univ Politecn Valencia, Dept Biotechnol, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Pascual-Ahuir, A (corresponding author), Univ Politecn Valencia, Dept Biotechnol, Inst Biol Mol & Celular Plantas, Ingeniero Fausto Elio S-N, Valencia 46022, Spain.	apascual@ibmcp.upv.es; mproft@ibmcp.upv.es	Pascual-ahuir, Amparo/K-1338-2014; Proft, Markus/K-2323-2014	Proft, Markus/0000-0002-6788-5830; PASCUAL-AHUIR, AMPARO/0000-0001-6173-1526	Ministerio de Economia y Competitividad [BFU2011-23326]	Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by Ministerio de Economia y Competitividad Grant BFU2011-23326 (to M. P.).	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; Arino J, 2014, ADV MICROB PHYSIOL, V64, P1, DOI 10.1016/B978-0-12-800143-1.00001-4; Babazadeh R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080901; Berry DB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002353; Bouwman J, 2011, YEAST, V28, P43, DOI 10.1002/yea.1819; Cook KE, 2012, G3-GENES GENOM GENET, V2, P1129, DOI 10.1534/g3.112.003251; Czeko E, 2011, MOL CELL, V42, P261, DOI 10.1016/j.molcel.2011.02.033; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Dihazi H, 2004, J BIOL CHEM, V279, P23961, DOI 10.1074/jbc.M312974200; Dolz-Edo L, 2013, MOL CELL BIOL, V33, P2228, DOI 10.1128/MCB.00240-13; Esberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020829; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Guan QN, 2012, GENETICS, V192, P495, DOI 10.1534/genetics.112.143016; Hamilton CA, 2002, FEMS MICROBIOL LETT, V208, P227, DOI 10.1111/j.1574-6968.2002.tb11086.x; Hohmann S, 2002, INT REV CYTOL, V215, P149; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Hohmann S, 2009, FEBS LETT, V583, P4025, DOI 10.1016/j.febslet.2009.10.069; Kellermayer R, 2003, J CELL SCI, V116, P1637, DOI 10.1242/jcs.00372; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Li SC, 2012, EUKARYOT CELL, V11, P282, DOI 10.1128/EC.05198-11; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Martinez-Montanes F, 2010, OMICS, V14, P619, DOI 10.1089/omi.2010.0046; Miermont A, 2013, P NATL ACAD SCI USA, V110, P5725, DOI 10.1073/pnas.1215367110; Nadal-Ribelles M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r106; Norbeck J, 1996, J BIOL CHEM, V271, P13875, DOI 10.1074/jbc.271.23.13875; Ostergaard S, 2000, NAT BIOTECHNOL, V18, P1283, DOI 10.1038/82400; Petelenz-Kurdziel E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003084; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Proft M, 1999, MOL CELL BIOL, V19, P537; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Rep M, 1999, MICROBIOL-UK, V145, P715, DOI 10.1099/13500872-145-3-715; Rep M, 1999, MOL CELL BIOL, V19, P5474; Rienzo A, 2012, YEAST, V29, P219, DOI 10.1002/yea.2905; Rios G, 1997, YEAST, V13, P515, DOI 10.1002/(SICI)1097-0061(199705)13:6<515::AID-YEA102>3.0.CO;2-X; Ruiz-Roig C, 2012, MOL BIOL CELL, V23, P4286, DOI 10.1091/mbc.E12-04-0289; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Van Wuytswinkel O, 2000, MOL MICROBIOL, V37, P382, DOI 10.1046/j.1365-2958.2000.02002.x; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Wilson MD, 2013, CELL, V154, P983, DOI 10.1016/j.cell.2013.07.028; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a	49	19	19	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10163	10175		10.1074/jbc.M115.637264	http://dx.doi.org/10.1074/jbc.M115.637264			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25745106	Green Published, hybrid			2022-12-28	WOS:000353241100023
J	Zhang, YX; Diao, JJ; Colbert, KN; Lai, Y; Pfuetzner, RA; Padolina, MS; Vivona, S; Ressl, S; Cipriano, DJ; Choi, UB; Shah, N; Weis, WI; Brunger, AT				Zhang, Yunxiang; Diao, Jiajie; Colbert, Karen N.; Lai, Ying; Pfuetzner, Richard A.; Padolina, Mark S.; Vivona, Sandro; Ressl, Susanne; Cipriano, Daniel J.; Choi, Ucheor B.; Shah, Niket; Weis, William I.; Brunger, Axel T.			Munc18a Does Not Alter Fusion Rates Mediated by Neuronal SNAREs, Synaptotagmin, and Complexin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Exocytosis; Membrane Fusion; Neurotransmitter Release; SNARE Proteins; Synaptotagmin; Munc18; Single Vesicle Assay; Complexin; Fusion Machinery; Synaptic Vesicle	PROTEIN-KINASE-C; MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; CLOSED CONFORMATION; ESCHERICHIA-COLI; VESICLE DOCKING; SINGLE-MOLECULE; N-PEPTIDE; IN-VITRO; PHOSPHORYLATION	Sec1/Munc18 (SM) proteins are essential for membrane trafficking, but their molecular mechanism remains unclear. Using a single vesicle-vesicle content-mixing assay with reconstituted neuronal SNAREs, synaptotagmin-1, and complexin-1, we show that the neuronal SM protein Munc18a/nSec1 has no effect on the intrinsic kinetics of both spontaneous fusion and Ca2+-triggered fusion between vesicles that mimic synaptic vesicles and the plasma membrane. However, wild type Munc18a reduced vesicle association approximate to 50% when the vesicles bearing the t-SNAREs syntaxin-1A and SNAP-25 were preincubated with Munc18 for 30 min. Single molecule experiments with labeled SNAP-25 indicate that the reduction of vesicle association is a consequence of sequestration of syntaxin-1A by Munc18a and subsequent release of SNAP-25 (i.e. Munc18a captures syntaxin-1A via its high affinity interaction). Moreover, a phosphorylation mimic mutant of Munc18a with reduced affinity to syntaxin-1A results in less reduction of vesicle association. In summary, Munc18a does not directly affect fusion, although it has an effect on the t-SNARE complex, depending on the presence of other factors and experimental conditions. Our results suggest that Munc18a primarily acts at the prefusion stage.	[Zhang, Yunxiang; Diao, Jiajie; Colbert, Karen N.; Lai, Ying; Pfuetzner, Richard A.; Padolina, Mark S.; Vivona, Sandro; Ressl, Susanne; Cipriano, Daniel J.; Choi, Ucheor B.; Weis, William I.; Brunger, Axel T.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Zhang, Yunxiang; Diao, Jiajie; Lai, Ying; Pfuetzner, Richard A.; Padolina, Mark S.; Vivona, Sandro; Ressl, Susanne; Cipriano, Daniel J.; Choi, Ucheor B.; Brunger, Axel T.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Zhang, Yunxiang; Diao, Jiajie; Colbert, Karen N.; Lai, Ying; Pfuetzner, Richard A.; Padolina, Mark S.; Vivona, Sandro; Ressl, Susanne; Cipriano, Daniel J.; Choi, Ucheor B.; Shah, Niket; Weis, William I.; Brunger, Axel T.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Zhang, Yunxiang; Diao, Jiajie; Lai, Ying; Pfuetzner, Richard A.; Padolina, Mark S.; Vivona, Sandro; Ressl, Susanne; Cipriano, Daniel J.; Choi, Ucheor B.; Weis, William I.; Brunger, Axel T.] Stanford Univ, Dept Photon Sci, Stanford, CA 94305 USA; [Diao, Jiajie; Pfuetzner, Richard A.; Padolina, Mark S.; Cipriano, Daniel J.; Choi, Ucheor B.; Brunger, Axel T.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Weis, WI (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	bill.weis@stanford.edu; axel.brunger@stanford.edu	Weis, William I/G-1437-2011; Ressl, Susanne/AAT-2517-2021; Lai, Ying/E-5220-2015; Diao, Jiajie/A-3425-2008	Weis, William I/0000-0002-5583-6150; Lai, Ying/0000-0001-5347-5155; Diao, Jiajie/0000-0003-4288-3203; Brunger, Axel/0000-0001-5121-2036; Zhang, Yunxiang/0000-0002-6635-6443	National Institutes of Health [R37 MH63105, R01 MH58570]; National Science Foundation; Otto-Hahn Fellowship of the Max-Planck Society, Germany; Canadian Institutes of Health Research Postdoctoral Fellowship; Stanford University Dean's Postdoctoral Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058570, R37MH063105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Otto-Hahn Fellowship of the Max-Planck Society, Germany; Canadian Institutes of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Stanford University Dean's Postdoctoral Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 MH63105 (to A. T. B.) and R01 MH58570 (to W. I. W.).; Supported by a fellowship from the National Science Foundation and a Biophysics Training Grant from the National Institutes of Health.; Supported by the Otto-Hahn Fellowship of the Max-Planck Society, Germany.; Supported by a Canadian Institutes of Health Research Postdoctoral Fellowship and the Stanford University Dean's Postdoctoral Fellowship.	Barclay JW, 2008, BIOPHYS J, V94, P1084, DOI 10.1529/biophysj.107.111203; Bouwman J, 2006, J NEUROCHEM, V99, P84, DOI 10.1111/j.1471-4159.2006.04041.x; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Chen XC, 2008, J BIOMOL NMR, V41, P43, DOI 10.1007/s10858-008-9239-1; Choi UB, 2010, NAT STRUCT MOL BIOL, V17, P318, DOI 10.1038/nsmb.1763; Colbert KN, 2013, P NATL ACAD SCI USA, V110, P12637, DOI 10.1073/pnas.1303753110; Cypionka A, 2009, P NATL ACAD SCI USA, V106, P18575, DOI 10.1073/pnas.0906677106; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Diao JJ, 2013, J AM CHEM SOC, V135, P15274, DOI 10.1021/ja407392n; Diao JJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00592; Diao JJ, 2013, BIOESSAYS, V35, P658, DOI 10.1002/bies.201300010; Diao JJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00109; Diao JJ, 2012, NAT PROTOC, V7, P921, DOI 10.1038/nprot.2012.020; Diao JJ, 2010, ACS CHEM NEUROSCI, V1, P168, DOI 10.1021/cn900034p; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Edwards MR, 2012, J NEUROSCI, V32, P7042, DOI 10.1523/JNEUROSCI.4029-11.2012; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Genc O, 2014, ELIFE, V3, DOI 10.7554/eLife.01715; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Honigmann A, 2013, NAT STRUCT MOL BIOL, V20, P679, DOI 10.1038/nsmb.2570; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Kim JY, 2012, EMBO J, V31, P2144, DOI 10.1038/emboj.2012.57; Kummel D, 2011, NAT STRUCT MOL BIOL, V18, P927, DOI 10.1038/nsmb.2101; Kyoung MJ, 2013, NAT PROTOC, V8, P1, DOI 10.1038/nprot.2012.134; Kyoung M, 2011, P NATL ACAD SCI USA, V108, pE304, DOI 10.1073/pnas.1107900108; Lai Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03756; Li F, 2011, NAT STRUCT MOL BIOL, V18, P941, DOI 10.1038/nsmb.2102; Lobingier BT, 2014, ELIFE, V3, DOI 10.7554/eLife.02272; Lou XC, 2015, J BIOL CHEM, V290, P10535, DOI 10.1074/jbc.M114.631341; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Meijer M, 2012, EMBO J, V31, P2156, DOI 10.1038/emboj.2012.72; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Nili U, 2006, NEUROSCIENCE, V143, P487, DOI 10.1016/j.neuroscience.2006.08.014; Parisotto D, 2014, J BIOL CHEM, V289, P9639, DOI 10.1074/jbc.M113.514273; Pertsinidis A, 2013, P NATL ACAD SCI USA, V110, pE2812, DOI 10.1073/pnas.1310654110; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Rodkey TL, 2008, MOL BIOL CELL, V19, P5422, DOI 10.1091/mbc.E08-05-0538; Rowe J, 1999, J CELL SCI, V112, P1865; Scott BL, 2004, J CELL BIOL, V167, P75, DOI 10.1083/jcb.200405018; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sudhof TC, 2014, ANGEW CHEM INT EDIT, V53, P12696, DOI 10.1002/anie.201406359; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Toonen RFG, 2005, J NEUROCHEM, V93, P1393, DOI 10.1111/j.1471-4159.2005.03128.x; Trimbuch T, 2014, ELIFE, V3, DOI 10.7554/eLife.02391; Vennekate W, 2012, P NATL ACAD SCI USA, V109, P11037, DOI 10.1073/pnas.1116326109; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weninger K, 2003, P NATL ACAD SCI USA, V100, P14800, DOI 10.1073/pnas.2036428100; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Wierda KDB, 2007, NEURON, V54, P275, DOI 10.1016/j.neuron.2007.04.001; Xu H, 2011, P NATL ACAD SCI USA, V108, P17325, DOI 10.1073/pnas.1113888108; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247; Zhou P, 2013, EMBO J, V32, P159, DOI 10.1038/emboj.2012.307; Zick M, 2014, ELIFE, V3, DOI 10.7554/eLife.03251; Zick M, 2014, ELIFE, V3, DOI 10.7554/eLife.01879; Zick M, 2013, MOL BIOL CELL, V24, P3746, DOI 10.1091/mbc.E13-07-0419; Zorman S, 2014, ELIFE, V3, DOI 10.7554/eLife.03348	71	15	15	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10518	10534		10.1074/jbc.M114.630772	http://dx.doi.org/10.1074/jbc.M114.630772			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25716318	Green Published, hybrid			2022-12-28	WOS:000353241100050
J	Truttmann, MC; Wu, Q; Stiegeler, S; Duarte, JN; Ingram, J; Ploegh, HL				Truttmann, Matthias C.; Wu, Qin; Stiegeler, Sarah; Duarte, Joao N.; Ingram, Jessica; Ploegh, Hidde L.			HypE-specific Nanobodies as Tools to Modulate HypE-mediated Target AMPylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIC DOMAIN; POSTTRANSLATIONAL MODIFICATION; ADP-RIBOSYLATION; PROTEIN; ADENYLYLATION; OPTIMIZATION; TRANSFERASE; SUBSTRATE; MECHANISM; REVEALS	The covalent addition of mono-AMP to target proteins (AMPylation) by Fic domain-containing proteins is a poorly understood, yet highly conserved post-translational modification. Here, we describe the generation, evaluation, and application of four HypE-specific nanobodies: three that inhibit HypE-mediated target AMPylation in vitro and one that acts as an activator. All heavy chain-only antibody variable domains bind HypE when expressed as GFP fusions in intact cells. We observed localization of HypE at the nuclear envelope and further identified histones H2-H4, but not H1, as novel in vitro targets of the human Fic protein. Its role in histone modification provides a possible link between AMPylation and regulation of gene expression.	[Truttmann, Matthias C.; Wu, Qin; Stiegeler, Sarah; Duarte, Joao N.; Ingram, Jessica; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Ploegh, Hidde L.] MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu	truttmann, matthias/ABC-2727-2021; Duarte, Joao N/T-3839-2017	truttmann, matthias/0000-0002-0536-7923; Duarte, Joao N/0000-0002-4173-484X; Stiegeler, Sarah/0000-0001-9622-7629	Swiss National Science Foundation; Champalimaud Foundation; Portuguese Science and Technology Foundation; Portuguese Ministry of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM106409] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Champalimaud Foundation; Portuguese Science and Technology Foundation(Portuguese Foundation for Science and Technology); Portuguese Ministry of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Recipient of an Early Postdoc. Mobility fellowship from the Swiss National Science Foundation.; Calouste Gulbenkian Foundation Scholar. Supported by the Champalimaud Foundation, the Portuguese Science and Technology Foundation, and the Portuguese Ministry of Health.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BOULIKAS T, 1989, P NATL ACAD SCI USA, V86, P3499, DOI 10.1073/pnas.86.10.3499; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; Bunney T. D., 2014, STRUCTURE, V1016; BURZIO LO, 1979, J BIOL CHEM, V254, P3029; Campanacci V, 2013, EMBO J, V32, P1469, DOI 10.1038/emboj.2013.82; Castro-Roa D, 2013, NAT CHEM BIOL, V9, P811, DOI [10.1038/NCHEMBIO.1364, 10.1038/nchembio.1364]; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; CHOCK PB, 1980, ANNU REV BIOCHEM, V49, P813, DOI 10.1146/annurev.bi.49.070180.004121; Coffinier C, 2010, J BIOL CHEM, V285, P20818, DOI 10.1074/jbc.M110.128835; Cruz JW, 2014, J BIOL CHEM, V289, P7788, DOI 10.1074/jbc.M113.544429; Dougan SK, 2013, NATURE, V503, P406, DOI 10.1038/nature12637; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Gonzalez JM, 2011, BIOCHEM SOC T, V39, P1758, DOI 10.1042/BST20110653; Ham H, 2014, J BIOL CHEM, V289, P36059, DOI 10.1074/jbc.M114.612515; Hao YH, 2011, J BIOTECHNOL, V151, P251, DOI 10.1016/j.jbiotec.2010.12.013; Harmsen MM, 2006, APPL MICROBIOL BIOT, V72, P544, DOI 10.1007/s00253-005-0300-7; Itzen A, 2011, TRENDS BIOCHEM SCI, V36, P219, DOI 10.1016/j.tibs.2010.12.004; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Leavy O, 2010, NAT REV IMMUNOL, V10, P297, DOI 10.1038/nri2763; Lewallen DM, 2014, ACS CHEM BIOL, V9, P433, DOI 10.1021/cb4006886; Lin S, 2012, METHOD ENZYMOL, V512, P3, DOI 10.1016/B978-0-12-391940-3.00001-9; Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884; Mattoo S, 2011, J BIOL CHEM, V286, P32834, DOI 10.1074/jbc.M111.227603; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mishra N, 2012, J THROMB HAEMOST, V10, P1091, DOI 10.1111/j.1538-7836.2012.04738.x; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; O'Shea JJ, 2013, NEW ENGL J MED, V368, P161, DOI 10.1056/NEJMra1202117; Palanivelu DV, 2011, PROTEIN SCI, V20, P492, DOI 10.1002/pro.581; Rahman M, 2012, NAT NEUROSCI, V15, P871, DOI 10.1038/nn.3102; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Sanyal A, 2015, J BIOL CHEM, V290, P8482, DOI 10.1074/jbc.M114.618348; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Sosa BA, 2014, ELIFE, V3, DOI 10.7554/eLife.03239; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Swee LK, 2013, P NATL ACAD SCI USA, V110, P1428, DOI 10.1073/pnas.1214994110; Theile CS, 2013, NAT PROTOC, V8, P1800, DOI 10.1038/nprot.2013.102; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Wuethrich I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109883; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	46	28	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9087	9100		10.1074/jbc.M114.634287	http://dx.doi.org/10.1074/jbc.M114.634287			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25678711	hybrid, Green Published			2022-12-28	WOS:000352207100032
J	Gospodarska, E; Nowialis, P; Kozak, LP				Gospodarska, Emilia; Nowialis, Pawel; Kozak, Leslie P.			Mitochondrial Turnover A PHENOTYPE DISTINGUISHING BROWN ADIPOCYTES FROM INTERSCAPULAR BROWN ADIPOSE TISSUE AND WHITE ADIPOSE TISSUE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCOUPLING PROTEIN THERMOGENIN; WHITE FAT; C57BL/6J MICE; IN-VIVO; UCP1; EXPRESSION; INDUCTION; COLD; DEGRADATION; OBESITY	To determine the differences between brown adipocytes from interscapular brown tissue (iBAT) and those induced in white adipose tissue (WAT) with respect to their thermogenic capacity, we examined two essential characteristics: the dynamics of mitochondrial turnover during reversible transitions from 29 degrees C to 4 degrees C and the quantitative relationship between UCP1 and selected subunits of mitochondrial respiratory complex in the fully recruited state. Tofollowthekineticsofinductionandinvolutionofmitochondria, we determined the expression pattern of UCP1 and other mitochondrial proteins as well as analyzed mtDNA content after cold stimulation and reacclimation to thermoneutrality. We showed that UCP1 turnover is very different in iBAT and inguinal WAT (ingWAT); the former showed minimal changes in protein content, whereas the latter showed major changes. Similarly, in iBAT both mtDNA content and the expression of mitochondrial proteins were stable and expressed at similar levels during reversible transitions from 29 degrees C to 4 degrees C, whereas ingWAT revealed dynamic changes. Further analysis showed that in iBAT, the expression patterns for UCP1 and other mitochondrial proteins resembled each other, whereas in ingWAT, UCP1 varied similar to 100-fold during the transition from cold to warmth, and no other mitochondrial proteins matched UCP1. In turn, quantitative analysis of thermogenic capacity determined by estimating the proportion of UCP1 to respiratory complex components showed no significant differences between brown and brite adipocytes, suggesting similar thermogenic potentiality. Ourresults indicate that dynamics ofbrownadipocytes turnover during reversible transition from warm to cold may determine the thermogenic capacity of an individual in a changing temperature environment.	[Gospodarska, Emilia; Nowialis, Pawel; Kozak, Leslie P.] Polish Acad Sci, Inst Anim Reprod & Food Res, PL-10748 Olsztyn, Poland	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Kozak, LP (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Ul Tuwima 10, PL-10748 Olsztyn, Poland.	l.kozak@pan.olsztyn.pl		GOSPODARSKA, Emilia/0000-0003-1276-3761	Foundation for Polish Science [WELCOME/20104/3]; European Union Structural Funds in Poland; REFRESH project [FP7-REGPOT-2010-1-264103]	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union Structural Funds in Poland(European Commission); REFRESH project	This work was supported by the Foundation for Polish Science, WELCOME/20104/3, and by European Union Structural Funds in Poland within the Innovative Economy Programme and REFRESH project FP7-REGPOT-2010-1-264103 (to L. P. K.).	Andersson U, 1997, BIOCHEM J, V323, P379, DOI 10.1042/bj3230379; BUKOWIECKI L, 1982, AM J PHYSIOL, V242, pE353, DOI 10.1152/ajpendo.1982.242.6.E353; Cancello R, 1998, ENDOCRINOLOGY, V139, P4747, DOI 10.1210/en.139.11.4747; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Clarke KJ, 2012, BBA-BIOENERGETICS, V1817, P1759, DOI 10.1016/j.bbabio.2012.03.035; Coulter AA, 2003, PHYSIOL GENOMICS, V14, P139, DOI 10.1152/physiolgenomics.00057.2003; Cousin B, 1996, J CELL PHYSIOL, V167, P285, DOI 10.1002/(SICI)1097-4652(199605)167:2<285::AID-JCP12>3.0.CO;2-7; Forner F, 2009, CELL METAB, V10, P324, DOI 10.1016/j.cmet.2009.08.014; Giordano A, 2014, EUR J ENDOCRINOL, V170, pR159, DOI 10.1530/EJE-13-0945; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HOUSTEK J, 1995, J BIOL CHEM, V270, P7689, DOI 10.1074/jbc.270.13.7689; JACOBSSON A, 1994, AM J PHYSIOL-REG I, V267, pR999, DOI 10.1152/ajpregu.1994.267.4.R999; Jimenez M, 2003, EUR J BIOCHEM, V270, P699, DOI 10.1046/j.1432-1033.2003.03422.x; KLAUS S, 1991, INT J BIOCHEM, V23, P791, DOI 10.1016/0020-711X(91)90062-R; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Koza RA, 2000, J BIOL CHEM, V275, P34486, DOI 10.1074/jbc.M002136200; Kozak LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030392; Kozak LP, 2010, PROG MOL BIOL TRANSL, V94, P75, DOI 10.1016/S1877-1173(10)94004-0; Kramarova TV, 2008, FASEB J, V22, P55, DOI 10.1096/fj.07-8581com; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; Margineantu DH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001066; Moazed B, 2002, CAN J PHYSIOL PHARM, V80, P515, DOI 10.1139/Y02-067; Moazed B, 2002, CAN J PHYSIOL PHARM, V80, P541, DOI 10.1139/Y02-078; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Neutzner Albert, 2007, Novartis Found Symp, V287, P4; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; PUIGSERVER P, 1992, BIOCHEM J, V284, P393, DOI 10.1042/bj2840393; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Rossmeisl M, 2002, EUR J BIOCHEM, V269, P19, DOI 10.1046/j.0014-2956.2002.02627.x; ROTHWELL NJ, 1979, J COMP PHYSIOL PSYCH, V93, P1024, DOI 10.1037/h0077631; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Stefl B, 1998, AM J PHYSIOL-ENDOC M, V274, pE527, DOI 10.1152/ajpendo.1998.274.3.E527; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005	45	37	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8243	8255		10.1074/jbc.M115.637785	http://dx.doi.org/10.1074/jbc.M115.637785			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25645913	hybrid, Green Published			2022-12-28	WOS:000351662600021
J	Park, CH; Park, JE; Kim, TS; Kang, YH; Soung, NK; Zhou, M; Kim, NH; Bang, JK; Lee, KS				Park, Chi Hoon; Park, Jung-Eun; Kim, Tae-Sung; Kang, Young Hwi; Soung, Nak-Kyun; Zhou, Ming; Kim, Nam-Hyung; Bang, Jeong Kyu; Lee, Kyung S.			Mammalian Polo-like Kinase 1 (Plk1) Promotes Proper Chromosome Segregation by Phosphorylating and Delocalizing the PBIP1.CENP-Q Complex from Kinetochores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CELL-CYCLE; CENP-A; LOCALIZATION; POLO-LIKE-KINASE-1; CYTOKINESIS; MECHANISM; DIVISION; MITOSIS; DOMAIN	Mammalian Plk1 is critically required for proper M phase progression. Plk1 is self-recruited to prekinetochores/kinetochores by phosphorylating and binding to the Thr-78 motif of a kinetochore scaffold protein, PBIP1 (also called CENP-U/50), which forms a stable complex with another kinetochore component, CENP-Q. However, the mechanism regulating Plk1 localization to this site remains largely unknown. Here, we demonstrate that the PBIP1 . CENP-Q complex became hyperphosphorylated and rapidly delocalized from kinetochores as cells entered mitosis. Plk1 phosphorylated the CENP-Q subunit of the PBIP1.CENP-Q complex at multiple sites, and mutation of nine Plk1-dependent phosphorylation sites to Ala (9A) enhanced CENP-Q association with chromatin and prolonged CENP-Q localization to kinetochores. Conversely, mutation of the nine sites to phospho-mimicking Asp/Glu (9D/E) residues dissociated CENP-Q from chromatin and kept the CENP-Q(9D/E) mutant from localizing to interphase prekinetochores. Strikingly, both the 9A and 9D/E mutants induced a defect in proper chromosome segregation, suggesting that both timely localization of the PBIP1.CENP-Q complex to prekinetochores and delocalization from kinetochores are critical for normal M phase progression. Notably, although Plk1 did not alter the level of PBIP1 and CENP-Q ubiquitination, Plk1-dependent phosphorylation and delocalization of these proteins from kinetochores appeared to indirectly lead to their degradation in the cytosol. Thus, we propose that Plk1 regulates the timing of the delocalization and ultimate destruction of the PBIP1.CENP-Q complex and that these processes are important not only for promoting Plk1-dependent mitotic progression, but also for resetting the timing of Plk1 recruitment to prekinetochores in the next cell cycle.	[Park, Chi Hoon; Park, Jung-Eun; Kim, Tae-Sung; Lee, Kyung S.] NCI, NIH, Lab Metab, Bethesda, MD 20892 USA; [Kang, Young Hwi] Ewha Womans Univ, Immune & Vasc Cell Network Res Ctr, Dept Life Sci, Seoul 120750, South Korea; [Kang, Young Hwi] Ewha Womans Univ, Immune & Vasc Cell Network Res Ctr, GT5 Program, Seoul 120750, South Korea; [Soung, Nak-Kyun] Korea Res Inst Biosci & Biotechnol, Chem Biol Res Ctr, Ochang 363883, Chungbuk, South Korea; [Zhou, Ming] Frederick Natl Lab Canc Res, Lab Prote & Analyt Technol, Leidos Biomed Res, Frederick, MD 21702 USA; [Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju 361763, Chungbuk, South Korea; [Bang, Jeong Kyu] Korea Basic Sci Inst, Div Magnet Resonance, Ochang 363883, Chungbuk, South Korea	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ewha Womans University; Ewha Womans University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chungbuk National University; Korea Basic Science Institute (KBSI)	Lee, KS (corresponding author), NCI, NIH, Lab Metab, Ctr Canc Res, Bldg. 37,Rm 3118,9000 Rockville Pike, Bethesda, MD 20892 USA.	kyunglee@mail.nih.gov			NATIONAL CANCER INSTITUTE [ZIABC011324] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amaro AC, 2010, NAT CELL BIOL, V12, P319, DOI 10.1038/ncb2033; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Eskat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044717; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Kagawa N, 2014, CHROMOSOME RES, V22, P293, DOI 10.1007/s10577-014-9404-1; Kang YH, 2011, J BIOL CHEM, V286, P19744, DOI 10.1074/jbc.M111.224105; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Lee KS, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-4; Lee KS, 2008, CELL CYCLE, V7, P141, DOI 10.4161/cc.7.2.5272; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Park JE, 2011, P NATL ACAD SCI USA, V108, P8200, DOI 10.1073/pnas.1102020108; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Qi W, 2006, MOL BIOL CELL, V17, P3705, DOI 10.1091/mbc.E06-03-0240; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219	25	20	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8569	8581		10.1074/jbc.M114.623546	http://dx.doi.org/10.1074/jbc.M114.623546			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25670858	Green Published, hybrid			2022-12-28	WOS:000351662600047
J	Chen, JX; Enns, CA				Chen, Juxing; Enns, Caroline A.			CD81 Promotes Both the Degradation of Transferrin Receptor 2 (TfR2) and the Tfr2-mediated Maintenance of Hepcidin Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; Iron; Iron Metabolism; Protein Degradation; Tetraspanin	EPIDERMAL-GROWTH-FACTOR; ANTIMICROBIAL PEPTIDE HEPCIDIN; E3 UBIQUITIN LIGASE; SIGNAL-TRANSDUCTION; IRON OVERLOAD; JUVENILE HEMOCHROMATOSIS; MEDIATED ENDOCYTOSIS; HUMAN FIBROBLASTS; KNOCKOUT MOUSE; EGF RECEPTOR	Background: Loss of function mutations in TfR2 cause iron overload in the body. Results: CD81, a scaffold protein, controls the level of TfR2 and links TfR2 to E3 ligase, GRAIL. Conclusion: CD81 down-regulates TfR2 and increases hepcidin levels in Hep3B cells. Significance: The association of TfR2 with CD81 controls both TfR2 trafficking and hepcidin mRNA. Mutations in transferrin receptor 2 (TfR2) cause a rare form of the hereditary hemochromatosis, resulting in iron overload predominantly in the liver. TfR2 is primarily expressed in hepatocytes and is hypothesized to sense iron levels in the blood to positively regulate the expression of hepcidin through activation of the BMP signaling pathway. Hepcidin is a peptide hormone that negatively regulates iron egress from cells and thus limits intestinal iron uptake. In this study, a yeast two-hybrid approach using the cytoplasmic domain of TfR2 identified CD81 as an interacting protein. CD81 is an abundant tetraspanin in the liver. Co-precipitations of CD81 with different TfR2 constructs demonstrated that both the cytoplasmic and ecto-transmembrane domains of TfR2 interact with CD81. Knockdown of CD81 using siRNA significantly increased TfR2 levels by increasing the half-life of TfR2, indicating that CD81 promotes degradation of TfR2. Previous studies showed that CD81 is targeted for degradation by GRAIL, an ubiquitin E3 ligase. Knockdown of GRAIL in Hep3B-TfR2 cells increased TfR2 levels, consistent with inhibition of CD81 ubiquitination. These results suggest that down-regulation of CD81 by GRAIL targets TfR2 for degradation. Surprisingly, knockdown of CD81 decreased hepcidin expression, implying that the TfR2/CD81 complex is involved in the maintenance of hepcidin mRNA. Moreover, knockdown of CD81 did not affect the stimulation of hepcidin expression by BMP6 but increased both the expression of ID1 and SMAD7, direct targets of BMP signaling pathway, and the phosphorylation of ERK1/2, indicating that the CD81 regulates hepcidin expression differently from the BMP and ERK1/2 signaling pathways.	[Chen, Juxing; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97239 USA	Oregon Health & Science University	Enns, CA (corresponding author), Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	ennsca@ohsu.edu			National Institutes of Health [R01-DK072166, R37-DK054488]; American Heart Association [11POST5250029]; Collins Medical Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072166, R37DK054488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Collins Medical Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK072166 and R37-DK054488 (to C. A. E.). This work was also supported by American Heart Association Grant 11POST5250029 and a Collins Medical Trust grant (to J. C.).	Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Calzolari A, 2006, J CELL SCI, V119, P4486, DOI 10.1242/jcs.03228; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Carloni V, 2004, ONCOGENE, V23, P1566, DOI 10.1038/sj.onc.1207287; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; CARPENTER G, 1975, J BIOL CHEM, V250, P4297; Chen JX, 2007, J BIOL CHEM, V282, P6201, DOI 10.1074/jbc.M610127200; Chen JX, 2009, TRAFFIC, V10, P1488, DOI 10.1111/j.1600-0854.2009.00961.x; Corradini E, 2011, GASTROENTEROLOGY, V141, P1907, DOI 10.1053/j.gastro.2011.06.077; Cottrell GS, 2003, BIOCHEM SOC T, V31, P1191; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; DUNN WA, 1986, J CELL BIOL, V102, P24, DOI 10.1083/jcb.102.1.24; Falzacappa MVV, 2008, J MOL MED, V86, P531, DOI 10.1007/s00109-008-0313-7; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209; GORDEN P, 1978, P NATL ACAD SCI USA, V75, P5025, DOI 10.1073/pnas.75.10.5025; Guihard S, 2010, BLOOD, V115, P3686, DOI 10.1182/blood-2009-09-242487; JOHNSON AE, 1993, BRAIN RES, V622, P9, DOI 10.1016/0006-8993(93)90795-O; Johnson MB, 2007, MOL BIOL CELL, V18, P743, DOI 10.1091/mbc.E06-09-0798; Johnson MB, 2004, BLOOD, V104, P4287, DOI 10.1182/blood-2004-06-2477; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI WH, 1986, ENDOCRINOLOGY, V118, P413, DOI 10.1210/endo-118-1-413; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Lineberry N, 2008, J BIOL CHEM, V283, P28497, DOI 10.1074/jbc.M805092200; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; MILLER K, 1986, J CELL BIOL, V102, P500, DOI 10.1083/jcb.102.2.500; Nakamichi S, 2009, J MOL ENDOCRINOL, V42, P161, DOI 10.1677/JME-08-0145; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Poll M, 2010, HAEMATOL-HEMATOL J, V95, P1832, DOI 10.3324/haematol.2010.027003; Ramey G, 2009, HAEMATOL-HEMATOL J, V94, P765, DOI 10.3324/haematol.2008.003541; Reynolds GM, 2008, HEPATOLOGY, V47, P418, DOI 10.1002/hep.22028; Robb A, 2004, BLOOD, V104, P4294, DOI 10.1182/blood-2004-06-2481; Rocha-Perugini V, 2013, MOL CELL BIOL, V33, P3644, DOI 10.1128/MCB.00302-13; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Seaman MNJ, 1996, CURR OPIN CELL BIOL, V8, P549, DOI 10.1016/S0955-0674(96)80034-2; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Truksa J, 2009, BLOOD, V113, P688, DOI 10.1182/blood-2008-05-160184; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Vogt TM, 2003, BLOOD, V101, P2008, DOI 10.1182/blood-2002-09-2742; Wallace DF, 2009, HEPATOLOGY, V50, P1992, DOI 10.1002/hep.23198; Wallace DF, 2005, GUT, V54, P980, DOI 10.1136/gut.2004.062018; Wallace DF, 2002, BLOOD, V100, P692, DOI 10.1182/blood.V100.2.692; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Zona L, 2014, VIRUSES-BASEL, V6, P875, DOI 10.3390/v6020875	54	11	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7841	7850		10.1074/jbc.M114.632778	http://dx.doi.org/10.1074/jbc.M114.632778			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25635054	Green Published, hybrid			2022-12-28	WOS:000351613600042
J	Chotewutmontri, P; Bruce, BD				Chotewutmontri, Prakitchai; Bruce, Barry D.			Non-native, N-terminal Hsp70 Molecular Motor Recognition Elements in Transit Peptides Support Plastid Protein Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-Kilodalton Heat Shock Protein (Hsp70); Arabidopsis thaliana; Cell Biology; Chloroplast; Molecular Motor; Protein Translocation; Transit Peptide	IN-VIVO IMPORT; SMALL-SUBUNIT; SEQUENCE MOTIFS; SUBCELLULAR-LOCALIZATION; ARABIDOPSIS CHLOROPLASTS; SUBSTRATE-SPECIFICITY; ENVELOPE MEMBRANES; TARGETING SEQUENCE; PRECURSOR PROTEINS; ESCHERICHIA-COLI	Background: Transit peptides direct the import of the majority of chloroplast-destined proteins into chloroplasts. Results: Multiple unrelated Hsp70 recognition elements are able to substitute for the translocation determinant domain of transit peptides. Conclusion: The majority of transit peptides utilize Hsp70-interacting property to initiate import. Significance: This finding expands the mechanistic view of the chloroplast protein import process. Previously, we identified the N-terminal domain of transit peptides (TPs) as a major determinant for the translocation step in plastid protein import. Analysis of Arabidopsis TP dataset revealed that this domain has two overlapping characteristics, highly uncharged and Hsp70-interacting. To investigate these two properties, we replaced the N-terminal domains of the TP of the small subunit of ribulose-1,5-bisphosphate carboxylase/oxygenase and its reverse peptide with a series of unrelated peptides whose affinities to the chloroplast stromal Hsp70 have been determined. Bioinformatic analysis indicated that eight out of nine peptides in this series are not similar to the TP N terminus. Using in vivo and in vitro protein import assays, the majority of the precursors containing Hsp70-binding elements were targeted to plastids, whereas none of the chimeric precursors lacking an N-terminal Hsp70-binding element were targeted to the plastids. Moreover, a pulse-chase assay showed that two chimeric precursors with the most uncharged peptides failed to translocate into the stroma. The ability of multiple unrelated Hsp70-binding elements to support protein import verified that the majority of TPs utilize an N-terminal Hsp70-binding domain during translocation and expand the mechanistic view of the import process. This work also indicates that synthetic biology may be utilized to create de novo TPs that exceed the targeting activity of naturally occurring sequences.	[Chotewutmontri, Prakitchai; Bruce, Barry D.] Univ Tennessee, Grad Sch Genome Sci & Technol, Knoxville, TN 37996 USA; [Bruce, Barry D.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Bruce, BD (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	bbruce@utk.edu	Chotewutmontri, Prakitchai/AAB-7079-2019	Chotewutmontri, Prakitchai/0000-0002-8672-2973	National Science Foundation Program in Cell Biology [MCB-0628670, MCB-0344601]; TN-SCORE, a multidisciplinary research program - NSF-EPSCOR [EPS-1004083]; Gibson Family Foundation	National Science Foundation Program in Cell Biology; TN-SCORE, a multidisciplinary research program - NSF-EPSCOR; Gibson Family Foundation	This work was supported in part by National Science Foundation Program in Cell Biology Grants MCB-0628670 and MCB-0344601 (to B. D. B.), TN-SCORE, a multidisciplinary research program sponsored by NSF-EPSCOR Grant EPS-1004083 (to B. D. B.), and support from the Gibson Family Foundation (to B. D. B.).	Akita M, 1997, J CELL BIOL, V136, P983, DOI 10.1083/jcb.136.5.983; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMERICA T, 1994, PLANT MOL BIOL, V24, P283, DOI 10.1007/BF00020168; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bionda T, 2010, J MOL BIOL, V402, P510, DOI 10.1016/j.jmb.2010.07.052; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Briesemeister S, 2010, BIOINFORMATICS, V26, P1232, DOI 10.1093/bioinformatics/btq115; Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Bruce BD, 2001, BBA-MOL CELL RES, V1541, P2, DOI 10.1016/S0167-4889(01)00149-5; Bruce BD, 1998, PLANT MOL BIOL, V38, P223, DOI 10.1023/A:1006094308805; Bruch EM, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-57; Chotewutmontri P, 2012, PLANT CELL, V24, P3040, DOI 10.1105/tpc.112.098327; Chou ML, 2006, J CELL BIOL, V175, P893, DOI 10.1083/jcb.200609172; Chu CC, 2012, PLANT PHYSIOL, V158, P1656, DOI 10.1104/pp.112.193300; Constan D, 2004, PLANT PHYSIOL, V136, P3605, DOI 10.1104/pp.104.052928; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dabney-Smith C, 1999, J BIOL CHEM, V274, P32351, DOI 10.1074/jbc.274.45.32351; de Planque MRR, 2003, BIOCHEMISTRY-US, V42, P5341, DOI 10.1021/bi027000r; DOBBERSTEIN B, 1977, P NATL ACAD SCI USA, V74, P1082, DOI 10.1073/pnas.74.3.1082; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Flores-Perez U, 2013, BBA-MOL CELL RES, V1833, P332, DOI 10.1016/j.bbamcr.2012.03.019; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Henikoff S, 1996, CURR OPIN STRUC BIOL, V6, P353, DOI 10.1016/S0959-440X(96)80055-8; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Inoue H, 2013, P NATL ACAD SCI USA, V110, P3173, DOI 10.1073/pnas.1219229110; Ivey RA, 2000, PLANT PHYSIOL, V122, P1289, DOI 10.1104/pp.122.4.1289; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Klee EW, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-256; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; KLEIN RR, 1992, PLANT PHYSIOL, V98, P546, DOI 10.1104/pp.98.2.546; Kovacheva S, 2005, PLANT J, V41, P412, DOI 10.1111/j.1365-313X.2004.02307.x; Kovacheva S, 2007, PLANT J, V50, P364, DOI 10.1111/j.1365-313X.2007.03060.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Lee DW, 2008, PLANT CELL, V20, P1603, DOI 10.1105/tpc.108.060541; Lee DW, 2009, PLANT PHYSIOL, V151, P129, DOI 10.1104/pp.109.140673; Lee DW, 2006, PLANT PHYSIOL, V140, P466, DOI 10.1104/pp.105.074575; Lee KH, 2002, MOL CELLS, V14, P388; Li HM, 2013, TRENDS PLANT SCI, V18, P360, DOI 10.1016/j.tplants.2013.04.003; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; MARSHALL JS, 1992, PLANT PHYSIOL, V100, P1048, DOI 10.1104/pp.100.2.1048; MARSHALL JS, 1990, P NATL ACAD SCI USA, V87, P374, DOI 10.1073/pnas.87.1.374; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Mizuno S, 2012, FEBS J, V279, P1474, DOI 10.1111/j.1742-4658.2012.08540.x; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olinares PDB, 2011, BBA-BIOENERGETICS, V1807, P999, DOI 10.1016/j.bbabio.2010.12.003; OLSEN LJ, 1992, J BIOL CHEM, V267, P433; Petsalaki Evangelia I., 2006, Genomics Proteomics & Bioinformatics, V4, P48, DOI 10.1016/S1672-0229(06)60016-8; PILON M, 1995, J BIOL CHEM, V270, P3882, DOI 10.1074/jbc.270.8.3882; Pinnaduwage P, 1996, J BIOL CHEM, V271, P32907, DOI 10.1074/jbc.271.51.32907; Reddick LE, 2008, METHOD CELL BIOL, V90, P365, DOI 10.1016/S0091-679X(08)00816-9; Rensink WA, 1998, PLANT PHYSIOL, V118, P691, DOI 10.1104/pp.118.2.691; Rial DV, 2000, EUR J BIOCHEM, V267, P6239, DOI 10.1046/j.1432-1327.2000.01707.x; Rial DV, 2003, J BIOL CHEM, V278, P46473, DOI 10.1074/jbc.M306684200; Richly E, 2004, GENE, V329, P11, DOI 10.1016/j.gene.2004.01.008; Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Ruprecht M, 2010, MOL PLANT, V3, P499, DOI 10.1093/mp/ssp116; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHMITT M, 1995, EMBO J, V14, P3434, DOI 10.1002/j.1460-2075.1995.tb07349.x; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; SHANKLIN J, 1995, PLANT CELL, V7, P1713, DOI 10.1105/tpc.7.10.1713; Shi LX, 2013, BBA-MOL CELL RES, V1833, P314, DOI 10.1016/j.bbamcr.2012.10.002; Shi LX, 2011, PLANT SIGNAL BEHAV, V6, P1397, DOI 10.4161/psb.6.9.16916; Shi LX, 2010, PLANT CELL, V22, P205, DOI 10.1105/tpc.109.071464; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Su PH, 2010, PLANT CELL, V22, P1516, DOI 10.1105/tpc.109.071415; Teng YS, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001416; THEG SM, 1989, J BIOL CHEM, V264, P6730; vandenWijngaard PWJ, 1997, J BIOL CHEM, V272, P29430, DOI 10.1074/jbc.272.47.29430; VONHEIJNE G, 1991, FEBS LETT, V278, P1, DOI 10.1016/0014-5793(91)80069-F; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; VONHEIJNE G, 1991, PLANT MOL BIOL REP, V9, P104; Wilkins MR, 1999, METH MOL B, V112, P531; Xia D, 2004, J STRUCT BIOL, V146, P166, DOI 10.1016/j.jsb.2003.11.025; Zhang XP, 2002, TRENDS PLANT SCI, V7, P14, DOI 10.1016/S1360-1385(01)02180-X; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	92	27	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7602	7621		10.1074/jbc.M114.633586	http://dx.doi.org/10.1074/jbc.M114.633586			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25645915	hybrid, Green Published			2022-12-28	WOS:000351613600024
J	Liang, X; Samways, DSK; Wolf, K; Bowles, EA; Richards, JP; Bruno, J; Dutertre, S; DiPaolo, RJ; Egan, TM				Liang, Xin; Samways, Damien S. K.; Wolf, Kyle; Bowles, Elizabeth A.; Richards, Jennifer P.; Bruno, Jonathan; Dutertre, Sebastien; DiPaolo, Richard J.; Egan, Terrance M.			Quantifying Ca2+ Current and Permeability in ATP-gated P2X7 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Transport; Ion Channel; Lymphocyte; Macrophage; Purinergic Receptor; Fractional Calcium Current; Ligand-gated Ion Channel; Pore Dilation; Relative Calcium Permeability	CENTRAL-NERVOUS-SYSTEM; P2X(7) RECEPTOR; EXTRACELLULAR ATP; NEUROTRANSMITTER RELEASE; ALLOSTERIC MODULATION; CALCIUM PERMEABILITY; CATION PERMEABILITY; IL-1-BETA SECRETION; NUCLEOTIDE RECEPTOR; DIVALENT-CATIONS	Background: Ca2+ triggers many of the actions of extracellular ATP. Results: We measured the Ca2+ component of the ATP-gated non-selective cation current of P2X7 receptors. Conclusion: Ca2+ flux varied with the species of origin, the splice variant, and the agonist concentration. Significance: Our results suggest that domains that lie outside of the pore regulate the Ca2+ flux of P2X7 receptors. ATP-gated P2X7 receptors are prominently expressed in inflammatory cells and play a key role in the immune response. A major consequence of receptor activation is the regulated influx of Ca2+ through the self-contained cation non-selective channel. Although the physiological importance of the resulting rise in intracellular Ca2+ is universally acknowledged, the biophysics of the Ca2+ flux responsible for the effects are poorly understood, largely because traditional methods of measuring Ca2+ permeability are difficult to apply to P2X7 receptors. Here we use an alternative approach, called dye-overload patch-clamp photometry, to quantify the agonist-gated Ca2+ flux of recombinant P2X7 receptors of dog, guinea pig, human, monkey, mouse, rat, and zebrafish. We find that the magnitude of the Ca2+ component of the ATP-gated current depends on the species of origin, the splice variant, and the concentration of the purinergic agonist. We also measured a significant contribution of Ca2+ to the agonist-gated current of the native P2X7Rs of mouse and human immune cells. Our results provide cross-species quantitative measures of the Ca2+ current of the P2X7 receptor for the first time, and suggest that the cytoplasmic N terminus plays a meaningful role in regulating the flow of Ca2+ through the channel.	[Liang, Xin; Bowles, Elizabeth A.; Richards, Jennifer P.; Egan, Terrance M.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Liang, Xin; Bowles, Elizabeth A.; Richards, Jennifer P.; Egan, Terrance M.] St Louis Univ, Sch Med, Ctr Neurosci, St Louis, MO 63104 USA; [Wolf, Kyle; DiPaolo, Richard J.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA; [Bruno, Jonathan] St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO 63104 USA; [Samways, Damien S. K.] Clarkson Univ, Dept Biol, Potsdam, NY 13699 USA; [Dutertre, Sebastien] Univ Montpellier 2, CNRS, UMR 5247, Inst Biomol Max Mousseron, Montpellier, France	Saint Louis University; Saint Louis University; Saint Louis University; Saint Louis University; Clarkson University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Egan, TM (corresponding author), 1402 South Grand Blvd, St Louis, MO 63104 USA.	egantm@slu.edu	Bruno, Jonathan/HII-3034-2022	Egan, Terrance/0000-0002-7249-3161; Wolf, Kyle/0000-0003-4874-2911; Dutertre, Sebastien/0000-0002-2945-1484	National Institutes of Health [HL56236]; American Cancer Society [12-171-01-LIB]; St. Louis University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); St. Louis University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL56236 (to T. M. E.) American Cancer Society Research Scholar Grant 12-171-01-LIB (to R. J. D.), and Blue Ribbon Funding from the St. Louis University School of Medicine (to T. M. E.).	Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Alloisio S, 2008, FEBS LETT, V582, P3948, DOI 10.1016/j.febslet.2008.10.041; Baconguis I, 2013, CURR OPIN STRUC BIOL, V23, P277, DOI 10.1016/j.sbi.2013.04.005; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; BRETSCHNEIDER F, 1995, PFLUG ARCH EUR J PHY, V429, P691, DOI 10.1007/BF00373990; Browne LE, 2013, J NEUROSCI, V33, P3557, DOI 10.1523/JNEUROSCI.2235-12.2013; Browne LE, 2011, NAT NEUROSCI, V14, P17, DOI 10.1038/nn.2705; Burnashev N, 1996, CURR OPIN NEUROBIOL, V6, P311, DOI 10.1016/S0959-4388(96)80113-9; Burnashev N, 1998, CELL CALCIUM, V24, P325, DOI 10.1016/S0143-4160(98)90056-2; Burnstock G, 2011, ADV PHARMACOL, V61, P333, DOI 10.1016/B978-0-12-385526-8.00011-4; Chen LF, 2006, CRIT REV IMMUNOL, V26, P499, DOI 10.1615/CritRevImmunol.v26.i6.30; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; Cuadra AE, 2014, J CELL PHYSIOL, V229, P333, DOI 10.1002/jcp.24453; Davies John Q, 2005, Methods Mol Biol, V290, P91; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Di Virgilio F, 2009, CURR OPIN PHARMACOL, V9, P507, DOI 10.1016/j.coph.2009.06.021; Di Virgilio F, 2009, TRENDS NEUROSCI, V32, P79, DOI 10.1016/j.tins.2008.11.003; DIVIRGILIO F, 1990, IMMUNOL TODAY, V11, P274, DOI 10.1016/0167-5699(90)90111-L; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Faroni A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.268; Fischer W, 2003, J NEUROCHEM, V85, P779, DOI 10.1046/j.1471-4159.2003.01716.x; Fisher JA, 2004, J NEUROSCI, V24, P10475, DOI 10.1523/JNEUROSCI.3250-04.2004; Frings S, 2000, METHOD ENZYMOL, V315, P797; Gallin E. K., 1989, NEUTROPHIL CELLULAR, P243; Glaser T, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-12; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; Grol MW, 2009, PURINERG SIGNAL, V5, P205, DOI 10.1007/s11302-009-9139-1; Gudipaty L, 2003, AM J PHYSIOL-CELL PH, V285, pC286, DOI 10.1152/ajpcell.00070.2003; Guerra AN, 2007, PURINERG SIGNAL, V3, P39, DOI 10.1007/s11302-006-9035-x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Hanley PJ, 2012, J BIOL CHEM, V287, P10650, DOI 10.1074/jbc.M111.332676; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; He ML, 2003, AM J PHYSIOL-CELL PH, V285, pC467, DOI 10.1152/ajpcell.00042.2003; Hille B., 1992, IONIC CHANNELS EXCIT, P21; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jatzke C, 2002, J PHYSIOL-LONDON, V538, P25, DOI 10.1113/jphysiol.2001.012897; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Jiang LH, 2012, CELL HEALTH CYTOSKEL, V4, P83, DOI 10.2147/CHC.S27196; Jiang LH, 2009, EUR BIOPHYS J BIOPHY, V38, P339, DOI 10.1007/s00249-008-0315-y; Jiang RT, 2013, TRENDS BIOCHEM SCI, V38, P20, DOI 10.1016/j.tibs.2012.10.006; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Khakh BS, 2012, NEURON, V76, P51, DOI 10.1016/j.neuron.2012.09.024; Koles L, 2011, ADV PHARMACOL, V61, P441, DOI 10.1016/B978-0-12-385526-8.00014-X; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Marcoli M, 2008, J NEUROCHEM, V105, P2330, DOI 10.1111/j.1471-4159.2008.05322.x; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; Nicke A, 2004, EUR J BIOCHEM, V271, P2293, DOI 10.1111/j.1432-1033.2004.04171.x; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; Norenberg W, 2012, BRIT J PHARMACOL, V167, P48, DOI 10.1111/j.1476-5381.2012.01987.x; North RA, 2013, MOL PHARMACOL, V83, P759, DOI 10.1124/mol.112.083758; Notomi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053338; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Ozaki H, 2004, NEUROGASTROENT MOTIL, V16, P39, DOI 10.1046/j.1365-2982.2003.00461.x; Pankratov Y, 2014, EUR J PHARMACOL, V739, P60, DOI 10.1016/j.ejphar.2013.11.017; Partridge LD, 1998, METHOD ENZYMOL, V293, P371; Paukert M, 2002, FEBS LETT, V513, P253, DOI 10.1016/S0014-5793(02)02324-4; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Riedel T, 2007, BIOPHYS J, V93, P846, DOI 10.1529/biophysj.106.103614; ROGERS M, 1995, BIOPHYS J, V68, P501, DOI 10.1016/S0006-3495(95)80211-0; Rubini P, 2014, N-S ARCH PHARMACOL, V387, P943, DOI 10.1007/s00210-014-1005-1; Samways DSK, 2008, J BIOL CHEM, V283, P5110, DOI 10.1074/jbc.M708713200; Samways DSK, 2007, J GEN PHYSIOL, V129, P245, DOI 10.1085/jgp.200609677; Samways DSK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00006; Samways DSK, 2012, J BIOL CHEM, V287, P7594, DOI 10.1074/jbc.M111.322461; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; Scatizzi JC, 2009, EUR J IMMUNOL, V39, P820, DOI 10.1002/eji.200838683; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Schwarz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041269; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sim JA, 2007, BRIT J PHARMACOL, V152, P1283, DOI 10.1038/sj.bjp.0707504; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Sperlagh B, 2002, J NEUROCHEM, V81, P1196, DOI 10.1046/j.1471-4159.2002.00920.x; Sperlagh B, 2007, PURINERG SIGNAL, V3, P269, DOI 10.1007/s11302-007-9080-0; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Stojilkovic SS, 2014, ANTIOXID REDOX SIGN, V21, P953, DOI 10.1089/ars.2013.5549; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Taylor SRJ, 2009, J LEUKOCYTE BIOL, V85, P978, DOI 10.1189/jlb.0408251; Torres GE, 1999, J BIOL CHEM, V274, P22359, DOI 10.1074/jbc.274.32.22359; Toulme E, 2010, J GEN PHYSIOL, V135, P333, DOI 10.1085/jgp.200910336; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Volonte C, 2012, CNS NEUROL DISORD-DR, V11, P705, DOI 10.2174/187152712803581137; Weisman GA, 2012, MOL NEUROBIOL, V46, P96, DOI 10.1007/s12035-012-8263-z; Wollmuth LP, 1998, J GEN PHYSIOL, V112, P623, DOI 10.1085/jgp.112.5.623; Xu XJ, 2012, J CELL SCI, V125, P3776, DOI 10.1242/jcs.099374; Yan ZH, 2011, J GEN PHYSIOL, V138, P437, DOI 10.1085/jgp.201110647; Yan ZH, 2010, J NEUROSCI, V30, P14213, DOI 10.1523/JNEUROSCI.2390-10.2010; Yan ZH, 2008, J GEN PHYSIOL, V132, P563, DOI 10.1085/jgp.200810059; Zeilhofer HU, 1996, J NEUROPHYSIOL, V76, P2834, DOI 10.1152/jn.1996.76.5.2834; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	100	27	27	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7930	7942		10.1074/jbc.M114.627810	http://dx.doi.org/10.1074/jbc.M114.627810			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25645917	Green Published, hybrid			2022-12-28	WOS:000351613600050
J	Zhao, XC; Yang, H; Liu, W; Duan, XY; Shang, WN; Xia, DJ; Tong, C				Zhao, Xiaocui; Yang, Huan; Liu, Wei; Duan, Xiuying; Shang, Weina; Xia, Dajing; Tong, Chao			Sec22 Regulates Endoplasmic Reticulum Morphology but Not Autophagy and Is Required for Eye Development in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Drosophila; Endoplasmic Reticulum (ER); Golgi; SNARE Proteins	MEMBRANE-FUSION; PLASMA-MEMBRANE; MOLECULAR-BASIS; GOLGI; ER; TRANSPORT; COMPLEX; MORPHOGENESIS; BIOGENESIS; EXPANSION	Background: ER morphological changes are often observed in disease conditions, but the molecular mechanisms remain unclear. Results: Malfunction of Sec22 and its binding partners resulted in ER expansion and defects in fly eye development. Conclusion: Sec22 regulates ER morphology through regulating ER-Golgi trafficking but not autophagy. Significance: ER morphology changes under the disease conditions might be due to the defects of ER-Golgi trafficking. The endoplasmic reticulum (ER) is a highly dynamic organelle that plays a critical role in many cellular processes. Abnormal ER morphology is associated with some human diseases, although little is known regarding how ER morphology is regulated. Using a forward genetic screen to identify genes that regulated ER morphology in Drosophila, we identified a mutant of Sec22, the orthologs of which in yeast, plants, and humans are required for ER to Golgi trafficking. However, the physiological function of Sec22 has not been previously investigated in animal development. A loss of Sec22 resulted in ER proliferation and expansion, enlargement of late endosomes, and abnormal Golgi morphology in mutant larvae fat body cells. However, starvation-induced autophagy was not affected by a loss of Sec22. Mosaic analysis of the eye revealed that Sec22 was required for photoreceptor morphogenesis. In Sec22 mutant photoreceptor cells, the ER was highly expanded and gradually lost normal morphology with aging. The rhabdomeres in mutants were small and sometimes fused with each other. The morphology of Sec22 mutant eyes resembled the eye morphology of flies with overexpressed eyc (eyes closed). eyc encodes for a Drosophila p47 protein that is required for membrane fusion. A loss of Syntaxin5 (Syx5), encoding for a t-SNARE on Golgi, also phenocopied the Sec22 mutant. Sec22 formed complexes with Syx5 and Eyc. Thus, we propose that appropriate trafficking between the ER and Golgi is required for maintaining ER morphology and for Drosophila eye morphogenesis.	[Zhao, Xiaocui; Yang, Huan; Liu, Wei; Duan, Xiuying; Shang, Weina; Tong, Chao] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhao, Xiaocui; Yang, Huan; Liu, Wei; Duan, Xiuying; Shang, Weina; Tong, Chao] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Yang, Huan; Xia, Dajing] Zhejiang Univ, Sch Publ Hlth, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Xia, DJ (corresponding author), Zhejiang Univ, Sch Publ Hlth, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	dxia@zju.edu.cn		Tong, Chao/0000-0001-6521-5465	National Basic Research Program of China [2012CB966600, 2014CB943100]; National Natural Science Foundation of China [31271432]; Specialized Research Fund for the Doctoral Program of Higher Education Grant [20130101110116]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education Grant	Supported by National Basic Research Program of China Grants 2012CB966600 and 2014CB943100, National Natural Science Foundation of China Grant 31271432, and Specialized Research Fund for the Doctoral Program of Higher Education Grant 20130101110116. To whom correspondence may be addressed: Life Sciences Institute, Zhejiang University, 866 Yuhangtang Rd., Hangzhou 310058, China. Tel.: 86-571-88981370; E-mail: ctong@zju.edu.cn.	ACHARYA U, 1995, CELL, V82, P895, DOI 10.1016/0092-8674(95)90269-4; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; Bernard A, 2013, DEV CELL, V25, P116, DOI 10.1016/j.devcel.2013.04.004; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Chen SL, 2013, CURR OPIN CELL BIOL, V25, P428, DOI 10.1016/j.ceb.2013.02.006; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; Draxl S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3092; Edwardson JM, 1998, CURR BIOL, V8, pR390, DOI 10.1016/S0960-9822(98)70245-3; El-Kasmi F, 2011, PLANT J, V66, P268, DOI 10.1111/j.1365-313X.2011.04487.x; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Hay JC, 1997, CELL, V89, P149, DOI 10.1016/S0092-8674(00)80191-9; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Juhasz Gabor, 2008, V445, P125, DOI 10.1007/978-1-59745-157-4_8; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017; Lin SY, 2012, INT J BIOCHEM CELL B, V44, P1436, DOI 10.1016/j.biocel.2012.05.013; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Mattaj IW, 2004, NAT REV MOL CELL BIO, V5, P65, DOI 10.1038/nrm1263; MELLMAN I, 1995, CELL, V82, P869, DOI 10.1016/0092-8674(95)90018-7; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moreau K, 2012, AUTOPHAGY, V8, P861, DOI 10.4161/auto.20060; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Paek I, 1997, J CELL BIOL, V137, P1017, DOI 10.1083/jcb.137.5.1017; Petkovic M, 2014, NAT CELL BIOL, V16, P434, DOI 10.1038/ncb2937; Pircs K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044214; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Sacher M, 1997, J BIOL CHEM, V272, P17134, DOI 10.1074/jbc.272.27.17134; Sang TK, 2002, DEVELOPMENT, V129, P143; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Song WW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013193; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x; Voeltz GK, 2007, NAT REV MOL CELL BIO, V8, P258, DOI 10.1038/nrm2119; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zhang K, 2013, J CELL BIOL, V200, P807, DOI 10.1083/jcb.201208033	47	21	22	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7943	7951		10.1074/jbc.M115.640920	http://dx.doi.org/10.1074/jbc.M115.640920			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25670863	Green Published, hybrid			2022-12-28	WOS:000351613600051
J	Lee, SA; Kim, SM; Suh, BK; Sun, HY; Park, YU; Hong, JH; Park, C; Nguyen, MD; Nagata, K; Yoo, JY; Park, SK				Lee, Seol-Ae; Kim, Seong-Mo; Suh, Bo Kyoung; Sun, Hwa-Young; Park, Young-Un; Hong, Ji-Ho; Park, Cana; Minh Dang Nguyen; Nagata, Koh-ichi; Yoo, Joo-Yeon; Park, Sang Ki			Disrupted-in-schizophrenia 1 (DISC1) Regulates Dysbindin Function by Enhancing Its Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL-FORMATION; UBIQUITIN-LIGASE; ORGANELLES COMPLEX-1; SUSCEPTIBILITY GENE; NEURITE OUTGROWTH; PROTEIN; DTNBP1; BLOC-1; ASSOCIATION; BIOGENESIS	Dysbindin and DISC1 are schizophrenia susceptibility factors playing roles in neuronal development. Here we show that the physical interaction between dysbindin and DISCI is critical for the stability of dysbindin and for the process of neurite outgrowth. We found that DISCI forms a complex with dysbindin and increases its stability in association with a reduction in ubiquitylation. Furthermore, knockdown of DISCI or expression of a deletion mutant, DISCI lacking amino acid residues 403-504 of DISC1 (DISC1(Delta 403-504)), effectively decreased levels of endogenous dysbindin. Finally, the neurite outgrowth defect induced by knockdown of DISCI was partially reversed by coexpression of dysbindin. Taken together, these results indicate that dysbindin and DISC1 form a physiologically functional complex that is essential for normal neurite outgrowth.	[Lee, Seol-Ae; Kim, Seong-Mo; Suh, Bo Kyoung; Sun, Hwa-Young; Park, Young-Un; Hong, Ji-Ho; Park, Cana; Yoo, Joo-Yeon; Park, Sang Ki] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Nagata, Koh-ichi] Aichi Human Serv Ctr, Inst Dev Res, Dept Mol Neurobiol, Kasugai, Aichi 4800392, Japan	Pohang University of Science & Technology (POSTECH); University of Calgary; University of Calgary; University of Calgary	Park, SK (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea.	skpark@postech.ac.kr			ministry of science, ICT, and future planning ((MSIP) [NRF-2012R1A2A2A01012923, NRF-2012R1A4A1028200, NRF-2013R1A1A2074251]; national research foundation (NRF) of Korea [NRF-2012K2A1A2033117]; POSTECH basic science research institute (BSRI) Fund	ministry of science, ICT, and future planning ((MSIP); national research foundation (NRF) of Korea(National Research Foundation of Korea); POSTECH basic science research institute (BSRI) Fund	This work was supported by Grants (NRF-2012R1A2A2A01012923, NRF-2012R1A4A1028200, and NRF-2013R1A1A2074251 from the ministry of science, ICT, and future planning ((MSIP) and by the Framework of International Cooperation Program managed by national research foundation (NRF) of Korea (Grant NRF-2012K2A1A2033117). This work was also supported by the POSTECH basic science research institute (BSRI) Fund.	ARNOLD SE, 1991, P NATL ACAD SCI USA, V88, P10850, DOI 10.1073/pnas.88.23.10850; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Buxhoeveden D, 2000, BIOL PSYCHIAT, V47, P681, DOI 10.1016/S0006-3223(99)00275-9; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Carr GV, 2013, BEHAV BRAIN RES, V241, P173, DOI 10.1016/j.bbr.2012.12.021; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Fukuda T, 2010, J BIOL CHEM, V285, P40554, DOI 10.1074/jbc.M110.179481; Funke B, 2004, AM J HUM GENET, V75, P891, DOI 10.1086/425279; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Guo AY, 2009, MOL PSYCHIATR, V14, P18, DOI 10.1038/mp.2008.88; Hattori S, 2008, BIOCHEM BIOPH RES CO, V373, P298, DOI 10.1016/j.bbrc.2008.06.016; Hattori T, 2007, MOL PSYCHIATR, V12, P398, DOI 10.1038/sj.mp.4001945; Hattori T, 2010, MOL PSYCHIATR, V15, P798, DOI 10.1038/mp.2010.60; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Ishizuka K, 2011, NATURE, V473, P92, DOI 10.1038/nature09859; Ito H, 2010, MOL PSYCHIATR, V15, P976, DOI [10.1038/mp.2010.69, 10.1038/mp.2010.93]; Jaaro-Peled H, 2009, PROG BRAIN RES, V179, P75, DOI 10.1016/S0079-6123(09)17909-8; Kalus P, 2000, NEUROREPORT, V11, P3621, DOI 10.1097/00001756-200011090-00044; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2006, HUM MOL GENET, V15, P3313, DOI 10.1093/hmg/ddl407; Kubota K, 2009, BIOCHEM BIOPH RES CO, V379, P191, DOI 10.1016/j.bbrc.2008.12.017; Kuroda K, 2011, HUM MOL GENET, V20, P4666, DOI 10.1093/hmg/ddr400; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Ma TM, 2013, MOL PSYCHIATR, V18, P557, DOI 10.1038/mp.2012.97; Ma X, 2011, MOL PSYCHIATR, V16, P1105, DOI 10.1038/mp.2011.43; Mead CLR, 2010, J NEUROCHEM, V113, P1491, DOI 10.1111/j.1471-4159.2010.06690.x; Meyer KD, 2009, HUM MOL GENET, V18, P3286, DOI 10.1093/hmg/ddp266; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Morris DW, 2008, BIOL PSYCHIAT, V63, P24, DOI 10.1016/j.biopsych.2006.12.025; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; O'Donovan MC, 2003, HUM MOL GENET, V12, pR125, DOI 10.1093/hmg/ddg302; Ottis P, 2011, BIOL PSYCHIAT, V70, P604, DOI 10.1016/j.biopsych.2011.03.027; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Papaleo F, 2012, MOL PSYCHIATR, V17, P85, DOI 10.1038/mp.2010.106; Park YU, 2010, P NATL ACAD SCI USA, V107, P17785, DOI 10.1073/pnas.1004361107; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Selemon LD, 2004, AM J PSYCHIAT, V161, P1564, DOI 10.1176/appi.ajp.161.9.1564; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Tang JX, 2003, MOL PSYCHIATR, V8, P717, DOI 10.1038/sj.mp.4001287; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Weickert CS, 2008, SCHIZOPHR RES, V98, P105, DOI 10.1016/j.schres.2007.05.041	49	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7087	7096		10.1074/jbc.M114.614750	http://dx.doi.org/10.1074/jbc.M114.614750			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25635053	Green Published, hybrid			2022-12-28	WOS:000350991500040
J	Han, H; Monroe, N; Votteler, J; Shakya, B; Sundquist, WI; Hill, CP				Han, Han; Monroe, Nicole; Votteler, Joerg; Shakya, Binita; Sundquist, Wesley I.; Hill, Christopher P.			Binding of Substrates to the Central Pore of the Vps4 ATPase Is Autoinhibited by the Microtubule Interacting and Trafficking (MIT) Domain and Activated by MIT Interacting Motifs (MIMs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCRT-III; STRUCTURAL BASIS; MEMBRANE ASSOCIATION; PLASMA-MEMBRANE; PROTEIN; TRANSLOCATION; COMPLEX; RECOGNITION; INSIGHTS; CYTOKINESIS	The endosomal sorting complexes required for transport (ESCRT) pathway drives reverse topology membrane fission events within multiple cellular pathways, including cytokinesis, multivesicular body biogenesis, repair of the plasma membrane, nuclear membrane vesicle formation, and HIV budding. The AAA ATPase Vps4 is recruited to membrane necks shortly before fission, where it catalyzes disassembly of the ESCRT-III lattice. The N-terminal Vps4 microtubule-interacting and trafficking (MIT) domains initially bind the C-terminal MIT-interacting motifs (MIMs) of ESCRT-III subunits, but it is unclear how the enzyme then remodels these substrates in response to ATP hydrolysis. Here, we report quantitative binding studies that demonstrate that residues from helix 5 of the Vps2p subunit of ESCRT-III bind to the central pore of an asymmetric Vps4p hexamer in a manner that is dependent upon the presence of flexible nucleotide analogs that can mimic multiple states in the ATP hydrolysis cycle. We also find that substrate engagement is autoinhibited by the Vps4p MIT domain and that this inhibition is relieved by binding of either Type 1 or Type 2 MIM elements, which bind the Vps4p MIT domain through different interfaces. These observations support the model that Vps4 substrates are initially recruited by an MIM-MIT interaction that activates the Vps4 central pore to engage substrates and generate force, thereby triggering ESCRT-III disassembly.	[Han, Han; Monroe, Nicole; Votteler, Joerg; Shakya, Binita; Sundquist, Wesley I.; Hill, Christopher P.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Sundquist, WI (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	wes@biochem.utah.edu; chris@biochem.utah.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [NCI P30CA042014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055434, R01AI051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545, R01GM112080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Matthew Weinstock, Michael Jacobsen, and Michael Kay for peptide synthesis and Frank Whitby for helpful discussions and comments on the manuscript. Portions of this work (mass spectrometry and DNA sequencing) were performed in Core Facilities at the University of Utah, which were supported by National Institutes of Health Grant NCI P30CA042014.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Braig K, 2000, STRUCTURE, V8, P567, DOI 10.1016/S0969-2126(00)00145-3; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chan WC, 2000, FMOC SOLID PHASE PEP; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; Cormier Catherine Y., 2011, Journal of Structural and Functional Genomics, V12, P55, DOI 10.1007/s10969-011-9100-8; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Forster F, 2013, STRUCTURE, V21, P1551, DOI 10.1016/j.str.2013.08.010; Gonciarz MD, 2008, J MOL BIOL, V384, P878, DOI 10.1016/j.jmb.2008.09.066; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hartmann C, 2008, J MOL BIOL, V377, P352, DOI 10.1016/j.jmb.2008.01.010; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hill CP, 2012, BBA-MOL CELL RES, V1823, P172, DOI 10.1016/j.bbamcr.2011.08.017; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Inoue M, 2008, TRAFFIC, V9, P2180, DOI 10.1111/j.1600-0854.2008.00831.x; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; Kieffer CC, 2008, PSYCHOANAL INQ, V28, P1, DOI 10.1080/07351690701787077; Landsberg MJ, 2009, STRUCTURE, V17, P427, DOI 10.1016/j.str.2008.12.020; Lee C, 2002, J BIOL CHEM, V277, P34760, DOI 10.1074/jbc.M204750200; Lottridge JM, 2006, P NATL ACAD SCI USA, V103, P6202, DOI 10.1073/pnas.0601712103; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Matyskiela ME, 2013, J MOL BIOL, V425, P199, DOI 10.1016/j.jmb.2012.11.001; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Monroe N, 2014, J MOL BIOL, V426, P510, DOI 10.1016/j.jmb.2013.09.043; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shestakova A, 2013, J BIOL CHEM, V288, P26810, DOI 10.1074/jbc.M113.497032; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Sysoeva TA, 2013, GENE DEV, V27, P2500, DOI 10.1101/gad.229385.113; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Vild CJ, 2014, J BIOL CHEM, V289, P10378, DOI 10.1074/jbc.M113.532960; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Webster BM, 2014, CELL, V159, P388, DOI 10.1016/j.cell.2014.09.012; Wehman AM, 2011, CURR BIOL, V21, P1951, DOI 10.1016/j.cub.2011.10.040; Weiss ER, 2011, J MOL BIOL, V410, P525, DOI 10.1016/j.jmb.2011.04.055; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Xiao JY, 2007, J MOL BIOL, V374, P655, DOI 10.1016/j.jmb.2007.09.067; Xiao JY, 2009, MOL BIOL CELL, V20, P3514, DOI 10.1091/mbc.E09-05-0403; Yang D, 2010, STRUCTURE, V18, P976, DOI 10.1016/j.str.2010.04.014; Yeo SCL, 2003, J CELL SCI, V116, P3957, DOI 10.1242/jcs.00751; Yu ZH, 2008, J MOL BIOL, V377, P364, DOI 10.1016/j.jmb.2008.01.009; Zhao ML, 2015, NATURE, V518, P61, DOI 10.1038/nature14148	69	26	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13490	13499		10.1074/jbc.M115.642355	http://dx.doi.org/10.1074/jbc.M115.642355			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25833946	hybrid, Green Published			2022-12-28	WOS:000354975700043
J	Jiang, L; Wei, YX; Ronquillo, CC; Marc, RE; Yoder, BK; Frederick, JM; Baehr, W				Jiang, Li; Wei, Yuxiao; Ronquillo, Cecinio C.; Marc, Robert E.; Yoder, Bradley K.; Frederick, Jeanne M.; Baehr, Wolfgang			Heterotrimeric Kinesin-2 (KIF3) Mediates Transition Zone and Axoneme Formation of Mouse Photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC KIDNEY-DISEASE; INTRAFLAGELLAR TRANSPORT; PRIMARY CILIUM; OUTER SEGMENT; IFT-PARTICLES; SENSORY CILIA; GENE TG737; PROTEIN; ROD; TRAFFICKING	Anterograde intraflagellar transport (IFT) employing kinesin-2 molecular motors has been implicated in trafficking of photoreceptor outer segment proteins. We generated embryonic retina-specific (prefix "emb") and adult tamoxifen-induced (prefix "tam") deletions of KIF3a and IFT88 in adult mice to study photoreceptor ciliogenesis and protein trafficking. In (emb)Kif3a(-/-) and in (emb)Ift88(-/-) mice, basal bodies failed to extend transition zones (connecting cilia) with outer segments, and visual pigments mistrafficked. In contrast, (tam)Kif3a(-/-) and (tam)Ift88(-/-) photoreceptor axonemes disintegrated slowly post-induction, starting distally, but rhodopsin and cone pigments trafficked normally for more than 2 weeks, a time interval during which the outer segment is completely renewed. The results demonstrate that visual pigments transport to the retinal outer segment despite removal of KIF3 and IFT88, and KIF3-mediated anterograde IFT is responsible for photoreceptor transition zone and axoneme formation.	[Jiang, Li; Wei, Yuxiao; Ronquillo, Cecinio C.; Marc, Robert E.; Frederick, Jeanne M.; Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; [Yoder, Bradley K.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Alabama System; University of Alabama Birmingham; Utah System of Higher Education; University of Utah	Jiang, L (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA.	li.jiang@hsc.utah.edu; wbaehr@hsc.utah.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [P30 DK074038]; NATIONAL EYE INSTITUTE [P30EY014800, R01EY015128, R01EY019298, R01EY002576, R01EY008123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Kevin Rapp for assistance in TEM experiments. The IFT88 conditional allele was provided by the National Institutes of Health supported Heptorenal Fibrocystic Disease Core Center (HRFDCC, P30 DK074038, B. Yoder).	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; Bader JR, 2012, VISION RES, V75, P37, DOI 10.1016/j.visres.2012.10.009; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Bhowmick R, 2009, TRAFFIC, V10, P648, DOI 10.1111/j.1600-0854.2009.00896.x; Chuang JZ, 2007, CELL, V130, P535, DOI 10.1016/j.cell.2007.06.030; Chuang Jen-Zen, 2015, Cilia, V4, P4, DOI 10.1186/s13630-015-0013-1; COLE DG, 1992, J CELL SCI, V101, P291; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Eckmiller MS, 1998, ACTA ANAT, V162, P133; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Giessl A, 2006, VISION RES, V46, P4502, DOI 10.1016/j.visres.2006.07.029; Gilliam JC, 2012, CELL, V151, P1029, DOI 10.1016/j.cell.2012.10.038; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Haycraft CJ, 2001, DEVELOPMENT, V128, P1493; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Insinna C, 2008, DEV DYNAM, V237, P1982, DOI 10.1002/dvdy.21554; Jiang L, 2011, P NATL ACAD SCI USA, V108, P18476, DOI 10.1073/pnas.1112758108; Jones BW, 2011, J COMP NEUROL, V519, P2713, DOI 10.1002/cne.22703; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kodani A, 2013, EMBO J, V32, P597, DOI 10.1038/emboj.2013.3; Kozminski Keith G., 1998, Cell Motility and the Cytoskeleton, V39, P347; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Li S, 2005, GENESIS, V41, P73, DOI 10.1002/gene.20097; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Liu Q, 2003, INVEST OPHTH VIS SCI, V44, P4171, DOI 10.1167/iovs.03-0410; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; McIntyre JC, 2012, NAT MED, V18, P1423, DOI 10.1038/nm.2860; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Neugebauer JM, 2009, NATURE, V458, P651, DOI 10.1038/nature07753; OLNEY JW, 1968, INVEST OPHTH VISUAL, V7, P250; ONUCHIC LF, 1995, MAMM GENOME, V6, P805, DOI 10.1007/BF00539009; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Pearring JN, 2013, PROG RETIN EYE RES, V36, P24, DOI 10.1016/j.preteyeres.2013.03.002; Praetorius HA, 2003, CURR OPIN NEPHROL HY, V12, P517, DOI 10.1097/00041552-200309000-00006; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Scholey JM, 2013, CURR BIOL, V23, pR956, DOI 10.1016/j.cub.2013.09.032; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Scholey JM, 2012, VISION RES, V75, P44, DOI 10.1016/j.visres.2012.06.015; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; Signor D, 1999, MOL BIOL CELL, V10, P345, DOI 10.1091/mbc.10.2.345; SOROKIN SP, 1968, J CELL SCI, V3, P207; Sukumaran S, 2009, VISION RES, V49, P479, DOI 10.1016/j.visres.2008.12.009; Trivedi D, 2012, J NEUROSCI, V32, P10587, DOI 10.1523/JNEUROSCI.0015-12.2012; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Wong-Riley Margaret T T, 2012, Biomol Concepts, V3, P267; Yamashita T, 2009, J NEUROSCI, V29, P9748, DOI 10.1523/JNEUROSCI.5854-08.2009; Ying GX, 2014, J NEUROSCI, V34, P6377, DOI 10.1523/JNEUROSCI.0067-14.2014; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700; Zhang JM, 2008, INVEST OPHTH VIS SCI, V49, P5561, DOI 10.1167/iovs.08-2226	65	39	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12765	12778		10.1074/jbc.M115.638437	http://dx.doi.org/10.1074/jbc.M115.638437			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25825494	Green Published, hybrid			2022-12-28	WOS:000354569000028
J	Kemp, MG; Lindsey-Boltz, LA; Sancar, A				Kemp, Michael G.; Lindsey-Boltz, Laura A.; Sancar, Aziz			UV Light Potentiates STING (Stimulator of Interferon Genes)-dependent Innate Immune Signaling through Deregulation of ULK1 (Unc51-like Kinase 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Autoimmunity; Autophagy; Cell Signaling; DNA Damage; DNA Damage Response; DNA Repair; Innate Immunity; Interferon; Nucleotide Excision Repair	NUCLEOTIDE EXCISION-REPAIR; CYCLIC GMP-AMP; CUTANEOUS LUPUS-ERYTHEMATOSUS; NF-KAPPA-B; CYTOSOLIC DNA; DI-GMP; HUMAN-CELLS; DARK SIDE; ACTIVATION; AMBRA1	Background: UV wavelengths of sunlight exacerbate the symptoms of autoimmunity. Results: UV and UV-mimetic chemical carcinogens stimulate STING-dependent innate immune signaling in keratinocytes and other human cells by disrupting the STING negative regulator ULK1. Conclusion: STING-dependent innate immune signaling is elevated in UV-irradiated human cells. Significance: Deregulation of innate immune signaling by UV light may contribute to autoimmunity. The mechanism by which ultraviolet (UV) wavelengths of sunlight trigger or exacerbate the symptoms of the autoimmune disorder lupus erythematosus is not known but may involve a role for the innate immune system. Here we show that UV radiation potentiates STING (stimulator of interferon genes)-dependent activation of the immune signaling transcription factor interferon regulatory factor 3 (IRF3) in response to cytosolic DNA and cyclic dinucleotides in keratinocytes and other human cells. Furthermore, we find that modulation of this innate immune response also occurs with UV-mimetic chemical carcinogens and in a manner that is independent of DNA repair and several DNA damage and cell stress response signaling pathways. Rather, we find that the stimulation of STING-dependent IRF3 activation by UV is due to apoptotic signaling-dependent disruption of ULK1 (Unc51-like kinase 1), a pro-autophagic protein that negatively regulates STING. Thus, deregulation of ULK1 signaling by UV-induced DNA damage may contribute to the negative effects of sunlight UV exposure in patients with autoimmune disorders.	[Kemp, Michael G.; Lindsey-Boltz, Laura A.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Kemp, MG (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Campus Box 7260, Chapel Hill, NC 27599 USA.	michael_kemp@med.unc.edu; aziz_sancar@med.unc.edu	Kemp, Michael G./AAT-1545-2021; Lindsey-Boltz, Laura/A-3121-2010; Regan, Clinton/E-6250-2012	Kemp, Michael G./0000-0001-8203-0745; Lindsey-Boltz, Laura/0000-0001-6493-8194; 	National Institutes of Health [R01GM32833, R21ES024425, P30ES010126]; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES024425, P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM32833 and R21ES024425 (to A. S.) and P30ES010126 (UNC Center for Environmental Health and Susceptibility Pilot Project Award; to M. K.).	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; BAER RL, 1965, ARCH DERMATOL, V92, P124, DOI 10.1001/archderm.92.2.124; Barbhaiya M, 2014, LUPUS, V23, P588, DOI 10.1177/0961203314530488; Bijl M, 2006, LUPUS, V15, P724, DOI 10.1177/0961203306071705; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Caricchio R, 2003, J IMMUNOL, V171, P5778, DOI 10.4049/jimmunol.171.11.5778; Choi JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1179; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Corazzari M, 2012, AUTOPHAGY, V8, P1255, DOI 10.4161/auto.20671; Danilchanka O, 2013, CELL, V154, P962, DOI 10.1016/j.cell.2013.08.014; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; EPSTEIN JH, 1965, ARCH DERMATOL, V91, P483, DOI 10.1001/archderm.1965.01600110069013; Fimia GM, 2013, ONCOGENE, V32, P3311, DOI 10.1038/onc.2012.455; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Goubau D, 2009, EUR J IMMUNOL, V39, P527, DOI 10.1002/eji.200838832; Hildesheim J, 2004, DNA REPAIR, V3, P567, DOI 10.1016/j.dnarep.2004.02.012; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Kemp MG, 2014, J BIOL CHEM, V289, P26574, DOI 10.1074/jbc.M114.597088; Kirshner JR, 2005, J VIROL, V79, P9320, DOI 10.1128/JVI.79.14.9320-9324.2005; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Kuhn A, 2006, ARTHRITIS RHEUM-US, V54, P939, DOI 10.1002/art.21658; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Nelson P, 2014, LUPUS, V23, P596, DOI 10.1177/0961203314531637; O'Neill LAJ, 2013, SCIENCE, V339, P763, DOI 10.1126/science.1234724; Pagliarini V, 2012, CELL DEATH DIFFER, V19, P1495, DOI 10.1038/cdd.2012.27; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Schaap P, 2013, IUBMB LIFE, V65, P897, DOI 10.1002/iub.1212; Schmidt E, 2007, ANN NY ACAD SCI, V1108, P35, DOI 10.1196/annals.1422.004; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; STERN RS, 1986, JAMA-J AM MED ASSOC, V255, P3120, DOI 10.1001/jama.255.22.3120; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yu C, 2013, J AUTOIMMUN, V41, P34, DOI 10.1016/j.jaut.2013.01.007; Zandman-Goddard G, 2003, CLIN REV ALLERG IMMU, V25, P29, DOI 10.1385/CRIAI:25:1:29; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	53	35	36	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12184	12194		10.1074/jbc.M115.649301	http://dx.doi.org/10.1074/jbc.M115.649301			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25792739	Green Published, hybrid			2022-12-28	WOS:000354388600030
J	Li, YF; Song, DL; Song, Y; Zhao, LL; Wolkow, N; Tobias, JW; Song, WC; Dunaief, JL				Li, Yafeng; Song, Delu; Song, Ying; Zhao, Liangliang; Wolkow, Natalie; Tobias, John W.; Song, Wenchao; Dunaief, Joshua L.			Iron-induced Local Complement Component 3 (C3) Up-regulation via Non-canonical Transforming Growth Factor (TGF)- Signaling in the Retinal Pigment Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CCAAT; Enhancer-binding Protein (C; EBP); Extracellular Signal-regulated Kinase (ERK); Iron; Signaling; Transforming Growth Factor (TGF-); AMD; C3; RPE; SMAD3	FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; OXIDATIVE STRESS; FACTOR-B; SMAD PROTEINS; KNOCKOUT MICE; ACTIVATION; CELLS; PHOSPHORYLATION; RISK	Background: Human age-related macular degeneration (AMD) retinas exhibit iron overload and localized C3 accumulation in the retinal pigment epithelium (RPE). Results: Iron induces C3 expression via ERK1/2, SMAD3, and CCAAT/enhancer-binding protein- (C/EBP-) in a non-canonical TGF- signaling pathway. Conclusion: An iron-mediated pathway leads to complement dysregulation, an etiologic feature of AMD. Significance: Regulating iron-induced C3 expression suggests a novel therapeutic approach for AMD. Dysregulation of iron homeostasis may be a pathogenic factor in age-related macular degeneration (AMD). Meanwhile, the formation of complement-containing deposits under the retinal pigment epithelial (RPE) cell layer is a pathognomonic feature of AMD. In this study, we investigated the molecular mechanisms by which complement component 3 (C3), a central protein in the complement cascade, is up-regulated by iron in RPE cells. Modulation of TGF- signaling, involving ERK1/2, SMAD3, and CCAAT/enhancer-binding protein-, is responsible for iron-induced C3 expression. The differential effects of spatially distinct SMAD3 phosphorylation sites at the linker region and at the C terminus determined the up-regulation of C3. Pharmacologic inhibition of either ERK1/2 or SMAD3 phosphorylation decreased iron-induced C3 expression levels. Knockdown of SMAD3 blocked the iron-induced up-regulation and nuclear accumulation of CCAAT/enhancer-binding protein-, a transcription factor that has been shown previously to bind the basic leucine zipper 1 domain in the C3 promoter. We show herein that mutation of this domain reduced iron-induced C3 promoter activity. In vivo studies support our in vitro finding of iron-induced C3 up-regulation. Mice with a mosaic pattern of RPE-specific iron overload demonstrated co-localization of iron-induced ferritin and C3d deposits. Humans with aceruloplasminemia causing RPE iron overload had increased RPE C3d deposition. The molecular events in the iron-C3 pathway represent therapeutic targets for AMD or other diseases exacerbated by iron-induced local complement dysregulation.	[Li, Yafeng; Song, Delu; Song, Ying; Zhao, Liangliang; Wolkow, Natalie; Dunaief, Joshua L.] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Tobias, John W.] Univ Penn, Penn Mol Profiling Facil, Philadelphia, PA 19104 USA; [Song, Wenchao] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Dunaief, JL (corresponding author), Univ Penn, Scheie Eye Inst, Perelman Sch Med, Dept Ophthalmol,Stellar Chance Labs 305B, 422 Curie Blvd, Philadelphia, PA 19104 USA.	jdunaief@mail.med.upenn.edu	Regan, Clinton/E-6250-2012	Wolkow, Natalie/0000-0003-1524-115X	National Institutes of Health [R01EY015240, R01EY023709, T32EY007035]; Research to Prevent Blindness; Beckman Institute for Macular Research; Paul and Evanina Bell Mackall Foundation Trust; F. M. Kirby Foundation; NATIONAL EYE INSTITUTE [R01EY023709, T32EY007035, P30EY001583, R01EY015240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Beckman Institute for Macular Research; Paul and Evanina Bell Mackall Foundation Trust; F. M. Kirby Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY015240 (to J. L. D.), R01EY023709 (to W. S.), and T32EY007035, a vision science training grant (to the University of Pennsylvania). This work was also supported by Research to Prevent Blindness, The Beckman Institute for Macular Research, the Paul and Evanina Bell Mackall Foundation Trust, and the F. M. Kirby Foundation.	Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Bae E, 2012, BIOCHEM BIOPH RES CO, V427, P593, DOI 10.1016/j.bbrc.2012.09.103; Chen M, 2007, EXP EYE RES, V84, P635, DOI 10.1016/j.exer.2006.11.015; Chen M, 2008, EXP EYE RES, V87, P543, DOI 10.1016/j.exer.2008.09.005; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dridi S, 2012, P NATL ACAD SCI USA, V109, P13781, DOI 10.1073/pnas.1206494109; Dunaief JL, 2006, INVEST OPHTH VIS SCI, V47, P4660, DOI 10.1167/iovs.06-0568; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Feinberg MW, 2004, J BIOL CHEM, V279, P16388, DOI 10.1074/jbc.M309664200; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Grassmann F, 2014, ADV EXP MED BIOL, V801, P291, DOI 10.1007/978-1-4614-3209-8_37; Guymer RH, 2011, INVEST OPHTH VIS SCI, V52, P4639, DOI 10.1167/iovs.10-7120; Hadziahmetovic M, 2008, INVEST OPHTH VIS SCI, V49, P2728, DOI 10.1167/iovs.07-1472; Hadziahmetovic M, 2012, TRANSL VIS SCI TECHN, V1, DOI 10.1167/tvst.1.3.2; Hadziahmetovic M, 2012, INVEST OPHTH VIS SCI, V53, P5231, DOI 10.1167/iovs.12-10204; Hadziahmetovic M, 2011, INVEST OPHTH VIS SCI, V52, P109, DOI 10.1167/iovs.10-6113; Hahn P, 2004, P NATL ACAD SCI USA, V101, P13850, DOI 10.1073/pnas.0405146101; Hahn P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1099, DOI 10.1001/archopht.121.8.1099; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Handa JT, 2012, MOL ASPECTS MED, V33, P418, DOI 10.1016/j.mam.2012.03.006; Hough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042513; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; JUAN TSC, 1993, P NATL ACAD SCI USA, V90, P2584, DOI 10.1073/pnas.90.7.2584; Kamato D, 2014, J PHARM PHARMACOL, V66, P1722, DOI 10.1111/jphp.12298; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; KOLB WP, 1989, COMPLEMENT INFLAMMAT, V6, P175, DOI 10.1159/000463093; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kunchithapautham K, 2014, J BIOL CHEM, V289, P14534, DOI 10.1074/jbc.M114.564674; Kunchithapautham K, 2011, J BIOL CHEM, V286, P23717, DOI 10.1074/jbc.M110.214593; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Maranto J, 2008, J NEUROIMMUNE PHARM, V3, P43, DOI 10.1007/s11481-007-9096-9; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Morgan BP, 2005, IMMUNOL LETT, V97, P171, DOI 10.1016/j.imlet.2004.11.010; Munoz P, 2011, J BIOL CHEM, V286, P13382, DOI 10.1074/jbc.M110.213785; Perkins SJ, 2012, IMMUNOBIOLOGY, V217, P281, DOI 10.1016/j.imbio.2011.10.003; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Salvador GA, 2011, NEUROTOXICOLOGY, V32, P75, DOI 10.1016/j.neuro.2010.11.006; Seddon JM, 2013, NAT GENET, V45, P1366, DOI 10.1038/ng.2741; Song DL, 2012, FREE RADICAL BIO MED, V53, P64, DOI 10.1016/j.freeradbiomed.2012.04.020; Tarasewicz E, 2012, CELL CYCLE, V11, P2443, DOI 10.4161/cc.20546; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang G., 2008, THESIS STATE U NEW J; Wang GN, 2009, J BIOL CHEM, V284, P9663, DOI 10.1074/jbc.M809281200; WILSON DR, 1990, MOL CELL BIOL, V10, P6181, DOI 10.1128/MCB.10.12.6181; Wolkow N, 2012, AM J PATHOL, V180, P1614, DOI 10.1016/j.ajpath.2011.12.041; Wolkow N, 2011, ARCH OPHTHALMOL-CHIC, V129, P1466, DOI 10.1001/archophthalmol.2011.309; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zipfel PF, 2010, ADV EXP MED BIOL, V703, P9, DOI 10.1007/978-1-4419-5635-4_2	61	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11918	11934		10.1074/jbc.M115.645903	http://dx.doi.org/10.1074/jbc.M115.645903			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25802332	Green Published, hybrid			2022-12-28	WOS:000354388600010
J	Wright, CM; van der Merwe, M; DeBrot, AH; Bjornsti, MA				Wright, Christine M.; van der Merwe, Marie; DeBrot, Amanda H.; Bjornsti, Mary-Ann			DNA Topoisomerase I Domain Interactions Impact Enzyme Activity and Sensitivity to Camptothecin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; DNA Topoisomerase; Protein Chimera; Protein Domain; Saccharomyces cerevisiae; Camptothecin	N-TERMINAL DOMAIN; CATALYTIC-ACTIVITY; FUNCTIONAL LINKER; MECHANISM; SITE; RESISTANCE; CLAMP; IDENTIFICATION; MUTATION; ARCHITECTURE	Background: Despite similarities in mechanism and architecture, human DNA topoisomerase I (Top1) is approximate to 100-fold more sensitive to camptothecin (CPT) than yeast Top1. Results: Reciprocal swaps of conserved and divergent protein domains alter chimeric Top1 activity. Conclusion: Conserved core and C-terminal domains dictate Top1 biochemical behavior and intrinsic CPT sensitivity. Significance: Interactions between nonconserved structural domains of Top1 impair cell viability, independent of enzyme catalysis. During processes such as DNA replication and transcription, DNA topoisomerase I (Top1) catalyzes the relaxation of DNA supercoils. The nuclear enzyme is also the cellular target of camptothecin (CPT) chemotherapeutics. Top1 contains four domains: the highly conserved core and C-terminal domains involved in catalysis, a coiled-coil linker domain of variable length, and a poorly conserved N-terminal domain. Yeast and human Top1 share a common reaction mechanism and domain structure. However, the human Top1 is approximate to 100-fold more sensitive to CPT. Moreover, substitutions of a conserved Gly(717) residue, which alter intrinsic enzyme sensitivity to CPT, induce distinct phenotypes in yeast. To address the structural basis for these differences, reciprocal swaps of yeast and human Top1 domains were engineered in chimeric enzymes. Here we report that intrinsic Top1 sensitivity to CPT is dictated by the composition of the conserved core and C-terminal domains. However, independent of CPT, biochemically similar chimeric enzymes produced strikingly distinct phenotypes in yeast. Expression of a human Top1 chimera containing the yeast linker domain proved toxic, even in the context of a catalytically inactive Y723F enzyme. Lethality was suppressed either by splicing the yeast N-terminal domain into the chimera, deleting the human N-terminal residues, or in enzymes reconstituted by polypeptide complementation. These data demonstrate a functional interaction between the N-terminal and linker domains, which, when mispaired between yeast and human enzymes, induces cell lethality. Because toxicity was independent of enzyme catalysis, the inappropriate coordination of N-terminal and linker domains may induce aberrant Top1-protein interactions to impair cell growth.	[Wright, Christine M.; DeBrot, Amanda H.; Bjornsti, Mary-Ann] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; [van der Merwe, Marie] St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA	University of Alabama System; University of Alabama Birmingham; St Jude Children's Research Hospital	Bjornsti, MA (corresponding author), Univ Alabama Birmingham, Dept Pharmacol & Toxicol, 1670 Univ Blvd, Birmingham, AL 35294 USA.	bjornsti@uab.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [CA58755]; University of Alabama at Birmingham Cancer Center [P30CA013148]; NATIONAL CANCER INSTITUTE [R01CA058755, P30CA013148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA58755 (to M.-A. B.). This work was also supported by University of Alabama at Birmingham Cancer Center Core Grant P30CA013148.	Albor A, 1998, CANCER RES, V58, P2091; ALSNER J, 1992, J BIOL CHEM, V267, P12408; Arno B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068404; Bharti AK, 1996, J BIOL CHEM, V271, P1993, DOI 10.1074/jbc.271.4.1993; BJORNSTI MA, 1987, P NATL ACAD SCI USA, V84, P8971, DOI 10.1073/pnas.84.24.8971; Bjornsti MA, 2002, CANCER CELL, V2, P267, DOI 10.1016/S1535-6108(02)00160-5; Carey JF, 2003, P NATL ACAD SCI USA, V100, P5640, DOI 10.1073/pnas.1031537100; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen SH, 2013, ANNU REV BIOCHEM, V82, P139, DOI 10.1146/annurev-biochem-061809-100002; Chrencik JE, 2004, J MOL BIOL, V339, P773, DOI 10.1016/j.jmb.2004.03.007; Christensen MO, 2002, J BIOL CHEM, V277, P35932, DOI 10.1074/jbc.M204738200; Colley WC, 2004, J BIOL CHEM, V279, P54069, DOI 10.1074/jbc.M409764200; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Czubaty A, 2005, BBA-PROTEINS PROTEOM, V1749, P133, DOI 10.1016/j.bbapap.2005.03.007; DARPA P, 1988, P NATL ACAD SCI USA, V85, P2543, DOI 10.1073/pnas.85.8.2543; Fertala J, 2000, J BIOL CHEM, V275, P15246, DOI 10.1074/jbc.275.20.15246; Fiorani P, 1999, MOL PHARMACOL, V56, P1105, DOI 10.1124/mol.56.6.1105; Fiorani P, 2003, J BIOL CHEM, V278, P43268, DOI 10.1074/jbc.M303899200; Frohlich RF, 2004, J MOL BIOL, V336, P93, DOI 10.1016/j.jmb.2003.12.007; Frohlich RF, 2008, BIOCHEMISTRY-US, V47, P7127, DOI 10.1021/bi800031k; Frohlich RF, 2007, NUCLEIC ACIDS RES, V35, P6170, DOI 10.1093/nar/gkm669; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Girstun A, 2008, BIOCHEM BIOPH RES CO, V366, P250, DOI 10.1016/j.bbrc.2007.11.131; Gongora C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-64; Haluska P, 1998, ADV ENZYME REGUL, V38, P253, DOI 10.1016/S0065-2571(97)00008-3; Ioanoviciu A, 2005, J MED CHEM, V48, P4803, DOI 10.1021/jm050076b; Jansen JG, 2007, MOL CELL, V28, P522, DOI 10.1016/j.molcel.2007.11.005; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Krogh BO, 2000, MOL CELL, V5, P1035, DOI 10.1016/S1097-2765(00)80268-3; Krogh BO, 2002, P NATL ACAD SCI USA, V99, P1853, DOI 10.1073/pnas.032613199; Laco GS, 2008, BIOCHEM J, V411, P523, DOI 10.1042/BJ20071436; Lisby M, 2001, J BIOL CHEM, V276, P20220, DOI 10.1074/jbc.M010991200; Megonigal MD, 1997, J BIOL CHEM, V272, P12801, DOI 10.1074/jbc.272.19.12801; Palle K, 2008, J BIOL CHEM, V283, P27767, DOI 10.1074/jbc.M804826200; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; SHUMAN S, 1988, J BIOL CHEM, V263, P16401; Shykind BM, 1997, GENE DEV, V11, P397, DOI 10.1101/gad.11.3.397; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1999, J BIOL CHEM, V274, P32950, DOI 10.1074/jbc.274.46.32950; Stewart L, 1997, J MOL BIOL, V269, P355, DOI 10.1006/jmbi.1997.1056; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stewart L, 1996, J BIOL CHEM, V271, P7602, DOI 10.1074/jbc.271.13.7602; Tesauro C., 2012, J AMINO ACIDS, V2012; van der Merwe M, 2008, J BIOL CHEM, V283, P3305, DOI 10.1074/jbc.M705781200; van Waardenburg RCAM, 2006, MOL CELL BIOL, V26, P4958, DOI 10.1128/MCB.00160-06; Villa H, 2003, J BIOL CHEM, V278, P3521, DOI 10.1074/jbc.M203991200; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Woo MH, 2003, P NATL ACAD SCI USA, V100, P13767, DOI 10.1073/pnas.2235886100; Woo MH, 2002, J BIOL CHEM, V277, P3813, DOI 10.1074/jbc.M110484200; Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998	55	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12068	12078		10.1074/jbc.M114.635078	http://dx.doi.org/10.1074/jbc.M114.635078			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25795777	Green Published, hybrid			2022-12-28	WOS:000354388600022
J	You, LY; Yan, KZ; Zou, JF; Zhao, H; Bertos, NR; Park, M; Wang, E; Yang, XJ				You, Linya; Yan, Kezhi; Zou, Jinfeng; Zhao, Hong; Bertos, Nicholas R.; Park, Morag; Wang, Edwin; Yang, Xiang-Jiao			The Chromatin Regulator Brpf1 Regulates Embryo Development and Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; LEUKEMIA ZINC-FINGER; HISTONE ACETYLTRANSFERASE KAT6B; CAUSE GENITOPATELLAR SYNDROME; ACUTE MYELOID-LEUKEMIA; DE-NOVO MUTATIONS; MICE LACKING; PLACENTAL DEVELOPMENT; GENE-EXPRESSION; BREAST-CANCER	With hundreds of chromatin regulators identified in mammals, an emerging issue is how they modulate biological and pathological processes. BRPF1 (bromodomain-and PHD finger-containing protein 1) is a unique chromatin regulator possessing two PHD fingers, one bromodomain and a PWWP domain for recognizing multiple histone modifications. In addition, it binds to the acetyltransferases MOZ, MORF, and HBO1 (also known as KAT6A, KAT6B, and KAT7, respectively) to promote complex formation, restrict substrate specificity, and enhance enzymatic activity. Wehave recently showed that ablation of the mouse Brpf1 gene causes embryonic lethality at E9.5. Here we present systematic analyses of the mutant animals and demonstrate that the ablation leads to vascular defects in the placenta, yolk sac, and embryo proper, as well as abnormal neural tube closure. At the cellular level, Brpf1 loss inhibits proliferation of embryonic fibroblasts and hematopoietic progenitors. Molecularly, the loss reduces transcription of a ribosomal protein L10 (Rpl10)-like gene and the cell cycle inhibitor p27, and increases expression of the cell-cycle inhibitor p16 and a novel protein homologous to Scp3, a synaptonemal complex protein critical for chromosome association and embryo survival. These results uncover a crucial role of Brpf1 in controlling mouse embryo development and regulating cellular and gene expression programs.	[You, Linya; Yan, Kezhi; Zhao, Hong; Bertos, Nicholas R.; Park, Morag; Yang, Xiang-Jiao] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [You, Linya; Park, Morag; Yang, Xiang-Jiao] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Yan, Kezhi; Park, Morag; Yang, Xiang-Jiao] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Zou, Jinfeng; Wang, Edwin] Natl Res Council Canada, Montreal, PQ H4P 2R2, Canada; [Park, Morag; Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; McGill University; National Research Council Canada; McGill University	Yang, XJ (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	xiang-jiao.yang@mcgill.ca	Wang, Edwin/Y-1553-2019	You, Linya/0000-0002-2569-0269	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by operating grants from Canadian Institutes of Health Research (CIHR) and Natural Sciences and Engineering Research Council of Canada (NSERC) (to X.-J. Y.).	Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Arboleda VA, 2015, AM J HUM GENET, V96, P498, DOI 10.1016/j.ajhg.2015.01.017; Baron MH, 2013, BLOOD CELL MOL DIS, V51, P213, DOI 10.1016/j.bcmd.2013.07.006; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Brooks SS, 2014, GENETICS, V198, P723, DOI 10.1534/genetics.114.168211; Bu P, 2007, MOL CELL BIOL, V27, P3405, DOI 10.1128/MCB.00066-07; Campeau PM, 2012, AM J HUM GENET, V90, P282, DOI 10.1016/j.ajhg.2011.11.023; Canault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013433; Chamberlin HM, 2000, DEVELOPMENT, V127, P713; Champagne N, 1999, J BIOL CHEM, V274, P28528, DOI 10.1074/jbc.274.40.28528; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Chinen Y, 2014, GENE CHROMOSOME CANC, V53, P299, DOI 10.1002/gcc.22140; Chiocchetti A, 2011, AM J MED GENET A, V155A, P1472, DOI 10.1002/ajmg.a.33977; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Grienenberger A, 2002, CURR BIOL, V12, P762, DOI 10.1016/S0960-9822(02)00814-X; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hibiya K, 2009, DEV BIOL, V329, P176, DOI 10.1016/j.ydbio.2009.02.021; HORAK ER, 1992, LANCET, V340, P1120, DOI 10.1016/0140-6736(92)93150-L; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Katsumoto T, 2006, GENE DEV, V20, P1321, DOI 10.1101/gad.1393106; Kaufman M.H., 1999, ANATOMICAL BASIS MOU; Kaufmann M. H., 1994, ATLAS MOUSE DEV; Kim GW, 2013, J BIOL CHEM, V288, P20334, DOI 10.1074/jbc.M113.464792; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kraft M, 2011, J CLIN INVEST, V121, P3479, DOI 10.1172/JCI43428; Kueh AJ, 2011, MOL CELL BIOL, V31, P845, DOI 10.1128/MCB.00159-10; Lalonde ME, 2014, GENE DEV, V28, P1029, DOI 10.1101/gad.236331.113; Lalonde ME, 2013, GENE DEV, V27, P2009, DOI 10.1101/gad.223396.113; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Laue K, 2008, DEVELOPMENT, V135, P1935, DOI 10.1242/dev.017160; Li YH, 1998, NAT GENET, V20, P309, DOI 10.1038/3129; Lubula MY, 2014, FEBS LETT, V588, P3844, DOI 10.1016/j.febslet.2014.09.028; Lynch H, 2013, BREAST J, V19, P520, DOI 10.1111/tbj.12145; MEMBERG SP, 1995, J NEUROBIOL, V27, P26, DOI 10.1002/neu.480270104; Mishima Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6872; Mishima Y, 2011, BLOOD, V118, P2443, DOI 10.1182/blood-2011-01-331892; Moore SDP, 2004, CANCER RES, V64, P5570, DOI 10.1158/0008-5472.CAN-04-0050; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Narla A, 2011, BLOOD, V118, P4300, DOI 10.1182/blood-2011-08-372250; ORKIN SH, 1975, P NATL ACAD SCI USA, V72, P98, DOI 10.1073/pnas.72.1.98; Panagopoulos I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117010; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Perez-Campo FM, 2009, BLOOD, V113, P4866, DOI 10.1182/blood-2008-04-152017; Perry J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-6; Piton A, 2013, AM J HUM GENET, V93, P368, DOI 10.1016/j.ajhg.2013.06.013; Qin S, 2011, J BIOL CHEM, V286, P36944, DOI 10.1074/jbc.M111.244400; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sengupta J, 2010, J CELL BIOL, V189, P1079, DOI 10.1083/jcb.201001124; Sheikh BN, 2015, BLOOD, V125, P1910, DOI 10.1182/blood-2014-08-594655; Shi YQ, 2013, GENE, V527, P352, DOI 10.1016/j.gene.2013.06.033; SIEGEL JN, 1987, J EXP MED, V166, P1702, DOI 10.1084/jem.166.6.1702; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Simpson MA, 2012, AM J HUM GENET, V90, P290, DOI 10.1016/j.ajhg.2011.11.024; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Sulima SO, 2014, P NATL ACAD SCI USA, V111, P5640, DOI 10.1073/pnas.1400247111; Sulima SO, 2014, NUCLEIC ACIDS RES, V42, P2049, DOI 10.1093/nar/gkt1107; Szakszon K, 2013, AM J MED GENET A, V161A, P884, DOI 10.1002/ajmg.a.35848; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tham E, 2015, AM J HUM GENET, V96, P507, DOI 10.1016/j.ajhg.2015.01.016; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; Thomas T, 2000, DEVELOPMENT, V127, P2537; Tsutsumi M, 2011, BIOL REPROD, V85, P165, DOI 10.1095/biolreprod.110.087270; Uechi T, 2002, NUCLEIC ACIDS RES, V30, P5369, DOI 10.1093/nar/gkf696; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Vandewalle J, 2009, AM J HUM GENET, V85, P809, DOI 10.1016/j.ajhg.2009.10.019; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; VINDELOV LL, 1977, VIRCHOWS ARCH B, V24, P227; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; You LY, 2015, J BIOL CHEM, V290, P7114, DOI 10.1074/jbc.M114.635250; You LY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005034; You LY, 2014, EPIGENETICS-US, V9, P860, DOI 10.4161/epi.28530; Yu HC, 2014, AM J MED GENET A, V164, P950, DOI 10.1002/ajmg.a.36379; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang Y, 2013, DEV CELL, V24, P411, DOI 10.1016/j.devcel.2013.01.018; Zhuang XJ, 2014, CELL CYCLE, V13, P2230, DOI 10.4161/cc.29265	89	26	26	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11349	11364		10.1074/jbc.M115.643189	http://dx.doi.org/10.1074/jbc.M115.643189			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25773539	Green Published, hybrid			2022-12-28	WOS:000353719400012
J	Cho, JH; Dimri, M; Dimri, GP				Cho, Joon-Ho; Dimri, Manjari; Dimri, Goberdhan P.			MicroRNA-31 Is a Transcriptional Target of Histone Deacetylase Inhibitors and a Regulator of Cellular Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Histone Deacetylase Inhibitor (HDAC Inhibitor) (HDI); MicroRNA (miRNA); Polycomb; Senescence; bmi1	POLYCOMB GROUP PROTEIN; BREAST-CANCER CELLS; MAMMARY EPITHELIAL-CELLS; DOWN-REGULATION; TUMOR-SUPPRESSOR; LIFE-SPAN; IN-VIVO; H-RAS; EXPRESSION; BMI-1	Background: Histone deacetylase inhibitor (HDACi) inhibits expression of polycomb group proteins and can differentially regulate expression of miRNAs. Results: HDACi up-regulated expression of miR-31, which down-regulated BMI1 and induced cellular senescence. Conclusion: miR-31 is a novel target of HDACi, and is a novel regulator of cellular senescence. Significance: HDACi can be used to induce miR-31, which in turn can cause senescence in cancer cells. MicroRNAs (miRNAs) have emerged as important regulators of tumorigenesis. Several miRNAs, which can function either as oncomiRs or tumor suppressive miRs are deregulated in cancer cells. The microRNA-31 (miR-31) has been shown to be overexpressed in metastatic breast cancer. It promotes multiple oncogenic phenotypes, including proliferation, motility, and invasion of cancer cells. Using a breast cancer-related miRNA array analysis, we identified miR-31 as a novel target of histone deacetylase inhibitors (HDACi) in breast cancer cells. Specifically, we show that sodium butyrate (NaB) and panobinostat (LBH589), two broad-spectrum HDAC inhibitors up-regulate hsa-miR-31 (miR-31). The up-regulation of miR-31 was accompanied by repression of the polycomb group (PcG) protein BMI1 and induction of cellular senescence. We further show that inhibition of miR-31 overcomes the senescence-inducing effect of HDACi, and restores expression of the PcG protein BMI1. Interestingly, BMI1 also acts as a repressor of miR-31 transcription, suggesting a cross-negative feedback loop between the expression of miR-31 and BMI1. Our data suggest that miR-31 is an important physiological target of HDACi, and that it is an important regulator of senescence relevant to cancer. These studies further suggest that manipulation of miR-31 expression can be used to modulate senescence-related pathological conditions such as cancer, and the aging process.	[Cho, Joon-Ho; Dimri, Manjari; Dimri, Goberdhan P.] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA	George Washington University	Dimri, M (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA.	mdimri@gwu.edu; gdimri@gwu.edu	Dimri, Goberdhan/AAO-4210-2021		National Institutes of Health from the NCI [RO1 CA094150]; NATIONAL CANCER INSTITUTE [R01CA094150] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA094150 from the NCI (to G. P. D.)	Asangani IA, 2012, ONCOTARGET, V3, P1011, DOI 10.18632/oncotarget.622; Augoff K, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-5; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bommi PV, 2010, CELL CYCLE, V9, P2663, DOI 10.4161/cc.9.13.12147; Chatterjee N, 2013, CANCER BIOL THER, V14, P658, DOI 10.4161/cbt.25088; Cho JH, 2013, J BIOL CHEM, V288, P3406, DOI 10.1074/jbc.M112.422931; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dimri GP, 2002, CANCER RES, V62, P4736; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Dimri M, 2015, J BIOL CHEM, V290, P3033, DOI 10.1074/jbc.M114.615179; Dimri M, 2013, CELL CYCLE, V12, P3537, DOI 10.4161/cc.26592; Dutton A, 2007, BLOOD, V109, P2597, DOI 10.1182/blood-2006-05-020545; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fiskus W, 2006, MOL CANCER THER, V5, P3096, DOI 10.1158/1535-7163.MCT-06-0418; Gargiulo G, 2013, CANCER CELL, V23, P660, DOI 10.1016/j.ccr.2013.03.030; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Hulf T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-54; Iorio MV, 2012, CARCINOGENESIS, V33, P1126, DOI 10.1093/carcin/bgs140; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Itahana Koji, 2013, Methods Mol Biol, V965, P143, DOI 10.1007/978-1-62703-239-1_8; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Kim RH, 2010, EXP CELL RES, V316, P2600, DOI 10.1016/j.yexcr.2010.04.013; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Laurila EM, 2013, GENE CHROMOSOME CANC, V52, P1103, DOI 10.1002/gcc.22107; Lee JY, 2014, ONCOGENE, V33, P1325, DOI 10.1038/onc.2013.53; Lin PC, 2013, CANCER RES, V73, P1232, DOI 10.1158/0008-5472.CAN-12-2968; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Neves Rui, 2010, BMC Res Notes, V3, P219, DOI 10.1186/1756-0500-3-219; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Rhodes LV, 2012, ONCOL REP, V27, P10, DOI 10.3892/or.2011.1488; Sahasrabuddhe AA, 2011, CELL CYCLE, V10, P1322, DOI 10.4161/cc.10.8.15372; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Valastyan S, 2011, GENE DEV, V25, P646, DOI 10.1101/gad.2004211; Valastyan S, 2010, CELL CYCLE, V9, P2124, DOI 10.4161/cc.9.11.11843; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wang S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.79; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015	58	58	62	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10555	10567		10.1074/jbc.M114.624361	http://dx.doi.org/10.1074/jbc.M114.624361			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25737447	Green Published, hybrid			2022-12-28	WOS:000353241100053
J	Yu, QJ; Carbone, CJ; Katlinskaya, YV; Zheng, H; Zheng, K; Luo, MC; Wang, PJ; Greenberg, RA; Fuchs, SY				Yu, Qiujing; Carbone, Christopher J.; Katlinskaya, Yuliya V.; Zheng, Hui; Zheng, Ke; Luo, Mengcheng; Wang, P. Jeremy; Greenberg, Roger A.; Fuchs, Serge Y.			Type I Interferon Controls Propagation of Long Interspersed Element-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; genomic instability; interferon; receptor; signaling; LINE-1; radiation; retrotransposon	SYSTEMIC-LUPUS-ERYTHEMATOSUS; CULTURED HUMAN-CELLS; L1 RETROTRANSPOSITION; DNA-DAMAGE; LINE-1 RETROTRANSPOSITION; HUMAN HEPATOCYTES; APOBEC3; RESPONSES; PROTEINS; RECEPTOR	Type I interferons (IFN) including IFN and IFN are critical for the cellular defense against viruses. Here we report that increased levels of IFN were found in testes from mice deficient in MOV10L1, a germ cell-specific RNA helicase that plays a key role in limiting the propagation of retrotransposons including Long Interspersed Element-1 (LINE-1). Additional experiments revealed that activation of LINE-1 retrotransposons increases the expression of IFN and of IFN-stimulated genes. Conversely, pretreatment of cells with IFN suppressed the replication of LINE-1. Furthermore, the efficacy of LINE-1 replication was increased in isogenic cell lines harboring inactivating mutations in diverse elements of the IFN signaling pathway. Knockdown of the IFN receptor chain IFNAR1 also stimulated LINE-1 propagation in vitro. Finally, a greater accumulation of LINE-1 was found in mice that lack IFNAR1 compared with wild type mice. We propose that LINE-1-induced IFN plays an important role in restricting LINE-1 propagation and discuss the putative role of IFN in preserving the genome stability.	[Yu, Qiujing; Carbone, Christopher J.; Katlinskaya, Yuliya V.; Zheng, Hui; Zheng, Ke; Luo, Mengcheng; Wang, P. Jeremy; Fuchs, Serge Y.] Univ Penn, Dept Anim Biol, Sch Vet Med, Philadelphia, PA 19104 USA; [Greenberg, Roger A.] Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Basser Res Ctr BRCA,Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Fuchs, SY (corresponding author), Univ Penn, Dept Anim Biol, Sch Vet Med, Philadelphia, PA 19104 USA.	syfuchs@vet.upenn.edu	Zheng, Hui/ABD-6141-2021		National Institutes of Health/National Cancer Institute [CA092900, CA142425]; National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA142425, R01CA092900, P01CA165997] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health/National Cancer Institute Grants CA092900 and CA142425 (to S. Y. F.). Funding for open access charges is by the National Institutes of Health.	Belgnaoui SM, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-13; Bhattacharya S, 2014, EMBO MOL MED, V6, P384, DOI 10.1002/emmm.201303236; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Bronson PG, 2012, CURR OPIN IMMUNOL, V24, P530, DOI 10.1016/j.coi.2012.07.008; Brzostek-Racine S, 2011, J IMMUNOL, V187, P5336, DOI 10.4049/jimmunol.1100040; Crow MK, 2010, AUTOIMMUNITY, V43, P7, DOI 10.3109/08916930903374865; Elkon KB, 2012, CURR OPIN RHEUMATOL, V24, P499, DOI 10.1097/BOR.0b013e3283562c3e; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Farkash EA, 2006, NUCLEIC ACIDS RES, V34, P1196, DOI 10.1093/nar/gkj522; Frost RJA, 2010, P NATL ACAD SCI USA, V107, P11847, DOI 10.1073/pnas.1007158107; Fuchs SY, 2013, J INTERF CYTOK RES, V33, P211, DOI 10.1089/jir.2012.0117; Fuchs SY, 2012, GROWTH FACTORS, V30, P141, DOI 10.3109/08977194.2012.669382; Furano AV, 2000, PROG NUCLEIC ACID RE, V64, P255, DOI 10.1016/S0079-6603(00)64007-2; Galligan CL, 2006, IMMUNOL RES, V35, P27, DOI 10.1385/IR:35:1:27; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Goodier JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002941; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kim T, 1999, J BIOL CHEM, V274, P30686, DOI 10.1074/jbc.274.43.30686; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leonova KI, 2013, P NATL ACAD SCI USA, V110, pE89, DOI 10.1073/pnas.1216922110; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Lovsin N, 2009, ANN NY ACAD SCI, V1178, P268, DOI 10.1111/j.1749-6632.2009.05006.x; Marijanovic Z, 2006, BIOCHEM J, V397, P31, DOI 10.1042/BJ20060272; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Moiseeva O, 2006, MOL BIOL CELL, V17, P1583, DOI 10.1091/mbc.E05-09-0858; Morrish TA, 2007, NATURE, V446, P208, DOI 10.1038/nature05560; Munoz-Fontela C, 2008, J EXP MED, V205, P1929, DOI 10.1084/jem.20080383; Nakkuntod J, 2011, CLIN CHIM ACTA, V412, P1457, DOI 10.1016/j.cca.2011.04.002; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Prak ETL, 2003, P NATL ACAD SCI USA, V100, P1832, DOI 10.1073/pnas.0337627100; Rangwala SH, 2009, METHODS, V49, P219, DOI 10.1016/j.ymeth.2009.04.012; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Tanaka Y, 2006, BIOCHEM BIOPH RES CO, V341, P314, DOI 10.1016/j.bbrc.2005.12.192; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Wallace NA, 2008, GENE, V419, P75, DOI 10.1016/j.gene.2008.04.013; Weitzman MD, 2010, ANNU REV MICROBIOL, V64, P61, DOI 10.1146/annurev.micro.112408.134016; Zhang A, 2014, NUCLEIC ACIDS RES, V42, P3803, DOI 10.1093/nar/gkt1308; Zheng H, 2013, CELL REP, V5, P180, DOI 10.1016/j.celrep.2013.08.025; Zheng K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003038; Zheng K, 2010, P NATL ACAD SCI USA, V107, P11841, DOI 10.1073/pnas.1003953107	51	46	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10191	10199		10.1074/jbc.M114.612374	http://dx.doi.org/10.1074/jbc.M114.612374			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25716322	Green Published, hybrid			2022-12-28	WOS:000353241100025
J	Danielson, BT; Knudson, CB; Knudson, W				Danielson, Ben T.; Knudson, Cheryl B.; Knudson, Warren			Extracellular Processing of the Cartilage Proteoglycan Aggregate and Its Effect on CD44-mediated Internalization of Hyaluronan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ARTICULAR-CARTILAGE; AGE-RELATED-CHANGES; RECEPTOR-MEDIATED ENDOCYTOSIS; SWARM RAT CHONDROSARCOMA; SMOOTH-MUSCLE-CELLS; PERICELLULAR MATRIX; G1 DOMAIN; IN-VIVO; CHONDROITIN SULFATE; SYNOVIAL-FLUID	In many cells hyaluronan receptor CD44 mediates the endocytosis of hyaluronan and its delivery to endosomes/lysosornes. The regulation of this process remains largely unknown. In most extracellular matrices hyaluronan is not present as a free polysaccharide but often is found in complex with other small proteins and macromolecules such as proteoglycans. This is especially true in cartilage, where hyaluronan assembles into an aggregate structure with the large proteoglycan termed aggrecan. In this study when purified aggrecan was added to FITC-conjugated hyaluronan, no internalization of hyaluronan was detected. This suggested that the overall size of the aggregate prevented hyaluronan endocytosis and furthermore that proteolysis of the aggrecan was a required prerequisite for local, cell-based turnover of hyaluronan. To test this hypothesis, limited C-terminal digestion of aggrecan was performed to determine whether a size range of aggrecan exists that permits hyaluronan endocytosis. Our data demonstrate that only limited degradation of the aggrecan monomer was required to allow for hyaluronan internalization. When hyaluronan was combined with partially degraded, dansyl chloride-labeled aggrecan, blue fluorescent aggrecan was also visualized within intracellular vesicles. It was also determined that sonicated hyaluronan of smaller molecular size was internalized more readily than high molecular mass hyaluronan. However, the addition of intact aggrecan to hyaluronan chains sonicated for 5 and 10 s reblocked their endocytosis, whereas aggregates containing 15-s sonicated hyaluronan were internalized. These data suggest that hyaluronan endocytosis is regulated in large part by the extracellular proteolytic processing of hyaluronan-bound proteoglycan.	[Danielson, Ben T.; Knudson, Cheryl B.; Knudson, Warren] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, 600 Moye Blvd,Mailstop 620, Greenville, NC 27834 USA	University of North Carolina; East Carolina University	Knudson, W (corresponding author), E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, 600 Moye Blvd,Mailstop 620, Greenville, NC 27834 USA.	knudsonw@ecu.edu			National Institutes of Health [R01-AR43384, R21 AR066581-01, R01-AR39507]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043384, R21AR066581, R01AR039507] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AR43384 (to W. K.), R21 AR066581-01 (to W. K.), and R01-AR39507 (to C. B. K.).	Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Aguiar DJ, 1999, EXP CELL RES, V252, P292, DOI 10.1006/excr.1999.4641; Ariyoshi W, 2010, J BIOL CHEM, V285, P36216, DOI 10.1074/jbc.M110.129270; Aspberg A, 2012, J HISTOCHEM CYTOCHEM, V60, P987, DOI 10.1369/0022155412464376; Bartzatt R, 2001, J BIOCHEM BIOPH METH, V47, P189, DOI 10.1016/S0165-022X(00)00136-6; Bhilocha S, 2011, ANAL BIOCHEM, V417, P41, DOI 10.1016/j.ab.2011.05.026; BUCKWALTER JA, 1985, J ORTHOP RES, V3, P251, DOI 10.1002/jor.1100030301; BUCKWALTER JA, 1982, J BIOL CHEM, V257, P9830; CAPUTO CB, 1980, ARCH BIOCHEM BIOPHYS, V204, P220, DOI 10.1016/0003-9861(80)90027-2; CHOI HU, 1971, P NATL ACAD SCI USA, V68, P877, DOI 10.1073/pnas.68.5.877; Cowman MK, 2011, ANAL BIOCHEM, V417, P50, DOI 10.1016/j.ab.2011.05.023; CULTY M, 1994, J CELL PHYSIOL, V160, P275, DOI 10.1002/jcp.1041600209; CULTY M, 1992, J CELL BIOL, V116, P1055, DOI 10.1083/jcb.116.4.1055; Dunmore BJ, 2013, HUM MOL GENET, V22, P3667, DOI 10.1093/hmg/ddt216; Durigova M, 2008, OSTEOARTHR CARTILAGE, V16, P98, DOI 10.1016/j.joca.2007.05.002; Embry JJ, 2003, ARTHRITIS RHEUM-US, V48, P3431, DOI 10.1002/art.11323; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; FLANNERY CR, 1992, J BIOL CHEM, V267, P1008; Flory JJE, 2006, ARTHRITIS RHEUM-US, V54, P443, DOI 10.1002/art.21623; Fosang AJ, 2008, EUR CELLS MATER, V15, P11, DOI 10.22203/eCM.v015a02; FRASER JRE, 1988, BIOCHEM J, V256, P153, DOI 10.1042/bj2560153; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Guzik K, 2007, CELL DEATH DIFFER, V14, P171, DOI 10.1038/sj.cdd.4401927; Haapala J, 1996, J RHEUMATOL, V23, P1586; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; HASCALL VC, 1976, J BIOL CHEM, V251, P3511; Hattori N, 2011, J BIOL CHEM, V286, P34298, DOI 10.1074/jbc.M111.254938; HOLMES MWA, 1988, BIOCHEM J, V250, P435, DOI 10.1042/bj2500435; HUA Q, 1993, J CELL SCI, V106, P365; Hudson KS, 2010, ANAT REC, V293, P1669, DOI 10.1002/ar.21235; Ida M, 2006, J BIOL CHEM, V281, P5982, DOI 10.1074/jbc.M507130200; Ito T, 2004, AM J PATHOL, V164, P1979, DOI 10.1016/S0002-9440(10)63758-3; Jiang H, 2002, J BIOL CHEM, V277, P10531, DOI 10.1074/jbc.M108654200; Jiang H, 2001, ARTHRITIS RHEUM-US, V44, P2599, DOI 10.1002/1529-0131(200111)44:11<2599::AID-ART440>3.0.CO;2-Y; Kern CB, 2007, DEV DYNAM, V236, P671, DOI 10.1002/dvdy.21059; KNUDSON CB, 1985, J CELL BIOL, V100, P1753, DOI 10.1083/jcb.100.5.1753; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; Knudson W, 2000, ARTHRITIS RHEUM-US, V43, P1165, DOI 10.1002/1529-0131(200005)43:5<1165::AID-ANR27>3.0.CO;2-H; Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320; KNUDSON W, 1993, P NATL ACAD SCI USA, V90, P4003, DOI 10.1073/pnas.90.9.4003; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; KUCHARSKA AM, 1990, J ORTHOPAED RES, V8, P781, DOI 10.1002/jor.1100080602; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; LOHMANDER LS, 1993, ARTHRITIS RHEUM-US, V36, P181, DOI 10.1002/art.1780360207; MCGUIRE PG, 1987, J CELL PHYSIOL, V133, P267, DOI 10.1002/jcp.1041330210; Mellor L, 2013, J BIOL CHEM, V288, P25838, DOI 10.1074/jbc.M113.494872; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; MORALES TI, 1988, J BIOL CHEM, V263, P3632; NG CK, 1992, ARCH BIOCHEM BIOPHYS, V298, P70, DOI 10.1016/0003-9861(92)90095-E; Nishida Y, 2000, ARTHRITIS RHEUM, V43, P1315, DOI 10.1002/1529-0131(200006)43:6<1315::AID-ANR14>3.0.CO;2-#; PITA JC, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P455; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; Roughley PJ, 2006, EUR SPINE J, V15, pS326, DOI 10.1007/s00586-006-0127-7; Sandy JD, 2001, BIOCHEM J, V358, P615, DOI 10.1042/0264-6021:3580615; Sherman LS, 2008, TRENDS NEUROSCI, V31, P44, DOI 10.1016/j.tins.2007.11.001; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Stupka N, 2013, J BIOL CHEM, V288, P1907, DOI 10.1074/jbc.M112.429647; SWEET MBE, 1979, ARCH BIOCHEM BIOPHYS, V198, P439, DOI 10.1016/0003-9861(79)90518-6; Sztrolovics R, 2002, BIOCHEM J, V362, P473, DOI 10.1042/0264-6021:3620473; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; TENGBLAD A, 1979, BIOCHIM BIOPHYS ACTA, V578, P281, DOI 10.1016/0005-2795(79)90158-2; Thankamony SP, 2006, J BIOL CHEM, V281, P34601, DOI 10.1074/jbc.M601530200; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; UNDERHILL CB, 1993, DEV BIOL, V155, P324, DOI 10.1006/dbio.1993.1032; WIBO M, 1974, J CELL BIOL, V63, P430, DOI 10.1083/jcb.63.2.430; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690	71	13	14	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9555	9570		10.1074/jbc.M115.643171	http://dx.doi.org/10.1074/jbc.M115.643171			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25733665	hybrid, Green Published			2022-12-28	WOS:000352729400022
J	Garcia-Rodriguez, N; Manzano-Lopez, J; Munoz-Bravo, M; Fernandez-Garcia, E; Muniz, M; Wellinger, RE				Garcia-Rodriguez, Nestor; Manzano-Lopez, Javier; Munoz-Bravo, Miguel; Fernandez-Garcia, Elisabet; Muniz, Manuel; Wellinger, Ralf Erik			Manganese Redistribution by Calcium-stimulated Vesicle Trafficking Bypasses the Need for P-type ATPase Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SECRETORY PATHWAY; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; SUPEROXIDE-DISMUTASE; OXIDATIVE DAMAGE; GOLGI-COMPLEX; NRAMP FAMILY; ION-PUMP; TRANSPORT; PROTEIN	Regulation of intracellular ion homeostasis is essential for eukaryotic cell physiology. An example is provided by loss of ATP2C1 function, which leads to skin ulceration, improper keratinocyte adhesion, and cancer formation in Hailey-Hailey patients. The yeast ATP2C1 orthologue PMR1 codes for a Mn2+/Ca2+ transporter that is crucial for cis-Golgi manganese supply. Here, we present evidence that calcium overcomes the lack of Pmr1 through vesicle trafficking-stimulated manganese delivery and requires the endoplasmic reticulum Mn2+ transporter Spf1 and the late endosome/trans-Golgi Nramp metal transporter Smf2. Smf2 co-localizes with the putative Mn2+ transporter Atx2, and ATX2 overexpression counteracts the beneficial impact of calcium treatment. Our findings suggest that vesicle trafficking promotes organelle-specific ion interchange and cytoplasmic metal detoxification independent of calcineurin signaling or metal transporter re-localization. Our study identifies an alternative mode for cis-Golgi manganese supply in yeast and provides new perspectives for Hailey-Hailey disease treatment.	[Garcia-Rodriguez, Nestor; Munoz-Bravo, Miguel; Fernandez-Garcia, Elisabet; Wellinger, Ralf Erik] Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville 41092, Spain; [Manzano-Lopez, Javier; Muniz, Manuel] Univ Seville, Dept Biol Celular, Inst Biomed Sevilla IBiS, E-41012 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS)	Wellinger, RE (corresponding author), Univ Seville, Dept Mol Biol, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Av Amer Vespucio S-N, Seville 41092, Spain.	ralf.wellinger@cabimer.es	Manzano-Lopez, Javier/ABH-9468-2020; IBIS, EUCARIONTES/H-7494-2016; García-Rodríguez, Néstor/AAH-1450-2019; muñiz, manuel/Q-2890-2019; Wellinger, Ralf Erik/L-8463-2014	muñiz, manuel/0000-0001-8011-6991; Wellinger, Ralf Erik/0000-0002-4421-6618; Manzano-Lopez, Javier/0000-0002-7149-1690; Fernandez-Garcia, Elisabet/0000-0002-2429-2672; Garcia Rodriguez, Nestor/0000-0002-4049-1604	Spanish Ministry of Science and Innovation [BFU2010-21339, BFU2011-24513]; Junta de Andalucia-European Union [08-CTS-04297, P11-CTS-7962]; Junta de Andalucia [P09-CV1-4503]; University of Seville/El Monte Foundation; University of Seville	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia-European Union; Junta de Andalucia(Junta de Andalucia); University of Seville/El Monte Foundation; University of Seville	This work was supported by giants from the Spanish Ministry of Science and Innovation (BFU2010-21339) and the Junta de Andalucia-European Union (08-CTS-04297 and P11-CTS-7962) (to R. E W.) and by a grant from the Spanish Ministry of Science and Innovation (BFU2011-24513) and the Junta de Andalucia (P09-CV1-4503) (to M. M.).r Recipient of a pre-doctoral training grant from the University of Seville/El Monte Foundation.r Recipient of a pre-doctoral training grant from the University of Seville.	Abeliovich H, 1998, J BIOL CHEM, V273, P11719, DOI 10.1074/jbc.273.19.11719; Ahluwalia JP, 2001, J BIOL CHEM, V276, P34148, DOI 10.1074/jbc.M105398200; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Atkinson PGP, 1999, IMMUNOLOGY, V96, P656; Bates S, 2005, J BIOL CHEM, V280, P23408, DOI 10.1074/jbc.M502162200; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; Brown DR, 2000, EMBO J, V19, P1180, DOI 10.1093/emboj/19.6.1180; Chen JL, 2002, J BIOL CHEM, V277, P35682, DOI 10.1074/jbc.M204157200; Chesi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034178; Cohen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085519; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Crowley JD, 2000, MET IONS BIOL SYST, V37, P209; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Duden R, 1998, EMBO J, V17, P985, DOI 10.1093/emboj/17.4.985; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Funakoshi M, 2000, MOL GEN GENET, V264, P29, DOI 10.1007/s004380000300; Garcia-Rodriguez N, 2012, J BIOL CHEM, V287, P18717, DOI 10.1074/jbc.M112.358309; Goswami T, 2001, BIOCHEM J, V354, P511, DOI 10.1042/0264-6021:3540511; GRAHAM TR, 1991, J CELL BIOL, V114, P207, DOI 10.1083/jcb.114.2.207; GRAHAM TR, 1994, J CELL BIOL, V127, P667, DOI 10.1083/jcb.127.3.667; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Jensen LT, 2009, MOL BIOL CELL, V20, P2810, DOI 10.1091/mbc.E08-10-1084; Jensen LT, 2003, J BIOL CHEM, V278, P42036, DOI 10.1074/jbc.M307413200; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lin SJ, 1996, MOL CELL BIOL, V16, P6303; Liu XF, 1999, J BIOL CHEM, V274, P4863, DOI 10.1074/jbc.274.8.4863; Lue NF, 2005, P NATL ACAD SCI USA, V102, P9778, DOI 10.1073/pnas.0502252102; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; Mandal D, 2000, J BIOL CHEM, V275, P23933, DOI 10.1074/jbc.M002619200; Markgraf DF, 2009, MOL BIOL CELL, V20, P5276, DOI 10.1091/mbc.E09-06-0521; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; MAYORGA LS, 1994, J BIOL CHEM, V269, P30927; Missiaen L, 2004, BIOCHEM BIOPH RES CO, V322, P1204, DOI 10.1016/j.bbrc.2004.07.128; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Muren E, 2001, YEAST, V18, P163, DOI 10.1002/1097-0061(20010130)18:2<163::AID-YEA659>3.0.CO;2-#; Nevo Y, 2006, BBA-MOL CELL RES, V1763, P609, DOI 10.1016/j.bbamcr.2006.05.007; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Paidhungat M, 1998, GENETICS, V148, P1777; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Peyroche A, 2001, J CELL SCI, V114, P2241; Pittman JK, 2004, MOL MICROBIOL, V54, P1104, DOI 10.1111/j.1365-2958.2004.04332.x; Porat A, 2000, J BIOL CHEM, V275, P29233, DOI 10.1074/jbc.M005316200; Portnoy ME, 2000, MOL CELL BIOL, V20, P7893, DOI 10.1128/MCB.20.21.7893-7902.2000; Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102; RAM AFJ, 1994, YEAST, V10, P1019, DOI 10.1002/yea.320100804; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; RIEZMAN H, 1985, CELL, V40, P1001, DOI 10.1016/0092-8674(85)90360-5; Rimon N, 2011, J CELL SCI, V124, P3743, DOI 10.1242/jcs.087486; Robinson M, 2006, MOL BIOL CELL, V17, P1845, DOI 10.1091/mbc.E05-09-0832; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; Snaith HA, 2005, EMBO J, V24, P3690, DOI 10.1038/sj.emboj.7600838; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; Supek F, 1996, P NATL ACAD SCI USA, V93, P5105, DOI 10.1073/pnas.93.10.5105; Suzuki C, 1999, MOL MICROBIOL, V32, P813, DOI 10.1046/j.1365-2958.1999.01400.x; Techau ME, 2007, J BIOL CHEM, V282, P35646, DOI 10.1074/jbc.M707057200; Vashist S, 2002, MOL BIOL CELL, V13, P3955, DOI 10.1091/mbc.02-06-0090; Wuestehube LJ, 1996, GENETICS, V142, P393; Yadav J, 2007, MOL BIOL CELL, V18, P1480, DOI 10.1091/mbc.E06-11-1049; Yoshida M, 2006, J DERMATOL SCI, V43, P21, DOI 10.1016/j.jdermsci.2006.03.003; Zwilling BS, 1999, INFECT IMMUN, V67, P1386, DOI 10.1128/IAI.67.3.1386-1392.1999	68	16	17	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9335	9347		10.1074/jbc.M114.616334	http://dx.doi.org/10.1074/jbc.M114.616334			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713143	Green Published, hybrid			2022-12-28	WOS:000352729400003
J	Jansson, PJ; Yamagishi, T; Arvind, A; Seebacher, N; Gutierrez, E; Stacy, A; Maleki, S; Sharp, D; Sahni, S; Richardson, DR				Jansson, Patric J.; Yamagishi, Tetsuo; Arvind, Akanksha; Seebacher, Nicole; Gutierrez, Elaine; Stacy, Alexandra; Maleki, Sanaz; Sharp, Danae; Sahni, Sumit; Richardson, Des R.			Di-2-pyridylketone 4,4-Dimethyl-3-thiosemicarbazone (Dp44mT) Overcomes Multidrug Resistance by a Novel Mechanism Involving the Hijacking of Lysosomal P-Glycoprotein (Pgp)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; IRON CHELATORS; ANTITUMOR-ACTIVITY; REGULATED GENE-1; UP-REGULATION; DRUG EFFLUX; ABC TRANSPORTERS; ATPASE ACTIVITY; PLASMA-CELLS; IN-VITRO	Multidrug resistance (MDR) is a major obstacle in cancer treatment. More than half of human cancers express multidrug-resistant P-glycoprotein (Pgp), which correlates with a poor prognosis. Intriguingly, through an unknown mechanism, some drugs have greater activity in drug-resistant tumor cells than their drug-sensitive counterparts. Herein, we investigate how the novel anti-tumor agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes MDR. Four different cell types were utilized to evaluate the effect of Pgp-potentiated lysosomal targeting of drugs to overcome MDR. To assess the mechanism of how Dp44mT overcomes drug resistance, cellular studies utilized Pgp inhibitors, Pgp silencing, lysosornotropic agents, proliferation assays, immunoblotting, a Pgp-ATPase activity assay, radiolabeled drug uptake/effittx, a rhodamine 123 retention assay, lysosomal membrane permeability assessment, and DCF (2',7'-dichlorafluorescin) redox studies. Anti-tumor activity and selectivity of Dp44mT in Pgp-expressing, MDR cells versus drug-sensitive cells were studied using a BALB/c nu/nu xenograft mouse model. We demonstrate that Dp44mT is transported by the lysosomal Pgp drug pump, causing lysosomal targeting of Dp44mT and resulting in enhanced cytotoxicity in MDR cells. Lysosornal Pgp and pH were shown to be crucial for increasing Dp44mT-mediated lysosomal damage and subsequent cytotoxicity in drug-resistant cells, with Dp44mT being demonstrated to be a Pgp substrate. Indeed, Pgp-dependent lysosomal damage and cytotoxicity of Dp44mT were abrogated by Pgp inhibitors, Pgp silencing, or increasing lysosomal pH using lysosomotropic bases. In vivo, Dp44mT potently targeted chemotherapy-resistant human Pgp-expressing xenografted tumors relative to non-Pgp-expressing tumors in mice. This study highlights a novel Pgp hijacking strategy of the unique dipyridylthiosenticarbazone series of thiosemicarbazones that overcome MDR via utilization of lysosomal Pgp transport activity.	[Jansson, Patric J.; Richardson, Des R.] Univ Sydney, Mol Pharmacol & Pathol Program, Dept Pathol, Blackburn Bldg D06, Sydney, NSW 2006, Australia	University of Sydney	Jansson, PJ (corresponding author), Univ Sydney, Mol Pharmacol & Pathol Program, Dept Pathol, Blackburn Bldg D06, Sydney, NSW 2006, Australia.	patric.jansson@sydney.edu.au; d.richardson@med.usyd.edu.au	Jansson, Patric/AAC-4221-2022	Jansson, Patric/0000-0002-9322-653X; Sahni, Sumit/0000-0002-2900-8845; Richardson, Des/0000-0003-0960-6415; Seebacher, Nicole/0000-0002-8616-8407; Richardson, Des/0000-0002-5506-3274	Cancer Institute New South Wales; Prostate Cancer Foundation of Australia; Senior Principal Research Fellowship; National Health and Medical Research Council of Australia	Cancer Institute New South Wales; Prostate Cancer Foundation of Australia; Senior Principal Research Fellowship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a fellowship from the Cancer Institute New South Wales and Prostate Cancer Foundation of Australia (to P. J. J.) and by a Senior Principal Research Fellowship and project grant funding from the National Health and Medical Research Council of Australia (to D. R. R.). P. J. J., T. Y., and D. R. R. are co-inventors on the patent entitled "Chemotherapy for drug resistant cancer cells" (PCT/AU2013/001344). D. R. R. consults for Oncochel Therapeutics LLC and Pty. Ltd., the license holder of this patent application. D. R. R. is also a stakeholder in Oncochel Therapeutics LLC and Pty. Ltd.	Agostinelli E, 2007, INT J ONCOL, V31, P473; Akhtar N, 2011, EXPERT OPIN THER PAT, V21, P561, DOI 10.1517/13543776.2011.561784; Allen JD, 2002, MOL CANCER THER, V1, P417; Ansbro MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060334; ANTOINE JC, 1985, BIOL CELL, V55, P41, DOI 10.1111/j.1768-322X.1985.tb00408.x; Banas A, 2010, J BIOL INORG CHEM, V15, P1147, DOI 10.1007/s00775-010-0675-5; Bihorel S, 2007, PHARM RES-DORDR, V24, P1720, DOI 10.1007/s11095-007-9278-4; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boquete AL, 2001, CANCER LETT, V165, P111, DOI 10.1016/S0304-3835(01)00410-4; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Choi YH, 2014, CURR PHARM DESIGN, V20, P793, DOI 10.2174/138161282005140214165212; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Guntupalli JNR, 2007, EUR J CANCER PREV, V16, P108, DOI 10.1097/01.cej.0000228409.75976.b6; Gupte A, 2009, CANCER TREAT REV, V35, P32, DOI 10.1016/j.ctrv.2008.07.004; HABIB FK, 1980, CLIN CHIM ACTA, V104, P329, DOI 10.1016/0009-8981(80)90390-3; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heffeter P, 2007, BIOCHEM PHARMACOL, V73, P1873, DOI 10.1016/j.bcp.2007.03.002; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Ivanova S, 2008, METHOD ENZYMOL, V442, P183, DOI 10.1016/S0076-6879(08)01409-2; Jansson PJ, 2010, J MED CHEM, V53, P5759, DOI 10.1021/jm100561b; Kalalinia F, 2014, IRAN J PHARM RES, V13, P1393; Kalinowski DS, 2007, J MED CHEM, V50, P3716, DOI 10.1021/jm070445z; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Lee Y, 2004, WATER RES, V38, P2579, DOI 10.1016/j.watres.2004.02.028; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Ludwig JA, 2006, CANCER RES, V66, P4808, DOI 10.1158/0008-5472.CAN-05-3322; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Morrow CS, 2006, MOL PHARMACOL, V69, P1499, DOI 10.1124/mol.105.017988; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Murphy L, 2008, BBA-PROTEINS PROTEOM, V1784, P1184, DOI 10.1016/j.bbapap.2008.04.014; Ogihara T, 2006, DRUG METAB PHARMACOK, V21, P238, DOI 10.2133/dmpk.21.238; Pilarski LM, 1997, BLOOD, V90, P3751, DOI 10.1182/blood.V90.9.3751; PISONI RL, 1990, J CELL BIOL, V110, P327, DOI 10.1083/jcb.110.2.327; Rao VA, 2009, CANCER RES, V69, P948, DOI 10.1158/0008-5472.CAN-08-1437; Saneja A, 2014, EXPERT OPIN DRUG DEL, V11, P121, DOI 10.1517/17425247.2014.865014; Sapota A, 2009, BIOMETALS, V22, P1041, DOI 10.1007/s10534-009-9255-y; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; SHEN DW, 1986, J BIOL CHEM, V261, P7762; STYRT B, 1986, BLOOD, V67, P334; URBATSCH IL, 1994, BIOCHEMISTRY-US, V33, P7069, DOI 10.1021/bi00189a008; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; Watts RN, 2006, P NATL ACAD SCI USA, V103, P7670, DOI 10.1073/pnas.0602515103; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Xiong SB, 2010, J PHARM SCI-US, V99, P5011, DOI 10.1002/jps.22210; Yamagishi Tetsuo, 2013, J Biol Chem, V288, P31761, DOI 10.1074/jbc.M113.514091; Yelamanchili SV, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-52; Yu Y, 2012, BRIT J PHARMACOL, V165, P148, DOI 10.1111/j.1476-5381.2011.01526.x; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868	57	95	95	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9588	9603		10.1074/jbc.M114.631283	http://dx.doi.org/10.1074/jbc.M114.631283			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25720491	Green Published, hybrid			2022-12-28	WOS:000352729400024
J	Schulenburg, C; Stark, Y; Kunzle, M; Hilvert, D				Schulenburg, Cindy; Stark, Yvonne; Kuenzle, Matthias; Hilvert, Donald			Comparative Laboratory Evolution of Ordered and Disordered Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROFOLATE-REDUCTASE CATALYSIS; ESCHERICHIA-COLI; HYDRIDE TRANSFER; PROTEIN EVOLUTION; DISTAL MUTATIONS; STRUCTURAL DETERMINANTS; DIRECTED EVOLUTION; TERTIARY STRUCTURE; MECHANISM; SELECTION	Intrinsically disordered proteins are ubiquitous in nature. To assess potential evolutionary advantages and disadvantages of structural disorder under controlled laboratory conditions, we directly compared the evolvability of weakly active ordered and disordered variants of dihydrofolate reductase by genetic selection. The circularly permuted Escherichia coil enzyme, which exists as a molten globule in the absence of ligands, and a well folded deletion mutant of the Bacillus stearothermophilus enzyme served as starting points. Both scaffolds evolved at similar rates and to similar extents, reaching near-native activity after three rounds of mutagenesis and selection. Surprisingly, however, the starting structural properties of the two scaffolds changed only marginally during optimization. Although the ordered and disordered proteins accumulated distinct sets of mutations, the changes introduced likely improved catalytic efficiency indirectly in both cases by bolstering the network of dynamic conformational fluctuations that productively couple into the reaction coordinate.	[Schulenburg, Cindy; Stark, Yvonne; Kuenzle, Matthias; Hilvert, Donald] ETH, Organ Chem Lab, Vladimir Prelog Weg 1-5-10, CH-8093 Zurich, Switzerland	ETH Zurich	Hilvert, D (corresponding author), ETH, Organ Chem Lab, Vladimir Prelog Weg 1-5-10, CH-8093 Zurich, Switzerland.	hilvert@org.chem.ethz.ch		Kunzle, Matthias/0000-0003-1710-9822	Swiss National Science Foundation; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	This work was supported by the Swiss National Science Foundation and the ETH Zurich.	Besenmatter W, 2007, PROTEINS, V66, P500, DOI 10.1002/prot.21227; Bloom JD, 2004, BIOPHYS J, V86, P2758, DOI 10.1016/S0006-3495(04)74329-5; Bloom JD, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-29; Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2013, BIOCHEMISTRY-US, V52, P4605, DOI 10.1021/bi400563c; Boehr DD, 2010, P NATL ACAD SCI USA, V107, P1373, DOI 10.1073/pnas.0914163107; Brown C, 2002, EMBED SYST PROGRAM, V15, P55; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; Butz M, 2011, BIOCHEMISTRY-US, V50, P8594, DOI 10.1021/bi2011338; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Francis K, 2013, J BIOL CHEM, V288, P35961, DOI 10.1074/jbc.M113.507632; Franzosa EA, 2009, MOL BIOL EVOL, V26, P2387, DOI 10.1093/molbev/msp146; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Herrington MB, 1999, CAN J MICROBIOL, V45, P191, DOI 10.1139/cjm-45-3-191; Horiuchi Y, 2010, BBA-PROTEINS PROTEOM, V1804, P846, DOI 10.1016/j.bbapap.2009.12.011; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; Kast P, 1996, P NATL ACAD SCI USA, V93, P5043, DOI 10.1073/pnas.93.10.5043; Kim HS, 2005, BIOCHEMISTRY-US, V44, P11428, DOI 10.1021/bi050630j; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Lin YS, 2007, MOL BIOL EVOL, V24, P1005, DOI 10.1093/molbev/msm019; Luk LYP, 2013, P NATL ACAD SCI USA, V110, P16344, DOI 10.1073/pnas.1312437110; Neuenschwander M., 2011, PROTEIN ENG HDB, P537; Nilsson J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r65; Pervushin K, 2007, NAT STRUCT MOL BIOL, V14, P1202, DOI 10.1038/nsmb1325; PROTASOVA NY, 1994, PROTEIN ENG, V7, P1373, DOI 10.1093/protein/7.11.1373; Rajagopalan PTR, 2002, BIOCHEMISTRY-US, V41, P12618, DOI 10.1021/bi026369d; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Rod TH, 2003, P NATL ACAD SCI USA, V100, P6980, DOI 10.1073/pnas.1230801100; Roderer K., 2012, THESIS; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Sambrook J., 2001, MOL CLONING LAB MANU; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; Schulenburg C, 2013, TOP CURR CHEM, V337, P41, DOI 10.1007/128_2012_411; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Singh P, 2014, J AM CHEM SOC, V136, P2575, DOI 10.1021/ja411998h; STONE SR, 1982, BIOCHEMISTRY-US, V21, P3757, DOI 10.1021/bi00259a006; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Uversky VN, 1996, PROTEIN SCI, V5, P1844, DOI 10.1002/pro.5560050910; Vendruscolo M, 2010, CURR OPIN CHEM BIOL, V14, P671, DOI 10.1016/j.cbpa.2010.08.022; Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j; Wang L, 2006, P NATL ACAD SCI USA, V103, P15753, DOI 10.1073/pnas.0606976103; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Wang Z, 2014, J AM CHEM SOC, V136, P8333, DOI 10.1021/ja501936d; Wong KF, 2005, P NATL ACAD SCI USA, V102, P6807, DOI 10.1073/pnas.0408343102	54	10	10	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9310	9320		10.1074/jbc.m115.638080	http://dx.doi.org/10.1074/jbc.m115.638080			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25697360	Green Published, hybrid			2022-12-28	WOS:000352729400001
J	Wang, Y; Zhang, YL; Han, SL; Hu, X; Zhou, Y; Mu, JF; Pei, RJ; Wu, CC; Chen, XW				Wang, Yun; Zhang, Yongli; Han, Shili; Hu, Xue; Zhou, Yuan; Mu, Jingfang; Pei, Rongjuan; Wu, Chunchen; Chen, Xinwen			Identification of a Novel Regulatory Sequence of Actin Nucleation Promoting Factor Encoded by Autographa californica Multiple Nucleopolyhedrovirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; ARP2/3 COMPLEX; CELLULAR CONTROL; WASP; BV/ODV-C42; POLYMERIZATION; DEGRADATION; MOTILITY; SURFACE; P78/83	Actin polymerization induced by nucleation promoting factors (NPFs) is one of the most fundamental biological processes in eukaryotic cells. NPFs contain a conserved output domain (VGA domain) near the C terminus, which interacts with and activates the cellular actin-related protein 2/3 complex (Arp2/3) to induce actin polymerization and a diverse regulatory domain near the N terminus. Autographa californica multiple nucleopolyhedrovirus (AcMNPV) nudeocapsid protein P78/83 is a virus-encoded NPF that contains a C-terminal VGA domain and induces actin polymerization in virus-infected cells. However, there is no similarity between the N terminus of P78/83 and that of other identified NPFs, suggesting that P78/83 may possess a unique regulatory mechanism. In this study, we identified a multifunctional regulatory sequence (MRS) located near the N terminus of P78/83 and determined that one of its functions is to serve as a degron to mediate P78/83 degradation in a proteasome-dependent manner. In AcMNPV-infected cells, the MRS also binds to another nucleocapsid protein. BV/ODV-C42, which stabilizes P78/83 and modulates the P78/83-Arp2/3 interaction to orchestrate actin polymerization. In addition, the MRS is also essential for the incorporation of P78/83 into the nudeocapsid, ensuring virion mobility powered by P78/83-induced actin polymerization. The triple functions of the MRS enable P78/83 to serve as an essential viral protein in the AcMNPV replication cycle, and the possible roles of the MRS in orchestrating the virus-induced actin polymerization and viral genuine decapsidation are discussed.	[Wang, Yun; Zhang, Yongli; Hu, Xue; Zhou, Yuan; Mu, Jingfang; Pei, Rongjuan; Wu, Chunchen; Chen, Xinwen] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China; [Zhang, Yongli; Mu, Jingfang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Han, Shili] Cent China Normal Univ, Wuhan 430000, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Central China Normal University	Wang, Y (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.	wangyun@wh.iov.cn; chenxw@wh.iov.cn			National Natural Science Foundation of China [31030027, 31270191, 31321001]; Royal Dutch Academy of Science and Arts [08-PSA-BD-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Dutch Academy of Science and Arts	This work was supported by National Natural Science Foundation of China Grants 31030027, 31270191, and 31321001 and Royal Dutch Academy of Science and Arts Grant 08-PSA-BD-01.	Braunagel SC, 2001, J VIROL, V75, P12331, DOI 10.1128/JVI.75.24.12331-12338.2001; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chen YR, 2013, J VIROL, V87, P6391, DOI 10.1128/JVI.00194-13; Goley ED, 2006, SCIENCE, V314, P464, DOI 10.1126/science.1133348; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Han Shi-li, 2012, Chinese Journal of Virology, V28, P601; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; King SJ, 2011, EMBO J, V30, P1705, DOI 10.1038/emboj.2011.82; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Li K, 2010, J VIROL, V84, P7857, DOI 10.1128/JVI.00174-10; Machesky LM, 1999, CURR OPIN CELL BIOL, V11, P117, DOI 10.1016/S0955-0674(99)80014-3; Machesky LM, 2001, TRENDS CELL BIOL, V11, P286, DOI 10.1016/S0962-8924(01)02009-8; Mueller J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001765; Nie YC, 2006, VIRUS RES, V116, P129, DOI 10.1016/j.virusres.2005.09.007; Ohkawa T, 1999, VIROLOGY, V264, P1, DOI 10.1006/viro.1999.0008; Ohkawa T, 2010, J CELL BIOL, V190, P187, DOI 10.1083/jcb.201001162; Pan F, 2004, J BIOL CHEM, V279, P54629, DOI 10.1074/jbc.M402357200; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Reicher B, 2012, MOL CELL BIOL, V32, P3153, DOI 10.1128/MCB.00161-12; Rohrmann G.F., 2019, BACULOVIRUS MOL BIOL; Russell RLQ, 1997, VIROLOGY, V227, P142, DOI 10.1006/viro.1996.8304; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Wang Y, 2008, J VIROL, V82, P4554, DOI 10.1128/JVI.02510-07; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133	27	9	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9533	9541		10.1074/jbc.M114.635441	http://dx.doi.org/10.1074/jbc.M114.635441			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25691574	Green Published, hybrid			2022-12-28	WOS:000352729400020
J	Sarkar, P; Randall, SM; Collier, TS; Nero, A; Russell, TA; Muddiman, DC; Rao, BM				Sarkar, Prasenjit; Randall, Shan M.; Collier, Timothy S.; Nero, Anthony; Russell, Teal A.; Muddiman, David C.; Rao, Balaji M.			Activin/Nodal Signaling Switches the Terminal Fate of Human Embryonic Stem Cell-derived Trophoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; EFFICIENT NEURAL CONVERSION; HUMAN OVIDUCTAL CELLS; IN-VITRO; GENE-EXPRESSION; EXTRAEMBRYONIC LINEAGES; CHORIONIC-GONADOTROPIN; CULTURE-CONDITIONS; CARCINOMA-CELLS; HUMAN-PLACENTA	Human embryonic stem cells (hESCs) have been routinely treated with bone morphogenetic protein and/or inhibitors of activin/nodal signaling to obtain cells that express trophoblast markers. Trophoblasts can terminally differentiate to either extravillous trophoblasts or syncytiotrophoblasts. The signaling pathways that govern the terminal fate of these trophoblasts are not understood. We show that activin/nodal signaling switches the terminal fate of these hESC-derived trophoblasts. Inhibition of activin/nodal signaling leads to formation of extravillous trophoblast, whereas loss of activin/nodal inhibition leads to the formation of syncytiotrophoblasts. Also, the ability of hESCs to form bona fide trophoblasts has been intensely debated. We have examined hESC-derived trophoblasts in the light of stringent criteria that were proposed recently, such as hypomethylation of the ELF5-2b promoter region and down-regulation of HLA class I antigens. We report that trophoblasts that possess these properties can indeed be obtained from hESCs.	[Sarkar, Prasenjit; Nero, Anthony; Rao, Balaji M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Randall, Shan M.; Collier, Timothy S.; Muddiman, David C.] N Carolina State Univ, WM Keck FT ICR Mass Spectrometry Lab, Dept Chem, Raleigh, NC 27695 USA; [Russell, Teal A.] N Carolina State Univ, Dept Biochem, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Rao, BM (corresponding author), N Carolina State Univ, Dept Chem & Biomol Engn, Campus Box 7905,EB1, Raleigh, NC 27695 USA.	bmrao@ncsu.edu	Sarkar, Prasenjit/ABB-8088-2021	Sarkar, Prasenjit/0000-0001-6459-3181; Collier, Timothy/0000-0002-1102-8741; Muddiman, David/0000-0003-2216-499X; Rao, Balaji/0000-0001-5695-8953	National Science Foundation [CBET-0966859]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant CBET-0966859.	Aghajanova L, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092775; Amita M, 2013, P NATL ACAD SCI USA, V110, pE1212, DOI 10.1073/pnas.1303094110; Andrews GL, 2009, J CHROMATOGR B, V877, P948, DOI 10.1016/j.jchromb.2009.02.040; Arganaraz ME, 2007, GENES GENET SYST, V82, P171, DOI 10.1266/ggs.82.171; BASS KE, 1994, DEV BIOL, V164, P550, DOI 10.1006/dbio.1994.1223; Bearfield C, 2005, EUR J ENDOCRINOL, V152, P909, DOI 10.1530/eje.1.01928; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Birkedal-Hansen Henning, 2008, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1008s40; Bischof P, 2005, INT J BIOCHEM CELL B, V37, P1, DOI 10.1016/j.biocel.2004.05.014; Caniggia I, 1999, J CLIN INVEST, V103, P1641, DOI 10.1172/JCI6380; Caniggia I, 1997, ENDOCRINOLOGY, V138, P3976, DOI 10.1210/en.138.9.3976; Caniggia I, 1997, ENDOCRINOLOGY, V138, P4977, DOI 10.1210/en.138.11.4977; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen GB, 2008, CELL STEM CELL, V2, P345, DOI 10.1016/j.stem.2008.02.004; Chen YS, 2012, STEM CELL TRANSL MED, V1, P83, DOI 10.5966/sctm.2011-0022; Chen Y, 2013, BIOCHEM BIOPH RES CO, V436, P677, DOI 10.1016/j.bbrc.2013.06.016; Collier TS, 2011, RAPID COMMUN MASS SP, V25, P2524, DOI 10.1002/rcm.5151; Collier TS, 2010, J AM SOC MASS SPECTR, V21, P879, DOI 10.1016/j.jasms.2010.01.031; Das P, 2007, STEM CELL RES, V1, P61, DOI 10.1016/j.scr.2007.09.004; Arganaraz ME, 2012, ZYGOTE, V20, P53, DOI 10.1017/S0967199410000602; Erb TM, 2011, STEM CELLS DEV, V20, P1601, DOI 10.1089/scd.2010.0281; Ezashi T, 2012, CELL TISSUE RES, V349, P809, DOI 10.1007/s00441-012-1371-2; Frost JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011595; Genbacev O, 2011, STEM CELLS, V29, P1427, DOI 10.1002/stem.686; Gerami-Naini B, 2004, ENDOCRINOLOGY, V145, P1517, DOI 10.1210/en.2003-1241; Gerbaud P, 2011, ENDOCRINOLOGY, V152, P5017, DOI 10.1210/en.2011-1193; Giakoumopoulos M, 2010, REPROD SCI, V17, P798, DOI 10.1177/1933719110371853; GRAHAM CH, 1992, BIOL REPROD, V46, P561, DOI 10.1095/biolreprod46.4.561; Graham CH, 1997, PLACENTA, V18, P137, DOI 10.1016/S0143-4004(97)90085-0; GRAHAM CH, 1991, J CELL PHYSIOL, V148, P228, DOI 10.1002/jcp.1041480207; Hackett JA, 2013, STEM CELL REP, V1, P518, DOI 10.1016/j.stemcr.2013.11.010; Harun R, 2006, HUM REPROD, V21, P1349, DOI 10.1093/humrep/del017; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Hayashi Y, 2010, IN VITRO CELL DEV-AN, V46, P416, DOI 10.1007/s11626-009-9266-6; He SY, 2008, STEM CELLS, V26, P842, DOI 10.1634/stemcells.2007-0356; Hemberger M, 2010, HUM MOL GENET, V19, P2456, DOI 10.1093/hmg/ddq128; Home P, 2012, P NATL ACAD SCI USA, V109, P7362, DOI 10.1073/pnas.1201595109; Hoya-Arias R, 2011, STEM CELLS DEV, V20, P1889, DOI 10.1089/scd.2010.0437; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Karmakar S, 2002, AM J REPROD IMMUNOL, V48, P210, DOI 10.1034/j.1600-0897.2002.01151.x; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Lai YM, 1996, HUM REPROD, V11, P1281; LaMarca HL, 2008, HUM REPROD, V23, P1733, DOI 10.1093/humrep/den178; Laurila R, 2013, INT J CLIN EXP PATHO, V6, P1400; Law J, 2014, CELL SIGNAL, V26, P1935, DOI 10.1016/j.cellsig.2014.05.009; Lee KB, 2009, ENDOCRINOLOGY, V150, P2463, DOI 10.1210/en.2008-1574; Li YC, 2013, DEVELOPMENT, V140, P3965, DOI 10.1242/dev.092155; Lichtner B, 2013, BIOMATERIALS, V34, P9789, DOI 10.1016/j.biomaterials.2013.08.084; Lin G, 2010, METHODS MOL BIOL, V636, P1, DOI 10.1007/978-1-60761-691-7_1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd RE, 2009, REPRODUCTION, V137, P679, DOI 10.1530/REP-08-0405; Ma GT, 2001, DEV BIOL, V236, P124, DOI 10.1006/dbio.2001.0334; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Mahmood A, 2010, J BONE MINER RES, V25, P1216, DOI 10.1002/jbmr.34; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Marchand M, 2011, BIOL REPROD, V84, P1258, DOI 10.1095/biolreprod.110.086413; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; MINAMI N, 1994, THERIOGENOLOGY, V41, P1435, DOI 10.1016/0093-691X(94)90194-N; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; Morrish DW, 1998, J REPROD IMMUNOL, V39, P179, DOI 10.1016/S0165-0378(98)00021-7; Morrish DW, 1997, PLACENTA, V18, P577, DOI 10.1016/0143-4004(77)90013-3; MORRISH DW, 1987, J CLIN ENDOCR METAB, V65, P1282, DOI 10.1210/jcem-65-6-1282; Nadeem L, 2011, AM J PATHOL, V178, P1177, DOI 10.1016/j.ajpath.2010.11.066; Natale DRC, 2009, DEV BIOL, V335, P120, DOI 10.1016/j.ydbio.2009.08.022; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; O'Driscoll CM, 2013, BBA-MOL CELL RES, V1833, P460, DOI 10.1016/j.bbamcr.2012.11.012; Patani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007327; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Peiffer I, 2007, STEM CELLS DEV, V16, P393, DOI 10.1089/scd.2006.0013; Peng S, 2011, CELL BIOL INT, V35, P587, DOI 10.1042/CBI20100452; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Refaat B, 2011, HUM REPROD, V26, P3346, DOI 10.1093/humrep/der331; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Roberts RM, 2014, REPRODUCTION, V147, pD1, DOI 10.1530/REP-14-0080; Salilew-Wondim D, 2012, ANIM REPROD SCI, V134, P9, DOI 10.1016/j.anireprosci.2012.08.006; Schulz LC, 2008, PLACENTA, V29, pS10, DOI 10.1016/j.placenta.2007.10.009; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sudheer S, 2012, STEM CELLS DEV, V21, P2987, DOI 10.1089/scd.2012.0099; Telugu BP, 2013, PLACENTA, V34, P536, DOI 10.1016/j.placenta.2013.03.016; Tiruthani K, 2013, BIOTECHNOL J, V8, P421, DOI 10.1002/biot.201200203; Trigal B, 2011, THERIOGENOLOGY, V75, P584, DOI 10.1016/j.theriogenology.2010.09.010; Udayashankar R, 2011, HUM REPROD, V26, P398, DOI 10.1093/humrep/deq350; West FD, 2010, HUM REPROD, V25, P168, DOI 10.1093/humrep/dep338; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wolfrum K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013703; Wu Z, 2008, J BIOL CHEM, V283, P24991, DOI 10.1074/jbc.M803893200; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu JS, 2000, FERTIL STERIL, V74, P1215, DOI 10.1016/S0015-0282(00)01618-6; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2006, METH MOLEC MED, V121, P189; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yadav PS, 1998, ANIM REPROD SCI, V51, P301, DOI 10.1016/S0378-4320(98)00076-1; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Yu XB, 2008, CELL STEM CELL, V2, P461, DOI 10.1016/j.stem.2008.03.001; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	102	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8834	8848		10.1074/jbc.M114.620641	http://dx.doi.org/10.1074/jbc.M114.620641			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25670856	Green Published, hybrid			2022-12-28	WOS:000352207100013
J	Burnett, SF; Farre, JC; Nazarko, TY; Subramani, S				Burnett, Sarah F.; Farre, Jean-Claude; Nazarko, Taras Y.; Subramani, Suresh			Peroxisomal Pex3 Activates Selective Autophagy of Peroxisomes via Interaction with the Pexophagy Receptor Atg30	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PICHIA-PASTORIS; MEMBRANE-PROTEIN; SACCHAROMYCES-CEREVISIAE; TAGS PEROXISOMES; PEX19P; DEGRADATION; BIOGENESIS; MITOPHAGY; PATHWAYS; DOCKING	Pexophagy is a process that selectively degrades peroxisomes by autophagy. The Pichia pastoris pexophagy receptor Atg30 is recruited to peroxisomes under peroxisome proliferation conditions. During pexophagy, Atg30 undergoes phosphorylation, a prerequisite for its interactions with the autophagy scaffold protein Atg11 and the ubiquitin-like protein Atg8. Atg30 is subsequently shuttled to the vacuole along with the targeted peroxisome for degradation. Here, we defined the binding site for Atg30 on the peroxisomal membrane protein Pex3 and uncovered a role for Pex3 in the activation of Atg30 via phosphorylation and in the recruitment of Atg11 to the receptor protein complex. Pex3 is classically a docking protein for other proteins that affect peroxisome biogenesis, division, and segregation. We conclude that Pex3 has a role beyond simple docking of Atg30 and that its interaction with Atg30 regulates pexophagy in the yeast P. pastoris.	[Burnett, Sarah F.; Farre, Jean-Claude; Nazarko, Taras Y.; Subramani, Suresh] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Subramani, S (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	ssubramani@ucsd.edu			National Institutes of Health [GM069373]; Mentored Research Scientist Development Award [K01DK094843]; National Science Foundation [0742551]; Chancellor Associates Chair; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK094843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mentored Research Scientist Development Award; National Science Foundation(National Science Foundation (NSF)); Chancellor Associates Chair; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069373 (to S. S.) and Mentored Research Scientist Development Award K01DK094843 (to T. Y. N.).; Supported by Graduate STEM Fellows in K-12 Education Grant 0742551 from the National Science Foundation (to Dr. Maarten Chrispeels) and by a Chancellor Associates Chair (to S. S.).	Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Chang JL, 2009, J CELL BIOL, V187, P233, DOI 10.1083/jcb.200902117; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; Deosaran E, 2013, J CELL SCI, V126, P939, DOI 10.1242/jcs.114819; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Farre JC, 2008, DEV CELL, V14, P365, DOI 10.1016/j.devcel.2007.12.011; Farre JC, 2013, EMBO REP, V14, P441, DOI 10.1038/embor.2013.40; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; Hattula K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103101; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kanki T, 2013, EMBO REP, V14, P788, DOI 10.1038/embor.2013.114; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Knoblach B, 2013, EMBO J, V32, P2439, DOI 10.1038/emboj.2013.170; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Manjithaya R, 2010, J CELL BIOL, V189, P303, DOI 10.1083/jcb.200909154; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Munck JM, 2009, J CELL BIOL, V187, P463, DOI 10.1083/jcb.200906161; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nazarko TY, 2014, J CELL BIOL, V204, P541, DOI 10.1083/jcb.201307050; Nazarko TY, 2009, MOL BIOL CELL, V20, P3828, DOI 10.1091/mbc.E09-03-0221; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Pfaffenwimmer T, 2014, EMBO REP, V15, P862, DOI 10.15252/embr.201438932; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Sato Y, 2010, EMBO J, V29, P4083, DOI 10.1038/emboj.2010.293; Schmidt F, 2012, TRAFFIC, V13, P1244, DOI 10.1111/j.1600-0854.2012.01380.x; Schmidt F, 2010, J BIOL CHEM, V285, P25410, DOI 10.1074/jbc.M110.138503; Schueller N, 2010, EMBO J, V29, P2491, DOI 10.1038/emboj.2010.115; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Snyder WB, 1999, MOL BIOL CELL, V10, P1745, DOI 10.1091/mbc.10.6.1745; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; Tan CC, 2014, NEUROBIOL AGING, V35, P941, DOI 10.1016/j.neurobiolaging.2013.11.019; Tanaka C, 2014, J CELL BIOL, V207, P91, DOI 10.1083/jcb.201402128; Till Andreas, 2012, Int J Cell Biol, V2012, P512721, DOI 10.1155/2012/512721; Vasko R, 2013, ANTIOXID REDOX SIGN, V19, P211, DOI 10.1089/ars.2012.4768; Wiemer EAC, 1996, J BIOL CHEM, V271, P18973, DOI 10.1074/jbc.271.31.18973; Williams C, 2013, BIOCHEM BIOPH RES CO, V438, P395, DOI 10.1016/j.bbrc.2013.07.086; Yamashita SI, 2014, AUTOPHAGY, V10, P1549, DOI 10.4161/auto.29329; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Zhang JW, 2013, NAT CELL BIOL, V15, P1186, DOI 10.1038/ncb2822	43	35	36	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8623	8631		10.1074/jbc.M114.619338	http://dx.doi.org/10.1074/jbc.M114.619338			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25694426	hybrid, Green Published			2022-12-28	WOS:000351662600052
J	Makino, S; Mishima, Y; Inoue, K; Inada, T				Makino, Shiho; Mishima, Yuichiro; Inoue, Kunio; Inada, Toshifumi			Roles of mRNA Fate Modulators Dhh1 and Pat1 in TNRC6-dependent Gene Silencing Recapitulated in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATIONAL REPRESSION; CCR4-NOT COMPLEX; MEDIATED DEADENYLATION; DECAPPING COMPLEXES; ZEBRAFISH MIR-430; GW182 PROTEINS; MIRNA TARGETS; IN-VITRO; DROSOPHILA; MICRORNAS	The CCR4-NOT complex, the major deadenylase in eukaryotes, plays crucial roles in gene expression at the levels of transcription, mRNA decay, and protein degradation. GW182/TNRC6 proteins, which are core components of the microRNAinduced silencing complex in animals, stimulate deadenylation and repress translation via recruitment of the CCR4-NOT complex. Here we report a heterologous experimental system that recapitulates the recruitment of CCR4-NOT complex by TNRC6 in S. cerevisiae. Using this system, we characterize conserved functions of theCCR4-NOTcomplex. The complex stimulates degradation of mRNA from the 5' end by Xrn1, in a manner independent of both translation and deadenylation. This degradation pathway is probably conserved in miRNA-mediated gene silencing in zebrafish. Furthermore, the mRNA fate modulators Dhh1 and Pat1 redundantly stimulatemRNAdecay, but both factors are required for poly(A) tail-independent translation repression by tethered TNRC6A. Our tethering-based reconstitution system reveals that the conserved architecture of Not1/CNOT1 provides a binding surface for TNRC6, thereby connecting microRNA-induced silencing complex to the decapping machinery as well as the translation apparatus.	[Makino, Shiho; Inada, Toshifumi] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Mishima, Yuichiro] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Mishima, Yuichiro] Univ Tokyo, Dept Med Genome Sci, Bunkyo Ku, Tokyo 1130032, Japan; [Inoue, Kunio] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 6578501, Japan	Tohoku University; University of Tokyo; University of Tokyo; Kobe University	Mishima, Y (corresponding author), Univ Tokyo, Dept Med Genome Sci, Bunkyo Ku, Tokyo 1130032, Japan.	mishima@iam.u-tokyo.ac.jp; tinada@m.tohoku.ac.jp	Mishima, Yuichiro/I-3881-2019; Inada, Toshifumi/AAE-1517-2019	Mishima, Yuichiro/0000-0002-1075-9454; Makino, Shiho/0000-0001-6147-737X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20112006, 26116003, 24115711]; Mitsubishi Foundation; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [13J02601] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-aid for Scientific Research on Innovative Areas "RNA regulation" (20112006) and "Nascent chain biology" (26116003) (to T. I.) and "non-coding RNA" (24115711) (to Y. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by Research Grants in the Natural Sciences, Mitsubishi Foundation (to T. I.).; Recipient of a Japan Society for the Promotion of Science Research Fellowship.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Anderson JSJ, 1996, CURR BIOL, V6, P780; Barisic-Jager E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071860; Basquin J, 2012, MOL CELL, V48, P207, DOI 10.1016/j.molcel.2012.08.014; Bawankar P, 2013, RNA BIOL, V10, P228, DOI 10.4161/rna.23018; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Braun JE, 2012, NAT STRUCT MOL BIOL, V19, P1324, DOI 10.1038/nsmb.2413; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Chekulaeva M, 2009, RNA, V15, P794, DOI 10.1261/rna.1364909; Chen CYA, 2009, NAT STRUCT MOL BIOL, V16, P1160, DOI 10.1038/nsmb.1709; Chen Y, 2014, MOL CELL, V54, P737, DOI 10.1016/j.molcel.2014.03.034; Christie M, 2013, MOL CELL, V51, P360, DOI 10.1016/j.molcel.2013.07.011; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Eulalio A, 2009, RNA, V15, P1067, DOI 10.1261/rna.1605509; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fukao A, 2014, MOL CELL, V56, P79, DOI 10.1016/j.molcel.2014.09.005; Fukaya T, 2014, MOL CELL, V56, P67, DOI 10.1016/j.molcel.2014.09.004; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Fukaya T, 2011, EMBO J, V30, P4998, DOI 10.1038/emboj.2011.426; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Haas G, 2010, J CELL BIOL, V189, P289, DOI 10.1083/jcb.200910141; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Jager E, 2010, RNA BIOL, V7, P381; Kuroha K, 2009, EMBO REP, V10, P1265, DOI 10.1038/embor.2009.200; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Maillet L, 2002, J BIOL CHEM, V277, P2835, DOI 10.1074/jbc.M107979200; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mathys H, 2014, MOL CELL, V54, P751, DOI 10.1016/j.molcel.2014.03.036; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Miller JE, 2012, CRIT REV BIOCHEM MOL, V47, P315, DOI 10.3109/10409238.2012.667214; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Minshall N, 2009, MOL BIOL CELL, V20, P2464, DOI 10.1091/mbc.E09-01-0035; Mishima Y, 2012, P NATL ACAD SCI USA, V109, P1104, DOI 10.1073/pnas.1113350109; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Nishihara T, 2013, NUCLEIC ACIDS RES, V41, P8692, DOI 10.1093/nar/gkt619; Ozgur S, 2010, MOL CELL BIOL, V30, P4308, DOI 10.1128/MCB.00429-10; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Petit AP, 2012, NUCLEIC ACIDS RES, V40, P11058, DOI 10.1093/nar/gks883; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; Rouya C, 2014, RNA, V20, P1398, DOI 10.1261/rna.045302.114; Suk K, 2011, NUCLEIC ACIDS RES, V39, pE43, DOI 10.1093/nar/gkq1321; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Tritschler F, 2008, MOL CELL BIOL, V28, P6695, DOI 10.1128/MCB.00759-08; Tritschler F, 2009, P NATL ACAD SCI USA, V106, P21591, DOI 10.1073/pnas.0909871106; Tsuboi T, 2010, J BIOL CHEM, V285, P33589, DOI 10.1074/jbc.M110.117150; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Wahle E, 2013, BBA-GENE REGUL MECH, V1829, P561, DOI 10.1016/j.bbagrm.2013.01.003; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zdanowicz A, 2009, MOL CELL, V35, P881, DOI 10.1016/j.molcel.2009.09.009	67	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8331	8347		10.1074/jbc.M114.615088	http://dx.doi.org/10.1074/jbc.M114.615088			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25657010	Green Published, hybrid			2022-12-28	WOS:000351662600028
J	Manchekar, M; Liu, YW; Sun, ZH; Richardson, PE; Dashti, N				Manchekar, Medha; Liu, Yanwen; Sun, Zhihuan; Richardson, Paul E.; Dashti, Nassrin			Phospholipid Transfer Protein Plays a Major Role in the Initiation of Apolipoprotein B-containing Lipoprotein Assembly in Mouse Primary Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; LOW-DENSITY-LIPOPROTEIN; MCA-RH7777 CELLS; ABETALIPOPROTEINEMIA GENE; PLASMA LIPOPROTEINS; A-I; SECRETION; PARTICLE; MICE; DEFICIENCY	In this study, we tested the hypothesis that phospholipid transfer protein (PLTP) is a plausible mediator of phospholipid (PL) transfer to the N-terminal 1000 residues of apoB (apoB: 1000) leading to the initiation of apoB-containing lipoprotein assembly. To this end, primary hepatocytes from wild type (WT) and PLTP knock-out (KO) mice were transduced with adenovirus- apoB:1000 with or without co-transduction with adenovirus- PLTP, and the assembly and secretion of apoB:1000-containing lipoproteins were assessed. PLTP deficiency resulted in a 65 and 72% reduction in the protein and lipid content, respectively, of secreted apoB:1000-containing lipoproteins. Particles secreted by WT hepatocytes contained 69% PL, 9% diacylglycerol (DAG), and 23% triacylglycerol (TAG) with a stoichiometry of 46 PL, 6 DAG, and 15 TAG molecules per apoB:1000. PLTP absence drastically altered the lipid composition of apoB:1000 lipoproteins; these particles contained 46% PL, 13% DAG, and 41% TAG with a stoichiometry of 27 PL, 10 DAG, and 23 TAG molecules per apoB:1000. Reintroduction of Pltp gene into PLTP-KO hepatocytes stimulated the lipidation and secretion of apoB:1000-containing lipoproteins by similar to 3-fold; the lipid composition and stoichiometry of these particles were identical to those secreted byWThepatocytes. In contrast to the WT, apoB: 1000 in PLTP-KO hepatocytes was susceptible to intracellular degradation predominantly in the post-endoplasmic reticulum, presecretory compartment. Reintroduction of Pltp gene into PLTP-KO hepatocytes restored the stability of apoB:1000. These results provide compelling evidence that in hepatocytes initial recruitment of PL by apoB:1000 leading to the formation of the PL-rich apoB-containing initiation complex is mediated to a large extent by PLTP.	[Manchekar, Medha; Liu, Yanwen; Sun, Zhihuan; Dashti, Nassrin] Univ Alabama Birmingham, Div Gerontol Geriatr & Palliat Care, Dept Med, Basic Sci Sect, Birmingham, AL 35294 USA; [Richardson, Paul E.] Coastal Carolina Univ, Dept Chem & Phys, Conway, SC 29528 USA	University of Alabama System; University of Alabama Birmingham; Coastal Carolina University	Dashti, N (corresponding author), Univ Alabama Birmingham, Div Gerontol Geriatr & Palliat Care, Dept Med, 1808 7th Ave S,BDB-D680, Birmingham, AL 35292 USA.	ndashti@uabmc.edu			National Institutes of Health [RO1 HL-112647]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL-112647.	ALAUPOVI.P, 1972, BIOCHIM BIOPHYS ACTA, V260, P689, DOI 10.1016/0005-2760(72)90018-5; BAKER ME, 1988, BIOCHEM J, V255, P1057, DOI 10.1042/bj2551057; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; DASHTI N, 1980, BIOCHIM BIOPHYS ACTA, V618, P347, DOI 10.1016/0005-2760(80)90041-7; Dashti N, 2002, BIOCHEMISTRY-US, V41, P6978, DOI 10.1021/bi011757l; Dashti N, 2007, J BIOL CHEM, V282, P28597, DOI 10.1074/jbc.M700229200; DAVIS RA, 1982, J BIOL CHEM, V257, P908; EDELSTEIN C, 1979, J LIPID RES, V20, P143; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ginsberg HN, 2009, J LIPID RES, V50, pS162, DOI 10.1194/jlr.R800090-JLR200; Hamilton RL, 1998, J LIPID RES, V39, P1543; Honkakoski P, 1998, BIOCHEM J, V330, P889, DOI 10.1042/bj3300889; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P572, DOI 10.1097/MOL.0b013e328312707c; Jiang XC, 1999, J CLIN INVEST, V103, P907, DOI 10.1172/JCI5578; Jiang XC, 2001, NAT MED, V7, P847, DOI 10.1038/89977; Jiang XC, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-75; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu YW, 2010, J LIPID RES, V51, P2253, DOI 10.1194/jlr.M005371; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo Y, 2010, J PHARMACOL EXP THER, V332, P1100, DOI 10.1124/jpet.109.161232; Manchekar M, 2004, J BIOL CHEM, V279, P39757, DOI 10.1074/jbc.M406302200; Manchekar M, 2008, J BIOL CHEM, V283, P29251, DOI 10.1074/jbc.M804912200; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; Okazaki H, 2010, J BIOL CHEM, V285, P6801, DOI 10.1074/jbc.M109.079459; Olofsson SO, 2000, TRENDS CARDIOVAS MED, V10, P338, DOI 10.1016/S1050-1738(01)00071-8; Oram JF, 2008, J BIOL CHEM, V283, P11541, DOI 10.1074/jbc.M800117200; Ponsin G, 2003, BIOCHEMISTRY-US, V42, P4444, DOI 10.1021/bi027006g; RAAG R, 1988, J MOL BIOL, V200, P553, DOI 10.1016/0022-2836(88)90542-6; Rava P, 2006, J BIOL CHEM, V281, P11019, DOI 10.1074/jbc.M512823200; Richardson PE, 2005, BIOPHYS J, V88, P2789, DOI 10.1529/biophysj.104.046235; SHOULDERS CC, 1994, NAT STRUCT BIOL, V1, P285, DOI 10.1038/nsb0594-285; Siggins S, 2007, ATHEROSCLEROSIS, V190, P114, DOI 10.1016/j.atherosclerosis.2006.02.037; Tran K, 2000, J BIOL CHEM, V275, P25023, DOI 10.1074/jbc.M908971199; van Haperen R, 2002, J BIOL CHEM, V277, P48938, DOI 10.1074/jbc.M209128200; van Tol A, 2002, CURR OPIN LIPIDOL, V13, P135, DOI 10.1097/00041433-200204000-00004; Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793; WETTERAU JR, 1992, SCIENCE, V258, P999; Wetterau JR, 1998, SCIENCE, V282, P751, DOI 10.1126/science.282.5389.751; YAO ZM, 1992, J BIOL CHEM, V267, P1175; Yazdanyar A, 2013, ARTERIOSCL THROM VAS, V33, P2058, DOI 10.1161/ATVBAHA.113.301628; Yazdanyar A, 2012, HEPATOLOGY, V56, P576, DOI 10.1002/hep.25648	45	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8196	8205		10.1074/jbc.M114.602748	http://dx.doi.org/10.1074/jbc.M114.602748			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25638820	hybrid, Green Published			2022-12-28	WOS:000351662600017
J	Nardi, F; Hoffmann, TM; Stretton, C; Cwiklinski, E; Taylor, PM; Hundal, HS				Nardi, Francesca; Hoffmann, Thorsten M.; Stretton, Clare; Cwiklinski, Emma; Taylor, Peter M.; Hundal, Harinder S.			Proteasomal Modulation of Cellular SNAT2 (SLC38A2) Abundance and Function by Unsaturated Fatty Acid Availability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CELLS; SYSTEM-A; UBIQUITIN-PROTEASOME; INNATE IMMUNITY; TRANSPORTER; ACTIVATION; PATHWAYS; INSULIN; DEGRADATION; GENE	Expression and activity of the System A/SNAT2 (SLC38A2) amino acid transporter is up-regulated by amino acid starvation and hypertonicity by a mechanism dependent on both ATF4mediated transcription of the SLC38A2 gene and enhanced stabilization of SNAT2 itself, which forms part of an integrated cellular stress response to nutrient deprivation and osmotic stress. Here we demonstrate that this adaptive increase in System A function is restrained in cells subjected to prior incubation with linoleic acid (LOA, an unsaturated C18: 2 fatty acid) for 24 h. While fatty acid treatment had no detectable effect upon stress-induced SNAT2 or ATF4 gene transcription, the associated increase in SNAT2 protein/membrane transport activity were strongly suppressed in L6 myotubes or HeLa cells preincubated with LOA. Cellular ubiquitination of many proteins was increased by LOA and although the fatty acid-induced loss of SNAT2 could be attenuated by proteasomal inhibition, the functional increase in System A transport activity associated with amino acid starvation/hypertonicity that depends upon processing/maturation and delivery ofSNAT2to the cell surface could not be rescued. LOA up-regulated cellular expression of Nedd4.2, an E3-ligase implicated in SNAT2 ubiquitination, but shRNA-directed Nedd4.2 gene silencing could not curb fatty acid-induced loss of SNAT2 adaptation. However, expression of SNAT2 in which seven putative lysyl-ubiquitination sites in the cytoplasmic N-terminal domain were mutated to alanine protected SNAT2 against LOA-induced proteasomal degradation. Collectively, our findings indicate that increased availability of unsaturated fatty acids can compromise the stress-induced induction/adaptation in SNAT2 expression and function by promoting its degradation via the ubiquitin-proteasome system.	[Nardi, Francesca; Hoffmann, Thorsten M.; Stretton, Clare; Cwiklinski, Emma; Taylor, Peter M.; Hundal, Harinder S.] Univ Dundee, Coll Life Sci, Sir James Black Ctr, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland	University of Dundee	Hundal, HS (corresponding author), Univ Dundee, Coll Life Sci, Sir James Black Ctr, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland.	h.s.hundal@dundee.ac.uk	Hundal, Hari/A-8990-2008	Hundal, Hari/0000-0002-7621-4932	Diabetes UK; Wellcome Trust; Biotechnology and Biological Sciences Research Council; BBSRC [BB/I007261/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I007261/1] Funding Source: researchfish	Diabetes UK(Diabetes UK); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Diabetes UK, The Wellcome Trust, and the Biotechnology and Biological Sciences Research Council.	Ando H, 2004, J BIOL CHEM, V279, P15427, DOI 10.1074/jbc.M313701200; Baird FE, 2009, AM J PHYSIOL-ENDOC M, V297, pE822, DOI 10.1152/ajpendo.00330.2009; Burri L, 2010, PPAR RES, V2010, DOI 10.1155/2010/542359; DAHLMANN B, 1985, BIOCHEM J, V228, P171, DOI 10.1042/bj2280171; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Franchi-Gazzola R, 1999, J BIOL CHEM, V274, P28922, DOI 10.1074/jbc.274.41.28922; GAZZOLA GC, 1981, J BIOL CHEM, V256, P3191; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Hyde R, 2003, BIOCHEM J, V373, P1, DOI 10.1042/BJ20030405; Hyde R, 2002, J BIOL CHEM, V277, P13628, DOI 10.1074/jbc.M108609200; Hyde R, 2001, BIOCHEM J, V355, P563, DOI 10.1042/bj3550563; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Hyde Russell, 2005, FASEB J, V19, P461; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jones HN, 2010, DIABETES, V59, P1161, DOI 10.2337/db09-0824; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Lopez-Fontanals M, 2003, J GEN PHYSIOL, V122, P5, DOI 10.1085/jgp.200308800; Luzio JP, 2009, BIOCHEM SOC T, V37, P1019, DOI 10.1042/BST0371019; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinilla Jorge, 2011, Front Biosci (Elite Ed), V3, P1289; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Ringseis R, 2013, BBA-GEN SUBJECTS, V1830, P2105, DOI 10.1016/j.bbagen.2012.09.024; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Schioth HB, 2013, MOL ASPECTS MED, V34, P571, DOI 10.1016/j.mam.2012.07.012; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Smith J, 2008, J BIOL CHEM, V283, P13578, DOI 10.1074/jbc.M800008200; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wijngaarden MA, 2014, AM J PHYSIOL-ENDOC M, V307, pE885, DOI 10.1152/ajpendo.00215.2014; Zhao NN, 2014, P NATL ACAD SCI USA, V111, P9175, DOI 10.1073/pnas.1405355111; Zhou Q, 2007, ENDOCRINOLOGY, V148, P5696, DOI 10.1210/en.2007-0183	36	27	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8173	8184		10.1074/jbc.M114.625137	http://dx.doi.org/10.1074/jbc.M114.625137			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25653282	Green Published, hybrid			2022-12-28	WOS:000351662600015
J	Sawada, J; Li, FF; Komatsu, M				Sawada, Junko; Li, Fangfei; Komatsu, Masanobu			R-Ras Protein Inhibits Autophosphorylation of Vascular Endothelial Growth Factor Receptor 2 in Endothelial Cells and Suppresses Receptor Activation in Tumor Vasculature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; INTEGRIN ACTIVATION; BLOOD-VESSELS; ANTIANGIOGENIC THERAPY; EPITHELIAL-CELLS; ANGIOGENESIS; NORMALIZATION; ENDOCYTOSIS; METASTASIS; KINASE	Abnormal angiogenesis is associated with a broad range of medical conditions, including cancer. The formation of neovasculature with functionally defective blood vessels significantly impacts tumor progression, metastasis, and the efficacy of anticancer therapies. Vascular endothelial growth factor (VEGF) potently induces vascular permeability and vessel growth in the tumor microenvironment, and its inhibition normalizes tumor vasculature. In contrast, the signaling of the small GTPase R-Ras inhibits excessive angiogenic growth and promotes the maturation of regenerating blood vessels. R-Ras signaling counteracts VEGF-induced vessel sprouting, permeability, and invasive activities of endothelial cells. In this study, we investigated the effect of R-Ras on VEGF receptor 2 (VEGFR2) activation by VEGF, the key mechanism for angiogenic stimulation. We show that tyrosine phosphorylation of VEGFR2 is significantly elevated in the tumor vasculature and dermal microvessels of VEGF-injected skin in R-Ras knockout mice. In cultured endothelial cells, R-Ras suppressed the internalization of VEGFR2, which is required for full activation of the receptor by VEGF. Consequently, R-Ras strongly suppressed autophosphorylation of the receptor at all five major tyrosine phosphorylation sites. Conversely, silencing of R-Ras resulted in increased VEGFR2 phosphorylation. This effect of R-Ras onVEGFR2was, at least in part, dependent on vascular endothelial cadherin. These findings identify a novel function of R-Ras to control the response of endothelial cells to VEGF and suggest an underlying mechanism by which R-Ras regulates angiogenesis.	Sanford Burnham Med Res Inst Lake Nona, Cardiovasc Pathobiol Program, Orlando, FL 32827 USA; Sanford Burnham Med Res Inst Lake Nona, Tumor Microenvironm & Metastasis Program, Orlando, FL 32827 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Komatsu, M (corresponding author), Sanford Burnham Med Res Inst Lake Nona, 6400 Sanger Rd, Orlando, FL 32827 USA.	mkomatsu@sanfordburnham.org	Komatsu, Masanobu/AAV-3013-2020	Komatsu, Masanobu/0000-0001-7548-137X	NCI/National Institutes of Health [CA125255]; Florida Department of Health Bankhead-Coley Cancer Research Program [4BB17]; Florida Breast Cancer Foundation [3021180]; NATIONAL CANCER INSTITUTE [R01CA125255] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Department of Health Bankhead-Coley Cancer Research Program; Florida Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI/National Institutes of Health Grant CA125255. This work was also supported by Florida Department of Health Bankhead-Coley Cancer Research Program 4BB17 and by Florida Breast Cancer Foundation Grant 3021180.	Barbieri MA, 1998, J BIOL CHEM, V273, P19367, DOI 10.1074/jbc.273.31.19367; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/NNANO.2012.45, 10.1038/nnano.2012.45]; Conklin MW, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-14; De Bock K, 2011, CURR OPIN GENET DEV, V21, P73, DOI 10.1016/j.gde.2010.10.008; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Fehrenbacher N, 2009, CURR BIOL, V19, pR454, DOI 10.1016/j.cub.2009.04.045; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Gerhardt H, 2008, J MOL MED, V86, P135, DOI 10.1007/s00109-007-0258-2; GRAZIA LM, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jeong HW, 2005, CANCER RES, V65, P507; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Komatsu M, 2005, NAT MED, V11, P1346, DOI 10.1038/nm1324; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lanahan A, 2013, DEV CELL, V25, P156, DOI 10.1016/j.devcel.2013.03.019; LOWE DG, 1987, CELL, V48, P137, DOI 10.1016/0092-8674(87)90364-3; LOWE DG, 1987, MOL CELL BIOL, V7, P2845, DOI 10.1128/MCB.7.8.2845; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Marte BM, 1997, CURR BIOL, V7, P63, DOI 10.1016/S0960-9822(06)00028-5; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Misaki R, 2010, J CELL BIOL, V191, P23, DOI 10.1083/jcb.200911143; Mora N, 2007, CANCER IMMUNOL IMMUN, V56, P535, DOI 10.1007/s00262-006-0205-z; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pitulescu ME, 2014, CELL ADHES MIGR, V8, P366, DOI 10.4161/19336918.2014.970010; Rincon-Arano H, 2003, CANCER, V97, P575, DOI 10.1002/cncr.11093; Sandri C, 2012, CELL RES, V22, P1479, DOI 10.1038/cr.2012.110; Sawada J, 2012, CELL CYCLE, V11, P4285, DOI 10.4161/cc.22465; Sawada J, 2012, CANCER CELL, V22, P235, DOI 10.1016/j.ccr.2012.06.013; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; SELF AJ, 1993, ONCOGENE, V8, P655; Sethi T, 1999, MOL BIOL CELL, V10, P1799, DOI 10.1091/mbc.10.6.1799; Song J, 2014, ONCOL REP, V31, P2776, DOI 10.3892/or.2014.3121; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Takaya A, 2007, MOL BIOL CELL, V18, P1850, DOI 10.1091/mbc.E06-08-0765; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Wang BC, 2000, J BIOL CHEM, V275, P5222, DOI 10.1074/jbc.275.7.5222; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/j.ccr.2004.10.011; Wozniak MA, 2005, MOL BIOL CELL, V16, P84, DOI 10.1091/mbc.E04-04-0277; Yu Y, 2002, ONCOGENE, V21, P7557, DOI 10.1038/sj.onc.1205961; Yu Y, 2006, MOL CELL BIOL, V26, P6372, DOI 10.1128/MCB.00509-05; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813; Zou JX, 2002, J BIOL CHEM, V277, P1824, DOI 10.1074/jbc.M103133200	49	23	23	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8133	8145		10.1074/jbc.M114.591511	http://dx.doi.org/10.1074/jbc.M114.591511			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25645912	Green Published, hybrid			2022-12-28	WOS:000351662600011
J	Tiano, JP; Springer, DA; Rane, SG				Tiano, Joseph P.; Springer, Danielle A.; Rane, Sushil G.			SMAD3 Negatively Regulates Serum Irisin and Skeletal Muscle FNDC5 and Peroxisome Proliferator-activated Receptor gamma Coactivator 1-alpha (PGC-1 alpha) during Exercise	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Exercise; Obesity; Skeletal Muscle; SMAD Transcription Factor; Transforming Growth Factor Beta (TGF-B); Irisin	BROWN ADIPOSE-TISSUE; TGF-BETA; TRANSCRIPTION FACTORS; TARGETED DISRUPTION; INSULIN-RESISTANCE; AEROBIC EXERCISE; OBESITY; FAT; GROWTH; EXPRESSION	Background: Mothers against decapentaplegic homolog 3 (SMAD3) and FNDC5/irisin are molecules that modulate energy metabolism and body weight regulation. Results: SMAD3 negatively regulates irisin during exercise and suppresses FNDC5 and PGC-1 in cultured skeletal muscle cells. Conclusion: SMAD3 suppresses irisin/FNDC5 in skeletal muscle. Significance: This study sheds light on the poorly understood regulation of irisin/FNDC5 in skeletal muscle. Beige adipose cells are a distinct and inducible type of thermogenic fat cell that express the mitochondrial uncoupling protein-1 and thus represent a powerful target for treating obesity. Mice lacking the TGF- effector protein SMAD3 are protected against diet-induced obesity because of browning of their white adipose tissue (WAT), leading to increased whole body energy expenditure. However, the role SMAD3 plays in WAT browning is not clearly understood. Irisin is an exercise-induced skeletal muscle hormone that induces WAT browning similar to that observed in SMAD3-deficient mice. Together, these observations suggested that SMAD3 may negatively regulate irisin production and/or secretion from skeletal muscle. To address this question, we used wild-type and SMAD3 knock-out (Smad3(-/-)) mice subjected to an exercise regime and C2C12 myotubes treated with TGF-, a TGF- receptor 1 pharmacological inhibitor, adenovirus expressing constitutively active SMAD3, or siRNA against SMAD3. We find that in Smad3(-/-) mice, exercise increases serum irisin and skeletal muscle FNDC5 (irisin precursor) and its upstream activator peroxisome proliferator-activated receptor coactivator 1- (PGC-1) to a greater extent than in wild-type mice. In C2C12 myotubes, TGF- suppresses FNDC5 and PGC-1 mRNA and protein levels via SMAD3 and promotes SMAD3 binding to the FNDC5 and PGC-1 promoters. These data establish that SMAD3 suppresses FNDC5 and PGC-1 in skeletal muscle cells. These findings shed light on the poorly understood regulation of irisin/FNDC5 by demonstrating a novel association between irisin and SMAD3 signaling in skeletal muscle.	[Tiano, Joseph P.; Rane, Sushil G.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Springer, Danielle A.] NHLBI, Murine Phenotyping Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rane, SG (corresponding author), NIDDK, Cell Growth & Metab Sect, Diabet Endocrinol & Obes Branch, NIH,Clin Res Ctr, West Labs 5-5940,10 Ctr Dr, Bethesda, MD 20892 USA.	ranes@niddk.nih.gov			National Institutes of Health intramural program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, ZIGHL006190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055106, ZIADK055107] Funding Source: NIH RePORTER	National Institutes of Health intramural program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health intramural program.	Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Baar K, 2004, P NUTR SOC, V63, P269, DOI 10.1079/PNS2004334; Bonala S, 2014, J BIOL CHEM, V289, P7654, DOI 10.1074/jbc.M113.529925; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Crawford AG, 2010, POPUL HEALTH MANAG, V13, P151, DOI 10.1089/pop.2009.0039; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dalbo VJ, 2011, J GERONTOL A-BIOL, V66, P855, DOI 10.1093/gerona/glr091; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Ferrer-Martinez A, 2002, DEV DYNAM, V224, P154, DOI 10.1002/dvdy.10099; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Goodman CA, 2013, MOL ENDOCRINOL, V27, P1946, DOI 10.1210/me.2013-1194; Hofmann T, 2014, PEPTIDES, V54, P89, DOI 10.1016/j.peptides.2014.01.016; Huh JY, 2015, J CLIN ENDOCR METAB, V100, pE453, DOI 10.1210/jc.2014-2416; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim WK, 2012, INT J BIOCHEM CELL B, V44, P327, DOI 10.1016/j.biocel.2011.11.004; Kollias HD, 2006, MOL CELL BIOL, V26, P6248, DOI 10.1128/MCB.00384-06; Kraemer RR, 2014, HORM METAB RES, V46, P150, DOI 10.1055/s-0033-1355381; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Lach-Trifilieff E, 2014, MOL CELL BIOL, V34, P606, DOI 10.1128/MCB.01307-13; Lecker SH, 2012, CIRC-HEART FAIL, V5, P812, DOI 10.1161/CIRCHEARTFAILURE.112.969543; Lee P., 2013, INT J OBES LOND, V38, P170; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Lokireddy S, 2011, MOL ENDOCRINOL, V25, P1936, DOI 10.1210/me.2011-1124; Matsumoto K, 1996, J APPL PHYSIOL, V81, P1843, DOI 10.1152/jappl.1996.81.4.1843; Millet C, 2009, J BIOL CHEM, V284, P19808, DOI 10.1074/jbc.M109.016667; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073680; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Sacks HS, 2013, J CLIN ENDOCR METAB, V98, pE1448, DOI 10.1210/jc.2013-1265; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shan TZ, 2013, FASEB J, V27, P1981, DOI 10.1096/fj.12-225755; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sohn EJ, 2012, CELL MOL BIOL, V58, P1763, DOI 10.1170/207; Tan CK, 2011, DIABETES, V60, P464, DOI 10.2337/db10-0801; Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4; Trachtman H, 2011, KIDNEY INT, V79, P1236, DOI 10.1038/ki.2011.33; Tsuchiya Y, 2014, TOHOKU J EXP MED, V233, P135, DOI 10.1620/tjem.233.135; Tsurutani Y, 2011, BIOCHEM BIOPH RES CO, V407, P68, DOI 10.1016/j.bbrc.2011.02.106; Watts R, 2013, OBESITY, V21, P525, DOI 10.1002/oby.20070; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yan JQ, 2014, NAT MED, V20, P1001, DOI 10.1038/nm.3616; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yoshida H, 2013, BBA-GEN SUBJECTS, V1830, P5027, DOI 10.1016/j.bbagen.2013.06.036; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	66	52	55	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7671	7684		10.1074/jbc.M114.617399	http://dx.doi.org/10.1074/jbc.M114.617399			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25648888	hybrid, Green Published			2022-12-28	WOS:000351613600029
J	Katta, K; Imran, T; Busse-Wicher, M; Gronning, M; Czajkowski, S; Kusche-Gullberg, M				Katta, Kirankumar; Imran, Tabasum; Busse-Wicher, Marta; Gronning, Mona; Czajkowski, Szymon; Kusche-Gullberg, Marion			Reduced Expression of EXTL2, a Member of the Exostosin (EXT) Family of Glycosyltransferases, in Human Embryonic Kidney 293 Cells Results in Longer Heparan Sulfate Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR SUPPRESSORS; MULTIPLE EXOSTOSES; BIOSYNTHESIS; PROTEINS; ELONGATION; COMPLEX; PCR	Heparan sulfate proteoglycans are ubiquitously located on cell surfaces and in the extracellular matrices. The negatively charged heparan sulfate chains interact with a multitude of different proteins, thereby influencing a variety of cellular and developmental processes, for example cell adhesion, migration, tissue morphogenesis, and differentiation. The human exostosin (EXT) family of genes contains five members: the heparan sulfate polymerizing enzymes, EXT1 and EXT2, and three EXT-like genes, EXTL1, EXTL2, and EXTL3. EXTL2 has been ascribed activities related to the initiation and termination of heparan sulfate chains. Here we further investigated the role of EXTL2 in heparan sulfate chain elongation by gene silencing and overexpression strategies. We found that siRNA-mediated knockdown of EXTL2 in human embryonic kidney 293 cells resulted in increased chain length, whereas overexpression of EXTL2 in the same cell line had little or no effect on heparan sulfate chain length. To study in more detail the role of EXTL2 in heparan sulfate chain elongation, we tested the ability of the overexpressed protein to catalyze the in vitro incorporation of N-acetylglucosamine and N-acetylgalactosamine to oligosaccharide acceptors resembling unmodified heparan sulfate and chondroitin sulfate precursor molecules. Analysis of the generated products revealed that recombinant EXTL2 showed weak ability to transfer N-acetylgalactosamine to heparan sulfate precursor molecules but also, that EXTL2 exhibited much stronger in vitro N-acetylglucosamine-transferase activity related to elongation of heparan sulfate chains.	[Katta, Kirankumar; Imran, Tabasum; Gronning, Mona; Czajkowski, Szymon; Kusche-Gullberg, Marion] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; [Busse-Wicher, Marta] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Bergen; University of Cambridge	Kusche-Gullberg, M (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.	Marion.Kusche@biomed.uib.no	Kusche-Gullberg, Marion/P-4466-2016	Kusche-Gullberg, Marion/0000-0002-5636-1695; Busse-Wicher, Marta/0000-0001-6290-2462	University of Bergen; Norwegian Cancer Society [3292722-2012]	University of Bergen; Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from the University of Bergen and the Norwegian Cancer Society (3292722-2012).	Busse M, 2003, J BIOL CHEM, V278, P41333, DOI 10.1074/jbc.M308314200; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Busse-Wicher M, 2014, MATRIX BIOL, V35, P25, DOI 10.1016/j.matbio.2013.10.001; COOK A, 1993, AM J HUM GENET, V53, P71; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Feta A, 2009, BIOCHEM J, V419, P585, DOI 10.1042/BJ20082081; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; Kitagawa H, 2001, J BIOL CHEM, V276, P4834, DOI 10.1074/jbc.C000835200; Lidholt K, 1997, J BIOL CHEM, V272, P2682, DOI 10.1074/jbc.272.5.2682; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyon M, 1998, MATRIX BIOL, V17, P485, DOI 10.1016/S0945-053X(98)90096-8; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Nadanaka S, 2013, J BIOL CHEM, V288, P9321, DOI 10.1074/jbc.M112.416909; Oesterholm C, 2009, J BIOL CHEM, V284, P34935, DOI 10.1074/jbc.M109.005264; Okada M, 2010, BIOCHEM J, V428, P463, DOI 10.1042/BJ20100101; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; WU YQ, 1994, HUM MOL GENET, V3, P167, DOI 10.1093/hmg/3.1.167; Yamada S, 2004, J BIOL CHEM, V279, P32134, DOI 10.1074/jbc.M312624200	25	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13168	13177		10.1074/jbc.M114.631754	http://dx.doi.org/10.1074/jbc.M114.631754			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25829497	hybrid, Green Published			2022-12-28	WOS:000354975700019
J	Tirodkar, TS; Lu, P; Bai, AP; Scheffel, MJ; Gencer, S; Garrett-Mayer, E; Bielawska, A; Ogretmen, B; Voelkel-Johnson, C				Tirodkar, Tejas S.; Lu, Ping; Bai, Aiping; Scheffel, Matthew J.; Gencer, Salih; Garrett-Mayer, Elizabeth; Bielawska, Alicja; Ogretmen, Besim; Voelkel-Johnson, Christina			Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; SPHINGOLIPID METABOLISM; INDUCED APOPTOSIS; CARCINOMA-CELLS; TUMOR-CELLS; INDUCTION; STRESS; AUTOPHAGY; LIVER; SUPPRESSION	A family of six ceramide synthases with distinct but overlapping substrate specificities is responsible for generation of ceramides with acyl chains ranging from similar to 14-26 carbons. Ceramide synthase 6 (CerS6) preferentially generates C-14- and C-16-ceramides, and we have previously shown that down-regulation of this enzyme decreases apoptotic susceptibility. In this study, we further evaluated how increased CerS6 expression impacts sphingolipid composition and metabolism. Overexpression of CerS6 in HT29 colon cancer cells resulted in increased apoptotic susceptibility and preferential generation of C-16-ceramide, which occurred at the expense of very long chain, saturated ceramides. These changes were also reflected in sphingomyelin composition. HT-CerS6 cells had increased intracellular levels of sphingosine, which is generated by ceramidases upon hydrolysis of ceramide. qRT-PCR analysis revealed that only expression of acid ceramidase (ASAH1) was increased. The increase in acid ceramidase was confirmed by expression and activity analyses. Pharmacological inhibition of JNK (SP600125) or curcumin reduced transcriptional up-regulation of acid ceramidase. Using an acid ceramidase promoter driven luciferase reporter plasmid, we demonstrated that CerS1 has no effect on transcriptional activation of acid ceramidase and that CerS2 slightly but significantly decreased the luciferase signal. Similar to CerS6, overexpression of CerS3-5 resulted in an similar to 2-fold increase in luciferase reporter gene activity. Exogenous ceramide failed to induce reporter activity, while a CerS inhibitor and a catalytically inactive mutant of CerS6 failed to reduce it. Taken together, these results suggest that increased expression of CerS6 can mediate transcriptional activation of acid ceramidase in a JNK-dependent manner that is independent of CerS6 activity.	[Tirodkar, Tejas S.; Lu, Ping; Scheffel, Matthew J.; Voelkel-Johnson, Christina] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Bai, Aiping; Gencer, Salih; Bielawska, Alicja; Ogretmen, Besim] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Garrett-Mayer, Elizabeth] Med Univ S Carolina, Dept Publ Hlth, Charleston, SC 29425 USA; [Gencer, Salih] Dept Mol Biol & Genet, TR-34662 Istanbul, Turkey	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Voelkel-Johnson, C (corresponding author), Med Univ S Carolina, Dept Microbiol & Immunol, 173 Ashley Ave, Charleston, SC 29425 USA.	johnsocv@musc.edu	Regan, Clinton/E-6250-2012; Gencer, Salih/AAL-5502-2020; Gencer, Salih/B-6436-2012	Garrett-Mayer, Elizabeth/0000-0003-4709-0333	MUSC; Lipidomics and Flow Cytometry Shared Resources, Hollings Cancer Center, MUSC [P30 CA138313]; National Institutes of Health [P01 CA154778];  [CA88032];  [CA173687];  [DE016572]; NATIONAL CANCER INSTITUTE [R01CA173687, P01CA154778, P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016572] Funding Source: NIH RePORTER	MUSC; Lipidomics and Flow Cytometry Shared Resources, Hollings Cancer Center, MUSC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was supported by MUSC intramural funds (to C. V. J.) and in part by the Lipidomics and Flow Cytometry Shared Resources, Hollings Cancer Center, MUSC (P30 CA138313).; Supported by CA88032, CA173687, and DE016572.; Supported by National Institutes of Health Grant P01 CA154778.	Alexaki A, 2014, J LIPID RES, V55, P2521, DOI 10.1194/jlr.M051862; Bai AP, 2014, BIOORGAN MED CHEM, V22, P6933, DOI 10.1016/j.bmc.2014.10.025; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; Bierhaus A, 1997, THROMB HAEMOSTASIS, V77, P772; Cheng JC, 2013, J CLIN INVEST, V123, P4344, DOI 10.1172/JCI64791; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Hanker LC, 2013, INT J GYNECOL PATHOL, V32, P249, DOI 10.1097/PGP.0b013e3182673982; Hartmann D., INT J BIOCH CELL BIO, V44, P620; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; Jensen SA, 2014, P NATL ACAD SCI USA, V111, P5682, DOI 10.1073/pnas.1316700111; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Lucki N, 2009, BBA-MOL CELL BIOL L, V1791, P706, DOI 10.1016/j.bbalip.2009.03.005; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Meixner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-22; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Park MA, 2010, CANCER RES, V70, P6313, DOI 10.1158/0008-5472.CAN-10-0999; Park MA, 2009, MOL CANCER THER, V8, P1280, DOI 10.1158/1535-7163.MCT-09-0073; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Ruvolo PP, 2003, PHARMACOL RES, V47, P383, DOI 10.1016/S1043-6618(03)00050-1; Sanger N, 2015, MOL ONCOL, V9, P58, DOI 10.1016/j.molonc.2014.07.016; Schiffmann S, 2012, J IMMUNOL, V188, P5723, DOI 10.4049/jimmunol.1103109; Schiffmann S, 2010, BIOCHEM PHARMACOL, V80, P1632, DOI 10.1016/j.bcp.2010.08.012; Sehgal Vasudha, 2013, Genes Cancer, V4, P409, DOI 10.1177/1947601913507577; Senkal CE, 2011, J BIOL CHEM, V286, P42446, DOI 10.1074/jbc.M111.287383; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Separovic D, 2012, ANTICANCER RES, V32, P753; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Tang HW, 2013, DEV CELL, V27, P489, DOI 10.1016/j.devcel.2013.10.017; Tirodkar T. S., 2012, Experimental Oncology, V34, P231; Turner LS, 2011, PROSTATE CANCER P D, V14, P30, DOI 10.1038/pcan.2010.47; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Voelkel-Johnson C, 2005, MOL CANCER THER, V4, P1320, DOI 10.1158/1535-7163.MCT-05-0086; Walker T, 2010, MOL CANCER THER, V9, P1378, DOI 10.1158/1535-7163.MCT-09-1131; Walker T, 2009, MOL PHARMACOL, V76, P342, DOI 10.1124/mol.109.056523; WESTWICK JK, 1995, J BIOL CHEM, V270, P22689, DOI 10.1074/jbc.270.39.22689; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701	50	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13157	13167		10.1074/jbc.M114.631325	http://dx.doi.org/10.1074/jbc.M114.631325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25839235	Green Published, hybrid			2022-12-28	WOS:000354975700018
J	Jang, SH; Byun, JK; Jeon, WI; Choi, SY; Park, J; Lee, BH; Yang, JE; Park, JB; O'Grady, SM; Kim, DY; Ryu, PD; Joo, SW; Lee, SY				Jang, Soo Hwa; Byun, Jun Kyu; Jeon, Won-Il; Choi, Seon Young; Park, Jin; Lee, Bo Hyung; Yang, Ji Eun; Park, Jin Bong; O'Grady, Scott M.; Kim, Dae-Yong; Ryu, Pan Dong; Joo, Sang-Woo; Lee, So Yeong			Nuclear Localization and Functional Characteristics of Voltage-gated Potassium Channel Kv1.3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION CHANNELS; K+-CHANNELS; ENVELOPE; CELLS; CREB; TRANSCRIPTION; EXPRESSION; APOPTOSIS; PROTEIN; COLOCALIZATION	It is widely known that ion channels are expressed in the plasma membrane. However, a few studies have suggested that several ion channels including voltage-gated K+ (Kv) channels also exist in intracellular organelles where they are involved in the biochemical events associated with cell signaling. In the present study, Western blot analysis using fractionated protein clearly indicates that Kv1.3 channels are expressed in the nuclei of MCF7, A549, and SNU-484 cancer cells and human brain tissues. In addition, Kv1.3 is located in the plasma membrane and the nucleus of Jurkat T cells. Nuclear membrane hyperpolarization after treatment with margatoxin (MgTX), a specific blocker of Kv1.3 channels, provides evidence for functional channels at the nuclear membrane of A549 cells. MgTX-induced hyperpolarization is abolished in the nuclei of Kv1.3 silenced cells, and the effects of MgTX are dependent on the magnitude of the K+ gradient across the nuclear membrane. Selective Kv1.3 blockers induce the phosphorylation of cAMP response element-binding protein (CREB) and c-Fos activation. Moreover, Kv1.3 is shown to form a complex with the upstream binding factor 1 in the nucleus. Chromatin immunoprecipitation assay reveals that Sp1 transcription factor is directly bound to the promoter region of the Kv1.3 gene, and the Sp1 regulates Kv1.3 expression in the nucleus of A549 cells. These results demonstrate that Kv1.3 channels are primarily localized in the nucleus of several types of cancer cells and human brain tissues where they are capable of regulating nuclear membrane potential and activation of transcription factors, such as phosphorylated CREB and c-Fos.	[Jang, Soo Hwa; Byun, Jun Kyu; Jeon, Won-Il; Choi, Seon Young; Lee, Bo Hyung; Yang, Ji Eun; Ryu, Pan Dong; Lee, So Yeong] Seoul Natl Univ, Coll Vet Med, Lab Vet Pharmacol, Seoul 151742, South Korea; [Kim, Dae-Yong] Seoul Natl Univ, Coll Vet Med, Labs Vet Pathol, Seoul 151742, South Korea; [Kim, Dae-Yong] Seoul Natl Univ, Res Inst Vet Sci, Seoul 151742, South Korea; [Jang, Soo Hwa] Univ Ulsan, Sch Biol Sci, Biomed Res Ctr, Ulsan 680749, South Korea; [Park, Jin; Joo, Sang-Woo] Soongsil Univ, Dept Chem, Seoul 156743, South Korea; [Park, Jin Bong] Chungnam Natl Univ, Sch Med, Dept Physiol, Taejon 305764, South Korea; [O'Grady, Scott M.] Univ Minnesota, Dept Anim Sci & Integrat Biol & Physiol, St Paul, MN 55455 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Ulsan; Soongsil University; Chungnam National University; University of Minnesota System; University of Minnesota Twin Cities	Lee, SY (corresponding author), Seoul Natl Univ, Coll Vet Med, Lab Vet Pharmacol, 1 Gwanak Ro, Seoul 151742, South Korea.	leeso@snu.ac.kr	Ryu, Pan Dong/AGX-5700-2022	Jang, Soohwa/0000-0003-3686-5930; Lee, Bo-Hyung/0000-0002-4523-4236; Ryu, Pan Dong/0000-0003-4130-2251; Park, Jin Bong/0000-0002-0081-945X	Basic Science Research Program [NRF-2010-0011556]; BK21 PLUS Program for Creative Veterinary Science Research; Priority Research Center Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2009-0094050]	Basic Science Research Program; BK21 PLUS Program for Creative Veterinary Science Research; Priority Research Center Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology	This work was supported by Basic Science Research Program Grant NRF-2010-0011556, the BK21 PLUS Program for Creative Veterinary Science Research, and Priority Research Center Program Grant 2009-0094050 through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology.	BALSALOBRE A, 1995, ONCOGENE, V11, P455; Bednarczyk P, 2010, BIOCHEM BIOPH RES CO, V397, P614, DOI 10.1016/j.bbrc.2010.06.011; Bkaily G, 2009, CAN J PHYSIOL PHARM, V87, P108, DOI 10.1139/Y08-115; BUSTAMANTE JO, 1993, BIOPHYS J, V64, P1735, DOI 10.1016/S0006-3495(93)81545-5; BUSTAMANTE JO, 1992, PFLUG ARCH EUR J PHY, V421, P473, DOI 10.1007/BF00370259; Buyse G, 1998, BIOCHEM J, V330, P1015, DOI 10.1042/bj3301015; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Coleman SK, 1999, J NEUROCHEM, V73, P849, DOI 10.1046/j.1471-4159.1999.0730849.x; Conkright MD, 2005, TRENDS CELL BIOL, V15, P457, DOI 10.1016/j.tcb.2005.07.007; Coussin F, 2003, BIOCHEM PHARMACOL, V66, P1861, DOI 10.1016/S0006-2952(03)00546-X; Draguhn A, 1997, J MEMBRANE BIOL, V158, P159, DOI 10.1007/s002329900253; Fountain SJ, 2007, AM J PHYSIOL-HEART C, V293, pH2719, DOI 10.1152/ajpheart.00637.2007; Franco-Obregon A, 2000, BIOPHYS J, V79, P202, DOI 10.1016/S0006-3495(00)76284-9; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hille B., 2001, ION CHANNELS EXCITAB, P131; Hu LN, 2012, J BIOL CHEM, V287, P1261, DOI 10.1074/jbc.M111.296798; Jang SH, 2011, J VET SCI, V12, P35, DOI 10.4142/jvs.2011.12.1.35; Jang SH, 2011, EUR J PHARMACOL, V651, P26, DOI 10.1016/j.ejphar.2010.10.066; KACZMAREK L, 1990, ACTA NEUROBIOL EXP, V50, P173; Kass-Simon G, 2009, J EXP ZOOL PART A, V311A, P763, DOI 10.1002/jez.563; KAUFMANN SH, 1983, J BIOL CHEM, V258, P2710; KONING AJ, 1993, CELL MOTIL CYTOSKEL, V25, P111, DOI 10.1002/cm.970250202; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Leanza L, 2012, EMBO MOL MED, V4, P577, DOI 10.1002/emmm.201200235; Li Q, 2012, BIOCHEM J, V441, P859, DOI 10.1042/BJ20111604; Linnerth NM, 2005, ONCOGENE, V24, P7310, DOI 10.1038/sj.onc.1208882; Loew L. M., 1993, FLUORESCENT LUMINESC, P150; Marks DR, 2007, J NEUROCHEM, V103, P1608, DOI 10.1111/j.1471-4159.2007.04870.x; MARUYAMA Y, 1995, PFLUG ARCH EUR J PHY, V430, P148, DOI 10.1007/BF00373851; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; MAZZANTI M, 1990, NATURE, V343, P764, DOI 10.1038/343764a0; MAZZANTI M, 1991, J MEMBRANE BIOL, V121, P189, DOI 10.1007/BF01870532; Mazzanti M, 2001, PHYSIOL REV, V81, P1, DOI 10.1152/physrev.2001.81.1.1; Napp J, 2005, J BIOL CHEM, V280, P29506, DOI 10.1074/jbc.M504228200; O'Grady SM, 2005, INT J BIOCHEM CELL B, V37, P1578, DOI 10.1016/j.biocel.2005.04.002; Okada S, 1999, BLOOD, V93, P816, DOI 10.1182/blood.V93.3.816.403k21_816_825; Olsen ML, 2004, GLIA, V46, P63, DOI 10.1002/glia.10346; Panyi G, 2003, P NATL ACAD SCI USA, V100, P2592, DOI 10.1073/pnas.0438057100; Pongs O, 1999, ANN NY ACAD SCI, V868, P344, DOI 10.1111/j.1749-6632.1999.tb11296.x; Quesada I, 2002, P NATL ACAD SCI USA, V99, P9544, DOI 10.1073/pnas.142039299; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Saria A, 2000, AMINO ACIDS, V19, P23, DOI 10.1007/s007260070030; Sawka-Verhelle D, 2004, J BIOL CHEM, V279, P17772, DOI 10.1074/jbc.M311991200; Schulz DJ, 2008, CELL MOL LIFE SCI, V65, P2215, DOI 10.1007/s00018-008-8060-z; Simon M, 1997, CELL PHYSIOL BIOCHEM, V7, P243, DOI 10.1159/000154879; Sole L, 2009, J CELL SCI, V122, P3738, DOI 10.1242/jcs.056689; Sonner PA, 2007, J PHYSIOL-LONDON, V582, P1219, DOI 10.1113/jphysiol.2007.134379; Stonehouse AH, 2003, J MOL NEUROSCI, V20, P189, DOI 10.1385/JMN:20:2:189; Szabo I, 2005, J BIOL CHEM, V280, P12790, DOI 10.1074/jbc.M413548200; Szabo I, 2008, P NATL ACAD SCI USA, V105, P14861, DOI [10.1073/pnas.0804236105, 10.1073/pnas.0804236T05]; Thomas DP, 2000, J CELL SCI, V113, P439; Valenzuela SM, 2000, J PHYSIOL-LONDON, V529, P541, DOI 10.1111/j.1469-7793.2000.00541.x; Wang W, 2011, CELL PHYSIOL BIOCHEM, V28, P199, DOI 10.1159/000331731; Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859	55	34	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12547	12557		10.1074/jbc.M114.561324	http://dx.doi.org/10.1074/jbc.M114.561324			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25829491	Green Published, hybrid			2022-12-28	WOS:000354569000011
J	Dewhare, SS; Umesh, TG; Muniyappa, K				Dewhare, Shivendra Singh; Umesh, T. G.; Muniyappa, K.			Molecular and Functional Characterization of RecD, a Novel Member of the SF1 Family of Helicases, from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atomic Force Microscopy (AFM); ATPase; Bioinformatics; Cloning; DNA Helicase; DNA Recombination; Enzyme Kinetics; Infectious Disease; Mycobacteria; Mycobacterium tuberculosis	BACTERIOPHAGE-T4 DDA HELICASE; ATOMIC-FORCE MICROSCOPY; ESCHERICHIA-COLI-UVRD; DNA-DEPENDENT ATPASE; RECBCD ENZYME; BACILLUS-SUBTILIS; STRAND EXCHANGE; IN-VITRO; HOMOLOGOUS RECOMBINATION; DEINOCOCCUS-RADIODURANS	Background: The heterotrimeric M. tuberculosis RecBCD complex, or each of its individual subunits, remains uncharacterized. Results: MtRecD exists as a homodimer in solution, catalyzes ssDNA-dependent ATP hydrolysis, unwinding of DNA replication/recombination intermediates, and interacts with RecA. Conclusion: MtRecD possesses strong 5 3- and weak 3 5-helicase activities. Significance: These findings provide insights into the mechanism underlying DSB repair and homologous recombination in mycobacteria. The annotated whole-genome sequence of Mycobacterium tuberculosis revealed the presence of a putative recD gene; however, the biochemical characteristics of its encoded protein product (MtRecD) remain largely unknown. Here, we show that MtRecD exists in solution as a stable homodimer. Protein-DNA binding assays revealed that MtRecD binds efficiently to single-stranded DNA and linear duplexes containing 5 overhangs relative to the 3 overhangs but not to blunt-ended duplex. Furthermore, MtRecD bound more robustly to a variety of Y-shaped DNA structures having 18-nucleotide overhangs but not to a similar substrate containing 5-nucleotide overhangs. MtRecD formed more salt-tolerant complexes with Y-shaped structures compared with linear duplex having 3 overhangs. The intrinsic ATPase activity of MtRecD was stimulated by single-stranded DNA. Site-specific mutagenesis of Lys-179 in motif I abolished the ATPase activity of MtRecD. Interestingly, although MtRecD-catalyzed unwinding showed a markedly higher preference for duplex substrates with 5 overhangs, it could also catalyze significant unwinding of substrates containing 3 overhangs. These results support the notion that MtRecD is a bipolar helicase with strong 5 3 and weak 3 5 unwinding activities. The extent of unwinding of Y-shaped DNA structures was approximate to 3-fold lower compared with duplexes with 5 overhangs. Notably, direct interaction between MtRecD and its cognate RecA led to inhibition of DNA strand exchange promoted by RecA. Altogether, these studies provide the first detailed characterization of MtRecD and present important insights into the type of DNA structure the enzyme is likely to act upon during the processes of DNA repair or homologous recombination.	[Dewhare, Shivendra Singh; Umesh, T. G.; Muniyappa, K.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Muniyappa, K (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	kmbc@biochem.iisc.ernet.in			Council of Scientific and Industrial Research; Dept. of Biotechnology, New Delhi, India; J.C. Bose National Fellowship, Department of Science and Technology, New Delhi, India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Dept. of Biotechnology, New Delhi, India; J.C. Bose National Fellowship, Department of Science and Technology, New Delhi, India	This work was supported in part by a senior research fellowship (to S. S. D.) and a postdoctoral fellowship (to T. G. U.) from the Council of Scientific and Industrial Research and Dept. of Biotechnology, New Delhi, India.; Recipient of J.C. Bose National Fellowship, Department of Science and Technology, New Delhi, India. To whom correspondence should be addressed. Tel.: 91-80-2293-2235/2360 0278; Fax: 91-80-23600814/0683; E-mail: kmbc@biochem.iisc.ernet.in.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amundsen SK, 2000, P NATL ACAD SCI USA, V97, P7399, DOI 10.1073/pnas.130192397; AMUNDSEN SK, 1986, P NATL ACAD SCI USA, V83, P5558, DOI 10.1073/pnas.83.15.5558; Anand SP, 2007, J BACTERIOL, V189, P4502, DOI 10.1128/JB.00376-07; Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; Bianco P R, 1998, Front Biosci, V3, pD570; BIEK DP, 1986, J BACTERIOL, V167, P594, DOI 10.1128/jb.167.2.594-603.1986; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chedin F, 2000, J MOL BIOL, V298, P7, DOI 10.1006/jmbi.2000.3556; Chedin F, 1998, MOL MICROBIOL, V29, P1369, DOI 10.1046/j.1365-2958.1998.01018.x; Chedin F, 2002, MOL MICROBIOL, V43, P823, DOI 10.1046/j.1365-2958.2002.02785.x; Chen HW, 1997, J BIOL CHEM, V272, P10072; Chen HW, 1998, J MOL BIOL, V278, P89, DOI 10.1006/jmbi.1998.1694; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Curti E, 2007, J BACTERIOL, V189, P1542, DOI 10.1128/JB.01421-06; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Dos Vultos T, 2009, FEMS MICROBIOL REV, V33, P471, DOI 10.1111/j.1574-6976.2009.00170.x; Drees JC, 2004, MOL CELL, V15, P789, DOI 10.1016/j.molcel.2004.08.026; EDSTROM RD, 1990, BIOPHYS J, V58, P1437, DOI 10.1016/S0006-3495(90)82489-9; Fagerburg MV, 2012, NUCLEIC ACIDS RES, V40, P8416, DOI 10.1093/nar/gks641; Ganesh N, 2003, PROTEINS, V53, P6, DOI 10.1002/prot.10433; Gilhooly Neville Surain, 2013, Front Biosci (Schol Ed), V5, P206; Guhan N, 2003, NUCLEIC ACIDS RES, V31, P4184, DOI 10.1093/nar/gkg475; Gupta R, 2011, MOL MICROBIOL, V79, P316, DOI 10.1111/j.1365-2958.2010.07463.x; HABEEB AFS, 1968, ARCH BIOCHEM BIOPHYS, V126, P16, DOI 10.1016/0003-9861(68)90554-7; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; HOWARDFLANDERS P, 1966, GENETICS, V53, P1137; JULIN DA, 1987, J BIOL CHEM, V262, P9044; Khan K, 2010, PROTEIN EXPRES PURIF, V72, P42, DOI 10.1016/j.pep.2010.03.016; Kironmai KM, 1998, MOL CELL BIOL, V18, P1424, DOI 10.1128/MCB.18.3.1424; Kooistra J, 1997, MOL MICROBIOL, V23, P137, DOI 10.1046/j.1365-2958.1997.1991570.x; KORANGY F, 1992, J BIOL CHEM, V267, P1733; Kumar RA, 1996, BIOCHEMISTRY-US, V35, P1793, DOI 10.1021/bi9517751; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Li F, 2008, MUTAT RES-FUND MOL M, V637, P101, DOI 10.1016/j.mrfmmm.2007.07.008; LOVETT ST, 1988, GENETICS, V120, P37; Maluf NK, 2003, J BIOL CHEM, V278, P31930, DOI 10.1074/jbc.M304223200; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; MASTERSON C, 1992, J BIOL CHEM, V267, P13564; MENDONCA VM, 1993, J BACTERIOL, V175, P4641, DOI 10.1128/JB.175.15.4641-4651.1993; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; Morris PD, 2001, J BIOL CHEM, V276, P19691, DOI 10.1074/jbc.M010928200; Muniyappa K, 2000, MICROBIOL-UK, V146, P2093, DOI 10.1099/00221287-146-9-2093; Nanduri B, 2002, P NATL ACAD SCI USA, V99, P14722, DOI 10.1073/pnas.232401899; PALAS KM, 1990, J BIOL CHEM, V265, P3447; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Pitcher RS, 2007, ANNU REV MICROBIOL, V61, P259, DOI 10.1146/annurev.micro.61.080706.093354; Quiberoni A, 2001, J BACTERIOL, V183, P4071, DOI 10.1128/JB.183.13.4071-4078.2001; Reddy MS, 2001, J BIOL CHEM, V276, P45959, DOI 10.1074/jbc.M103523200; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P602, DOI 10.1021/bi00053a028; Saikrishnan K, 2008, EMBO J, V27, P2222, DOI 10.1038/emboj.2008.144; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Satapathy AK, 2008, FEBS J, V275, P1835, DOI 10.1111/j.1742-4658.2008.06342.x; Shadrick WR, 2010, J BIOL CHEM, V285, P17292, DOI 10.1074/jbc.M110.111427; Sikora B, 2006, J BIOL CHEM, V281, P36110, DOI 10.1074/jbc.M604412200; Singh P, 2010, BIOCHEMISTRY-US, V49, P4872, DOI 10.1021/bi902021d; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sinha KM, 2009, GENE DEV, V23, P1423, DOI 10.1101/gad.1805709; SMITH GR, 1995, PHILOS T ROY SOC B, V347, P13, DOI 10.1098/rstb.1995.0003; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; Stohl EA, 2003, J BIOL CHEM, V278, P2278, DOI 10.1074/jbc.M210496200; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Unciuleac MC, 2010, J BIOL CHEM, V285, P34319, DOI 10.1074/jbc.M110.162925; Unciuleac MC, 2010, J BIOL CHEM, V285, P2632, DOI 10.1074/jbc.M109.076133; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Venkatesh R, 2002, P NATL ACAD SCI USA, V99, P12091, DOI 10.1073/pnas.192178999; Wang JL, 2004, J BIOL CHEM, V279, P52024, DOI 10.1074/jbc.M408645200; Warner DF, 2011, MOL MICROBIOL, V79, P283, DOI 10.1111/j.1365-2958.2010.07462.x; Yang Y, 2003, METHODS, V29, P175, DOI 10.1016/S1046-2023(02)00308-0; Yang Y, 2008, NUCLEIC ACIDS RES, V36, P1976, DOI 10.1093/nar/gkm1174	76	3	3	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11948	11968		10.1074/jbc.M114.619395	http://dx.doi.org/10.1074/jbc.M114.619395			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25802334	hybrid, Green Published			2022-12-28	WOS:000354388600013
J	Liu, Y; Lear, T; Iannone, O; Shiva, S; Corey, C; Rajbhandari, S; Jerome, J; Chen, BB; Mallampalli, RK				Liu, Yuan; Lear, Travis; Iannone, Olivia; Shiva, Sruti; Corey, Catherine; Rajbhandari, Shristi; Jerome, Jacob; Chen, Bill B.; Mallampalli, Rama K.			The Proapoptotic F-box Protein Fbxl7 Regulates Mitochondrial Function by Mediating the Ubiquitylation and Proteasomal Degradation of Survivin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; E3 Ubiquitin Ligase; Lung Injury; Mitochondria; Protein Degradation; Oxygen	SCF UBIQUITIN LIGASE; RECOGNIZES SUGAR CHAINS; X-LINKED INHIBITOR; IAP PROTEINS; CANCER; APOPTOSIS; COMPLEX; FAMILY; PHOSPHORYLATION; LOCALIZATION	Background: The SCF ubiquitin E3 ligase component Fbxl7 possesses proapoptotic activity. Results: Fbxl7 targets the antiapoptotic protein survivin for polyubiquitylation and proteasomal degradation. Conclusion: Survivin protects mitochondria from damage induced by Fbxl7. Significance: Understanding how F-box proteins regulate survivin might impact therapies to preserve cellular bioenergetics. Fbxl7, a component of the Skp1<bold>Cul</bold>1<bold>F</bold>-box protein type ubiquitin E3 ligase, regulates mitotic cell cycle progression. Here we demonstrate that overexpression of Fbxl7 in lung epithelia decreases the protein abundance of survivin, a member of the inhibitor of apoptosis family. Fbxl7 mediates polyubiquitylation and proteasomal degradation of survivin by interacting with Glu-126 within its carboxyl-terminal helix. Furthermore, both Lys-90 and Lys-91 within survivin serve as ubiquitin acceptor sites. Ectopically expressed Fbxl7 impairs mitochondrial function, whereas depletion of Fbxl7 protects mitochondria from actions of carbonyl cyanide m-chlorophenylhydrazone, an inhibitor of oxidative phosphorylation. Compared with wild-type survivin, cellular expression of a survivin mutant protein deficient in its ability to interact with Fbxl7 (E126A) and a ubiquitylation-resistant double point mutant (KK90RR/KK91RR) rescued mitochondria to a larger extent from damage induced by overexpression of Fbxl7. Therefore, these data suggest that the Skp1<bold>Cul</bold>1<bold>F</bold>-box protein complex subunit Fbxl7 modulates mitochondrial function by controlling the cellular abundance of survivin. The results raise opportunities for F-box protein targeting to preserve mitochondrial function.	[Liu, Yuan; Lear, Travis; Iannone, Olivia; Rajbhandari, Shristi; Jerome, Jacob; Chen, Bill B.; Mallampalli, Rama K.] Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Shiva, Sruti; Corey, Catherine] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Chen, BB (corresponding author), Univ Pittsburgh, Dept Med, Pulm Allergy & Crit Care Med, Biomed Sci Tower 1,W1254, Pittsburgh, PA 15213 USA.	chenb@upmc.edu; mallampallirk@upmc.edu	Regan, Clinton/E-6250-2012	Lear, Travis/0000-0001-9156-0844	National Institutes of Health [HL096376, HL097376, HL098174, HL081784, 1UH2HL123502, P01 HL114453, HL116472]; Department of Veterans Affairs; Flight Attendants Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097376, R01HL096376, P01HL114453, UH2HL123502, R01HL098174, R01HL081784, R01HL116472] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Flight Attendants Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health R01 Grants HL096376, HL097376, HL098174, HL081784, 1UH2HL123502, and P01 HL114453 (to R. K. M.) and HL116472 (to B. B. C.). This work was also supported by a merit review award from the Department of Veterans Affairs and the Flight Attendants Medical Research Institute.	Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Blees JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046567; Cai Q, 2011, J MED CHEM, V54, P2714, DOI 10.1021/jm101505d; Cao C, 2004, ONCOGENE, V23, P7047, DOI 10.1038/sj.onc.1207929; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chan CH, 2013, CELL, V154, P556, DOI 10.1016/j.cell.2013.06.048; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Coon TA, 2012, CELL CYCLE, V11, P721, DOI 10.4161/cc.11.4.19171; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Gazzaniga P, 2003, ANN ONCOL, V14, P85, DOI 10.1093/annonc/mdg002; Hagenbuchner J, 2013, ONCOGENE, V32, P4748, DOI 10.1038/onc.2012.500; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Infante JR, 2014, J CLIN ONCOL, V32, P3103, DOI 10.1200/JCO.2013.52.3993; Kuchay S, 2013, NAT CELL BIOL, V15, P472, DOI 10.1038/ncb2731; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li ZJ, 2014, MOL CELL, V54, P805, DOI 10.1016/j.molcel.2014.03.046; Liu Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.585; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Rico-Bautista E, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-153; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Skaar JR, 2014, NAT REV DRUG DISCOV, V13, P889, DOI 10.1038/nrd4432; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Tamm I, 2004, CLIN CANCER RES, V10, P3737, DOI 10.1158/1078-0432.CCR-03-0642; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Wang HJ, 2010, J BIOL CHEM, V285, P36129, DOI 10.1074/jbc.M110.152777; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; Weathington NM, 2014, J CLIN INVEST, V124, P6, DOI 10.1172/JCI71602; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Wheatley SP, 2004, J BIOL CHEM, V279, P5655, DOI 10.1074/jbc.M311299200; Wu L, 2012, CHEM BIOL, V19, P1515, DOI 10.1016/j.chembiol.2012.09.015; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341; Zou CB, 2013, J BIOL CHEM, V288, P6306, DOI 10.1074/jbc.M112.426882	41	41	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11843	11852		10.1074/jbc.M114.629931	http://dx.doi.org/10.1074/jbc.M114.629931			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25778398	hybrid, Green Published			2022-12-28	WOS:000354388600004
J	Nanduri, R; Mahajan, S; Bhagyaraj, E; Sethi, K; Kalra, R; Chandra, V; Gupta, P				Nanduri, Ravikanth; Mahajan, Sahil; Bhagyaraj, Ella; Sethi, Kanupriya; Kalra, Rashi; Chandra, Vemika; Gupta, Pawan			The Active Form of Vitamin D Transcriptionally Represses Smad7 Signaling and Activates Extracellular Signal-regulated Kinase (ERK) to Inhibit the Differentiation of a Inflammatory T Helper Cell Subset and Suppress Experimental Autoimmune Encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmune Disease; Nuclear Receptor; Phosphorylation; T Helper Cells; Transcription Target Gene; VDR; Smad7; Gene Repression; ERK; EAE	GROWTH-FACTOR-BETA; TGF-BETA; 1,25-DIHYDROXYVITAMIN D-3; D-RECEPTOR; FOXP3 EXPRESSION; RETINOIC ACID; MULTIPLE-SCLEROSIS; PROTEIN-KINASES; TH17 CELLS; CROSS-TALK	Background: Transcriptional regulation of Smads that modulate T helper (Th) cell differentiation is not well understood. Results: Active form of vitamin D (1,25(OH)(2)D-3) leads to VDR-RXR-Smad3-HDAC2 repressive complex on VDRE-Smad7 promoter. 1,25(OH)(2)D-3 activates ERK. Conclusion: 1,25(OH)(2)D-3-VDR represses Smad7 and activates ERK leading to inhibition of inflammatory T cells and EAE. Significance: TGF Smad and non-Smad MAPK are involved in 1,25(OH)(2)D-3-VDR mediated inhibition of EAE. The ability of the active form of vitamin D, 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3), to transcriptionally modulate Smads to inhibit Th17 differentiation and experimental autoimmune encephalomyelitis (EAE) has not been adequately studied. This study reports modulation of Smad signaling by the specific binding of the VDR along with its heterodimeric partner RXR to the negative vitamin D response element on the promoter of Smad7, which leads to Smad7 gene repression. The vitamin D receptor-mediated increase in Smad3 expression partially explains the IL10 augmentation seen in Th17 cells. Furthermore, the VDR axis also modulates non-Smad signaling by activating ERK during differentiation of Th17 cells, which inhibits the Th17-specific genes il17a, il17f, il22, and il23r. In vivo EAE experiments revealed that, 1,25(OH)(2)D-3 suppression of EAE correlates with the Smad7 expression in the spleen and lymph nodes. Furthermore, Smad7 expression also correlates well with IL17 and IFN expression in CNS infiltered inflammatory T cells. We also observed similar gene repression of Smad7 in in vitro differentiated Th1 cells when cultured in presence of 1,25(OH)(2)D-3. The above canonical and non-canonical pathways in part address the ability of 1,25(OH)(2)D-3-VDR to inhibit EAE.	[Nanduri, Ravikanth; Mahajan, Sahil; Bhagyaraj, Ella; Sethi, Kanupriya; Kalra, Rashi; Chandra, Vemika; Gupta, Pawan] CSIR, Dept Prot Sci & Mol Biol, Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Gupta, P (corresponding author), CSIR, Dept Prot Sci & Mol Biol, Inst Microbial Technol, Sect 39 A, Chandigarh 160036, India.	pawan@imtech.res.in	NANDURI, RAVIKANTH/Q-9729-2018; Chandra, Vemika/AAK-6997-2020	NANDURI, RAVIKANTH/0000-0002-0031-2333; Chandra, Vemika/0000-0001-5360-7875; Ella, Bhagyaraj/0000-0002-5887-9228	Institute of Microbial Technology (IMTECH; a constituent laboratory of the Council of Scientific and Industrial Research)	Institute of Microbial Technology (IMTECH; a constituent laboratory of the Council of Scientific and Industrial Research)	We thank Dr. Girish Sahni for help and effort. We also thank Institute of Microbial Technology (IMTECH; a constituent laboratory of the Council of Scientific and Industrial Research) for facilities and financial support.	Aoki CA, 2005, AUTOIMMUN REV, V4, P450, DOI 10.1016/j.autrev.2005.03.006; Bruce D, 2011, INT IMMUNOL, V23, P519, DOI 10.1093/intimm/dxr045; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Cantorna MT, 1998, J NUTR, V128, P68, DOI 10.1093/jn/128.1.68; Cao W, 2011, IMMUNITY, V35, P273, DOI 10.1016/j.immuni.2011.06.011; Cao ZH, 2003, BLOOD, V101, P498, DOI 10.1182/blood-2002-05-1549; Chandra V, 2013, J BIOL CHEM, V288, P10692, DOI 10.1074/jbc.M113.455915; Chang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012925; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Cui GL, 2009, J BIOL CHEM, V284, P28420, DOI 10.1074/jbc.M109.012674; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028; Dkhar HK, 2014, J IMMUNOL, V193, P295, DOI 10.4049/jimmunol.1400092; Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399; Eisenstein EM, 2009, PEDIATR RES, V65, p26R, DOI 10.1203/PDR.0b013e31819e76c7; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Eloranta JJ, 2012, MOL PHARMACOL, V82, P37, DOI 10.1124/mol.112.077909; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frey RS, 1997, CANCER LETT, V117, P41, DOI 10.1016/S0304-3835(97)00211-5; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Grishkan IV, 2013, P NATL ACAD SCI USA, V110, P21101, DOI 10.1073/pnas.1306072110; HARTSOUGH MT, 1995, J BIOL CHEM, V270, P7117, DOI 10.1074/jbc.270.13.7117; Haussler MR, 2008, NUTR REV, V66, pS98, DOI 10.1111/j.1753-4887.2008.00093.x; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Joshi S, 2011, MOL CELL BIOL, V31, P3653, DOI 10.1128/MCB.05020-11; Kang SW, 2012, J IMMUNOL, V188, P5276, DOI 10.4049/jimmunol.1101211; Kleiter I, 2010, BRAIN, V133, P1067, DOI 10.1093/brain/awq039; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Lambert Jr, 2001, METH MOL B, V176, P273; Lu L, 2010, J IMMUNOL, V184, P4295, DOI 10.4049/jimmunol.0903418; Luwor RB, 2013, ONCOGENE, V32, P2433, DOI 10.1038/onc.2012.260; Martinez GJ, 2010, J BIOL CHEM, V285, P29039, DOI 10.1074/jbc.C110.155820; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Mizobucbi T, 2003, J IMMUNOL, V171, P1140, DOI 10.4049/jimmunol.171.3.1140; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Moustakas A, 2001, J CELL SCI, V114, P4359; Nagarajan RP, 1999, J BIOL CHEM, V274, P33412, DOI 10.1074/jbc.274.47.33412; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Narayanan R, 2004, J BIOL CHEM, V279, P47298, DOI 10.1074/jbc.M404101200; Nonn L, 2006, CANCER RES, V66, P4516, DOI 10.1158/0008-5472.CAN-05-3796; Palmer MT, 2011, J BIOL CHEM, V286, P997, DOI 10.1074/jbc.M110.163790; Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269; Ravid A, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730525; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rizzo A, 2014, CARCINOGENESIS, V35, P1536, DOI 10.1093/carcin/bgu027; Rizzo A, 2011, CANCER RES, V71, P7423, DOI 10.1158/0008-5472.CAN-11-1895; Russell J, 1999, J BONE MINER RES, V14, P1828, DOI 10.1359/jbmr.1999.14.11.1828; Schlenner SM, 2012, J EXP MED, V209, P1529, DOI 10.1084/jem.20112646; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Song CZ, 1999, P NATL ACAD SCI USA, V96, P11776, DOI 10.1073/pnas.96.21.11776; Spach KM, 2006, J IMMUNOL, V177, P6030, DOI 10.4049/jimmunol.177.9.6030; Spanier JA, 2012, J IMMUNOL, V189, P3188, DOI 10.4049/jimmunol.1102925; Sporici R, 2010, EUR J IMMUNOL, V40, P2751, DOI 10.1002/eji.200939975; Staeva-Vieira TP, 2002, J IMMUNOL, V168, P1181, DOI 10.4049/jimmunol.168.3.1181; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Tan AHM, 2010, J IMMUNOL, V184, P1849, DOI 10.4049/jimmunol.0901509; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Wu W, 2007, CANCER LETT, V254, P75, DOI 10.1016/j.canlet.2007.02.013; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	70	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12222	12236		10.1074/jbc.M114.621839	http://dx.doi.org/10.1074/jbc.M114.621839			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25809484	hybrid, Green Published			2022-12-28	WOS:000354388600033
J	Francy, CA; Alvarez, FJD; Zhou, L; Ramachandran, R; Mears, JA				Francy, Christopher A.; Alvarez, Frances J. D.; Zhou, Louie; Ramachandran, Rajesh; Mears, Jason A.			The Mechanoenzymatic Core of Dynamin-related Protein 1 Comprises the Minimal Machinery Required for Membrane Constriction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL FISSION; GTPASE DRP1; DIVISION; DOMAIN; PHOSPHORYLATION; MORPHOLOGY; APOPTOSIS; FUSION; DNM1; INHIBITION	Mitochondria are dynamic organelles that continually undergo cycles of fission and fusion. Dynamin-related protein 1 (Drp1), a large GTPase of the dynamin superfamily, is the main mediator of mitochondrial fission. Like prototypical dynamin, Drp1 is composed of a mechanochemical core consisting of the GTPase, middle, and GTPase effector domain regions. In place of the pleckstrin homology domain in dynamin, however, Drp1 contains an unstructured variable domain, whose function is not yet fully resolved. Here, using time-resolved EM and rigorous statistical analyses, we establish the ability of full-length Drp1 to constrict lipid bilayers through a GTP hydrolysis-dependent mechanism. We also show the variable domain limits premature Drp1 assembly in solution and promotes membrane curvature. Furthermore, the mechanochemical core of Drp1, absent of the variable domain, is sufficient to mediate GTP hydrolysis-dependent membrane constriction.	[Francy, Christopher A.; Alvarez, Frances J. D.; Zhou, Louie; Mears, Jason A.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Francy, Christopher A.; Alvarez, Frances J. D.; Zhou, Louie; Mears, Jason A.] Case Western Reserve Univ, Sch Med, Ctr Mitochondrial Dis, Cleveland, OH 44106 USA; [Francy, Christopher A.; Alvarez, Frances J. D.; Zhou, Louie; Ramachandran, Rajesh; Mears, Jason A.] Case Western Reserve Univ, Sch Med, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Ramachandran, Rajesh] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Mears, JA (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	jason.mears@case.edu	Regan, Clinton/E-6250-2012; Ramachandran, Rajesh/A-1337-2011	Ramachandran, Rajesh/0000-0002-4645-2841; Mears, Jason/0000-0002-5199-4872; Alvarez, Frances/0000-0001-9742-6064	National Institutes of Health [2T32GM008803-11A1]; American Heart Association [SDG12SDG9130039, 13BGIA14810010]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Training Grant 2T32GM008803-11A1 (to C. A. F.). This work was also supported by American Heart Association Grants SDG12SDG9130039 (to J. A. M.) and 13BGIA14810010 (to R. R.).	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bustillo-Zabalbeitia I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102738; Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Drin G, 2008, SCIENCE, V320, P670, DOI 10.1126/science.1155821; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Herzig S, 2008, CURR MOL MED, V8, P131, DOI 10.2174/156652408783769625; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Lackner LL, 2010, CHEM BIOL, V17, P578, DOI 10.1016/j.chembiol.2010.05.016; Lewis RNAH, 2009, BBA-BIOMEMBRANES, V1788, P2069, DOI 10.1016/j.bbamem.2009.03.014; Li SA, 2015, J CELL BIOL, V208, P109, DOI 10.1083/jcb.201404050; Macdonald PJ, 2014, MOL BIOL CELL, V25, P1905, DOI 10.1091/mbc.E14-02-0728; Mears JA, 2008, METHOD CELL BIOL, V88, P237, DOI 10.1016/S0091-679X(08)00413-5; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Muhlberg AB, 2000, METHODS, V20, P475, DOI 10.1006/meth.2000.0960; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Perfettini JL, 2005, TRENDS CELL BIOL, V15, P179, DOI 10.1016/j.tcb.2005.02.005; Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Strack S, 2012, J BIOL CHEM, V287, P10990, DOI 10.1074/jbc.M112.342105; Su YC, 2013, HUM MOL GENET, V22, P4545, DOI 10.1093/hmg/ddt301; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Sundborger AC, 2014, CELL REP, V8, P734, DOI 10.1016/j.celrep.2014.06.054; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Ugarte-Uribe B, 2014, J BIOL CHEM, V289, P30645, DOI 10.1074/jbc.M114.575779; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Zhang YF, 2011, J BIOCHEM, V150, P627, DOI 10.1093/jb/mvr102; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	53	65	65	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11692	11703		10.1074/jbc.M114.610881	http://dx.doi.org/10.1074/jbc.M114.610881			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25770210	hybrid, Green Published			2022-12-28	WOS:000353719400042
J	Daidoji, T; Watanabe, Y; Ibrahim, MS; Yasugi, M; Maruyama, H; Masuda, T; Arai, F; Ohba, T; Honda, A; Ikuta, K; Nakaya, T				Daidoji, Tomo; Watanabe, Yohei; Ibrahim, Madiha S.; Yasugi, Mayo; Maruyama, Hisataka; Masuda, Taisuke; Arai, Fumihito; Ohba, Tomoyuki; Honda, Ayae; Ikuta, Kazuyoshi; Nakaya, Takaaki			Avian Influenza Virus Infection of Immortalized Human Respiratory Epithelial Cells Depends upon a Delicate Balance between Hemagglutinin Acid Stability and Endosomal pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN AIRWAY EPITHELIUM; RECEPTOR-MEDIATED ENDOCYTOSIS; HAMSTER OVARY CELLS; MEMBRANE-FUSION; A VIRUSES; MOLECULAR-BASIS; ACIDIFICATION; TRANSFERRIN; PATHOGENICITY; GLYCOPROTEIN	The highly pathogenic avian influenza (AI) virus, H5N1, is a serious threat to public health worldwide. Both the currently circulating H5N1 and previously circulating AI viruses recognize avian-type receptors; however, only the H5N1 is highly infectious and virulent in humans. The mechanism(s) underlying this difference in infectivity remains unclear. The aim of this study was to clarify the mechanisms responsible for the difference in infectivity between the current and previously circulating strains. Primary human small airway epithelial cells (SAECs) were transformed with the SV40 large T-antigen to establish a series of clones (SAEC-Ts). These clones were then used to test the infectivity of AI strains. Human SAEC-Ts could be broadly categorized into two different types based on their susceptibility (high or low) to the viruses. SAEC-T clones were poorly susceptible to previously circulating AI but were completely susceptible to the currently circulating H5N1. The hemagglutinin (HA) of the current H5N1 virus showed greater membrane fusion activity at higher pH levels than that of previous AI viruses, resulting in broader cell tropism. Moreover, the endosomal pH was lower in high susceptibility SAEC-T clones than that in low susceptibility SAEC-T clones. Taken together, the results of this study suggest that the infectivity of AI viruses, including H5N1, depends upon a delicate balance between the acid sensitivity of the viral HA and the pH within the endosomes of the target cell. Thus, one of the mechanisms underlying H5N1 pathogenesis in humans relies on its ability to fuse efficiently with the endosomes in human airway epithelial cells.	[Daidoji, Tomo; Nakaya, Takaaki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Infect Dis, Kyoto 6028566, Japan; [Watanabe, Yohei; Ibrahim, Madiha S.; Yasugi, Mayo; Ikuta, Kazuyoshi] Osaka Univ, Microbial Dis Res Inst, Dept Virol, Suita, Osaka 5650871, Japan; [Ibrahim, Madiha S.] Damanhour Univ, Fac Vet Med, Dept Microbiol, Damanhour 22771, Egypt; [Yasugi, Mayo] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Izumisano, Osaka 5988537, Japan; [Maruyama, Hisataka; Masuda, Taisuke; Arai, Fumihito] Nagoya Univ, Dept Micronano Syst Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Ohba, Tomoyuki; Honda, Ayae] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 7848584, Japan	Kyoto Prefectural University of Medicine; Osaka University; Egyptian Knowledge Bank (EKB); Damanhour University; Osaka Metropolitan University; Nagoya University; Hosei University	Nakaya, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Infect Dis, Kyoto 6028566, Japan.	makaya@koto.kpu-m.ac.jp	Oba, Tomoyuki/ABT-2152-2022; Ibrahim, Madiha Salah/AAS-6256-2021	Oba, Tomoyuki/0000-0002-6715-7892; Ibrahim, Madiha Salah/0000-0002-5756-5198; Watanabe, Yohei/0000-0002-8305-6952	Ministry of Education, Culture, Sports, Science and Technology [22790953, 24591480, 24659482, 23406033]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in aid for Scientific Research 22790953, 24591480, 24659482, and 23406033 from the Ministry of Education, Culture, Sports, Science and Technology.	Akita H, 2004, MOL THER, V9, P443, DOI 10.1016/j.ymthe.2004.01.005; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Boers JE, 1998, AM J RESP CRIT CARE, V157, P2000, DOI 10.1164/ajrccm.157.6.9707011; Boers JE, 1999, AM J RESP CRIT CARE, V159, P1585, DOI 10.1164/ajrccm.159.5.9806044; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; BOWEN TE, 1969, POULTRY SCI, V48, P608, DOI 10.3382/ps.0480608; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chapdelaine P, 2006, MOL HUM REPROD, V12, P309, DOI 10.1093/molehr/gal034; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Daidoji T, 2008, J VIROL, V82, P11294, DOI 10.1128/JVI.01192-08; DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6; Di Lonardo A, 2002, J VIROL METHODS, V101, P189, DOI 10.1016/S0166-0934(01)00437-2; DuBois RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002398; Dutch RE, 2000, BIOSCIENCE REP, V20, P597; EVANS MJ, 1978, LAB INVEST, V38, P648; Farner Donald S., 1942, POULTRY SCI, V21, P445, DOI 10.3382/ps.0210445; Fischer H, 2006, J MEMBRANE BIOL, V211, P139, DOI 10.1007/s00232-006-0861-0; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Galloway SE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003151; Garten W, 1999, TRENDS MICROBIOL, V7, P99, DOI 10.1016/S0966-842X(99)01460-2; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Ilyushina NA, 2012, J VIROL, V86, P11725, DOI 10.1128/JVI.01477-12; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; KILLISCH I, 1992, J CELL SCI, V103, P211; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lakadamyali M, 2004, MICROBES INFECT, V6, P929, DOI 10.1016/j.micinf.2004.05.002; LI Y, 1993, J VIROL, V67, P4070, DOI 10.1128/JVI.67.7.4070-4077.1993; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Nagahama M, 2011, FEBS J, V278, P3395, DOI 10.1111/j.1742-4658.2011.08263.x; OVERLY CC, 1995, P NATL ACAD SCI USA, V92, P3156, DOI 10.1073/pnas.92.8.3156; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; PEREZ L, 1994, J GEN VIROL, V75, P2595, DOI 10.1099/0022-1317-75-10-2595; Reed ML, 2010, J VIROL, V84, P1527, DOI 10.1128/JVI.02069-09; ROBBINS AR, 1983, J CELL BIOL, V96, P1064, DOI 10.1083/jcb.96.4.1064; Rybak SL, 1998, J CELL PHYSIOL, V176, P216, DOI 10.1002/(SICI)1097-4652(199807)176:1<216::AID-JCP23>3.3.CO;2-M; Sakai T, 2006, J VIROL, V80, P2013, DOI 10.1128/JVI.80.4.2013-2018.2006; Schibli DJ, 2004, MOL MEMBR BIOL, V21, P361, DOI 10.1080/09687860400017784; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; SIPE DM, 1991, J BIOL CHEM, V266, P3469; SIPE DM, 1987, P NATL ACAD SCI USA, V84, P7119, DOI 10.1073/pnas.84.20.7119; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SLEMONS RD, 1995, AVIAN DIS, V39, P521, DOI 10.2307/1591804; Spackman E, 2005, VIRUS RES, V114, P89, DOI 10.1016/j.virusres.2005.05.013; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Tumpey TM, 2002, P NATL ACAD SCI USA, V99, P13849, DOI 10.1073/pnas.212519699; TYCKO B, 1982, CELL, V28, P643, DOI 10.1016/0092-8674(82)90219-7; Ueda M, 2010, J VIROL, V84, P3068, DOI 10.1128/JVI.01923-09; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; VANRENSWOUDE J, 1982, P NATL ACAD SCI-BIOL, V79, P6186; Viguier C, 2009, TRENDS BIOTECHNOL, V27, P486, DOI 10.1016/j.tibtech.2009.05.004; Wang GH, 2008, J GEN VIROL, V89, P697, DOI 10.1099/vir.0.83419-0; Washington N, 2000, INT J PHARM, V198, P139, DOI 10.1016/S0378-5173(99)00442-1; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; World Health Organization, 2013, CUM NUMB CONF HUM CA; Xu CL, 2013, EMERG INFECT DIS, V19, P1289, DOI 10.3201/eid1908.130662; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2723, DOI 10.1083/jcb.105.6.2723; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8; YOSHIMURA A, 1984, J VIROL, V51, P497, DOI 10.1128/JVI.51.2.497-504.1984; ZEN K, 1992, J CELL BIOL, V119, P99, DOI 10.1083/jcb.119.1.99; Zhang XY, 2002, CLIN EXP IMMUNOL, V129, P288, DOI 10.1046/j.1365-2249.2002.01889.x; Zhang Y, 2010, J IMMUNOL, V184, P5104, DOI 10.4049/jimmunol.0902851	69	23	25	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10627	10642		10.1074/jbc.M114.611327	http://dx.doi.org/10.1074/jbc.M114.611327			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25673693	Green Published, hybrid			2022-12-28	WOS:000353404500005
J	Joseph, BK; Liu, HY; Francisco, J; Pandya, D; Donigan, M; Gallo-Ebert, C; Giordano, C; Bata, A; Nickels, JT				Joseph, Biny K.; Liu, Hsing-Yin; Francisco, Jamie; Pandya, Devanshi; Donigan, Melissa; Gallo-Ebert, Christina; Giordano, Caroline; Bata, Adam; Nickels, Joseph T., Jr.			Inhibition of AMP Kinase by the Protein Phosphatase 2A Heterotrimer, PP2A(Ppp2r2d)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE THREONINE PHOSPHATASES; ACETYL-COA CARBOXYLASE; REGULATORY SUBUNITS; INSULIN; GLUCOSE; CELL; ACTIVATION; EXPRESSION; MECHANISM; LIPOLYSIS	AMP kinase is a heterotrimeric serine/threonine protein kinase that regulates a number of metabolic processes, including lipid biosynthesis and metabolism. AMP kinase activity is regulated by phosphorylation, and the kinases involved have been uncovered. The particular phosphatases counteracting these kinases remain elusive. Here we discovered that the protein phosphatase 2A heterotrimer, PP2A(Ppp2r2d), regulates the phosphorylation state of AMP kinase by dephosphorylating Thr-172, a residue that activates kinase activity when phosphorylated. Co-immunoprecipitation and co-localization studies indicated that PP2A(Ppp2r2d) directly interacted with AMP kinase. PP2A(Ppp2r2d) dephosphorylated Thr-172 in rat aortic and human vascular smooth muscle cells. A positive correlation existed between decreased phosphorylation, decreased acetyl-CoA carboxylase Acc1 phosphorylation, and sterol response element-binding protein 1c-dependent gene expression. PP2APpp2r2d protein expression was up-regulated in the aortas of mice fed a high fat diet, and the increased expression correlated with increased blood lipid levels. Finally, we found that the aortas of mice fed a high fat diet had decreased AMP kinase Thr-172 phosphorylation, and contained an Ampk-PP2A(Ppp2r2d) complex. Thus, PP2A(Ppp2r2d) may antagonize the aortic AMP kinase activity necessary for maintaining normal aortic lipid metabolism. Inhibiting PP2A(Ppp2r2d) or activating AMP kinase represents a potential pharmacological treatment for many lipid-related diseases.	[Joseph, Biny K.; Liu, Hsing-Yin; Francisco, Jamie; Pandya, Devanshi; Donigan, Melissa; Gallo-Ebert, Christina; Nickels, Joseph T., Jr.] Inst Metab Disorders, Hamilton, NJ 08691 USA; [Giordano, Caroline; Bata, Adam] Genesis Biotechnol Grp, Invivotek, Hamilton, NJ 08691 USA		Nickels, JT (corresponding author), Inst Metab Disorders, Hamilton, NJ 08691 USA.	jnickels@venenumbiodesign.com		Gallo-Ebert, Christina/0000-0003-0985-3547	Genesis Biotechnology Group	Genesis Biotechnology Group	This work was supported by the Genesis Biotechnology Group.	Boon H, 2008, DIABETOLOGIA, V51, P1893, DOI 10.1007/s00125-008-1108-7; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Chen L, 2013, NATURE, V498, pE8, DOI 10.1038/nature12189; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x; COHEN PTW, 1990, FEBS LETT, V268, P355, DOI 10.1016/0014-5793(90)81285-V; DEPAOLIROACH AA, 1994, ADV ENZYME REGUL, V34, P199, DOI 10.1016/0065-2571(94)90017-5; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Galbo T, 2013, AGING-US, V5, P770, DOI 10.18632/aging.100611; Galbo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027424; Garcia-Haro L, 2010, FASEB J, V24, P5080, DOI 10.1096/fj.10-166306; GARTON AJ, 1989, EUR J BIOCHEM, V179, P249, DOI 10.1111/j.1432-1033.1989.tb14548.x; Gimeno-Alcaniz JV, 2003, J MOL BIOL, V333, P201, DOI 10.1016/j.jmb.2003.08.022; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Hardie DG, 2011, TRENDS BIOCHEM SCI, V36, P470, DOI 10.1016/j.tibs.2011.06.004; HARDIE DG, 1990, SYM SOC EXP BIOL, V44, P241; Hojlund K, 2002, EUR J CLIN INVEST, V32, P918, DOI 10.1046/j.1365-2362.2002.01098.x; Jump DB, 2011, CURR OPIN CLIN NUTR, V14, P115, DOI 10.1097/MCO.0b013e328342991c; Jun HS, 2008, OBESITY, V16, P1226, DOI 10.1038/oby.2008.220; Khoo Michael C K, 2013, IEEE Rev Biomed Eng, V6, P143, DOI 10.1109/RBME.2012.2232651; King TD, 2006, BIOCHEM PHARMACOL, V71, P1637, DOI 10.1016/j.bcp.2006.03.005; Kinney BP, 2010, ENDOCRINOLOGY, V151, P3624, DOI 10.1210/en.2010-0245; Kowluru A, 1997, FEBS LETT, V418, P179, DOI 10.1016/S0014-5793(97)01379-3; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lian ZQ, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-67; MOORE F, 1991, EUR J BIOCHEM, V199, P691, DOI 10.1111/j.1432-1033.1991.tb16172.x; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Munday MR, 1999, ADV ENZYME REGUL, V39, P205, DOI 10.1016/S0065-2571(98)00016-8; Nagata D, 2010, HYPERTENS RES, V33, P22, DOI 10.1038/hr.2009.187; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Park S, 2013, CELL CALCIUM, V53, P217, DOI 10.1016/j.ceca.2012.12.001; Pawlyk AC, 2014, DIABETES, V63, P2590, DOI 10.2337/db13-1367; Rana S, 2015, J MED CHEM, V58, P2, DOI 10.1021/jm401994c; Rice LM, 2014, J BIOL CHEM, V289, P17268, DOI 10.1074/jbc.M114.570390; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Steinberg GR, 2006, CAN J PHYSIOL PHARM, V84, P655, DOI 10.1139/Y06-005; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; TAMURA S, 1980, EUR J BIOCHEM, V104, P347, DOI 10.1111/j.1432-1033.1980.tb04435.x; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Valentine RJ, 2014, ARCH BIOCHEM BIOPHYS, V562, P62, DOI 10.1016/j.abb.2014.08.013; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013096; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Wu J, 2013, J BIOL CHEM, V288, P35904, DOI 10.1074/jbc.M113.508747; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Zhu XN, 2014, CELL SIGNAL, V26, P825, DOI 10.1016/j.cellsig.2014.01.002	57	53	53	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10588	10598		10.1074/jbc.M114.626259	http://dx.doi.org/10.1074/jbc.M114.626259			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25694423	hybrid, Green Published			2022-12-28	WOS:000353404500002
J	Kobayashi, H; Yoshida, T; Miyakawa, T; Tashiro, M; Okamoto, K; Yamanaka, H; Tanokura, M; Tsuge, H				Kobayashi, Hidetomo; Yoshida, Toru; Miyakawa, Takuya; Tashiro, Mitsuru; Okamoto, Keinosuke; Yamanaka, Hiroyasu; Tanokura, Masaru; Tsuge, Hideaki			Structural Basis for Action of the External Chaperone for a Propeptide-deficient Serine Protease from Aeromonas sobria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENUS AEROMONAS; 3' END; SUBTILISIN; ACTIVATION; SUBTILASES; SEQUENCE; ASP	Subtilisin-like proteases are broadly expressed in organisms ranging from bacteria to mammals. During maturation of these enzymes, N-terminal propeptides function as intramolecular chaperones, assisting the folding of their catalytic domains. However, we have identified an exceptional case, the serine protease from Aeromonas sobria (ASP), that lacks a propeptide. Instead, ORF2, a protein encoded just downstream of asp, appears essential for proper ASP folding. The mechanism by which ORF2 functions remains an open question, because it shares no sequence homology with any known intramolecular propeptide or other protein. Here we report the crystal structure of the ORF2-ASP complex and the solution structure of free ORF2. ORF2 consists of three regions: an N-terminal extension, a central body, and a C-terminal tail. Together, the structure of the central body and the C-terminal tail is similar to that of the intramolecular propeptide. The N-terminal extension, which is not seen in other subtilisin-like enzymes, is intrinsically disordered but forms some degree of secondary structure upon binding ASP. Wealso show that C-terminal (Delta C1 and Delta C5) or N-terminal (Delta N43 and Delta N64) deletion eliminates the ability of ORF2 to function as a chaperone. Characterization of the maturation of ASP with ORF2 showed that folding occurs in the periplasmic space and is followed by translocation into extracellular space and dissociation from ORF2, generating active ASP. Finally, a PSI-BLAST search revealed that operons encoding subtilases and their external chaperones are widely distributed among Gram-negative bacteria, suggesting that ASP and its homologs form a novel family of subtilases having an external chaperone.	[Kobayashi, Hidetomo; Yamanaka, Hiroyasu] Hiroshima Int Univ, Lab Mol Microbiol Sci, Fac Pharmaceut Sci, Kure, Hiroshima 7370112, Japan; [Yoshida, Toru; Tsuge, Hideaki] Kyoto Sangyo Univ, Fac Life Sci, Dept Bioresource & Environm Sci, Kyoto 6038555, Japan; [Miyakawa, Takuya; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Tashiro, Mitsuru] Meisei Univ, Coll Sci & Technol, Dept Chem, Hino, Tokyo 1910042, Japan; [Okamoto, Keinosuke] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pharmacogenet, Okayama 7008530, Japan	Kyoto Sangyo University; University of Tokyo; Meisei University; Okayama University	Tsuge, H (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Kyoto 6038555, Japan.	tsuge@cc.kyoto-su.ac.jp	Yamanaka, Hiroyasu/AAG-7880-2021; Tsuge, Hideaki/ABF-6424-2021	Tanokura, Masaru/0000-0001-5072-2480; Tsuge, Hideaki/0000-0003-0166-9163; Kobayashi, Hidetomo/0000-0002-5918-4268	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Strategic Research Foundation Grant-aided Project for Private Universities; MEXT/JSPS KAKENHI [25121733]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Foundation Grant-aided Project for Private Universities; MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Strategic Research Foundation Grant-aided Project for Private Universities, and Grant-in-Aid for Scientific Research on Innovative Areas, MEXT/JSPS KAKENHI Grant 25121733.	Buevich AV, 2001, J BIOMOL NMR, V20, P233, DOI 10.1023/A:1011243116136; Chuang YC, 1997, MICROBIOL-SGM, V143, P803, DOI 10.1099/00221287-143-3-803; EDER J, 1993, BIOCHEMISTRY-US, V32, P18, DOI 10.1021/bi00052a004; EDER J, 1993, J MOL BIOL, V233, P293, DOI 10.1006/jmbi.1993.1507; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujii Y, 1998, MICROBIOL IMMUNOL, V42, P703, DOI 10.1111/j.1348-0421.1998.tb02343.x; Galindo CL, 2004, J BIOL CHEM, V279, P37597, DOI 10.1074/jbc.M404641200; Gamble M, 2011, P NATL ACAD SCI USA, V108, P3536, DOI 10.1073/pnas.1014229108; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Imamura T, 2006, J IMMUNOL, V177, P8723, DOI 10.4049/jimmunol.177.12.8723; Inouye M, 2001, NAT STRUCT BIOL, V8, P321, DOI 10.1038/86194; JAEGER KE, 1994, FEMS MICROBIOL REV, V15, P29, DOI 10.1016/0168-6445(94)90025-6; Jain SC, 1998, J MOL BIOL, V284, P137, DOI 10.1006/jmbi.1998.2161; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Janda JM, 1998, CLIN INFECT DIS, V27, P332, DOI 10.1086/514652; JANDA JM, 1987, J INFECT DIS, V155, P589, DOI 10.1093/infdis/155.3.589; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; JONES BL, 1995, J ANTIMICROB CHEMOTH, V35, P453, DOI 10.1093/jac/35.4.453; Kobayashi H, 2006, FEMS MICROBIOL LETT, V256, P165, DOI 10.1111/j.1574-6968.2006.00134.x; Kobayashi H, 2009, MICROBIOL IMMUNOL, V53, P647, DOI 10.1111/j.1348-0421.2009.00175.x; Kobayashi H, 2009, J BIOL CHEM, V284, P27655, DOI 10.1074/jbc.M109.006114; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nitta H, 2008, J IMMUNOL, V181, P3602, DOI 10.4049/jimmunol.181.5.3602; Nitta H, 2007, FEBS LETT, V581, P5935, DOI 10.1016/j.febslet.2007.11.076; Nomura T, 2002, J BACTERIOL, V184, P7058, DOI 10.1128/JB.184.24.7058-7061.2002; Okamoto K, 2000, MICROBIOL IMMUNOL, V44, P787, DOI 10.1111/j.1348-0421.2000.tb02565.x; Pauwels K, 2007, MOL MICROBIOL, V64, P917, DOI 10.1111/j.1365-2958.2007.05718.x; SHINDE U, 1993, P NATL ACAD SCI USA, V90, P6924, DOI 10.1073/pnas.90.15.6924; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; STOCK JB, 1977, J BIOL CHEM, V252, P7850; Subbian E, 2004, BIOCHEMISTRY-US, V43, P14348, DOI 10.1021/bi048397x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka S, 2009, J MOL BIOL, V394, P306, DOI 10.1016/j.jmb.2009.09.028; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; ZHU XL, 1989, NATURE, V339, P483, DOI 10.1038/339483a0	38	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11130	11143		10.1074/jbc.M114.622852	http://dx.doi.org/10.1074/jbc.M114.622852			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25784551	Green Published, hybrid			2022-12-28	WOS:000353404500047
J	Lewinski, MK; Jafari, M; Zhang, H; Opella, SJ; Guatelli, J				Lewinski, Mary K.; Jafari, Moein; Zhang, Hua; Opella, Stanley J.; Guatelli, John			Membrane Anchoring by a C-terminal Tryptophan Enables HIV-1 Vpu to Displace Bone Marrow Stromal Antigen 2 (BST2) from Sites of Viral Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTION FACTOR; CELL-SURFACE; TRANSMEMBRANE DOMAIN; PARTICLE RELEASE; VIRION RELEASE; PROTEIN VPU; TETHERIN; BST-2/TETHERIN; MICRODOMAINS; DEGRADATION	The restriction factor BST2 (tetherin) prevents the release of enveloped viruses from the host cell and is counteracted by HIV-1 Vpu. Vpu and BST2 interact directly via their transmembrane domains. This interaction enables Vpu to induce the surface down-regulation and the degradation of BST2, but neither of these activities fully accounts for the ability of Vpu to enhance virion release. During a study of naturally occurring Vpu proteins, we found that a tryptophan residue near the Vpu C terminus is particularly important for enhancing virion release. Vpu proteins with a W76G polymorphism degraded and down-regulated BST2 from the cell surface, yet they inefficiently stimulated virion release. Here we explore the mechanism of this anomaly. We find that Trp-76 is critical for the ability of Vpu to displace BST2 from sites of viral assembly in the plane of the plasma membrane. This effect does not appear to involve a general reorganization of the membrane microdomains associated with virion assembly, but rather is a specific effect of Vpu on BST2. Using NMR spectroscopy, we find that the cytoplasmic domain of Vpu and Trp-76 specifically interact with lipids. Moreover, paramagnetic relaxation enhancement studies show that Trp-76 inserts into the lipid. These data are consistent with a model whereby Trp-76 anchors the C terminus of the cytoplasmic tail of Vpu to the plasma membrane, enabling the movement of Vpu-bound BST2 away from viral assembly sites.	[Lewinski, Mary K.; Jafari, Moein; Guatelli, John] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Zhang, Hua; Opella, Stanley J.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Lewinski, Mary K.; Guatelli, John] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Opella, SJ (corresponding author), Nat Sci Bldg,Rm 3121,9500 Gilman Dr,MC 307, La Jolla, CA 92093 USA.	sopella@ucsd.edu; jguatelli@ucsd.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R21AI114397, R37AI081668, P41EB002031, RO1EB005161, RO1GM099986, RO1GM066978, T32 AI007384]; James B. Pendleton Charitable Trust; University of California, San Diego, Center for AIDS Research (CFAR); NIH [P30 AI036214]; NIAID; NCI; NIMH; NIDA; NICHD; NHLBI; NIA; NIGMS; NIDDK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007384, R37AI081668, P30AI036214, R21AI114397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005161, P41EB002031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099986, R01GM066978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James B. Pendleton Charitable Trust; University of California, San Diego, Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AI114397 (to J. G. and M. K. L.), R37AI081668 (to J. G.), and P41EB002031, RO1EB005161, RO1GM099986, and RO1GM066978 (to S. J. O.), The James B. Pendleton Charitable Trust and the University of California, San Diego, Center for AIDS Research (CFAR), NIH funded program Grant P30 AI036214, which is supported by the NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, and NIDDK.; Supported in part by National Institutes of Health Training Grant T32 AI007384.	Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Billcliff PG, 2013, J CELL SCI, V126, P1553, DOI 10.1242/jcs.112953; Bour S, 1999, J BIOL CHEM, V274, P33800, DOI 10.1074/jbc.274.47.33800; Campos B, 1998, BIOCHEMISTRY-US, V37, P8004, DOI 10.1021/bi973142n; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Homann S, 2011, J VIROL, V85, P10659, DOI 10.1128/JVI.05524-11; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jafari M, 2014, J VIROL, V88, P5062, DOI 10.1128/JVI.03472-13; Janvier K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001265; Jia XF, 2014, ELIFE, V3, DOI 10.7554/eLife.02362; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kobayashi T, 2011, J VIROL, V85, P932, DOI 10.1128/JVI.01668-10; Krementsov DN, 2010, TRAFFIC, V11, P1401, DOI 10.1111/j.1600-0854.2010.01111.x; Kuhl A, 2011, J INFECT DIS, V204, pS850, DOI 10.1093/infdis/jir378; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lau D, 2011, J VIROL, V85, P9834, DOI 10.1128/JVI.02633-10; Ma C, 2002, PROTEIN SCI, V11, P546, DOI 10.1110/ps.37302; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; McNatt MW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003299; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nydegger S, 2006, J CELL BIOL, V173, P795, DOI 10.1083/jcb.200508165; Park SH, 2006, BIOPHYS J, V91, P3032, DOI 10.1529/biophysj.106.087106; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Petit SJ, 2011, J GEN VIROL, V92, P2937, DOI 10.1099/vir.0.035931-0; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Skasko M, 2012, J BIOL CHEM, V287, P58, DOI 10.1074/jbc.M111.296772; Thali M, 2011, BIOCHEM SOC T, V39, P529, DOI 10.1042/BST0390529; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Vigan R, 2010, J VIROL, V84, P12958, DOI 10.1128/JVI.01699-10; Wittlich M, 2009, FEBS J, V276, P6560, DOI 10.1111/j.1742-4658.2009.07363.x	45	29	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10919	10933		10.1074/jbc.M114.630095	http://dx.doi.org/10.1074/jbc.M114.630095			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25759385	Green Published, hybrid			2022-12-28	WOS:000353404500030
J	Soudi, M; Paumann-Page, M; Delporte, C; Pirker, KF; Bellei, M; Edenhofer, E; Stadlmayr, G; Battistuzzi, G; Boudjeltia, KZ; Furtmuller, PG; Van Antwerpen, P; Obinger, C				Soudi, Monika; Paumann-Page, Martina; Delporte, Cedric; Pirker, Katharina F.; Bellei, Marzia; Edenhofer, Eva; Stadlmayr, Gerhard; Battistuzzi, Gianantonio; Boudjeltia, Karim Zouaoui; Furtmueller, Paul G.; Van Antwerpen, Pierre; Obinger, Christian			Multidomain Human Peroxidasin 1 Is a Highly Glycosylated and Stable Homotrimeric High Spin Ferric Peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDOX THERMODYNAMICS; HYPOHALOUS ACIDS; PROTEIN; HEME; MYELOPEROXIDASE; LACTOPEROXIDASE; PREDICTION; MUTATIONS; EVOLUTION; IMPACT	Human peroxidasin 1 (hsPxd01) is a multidomain heme peroxidase that uses bromide as a cofactor for the formation of sulfilimine cross-links. The latter confers critical structural reinforcement to collagen IV scaffolds. Here, hsPxd01 and various truncated variants lacking nonenzymatic domains were recombinantly expressed in HEK cell lines. The N-glycosylation site occupancy and disulfide pattern, the oligomeric structure, and unfolding pathway are reported. The homotrimeric iron protein contains a covalently bound ferric high spin heme per subunit with a standard reduction potential of the Fe(III)/Fe(II) couple of -233 +/- 5mV at pH 7.0. Despite sequence homology at the active site and biophysical properties similar to human peroxidases, the catalytic efficiency of bromide oxidation (k(cat)/K-M(app)) of full-length hsPxd01 is rather low but increased upon truncation. This is discussed with respect to its structure and proposed biosynthetic function in collagen IV cross-linking.	[Soudi, Monika; Paumann-Page, Martina; Pirker, Katharina F.; Edenhofer, Eva; Stadlmayr, Gerhard; Furtmueller, Paul G.; Obinger, Christian] BOKU Univ Nat Resources & Life Sci, Dept Chem, Div Biochem, A-1190 Vienna, Austria; [Delporte, Cedric; Van Antwerpen, Pierre] Univ Libre Bruxelles, Lab Pharmaceut Chem & Analyt Platform, Fac Pharm, B-1050 Brussels, Belgium; [Bellei, Marzia] Univ Modena & Reggio Emilia, Dept Life Sci, I-41125 Modena, Italy; [Battistuzzi, Gianantonio] Univ Modena & Reggio Emilia, Dept Chem & Geol, I-41125 Modena, Italy; [Boudjeltia, Karim Zouaoui] Univ Libre Bruxelles, Lab Expt Med ULB Unit 222, CHU Charleroi, A Vesale Hosp, B-6110 Montignies le Tilleul, Belgium	University of Natural Resources & Life Sciences, Vienna; Universite Libre de Bruxelles; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universite Libre de Bruxelles	Obinger, C (corresponding author), BOKU Univ Nat Resources & Life Sci, Dept Chem, Div Biochem, Muthgasse 18, A-1190 Vienna, Austria.	christian.obinger@boku.ac.at	Furtmüller, Paul G./Y-5819-2018; Obinger, Christian/AAV-3173-2021; Battistuzzi, Gianantonio/L-7183-2015; Delporte, Cedric/C-2228-2013	Furtmüller, Paul G./0000-0002-1199-2469; Battistuzzi, Gianantonio/0000-0003-4716-5745; Obinger, Christian/0000-0002-7133-3430; Van Antwerpen, Pierre/0000-0002-4934-8863; Delporte, Cedric/0000-0001-7453-7028	Austrian Science Fund [P25538]; Doctoral Program BioToP-Biomolecular Technology of Proteins Grant [EWE W1224]; Belgian Fund for Scientific Research Grant [34553.08]; Fond d'Encouragement a la Recherche (Universite Libre de Bruxelles); Belgian Fund for Scientific Research; Austrian Science Fund (FWF) [P 25538] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Doctoral Program BioToP-Biomolecular Technology of Proteins Grant; Belgian Fund for Scientific Research Grant(Fonds de la Recherche Scientifique - FNRS); Fond d'Encouragement a la Recherche (Universite Libre de Bruxelles); Belgian Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by Austrian Science Fund Project P25538, Doctoral Program BioToP-Biomolecular Technology of Proteins Grant EWE W1224, Belgian Fund for Scientific Research Grant 34553.08, and a grant from the Fond d'Encouragement a la Recherche 2007 (Universite Libre de Bruxelles).; Postdoctoral researcher funded by the Belgian Fund for Scientific Research.	Arnhold J, 2003, REDOX REP, V8, P179, DOI 10.1179/135100003225002664; Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Auchere F, 1999, BIOCHEM J, V343, P603, DOI 10.1042/0264-6021:3430603; Auer M, 2013, J BIOL CHEM, V288, P27181, DOI 10.1074/jbc.M113.477067; Banerjee S, 2011, BIOTECHNOL J, V6, P231, DOI 10.1002/biot.201000375; Banerjee S, 2011, BBA-PROTEINS PROTEOM, V1814, P375, DOI 10.1016/j.bbapap.2010.09.015; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Battistuzzi G, 2002, J AM CHEM SOC, V124, P26, DOI 10.1021/ja017188m; Battistuzzi G, 2006, BIOCHEMISTRY-US, V45, P12750, DOI 10.1021/bi061647k; Battistuzzi G, 2011, BIOCHEMISTRY-US, V50, P7987, DOI [10.1021/bi20084321, 10.1021/bi2008432]; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V494, P72, DOI 10.1016/j.abb.2009.11.021; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Cheng GJ, 2011, FREE RADICAL BIO MED, V51, P1445, DOI 10.1016/j.freeradbiomed.2011.07.002; Cheng GJ, 2008, FREE RADICAL BIO MED, V45, P1682, DOI 10.1016/j.freeradbiomed.2008.09.009; Choi A, 2015, EUR J HUM GENET, V23, P337, DOI 10.1038/ejhg.2014.119; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Delporte C, 2014, J LIPID RES, V55, P747, DOI 10.1194/jlr.M047449; Feissner R, 2003, ANAL BIOCHEM, V315, P90, DOI 10.1016/S0003-2697(02)00658-9; Fidler AL, 2014, P NATL ACAD SCI USA, V111, P331, DOI 10.1073/pnas.1318499111; Forbes LV, 2013, J BIOL CHEM, V288, P36636, DOI 10.1074/jbc.M113.507756; Gotenstein JR, 2010, DEVELOPMENT, V137, P3603, DOI 10.1242/dev.049189; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Jensen LJ, 2002, J MOL BIOL, V319, P1257, DOI 10.1016/S0022-2836(02)00379-0; Kessler J, 2008, THYROID, V18, P769, DOI 10.1089/thy.2007.0310; Khan K, 2011, AM J HUM GENET, V89, P464, DOI 10.1016/j.ajhg.2011.08.005; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Li H, 2012, FREE RADICAL BIO MED, V53, P1954, DOI 10.1016/j.freeradbiomed.2012.08.597; Liu Y, 2010, J NEURO-ONCOL, V99, P13, DOI 10.1007/s11060-009-0105-0; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; NELSON RE, 1994, EMBO J, V13, P3438, DOI 10.1002/j.1460-2075.1994.tb06649.x; OHLSSON PI, 1983, ACTA CHEM SCAND B, V37, P917, DOI 10.3891/acta.chem.scand.37b-0917; PEISACH J, 1971, J BIOL CHEM, V246, P3342; Peterfi Z, 2014, CARDIOVASC RES, V101, P393, DOI 10.1093/cvr/cvt256; Peterfi Z, 2009, AM J PATHOL, V175, P725, DOI 10.2353/ajpath.2009.080693; Prutz WA, 2000, ARCH BIOCHEM BIOPHYS, V380, P181, DOI 10.1006/abbi.2000.1914; Ruf J, 2006, ARCH BIOCHEM BIOPHYS, V445, P269, DOI 10.1016/j.abb.2005.06.023; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; Soudi M, 2012, CHEM BIODIVERS, V9, P1776, DOI 10.1002/cbdv.201100438; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Tindall AJ, 2005, DEV DYNAM, V232, P377, DOI 10.1002/dvdy.20226; Tom Roseanne, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4979; Tom Roseanne, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4976; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950; Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g	45	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10876	10890		10.1074/jbc.M114.632273	http://dx.doi.org/10.1074/jbc.M114.632273			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25713063	hybrid, Green Published			2022-12-28	WOS:000353404500027
J	Williams, JA; Ni, HM; Haynes, A; Manley, S; Li, Y; Jaeschke, H; Ding, WX				Williams, Jessica A.; Ni, Hong-Min; Haynes, Anna; Manley, Sharon; Li, Yuan; Jaeschke, Hartmut; Ding, Wen-Xing			Chronic Deletion and Acute Knockdown of Parkin Have Differential Responses to Acetaminophen-induced Mitophagy and Liver Injury in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL KINASE; JNK ACTIVATION; AUTOPHAGY; MITOCHONDRIA; MECHANISM; APOPTOSIS; PROMOTES; MCL-1; GENE; NIX	We previously demonstrated that pharmacological induction of autophagy protected against acetaminophen (APAP)-induced liver injury in mice by clearing damaged mitochondria. However, the mechanism for removal of mitochondria by autophagy is unknown. Parkin, an E3 ubiquitin ligase, has been shown to be required for mitophagy induction in cultured mammalian cells following mitochondrial depolarization, but its role in vivo is not clear. The purpose of this study was to investigate the role of Parkin-mediated mitophagy in protection against APAP-induced liver injury. We found that Parkin translocated to mitochondria in mouse livers after APAP treatment followed by mitochondrial protein ubiquitination and mitophagy induction. To our surprise, we found that mitophagy still occurred in Parkin knock-out (KO) mice after APAP treatment based on electron microscopy analysis and Western blot analysis for some mitochondrial proteins, and Parkin KO mice were protected against APAP-induced liver injury compared with wild type mice. Mechanistically, we found that Parkin KO mice had decreased activated c-Jun N-terminal kinase (JNK), increased induction of myeloid leukemia cell differentiation protein (Mcl-1) expression, and increased hepatocyte proliferation after APAP treatment in their livers compared with WT mice. In contrast to chronic deletion of Parkin, acute knockdown of Parkin in mouse livers using adenovirus shRNA reduced mitophagy and Mcl-1 expression but increased JNK activation after APAP administration, which exacerbated APAP-induced liver injury. Therefore, chronic deletion (KO) and acute knockdown of Parkin have differential responses to APAP-induced mitophagy and liver injury in mice.	[Williams, Jessica A.; Ni, Hong-Min; Haynes, Anna; Manley, Sharon; Li, Yuan; Jaeschke, Hartmut; Ding, Wen-Xing] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Ding, WX (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, MS 1018,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	wxding@kumc.edu	Li, Yuan/J-7786-2019; Regan, Clinton/E-6250-2012; Jaeschke, Hartmut/J-6285-2013	Li, Yuan/0000-0002-3171-8053; Manley, Sharon/0000-0002-2411-9706	National Institutes of Health COBRE Grant [9P20GM104936]; National Institutes of Health [S10RR027564]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027564, P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936, P20GM103549, P20GM103418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA020518, R01AA020518] Funding Source: NIH RePORTER	National Institutes of Health COBRE Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We acknowledge the Electron Microscopy Research Lab Facility for assistance with the electron microscopy. The EMRL is supported in part by National Institutes of Health COBRE Grant 9P20GM104936, The JEOL JEM-1400 TEM used in the study was purchased with funds from National Institutes of Health Grant S10RR027564. We thank Margitta Lebofsky for technical assistance for the measurement of hepatic GSH.	Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chu CT, 2014, AUTOPHAGY, V10, P376, DOI 10.4161/auto.27191; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; Ding W. X., 2012, J BIOL CHEM, V287, P42379; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Ding WX, 2004, HEPATOLOGY, V40, P403, DOI 10.1002/hep.20310; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Doddareddy MR, 2012, CURR MED CHEM, V19, P163; Dunn C, 2002, CELL SIGNAL, V14, P585, DOI 10.1016/S0898-6568(01)00275-3; Ekholm-Reed S, 2013, MOL CELL BIOL, V33, P3627, DOI 10.1128/MCB.00535-13; Fujiwara M, 2008, ONCOGENE, V27, P6002, DOI 10.1038/onc.2008.199; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Getachew Y, 2010, BIOCHEM PHARMACOL, V79, P1363, DOI 10.1016/j.bcp.2009.12.019; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Henderson NC, 2007, GUT, V56, P982, DOI 10.1136/gut.2006.104372; Hwang S, 2010, MOL CELLS, V29, P575, DOI 10.1007/s10059-010-0068-1; JAESCHKE H, 1990, METHOD ENZYMOL, V186, P752; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Larson Anne M, 2007, Clin Liver Dis, V11, P525, DOI 10.1016/j.cld.2007.06.006; Latchoumycandane C, 2007, HEPATOLOGY, V45, P412, DOI 10.1002/hep.21475; Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Liu M, 2008, J BIOL CHEM, V283, P35783, DOI 10.1074/jbc.M806860200; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; McGill M. R., 2013, PHARM RES, V30, P2174; McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Ni HM, 2013, REDOX BIOL, V1, P427, DOI 10.1016/j.redox.2013.08.005; Ni HM, 2013, AM J PATHOL, V183, P1815, DOI 10.1016/j.ajpath.2013.08.011; Ni HM, 2012, TOXICOL SCI, V127, P438, DOI 10.1093/toxsci/kfs133; Ni HM, 2012, HEPATOLOGY, V55, P222, DOI 10.1002/hep.24690; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Piquereau J, 2013, AUTOPHAGY, V9, P1837, DOI 10.4161/auto.26502; Reggiori Fulvio, 2012, Int J Cell Biol, V2012, P156272, DOI 10.1155/2012/156272; Ryan PM, 2012, CHEM RES TOXICOL, V25, P83, DOI 10.1021/tx2003992; Saito C, 2010, TOXICOL APPL PHARM, V246, P8, DOI 10.1016/j.taap.2010.04.015; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Sharma M, 2012, MOL PHARMACOL, V82, P1001, DOI 10.1124/mol.112.079863; Shinohara M, 2010, J BIOL CHEM, V285, P8244, DOI 10.1074/jbc.M109.054999; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang F, 2004, GENE CHROMOSOME CANC, V40, P85, DOI 10.1002/gcc.20020; Wang W, 2014, MOL CANCER THER, V13, P1480, DOI 10.1158/1535-7163.MCT-13-0629; Warr MR, 2008, CURR MOL MED, V8, P138; Williams JA, 2013, PHARM RES-DORDR, V30, P2279, DOI 10.1007/s11095-013-1139-8; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang J, 2008, AUTOPHAGY, V4, P354, DOI 10.4161/auto.5552	56	58	62	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10934	10946		10.1074/jbc.M114.602284	http://dx.doi.org/10.1074/jbc.M114.602284			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25752611	Green Published, hybrid			2022-12-28	WOS:000353404500031
J	Yuan, L; Seong, E; Beuscher, JL; Arikkath, J				Yuan, Li; Seong, Eunju; Beuscher, James L.; Arikkath, Jyothi			delta-Catenin Regulates Spine Architecture via Cadherin and PDZ-dependent Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DU-CHAT SYNDROME; REPEAT PROTEIN/DELTA-CATENIN; DENDRITIC SPINE; N-CADHERIN; INTELLECTUAL DISABILITY; SYNAPTIC PLASTICITY; MENTAL-RETARDATION; NEURONAL DENSITY; AMPA RECEPTORS; SYNAPSES	The ability of neurons to maintain spine architecture and modulate it in response to synaptic activity is a crucial component of the cellular machinery that underlies information storage in pyramidal neurons of the hippocampus. Here we show a critical role for delta-catenin, a component of the cadherin-catenin cell adhesion complex, in regulating spine head width and length in pyramidal neurons of the hippocampus. The loss of Ctnnd2, the gene encoding delta-catenin, has been associated with the intellectual disability observed in the cri du chat syndrome, suggesting that the functional roles of delta-catenin are vital for neuronal integrity and higher order functions. We demonstrate that loss of delta-catenin in a mouse model or knockdown of delta-catenin in pyramidal neurons compromises spine head width and length, without altering spine dynamics. This is accompanied by a reduction in the levels of synaptic N-cadherin. The ability of delta-catenin to modulate spine architecture is critically dependent on its ability to interact with cadherin and PDZ domain-containing proteins. We propose that loss of delta-catenin during development perturbs synaptic architecture leading to developmental aberrations in neural circuit formation that contribute to the learning disabilities in a mouse model and humans with cri du chat syndrome.	[Yuan, Li; Arikkath, Jyothi] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Seong, Eunju; Beuscher, James L.; Arikkath, Jyothi] Univ Nebraska Med Ctr, Dev Neurosci, Munroe Meyer Inst, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Arikkath, J (corresponding author), Univ Nebraska Med Ctr, Dev Neurosci, Munroe Meyer Inst, Omaha, NE 68198 USA.	Jyothi.arikkath@unmc.edu	Seong, Eunju/ABH-2705-2020		National Institutes of Health Institutional Development Award (IDeA) from the NIGMS [5P20GM103471-10]; Munroe-Meyer Institute; Alzheimer's Association; Nebraska Research Initiative; Nebraska EPSCoR [EPS-1004094]; University of Nebraska Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103471, P30GM110768] Funding Source: NIH RePORTER	National Institutes of Health Institutional Development Award (IDeA) from the NIGMS; Munroe-Meyer Institute; Alzheimer's Association(Alzheimer's Association); Nebraska Research Initiative; Nebraska EPSCoR; University of Nebraska Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Institutional Development Award (IDeA) Grant 5P20GM103471-10 from the NIGMS, start up funds from the Munroe-Meyer Institute, and grants from the Alzheimer's Association, The Nebraska Research Initiative, and Nebraska EPSCoR Grant EPS-1004094.; Supported by a graduate student fellowship from the University of Nebraska Medical Center.	Araya R, 2014, P NATL ACAD SCI USA, V111, pE2895, DOI 10.1073/pnas.1321869111; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Arikkath J, 2008, J NEUROSCI, V28, P7047, DOI 10.1523/JNEUROSCI.0451-08.2008; Arikkath J, 2009, MOL NEUROBIOL, V40, P46, DOI 10.1007/s12035-009-8068-x; Arikkath J, 2009, J NEUROSCI, V29, P5435, DOI 10.1523/JNEUROSCI.0835-09.2009; Biffi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083899; Boda B, 2014, EUR J NEUROSCI, V39, P1130, DOI 10.1111/ejn.12488; Bosch M, 2014, NEURON, V82, P444, DOI 10.1016/j.neuron.2014.03.021; Brigidi GS, 2014, NAT NEUROSCI, V17, P522, DOI 10.1038/nn.3657; Chiurazzi P, 2000, CURR OPIN PEDIATR, V12, P529, DOI 10.1097/00008480-200012000-00003; Clement JP, 2012, CELL, V151, P709, DOI 10.1016/j.cell.2012.08.045; Cullen DK, 2010, BRAIN RES, V1359, P44, DOI 10.1016/j.brainres.2010.08.058; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Deguchi M, 2000, J BIOL CHEM, V275, P29875, DOI 10.1074/jbc.M005384200; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Gai X, 2012, MOL PSYCHIATR, V17, P402, DOI 10.1038/mp.2011.10; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Heisler FF, 2014, P NATL ACAD SCI USA, V111, P5030, DOI 10.1073/pnas.1304301111; Ide N, 1999, BIOCHEM BIOPH RES CO, V256, P456, DOI 10.1006/bbrc.1999.0364; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Ivenshitz M, 2010, J NEUROPHYSIOL, V104, P1052, DOI 10.1152/jn.00914.2009; Izawa I, 2002, J BIOL CHEM, V277, P5345, DOI 10.1074/jbc.M110052200; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kim H, 2012, BBA-MOL BASIS DIS, V1822, P509, DOI 10.1016/j.bbadis.2011.12.015; Kosik KS, 2005, TRENDS CELL BIOL, V15, P172, DOI 10.1016/j.tcb.2005.01.004; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Levesque G, 1999, J NEUROCHEM, V72, P999, DOI 10.1046/j.1471-4159.1999.0720999.x; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Mysore SP, 2007, FRONT CELL NEUROSCI, V1, DOI 10.3389/neuro.03.001.2007; Mysore SP, 2008, FRONT NEUROSCI-SWITZ, V2, P168, DOI 10.3389/neuro.01.035.2008; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Oe Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01957; Oh WC, 2013, P NATL ACAD SCI USA, V110, pE305, DOI 10.1073/pnas.1214705110; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Paffenholz R, 1999, EXP CELL RES, V250, P452, DOI 10.1006/excr.1999.4534; Pavlowsky A, 2012, MOL PSYCHIATR, V17, P682, DOI 10.1038/mp.2011.139; Pielarski KN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054105; Reines A, 2012, J NEUROSCI, V32, P6323, DOI 10.1523/JNEUROSCI.0916-12.2012; Restituito S, 2011, J NEUROSCI, V31, P12083, DOI 10.1523/JNEUROSCI.2513-11.2011; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Sardina JM, 2014, AM J MED GENET A, V164, P1761, DOI 10.1002/ajmg.a.36494; Sheng M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0138; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tai CY, 2008, CURR OPIN CELL BIOL, V20, P567, DOI 10.1016/j.ceb.2008.06.003; Tonnesen J, 2014, NAT NEUROSCI, V17, P678, DOI 10.1038/nn.3682; VanLeeuwen JE, 2012, J NEUROCHEM, V123, P781, DOI 10.1111/j.1471-4159.2012.07899.x; Verpelli C, 2013, EUR J PHARMACOL, V719, P112, DOI 10.1016/j.ejphar.2013.07.023; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Williams ME, 2011, NEURON, V71, P640, DOI 10.1016/j.neuron.2011.06.019; Yam PT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079679; Yuan Y, 2013, NEUROSCI LETT, V536, P10, DOI 10.1016/j.neulet.2013.01.002; Zhang XX, 2005, AM J HUM GENET, V76, P312, DOI 10.1086/427762	56	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10947	10957		10.1074/jbc.M114.632679	http://dx.doi.org/10.1074/jbc.M114.632679			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25724647	Green Published, hybrid			2022-12-28	WOS:000353404500032
J	Liu, ML; Chen, HZ; Wei, L; Hu, DR; Dong, K; Jia, WP; Dong, LQ; Liu, F				Liu, Meilian; Chen, Hongzhi; Wei, Li; Hu, Derong; Dong, Kun; Jia, Weiping; Dong, Lily Q.; Liu, Feng			Endoplasmic Reticulum (ER) Localization Is Critical for DsbA-L Protein to Suppress ER Stress and Adiponectin Down-regulation in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adiponectin; Endoplasmic Reticulum (ER); Endoplasmic Reticulum Stress (ER Stress); Endoplasmic Reticulum-associated Protein Degradation (ERAD); Mitochondria; DsbA-L; ER Localization	GLUTATHIONE-S-TRANSFERASE; SIGNALING PATHWAY; ENDOCRINE ORGAN; ADIPOSE-TISSUE; CLASS-KAPPA; MULTIMERIZATION; KINASE; ACRP30/ADIPONECTIN; MITOCHONDRIA; ACTIVATION	Adiponectin is an adipokine with insulin-sensitizing and anti-inflammatory functions. We previously reported that adiponectin multimerization and stability are promoted by the disulfide bond A oxidoreductase-like protein (DsbA-L) in cells and in vivo. However, the precise mechanism by which DsbA-L regulates adiponectin biosynthesis remains elusive. Here we show that DsbA-L is co-localized with the endoplasmic reticulum (ER) marker protein disulfide isomerase and the mitochondrial marker MitoTracker. In addition, DsbA-L interacts with the ER chaperone protein Ero1-L in 3T3-L1 adipocytes. In silico analysis and truncation mapping studies revealed that DsbA-L contains an ER targeting signal at its N terminus. Deletion of the first 6 residues at the N terminus greatly impaired DsbA-L localization in the ER. Overexpression of the wild type but not the ER localization-defective mutant of DsbA-L protects against thapsigargin-induced ER stress and adiponectin down-regulation in 3T3-L1 adipocytes. In addition, overexpression of the wild type but not the ER localization-defective mutant of DsbA-L promotes adiponectin multimerization. Together, our results reveal that DsbA-L is localized in both the mitochondria and the ER in adipocytes and that its ER localization plays a critical role in suppressing ER stress and promoting adiponectin biosynthesis and secretion.	[Liu, Meilian; Chen, Hongzhi; Liu, Feng] Cent S Univ, Xiangya Hosp 2, Metab Syndrome Res Ctr, Changsha 410011, Hunan, Peoples R China; [Liu, Meilian] Univ New Mexico, Dept Biochem, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Liu, Meilian] Univ New Mexico, Dept Mol Biol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Wei, Li; Hu, Derong; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Chen, Hongzhi; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Dong, Kun; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Wei, Li; Dong, Kun; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab,Shanghai Clin Ctr Diabet, Shanghai Diabet Inst,Shanghai Key Lab Diabet Mell, Shanghai 200025, Peoples R China	Central South University; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Shanghai Jiao Tong University	Liu, F (corresponding author), Cent S Univ, Xiangya Hosp 2, Metab Syndrome Res Ctr, Changsha 410011, Hunan, Peoples R China.	LiuF@uthscsa.edu	Liu, Feng/CAG-8962-2022	Chen, Hongzhi/0000-0001-6060-3776	National Institutes of Health [R01 DK76902, R01 DK080344]; American Diabetes Association [1-12-BS-115, 1-13-JF-37]; American Heart Association (AHA) [11PRE7970021]; Translational Science Training (TST) Across Disciplines program at the University of Texas Health Science Center at San Antonio; University of Texas System Graduate Programs Initiative; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076902, R01DK080344] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association (AHA)(American Heart Association); Translational Science Training (TST) Across Disciplines program at the University of Texas Health Science Center at San Antonio; University of Texas System Graduate Programs Initiative; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK76902 (to F. L.) and R01 DK080344 (to L. Q. D). This work was also supported by a Research Award (1-12-BS-115 to F. L.) and a Junior Faculty Research Award (1-13-JF-37 to M. L.) from the American Diabetes Association.; Supported by a predoctoral fellowship from the American Heart Association (AHA) (11PRE7970021) and a fellowship from the Translational Science Training (TST) Across Disciplines program at the University of Texas Health Science Center at San Antonio, with funding provided by the University of Texas System Graduate Programs Initiative.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Bozidis Petros, 2007, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0327s37; Dong LQ, 2000, P NATL ACAD SCI USA, V97, P5089, DOI 10.1073/pnas.090491897; Germain M., 2003, SCI STKE, pe10; HARRIS JM, 1991, BIOCHEM J, V278, P137, DOI 10.1042/bj2780137; Hu SH, 1997, J MOL BIOL, V268, P137, DOI 10.1006/jmbi.1997.0940; Jowsey IR, 2003, BIOCHEM J, V373, P559, DOI 10.1042/BJ20030415; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Liu ML, 2012, DIABETES, V61, P2776, DOI 10.2337/db12-0169; Liu M, 2008, P NATL ACAD SCI USA, V105, P18302, DOI 10.1073/pnas.0806341105; Nebert Daniel W., 2004, Human Genomics, V1, P460; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Qiang L, 2007, MOL CELL BIOL, V27, P4698, DOI 10.1128/MCB.02279-06; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Thomson RE, 2004, J HISTOCHEM CYTOCHEM, V52, P653, DOI 10.1177/002215540405200509; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Wick KR, 2003, J BIOL CHEM, V278, P8460, DOI 10.1074/jbc.M208518200; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhou LJ, 2010, DIABETES, V59, P2809, DOI 10.2337/db10-0412	26	27	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10143	10148		10.1074/jbc.M115.645416	http://dx.doi.org/10.1074/jbc.M115.645416			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25739441	hybrid, Green Published			2022-12-28	WOS:000353241100021
J	Huang, W; Kim, HRC				Huang, Wei; Kim, Hyeong-Reh Choi			Dynamic Regulation of Platelet-derived Growth Factor D (PDGF-D) Activity and Extracellular Spatial Distribution by Matriptase-mediated Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ACTIVATED LIGAND; PROSTATE-CANCER; BETA-RECEPTOR; PERICYTE LOSS; B RETENTION; MEMBERS; FAMILY; CELLS; CHAIN; IDENTIFICATION	The oncogenic roles of PDGF-D and its proteolytic activator, matriptase, have been strongly implicated in human prostate cancer. Latent full-length PDGF-D (FL-D) consists of a CUB domain, a growth factor domain (GFD), and the hinge region in between. Matriptase processes the FL-D dimer into a GFD dimer (GFD-D) in a stepwise manner, involving generation of a hemidimer (HD), an intermediate product containing one FL-D subunit and one GFD subunit. Although the HD is a pro-growth factor that can be processed into the GFD-D by matriptase, the HD can also act as a dominant-negative ligand that prevents PDGF-B-mediated beta-PDGF receptor activation in fibroblasts. The active GFD-D can be further cleaved into a smaller and yet inactive form if matriptase-mediated proteolysis persists. Through mutagenesis and functional analyses, we found that the R(340)R(341)GR(343)A (P4-P1/P1') motif within the GFD is the matriptase cleavage site through which matriptase can deactivate PDGF-D. Comparative sequence analysis based on the published crystal structure of PDGF-B predicted that the matriptase cleavage site R(340)R(341)GR(343)A is within loop III of the GFD, a critical structural element for its binding with the beta-PDGF receptor. Interestingly, we also found that matriptase processing regulates the deposition of PDGF-D dimer species into the extracellular matrix (ECM) with increased binding from the FL-D dimer, to the HD, and to the GFD-D. Furthermore, we provide evidence that R(340)R(341)GR(343)A within the GFD is critical for PDGF-D deposition and binding to the ECM. In this study, we report a structural element crucial for the biological function and ECM deposition of PDGF-D and provide molecular insight into the dynamic functional interplay between the serine protease matriptase and PDGF-D.	[Huang, Wei; Kim, Hyeong-Reh Choi] Wayne State Univ, Sch Med, Dept Pathol, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University	Kim, HRC (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA.	hrckim@med.wayne.edu			National Institutes of Health from NCI [R01 CA123362]; NATIONAL CANCER INSTITUTE [R01CA123362] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA123362 from NCI (to H.- R. C. K.).	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; DIGLIO CA, 1983, J CELL BIOL, V97, P15, DOI 10.1083/jcb.97.1.15; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Floege J, 2003, J AM SOC NEPHROL, V14, P2690, DOI 10.1097/01.ASN.0000090831.40856.69; Gilbertson DG, 2001, J BIOL CHEM, V276, P27406, DOI 10.1074/jbc.M101056200; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hsu YC, 2011, J CELL PHYSIOL, V226, P2721, DOI 10.1002/jcp.22623; Huang W, 2012, ONCOGENE, V31, P4527, DOI 10.1038/onc.2011.573; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Li XR, 2003, CYTOKINE GROWTH F R, V14, P91, DOI 10.1016/S1359-6101(02)00090-4; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Najy AJ, 2012, MOL CANCER RES, V10, P1087, DOI 10.1158/1541-7786.MCR-12-0071; Nystrom HC, 2006, CARDIOVASC RES, V71, P557, DOI 10.1016/j.cardiores.2006.05.019; OEFNER C, 1992, EMBO J, V11, P3921, DOI 10.1002/j.1460-2075.1992.tb05485.x; Ostendorf T, 2003, J AM SOC NEPHROL, V14, P2237, DOI 10.1097/01.ASN.0000083393.00959.02; OSTMAN A, 1991, CELL REGUL, V2, P503, DOI 10.1091/mbc.2.7.503; Reigstad LJ, 2005, FEBS J, V272, P5723, DOI 10.1111/j.1742-4658.2005.04989.x; Schilling D, 1998, BIOCHEM J, V333, P637, DOI 10.1042/bj3330637; Siegfried G, 2005, ONCOGENE, V24, P6925, DOI 10.1038/sj.onc.1208838; Siegfried G, 2003, CANCER RES, V63, P1458; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Ustach CV, 2004, CANCER RES, V64, P1722, DOI 10.1158/0008-5472.CAN-03-3047; Wang C, 2014, MOL PHARMACEUT, V11, P2115, DOI 10.1021/mp5000828; Yang Y, 2008, P NATL ACAD SCI USA, V105, P7681, DOI 10.1073/pnas.0802896105; Yu JH, 2003, J BIOCHEM MOL BIOL, V36, P49; Zhou Z, 2009, THROMB RES, V124, P323, DOI 10.1016/j.thromres.2008.09.007; Ziu M, 2006, J NEURO-ONCOL, V79, P125, DOI 10.1007/s11060-006-9121-5	35	12	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9162	9170		10.1074/jbc.M114.610865	http://dx.doi.org/10.1074/jbc.M114.610865			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25678707	Green Published, hybrid			2022-12-28	WOS:000352207100039
J	Peng, LR; Yuan, ZG; Li, YX; Ling, HB; Izumi, V; Fang, B; Fukasawa, K; Koomen, J; Chen, JD; Seto, E				Peng, Lirong; Yuan, Zhigang; Li, Yixuan; Ling, Hongbo; Izumi, Victoria; Fang, Bin; Fukasawa, Kenji; Koomen, John; Chen, Jiandong; Seto, Edward			Ubiquitinated Sirtuin 1 (SIRT1) Function Is Modulated during DNA Damage-induced Cell Death and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUBIQUITIN CHAINS; MAMMALIAN SIRTUINS; P53; PROTEIN; DEACETYLATION; DEGRADATION; APOPTOSIS; ACETYLATION; ACTIVATION; MDM2	Downstream signaling of physiological and pathological cell responses depends on post-translational modification such as ubiquitination. The mechanisms regulating downstream DNA damage response (DDR) signaling are not completely elucidated. Sirtuin 1 (SIRT1), the founding member of Class III histone deacetylases, regulates multiple steps in DDR and is closely associated with many physiological and pathological processes. However, the role of post-translational modification or ubiquitination of SIRT1 during DDR is unclear. We show that SIRT1 is dynamically and distinctly ubiquitinated in response to DNA damage. SIRT1 was ubiquitinated by the MDM2 E3 ligase in vitro and in vivo. SIRT1 ubiquitination under normal conditions had no effect on its enzymatic activity or rate of degradation; hypo-ubiquitination, however, reduced SIRT1 nuclear localization. Ubiquitination of SIRT1 affected its function in cell death and survival in response to DNA damage. Our results suggest that ubiquitination is required for SIRT1 function during DDR.	[Peng, Lirong; Yuan, Zhigang; Li, Yixuan; Ling, Hongbo; Izumi, Victoria; Fang, Bin; Fukasawa, Kenji; Koomen, John; Chen, Jiandong; Seto, Edward] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Seto, E (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	ed.seto@moffitt.org	li, yixuan/P-5376-2016	Li, Yixuan/0000-0002-3550-8192	National Institutes of Health; Kaul Foundation; James and Esther King Biomedical Research Program; NATIONAL CANCER INSTITUTE [R01CA169210, P30CA076292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kaul Foundation; James and Esther King Biomedical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health grants (to E. S.). This work was also supported by grants from Kaul Foundation (to E. S.) and a fellowship from the James and Esther King Biomedical Research Program (to L. P.).	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; Byles V, 2010, INT J BIOL SCI, V6, P599; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cao C, 2009, J CELL MOL MED, V13, P3632, DOI 10.1111/j.1582-4934.2008.00453.x; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Choo Yeun Su, 2009, J Vis Exp, DOI 10.3791/1293; Ding Y, 2013, J BIOL CHEM, V288, P8289, DOI 10.1074/jbc.M112.433185; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Gorospe M, 2008, TRENDS CELL BIOL, V18, P77, DOI 10.1016/j.tcb.2007.11.007; Guan D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.185; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jeong J, 2007, EXP MOL MED, V39, P8, DOI 10.1038/emm.2007.2; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mao YF, 2011, J BIOL CHEM, V286, P41852, DOI 10.1074/jbc.M111.288514; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Peng LR, 2012, MOL CELL BIOL, V32, P2823, DOI 10.1128/MCB.00496-12; Peng LR, 2011, MOL CELL BIOL, V31, P4720, DOI 10.1128/MCB.06147-11; Peng Lirong, 2011, Handb Exp Pharmacol, V206, P39, DOI 10.1007/978-3-642-21631-2_3; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Satoh Akiko, 2011, Handb Exp Pharmacol, V206, P125, DOI 10.1007/978-3-642-21631-2_7; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Wu CY, 2011, J BIOL CHEM, V286, P30806, DOI 10.1074/jbc.M111.257469; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zhang Y, 2009, ONCOGENE, V28, P445, DOI 10.1038/onc.2008.388	43	37	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8904	8912		10.1074/jbc.M114.612796	http://dx.doi.org/10.1074/jbc.M114.612796			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25670865	Green Published, hybrid			2022-12-28	WOS:000352207100018
J	Shim, SY; de Castro, IP; Neumayer, G; Wang, J; Park, SK; Sanada, K; Nguyen, MD				Shim, Su Yeon; Perez de Castro, Ignacio; Neumayer, Gernot; Wang, Jian; Park, Sang Ki; Sanada, Kamon; Minh Dang Nguyen			Phosphorylation of Targeting Protein for Xenopus Kinesin-like Protein 2 (TPX2) at Threonine 72 in Spindle Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; AURORA-A ACTIVATION; QUANTITATIVE PHOSPHOPROTEOMICS; MICROTUBULE NUCLEATION; IDENTIFICATION; STABILITY; CDK2; CDC2; PHOSPHOSITEPLUS; LOCALIZATION	The human ortholog of the targeting protein for Xenopus kinesin-like protein 2 (TPX2) is a cytoskeletal protein that plays a major role in spindle assembly and is required for mitosis. During spindle morphogenesis, TPX2 cooperates with Aurora A kinase and Eg5 kinesin to regulate microtubule organization. TPX2 displays over 40 putative phosphorylation sites identified from various high-throughput proteomic screenings. In this study, we characterize the phosphorylation of threonine 72 (Thr(72)) in human TPX2, a residue highly conserved across species. We find that Cdk1/2 phosphorylate TPX2 in vitro and in vivo. Using homemade antibodies specific for TPX2 phosphorylated at Thr(72), we show that this phosphorylation is cell cycle-dependent and peaks at M phase. Endogenous TPX2 phosphorylated at Thr(72) does not associate with the mitotic spindle. Furthermore, ectopic GFP-TPX2 T72A preferentially concentrates on the spindle, whereas GFP-TPX2 WT distributes to both spindle and cytosol. The T72A mutant also increases the proportion of cells with multipolar spindles phenotype. This effect is associated with increased Aurora A activity and abnormally elongated spindles, indicative of higher Eg5 activity. In summary, we propose that phosphorylation of Thr(72) regulates TPX2 localization and impacts spindle assembly via Aurora A and Eg5.	[Shim, Su Yeon; Neumayer, Gernot; Wang, Jian; Minh Dang Nguyen] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Shim, Su Yeon; Neumayer, Gernot; Wang, Jian; Minh Dang Nguyen] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Shim, Su Yeon; Neumayer, Gernot; Wang, Jian; Minh Dang Nguyen] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Shim, Su Yeon; Neumayer, Gernot; Wang, Jian; Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Park, Sang Ki] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Sanada, Kamon] Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Perez de Castro, Ignacio] CNIO, Cell Div, Madrid 28029, Spain; [Perez de Castro, Ignacio] CNIO, Canc Grp, Madrid 28029, Spain	University of Calgary; University of Calgary; University of Calgary; University of Calgary; Pohang University of Science & Technology (POSTECH); University of Tokyo; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Nguyen, MD (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada.	mdnguyen@ucalgary.ca	de Castro, Ignacio Pérez/A-6260-2012	de Castro, Ignacio Pérez/0000-0002-8822-8274; Sanada, Kamon/0000-0002-0280-8957	Canadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions (AIHS); Spanish Ministry of Economy and Competitiveness Programa de Accion Estrategica de Salud [PI14-00227]; Framework of International Cooperation Program [2012K2A1A2033117]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Daiichi Sankyo Foundation of Life Science; Austrian Academy of Science; Human Frontier Science Program Organization; CIHR; AIHS; Grants-in-Aid for Scientific Research [26640005] Funding Source: KAKEN	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions (AIHS); Spanish Ministry of Economy and Competitiveness Programa de Accion Estrategica de Salud; Framework of International Cooperation Program; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Daiichi Sankyo Foundation of Life Science; Austrian Academy of Science; Human Frontier Science Program Organization(Human Frontier Science Program); CIHR(Canadian Institutes of Health Research (CIHR)); AIHS; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Canadian Institutes of Health Research (CIHR) (to M. D. N.), Alberta Innovates Health Solutions (AIHS) (to M. D. N.), the Spanish Ministry of Economy and Competitiveness Programa de Accion Estrategica de Salud, 2014, Grant PI14-00227 (to I. P. dC), Framework of International Cooperation Program, managed by National Research Foundation of Korea, Grant 2012K2A1A2033117 (to M. D. N. and S. K. P.), a Grant-in-Aid for Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a research grant from Daiichi Sankyo Foundation of Life Science (to K. S.).; Received a DOC scholarship from the Austrian Academy of Science.; Held a Career Development Award from the Human Frontier Science Program Organization, a New Investigator Award from the CIHR, and a Scholar Award from the AIHS.	Aguirre-Portoles C, 2012, CANCER RES, V72, P1518, DOI 10.1158/0008-5472.CAN-11-1971; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Asteriti IA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-131; Asteriti IA, 2010, BBA-REV CANCER, V1806, P230, DOI 10.1016/j.bbcan.2010.08.001; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; BELENGUER P, 1990, MOL CELL BIOL, V10, P3607, DOI 10.1128/MCB.10.7.3607; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Brunet S, 2004, MOL BIOL CELL, V15, P5318, DOI 10.1091/mbc.E04-05-0385; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Eckerdt F, 2008, CURR BIOL, V18, P519, DOI 10.1016/j.cub.2008.02.077; Eckerdt F, 2009, CELL CYCLE, V8, P2413, DOI 10.4161/cc.8.15.9086; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Franz-Wachtel M, 2012, MOL CELL PROTEOMICS, V11, P160, DOI 10.1074/mcp.M111.016014; Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0; Giubettini M, 2011, J CELL SCI, V124, P113, DOI 10.1242/jcs.075457; Grosstessner-Hain K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008540; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Havlicek L, 1997, J MED CHEM, V40, P408, DOI 10.1021/jm960666x; Heidebrecht HJ, 1997, BLOOD, V90, P226; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; Ma N, 2011, J CELL BIOL, V195, P87, DOI 10.1083/jcb.201106149; Malik R, 2009, J PROTEOME RES, V8, P4553, DOI 10.1021/pr9003773; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Neumayer G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110994; Neumayer G, 2014, CELL MOL LIFE SCI, V71, P3027, DOI 10.1007/s00018-014-1582-7; Neumayer G, 2012, J BIOL CHEM, V287, P42206, DOI 10.1074/jbc.M112.385674; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Perez de Castro Ignacio, 2012, Genes Cancer, V3, P721, DOI 10.1177/1947601912473306; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Sharma P, 1999, P NATL ACAD SCI USA, V96, P11156, DOI 10.1073/pnas.96.20.11156; Shiromizu T, 2013, J PROTEOME RES, V12, P2414, DOI 10.1021/pr300825v; Sillars-Hardebol AH, 2012, GUT, V61, P1568, DOI 10.1136/gutjnl-2011-301153; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; Stewart S, 2005, MOL CELL BIOL, V25, P10516, DOI 10.1128/MCB.25.23.10516-10527.2005; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Trieselmann N, 2003, J CELL SCI, V116, P4791, DOI 10.1242/jcs.00798; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Weber C, 2012, J PROTEOMICS, V75, P1343, DOI 10.1016/j.jprot.2011.11.004; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Zheng M, 1998, J NEUROBIOL, V35, P141, DOI 10.1002/(SICI)1097-4695(199805)35:2<141::AID-NEU2>3.0.CO;2-4; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k	59	15	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9122	9134		10.1074/jbc.M114.591545	http://dx.doi.org/10.1074/jbc.M114.591545			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25688093	hybrid, Green Published			2022-12-28	WOS:000352207100035
J	Haakenson, JK; Khokhlatchev, AV; Choi, YJ; Linton, SS; Zhang, P; Zaki, PM; Fu, CL; Cooper, TK; Manni, A; Zhu, JJ; Fox, TE; Dong, C; Kester, M				Haakenson, Jeremy K.; Khokhlatchev, Andrei V.; Choi, Younhee J.; Linton, Samuel S.; Zhang, Pu; Zaki, Peter M.; Fu, Changliang; Cooper, Timothy K.; Manni, Andrea; Zhu, Junjia; Fox, Todd E.; Dong, Cheng; Kester, Mark			Lysosomal Degradation of CD44 Mediates Ceramide Nanoliposome-induced Anoikis and Diminished Extravasation in Metastatic Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; STRUCTURED MEMBRANE MICRODOMAINS; HYDRODYNAMIC SHEAR; MELANOMA ADHESION; INDUCED APOPTOSIS; IN-VITRO; DELIVERY; TRANSLOCATION; PROSTATE; PROMOTES	The ceramide nanoliposome (CNL) has shown promise in being able to treat a variety of primary tumors. However, its potential for treating metastatic cancer remains unknown. In this study, we demonstrate that CNL increases anoikis while preventing cancer cell extravasation under both static and physiological fluid flow conditions. Mechanistically, CNL limits metastases by decreasing CD44 protein levels in human breast and pancreatic cancer cells via lysosomal degradation of CD44, independent of palmitoylation or proteasome targeting. siRNA down-regulation of CD44 mimics CNL-induced anoikis and diminished extravasation of cancer cells. Taken together, our data indicate that ceramide limits CD44-dependent cancer cell migration, suggesting that CNL could be used to prevent and treat solid tumor metastasis.	[Haakenson, Jeremy K.; Linton, Samuel S.; Kester, Mark] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Cooper, Timothy K.] Penn State Univ, Coll Med, Dept Comparat Med, Hershey, PA 17033 USA; [Manni, Andrea] Penn State Univ, Coll Med, Dept Med, Hershey, PA 17033 USA; [Zhu, Junjia] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA 17033 USA; [Khokhlatchev, Andrei V.; Choi, Younhee J.; Fox, Todd E.; Kester, Mark] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Zhang, Pu; Zaki, Peter M.; Fu, Changliang; Dong, Cheng] Penn State Univ, Dept Bioengn, State Coll, PA 16801 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Kester, M (corresponding author), Univ Virginia, POB 800334, Charlottesville, VA 22908 USA.	mkester@virginia.edu	Kester, Mark/ABG-4615-2020	Linton, Samuel/0000-0003-2419-0673	National Institutes of Health [CA-125707]; National Science Foundation [CBET-0729091, CBET-1330633]; G. Thomas Passananti Endowment from the Penn State College of Medicine; NATIONAL CANCER INSTITUTE [R01CA125707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); G. Thomas Passananti Endowment from the Penn State College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-125707 (to C. D.). This work was also supported by National Science Foundation Grants CBET-0729091 and CBET-1330633 (to C. D.) and funds from the G. Thomas Passananti Endowment from the Penn State College of Medicine (to M. K.). Penn State Research Foundation has licensed CNL technology to Keystone Nano, Inc. (State College, PA). M. K. is chief medical officer and co-founder of Keystone Nano.	Adiseshaiah PP, 2013, CANCER LETT, V337, P254, DOI 10.1016/j.canlet.2013.04.034; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Gauger KJ, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-11; HART IR, 1989, CURR OPIN IMMUNOL, V1, P900, DOI 10.1016/0952-7915(89)90068-X; Heakal Y, 2009, MOL CANCER RES, V7, P724, DOI 10.1158/1541-7786.MCR-08-0322; Hu W, 2005, MOL BIOL CELL, V16, P1555, DOI 10.1091/mbc.E04-07-0594; Jiang YX, 2011, CANCER BIOL THER, V12, P574, DOI 10.4161/cbt.12.7.15971; Kaiser JM, 2013, NANOMED-NANOTECHNOL, V9, P130, DOI 10.1016/j.nano.2012.03.004; Kim HJ, 2008, CANCER LETT, V260, P88, DOI 10.1016/j.canlet.2007.10.030; Lakshman M, 2004, EXP MOL PATHOL, V77, P18, DOI 10.1016/j.yexmp.2004.03.002; Lesley J, 1997, GLYCOCONJUGATE J, V14, P611, DOI 10.1023/A:1018540610858; Liang S, 2005, EXP CELL RES, V310, P282, DOI 10.1016/j.yexcr.2005.07.028; Liang S, 2008, ANN BIOMED ENG, V36, P661, DOI 10.1007/s10439-008-9445-8; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Liu X, 2010, BLOOD, V116, P4192, DOI 10.1182/blood-2010-02-271080; Lou W, 1999, CANCER RES, V59, P2329; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; Ouhtit A, 2007, AM J PATHOL, V171, P2033, DOI 10.2353/ajpath.2007.070535; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Radotra B, 1997, J PATHOL, V181, P434; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Slattery MJ, 2005, AM J PHYSIOL-CELL PH, V288, pC831, DOI 10.1152/ajpcell.00439.2004; Stover T, 2003, J PHARMACOL EXP THER, V307, P468, DOI 10.1124/jpet.103.054056; Stover TC, 2005, CLIN CANCER RES, V11, P3465, DOI 10.1158/1078-0432.CCR-04-1770; Su YJ, 2011, EMBO J, V30, P3186, DOI 10.1038/emboj.2011.211; Tagaram HRS, 2011, GUT, V60, P695, DOI 10.1136/gut.2010.216671; Thankamony SP, 2006, J BIOL CHEM, V281, P34601, DOI 10.1074/jbc.M601530200; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Widau RC, 2010, J BIOL CHEM, V285, P13827, DOI 10.1074/jbc.M109.085076; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P; ZOLLER M, 1995, J MOL MED, V73, P425	37	13	13	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8632	8643		10.1074/jbc.M114.609677	http://dx.doi.org/10.1074/jbc.M114.609677			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25681441	Green Published, hybrid			2022-12-28	WOS:000351662600053
J	Nolan, KD; Franco, OE; Hance, MW; Hayward, SW; Isaacs, JS				Nolan, Krystal D.; Franco, Omar E.; Hance, Michael W.; Hayward, Simon W.; Isaacs, Jennifer S.			Tumor-secreted Hsp90 Subverts Polycomb Function to Drive Prostate Tumor Growth and Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; EPITHELIAL-MESENCHYMAL TRANSITION; GROUP PROTEIN EZH2; E-CADHERIN; CELL-MIGRATION; TRANSCRIPTIONAL REPRESSION; NASOPHARYNGEAL CARCINOMA; CANCER METASTASIS; SERUM BIOMARKER; UP-REGULATION	Prostate cancer remains the second highest contributor to male cancer-related lethality. The transition of a subset of tumors from indolent to invasive disease is associated with a poor clinical outcome. Activation of the epithelial to mesenchymal transition (EMT) genetic program is a major risk factor for cancer progression. We recently reported that secreted extracellular Hsp90 (eHsp90) initiates EMT in prostate cancer cells, coincident with its enhanced expression in mesenchymal models. Our current work substantially extended these findings in defining a pathway linking eHsp90 signaling to EZH2 function, a methyltransferase of the Polycombrepressor complex. EZH2 is also implicated in EMT activation, and its up-regulation represents one of the most frequent epigenetic alterations during prostate cancer progression. We have now highlighted a novel epigenetic function for eHsp90 via its modulation of EZH2 expression and activity. Mechanistically, eHsp90 initiated sustained activation of MEK/ERK, a signal critical for facilitating EZH2 transcriptional up-regulation and recruitment to the E-cadherin promoter. We further demonstrated that an eHsp90-EZH2 pathway orchestrates an expanded repertoire of EMT-related events including Snail and Twist expression, tumor cell motility, and anoikis resistance. To evaluate the role of eHsp90 in vivo, eHsp90 secretion was stably enforced in a prostate cancer cell line resembling indolent disease. Remarkably, eHsp90 was sufficient to induce tumor growth, suppress E-cadherin, and initiate localized invasion, events that are exquisitely dependent upon EZH2 function. In summary, our findings illuminate a hitherto unknown epigenetic function for eHsp90 and support a model wherein tumor eHsp90 functions as a rheostat for EZH2 expression and activity to orchestrate mesenchymal properties and coincident aggressive behavior.	[Nolan, Krystal D.; Hance, Michael W.; Isaacs, Jennifer S.] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA; [Franco, Omar E.; Hayward, Simon W.] Vanderbilt Univ, Med Ctr, Dept Urol & Canc Biol, Nashville, TN 37232 USA	Medical University of South Carolina; Vanderbilt University	Isaacs, JS (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol, Hollings Canc Ctr, 86 Jonathan Lucas St, Charleston, SC 29425 USA.	ofrancocoronel@northshore.org; shayward@northshore.org; isaacsj@musc.edu		Hayward, Simon/0000-0002-6059-6550	Cancer Center Support Grant [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313, F31CA177015, R01CA187342, U01CA151924] Funding Source: NIH RePORTER	Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Joy Ware for the P69 and M12 cells, Chris Lindsey and Craig Beeson for synthesis of NPGA, and Maarten van Lohuizen for the EZH2-H694L expression plasmid. The imaging facilities for this research were supported in part by Cancer Center Support Grant P30 CA138313 to the Hollings Cancer Center, Medical University of South Carolina.	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Arzate-Mejia RG, 2011, IUBMB LIFE, V63, P881, DOI 10.1002/iub.557; Bae VL, 1998, PROSTATE, V34, P275, DOI 10.1002/(SICI)1097-0045(19980301)34:4<275::AID-PROS5>3.0.CO;2-G; Bohonowych JE, 2014, PROSTATE, V74, P395, DOI 10.1002/pros.22761; Burgess EF, 2008, PROTEOM CLIN APPL, V2, P1223, DOI 10.1002/prca.200780073; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen JZ, 2014, CANCER RES, V74, P4353, DOI 10.1158/0008-5472.CAN-14-0181; Chen JS, 2010, J BIOL CHEM, V285, P25458, DOI 10.1074/jbc.M110.139345; Chen WS, 2013, J BIOL CHEM, V288, P9001, DOI 10.1074/jbc.M112.437897; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Efstathiou E, 2010, CLIN CANCER RES, V16, P1100, DOI 10.1158/1078-0432.CCR-09-1215; Franco OE, 2011, CANCER RES, V71, P1272, DOI 10.1158/0008-5472.CAN-10-3142; Frisch SM, 2013, J CELL SCI, V126, P21, DOI 10.1242/jcs.120907; Fujii S, 2011, ONCOGENE, V30, P4118, DOI 10.1038/onc.2011.118; Gopal U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017649; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Hance MW, 2014, CANCERS, V6, P1065, DOI 10.3390/cancers6021065; Hance MW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.389015; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Hwang-Verslues WW, 2013, P NATL ACAD SCI USA, V110, P12331, DOI 10.1073/pnas.1222684110; Ishii K, 2005, LAB INVEST, V85, P1086, DOI 10.1038/labinvest.3700310; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prensner JR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003180; Ren G, 2012, CANCER RES, V72, P3091, DOI 10.1158/0008-5472.CAN-11-3546; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smolen GA, 2010, GENE DEV, V24, P2654, DOI 10.1101/gad.1989110; Stellas D, 2007, CLIN CANCER RES, V13, P1831, DOI 10.1158/1078-0432.CCR-06-1585; Sun YY, 2010, INT J MOL SCI, V11, P1423, DOI 10.3390/ijms11041423; Tee WW, 2014, CELL, V156, P678, DOI 10.1016/j.cell.2014.01.009; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020; Tong ZT, 2012, ONCOGENE, V31, P583, DOI 10.1038/onc.2011.254; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Verma SK, 2012, ACS MED CHEM LETT, V3, P1091, DOI 10.1021/ml3003346; Wallace TJ, 2014, J CANCER, V5, P3, DOI 10.7150/jca.7709; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Xie DX, 2010, P NATL ACAD SCI USA, V107, P2485, DOI 10.1073/pnas.0908133107; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhau Haiyen E., 2000, Cancer, V88, P2995, DOI 10.1002/1097-0142(20000615)88:12+<2995::AID-CNCR15>3.0.CO;2-Y	52	52	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8271	8282		10.1074/jbc.M115.637496	http://dx.doi.org/10.1074/jbc.M115.637496			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25670862	Green Published, hybrid			2022-12-28	WOS:000351662600023
J	de Figueiredo, ASP; Salmon, AB; Bruno, F; Jimenez, F; Martinez, HG; Halade, GV; Ahuja, SS; Clark, RA; DeFronzo, RA; Abboud, HE; El Jamali, A				de Figueiredo, Alvaro Souto Padron; Salmon, Adam B.; Bruno, Francesca; Jimenez, Fabio; Martinez, Herman G.; Halade, Ganesh V.; Ahuja, Seema S.; Clark, Robert A.; DeFronzo, Ralph A.; Abboud, Hanna E.; El Jamali, Amina			Nox2 Mediates Skeletal Muscle Insulin Resistance Induced by a High Fat Diet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASE ACTIVITY; ELECTRON-TRANSPORT; DIABETES-MELLITUS; OXIDATIVE STRESS; PLASMA-MEMBRANE; NAD(P)H OXIDASE; L6 MYOTUBES; GLUCOSE; GLUT4; DYSFUNCTION	Inflammation and oxidative stress through the production of reactive oxygen species (ROS) are consistently associated with metabolic syndrome/type 2 diabetes. Although the role of Nox2, a major ROS-generating enzyme, is well described in host defense and inflammation, little is known about its potential role in insulin resistance in skeletal muscle. Insulin resistance induced by a high fat diet was mitigated in Nox2-null mice compared with wild-type mice after 3 or 9 months on the diet. High fat feeding increased Nox2 expression, superoxide production, and impaired insulin signaling in skeletal muscle tissue of wild-type mice but not in Nox2-null mice. Exposure of C2C12 cultured myotubes to either high glucose concentration, palmitate, or H2O2 decreases insulin-induced Akt phosphorylation and glucose uptake. Pretreatment with catalase abrogated these effects, indicating a key role for H2O2 in mediating insulin resistance. Down-regulation of Nox2 in C2C12 cells by shRNA prevented insulin resistance induced by high glucose or palmitate but not H2O2. These data indicate that increased production of ROS in insulin resistance induced by high glucose in skeletal muscle cells is a consequence of Nox2 activation. This is the first report to show that Nox2 is a key mediator of insulin resistance in skeletal muscle.	[de Figueiredo, Alvaro Souto Padron; Bruno, Francesca; Jimenez, Fabio; Martinez, Herman G.; Halade, Ganesh V.; Ahuja, Seema S.; Clark, Robert A.; DeFronzo, Ralph A.; Abboud, Hanna E.; El Jamali, Amina] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Salmon, Adam B.] Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX 78245 USA; [Salmon, Adam B.; Ahuja, Seema S.; Clark, Robert A.; DeFronzo, Ralph A.; Abboud, Hanna E.] South Texas Vet Hlth Care Syst, Audie L Murphy Hosp, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	El Jamali, A (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	AkoulouzeBik@uthscsa.edu	Clark, Robert/Q-6764-2019; Regan, Clinton/E-6250-2012	Clark, Robert/0000-0002-4892-3619; 	National Institutes of Health [P30 CA054174, P30 AG013319, P01 AG019316]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149, UL1TR001120, KL2TR000118] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK084297, R01DK033665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013319, P01AG019316] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The confocal microscopy studies were performed in the Institutional Optical Imaging Facility of the University of Texas Health Science Center at San Antonio, which is supported by National Institutes of Health Grants P30 CA054174 (Cancer Therapy and Research Center), P30 AG013319 (Nathan Shock Center), and P01 AG019316 (Aging, Oxidative Stress, and Cell Death). We thank Drs. Alain Virion for helpful discussions, Dr. John Cornell for insightful advice on statistical analysis, Dr. James Lechleiter for expert guidance on the confocal microscope image acquisition and analysis, and Yimin Wu, Maria Gamez, and Jacob Crandall for expert technical assistance.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Badin PM, 2013, ENDOCRINOLOGY, V154, P1444, DOI 10.1210/en.2012-2029; Baniulis D, 2005, BBA-PROTEINS PROTEOM, V1752, P186, DOI 10.1016/j.bbapap.2005.07.018; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; El Jamali A, 2008, FREE RADICAL BIO MED, V44, P868, DOI 10.1016/j.freeradbiomed.2007.11.020; El Jamali A, 2010, FREE RADICAL BIO MED, V48, P798, DOI 10.1016/j.freeradbiomed.2009.12.018; Espinosa A, 2009, J BIOL CHEM, V284, P2568, DOI 10.1074/jbc.M804249200; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Gaster M, 2000, AM J PHYSIOL-ENDOC M, V278, pE910, DOI 10.1152/ajpendo.2000.278.5.E910; Gaster M, 2001, DIABETES, V50, P1324, DOI 10.2337/diabetes.50.6.1324; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Girousse A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001485; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397; GOLLNICK PD, 1984, HISTOCHEMISTRY, V81, P379, DOI 10.1007/BF00514333; Halade GV, 2011, EXP GERONTOL, V46, P43, DOI 10.1016/j.exger.2010.09.014; Hidalgo C, 2006, J BIOL CHEM, V281, P26473, DOI 10.1074/jbc.M600451200; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Huang C, 2002, DIABETES, V51, P2090, DOI 10.2337/diabetes.51.7.2090; Jackson MJ, 2008, FREE RADICAL BIO MED, V44, P132, DOI 10.1016/j.freeradbiomed.2007.06.003; KERN M, 1990, BIOCHEM J, V270, P397, DOI 10.1042/bj2700397; Kriketos AD, 1996, AM J PHYSIOL-REG I, V270, pR1332, DOI 10.1152/ajpregu.1996.270.6.R1332; Lambertucci RH, 2008, J CELL PHYSIOL, V216, P796, DOI 10.1002/jcp.21463; Lee CF, 2010, CIRC RES, V106, P1489, DOI 10.1161/CIRCRESAHA.109.215392; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; Mofarrahi M, 2008, ANTIOXID REDOX SIGN, V10, P559, DOI 10.1089/ars.2007.1792; Nedachi T, 2006, AM J PHYSIOL-ENDOC M, V291, pE817, DOI 10.1152/ajpendo.00194.2006; OLEFSKY J, 1974, J CLIN INVEST, V53, P64, DOI 10.1172/JCI107560; Pepping JK, 2013, AM J PHYSIOL-ENDOC M, V304, pE392, DOI 10.1152/ajpendo.00398.2012; Piao YJ, 2005, FREE RADICAL BIO MED, V38, P989, DOI 10.1016/j.freeradbiomed.2004.11.011; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Sukumar P, 2013, DIABETES, V62, P2130, DOI 10.2337/db12-1294; Timmers S, 2012, P NATL ACAD SCI USA, V109, P11711, DOI 10.1073/pnas.1206868109; Williams CR, 2012, AM J PHYSIOL-CELL PH, V303, pC213, DOI 10.1152/ajpcell.00227.2011; Xiang FL, 2010, DIABETES, V59, P2603, DOI 10.2337/db09-1562; YAFFE D, 1977, DIFFERENTIATION, V7, P159, DOI 10.1111/j.1432-0436.1977.tb01507.x; Yap A, 2007, CYTOTECHNOLOGY, V55, P103, DOI 10.1007/s10616-007-9107-y; Zierath JR, 1996, DIABETOLOGIA, V39, P1180, DOI 10.1007/BF02658504; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zuo L, 2003, ANTIOXID REDOX SIGN, V5, P667, DOI 10.1089/152308603770310347	48	59	60	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13427	13439		10.1074/jbc.M114.626077	http://dx.doi.org/10.1074/jbc.M114.626077			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25825489	Green Published, hybrid			2022-12-28	WOS:000354975700038
J	Chaudhuri, AD; Kabaria, S; Choi, DC; Mouradian, MM; Junn, E				Chaudhuri, Amrita Datta; Kabaria, Savan; Choi, Doo Chul; Mouradian, M. Maral; Junn, Eunsung			MicroRNA-7 Promotes Glycolysis to Protect against 1-Methyl-4-phenylpyridinium-induced Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycolysis; microRNA (miRNA); neurodegenerative disease; NF-kappa B (NF-KB); Parkinson disease; 1-methyl-4-phenylpyridinium; RelA; microRNA-7; glycolysis	NF-KAPPA-B; ALPHA-SYNUCLEIN EXPRESSION; MITOCHONDRIAL COMPLEX-I; PARKINSONS-DISEASE; ALLOSTERIC REGULATION; GENE-EXPRESSION; PYRUVATE-KINASE; NEUROBLASTOMA-CELLS; OXIDATIVE STRESS; BRAIN	Background: The dopaminergic neurotoxin, 1-methyl-4-phenylpyridinium (MPP+), kills cells by inhibiting mitochondrial oxidative phosphorylation. Results: MicroRNA-7-mediated repression of RelA expression and subsequent increase in glucose transporter Glut3 level augments glycolysis in neuronal cells. Conclusion: MicroRNA-7 protects cells against MPP+-induced cytotoxicity by enhancing glycolysis. Significance: MicroRNA-7 could potentially mitigate the effects of mitochondrial oxidative phosphorylation defects in Parkinson disease. Parkinson disease is associated with decreased activity of the mitochondrial electron transport chain. This defect can be recapitulated in vitro by challenging dopaminergic cells with 1-methyl-4-phenylpyridinium (MPP+), a neurotoxin that inhibits complex I of electron transport chain. Consequently, oxidative phosphorylation is blocked, and cells become dependent on glycolysis for ATP production. Therefore, increasing the rate of glycolysis might help cells to produce more ATP to meet their energy demands. In the present study, we show that microRNA-7, a non-coding RNA that protects dopaminergic neuronal cells against MPP+-induced cell death, promotes glycolysis in dopaminergic SH-SY5Y and differentiated human neural progenitor ReNcell VM cells, as evidenced by increased ATP production, glucose consumption, and lactic acid production. Through a series of experiments, we demonstrate that targeted repression of RelA by microRNA-7, as well as subsequent increase in the neuronal glucose transporter 3 (Glut3), underlies this glycolysis-promoting effect. Consistently, silencing Glut3 expression diminishes the protective effect of microRNA-7 against MPP+. Further, microRNA-7 fails to prevent MPP+-induced cell death when SH-SY5Y cells are cultured in a low glucose medium, as well as when differentiated ReNcell VM cells or primary mouse neurons are treated with the hexokinase inhibitor, 2-deoxy-d-glucose, indicating that a functional glycolytic pathway is required for this protective effect. In conclusion, microRNA-7, by down-regulating RelA, augments Glut3 expression, promotes glycolysis, and subsequently prevents MPP+-induced cell death. This protective effect of microRNA-7 could be exploited to correct the defects in oxidative phosphorylation in Parkinson disease.	[Chaudhuri, Amrita Datta; Kabaria, Savan; Choi, Doo Chul; Mouradian, M. Maral; Junn, Eunsung] Rutgers Robert Wood Johnson Med Sch, Dept Neurol, Ctr Neurodegenerat & Neuroimmunol Dis, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Junn, E (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Neurol, 683 Hoes Lane W,Rm 185, Piscataway, NJ 08854 USA.	junneu@rwjms.rutgers.edu	Regan, Clinton/E-6250-2012	Junn, Eunsung/0000-0001-5694-2599	National Institutes of Health [NS070898]; National Center for Complementary & Integrative Health [R01AT006868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073994, R01NS070898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant NS070898 (to E. J.).	BATES TE, 1994, J NEUROCHEM, V63, P640; Carter KL, 2002, J VIROL, V76, P10427, DOI 10.1128/JVI.76.20.10427-10436.2002; CHAN P, 1993, J NEUROCHEM, V61, P610; Chen HL, 2010, BIOCHEM BIOPH RES CO, V394, P921, DOI 10.1016/j.bbrc.2010.03.076; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Choi DC, 2014, J NEUROSCI, V34, P12725, DOI 10.1523/JNEUROSCI.0985-14.2014; Clarke Donald D., 1999, P637; Cui HJ, 2002, MOL CANCER THER, V1, P679; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Fragkouli A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00182; Harraz MM, 2011, J CHEM NEUROANAT, V42, P127, DOI 10.1016/j.jchemneu.2011.01.005; Hinz M, 2002, J EXP MED, V196, P605, DOI 10.1084/jem.20020062; Junn E, 2012, PHARMACOL THERAPEUT, V133, P142, DOI 10.1016/j.pharmthera.2011.10.002; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kawauchi K, 2008, BIOCHEM BIOPH RES CO, V372, P137, DOI 10.1016/j.bbrc.2008.05.021; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Knight AL, 2014, CELL METAB, V20, P145, DOI 10.1016/j.cmet.2014.04.017; Koga K, 2006, EUR J NEUROSCI, V23, P1077, DOI 10.1111/j.1460-9568.2006.04610.x; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Mattevi A, 1996, FEBS LETT, V389, P15, DOI 10.1016/0014-5793(96)00462-0; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; Mazzio E, 2003, NEUROTOXICOLOGY, V24, P137, DOI 10.1016/S0161-813X(02)00110-9; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Planavila A, 2005, J BIOL CHEM, V280, P17464, DOI 10.1074/jbc.M414220200; Pollock A, 2014, CELL REP, V7, P1184, DOI 10.1016/j.celrep.2014.04.003; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Silva JLT, 2005, MOL CELL ENDOCRINOL, V240, P82, DOI 10.1016/j.mce.2005.05.006; Sommermann TG, 2011, CANCER RES, V71, P7291, DOI 10.1158/0008-5472.CAN-11-1715; Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Yelamanchili SV, 2010, J NEUROIMMUNE PHARM, V5, P63, DOI 10.1007/s11481-009-9172-4	37	45	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12425	12434		10.1074/jbc.M114.625962	http://dx.doi.org/10.1074/jbc.M114.625962			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25814668	Green Published, hybrid			2022-12-28	WOS:000354388600050
J	Midgley, AC; Duggal, L; Jenkins, R; Hascall, V; Steadman, R; Phillips, AO; Meran, S				Midgley, Adam C.; Duggal, Lucy; Jenkins, Robert; Hascall, Vincent; Steadman, Robert; Phillips, Aled O.; Meran, Soma			Hyaluronan Regulates Bone Morphogenetic Protein-7-dependent Prevention and Reversal of Myofibroblast Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; SMOOTH-MUSCLE-CELLS; MESENCHYMAL TRANSITION; SERUM HYALURONATE; BINDING DOMAIN; CD44 ISOFORMS; RECEPTOR; BMP-7; EXPRESSION; LIVER	Hyaluronan (HA) promotes transforming growth factor (TGF)-beta 1-driven myofibroblast phenotype. However, HA can also have disease-limiting activity. Bone morphogenetic protein-7 (BMP7) is an antifibrotic cytokine that antagonizes TGF-beta 1, and isolated studies have demonstrated that HA can both mediate and modulate BMP7 responses. In this study, we investigated whether BMP7 can modulate HA in a manner that leads to prevention/reversal of TGF-beta 1-driven myofibroblast differentiation in human lung fibroblasts. Results demonstrated that BMP7 prevented and reversed TGF-beta 1-driven myofibroblast differentiation through a novel mechanism. BMP7 promoted the dissolution and internalization of cell-surface HA into cytoplasmic endosomes. Endosomal HA co-localized with the HA-degrading enzymes, hyaluronidase-1 and hyaluronidase-2 (Hyal2). Moreover, BMP7 showed differential regulation of CD44 standard and variant isoform expression, when compared with TGF-beta 1. In particular, BMP7 increased membrane expression of CD44v7/8. Inhibiting CD44v7/8 as well as blocking Hyal2 and the Na+/H+ exchanger-1 at the cell-surface prevented BMP7-driven HA internalization and BMP7-mediated prevention/reversal of myofibroblast phenotype. In summary, a novel mechanism of TGF-beta 1 antagonism byBMP7is shown and identifies alteration in HA as critical in mediating BMP7 responses. In addition, we identify Hyal2 and CD44v7/8 as new potential targets for manipulation in prevention and reversal of fibrotic pathology.	[Midgley, Adam C.; Duggal, Lucy; Jenkins, Robert; Steadman, Robert; Phillips, Aled O.; Meran, Soma] Cardiff Univ, Inst Nephrol, Inst Mol & Expt Med, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Hascall, Vincent] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA	Cardiff University; Cleveland Clinic Foundation	Meran, S (corresponding author), Cardiff Univ, Inst Nephrol, Inst Mol & Expt Med, Sch Med, Cardiff CF14 4XN, S Glam, Wales.	merans@cf.ac.uk	Steadman, Robert/O-1614-2016; Midgley, Adam C./P-8108-2019	Steadman, Robert/0000-0002-1303-2496; Midgley, Adam C./0000-0002-7622-0275; Phillips, Aled/0000-0001-9744-7113; Jenkins, Robert/0000-0001-8500-9044	Medical Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER; Kidney Research UK [PDF6/2013] Funding Source: researchfish; Medical Research Council [MR/K010328/1] Funding Source: researchfish; MRC [MR/K010328/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by funding from the Medical Research Council.	Andhare RA, 2009, OSTEOARTHR CARTILAGE, V17, P906, DOI 10.1016/j.joca.2008.12.007; ANSCHER MS, 1993, NEW ENGL J MED, V328, P1592, DOI 10.1056/NEJM199306033282203; Banerji S, 1998, PROTEIN EXPRES PURIF, V14, P371, DOI 10.1006/prep.1998.0971; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; BJERMER L, 1989, THORAX, V44, P126, DOI 10.1136/thx.44.2.126; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bourguignon Lilly Y. W., 1998, Frontiers in Bioscience, V3, pD637; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Buijs JT, 2010, CURR PHARM DESIGN, V16, P1291; Chen L, 2012, MATRIX BIOL, V31, P373, DOI 10.1016/j.matbio.2012.10.002; Clark RA, 1996, J CELL BIOL, V134, P1075, DOI 10.1083/jcb.134.4.1075; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; Duterme C, 2009, J BIOL CHEM, V284, P33495, DOI 10.1074/jbc.M109.044362; EGGLI PS, 1995, J HISTOCHEM CYTOCHEM, V43, P689, DOI 10.1177/43.7.7608523; Evanko SP, 1999, J HISTOCHEM CYTOCHEM, V47, P1331, DOI 10.1177/002215549904701013; Evanko SP, 2004, J HISTOCHEM CYTOCHEM, V52, P1525, DOI 10.1369/jhc.4A6356.2004; FURUKAWA K, 1977, BIOCHIM BIOPHYS ACTA, V499, P278, DOI 10.1016/0304-4165(77)90010-1; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Goumenos D, 1998, NEPHROL DIAL TRANSPL, V13, P1652, DOI 10.1093/ndt/13.7.1652; GOUMENOS DS, 1994, NEPHROL DIAL TRANSPL, V9, P1418; Guo W, 2014, ONCOGENE, V33, P537, DOI 10.1038/onc.2013.260; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Hruska KA, 2000, AM J PHYSIOL-RENAL, V279, pF130, DOI 10.1152/ajprenal.2000.279.1.F130; Hsu LJ, 2009, J BIOL CHEM, V284, P16049, DOI 10.1074/jbc.M806688200; Ito T, 2004, J BIOL CHEM, V279, P25326, DOI 10.1074/jbc.M403135200; Johnsson C, 1996, KIDNEY INT, V50, P1224, DOI 10.1038/ki.1996.431; KAN FWK, 1990, ANAT REC, V228, P370, DOI 10.1002/ar.1092280403; KASPER M, 1995, AM J RESP CELL MOL, V13, P648, DOI 10.1165/ajrcmb.13.6.7576702; Kinoshita K, 2007, GUT, V56, P706, DOI 10.1136/gut.2006.092460; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Lesley J, 2000, J BIOL CHEM, V275, P26967; Lewis A, 2008, HISTOL HISTOPATHOL, V23, P731, DOI 10.14670/HH-23.731; LONDONO I, 1988, J HISTOCHEM CYTOCHEM, V36, P1005, DOI 10.1177/36.8.3392391; Luo DD, 2010, AM J PATHOL, V176, P1139, DOI 10.2353/ajpath.2010.090459; MARGOLIS RK, 1976, BIOCHIM BIOPHYS ACTA, V451, P465, DOI 10.1016/0304-4165(76)90141-0; Matuschek C, 2014, EUR J MED RES, V19, DOI 10.1186/2047-783X-19-6; Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Meran S, 2013, AM J PATHOL, V182, P2223, DOI 10.1016/j.ajpath.2013.02.038; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Miletti-Gonzalez KE, 2012, J BIOL CHEM, V287, P18995, DOI 10.1074/jbc.M111.318774; Misra S, 2009, J BIOL CHEM, V284, P12432, DOI 10.1074/jbc.M806772200; Motazed R, 2008, PHARM RES-DORDR, V25, P2440, DOI 10.1007/s11095-008-9551-1; Myllarniemi M, 2008, AM J RESP CRIT CARE, V177, P321, DOI 10.1164/rccm.200706-945OC; NISHIKAWA K, 1993, LAB INVEST, V68, P146; NYBERG A, 1988, HEPATOLOGY, V8, P142, DOI 10.1002/hep.1840080127; Olsson E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-418; Peterson RS, 2004, J CELL BIOL, V166, P1081, DOI 10.1083/jcb.200402138; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Rampanelli E, 2014, KIDNEY INT, V86, P558, DOI 10.1038/ki.2014.87; Rees JRE, 2006, CANCER RES, V66, P9583, DOI 10.1158/0008-5472.CAN-06-1842; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; RIPELLINO JA, 1989, J CELL BIOL, V108, P1899, DOI 10.1083/jcb.108.5.1899; Sano N, 2001, NEPHRON, V89, P416, DOI 10.1159/000046113; Seiter S, 2000, INT IMMUNOL, V12, P37, DOI 10.1093/intimm/12.1.37; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selbi W, 2004, J AM SOC NEPHROL, V15, P1199, DOI 10.1097/01.ASN.0000125619.27422.8E; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Stickel F, 2003, EUR J GASTROEN HEPAT, V15, P945, DOI 10.1097/00042737-200309000-00002; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vukicevic S, 1998, J CLIN INVEST, V102, P202, DOI 10.1172/JCI2237; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Wang Q, 2002, AM J PATHOL, V161, P2219, DOI 10.1016/S0002-9440(10)64498-7; Wang S, 2003, KIDNEY INT, V63, P2037, DOI 10.1046/j.1523-1755.2003.00035.x; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Wolny PM, 2010, J BIOL CHEM, V285, P30170, DOI 10.1074/jbc.M110.137562; Yang GX, 2013, TOXICOL LETT, V220, P103, DOI 10.1016/j.toxlet.2013.04.017; Zaman A, 2005, AM J RESP CELL MOL, V33, P447, DOI 10.1165/rcmb.2004-0333OC; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; ZOLLER M, 1995, J MOL MED, V73, P425	86	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11218	11234		10.1074/jbc.M114.625939	http://dx.doi.org/10.1074/jbc.M114.625939			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25716319	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000353719400002
J	Cymer, F; Hedman, R; Ismail, N; von Heijne, G				Cymer, Florian; Hedman, Rickard; Ismail, Nurzian; von Heijne, Gunnar			Exploration of the Arrest Peptide Sequence Space Reveals Arrest-enhanced Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Protein Secretion; Ribosome Function; Translation; Translation Elongation Factor; Translation Regulation; SecM	FACTOR EF-P; POLYPROLINE STRETCHES; ESCHERICHIA-COLI; RIBOSOME; TRANSLATION; MEMBRANE; SITE; TRANSLOCON; SENSOR	Translational arrest peptides (APs) are short stretches of polypeptides that induce translational stalling when synthesized on a ribosome. Mechanical pulling forces acting on the nascent chain can weaken or even abolish stalling. APs can therefore be used as in vivo force sensors, making it possible to measure the forces that act on a nascent chain during translation with single-residue resolution. It is also possible to score the relative strengths of APs by subjecting them to a given pulling force and ranking them according to stalling efficiency. Using the latter approach, we now report an extensive mutagenesis scan of a strong mutant variant of the Mannheimia succiniciproducens SecM AP and identify mutations that further increase the stalling efficiency. Combining three such mutations, we designed an AP that withstands the strongest pulling force we are able to generate at present. We further show that diproline stretches in a nascent protein act as very strong APs when translation is carried out in the absence of elongation factor P. Our findings highlight critical residues in APs, show that certain amino acid sequences induce very strong translational arrest and provide a toolbox of APs of varying strengths that can be used for in vivo force measurements.	[Cymer, Florian; Hedman, Rickard; Ismail, Nurzian; von Heijne, Gunnar] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, S-10691 Stockholm, Sweden; [von Heijne, Gunnar] Stockholm Univ, Sci Life Lab, S-17121 Solna, Sweden	Stockholm University; Stockholm University	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	gunnar@dbb.su.se	von Heijne, Gunnar/F-5576-2011; von Heijne, Gunnar/AAH-9389-2019	von Heijne, Gunnar/0000-0002-4490-8569; Cymer, Florian/0000-0002-6548-8743	European Research Council [ERC-2008-AdG 232648]; Knut and Alice Wallenberg Foundation; Swedish Foundation for Strategic Research; Swedish Research Council; Swedish Cancer Foundation; Deutsche Forschungsgemeinschaft [CY 74/1-1]	European Research Council(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by European Research Council Grant ERC-2008-AdG 232648, the Knut and Alice Wallenberg Foundation, the Swedish Foundation for Strategic Research, the Swedish Research Council, and the Swedish Cancer Foundation (to G. V. H.) and by a Deutsche Forschungsgemeinschaft Research Fellowship CY 74/1-1 (to F. C.).	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bhushan S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000581; Bhushan S, 2010, MOL CELL, V40, P138, DOI 10.1016/j.molcel.2010.09.009; Bischoff L, 2014, CELL REP, V9, P469, DOI 10.1016/j.celrep.2014.09.011; Butkus ME, 2003, J BACTERIOL, V185, P6719, DOI 10.1128/JB.185.22.6719-6722.2003; Chiba S, 2009, EMBO J, V28, P3461, DOI 10.1038/emboj.2009.280; Cymer F, 2014, FEBS LETT, V588, P1930, DOI 10.1016/j.febslet.2014.03.050; Cymer F, 2013, P NATL ACAD SCI USA, V110, P14640, DOI 10.1073/pnas.1306787110; Elgamal S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004553; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Gumbart J, 2012, BIOPHYS J, V103, P331, DOI 10.1016/j.bpj.2012.06.005; Ismail N, 2015, NAT STRUCT MOL BIOL, V22, P145, DOI 10.1038/nsmb.2940; Ismail N, 2012, NAT STRUCT MOL BIOL, V19, P1018, DOI 10.1038/nsmb.2376; Ito K, 2013, ANNU REV BIOCHEM, V82, P171, DOI 10.1146/annurev-biochem-080211-105026; Peil L, 2013, P NATL ACAD SCI USA, V110, P15265, DOI 10.1073/pnas.1310642110; Sarker S, 2000, J BACTERIOL, V182, P5592, DOI 10.1128/JB.182.19.5592-5595.2000; Starosta AL, 2014, NUCLEIC ACIDS RES, V42, P10711, DOI 10.1093/nar/gku768; Tanner DR, 2009, J BIOL CHEM, V284, P34809, DOI 10.1074/jbc.M109.039040; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Woolstenhulme CJ, 2013, P NATL ACAD SCI USA, V110, pE878, DOI 10.1073/pnas.1219536110; Yap MN, 2009, MOL CELL, V34, P201, DOI 10.1016/j.molcel.2009.04.002; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	24	34	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10208	10215		10.1074/jbc.M115.641555	http://dx.doi.org/10.1074/jbc.M115.641555			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25713070	Green Published, hybrid			2022-12-28	WOS:000353241100027
J	Lou, XC; Shin, J; Yang, Y; Kim, J; Shin, YK				Lou, Xiaochu; Shin, Jaeil; Yang, Yoosoo; Kim, Jaewook; Shin, Yeon-Kyun			Synaptotagmin-1 Is an Antagonist for Munc18-1 in SNARE Zippering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Exocytosis; Fusion Protein; Membrane Fusion; Neurotransmitter Release; Single Molecule Biophysics; Soluble NSF Attachment Protein Receptor (SNARE)	SYNAPTIC PROTEIN SNAP-25; VESICLE FUSION ASSAY; MEMBRANE-FUSION; SEC1/MUNC18 PROTEINS; NEUROTRANSMITTER RELEASE; 3-DIMENSIONAL STRUCTURE; CONFORMATIONAL SWITCH; SINGLE-MOLECULE; 4-HELIX BUNDLE; CA2+ SENSOR	Background: The molecular mechanisms of the critical necessity of Munc18-1 protein for neurotransmitter release remain unclear. Results: Synaptotagmin-1 competes with Munc18-1 in SNARE zippering and fusion pore opening. Conclusion: Synaptotagmin-1 wins the tug-of-war in gaining control of the SNAREpin at the moment of membrane fusion. Significance: This work clarifies an ambiguity concerning the Munc18-1 function in neuroexocytosis. In neuroexocytosis, SNAREs and Munc18-1 may consist of the minimal membrane fusion machinery. Consistent with this notion, we observed, using single molecule fluorescence assays, that Munc18-1 stimulates SNARE zippering and SNARE-dependent lipid mixing in the absence of a major Ca2+ sensor synaptotagmin-1 (Syt1), providing the structural basis for the conserved function of Sec1/Munc18 proteins in exocytosis. However, when full-length Syt1 is present, no enhancement of SNARE zippering and no acceleration of Ca2+-triggered content mixing by Munc18-1 are observed. Thus, our results show that Syt1 acts as an antagonist for Munc18-1 in SNARE zippering and fusion pore opening. Although the Sec1/Munc18 family may serve as part of the fusion machinery in other exocytotic pathways, Munc18-1 may have evolved to play a different role, such as regulating syntaxin-1a in neuroexocytosis.	[Lou, Xiaochu; Shin, Jaeil; Shin, Yeon-Kyun] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Yang, Yoosoo; Kim, Jaewook; Shin, Yeon-Kyun] KIST, Biomed Res Inst, Seoul 136791, South Korea	Iowa State University; Korea Institute of Science & Technology (KIST)	Shin, YK (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Mol Biol 4152, Ames, IA 50011 USA.	colishin@iastate.edu			National Institutes of Health [R01 GM051290]; Korea Institute of Science and Technology (KIST) Institutional Project [2E25520]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Institute of Science and Technology (KIST) Institutional Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM051290 (to Y.-K. S.). This work was also supported by Korea Institute of Science and Technology (KIST) Institutional Project 2E25520.	Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Breidenbach MA, 2005, TRENDS MOL MED, V11, P377, DOI 10.1016/j.molmed.2005.06.012; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Diao JJ, 2012, NAT PROTOC, V7, P921, DOI 10.1038/nprot.2012.020; Diao JJ, 2010, ACS CHEM NEUROSCI, V1, P168, DOI 10.1021/cn900034p; Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Honigmann A, 2013, NAT STRUCT MOL BIOL, V20, P679, DOI 10.1038/nsmb.2570; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Keller JE, 2001, J BIOL CHEM, V276, P13476, DOI 10.1074/jbc.M010992200; Kim JY, 2012, EMBO J, V31, P2144, DOI 10.1038/emboj.2012.57; Kyoung MJ, 2013, NAT PROTOC, V8, P1, DOI 10.1038/nprot.2012.134; Lai Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04575; Lai Y, 2013, BIOCHEM J, V456, P25, DOI 10.1042/BJ20130949; Lai Y, 2013, P NATL ACAD SCI USA, V110, P1333, DOI 10.1073/pnas.1218818110; Lai Y, 2012, BIOCHEM J, V443, P223, DOI 10.1042/BJ20112044; Lee HK, 2010, SCIENCE, V328, P760, DOI 10.1126/science.1187722; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Parisotto D, 2014, J BIOL CHEM, V289, P9639, DOI 10.1074/jbc.M113.514273; Parisotto D, 2012, J BIOL CHEM, V287, P31041, DOI 10.1074/jbc.M112.386805; PERIN MS, 1991, J BIOL CHEM, V266, P623; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; SCHEKMAN R, 1992, Current Opinion in Cell Biology, V4, P587, DOI 10.1016/0955-0674(92)90076-O; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; Shin J, 2014, BIOCHEM J, V459, P95, DOI 10.1042/BJ20131668; Shin YK, 2013, P NATL ACAD SCI USA, V110, P14116, DOI 10.1073/pnas.1313749110; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weninger K, 2003, P NATL ACAD SCI USA, V100, P14800, DOI 10.1073/pnas.2036428100; Xiao WZ, 2001, NAT STRUCT BIOL, V8, P308, DOI 10.1038/86174; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878; Yoon TY, 2008, NAT STRUCT MOL BIOL, V15, P707, DOI 10.1038/nsmb.1446; Yoon TY, 2006, P NATL ACAD SCI USA, V103, P19731, DOI 10.1073/pnas.0606032103; Yu HJ, 2013, P NATL ACAD SCI USA, V110, pE3271, DOI 10.1073/pnas.1311232110; Zhang YX, 2015, J BIOL CHEM, V290, P10518, DOI 10.1074/jbc.M114.630772	65	17	17	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10535	10543		10.1074/jbc.M114.631341	http://dx.doi.org/10.1074/jbc.M114.631341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25716321	Green Published, hybrid			2022-12-28	WOS:000353241100051
J	Repmann, S; Olivera-Harris, M; Jiricny, J				Repmann, Simone; Olivera-Harris, Maite; Jiricny, Josef			Influence of Oxidized Purine Processing on Strand Directionality of Mismatch Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Base Excision Repair (BER); DNA Damage; DNA Mismatch Repair; DNA Repair; Oxidative Stress	BASE-EXCISION-REPAIR; HUMAN MUTY HOMOLOG; MUTAGENIC SUBSTRATE; DNA-REPLICATION; ATPASE ACTIVITY; PROTEIN; ALPHA; 8-OXOGUANINE; GLYCOSYLASE; EXTRACTS	Replicative DNA polymerases are high fidelity enzymes that misincorporate nucleotides into nascent DNA with a frequency lower than [1/10(5)], and this precision is improved to about [1/10(7)] by their proofreading activity. Because this fidelity is insufficient to replicate most genomes without error, nature evolved postreplicative mismatch repair (MMR), which improves the fidelity of DNA replication by up to 3 orders of magnitude through correcting biosynthetic errors that escaped proofreading. MMR must be able to recognize non-Watson-Crick base pairs and excise the misincorporated nucleotides from the nascent DNA strand, which carries by definition the erroneous genetic information. In eukaryotes, MMR is believed to be directed to the nascent strand by preexisting discontinuities such as gaps between Okazaki fragments in the lagging strand or breaks in the leading strand generated by the mismatch-activated endonuclease of the MutL homologs PMS1 in yeast and PMS2 in vertebrates. We recently demonstrated that the eukaryotic MMR machinery can make use also of strand breaks arising during excision of uracils or ribonucleotides from DNA. We now show that intermediates of MutY homolog-dependent excision of adenines mispaired with 8-oxoguanine (G(O)) also act as MMR initiation sites in extracts of human cells or Xenopus laevis eggs. Unexpectedly, G(O)/C pairs were not processed in these extracts and failed to affect MMR directionality, but extracts supplemented with exogenous 8-oxoguanine DNA glycosylase (OGG1) did so. Because OGG1-mediated excision of G(O) might misdirect MMR to the template strand, our findings suggest that OGG1 activity might be inhibited during MMR.	[Repmann, Simone; Olivera-Harris, Maite; Jiricny, Josef] Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Repmann, Simone; Olivera-Harris, Maite; Jiricny, Josef] Swiss Inst Technol Zurich, CH-8057 Zurich, Switzerland	University of Zurich	Jiricny, J (corresponding author), Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jiricny@imcr.uzh.ch			Swiss National Science Foundation [310030B-133123, 31003A-149989]; European Research Council ["MIRIAM" 294537]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission)	This work was supported by Swiss National Science Foundation Grants 310030B-133123 and 31003A-149989 and European Research Council Grant "MIRIAM" 294537.	Avkin S, 2002, MUTAT RES-FUND MOL M, V510, P81, DOI 10.1016/S0027-5107(02)00254-3; Baerenfaller K, 2006, METHOD ENZYMOL, V408, P285, DOI 10.1016/S0076-6879(06)08018-9; Boldogh I, 2001, NUCLEIC ACIDS RES, V29, P2802, DOI 10.1093/nar/29.13.2802; BROOKS P, 1989, P NATL ACAD SCI USA, V86, P4425, DOI 10.1073/pnas.86.12.4425; Burrows CJ, 1998, CHEM REV, V98, P1109, DOI 10.1021/cr960421s; Collins AR, 1999, BIOESSAYS, V21, P238, DOI 10.1002/(SICI)1521-1878(199903)21:3<238::AID-BIES8>3.0.CO;2-3; Colussi C, 2002, CURR BIOL, V12, P912, DOI 10.1016/S0960-9822(02)00863-1; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Dherin C, 1999, NUCLEIC ACIDS RES, V27, P4001, DOI 10.1093/nar/27.20.4001; DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; Dufner P, 2000, J BIOL CHEM, V275, P36550, DOI 10.1074/jbc.M005987200; Einolf HJ, 2001, J BIOL CHEM, V276, P3764, DOI 10.1074/jbc.M006696200; FANG WH, 1993, J BIOL CHEM, V268, P11838; Fortini P, 2003, MUTAT RES-FUND MOL M, V531, P127, DOI 10.1016/j.mrfmmm.2003.07.004; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Gedik CM, 2005, FASEB J, V19, P82, DOI 10.1096/fj.04-1767fje; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; Gillespie PJ, 2012, METHODS, V57, P203, DOI 10.1016/j.ymeth.2012.03.029; Gu YS, 2002, J BIOL CHEM, V277, P11135, DOI 10.1074/jbc.M108618200; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Jacobs AL, 2012, CHROMOSOMA, V121, P1, DOI 10.1007/s00412-011-0347-4; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; KOI M, 1994, CANCER RES, V54, P4308; KUBOTA Y, 1993, J CELL BIOL, V123, P1321, DOI 10.1083/jcb.123.6.1321; LAHUE RS, 1988, MUTAT RES, V198, P37, DOI 10.1016/0027-5107(88)90037-1; Larson ED, 2003, DNA REPAIR, V2, P1199, DOI 10.1016/S1568-7864(03)00140-X; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Mazurek A, 2002, J BIOL CHEM, V277, P8260, DOI 10.1074/jbc.M111269200; MCAULEYHECHT KE, 1994, BIOCHEMISTRY-US, V33, P10266, DOI 10.1021/bi00200a006; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; MO JY, 1992, P NATL ACAD SCI USA, V89, P11021, DOI 10.1073/pnas.89.22.11021; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553; Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355; Pena-Diaz J, 2012, MOL CELL, V47, P669, DOI 10.1016/j.molcel.2012.07.006; Pena-Diaz J, 2010, P NATL ACAD SCI USA, V107, P16409, DOI 10.1073/pnas.1011692107; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Russo MT, 2004, MOL CELL BIOL, V24, P465, DOI 10.1128/MCB.24.1.465-474.2004; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; Schanz S, 2009, P NATL ACAD SCI USA, V106, P5593, DOI 10.1073/pnas.0901726106; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; Ushijima Y, 2005, NUCLEIC ACIDS RES, V33, P672, DOI 10.1093/nar/gki214; van Loon B, 2009, P NATL ACAD SCI USA, V106, P18201, DOI 10.1073/pnas.0907280106; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018	52	14	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					9986	9999		10.1074/jbc.M114.629907	http://dx.doi.org/10.1074/jbc.M114.629907			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25694431	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000353241100008
J	Liao, P; Yu, DJ; Hu, ZY; Liang, MC; Wang, JJ; Yu, CY; Ng, G; Yong, TF; Soon, JL; Chua, YL; Soong, TW				Liao, Ping; Yu, Dejie; Hu, Zhenyu; Liang, Mui Cheng; Wang, Jue Jin; Yu, Chye Yun; Ng, Gandi; Yong, Tan Fong; Soon, Jia Lin; Chua, Yeow Leng; Soong, Tuck Wah			Alternative Splicing Generates a Novel Truncated Ca(v)1.2 Channel in Neonatal Rat Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNEL; CA2+ CHANNEL; BETA-SUBUNIT; N-TERMINUS; SENSITIVITY; PREDICTS; PROTEIN	L-type Ca(v)1.2 Ca2+ channel undergoes extensive alternative splicing, generating functionally different channels. Alternatively spliced Ca(v)1.2 Ca2+ channels have been found to be expressed in a tissue-specific manner or under pathological conditions. To provide a more comprehensive understanding of alternative splicing in Ca(v)1.2 channel, we systematically investigated the splicing patterns in the neonatal and adult rat hearts. The neonatal heart expresses a novel 104-bp exon 33L at the IVS3-4 linker that is generated by the use of an alternative acceptor site. Inclusion of exon 33L causes frameshift and C-terminal truncation. Whole-cell electrophysiological recordings of Ca(v)1.2(33L) channels expressed in HEK 293 cells did not detect any current. However, when co-expressed with wild type Ca(v)1.2 channels, Ca(v)1.2(33L) channels reduced the current density and altered the electrophysiological properties of the wild type Ca(v)1.2 channels. Interestingly, the truncated 3.5-domain Ca(v)1.2(33L) channels also yielded a dominant negative effect on Ca(v)1.3 channels, but not on Ca(v)3.2 channels, suggesting that Ca-v beta subunits is required for Ca(v)1.2(33L) regulation. A biochemical study provided evidence that Ca(v)1.2(33L) channels enhanced protein degradation of wild type channels via the ubiquitin-proteasome system. Although the physiological significance of the Ca(v)1.2(33L) channels in neonatal heart is still unknown, our report demonstrates the ability of this novel truncated channel to modulate the activity of the functional Ca(v)1.2 channels. Moreover, the human Ca(v)1.2 channel also contains exon 33L that is developmentally regulated in heart. Unexpectedly, human exon 33L has a one-nucleotide insertion that allowed in-frame translation of a full Ca(v)1.2 channel. An electrophysiological study showed that human Ca(v)1.2(33L) channel is a functional channel but conducts Ca2+ ions at a much lower level.	[Liao, Ping; Yu, Chye Yun; Ng, Gandi; Soong, Tuck Wah] Natl Inst Neurosci, Singapore 308433, Singapore; [Liao, Ping] Duke NUS Grad Med Sch Singapore, Singapore 169857, Singapore; [Yu, Dejie; Hu, Zhenyu; Liang, Mui Cheng; Wang, Jue Jin; Yong, Tan Fong; Soong, Tuck Wah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore; [Soon, Jia Lin; Chua, Yeow Leng] Natl Heart Ctr Singapore, Singapore 169609, Singapore	National Neuroscience Institute (NNI); National University of Singapore; National University of Singapore; National Heart Centre Singapore	Soong, TW (corresponding author), Natl Inst Neurosci, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	ping_liao@nni.com.sg; tuck_wah_soong@nuhs.edu.sg	Juejin, Wang/ABA-7017-2020; Wang, Jue/GVU-0480-2022	Liang, Mui Cheng/0000-0003-1208-0733	Singapore Ministry of Health's National Medical Research Council	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	This work was supported by a grant from Singapore Ministry of Health's National Medical Research Council (to T. W. S.) and a grant from Singapore Ministry of Health's National Medical Research Council (to P. L.).	Abernethy DR, 2002, J PHARMACOL EXP THER, V300, P724, DOI 10.1124/jpet.300.3.724; Ahern CA, 2001, P NATL ACAD SCI USA, V98, P6935, DOI 10.1073/pnas.111001898; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cheng XY, 2007, J BIOL CHEM, V282, P29211, DOI 10.1074/jbc.M610623200; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; DIEBOLD RJ, 1992, P NATL ACAD SCI USA, V89, P1497, DOI 10.1073/pnas.89.4.1497; Ebihara T, 2002, FEBS LETT, V529, P203, DOI 10.1016/S0014-5793(02)03340-9; GIDHJAIN M, 1995, BIOCHEM BIOPH RES CO, V216, P892, DOI 10.1006/bbrc.1995.2705; Huang H, 2013, MOL PHARMACOL, V84, P643, DOI 10.1124/mol.113.087155; Kobrinsky E, 2005, J BIOL CHEM, V280, P12474, DOI 10.1074/jbc.M412140200; Liao P, 2005, CARDIOVASC RES, V68, P197, DOI 10.1016/j.cardiores.2005.06.024; Liao P, 2004, J BIOL CHEM, V279, P50329, DOI 10.1074/jbc.M409436200; Liao P, 2007, J BIOL CHEM, V282, P35133, DOI 10.1074/jbc.M705478200; Liao P, 2009, PFLUG ARCH EUR J PHY, V458, P701, DOI 10.1007/s00424-009-0652-4; Liao P, 2009, PFLUG ARCH EUR J PHY, V458, P481, DOI 10.1007/s00424-009-0635-5; Plummer NW, 1997, J BIOL CHEM, V272, P24008, DOI 10.1074/jbc.272.38.24008; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Raghib A, 2001, J NEUROSCI, V21, P8495, DOI 10.1523/JNEUROSCI.21-21-08495.2001; Takahashi SX, 2004, P NATL ACAD SCI USA, V101, P7193, DOI 10.1073/pnas.0306665101; Tang ZZ, 2009, MOL CELL BIOL, V29, P4757, DOI 10.1128/MCB.00608-09; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Tao J, 2008, MOL PHARMACOL, V73, P1596, DOI 10.1124/mol.107.043612; Tiwari S, 2006, P NATL ACAD SCI USA, V103, P17024, DOI 10.1073/pnas.0606539103; Vornanen M, 1996, CARDIOVASC RES, V32, P400, DOI 10.1016/0008-6363(96)00083-1; Vornanen M, 1996, MOL CELL BIOCHEM, V164, P5, DOI 10.1007/BF00408635; Welling A, 1997, CIRC RES, V81, P526, DOI 10.1161/01.RES.81.4.526; Wielowieyski PA, 2001, J BIOL CHEM, V276, P1398, DOI 10.1074/jbc.M006868200; Yang YB, 2000, J MOL CELL CARDIOL, V32, P973, DOI 10.1006/jmcc.2000.1138; Zuhlke RD, 1998, FEBS LETT, V427, P220, DOI 10.1016/S0014-5793(98)00425-6	30	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9262	9272		10.1074/jbc.M114.594911	http://dx.doi.org/10.1074/jbc.M114.594911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25694430	Green Published, hybrid			2022-12-28	WOS:000352207100047
J	Okon, IS; Coughlan, KA; Zhang, M; Wang, QX; Zou, MH				Okon, Imoh S.; Coughlan, Kathleen A.; Zhang, Miao; Wang, Qiongxin; Zou, Ming-Hui			Gefitinib-mediated Reactive Oxygen Specie (ROS) Instigates Mitochondrial Dysfunction and Drug Resistance in Lung Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; EPITHELIAL-MESENCHYMAL TRANSITION; ADHESION MOLECULES; OXIDATIVE STRESS; KINASE DOMAIN; EGFR KINASE; FASCIN; CD44; MUTATIONS; VIMENTIN	Therapeutic benefits offered by tyrosine kinase inhibitors (TKIs), such as gefitinib (Iressa) and erlotinib (Tarceva), are limited due to the development of resistance, which contributes to treatment failure and cancer-related mortality. The aim of this study was to elucidate mechanistic insight into cellular perturbations that accompany acquired gefitinib resistance in lung cancer cells. Several lung adenocarcinoma (LAD) cell lines were screened to characterize epidermal growth factor receptor (EGFR) expression and mutation profile. To circumvent intrinsic variations between cell lines with respect to response to drug treatments, we generated gefitinib-resistant H1650 clone by long-term, chronic culture under gefitinib selection of parental cell line. Isogenic cells were analyzed by microarray, Western blot, flow cytometry, and confocal and transmission electron microscope. We observed that although chronic gefitinib treatment provided effective action against its primary target (aberrant EGFR activity), secondary effects resulted in increased cellular reactive oxygen species (ROS). Gefitinib-mediated ROS correlated with epithelial-mesenchymal transition, as well as striking perturbation of mitochondrial morphology and function. However, gefitinib treatment in the presence of ROS scavenger provided a partial rescue of mitochondrial aberrations. Furthermore, withdrawal of gefitinib from previously resistant clones correlated with normalized expression of epithelial-mesenchymal transition genes. These findings demonstrate that chronic gefitinib treatment promotes ROS and mitochondrial dysfunction in lung cancer cells. Antioxidants may alleviate ROS-mediated resistance.	[Okon, Imoh S.; Coughlan, Kathleen A.; Zhang, Miao; Wang, Qiongxin; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Sect Mol Med, Oklahoma City, OK 73104 USA; [Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zou, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, BSEB 306A,941 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu	Kim, Han/AAA-5787-2021; Kim, Jonghan/AAH-9562-2021	Kim, Jonghan/0000-0002-6473-6186	National Institutes of Health [HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488, AG047776]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074399, R01HL110488, R01HL080499, R01HL089920, R01HL096032, R01HL105157, R01HL079584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants (HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488, and AG047776) from the National Institutes of Health to M. H. Z.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Alam H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-32; Amann J, 2005, CANCER RES, V65, P226; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Calvert TJ, 2008, AM J PHYSIOL-HEART C, V294, pH1621, DOI 10.1152/ajpheart.01008.2007; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chen JL, 2014, ADV MECH ENG, DOI 10.1155/2014/712740; Chernoivanenko IS, 2013, RUSS J DEV BIOL+, V44, P144, DOI 10.1134/S1062360413030016; Cichy J, 2003, J CELL BIOL, V161, P839, DOI 10.1083/jcb.200302098; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Dutsch-Wicherek M, 2010, AM J REPROD IMMUNOL, V63, P181, DOI 10.1111/j.1600-0897.2009.00803.x; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Hoelzle MK, 2012, MOL BIOL CELL, V23, P310, DOI 10.1091/mbc.E11-08-0719; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Martin E, 2005, J NEUROSCI RES, V79, P240, DOI 10.1002/jnr.20293; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; SOMMERS CL, 1992, CANCER RES, V52, P5190; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Stewart CJR, 2012, J CLIN PATHOL, V65, P213, DOI 10.1136/jclinpath-2011-200425; THOMPSON EW, 1994, CLIN EXP METASTAS, V12, P181, DOI 10.1007/BF01753886; Uramoto H, 2010, ANTICANCER RES, V30, P2513; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zanet J, 2012, J CELL BIOL, V197, P477, DOI 10.1083/jcb.201110135; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	44	64	68	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9101	9110		10.1074/jbc.M114.631580	http://dx.doi.org/10.1074/jbc.M114.631580			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25681445	hybrid, Green Published			2022-12-28	WOS:000352207100033
J	Corradini, E; Burgers, PP; Plank, M; Heck, AJR; Scholten, A				Corradini, Eleonora; Burgers, Pepijn P.; Plank, Michael; Heck, Albert J. R.; Scholten, Arjen			Huntingtin-associated Protein 1 (HAP1) Is a cGMP-dependent Kinase Anchoring Protein (GKAP) Specific for the cGMP-dependent Protein Kinase I beta Isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic GMP (cGMP); Mass Spectrometry (MS); Protein Kinase G (PKG); Proteomics; Signal Transduction; Chemical Proteomics; HAP1	REVEALS MOLECULAR DETAILS; CHEMICAL PROTEOMICS; CRYSTAL-STRUCTURE; LEUCINE-ZIPPER; MASS-SPECTROMETRY; TFII-I; AKAP; CAMP; BINDING; ALPHA	Background: Protein kinase compartmentalization through anchoring proteins provides spatiotemporal specificity. Results: Competitive elution combined with cyclic nucleotide affinity enrichment identifies HAP1 as a putative novel PKG anchoring protein (GKAP). Conclusion: Secondary structure predictions, in vitro binding studies, and site-directed mutagenesis define the binding domain and classify HAP1 as a GKAP specifically anchoring PKG I. Significance: The repertoire of PKG anchoring proteins is expanded, enforcing that also PKG signaling is tightly spatiotemporally regulated. Protein-protein interactions are important in providing compartmentalization and specificity in cellular signal transduction. Many studies have hallmarked the well designed compartmentalization of the cAMP-dependent protein kinase (PKA) through its anchoring proteins. Much less data are available on the compartmentalization of its closest homolog, cGMP-dependent protein kinase (PKG), via its own PKG anchoring proteins (GKAPs). For the enrichment, screening, and discovery of (novel) PKA anchoring proteins, a plethora of methodologies is available, including our previously described chemical proteomics approach based on immobilized cAMP or cGMP. Although this method was demonstrated to be effective, each immobilized cyclic nucleotide did not discriminate in the enrichment for either PKA or PKG and their secondary interactors. Hence, with PKG signaling components being less abundant in most tissues, it turned out to be challenging to enrich and identify GKAPs. Here we extend this cAMP-based chemical proteomics approach using competitive concentrations of free cyclic nucleotides to isolate each kinase and its secondary interactors. Using this approach, we identified Huntingtin-associated protein 1 (HAP1) as a putative novel GKAP. Through sequence alignment with known GKAPs and secondary structure prediction analysis, we defined a small sequence domain mediating the interaction with PKG I but not PKG I. In vitro binding studies and site-directed mutagenesis further confirmed the specificity and affinity of HAP1 binding to the PKG I N terminus. These data fully support that HAP1 is a GKAP, anchoring specifically to the cGMP-dependent protein kinase isoform I, and provide further evidence that also PKG spatiotemporal signaling is largely controlled by anchoring proteins.	[Corradini, Eleonora; Burgers, Pepijn P.; Plank, Michael; Heck, Albert J. R.; Scholten, Arjen] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands; [Corradini, Eleonora; Burgers, Pepijn P.; Plank, Michael; Heck, Albert J. R.; Scholten, Arjen] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Corradini, Eleonora; Burgers, Pepijn P.; Plank, Michael; Heck, Albert J. R.; Scholten, Arjen] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University	Heck, AJR (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	a.j.r.heck@uu.nl	Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404	European Union [262067]; Netherlands Organization for Scientific Research (NWO) [184.032.201]	European Union(European Commission); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Part of this work was performed within the framework of PRIME-XS Project Grant 262067 funded by the European Union 7th Framework Program and the Netherlands Organization for Scientific Research (NWO)-supported large scale proteomics facility Proteins@Work (Project 184.032.201) embedded in the Netherlands Proteomics Centre.	Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Ammendola A, 2001, J BIOL CHEM, V276, P24153, DOI 10.1074/jbc.M101530200; Aye TT, 2012, J MOL CELL CARDIOL, V52, P511, DOI 10.1016/j.yjmcc.2011.06.003; Bantscheff M, 2009, DRUG DISCOV TODAY, V14, P1021, DOI 10.1016/j.drudis.2009.07.001; Burgers PP, 2015, BIOCHEMISTRY-US, V54, P11, DOI 10.1021/bi500721a; Burgers PP, 2012, J BIOL CHEM, V287, P43789, DOI 10.1074/jbc.M112.395970; CARR DW, 1991, J BIOL CHEM, V266, P14188; Casteel DE, 2010, J BIOL CHEM, V285, P32684, DOI 10.1074/jbc.C110.161430; Casteel DE, 2005, J BIOL CHEM, V280, P38211, DOI 10.1074/jbc.M507021200; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DEJONGE HR, 1981, ADV CYCLIC NUCL PROT, V14, P315; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Feil R, 2002, CIRC RES, V90, P1080, DOI 10.1161/01.RES.0000019586.95768.40; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; FRENCH PJ, 1995, J BIOL CHEM, V270, P26626, DOI 10.1074/jbc.270.44.26626; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Hundsrucker C, 2010, J BIOL CHEM, V285, P5507, DOI 10.1074/jbc.M109.047944; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Kovanich D, 2010, CHEMBIOCHEM, V11, P963, DOI 10.1002/cbic.201000058; LOHMANN SM, 1981, P NATL ACAD SCI-BIOL, V78, P653, DOI 10.1073/pnas.78.1.653; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Pelligrino DA, 1998, PROG NEUROBIOL, V56, P1, DOI 10.1016/S0301-0082(98)00009-4; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Prigge JR, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-76; Reger AS, 2014, J BIOL CHEM, V289, P25393, DOI 10.1074/jbc.M114.575894; Richie-Jannetta R, 2003, J BIOL CHEM, V278, P50070, DOI 10.1074/jbc.M306796200; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Scholten A, 2007, J PROTEOME RES, V6, P1705, DOI 10.1021/pr060601a; Scholten A, 2006, J PROTEOME RES, V5, P1435, DOI 10.1021/pr0600529; Sharma AK, 2008, J BIOL CHEM, V283, P32860, DOI 10.1074/jbc.M804916200; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Skroblin P, 2010, INT REV CEL MOL BIO, V283, P235, DOI 10.1016/S1937-6448(10)83005-9; Stangherlin A, 2011, J CARDIOVASC PHARM, V58, P345, DOI 10.1097/FJC.0b013e3182214f2b; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Vo NK, 1998, BIOCHEM BIOPH RES CO, V246, P831, DOI 10.1006/bbrc.1998.8722; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; WERNET W, 1989, FEBS LETT, V251, P191, DOI 10.1016/0014-5793(89)81453-X; WOLFE L, 1989, J BIOL CHEM, V264, P4157; Wong JWH, 2009, PROTEOMICS, V9, P40, DOI 10.1002/pmic.200800185; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yuasa K, 2000, J BIOL CHEM, V275, P4897, DOI 10.1074/jbc.275.7.4897; Yuasa K, 2008, BIOCHEM BIOPH RES CO, V374, P522, DOI 10.1016/j.bbrc.2008.07.071	49	12	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7887	7896		10.1074/jbc.M114.622613	http://dx.doi.org/10.1074/jbc.M114.622613			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25653285	hybrid, Green Published			2022-12-28	WOS:000351613600046
J	Nieves-Cintron, M; Nystoriak, MA; Prada, MP; Johnson, K; Fayer, W; Dell'Acqua, ML; Scott, JD; Navedo, MF				Nieves-Cintron, Madeline; Nystoriak, Matthew A.; Prada, Maria Paz; Johnson, Kenneth; Fayer, William; Dell'Acqua, Mark L.; Scott, John D.; Navedo, Manuel F.			Selective Down-regulation of K(V)2.1 Function Contributes to Enhanced Arterial Tone during Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; Ion Channel; Scaffold Protein; Type 2 Diabetes; Vascular Smooth Muscle Cells; AKAP150; Cerebral Arteries; High Fat Diet Mouse; Hyperglycemia	SMOOTH-MUSCLE-CELLS; GATED K+ CHANNELS; PROTEIN-KINASE-C; CEREBRAL-ARTERIES; POTASSIUM CHANNELS; LARGE-CONDUCTANCE; LOCAL-REGULATION; CA2+ CHANNELS; RAT; DIAMETER	Background: K-V channels in vascular smooth muscle cells (VSMCs) regulate arterial tone. Results: K(V)2.1 in VSMCs is down-regulated via AKAP150-CaN-dependent NFATc3 signaling during diabetes. Conclusion: Transcriptional suppression of K(V)2.1 contributes to enhanced arterial tone in diabetes. Significance: AKAP150-CaN-dependent activation of NFATc3 may be a general mechanism for transcriptional regulation of K+ channels, and a valuable target to prevent and treat diabetic vascular complications. Enhanced arterial tone is a leading cause of vascular complications during diabetes. Voltage-gated K+ (K-V) channels are key regulators of vascular smooth muscle cells (VSMCs) contractility and arterial tone. Whether impaired K-V channel function contributes to enhance arterial tone during diabetes is unclear. Here, we demonstrate a reduction in K-V-mediated currents (I-Kv) in VSMCs from a high fat diet (HFD) mouse model of type 2 diabetes. In particular, I-Kv sensitive to stromatoxin (ScTx), a potent K(V)2 blocker, were selectively reduced in diabetic VSMCs. This was associated with decreased K(V)2-mediated regulation of arterial tone and suppression of the K(V)2.1 subunit mRNA and protein in VSMCs/arteries isolated from HFD mice. We identified protein kinase A anchoring protein 150 (AKAP150), via targeting of the phosphatase calcineurin (CaN), and the transcription factor nuclear factor of activated T-cells c3 (NFATc3) as required determinants of K(V)2.1 suppression during diabetes. Interestingly, substantial reduction in transcript levels for K(V)2.1 preceded down-regulation of large conductance Ca2+-activated K+ (BKCa) channel 1 subunits, which are ultimately suppressed in chronic hyperglycemia to a similar extent. Together, our study supports the concept that transcriptional suppression of K(V)2.1 by activation of the AKAP150-CaN/NFATc3 signaling axis contributes to enhanced arterial tone during diabetes.	[Nieves-Cintron, Madeline; Nystoriak, Matthew A.; Prada, Maria Paz; Johnson, Kenneth; Fayer, William; Navedo, Manuel F.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Dell'Acqua, Mark L.] Univ Colorado, Dept Pharmacol, Denver, CO 80045 USA; [Scott, John D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Scott, John D.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of California System; University of California Davis; University of Colorado System; University of Colorado Denver; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Navedo, MF (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	mfnavedo@ucdavis.edu			National Institutes of Health [R01HL098200]; American Heart Association Grant (AHA) [AHA-14GRNT18730054]; NHLBI [HL-086350, HL-07828]; Lawrence J. and Florence A. DeGeorge Charitable Trust; National Institutes of Health through the NIGMS [T32GM099608];  [AHA-13POST12730001]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098200, T32HL007828, T32HL086350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441, P30DK017047, R01DK105542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM099608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Grant (AHA)(American Heart Association); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Lawrence J. and Florence A. DeGeorge Charitable Trust; National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01HL098200 and American Heart Association Grant (AHA) AHA-14GRNT18730054 (to M. F. N.), and NHLBI training grants HL-086350 and HL-07828 and Grant AHA-13POST12730001 and the Lawrence J. and Florence A. DeGeorge Charitable Trust (to M. A. N.). This work was also supported by National Institutes of Health Grant T32GM099608 (to M. P. P.) through the NIGMS.	Albarwani S, 2003, J PHYSIOL-LONDON, V551, P751, DOI 10.1113/jphysiol.2003.040014; Amberg GC, 2004, J BIOL CHEM, V279, P47326, DOI 10.1074/jbc.M408789200; Amberg GC, 2006, AM J PHYSIOL-CELL PH, V291, pC348, DOI 10.1152/ajpcell.00086.2006; Amberg GC, 2010, CIRC RES, V107, P1002, DOI 10.1161/CIRCRESAHA.110.217018; Bagi Z, 2005, ARTERIOSCL THROM VAS, V25, P1610, DOI 10.1161/01.ATV.0000172688.26838.9f; Cooper ME, 2001, AM J HYPERTENS, V14, P475, DOI 10.1016/S0895-7061(00)01323-6; Dong L, 2008, J CEREBR BLOOD F MET, V28, P377, DOI 10.1038/sj.jcbfm.9600536; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gomez MF, 2003, J BIOL CHEM, V278, P46847, DOI 10.1074/jbc.M304765200; Hayabuchi Y, 2001, AM J PHYSIOL-HEART C, V281, pH2480, DOI 10.1152/ajpheart.2001.281.6.H2480; Jaggar JH, 1998, ACTA PHYSIOL SCAND, V164, P577; Kidd MW, 2013, FASEB J, V27; Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722; KNOT HJ, 1995, AM J PHYSIOL-HEART C, V269, pH348, DOI 10.1152/ajpheart.1995.269.1.H348; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Lagaud GJL, 2001, J VASC RES, V38, P578, DOI 10.1159/000051094; Li HM, 2012, NAT STRUCT MOL BIOL, V19, P337, DOI 10.1038/nsmb.2238; Liu YP, 2001, CIRC RES, V89, P146, DOI 10.1161/hh1401.093294; Lu Y, 2002, LIFE SCI, V71, P1465, DOI 10.1016/S0024-3205(02)01922-7; Marzian S, 2013, NAT CHEM BIOL, V9, P507, DOI 10.1038/nchembio.1271; McGahon MK, 2007, CIRC RES, V100, P703, DOI 10.1161/01.RES.0000260182.36481.c9; Moore CL, 2014, CIRC RES, V114, P1258, DOI 10.1161/CIRCRESAHA.114.303167; Navedo MF, 2008, CIRC RES, V102, pE1, DOI 10.1161/CIRCRESAHA.107.167809; Navedo MF, 2013, MICROCIRCULATION, V20, P290, DOI 10.1111/micc.12021; Navedo MF, 2013, J MOL CELL CARDIOL, V58, P67, DOI 10.1016/j.yjmcc.2012.11.018; Navedo MF, 2010, AM J PHYSIOL-CELL PH, V298, pC211, DOI 10.1152/ajpcell.00267.2009; Navedo MF, 2005, P NATL ACAD SCI USA, V102, P11112, DOI 10.1073/pnas.0500360102; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Nieves-Cintron M, 2008, P NATL ACAD SCI USA, V105, P15623, DOI 10.1073/pnas.0808759105; Nieves-Cintron M, 2007, J BIOL CHEM, V282, P3231, DOI 10.1074/jbc.M608822200; Nystoriak MA, 2014, CIRC RES, V114, P607, DOI 10.1161/CIRCRESAHA.114.302168; Nystoriak MA, 2013, BBA-MOL CELL RES, V1833, P1657, DOI 10.1016/j.bbamcr.2012.10.027; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Rainbow RD, 2006, J PHYSIOL-LONDON, V575, P833, DOI 10.1113/jphysiol.2006.114009; Ramana KV, 2005, DIABETES, V54, P818, DOI 10.2337/diabetes.54.3.818; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Sena CM, 2013, BBA-MOL BASIS DIS, V1832, P2216, DOI 10.1016/j.bbadis.2013.08.006; Straub SV, 2009, AM J PHYSIOL-CELL PH, V297, pC788, DOI 10.1152/ajpcell.00148.2009; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Vennekamp J, 2004, MOL PHARMACOL, V65, P1364, DOI 10.1124/mol.65.6.1364; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Xu CL, 1999, AM J PHYSIOL-GASTR L, V277, pG1055, DOI 10.1152/ajpgi.1999.277.5.G1055; Zhang DM, 2010, CIRC RES, V107, P1454, DOI 10.1161/CIRCRESAHA.110.228361; Zhong XZ, 2010, J PHYSIOL-LONDON, V588, P4519, DOI 10.1113/jphysiol.2010.196618; Zimmermann PA, 1997, CIRC RES, V81, P996	47	22	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7918	7929		10.1074/jbc.M114.622811	http://dx.doi.org/10.1074/jbc.M114.622811			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25670860	Green Published, hybrid			2022-12-28	WOS:000351613600049
J	Rahman, MA; Sobia, P; Dwivedi, VP; Bhawsar, A; Singh, DK; Sharma, P; Moodley, P; Van Kaer, L; Bishai, WR; Das, G				Rahman, Md. Aejazur; Sobia, Parveen; Dwivedi, Ved Prakash; Bhawsar, Aakansha; Singh, Dhiraj Kumar; Sharma, Pawan; Moodley, Prashini; Van Kaer, Luc; Bishai, William R.; Das, Gobardhan			Mycobacterium tuberculosis TlyA Protein Negatively Regulates T Helper (Th) 1 and Th17 Differentiation and Promotes Tuberculosis Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETED ANTIGENIC TARGET; PHAGOSOME MATURATION; INTERFERON-GAMMA; IN-VITRO; INFECTION; AUTOPHAGY; HOST; IMMUNITY; DEFENSE; VACCINE	Mycobacterium tuberculosis, the causative agent of tuberculosis, is an ancient pathogen and a major cause of death world-wide. Although various virulence factors of M. tuberculosis have been identified, its pathogenesis remains incompletely understood. TlyA is a virulence factor in several bacterial infections and is evolutionarily conserved in many Gram-positive bacteria, but its function in M. tuberculosis pathogenesis has not been elucidated. Here, we report that TlyA significantly contributes to the pathogenesis of M. tuberculosis. We show that a TlyA mutant M. tuberculosis strain induces increased IL-12 and reduced IL-1 beta and IL-10 cytokine responses, which sharply contrasts with theimmuneresponses induced by wild type M. tuberculosis. Furthermore, compared with wild type M. tuberculosis, TlyA-deficient M. tuberculosis bacteria are more susceptible to autophagy in macrophages. Consequently, animals infected with the TlyA mutant M. tuberculosis organisms exhibited increased host-protective immune responses, reduced bacillary load, and increased survival compared with animals infected with wild type M. tuberculosis. Thus, M. tuberculosis employs TlyA as a host evasion factor, thereby contributing to its virulence.	[Rahman, Md. Aejazur; Sobia, Parveen; Dwivedi, Ved Prakash; Moodley, Prashini; Das, Gobardhan] Univ KwaZulu Natal, Sch Lab Med & Med Sci, ZA-4001 Durban, South Africa; [Sharma, Pawan] North Eastern Reg Biotechnol Programme Management, New Delhi, India; [Van Kaer, Luc] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Bishai, William R.] Johns Hopkins Sch Med, Ctr TB Res, Dept Med, Div Infect Dis, Baltimore, MD 21231 USA; [Bhawsar, Aakansha; Singh, Dhiraj Kumar; Das, Gobardhan] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India	University of Kwazulu Natal; Vanderbilt University; Johns Hopkins University; Johns Hopkins Medicine; Jawaharlal Nehru University, New Delhi	Das, G (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India.	gobardhan.das07@gmail.com	Sharma, Pawan/F-7806-2010; Van Kaer, Luc/H-1033-2015; Rhaman, Aejazur/AAC-5104-2019	Sharma, Pawan/0000-0002-2525-5451; Van Kaer, Luc/0000-0001-5275-2309; Rhaman, Aejazur/0000-0002-2616-3372; Dwivedi, Ved Prakash/0000-0003-4321-2567; Singh, Dhiraj/0000-0001-5507-1197				Ahmad S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/814943; Arend SM, 2000, J INFECT DIS, V181, P1850, DOI 10.1086/315448; Bhattacharya D, 2014, J BIOL CHEM, V289, P16508, DOI 10.1074/jbc.M114.558098; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bradfute SB, 2013, CURR OPIN MICROBIOL, V16, P355, DOI 10.1016/j.mib.2013.05.003; Butt AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043080; Chan J, 2004, CLIN IMMUNOL, V110, P2, DOI 10.1016/S1521-6616(03)00210-9; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424; Deretic V, 2009, CURR TOP MICROBIOL, V335, P169, DOI 10.1007/978-3-642-00302-8_8; Dwivedi VP, 2012, J BIOL CHEM, V287, P33656, DOI 10.1074/jbc.M112.375154; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Flynn JL, 2005, TRENDS MICROBIOL, V13, P98, DOI 10.1016/j.tim.2005.01.005; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fratti RA, 2003, J BIOL CHEM, V278, P46961, DOI 10.1074/jbc.M305225200; Glickman MS, 2001, CELL, V104, P477, DOI 10.1016/S0092-8674(01)00236-7; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hall BS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004061; Jo EK, 2013, PATHOG DIS, V67, P108, DOI 10.1111/2049-632X.12023; Kumar P, 2012, IMMUNOL CELL BIOL, V90, P411, DOI 10.1038/icb.2011.54; Li N, 2012, MOL BIOL REP, V39, P4655, DOI 10.1007/s11033-011-1257-5; Li S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073563, 10.1371/journal.pone.0053163, 10.1371/journal.pone.0081438]; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Makinoshima H, 2005, NATURE, V436, P406, DOI 10.1038/nature03713; Martino MC, 2001, INFECT IMMUN, V69, P1697, DOI 10.1128/IAI.69.3.1697-1703.2001; McCluskey J, 2002, INFECT IMMUN, V70, P2899, DOI 10.1128/IAI.70.6.2899-2907.2002; Monshupanee T, 2012, MOL MICROBIOL, V85, P1194, DOI 10.1111/j.1365-2958.2012.08168.x; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Peng H, 2011, J BIOL CHEM, V286, P24508, DOI 10.1074/jbc.M111.234062; Petersen HJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00120; Prados-Rosales R, 2011, J CLIN INVEST, V121, P1471, DOI 10.1172/JCI44261; Raghuvanshi S, 2010, P NATL ACAD SCI USA, V107, P21653, DOI 10.1073/pnas.1007967107; Rahman A, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-35; Rahman MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086886; Rook GAW, 2004, TRENDS IMMUNOL, V25, P483, DOI 10.1016/j.it.2004.06.005; Rosenzweig SD, 2005, IMMUNOL REV, V203, P38, DOI 10.1111/j.0105-2896.2005.00227.x; SAHA B, 1994, EUR J IMMUNOL, V24, P2618, DOI 10.1002/eji.1830241108; Sakamoto K, 2012, VET PATHOL, V49, P423, DOI 10.1177/0300985811429313; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Singh PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018564; Sklar JG, 2010, MOL MICROBIOL, V77, P605, DOI 10.1111/j.1365-2958.2010.07232.x; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; Wang QL, 2001, INFECT IMMUN, V69, P2270, DOI 10.1128/IAI.69.4.2270-2276.2001; Yamada H, 2000, LAB INVEST, V80, P759, DOI 10.1038/labinvest.3780079; Yuk JM, 2014, CLIN EXP VACCINE RES, V3, P155, DOI 10.7774/cevr.2014.3.2.155; Zhang XQ, 2010, CANCER GENE THER, V17, P579, DOI 10.1038/cgt.2010.14	56	23	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14407	14417		10.1074/jbc.M115.653600	http://dx.doi.org/10.1074/jbc.M115.653600			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25847237	Green Published, hybrid			2022-12-28	WOS:000355754600012
J	Dunschede, B; Trager, C; Schoder, CV; Ziehe, D; Walter, B; Funke, S; Hofmann, E; Schunemann, D				Duenschede, Beatrix; Traeger, Chantal; Schoeder, Christine Vera; Ziehe, Dominik; Walter, Bjoern; Funke, Silke; Hofmann, Eckhard; Schuenemann, Danja			Chloroplast SRP54 Was Recruited for Posttranslational Protein Transport via Complex Formation with Chloroplast SRP43 during Land Plant Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; ALGA CHLAMYDOMONAS-REINHARDTII; THYLAKOID MEMBRANE-PROTEIN; CHLOROPHYLL ANTENNA; BINDING PROTEIN; 54-KDA SUBUNIT; COMPONENTS; HOMOLOG; CPSRP43; GENE	In bacteria, membrane proteins are targeted cotranslationally via a signal recognition particle (SRP). During the evolution of higher plant chloroplasts from cyanobacteria, the SRP pathway underwent striking adaptations that enable the posttranslational transport of the abundant light-harvesting chlorophyll-a/b-binding proteins (LHCPs). The conserved 54-kDa SRP subunit in higher plant chloroplasts (cpSRP54) is not bound to an SRP RNA, an essential SRP component in bacteria, but forms a stable heterodimer with the chloroplast-specific cpSRP43. This heterodimeric cpSRP recognizes LHCP and delivers it to the thylakoid membrane whereby cpSRP43 plays a central role. This study shows that the cpSRP system in the green alga Chlamydomonas reinhardtii differs significantly from that of higher plants as cpSRP43 is not complexed to cpSRP54 in Chlamydomonas and cpSRP54 is not involved in LHCP recognition. This divergence is attributed to altered residues within the cpSRP54 tail and the second chromodomain of cpSRP43 that are crucial for the formation of the binding interface in Arabidopsis. These changes are highly conserved among chlorophytes, whereas all land plants contain cpSRP proteins with typical interaction motifs. These data demonstrate that the coevolution of LHCPs and cpSRP43 occurred independently of complex formation with cpSRP54 and that the interaction between cpSRP54 and cpSRP43 evolved later during the transition from chlorophytes to land plants. Furthermore, our data show that in higher plants a heterodimeric form of cpSRP is required for the formation of a low molecular weight transit complex with LHCP.	[Duenschede, Beatrix; Traeger, Chantal; Schoeder, Christine Vera; Ziehe, Dominik; Walter, Bjoern; Funke, Silke; Schuenemann, Danja] Ruhr Univ Bochum, Mol Biol Plant Organelles, D-44780 Bochum, Germany; [Hofmann, Eckhard] Ruhr Univ Bochum, Prot Crystallog, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Schunemann, D (corresponding author), Ruhr Univ Bochum, Fac Biol & Biotechnol, Mol Biol Plant Organelles, D-44780 Bochum, Germany.	Danja.Schuenemann@rub.de	Hofmann, Eckhard/GPF-5024-2022	Schuenemann, Danja/0000-0001-8894-7685; Hofmann, Eckhard/0000-0003-4874-372X	Deutsche Forschungsgemeinschaft (DFG) [SFB 642, SCHU 1163/5-1]; Ruhr University Research School - Germany's Excellence Initiative (DFG) [GSC 98/1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ruhr University Research School - Germany's Excellence Initiative (DFG)	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants SFB 642 and SCHU 1163/5-1 and by the Ruhr University Research School funded by Germany's Excellence Initiative (DFG Grant GSC 98/1).	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Alboresi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002033; Bals T, 2010, FEBS LETT, V584, P4138, DOI 10.1016/j.febslet.2010.08.053; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; FRANKLIN AE, 1993, J BIOL CHEM, V268, P22175; Funke S, 2005, J BIOL CHEM, V280, P8912, DOI 10.1074/jbc.M409992200; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; Grudnik P, 2009, BIOL CHEM, V390, P775, DOI 10.1515/BC.2009.102; Harris E. H, 1989, CHLAMYDOMONAS SOURCE, P242; Hermkes R, 2006, FEBS LETT, V580, P3107, DOI 10.1016/j.febslet.2006.04.055; Holdermann I, 2012, NAT STRUCT MOL BIOL, V19, P260, DOI 10.1038/nsmb.2196; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kirst H, 2012, PLANT PHYSIOL, V160, P2251, DOI 10.1104/pp.112.206672; Kirst H, 2012, PLANT PHYSIOL, V158, P930, DOI 10.1104/pp.111.189910; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Kogata N, 1999, FEBS LETT, V447, P329, DOI 10.1016/S0014-5793(99)00305-1; Lewis NE, 2010, J BIOL CHEM, V285, P34220, DOI 10.1074/jbc.M110.160093; Mason CB, 2006, NAT PROTOC, V1, P2227, DOI 10.1038/nprot.2006.348; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Nilsson R, 2002, FEBS LETT, V524, P127, DOI 10.1016/S0014-5793(02)03016-8; Nilsson R, 1999, EMBO J, V18, P733, DOI 10.1093/emboj/18.3.733; Nussaume L, 2008, NAT CHEM BIOL, V4, P529, DOI 10.1038/nchembio0908-529; PAULSEN H, 1993, EUR J BIOCHEM, V215, P809, DOI 10.1111/j.1432-1033.1993.tb18096.x; PAYAN LA, 1991, J CELL BIOL, V112, P603, DOI 10.1083/jcb.112.4.603; Richter CV, 2010, EUR J CELL BIOL, V89, P965, DOI 10.1016/j.ejcb.2010.06.020; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Trager C, 2012, PLANT CELL, V24, P4819, DOI 10.1105/tpc.112.102996; Tu CJ, 1999, J BIOL CHEM, V274, P27219, DOI 10.1074/jbc.274.38.27219; Tzvetkova-Chevolleau T, 2007, PLANT CELL, V19, P1635, DOI 10.1105/tpc.106.048959; Yuan J, 2002, J BIOL CHEM, V277, P32400, DOI 10.1074/jbc.M206192200	36	24	25	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13104	13114		10.1074/jbc.M114.597922	http://dx.doi.org/10.1074/jbc.M114.597922			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25833951	Green Published, hybrid			2022-12-28	WOS:000354975700014
J	Vigliarolo, T; Guida, L; Millo, E; Fresia, C; Turco, E; De Flora, A; Zocchi, E				Vigliarolo, Tiziana; Guida, Lucrezia; Millo, Enrico; Fresia, Chiara; Turco, Emilia; De Flora, Antonio; Zocchi, Elena			Abscisic Acid Transport in Human Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; MOLECULAR CHARACTERIZATION; HUMAN GRANULOCYTES; PLASMA-MEMBRANE; ANION-EXCHANGE; PROTEIN; CELL; 2ND-MESSENGER; BINDING; IDENTIFICATION	Abscisic acid (ABA) is a plant hormone involved in the response to environmental stress. Recently, ABA has been shown to be present and active also in mammals, where it stimulates the functional activity of innate immune cells, of mesenchymal and hemopoietic stem cells, and insulin-releasing pancreatic beta-cells. LANCL2, the ABA receptor in mammalian cells, is a peripheral membrane protein that localizes at the intracellular side of the plasma membrane. Here we investigated the mechanism enabling ABA transport across the plasmamembrane of human red blood cells (RBC). Both influx and efflux of [H-3] ABA occur across intact RBC, as detected by radiometric and chromatographic methods. ABA binds specifically to Band 3 (the RBC anion transporter), as determined by labeling of RBC membranes with biotinylated ABA. Proteoliposomes reconstituted with human purified Band 3 transport [H-3] ABA and [S-35] sulfate, and ABA transport is sensitive to the specific Band 3 inhibitor 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid. Once inside RBC, ABA stimulates ATP release through the LANCL2-mediated activation of adenylate cyclase. As ATP released from RBC is known to exert a vasodilator response, these results suggest a role for plasma ABA in the regulation of vascular tone.	[Vigliarolo, Tiziana; Guida, Lucrezia; Fresia, Chiara; De Flora, Antonio; Zocchi, Elena] Univ Genoa, Dept Expt Med, Biochem Sect, I-16132 Genoa, Italy; [Millo, Enrico] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Turco, Emilia] Univ Turin, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy	University of Genoa; University of Genoa; University of Turin	Vigliarolo, T (corresponding author), Univ Genoa, Dept Expt Med, Biochem Sect, Viale Benedetto 15 1, I-16132 Genoa, Italy.	tiziana.vigliarolo@edu.unige.it	Millo, Enrico/K-3218-2018	Millo, Enrico/0000-0002-4019-0051; FRESIA, CHIARA MARTA/0000-0002-9177-4655	Italian Ministry of Education, University and Scientific Research [PRIN 2007BZ4RX3_005]; Fondazione CARIGE; Compagnia di S. Paolo di Torino [ROL 316]	Italian Ministry of Education, University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Fondazione CARIGE(Fondazione Carige); Compagnia di S. Paolo di Torino(Compagnia di San Paolo)	This work was supported in part by the Italian Ministry of Education, University and Scientific Research Grant PRIN 2007BZ4RX3_005, the Fondazione CARIGE, and the Compagnia di S. Paolo di Torino (ID ROL 316).	Badrnya S, 2014, ARTERIOSCL THROM VAS, V34, P571, DOI 10.1161/ATVBAHA.113.302919; Bodrato N, 2009, J BIOL CHEM, V284, P14777, DOI 10.1074/jbc.M802604200; Boursiac Y, 2013, TRENDS PLANT SCI, V18, P325, DOI 10.1016/j.tplants.2013.01.007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruzzone S, 2001, FASEB J, V15, P10; Bruzzone S., 2012, MESSENGER, V1, P141; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Bruzzone S, 2012, FASEB J, V26, P1251, DOI 10.1096/fj.11-190140; De Flora A., 2014, MESSENGER, V3, P1; Ellsworth ML, 2012, J PHYSIOL-LONDON, V590, P4985, DOI 10.1113/jphysiol.2012.233106; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; FALKE JJ, 1984, J BIOL CHEM, V259, P6472; Franco L, 1998, FASEB J, V12, P1507; Gatto C, 1997, ARCH BIOCHEM BIOPHYS, V340, P90, DOI 10.1006/abbi.1997.9879; Grozio A, 2013, NUCLEIC ACID THER, V23, P322, DOI 10.1089/nat.2013.0418; Grozio A, 2011, BIOCHEM BIOPH RES CO, V415, P696, DOI 10.1016/j.bbrc.2011.10.143; Guo JJ, 2011, J INTEGR PLANT BIOL, V53, P469, DOI 10.1111/j.1744-7909.2011.01044.x; Guri AJ, 2010, J NUTR BIOCHEM, V21, P1178, DOI 10.1016/j.jnutbio.2009.10.003; JENNINGS ML, 1984, BIOCHEMISTRY-US, V23, P6432, DOI 10.1021/bi00321a024; Jennings ML, 2005, BIOPHYS J, V88, P2681, DOI 10.1529/biophysj.104.056812; JENNINGS ML, 1976, J MEMBRANE BIOL, V28, P187, DOI 10.1007/BF01869697; Joshi-Saha A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002164; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kanno Y, 2012, P NATL ACAD SCI USA, V109, P9653, DOI 10.1073/pnas.1203567109; Kawaguchi Y, 2013, BIOORG MED CHEM LETT, V23, P3738, DOI 10.1016/j.bmcl.2013.05.008; Kuromori T, 2010, PLANT SIGNAL BEHAV, V5, P1124, DOI 10.4161/psb.5.9.12566; Landlinger C, 2006, BBA-BIOMEMBRANES, V1758, P1759, DOI 10.1016/j.bbamem.2006.07.018; LEPAGEDEGIVRY MT, 1986, P NATL ACAD SCI USA, V83, P1155; Li HH, 2011, BIOCHEM PHARMACOL, V82, P701, DOI 10.1016/j.bcp.2011.06.042; Liu DS, 1996, BIOCHEMISTRY-US, V35, P15228, DOI 10.1021/bi961443b; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu PY, 2011, J MOL MODEL, V17, P543, DOI 10.1007/s00894-010-0748-y; Magnone M, 2009, J BIOL CHEM, V284, P17808, DOI 10.1074/jbc.M809546200; Mayer H, 1998, BBA-GENE STRUCT EXPR, V1399, P51, DOI 10.1016/S0167-4781(98)00091-8; Mizutani M, 2013, FEBS LETT, V587, P23, DOI 10.1016/j.febslet.2012.11.009; Montalbetti N, 2011, J BIOL CHEM, V286, P38397, DOI 10.1074/jbc.M111.221713; Moriya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078235; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; NIGGLI V, 1982, FEBS LETT, V138, P164, DOI 10.1016/0014-5793(82)80432-8; PEDEMONTE CH, 1988, BIOCHEMISTRY-US, V27, P7966, DOI 10.1021/bi00420a056; POOLE RC, 1991, BIOCHEM J, V275, P307, DOI 10.1042/bj2750307; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; RUETZ S, 1988, P NATL ACAD SCI USA, V85, P6147, DOI 10.1073/pnas.85.16.6147; Scarfi S, 2009, STEM CELLS, V27, P2469, DOI 10.1002/stem.173; Scarfi S, 2008, STEM CELLS, V26, P2855, DOI 10.1634/stemcells.2008-0488; Schubert K, 2011, EUR J IMMUNOL, V41, P645, DOI 10.1002/eji.201041117; Sturla L, 2011, BIOCHEM BIOPH RES CO, V415, P390, DOI 10.1016/j.bbrc.2011.10.079; Sturla L, 2009, J BIOL CHEM, V284, P28045, DOI 10.1074/jbc.M109.035329; WERNER PK, 1985, BIOCHEMISTRY-US, V24, P6375, DOI 10.1021/bi00344a009; Wu Zhong-Yi, 1996, Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai), V28, P694; Xue-Xuan X, 2010, CRIT REV BIOTECHNOL, V30, P222, DOI 10.3109/07388551.2010.487186; Yamazaki D, 2003, PLANT J, V35, P129, DOI 10.1046/j.1365-313X.2003.01782.x; Zhang HW, 2014, MOL PLANT, V7, P1522, DOI 10.1093/mp/ssu063	55	15	16	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13042	13052		10.1074/jbc.M114.629501	http://dx.doi.org/10.1074/jbc.M114.629501			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847240	Green Published, hybrid			2022-12-28	WOS:000354975700009
J	Fu, W; Shi, DY; Westaway, D; Jhamandas, JH				Fu, Wen; Shi, Diya; Westaway, David; Jhamandas, Jack H.			Bioenergetic Mechanisms in Astrocytes May Contribute to Amyloid Plaque Deposition and Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; IN-VITRO; METABOLISM; NEURONS; BRAIN; PROTEIN; GLYCOLYSIS; EXPRESSION; CANCER; ENERGY	Alzheimer disease (AD) is characterized neuropathologically by synaptic disruption, neuronal loss, and deposition of amyloid beta (A beta) protein in brain structures that are critical for memory and cognition. There is increasing appreciation, however, that astrocytes, which are the major non-neuronal glial cells, may play an important role in AD pathogenesis. Unlike neurons, astrocytes are resistant to A beta cytotoxicity, which may, in part, be related to their greater reliance on glycolytic metabolism. Here we show that, in cultures of human fetal astrocytes, pharmacological inhibition or molecular down-regulation of a main enzymatic regulator of glycolysis, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFKFB3), results in increased accumulation of A beta within and around astrocytes and greater vulnerability of these cells to A beta toxicity. We further investigated age-dependent changes in PFKFB3 and astrocytes in AD transgenic mice (TgCRND8) that overexpress human A beta. Using a combination of Western blotting and immunohistochemistry, weidentified an increase in glial fibrillary acidic protein expression in astrocytes that paralleled the escalation of the A beta plaque burden in TgCRND8 mice in an age-dependent manner. Furthermore, PFKFB3 expression also demonstrated an increase in these mice, although at a later age (9 months) than GFAP and A beta. Immunohistochemical staining showed significant reactive astrogliosis surrounding A beta plaques with increased PFKFB3 activity in 12-month-old TgCRND8 mice, an age when AD pathology and behavioral deficits are fully manifested. These studies shed light on the unique bioenergetic mechanisms within astrocytes that may contribute to the development of AD pathology.	[Fu, Wen; Shi, Diya; Westaway, David; Jhamandas, Jack H.] Univ Alberta, Dept Med, Div Neurol, Edmonton, AB T6G 2S2, Canada; [Westaway, David] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Fu, Wen; Shi, Diya; Westaway, David; Jhamandas, Jack H.] Univ Alberta, Inst Neurosci & Mental Hlth, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; University of Alberta	Jhamandas, JH (corresponding author), Univ Alberta, Dept Med Neurol, Heritage Med Res Ctr 530, Edmonton, AB T6G 2S2, Canada.	jack.jhamandas@ualberta.ca			Alberta Bio-Solutions (Alberta Prion Research Institute); Alzheimer's Society of Alberta and Nunavut; University Hospital Foundation (FoMD/UHF medical grants competition)	Alberta Bio-Solutions (Alberta Prion Research Institute); Alzheimer's Society of Alberta and Nunavut; University Hospital Foundation (FoMD/UHF medical grants competition)	This research was supported by grants from Alberta Bio-Solutions (Alberta Prion Research Institute), the Alzheimer's Society of Alberta and Nunavut, and the University Hospital Foundation (FoMD/UHF medical grants competition).	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; Bhat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045069; Bigl M, 1999, J NEURAL TRANSM, V106, P499, DOI 10.1007/s007020050174; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Clem BF, 2013, MOL CANCER THER, V12, P1461, DOI 10.1158/1535-7163.MCT-13-0097; Demetrius LA, 2013, BIOGERONTOLOGY, V14, P641, DOI 10.1007/s10522-013-9479-7; Demetrius LA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0006; Demetrius LA, 2012, BIOGERONTOLOGY, V13, P583, DOI 10.1007/s10522-012-9403-6; Ding F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079977; Ferreira IL, 2010, CURR DRUG TARGETS, V11, P1193; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Fu W, 2013, NEUROSCIENCE, V250, P520, DOI 10.1016/j.neuroscience.2013.07.029; Garwood CJ, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.50; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Heneka MT, 2010, BRAIN RES REV, V63, P189, DOI 10.1016/j.brainresrev.2009.11.004; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Jhamandas JH, 2011, AM J PATHOL, V178, P140, DOI 10.1016/j.ajpath.2010.11.022; Kamphuis W, 2014, NEUROBIOL AGING, V35, P492, DOI 10.1016/j.neurobiolaging.2013.09.035; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Lynch AM, 2010, AGING DIS, V1, P262; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Nagele RG, 2003, BRAIN RES, V971, P197, DOI 10.1016/S0006-8993(03)02361-8; Nielsen HM, 2009, GLIA, V57, P978, DOI 10.1002/glia.20822; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Sotroniew M. V., 2010, ACTA NEUROPATHOL, V119, P7; Swerdlow RH, 2007, NEUROBIOL AGING, V28, P1465, DOI 10.1016/j.neurobiolaging.2006.06.021; Tomi M, 2013, BRAIN RES, V1495, P61, DOI 10.1016/j.brainres.2012.11.050; Verkhratsky A, 2012, ASN NEURO, V4, DOI 10.1042/AN20120010; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Yao J, 2011, MOL ASPECTS MED, V32, P247, DOI 10.1016/j.mam.2011.10.005	41	43	45	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12504	12513		10.1074/jbc.M114.618157	http://dx.doi.org/10.1074/jbc.M114.618157			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25814669	Green Published, hybrid			2022-12-28	WOS:000354569000007
J	Ho, CCM; Guo, N; Sockolosky, JT; Ring, AM; Weiskopf, K; Ozkan, E; Mori, Y; Weissman, IL; Garcia, KC				Ho, Chia Chi M.; Guo, Nan; Sockolosky, Jonathan T.; Ring, Aaron M.; Weiskopf, Kipp; Oezkan, Engin; Mori, Yasuo; Weissman, Irving L.; Garcia, K. Christopher			"Velcro" Engineering of High Affinity CD47 Ectodomain as Signal Regulatory Protein alpha(SIRP alpha) Antagonists That Enhance Antibody-dependent Cellular Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA SIRP-ALPHA; YEAST SURFACE DISPLAY; CELLS; MACROPHAGES; TRANSPORT; BINDING; 5-OXOPROLINE; SPECIFICITY; ENGRAFTMENT; EXPRESSION	CD47 is a cell surface protein that transmits an anti-phagocytic signal, known as the "don't-eat-me" signal, to macrophages upon engaging its receptor signal regulatory protein alpha (SIRP alpha). Molecules that antagonize the CD47-SIRP alpha interaction by binding to CD47, such as anti-CD47 antibodies and the engineered SIRP alpha variant CV1, have been shown to facilitate macrophage-mediated anti-tumor responses. However, these strategies targeting CD47 are handicapped by large antigen sinks in vivo and indiscriminate cell binding due to ubiquitous expression of CD47. These factors reduce bioavailability and increase the risk of toxicity. Here, we present an alternative strategy to antagonize the CD47-SIRP alpha pathway by engineering high affinity CD47 variants that target SIRP alpha, which has restricted tissue expression. CD47 proved to be refractive to conventional affinity maturation techniques targeting its binding interface with SIRP alpha. Therefore, we developed a novel engineering approach, whereby we augmented the existing contact interface via N-terminal peptide extension, coined "Velcro" engineering. The high affinity variant (Velcro-CD47) bound to the two most prominent human SIRP alpha alleles with greatly increased affinity relative to wild-type CD47 and potently antagonized CD47 binding to SIRP alpha on human macrophages. Velcro-CD47 synergizes with tumor-specific monoclonal antibodies to enhance macrophage phagocytosis of tumor cells in vitro, with similar potency as CV1. Finally, Velcro-CD47 interacts specifically with a subset of myeloid-derived cells in human blood, whereas CV1 binds all myeloid, lymphoid, and erythroid populations interrogated. This is consistent with the restricted expression of SIRP alpha compared with CD47. Herein, we have demonstrated that "Velcro" engineering is a powerful protein-engineering tool with potential applications to other systems and that Velcro-CD47 could be an alternative adjuvant to CD47-targeting agents for cancer immunotherapy.	[Ho, Chia Chi M.] Stanford Univ, Sch Engn, Dept Bioengn, Stanford, CA 94305 USA; [Ho, Chia Chi M.; Sockolosky, Jonathan T.; Ring, Aaron M.; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Ho, Chia Chi M.; Guo, Nan; Weiskopf, Kipp; Mori, Yasuo; Weissman, Irving L.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Ho, Chia Chi M.; Sockolosky, Jonathan T.; Ring, Aaron M.; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Ho, Chia Chi M.; Guo, Nan; Weiskopf, Kipp; Mori, Yasuo; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Sch Med, Ludwig Ctr Canc Stem Cell Res & Med, Stanford, CA 94305 USA; [Mori, Yasuo; Weissman, Irving L.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Beckman B171B,279 Campus Dr, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Regan, Clinton/E-6250-2012	Ring, Aaron/0000-0003-3699-2446; Ozkan, Engin/0000-0002-0263-6729	National Institutes of Health [R01CA177684]; Siebel Stem Cell Institute; Stanford Molecular and Cellular Immunobiology National Institutes of Health Training Grant [5T32 AI072905]; Virginia and D. K. Ludwig Fund for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA177684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290, R43AI072905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siebel Stem Cell Institute; Stanford Molecular and Cellular Immunobiology National Institutes of Health Training Grant; Virginia and D. K. Ludwig Fund for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA177684 (to K. C. G.). This work was also supported by Siebel Stem Cell Institute (to C. H.), by Stanford Molecular and Cellular Immunobiology National Institutes of Health Training Grant 5T32 AI072905 (to J. T. S.), and by the Virginia and D. K. Ludwig Fund for Cancer Research (to I. L. W.).	Adams S, 1998, J IMMUNOL, V161, P1853; Baba N, 2013, J EXP MED, V210, P1251, DOI 10.1084/jem.20122037; Bain CC, 2011, EUR J IMMUNOL, V41, P2494, DOI 10.1002/eji.201141714; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Bhargava P, 2012, BIOCHEM J, V442, P253, DOI 10.1042/BJ20111708; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Boder ET, 1998, BIOTECHNOL PROGR, V14, P55, DOI 10.1021/bp970144q; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Caoili Salvador Eugenio C., 2012, Advances in Bioinformatics, V2012, P346765, DOI 10.1155/2012/346765; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Chao MP, 2011, BLOOD, V118, P4890, DOI 10.1182/blood-2011-02-338020; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Chen JM, 2013, PROTEIN SCI, V22, P510, DOI 10.1002/pro.2230; Desai N, 2012, AAPS J, V14, P282, DOI 10.1208/s12248-012-9339-4; Edris B, 2012, P NATL ACAD SCI USA, V109, P6656, DOI 10.1073/pnas.1121629109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foote J, 2000, P NATL ACAD SCI USA, V97, P10679, DOI 10.1073/pnas.97.20.10679; GANAPATHY V, 1983, J BIOL CHEM, V258, P2266; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hatherley D, 2014, J BIOL CHEM, V289, P10024, DOI 10.1074/jbc.M114.550558; Houot R, 2011, TRENDS IMMUNOL, V32, P510, DOI 10.1016/j.it.2011.07.003; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Junttila IS, 2012, NAT CHEM BIOL, V8, P990, DOI [10.1038/NCHEMBIO.1096, 10.1038/nchembio.1096]; Lamminmaki U, 1999, J MOL BIOL, V291, P589, DOI 10.1006/jmbi.1999.2981; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Liu Y, 2007, J MOL BIOL, V365, P680, DOI 10.1016/j.jmb.2006.09.079; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MAACK T, 1979, KIDNEY INT, V16, P251, DOI 10.1038/ki.1979.128; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Miyauchi S, 2010, BBA-BIOMEMBRANES, V1798, P1164, DOI 10.1016/j.bbamem.2010.03.002; Momtaz P, 2014, PHARMACOGEN PERS MED, V7, P357, DOI 10.2147/PGPM.S53163; Mori Y, 2009, J EXP MED, V206, P183, DOI 10.1084/jem.20081756; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Peggs KS, 2006, CURR OPIN IMMUNOL, V18, P206, DOI 10.1016/j.coi.2006.01.011; Pepper LR, 2008, COMB CHEM HIGH T SCR, V11, P127; Poulsen TR, 2011, J IMMUNOL, V187, P4229, DOI 10.4049/jimmunol.1000928; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Shin DS, 2015, CURR OPIN IMMUNOL, V33, P23, DOI 10.1016/j.coi.2015.01.006; Strowig T, 2011, P NATL ACAD SCI USA, V108, P13218, DOI 10.1073/pnas.1109769108; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; Wang H, 2007, BLOOD, V109, P836, DOI 10.1182/blood-2006-04-019794; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Weissleder R, 2014, NAT MATER, V13, P125, DOI [10.1038/nmat3780, 10.1038/NMAT3780]; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108	59	62	78	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12650	12663		10.1074/jbc.M115.648220	http://dx.doi.org/10.1074/jbc.M115.648220			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25837251	hybrid, Green Published			2022-12-28	WOS:000354569000019
J	Leslie, PL; Ke, HM; Zhang, YP				Leslie, Patrick L.; Ke, Hengming; Zhang, Yanping			The MDM2 RING Domain and Central Acidic Domain Play Distinct Roles in MDM2 Protein Homodimerization and MDM2-MDMX Protein Heterodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE ACTIVITY; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; P53 ACTIVITY; DNA-DAMAGE; E3; DEGRADATION; STABILITY; PROMOTES; RESCUE	The oncoprotein murine double minute 2 (MDM2) is an E3 ligase that plays a prominent role in p53 suppression by promoting its polyubiquitination and proteasomal degradation. In its active form, MDM2 forms homodimers as well as heterodimers with the homologous protein murine double minute 4 (MDMX), both of which are thought to occur through their respective C-terminal RING (really interesting new gene) domains. In this study, using multiple MDM2 mutants, we show evidence suggesting that MDM2 homo-and heterodimerization occur through distinct mechanisms because MDM2 RING domain mutations that inhibit MDM2 interaction with MDMX do not affect MDM2 interaction with WT MDM2. Intriguingly, deletion of a portion of the MDM2 central acidic domain selectively inhibits interaction with MDM2 while leaving intact the ability of MDM2 to interact with MDMX and to ubiquitinate p53. Further analysis of an MDM2 C-terminal deletion mutant reveals that the C-terminal residues of MDM2 are required for both MDM2 and MDMX interaction. Collectively, our results suggest a model in which MDM2-MDMX heterodimerization requires the extreme C terminus and proper RING domain structure of MDM2, whereas MDM2 homodimerization requires the extreme C terminus and the central acidic domain of MDM2, suggesting that MDM2 homo- and heterodimers utilize distinct MDM2 domains. Our study is the first to report mutations capable of separating MDM2 homo-and heterodimerization.	[Leslie, Patrick L.; Zhang, Yanping] Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27514 USA; [Leslie, Patrick L.] Univ N Carolina, Sch Med, Curriculum Genet & Mol Biol, Chapel Hill, NC 27514 USA; [Zhang, Yanping] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27514 USA; [Ke, Hengming] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA; [Leslie, Patrick L.; Zhang, Yanping] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Zhang, Yanping] Xuzhou Med Coll, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Inst Canc, Xuzhou 221002, Jiangsu, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Xuzhou Medical University	Zhang, YP (corresponding author), Univ N Carolina, Dept Pharmacol, Dept Radiat Oncol, 450 West Dr, Chapel Hill, NC 27599 USA.	ypzhang@med.unc.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [CA127770, CA167637]; American Cancer Society; University of North Carolina Genetics and Molecular Biology Training Grant [5T32 GM007092]; NSFC; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy; NATIONAL CANCER INSTITUTE [R01CA127770, R01CA100302, R01CA155235, R01CA167637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); University of North Carolina Genetics and Molecular Biology Training Grant; NSFC(National Natural Science Foundation of China (NSFC)); Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported, in whole or in part, by National Institutes of Health Grants CA127770 and CA167637 (to Y. Z.). This work was also supported by a grant from the American Cancer Society (to Y. Z.), a fellowship from the University of North Carolina Genetics and Molecular Biology Training Grant 5T32 GM007092 (to P. L.), and grants from the NSFC and Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy (to Y. Z.).	Argentini M, 2001, ONCOGENE, V20, P1267, DOI 10.1038/sj.onc.1204241; Cheng Q, 2011, MOL CELL BIOL, V31, P4951, DOI 10.1128/MCB.05553-11; Cheng Q, 2009, EMBO J, V28, P3857, DOI 10.1038/emboj.2009.294; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dang JJ, 2002, CANCER RES, V62, P1222; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Dolezelova P, 2012, CELL CYCLE, V11, P953, DOI 10.4161/cc.11.5.19445; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Ito M, 2011, CLIN CANCER RES, V17, P416, DOI 10.1158/1078-0432.CCR-10-2050; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kostic M, 2006, J MOL BIOL, V363, P433, DOI 10.1016/j.jmb.2006.08.027; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kulikov R, 2010, P NATL ACAD SCI USA, V107, P10038, DOI 10.1073/pnas.0911716107; Lam S, 2010, ONCOGENE, V29, P2415, DOI 10.1038/onc.2009.522; Li X, 2012, ONCOGENE, V31, P3721, DOI 10.1038/onc.2011.534; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; LUNA RMD, 1995, NATURE, V378, P203; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Pant V, 2011, P NATL ACAD SCI USA, V108, P11995, DOI 10.1073/pnas.1102241108; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Zhu QZ, 2001, J BIOL CHEM, V276, P29695, DOI 10.1074/jbc.M102634200	36	33	37	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12941	12950		10.1074/jbc.M115.644435	http://dx.doi.org/10.1074/jbc.M115.644435			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25809483	hybrid, Green Published			2022-12-28	WOS:000354569000043
J	Shivanna, S; Harrold, I; Shashar, M; Meyer, R; Kiang, C; Francis, J; Zhao, Q; Feng, H; Edelman, ER; Rahimi, N; Chitalia, VC				Shivanna, Sowmya; Harrold, Itrat; Shashar, Moshe; Meyer, Rosanna; Kiang, Chrystelle; Francis, Jean; Zhao, Qing; Feng, Hui; Edelman, Elazer R.; Rahimi, Nader; Chitalia, Vipul C.			The c-Cbl Ubiquitin Ligase Regulates Nuclear beta-Catenin and Angiogenesis by Its Tyrosine Phosphorylation Mediated through the Wnt Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; INHIBITS ANGIOGENESIS; TUMOR-GROWTH; ACTIVATION; PLC-GAMMA-1; STABILITY; TARGETS; ROLES	Wnt signaling plays important roles in both the tumor-induced angiogenesis and tumorigenesis through the transcriptionally active nuclear beta-catenin. Recently, c-Cbl was identified as a unique E3 ubiquitin ligase targeting the active nuclear beta-catenin. However, little is known about the molecular mechanisms by which c-Cbl regulates ubiquitination and degradation of active beta-catenin. Here, we demonstrate that Wnt activation promotes the phosphorylation of c-Cbl at tyrosine 731(Tyr-731), which increases c-Cbl dimerization and binding to beta-catenin. Tyr-731 phosphorylation and dimerization mediate c-Cbl nuclear translocation and lead to the degradation of nuclearly active beta-catenin in the Wnt-on phase. c-Cbl activation also inhibits expression of the pro-angiogenic Wnt targets, IL-8 and VEGF. Phospho-Tyr-731-inactive mutant c-Cbl (Y731F) enhances and phosphomimetic mutant c-Cbl (Y731E) suppresses angiogenesis in zebrafish. Taken together, we have identified a novel mechanism for the regulation of active nuclear beta-catenin by c-Cbl and its critical role in angiogenesis. This mechanism can be further explored to modulate both the pathological angiogenesis and the tumorigenesis.	[Shivanna, Sowmya; Shashar, Moshe; Francis, Jean; Chitalia, Vipul C.] Boston Univ, Sch Med, Dept Med, Renal Sect, Boston, MA 02118 USA; [Harrold, Itrat; Feng, Hui] Boston Univ, Sch Med, Dept Pharmacol, Sect Hematol & Med Oncol, Boston, MA 02118 USA; [Harrold, Itrat; Feng, Hui] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Meyer, Rosanna; Zhao, Qing; Rahimi, Nader] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Kiang, Chrystelle; Edelman, Elazer R.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Edelman, Elazer R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div,Dept Med, Boston, MA 02115 USA	Boston University; Boston University; Boston University; Boston University; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Chitalia, VC (corresponding author), Boston Univ, Med Ctr, Evans Biomed Res Ctr, Renal Sect,Dept Med, X-530, Boston, MA 02118 USA.	vichital@bu.edu	Feng, Hui/L-4343-2019; Francis, Jean M/O-9968-2017; Feng, Hui/D-4423-2019	Feng, Hui/0000-0003-1318-821X; shashar, moshe/0000-0002-9744-856X; Rahimi, Nader/0000-0002-6745-1725	National Institutes of Health from NCI [RO1 CA175382]; NHLBI [R01 GM49039, CA191970, R01EY017955, T32 HL007501]; American Cancer Society [IRG-72-001-36]; Sharon Anderson American Society of Nephrology Fellowship Award;  [R00CA134743]; NATIONAL CANCER INSTITUTE [R00CA134743, R21CA191970, R01CA175382] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017955] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049039] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Cancer Society(American Cancer Society); Sharon Anderson American Society of Nephrology Fellowship Award; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA175382 from NCI (to V. C. C.), Grant R01 GM49039 (to E. R. E.), Grants CA191970 and R01EY017955 (to N. R.), Grant T32 HL007501 from NHLBI (to I. H.), and Grant R00CA134743 (to H. F.). This work was also supported by American Cancer Society Grant IRG-72-001-36 (to H. F.) and the Sharon Anderson American Society of Nephrology Fellowship Award (to M. S.).	Bartkiewicz M, 1999, J BIOL CHEM, V274, P30887, DOI 10.1074/jbc.274.43.30887; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Chitalia V, 2013, J BIOL CHEM, V288, P23505, DOI 10.1074/jbc.M113.473801; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Harisis GN, 2013, J PEDIATR SURG, V48, P1573, DOI 10.1016/j.jpedsurg.2012.08.038; Hartsough EJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004289; Hu J, 2009, CANCER RES, V69, P6951, DOI 10.1158/0008-5472.CAN-09-0541; Husain D, 2010, INVEST OPHTH VIS SCI, V51, P6803, DOI 10.1167/iovs.10-5255; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Liu J, 2002, MOL CELL BIOL, V22, P3599, DOI 10.1128/MCB.22.11.3599-3609.2002; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; Luscan A, 2014, CLIN CANCER RES, V20, P358, DOI 10.1158/1078-0432.CCR-13-0780; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Meyer RD, 2011, ONCOGENE, V30, P2198, DOI 10.1038/onc.2010.597; Meyer RD, 2011, MOL CELL BIOL, V31, P2010, DOI 10.1128/MCB.01006-10; Nicoli S, 2007, NAT PROTOC, V2, P2918, DOI 10.1038/nprot.2007.412; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Parmalee NL, 2008, CURR DRUG TARGETS, V9, P558, DOI 10.2174/138945008784911822; Planutis K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05630; Rahimi N, 2009, BIOCHEM SOC T, V37, P1189, DOI 10.1042/BST0371189; Ramachandran I, 2012, ONCOGENE, V31, P2725, DOI 10.1038/onc.2011.455; Reis M, 2013, EXP CELL RES, V319, P1317, DOI 10.1016/j.yexcr.2012.12.023; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Singh AJ, 2007, P NATL ACAD SCI USA, V104, P5413, DOI 10.1073/pnas.0700809104; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zhang M, 2012, DEVELOPMENT, V139, P2009, DOI 10.1242/dev.074435	30	29	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12537	12546		10.1074/jbc.M114.616623	http://dx.doi.org/10.1074/jbc.M114.616623			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25784557	Green Published, hybrid			2022-12-28	WOS:000354569000010
J	Yang, XM; Li, HY; Lai, TP; Sun, HZ				Yang, Xinming; Li, Hongyan; Lai, Tsz-Pui; Sun, Hongzhe			UreE-UreG Complex Facilitates Nickel Transfer and Preactivates GTPase of UreG in Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UREASE ACCESSORY PROTEIN; HISTIDINE-RICH PROTEIN; METAL-BINDING SITES; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; BACILLUS-PASTEURII; FACTOR-HYPB; HPN-LIKE; HYDROGENASE; MATURATION	The pathogenicity of Helicobacter pylori relies heavily on urease, which converts urea to ammonia to neutralize the stomach acid. Incorporation of Ni2+ into the active site of urease requires a battery of chaperones. Both metallochaperones UreE and UreG play important roles in the urease activation. In this study, we demonstrate that, in the presence of GTP and Mg2+, UreG binds Ni2+ with an affinity (K-d) of similar to 0.36 mu M. The GTPase activity of Ni2+-UreG is stimulated by both K+ (or NH4+) and HCO3- to a biologically relevant level, suggesting that K+/NH4+ and HCO3- might serve as GTPase elements of UreG. We show that complexation of UreE and UreG results in two protein complexes, i.e. 2E-2G and 2E-G, with the former being formed only in the presence of both GTP and Mg2+. Mutagenesis studies reveal that Arg-101 on UreE and Cys-66 on UreG are critical for stabilization of 2E-2G complex. Combined biophysical and bio-assay studies show that the formation of 2E-2G complex not only facilitates nickel transfer from UreE to UreG, but also enhances the binding of GTP. This suggests that UreE might also serve as a structural scaffold for recruitment of GTP to UreG. Importantly, we demonstrate for the first time that UreE serves as a bridge to grasp Ni2+ from HypA, subsequently donating it to UreG. The study expands our horizons on the molecular details of nickel translocation among metallochaperones UreE, UreG, and HypA, which further extends our knowledge on the urease maturation process.	[Yang, Xinming; Li, Hongyan; Lai, Tsz-Pui; Sun, Hongzhe] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Sun, HZ (corresponding author), Univ Hong Kong, Dept Chem, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	hsun@hku.hk	/D-3123-2009	/0000-0001-6697-6899; YANG, Xinming/0000-0001-6240-5212	Research Grants of Council of Hong Kong [704909, N_HKU75209, 704612, 703913, HKU6/11G]; University of Hong Kong	Research Grants of Council of Hong Kong; University of Hong Kong(University of Hong Kong)	This work was supported by the Research Grants of Council of Hong Kong (Grants 704909, N_HKU75209, 704612, 703913, and HKU6/11G) and the University of Hong Kong (for an emerging Strategic Research Theme on Integrative Biology).	Banaszak K, 2012, BIOCHEM J, V441, P1017, DOI 10.1042/BJ20111659; Bellucci M, 2009, BIOCHEM J, V422, P91, DOI 10.1042/BJ20090434; Benoit SL, 2007, MICROBIOL-SGM, V153, P3748, DOI 10.1099/mic.0.2007/010520-0; Benoit SL, 2012, BBA-GEN SUBJECTS, V1820, P1519, DOI 10.1016/j.bbagen.2012.06.002; Boer JL, 2012, BIOCHEMISTRY-US, V51, P2298, DOI 10.1021/bi3000897; Boer JL, 2010, BIOCHEMISTRY-US, V49, P5859, DOI 10.1021/bi1004987; Carter EL, 2009, METALLOMICS, V1, P207, DOI 10.1039/b903311d; Casalot L, 2001, TRENDS MICROBIOL, V9, P228, DOI 10.1016/S0966-842X(01)02009-1; Chan KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032592; Cheng TF, 2013, METALLOMICS, V5, P804, DOI 10.1039/c3mt00014a; Cheng TF, 2012, J BIOL INORG CHEM, V17, P331, DOI 10.1007/s00775-011-0855-y; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Cun SJ, 2008, J BIOL CHEM, V283, P15142, DOI 10.1074/jbc.M800591200; Cun SJ, 2010, P NATL ACAD SCI USA, V107, P4943, DOI 10.1073/pnas.0913970107; Douglas CD, 2013, BIOCHEMISTRY-US, V52, P6030, DOI 10.1021/bi400812r; EVANS DJ, 1991, MICROB PATHOGENESIS, V10, P15, DOI 10.1016/0882-4010(91)90062-F; Fong YH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001678; Garner JA, 1996, INFECT IMMUN, V64, P4197, DOI 10.1128/IAI.64.10.4197-4203.1996; Ge RG, 2006, BIOCHEM J, V393, P285, DOI 10.1042/BJ20051160; Ge RG, 2006, J AM CHEM SOC, V128, P11330, DOI 10.1021/ja062589t; Kaluarachchi H, 2012, J MOL BIOL, V417, P28, DOI 10.1016/j.jmb.2012.01.037; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leach MR, 2007, J BIOL CHEM, V282, P16177, DOI 10.1074/jbc.M610834200; Leach MR, 2007, CURR OPIN CHEM BIOL, V11, P159, DOI 10.1016/j.cbpa.2007.01.011; Li YJ, 2009, CHEM REV, V109, P4617, DOI 10.1021/cr900010n; Maier RJ, 1996, FEMS MICROBIOL LETT, V141, P71; Martin-Diaconescu V, 2012, J BIOL INORG CHEM, V17, P353, DOI 10.1007/s00775-011-0857-9; Mehta N, 2003, J BACTERIOL, V185, P726, DOI 10.1128/JB.185.3.726-734.2003; Mehta N, 2003, MICROB PATHOGENESIS, V35, P229, DOI 10.1016/S0882-4010(03)00151-7; Moncrief MBC, 1997, J BACTERIOL, V179, P4081, DOI 10.1128/jb.179.13.4081-4086.1997; Olson JW, 2001, MOL MICROBIOL, V39, P176, DOI 10.1046/j.1365-2958.2001.02244.x; Park IS, 1996, BIOCHEMISTRY-US, V35, P5345, DOI 10.1021/bi952894j; PARK IS, 1995, J BACTERIOL, V177, P1947, DOI 10.1128/jb.177.8.1947-1951.1995; Real-Guerra R, 2012, PLANT MOL BIOL, V78, P461, DOI 10.1007/s11103-012-9878-1; Remaut H, 2001, J BIOL CHEM, V276, P49365, DOI 10.1074/jbc.M108304200; RYAN DK, 1982, ANAL CHEM, V54, P986, DOI 10.1021/ac00243a033; Shi R, 2010, BIOCHEMISTRY-US, V49, P7080, DOI 10.1021/bi100372h; Song HK, 2001, J BIOL CHEM, V276, P49359, DOI 10.1074/jbc.M108619200; Soriano A, 1999, P NATL ACAD SCI USA, V96, P11140, DOI 10.1073/pnas.96.20.11140; Stola M, 2006, BIOCHEMISTRY-US, V45, P6495, DOI 10.1021/bi0601003; Sydor AM, 2014, J BIOL CHEM, V289, P3828, DOI 10.1074/jbc.M113.502781; Sydor AM, 2013, METAL IONS LIFE SCI, V12, P375, DOI 10.1007/978-94-007-5561-1_11; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; WARREN JR, 1983, LANCET, V1, P1273; Watanabe S, 2009, J MOL BIOL, V394, P448, DOI 10.1016/j.jmb.2009.09.030; Xia W, 2012, J BIOL CHEM, V287, P6753, DOI 10.1074/jbc.M111.287581; Xia W, 2009, J AM CHEM SOC, V131, P10031, DOI 10.1021/ja900543y; Yang XM, 2014, METALLOMICS, V6, P1731, DOI 10.1039/c4mt00134f; Zambelli B, 2005, J BIOL CHEM, V280, P4684, DOI 10.1074/jbc.M408483200; Zambelli B, 2009, PROTEINS, V74, P222, DOI 10.1002/prot.22205; Zambelli B, 2007, BIOCHEMISTRY-US, V46, P3171, DOI 10.1021/bi6024676; Zambelli B, 2014, J BIOL INORG CHEM, V19, P319, DOI 10.1007/s00775-013-1068-3; Zambelli B, 2011, ACCOUNTS CHEM RES, V44, P520, DOI 10.1021/ar200041k; Zeng YB, 2008, J BIOL INORG CHEM, V13, P1121, DOI 10.1007/s00775-008-0397-0; Zeng YB, 2011, CHEM-EUR J, V17, P5852, DOI 10.1002/chem.201100279	55	43	44	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12474	12485		10.1074/jbc.M114.632364	http://dx.doi.org/10.1074/jbc.M114.632364			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25752610	Green Published, hybrid			2022-12-28	WOS:000354569000004
J	Steblyanko, M; Anikeeva, N; Campbell, KS; Keen, JH; Sykulev, Y				Steblyanko, Maria; Anikeeva, Nadia; Campbell, Kerry S.; Keen, James H.; Sykulev, Yuri			Integrins Influence the Size and Dynamics of Signaling Microclusters in a Pyk2-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellular immune response; immunology; lymphocyte; natural killer cells (NK cells); signaling; ADCC; Cytotoxic lymphocytes; Integrin receptors; signaling microclusters; killing kinetics	T-CELL-RECEPTOR; IMMUNOLOGICAL SYNAPSE; CYTOLYTIC ACTIVITY; TYROSINE KINASE; RING JUNCTION; ADHESION; ACTIVATION; LYMPHOCYTES; MOLECULES; BINDING	Background: The mechanism by which integrin signaling regulates lymphocyte cytolytic activity is poorly understood. Results: The extent of integrin ligation influences the size and dynamics of signaling microclusters. Conclusion: Integrins regulate the magnitude and duration of proximal signaling that affect lymphocyte degranulation kinetics and the rate of target cell lysis. Significance: Integrin engagement ensures more rapid cytolytic granule release and faster target cell destruction. Integrin engagement on lymphocytes initiates outside-in signaling that is required for cytoskeleton remodeling and the formation of the synaptic interface. However, the mechanism by which the outside-in signal contributes to receptor-mediated intracellular signaling that regulates the kinetics of granule delivery and efficiency of cytolytic activity is not well understood. We have found that variations in ICAM-1 expression on tumor cells influence killing kinetics of these cells by CD16.NK-92 cytolytic effectors suggesting that changes in integrin ligation on the effector cells regulate the kinetics of cytolytic activity by the effector cells. To understand how variations of the integrin receptor ligation may alter cytolytic activity of CD16.NK-92 cells, we analyzed molecular events at the contact area of these cells exposed to planar lipid bilayers that display integrin ligands at different densities and activating CD16-specific antibodies. Changes in the extent of integrin ligation on CD16.NK-92 cells at the cell/bilayer interface revealed that the integrin signal influences the size and the dynamics of activating receptor microclusters in a Pyk2-dependent manner. Integrin-mediated changes of the intracellular signaling significantly affected the kinetics of degranulation of CD16.NK-92 cells providing evidence that integrins regulate the rate of target cell destruction in antibody-dependent cell cytotoxicity (ADCC).	[Steblyanko, Maria; Anikeeva, Nadia; Sykulev, Yuri] Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Keen, James H.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Campbell, Kerry S.] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Jefferson University; Jefferson University; Fox Chase Cancer Center	Sykulev, Y (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Ctr, 233S 10th St,BLSB 706, Philadelphia, PA 19107 USA.	Yuri.Sykulev@Jefferson.edu	Regan, Clinton/E-6250-2012; Campbell, Kerry S./T-1381-2019		National Institutes of Health [AI52812, CA131973, CA083859, GM49217]; NATIONAL CANCER INSTITUTE [P30CA056036, R01CA083859, R21CA131973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052812, R56AI052812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants to Y.S. (AI52812; CA131973), to K.S.C. (CA083859), and to J.H.K. (GM49217). CD16.NK-92 cells are protected by patents or pending patents by K.S.C. and licensed through Conkwest, Inc.	Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; Anikeeva N, 2006, P NATL ACAD SCI USA, V103, P16846, DOI 10.1073/pnas.0607771103; Anikeeva N, 2014, EUR J IMMUNOL, V44, P2331, DOI 10.1002/eji.201344179; Anikeeva N, 2011, IMMUNOL RES, V51, P183, DOI 10.1007/s12026-011-8252-8; Baker RG, 2009, MOL CELL BIOL, V29, P5578, DOI 10.1128/MCB.00283-09; Beal AM, 2008, J IMMUNOL, V181, P4815, DOI 10.4049/jimmunol.181.7.4815; Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Cho DH, 2000, CELL IMMUNOL, V199, P1, DOI 10.1006/cimm.1999.1592; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Dagnino L, 2011, J CELL COMMUN SIGNAL, V5, P81, DOI 10.1007/s12079-011-0124-4; DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D; Dustin ML, 2010, IMMUNOL REV, V235, P24, DOI 10.1111/j.0105-2896.2010.00904.x; Frieser M, 1996, EUR J IMMUNOL, V26, P3127, DOI 10.1002/eji.1830261245; Gustafson KS, 1996, J BIOL CHEM, V271, P20035, DOI 10.1074/jbc.271.33.20035; Han S, 2009, J BIOL CHEM, V284, P13193, DOI 10.1074/jbc.M809038200; Hiregowdara D, 1997, J BIOL CHEM, V272, P10804; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Huang CC, 2000, J BIOL CHEM, V275, P21514, DOI 10.1074/jbc.M002286200; Jenkins MR, 2014, ELIFE, V3, DOI 10.7554/eLife.01310; Kahn ML, 2006, NAT IMMUNOL, V7, P1286, DOI 10.1038/ni1206-1286; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; March ME, 2011, J IMMUNOL, V186, P2998, DOI 10.4049/jimmunol.1002438; Miah SMS, 2010, METHODS MOL BIOL, V612, P199, DOI 10.1007/978-1-60761-362-6_13; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Poenie M., 2012, ROLE MTOC T CELL EFF; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; Segura JM, 2008, J BIOL CHEM, V283, P24254, DOI 10.1074/jbc.M803549200; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Somersalo K, 2004, J CLIN INVEST, V113, P49, DOI 10.1172/JCI200419337; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Sykulev Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3153pe50; Thauland TJ, 2010, IMMUNOLOGY, V131, P466, DOI 10.1111/j.1365-2567.2010.03366.x; Treanor B, 2009, BIOCHEM SOC T, V37, P1014, DOI 10.1042/BST0371014; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vorup-Jensen T, 2005, P NATL ACAD SCI USA, V102, P1614, DOI 10.1073/pnas.0409057102; Wu CY, 2005, TRENDS CELL BIOL, V15, P460, DOI 10.1016/j.tcb.2005.07.002; Yakubenko VP, 2002, J BIOL CHEM, V277, P48635, DOI 10.1074/jbc.M208877200; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yu Y, 2013, J CELL SCI, V126, P1049, DOI 10.1242/jcs.098210; Zhang MG, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005629	51	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11833	11842		10.1074/jbc.M114.614719	http://dx.doi.org/10.1074/jbc.M114.614719			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25778396	hybrid, Green Published			2022-12-28	WOS:000354388600003
J	Petherick, KJ; Conway, OJL; Mpamhanga, C; Osborne, SA; Kamal, A; Saxty, B; Ganley, IG				Petherick, Katy J.; Conway, Owen J. L.; Mpamhanga, Chido; Osborne, Simon A.; Kamal, Ahmad; Saxty, Barbara; Ganley, Ian G.			Pharmacological Inhibition of ULK1 Kinase Blocks Mammalian Target of Rapamycin (mTOR)-dependent Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADVANCED SOLID TUMORS; PHASE-I TRIAL; PROTEIN-KINASE; CROSS-TALK; COMPLEX; HYDROXYCHLOROQUINE; PHOSPHORYLATION; VPS34; AMPK; MTOR	Autophagy is a cell-protective and degradative process that recycles damaged and long-lived cellular components. Cancer cells are thought to take advantage of autophagy to help them to cope with the stress of tumorigenesis; thus targeting autophagy is an attractive therapeutic approach. However, there are currently no specific inhibitors of autophagy. ULK1, a serine/threonine protein kinase, is essential for the initial stages of autophagy, and here we report that two compounds, MRT67307 and MRT68921, potently inhibit ULK1 and ULK2 in vitro and block autophagy in cells. Using a drug-resistant ULK1 mutant, we show that the autophagy-inhibiting capacity of the compounds is specifically through ULK1. ULK1 inhibition results in accumulation of stalled early autophagosomal structures, indicating a role for ULK1 in the maturation of autophagosomes as well as initiation.	[Petherick, Katy J.; Conway, Owen J. L.; Ganley, Ian G.] Univ Dundee, MRC, Prot Phosphorylat & Ubiquitylat Unit, Coll Life Sci, Dundee DD1 5EH, Scotland; [Mpamhanga, Chido; Osborne, Simon A.; Kamal, Ahmad; Saxty, Barbara] MRC, Technol Ctr Therapeut Discovery, London NW7 1AD, England	University of Dundee	Ganley, IG (corresponding author), Univ Dundee, MRC, Prot Phosphorylat & Ubiquitylat Unit, Coll Life Sci, Dundee DD1 5EH, Scotland.	i.ganley@dundee.ac.uk		Ganley, Ian/0000-0003-1481-9407; Conway, Owen/0000-0002-0640-1038	Medical Research Council; Division of Signal Transduction Therapy Unit; AstraZeneca; Boehringer-Ingelheim; GlaxoSmithKline; Merck KGaA; Janssen Pharmaceutica; Pfizer; Medical Research Council [MC_UP_A500_1019, MC_UU_12016/4] Funding Source: Medline; MRC [MC_UU_12016/4] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Division of Signal Transduction Therapy Unit; AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck KGaA; Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council and by the Division of Signal Transduction Therapy Unit (including AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck KGaA, Janssen Pharmaceutica, and Pfizer).	Bago R, 2014, BIOCHEM J, V463, P413, DOI 10.1042/BJ20140889; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barnard RA, 2014, AUTOPHAGY, V10, P1415, DOI 10.4161/auto.29165; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Dowdle WE, 2014, NAT CELL BIOL, V16, P1069, DOI 10.1038/ncb3053; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Karanasios E, 2013, J CELL SCI, V126, P5224, DOI 10.1242/jcs.132415; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Mack HID, 2012, AUTOPHAGY, V8, P1197, DOI 10.4161/auto.20586; Mahalingam D, 2014, AUTOPHAGY, V10, P1403, DOI 10.4161/auto.29231; McIver EG, 2012, BIOORG MED CHEM LETT, V22, P7169, DOI 10.1016/j.bmcl.2012.09.063; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Newman AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050672; Poklepovic A, 2014, AUTOPHAGY, V10, P1478, DOI 10.4161/auto.29428; Rangwala R, 2014, AUTOPHAGY, V10, P1391, DOI 10.4161/auto.29119; Rangwala R, 2014, AUTOPHAGY, V10, P1369, DOI 10.4161/auto.29118; Ronan B, 2014, NAT CHEM BIOL, V10, P1013, DOI 10.1038/nchembio.1681; Rosenfeld MR, 2014, AUTOPHAGY, V10, P1359, DOI 10.4161/auto.28984; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Slobodkin MR, 2013, ESSAYS BIOCHEM, V55, P51, DOI [10.1042/bse0550051, 10.1042/BSE0550051]; Thorburn A, 2014, MOL PHARMACOL, V85, P830, DOI 10.1124/mol.114.091850; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Vogl DT, 2014, AUTOPHAGY, V10, P1380, DOI 10.4161/auto.29264; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323	47	207	217	4	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11376	11383		10.1074/jbc.C114.627778	http://dx.doi.org/10.1074/jbc.C114.627778			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25833948	Green Published, hybrid			2022-12-28	WOS:000353719400014
J	Harrington, CR; Storey, JMD; Clunas, S; Harrington, KA; Horsley, D; Ishaq, A; Kemp, SJ; Larch, CP; Marshall, C; Nicoll, SL; Rickard, JE; Simpson, M; Sinclair, JP; Storey, LJ; Wischik, CM				Harrington, Charles R.; Storey, John M. D.; Clunas, Scott; Harrington, Kathleen A.; Horsley, David; Ishaq, Ahtsham; Kemp, Steven J.; Larch, Christopher P.; Marshall, Colin; Nicoll, Sarah L.; Rickard, Janet E.; Simpson, Michael; Sinclair, James P.; Storey, Lynda J.; Wischik, Claude M.			Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; TRUNCATED TAU; NEUROFIBRILLARY DEGENERATION; ENDOPLASMIC-RETICULUM; MICROTUBULE BINDING; METHYLENE-BLUE; IN-VITRO; PROTEIN; EXPRESSION; CELLS	Alzheimer disease (AD) is a degenerative tauopathy characterized by aggregation of Tau protein through the repeat domain to form intraneuronal paired helical filaments (PHFs). We report two cell models in which we control the inherent toxicity of the core Tau fragment. These models demonstrate the properties of prion-like recruitment of full-length Tau into an aggregation pathway in which template-directed, endogenous truncation propagates aggregation through the core Tau binding domain. We use these in combination with dissolution of native PHFs to quantify the activity of Tau aggregation inhibitors (TAIs). We report the synthesis of novel stable crystalline leucomethylthioninium salts (LMTX (R)), which overcome the pharmacokinetic limitations of methylthioninium chloride. LMTX (R), as either a dihydromesylate or a dihydrobromide salt, retains TAI activity in vitro and disrupts PHFs isolated from AD brain tissues at 0.16 mu M. The K-i value for intracellular TAI activity, which we have been able to determine for the first time, is 0.12 mu M. These values are close to the steady state trough brain concentration of methylthioninium ion (0.18 mu M) that is required to arrest progression of AD on clinical and imaging end points and the minimum brain concentration (0.13 mu M) required to reverse behavioral deficits and pathology in Tau transgenic mice.	[Harrington, Charles R.; Harrington, Kathleen A.; Horsley, David; Rickard, Janet E.; Wischik, Claude M.] Univ Aberdeen, Sch Med & Dent, Aberdeen AB25 2ZP, Scotland; [Harrington, Charles R.; Storey, John M. D.; Wischik, Claude M.] TauRx Therapeut Ltd, Singapore 068805, Singapore; [Harrington, Charles R.; Storey, John M. D.; Clunas, Scott; Ishaq, Ahtsham; Kemp, Steven J.; Larch, Christopher P.; Marshall, Colin; Nicoll, Sarah L.; Simpson, Michael; Sinclair, James P.; Storey, Lynda J.] Univ Aberdeen, Dept Chem, Aberdeen AB24 3UE, Scotland	University of Aberdeen; University of Aberdeen	Harrington, CR (corresponding author), Univ Aberdeen, Sch Med & Dent, Foresterhill, Aberdeen AB25 2ZP, Scotland.	c.harrington@abdn.ac.uk; cmw@taurx.com		Larch, Christopher/0000-0003-2463-3120; Storey, John/0000-0002-5261-5467; Harrington, Charles/0000-0003-2250-3920	TauRx Therapeutics Ltd.	TauRx Therapeutics Ltd.	This work was supported by grants from TauRx Therapeutics Ltd. C. R. H. (Chief Scientific Officer), J. M. D. S. (Head of Technical), and C. M. W. (Executive Chairman) are officers in TauRx Therapeutics Ltd., and C. R. H., J. M. D. S., S. C., D. H., A. I., S. J. K., C. P. L., C. M., S. L. N., J. E. R., M. S., J. P. S., L. J. S., and C. M. W. are co-inventors on various patents related to this investigation.	Akoury E, 2013, ANGEW CHEM INT EDIT, V52, P3511, DOI 10.1002/anie.201208290; Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; Bacallao R., 2006, HDB BIOL CONFOCAL MI, P368, DOI [10.1007/978-0-387-45524-2_18, DOI 10.1007/978-0-387-45524-2_18]; Baddeley TC, 2015, J PHARMACOL EXP THER, V352, P110, DOI 10.1124/jpet.114.219352; BANCHER C, 1993, NEUROSCI LETT, V162, P179, DOI 10.1016/0304-3940(93)90590-H; Bancher C, 1996, EUR ARCH PSY CLIN N, V246, P137, DOI 10.1007/BF02189115; BAUM L, 1995, MOL BRAIN RES, V34, P1, DOI 10.1016/0169-328X(95)00111-5; Bulic B, 2007, ANGEW CHEM INT EDIT, V46, P9215, DOI 10.1002/anie.200704051; Bulic B, 2009, ANGEW CHEM INT EDIT, V48, P1741, DOI 10.1002/anie.200802621; Chidley J. S., 1969, United States Patent, Patent No. 3463532; Chirita C, 2004, BIOCHEMISTRY-US, V43, P2879, DOI 10.1021/bi036094h; Clavaguera F, 2013, BRAIN PATHOL, V23, P342, DOI 10.1111/bpa.12044; Crowe A, 2007, BIOCHEM BIOPH RES CO, V358, P1, DOI 10.1016/j.bbrc.2007.03.056; CROWTHER RA, 1992, FEBS LETT, V309, P199, DOI 10.1016/0014-5793(92)81094-3; Duyckaerts C, 1997, NEUROBIOL AGING, V18, P267, DOI 10.1016/S0197-4580(97)80306-5; Fasulo L., 1996, ALZHEIMERS RES, V2, P195; Fatouros C, 2012, HUM MOL GENET, V21, P3587, DOI 10.1093/hmg/dds190; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Giannakopoulos P, 1997, BRAIN RES REV, V25, P217, DOI 10.1016/S0165-0173(97)00023-4; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GORMAN CM, 1983, NUCLEIC ACIDS RES, V11, P7631, DOI 10.1093/nar/11.21.7631; Grober E, 1999, NEUROBIOL AGING, V20, P573, DOI 10.1016/S0197-4580(99)00063-9; Hall GF, 2002, J MOL NEUROSCI, V19, P253; HARRINGTON CR, 1991, P NATL ACAD SCI USA, V88, P5842, DOI 10.1073/pnas.88.13.5842; Honson NS, 2007, BIOCHEM BIOPH RES CO, V363, P229, DOI 10.1016/j.bbrc.2007.08.166; Hrnkova M, 2007, BRAIN RES, V1130, P206, DOI 10.1016/j.brainres.2006.10.085; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; KRUH J, 1982, MOL CELL BIOCHEM, V42, P65; LAI RYK, 1995, NEUROBIOL AGING, V16, P433, DOI 10.1016/0197-4580(95)00041-C; LEE G, 1992, J CELL SCI, V102, P227; Li WK, 2009, J NEUROCHEM, V110, P1339, DOI 10.1111/j.1471-4159.2009.06224.x; MARR HE, 1973, ACTA CRYSTALLOGR B, VB 29, P847, DOI 10.1107/S0567740873003432; Melis V., 2015, CELL MOL LIFE SCI, DOI [10.1007/s00018-00014-01804-z, DOI 10.1007/S00018-00014-01804-Z]; Melisa V, 2015, BEHAV PHARMACOL, V26, P353, DOI 10.1097/FBP.0000000000000133; MENA R, 1995, ACTA NEUROPATHOL, V89, P50, DOI 10.1007/BF00294259; Mena R, 1996, ACTA NEUROPATHOL, V91, P633, DOI 10.1007/s004010050477; NOVAK M, 1991, P NATL ACAD SCI USA, V88, P5837, DOI 10.1073/pnas.88.13.5837; Partridge KA, 1999, CYTOTECHNOLOGY, V30, P37, DOI 10.1023/A:1008079901508; Perreault S, 2009, J NEUROPATH EXP NEUR, V68, P503, DOI 10.1097/NEN.0b013e3181a1fc49; Pickhardt M, 2005, J BIOL CHEM, V280, P3628, DOI 10.1074/jbc.M410984200; Pickhardt M, 2007, BIOCHEMISTRY-US, V46, P10016, DOI 10.1021/bi700878g; Rager T, 2012, PHYS CHEM CHEM PHYS, V14, P8074, DOI 10.1039/c2cp40128b; Rankin CA, 2008, J ALZHEIMERS DIS, V14, P411; RESCH JF, 1991, BIOORG MED CHEM LETT, V1, P519, DOI 10.1016/S0960-894X(01)80457-1; ROGALSKI AA, 1984, J CELL BIOL, V99, P1092, DOI 10.1083/jcb.99.3.1092; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; Wischik C., 1997, BRAIN MICROTUBULE AS, P185; Wischik CM, 2015, J ALZHEIMERS DIS, V44, P705, DOI 10.3233/JAD-142874; Wischik CM, 2014, BIOCHEM PHARMACOL, V88, P529, DOI 10.1016/j.bcp.2013.12.008; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Wischik CM, 2008, US Patent, Patent No. 7335505; Zilka N, 2006, FEBS LETT, V580, P3582, DOI 10.1016/j.febslet.2006.05.029	57	63	76	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10862	10875		10.1074/jbc.M114.616029	http://dx.doi.org/10.1074/jbc.M114.616029			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25759392	Green Published, hybrid			2022-12-28	WOS:000353404500026
J	MacDonald, MJ; Ade, L; Ntambi, JM; Ansari, IU; Stoker, SW				MacDonald, Michael J.; Ade, Lacmbouh; Ntambi, James M.; Ansari, Israr-Ul H.; Stoker, Scott W.			Characterization of Phospholipids in Insulin Secretory Granules and Mitochondria in Pancreatic Beta Cells and Their Changes with Glucose Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-CITRATE-LYASE; FATTY-ACID SYNTHASE; PYRUVATE-CARBOXYLASE; INS-1 CELLS; LIPID-COMPOSITION; SUBCELLULAR MEMBRANES; CHROMAFFIN GRANULES; UNRESPONSIVE POOLS; TARGET MEMBRANE; ISLETS	The lipid composition of insulin secretory granules (ISG) has never previously been thoroughly characterized. We characterized the phospholipid composition of ISG and mitochondria in pancreatic beta cells without and with glucose stimulation. The phospholipid/protein ratios of most phospholipids containing unsaturated fatty acids were higher in ISG than in whole cells and in mitochondria. The concentrations of negatively charged phospholipids, phosphatidylserine, and phosphatidylinositol in ISG were 5-fold higher than in the whole cell. In ISG phosphatidylserine, phosphatidylinositol, phosphatidylethanolamine, and sphingomyelin, fatty acids 12:0 and 14:0 were high, as were phosphatidylserine and phosphatidylinositol containing 18-carbon unsaturated FA. With glucose stimulation, the concentration of many ISG phosphatidylserines and phosphatidylinositols increased; unsaturated fatty acids in phosphatidylserine increased; and most phosphatidylethanolamines, phosphatidylcholines, sphingomyelins, and lysophosphatidylcholines were unchanged. Unsaturation and shorter fatty acid length in phospholipids facilitate curvature and fluidity of membranes, which favors fusion of membranes. Recent evidence suggests that negatively charged phospholipids, such as phosphatidylserine, act as coupling factors enhancing the interaction of positively charged regions in SNARE proteins in synaptic or secretory vesicle membrane lipid bilayers with positively charged regions in SNARE proteins in the plasma membrane lipid bilayer to facilitate docking of vesicles to the plasma membrane during exocytosis. The results indicate that ISG phospholipids are in a dynamic state and are consistent with the idea that changes in ISG phospholipids facilitate fusion of ISG with the plasma membrane-enhancing glucose-stimulated insulin exocytosis.	[MacDonald, Michael J.; Ansari, Israr-Ul H.; Stoker, Scott W.] Univ Wisconsin, Childrens Diabet Ctr, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Ade, Lacmbouh; Ntambi, James M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Ntambi, James M.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	MacDonald, MJ (corresponding author), Univ Wisconsin, Childrens Diabet Ctr, Sch Med & Publ Hlth, Madison, WI 53706 USA.	mjmacdon@wisc.edu		ANSARI, Israrul/0000-0003-0326-0329; MacDonald, Michael/0000-0002-0201-9245	National Institutes of Health [DK28348]; Nowlin Family Trust of the In Faith Community Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028348, R55DK028348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nowlin Family Trust of the In Faith Community Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK28348. This work was also supported by the Nowlin Family Trust of the In Faith Community Foundation.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRECKENRIDGE WC, 1973, BIOCHIM BIOPHYS ACTA, V320, P681, DOI 10.1016/0304-4165(73)90148-7; BRECKENRIDGE WC, 1972, BIOCHIM BIOPHYS ACTA, V266, P695, DOI 10.1016/0005-2736(72)90365-3; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Brun T, 1996, DIABETES, V45, P190, DOI 10.2337/diabetes.45.2.190; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; CASTLE JD, 1987, ANN NY ACAD SCI, V493, P448, DOI 10.1111/j.1749-6632.1987.tb27230.x; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Clark MR, 2011, NAT IMMUNOL, V12, P373, DOI 10.1038/ni.2024; Cline GW, 2011, DIABETES METAB J, V35, P458, DOI 10.4093/dmj.2011.35.5.458; Cline GW, 2011, BIOCHEM BIOPH RES CO, V415, P30, DOI 10.1016/j.bbrc.2011.09.153; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; de Haro L, 2004, P NATL ACAD SCI USA, V101, P1578, DOI 10.1073/pnas.0303274101; Devaux PF, 2008, BBA-BIOMEMBRANES, V1778, P1591, DOI 10.1016/j.bbamem.2008.03.007; Dobrzyn A, 2005, J BIOL CHEM, V280, P23356, DOI 10.1074/jbc.M502436200; Domanska MK, 2010, BIOPHYS J, V99, P2936, DOI 10.1016/j.bpj.2010.09.011; DREYFUS H, 1977, BIOCHIM BIOPHYS ACTA, V489, P89, DOI 10.1016/0005-2760(77)90235-1; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Hasan NM, 2010, ARCH BIOCHEM BIOPHYS, V499, P62, DOI 10.1016/j.abb.2010.05.007; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; JACOBSSON G, 1994, P NATL ACAD SCI USA, V91, P12487, DOI 10.1073/pnas.91.26.12487; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; KELLEY GG, 1995, AM J PHYSIOL-ENDOC M, V269, pE575, DOI 10.1152/ajpendo.1995.269.3.E575; Kooijman EE, 2009, BIOCHEMISTRY-US, V48, P9360, DOI 10.1021/bi9008616; KOWLURU A, 1985, ARCH BIOCHEM BIOPHYS, V242, P72, DOI 10.1016/0003-9861(85)90481-3; KOWLURU A, 1994, BBA-MOL CELL RES, V1222, P348, DOI 10.1016/0167-4889(94)90040-X; Kruit JK, 2011, DIABETES, V60, P3186, DOI 10.2337/db11-0081; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lorenz MA, 2013, J BIOL CHEM, V288, P10923, DOI 10.1074/jbc.M112.414961; MacDonald MJ, 2013, HORM METAB RES, V45, P391, DOI 10.1055/s-0032-1329987; MacDonald MJ, 2008, MOL CELL BIOCHEM, V313, P195, DOI 10.1007/s11010-008-9757-x; MacDonald MJ, 2008, BBA-GEN SUBJECTS, V1780, P966, DOI 10.1016/j.bbagen.2008.03.017; MacDonald MJ, 2008, ARCH BIOCHEM BIOPHYS, V470, P153, DOI 10.1016/j.abb.2007.11.017; MacDonald MJ, 2008, AM J PHYSIOL-CELL PH, V294, pC442, DOI 10.1152/ajpcell.00368.2007; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; MacDonald MJ, 2013, ARCH BIOCHEM BIOPHYS, V532, P23, DOI 10.1016/j.abb.2013.01.002; MacDonald MJ, 2011, J BIOL CHEM, V286, P18383, DOI 10.1074/jbc.M111.241182; MACDONALD MJ, 1981, BIOCHIM BIOPHYS ACTA, V663, P302, DOI 10.1016/0005-2760(81)90216-2; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287; Morton LA, 2013, ACS CHEM BIOL, V8, P218, DOI 10.1021/cb300429e; Mourad NI, 2010, AM J PHYSIOL-CELL PH, V299, pC389, DOI 10.1152/ajpcell.00138.2010; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Oh E, 2012, J BIOL CHEM, V287, P25821, DOI 10.1074/jbc.M112.361501; Panten U, 2013, METABOLISM, V62, P1375, DOI 10.1016/j.metabol.2013.05.006; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Prentki M, 2012, MOL CELL ENDOCRINOL, V353, P88, DOI 10.1016/j.mce.2011.11.004; Quetglas S, 2002, EMBO J, V21, P3970, DOI 10.1093/emboj/cdf404; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P13499, DOI 10.1021/bi00212a015; Ramanadham S, 1998, BIOCHEMISTRY-US, V37, P4553, DOI 10.1021/bi9722507; RANA RS, 1985, J BIOL CHEM, V260, P7861; RANA RS, 1986, J CELL BIOCHEM, V32, P143, DOI 10.1002/jcb.240320206; RANA RS, 1986, ARCH BIOCHEM BIOPHYS, V245, P411, DOI 10.1016/0003-9861(86)90232-8; RANA RS, 1987, J BIOL CHEM, V262, P13567; RHODES CJ, 1989, J BIOL CHEM, V264, P14240; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Straub SG, 2004, AM J PHYSIOL-CELL PH, V287, pC565, DOI 10.1152/ajpcell.00079.2004; Sturek JM, 2010, J CLIN INVEST, V120, P2575, DOI 10.1172/JCI41280; Thiele C, 1998, SEMIN CELL DEV BIOL, V9, P511, DOI 10.1006/scdb.1998.0259; Thurmond D. C., 2000, MADAME CURIE BIOSCIE; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; TURK J, 1986, BIOCHEM J, V237, P259, DOI 10.1042/bj2370259; TURK J, 1986, BIOCHIM BIOPHYS ACTA, V879, P399, DOI 10.1016/0005-2760(86)90232-8; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; Vance DE, 2008, N COMP BIOC, P213, DOI 10.1016/B978-044453219-0.50010-6; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Wang TT, 2009, BIOPHYS J, V96, P4122, DOI 10.1016/j.bpj.2009.02.050; Wang ZX, 2010, J BIOL CHEM, V285, P6186, DOI 10.1074/jbc.M109.072421; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; WESTHEAD EW, 1987, ANN NY ACAD SCI, V493, P92, DOI 10.1111/j.1749-6632.1987.tb27186.x; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; Williams D, 2009, MOL BIOL CELL, V20, P4910, DOI 10.1091/mbc.E09-04-0284; WINKLER H, 1976, NEUROSCIENCE, V1, P65, DOI 10.1016/0306-4522(76)90001-4; Xu J, 2008, DIABETOLOGIA, V51, P2022, DOI 10.1007/s00125-008-1130-9; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhang Z, 2009, MOL BIOL CELL, V20, P5086, DOI 10.1091/mbc.E09-08-0691	87	35	35	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11075	11092		10.1074/jbc.M114.628420	http://dx.doi.org/10.1074/jbc.M114.628420			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25762724	hybrid, Green Published			2022-12-28	WOS:000353404500043
J	Manhart, CM; McHenry, CS				Manhart, Carol M.; McHenry, Charles S.			Identification of Subunit Binding Positions on a Model Fork and Displacements That Occur during Sequential Assembly of the Escherichia coli Primosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; STALLED REPLICATION FORKS; CRYSTAL-STRUCTURE; RESTART PRIMOSOME; LEADING-STRAND; PRIA HELICASE; PROTEIN PRIB; COMPLEXES; MECHANISM; RELEASE	When replication stalls and forks disassemble, the restart primosome is required to reload the replicative helicase so that chromosomal replication can be reinitiated. We have taken a photo-cross-linking approach, using model replication forks containing a phenyl diazirine placed at single locations, to determine the positions of primosomal protein binding and changes in interactions that occur during the assembly reaction. This approach revealed a novel mode for single-stranded DNA-binding protein (SSB)-DNA binding, in which SSB interacts with both the leading and lagging single-strand segments and the parental duplex of the fork. Cross-linking to a novel region within SSB is observed only when it is bound to forked structures. This binding mode is also followed by PriB. PriA binds to the fork, excluding SSB and PriB, interacting with the primer terminus, single-stranded leading and lagging strands and duplex in immediate proximity of the fork. SSB binds to flanking single-stranded segments distal to the fork in the presence of PriA. The addition of PriB or DnaT to a PriA-SSB-fork complex does not lead to cross-linking or displacement, suggesting that their association is through protein-protein interactions at early stages of the reaction. Upon addition of DnaC and the DnaB helicase in the presence of ATP gamma S, helicase is assembled, leading to contacts within the duplex region on the tracking (lagging) strand and strong contacts with the displaced leading single strand near the fork. PriA is displaced from DNA upon helicase assembly.	[Manhart, Carol M.; McHenry, Charles S.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA	University of Colorado System; University of Colorado Boulder	McHenry, CS (corresponding author), Univ Colorado, Dept Chem & Biochem, 3415 Colorado Ave,UCB596, Boulder, CO 80303 USA.	charles.mchenry@colorado.edu	Manhart, Carol/AAQ-4938-2020		National Science Foundation [MCB-1329285]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-1329285.	Aarattuthodiyil S, 2014, NUCLEIC ACIDS RES, V42, P11707, DOI 10.1093/nar/gku845; BUJALOWSKI W, 1988, J BIOL CHEM, V263, P4629; Cadman CJ, 2005, J BIOL CHEM, V280, P39693, DOI 10.1074/jbc.M508521200; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Dohrmann PR, 2011, J MOL BIOL, V414, P15, DOI 10.1016/j.jmb.2011.09.039; Galletto R, 2004, J MOL BIOL, V343, P101, DOI 10.1016/j.jmb.2004.07.056; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Huang CY, 2006, NUCLEIC ACIDS RES, V34, P3878, DOI 10.1093/nar/gkl536; Huang Yen-Hua, 2014, Biomed Res Int, V2014, P195162, DOI 10.1155/2014/195162; Huang YH, 2013, GENES CELLS, V18, P1007, DOI 10.1111/gtc.12095; Huang YH, 2012, GENES CELLS, V17, P837, DOI 10.1111/gtc.12001; Jones JM, 2001, J MOL BIOL, V312, P935, DOI 10.1006/jmbi.2001.4930; Learn BA, 1997, P NATL ACAD SCI USA, V94, P1154, DOI 10.1073/pnas.94.4.1154; LEE MS, 1989, J BIOL CHEM, V264, P14531; Liu J, 1999, J BIOL CHEM, V274, P25033, DOI 10.1074/jbc.274.35.25033; Lopper M, 2004, STRUCTURE, V12, P1967, DOI 10.1016/j.str.2004.09.004; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; Manhart CM, 2013, J BIOL CHEM, V288, P3989, DOI 10.1074/jbc.M112.435966; Marians KJ, 1995, METHOD ENZYMOL, V262, P507; MOK M, 1987, J BIOL CHEM, V262, P16644; Ng JY, 1996, J BIOL CHEM, V271, P15642, DOI 10.1074/jbc.271.26.15642; Nurse P, 1999, J BIOL CHEM, V274, P25026, DOI 10.1074/jbc.274.35.25026; OUZOUNIS CA, 1991, NUCLEIC ACIDS RES, V19, P6953, DOI 10.1093/nar/19.24.6953; Ponomarev VA, 2003, J MOL MICROB BIOTECH, V5, P225, DOI 10.1159/000071074; Sandler SJ, 2000, J BACTERIOL, V182, P9, DOI 10.1128/JB.182.1.9-13.2000; Sasaki K, 2007, EMBO J, V26, P2584, DOI 10.1038/sj.emboj.7601697; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Tanaka T, 2007, J BIOL CHEM, V282, P19917, DOI 10.1074/jbc.M701848200; Tate JJ, 1998, NUCLEIC ACIDS RES, V26, P1421, DOI 10.1093/nar/26.6.1421; WAHLE E, 1989, J BIOL CHEM, V264, P2469; WU CA, 1992, J BIOL CHEM, V267, P4030; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3; Yuan Q, 2009, J BIOL CHEM, V284, P31672, DOI 10.1074/jbc.M109.050740	36	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10828	10839		10.1074/jbc.M115.642066	http://dx.doi.org/10.1074/jbc.M115.642066			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25745110	Green Published, hybrid			2022-12-28	WOS:000353404500023
J	Overland, AC; Insel, PA				Overland, Aaron C.; Insel, Paul A.			Heterotrimeric G Proteins Directly Regulate MMP14/Membrane Type-1 Matrix Metalloprotease A NOVEL MECHANISM FOR GPCR-EGFR TRANSACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epidermal Growth Factor Receptor (EGFR); G Protein-coupled Receptor (GPCR); Matrix Metalloproteinase (MMP); Membrane Protein; Signal Transduction	EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR TRANSACTIVATION; COUPLED RECEPTORS; ANGIOTENSIN-II; ECTODOMAIN CLEAVAGE; CANCER-THERAPY; MT1-MMP; CELLS; ACTIVATION; KINASE	Agonist stimulation of G protein-coupled receptors (GPCRs) can transactivate epidermal growth factor receptors (EGFRs), but the precise mechanisms for this transactivation have not been defined. Key to this process is the protease-mediated shedding of membrane-tethered ligands, which then activate EGFRs. The specific proteases and the events involved in GPCR-EGFR transactivation are not fully understood. We have tested the hypothesis that transactivation can occur by a membrane-delimited process: direct increase in the activity of membrane type-1 matrix metalloprotease (MMP14, MT1-MMP) by heterotrimeric G proteins, and in turn, the generation of heparin-binding epidermal growth factor (HB-EGF) and activation of EGFR. Using membranes prepared from adult rat cardiac myocytes and fibroblasts, we found that MMP14 activity is increased by angiotensin II, phenylephrine, GTP, and guanosine 5-O-[-thio]triphosphate (GTPS). MMP14 activation by GTPS occurs in a concentration- and time-dependent manner, does not occur in response to GMP or adenosine 5-[-thio]triphosphate (ATPS), and is not blunted by inhibitors of Src, PKC, phospholipase C (PLC), PI3K, or soluble MMPs. This activation is specific to MMP14 as it is inhibited by a specific MMP14 peptide inhibitor and siRNA knockdown. MMP14 activation by GTPS is pertussis toxin-sensitive. A role for heterotrimeric G protein subunits was shown by using the G inhibitor gallein and the direct activation of recombinant MMP14 by purified subunits. GTPS-stimulated activation of MMP14 also results in membrane release of HB-EGF and the activation of EGFR. These results define a previously unrecognized, membrane-delimited mechanism for EGFR transactivation via direct G protein activation of MMP14 and identify MMP14 as a heterotrimeric G protein-regulated effector.	[Overland, Aaron C.; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Insel, PA (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pinsel@ucsd.edu			American Heart Association [13POST14810015]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007444] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by an American Heart Association postdoctoral fellowship (13POST14810015) (to A. C. O.).	Amorino GP, 2007, ONCOGENE, V26, P745, DOI 10.1038/sj.onc.1209814; Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Arroyo AG, 2007, CURR PHARM DESIGN, V13, P1787, DOI 10.2174/138161207780831284; Belcheva MM, 2001, J BIOL CHEM, V276, P33847, DOI 10.1074/jbc.M101535200; Bokemeyer D, 2000, KIDNEY INT, V58, P549, DOI 10.1046/j.1523-1755.2000.t01-1-00201.x; Brown CL, 1998, J BIOL CHEM, V273, P17258, DOI 10.1074/jbc.273.27.17258; Castagliuolo I, 2000, J BIOL CHEM, V275, P26545, DOI 10.1074/jbc.M003990200; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Dempsey PJ, 1997, J CELL BIOL, V138, P747, DOI 10.1083/jcb.138.4.747; Gingras D, 2010, BBA-MOL CELL RES, V1803, P142, DOI 10.1016/j.bbamcr.2009.04.011; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Huang SM, 1999, INVEST NEW DRUG, V17, P259, DOI 10.1023/A:1006384521198; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; Mahajan R, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004075; Miyamoto S, 2004, CANCER RES, V64, P5720, DOI 10.1158/0008-5472.CAN-04-0811; Nishihara T, 2015, J BIOL CHEM, V290, P3693, DOI 10.1074/jbc.M114.603431; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Ouyang MX, 2010, CANCER RES, V70, P2204, DOI 10.1158/0008-5472.CAN-09-3698; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Rosse C, 2014, P NATL ACAD SCI USA, V111, pE1872, DOI 10.1073/pnas.1400749111; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Rusinova R, 2007, J BIOL CHEM, V282, P34019, DOI 10.1074/jbc.M704928200; Sato H, 2010, CANCER SCI, V101, P843, DOI 10.1111/j.1349-7006.2010.01498.x; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Shah BH, 2006, J NEUROCHEM, V96, P520, DOI 10.1111/j.1471-4159.2005.03585.x; Shah BH, 2004, MOL ENDOCRINOL, V18, P2035, DOI 10.1210/me.2003-0476; Smith NJ, 2004, CELL MOL LIFE SCI, V61, P2695, DOI 10.1007/s00018-004-4244-3; Sounni NE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00111; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Suojanen J, 2009, CANCER BIOL THER, V8, P2362, DOI 10.4161/cbt.8.24.10139; Thomas WG, 2002, CIRC RES, V90, P135, DOI 10.1161/hh0202.104109; Turner NA, 2012, IUBMB LIFE, V64, P143, DOI 10.1002/iub.594; Uchiyama-Tanaka Y, 2002, KIDNEY INT, V62, P799, DOI 10.1046/j.1523-1755.2002.00537.x; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105	45	28	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					9941	9947		10.1074/jbc.C115.647073	http://dx.doi.org/10.1074/jbc.C115.647073			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25759388	Green Published, hybrid			2022-12-28	WOS:000353241100001
J	Bhattacharjee, A; Reuter, S; Trojnar, E; Kolodziejczyk, R; Seeberger, H; Hyvarinen, S; Uzonyi, B; Szilagyi, A; Prohaszka, Z; Goldman, A; Jozsi, M; Jokiranta, TS				Bhattacharjee, Arnab; Reuter, Stefanie; Trojnar, Eszter; Kolodziejczyk, Robert; Seeberger, Harald; Hyvarinen, Satu; Uzonyi, Barbara; Szilagyi, Agnes; Prohaszka, Zoltan; Goldman, Adrian; Jozsi, Mihaly; Jokiranta, T. Sakari			The Major Autoantibody Epitope on Factor H in Atypical Hemolytic Uremic Syndrome Is Structurally Different from Its Homologous Site in Factor H-related Protein 1, Supporting a Novel Model for Induction of Autoimmunity in This Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT FACTOR-H; RECOGNITION FUNCTIONS; ALTERNATIVE PATHWAY; C-TERMINUS; C3B; MUTATIONS; GENE; BINDING; SURFACE; CELLS	Atypical hemolytic uremic syndrome (aHUS) is characterized by complement attack against host cells due to mutations in complement proteins or autoantibodies against complement factor H (CFH). It is unknown why nearly all patients with autoimmune aHUS lack CFHR1 (CFH-related protein-1). These patients have autoantibodies against CFH domains 19 and 20 (CFH19-20), which are nearly identical to CFHR1,1 domains 4 and 5 (CFHR1(4-5)), Here, binding site mapping of autoantibodies from 17 patients using mutant CFH19-20 constructs revealed an autoantibody epitope cluster within a loop on domain 20, next to the two buried residues that are different in CFH19-20 and CFHR1(4-5). The crystal structure of CFHR1(4-5) revealed a difference in conformation of the autoantigenic loop in the C-terminal domains of CFH and CFHR1, explaining the variation in binding of autoantibodies from some aHUS patients to CFH19-20 and CFHR1(4-5). The autoantigenic loop on CFH seems to be generally flexible, as its conformation in previously published structures of CFH19-20 bound to the microbial protein OspE and a sialic acid glycan is somewhat altered. Cumulalively, our data suggest that association of CFHR1 deficiency with autoimmune aHUS could be due to the structural difference between CFHR1 and the autoantigenic CFH epitope, suggesting a novel explanation for CFHR1 deficiency in the pathogenesis of autoimmune aHUS.	[Bhattacharjee, Arnab; Hyvarinen, Satu; Jokiranta, T. Sakari] Univ Helsinki, Medicum, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland; [Bhattacharjee, Arnab; Hyvarinen, Satu; Jokiranta, T. Sakari] Univ Helsinki, Immunobiol Res Program Unit, FIN-00014 Helsinki, Finland; [Bhattacharjee, Arnab; Hyvarinen, Satu; Jokiranta, T. Sakari] Helsinki Univ Hosp, Helsinki 00014, Finland; [Bhattacharjee, Arnab; Kolodziejczyk, Robert; Goldman, Adrian] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Kolodziejczyk, Robert; Goldman, Adrian] Univ Helsinki, Div Biochem & Biotechnol, Dept Biosci, FIN-00014 Helsinki, Finland; [Reuter, Stefanie; Seeberger, Harald; Jozsi, Mihaly] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jr Res Grp Cellular Immupobiol, D-07745 Jena, Germany; [Trojnar, Eszter; Szilagyi, Agnes; Prohaszka, Zoltan] Semmelweis Univ, Dept Internal Med 3, Res Lab, H-1125 Budapest, Hungary; [Uzonyi, Barbara] Eotvos Lorand Univ, MTA ELTE Immunol Res Grp, H-1117 Budapest, Hungary; [Jozsi, Mihaly] Eotvos Lorand Univ, MTA ELTE Lendulet Complement Res Grp, Dept Immunol, H-1117 Budapest, Hungary	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Hans Knoll Institute (HKI); Semmelweis University; Eotvos Lorand University; Eotvos Lorand University	Bhattacharjee, A (corresponding author), Univ Helsinki, Haartman Inst, POB 21 Haartmaninkatu 3, FIN-00014 Helsinki, Finland.	arnab.bhattacharjee@helsinki.fi; mihaly.jozsi@gmx.net	Trojnar, Eszter/R-2833-2016; Prohászka, Zoltán/F-2191-2010; Jozsi, Mihaly/I-7872-2018; Uzonyi, Barbara/J-3973-2018; Szilagyi, Agnes/F-2337-2010; Kolodziejczyk, Robert/G-9274-2015	Trojnar, Eszter/0000-0002-3266-2477; Prohászka, Zoltán/0000-0003-1761-7982; Jozsi, Mihaly/0000-0002-5520-5535; Uzonyi, Barbara/0000-0002-9680-1974; Szilagyi, Agnes/0000-0002-9769-3215; Reuter nee Strobel, Stefanie/0000-0002-3805-4632; Bhattacharjee, Arnab/0000-0002-9613-7911; Goldman, Adrian/0000-0001-8032-9700	Sigrid Juselius Foundation; Academy of Finland [1252206, 128646, 255922, 259793]; Hungarian Scientific Research Fund [OTKA 100687, OTKA 109055]; German Research Fund [JO 844/1-1]; Hungarian Academy of Sciences [LP2012-43]; Biotechnology and Biological Sciences Research Council [BB/L015056/1, BB/M021610/1] Funding Source: researchfish; BBSRC [BB/M021610/1, BB/L015056/1] Funding Source: UKRI	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); German Research Fund; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Sigrid Juselius Foundation and Academy of Finland Grant 1252206 (to A. G.) and Grants 128646, 255922, and 259793 (to T. S. J.); Hungarian Scientific Research Fund Grants OTKA 100687 (to Z. P.) and OTKA 109055 (to M. J.); and German Research Fund Grant JO 844/1-1 and Hungarian Academy of Sciences Grant LP2012-43 (to M. J.).	Abarrategui-Garrido C, 2009, BLOOD, V114, P4261, DOI 10.1182/blood-2009-05-223834; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bhattacharjee A, 2013, J BIOL CHEM, V288, P18685, DOI 10.1074/jbc.M113.459040; Bhattacharjee A, 2010, MOL IMMUNOL, V47, P1686, DOI 10.1016/j.molimm.2010.03.007; Blanc C, 2012, J IMMUNOL, V189, P3528, DOI 10.4049/jimmunol.1200679; Blaum BS, 2015, NAT CHEM BIOL, V11, P77, DOI [10.1038/NCHEMBIO.1696, 10.1038/nchembio.1696]; Castiblanco-Valencia MM, 2012, J INFECT DIS, V205, P995, DOI 10.1093/infdis/jir875; de Jorge EG, 2013, P NATL ACAD SCI USA, V110, P4685, DOI 10.1073/pnas.1219260110; Dragon-Durey MA, 2009, J MED GENET, V46, P447, DOI 10.1136/jmg.2008.064766; Dragon-Durey MA, 2005, J AM SOC NEPHROL, V16, P555, DOI 10.1681/ASN.2004050380; Dragon-Durey MA, 2010, J AM SOC NEPHROL, V21, P2180, DOI 10.1681/ASN.2010030315; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eyler SJ, 2013, PEDIATR NEPHROL, V28, P2221, DOI 10.1007/s00467-013-2560-2; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; FREDDO L, 1986, J IMMUNOL, V137, P3821; FRITZLER MJ, 1991, CLIN MICROBIOL REV, V4, P256, DOI 10.1128/CMR.4.3.256-269.1991; Hebecker M, 2012, J BIOL CHEM, V287, P19528, DOI 10.1074/jbc.M112.364471; Heinen Stefan, 2006, Hum Mutat, V27, P292, DOI 10.1002/humu.9408; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; Herbert AP, 2012, BIOCHEMISTRY-US, V51, P1874, DOI 10.1021/bi201689j; Hofer J, 2013, CLIN J AM SOC NEPHRO, V8, P407, DOI 10.2215/CJN.01260212; Holmes LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060352; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jozsi M, 2008, BLOOD, V111, P1512, DOI 10.1182/blood-2007-09-109876; Jozsi M, 2007, BLOOD, V110, P1516, DOI 10.1182/blood-2007-02-071472; Jozsi M, 2006, J AM SOC NEPHROL, V17, P170, DOI 10.1681/ASN.2005080868; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Lehtinen MJ, 2009, J BIOL CHEM, V284, P15650, DOI 10.1074/jbc.M900814200; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; McCarthy AA, 2009, J SYNCHROTRON RADIAT, V16, P803, DOI 10.1107/S0909049509035377; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meri T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003308; Moore I, 2010, BLOOD, V115, P379, DOI 10.1182/blood-2009-05-221549; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Pangburn MK, 2002, J IMMUNOL, V169, P4702, DOI 10.4049/jimmunol.169.9.4702; Roumenina L, 2013, MOL IMMUNOL, V56, P248, DOI 10.1016/j.molimm.2013.05.030; Sanchez-Corral P, 2004, MOL IMMUNOL, V41, P81, DOI 10.1016/j.molimm.2004.01.003; Sanchez-Corral P, 2010, BRIT J HAEMATOL, V150, P529, DOI 10.1111/j.1365-2141.2010.08295.x; Sinha A, 2014, KIDNEY INT, V85, P1151, DOI 10.1038/ki.2013.373; Strobel S, 2011, KIDNEY INT, V80, P397, DOI 10.1038/ki.2011.152; Strobel S, 2010, NEPHROL DIAL TRANSPL, V25, P136, DOI 10.1093/ndt/gfp388; Venables JP, 2006, PLOS MED, V3, P1957, DOI 10.1371/journal.pmed.0030431; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	48	48	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9500	9510		10.1074/jbc.M114.630871	http://dx.doi.org/10.1074/jbc.M114.630871			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25659429	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000352729400017
J	Grabarczyk, DB; Chappell, PE; Eisel, B; Johnson, S; Lea, SM; Berks, BC				Grabarczyk, Daniel B.; Chappell, Paul E.; Eisel, Bianca; Johnson, Steven; Lea, Susan M.; Berks, Ben C.			Mechanism of Thiosulfate Oxidation in the SoxA Family of Cysteine-ligated Cytochromes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME PROTEIN; COMPLEX; SYSTEM; REPLACEMENT; REFINEMENT; GENERATION	Thiosulfate dehydrogenase (TsdA) catalyzes the oxidation of two thiosulfate molecules to form tetrathionate and is predicted to use an unusual cysteine-ligated heme as the catalytic cofactor. We have determined the structure of Allochromatium vinosum TsdA to a resolution of 1.3 angstrom. This structure confirms the active site heme ligation, identifies a thiosulfate binding site within the active site cavity, and reveals an electron transfer route from the catalytic heme, through a second heme group to the external electron acceptor. We provide multiple lines of evidence that the catalytic reaction proceeds through the intermediate formation of a S-thiosulfonate derivative of the heme cysteine ligand: the cysteine is reactive and is accessible to electrophilic attack; cysteine S-thiosulfonate is formed by the addition of thiosulfate or following the reverse reaction with tetrathionate; the S-thiosulfonate modification is removed through catalysis; and alkylating the cysteine blocks activity. Active site amino acid residues required for catalysis were identified by mutagenesis and are inferred to also play a role in stabilizing the S-thiosulfonate intermediate. The enzyme SoxAX, which catalyzes the first step in the bacterial Sox thiosulfate oxidation pathway, is homologous to TsdA and can be inferred to use a related catalytic mechanism.	[Grabarczyk, Daniel B.; Eisel, Bianca; Berks, Ben C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Chappell, Paul E.; Johnson, Steven; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; University of Oxford	Lea, SM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	susan.lea@path.ox.ac.uk; ben.berks@bioch.ox.ac.uk	Lea, Susan M/B-7678-2009; Johnson, Steven J/F-9182-2016	Lea, Susan M/0000-0001-9287-8053; Johnson, Steven J/0000-0002-7877-3543; Berks, Ben/0000-0001-9685-4067; Grabarczyk, Daniel/0000-0003-0216-7085	Biotechnology and Biological Sciences Research Council; Medical Research Council [G0900888]; Biotechnology and Biological Sciences Research Council [1091176, 991163] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by studentships from the Biotechnology and Biological Sciences Research Council.; Supported by Medical Research Council Grant G0900888.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alric J, 2004, J BIOL CHEM, V279, P26090, DOI 10.1074/jbc.M400361200; Argyrou A, 2004, PROG NUCLEIC ACID RE, V78, P89, DOI 10.1016/S0079-6603(04)78003-4; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Bach RD, 2008, J ORG CHEM, V73, P12, DOI 10.1021/jo702051f; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Dambe T, 2005, J STRUCT BIOL, V152, P229, DOI 10.1016/j.jsb.2005.09.002; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Denkmann K, 2012, ENVIRON MICROBIOL, V14, P2673, DOI 10.1111/j.1462-2920.2012.02820.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fedurco M, 2004, BBA-PROTEINS PROTEOM, V1703, P31, DOI 10.1016/j.bbapap.2004.09.013; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Gregersen LH, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00116; Grein F, 2010, BIOCHEMISTRY-US, V49, P8290, DOI 10.1021/bi1007673; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; Inaba K, 2006, P NATL ACAD SCI USA, V103, P287, DOI 10.1073/pnas.0507570103; JORGENSEN BB, 1991, APPL ENVIRON MICROB, V57, P847; Kappler U, 2008, J BIOL CHEM, V283, P22206, DOI 10.1074/jbc.M800315200; Kappler U, 2013, CELL MOL LIFE SCI, V70, P977, DOI 10.1007/s00018-012-1098-y; Kilmartin JR, 2011, J BIOL CHEM, V286, P24872, DOI 10.1074/jbc.M110.212183; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Levitt MD, 1999, J CLIN INVEST, V104, P1107, DOI 10.1172/JCI7712; Liu YW, 2013, MOL MICROBIOL, V88, P173, DOI 10.1111/mmi.12176; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; Moser CC, 2008, BBA-BIOENERGETICS, V1777, P1032, DOI 10.1016/j.bbabio.2008.04.021; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NICOLA NA, 1977, EUR J BIOCHEM, V78, P133, DOI 10.1111/j.1432-1033.1977.tb11722.x; Sambrook J., 2001, MOL CLONING LAB MANU; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Suga M, 2013, FEBS LETT, V587, P3267, DOI 10.1016/j.febslet.2013.08.023; Sun YH, 2014, P NATL ACAD SCI USA, V111, P6570, DOI 10.1073/pnas.1322274111; Tarry M, 2012, PROTEIN EXPRES PURIF, V82, P373, DOI 10.1016/j.pep.2012.02.003; TERVOORT MJ, 1981, BIOCHIM BIOPHYS ACTA, V637, P245, DOI 10.1016/0005-2728(81)90163-8; Ukita S, 2010, FEMS MICROBIOL LETT, V313, P61, DOI 10.1111/j.1574-6968.2010.02122.x; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Van Driessche G, 2006, FEBS J, V273, P2801, DOI 10.1111/j.1742-4658.2006.05296.x; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	41	14	14	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9209	9221		10.1074/jbc.M114.618025	http://dx.doi.org/10.1074/jbc.M114.618025			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25673696	Green Published, hybrid			2022-12-28	WOS:000352207100043
J	Slutzki, M; Reshef, D; Barak, Y; Haimovitz, R; Rotem-Bamberger, S; Lamed, R; Bayer, EA; Schueler-Furman, O				Slutzki, Michal; Reshef, Dan; Barak, Yoav; Haimovitz, Rachel; Rotem-Bamberger, Shahar; Lamed, Raphael; Bayer, Edward A.; Schueler-Furman, Ora			Crucial Roles of Single Residues in Binding Affinity, Specificity, and Promiscuity in the Cellulosomal Cohesin-Dockerin Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN DOCKING; CLOSTRIDIUM-THERMOCELLUM; COMPUTATIONAL DESIGN; DOMAIN; RECOGNITION; SURFACE; DEGRADATION; COMPONENTS; STABILITY; MECHANISM	Interactions between cohesin and dockerin modules play a crucial role in the assembly of multienzyme cellulosome complexes. Although intraspecies cohesin and dockerin modules bind in general with high affinity but indiscriminately, cross-species binding is rare. Here, we combined ELISA-based experiments with Rosetta-based computational design to evaluate the contribution of distinct residues at the Clostridium thermocellum cohesin-dockerin interface to binding affinity, specificity, and promiscuity. We found that single mutations can show distinct and significant effects on binding affinity and specificity. In particular, mutations at cohesin position Asn(37) show dramatic variability in their effect on dockerin binding affinity and specificity: the N37A mutant binds promiscuously both to cognate (C. thermocellum) as well as to non-cognate Clostridium cellulolyticum dockerin. N37L in turn switches binding specificity: compared with the wild-type C. thermocellum cohesin, this mutant shows significantly increased preference for C. cellulolyticum dockerin combined with strongly reduced binding to its cognate C. thermocellum dockerin. The observation that a single mutation can overcome the naturally observed specificity barrier provides insights into the evolutionary dynamics of this system that allows rapid modulation of binding specificity within a high affinity background.	[Slutzki, Michal; Barak, Yoav; Haimovitz, Rachel; Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-7610001 Rehovot, Israel; [Reshef, Dan; Rotem-Bamberger, Shahar; Schueler-Furman, Ora] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, Inst Med Res Israel Canada, IL-9112102 Jerusalem, Israel; [Lamed, Raphael] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-6997801 Ramat Aviv, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; Tel Aviv University	Schueler-Furman, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, IL-9112102 Jerusalem, Israel.	oraf@ekmd.huji.ac.il	Schueler-Furman, Ora/AAC-5932-2020	Schueler-Furman, Ora/0000-0002-1624-0362	Israel Science Foundation (ISF) - Israel Academy of Science and Humanities [306/06, 319/11, 1349/13, 24/11]; Israel Science Foundation (ISF) - Israel Academy of Science and Humanities (Sidney E. Frank Foundation through the ISF); United States-Israel Binational Science Foundation, Jerusalem, Israel [2009418, 2013284]; European Research Council [310873]; European Union [NMP.2013.1.1-2, 604530]; European Research Area-Industrial Biology Consortium [EIB.12.022]	Israel Science Foundation (ISF) - Israel Academy of Science and Humanities; Israel Science Foundation (ISF) - Israel Academy of Science and Humanities (Sidney E. Frank Foundation through the ISF); United States-Israel Binational Science Foundation, Jerusalem, Israel(US-Israel Binational Science Foundation); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); European Research Area-Industrial Biology Consortium	This work was supported, in whole or in part, by the Israel Science Foundation (ISF) funded by the Israel Academy of Science and Humanities (Grants 306/06 and 319/11 to O. S.-F., 1349/13 to E. A. B., and 24/11 to R. L. by The Sidney E. Frank Foundation through the ISF); the United States-Israel Binational Science Foundation, Jerusalem, Israel (Grants 2009418 to O. S.-F. and 2013284 to E. A. B.); the European Research Council (Starting Grant 310873 to O. S.-F.); the European Union, Area NMP.2013.1.1-2: (Selfassembly of naturally occurring nanosystems: CellulosomePlus Project 604530 to E. A. B.), and a European Research Area-Industrial Biology Consortium (EIB.12.022, acronym FiberFuel, to E. A. B.).	Adams JJ, 2008, P NATL ACAD SCI USA, V105, P12194, DOI 10.1073/pnas.0803154105; Adams JJ, 2006, P NATL ACAD SCI USA, V103, P305, DOI 10.1073/pnas.0507109103; Akiva E, 2008, P NATL ACAD SCI USA, V105, P13292, DOI 10.1073/pnas.0801207105; Bahari L, 2011, J IND MICROBIOL BIOT, V38, P825, DOI 10.1007/s10295-010-0848-9; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barak Y, 2005, J MOL RECOGNIT, V18, P491, DOI 10.1002/jmr.749; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Caspi J, 2008, J BIOTECHNOL, V135, P351, DOI 10.1016/j.jbiotec.2008.05.003; Caspi J, 2009, APPL ENVIRON MICROB, V75, P7335, DOI 10.1128/AEM.01241-09; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Haimovitz R, 2008, PROTEOMICS, V8, P968, DOI 10.1002/pmic.200700486; Halperin I, 2006, PROTEINS, V63, P832, DOI 10.1002/prot.20933; Handelsman T, 2004, FEBS LETT, V572, P195, DOI 10.1016/j.febslet.2004.07.040; Joachimiak LA, 2006, J MOL BIOL, V361, P195, DOI 10.1016/j.jmb.2006.05.022; Kahel-Raifer H, 2010, FEMS MICROBIOL LETT, V308, P84, DOI 10.1111/j.1574-6968.2010.01997.x; Kaneko T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000796; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Kleanthous C, 2001, TRENDS BIOCHEM SCI, V26, P624, DOI 10.1016/S0968-0004(01)01941-7; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Lapidot A, 1996, J BIOTECHNOL, V51, P259, DOI 10.1016/S0168-1656(96)01604-5; Levin KB, 2009, NAT STRUCT MOL BIOL, V16, P1049, DOI 10.1038/nsmb.1670; Li W, 1998, BIOCHEMISTRY-US, V37, P11771, DOI 10.1021/bi9808621; Lytle BL, 2000, ARCH BIOCHEM BIOPHYS, V379, P237, DOI 10.1006/abbi.2000.1882; Mandell DJ, 2009, NAT CHEM BIOL, V5, P797, DOI 10.1038/nchembio.251; Mechaly A, 2001, J BIOL CHEM, V276, P9883, DOI 10.1074/jbc.M009237200; Mingardon F, 2007, APPL ENVIRON MICROB, V73, P7138, DOI 10.1128/AEM.01306-07; Mingardon F, 2007, APPL ENVIRON MICROB, V73, P3822, DOI 10.1128/AEM.00398-07; Miras I, 2002, BIOCHEMISTRY-US, V41, P2115, DOI 10.1021/bi011854e; Morais S, 2013, APPL ENVIRON MICROB, V79, P5242, DOI 10.1128/AEM.01211-13; Morais S, 2012, MBIO, V3, DOI 10.1128/mBio.00508-12; Morais S, 2011, MBIO, V2, DOI 10.1128/mBio.00233-11; Morais S, 2010, APPL ENVIRON MICROB, V76, P3787, DOI 10.1128/AEM.00266-10; Motulsky H, 2004, FITTING MODELS BIOL, P256; Nakar D, 2004, J BIOL CHEM, V279, P42881, DOI 10.1074/jbc.M407350200; Nataf Y, 2010, P NATL ACAD SCI USA, V107, P18646, DOI 10.1073/pnas.1012175107; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pages S, 1997, PROTEINS, V29, P517, DOI 10.1002/(SICI)1097-0134(199712)29:4<517::AID-PROT11>3.3.CO;2-I; Pinheiro BA, 2008, J BIOL CHEM, V283, P18422, DOI 10.1074/jbc.M801533200; Potapov V, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-374; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Sakka K, 2011, FEMS MICROBIOL LETT, V314, P75, DOI 10.1111/j.1574-6968.2010.02146.x; Sakka K, 2009, FEMS MICROBIOL LETT, V300, P249, DOI 10.1111/j.1574-6968.2009.01788.x; Schreiber G, 2013, CURR OPIN STRUC BIOL, V23, P903, DOI 10.1016/j.sbi.2013.08.003; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Schueler-Furman O, 2005, PROTEINS, V60, P187, DOI 10.1002/prot.20556; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sharabi O, 2011, PROTEINS, V79, P1487, DOI 10.1002/prot.22977; Slutzki M, 2012, J MOL RECOGNIT, V25, P616, DOI 10.1002/jmr.2178; Slutzki M, 2012, METHOD ENZYMOL, V510, P417, DOI 10.1016/B978-0-12-415931-0.00022-7; Vazana Y, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-182; Vazana Y, 2010, APPL ENVIRON MICROB, V76, P3236, DOI 10.1128/AEM.00009-10; Wang C, 2005, PROTEIN SCI, V14, P1328, DOI 10.1110/ps.041222905; Weichenberger CX, 2006, BIOINFORMATICS, V22, P1397, DOI 10.1093/bioinformatics/btl128; Weinstein JY, 2015, J MOL RECOGNIT, V28, P148, DOI 10.1002/jmr.2380; Xu JC, 2009, PROTEIN SCI, V18, P949, DOI 10.1002/pro.105	65	10	10	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13654	13666		10.1074/jbc.M115.651208	http://dx.doi.org/10.1074/jbc.M115.651208			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25833947	Green Published, hybrid			2022-12-28	WOS:000355313000003
J	Souri, M; Osaki, T; Ichinose, A				Souri, Masayoshi; Osaki, Tsukasa; Ichinose, Akitada			The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Blood; Coagulation Factor; Fibrin; Protein Cross-linking; Transglutaminase; Bleeding Disease	PLASMA FACTOR-XIII; BLOOD-COAGULATION; 3-DIMENSIONAL STRUCTURE; THROMBIN; DEFICIENCY; PEPTIDE; POLYMERIZATION; ACTIVATION; PROTEINS; CALCIUM	Background: The B subunit of factor XIII (FXIII-B) was previously thought to inhibit fibrin cross-linking by preventing thrombin-mediated activation of the A subunit (FXIII-A). Results: FXIII-B accelerated FXIII-A activation and subsequent fibrin cross-linking by formation of an FXIII-A, fibrinogen, and thrombin ternary complex. Conclusion: FXIII-B accelerated fibrin cross-linking. Significance: FXIII-B deficiency leads to impaired fibrin stabilization. Covalent cross-linking of fibrin chains is required for stable blood clot formation, which is catalyzed by coagulation factor XIII (FXIII), a proenzyme of plasma transglutaminase consisting of catalytic A (FXIII-A) and non-catalytic B subunits (FXIII-B). Herein, we demonstrate that FXIII-B accelerates fibrin cross-linking. Depletion of FXIII-B from normal plasma supplemented with a physiological level of recombinant FXIII-A resulted in delayed fibrin cross-linking, reduced incorporation of FXIII-A into fibrin clots, and impaired activation peptide cleavage by thrombin; the addition of recombinant FXIII-B restored normal fibrin cross-linking, FXIII-A incorporation into fibrin clots, and activation peptide cleavage by thrombin. Immunoprecipitation with an anti-fibrinogen antibody revealed an interaction between the FXIII heterotetramer and fibrinogen mediated by FXIII-B and not FXIII-A. FXIII-B probably binds the -chain of fibrinogen with its D-domain, which is near the fibrin polymerization pockets, and dissociates from fibrin during or after cross-linking between -chains. Thus, FXIII-B plays important roles in the formation of a ternary complex between proenzyme FXIII, prosubstrate fibrinogen, and activator thrombin. Accordingly, congenital or acquired FXIII-B deficiency may result in increased bleeding tendency through impaired fibrin stabilization due to decreased FXIII-A activation by thrombin and secondary FXIII-A deficiency arising from enhanced circulatory clearance.	[Souri, Masayoshi; Osaki, Tsukasa; Ichinose, Akitada] Yamagata Univ, Sch Med, Dept Mol Pathobiochem & Pathobiol, Yamagata 9909585, Japan	Yamagata University	Ichinose, A (corresponding author), Yamagata Univ, Sch Med, Dept Mol Pathobiochem & Pathobiol, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	aichinos@med.id.yamagata-u.ac.jp		Osaki, Tsukasa/0000-0002-9487-3253	Japanese Ministry of Education, Culture, Sports, Science, and Technology	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a research grant from the Japanese Ministry of Education, Culture, Sports, Science, and Technology and was presented in part at the 35th Annual Meeting of the Japanese Society on Thrombosis and Hemostasis in Yamagata in May 2013 and at the 24th Congress of the International Society on Thrombosis and Hemostasis in Amsterdam in July 2013.	BINNIE CG, 1993, BLOOD, V81, P3186; BLOMBACK B, 1978, NATURE, V275, P501, DOI 10.1038/275501a0; CREDO RB, 1978, P NATL ACAD SCI USA, V75, P4234, DOI 10.1073/pnas.75.9.4234; CURTIS CG, 1974, BIOCHEMISTRY-US, V13, P3774, DOI 10.1021/bi00715a024; GREENBERG CS, 1985, BLOOD, V66, P1028; GREENBERG CS, 1985, BLOOD, V66, P466; GREENBERG CS, 1987, BLOOD, V69, P867; GREENBERG CS, 1982, J BIOL CHEM, V257, P6096; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P4633, DOI 10.1021/bi00364a027; Ivaskevicius V, 2010, HAEMOPHILIA, V16, P675, DOI 10.1111/j.1365-2516.2010.02207.x; Iwata H, 2009, J THROMB HAEMOST, V7, P1084, DOI 10.1111/j.1538-7836.2009.03443.x; Izumi T, 1996, BLOOD, V87, P2769, DOI 10.1182/blood.V87.7.2769.bloodjournal8772769; JANUS TJ, 1983, BIOCHEMISTRY-US, V22, P6269, DOI 10.1021/bi00295a035; Katona E, 2014, BLOOD, V123, P1757, DOI 10.1182/blood-2013-10-533596; Koseki S, 2001, BLOOD, V97, P2667, DOI 10.1182/blood.V97.9.2667; LAUDANO AP, 1978, P NATL ACAD SCI USA, V75, P3085, DOI 10.1073/pnas.75.7.3085; LEWIS SD, 1985, BIOCHEMISTRY-US, V24, P6772, DOI 10.1021/bi00345a007; LOEWY AG, 1961, J BIOL CHEM, V236, P2634; Lorand L, 2001, ANN NY ACAD SCI, V936, P291; MARY A, 1987, BIOCHEM BIOPH RES CO, V147, P608, DOI 10.1016/0006-291X(87)90974-0; Moaddel M, 2000, BIOCHEMISTRY-US, V39, P6698, DOI 10.1021/bi000098u; OLEXA SA, 1980, P NATL ACAD SCI-BIOL, V77, P1374, DOI 10.1073/pnas.77.3.1374; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Pechik I, 2004, P NATL ACAD SCI USA, V101, P2718, DOI 10.1073/pnas.0303440101; PIZZO SV, 1973, J BIOL CHEM, V248, P4584; Pratt KP, 1997, P NATL ACAD SCI USA, V94, P7176, DOI 10.1073/pnas.94.14.7176; RADEK JT, 1993, BIOCHEMISTRY-US, V32, P3527, DOI 10.1021/bi00065a002; Saha N, 2000, GENET EPIDEMIOL, V19, P440, DOI 10.1002/1098-2272(200012)19:4<440::AID-GEPI14>3.0.CO;2-8; SAITO M, 1990, BRIT J HAEMATOL, V74, P290, DOI 10.1111/j.1365-2141.1990.tb02585.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Siebenlist KR, 1996, BIOCHEMISTRY-US, V35, P10448, DOI 10.1021/bi9606206; Souri M, 2008, BIOCHEMISTRY-US, V47, P8656, DOI 10.1021/bi8006143; Souri M, 2008, INT J HEMATOL, V87, P60, DOI 10.1007/s12185-007-0005-z; Tsurupa G, 2010, BIOCHEMISTRY-US, V49, P7643, DOI 10.1021/bi1010317; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296; Yuasa Y, 2014, THER APHER DIAL, V18, P93, DOI 10.1111/1744-9987.12056	36	30	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12027	12039		10.1074/jbc.M114.608570	http://dx.doi.org/10.1074/jbc.M114.608570			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25809477	Green Published, hybrid			2022-12-28	WOS:000354388600018
J	Yusuf, NA; Green, JL; Wall, RJ; Knuepfer, E; Moon, RW; Schulte-Huxel, C; Stanway, RR; Martin, SR; Howell, SA; Douse, CH; Cota, E; Tate, EW; Tewari, R; Holder, AA				Yusuf, Noor A.; Green, Judith L.; Wall, Richard J.; Knuepfer, Ellen; Moon, Robert W.; Schulte-Huxel, Christina; Stanway, Rebecca R.; Martin, Stephen R.; Howell, Steven A.; Douse, Christopher H.; Cota, Ernesto; Tate, Edward W.; Tewari, Rita; Holder, Anthony A.			The Plasmodium Class XIV Myosin, MyoB, Has a Distinct Subcellular Location in Invasive and Motile Stages of the Malaria Parasite and an Unusual Light Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Invasion; Malaria; Molecular Motor; Myosin; Parasite; Peptide Interaction; Plasmodium; Myosin Light Chain	TOXOPLASMA-GONDII; CELL INVASION; FALCIPARUM MEROZOITES; PHYLOGENETIC TREES; CIRCULAR-DICHROISM; COMPLEX; MOTOR; TAIL; GLIDEOSOME; SEQUENCES	Background: Malaria parasites possess two unusual class XIV myosins, myosin A that drives gliding motility and myosin B that is uncharacterized. Results: Myosin B is located at the extreme apical end of motile and invasive parasites, binding a very large and unusual light chain. Conclusion: Myosin B differs substantially from myosin A in location and function. Significance: An unusual myosin and its light chain extend the known diversity of these families. Myosin B (MyoB) is one of the two short class XIV myosins encoded in the Plasmodium genome. Class XIV myosins are characterized by a catalytic head, a modified neck, and the absence of a tail region. Myosin A (MyoA), the other class XIV myosin in Plasmodium, has been established as a component of the glideosome complex important in motility and cell invasion, but MyoB is not well characterized. We analyzed the properties of MyoB using three parasite species as follows: Plasmodium falciparum, Plasmodium berghei, and Plasmodium knowlesi. MyoB is expressed in all invasive stages (merozoites, ookinetes, and sporozoites) of the life cycle, and the protein is found in a discrete apical location in these polarized cells. In P. falciparum, MyoB is synthesized very late in schizogony/merogony, and its location in merozoites is distinct from, and anterior to, that of a range of known proteins present in the rhoptries, rhoptry neck or micronemes. Unlike MyoA, MyoB is not associated with glideosome complex proteins, including the MyoA light chain, myosin A tail domain-interacting protein (MTIP). A unique MyoB light chain (MLC-B) was identified that contains a calmodulin-like domain at the C terminus and an extended N-terminal region. MLC-B localizes to the same extreme apical pole in the cell as MyoB, and the two proteins form a complex. We propose that MLC-B is a MyoB-specific light chain, and for the short class XIV myosins that lack a tail region, the atypical myosin light chains may fulfill that role.	[Yusuf, Noor A.; Green, Judith L.; Knuepfer, Ellen; Moon, Robert W.; Schulte-Huxel, Christina; Holder, Anthony A.] MRC, Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; [Martin, Stephen R.] MRC, Natl Inst Med Res, Div Phys Biochem, London NW7 1AA, England; [Howell, Steven A.] MRC, Natl Inst Med Res, Div Mol Struct, London NW7 1AA, England; [Wall, Richard J.; Tewari, Rita] Univ Nottingham, Sch Life Sci, Queens Med Ctr, Nottingham NG2 7UH, England; [Stanway, Rebecca R.] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland; [Douse, Christopher H.; Cota, Ernesto; Tate, Edward W.] Univ London Imperial Coll Sci Technol & Med, Inst Chem Biol, London SW7 2AZ, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of Nottingham; University of Bern; Imperial College London	Holder, AA (corresponding author), MRC, Natl Inst Med Res, Div Parasitol, Mill Hill, London NW7 1AA, England.	aholder@nimr.mrc.ac.uk	Moon, Robert/AAF-9808-2019; Holder, Anthony A/A-7554-2013	Holder, Anthony A/0000-0002-8490-6058; Moon, Robert/0000-0002-9070-4292; Knuepfer, Ellen/0000-0002-6090-1877; Green, Judith/0000-0001-6825-9404; Douse, Christopher/0000-0002-1604-8944; Tate, Edward/0000-0003-2213-5814; Wall, Richard J./0000-0003-3487-3187; Tewari, Rita/0000-0003-3943-1847	Medical Research Council [U117532067, G0900109, MR/K011782/1]; Islamic Development Bank, Saudi Arabia; Institute of Chemical Biology EPSRC Centre for Doctoral Training at the Department of Chemistry, Imperial College London; The Francis Crick Institute [10015, 10097] Funding Source: researchfish; MRC [G0900109, MR/K011782/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Islamic Development Bank, Saudi Arabia; Institute of Chemical Biology EPSRC Centre for Doctoral Training at the Department of Chemistry, Imperial College London(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part Medical Research Council Grant U117532067.; Recipient of a Ph.D. Merit Scholarship from the Islamic Development Bank, Saudi Arabia. Present address: Institute for Medical Research, Jalan Pahang, 50588 Kuala Lumpur, Malaysia.; Supported by Medical Research Council Investigator Award and Medical Research Council Grant G0900109 and MR/K011782/1.; Recipient of a studentship from the Institute of Chemical Biology EPSRC Centre for Doctoral Training at the Department of Chemistry, Imperial College London. Present address: Medical Research Council Laboratory of Molecular Biology, Francis Crick Ave., Cambridge, CB2 0QH, United Kingdom.	Angrisano F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032188; Armstrong CT, 2011, BIOINFORMATICS, V27, P1908, DOI 10.1093/bioinformatics/btr299; BANNISTER LH, 1995, ANN TROP MED PARASIT, V89, P105, DOI 10.1080/00034983.1995.11812940; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Beetsma AL, 1998, EXP PARASITOL, V88, P69, DOI 10.1006/expr.1998.4203; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bookwalter CS, 2014, J BIOL CHEM, V289, P30832, DOI 10.1074/jbc.M114.572453; Bosch J, 2006, P NATL ACAD SCI USA, V103, P4852, DOI 10.1073/pnas.0510907103; Bosch J, 2007, J MOL BIOL, V372, P77, DOI 10.1016/j.jmb.2007.06.016; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Chaparro-Olaya J, 2005, CELL MOTIL CYTOSKEL, V60, P200, DOI 10.1002/cm.20055; Chaparro-Olaya J, 2003, EUR J PROTISTOL, V39, P423, DOI 10.1078/0932-4739-00015; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Douse CH, 2014, ACS CHEM BIOL, V9, P2204, DOI 10.1021/cb500271c; Douse CH, 2012, J BIOL CHEM, V287, P36968, DOI 10.1074/jbc.M112.379842; Farrow RE, 2011, SEMIN CELL DEV BIOL, V22, P953, DOI 10.1016/j.semcdb.2011.09.022; Feng DF, 1996, METHOD ENZYMOL, V266, P368; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Fowler RE, 2001, MOL BIOCHEM PARASIT, V117, P187, DOI 10.1016/S0166-6851(01)00351-6; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Green JL, 2006, J MOL BIOL, V355, P933, DOI 10.1016/j.jmb.2005.11.027; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002948; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Hettmann C, 2000, MOL BIOL CELL, V11, P1385, DOI 10.1091/mbc.11.4.1385; Heuck A, 2007, P NATL ACAD SCI USA, V104, P19778, DOI 10.1073/pnas.0706780104; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Johnson TM, 2007, MOL BIOL CELL, V18, P3039, DOI 10.1091/mbc.E07-01-0040; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Knuepfer E, 2014, CELL MICROBIOL, V16, P657, DOI 10.1111/cmi.12181; LOWEY S, 1993, NATURE, V365, P454, DOI 10.1038/365454a0; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; Martin SR, 2008, METHOD CELL BIOL, V84, P263, DOI 10.1016/S009l-679X(07)84010-6; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Moon RW, 2013, P NATL ACAD SCI USA, V110, P531, DOI 10.1073/pnas.1216457110; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Patzewitz EM, 2013, CELL REP, V3, P622, DOI 10.1016/j.celrep.2013.01.032; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinder JC, 1998, J CELL SCI, V111, P1831; READ M, 1993, PARASITOLOGY, V106, P223, DOI 10.1017/S0031182000075041; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; Ridzuan MAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033845; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Thomas JC, 2010, MOL BIOSYST, V6, P494, DOI 10.1039/b922093c; TRYBUS KM, 1994, J MUSCLE RES CELL M, V15, P587, DOI 10.1007/BF00121066; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030	50	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12147	12164		10.1074/jbc.M115.637694	http://dx.doi.org/10.1074/jbc.M115.637694			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25802338	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000354388600028
J	Ji, L; Xu, JJ; Liu, J; Amjad, A; Zhang, K; Liu, QW; Zhou, L; Xiao, JR; Li, XT				Ji, Lei; Xu, Jinjin; Liu, Jian; Amjad, Ali; Zhang, Kun; Liu, Qingwu; Zhou, Lei; Xiao, Jianru; Li, Xiaotao			Mutant p53 Promotes Tumor Cell Malignancy by Both Positive and Negative Regulation of the Transforming Growth Factor beta (TGF-beta) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; WILD-TYPE; DIFFERENTIAL REGULATION; MOUSE MODELS; SMAD2; GAIN; EXPRESSION; MUTATIONS; GENE; SUPPRESSOR	Specific p53 mutations abrogate tumor-suppressive functions by gaining new abilities to promote tumorigenesis. Inactivation of p53 is known to distort TGF-beta signaling, which paradoxically displays both tumor-suppressive and pro-oncogenic functions. The molecular mechanisms of how mutant p53 simultaneously antagonizes the tumor-suppressive and synergizes the tumor-promoting function of the TGF-beta pathway remain elusive. Here we demonstrate that mutant p53 differentially regulates subsets of TGF-beta target genes by enhanced binding to the MH2 domain in Smad3 upon the integration of ERK signaling, therefore disrupting Smad3/Smad4 complex formation. Silencing Smad2, inhibition of ERK, or introducing a phosphorylation-defective mutation at Ser-392 in p53 abrogates the R175H mutant p53-dependent regulation of these TGF-beta target genes. Our study shows a mechanism to reconcile the seemingly contradictory observations that mutant p53 can both attenuate and cooperate with the TGF-beta pathway to promote cancer cell malignancy in the same cell type.	[Ji, Lei; Xu, Jinjin; Amjad, Ali; Zhang, Kun; Liu, Qingwu; Zhou, Lei; Li, Xiaotao] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai Key Lab Brain Funct Genom,Minist Educ, Shanghai 200241, Peoples R China; [Liu, Jian; Li, Xiaotao] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Xiao, Jianru] Second Mil Med Univ, Changzheng Hosp, Dept Orthoped Oncol, Shanghai 200003, Peoples R China	East China Normal University; Baylor College of Medicine; Naval Medical University	Xiao, JR (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Orthoped Oncol, 415 Fengyang Rd, Shanghai 200003, Peoples R China.	jianruxiao@163.com; xiaotaol@bcm.edu	Xiao, Jian/GYU-4351-2022	Liu, Jian/0000-0002-1447-0973; Ji, Lei/0000-0002-6608-6009	National Basic Research Program of China [2011CB504200, 2015CB910403]; National Natural Science Foundation of China [814710066, 81261120555, 31071875, 31200878]; Science and Technology Commission of Shanghai Municipality [14430712100]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Basic Research Program of China Grants 2011CB504200 and 2015CB910403; National Natural Science Foundation of China Grants 814710066, 81261120555, 31071875, and 31200878; and Science and Technology Commission of Shanghai Municipality Grant 14430712100.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Ali A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3667; Attisano L, 2001, MOL CELL ENDOCRINOL, V180, P3, DOI 10.1016/S0303-7207(01)00524-X; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Chen YB, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-328; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Deb D, 2002, ONCOGENE, V21, P176, DOI 10.1038/sj/onc/1205035; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Di Minin G, 2014, MOL CELL, V56, P617, DOI 10.1016/j.molcel.2014.10.013; Duda DG, 2003, ONCOGENE, V22, P6857, DOI 10.1038/sj.onc.1206751; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Hanel W, 2013, CELL DEATH DIFFER, V20, P898, DOI 10.1038/cdd.2013.17; Jazag A, 2005, ONCOGENE, V24, P662, DOI 10.1038/sj.onc.1208102; Kalo E, 2007, MOL CELL BIOL, V27, P8228, DOI 10.1128/MCB.00374-07; Kim E, 2004, J CELL BIOCHEM, V93, P878, DOI 10.1002/jcb.20271; Kretschmer A, 2003, ONCOGENE, V22, P6748, DOI 10.1038/sj.onc.1206791; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lanyi A, 1998, ONCOGENE, V16, P3169, DOI 10.1038/sj.onc.1201857; Lee HJ, 2004, J BIOL CHEM, V279, P2666, DOI 10.1074/jbc.M310591200; Lin Xia, 2005, J RNAi Gene Silencing, V1, P38; Long JY, 2003, P NATL ACAD SCI USA, V100, P9791, DOI 10.1073/pnas.1733973100; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Park SH, 2008, MOL ENDOCRINOL, V22, P2085, DOI 10.1210/me.2007-0512; Peng BL, 2002, CLIN CANCER RES, V8, P3628; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Shinto O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-652; Sigal A, 2000, CANCER RES, V60, P6788; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Takenoshita S, 1998, GENOMICS, V48, P1, DOI 10.1006/geno.1997.5149; Ungefroren H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-67; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang H, 2005, J BIOL CHEM, V280, P5154, DOI 10.1074/jbc.M411575200; Wang H, 2008, ONCOGENE, V27, P6791, DOI 10.1038/onc.2008.291; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Zhang L, 2015, MOL CELL BIOCHEM, V400, P17, DOI 10.1007/s11010-014-2258-1	51	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11729	11740		10.1074/jbc.M115.639351	http://dx.doi.org/10.1074/jbc.M115.639351			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25767119	Green Published, hybrid			2022-12-28	WOS:000353719400045
J	Kamal, M; Gbahou, F; Guillaume, JL; Daulat, AM; Benleulmi-Chaachoua, A; Luka, M; Chen, P; Anaraki, DK; Baroncini, M; la Cour, CM; Millan, MJ; Prevot, V; Delagrange, P; Jockers, R				Kamal, Maud; Gbahou, Florence; Guillaume, Jean-Luc; Daulat, Avais M.; Benleulmi-Chaachoua, Abla; Luka, Marine; Chen, Patty; Anaraki, Dina Kalbasi; Baroncini, Marc; la Cour, Clotilde Mannoury; Millan, Mark J.; Prevot, Vincent; Delagrange, Philippe; Jockers, Ralf			Convergence of Melatonin and Serotonin (5-HT) Signaling at MT2/5-HT2C Receptor Heteromers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-PROTEIN; ALZHEIMERS-DISEASE; BETA-ARRESTIN; LIVING CELLS; MT2; HETERODIMERIZATION; DIMERS; DESENSITIZATION; TRANSDUCTION; DIMERIZATION	Inasmuch as the neurohormone melatonin is synthetically derived from serotonin (5-HT), a close interrelationship between both has long been suspected. The present study reveals a hitherto unrecognized cross-talk mediated via physical association of melatonin MT2 and 5-HT2C receptors into functional heteromers. This is of particular interest in light of the "synergistic" melatonin agonist/5-HT2C antagonist profile of the novel antidepressant agomelatine. A suite of co-immunoprecipitation, bioluminescence resonance energy transfer, and pharmacological techniques was exploited to demonstrate formation of functional MT2 and 5-HT2C receptor heteromers both in transfected cells and in human cortex and hippocampus. MT2/5-HT2C heteromers amplified the 5-HT-mediated Gq/phospholipase C response and triggered melatonin-induced unidirectional transactivation of the 5-HT2C protomer of MT2/5-HT2C heteromers. Pharmacological studies revealed distinct functional properties for agomelatine, which shows "biased signaling." These observations demonstrate the existence of functionally unique MT2/5-HT2C heteromers and suggest that the antidepressant agomelatine has a distinctive profile at these sites potentially involved in its therapeutic effects on major depression and generalized anxiety disorder. Finally, MT2/5-HT2C heteromers provide a new strategy for the discovery of novel agents for the treatment of psychiatric disorders.	[Kamal, Maud; Gbahou, Florence; Guillaume, Jean-Luc; Daulat, Avais M.; Benleulmi-Chaachoua, Abla; Luka, Marine; Chen, Patty; Anaraki, Dina Kalbasi; Jockers, Ralf] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [Kamal, Maud; Gbahou, Florence; Guillaume, Jean-Luc; Daulat, Avais M.; Benleulmi-Chaachoua, Abla; Luka, Marine; Chen, Patty; Anaraki, Dina Kalbasi; Jockers, Ralf] CNRS, UMR 8104, F-75014 Paris, France; [Kamal, Maud; Gbahou, Florence; Guillaume, Jean-Luc; Daulat, Avais M.; Benleulmi-Chaachoua, Abla; Luka, Marine; Chen, Patty; Anaraki, Dina Kalbasi; Jockers, Ralf] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Baroncini, Marc; Prevot, Vincent] Jean Pierre Aubert Res Ctr, U837, INSERM, F-59045 Lille, France; [la Cour, Clotilde Mannoury; Millan, Mark J.; Delagrange, Philippe] Inst Rech Servier, F-78290 Croissy Sur Seine, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Servier; Institut de Recherches Internationales Servier	Jockers, R (corresponding author), Inst Cochin, 22 Rue Mechain, F-75014 Paris, France.	ralf.jockers@inserm.fr	Prevot, Vincent/E-5720-2016; Gbahou, Florence/L-4664-2017; Jockers, Ralf/Q-2100-2019; Jockers, Ralf/P-2272-2017	Prevot, Vincent/0000-0001-7185-3615; Jockers, Ralf/0000-0002-4354-1750; Jockers, Ralf/0000-0002-4354-1750; Daulat, Avais/0000-0002-3076-2132	Fondation Recherche Medicale (Equipe FRM); French National Research Agency (ANR) Recherches Partenariales et Innovation Biomedicale [MED-HET-REC-2]; INSERM; CNRS; Who am I? laboratory of excellence - French Government [ANR-11-LABX-0071]; ANR [ANR-11-IDEX-0005-01]	Fondation Recherche Medicale (Equipe FRM); French National Research Agency (ANR) Recherches Partenariales et Innovation Biomedicale(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Who am I? laboratory of excellence - French Government; ANR(French National Research Agency (ANR))	This work was supported by grants from the Fondation Recherche Medicale (Equipe FRM to R. J.), The French National Research Agency (ANR) Recherches Partenariales et Innovation Biomedicale 2012 "MED-HET-REC-2," INSERM, CNRS, and the Who am I? laboratory of excellence ANR-11-LABX-0071 funded by the French Government through its "Investments for the Future" program operated by the ANR under Grant ANR-11-IDEX-0005-01.	Audinot V, 2003, N-S ARCH PHARMACOL, V367, P553, DOI 10.1007/s00210-003-0751-2; Berthouze M, 2005, FEBS LETT, V579, P2973, DOI 10.1016/j.febslet.2005.04.040; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Brunner P, 2006, EUR J HISTOCHEM, V50, P311; Charest PG, 2005, EMBO REP, V6, P334, DOI 10.1038/sj.embor.7400373; Chaste P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011495; Couturier C, 2003, J BIOL CHEM, V278, P26604, DOI 10.1074/jbc.M302002200; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Guillaume JL, 2008, J BIOL CHEM, V283, P16762, DOI 10.1074/jbc.M802069200; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Jockers R, 1998, ENDOCRINOLOGY, V139, P2676, DOI 10.1210/en.139.6.2676; Kamal Maud, 2009, Biotechnology Journal, V4, P1337, DOI 10.1002/biot.200900016; MacKenzie RS, 2002, BIOCHEM PHARMACOL, V63, P587, DOI 10.1016/S0006-2952(01)00881-4; Marion S, 2004, J BIOL CHEM, V279, P2945, DOI 10.1074/jbc.M308742200; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Millan MJ, 2008, TRENDS PHARMACOL SCI, V29, P454, DOI 10.1016/j.tips.2008.06.007; Millan MJ, 2003, J PHARMACOL EXP THER, V306, P954, DOI 10.1124/jpet.103.051797; Millan MJ, 2006, PHARMACOL THERAPEUT, V110, P135, DOI 10.1016/j.pharmthera.2005.11.006; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Pasqualetti M, 1999, NEUROSCIENCE, V92, P601, DOI 10.1016/S0306-4522(99)00011-1; Pei L, 2010, NAT MED, V16, P1393, DOI 10.1038/nm.2263; Petit L, 1999, BIOCHEM PHARMACOL, V58, P633, DOI 10.1016/S0006-2952(99)00134-3; Prosser RA, 1999, BRAIN RES, V818, P408, DOI 10.1016/S0006-8993(98)01295-5; Racagni G, 2011, WORLD J BIOL PSYCHIA, V12, P574, DOI 10.3109/15622975.2011.595823; Savaskan E, 2005, J PINEAL RES, V38, P10, DOI 10.1111/j.1600-079X.2004.00169.x; Wong EHF, 2010, PHARMACOL THERAPEUT, V126, P173, DOI 10.1016/j.pharmthera.2010.02.001; Ying SW, 1996, EUR J PHARMACOL, V296, P33, DOI 10.1016/0014-2999(95)00684-2	31	70	72	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11537	11546		10.1074/jbc.M114.559542	http://dx.doi.org/10.1074/jbc.M114.559542			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25770211	Green Published, hybrid			2022-12-28	WOS:000353719400029
J	Serebryany, E; King, JA				Serebryany, Eugene; King, Jonathan A.			Wild-type Human gamma D-crystallin Promotes Aggregation of Its Oxidation-mimicking, Misfolding-prone W42Q Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEK KEY DOMAINS; PROTEIN AGGREGATION; IN-VITRO; SUPEROXIDE-DISMUTASE; S-CRYSTALLIN; HUMAN LENS; CATARACT FORMATION; STABILITY; MECHANISM; POLYMERIZATION	Non-native protein conformers generated by mutation or chemical damage template aggregation of wild-type, undamaged polypeptides in diseases ranging from amyotrophic lateral sclerosis to cancer. We tested for such interactions in the natively monomeric human eye lens protein gamma D-crystallin, whose aggregation leads to cataract disease. The oxidation-mimicking W42Q mutant of gamma D-crystallin formed non-native polymers starting from a native-like state under physiological conditions. Aggregation occurred in the temperature range 35-45 degrees C, in which the mutant protein began to lose the native conformation of its N-terminal domain. Surprisingly, wild-type gamma D-crystallin promoted W42Q polymerization in a catalytic manner, even at mutant concentrations too low for homogeneous nucleation to occur. The presence of wild-type protein also downshifted the temperature range of W42Q aggregation. W42Q aggregation required formation of a non-native intramolecular disulfide bond but not intermolecular cross-linking. Transient WT/W42Q binding may catalyze this oxidative mis-folding event in the mutant. That a more stable variant in a mixture can specifically promote aggregation of a less stable one rationalizes how extensive aggregation of rare damaged polypeptides can occur during the course of aging.	[Serebryany, Eugene; King, Jonathan A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	King, JA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave 68-318, Cambridge, MA 02139 USA.	jaking@mit.edu	Serebryany, Eugene/E-4595-2017		National Institutes of Health from the National Eye Institute [EY015834]; Massachusetts Institute of Technology Biology/Merck academic support fellowships; NATIONAL EYE INSTITUTE [R01EY015834] Funding Source: NIH RePORTER	National Institutes of Health from the National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Massachusetts Institute of Technology Biology/Merck academic support fellowships; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY015834 from the National Eye Institute (to J. A. K.). This work was also supported by Massachusetts Institute of Technology Biology/Merck academic support fellowships to (E. S.).	Adachi K, 2006, J MOL BIOL, V362, P528, DOI 10.1016/j.jmb.2006.07.047; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Audet JN, 2010, NEUROBIOL DIS, V40, P245, DOI 10.1016/j.nbd.2010.05.031; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Chen J, 2009, BIOCHEMISTRY-US, V48, P3708, DOI 10.1021/bi802177g; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Das P, 2011, P NATL ACAD SCI USA, V108, P10514, DOI 10.1073/pnas.1019152108; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Hains PG, 2007, J PROTEOME RES, V6, P3935, DOI 10.1021/pr070138h; Hains PG, 2008, BBA-PROTEINS PROTEOM, V1784, P1959, DOI 10.1016/j.bbapap.2008.07.016; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; Ji FL, 2013, PROTEINS, V81, P1493, DOI 10.1002/prot.24321; Ji FL, 2013, J BIOL CHEM, V288, P99, DOI 10.1074/jbc.M112.416354; Ji FL, 2012, BIOCHEMISTRY-US, V51, P2588, DOI 10.1021/bi300199d; Jung J, 2009, BIOCHEMISTRY-US, V48, P2597, DOI 10.1021/bi802292q; Keenan J, 2008, MOL VIS, V14, P1245; Kirby E. P., 1970, J PHYS CHEM-US, V74, P4480, DOI DOI 10.1021/J100720A004; Kosinski-Collins MS, 2004, PROTEIN SCI, V13, P2223, DOI 10.1110/ps.04627004; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Krishnan B, 2011, NAT STRUCT MOL BIOL, V18, P222, DOI 10.1038/nsmb.1976; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Lee S, 2010, J MOL BIOL, V399, P320, DOI 10.1016/j.jmb.2010.04.003; Lindahl K, 2009, BIOCHEM BIOPH RES CO, V384, P501, DOI 10.1016/j.bbrc.2009.05.006; Lynch M, 2012, MOL BIOL EVOL, V29, P1353, DOI 10.1093/molbev/msr300; Mahler B, 2011, J MOL BIOL, V405, P840, DOI 10.1016/j.jmb.2010.11.005; McNulty R, 2004, J PHYSIOL-LONDON, V559, P883, DOI 10.1113/jphysiol.2004.068619; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Mills IA, 2007, PROTEIN SCI, V16, P2427, DOI 10.1110/ps.072970207; MITRAKI A, 1991, SCIENCE, V253, P54, DOI 10.1126/science.1648264; Moran SD, 2013, BIOCHEMISTRY-US, V52, P6169, DOI 10.1021/bi4008353; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Moreau KL, 2009, J BIOL CHEM, V284, P33285, DOI 10.1074/jbc.M109.031344; Nosil P, 2011, TRENDS ECOL EVOL, V26, P160, DOI 10.1016/j.tree.2011.01.001; Pande A, 2009, BIOCHEMISTRY-US, V48, P4937, DOI 10.1021/bi9004182; Papanikolopoulou K, 2008, MOL VIS, V14, P81; Rousseau F, 2001, P NATL ACAD SCI USA, V98, P5596, DOI 10.1073/pnas.101542098; Schafheimer N, 2013, PHOTOCHEM PHOTOBIOL, V89, P1106, DOI 10.1111/php.12096; Serebryany E, 2014, PROG BIOPHYS MOL BIO, V115, P32, DOI 10.1016/j.pbiomolbio.2014.05.002; Shi YH, 2013, J AM CHEM SOC, V135, P15897, DOI 10.1021/ja407801x; SIEZEN RJ, 1985, P NATL ACAD SCI USA, V82, P1701, DOI 10.1073/pnas.82.6.1701; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Wang BB, 2011, HUM MUTAT, V32, pE1939, DOI 10.1002/humu.21386; Wang Y, 2010, P NATL ACAD SCI USA, V107, P13282, DOI 10.1073/pnas.1008353107; Wei M, 2015, INVEST OPHTH VIS SCI, V56, P598, DOI 10.1167/iovs.14-15452; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Wilcken R, 2012, P NATL ACAD SCI USA, V109, P13584, DOI 10.1073/pnas.1211550109; Witan H, 2008, HUM MOL GENET, V17, P1373, DOI 10.1093/hmg/ddn025; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Xia Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01560; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171	61	22	22	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11491	11503		10.1074/jbc.M114.621581	http://dx.doi.org/10.1074/jbc.M114.621581			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25787081	hybrid, Green Published			2022-12-28	WOS:000353719400025
J	Dwyer, CA; Katoh, T; Tiemeyer, M; Matthews, RT				Dwyer, Chrissa A.; Katoh, Toshihiko; Tiemeyer, Michael; Matthews, Russell T.			Neurons and Glia Modify Receptor Protein-tyrosine Phosphatase zeta (RPTP zeta)/Phosphacan with Cell-specific O-Mannosyl Glycans in the Developing Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain; Extracellular Matrix; Glycosylation; Muscular Dystrophy; Proteoglycan; Cat-315; O-Glycan; O-Mannose; POMGnT1; RPTPzeta; Phosphacan	CHONDROITIN SULFATE PROTEOGLYCAN; CONGENITAL MUSCULAR-DYSTROPHY; REDUCTIVE ALKALINE-HYDROLYSIS; ALPHA-DYSTROGLYCAN; DEVELOPMENTAL EXPRESSION; ADHESION MOLECULES; MOUSE-BRAIN; STEM-CELLS; RAT-BRAIN; RPTP-BETA	Protein O-mannosylation is a glycan modification that is required for normal nervous system development and function. Mutations in genes involved in protein O-mannosyl glycosylation give rise to a group of neurodevelopmental disorders known as congenital muscular dystrophies (CMDs) with associated CNS abnormalities. Our previous work demonstrated that receptor protein-tyrosine phosphatase (RPTP)/phosphacan is hypoglycosylated in a mouse model of one of these CMDs, known as muscle-eye-brain disease, a disorder that is caused by loss of an enzyme (protein O-mannose -1,2-N-acetylglucosaminyltransferase 1) that modifies O-mannosyl glycans. In addition, monoclonal antibodies Cat-315 and 3F8 were demonstrated to detect O-mannosyl glycan modifications on RPTP/phosphacan. Here, we show that O-mannosyl glycan epitopes recognized by these antibodies define biochemically distinct glycoforms of RPTP/phosphacan and that these glycoforms differentially decorate the surface of distinct populations of neural cells. To provide a further structural basis for immunochemically based glycoform differences, we characterized the O-linked glycan heterogeneity of RPTP/phosphacan in the early postnatal mouse brain by multidimensional mass spectrometry. Structural characterization of the O-linked glycans released from purified RPTP/phosphacan demonstrated that this protein is a significant substrate for protein O-mannosylation and led to the identification of several novel O-mannose-linked glycan structures, including sulfo-N-acetyllactosamine containing modifications. Taken together, our results suggest that specific glycan modifications may tailor the function of this protein to the unique needs of specific cells. Furthermore, their absence in CMDs suggests that hypoglycosylation of RPTP/phosphacan may have different functional consequences in neurons and glia.	[Dwyer, Chrissa A.; Matthews, Russell T.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Katoh, Toshihiko; Tiemeyer, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University System of Georgia; University of Georgia	Matthews, RT (corresponding author), SUNY Upstate Med Univ, Dept Neurosci & Physiol, 750 E Adams St, Syracuse, NY 13210 USA.	matthewr@upstate.edu		Dwyer, Chrissa/0000-0003-4565-2558	National Institutes of Health (NIH), NINDS [NS069660]; NIH, NCRR [P41RR018502]; NIH, NIGMS [P41GM103490]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069660] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NINDS, Grant NS069660 (to R. T. M.). Support and access to instrumentation was also provided through NIH, NCRR, Grant P41RR018502 and NIH, NIGMS, Grant P41GM103490.	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; Alvarez-Manilla G, 2010, GLYCOBIOLOGY, V20, P166, DOI 10.1093/glycob/cwp158; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; BARNEA G, 1994, J BIOL CHEM, V269, P14349; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bleckmann C, 2009, BIOL CHEM, V390, P627, DOI 10.1515/BC.2009.044; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Canoll PD, 1996, J NEUROSCI RES, V44, P199, DOI 10.1002/(SICI)1097-4547(19960501)44:3<199::AID-JNR1>3.0.CO;2-B; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Dino MR, 2006, NEUROSCIENCE, V142, P1055, DOI 10.1016/j.neuroscience.2006.07.054; Dwyer CA, 2012, NEUROSCIENCE, V220, P47, DOI 10.1016/j.neuroscience.2012.06.026; Faissner A, 2006, ADV EXP MED BIOL, V557, P25; FINNE J, 1979, J BIOL CHEM, V254, P295; Garwood J, 2003, J BIOL CHEM, V278, P24164, DOI 10.1074/jbc.M211721200; Giamanco KA, 2010, NEUROSCIENCE, V170, P1314, DOI 10.1016/j.neuroscience.2010.08.032; Goldberg HA, 1997, ANAL BIOCHEM, V251, P227, DOI 10.1006/abio.1997.2252; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Hayashi N, 2005, NEUROSCIENCE, V131, P331, DOI 10.1016/j.neuroscience.2004.11.017; Ida M, 2006, J BIOL CHEM, V281, P5982, DOI 10.1074/jbc.M507130200; Inamori K, 2004, J BIOL CHEM, V279, P2337, DOI 10.1074/jbc.C300480200; Inamori K, 2013, GLYCOBIOLOGY, V23, P295, DOI 10.1093/glycob/cws152; Kanekiyo K, 2013, J NEUROSCI, V33, P10037, DOI 10.1523/JNEUROSCI.3137-12.2013; Kogelberg H, 2001, CARBOHYD RES, V331, P393, DOI 10.1016/S0008-6215(01)00051-9; KRUSIUS T, 1986, J BIOL CHEM, V261, P8237; KRUSIUS T, 1987, BIOCHEM J, V245, P229, DOI 10.1042/bj2450229; Kumagai T, 2013, ANAL CHEM, V85, P8692, DOI 10.1021/ac4015935; Lamprianou S, 2011, P NATL ACAD SCI USA, V108, P17498, DOI 10.1073/pnas.1108774108; Lander C, 1998, J NEUROSCI, V18, P174; Lee JK, 2012, J BIOL CHEM, V287, P28526, DOI 10.1074/jbc.M112.367565; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; MAEDA N, 1995, NEUROSCIENCE, V67, P23, DOI 10.1016/0306-4522(94)00069-H; MAUREL P, 1995, DNA SEQUENCE, V5, P323, DOI 10.3109/10425179509030989; MAUREL P, 1994, P NATL ACAD SCI USA, V91, P2512, DOI 10.1073/pnas.91.7.2512; McClain CR, 2012, J NEUROSCI, V32, P15066, DOI 10.1523/JNEUROSCI.1320-12.2012; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; MILEV P, 1994, J CELL BIOL, V127, P1703, DOI 10.1083/jcb.127.6.1703; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Morise J, 2014, GLYCOBIOLOGY, V24, P314, DOI 10.1093/glycob/cwt116; Niisato K, 2005, J NEUROSCI, V25, P1081, DOI 10.1523/JNEUROSCI.2565.04.2005; Pacharra S, 2013, J PROTEOME RES, V12, P1764, DOI 10.1021/pr3011028; Pacharra S, 2012, J PROTEOME RES, V11, P3955, DOI 10.1021/pr200996y; Praissman JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03943; Ranjan M, 1996, MOL CELL NEUROSCI, V7, P404, DOI 10.1006/mcne.1996.0029; RAUCH U, 1991, J BIOL CHEM, V266, P14785; Satz JS, 2010, J NEUROSCI, V30, P14560, DOI 10.1523/JNEUROSCI.3247-10.2010; Schessl Joachim, 2006, Semin Pediatr Neurol, V13, P80, DOI 10.1016/j.spen.2006.06.003; SHITARA K, 1994, J BIOL CHEM, V269, P20189; Soh BS, 2007, STEM CELLS, V25, P3029, DOI 10.1634/stemcells.2007-0372; Stalnaker SH, 2011, J BIOL CHEM, V286, P21180, DOI 10.1074/jbc.M110.203281; Viapiano MS, 2003, J BIOL CHEM, V278, P33239, DOI 10.1074/jbc.M303480200; Willer T, 2014, ELIFE, V3, DOI 10.7554/eLife.03941; Winterhalter PR, 2013, FEBS LETT, V587, P3715, DOI 10.1016/j.febslet.2013.09.041; Yagi H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03288; Yaji S, 2015, GLYCOBIOLOGY, V25, P376, DOI 10.1093/glycob/cwu118; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Yoshihara T, 2009, J BIOL CHEM, V284, P12550, DOI 10.1074/jbc.M809188200	64	24	25	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10256	10273		10.1074/jbc.M114.614099	http://dx.doi.org/10.1074/jbc.M114.614099			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25737452	Green Published, hybrid			2022-12-28	WOS:000353241100031
J	Nakajima, T; Kitagawa, K; Ohhata, T; Sakai, S; Uchida, C; Shibata, K; Minegishi, N; Yumimoto, K; Nakayama, KI; Masumoto, K; Katou, F; Niida, H; Kitagawa, M				Nakajima, Tomomi; Kitagawa, Kyoko; Ohhata, Tatsuya; Sakai, Satoshi; Uchida, Chiharu; Shibata, Kiyoshi; Minegishi, Naoko; Yumimoto, Kanae; Nakayama, Keiichi I.; Masumoto, Kazuma; Katou, Fuminori; Niida, Hiroyuki; Kitagawa, Masatoshi			Regulation of GATA-binding Protein 2 Levels via Ubiquitin-dependent Degradation by Fbw7 INVOLVEMENT OF CYCLIN B-CYCLIN- DEPENDENT KINASE 1-MEDIATED PHOSPHORYLATION OF THR176 IN GATA-BINDING PROTEIN 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclin-dependent Kinase (CDK); GATA Transcription Factor; Phosphorylation; Protein Degradation; Ubiquitin Ligase; Ubiquitylation (Ubiquitination); Fbw7	T-CELL DEVELOPMENT; F-BOX PROTEIN; MOUSE C-MYB; TRANSCRIPTION FACTOR; TUMOR-SUPPRESSOR; ENFORCED EXPRESSION; HEMATOPOIETIC STEM; BUTYROLACTONE-I; FBXW7 ACTS; SCFFBW7	A GATA family transcription factor, GATA-binding protein 2 (GATA2), participates in cell growth and differentiation of various cells, such as hematopoietic stem cells. Although its expression level is controlled by transcriptional induction and proteolytic degradation, the responsible E3 ligase has not been identified. Here, we demonstrate that F-box/WD repeat-containing protein 7 (Fbw7/Fbxw7), a component of Skp1, Cullin 1, F-box-containing complex (SCF)-type E3 ligase, is an E3 ligase for GATA2. GATA2 contains a cell division control protein 4 (Cdc4) phosphodegron (CPD), a consensus motif for ubiquitylation by Fbw7, which includes Thr(176). Ectopic expression of Fbw7 destabilized GATA2 and promoted its proteasomal degradation. Substitution of threonine 176 to alanine in GATA2 inhibited binding with Fbw7, and the ubiquitylation and degradation of GATA2 by Fbw7 was suppressed. The CPD kinase, which mediates the phosphorylation of Thr(176), was cyclin B-cyclin-dependent kinase 1 (CDK1). Moreover, depletion of endogenous Fbw7 stabilized endogenous GATA2 in K562 cells. Conditional Fbw7 depletion in mice increased GATA2 levels in hematopoietic stem cells and myeloid progenitors at the early stage. Increased GATA2 levels in Fbw7-conditional knock-out mice were correlated with a decrease in a c-Kit high expressing population of myeloid progenitor cells. Our results suggest that Fbw7 is a bona fide E3 ubiquitin ligase for GATA2 in vivo.	[Nakajima, Tomomi; Kitagawa, Kyoko; Ohhata, Tatsuya; Sakai, Satoshi; Niida, Hiroyuki; Kitagawa, Masatoshi] Hamamatsu Univ Sch Med, Dept Mol Biol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Nakajima, Tomomi; Masumoto, Kazuma; Katou, Fuminori] Hamamatsu Univ Sch Med, Oral & Maxillofacial Surg, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Uchida, Chiharu; Shibata, Kiyoshi] Hamamatsu Univ Sch Med, Res Equipment Ctr, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Minegishi, Naoko] Tohoku Univ, Dept Biobank Life Sci, Sch Med, Aoba Ku, Sendai, Miyagi 9808573, Japan; [Yumimoto, Kanae; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Tohoku University; Kyushu University	Kitagawa, M (corresponding author), Hamamatsu Univ Sch Med, Dept Mol Biol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	kitamasa@hama-med.ac.jp		Ohhata, Tatsuya/0000-0003-1124-6164	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24570151, 25112508]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grants-in-aid 24570151 (to K. K.) and 25112508 (to M. K.).	Fu L, 2009, CANCER RES, V69, P8967, DOI 10.1158/0008-5472.CAN-09-2190; Fukushima H, 2012, CELL REP, V1, P434, DOI 10.1016/j.celrep.2012.04.002; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hatakeyama S, 2003, BIOCHEM BIOPH RES CO, V302, P635, DOI 10.1016/S0006-291X(03)00245-6; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Ishida H, 2012, EUR J PEDIATR, V171, P1273, DOI 10.1007/s00431-012-1715-7; Kanei-Ishii C, 2008, J BIOL CHEM, V283, P30540, DOI 10.1074/jbc.M804340200; Kitagawa K, 2009, ONCOGENE, V28, P2393, DOI 10.1038/onc.2009.111; Kitagawa K, 2014, MOL CELL BIOL, V34, P2732, DOI 10.1128/MCB.01549-13; Kitagawa K, 2012, CURR DRUG TARGETS, V13, P1641, DOI 10.2174/138945012803529974; Kitagawa K, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-27; Kitagawa K, 2009, CANCER SCI, V100, P1374, DOI 10.1111/j.1349-7006.2009.01196.x; KITAGAWA M, 1994, ONCOGENE, V9, P2549; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; KITAGAWA M, 1993, ONCOGENE, V8, P2425; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Koga S, 2007, BLOOD, V109, P4200, DOI 10.1182/blood-2006-08-044149; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Minegishi N, 2005, GENES CELLS, V10, P693, DOI 10.1111/j.1365-2443.2005.00864.x; Minegishi N, 2003, BLOOD, V102, P896, DOI 10.1182/blood-2002-12-3809; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nawijn MC, 2001, J IMMUNOL, V167, P715, DOI 10.4049/jimmunol.167.2.715; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; PINES J, 1993, TRENDS BIOCHEM SCI, V18, P195, DOI 10.1016/0968-0004(93)90185-P; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Reavie L, 2013, CANCER CELL, V23, P362, DOI 10.1016/j.ccr.2013.01.025; Rodrigues NP, 2012, INT J BIOCHEM CELL B, V44, P457, DOI 10.1016/j.biocel.2011.12.004; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Shimizu R, 2012, CANCER SCI, V103, P2039, DOI 10.1111/cas.12007; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Spinner MA, 2014, BLOOD, V123, P809, DOI 10.1182/blood-2013-07-515528; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Takeishi S, 2013, CANCER CELL, V23, P347, DOI 10.1016/j.ccr.2013.01.026; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tipping AJ, 2009, BLOOD, V113, P2661, DOI 10.1182/blood-2008-06-161117; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Vicente C, 2012, CRIT REV ONCOL HEMAT, V82, P1, DOI 10.1016/j.critrevonc.2011.04.007; Wang ZW, 2012, FEBS LETT, V586, P1409, DOI 10.1016/j.febslet.2012.03.017; Wang ZW, 2012, EMBO REP, V13, P36, DOI 10.1038/embor.2011.231; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Yumimoto K, 2012, J PROTEOME RES, V11, P3175, DOI 10.1021/pr201216u	54	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10368	10381		10.1074/jbc.M114.613018	http://dx.doi.org/10.1074/jbc.M114.613018			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25670854	Green Published, hybrid			2022-12-28	WOS:000353241100038
J	Tomasovic, A; Kurrle, N; Surun, D; Heidler, J; Husnjak, K; Poser, I; Schnutgen, F; Scheibe, S; Seimetz, M; Jaksch, P; Hyman, A; Weissmann, N; von Melchner, H				Tomasovic, Ana; Kurrle, Nina; Sueruen, Duran; Heidler, Juliana; Husnjak, Koraljka; Poser, Ina; Schnuetgen, Frank; Scheibe, Susan; Seimetz, Michael; Jaksch, Peter; Hyman, Anthony; Weissmann, Norbert; von Melchner, Harald			Sestrin 2 Protein Regulates Platelet-derived Growth Factor Receptor beta (Pdgfr beta) Expression by Modulating Proteasomal and Nrf2 Transcription Factor Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; EMBRYONIC STEM-CELLS; 20S PROTEASOME; OXIDATIVE STRESS; PEROXIREDOXINS; SUBUNIT; GENES; DEGRADATION; PATHWAY; COMPLEX	We recently identified the antioxidant protein Sestrin 2 (Sesn2) as a suppressor of platelet-derived growth factor receptor beta (Pdgfr beta) signaling and Pdgfr beta signaling as an inducer of lung regeneration and injury repair. Here, we identified Sesn2 and the antioxidant gene inducer nuclear factor erythroid 2-related factor 2 (Nrf2) as positive regulators of proteasomal function. Inactivation of Sesn2 or Nrf2 induced reactive oxygen species-mediated proteasomal inhibition and Pdgfr beta accumulation. Using bacterial artificial chromosome (BAC) transgenic HeLa and mouse embryonic stem cells stably expressing enhanced green fluorescent protein-tagged Sesn2 at nearly endogenous levels, we also showed that Sesn2 physically interacts with 2-Cys peroxiredoxins and Nrf2 albeit under different reductive conditions. Overall, we characterized a novel, redox-sensitive Sesn2/Pdgfr beta suppressor pathway that negatively interferes with lung regeneration and is up-regulated in the emphysematous lungs of patients with chronic obstructive pulmonary disease (COPD).	[Tomasovic, Ana; Kurrle, Nina; Sueruen, Duran; Heidler, Juliana; Schnuetgen, Frank; von Melchner, Harald] Goethe Univ Frankfurt, Sch Med, Dept Mol Hematol, D-60590 Frankfurt, Germany; [Husnjak, Koraljka] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany; [Poser, Ina; Hyman, Anthony] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Scheibe, Susan; Seimetz, Michael; Weissmann, Norbert] UGMLC, Dept Internal Med, Univ Giessen, Excellence Cluster Cardiopulm Syst ECCPS, D-35392 Giessen, Germany; [Jaksch, Peter] Univ Hosp Vienna, Dept Thorac Surg, A-1090 Vienna, Austria	Goethe University Frankfurt; Goethe University Frankfurt; Max Planck Society; Justus Liebig University Giessen; University Hospital Vienna	von Melchner, H (corresponding author), Goethe Univ Frankfurt, Sch Med, Dept Mol Hematol, D-60590 Frankfurt, Germany.	melchner@em.uni-frankfurt.de	Hyman, Tony/F-1923-2011; Schnütgen, Frank/ABD-8637-2020; Husnjak, Koraljka/C-3717-2015	Schnütgen, Frank/0000-0002-2426-6685; Husnjak, Koraljka/0000-0003-0573-6239; jaksch, peter/0000-0003-4635-3242; Weissmann, Norbert/0000-0003-2675-3871	Deutsche Forschungsgemeinschaft (DFG) [SFB815]; DFG [ME 820-2]; Else Kroner-Fresenius-Stiftung [2011-A47]; Bundesministerium fur Bildung und Forschung (NGFN-plus-DiGtoP consortium) [01GS0858]; Excellence Cluster Cardiopulmonary System (ECCPS); Boehringer Ingelheim Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung; Bundesministerium fur Bildung und Forschung (NGFN-plus-DiGtoP consortium)(Federal Ministry of Education & Research (BMBF)); Excellence Cluster Cardiopulmonary System (ECCPS)(German Research Foundation (DFG)); Boehringer Ingelheim Foundation(Boehringer Ingelheim)	This work was supported by the SFB815 "Redox Signaling" of the Deutsche Forschungsgemeinschaft (DFG) and by individual grants from the DFG (ME 820-2) and the Else Kroner-Fresenius-Stiftung (2011-A47) (to H. v. M. and N. W.) and from the Bundesministerium fur Bildung und Forschung (NGFN-plus-DiGtoP consortium/01GS0858 (to H. v. M. and A. H.). Additional support was received from the Excellence Cluster Cardiopulmonary System (ECCPS) and the Boehringer Ingelheim Foundation.	Andersen KM, 2009, J BIOL CHEM, V284, P15246, DOI 10.1074/jbc.M900016200; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002; Baker TA, 2014, PHYSIOL RES, V63, P311, DOI 10.33549/physiolres.932607; Biswal Shyam, 2012, Proc Am Thorac Soc, V9, P47, DOI 10.1513/pats.201201-009MS; Brandsma CA, 2015, THORAX, V70, P21, DOI 10.1136/thoraxjnl-2014-205091; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Chen YH, 2006, BLOOD, V108, P566, DOI 10.1182/blood-2005-12-4777; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Comandini A, 2010, PULM PHARMACOL THER, V23, P482, DOI 10.1016/j.pupt.2010.05.006; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dagnell M, 2013, P NATL ACAD SCI USA, V110, P13398, DOI 10.1073/pnas.1302891110; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Heidler J, 2013, DIS MODEL MECH, V6, P1378, DOI 10.1242/dmm.013482; Hendil KB, 2009, J MOL BIOL, V394, P320, DOI 10.1016/j.jmb.2009.09.038; Hewitt KJ, 2009, TISSUE ENG PT A, V15, P3417, DOI [10.1089/ten.tea.2009.0060, 10.1089/ten.TEA.2009.0060]; Hubner RH, 2009, MOL MED, V15, P203, DOI 10.2119/molmed.2008.00130; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ishisaki A, 1997, EUR J BIOCHEM, V246, P142, DOI 10.1111/j.1432-1033.1997.t01-2-00142.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jayarapu K, 2004, BIOCHEM BIOPH RES CO, V314, P523, DOI 10.1016/j.bbrc.2003.12.119; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kurrle N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084393; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lau A, 2013, ANTIOXID REDOX SIGN, V18, P91, DOI 10.1089/ars.2012.4754; Liu SY, 2011, FEBS LETT, V585, P1853, DOI 10.1016/j.febslet.2011.04.041; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Malhotra D, 2009, AM J RESP CRIT CARE, V180, P1196, DOI 10.1164/rccm.200903-0324OC; Manni I, 2008, MOL BIOL CELL, V19, P5203, DOI 10.1091/mbc.E08-03-0295; Mittal M, 2007, CIRC RES, V101, P258, DOI 10.1161/CIRCRESAHA.107.148015; MORI S, 1995, BIOCHEM BIOPH RES CO, V217, P224, DOI 10.1006/bbrc.1995.2767; Nystrom T, 2012, GENE DEV, V26, P2001, DOI 10.1101/gad.200006.112; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Pierrou S, 2007, AM J RESP CRIT CARE, V175, P577, DOI 10.1164/rccm.200607-931OC; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Schnutgen F, 2011, NAT METHODS, V8, P103, DOI 10.1038/nmeth0211-103; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Tomasovic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029739; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232; Wempe F, 2010, DIS MODEL MECH, V3, P246, DOI 10.1242/dmm.004234; Wiseman RL, 2009, J BIOL CHEM, V284, P15233, DOI 10.1074/jbc.M109.002121; Woo HA, 2009, ANTIOXID REDOX SIGN, V11, P739, DOI 10.1089/ARS.2008.2360; Zalvide J, 1998, MOL CELL BIOL, V18, P1408, DOI 10.1128/MCB.18.3.1408; Zhu LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055695	52	15	17	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9738	9752		10.1074/jbc.M114.632133	http://dx.doi.org/10.1074/jbc.M114.632133			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25716320	hybrid, Green Published			2022-12-28	WOS:000352729400035
J	Golan, Y; Berman, B; Assaraf, YG				Golan, Yarden; Berman, Bluma; Assaraf, Yehuda G.			Heterodimerization, Altered Subcellular Localization, and Function of Multiple Zinc Transporters in Viable Cells Using Bimolecular Fluorescence Complementation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVING CELLS; INTRACELLULAR ZINC; ALZHEIMERS-DISEASE; SLC30A2 ZNT-2; DEFICIENCY; EXPRESSION; FAMILY; VISUALIZATION; TOXICITY; MUTATION	Zinc plays a crucial role in numerous key physiological functions. Zinc transporters (ZnTs) mediate zinc efflux and compartmentalization in intracellular organelles; thus, ZnTs play a central role in zinc homeostasis. We have recently shown the in situ dimerization and function of multiple normal and mutant ZnTs using bimolecular fluorescence complementation (BiFC). Prompted by these findings, we here uncovered the heterodimerization, altered subcellular localization, and function of multiple ZnTs in live cells using this sensitive BiFC technique. We show that ZnT1, -2, -3, and -4 form stable heterodimers at distinct intracellular compartments, some of which are completely different from their homodimer localization. Specifically, unlike the plasma membrane (PM) localization of ZnT1 homodimers, ZnT1-ZnT3 heterodimers localized at intracellular vesicles. Furthermore, upon heterodimerization with ZnT1, the zinc transporters ZnT2 and ZnT4 surprisingly localized at the PM, as opposed to their vesicular homodimer localization. We further demonstrate the deleterious effect that the G87R-ZnT2 mutation, associated with transient neonatal zinc deficiency, has on ZnT1, ZnT3, and ZnT4 upon heterodimerization. The functionality of the various ZnTs was assessed by the dual BiFC-Zinquin assay. We also undertook a novel transfection competition assay with ZnT cDNAs to confirm that the driving force for heterodimer formation is the core structure of ZnTs and not the BiFC tags. These findings uncover a novel network of homo-and heterodimers of ZnTs with distinct subcellular localizations and function, hence highlighting their possible role in zinc homeostasis under physiological and pathological conditions.	[Golan, Yarden; Berman, Bluma; Assaraf, Yehuda G.] Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Assaraf, YG (corresponding author), Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel.	assaraf@tx.technion.ac.il		Golan, Yarden/0000-0002-3043-3638; Assaraf, Yehuda G./0000-0001-6692-8221				Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Beyer N, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-53; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Falcon-Perez JM, 2007, EXP CELL RES, V313, P1473, DOI 10.1016/j.yexcr.2007.02.006; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Gohlke Henning, 2008, Rev Diabet Stud, V5, P25, DOI 10.1900/RDS.2008.5.25; Haider AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025818; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Itsumura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064045; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Kambe T, 2014, CELL MOL LIFE SCI, V71, P3281, DOI 10.1007/s00018-014-1617-0; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Kilpatrick Laura E, 2012, Methods Mol Biol, V897, P109, DOI 10.1007/978-1-61779-909-9_6; KRIEGER I, 1986, AM J CLIN NUTR, V43, P955, DOI 10.1093/ajcn/43.6.955; Kukic I, 2014, J CELL SCI, V127, P3094, DOI 10.1242/jcs.145318; Lasry I, 2014, J BIOL CHEM, V289, P7275, DOI 10.1074/jbc.M113.533786; Lasry I, 2012, J BIOL CHEM, V287, P29348, DOI 10.1074/jbc.M112.368159; Lazarczyk M, 2009, MICROBIOL MOL BIOL R, V73, P348, DOI 10.1128/MMBR.00033-08; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee J, 2011, BRAIN RES BULL, V86, P314, DOI 10.1016/j.brainresbull.2011.08.011; Lopez V, 2009, BIOCHEM J, V422, P43, DOI 10.1042/BJ20081189; Navarro ML, 2014, PEDIATR DERMATOL, V31, P251, DOI 10.1111/pde.12257; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Michalczyk AA, 2002, BIOCHEM J, V364, P105, DOI 10.1042/bj3640105; Miletta MC, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/259189; Nolte C, 2004, GLIA, V48, P145, DOI 10.1002/glia.20065; Overbeck S, 2008, J LEUKOCYTE BIOL, V83, P368, DOI 10.1189/jlb.0307148; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Prasad AS, 2012, J TRACE ELEM MED BIO, V26, P66, DOI 10.1016/j.jtemb.2012.04.004; Qian LX, 2009, AM J PHYSIOL-CELL PH, V297, pC369, DOI 10.1152/ajpcell.00589.2008; Salazar G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005896; Seo YA, 2011, AM J PHYSIOL-CELL PH, V300, pC1479, DOI 10.1152/ajpcell.00420.2010; Seo YA, 2010, PHYSIOL GENOMICS, V42A, P219, DOI 10.1152/physiolgenomics.00137.2010; Susperreguy S, 2011, EXP CELL RES, V317, P706, DOI 10.1016/j.yexcr.2010.11.008; Vaniotis G, 2011, AM J PHYSIOL-HEART C, V301, pH1754, DOI 10.1152/ajpheart.00657.2011; Weijers RNM, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-33; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568	42	33	33	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9050	9063		10.1074/jbc.M114.617332	http://dx.doi.org/10.1074/jbc.M114.617332			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25657003	Green Published, hybrid			2022-12-28	WOS:000352207100029
J	Scrima, N; Lepault, J; Boulard, Y; Pasdeloup, D; Bressanelli, S; Roche, S				Scrima, Nathalie; Lepault, Jean; Boulard, Yves; Pasdeloup, David; Bressanelli, Stephane; Roche, Stephane			Insights into Herpesvirus Tegument Organization from Structural Analyses of the 970 Central Residues of HSV-1 UL36 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLEX-VIRUS 1; NUCLEAR-LOCALIZATION SIGNAL; PSEUDORABIES VIRUS; CAPSID TRANSPORT; MOLECULAR-DYNAMICS; TYPE-1; VP1-2; DNA; VISUALIZATION; ASSOCIATION	The tegument of all herpesviruses contains a capsid-bound large protein that is essential for multiple viral processes, including capsid transport, decapsidation at the nuclear pore complex, particle assembly, and secondary envelopment, through mechanisms that are still incompletely understood. We report here a structural characterization of the central 970 residues of this protein for herpes simplex virus type 1 (HSV-1 UL36, 3164 residues). This large fragment is essentially a 34-nm-long monomeric fiber. The crystal structure of its C terminus shows an elongated domain-swapped dimer. Modeling and molecular dynamics simulations give a likely molecular organization for the monomeric form and extend our findings to alphaherpesvirinae. Hence, we propose that an essential feature of UL36 is the existence in its central region of a stalk capable of connecting capsid and membrane across the tegument and that the ability to switch between monomeric and dimeric forms may help UL36 fulfill its multiple functions.	[Scrima, Nathalie; Lepault, Jean; Boulard, Yves; Bressanelli, Stephane; Roche, Stephane] Inst Integrat Biol Cell I2BC, F-91198 Gif Sur Yvette, France; [Boulard, Yves] Commissariat Energie Atom, Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France; [Pasdeloup, David] INSERM, Fac Pharm, UMR 984, F-92290 Chatenay Malabry, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Bressanelli, S (corresponding author), Inst Integrat Biol Cell I2BC, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	stephane.bressanelli@vms.cnrs-gif.fr; stephane.roche@vms.cnrs-gif.fr	Lepault, Jean/AAN-8859-2020	Bressanelli, Stephane/0000-0002-0921-6727; Pasdeloup, David/0000-0003-3922-4493				Abaitua F, 2008, J VIROL, V82, P5234, DOI 10.1128/JVI.02497-07; Abaitua F, 2012, J VIROL, V86, P8998, DOI 10.1128/JVI.01209-12; Abaitua F, 2011, J VIROL, V85, P2024, DOI 10.1128/JVI.01895-10; Abaitua F, 2009, J GEN VIROL, V90, P2353, DOI 10.1099/vir.0.012492-0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aggarwal A, 2012, J VIROL, V86, P6123, DOI 10.1128/JVI.07016-11; Antinone SE, 2010, J VIROL, V84, P13019, DOI 10.1128/JVI.01296-10; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bolstad M, 2011, J VIROL, V85, P8738, DOI 10.1128/JVI.00798-11; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen DH, 1999, VIROLOGY, V260, P10, DOI 10.1006/viro.1999.9791; Coller KE, 2007, J VIROL, V81, P11790, DOI 10.1128/JVI.01113-07; Copeland AM, 2009, J VIROL, V83, P1660, DOI 10.1128/JVI.01139-08; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Desai PJ, 2000, J VIROL, V74, P11608, DOI 10.1128/JVI.74.24.11608-11618.2000; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fuchs W, 2004, J VIROL, V78, P11879, DOI 10.1128/JVI.78.21.11879-11889.2004; Granzow H, 2005, J VIROL, V79, P3200, DOI 10.1128/JVI.79.5.3200-3205.2005; Grunewald K, 2003, SCIENCE, V302, P1396, DOI 10.1126/science.1090284; Jambunathan N, 2014, J VIROL, V88, P5927, DOI 10.1128/JVI.00278-14; Jovasevic V, 2008, J VIROL, V82, P3311, DOI 10.1128/JVI.01919-07; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kattenhorn LM, 2005, MOL CELL, V19, P547, DOI 10.1016/j.molcel.2005.07.003; Klupp BG, 2002, J VIROL, V76, P3065, DOI 10.1128/JVI.76.6.3065-3071.2002; Ko DH, 2010, J VIROL, V84, P1397, DOI 10.1128/JVI.01721-09; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee JIH, 2006, J VIROL, V80, P12086, DOI 10.1128/JVI.01184-06; Luxton GWG, 2006, J VIROL, V80, P201, DOI 10.1128/JVI.80.1.201-209.2006; Luxton GWG, 2005, P NATL ACAD SCI USA, V102, P5832, DOI 10.1073/pnas.0500803102; McElwee M, 2013, J VIROL, V87, P11008, DOI 10.1128/JVI.01633-13; Mijatov B, 2007, VIROLOGY, V368, P26, DOI 10.1016/j.virol.2007.07.005; Newcomb WW, 2010, J VIROL, V84, P9408, DOI 10.1128/JVI.00361-10; Pasdeloup D, 2013, J VIROL, V87, P7102, DOI 10.1128/JVI.00764-13; Pasdeloup D, 2013, J VIROL, V87, P2857, DOI 10.1128/JVI.02676-12; Pasdeloup D, 2009, J VIROL, V83, P6610, DOI 10.1128/JVI.02655-08; Radtke K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000991; Roberts APE, 2009, J VIROL, V83, P105, DOI 10.1128/JVI.01032-08; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandbaumhuter M, 2013, CELL MICROBIOL, V15, P248, DOI 10.1111/cmi.12075; Schlieker C, 2005, J VIROL, V79, P15582, DOI 10.1128/JVI.79.24.15582-15585.2005; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen C, 2008, PROTEINS, V71, P1744, DOI 10.1002/prot.21857; Svobodova S, 2012, J VIROL, V86, P473, DOI 10.1128/JVI.05981-11; Tullman JA, 2014, J VIROL, V88, P8256, DOI 10.1128/JVI.00971-14; Vittone V, 2005, J VIROL, V79, P9566, DOI 10.1128/JVI.79.15.9566-9571.2005; Wang SM, 2013, J SPECTROSC, V2013, P1, DOI 10.1155/2013/646050; Zaichick SV, 2013, CELL HOST MICROBE, V13, P193, DOI 10.1016/j.chom.2013.01.009; Zhou ZH, 1999, J VIROL, V73, P3210, DOI 10.1128/JVI.73.4.3210-3218.1999; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27	53	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8820	8833		10.1074/jbc.M114.612838	http://dx.doi.org/10.1074/jbc.M114.612838			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25678705	hybrid, Green Published			2022-12-28	WOS:000352207100012
J	Thaysen-Andersen, M; Venkatakrishnan, V; Loke, I; Laurini, C; Diestel, S; Parker, BL; Packer, NH				Thaysen-Andersen, Morten; Venkatakrishnan, Vignesh; Loke, Ian; Laurini, Christine; Diestel, Simone; Parker, Benjamin L.; Packer, Nicolle H.			Human Neutrophils Secrete Bioactive Paucimannosidic Proteins from Azurophilic Granules into Pathogen-Infected Sputum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-HEXOSAMINIDASE-B; N-GLYCANS; CAENORHABDITIS-ELEGANS; STRUCTURAL-ANALYSIS; INSECT CELLS; GLYCOSYLATION; CANCER; EXPRESSION; MODEL; LIFE	Unlike plants and invertebrates, mammals reportedly lack proteins displaying asparagine (N)-linked paucimannosylation (mannose(1-3)fucose(0-1)N-acetylglucosamine(2)Asn). Enabled by technology advancements in system-wide biomolecular characterization, we document that protein paucimannosylation is a significant host-derived molecular signature of neutrophil-rich sputum from pathogen-infected human lungs and is negligible in pathogen-free sputum. Five types of paucimannosidic N-glycans were carried by compartment-specific and inflammation-associated proteins of the azurophilic granules of human neutrophils including myeloperoxidase (MPO), azurocidin, and neutrophil elastase. The timely expressed human azurophilic granule-resident beta-hexosaminidase A displayed the capacity to generate paucimannosidic N-glycans by trimming hybrid/complex type N-glycan intermediates with relative broad substrate specificity. Paucimannosidic N-glycoepitopes showed significant co-localization with beta-hexosaminidase A and the azurophilic marker MPO in human neutrophils using immunocytochemistry. Furthermore, promyelocyte stage-specific expression of genes coding for paucimannosidic proteins and biosynthetic enzymes indicated a novel spatio-temporal biosynthetic route in early neutrophil maturation. The absence of bacterial exoglycosidase activities and paucimannosidic N-glycans excluded exogenous origins of paucimannosylation. Paucimannosidic proteins from isolated and sputum neutrophils were preferentially secreted upon inoculation with virulent Pseudomonas aeruginosa. Finally, paucimannosidic proteins displayed affinities to mannose-binding lectin, suggesting immune-related functions of paucimannosylation in activated human neutrophils. In conclusion, we are the first to document that human neutrophils produce, store and, upon activation, selectively secrete bioactive paucimannosidic proteins into sputum of lungs undergoing pathogen-based inflammation.	[Thaysen-Andersen, Morten; Venkatakrishnan, Vignesh; Loke, Ian; Packer, Nicolle H.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Laurini, Christine; Diestel, Simone] Univ Bonn, Inst Nutr & Food Sci, D-53113 Bonn, Germany; [Parker, Benjamin L.] Garvan Inst Med Res, Diabet & Obes Program, Sydney, NSW 2010, Australia	Macquarie University; University of Bonn; Garvan Institute of Medical Research	Thaysen-Andersen, M (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	morten.andersen@mq.edu.au	Loke, Ian/H-7377-2013; Packer, Nicolle/Q-8929-2019	Loke, Ian/0000-0002-2558-0975; Thaysen-Andersen, Morten/0000-0001-8327-6843; Packer, Nicolle/0000-0002-7532-4021	Australian Research Council Super Science Program [FS110200026]; Early Career Fellowship, Cancer Institute NSW	Australian Research Council Super Science Program(Australian Research Council); Early Career Fellowship, Cancer Institute NSW	This work was supported by the Australian Research Council Super Science Program (FS110200026).; Funded by an Early Career Fellowship, Cancer Institute NSW.	Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; Altmann F, 2001, BIOCHIMIE, V83, P703, DOI 10.1016/S0300-9084(01)01297-4; Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; Babu P, 2009, GLYCOCONJUGATE J, V26, P975, DOI 10.1007/s10719-008-9146-4; Balog CIA, 2012, MOL CELL PROTEOMICS, V11, P571, DOI 10.1074/mcp.M111.011601; Bilyy RO, 2012, J BIOL CHEM, V287, P496, DOI 10.1074/jbc.M111.273144; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Bouckaert J, 2006, MOL MICROBIOL, V61, P1556, DOI 10.1111/j.1365-2958.2006.05352.x; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cipollo JF, 2002, J BIOL CHEM, V277, P49143, DOI 10.1074/jbc.M208020200; Dam S, 2013, J PROTEOME RES, V12, P3383, DOI 10.1021/pr400224s; Everest-Dass AV, 2012, GLYCOBIOLOGY, V22, P1465, DOI 10.1093/glycob/cws112; Faid V, 2006, GLYCOBIOLOGY, V16, P440, DOI 10.1093/glycob/cwj081; Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; Hashii N, 2009, IMMUNOLOGY, V126, P336, DOI 10.1111/j.1365-2567.2008.02898.x; HASLAM SM, 2002, BIOCH SOC S, V69, P117; Hepbildikler ST, 2002, J BIOL CHEM, V277, P2562, DOI 10.1074/jbc.M105457200; Jayaram L, 2007, CAN RESPIR J, V14, P99, DOI 10.1155/2007/679742; Jensen PH, 2012, NAT PROTOC, V7, P1299, DOI 10.1038/nprot.2012.063; Jin CS, 2012, J BIOL CHEM, V287, P35922, DOI 10.1074/jbc.M112.363119; Joosten CE, 2004, BIOTECHNOL PROGR, V20, P1273, DOI 10.1021/bp034378n; Kain R, 2008, NAT MED, V14, P1088, DOI 10.1038/nm.1874; Kaprio T, 2015, MOL CELL PROTEOMICS, V14, P277, DOI 10.1074/mcp.M114.041632; Kjeldsen L, 1998, J LEUKOCYTE BIOL, V64, P72, DOI 10.1002/jlb.64.1.72; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Lee LY, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00404; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Leymarie N, 2013, MOL CELL PROTEOMICS, V12, P2935, DOI 10.1074/mcp.M113.030643; Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200; MEIER EM, 1991, J BIOL CHEM, V266, P1879; MIYASAKI KT, 1991, INFECT IMMUN, V59, P3760, DOI 10.1128/IAI.59.10.3760-3767.1991; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Mysling S, 2010, ANAL CHEM, V82, P5598, DOI 10.1021/ac100530w; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Olczak M, 2002, BIOCHEM BIOPH RES CO, V293, P213, DOI 10.1016/S0006-291X(02)00201-2; Parker BL, 2013, J PROTEOME RES, V12, P5791, DOI 10.1021/pr400783j; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Ravnsborg T, 2010, BBA-PROTEINS PROTEOM, V1804, P2046, DOI 10.1016/j.bbapap.2010.07.001; Rorvig S, 2013, J LEUKOCYTE BIOL, V94, P711, DOI 10.1189/jlb.1212619; Sarkar M, 2006, J BIOL CHEM, V281, P12776, DOI 10.1074/jbc.M512769200; Schachter H, 2011, FLY, V5, P18, DOI 10.4161/fly.5.1.13920; Schachter H, 2009, CARBOHYD RES, V344, P1391, DOI 10.1016/j.carres.2009.04.028; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Schiller B, 2012, BIOL CHEM, V393, P661, DOI 10.1515/hsz-2012-0150; Schuette CG, 2001, GLYCOBIOLOGY, V11, P549, DOI 10.1093/glycob/11.7.549; Sethi MK, 2014, J PROTEOME RES, V13, P277, DOI 10.1021/pr400861m; Shi H, 2006, METHOD ENZYMOL, V417, P359, DOI 10.1016/S0076-6879(06)17022-6; Taganna J, 2011, BIOCHEM SOC T, V39, P349, DOI 10.1042/BST0390349; Thaysen-Andersen M, 2012, GLYCOBIOLOGY, V22, P1440, DOI 10.1093/glycob/cws110; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Timar CI, 2013, BLOOD, V121, P510, DOI 10.1182/blood-2012-05-431114; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; van Remoortere A, 2003, GLYCOBIOLOGY, V13, P217, DOI 10.1093/glycob/cwg025; Venkatakrishnan V, 2015, GLYCOBIOLOGY, V25, P88, DOI 10.1093/glycob/cwu092; Winchester B, 2005, GLYCOBIOLOGY, V15, p1R, DOI 10.1093/glycob/cwi041; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Yagi H, 2012, J BIOL CHEM, V287, P24356, DOI 10.1074/jbc.M112.365643; Zhang WL, 2003, BIOCHEM J, V372, P53, DOI 10.1042/BJ20021931; Zinchuk V, 2013, SCI REP-UK, V3, DOI 10.1038/srep01365; Zipser B, 2012, J CARBOHYD CHEM, V31, P504, DOI 10.1080/07328303.2012.661112; Zoega M, 2012, J PROTEOMICS, V75, P1472, DOI 10.1016/j.jprot.2011.11.019	73	67	71	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8789	8802		10.1074/jbc.M114.631622	http://dx.doi.org/10.1074/jbc.M114.631622			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25645918	hybrid, Green Published			2022-12-28	WOS:000352207100010
J	Ngu, M; Hirata, E; Suzuki, K				Ngu, Meipin; Hirata, Eri; Suzuki, Kuninori			Visualization of Atg3 during Autophagosome Formation in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASM; PROTEINS; YEAST; DELIVERY; MUTANTS; COMPLEX; SYSTEM; ENZYME	Macroautophagy (autophagy) is a highly conserved cellular recycling process involved in degradation of eukaryotic cellular components. During autophagy, macromolecules and organelles are sequestered into the double-membrane autophagosome and degraded in the vacuole/lysosome. Autophagy-related 8 (Atg8), a core Atg protein essential for autophagosome formation, is a marker of several autophagic structures: the pre-autophagosomal structure (PAS), isolation membrane (IM), and autophagosome. Atg8 is conjugated to phosphatidylethanolamine (PE) through a ubiquitin-like conjugation system to yield Atg8-PE; this reaction is called Atg8 lipidation. Although the mechanisms of Atg8 lipidation have been well studied in vitro, the cellular locale of Atg8 lipidation remains enigmatic. Atg3 is an E2-like enzyme that catalyzes the conjugation reaction between Atg8 and PE. Therefore, we hypothesized that the localization of Atg3 would provide insights about the site of the lipidation reaction. To explore this idea, we constructed functional GFP-tagged Atg3 (Atg3-GFP) by inserting the GFP portion immediately after the handle region of Atg3. During autophagy, Atg3-GFP transiently formed a single dot per cell on the vacuolar membrane. This Atg3-GFP dot colocalized with 2 x mCherry-tagged Atg8, demonstrating that Atg3 is localized to autophagic structures. Furthermore, we found that Atg3-GFP is localized to theIMby fine-localization analysis. The localization of Atg3 suggests that Atg3 plays an important role in autophagosome formation at the IM.	[Ngu, Meipin; Hirata, Eri; Suzuki, Kuninori] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; [Suzuki, Kuninori] Univ Tokyo, Grad Sch Frontier Sci, Bioimaging Ctr, Kashiwa, Chiba 2778562, Japan	University of Tokyo; University of Tokyo	Suzuki, K (corresponding author), Univ Tokyo, FSB 101,5-1-5 Kashiwanoha, Kashiwa, Chiba 2778562, Japan.	kuninori@k.u-tokyo.ac.jp			International Kyowa Scholarship Foundation; Hamaguchi Foundation for the Advancement of Biochemistry; Mishima Kaiun Memorial Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science; Takeda Science Foundation; Yamada Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [24121707, 24657083, 25291040]; Grants-in-Aid for Scientific Research [26111505] Funding Source: KAKEN	International Kyowa Scholarship Foundation; Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Takeda Science Foundation(Takeda Science Foundation (TSF)); Yamada Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the International Kyowa Scholarship Foundation (to M. N.), the Hamaguchi Foundation for the Advancement of Biochemistry (to K. S.), the Mishima Kaiun Memorial Foundation (to K. S.), the NOVARTIS Foundation (Japan) for the Promotion of Science (to K. S.), the Takeda Science Foundation (to K. S.), the Yamada Science Foundation (to K. S.), and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24121707, 24657083, and 25291040) (to K. S.).	Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hanada T, 2009, FEBS LETT, V583, P1078, DOI 10.1016/j.febslet.2009.03.009; HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Kaiser SE, 2012, NAT STRUCT MOL BIOL, V19, P1242, DOI 10.1038/nsmb.2415; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; SIKORSKI RS, 1989, GENETICS, V122, P19; Suzuki K, 2002, DEV CELL, V3, P815, DOI 10.1016/S1534-5807(02)00359-3; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091651; Suzuki K, 2013, J CELL SCI, V126, P2534, DOI 10.1242/jcs.122960; Suzuki K, 2011, DEV CELL, V21, P358, DOI 10.1016/j.devcel.2011.06.023; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670	34	20	21	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8146	8153		10.1074/jbc.M114.626952	http://dx.doi.org/10.1074/jbc.M114.626952			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25645919	Green Published, hybrid			2022-12-28	WOS:000351662600012
J	Capurro, M; Shi, W; Izumikawa, T; Kitagawa, H; Filmus, J				Capurro, Mariana; Shi, Wen; Izumikawa, Tomomi; Kitagawa, Hiroshi; Filmus, Jorge			Processing by Convertases Is Required for Glypican-3-induced Inhibition of Hedgehog Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Convertase; Glycosaminoglycan; Hedgehog Signaling Pathway; Heparan Sulfate; Proteoglycan; Glypican-3	GOLABI-BEHMEL-SYNDROME; HEPATOCELLULAR-CARCINOMA; CORE PROTEIN; CELL-SURFACE; DALLY-LIKE; GLYPICANS; OVERGROWTH; MORPHOGEN; GROWTH; STIMULATION	Background: Glypican-3 (GPC3) is a proteoglycan that is cleaved by convertases and that inhibits Hedgehog signaling. Results: Convertase-resistant GPC3 stimulates Hedgehog signaling, and unlike wild-type GPC3, binds to Patched through its heparan sulfate chains. Conclusion: Convertase cleavage is required for GPC3-induced inhibition of Hedgehog signaling. Significance: The structure of the GPC3 core-protein determines the binding properties of heparan sulfate chains. Glypican-3 (GPC3) is one of the six members of the mammalian glypican family. We have previously reported that GPC3 inhibits Hedgehog (Hh) signaling by competing with Patched (Ptc) for Hh binding. We also showed that GPC3 binds with high affinity to Hh through its core protein, but that it does not interact with Ptc. Several members of the glypican family, including GPC3, are subjected to an endoproteolytic cleavage by the furin-like convertase family of endoproteases. Surprisingly, however, we have found that a mutant GPC3 that cannot be processed by convertases is as potent as wild-type GPC3 in stimulating Wnt activity in hepatocellular carcinoma cell lines and 293T cells and in promoting hepatocellular carcinoma growth. In this study, we show that processing by convertases is essential for GPC3-induced inhibition of Hh signaling. Moreover, we show that a convertase-resistant GPC3 stimulates Hh signaling by increasing the binding of this growth factor to Ptc. Consistent with this, we show that the convertase-resistant mutant binds to both Hh and Ptc through its heparan sulfate (HS) chains. Unexpectedly, we found that the mutant core protein does not bind to Hh. We also report that the convertase-resistant mutant GPC3 carries HS chains with a significantly higher degree of sulfation than those of wild-type GPC3. We propose that the structural changes generated by the lack of cleavage determine a change in the sulfation of the HS chains and that these hypersulfated chains mediate the interaction of the mutant GPC3 with Ptc.	[Capurro, Mariana; Shi, Wen; Izumikawa, Tomomi; Filmus, Jorge] Univ Toronto, Sunnybrook Res Inst, Biol Sci, Toronto, ON M4N 3M5, Canada; [Capurro, Mariana; Shi, Wen; Izumikawa, Tomomi; Filmus, Jorge] Univ Toronto, Dept Med Biophys, Toronto, ON M4N 3M5, Canada; [Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Kobe Pharmaceutical University	Filmus, J (corresponding author), Sunnybrook Res Inst, Rm S218,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	jorge.filmus@sri.utoronto.ca	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079; Capurro, Mariana/0000-0002-4560-7186	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035; Cano-Gauci DF, 1999, J CELL BIOL, V146, P255; Capurro M, 2003, GASTROENTEROLOGY, V125, P89, DOI 10.1016/S0016-5085(03)00689-9; Capurro M, 2014, J CELL SCI, V127, P1565, DOI 10.1242/jcs.140871; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Capurro MI, 2012, J CELL SCI, V125, P3380, DOI 10.1242/jcs.098889; Capurro MI, 2009, EMBO REP, V10, P901, DOI 10.1038/embor.2009.98; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Capurro MI, 2005, J BIOL CHEM, V280, P41201, DOI 10.1074/jbc.M507004200; De Cat B, 2003, J CELL BIOL, V163, P625, DOI 10.1083/jcb.200302152; De Cat B, 2001, SEMIN CELL DEV BIOL, V12, P117, DOI 10.1006/scdb.2000.0240; Dejima K, 2011, J BIOL CHEM, V286, P17103, DOI 10.1074/jbc.M110.208082; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Filmus J, 2014, MATRIX BIOL, V35, P248, DOI 10.1016/j.matbio.2013.12.007; Filmus J, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P209; Gao W, 2014, HEPATOLOGY, V60, P576, DOI 10.1002/hep.26996; Gutierrez J, 2010, MOL CELL BIOL, V30, P1634, DOI 10.1128/MCB.01164-09; Jackson SM, 1997, DEVELOPMENT, V124, P4113; Kreuger J, 2012, J HISTOCHEM CYTOCHEM, V60, P898, DOI 10.1369/0022155412464972; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Song HH, 2002, BBA-GEN SUBJECTS, V1573, P241, DOI 10.1016/S0304-4165(02)00390-2; Song HH, 2005, J BIOL CHEM, V280, P2116, DOI 10.1074/jbc.M410090200; Victor XV, 2009, J BIOL CHEM, V284, P25842, DOI 10.1074/jbc.M109.043208; Williams EH, 2010, P NATL ACAD SCI USA, V107, P5869, DOI 10.1073/pnas.1001777107; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yan D, 2010, DEVELOPMENT, V137, P2033, DOI 10.1242/dev.045740; Yan D, 2009, DEV CELL, V17, P470, DOI 10.1016/j.devcel.2009.09.001	29	17	18	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7576	7585		10.1074/jbc.M114.612705	http://dx.doi.org/10.1074/jbc.M114.612705			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25653284	Green Published, hybrid			2022-12-28	WOS:000351613600022
J	Mohanty, S; Jagannathan, L; Ganguli, G; Padhi, A; Roy, D; Alaridah, N; Saha, P; Nongthomba, U; Godaly, G; Gopal, RK; Banerjee, S; Sonawane, A				Mohanty, Soumitra; Jagannathan, Lakshmanan; Ganguli, Geetanjali; Padhi, Avinash; Roy, Debasish; Alaridah, Nader; Saha, Pratip; Nongthomba, Upendra; Godaly, Gabriela; Gopal, Ramesh Kumar; Banerjee, Sulagna; Sonawane, Avinash			A Mycobacterial Phosphoribosyltransferase Promotes Bacillary Survival by Inhibiting Oxidative Stress and Autophagy Pathways in Macrophages and Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; STEADY-STATE KINETICS; NECROSIS-FACTOR-ALPHA; ASN-LINKED GLYCANS; MYCOLOYL RESIDUES; SPECIES ROS; TUBERCULOSIS; PROTEIN; IDENTIFICATION; GLYCOSYLATION	Mycobacterium tuberculosis employs various strategies to modulate host immune responses to facilitate its persistence in macrophages. The M. tuberculosis cell wall contains numerous glycoproteins with unknown roles in pathogenesis. Here, by using Concanavalin A and LC-MS analysis, we identified a novel mannosylated glycoprotein phosphoribosyltransferase, encoded by Rv3242c from M. tuberculosis cell walls. Homology modeling, bioinformatic analyses, and an assay of phosphoribosyltransferase activity in Mycobacterium smegmatis expressing recombinant Rv3242c (MsmRv3242c) confirmed the mass spectrometry data. Using Mycobacterium marinum-zebrafish and the surrogate MsmRv3242c infection models, we proved that phosphoribosyltransferase is involved in mycobacterial virulence. Histological and infection assays showed that the M. marinum mimG mutant, an Rv3242c orthologue in a pathogenic M. marinum strain, was strongly attenuated in adult zebrafish and also survived less in macrophages. In contrast, infection with wild type and the complemented Delta mimG: Rv3242c M. marinum strains showed prominent pathological features, such as severe emaciation, skin lesions, hemorrhaging, and more zebrafish death. Similarly, recombinant Msm Rv3242c bacteria showed increased invasion in non-phagocytic epithelial cells and longer intracellular survival in macrophages as compared with wild type and vector control M. smegmatis strains. Further mechanistic studies revealed that the Rv3242c- and mimG-mediated enhancement of intramacrophagic survival was due to inhibition of autophagy, reactive oxygen species, and reduced activities of superoxide dismutase and catalase enzymes. Infection with MsmRv3242c also activated the MAPK pathway, NF-kappa B, and inflammatory cytokines. In summary, we show that a novel mycobacterial mannosylated phosphoribosyltransferase acts as a virulence and immunomodulatory factor, suggesting that it may constitute a novel target for antimycobacterial drugs.	[Mohanty, Soumitra; Jagannathan, Lakshmanan; Ganguli, Geetanjali; Padhi, Avinash; Sonawane, Avinash] KIIT Univ, Sch Biotechnol, Bhubaneswar 751024, Orissa, India; [Jagannathan, Lakshmanan; Gopal, Ramesh Kumar; Banerjee, Sulagna] Anna Univ, AU KBC Res Ctr, Madras 600025, Tamil Nadu, India; [Roy, Debasish; Nongthomba, Upendra] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Alaridah, Nader; Godaly, Gabriela] Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, S-22100 Lund, Sweden; [Saha, Pratip] Indian Inst Sci, Bioinformat Ctr, Bangalore 560012, Karnataka, India; [Banerjee, Sulagna] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA	Kalinga Institute of Industrial Technology (KIIT); Anna University; Anna University Chennai; Indian Institute of Science (IISC) - Bangalore; Lund University; Indian Institute of Science (IISC) - Bangalore; University of Minnesota System; University of Minnesota Twin Cities	Sonawane, A (corresponding author), KIIT Univ, Sch Biotechnol, Campus 11, Bhubaneswar 751024, Orissa, India.	asonawane@kiitbiotech.ac.in	Nongthomba, Upendra/AAY-3009-2021; Jagannathan, Lakshmanan/H-2965-2012; Sonawane, Avinash/S-9889-2019; Padhi, Avinash/AAM-7741-2021; Godaly, Gabriela/AAD-7545-2019	Jagannathan, Lakshmanan/0000-0003-0421-034X; Padhi, Avinash/0000-0002-5545-3598; Godaly, Gabriela/0000-0002-3467-1350; Roy, Debasish/0000-0003-4233-3295; Nongthomba, Upendra/0000-0002-0616-5995; Mohanty, Soumitra/0000-0003-0919-5062; Alaridah, Nader/0000-0003-3659-8203	ICMR [AMR/44/2011-ECD-I]; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research (CSIR), Government of India [09/1035/0005/2012-EMR-1]	ICMR(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by ICMR Grant AMR/44/2011-ECD-I (to A. S.). Zebrafish work at the laboratory of U. N. was supported by the Department of Biotechnology, Government of India.; Recipient of Senior Research Fellowship 09/1035/0005/2012-EMR-1 from the Council of Scientific and Industrial Research (CSIR), Government of India.	Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x; ANTHONY LSD, 1994, FEMS IMMUNOL MED MIC, V8, P299, DOI 10.1016/0928-8244(94)00004-2; Aoki K, 2004, J BIOL CHEM, V279, P39798, DOI 10.1074/jbc.M402677200; Bai XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061925; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bhat KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052601; Biazus G, 2009, PROTEIN EXPRES PURIF, V66, P185, DOI 10.1016/j.pep.2009.04.001; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo-San Pedro JM, 2013, CELL MOL LIFE SCI, V70, P121, DOI 10.1007/s00018-012-1061-y; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Broussard GW, 2007, COMP BIOCHEM PHYS C, V145, P45, DOI 10.1016/j.cbpc.2006.07.012; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Casas-Terradellas E, 2008, BBA-MOL CELL RES, V1783, P2241, DOI 10.1016/j.bbamcr.2008.08.011; Castric P, 2001, J BIOL CHEM, V276, P26479, DOI 10.1074/jbc.M102685200; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; Choi KP, 2002, J BACTERIOL, V184, P2420, DOI 10.1128/JB.184.9.2420-2428.2002; Coler RN, 2001, J IMMUNOL, V166, P6227, DOI 10.4049/jimmunol.166.10.6227; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; Daly TK, 2013, GENOME BIOL EVOL, V5, P217, DOI 10.1093/gbe/evs135; Danelishvili L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010474; Das K, 2001, BBA-MOL BASIS DIS, V1537, P1, DOI 10.1016/S0925-4439(01)00048-5; Davis AS, 2007, PLOS PATHOG, V3, P1887, DOI 10.1371/journal.ppat.0030186; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Diaz-Silvestre H, 2005, MICROB PATHOGENESIS, V39, P97, DOI 10.1016/j.micpath.2005.06.002; Dobos KM, 1996, J BACTERIOL, V178, P2498, DOI 10.1128/jb.178.9.2498-2506.1996; Ducati RG, 2006, MEM I OSWALDO CRUZ, V101, P697, DOI 10.1590/S0074-02762006000700001; Duckworth M, 2006, HELICOBACTER, V11, P287, DOI 10.1111/j.1523-5378.2006.00409.x; Ehlers MRW, 1998, TRENDS MICROBIOL, V6, P328, DOI 10.1016/S0966-842X(98)01301-8; Fenton MJ, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P405; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; Fratti RA, 2003, J BIOL CHEM, V278, P46961, DOI 10.1074/jbc.M305225200; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Gagliardi MC, 2009, INFECT IMMUN, V77, P4947, DOI 10.1128/IAI.00607-09; Ganguly N, 2008, IMMUNOL CELL BIOL, V86, P98, DOI 10.1038/sj.icb.7100117; Giacomini E, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/841346; Gonzalez-Zamnorano M, 2009, J PROTEOME RES, V8, P721, DOI 10.1021/pr800756a; Govender VS, 2014, MICROBIOL-SGM, V160, P1821, DOI 10.1099/mic.0.082206-0; Gupta D, 2010, J IMMUNOL, V184, P5444, DOI 10.4049/jimmunol.0903283; Hirabayashi Jun, 2002, J Biomol Tech, V13, P205; HOVEJENSEN B, 1986, J BIOL CHEM, V261, P6765; Jena P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050345; Juffermans NP, 2000, J INFECT DIS, V182, P888, DOI 10.1086/315750; Jung SB, 2006, INFECT IMMUN, V74, P2686, DOI 10.1128/IAI.74.5.2686-2696.2006; Kim L, 2005, J IMMUNOL, V174, P4178, DOI 10.4049/jimmunol.174.7.4178; Kremer L, 2002, LETT APPL MICROBIOL, V34, P233, DOI 10.1046/j.1472-765x.2002.01091.x; KRUG EC, 1989, J BIOL CHEM, V264, P10601; Krungkrai SR, 2004, MOL BIOCHEM PARASIT, V134, P245, DOI 10.1016/j.molbiopara.2003.12.006; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Kumar AS, 2012, MOL IMMUNOL, V49, P655, DOI 10.1016/j.molimm.2011.11.011; Lagier B, 1998, MOL MICROBIOL, V29, P465, DOI 10.1046/j.1365-2958.1998.00933.x; Lara M, 2004, APPL ENVIRON MICROB, V70, P679, DOI 10.1128/AEM.70.2.679-685.2004; Lim YJ, 2013, APOPTOSIS, V18, P150, DOI 10.1007/s10495-012-0792-4; Linton D, 2005, MOL MICROBIOL, V55, P1695, DOI 10.1111/j.1365-2958.2005.04519.x; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Manca C, 1997, INFECT IMMUN, V65, P4951, DOI 10.1128/IAI.65.12.4951-4957.1997; McCarthy TR, 2005, MOL MICROBIOL, V58, P774, DOI 10.1111/j.1365-2958.2005.04862.x; Mehta PK, 2006, MICROB PATHOGENESIS, V40, P139, DOI 10.1016/j.micpath.2005.12.002; Michell SL, 2003, J BIOL CHEM, V278, P16423, DOI 10.1074/jbc.M207959200; Miller BH, 2004, INFECT IMMUN, V72, P2872, DOI 10.1128/IAI.72.5.2872-2878.2004; Miltner E, 2005, INFECT IMMUN, V73, P4214, DOI 10.1128/IAI.73.7.4214-4221.2005; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Mukhopadhyay D, 2014, B ENVIRON CONTAM TOX, V93, P64, DOI 10.1007/s00128-014-1271-0; Munagala NR, 1998, BIOCHEMISTRY-US, V37, P4045, DOI 10.1021/bi972515h; Paglin S, 2001, CANCER RES, V61, P439; Palma C, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/690328; Park HJ, 2011, MOL IMMUNOL, V48, P720, DOI 10.1016/j.molimm.2010.10.020; PATTICHIS K, 1994, ANAL BIOCHEM, V221, P428, DOI 10.1006/abio.1994.1441; Pitarque S, 2005, BIOCHEM J, V392, P615, DOI 10.1042/BJ20050709; PLUMMER TH, 1995, J BIOL CHEM, V270, P13192, DOI 10.1074/jbc.270.22.13192; Prados-Rosales R, 2011, J CLIN INVEST, V121, P1471, DOI 10.1172/JCI44261; Prouty MG, 2003, FEMS MICROBIOL LETT, V225, P177, DOI 10.1016/S0378-1097(03)00446-4; Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x; Puech V, 2000, MOL MICROBIOL, V35, P1026, DOI 10.1046/j.1365-2958.2000.01738.x; Ragas A, 2007, J BIOL CHEM, V282, P5133, DOI 10.1074/jbc.M610183200; Rajadurai C. P., 2011, CURR BIOINFORM, DOI [10.2174/157489311798072954, DOI 10.2174/157489311798072954]; Rastogi RP, 2010, BIOCHEM BIOPH RES CO, V397, P603, DOI 10.1016/j.bbrc.2010.06.006; Ratner DM, 2008, EUKARYOT CELL, V7, P1930, DOI 10.1128/EC.00268-08; Reiling N, 2001, J IMMUNOL, V167, P3339, DOI 10.4049/jimmunol.167.6.3339; Roberts KJ, 2013, J LEUKOCYTE BIOL, V94, P481, DOI 10.1189/jlb.1012527; Rosenkrands I, 1998, INFECT IMMUN, V66, P2728, DOI 10.1128/IAI.66.6.2728-2735.1998; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Seto S, 2012, CELL MICROBIOL, V14, P710, DOI 10.1111/j.1462-5822.2012.01754.x; Sinha SC, 2001, CURR OPIN STRUC BIOL, V11, P733, DOI 10.1016/S0959-440X(01)00274-3; Sonawane A, 2012, CRIT REV MICROBIOL, V38, P250, DOI 10.3109/1040841X.2011.653550; Song CH, 2003, J CLIN IMMUNOL, V23, P194, DOI 10.1023/A:1023309928879; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; Stoop EJM, 2013, CELL MICROBIOL, V15, P2093, DOI 10.1111/cmi.12175; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Tiwari BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051686; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Torrelles JB, 2010, TUBERCULOSIS, V90, P84, DOI 10.1016/j.tube.2010.02.003; Wang P, 2012, AUTOPHAGY, V8, P77, DOI 10.4161/auto.8.1.18274; Watkins BY, 2012, INFECT IMMUN, V80, P3512, DOI 10.1128/IAI.00686-12; Whipps CM, 2012, ILAR J, V53, P95, DOI 10.1093/ilar.53.2.95; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x; World Health Organization, 2011, WORLD HLTH ORG GLOB; World Health Organization, 2010, GLOB TUB CONTR SURV; Xu YM, 1997, BIOCHEMISTRY-US, V36, P3700, DOI 10.1021/bi9616007; Yuan GG, 2014, J ENVIRON SCI, V26, P917, DOI 10.1016/S1001-0742(13)60510-0; YUAN L, 1992, BIOCHEMISTRY-US, V31, P806, DOI 10.1021/bi00118a024	108	25	27	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13321	13343		10.1074/jbc.M114.598482	http://dx.doi.org/10.1074/jbc.M114.598482			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25825498	Green Published, hybrid			2022-12-28	WOS:000354975700031
J	Tran, QK; VerMeer, M; Burgard, MA; Hassan, AB; Giles, J				Tran, Quang-Kim; VerMeer, Mark; Burgard, Michelle A.; Hassan, Ali B.; Giles, Jennifer			Hetero-oligomeric Complex between the G Protein-coupled Estrogen Receptor 1 and the Plasma Membrane Ca2+-ATPase 4b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NITRIC-OXIDE SYNTHASE; 30 GPR30; G-PROTEIN-COUPLED-RECEPTOR-30 GPR30; SMOOTH-MUSCLE; UP-REGULATION; 17-BETA-ESTRADIOL; ACTIVATION; CALMODULIN; ALPHA	The new G protein-coupled estrogen receptor 1 (GPER/GPR30) plays important roles in many organ systems. The plasma membrane Ca2+-ATPase (PMCA) is essential for removal of cytoplasmic Ca2+ and for shaping the time courses of Ca2+-dependent activities. Here, we show that PMCA and GPER/GPR30 physically interact and functionally influence each other. In primary endothelial cells, GPER/GPR30 agonist G-1 decreases PMCA-mediated Ca2+ extrusion by promoting PMCA tyrosine phosphorylation. GPER/GPR30 overexpression decreases PMCA activity, and G-1 further potentiates this effect. GPER/GPR30 knockdown increases PMCA activity, whereas PMCA knockdown substantially reduces GPER/GPR30-mediated phosphorylation of the extracellular signalrelated kinase (ERK1/2). GPER/GPR30 co-immunoprecipitates with PMCA with or without treatment with 17 beta-estradiol, thapsigargin, or G-1. Heterologously expressed GPER/GPR30 in HEK 293 cells co-localizes with PMCA4b, the main endothelial PMCA isoform. Endothelial cells robustly express the PDZ post-synaptic density protein (PSD)-95, whose knockdown reduces the association between GPER/GPR30 and PMCA. Additionally, the association between PMCA4b and GPER/GPR30 is substantially reduced by truncation of either or both of their C-terminal PDZ-binding motifs. Functionally, inhibition of PMCA activity is significantly reduced by truncation of GPER/GPR30's C-terminal PDZ-binding motif. These data strongly indicate that GPER/GPR30 and PMCA4b form a hetero-oligomeric complex in part via the anchoring action of PSD-95, in which they constitutively affect each other's function. Activation of GPER/GPR30 further inhibits PMCA activity through tyrosine phosphorylation of the pump. These interactions represent cross-talk between Ca2+ signaling and GPER/GPR30-mediated activities.	[Tran, Quang-Kim; VerMeer, Mark; Burgard, Michelle A.; Hassan, Ali B.; Giles, Jennifer] Des Moines Univ, Coll Osteopath Med, Dept Physiol & Pharmacol, Des Moines, IA 50312 USA		Tran, QK (corresponding author), Des Moines Univ, Coll Osteopath Med, Dept Physiol & Pharmacol, Ryan Hall 258,3320 Grand Ave, Des Moines, IA 50312 USA.	kim.tran@dmu.edu	Regan, Clinton/E-6250-2012	Tran, Kim/0000-0003-1881-1357	National Institutes of Health [HL112184]; Mentored Research Program at Des Moines University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL112184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mentored Research Program at Des Moines University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL112184 (to Q.-K. T.).; Supported by the Mentored Research Program at Des Moines University.	Akama KT, 2013, J BIOL CHEM, V288, P6438, DOI 10.1074/jbc.M112.412478; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; [Anonymous], 2014, ECONOMIST, V411, P30; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Bozulic LD, 2007, J THROMB HAEMOST, V5, P1041, DOI 10.1111/j.1538-7836.2007.02508.x; Broselid S, 2014, J BIOL CHEM, V289, P22117, DOI 10.1074/jbc.M114.566893; Brown C.S., 2007, PLATELETS, V18, P207; Caride AJ, 1999, J BIOL CHEM, V274, P35227, DOI 10.1074/jbc.274.49.35227; Dean William L, 2010, World J Biol Chem, V1, P265, DOI 10.4331/wjbc.v1.i9.265; Dean WL, 1997, J BIOL CHEM, V272, P15113, DOI 10.1074/jbc.272.24.15113; Delbeck M, 2011, MOL MED REP, V4, P37, DOI 10.3892/mmr.2010.402; Ding QM, 2009, AM J PHYSIOL-CELL PH, V297, pC1178, DOI 10.1152/ajpcell.00185.2009; Enyedi Agnes, 2011, Commun Integr Biol, V4, P340, DOI 10.4161/cib.4.3.15040; Evans NJ, 2008, CAN J PHYSIOL PHARM, V86, P526, DOI 10.1139/Y08-050; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Haas E, 2007, HYPERTENSION, V49, P1358, DOI 10.1161/HYPERTENSIONAHA.107.089995; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Hammond R, 2011, PSYCHONEUROENDOCRINO, V36, P182, DOI 10.1016/j.psyneuen.2010.07.007; Hart D, 2014, STEROIDS, V81, P49, DOI 10.1016/j.steroids.2013.11.004; JARRETT HW, 1977, BIOCHEM BIOPH RES CO, V77, P1210, DOI 10.1016/S0006-291X(77)80108-3; Kanda N, 2003, J INVEST DERMATOL, V121, P1500, DOI 10.1111/j.1523-1747.2003.12617.x; Krapivinsky G, 2011, P NATL ACAD SCI USA, V108, P19234, DOI 10.1073/pnas.1117231108; Lenhart PM, 2013, J MOL ENDOCRINOL, V51, P191, DOI 10.1530/JME-13-0021; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Otto C, 2008, ENDOCRINOLOGY, V149, P4846, DOI 10.1210/en.2008-0269; Padanyi R, 2009, BBA-MOL CELL RES, V1793, P1023, DOI 10.1016/j.bbamcr.2008.11.007; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Peyton C, 2011, BIOL REPROD, V85, P42, DOI 10.1095/biolreprod.110.088765; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Tran QK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089669; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rinaldi GJ, 2005, DIABETES METAB, V31, P487, DOI 10.1016/S1262-3636(07)70220-3; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Schuh K, 2003, J BIOL CHEM, V278, P41246, DOI 10.1074/jbc.M307606200; Schuh K, 2001, J CELL BIOL, V155, P201, DOI 10.1083/jcb.200104131; Sheng JZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1531, DOI 10.1152/ajpcell.00561.2007; Strehler EE, 2007, BIOCHEM SOC T, V35, P919, DOI 10.1042/BST0350919; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tran QK, 2005, CELL CALCIUM, V37, P541, DOI 10.1016/j.ceca.2005.02.001; Tran QK, 2003, J BIOL CHEM, V278, P24247, DOI 10.1074/jbc.C300165200; Tran QK, 2009, J BIOL CHEM, V284, P11892, DOI 10.1074/jbc.M806205200; Ullrich ND, 2008, AM J PHYSIOL-HEART C, V294, pH2421, DOI 10.1152/ajpheart.01225.2007; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344; Wan TC, 2003, THROMB HAEMOSTASIS, V89, P122; Wang C, 2009, J IMMUNOL, V182, P3294, DOI 10.4049/jimmunol.0803205; Wang X, 2002, CELL CALCIUM, V31, P265, DOI 10.1016/S0143-4160(02)00075-1; Watanabe H, 1999, BIOCHEM BIOPH RES CO, V265, P697, DOI 10.1006/bbrc.1999.1755; Yates MA, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-20	51	33	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13293	13307		10.1074/jbc.M114.628743	http://dx.doi.org/10.1074/jbc.M114.628743			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847233	Green Published, hybrid			2022-12-28	WOS:000354975700029
J	Billen, B; Brams, M; Debaveye, S; Remeeva, A; Alpizar, YA; Waelkens, E; Kreir, M; Bruggemann, A; Talavera, K; Nilius, B; Voets, T; Ulens, C				Billen, Bert; Brams, Marijke; Debaveye, Sarah; Remeeva, Alina; Alpizar, Yeranddy A.; Waelkens, Etienne; Kreir, Mohamed; Brueggemann, Andrea; Talavera, Karel; Nilius, Bernd; Voets, Thomas; Ulens, Chris			Different Ligands of the TRPV3 Cation Channel Cause Distinct Conformational Changes as Revealed by Intrinsic Tryptophan Fluorescence Quenching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN REPEAT DOMAIN; SIZE-EXCLUSION CHROMATOGRAPHY; ION CHANNELS; ELECTRON CRYOMICROSCOPY; CRYSTAL-STRUCTURE; RECEPTOR; HEAT; SENSITIVITY; MECHANISM; RESIDUES	TRPV3 is a thermosensitive ion channel primarily expressed in epithelial tissues of the skin, nose, and tongue. The channel has been implicated in environmental thermosensation, hyperalgesia in inflamed tissues, skin sensitization, and hair growth. Although transient receptor potential (TRP) channel research has vastly increased our understanding of the physiological mechanisms of nociception and thermosensation, the molecular mechanics of these ion channels are still largely elusive. In order to better comprehend the functional properties and the mechanism of action in TRP channels, high-resolution three-dimensional structures are indispensable, because they will yield the necessary insights into architectural intimacies at the atomic level. However, structural studies of membrane proteins are currently hampered by difficulties in protein purification and in establishing suitable crystallization conditions. In this report, we present a novel protocol for the purification of membrane proteins, which takes advantage of a C-terminal GFP fusion. Using this protocol, we purified human TRPV3. We show that the purified protein is a fully functional ion channel with properties akin to the native channel using planar patch clamp on reconstituted channels and intrinsic tryptophan fluorescence spectroscopy. Using intrinsic tryptophan fluorescence spectroscopy, we reveal clear distinctions in the molecular interaction of different ligands with the channel. Altogether, this study provides powerful tools to broaden our understanding of ligand interaction with TRPV channels, and the availability of purified human TRPV3 opens up perspectives for further structural and functional studies.	[Billen, Bert; Brams, Marijke; Debaveye, Sarah; Remeeva, Alina; Ulens, Chris] Univ Leuven, Lab Struct Neurobiol, Dept Cellular & Mol Med, B-3000 Leuven, Belgium; [Billen, Bert; Brams, Marijke; Debaveye, Sarah; Remeeva, Alina; Alpizar, Yeranddy A.; Talavera, Karel; Nilius, Bernd; Voets, Thomas; Ulens, Chris] Univ Leuven, TRP Res Platform Leuven TRPLe, Dept Cellular & Mol Med, B-3000 Leuven, Belgium; [Alpizar, Yeranddy A.; Talavera, Karel; Nilius, Bernd; Voets, Thomas] Univ Leuven, Lab Ion Channel Res, Dept Cellular & Mol Med, B-3000 Leuven, Belgium; [Waelkens, Etienne] Univ Leuven, Lab Prot Phosphorylat & Prote, Dept Cellular & Mol Med, B-3000 Leuven, Belgium; [Kreir, Mohamed; Brueggemann, Andrea] Nan Technol GmbH, D-80636 Munich, Germany	KU Leuven; KU Leuven; KU Leuven; KU Leuven	Billen, B (corresponding author), FWO Vlaanderen, Brussels, Belgium.	bert.billen@med.kuleuven.be	Remeeva, Alina/F-2772-2018; Voets, Thomas/AAD-4389-2019	Voets, Thomas/0000-0001-5526-5821; Remeeva, Alina/0000-0003-3977-3679; Alpizar, Yeranddy A/0000-0003-1959-5393; Bruggemann, Andrea/0000-0002-7325-6715; Kreir, Mohamed/0000-0001-9159-9554	Onderzoekstoelage Grant [OT/13/095]; FWO-Vlaanderen [G.0939.11, G.0762.13]	Onderzoekstoelage Grant; FWO-Vlaanderen(FWO)	This work was supported by Onderzoekstoelage Grant OT/13/095 and FWO-Vlaanderen Grants G.0939.11 and G.0762.13 (to C. U.).	Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Brown TE, 2013, HIPPOCAMPUS, V23, P662, DOI 10.1002/hipo.22125; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Doerner JF, 2011, J GEN PHYSIOL, V137, P271, DOI 10.1085/jgp.200910388; Duurkens RH, 2007, J BIOL CHEM, V282, P10380, DOI 10.1074/jbc.M608583200; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hensel H, 1981, Monogr Physiol Soc, V38, P1; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Huang SM, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-37; Huynh KW, 2014, STRUCTURE, V22, P260, DOI 10.1016/j.str.2013.11.008; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Julius D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005991; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kol S, 2013, FEBS J, V280, P6010, DOI 10.1111/febs.12520; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2011, J GEN PHYSIOL, V138, P509, DOI 10.1085/jgp.201110689; Lowry CA, 2009, J PSYCHOPHARMACOL, V23, P392, DOI 10.1177/0269881108099956; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Marics I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099828; McCleverty CJ, 2006, PROTEIN SCI, V15, P2201, DOI 10.1110/ps.062357206; Minor DL, 2007, NEURON, V54, P511, DOI 10.1016/j.neuron.2007.04.026; Miyamoto T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1371; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Moparthi L, 2014, P NATL ACAD SCI USA, V111, P16901, DOI 10.1073/pnas.1412689111; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Moussaieff A, 2008, FASEB J, V22, P3024, DOI 10.1096/fj.07-101865; Nilius B, 2014, J PHYSIOL-LONDON, V592, P295, DOI 10.1113/jphysiol.2013.255968; Nilius B, 2013, EXP DERMATOL, V22, P447, DOI 10.1111/exd.12163; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; SCHLESSINGER J, 1975, FEBS LETT, V52, P231, DOI 10.1016/0014-5793(75)80812-X; Sherkheli MA, 2013, PAK J PHARM SCI, V26, P431; Sherkheli MA, 2012, SCI WORLD J, DOI 10.1100/2012/982725; Sherkheli MA, 2009, J PHARM PHARM SCI, V12, P116, DOI 10.18433/J37C7K; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200; Vriens J, 2014, NAT REV NEUROSCI, V15, P573, DOI 10.1038/nrn3784; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010	55	7	7	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12964	12974		10.1074/jbc.M114.628925	http://dx.doi.org/10.1074/jbc.M114.628925			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25829496	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000354569000045
J	Bonsor, DA; Pham, KT; Beadenkopf, R; Diederichs, K; Haas, R; Beckett, D; Fischer, W; Sundberg, EJ				Bonsor, Daniel A.; Pham, Kieu T.; Beadenkopf, Robert; Diederichs, Kay; Haas, Rainer; Beckett, Dorothy; Fischer, Wolfgang; Sundberg, Eric J.			Integrin Engagement by the Helical RGD Motif of the Helicobacter pylori CagL Protein Is Regulated by pH-induced Displacement of a Neighboring Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATENT TGF-BETA; PATHOGENICITY ISLAND; IV SECRETION; 3-DIMENSIONAL STRUCTURE; EXTRACELLULAR-MATRIX; CELLS; STABILITY; INFECTION; ADHESION; BINDING	Arginine-aspartate-glycine (RGD) motifs are recognized by integrins to bridge cells to one another and the extracellular matrix. RGD motifs typically reside in exposed loop conformations. X-ray crystal structures of the Helicobacter pylori protein CagL revealed that RGD motifs can also exist in helical regions of proteins. Interactions between CagL and host gastric epithelial cell via integrins are required for the translocation of the bacterial oncoprotein CagA. Here, we have investigated the molecular basis of the CagL-host cell interactions using structural, biophysical, and functional analyses. We solved an x-ray crystal structure of CagL that revealed conformational changes induced by low pH not present in previous structures. Using analytical ultracentrifugation, we found that pH-induced conformational changes in CagL occur in solution and not just in the crystalline environment. By designing numerous CagL mutants based on all available crystal structures, we probed the functional roles of CagL conformational changes on cell surface integrin engagement. Together, our data indicate that the helical RGD motif in CagL is buried by a neighboring helix at lowpH to inhibit CagL binding to integrin, whereas at neutral pH the neighboring helix is displaced to allow integrin access to the CagL RGD motif. This novel molecular mechanism of regulating integrin-RGD motif interactions by changes in the chemical environment provides new insight to H. pylori-mediated oncogenesis.	[Bonsor, Daniel A.; Beadenkopf, Robert; Sundberg, Eric J.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Pham, Kieu T.; Haas, Rainer; Fischer, Wolfgang] Univ Munich, Max von Pettenkofer Inst, D-80336 Munich, Germany; [Diederichs, Kay] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Haas, Rainer] Ludwig Maximilians Univ Munchen, German Ctr Infect Res DZIF, Munich, Germany; [Beckett, Dorothy] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Munich; University of Konstanz; German Center for Infection Research; University of Munich; University System of Maryland; University of Maryland College Park	Sundberg, EJ (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	esundberg@ihv.umaryland.edu		Sundberg, Eric/0000-0003-0478-3033	Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft [HA2697/16-1, 17-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015899] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in part, by an Alexander von Humboldt Foundation Experienced Researcher Fellowship (to E. J. S.) and Research Grants HA2697/16-1 and 17-1 from the Deutsche Forschungsgemeinschaft (to R. H.).	Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Barden S, 2015, J MOL BIOL, V427, P1304, DOI 10.1016/j.jmb.2015.01.006; Barden S, 2014, ACTA CRYSTALLOGR D, V70, P1391, DOI 10.1107/S1399004714003150; Barden S, 2013, STRUCTURE, V21, P1931, DOI 10.1016/j.str.2013.08.018; BELANGER LF, 1946, ENDOCRINOLOGY, V39, P8, DOI 10.1210/endo-39-1-8; BLASER MJ, 1995, CANCER RES, V55, P2111; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Choi IJ, 2007, CELL MICROBIOL, V9, P2457, DOI 10.1111/j.1462-5822.2007.00973.x; Conradi J, 2012, AMINO ACIDS, V43, P219, DOI 10.1007/s00726-011-1066-0; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; DAVIS GE, 1992, BIOCHEM BIOPH RES CO, V182, P1025, DOI 10.1016/0006-291X(92)91834-D; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Dong XC, 2014, NAT STRUCT MOL BIOL, V21, P1091, DOI 10.1038/nsmb.2905; Dupeux F, 2011, ACTA CRYSTALLOGR D, V67, P915, DOI 10.1107/S0907444911036225; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gorrell RJ, 2013, CELL MICROBIOL, V15, P554, DOI 10.1111/cmi.12055; HOUMARD J, 1972, P NATL ACAD SCI USA, V69, P3506, DOI 10.1073/pnas.69.12.3506; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Pham KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035341; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; LEININGER E, 1991, P NATL ACAD SCI USA, V88, P345, DOI 10.1073/pnas.88.2.345; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; MASON PW, 1994, P NATL ACAD SCI USA, V91, P1932, DOI 10.1073/pnas.91.5.1932; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Odenbreit S, 2001, CELL MICROBIOL, V3, P21, DOI 10.1046/j.1462-5822.2001.00088.x; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Pang SS, 2014, J BIOL CHEM, V289, P6332, DOI 10.1074/jbc.M113.513135; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Schurpf T, 2012, FASEB J, V26, P3412, DOI 10.1096/fj.11-202036; Shaffer CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002237; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; STACHURA J, 1993, J CLIN GASTROENTEROL, V17, pS70, DOI 10.1097/00004836-199312001-00015; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stockbauer KE, 1999, P NATL ACAD SCI USA, V96, P242, DOI 10.1073/pnas.96.1.242; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tegtmeyer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097782; Wiedemann T, 2012, GUT, V61, P986, DOI 10.1136/gutjnl-2011-300525; Yeh YC, 2011, MOL CARCINOGEN, V50, P751, DOI 10.1002/mc.20753; Zhang YA, 2009, MICROBIOL RES, V164, P180, DOI 10.1016/j.micres.2006.10.010	46	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12929	12940		10.1074/jbc.M115.641829	http://dx.doi.org/10.1074/jbc.M115.641829			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25837254	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000354569000042
J	Civra, A; Giuffrida, MG; Donalisio, M; Napolitano, L; Takada, Y; Coulson, BS; Conti, A; Lembo, D				Civra, Andrea; Giuffrida, Maria Gabriella; Donalisio, Manuela; Napolitano, Lorenzo; Takada, Yoshikazu; Coulson, Barbara S.; Conti, Amedeo; Lembo, David			Identification of Equine Lactadherin-derived Peptides That Inhibit Rotavirus Infection via Integrin Receptor Competition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antiviral agent; integrin; peptides; proteomics; RNA virus; donkey; lactadherin; milk; rotavirus	ALPHA-2-BETA-1 INTEGRIN; HUMAN-MILK; I-DOMAIN; CELL-BINDING; PROTEIN; VP4; ATTACHMENT; GROWTH; VIRUS; ENTRY	Background: Human milk lactadherin protects breastfed infants against symptomatic rotavirus infections. Results: A 20-aa peptide (namely pDGE-RGD) derived from equine lactahderin inhibits human rotavirus infectivity. Conclusion: pDGE-RGD interacts specifically with 21 integrin, thus hindering the rotavirus-cell attachment process. Significance: The discovery of the pDGE-RGD peptide may prove useful in the development of inhibitors of receptor recognition by rotavirus or other integrin-using viruses. Human rotavirus is the leading cause of severe gastroenteritis in infants and children under the age of 5 years in both developed and developing countries. Human lactadherin, a milk fat globule membrane glycoprotein, inhibits human rotavirus infection in vitro, whereas bovine lactadherin is not active. Moreover, it protects breastfed infants against symptomatic rotavirus infections. To explore the potential antiviral activity of lactadherin sourced by equines, we undertook a proteomic analysis of milk fat globule membrane proteins from donkey milk and elucidated its amino acid sequence. Alignment of the human, bovine, and donkey lactadherin sequences revealed the presence of an Asp-Gly-Glu (DGE) (21) integrin-binding motif in the N-terminal domain of donkey sequence only. Because integrin (21) plays a critical role during early steps of rotavirus host cell adhesion, we tested a minilibrary of donkey lactadherin-derived peptides containing DGE sequence for anti-rotavirus activity. A 20-amino acid peptide containing both DGE and RGD motifs (named pDGE-RGD) showed the greatest activity, and its mechanism of antiviral action was characterized; pDGE-RGD binds to integrin (21) by means of the DGE motif and inhibits rotavirus attachment to the cell surface. These findings suggest the potential anti-rotavirus activity of equine lactadherin and support the feasibility of developing an anti-rotavirus peptide that acts by hindering virus-receptor binding.	[Civra, Andrea; Donalisio, Manuela; Lembo, David] Univ Turin, Dept Clin & Biol Sci, S Luigi Gonzaga Hosp, I-10043 Turin, Italy; [Giuffrida, Maria Gabriella; Napolitano, Lorenzo; Conti, Amedeo] Inst Sci Food Prod Natl Res Council ISPA CNR, Bioind Pk SilvanoFumero, Turin, Italy; [Takada, Yoshikazu] Univ Calif Davis, Dept Dermatol & Biochem & Mol Med, Sch Med, Sacramento, CA 95817 USA; [Coulson, Barbara S.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia	University of Turin; Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR); University of California System; University of California Davis; University of Melbourne	Lembo, D (corresponding author), Univ Turin, Dept Clin & Biol Sci, S Luigi Gonzaga Hosp, Reg Gonzole 10, I-10043 Turin, Italy.	david.lembo@unito.it	Giuffrida, Maria Gabriella/AAY-6314-2020	Giuffrida, Maria Gabriella/0000-0002-1297-2558; Lembo, David/0000-0002-0969-100X; Coulson, Barbara/0000-0002-2110-8147; takada, yoshikazu/0000-0001-5481-9589	Rotalactis; Piedmont Regional Call for Innovation Poles (POR-FESR Asse I-I.1.3 Innovation and SMEs): "Development of a food supplement based on equine milk for the prevention of Rotavirus infections"	Rotalactis; Piedmont Regional Call for Innovation Poles (POR-FESR Asse I-I.1.3 Innovation and SMEs): "Development of a food supplement based on equine milk for the prevention of Rotavirus infections"	This work was supported by a grant from the Piedmont Regional Call for Innovation Poles 2007-2013 (POR-FESR Asse I-I.1.3 Innovation and SMEs): "Development of a food supplement based on equine milk for the prevention of Rotavirus infections" received through Rotalactis s.r.l. A. C. and D. L. are founders of the start-up company Rotalactis that partially funded the research.	Ahrens IG, 2006, EXP CELL RES, V312, P925, DOI 10.1016/j.yexcr.2005.11.036; Azab W, 2012, J VIROL, V86, P2031, DOI 10.1128/JVI.06555-11; Barello C, 2008, MOL NUTR FOOD RES, V52, P1448, DOI 10.1002/mnfr.200700311; BASS DM, 1991, VIROLOGY, V183, P602, DOI 10.1016/0042-6822(91)90989-O; BERGELSON JM, 1994, CELL ADHES COMMUN, V2, P455, DOI 10.3109/15419069409004455; Cavaletto M, 2004, CLIN CHIM ACTA, V347, P41, DOI 10.1016/j.cccn.2004.04.026; Cebo C, 2012, J DAIRY SCI, V95, P1085, DOI 10.3168/jds.2011-4455; Ciarlet M, 2002, J VIROL, V76, P1109, DOI 10.1128/JVI.76.3.1109-1123.2002; COHEN J, 1979, ARCH VIROL, V60, P177, DOI 10.1007/BF01317489; Coulson B. S., 1997, LEUCOCYTE TYPING, P391; Coulson BS, 1997, P NATL ACAD SCI USA, V94, P5389, DOI 10.1073/pnas.94.10.5389; COULSON BS, 1985, J VIROL, V54, P14, DOI 10.1128/JVI.54.1.14-20.1985; D'Ambrosio C, 2008, PROTEOMICS, V8, P3657, DOI 10.1002/pmic.200701148; Desselberger U, 2014, VIRUS RES, V190, P75, DOI 10.1016/j.virusres.2014.06.016; Diaz-Salinas MA, 2014, J VIROL, V88, P4389, DOI 10.1128/JVI.03457-13; ESPEJO RT, 1981, J VIROL, V37, P156, DOI 10.1128/JVI.37.1.156-160.1981; ESTES MK, 1979, J GEN VIROL, V43, P403, DOI 10.1099/0022-1317-43-2-403; ESTES MK, 1981, J VIROL, V39, P879, DOI 10.1128/JVI.39.3.879-888.1981; Fleming FE, 2014, J VIROL, V88, P4558, DOI 10.1128/JVI.03431-13; Fortunato D, 2003, PROTEOMICS, V3, P897, DOI 10.1002/pmic.200300367; Gilbert JM, 1998, J VIROL, V72, P5323, DOI 10.1128/JVI.72.6.5323-5327.1998; Gleizes O, 2006, PEDIATR INFECT DIS J, V25, pS12, DOI 10.1097/01.inf.0000197563.03895.91; Graham KL, 2006, J GEN VIROL, V87, P1275, DOI 10.1099/vir.0.81580-0; Graham KL, 2004, J VIROL, V78, P11786, DOI 10.1128/JVI.78.21.11786-11797.2004; Graham KL, 2003, J VIROL, V77, P9969, DOI 10.1128/JVI.77.18.9969-9978.2003; Guerrero CA, 2000, P NATL ACAD SCI USA, V97, P14644, DOI 10.1073/pnas.250299897; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hewish MJ, 2000, J VIROL, V74, P228, DOI 10.1128/JVI.74.1.228-236.2000; Hoffmann C, 2010, J CELL SCI, V123, P4280, DOI 10.1242/jcs.064006; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KAMATA T, 1994, J BIOL CHEM, V269, P26006; KAMATA T, 1995, J BIOL CHEM, V270, P12531, DOI 10.1074/jbc.270.21.12531; King SL, 1997, J BIOL CHEM, V272, P28518, DOI 10.1074/jbc.272.45.28518; Kirkwood CD, 1998, J VIROL, V72, P9348, DOI 10.1128/JVI.72.11.9348-9352.1998; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kurugol Z, 2003, TURKISH J PEDIATR, V45, P290; Kvistgaard AS, 2004, J DAIRY SCI, V87, P4088, DOI 10.3168/jds.S0022-0302(04)73551-1; Lambri M, 2012, LWT-FOOD SCI TECHNOL, V46, P460, DOI 10.1016/j.lwt.2011.11.022; Londrigan SL, 2000, J GEN VIROL, V81, P2203, DOI 10.1099/0022-1317-81-9-2203; Lopez AM, 2007, BREASTFEED REV, V15, P15; Ludert JE, 1996, J VIROL, V70, P487, DOI 10.1128/JVI.70.1.487-493.1996; Mori S., 2013, MED SCI, V1, P20; Morrow Ardythe L, 2004, Semin Pediatr Infect Dis, V15, P221, DOI 10.1053/j.spid.2004.07.002; NAGESHA HS, 1988, J CLIN MICROBIOL, V26, P171, DOI 10.1128/JCM.26.2.171-174.1988; Newburg DS, 1998, LANCET, V351, P1160, DOI 10.1016/S0140-6736(97)10322-1; Ning Y, 2007, J BIOL CHEM, V282, P6380, DOI 10.1074/jbc.M610915200; PAPPIN DJC, 1993, CURR BIOL, V3, P487; Pisanu S, 2011, J PROTEOMICS, V74, P350, DOI 10.1016/j.jprot.2010.11.011; Prameela K K, 2012, Malays J Nutr, V18, P103; Ravindran MS, 2013, TRAFFIC, V14, P1182, DOI 10.1111/tra.12100; Raymond A, 2009, J CELL BIOCHEM, V106, P957, DOI 10.1002/jcb.22076; Reuter A, 2005, PROTEOMICS, V5, P282, DOI 10.1002/pmic.200400874; Shaw AL, 1996, ARCH VIROL, P21; Spertino S, 2012, MOL BIOSYST, V8, P967, DOI 10.1039/c2mb05400k; TAKADA Y, 1992, J CELL BIOL, V119, P913, DOI 10.1083/jcb.119.4.913; TAKADA Y, 1989, J CELL BIOL, V109, P397, DOI 10.1083/jcb.109.1.397; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Taylor MR, 1997, DNA CELL BIOL, V16, P861, DOI 10.1089/dna.1997.16.861; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Xing L, 2004, J BIOL CHEM, V279, P11632, DOI 10.1074/jbc.M312441200; YEAGER M, 1994, EMBO J, V13, P1011, DOI 10.1002/j.1460-2075.1994.tb06349.x; Zarate S, 2000, J VIROL, V74, P593, DOI 10.1128/JVI.74.2.593-599.2000	62	11	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12403	12414		10.1074/jbc.M114.620500	http://dx.doi.org/10.1074/jbc.M114.620500			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25814665	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000354388600048
J	Jokela, T; Oikari, S; Takabe, P; Rilla, K; Karna, R; Tammi, M; Tammi, R				Jokela, Tiina; Oikari, Sanna; Takabe, Piia; Rilla, Kirsi; Karna, Riikka; Tammi, Markku; Tammi, Raija			Interleukin-1-induced Reduction of CD44 Ser-325 Phosphorylation in Human Epidermal Keratinocytes Promotes CD44 Homomeric Complexes, Binding to Ezrin, and Extended, Monocyte-adhesive Hyaluronan Coats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CD44; Hyaluronan; Inflammation; Interleukin-1 (IL-1); Keratinocyte	EZRIN/RADIXIN/MOESIN ERM PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; CYTOPLASMIC DOMAIN; CELL-SURFACE; CYTOSKELETAL INTERACTION; PERICELLULAR HYALURONAN; ENDOTHELIAL-CELLS; HOMING RECEPTOR; ORGAN-CULTURE; CANCER-CELLS	Background: Interleukin-1 recruits leukocytes at the site of inflammation. Results: The interleukin-1-induced hyaluronan coat increased monocyte binding to keratinocytes through ezrin-associated CD44 homomers, enabled by reduced serine 325 phosphorylation. Conclusion: The organization of the cell surface hyaluronan coat is controlled by phosphorylation of CD44. Significance: Interleukin-1 release in inflamed tissues triggers signals that increase hyaluronan-dependent leukocyte binding. The proinflammatory cytokine interleukin-1 (IL-1) attracts leukocytes to sites of inflammation. One of the recruitment mechanisms involves the formation of extended, hyaluronan-rich pericellular coats on local fibroblasts, endothelial cells, and epithelial cells. In the present work, we studied how IL-1 turns on the monocyte adhesion of the hyaluronan coat on human keratinocytes. IL-1 did not influence hyaluronan synthesis or increase the amount of pericellular hyaluronan in these cells. Instead, we found that the increase in the hyaluronan-dependent monocyte binding was associated with the CD44 of the keratinocytes. Although IL-1 caused a small increase in the total amount of CD44, a more marked impact was the decrease of CD44 phosphorylation at serine 325. At the same time, IL-1 increased the association of CD44 with ezrin and complex formation of CD44 with itself. Treatment of keratinocyte cultures with KN93, an inhibitor of calmodulin kinase 2, known to phosphorylate Ser-325 in CD44, caused similar effects as IL-1 (i.e. homomerization of CD44 and its association with ezrin) and resulted in increased monocyte binding to keratinocytes in a hyaluronan-dependent way. Overexpression of wild type CD44 standard form, but not a corresponding CD44 mutant mimicking the Ser-325-phosphorylated form, was able to induce monocyte binding to keratinocytes. In conclusion, treatment of human keratinocytes with IL-1 changes the structure of their hyaluronan coat by influencing the amount, post-translational modification, and cytoskeletal association of CD44, thus enhancing monocyte retention on keratinocytes.	[Jokela, Tiina; Oikari, Sanna; Takabe, Piia; Rilla, Kirsi; Karna, Riikka; Tammi, Markku; Tammi, Raija] Univ Eastern Finland, Inst Biomed, Dept Med, Kuopio 70211, Finland	University of Eastern Finland	Oikari, S (corresponding author), Univ Eastern Finland, Inst Biomed, Dept Med, Yliopistonranta 1E,POB 1627, Kuopio 70211, Finland.	sanna.oikari@uef.fi	Tammi, Markku/AAQ-7878-2021; Jokela, Tiina/O-9206-2015	Jokela, Tiina/0000-0002-7521-3866; Rilla, Kirsi/0000-0002-7862-5727	Juselius Foundation; Cancer Center of the University of Eastern Finland; Saimaa Cancer Foundation; Special Government Funding of Kuopio University Hospital	Juselius Foundation; Cancer Center of the University of Eastern Finland; Saimaa Cancer Foundation; Special Government Funding of Kuopio University Hospital	This work was supported by grants from the Juselius Foundation (to R. T. and M. T.), the Cancer Center of the University of Eastern Finland (to R. T. and M. T.), the Saimaa Cancer Foundation (to S. O), and Special Government Funding of Kuopio University Hospital (M. T.).	BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bourguignon LYW, 2011, CYTOSKELETON, V68, P671, DOI 10.1002/cm.20544; Bourguignon LYW, 2000, J CELL BIOL, V150, P177, DOI 10.1083/jcb.150.1.177; Breitkreutz D, 1998, EUR J CELL BIOL, V75, P273, DOI 10.1016/S0171-9335(98)80123-4; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Buckley ST, 2011, AM J PHYSIOL-LUNG C, V300, pL548, DOI 10.1152/ajplung.00230.2010; Buerger C, 2012, J INVEST DERMATOL, V132, P2206, DOI 10.1038/jid.2012.123; CAMP RL, 1991, J CELL BIOL, V115, P1283, DOI 10.1083/jcb.115.5.1283; Campo GM, 2012, GENE, V494, P24, DOI 10.1016/j.gene.2011.11.064; CULTY M, 1994, J CELL PHYSIOL, V160, P275, DOI 10.1002/jcp.1041600209; Dai XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067666; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Desai B, 2009, J CELL BIOCHEM, V108, P272, DOI 10.1002/jcb.22248; Diaz-Perales A, 2005, J BIOL CHEM, V280, P30367, DOI 10.1074/jbc.M504533200; Donatello S, 2012, AM J PATHOL, V181, P2172, DOI 10.1016/j.ajpath.2012.08.025; Duterme C, 2009, J BIOL CHEM, V284, P33495, DOI 10.1074/jbc.M109.044362; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Evanko SP, 2009, J HISTOCHEM CYTOCHEM, V57, P1041, DOI 10.1369/jhc.2009.953802; GROVES RW, 1994, AM J PATHOL, V145, P1048; Heldin P, 2008, CONNECT TISSUE RES, V49, P215, DOI 10.1080/03008200802143323; Hiltunen ELJ, 2002, CANCER RES, V62, P6410; HUA Q, 1993, J CELL SCI, V106, P365; Huang ZD, 2014, J IMMUNOL, V192, P5285, DOI 10.4049/jimmunol.1303060; Ibrahim EM, 2006, INT J GYNECOL CANCER, V16, P1631, DOI 10.1111/j.1525-1438.2006.00637.x; Jameson JM, 2005, J EXP MED, V201, P1269, DOI 10.1084/jem.20042057; Jensen LE, 2010, CURR OPIN INVEST DR, V11, P1211; Jensen PV, 2004, HISTOCHEM CELL BIOL, V121, P361, DOI 10.1007/s00418-004-0648-2; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jiang H, 2001, ARTHRITIS RHEUM-US, V44, P2599, DOI 10.1002/1529-0131(200111)44:11<2599::AID-ART440>3.0.CO;2-Y; John GR, 2004, J NEUROSCI, V24, P2837, DOI 10.1523/JNEUROSCI.4789-03.2004; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Jokela TA, 2013, WOUND REPAIR REGEN, V21, P247, DOI 10.1111/wrr.12022; Kaneko F, 1991, Fukushima J Med Sci, V37, P103; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; Kim JH, 2000, EXP CELL RES, V256, P445, DOI 10.1006/excr.2000.4852; Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82; Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320; Kothapalli D, 2008, J BIOL CHEM, V283, P31823, DOI 10.1074/jbc.M802934200; Kozlova I, 2012, CELL SIGNAL, V24, P1856, DOI 10.1016/j.cellsig.2012.05.013; KUGELMAN LC, 1992, J INVEST DERMATOL, V99, P886; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Lefebvre DC, 2010, MOL IMMUNOL, V47, P1882, DOI 10.1016/j.molimm.2010.03.018; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; Lesley J, 2000, J BIOL CHEM, V275, P26967; Lesley J, 2000, EUR J IMMUNOL, V30, P245, DOI 10.1002/1521-4141(200001)30:1<245::AID-IMMU245>3.3.CO;2-O; Lewis CA, 2001, BIOCHEM J, V357, P843, DOI 10.1042/0264-6021:3570843; Li LL, 2006, J BIOL CHEM, V281, P26512, DOI 10.1074/jbc.M605607200; Liu DC, 1998, CELL IMMUNOL, V190, P132, DOI 10.1006/cimm.1998.1397; Liu YY, 2008, CRIT CARE, V12, DOI 10.1186/cc6982; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Mee JB, 2007, AM J PATHOL, V171, P32, DOI 10.2353/ajpath.2007.061067; Mellor L, 2013, J BIOL CHEM, V288, P25838, DOI 10.1074/jbc.M113.494872; Meran S, 2013, AM J PATHOL, V182, P2223, DOI 10.1016/j.ajpath.2013.02.038; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Nasti TH, 2012, PHOTOCHEM PHOTOBIOL, V88, P1111, DOI 10.1111/j.1751-1097.2012.01182.x; NEAME SJ, 1992, EMBO J, V11, P4733, DOI 10.1002/j.1460-2075.1992.tb05578.x; Nunomura W, 1997, J BIOL CHEM, V272, P30322, DOI 10.1074/jbc.272.48.30322; Oikari S, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P39; Okamoto I, 2002, AM J PATHOL, V160, P441, DOI 10.1016/S0002-9440(10)64863-8; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Pasonen-Seppanen S, 2012, HISTOCHEM CELL BIOL, V137, P107, DOI 10.1007/s00418-011-0883-2; Peck D, 1998, J CELL SCI, V111, P1595; PERSCHL A, 1995, EUR J IMMUNOL, V25, P495, DOI 10.1002/eji.1830250228; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; Rauhala L, 2013, J BIOL CHEM, V288, P17999, DOI 10.1074/jbc.M113.472530; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selbi W, 2004, J AM SOC NEPHROL, V15, P1199, DOI 10.1097/01.ASN.0000125619.27422.8E; Siiskonen H, 2014, EXP CELL RES, V320, P153, DOI 10.1016/j.yexcr.2013.09.021; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; Skandalis SS, 2010, IUBMB LIFE, V62, P833, DOI 10.1002/iub.392; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; TAMMI R, 1991, J INVEST DERMATOL, V97, P126, DOI 10.1111/1523-1747.ep12478553; Tammi R, 1998, J BIOL CHEM, V273, P28878, DOI 10.1074/jbc.273.44.28878; TAMMI R, 1994, ARCH DERMATOL RES, V286, P21, DOI 10.1007/BF00375839; TAMMI R, 1994, PROG HISTOCHEM CYTOC, V29, P1; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Terawaki S, 2010, EMBO J, V29, P236, DOI 10.1038/emboj.2009.323; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Thankamony SP, 2006, J BIOL CHEM, V281, P34601, DOI 10.1074/jbc.M601530200; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; Tsubaki H, 2005, EUR J OBSTET GYN R B, V122, P156, DOI 10.1016/j.ejogrb.2005.01.007; Tsui J, 2005, J BIOL CHEM, V280, P9210, DOI 10.1074/jbc.M407653200; Tuhkanen AL, 1997, J INVEST DERMATOL, V109, P213, DOI 10.1111/1523-1747.ep12319402; Tzircotis G, 2005, J CELL SCI, V118, P5119, DOI 10.1242/jcs.02629; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Wagner S, 2013, ANTIOXID REDOX SIGN, V18, P1063, DOI 10.1089/ars.2012.4818; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Wolny PM, 2010, J BIOL CHEM, V285, P30170, DOI 10.1074/jbc.M110.137562; Wong NKY, 2011, CELL SIGNAL, V23, P812, DOI 10.1016/j.cellsig.2011.01.003; Wu Y, 2011, J PATHOL, V225, P438, DOI 10.1002/path.2947; Xiao YJ, 2014, RHEUMATOLOGY, V53, P1291, DOI 10.1093/rheumatology/keu013; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497	106	14	15	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12379	12393		10.1074/jbc.M114.620864	http://dx.doi.org/10.1074/jbc.M114.620864			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25809479	hybrid, Green Published			2022-12-28	WOS:000354388600046
J	Meng, XB; Yang, SJ; Zhang, YP; Wang, XJ; Goodfellow, RX; Jia, YC; Thiel, KW; Reyes, HD; Yang, BL; Leslie, KK				Meng, Xiangbing; Yang, Shujie; Zhang, Yuping; Wang, Xinjun; Goodfellow, Renee X.; Jia, Yichen; Thiel, Kristina W.; Reyes, Henry D.; Yang, Baoli; Leslie, Kimberly K.			Genetic Deficiency of Mtdh Gene in Mice Causes Male Infertility via Impaired Spermatogenesis and Alterations in the Expression of Small Non-coding RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; DNA Damage; Meiosis; MicroRNA (miRNA); Reproduction; Spermatogenesis; MTDH; Male Infertility; Pachytene; piRNA; AEG-1; Mili; Rad18	ASTROCYTE ELEVATED GENE-1; BINDING PROTEIN; MOUSE MEIOSIS; AEG-1; CANCER; CELLS; MILI; HEPATOCARCINOGENESIS; CHEMORESISTANCE; METASTASIS	Background: MTDH is associated with poor prognosis in cancer, yet its biologic function is unclear. Results:Mtdh-null male mice are infertile, with a lack of mature sperm in testes and altered expression of small non-coding RNAs. Conclusion:Mtdh deficiency results in male infertility due to impaired spermatogenesis. Significance: The oncogene MTDH plays an indispensable role in male fertility. Increased expression of metadherin (MTDH, also known as AEG-1 and 3D3/LYRIC) has been associated with drug resistance, metastasis, and angiogenesis in a variety of cancers. However, the specific mechanisms through which MTDH is involved in these processes remain unclear. To uncover these mechanisms, we generated Mtdh knock-out mice via a targeted disruption of exon 3. Homozygous Mtdh knock-out mice are viable, but males are infertile. The homozygous male mice present with massive loss of spermatozoa as a consequence of meiotic failure. Accumulation of -H2AX in spermatocytes of homozygous Mtdh knock-out mice confirms an increase in unrepaired DNA breaks. We also examined expression of the DNA repair protein Rad18, which is regulated by MTDH at the post-transcriptional level. In testes from Mtdh exon 3-deficient mice, Rad18 foci were increased in the lumina of the seminiferous tubules. The Piwi-interacting RNA (piRNA)-interacting protein Mili was expressed at high levels in testes from Mtdh knock-out mice. Accordingly, genome-wide small RNA deep sequencing demonstrated altered expression of piRNAs in the testes of Mtdh knock-out mice as compared with wild type mice. In addition, we observed significantly reduced expression of microRNAs (miRNAs) including miR-16 and miR-19b, which are known to be significantly reduced in the semen of infertile men. In sum, our observations indicate a crucial role for MTDH in male fertility and the DNA repair mechanisms required for normal spermatogenesis.	[Meng, Xiangbing; Yang, Shujie; Zhang, Yuping; Wang, Xinjun; Goodfellow, Renee X.; Jia, Yichen; Thiel, Kristina W.; Reyes, Henry D.; Yang, Baoli; Leslie, Kimberly K.] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; [Meng, Xiangbing; Yang, Shujie; Leslie, Kimberly K.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Meng, XB (corresponding author), Univ Iowa, Dept Obstet & Gynecol, 200 Hawkins Dr, Iowa City, IA 52242 USA.	xiangbing-meng@uiowa.edu	Regan, Clinton/E-6250-2012	Thiel, Kristina/0000-0001-8295-864X; meng, xiangbing/0000-0002-9612-6438; Yang, Shujie/0000-0003-1753-3068; Wang, Xinjun/0000-0002-5062-4765; Leslie, Kimberly/0000-0002-2704-8990	National Institutes of Health [R01CA184101, R01CA99908]; Department of Obstetrics and Gynecology Research Development Fund; NATIONAL CANCER INSTITUTE [R01CA099908, R01CA184101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Obstetrics and Gynecology Research Development Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01CA184101 (to X. M. and K. K. L.) and R01CA99908 (to K. K. L.) and by the Department of Obstetrics and Gynecology Research Development Fund (to K. K. L.).	Ash SC, 2008, BIOCHEM BIOPH RES CO, V371, P333, DOI 10.1016/j.bbrc.2008.04.084; Blanco MA, 2011, J BIOL CHEM, V286, P19982, DOI 10.1074/jbc.M111.240077; Blanco-Rodriguez J, 2012, REPRODUCTION, V144, P699, DOI 10.1530/REP-12-0326; Chuma S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0338; Emdad L, 2013, ADV CANCER RES, V120, P75, DOI 10.1016/B978-0-12-401676-7.00003-6; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Gudmundsdottir K, 2004, TRENDS CELL BIOL, V14, P401, DOI 10.1016/j.tcb.2004.07.002; He XX, 2012, ONCOGENE, V31, P3357, DOI 10.1038/onc.2011.500; Hosokawa M, 2007, DEV BIOL, V301, P38, DOI 10.1016/j.ydbio.2006.10.046; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Jeon HY, 2010, GENE EXPR PATTERNS, V10, P361, DOI 10.1016/j.gep.2010.08.004; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lee SG, 2013, ADV CANCER RES, V120, P1, DOI 10.1016/B978-0-12-401676-7.00001-2; Liu T, 2012, MOL MED REP, V6, P535, DOI 10.3892/mmr.2012.967; Meng XB, 2013, ADV CANCER RES, V120, P135, DOI 10.1016/B978-0-12-401676-7.00005-X; Meng XB, 2012, J BIOL CHEM, V287, P4485, DOI 10.1074/jbc.C111.291518; Meng XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020920; Ran Maoliang, 2014, Yichuan, V36, P646, DOI 10.3724/SP.J.1005.2014.0646; Robertson CL, 2014, CANCER RES, V74, P6184, DOI 10.1158/0008-5472.CAN-14-1357; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Sarkar D, 2013, ADV CANCER RES, V120, pXI, DOI 10.1016/B978-0-12-401676-7.09987-3; Sarkar D, 2013, ADV CANCER RES, V120, P193, DOI 10.1016/B978-0-12-401676-7.00007-3; Sarkar D, 2013, ADV CANCER RES, V120, P39, DOI 10.1016/B978-0-12-401676-7.00002-4; Sciurano R, 2007, HUM REPROD, V22, P142, DOI 10.1093/humrep/del330; Srivastava J, 2014, CANCER RES, V74, P4364, DOI 10.1158/0008-5472.CAN-14-0421; Srivastava J, 2012, HEPATOLOGY, V56, P1782, DOI 10.1002/hep.25868; Sun JH, 2009, MECH DEVELOP, V126, P173, DOI 10.1016/j.mod.2008.11.004; Syrjanen JL, 2014, ELIFE, V3, DOI 10.7554/eLife.02963; Takubo K, 2006, BIOCHEM BIOPH RES CO, V351, P993, DOI 10.1016/j.bbrc.2006.10.145; Thirkettle HJ, 2009, ONCOGENE, V28, P3663, DOI 10.1038/onc.2009.223; Thorslund T, 2007, EMBO J, V26, P2915, DOI 10.1038/sj.emboj.7601739; Unhavaithaya Y, 2009, J BIOL CHEM, V284, P6507, DOI 10.1074/jbc.M809104200; Wan LL, 2014, CANCER CELL, V26, P92, DOI 10.1016/j.ccr.2014.04.027; Wang JQ, 2009, CURR BIOL, V19, P640, DOI 10.1016/j.cub.2009.02.061; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Yoo BK, 2010, CANCER RES, V70, P3249, DOI 10.1158/0008-5472.CAN-09-4009; Zhao J, 2014, DNA CELL BIOL, V33, P715, DOI 10.1089/dna.2014.2376	39	13	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11853	11864		10.1074/jbc.M114.627653	http://dx.doi.org/10.1074/jbc.M114.627653			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25787082	Green Published, hybrid			2022-12-28	WOS:000354388600005
J	Bart, G; Vico, NO; Hassinen, A; Pujol, FM; Deen, AJ; Ruusala, A; Tammi, RH; Squire, A; Heldin, P; Kellokumpu, S; Tammi, MI				Bart, Genevieve; Vico, Nuria Ortega; Hassinen, Antti; Pujol, Francois M.; Deen, Ashik Jawahar; Ruusala, Aino; Tammi, Raija H.; Squire, Anthony; Heldin, Paraskevi; Kellokumpu, Sakari; Tammi, Markku I.			Fluorescence Resonance Energy Transfer (FRET) and Proximity Ligation Assays Reveal Functionally Relevant Homo-and Heteromeric Complexes among Hyaluronan Synthases HAS1, HAS2, and HAS3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; DERMAL FIBROBLASTS; CANCER-CELLS; ACTIVATION; GLYCOSYLTRANSFERASES; TRANSLOCATION; GOLGI; LOCALIZATION; EXPRESSION; SINGLE	In vertebrates, hyaluronan is produced in the plasma membrane from cytosolic UDP-sugar substrates by hyaluronan synthase 1-3 (HAS1-3) isoenzymes that transfer N-acetylglucosamine (GlcNAc) and glucuronic acid (GlcUA) in alternative positions in the growing polysaccharide chain during its simultaneous extrusion into the extracellular space. It has been shown that HAS2 immunoprecipitates contain functional HAS2 homomers and also heteromers with HAS3 (Karousou, E., Kamiryo, M., Skandalis, S. S., Ruusala, A., Asteriou, T., Passi, A., Yamashita, H., Hellman, U., Heldin, C. H., and Heldin, P. (2010) The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination. J. Biol. Chem. 285, 23647-23654). Here we have systematically screened in live cells, potential interactions among the HAS isoenzymes using fluorescence resonance energy transfer (FRET) and flow cytometric quantification. We show that all HAS isoenzymes form homomeric and also heteromeric complexes with each other. The same complexes were detected both in Golgi apparatus and plasma membrane by using FRET microscopy and the acceptor photobleaching method. Proximity ligation assays with HAS antibodies confirmed the presence of HAS1-HAS2, HAS2-HAS2, and HAS2-HAS3 complexes between endogenously expressed HASs. C-terminal deletions revealed that the enzymes interact mainly via uncharacterized N-terminal 86-amino acid domain(s), but additional binding site(s) probably exist in their C-terminal parts. Of all the homomeric complexes HAS1 had the lowest and HAS3 the highest synthetic activity. Interestingly, HAS1 transfection reduced the synthesis of hyaluronan obtained by HAS2 and HAS3, suggesting functional cooperation between the isoenzymes. These data indicate a general tendency of HAS isoenzymes to form both homomeric and heteromeric complexes with potentially important functional consequences on hyaluronan synthesis.	[Bart, Genevieve; Deen, Ashik Jawahar; Tammi, Raija H.; Tammi, Markku I.] Univ Eastern Finland, Inst Biomed Anat, FI-70211 Kuopio, Finland; [Vico, Nuria Ortega; Hassinen, Antti; Pujol, Francois M.; Kellokumpu, Sakari] Univ Oulu, Fac Biochem & Mol Med, FI-90014 Oulu, Finland; [Ruusala, Aino; Heldin, Paraskevi] Uppsala Univ, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Squire, Anthony] Univ Clin Essen, Inst Expt Immunol & Imaging, D-45147 Essen, Germany	University of Eastern Finland; University of Oulu; Ludwig Institute for Cancer Research; Uppsala University; University of Duisburg Essen	Tammi, MI (corresponding author), Univ Eastern Finland, Inst Biomed, Sch Med, Yliopistonranta 1E,POB 1627, FI-70211 Kuopio, Finland.	tammi@uef.fi	Tammi, Markku/AAQ-7878-2021	Hassinen, Antti/0000-0001-9491-2868; Bart, Genevieve/0000-0001-9809-150X	Academy of Finland; Sigrid Juselius Foundation; National Glycoscience Graduate School; Kuopio University Hospital (EVO/VTR funds); University of Eastern Finland Spearhead Funds (Cancer Center of Eastern Finland); Magnus Ehrnrooth Foundation; Finnish Cultural Foundation; Ludwig Institute for Cancer Research; Swedish Cancer Society; Northern Savo Cultural Foundation; Northern Savo Cancer Funds; Centre for International Mobility	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); National Glycoscience Graduate School; Kuopio University Hospital (EVO/VTR funds); University of Eastern Finland Spearhead Funds (Cancer Center of Eastern Finland); Magnus Ehrnrooth Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Ludwig Institute for Cancer Research; Swedish Cancer Society(Swedish Cancer Society); Northern Savo Cultural Foundation; Northern Savo Cancer Funds; Centre for International Mobility	This work was supported by grants from the Academy of Finland (to S. K. and M. I. T.), the Sigrid Juselius Foundation (to M. I. T. and R. H. T.), the National Glycoscience Graduate School (to A. J. D., S. K., and M. I. T.), the Kuopio University Hospital (EVO/VTR funds) (to M. I. T.), the University of Eastern Finland Spearhead Funds (Cancer Center of Eastern Finland) (to M. I. T. and R. H. T.), the Magnus Ehrnrooth Foundation and the Finnish Cultural Foundation (to A. H.), and the Ludwig Institute for Cancer Research and the Swedish Cancer Society (to P. H.).; Recipient of grants from the Northern Savo Cultural Foundation, the Northern Savo Cancer Funds, and Centre for International Mobility.	Asplund T, 1998, BBA-GEN SUBJECTS, V1380, P377, DOI 10.1016/S0304-4165(98)00010-5; Bakkers J, 2004, DEVELOPMENT, V131, P525, DOI 10.1242/dev.00954; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Bobrov AG, 2008, ENVIRON MICROBIOL, V10, P1419, DOI 10.1111/j.1462-2920.2007.01554.x; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Declves AE, 2012, NEPHROL DIAL TRANSPL, V27, P3771, DOI 10.1093/ndt/gfs098; Deen AJ, 2014, J BIOL CHEM, V289, P8375, DOI 10.1074/jbc.M114.552133; Hagenfeld D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039096; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Hiltunen ELJ, 2002, CANCER RES, V62, P6410; Hubbard C, 2012, J MOL BIOL, V418, P21, DOI 10.1016/j.jmb.2012.01.053; Kang L, 2013, DIABETES, V62, P1888, DOI 10.2337/db12-1502; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Kokkonen N, 2004, J BIOL CHEM, V279, P39982, DOI 10.1074/jbc.M406698200; Kozlova I, 2012, CELL SIGNAL, V24, P1856, DOI 10.1016/j.cellsig.2012.05.013; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; McDonald TO, 2007, J HISTOCHEM CYTOCHEM, V55, P1149, DOI 10.1369/jhc.7A7221.2007; Medina AP, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-2; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Mullegger J, 2003, BIOL CHEM, V384, P175, DOI 10.1515/BC.2003.019; Oikari S, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P39; Opat AS, 2000, J BIOL CHEM, V275, P11836, DOI 10.1074/jbc.275.16.11836; Porsch H, 2013, ONCOGENE, V32, P4355, DOI 10.1038/onc.2012.475; PREHM P, 1984, BIOCHEM J, V220, P597, DOI 10.1042/bj2200597; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Pummill PE, 2001, J BIOL CHEM, V276, P39832, DOI 10.1074/jbc.M105489200; Rauhala L, 2013, J BIOL CHEM, V288, P17999, DOI 10.1074/jbc.M113.472530; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; Rilla K, 2013, EXP CELL RES, V319, P2006, DOI 10.1016/j.yexcr.2013.05.021; Rilla K, 2013, J BIOL CHEM, V288, P5973, DOI 10.1074/jbc.M112.443879; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Siiskonen H, 2014, EXP CELL RES, V320, P153, DOI 10.1016/j.yexcr.2013.09.021; Siiskonen H, 2013, GLYCOBIOLOGY, V23, P222, DOI 10.1093/glycob/cws149; Steiner S, 2013, EMBO J, V32, P354, DOI 10.1038/emboj.2012.315; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; TAMMI R, 1994, PROG HISTOCHEM CYTOC, V29, P1; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Thomas NK, 2010, EXP CELL RES, V316, P1241, DOI 10.1016/j.yexcr.2010.01.004; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; Tlapak-Simmons VL, 1998, J BIOL CHEM, V273, P26100, DOI 10.1074/jbc.273.40.26100; Tolg C, 2012, AM J PATHOL, V181, P1250, DOI 10.1016/j.ajpath.2012.06.036; Torronen K, 2014, HISTOCHEM CELL BIOL, V141, P17, DOI 10.1007/s00418-013-1143-4; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Yamada Y, 2004, J INVEST DERMATOL, V122, P631, DOI 10.1111/j.0022-202X.2004.22332.x	49	25	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11479	11490		10.1074/jbc.M115.640581	http://dx.doi.org/10.1074/jbc.M115.640581			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25795779	Green Published, hybrid			2022-12-28	WOS:000353719400024
J	Renner-Schneck, M; Hinderberger, I; Gisin, J; Exner, T; Mayer, C; Stehle, T				Renner-Schneck, Michaela; Hinderberger, Isabel; Gisin, Jonathan; Exner, Thomas; Mayer, Christoph; Stehle, Thilo			Crystal Structure of the N-Acetylmuramic Acid alpha-1-Phosphate (MurNAc-alpha 1-P) Uridylyltransferase MurU, a Minimal Sugar Nucleotidyltransferase and Potential Drug Target Enzyme in Gram-negative Pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CATALYTIC MECHANISM; PYROPHOSPHORYLASE; NUCLEOTIDYLYLTRANSFERASE; RESISTANCE	The N-acetylmuramic acid alpha-1-phosphate (MurNAc-alpha 1-P) uridylyltransferase MurU catalyzes the synthesis of uridine diphosphate (UDP)-MurNAc, a crucial precursor of the bacterial peptidoglycan cell wall. MurU is part of a recently identified cell wall recycling pathway in Gram-negative bacteria that bypasses the general de novo biosynthesis of UDP-MurNAc and contributes to high intrinsic resistance to the antibiotic fosfomycin, which targets UDP-MurNAc de novo biosynthesis. To provide insights into substrate binding and specificity, we solved crystal structures of MurU of Pseudomonas putida in native and ligand-bound states at high resolution. With the help of these structures, critical enzyme-substrate interactions were identified that enable tight binding of MurNAc-alpha 1-P to the active site of MurU. The MurU structures define a "minimal domain" required for general nucleotidyltransferase activity. They furthermore provide a structural basis for the chemical design of inhibitors of MurU that could serve as novel drugs in combination therapy against multidrug-resistant Gram-negative pathogens.	[Renner-Schneck, Michaela; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem IFIB, D-72076 Tubingen, Germany; [Hinderberger, Isabel; Gisin, Jonathan; Mayer, Christoph] Univ Tubingen, Interfac Inst Microbiol & Infect Med Tubingen IMI, Dept Biol, D-72076 Tubingen, Germany; [Exner, Thomas] Univ Tubingen, Inst Pharm, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Mayer, C (corresponding author), Interfac Inst Microbiol & Infect Med Tubingen IMI, Morgenstelle 28, D-72076 Tubingen, Germany.	christoph.mayer@uni-tuebingen.de; thilo.stehle@uni-tuebingen.de	Mayer, Christoph/S-8666-2017	Mayer, Christoph/0000-0003-4731-4851				Abendroth Jan, 2011, Journal of Structural and Functional Genomics, V12, P83, DOI 10.1007/s10969-011-9101-7; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barton WA, 2002, P NATL ACAD SCI USA, V99, P13397, DOI 10.1073/pnas.192468299; Barton WA, 2001, NAT STRUCT BIOL, V8, P545, DOI 10.1038/88618; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Blankenfeldt W, 2000, EMBO J, V19, P6652, DOI 10.1093/emboj/19.24.6652; Borisova M, 2014, MICROB DRUG RESIST, V20, P231, DOI 10.1089/mdr.2014.0036; Brown K, 1999, EMBO J, V18, P4096, DOI 10.1093/emboj/18.15.4096; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cox G, 2013, INT J MED MICROBIOL, V303, P287, DOI 10.1016/j.ijmm.2013.02.009; Dahl U, 2004, J BACTERIOL, V186, P2385, DOI 10.1128/JB.186.8.2385-2392.2004; Dauter Miroslawa, 2007, Methods Mol Biol, V364, P149; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gisin J, 2013, NAT CHEM BIOL, V9, P491, DOI 10.1038/nchembio.1289; Hadi T, 2008, BIOCHEMISTRY-US, V47, P11547, DOI 10.1021/bi8014532; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jaeger T, 2008, CELL MOL LIFE SCI, V65, P928, DOI 10.1007/s00018-007-7399-x; Jaeger T, 2005, J BIOL CHEM, V280, P30100, DOI 10.1074/jbc.M502208200; Jagtap PKA, 2013, J MOL BIOL, V425, P1745, DOI 10.1016/j.jmb.2013.02.019; Johnson JW, 2013, ANN NY ACAD SCI, V1277, P54, DOI 10.1111/j.1749-6632.2012.06813.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Litzinger S, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P3, DOI 10.1007/978-3-642-05062-6_1; Maruyama D, 2007, J BIOL CHEM, V282, P17221, DOI 10.1074/jbc.M611873200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mayer C., 2012, ENCY LIFE SCI; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michalopoulos AS, 2011, INT J INFECT DIS, V15, pE732, DOI 10.1016/j.ijid.2011.07.007; Moretti R, 2007, J BIOL CHEM, V282, P16942, DOI 10.1074/jbc.M701951200; Moretti R, 2011, J BIOL CHEM, V286, P13235, DOI 10.1074/jbc.M110.206433; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Pelissier MC, 2010, J BIOL CHEM, V285, P27468, DOI 10.1074/jbc.M109.095182; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Singh S, 2012, NAT PROD REP, V29, P1201, DOI 10.1039/c2np20039b; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	39	13	14	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10804	10813		10.1074/jbc.M114.620989	http://dx.doi.org/10.1074/jbc.M114.620989			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25767118	Green Published, hybrid			2022-12-28	WOS:000353404500021
J	Venditto, I; Najnnudin, S; Luis, AS; Ferreira, LMA; Sakka, K; Knox, JP; Gilbert, HJ; Fontes, CMGA				Venditto, Imnnacolata; Najnnudin, Shabir; Luis, Ana S.; Ferreira, Luis M. A.; Sakka, Kazuo; Knox, J. Paul; Gilbert, Harry J.; Fontes, Carlos M. G. A.			Family 46 Carbohydrate-binding Modules Contribute to the Enzymatic Hydrolysis of Xyloglucan and beta-1,3-1,4-Glucans through Distinct Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY CRYSTALLOGRAPHY; GLYCOSIDE HYDROLASES; DECISION-MAKING; CELLULOSE; ENZYMES; DOMAIN; CRYSTALLIZATION; CLASSIFICATION; RECOGNITION; SPECIFICITY	Structural carbohydrates comprise an extraordinary source of energy that remains poorly utilized by the biofuel sector as enzymes have restricted access to their substrates within the intricacy of plant cell walls. Carbohydrate active enzymes (CAZYmes) that target recalcitrant polysaccharides are modular enzymes containing noncatalytic carbohydrate-binding modules (CBMs) that direct enzymes to their cognate substrate, thus potentiating catalysis. In general, CBMs are functionally and structurally autonomous from their associated catalytic domains from which they are separated through flexible linker sequences. Here, we show that a C-terminal CBM46 derived from BhCel5B, a Bacillus halodurans endoglucanase, does not interact with beta-glucans independently but, uniquely, acts cooperatively with the catalytic domain of the enzyme in substrate recognition. The structure of BhCBM46 revealed a beta-sandwich fold that abuts onto the region of the substrate binding cleft upstream of the active site. BhCBM46 as a discrete entity is unable to bind to beta-glucans. Removal of BhCBM46 from BhCel5B, however, abrogates binding to beta-1,3-1,4-glucans while substantially decreasing the affinity for decorated beta-1,4-glucan homopolymers such as xyloglucan. The CBM46 was shown to contribute to xyloglucan hydrolysis only in the context of intact plant cell walls, but it potentiates enzymatic activity against purified beta-1,3-1,4-glucans in solution or within the cell wall. This report reveals the mechanism by which a CBM can promote enzyme activity through direct interaction with the substrate or by targeting regions of the plant cell wall where the target glucan is abundant.	[Venditto, Imnnacolata; Najnnudin, Shabir; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.] Polo Univ Alto da Ajuda, ULisboo, Fac Med, Ctr Interdisciplinar Invest Sanidade Anim, P-1300477 Lisbon, Portugal; [Luis, Ana S.; Gilbert, Harry J.] Newcastle Univ, Inst Cell & Mol Biosci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Sakka, Kazuo] Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan; [Knox, J. Paul] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England	Universidade de Lisboa; Newcastle University - UK; Mie University; University of Leeds	Gilbert, HJ (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	harry.gilbert@newcastle.ac.uk	Luis, Ana/ABE-5158-2020; Knox, Paul/H-4577-2012	Luis, Ana/0000-0002-5086-7353; Knox, Paul/0000-0002-9231-6891; Najmudin, Shabir/0000-0002-0429-5454; Fontes, Carlos/0000-0002-1219-9753; VENDITTO, IMMACOLATA/0000-0003-0392-2871	Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/BIA-PRO/103980/2008]; European Union Seventh Framework Programme FP7 under the WallTraC Project [263916]; European Union Seventh Framework Programme FP7 under BioStruct-X [283570, Biostruct-X_4399]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); European Union Seventh Framework Programme FP7 under the WallTraC Project; European Union Seventh Framework Programme FP7 under BioStruct-X	This work was supported by the Fundacao para a Ciencia e a Tecnologia, Portugal through Project PTDC/BIA-PRO/103980/2008. This work was also supported by European Union Seventh Framework Programme FP7 2007-2013 under the WallTraC Project Grant 263916 and BioStruct-X Grant Agreement 283570, Biostruct-X_4399.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2005, BIOCHEM J, V385, P479, DOI 10.1042/BJ20041473; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gilad R, 2003, J BACTERIOL, V185, P391, DOI 10.1128/JB.185.2.391-398.2003; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Gowen CM, 2010, CHEM BIODIVERS, V7, P1086, DOI 10.1002/cbdv.200900314; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Henrissat B, 2000, PLANT PHYSIOL, V124, P1515, DOI 10.1104/pp.124.4.1515; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Irwin D, 1998, J BACTERIOL, V180, P1709, DOI 10.1128/JB.180.7.1709-1714.1998; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meekins DA, 2014, P NATL ACAD SCI USA, V111, P7272, DOI 10.1073/pnas.1400757111; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Minic Z, 2006, PLANT PHYSIOL BIOCH, V44, P435, DOI 10.1016/j.plaphy.2006.08.001; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; Venditto I, 2014, ACTA CRYSTALLOGR F, V70, P1628, DOI 10.1107/S2053230X1402319X; Venditto I, 2014, ACTA CRYSTALLOGR F, V70, P754, DOI 10.1107/S2053230X14008395; Wamalwa BM, 2006, APPL ENVIRON MICROB, V72, P6851, DOI 10.1128/AEM.01209-06; Williams SJ, 2000, J AM CHEM SOC, V122, P4229, DOI 10.1021/ja0002870; Winn M. D., 2011, ACTA CRYSTALLOGR D, V67, P235; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308	52	30	32	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10572	10586		10.1074/jbc.M115.637827	http://dx.doi.org/10.1074/jbc.M115.637827			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25713075	Green Published, hybrid			2022-12-28	WOS:000353404500001
J	Kankipati, HN; Rubio-Texeira, M; Castermans, D; Diallinas, G; Thevelein, JM				Kankipati, Harish Nag; Rubio-Texeira, Marta; Castermans, Dries; Diallinas, George; Thevelein, Johan M.			Sul1 and Sul2 Sulfate Transceptors Signal to Protein Kinase A upon Exit of Sulfur Starvation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endocytosis; Membrane Transport; Protein Kinase A (PKA); Signaling; Transporter; Symporter; Signaling Agonist; Stationary Phase; Sulfate Sensing; Sulfate Transporter	AMINO-ACID PERMEASE; YEAST SACCHAROMYCES-CEREVISIAE; NUTRIENT-INDUCED ACTIVATION; DOWN-REGULATION; MUTATIONAL ANALYSIS; PLASMA-MEMBRANE; BINDING-SITE; HOST STRAINS; TRANSPORTER; PHOSPHATE	Background: Transceptors are transporters with an additional receptor function. Results: Sul1 and Sul2 signal to PKA in the absence of sulfate transport. Conclusion: Yeast Sul1 and Sul2 are sulfate transceptors. Significance: Transceptors could be a universal class of nutrient sensors. Sulfate is an essential nutrient with pronounced regulatory effects on cellular metabolism and proliferation. Little is known, however, about how sulfate is sensed by cells. Sul1 and Sul2 are sulfate transporters in the yeast Saccharomyces cerevisiae, strongly induced upon sulfur starvation and endocytosed upon the addition of sulfate. We reveal Sul1,2-dependent activation of PKA targets upon sulfate-induced exit from growth arrest after sulfur starvation. We provide two major arguments in favor of Sul1 and Sul2 acting as transceptors for signaling to PKA. First, the sulfate analogue, d-glucosamine 2-sulfate, acted as a non-transported agonist of signaling by Sul1 and Sul2. Second, mutagenesis to Gln of putative H+-binding residues, Glu-427 in Sul1 or Glu-443 in Sul2, abolished transport without affecting signaling. Hence, Sul1,2 can function as pure sulfate sensors. Sul1(E427Q) and Sul2(E443Q) are also deficient in sulfate-induced endocytosis, which can therefore be uncoupled from signaling. Overall, our data suggest that transceptors can undergo independent conformational changes, each responsible for triggering different downstream processes. The Sul1 and Sul2 transceptors are the first identified plasma membrane sensors for extracellular sulfate. High affinity transporters induced upon starvation for their substrate may generally act as transceptors during exit from starvation.	[Kankipati, Harish Nag; Rubio-Texeira, Marta; Castermans, Dries; Thevelein, Johan M.] Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, B-3001 Leuven Heverlee, Flanders, Belgium; [Kankipati, Harish Nag; Rubio-Texeira, Marta; Castermans, Dries; Thevelein, Johan M.] VIB, Dept Mol Microbiol, B-3001 Leuven Heverlee, Flanders, Belgium; [Diallinas, George] Univ Athens, Fac Biol, Athens 15784, Greece	KU Leuven; Flanders Institute for Biotechnology (VIB); National & Kapodistrian University of Athens	Thevelein, JM (corresponding author), KU Leuven VIB, Inst Bot & Microbiol, Mol Cell Biol Lab, Kasteelpk Arenberg 31, B-3001 Leuven Heverlee, Flanders, Belgium.	johan.thevelein@mmbio.vib-kuleuven.be	Diallinas, George/AAE-8457-2019; Thevelein, Johan M./AAK-4203-2021	Diallinas, George/0000-0002-3426-726X; 	DBOF Ph.D. fellowship from the KU Leuven Research Fund; VIB postdoctoral position; EC-Marie-Curie fellowship; FWO visiting fellowship; Fund for Scientific Research-Flanders; Interuniversity Attraction Poles Network [P6/14, P7/40]; Research Fund of KU Leuven (Concerted Research Actions); Hercules Foundation (Flanders)	DBOF Ph.D. fellowship from the KU Leuven Research Fund; VIB postdoctoral position; EC-Marie-Curie fellowship(European CommissionEuropean Commission Joint Research Centre); FWO visiting fellowship; Fund for Scientific Research-Flanders(FWO); Interuniversity Attraction Poles Network(Belgian Federal Science Policy Office); Research Fund of KU Leuven (Concerted Research Actions); Hercules Foundation (Flanders)	This work was supported by a DBOF Ph.D. fellowship from the KU Leuven Research Fund (to H. N. K.); a VIB postdoctoral position, an EC-Marie-Curie fellowship, and an FWO visiting fellowship (to M. R. T.); and grants from the Fund for Scientific Research-Flanders, Interuniversity Attraction Poles Network P6/14 and P7/40, the Research Fund of KU Leuven (Concerted Research Actions), and the Hercules Foundation (Flanders) (to J. M. T.).	Adams A., 1996, METHODS YEAST GENETI; Boer VM, 2003, J BIOL CHEM, V278, P3265, DOI 10.1074/jbc.M209759200; BRETON A, 1977, J BACTERIOL, V132, P224, DOI 10.1128/JB.132.1.224-232.1977; Cain NE, 2011, MOL BIOL CELL, V22, P1919, DOI 10.1091/mbc.E10-10-0800; Castermans D, 2012, CELL RES, V22, P1058, DOI 10.1038/cr.2012.20; Cherest H, 1997, GENETICS, V145, P627; CHEREST H, 1992, GENETICS, V130, P51; Colombo S, 1998, EMBO J, V17, P3326, DOI 10.1093/emboj/17.12.3326; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Diallinas G, 2013, BIOCHIMIE, V95, P1755, DOI 10.1016/j.biochi.2013.05.013; Diallinas G, 2008, CHANNELS, V2, P363, DOI 10.4161/chan.2.5.6902; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Doki S, 2013, P NATL ACAD SCI USA, V110, P11343, DOI 10.1073/pnas.1301079110; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Frillingos Stathis, 2012, Int J Biochem Mol Biol, V3, P250; Garczarek F, 2004, BIOPHYS J, V87, P2676, DOI 10.1529/biophysj.104.046433; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Gournas C, 2010, MOL MICROBIOL, V75, P246, DOI 10.1111/j.1365-2958.2009.06997.x; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; HIRIMBUREGAMA K, 1992, J GEN MICROBIOL, V138, P2035, DOI 10.1099/00221287-138-10-2035; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Iraqui I, 1999, MOL CELL BIOL, V19, P989; JAUNIAUX JC, 1990, EUR J BIOCHEM, V190, P39, DOI 10.1111/j.1432-1033.1990.tb15542.x; Jennings ML, 2012, BIOPHYS J, V102, P768, DOI 10.1016/j.bpj.2012.01.005; Jensen LT, 2009, MOL BIOL CELL, V20, P2810, DOI 10.1091/mbc.E08-10-1084; Jiang X, 2010, METALLOMICS, V2, P211, DOI 10.1039/b920471g; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Keener JM, 2013, TRAFFIC, V14, P412, DOI 10.1111/tra.12039; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Kosti V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041939; Lagerstedt JO, 2002, FEBS LETT, V526, P31, DOI 10.1016/S0014-5793(02)03109-5; LILLIE SH, 1980, J BACTERIOL, V143, P1384, DOI 10.1128/JB.143.3.1384-1394.1980; Liu XF, 1999, J MOL BIOL, V289, P885, DOI 10.1006/jmbi.1999.2815; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Marzluf GA, 1997, ANNU REV MICROBIOL, V51, P73, DOI 10.1146/annurev.micro.51.1.73; Mermelekas G, 2010, J BIOL CHEM, V285, P35011, DOI 10.1074/jbc.M110.170415; Ohana E, 2011, J GEN PHYSIOL, V137, P239, DOI 10.1085/jgp.201010531; Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; Perez-Torras S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.173; Petersson J, 1999, FEBS LETT, V462, P37, DOI 10.1016/S0014-5793(99)01471-4; Popova Y, 2010, P NATL ACAD SCI USA, V107, P2890, DOI 10.1073/pnas.0906546107; Risinger AL, 2006, MOL BIOL CELL, V17, P4411, DOI 10.1091/mbc.E06-06-0506; ROOMANS GM, 1979, BIOCHIM BIOPHYS ACTA, V551, P197, DOI 10.1016/0005-2736(79)90365-1; Rubio-Texeira M, 2006, MOL BIOL CELL, V17, P3031, DOI 10.1091/mbc.E05-07-0669; Rubio-Texeira M, 2012, NAT CHEM BIOL, V8, P400, DOI [10.1038/NCHEMBIO.910, 10.1038/nchembio.910]; Sahin-Toth M, 2000, P NATL ACAD SCI USA, V97, P10729, DOI 10.1073/pnas.200351797; Samyn DR, 2012, BIOCHEM J, V445, P413, DOI 10.1042/BJ20112086; Schepers W, 2012, J BIOL CHEM, V287, P44130, DOI 10.1074/jbc.M112.421503; Schothorst J, 2013, CURR GENET, V59, P197, DOI 10.1007/s00294-013-0413-y; Seron K, 1999, J BACTERIOL, V181, P1793; SIKORSKI RS, 1989, GENETICS, V122, P19; Smirnova IN, 2008, P NATL ACAD SCI USA, V105, P8896, DOI 10.1073/pnas.0803577105; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; STANBROUGH M, 1995, J BACTERIOL, V177, P94, DOI 10.1128/jb.177.1.94-102.1995; Takahashi H, 2012, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00119; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; THEVELEIN JM, 1985, J GEN MICROBIOL, V131, P3199; Thevelein JM, 2009, MOL BIOL EVOL, V26, P2407, DOI 10.1093/molbev/msp168; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Van Zeebroeck G, 2014, MOL MICROBIOL, V93, P213, DOI 10.1111/mmi.12654; Van Zeebroeck G, 2009, NAT CHEM BIOL, V5, P45, DOI 10.1038/nchembio.132; Walch-Liu P, 2008, PLANT J, V54, P820, DOI 10.1111/j.1365-313X.2008.03443.x; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang B, 2014, PLANT J, V77, P185, DOI 10.1111/tpj.12376	70	35	35	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10430	10446		10.1074/jbc.M114.629022	http://dx.doi.org/10.1074/jbc.M114.629022			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25724649	hybrid, Green Published			2022-12-28	WOS:000353241100043
J	Yang, YF; Keeler, C; Kuo, IY; Lolis, EJ; Ehrlich, BE; Hodsdon, ME				Yang, Yifei; Keeler, Camille; Kuo, Ivana Y.; Lolis, Elias J.; Ehrlich, Barbara E.; Hodsdon, Michael E.			Oligomerization of the Polycystin-2 C-terminal Tail and Effects on Its Ca2+-binding Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Calcium Intracellular Release; Calcium-binding Protein; Isothermal Titration Calorimetry (ITC); Nuclear Magnetic Resonance (NMR); EF-hand Proteins; Polycystic Kidney Disease	ISOTHERMAL TITRATION CALORIMETRY; EF-HAND PROTEINS; KIDNEY-DISEASE; CALCIUM-DEPENDENCE; CHANNEL ACTIVITY; BINDING; DOMAIN; NMR; IDENTIFICATION; DIMERIZATION	Background: The C-terminal tail of polycystin-2 (PC2 Cterm) is essential for channel assembly and regulation. Results: Both human and sea urchin PC2 Cterm form trimers and contain EF-hand domains that bind to Ca2+. Conclusion: Oligomerization affects Ca2+-binding profiles differently in human and sea urchin PC2. Significance: Characterization of the PC2 Cterm aids the understanding of PC2 channel regulation. Polycystin-2 (PC2) belongs to the transient receptor potential (TRP) family and forms a Ca2+-regulated channel. The C-terminal cytoplasmic tail of human PC2 (HPC2 Cterm) is important for PC2 channel assembly and regulation. In this study, we characterized the oligomeric states and Ca2+-binding profiles in the C-terminal tail using biophysical approaches. Specifically, we determined that HPC2 Cterm forms a trimer in solution with and without Ca2+ bound, although TRP channels are believed to be tetramers. We found that there is only one Ca2+-binding site in the HPC2 Cterm, located within its EF-hand domain. However, the Ca2+ binding affinity of the HPC2 Cterm trimer is greatly enhanced relative to the intrinsic binding affinity of the isolated EF-hand domain. We also employed the sea urchin PC2 (SUPC2) as a model for biophysical and structural characterization. The sea urchin C-terminal construct (SUPC2 Ccore) also forms trimers in solution, independent of Ca2+ binding. In contrast to the human PC2, the SUPC2 Ccore contains two cooperative Ca2+-binding sites within its EF-hand domain. Consequently, trimerization does not further improve the affinity of Ca2+ binding in the SUPC2 Ccore relative to the isolated EF-hand domain. Using NMR, we localized the Ca2+-binding sites in the SUPC2 Ccore and characterized the conformational changes in its EF-hand domain due to trimer formation. Our study provides a structural basis for understanding the Ca2+-dependent regulation of the PC2 channel by its cytosolic C-terminal domain. The improved methodology also serves as a good strategy to characterize other Ca2+-binding proteins.	[Yang, Yifei; Keeler, Camille; Hodsdon, Michael E.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Yang, Yifei; Kuo, Ivana Y.; Lolis, Elias J.; Ehrlich, Barbara E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Ehrlich, Barbara E.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Yang, YF (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	yifei.yang@yale.edu; michael.hodsdon@yale.edu	/AAX-8408-2021	/0000-0001-9657-9704; Kuo, Ivana/0000-0002-9867-2408; Lolis, Elias/0000-0002-7902-7868	National Institutes of Health (NIH) [R21RR032351, R01 DK087844]; NIH [1S10RR023748-01]; CSC-Yale World Scholars Predoctoral fellowship; American Heart Association Postdoctoral Fellowship [R10682]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023748, R21RR032351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087844] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSC-Yale World Scholars Predoctoral fellowship; American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants R21RR032351 (to C. K. and M. E. H.) and R01 DK087844 (to B. E. E. and M. E. H.). The SEC-LS/UV/RI instrumentation was supported by NIH Grant 1S10RR023748-01 (Keck Facility, Yale University).; Supported by CSC-Yale World Scholars Predoctoral fellowship; Supported by American Heart Association Postdoctoral Fellowship R10682.	Allen MD, 2014, PROTEIN SCI, V23, P1301, DOI 10.1002/pro.2513; Anyatonwu GI, 2007, P NATL ACAD SCI USA, V104, P6454, DOI 10.1073/pnas.0610324104; Anyatonwu GI, 2005, J BIOL CHEM, V280, P29488, DOI 10.1074/jbc.M504359200; Brown A, 2009, INT J MOL SCI, V10, P3457, DOI 10.3390/ijms10083457; Byerly DW, 2002, PROTEIN SCI, V11, P1850, DOI 10.1110/ps.0203402; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; Capozzi F, 2006, J BIOL INORG CHEM, V11, P949, DOI 10.1007/s00775-006-0163-0; Celic A, 2008, J BIOL CHEM, V283, P28305, DOI 10.1074/jbc.M802743200; Celic AS, 2012, J BIOL CHEM, V287, P17232, DOI 10.1074/jbc.M112.354613; Creighton T. E., 1997, PROTEIN STRUCTURE PR, P349; Crichlow GV, 2008, EMBO J, V27, P277, DOI 10.1038/sj.emboj.7601936; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Feng S, 2008, J BIOL CHEM, V283, P28471, DOI 10.1074/jbc.M803834200; Feng S, 2011, J BIOL CHEM, V286, P18994, DOI 10.1074/jbc.M110.192286; Ferreira FM, 2011, P NATL ACAD SCI USA, V108, P9833, DOI 10.1073/pnas.1106766108; Freire E, 2009, METHOD ENZYMOL, V455, P127, DOI 10.1016/S0076-6879(08)04205-5; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Giamarchi A, 2010, EMBO J, V29, P1176, DOI 10.1038/emboj.2010.18; Goddard TD, 2006, SPARKY 3 VERSION 3 1; Hamilton S, 2003, HYBRIDOMA HYBRIDOM, V22, P347, DOI 10.1089/153685903771797048; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Henzl MT, 2013, METHODS, V59, P336, DOI 10.1016/j.ymeth.2012.12.003; Henzl MT, 2010, BIOCHEMISTRY-US, V49, P2256, DOI 10.1021/bi902115v; Hsiao HH, 2010, BIOCHEMISTRY-US, V49, P4620, DOI 10.1021/bi9021445; Kawasaki H, 2012, PROTEINS, V80, P2592, DOI 10.1002/prot.24143; Keeler C, 2013, BIOPHYS J, V105, P2843, DOI 10.1016/j.bpj.2013.11.017; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Kuo IY, 2014, FASEB J, V28, P2332, DOI 10.1096/fj.13-247106; Liu HW, 2014, J BIOL CHEM, V289, P16914, DOI 10.1074/jbc.M114.557991; Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Petri ET, 2010, P NATL ACAD SCI USA, V107, P9176, DOI 10.1073/pnas.0912295107; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Streets AJ, 2013, HUM MOL GENET, V22, P1924, DOI 10.1093/hmg/ddt031; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414	39	10	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10544	10554		10.1074/jbc.M115.641803	http://dx.doi.org/10.1074/jbc.M115.641803			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25716316	hybrid, Green Published			2022-12-28	WOS:000353241100052
J	Zhang, TZ; Sell, P; Braun, U; Leitges, M				Zhang, Thianzhou; Sell, Philip; Braun, Ursula; Leitges, Michael			PKD1 Protein Is Involved in Reactive Oxygen Species-mediated Mitochondrial Depolarization in Cooperation with Protein Kinase C delta (PKC delta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Gene Knockout; Mitochondrial Apoptosis; Protein Kinase C (PKC); Protein Kinase D (PKD); Reactive Oxygen Species (ROS)	NF-KAPPA-B; BAX; APOPTOSIS; ACTIVATION; BCL-2; PHOSPHORYLATION; IDENTIFICATION; SURVIVAL; SITE; D1	Background: The in vivo functions of PKD1 are potentially associated with cancer development and aging. Results: Our results indicate that PKD1 is a key regulator involved in determining the threshold at which mitochondrial membranes depolarize after reactive oxygen-induced stress. Conclusion: This study defines a new function for PKD1 during reactive oxygen signaling. Significance: The involvement of PKD1 in mitochondrial depolarization suggests that PKD1 may be a therapeutic target. In this study, we used gene targeting in mice to identify the in vivo functions of PKD1. In addition to phenotypically characterizing the resulting knock-out animals, we also used mouse embryonic fibroblasts to investigate the associated signaling pathways in detail. This study is the first to use genetic deletion to reveal that PKD1 is a key regulator involved in determining the threshold of mitochondrial depolarization that leads to the production of reactive oxygen species. In addition, we also provide clear evidence that PKC is upstream of PKD1 in this process and acts as the activating kinase of PKD1. Therefore, our in vivo data indicate that PKD1 functions not only in the context of aging but also during nutrient deprivation, which occurs during specific phases of tumor growth.	[Zhang, Thianzhou; Sell, Philip; Braun, Ursula; Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, N-0349 Oslo, Norway	University of Oslo	Leitges, M (corresponding author), Univ Oslo, Biotechnol Ctr Oslo, Gaustadalleen 21, N-0349 Oslo, Norway.	michael.leitges@biotek.uio.no	Leitges, Michael/AAN-1953-2021	Leitges, Michael/0000-0003-4203-6995	Norwegian Research Council [197261]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Norwegian Research Council (Grant 197261).	BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Dejean LM, 2006, BBA-MOL BASIS DIS, V1762, P191, DOI 10.1016/j.bbadis.2005.07.002; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Doppler H, 2007, J BIOL CHEM, V282, P31873, DOI 10.1074/jbc.M703584200; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Joyner A., 1999, GENE TARGETING PRACT, P36; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; Michels Judith, 2013, Int J Cell Biol, V2013, P705294, DOI 10.1155/2013/705294; Renault TT, 2013, INT J BIOCHEM CELL B, V45, P64, DOI 10.1016/j.biocel.2012.09.022; Sevilla L, 2001, HISTOL HISTOPATHOL, V16, P595, DOI 10.14670/HH-16.595; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Steinberg SF, 2012, MOL PHARMACOL, V81, P284, DOI 10.1124/mol.111.075986; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Wang QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013393; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	26	16	19	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10472	10485		10.1074/jbc.M114.619148	http://dx.doi.org/10.1074/jbc.M114.619148			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25759386	Green Published, hybrid			2022-12-28	WOS:000353241100046
J	Marudamuthu, AS; Shetty, SK; Bhandary, YP; Karandashova, S; Thompson, M; Sathish, V; Florova, G; Hogan, TB; Pabelick, CM; Prakash, YS; Tsukasaki, Y; Fu, J; Ikebe, M; Idell, S; Shetty, S				Marudamuthu, Amarnath S.; Shetty, Shwetha K.; Bhandary, Yashodhar P.; Karandashova, Sophia; Thompson, Michael; Sathish, Venkatachalenn; Florova, Galina; Hogan, Taryn B.; Pabelick, Christina M.; Prakash, Y. S.; Tsukasaki, Yoshikazu; Fu, Jian; Ikebe, Mitsuo; Idell, Steven; Shetty, Sreerama			Plasminogen Activator Inhibitor-1 Suppresses Profibrotic Responses in Fibroblasts from Fibrotic Lungs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; EPITHELIAL-CELL APOPTOSIS; UROKINASE RECEPTOR; FIBRINOLYTIC SYSTEM; TYPE-1 EXPRESSION; TGF-BETA; IN-VITRO; MICE; PROLIFERATION; DEFICIENCY	Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease characterized by progressive interstitial scarification. A hallmark morphological lesion is the accumulation of myofibroblasts or fibrotic lung fibroblasts (FL-fibroblasts) in areas called fibroblastic foci. We previously demonstrated that the expression of both urokinase-type plasminogen activator (uPA) and the uPA receptor are elevated in FL-fibroblasts from the lungs of patients with IPF. FL-fibroblasts isolated from human IPF lungs and from mice with bleomycin-induced pulmonary fibrosis showed an increased rate of proliferation compared with normal lung fibroblasts (NL-fibroblasts) derived from histologically "normal" lung. Basal expression of plasminogen activator inhibitor-1 (PAI-1) in human and murine FL-fibroblasts was reduced, whereas collagen-I and alpha-smooth muscle actin were markedly elevated. Conversely, alveolar type II epithelial cells surrounding the fibrotic foci in situ, as well as those isolated from IPF lungs, showed increased activation of caspase-3 and PAI-1 with a parallel reduction in uPA expression. Transduction of an adenovirus PAI-1 cDNA construct (Ad-PAI-1) suppressed expression of uPA and collagen-I and attenuated proliferation in FL-fibroblasts. On the contrary, inhibition of basal PAL-1 in NL-fibroblasts increased collagen-I and alpha-smooth muscle actin. Fibroblasts isolated from PAI-1-deficient mice without lung injury also showed increased collagen-I and uPA. These changes were associated with increased Akt/phosphatase and tensin homolog proliferation/survival signals in FL-fibroblasts, which were reversed by transduction with Ad-PAI-i. This study defines a new role of PAL-1 in the control of fibroblast activation and expansion and its role in the pathogenesis of fibrosing lung disease and, in particular, IPF	[Marudamuthu, Amarnath S.; Shetty, Shwetha K.; Bhandary, Yashodhar P.; Karandashova, Sophia; Florova, Galina; Hogan, Taryn B.; Tsukasaki, Yoshikazu; Ikebe, Mitsuo; Idell, Steven; Shetty, Sreerama] Univ Texas Hlth Ctr Tyler, Dept Med, Texas Lung Injury Inst, 11937 US Highway 271, Tyler, TX 75708 USA; [Thompson, Michael; Sathish, Venkatachalenn; Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Fu, Jian] Univ Kentucky, Coll Med, Ctr Res Environm Dis & Toxicol, Lexington, KY 40536 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); Mayo Clinic; University of Kentucky	Shetty, S (corresponding author), Univ Texas Hlth Ctr Tyler, Dept Med, Texas Lung Injury Inst, 11937 US Highway 271, Tyler, TX 75708 USA.	sreerama.shetty@uthct.edu	Bhandary, Yashodhar P/J-9078-2017	Shetty, Shwetha Kumari/0000-0003-1762-8040; Prakash, Y S/0000-0002-2968-224X; venkatachalem, sathish/0000-0001-9770-8299	Flight Attendant Medical Research Institute [FAMRI-ID-123010]; American Heart Association [19020001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111696, R01HL073050] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Flight Attendant Medical Research Institute Clinical Innovator Award FAMRI-ID-123010 and American Heart Association Grant 19020001.	Ardite E, 2012, J CELL BIOL, V196, P163, DOI 10.1083/jcb.201105013; Baglole CJ, 2005, METH MOLEC MED, V117, P115; Balsara RD, 2007, CURR DRUG TARGETS, V8, P982, DOI 10.2174/138945007781662382; Balsara RD, 2006, J BIOL CHEM, V281, P22527, DOI 10.1074/jbc.M512819200; Bhandary YP, 2013, AM J PATHOL, V183, P131, DOI 10.1016/j.ajpath.2013.03.022; Bhandary YP, 2012, AM J PHYSIOL-LUNG C, V302, pL463, DOI 10.1152/ajplung.00099.2011; Chang W, 2010, J BIOL CHEM, V285, P8196, DOI 10.1074/jbc.M109.025684; Chuang-Tsai S, 2003, AM J PATHOL, V163, P445, DOI 10.1016/S0002-9440(10)63674-7; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Datta A, 2011, BRIT J PHARMACOL, V163, P141, DOI 10.1111/j.1476-5381.2011.01247.x; De Almeida CJG, 2013, CELL CYCLE, V12, P2248, DOI 10.4161/cc.25335; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Elzi DJ, 2012, P NATL ACAD SCI USA, V109, P12052, DOI 10.1073/pnas.1120437109; Gharaee-Kermani M, 2008, EXPERT OPIN INV DRUG, V17, P905, DOI 10.1517/13543784.17.6.905 ; Ghosh AK, 2010, CIRCULATION, V122, P1200, DOI 10.1161/CIRCULATIONAHA.110.955245; Henke C, 1996, AM J PATHOL, V149, P1639; Hertig A, 2003, FASEB J, V17, P1904, DOI 10.1096/fj.03-0084fje; Huang YF, 2003, J CLIN INVEST, V112, P379, DOI 10.1172/JCI200318038; IDELL S, 1992, AM J PHYSIOL, V263, pL487, DOI 10.1152/ajplung.1992.263.4.L487; Ji Y, 2011, ARTERIOSCL THROM VAS, V31, P1781, DOI 10.1161/ATVBAHA.111.228767; Kaikita K, 2001, CIRCULATION, V104, P839, DOI 10.1161/hc3301.092803; Kasper M, 2009, CURR CANCER DRUG TAR, V9, P341, DOI 10.2174/156800909788166501; Kouri FM, 2008, INT J BIOCHEM CELL B, V40, P1872, DOI 10.1016/j.biocel.2008.01.028; Larsson O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003220; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Liu RM, 2008, ANTIOXID REDOX SIGN, V10, P303, DOI 10.1089/ars.2007.1903; Martens JWM, 2003, THROMB HAEMOSTASIS, V89, P393; Marudamuthu AS, 2015, AM J PATHOL, V185, P55, DOI 10.1016/j.ajpath.2014.08.027; Mason Robert J., 1999, American Journal of Respiratory and Critical Care Medicine, V160, P1771; Mayoral R, 2010, J BIOL CHEM, V285, P3633, DOI 10.1074/jbc.M109.072900; McDougall S, 2006, PHILOS T R SOC A, V364, P1385, DOI [10.1098/rsta.2006.1773, 10.1098/rsta.2000.1773]; Mehta R, 2008, HAEMOPHILIA, V14, P1255, DOI 10.1111/j.1365-2516.2008.01834.x; MU XC, 1995, J CELL PHYSIOL, V165, P647, DOI 10.1002/jcp.1041650324; Mukai Y, 2007, AM J PHYSIOL-HEART C, V292, pH1937, DOI 10.1152/ajpheart.00868.2006; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Nho RS, 2006, J BIOL CHEM, V281, P33291, DOI 10.1074/jbc.M606450200; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; Osterholzer JJ, 2012, J PATHOL, V228, P170, DOI 10.1002/path.3992; Pechkovsky DV, 2012, AM J PATHOL, V180, P1398, DOI 10.1016/j.ajpath.2011.12.022; Ploplis VA, 2004, J BIOL CHEM, V279, P6143, DOI 10.1074/jbc.M307297200; RAGHU G, 1988, AM REV RESPIR DIS, V138, P703, DOI 10.1164/ajrccm/138.3.703; Samarakoon R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022896; Schneider DJ, 2008, THROMB HAEMOSTASIS, V100, P1037, DOI 10.1160/TH08-04-0234; Selman M, 2011, EXPERT OPIN EMERG DR, V16, P341, DOI 10.1517/14728214.2011.565049; Senoo T, 2010, THORAX, V65, P334, DOI 10.1136/thx.2009.119974; Serrano-Mollar A, 2007, AM J RESP CRIT CARE, V176, P1261, DOI 10.1164/rccm.200610-1491OC; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shetty S, 1996, AM J RESP CELL MOL, V15, P78, DOI 10.1165/ajrcmb.15.1.8679225; Shetty S, 2002, AM J PHYSIOL-LUNG C, V283, pL319, DOI 10.1152/ajplung.00395.2001; Shetty S, 2001, J BIOL CHEM, V276, P24549, DOI 10.1074/jbc.M101605200; Shetty SK, 2012, AM J RESP CELL MOL, V47, P474, DOI 10.1165/rcmb.2011-0390OC; Shetty S, 2007, MOL CELL BIOL, V27, P5607, DOI 10.1128/MCB.00080-07; Shetty S, 2008, J BIOL CHEM, V283, P19570, DOI 10.1074/jbc.M710268200; Shetty S, 2008, AM J PHYSIOL-LUNG C, V295, pL967, DOI 10.1152/ajplung.90349.2008; Sisson TH, 2002, AM J PHYSIOL-LUNG C, V283, pL1023, DOI 10.1152/ajplung.00049.2002; Sisson TH, 1999, HUM GENE THER, V10, P2315, DOI 10.1089/10430349950016960; Spitalieri P, 2012, EUR RESPIR J, V39, P446, DOI 10.1183/09031936.00005511; Suelves M, 2005, FRONT BIOSCI-LANDMRK, V10, P2978, DOI 10.2741/1754; SUGANUMA H, 1995, THORAX, V50, P984, DOI 10.1136/thx.50.9.984; Tanaka T, 2002, EUR RESPIR J, V20, P359, DOI 10.1183/09031936.02.00252602; Thannickal VJ, 2014, AM J PATHOL, V184, P1643, DOI 10.1016/j.ajpath.2014.02.003; Tourkina Elena, 2012, Open Rheumatol J, V6, P116, DOI 10.2174/1874312901206010116; Tucker TA, 2014, AM J RESP CELL MOL, V50, P316, DOI 10.1165/rcmb.2013-0300OC; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Xu Z, 2010, BLOOD, V115, P2038, DOI 10.1182/blood-2009-09-244962; Zhang YP, 2013, THROMB RES, V131, P64, DOI 10.1016/j.thromres.2012.09.003; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x; Zhao WL, 2001, CANCER RES, V61, P5537; Zhu S, 2009, AM J PHYSIOL-LUNG C, V297, pL97, DOI 10.1152/ajplung.90283.2008	72	37	41	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9428	9441		10.1074/jbc.M114.601815	http://dx.doi.org/10.1074/jbc.M114.601815			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25648892	Green Published, hybrid			2022-12-28	WOS:000352729400011
J	Kobayashi, S; Sato, M; Kasakoshi, T; Tsutsui, T; Sugimoto, M; Osaki, M; Okada, F; Igarashi, K; Hiratake, J; Homma, T; Conrad, M; Fujii, J; Soga, T; Bannai, S; Sato, H				Kobayashi, Sho; Sato, Mami; Kasakoshi, Takayuki; Tsutsui, Takumi; Sugimoto, Masahiro; Osaki, Mitsuhiko; Okada, Futoshi; Igarashi, Kiharu; Hiratake, Jun; Homma, Takujiro; Conrad, Marcus; Fujii, Junichi; Soga, Tomoyoshi; Bannai, Shiro; Sato, Hideyo			Cystathionine Is a Novel Substrate of Cystine/Glutamate Transporter IMPLICATIONS FOR IMMUNE FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-DIPLOID FIBROBLASTS; AMINO-ACID-TRANSPORT; SYSTEM X(C)(-); OXIDATIVE-STRESS; PLASMA-MEMBRANE; EXCHANGE TRANSPORTER; L-GLUTAMATE; CELL-LINES; L-CYSTINE; EXPRESSION	The cystine/glutamate transporter, designated as system x(c)(-), is important for maintaining intracellular glutathione levels and extracellular redox balance. The substrate-specific component of system x(c)(-), xCT, is strongly induced by various stimuli, including oxidative stress, whereas it is constitutively expressed only in specific brain regions and immune tissues, such as the thymus and spleen. Although cystine and glutamate are the well established substrates of system x(c)(-) and the knockout of xCT leads to alterations of extracellular redox balance, nothing is known about other potential substrates. We thus performed a comparative metabolite analysis of tissues from xCT-deficient and wild-type mice using capillary electrophoresis time-of-flight mass spectrometry. Although most of the analyzed metabolites did not show significant alterations between xCT-deficient and wild-type mice, cystathionine emerged as being absent specifically in the thymus and spleen of xCT-deficient mice. No expression of either cystathionine beta-synthase or cystathionine gamma-lyase was observed in the thymus and spleen of mice. In embryonic fibroblasts derived from wild-type embryos, cystine uptake was significantly inhibited by cystathionine in a concentration-dependent manner. Wild-type cells showed an intracellular accumulation of cystathionine when incubated in cystathionine-containing buffer, which concomitantly stimulated an increased release of glutamate into the extracellular space. By contrast, none of these effects could be observed in xCT-deficient cells. Remarkably, unlike knock-out cells, wild-type cells could be rescued from cystine deprivation-induced cell death by cystathionine supplementation. We thus conclude that cystathionine is a novel physiological substrate of system x(c)(-) and that the accumulation of cystathionine in immune tissues is exclusively mediated by system x(c)(-).	[Kobayashi, Sho; Sato, Mami; Kasakoshi, Takayuki; Tsutsui, Takumi; Igarashi, Kiharu; Bannai, Shiro; Sato, Hideyo] Yamagata Univ, Fac Agr, Dept Food & Appl Life Sci, Tsuruoka, Yamagata 9978555, Japan; [Kobayashi, Sho; Sato, Hideyo] Iwate Univ, United Grad Sch Agr Sci, Dept Funct Genom & Biotechnol, Morioka, Iwate 0208550, Japan; [Kobayashi, Sho; Conrad, Marcus] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Dev Genet, D-85764 Neuherberg, Germany; [Sugimoto, Masahiro; Bannai, Shiro] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan; [Osaki, Mitsuhiko; Okada, Futoshi] Tottori Univ, Fac Med, Div Pathol Biochem, Yonago, Tottori 6838503, Japan; [Osaki, Mitsuhiko; Okada, Futoshi] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori 6838503, Japan; [Hiratake, Jun] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Homma, Takujiro; Fujii, Junichi] Yamagata Univ, Grad Sch Med Sci, Dept Biochem & Mol Biol, Yamagata 9909585, Japan; [Sato, Hideyo] Niigata Univ, Fac Med, Dept Med Technol, Lab Biochem & Mol Biol,Chuo Ku, Niigata 9518518, Japan	Yamagata University; Iwate University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Keio University; Tottori University; Tottori University; Kyoto University; Yamagata University; Niigata University	Sato, H (corresponding author), Yamagata Univ, Fac Agr, Dept Food & Appl Life Sci, Tsuruoka, Yamagata 9978555, Japan.	hideyo-s@clg.niigata-u.ac.jp	Conrad, Marcus/E-8792-2015; Soga, Tomoyoshi/B-8105-2014; Homma, Takujiro/AAH-7386-2019	Conrad, Marcus/0000-0003-1140-5612; Soga, Tomoyoshi/0000-0001-9502-2509; Homma, Takujiro/0000-0003-3886-7411; Sugimoto, Masahiro/0000-0003-3316-2543; Okada, Futoshi/0000-0003-4733-1037; Sato, Mami/0000-0001-5292-8319	Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from the Japan Society for the Promotion of Sciences; Naito Foundation; Collaborative Research Program of the Institute for Chemical Research, Kyoto University [2013-43]	Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from the Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Collaborative Research Program of the Institute for Chemical Research, Kyoto University	This work was supported, in part, by the Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from the Japan Society for the Promotion of Sciences; a research grant from the Naito Foundation; and Collaborative Research Program of the Institute for Chemical Research, Kyoto University, Grant 2013-43.	Aitken SM, 2003, BIOCHEMISTRY-US, V42, P571, DOI 10.1021/bi026681n; BANNAI S, 1986, J MEMBRANE BIOL, V89, P1, DOI 10.1007/BF01870891; BANNAI S, 1984, J BIOL CHEM, V259, P2435; BANNAI S, 1980, J BIOL CHEM, V255, P2372; BANNAI S, 1986, J BIOL CHEM, V261, P2256; BANNAI S, 1981, J BIOL CHEM, V256, P5770; Barber T, 1999, J NUTR, V129, P928, DOI 10.1093/jn/129.5.928; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; De Bundel D, 2011, J NEUROSCI, V31, P5792, DOI 10.1523/JNEUROSCI.5465-10.2011; Dickhout JG, 2012, J BIOL CHEM, V287, P7603, DOI 10.1074/jbc.M111.304576; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Gout PW, 2001, LEUKEMIA, V15, P1633, DOI 10.1038/sj.leu.2402238; ISHII T, 1981, J BIOL CHEM, V256, P2387; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Julio-Pieper M, 2011, PHARMACOL REV, V63, P35, DOI 10.1124/pr.110.004036; Kobayashi S, 2012, FREE RADICAL BIO MED, V53, P2197, DOI 10.1016/j.freeradbiomed.2012.09.040; LEE WS, 1993, J CLIN INVEST, V91, P1959, DOI 10.1172/JCI116415; Lewerenz J, 2012, CELL DEATH DIFFER, V19, P847, DOI 10.1038/cdd.2011.165; Lewerenz J, 2014, ANTIOXID REDOX SIGN, V20, P2907, DOI 10.1089/ars.2013.5455; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Lo M, 2008, BRIT J CANCER, V99, P464, DOI 10.1038/sj.bjc.6604485; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Maclean KN, 2012, J BIOL CHEM, V287, P31994, DOI 10.1074/jbc.M112.355172; Massie A, 2011, FASEB J, V25, P1359, DOI 10.1096/fj.10-177212; Okuno S, 2003, BRIT J CANCER, V88, P951, DOI 10.1038/sj.bjc.6600786; Pacheco R, 2007, J NEUROIMMUNOL, V185, P9, DOI 10.1016/j.jneuroim.2007.01.003; Pacheco R, 2006, J IMMUNOL, V177, P6695, DOI 10.4049/jimmunol.177.10.6695; Patel SA, 2004, NEUROPHARMACOLOGY, V46, P273, DOI 10.1016/j.neuropharm.2003.08.006; Qin S, 2006, J NEUROSCI, V26, P3345, DOI 10.1523/JNEUROSCI.5186-05.2006; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Sato H, 2004, BIOCHEM BIOPH RES CO, V325, P109, DOI 10.1016/j.bbrc.2004.10.009; Sato H, 2002, J NEUROSCI, V22, P8028; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Sato H, 2000, ANTIOXID REDOX SIGN, V2, P665, DOI 10.1089/ars.2000.2.4-665; Savaskan NE, 2008, NAT MED, V14, P629, DOI 10.1038/nm1772; Sugimoto M, 2012, NUCLEIC ACIDS RES, V40, pD809, DOI 10.1093/nar/gkr1170; Taguchi Kumiko, 2007, J Inflamm (Lond), V4, P20, DOI 10.1186/1476-9255-4-20; TALLAN HH, 1958, J BIOL CHEM, V230, P707; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; VANWINKLE LJ, 1988, J BIOL CHEM, V263, P3150; Yadav AK, 2011, J BIOL CHEM, V286, P19714, DOI 10.1074/jbc.M111.240648	47	53	54	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8778	8788		10.1074/jbc.M114.625053	http://dx.doi.org/10.1074/jbc.M114.625053			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25713140	Green Published, hybrid			2022-12-28	WOS:000352207100009
J	Jing, YP; Liu, W; Wang, JX; Zhao, XF				Jing, Yu-Pu; Liu, Wen; Wang, Jin-Xing; Zhao, Xiao-Fan			The Steroid Hormone 20-Hydroxyecdysone via Nongenomic Pathway Activates Ca2+/Calmodulin-dependent Protein Kinase II to Regulate Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DROSOPHILA METAMORPHOSIS; HISTONE DEACETYLASES; TRANSCRIPTION FACTOR; PHOSPHORYLATION; RECEPTOR; CAMKII; MECHANISMS; CALMODULIN; COMPLEX	The steroid hormone 20-hydroxyecdysone (20E) triggers calcium signaling pathway to regulate 20E response gene expression, but the mechanism underlying this process remains unclear. We propose that the 20E-induced phosphorylation of Ca2+/calmodulin-dependent protein kinase II (CaMKII) serves an important function in 20E response gene transcription in the lepidopteran insect Helicoverpa armigera. CaMKII showed increased expression and phosphorylation during metamorphosis. 20E elevated CaMKII phosphorylation. However, the G protein-coupled receptor (GPCR) and ryanodine receptor inhibitor suramin, the phospholipase C inhibitor U73122, and the inositol 1,4,5-triphosphate receptor inhibitor xestospongin Csuppressed 20E-induced CaMKII phosphorylation. Twoecdysone- responsible GPCRs and G alpha(q) protein were involved in 20E-induced CaMKII phosphorylation by RNA interference analysis. 20E regulated CaMKII threonine phosphorylation at amino acid 290, thereby inducing CaMKII nuclear translocation. CaMKII knockdown by dsCaMKII injection into the larvae prevented the occurrence of larval-pupal transition and suppressed 20E response gene expression. CaMKII phosphorylation and nuclear translocation maintained USP1 lysine acetylation at amino acid 303 by inducing histone deacetylase 3 phosphorylation and nuclear export. The lysine acetylation of USP1 was necessary for the interaction of USP1 with EcRB1 and their binding to the ecdysone response element. Results suggest that 20E (via GPCR activation and calcium signaling) activates CaMKII phosphorylation and nuclear translocation, which regulate USP1 lysine acetylation to form an EcRB1-USP1 complex for 20E response gene transcription.	[Jing, Yu-Pu; Liu, Wen; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Peoples R China	Shandong University	Zhao, XF (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	xfzhao@sdu.edu.cn	Jing, Yu-Pu/AAE-3531-2022; Liu, Wen/S-8027-2019; Zhao, Xiao-Fan/AGW-9886-2022; Wang, Jin-Xing/AAU-1514-2021	Liu, Wen/0000-0002-4985-0618; Wang, Jin-Xing/0000-0003-0283-3930; Zhao, Xiao-Fan/0000-0003-1809-4730	National Natural Science Foundation of China [31230067]; National Basic Research Program of China Program 973 [2012CB114101]; Ph.D. Program Foundation of Ministry of Education of China [20120131110025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China Program 973(National Basic Research Program of China); Ph.D. Program Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grant 31230067, National Basic Research Program of China Program 973 Grant 2012CB114101, and Ph.D. Program Foundation of Ministry of Education of China Grant 20120131110025.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Cai MJ, 2014, J BIOL CHEM, V289, P26630, DOI 10.1074/jbc.M114.581876; Cai MJ, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-9; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Davis PJ, 2002, J ENDOCRINOL INVEST, V25, P377, DOI 10.1007/BF03344022; EMERY IF, 1994, DEVELOPMENT, V120, P3275; Erezyilmaz DF, 2006, P NATL ACAD SCI USA, V103, P6925, DOI 10.1073/pnas.0509983103; Erickson JR, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00059; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Fluck M, 2000, BIOCHEM BIOPH RES CO, V270, P488, DOI 10.1006/bbrc.2000.2457; Foglietti C, 2006, J BIOL CHEM, V281, P17968, DOI 10.1074/jbc.M511945200; Griffith Leslie C, 2003, Mol Interv, V3, P386, DOI 10.1124/mi.3.7.386; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; KENNEDY MB, 1981, P NATL ACAD SCI-BIOL, V78, P1293, DOI 10.1073/pnas.78.2.1293; Kreusser MM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00036; Lam GT, 1997, DEVELOPMENT, V124, P1757; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Lin YC, 2008, P NATL ACAD SCI USA, V105, P15791, DOI 10.1073/pnas.0804399105; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; Liu PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019776; Liu W, 2014, J BIOL CHEM, V289, P13026, DOI 10.1074/jbc.M113.547018; Liu W, 2014, ENDOCRINOLOGY, V155, P1738, DOI 10.1210/en.2013-2020; Liu W, 2013, BBA-GEN SUBJECTS, V1830, P5184, DOI 10.1016/j.bbagen.2013.06.037; Loweth JA, 2008, NEUROSCI LETT, V444, P157, DOI 10.1016/j.neulet.2008.08.004; Lu HQ, 2009, J BIOL CHEM, V284, P11100, DOI 10.1074/jbc.M806956200; Mane-Padros D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045019; Meldrum DR, 2007, AM J PATHOL, V170, P1148, DOI 10.2353/ajpath.2007.070025; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Nishita Y, 2014, INSECT MOL BIOL, V23, P341, DOI 10.1111/imb.12085; Pitt GS, 2007, CARDIOVASC RES, V73, P641, DOI 10.1016/j.cardiores.2006.10.019; Ren J, 2014, J STEROID BIOCHEM, V144, P313, DOI 10.1016/j.jsbmb.2014.08.006; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Sanden C, 2011, MOL PHARMACOL, V79, P400, DOI 10.1124/mol.110.069500; SCHULMAN H, 1978, P NATL ACAD SCI USA, V75, P5432, DOI 10.1073/pnas.75.11.5432; Shao HL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003127; Sun XP, 2006, ARCH INSECT BIOCHEM, V62, P116, DOI 10.1002/arch.20130; Tabata T, 2009, GENES CELLS, V14, P17, DOI 10.1111/j.1365-2443.2008.01246.x; Takeuchi M, 2001, J BIOCHEM, V130, P833, DOI 10.1093/oxfordjournals.jbchem.a003055; THOMPSON EB, 1995, CURR BIOL, V5, P730, DOI 10.1016/S0960-9822(95)00146-1; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Wolner I, 2005, BRIT J PHARMACOL, V146, P525, DOI 10.1038/sj.bjp.0706359; YAMAUCHI T, 1981, BIOCHEM BIOPH RES CO, V100, P807, DOI 10.1016/S0006-291X(81)80246-X; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0	52	18	23	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8469	8481		10.1074/jbc.M114.622696	http://dx.doi.org/10.1074/jbc.M114.622696			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25670853	Green Published, hybrid			2022-12-28	WOS:000351662600039
J	Li, QL; Deng, S; Ibarra, RA; Anderson, VE; Brunengraber, H; Zhang, GF				Li, Qingling; Deng, Shuang; Ibarra, Rafael A.; Anderson, Vernon E.; Brunengraber, Henri; Zhang, Guo-Fang			Multiple Mass Isotopomer Tracing of Acetyl-CoA Metabolism in Langendorff-perfused Rat Hearts CHANNELING OF ACETYL-CoA FROM PYRUVATE DEHYDROGENASE TO CARNITINE ACETYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FATTY-ACIDS; FRUCTOSE 6-PHOSPHATE; SKELETAL-MUSCLE; MALONYL-COA; ACETATE; OXIDATION; ENRICHMENT; COENZYME; ENZYME; ASSAY	We developed an isotopic technique to assess mitochondrial acetyl-CoA turnover (approximate to citric acid flux) in perfused rat hearts. Hearts are perfused with buffer containing tracer [C-13(2),H-2(3)]acetate, which forms M5 + M4 + M3 acetyl-CoA. The buffer may also contain one or two labeled substrates, which generate M2 acetyl-CoA ( e. g. [C-13(6)] glucose or [1,2-C-13(2)] palmitate) or/and M1 acetyl-CoA ( e. g. [1-13C] octanoate). The total acetylCoA turnover and the contributions of fuels to acetyl-CoA are calculated from the uptake of the acetate tracer and the mass isotopomer distribution of acetyl-CoA. The method was applied to measurements of acetyl-CoA turnover under different conditions ( glucose +/- palmitate +/- insulin +/- dichloroacetate). The data revealed ( i) substrate cycling between glycogen and glucose- 6-P and between glucose-6-P and triose phosphates, ( ii) the release of small excess acetyl groups as acetylcarnitine and ketone bodies, and ( iii) the channeling of mitochondrial acetylCoA from pyruvate dehydrogenase to carnitine acetyltransferase. Because of this channeling, the labeling of acetylcarnitine and ketone bodies released by the heart are not proxies of the labeling of mitochondrial acetyl-CoA.	[Li, Qingling; Deng, Shuang; Ibarra, Rafael A.; Brunengraber, Henri; Zhang, Guo-Fang] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Anderson, Vernon E.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Zhang, GF (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, 10900 Euclid Ave W-G48, Cleveland, OH 44106 USA.	gxz35@case.edu		Anderson, Vernon Emmett/0000-0002-1699-7621	National Institutes of Health [R33DK070291]; Case Mouse Metabolic and Phenotyping Center (MMPC) Grant [U24DK76174]; American Heart Association [12GRNT12050453]; Cleveland Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291, U24DK076174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Mouse Metabolic and Phenotyping Center (MMPC) Grant; American Heart Association(American Heart Association); Cleveland Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Roadmap Grant R33DK070291 and Case Mouse Metabolic and Phenotyping Center (MMPC) Grant U24DK76174 (to H. B.). This work was also supported by American Heart Association Grant 12GRNT12050453 (to G.-F. Z.) and by funds from the Cleveland Mt. Sinai Health Care Foundation.	Abbas AS, 1998, J MOL CELL CARDIOL, V30, P1305, DOI 10.1006/jmcc.1998.0693; BALLARD FJ, 1972, AM J CLIN NUTR, V25, P773; BEIS A, 1980, EUR J BIOCHEM, V104, P209, DOI 10.1111/j.1432-1033.1980.tb04417.x; Bian F, 2005, J BIOL CHEM, V280, P9265, DOI 10.1074/jbc.M412850200; Bian F, 2006, J MOL CELL CARDIOL, V41, P868, DOI 10.1016/j.yjmcc.2006.08.011; BRODERICK TL, 1992, J BIOL CHEM, V267, P3758; Burgess SC, 2001, ANAL BIOCHEM, V289, P187, DOI 10.1006/abio.2000.4930; CHALLISS RAJ, 1984, BIOCHEM J, V223, P849, DOI 10.1042/bj2230849; CHALLISS RAJ, 1984, BIOCHEM J, V221, P153, DOI 10.1042/bj2210153; CHANCE EM, 1983, J BIOL CHEM, V258, P3785; CHATHAM JC, 1995, J BIOL CHEM, V270, P7999, DOI 10.1074/jbc.270.14.7999; Comte B, 1997, J BIOL CHEM, V272, P26117, DOI 10.1074/jbc.272.42.26117; CRABTREE B, 1990, BIOCHEM J, V270, P219, DOI 10.1042/bj2700219; DAVID F, 1994, ANAL BIOCHEM, V218, P143, DOI 10.1006/abio.1994.1153; DESROSIERS C, 1990, AM J PHYSIOL, V258, pE519, DOI 10.1152/ajpendo.1990.258.3.E519; EGGERER H, 1965, BIOCHEM Z, V343, P111; FINK G, 1988, J BIOL CHEM, V263, P18036; FRITZ IB, 1963, J BIOL CHEM, V238, P2509; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Gu L, 2010, AM J PHYSIOL-ENDOC M, V298, pE362, DOI 10.1152/ajpendo.00384.2009; HACHEY DL, 1991, ANAL CHEM, V63, P919, DOI 10.1021/ac00009a017; Hazey JW, 1997, ANAL BIOCHEM, V248, P158, DOI 10.1006/abio.1997.2068; Henning SL, 1996, CIRCULATION, V93, P1549, DOI 10.1161/01.CIR.93.8.1549; HERSH LB, 1967, J BIOL CHEM, V242, P3468; HUTH W, 1973, H-S Z PHYSIOL CHEM, V354, P635, DOI 10.1515/bchm2.1973.354.1.635; LANDAU BR, 1986, METABOLISM, V35, P94, DOI 10.1016/0026-0495(86)90102-2; LEIGHTON F, 1989, J BIOL CHEM, V264, P10347; Li Q., 2013, FASEB J, V27; LINN TC, 1979, J BIOL CHEM, V254, P1691; Mitchell GA, 2008, MOL GENET METAB, V94, P4, DOI 10.1016/j.ymgme.2007.12.005; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Ovadi J, 1996, CELL BIOCHEM FUNCT, V14, P249; Panchal AR, 2000, AM J PHYSIOL-HEART C, V279, pH2390, DOI 10.1152/ajpheart.2000.279.5.H2390; POWERS L, 1995, J MASS SPECTROM, V30, P747, DOI 10.1002/jms.1190300514; RANDLE PJ, 1970, BIOCHEM J, V117, P677, DOI 10.1042/bj1170677; ROSIERS CD, 1988, ANAL BIOCHEM, V173, P96, DOI 10.1016/0003-2697(88)90165-0; Schroeder MA, 2012, CIRC-CARDIOVASC IMAG, V5, P201, DOI 10.1161/CIRCIMAGING.111.969451; Seiler SE, 2014, J LIPID RES, V55, P635, DOI 10.1194/jlr.M043448; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Tomcik K, 2011, ANAL BIOCHEM, V410, P110, DOI 10.1016/j.ab.2010.11.030; UZIEL G, 1988, MUSCLE NERVE, V11, P720, DOI 10.1002/mus.880110708; Yang WC, 2008, ANAL CHEM, V80, P9508, DOI 10.1021/ac801693c; Zhang GF, 2009, J BIOL CHEM, V284, P33521, DOI 10.1074/jbc.M109.055665	43	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8121	8132		10.1074/jbc.M114.631549	http://dx.doi.org/10.1074/jbc.M114.631549			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25645937	Green Published, hybrid			2022-12-28	WOS:000351662600010
J	Howard, MJ; Klemm, BP; Fierke, CA				Howard, Michael J.; Klemm, Bradley P.; Fierke, Carol A.			Mechanistic Studies Reveal Similar Catalytic Strategies for Phosphodiester Bond Hydrolysis by Protein-only and RNA-dependent Ribonuclease P	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR-TRANSFER-RNA; ACID-BASE CATALYSIS; ACTIVE-SITE; METAL-IONS; CLEAVAGE; DNA; SUBSTRATE; HOLOENZYME; EVOLUTION; AFFINITY	Ribonuclease P (RNase P) is an endonuclease that catalyzes the essential removal of the 5' end of tRNA precursors. Until recently, all identified RNase P enzymes were a ribonucleoprotein with a conserved catalytic RNA component. However, the discovery of protein-only RNase P (PRORP) shifted this paradigm, affording a unique opportunity to compare mechanistic strategies used by naturally evolved protein and RNA-based enzymes that catalyze the same reaction. Here we investigate the enzymatic mechanism of pre-tRNA hydrolysis catalyzed by the NYN (Nedd4-BP1, YacP nuclease) metallonuclease of Arabidopsis thaliana, PRORP1. Multiple and single turnover kinetic data support a mechanism where a step at or before chemistry is rate-limiting and provide a kinetic framework to interpret the results of metal alteration, mutations, and pH dependence. Catalytic activity has a cooperative dependence on the magnesium concentration (n(H) = 2) under k(cat)/K-m conditions, suggesting that PRORP1 catalysis is optimal with at least two active site metal ions, consistent with the crystal structure. Metal rescue of Asp-to-Ala mutations identified two aspartates important for enhancing metal ion affinity. The single turnover pH dependence of pre-tRNA cleavage revealed a single ionization (pK(a) similar to 8.7) important for catalysis, consistent with deprotonation of a metal-bound water nucleophile. The pH and metal dependence mirrors that observed for the RNA-based RNase P, suggesting similar catalytic mechanisms. Thus, despite different macromolecular composition, the RNA and protein-based RNase P act as dynamic scaffolds for the binding and positioning of magnesium ions to catalyze phosphodiester bond hydrolysis.	[Howard, Michael J.; Klemm, Bradley P.; Fierke, Carol A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Fierke, Carol A.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fierke, CA (corresponding author), Univ Michigan, Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA.	Fierke@umich.edu	Regan, Clinton/E-6250-2012	Klemm, Bradley/0000-0003-3484-3711	National Institutes of Health [RO1 GM055387]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM055387 (to C. A. F.).	Anantharaman Vivek, 2006, RNA Biol, V3, P18; Bastock JA, 2007, J MOL BIOL, V368, P421, DOI 10.1016/j.jmb.2007.01.083; BEEBE JA, 1994, BIOCHEMISTRY-US, V33, P10294, DOI 10.1021/bi00200a009; Bhaskaran H, 2014, BIOCHEMISTRY-US, V53, P1456, DOI 10.1021/bi401449z; Campbell FE, 2002, J MOL BIOL, V317, P21, DOI 10.1006/jmbi.2002.5413; Cassano AG, 2004, BIOCHEMISTRY-US, V43, P10547, DOI 10.1021/bi049188f; CECH TR, 1986, ANNU REV BIOCHEM, V55, P599, DOI 10.1146/annurev.biochem.55.1.599; Chen Y, 1997, BIOCHEMISTRY-US, V36, P2425; DAHM SC, 1993, BIOCHEMISTRY-US, V32, P13040, DOI 10.1021/bi00211a013; DAHM SC, 1991, BIOCHEMISTRY-US, V30, P9464, DOI 10.1021/bi00103a011; DOOLITTLE RF, 1994, TRENDS BIOCHEM SCI, V19, P15, DOI 10.1016/0968-0004(94)90167-8; Dupureur CM, 2010, METALLOMICS, V2, P609, DOI 10.1039/c0mt00013b; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Frank DN, 1997, P NATL ACAD SCI USA, V94, P14355, DOI 10.1073/pnas.94.26.14355; Giege R, 2012, WIRES RNA, V3, P37, DOI 10.1002/wrna.103; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; Gutmann B, 2012, GENE DEV, V26, P1022, DOI 10.1101/gad.189514.112; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Howard MJ, 2013, RNA BIOL, V10, P909, DOI 10.4161/rna.24513; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Hsieh J, 2009, RNA, V15, P1565, DOI 10.1261/rna.1639409; Hsieh J, 2009, RNA, V15, P224, DOI 10.1261/rna.1309409; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Kennedy AK, 2000, CELL, V101, P295, DOI 10.1016/S0092-8674(00)80839-9; KOSTREWA D, 1995, BIOCHEMISTRY-US, V34, P683, DOI 10.1021/bi00002a036; Kurz JC, 2002, BIOCHEMISTRY-US, V41, P9545, DOI 10.1021/bi025553w; Kurz JC, 1998, BIOCHEMISTRY-US, V37, P2393, DOI 10.1021/bi972530m; Liu X, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku850; Milligan J. F., 1989, METHOD ENZYMOL, V180, P51; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; O'Brien PJ, 2003, BIOCHEMISTRY-US, V42, P12418, DOI 10.1021/bi035177v; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Pavlova LV, 2012, CHEMBIOCHEM, V13, P2270, DOI 10.1002/cbic.201200434; Perrin D. D., 2012, BUFFERS PH METAL ION; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; Rossmanith W, 2012, BBA-GENE REGUL MECH, V1819, P1017, DOI 10.1016/j.bbagrm.2011.11.003; Rueda D, 2005, BIOCHEMISTRY-US, V44, P16130, DOI 10.1021/bi0519093; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Shan S, 2001, BIOCHEMISTRY-US, V40, P5161, DOI 10.1021/bi002887h; SILLEN LG, 1971, SPECIAL PUBLICATION, V25; Stanford NP, 1999, J MOL BIOL, V288, P105, DOI 10.1006/jmbi.1999.2673; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Syson K, 2008, J BIOL CHEM, V283, P28741, DOI 10.1074/jbc.M801264200; Thomas BC, 2000, RNA, V6, P545, DOI 10.1017/S1355838200991465; THOMPSON JE, 1994, J AM CHEM SOC, V116, P5467, DOI 10.1021/ja00091a060; Tock MR, 2003, EMBO J, V22, P995, DOI 10.1093/emboj/cdg098; Walker SC, 2006, CRIT REV BIOCHEM MOL, V41, P77, DOI 10.1080/10409230600602634; Warnecke JM, 1996, P NATL ACAD SCI USA, V93, P8924, DOI 10.1073/pnas.93.17.8924; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013	49	24	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13454	13464		10.1074/jbc.M115.644831	http://dx.doi.org/10.1074/jbc.M115.644831			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25817998	Green Published, hybrid			2022-12-28	WOS:000354975700040
J	Trakhtenberg, EF; Morkin, MI; Patel, KH; Fernandez, SG; Sang, A; Shaw, P; Liu, XF; Wang, Y; Mlacker, GM; Gao, H; Velmeshev, D; Dombrowski, SM; Vitek, MP; Goldberg, JL				Trakhtenberg, Ephraim F.; Morkin, Melina I.; Patel, Karan H.; Fernandez, Stephanie G.; Sang, Alan; Shaw, Peter; Liu, Xiongfei; Wang, Yan; Mlacker, Gregory M.; Gao, Han; Velmeshev, Dmitry; Dombrowski, Susan M.; Vitek, Michael P.; Goldberg, Jeffrey L.			The N-terminal Set-beta Protein Isoform Induces Neuronal Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING FACTOR-I; PHOSPHATASE 2A; MYELOID LEUKEMOGENESIS; PUTATIVE ONCOGENE; ALZHEIMER-DISEASE; AXON GROWTH; CELL-DEATH; INHIBITOR; LOCALIZATION; ONCOPROTEIN	Set-beta protein plays different roles in neurons, but the diversity of Set-beta neuronal isoforms and their functions have not been characterized. The expression and subcellular localization of Set-beta are altered in Alzheimer disease, cleavage of Set-beta leads to neuronal death after stroke, and the full-length Set-beta regulates retinal ganglion cell (RGC) and hippocampal neuron axon growth and regeneration in a subcellular localization-dependent manner. Here we used various biochemical approaches to investigate Set-beta isoforms and their role in the CNS, using the same type of neurons, RGCs, across studies. We found multiple alternatively spliced isoforms expressed from the Set locus in purified RGCs. Set transcripts containing the Set-beta-specific exon were the most highly expressed isoforms. We also identified a novel, alternatively spliced Set-beta transcript lacking the nuclear localization signal and demonstrated that the full-length (similar to 39-kDa) Set-beta is localized predominantly in the nucleus, whereas a shorter (similar to 25-kDa) Set-beta isoform is localized predominantly in the cytoplasm. Finally, we show that an N-terminal Set-beta cleavage product can induce neuronal death.	[Trakhtenberg, Ephraim F.; Gao, Han; Goldberg, Jeffrey L.] Univ Miami, Miller Sch Med, Neurosci Program, Miami, FL 33136 USA; [Trakhtenberg, Ephraim F.; Morkin, Melina I.; Patel, Karan H.; Fernandez, Stephanie G.; Liu, Xiongfei; Wang, Yan; Mlacker, Gregory M.; Goldberg, Jeffrey L.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Trakhtenberg, Ephraim F.; Morkin, Melina I.; Patel, Karan H.; Fernandez, Stephanie G.; Liu, Xiongfei; Wang, Yan; Mlacker, Gregory M.; Goldberg, Jeffrey L.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA; [Velmeshev, Dmitry] Univ Miami, Miller Sch Med, Mol & Cellular Pharmacol Program, Miami, FL 33136 USA; [Dombrowski, Susan M.] Genomatix Software, Ann Arbor, MI 48108 USA; [Dombrowski, Susan M.] Wayne State Univ, Dept Obstet & Gynecol, Sch Med, Detroit, MI 48201 USA; [Morkin, Melina I.; Sang, Alan; Shaw, Peter; Wang, Yan; Goldberg, Jeffrey L.] Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92093 USA; [Vitek, Michael P.] Oncotide Pharmaceut Inc, Durham, NC 27709 USA; [Vitek, Michael P.] Duke Univ, Dept Neurol, Med Ctr, Durham, NC 27708 USA	University of Miami; Bascom Palmer Eye Institute; University of Miami; University of Miami; University of Miami; Wayne State University; University of California System; University of California San Diego; Duke University	Trakhtenberg, EF (corresponding author), Univ Miami, Miller Sch Med, Neurosci Program, Miami, FL 33136 USA.	Ephraim.Trakhtenberg@childrens.harvard.edu; JLGoldberg@ucsd.edu		Gao, Han/0000-0002-6021-2764; Vitek, Michael/0000-0001-8140-8048; Velmeshev, Dmitry/0000-0002-6491-7307; Goldberg, Jeffrey/0000-0002-1390-7360	NEI/National Institutes of Health [EY020913, P30-EY022589, P30 EY014801]; NINDS/National Institutes of Health [T32NS007492]; American Heart Association [11PRE7310069]; Walter G. Ross Distinguished Chair in Ophthalmic Research; Research to Prevent Blindness, Inc.; Lois Pope LIFE fellowship; summer research scholarship; CAS Summer Research Program for Underrepresented Minorities and Women; NATIONAL EYE INSTITUTE [P30EY014801, R01EY020913, P30EY022589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007492] Funding Source: NIH RePORTER	NEI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); Walter G. Ross Distinguished Chair in Ophthalmic Research; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Lois Pope LIFE fellowship; summer research scholarship; CAS Summer Research Program for Underrepresented Minorities and Women; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NEI/National Institutes of Health Grants EY020913 (to J. L. G.), P30-EY022589 (to the Shiley Eye Center, University of California San Diego), and P30 EY014801 (to the University of Miami) and NINDS/National Institutes of Health Grant T32NS007492 (to E. F. T.). This work was also supported by American Heart Association Grant 11PRE7310069 (to E. F. T.), by the Walter G. Ross Distinguished Chair in Ophthalmic Research (to J. L. G.), by an unrestricted grant from Research to Prevent Blindness, Inc., by the Lois Pope LIFE fellowship and research awards (to E. F. T.), and by a summer research scholarship and the CAS Summer Research Program for Underrepresented Minorities and Women (to S. G. F.). M. P. V. is an employee and stockholder in Oncotide Pharmaceuticals, Inc. and an employee of Duke University Medical Center.	ADACHI Y, 1994, J BIOL CHEM, V269, P2258; Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; Briand S, 2011, NEUROBIOL AGING, V32, P1099, DOI 10.1016/j.neurobiolaging.2009.05.021; Carmona-Mora P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045155; Cervoni N, 2002, J BIOL CHEM, V277, P25026, DOI 10.1074/jbc.M202256200; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Christensen DJ, 2011, J IMMUNOL, V186, P2535, DOI 10.4049/jimmunol.1002847; Corredor RG, 2012, J NEUROSCI, V32, P7734, DOI 10.1523/JNEUROSCI.5288-11.2012; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Gamble MJ, 2007, NAT STRUCT MOL BIOL, V14, P548, DOI 10.1038/nsmb1248; Lam BD, 2013, FEBS LETT, V587, P111, DOI 10.1016/j.febslet.2012.11.013; Le Guelte A, 2012, J CELL SCI, V125, P4137, DOI 10.1242/jcs.108282; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; Merrick SE, 1997, J NEUROSCI, V17, P5726; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Nagata K, 1998, EXP CELL RES, V240, P274, DOI 10.1006/excr.1997.3930; NAGATA K, 1995, P NATL ACAD SCI USA, V92, P4279, DOI 10.1073/pnas.92.10.4279; Nunbhakdi-Craig V, 2007, J NEUROCHEM, V101, P959, DOI 10.1111/j.1471-4159.2007.04503.x; Piper M, 2008, J NEUROSCI, V28, P100, DOI 10.1523/JNEUROSCI.4490-07.2008; Qu DB, 2007, J NEUROCHEM, V103, P408, DOI 10.1111/j.1471-4159.2007.04747.x; Saito S, 1999, BIOCHEM BIOPH RES CO, V259, P471, DOI 10.1006/bbrc.1999.0790; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Switzer CH, 2011, ONCOGENE, V30, P2504, DOI 10.1038/onc.2010.622; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Trakhtenberg EF, 2014, J NEUROSCI, V34, P7361, DOI 10.1523/JNEUROSCI.3658-13.2014; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113; Vasudevan NT, 2011, MOL CELL, V41, P636, DOI 10.1016/j.molcel.2011.02.025; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Wang XC, 2010, FASEB J, V24, P4420, DOI 10.1096/fj.10-158477; Yu G, 2013, NEUROBIOL AGING, V34, P1748, DOI 10.1016/j.neurobiolaging.2012.12.025	36	8	8	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13417	13426		10.1074/jbc.M114.633883	http://dx.doi.org/10.1074/jbc.M114.633883			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25833944	hybrid, Green Published			2022-12-28	WOS:000354975700037
J	Blobaum, AL; Xu, S; Rowlinson, SW; Duggan, KC; Banerjee, S; Kudalkar, SN; Birmingham, WR; Ghebreselasie, K; Marnett, LJ				Blobaum, Anna L.; Xu, Shu; Rowlinson, Scott W.; Duggan, Kelsey C.; Banerjee, Surajit; Kudalkar, Shalley N.; Birmingham, William R.; Ghebreselasie, Kebreab; Marnett, Lawrence J.			Action at a Distance MUTATIONS OF PERIPHERAL RESIDUES TRANSFORM RAPID REVERSIBLE INHIBITORS TO SLOW, TIGHT BINDERS OF CYCLOOXYGENASE-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SELECTIVE INHIBITION; CROSS-TALK; CYCLOOXYGENASE-2; MECHANISM; MONOMERS; ASPIRIN; BINDING; PHENIX; ACID	Cyclooxygenase enzymes (COX-1 and COX-2) catalyze the conversion of arachidonic acid to prostaglandin G(2). The inhibitory activity of rapid, reversible COX inhibitors (ibuprofen, naproxen, mefenamic acid, and lumiracoxib) demonstrated a significant increase in potency and time dependence of inhibition against double tryptophan murine COX-2 mutants at the 89/90 and 89/119 positions. In contrast, the slow, time-dependent COX inhibitors (diclofenac, indomethacin, and flurbiprofen) were unaffected by those mutations. Further mutagenesis studies suggested that mutation at position 89 was principally responsible for the changes in inhibitory potency of rapid, reversible inhibitors, whereas mutation at position 90 may exert some effect on the potency of COX-2-selective diarylheterocycle inhibitors; no effect was observed with mutation at position 119. Several crystal structures with or without NSAIDs indicated that placement of a bulky residue at position 89 caused a closure of a gap at the lobby, and alteration of histidine to tryptophan at position 90 changed the electrostatic profile of the side pocket of COX-2. Thus, these two residues, especially Val-89 at the lobby region, are crucial for the entrance and exit of some NSAIDs from the COX active site.	[Blobaum, Anna L.; Xu, Shu; Rowlinson, Scott W.; Duggan, Kelsey C.; Kudalkar, Shalley N.; Birmingham, William R.; Ghebreselasie, Kebreab; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Biochem, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA; [Blobaum, Anna L.; Xu, Shu; Rowlinson, Scott W.; Duggan, Kelsey C.; Kudalkar, Shalley N.; Birmingham, William R.; Ghebreselasie, Kebreab; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37232 USA; [Blobaum, Anna L.; Xu, Shu; Rowlinson, Scott W.; Duggan, Kelsey C.; Kudalkar, Shalley N.; Birmingham, William R.; Ghebreselasie, Kebreab; Marnett, Lawrence J.] Vanderbilt Univ, Ctr Mol Toxicol, Dept Pharmacol,Ctr,Sch Med, Vanderbilt Inst Chem Biol,Vanderbilt Ingram Canc, Nashville, TN 37232 USA; [Banerjee, Surajit] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Banerjee, Surajit] Argonne Natl Lab, Northeastern Collaborat Access Team, Argonne, IL 60439 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Marnett, LJ (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu	Birmingham, William/J-4864-2017; Regan, Clinton/E-6250-2012; Xu, Shu/K-6089-2013; Xu, Shu/O-6667-2019	Birmingham, William/0000-0002-8880-5502; Xu, Shu/0000-0002-6876-7991; Xu, Shu/0000-0002-6876-7991; Banerjee, Surajit/0000-0002-9414-7163; Kudalkar, Shalley/0000-0001-9377-335X	National Institutes of Health [P41 GM103403]; United States DOE [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA089450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, P41GM103403, P01GM015431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Dr. Carol A. Rouzer for editorial assistance. This work is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamline, which is supported by National Institutes of Health Grant P41 GM103403 (NIGMS). Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; COPELAND RA, 1994, P NATL ACAD SCI USA, V91, P11202, DOI 10.1073/pnas.91.23.11202; Dong L, 2013, J BIOL CHEM, V288, P28641, DOI 10.1074/jbc.M113.505503; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FERREIRA SH, 1971, NATURE-NEW BIOL, V231, P237, DOI 10.1038/newbio231237a0; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalgutkar AS, 2000, P NATL ACAD SCI USA, V97, P925, DOI 10.1073/pnas.97.2.925; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Lanzo CA, 2000, BIOCHEMISTRY-US, V39, P6228, DOI 10.1021/bi992761o; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Rimon G, 2010, P NATL ACAD SCI USA, V107, P28, DOI 10.1073/pnas.0909765106; ROME LH, 1975, P NATL ACAD SCI USA, V72, P4863, DOI 10.1073/pnas.72.12.4863; Rowlinson SW, 2003, J BIOL CHEM, V278, P45763, DOI 10.1074/jbc.M305481200; Selinsky BS, 2001, BIOCHEMISTRY-US, V40, P5172, DOI 10.1021/bi010045s; Sidhu RS, 2010, BIOCHEMISTRY-US, V49, P7069, DOI 10.1021/bi1003298; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; SMITH JB, 1971, NATURE-NEW BIOL, V231, P235, DOI 10.1038/newbio231235a0; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Walker MC, 2001, BIOCHEM J, V357, P709, DOI 10.1042/0264-6021:3570709; Windsor MA, 2013, BIOORG MED CHEM LETT, V23, P5860, DOI 10.1016/j.bmcl.2013.08.097; Windsor MA, 2012, ACS MED CHEM LETT, V3, P759, DOI 10.1021/ml3001616; Xu S, 2014, J BIOL CHEM, V289, P6799, DOI 10.1074/jbc.M113.517987; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200	28	26	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12793	12803		10.1074/jbc.M114.635987	http://dx.doi.org/10.1074/jbc.M114.635987			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25825493	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000354569000030
J	Ji, YR; Kim, HJ; Bae, KB; Lee, S; Kim, MO; Ryoo, ZY				Ji, Young Rae; Kim, Hei Jung; Bae, Ki Beom; Lee, Sanggyu; Kim, Myoung Ok; Ryoo, Zae Young			Hepatic Serum Amyloid A1 Aggravates T Cell-mediated Hepatitis by Inducing Chemokines via Toll-like Receptor 2 in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; CONCANAVALIN-A; LIVER-DISEASE; VIRUS-INFECTION; TH17 CELLS; EXPRESSION; INFLAMMATION; ACTIVATION; INDUCTION; MIGRATION	Serum amyloid A is a proinflammatory molecule that induces leukocyte infiltration and promotes neutrophil adhesion to endothelial cells under inflammatory conditions. The aim of this study was to examine whether Saa1 aggravates T cell-mediated hepatitis by inducing chemokines in a liver-specific, Saa1-overexpressing, transgenic (TG) mouse model. We generated TG mice in which Saa1 was overexpressed specifically in liver tissue. The chemokines monocyte chemotactic protein 1 (MCP1), MIP1 alpha, MIP1 beta, interferon gamma-induced protein 10 (IP-10), and eotaxin were induced in Saa1 TG mice. After concanavalin A treatment, Saa1 expression was higher in Saa1 TG mice than in WT mice. More severe liver injury, increased hepatocyte apoptosis, and higher levels of hepatic enzymes were observed in Saa1 TG mice than in WT mice. Liver infiltration of CD4(+) T cells and macrophages increased after inducing hepatitis. Activation of T cells was higher in Saa1 TG mice than in WT mice, and the populations of Th17 cells and regulatory T cells were altered by overexpressing Saa1 in TG mice. Secretion of various cytokines, such as interferon gamma, tumor necrosis factor alpha, and interleukin 6, increased in Saa1 TG mice. Injecting a Toll-like receptor 2 (TLR2) antagonist in vivo inhibited chemokine expression and I kappa B alpha phosphorylation and showed that the induction of chemokines by Saa1 was dependent on TLR2. Hepatic Saa1 accelerated T cell-mediated hepatitis by inducing chemokine production and activating T cells by TLR2. Therefore, Saa1 might be a novel inflammatory factor that acts as a chemokine modulator in hepatitis.	[Ji, Young Rae; Kim, Hei Jung; Bae, Ki Beom; Lee, Sanggyu; Ryoo, Zae Young] Kyungpook Natl Univ, Sch Life Sci, KNU Creat BioRes Grp, Plus Project BK21, Taegu 702701, South Korea; [Kim, Myoung Ok] Kyungpook Natl Univ, Dept Anim Sci, Sangju 742711, South Korea	Kyungpook National University; Kyungpook National University	Ryoo, ZY (corresponding author), Kyungpook Natl Univ, Sch Life Sci & Biotechnol, 1370 Sankyuk Dong, Taegu, South Korea.	jaewoong64@hanmail.net	Ji, Youngrae/AAK-9711-2021; Ji, Youngrae/AAK-9724-2021; RYOO, ZAEYOUNG/AAQ-1573-2020	Ji, Youngrae/0000-0002-8825-9783; 	Next Generation BioGreen21 Program [PJ 009573]; National Research Foundation of Korea - Korean government (MSIP) [2008-0062618]	Next Generation BioGreen21 Program(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea - Korean government (MSIP)	This research was supported by Next Generation BioGreen21 Program Grant PJ 009573 and National Research Foundation of Korea grant 2008-0062618 funded by the Korean government (MSIP).	Ajuebor MN, 2007, AM J PATHOL, V170, P1975, DOI 10.2353/ajpath.2007.060690; Ajuebor MN, 2004, EUR J IMMUNOL, V34, P2907, DOI 10.1002/eji.200425071; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Cai ZH, 2007, J VIROL, V81, P6128, DOI 10.1128/JVI.02627-06; Cheng K, 2012, ANGEW CHEM INT EDIT, V51, P12246, DOI 10.1002/anie.201204910; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; EGGINK HF, 1982, CLIN EXP IMMUNOL, V50, P17; Erhardt A, 2011, J IMMUNOL, V186, P5284, DOI 10.4049/jimmunol.1003750; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; GANAPATHI MK, 1991, J IMMUNOL, V147, P1261; Hanidziar D, 2010, CURR OPIN ORGAN TRAN, V15, P411, DOI 10.1097/MOT.0b013e32833b7929; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Hogan B, 1994, MANIPULATING MOUSE E; Ito A, 1999, J IMMUNOL, V162, P4260; Kanellopoulos PN, 1996, J STRUCT BIOL, V116, P345, DOI 10.1006/jsbi.1996.0052; Kim SR, 2014, HEPATOL RES, V44, P584, DOI 10.1111/hepr.12145; Knolle PA, 1996, HEPATOLOGY, V24, P824, DOI 10.1002/hep.510240413; Lannergard A, 2003, SCAND J CLIN LAB INV, V63, P267, DOI 10.1080/00365510310001636; Lavie M, 2006, HEPATOLOGY, V44, P1626, DOI 10.1002/hep.21406; Lee HY, 2005, BIOCHEM BIOPH RES CO, V330, P989, DOI 10.1016/j.bbrc.2005.03.069; Leow KY, 2012, INFLAMM RES, V61, P391, DOI 10.1007/s00011-011-0424-4; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; MEEK RL, 1986, J EXP MED, V164, P2006, DOI 10.1084/jem.164.6.2006; Moreno C, 2005, HEPATOLOGY, V42, P854, DOI 10.1002/hep.20865; Ray A, 1999, J BIOL CHEM, V274, P4300, DOI 10.1074/jbc.274.7.4300; Saha A, 2011, NEPHROL DIAL TRANSPL, V26, P2407, DOI 10.1093/ndt/gfr224; Saiman Y, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00213; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Shim JW, 2009, EXP MOL MED, V41, P584, DOI 10.3858/emm.2009.41.8.064; Simpson KJ, 2003, CLIN SCI, V104, P47, DOI 10.1042/CS20020137; Su ZJ, 2013, DIAGN MICR INFEC DIS, V76, P437, DOI 10.1016/j.diagmicrobio.2013.04.026; Tilg H, 2006, LIVER INT, V26, P1029, DOI 10.1111/j.1478-3231.2006.01339.x; Tsui TY, 2007, SHOCK, V27, P165, DOI 10.1097/01.shk.0000239781.71516.61; Weber SN, 2010, BEST PRACT RES CL GA, V24, P635, DOI 10.1016/j.bpg.2010.07.013; XU LL, 1995, J IMMUNOL, V155, P1184; Zeremski M, 2008, HEPATOLOGY, V48, P1440, DOI 10.1002/hep.22500; Zeremski M, 2011, J HEPATOL, V55, P545, DOI 10.1016/j.jhep.2010.12.033; Zhou ML, 2014, INT IMMUNOPHARMACOL, V21, P241, DOI 10.1016/j.intimp.2014.04.027	41	30	31	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12804	12811		10.1074/jbc.M114.635763	http://dx.doi.org/10.1074/jbc.M114.635763			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25847238	hybrid, Green Published			2022-12-28	WOS:000354569000031
J	Latham, JA; Iavarone, AT; Barr, I; Juthani, PV; Klinman, JP				Latham, John A.; Iavarone, Anthony T.; Barr, Ian; Juthani, Prerak V.; Klinman, Judith P.			PqqD Is a Novel Peptide Chaperone That Forms a Ternary Complex with the Radical S-Adenosylmethionine Protein PqqE in the Pyrroloquinoline Quinone Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY SOLUTION; SIMILARITY NETWORKS; BACILLUS-SUBTILIS; SCATTERING; ENZYMES; VISUALIZATION; INTERMEDIATE; COMPUTATION; BIOGENESIS; GENERATION	Pyrroloquinoline quinone (PQQ) is a product of a ribosomally synthesized and post-translationally modified pathway consisting of five conserved genes, pqqA-E. PqqE is a radical S-adenosylmethionine (RS) protein with a C-terminal SPASM domain, and is proposed to catalyze the formation of a carbon-carbon bond between the glutamate and tyrosine side chains of the peptide substrate PqqA. PqqD is a 10-kDa protein with an unknown function, but is essential for PQQ production. Recently, in Kleb-siella pneumoniae (Kp), PqqD and PqqE were shown to interact; however, the stoichiometry and K-D were not obtained. Here, we show that the PqqE and PqqD interaction transcends species, also occurring in Methylobacterium extorquens AM1 (Me). The stoichiometry of the MePqqD and MePqqE interaction is 1: 1 and the KD, determined by surface plasmon resonance spectroscopy (SPR), was found to be similar to 12 mu M. Moreover, using SPR and isothermal calorimetry techniques, we establish for the first time that MePqqD binds MePqqA tightly (K-D similar to 200 nM). The formation of a ternary MePqqA-D-E complex was captured by native mass spectrometry and the K-D for the MePqqAD-MePqqE interaction was found to be similar to 5 mu M. Finally, using a bioinformatic analysis, we found that PqqD orthologues are associated with the RS-SPASM family of proteins (subtilosin, pyrroloquinoline quinone, anaerobic sulfatase maturating enzyme, and mycofactocin), all of which modify either peptides or proteins. In conclusion, we propose that PqqD is a novel peptide chaperone and that PqqD orthologues may play a similar role in peptide modification pathways that use an RS-SPASM protein.	[Latham, John A.; Iavarone, Anthony T.; Barr, Ian; Juthani, Prerak V.; Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Latham, John A.; Barr, Ian; Juthani, Prerak V.; Klinman, Judith P.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Latham, John A.; Iavarone, Anthony T.; Barr, Ian; Juthani, Prerak V.; Klinman, Judith P.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Klinman, JP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	klinman@berkeley.edu	Regan, Clinton/E-6250-2012	Barr, Ian/0000-0003-1805-1415; Juthani, Prerak/0000-0002-8760-3124; Latham, John/0000-0002-3034-1768	National Institutes of Health [GM 039296]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025765, R01GM039296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 039296 (to J. P. K.).	Anthony C, 2001, ANTIOXID REDOX SIGN, V3, P757, DOI 10.1089/15230860152664966; Anthony C, 1998, BIOCHEM SOC T, V26, P413, DOI 10.1042/bst0260413; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; BABASAKI K, 1985, J BIOCHEM, V98, P585, DOI 10.1093/oxfordjournals.jbchem.a135315; Barber AE, 2012, BIOINFORMATICS, V28, P2845, DOI 10.1093/bioinformatics/bts532; Beeson WT, 2011, APPL ENVIRON MICROB, V77, P650, DOI 10.1128/AEM.01922-10; Behling LA, 2008, J AM CHEM SOC, V130, P12604, DOI 10.1021/ja804747d; Bonnot F, 2013, BIOCHEMISTRY-US, V52, P4667, DOI 10.1021/bi4003315; Duquesne S, 2007, NAT PROD REP, V24, P708, DOI 10.1039/b516237h; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gliese N, 2010, ARCH MICROBIOL, V192, P1, DOI 10.1007/s00203-009-0523-6; Goodwin PM, 1998, ADV MICROB PHYSIOL, V40, P1, DOI 10.1016/S0065-2911(08)60129-0; GOOSEN N, 1992, J BACTERIOL, V174, P1426, DOI 10.1128/jb.174.4.1426-1427.1992; Grell TAJ, 2015, J BIOL CHEM, V290, P3964, DOI 10.1074/jbc.R114.581249; Haft DH, 2011, J BACTERIOL, V193, P2745, DOI 10.1128/JB.00040-11; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lobanov MY, 2008, MOL BIOL+, V42, P623, DOI 10.1134/S0026893308040195; Magnusson OT, 2004, P NATL ACAD SCI USA, V101, P7913, DOI 10.1073/pnas.0402640101; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Okada M, 2005, NAT CHEM BIOL, V1, P23, DOI 10.1038/nchembio709; Ozbabacan SEA, 2011, PROTEIN ENG DES SEL, V24, P635, DOI 10.1093/protein/gzr025; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Schneider KB, 2002, J BACTERIOL, V184, P410, DOI 10.1128/JB.184.2.410-419.2002; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen YQ, 2012, BIOCHEMISTRY-US, V51, P2265, DOI 10.1021/bi201763d; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Toyama H, 1997, MICROBIOL-SGM, V143, P595, DOI 10.1099/00221287-143-2-595; Tsai TY, 2009, PROTEINS, V76, P1042, DOI 10.1002/prot.22461; VELTEROP JS, 1995, J BACTERIOL, V177, P5088, DOI 10.1128/jb.177.17.5088-5098.1995; Wecksler SR, 2010, CHEM COMMUN, V46, P7031, DOI 10.1039/c0cc00968g; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Zhang Y, 2003, BIOPHYS J, V85, P1145, DOI 10.1016/S0006-3495(03)74551-2	40	58	60	2	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12908	12918		10.1074/jbc.M115.646521	http://dx.doi.org/10.1074/jbc.M115.646521			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25817994	hybrid, Green Published			2022-12-28	WOS:000354569000040
J	Scialpi, F; Mellis, D; Ditzel, M				Scialpi, Flavia; Mellis, David; Ditzel, Mark			EDD, a Ubiquitin-protein Ligase of the N-end Rule Pathway, Associates with Spindle Assembly Checkpoint Components and Regulates the Mitotic Response to Nocodazole	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; DROSOPHILA-MELANOGASTER; E3 LIGASE; CENP-E; CELLS; BUBR1; KINETOCHORES; EXPRESSION; MITOSIS; KINASE	In this work, we identify physical and genetic interactions that implicate E3 identified by differential display (EDD) in promoting spindle assembly checkpoint (SAC) function. During mitosis, the SAC initiates a mitotic checkpoint in response to chromosomes with kinetochores unattached to spindle pole microtubules. Similar to Budding uninhibited by benzimidazoles-related 1 (BUBR1) siRNA, a bona fide SAC component, EDD siRNA abrogated G(2)/M accumulation in response to the mitotic destabilizing agent nocodazole. Furthermore, EDD siRNA reduced mitotic cell viability and, in nocodazole-treated cells, increased expression of the promitotic progression protein cell division cycle 20 (CDC20). Copurification studies also identified physical interactions with CDC20, BUBR1, and other components of the SAC. Taken together, these observations highlight the potential role of EDD in regulating mitotic progression and the cellular response to perturbed mitosis.	[Scialpi, Flavia; Mellis, David; Ditzel, Mark] Western Gen Hosp, MRC Inst Genet & Mol Med, Edinburgh EH4 2XR, Midlothian, Scotland	University of Edinburgh	Ditzel, M (corresponding author), Western Gen Hosp, Edinburgh CRUK Canc Res Ctr, MRC Inst Genet & Mol Med, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	mark.ditzel@ed.ac.uk			Biotechnology and Biological Sciences Research Council New Investigator Award [BB/H012869/1]; Cancer Research UK; BBSRC [BB/H012869/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H012869/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council New Investigator Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by Biotechnology and Biological Sciences Research Council New Investigator Award (BB/H012869/1 (to M. D. and F. S.) and by Cancer Research UK.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Choi E, 2009, EMBO J, V28, P2077, DOI 10.1038/emboj.2009.123; DEBRABANDER M, 1977, CELL BIOL INT REP, V1, P177, DOI 10.1016/0309-1651(77)90038-8; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Foster SA, 2012, MOL CELL, V47, P921, DOI 10.1016/j.molcel.2012.07.031; Fuja TJ, 2004, CANCER RES, V64, P942, DOI 10.1158/0008-5472.CAN-03-2100; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Hay-Koren A, 2011, MOL BIOL CELL, V22, P399, DOI 10.1091/mbc.E10-05-0440; Hayashi MT, 2013, ONCOGENE, V32, P4593, DOI 10.1038/onc.2012.615; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Hu GQ, 2010, J BIOL CHEM, V285, P11800, DOI 10.1074/jbc.M109.079384; Huang HM, 2007, J CELL BIOL, V177, P413, DOI 10.1083/jcb.200701122; Huang Xuan, 2006, Methods Mol Biol, V314, P73; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kim EM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000015; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lee JD, 2002, DEVELOPMENT, V129, P5697, DOI 10.1242/dev.00159; Ling SY, 2011, J BIOL CHEM, V286, P14972, DOI 10.1074/jbc.M110.182527; Ma HT, 2011, METHODS MOL BIOL, V761, P151, DOI 10.1007/978-1-61779-182-6_10; MacPhail SH, 2003, RADIAT RES, V159, P759, DOI 10.1667/RR3003; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; MARTIN P, 1977, DEV BIOL, V55, P213, DOI 10.1016/0012-1606(77)90168-3; Meissner B, 2013, BLOOD, V121, P3161, DOI 10.1182/blood-2013-01-478834; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; Musacchio A, 2011, PHILOS T R SOC B, V366, P3595, DOI 10.1098/rstb.2011.0072; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Oikawa T, 2005, MOL CELL BIOL, V25, P4046, DOI 10.1128/MCB.25.10.4046-4061.2005; Okamoto K, 2013, NATURE, V494, P502, DOI 10.1038/nature11873; Patra D, 1998, GENE DEV, V12, P2549, DOI 10.1101/gad.12.16.2549; Saunders DN, 2004, MOL CELL BIOL, V24, P7225, DOI 10.1128/MCB.24.16.7225-7234.2004; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Smits VAJ, 2012, CELL CYCLE, V11, P715, DOI 10.4161/cc.11.4.19154; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Uetake Y, 2010, CURR BIOL, V20, P1666, DOI 10.1016/j.cub.2010.08.018; Uzunova K, 2012, NAT STRUCT MOL BIOL, V19, P1116, DOI 10.1038/nsmb.2412; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Zhang TY, 2014, P NATL ACAD SCI USA, V111, P12091, DOI 10.1073/pnas.1400230111	46	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12585	12594		10.1074/jbc.M114.625673	http://dx.doi.org/10.1074/jbc.M114.625673			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25833949	Green Published, hybrid			2022-12-28	WOS:000354569000014
J	Kashio, M; Tominaga, M				Kashio, Makiko; Tominaga, Makoto			Redox Signal-mediated Enhancement of the Temperature Sensitivity of Transient Receptor Potential Melastatin 2 (TRPM2) Elevates Glucose-induced Insulin Secretion from Pancreatic Islets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; glucose; insulin; ion channel; redox signaling	CHANNEL; ACTIVATION; OXIDATION; CELLS	Background: Transient receptor potential melastatin 2 (TRPM2) is a temperature-sensitive Ca2+-permeable ion channel involved in glucose-induced insulin secretion. Results: Hydrogen peroxide treatment caused a TRPM2-dependent increase in intracellular Ca2+ concentration. Glucose-induced insulin secretion from pancreatic islets was temperature-, antioxidant-, and TRPM2-dependent. Conclusion: Redox signal-mediated TRPM2 sensitization elevates glucose-induced insulin secretion. Significance: These results provide new insights into the involvement of TRPM2 sensitization in insulin secretion. Transient receptor potential melastatin 2 (TRPM2) is a thermosensitive Ca2+-permeable cation channel expressed by pancreatic cells where channel function is constantly affected by body temperature. We focused on the physiological functions of redox signal-mediated TRPM2 activity at body temperature. H2O2, an important molecule in redox signaling, reduced the temperature threshold for TRPM2 activation in pancreatic cells of WT mice but not in TRPM2KO cells. TRPM2-mediated [Ca2+](i) increases were likely caused by Ca2+ influx through the plasma membrane because the responses were abolished in the absence of extracellular Ca2+. In addition, TRPM2 activation downstream from the redox signal plus glucose stimulation enhanced glucose-induced insulin secretion. H2O2 application at 37 degrees C induced [Ca2+](i) increases not only in WT but also in TRPM2KO cells. This was likely due to the effect of H2O2 on K-ATP channel activity. However, the N-acetylcysteine-sensitive fraction of insulin secretion by WT islets was increased by temperature elevation, and this temperature-dependent enhancement was diminished significantly in TRPM2KO islets. These data suggest that endogenous redox signals in pancreatic cells elevate insulin secretion via TRPM2 sensitization and activity at body temperature. The results in this study could provide new therapeutic approaches for the regulation of diabetic conditions by focusing on the physiological function of TRPM2 and redox signals.	[Kashio, Makiko; Tominaga, Makoto] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Natl Inst Physiol Sci, Okazaki, Aichi 4448787, Japan; [Tominaga, Makoto] Grad Univ Adv Studies, Dept Physiol Sci, SOKENDAI, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan	Tominaga, M (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Natl Inst Physiol Sci, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	tominaga@nips.ac.jp		Kashio, Makiko/0000-0001-6404-2339	Japanese Ministry of Education, Culture, Sports, Science and Technology [24111561, 25860172]; Salt Science Research Foundation	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Salt Science Research Foundation	This work was supported by Japanese Ministry of Education, Culture, Sports, Science and Technology Grants 24111561 (to M. T.) 25860172 (to M. K.) and by The Salt Science Research Foundation.	Colsoul B, 2010, P NATL ACAD SCI USA, V107, P5208, DOI 10.1073/pnas.0913107107; ESCOLAR JC, 1990, J ENDOCRINOL, V125, P45, DOI 10.1677/joe.0.1250045; Faouzi M, 2014, HANDB EXP PHARMACOL, V222, P403, DOI 10.1007/978-3-642-54215-2_16; Gier B, 2009, J CLIN INVEST, V119, P3246, DOI 10.1172/JCI38817; Huang SM, 2008, J NEUROSCI, V28, P13727, DOI 10.1523/JNEUROSCI.5741-07.2008; Islam MS, 2010, ADV EXP MED BIOL, V654, P235, DOI 10.1007/978-90-481-3271-3_11; ISLAM MS, 1993, FEBS LETT, V319, P128, DOI 10.1016/0014-5793(93)80051-U; Kashio M, 2012, P NATL ACAD SCI USA, V109, P6745, DOI 10.1073/pnas.1114193109; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Maechler P, 2010, ADV EXP MED BIOL, V654, P193, DOI 10.1007/978-90-481-3271-3_9; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; Morgan D, 2009, ENDOCRINOLOGY, V150, P2197, DOI 10.1210/en.2008-1149; Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Spickett CM, 2006, BBA-PROTEINS PROTEOM, V1764, P1823, DOI 10.1016/j.bbapap.2006.09.013; Starkus JG, 2010, J PHYSIOL-LONDON, V588, P1227, DOI 10.1113/jphysiol.2010.187476; SUTTON R, 1986, TRANSPLANTATION, V42, P689, DOI 10.1097/00007890-198612000-00022; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Uchida K, 2014, CELL CALCIUM, V56, P332, DOI 10.1016/j.ceca.2014.07.001; Uchida K, 2011, DIABETES, V60, P119, DOI 10.2337/db10-0276; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T, 2014, HANDB EXP PHARMACOL, V223, P729, DOI 10.1007/978-3-319-05161-1_1; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yosida M, 2014, DIABETES, V63, P3394, DOI 10.2337/db13-1868	30	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12435	12442		10.1074/jbc.M115.649913	http://dx.doi.org/10.1074/jbc.M115.649913			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25817999	hybrid, Green Published			2022-12-28	WOS:000354388600051
J	Rouet, R; Dudgeon, K; Christie, M; Langley, D; Christ, D				Rouet, Romain; Dudgeon, Kip; Christie, Mary; Langley, David; Christ, Daniel			Fully Human V-H Single Domains That Rival the Stability and Cleft Recognition of Camelid Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biotechnology; Monoclonal Antibody; Phage Display; Protein Engineering; Protein Structure; Camelid Antibodies; Cleft Binding; Single Domains	COMPLEMENTARITY-DETERMINING REGIONS; BIOPHYSICAL PROPERTIES; CRYSTAL-STRUCTURE; VARIABLE DOMAINS; PHAGE DISPLAY; LIGHT-CHAINS; VHH DOMAINS; AGGREGATION; LIBRARIES; BINDING	Background: Camelid antibody domains are naturally stable and capable of cleft binding. Results: Protein engineering can endow human antibody domains with such properties. Conclusion: Our strategy does not require undesirable antibody framework changes. Significance: Robust building blocks for human therapeutic applications. Human V-H single domains represent a promising class of antibody fragments with applications as therapeutic modalities. Unfortunately, isolated human V-H domains also generally display poor biophysical properties and a propensity to aggregate. This has encouraged the development of non-human antibody domains as alternative means of antigen recognition and, in particular, camelid (VHH) domains. Naturally devoid of light chain partners, these domains are characterized by favorable biophysical properties and propensity for cleft binding, a highly desirable characteristic, allowing the targeting of cryptic epitopes. In contrast, previously reported structures of human V-H single domains had failed to recapitulate this property. Here we report the engineering and characterization of phage display libraries of stable human V-H domains and the selection of binders against a diverse set of antigens. Unlike camelized human domains, the domains do not rely on potentially immunogenic framework mutations and maintain the structure of the V-H/V-L interface. Structure determination in complex with hen egg white lysozyme revealed an extended V-H binding interface, with complementarity-determining region 3 deeply penetrating into the active site cleft, highly reminiscent of what has been observed for camelid domains. Taken together, our results demonstrate that fully human V-H domains can be constructed that are not only stable and well expressed but also rival the cleft binding properties of camelid antibodies.	[Rouet, Romain; Dudgeon, Kip; Christie, Mary; Langley, David; Christ, Daniel] Garvan Inst Med Res, Dept Immunol, Sydney, NSW 2010, Australia; [Christie, Mary; Christ, Daniel] Univ New S Wales, St Vincents Clin Sch, Fac Med, Sydney, NSW 2010, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney	Christ, D (corresponding author), Garvan Inst Med Res, 384 Victoria St, Sydney, NSW 2010, Australia.	d.christ@garvan.org.au	Christ, Daniel/C-1861-2018; Rouet, Romain/U-3511-2019; Langley, David B/B-1861-2009	Christ, Daniel/0000-0002-7313-3977; Langley, David B/0000-0003-2752-0041; Rouet, Romain/0000-0003-4210-9613; Christie, Mary/0000-0002-0955-665X	National Health and Medical Research Council; Australian Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council and the Australian Research Council.	Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christ D., 2011, International Patent, Patent No. [WO/2011/047442 A1, 2011047442]; De Genest E, 2005, J BIOL CHEM, V280, P14114, DOI 10.1074/jbc.M413011200; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; De Genst E, 2004, J BIOL CHEM, V279, P53593, DOI 10.1074/jbc.M407843200; De Genst E, 2013, J PHYS CHEM B, V117, P13245, DOI 10.1021/jp403425z; de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; Decanniere K, 2001, J MOL BIOL, V313, P473, DOI 10.1006/jmbi.2001.5075; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Dudgeon K, 2013, PROTEIN ENG DES SEL, V26, P671, DOI 10.1093/protein/gzt019; Dudgeon K, 2012, P NATL ACAD SCI USA, V109, P10879, DOI 10.1073/pnas.1202866109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Famm K, 2008, J MOL BIOL, V376, P926, DOI 10.1016/j.jmb.2007.10.075; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; Jansson B, 1998, FEMS IMMUNOL MED MIC, V20, P69, DOI 10.1016/S0928-8244(97)00108-9; Jespers L, 2004, NAT BIOTECHNOL, V22, P1161, DOI 10.1038/nbt1000; Jespers L, 2004, J MOL BIOL, V337, P893, DOI 10.1016/j.jmb.2004.02.013; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kabat EA, 1992, SEQUENCES PROTEINS I; Kim DY, 2012, PROTEIN ENG DES SEL, V25, P581, DOI 10.1093/protein/gzs055; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee CMY, 2007, NAT PROTOC, V2, P3001, DOI 10.1038/nprot.2007.448; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Lowe D, 2011, ADV PROTEIN CHEM STR, V84, P41, DOI 10.1016/B978-0-12-386483-3.00004-5; Lulf S, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-24; Ma XL, 2013, J MOL BIOL, V425, P2247, DOI 10.1016/j.jmb.2013.03.020; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; O'Connell D, 2002, J MOL BIOL, V321, P49, DOI 10.1016/S0022-2836(02)00561-2; Olichon A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-7; Perchiacca JM, 2011, PROTEINS, V79, P2637, DOI 10.1002/prot.23085; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Riechmann L, 1996, J MOL BIOL, V259, P957, DOI 10.1006/jmbi.1996.0373; Riechmann L, 1999, J IMMUNOL METHODS, V231, P25, DOI 10.1016/S0022-1759(99)00138-6; Rouet R, 2014, NAT BIOTECHNOL, V32, P136, DOI 10.1038/nbt.2812; Rouet R, 2014, FEBS LETT, V588, P269, DOI 10.1016/j.febslet.2013.11.029; Rouet Romain, 2012, Methods Mol Biol, V907, P195, DOI 10.1007/978-1-61779-974-7_10; Rouet R, 2012, NAT PROTOC, V7, P364, DOI 10.1038/nprot.2011.448; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; VIRNEKAS B, 1994, NUCLEIC ACIDS RES, V22, P5600, DOI 10.1093/nar/22.25.5600; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yu GW, 2009, J MOL BIOL, V385, P1578, DOI 10.1016/j.jmb.2008.11.043	61	35	40	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11905	11917		10.1074/jbc.M114.614842	http://dx.doi.org/10.1074/jbc.M114.614842			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25737448	Green Published, hybrid			2022-12-28	WOS:000354388600009
J	Zhang, YH; Shetty, K; Surleac, MD; Petrescu, AJ; Schatz, DG				Zhang, Yu-Hang; Shetty, Keerthi; Surleac, Marius D.; Petrescu, Andrei J.; Schatz, David G.			Mapping and Quantitation of the Interaction between the Recombination Activating Gene Proteins RAG1 and RAG2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid; Biosensor; DNA Recombination; Protein Structure; Protein-Protein Interaction; DNA Cleavage; RAG1; RAG2; V(D)J Recombination	SECONDARY STRUCTURE PREDICTION; V(D)J RECOMBINATION; TCRB RECOMBINATION; SIGNAL COMPLEXES; DNA TRANSPOSASE; ACTIVE-SITE; SERVER; IDENTIFICATION; INITIATION; SEQUENCE	Background: The RAG1-RAG2 interaction is critical for V(D)J recombination but is poorly understood. Results: The RAG1-RAG2 interaction has a binding constant of approximate to 0.4 m and requires only a small portion of RAG1. Conclusion: RAG1 and RAG2 interact with modest affinity using regions of RAG1 flanking the RAG1 catalytic region. Significance: Inefficient association of RAG1 with RAG2 could help limit damage to the genome. The RAG endonuclease consists of RAG1, which contains the active site for DNA cleavage, and RAG2, an accessory factor whose interaction with RAG1 is critical for catalytic function. How RAG2 activates RAG1 is not understood. Here, we used biolayer interferometry and pulldown assays to identify regions of RAG1 necessary for interaction with RAG2 and to measure the RAG1-RAG2 binding affinity (K-D approximate to 0.4 m) (where RAG1 and RAG2 are recombination activating genes 1 or 2). Using the Hermes transposase as a guide, we constructed a 36-kDa mini RAG1 capable of interacting robustly with RAG2. Mini-RAG1 consists primarily of the catalytic center and the residues N-terminal to it, but it lacks a zinc finger region in RAG1 previously implicated in binding RAG2. The ability of Mini-RAG1 to interact with RAG2 depends on a predicted -helix (amino acids 997-1008) near the RAG1 C terminus and a region of RAG1 from amino acids 479 to 559. Two adjacent acidic amino acids in this region (Asp-546 and Glu-547) are important for both the RAG1-RAG2 interaction and recombination activity, with Asp-546 of particular importance. Structural modeling of Mini-RAG1 suggests that Asp-546/Glu-547 lie near the predicted 997-1008 -helix and components of the active site, raising the possibility that RAG2 binding alters the structure of the RAG1 active site. Quantitative Western blotting allowed us to estimate that mouse thymocytes contain on average approximate to 1,800 monomers of RAG1 and approximate to 15,000 molecules of RAG2, implying that nuclear concentrations of RAG1 and RAG2 are below the K-D value for their interaction, which could help limit off-target RAG activity.	[Zhang, Yu-Hang; Shetty, Keerthi; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06511 USA; [Zhang, Yu-Hang; Shetty, Keerthi; Schatz, David G.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; [Surleac, Marius D.; Petrescu, Andrei J.] Acad Romana, Inst Biochem, Dept Bioinformat & Struct Biochem, Bucharest 060031, Romania; [Schatz, David G.] Howard Hughes Med Inst, New Haven, CT 06511 USA	Yale University; Yale University; Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; Howard Hughes Medical Institute	Schatz, DG (corresponding author), Yale Univ, Sch Med, Dept Immunol, Box 208011, New Haven, CT 06520 USA.	david.schatz@yale.edu	Surleac, Marius D/C-6182-2017; Regan, Clinton/E-6250-2012; Petrescu, Andrei-Jose J/G-4576-2016; Surleac, Marius/M-2859-2019	Surleac, Marius D/0000-0003-3218-4644; Petrescu, Andrei-Jose J/0000-0002-4478-3946; Surleac, Marius/0000-0003-3218-4644	National Institutes of Health [R37 AI32524, T32GM007223]; Executive Agency for Funding Higher Education, Research, Development, and Innovation [ID 3-0342-181/2011, PT-PCCA-4-0930-120/2014]; Romanian Academy of Institute of Biochemistry of the Romanian Academy; National Science Foundation Graduate Research Fellowship [DGE-1122492]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Executive Agency for Funding Higher Education, Research, Development, and Innovation; Romanian Academy of Institute of Biochemistry of the Romanian Academy; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 AI32524 (to D. G. S.). This work was also supported by Executive Agency for Funding Higher Education, Research, Development, and Innovation Grants ID 3-0342-181/2011 and PT-PCCA-4-0930-120/2014, and Romanian Academy Projects 1 and 3 of Institute of Biochemistry of the Romanian Academy (to A. J. P. and M. D. S.).; Supported in part by National Institutes of Health Grant T32GM007223 and by National Science Foundation Graduate Research Fellowship under Grant DGE-1122492.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Aidinis V, 2000, J IMMUNOL, V164, P5826, DOI 10.4049/jimmunol.164.11.5826; Arbuckle JL, 2001, J BIOL CHEM, V276, P37093, DOI 10.1074/jbc.M105988200; Banerjee JK, 2014, MOL CELL BIOL, V34, P2566, DOI 10.1128/MCB.00411-14; Bergeron S, 2006, METHOD ENZYMOL, V408, P511, DOI 10.1016/S0076-6879(06)08032-3; Bradley MN, 2003, MOL CELL BIOL, V23, P4841, DOI 10.1128/MCB.23.14.4841-4858.2003; Callebaut I, 1998, CELL MOL LIFE SCI, V54, P880, DOI 10.1007/s000180050216; Chan EAW, 2013, P NATL ACAD SCI USA, V110, pE4628, DOI 10.1073/pnas.1310846110; Chaumeil J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3231; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Coster G, 2012, J BIOL CHEM, V287, P36488, DOI 10.1074/jbc.M112.402487; De P, 2004, IMMUNOL REV, V200, P70, DOI 10.1111/j.0105-2896.2004.00154.x; Do T, 2008, PROTEIN EXPRES PURIF, V60, P147, DOI 10.1016/j.pep.2008.04.009; Eastman QM, 1999, MOL CELL BIOL, V19, P3788; Fabrini R, 2009, BIOCHEMISTRY-US, V48, P10473, DOI 10.1021/bi901238t; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; Fugmann SD, 2010, SEMIN IMMUNOL, V22, P10, DOI 10.1016/j.smim.2009.11.004; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gomez CA, 2000, MOL CELL BIOL, V20, P5653, DOI 10.1128/MCB.20.15.5653-5664.2000; Guermeur Y, 1997, THESIS U PIERRE MARI; Hanganu Andrei, 2009, Romanian Journal of Biochemistry, V46, P123; Hencken CG, 2012, NAT STRUCT MOL BIOL, V19, P834, DOI 10.1038/nsmb.2338; Hickman AB, 2005, NAT STRUCT MOL BIOL, V12, P715, DOI 10.1038/nsmb970; Hickman AB, 2014, CELL, V158, P353, DOI 10.1016/j.cell.2014.05.037; Huye LE, 2002, MOL CELL BIOL, V22, P3460, DOI 10.1128/MCB.22.10.3460-3473.2002; Jones JM, 2009, ARCH IMMUNOL THER EX, V57, P105, DOI 10.1007/s00005-009-0011-3; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; Ko JE, 2004, J BIOL CHEM, V279, P7715, DOI 10.1074/jbc.M311471200; LEU TMJ, 1995, MOL CELL BIOL, V15, P5657; McMahan CJ, 1997, J IMMUNOL, V158, P2202; Pawlowski M, 2013, NUCLEIC ACIDS RES, V41, pW389, DOI 10.1093/nar/gkt408; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rodgers KK, 1999, NUCLEIC ACIDS RES, V27, P2938, DOI 10.1093/nar/27.14.2938; Roman CAJ, 1997, IMMUNITY, V7, P13, DOI 10.1016/S1074-7613(00)80506-3; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SADOFSKY MJ, 1993, NUCLEIC ACIDS RES, V21, P5644, DOI 10.1093/nar/21.24.5644; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Swanson PC, 1999, MOL CELL BIOL, V19, P3674; Wang ZY, 2011, PROTEOMICS, V11, P3786, DOI 10.1002/pmic.201100196; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Yin FF, 2009, NAT STRUCT MOL BIOL, V16, P499, DOI 10.1038/nsmb.1593; Zhao SY, 2009, J MOL BIOL, V387, P744, DOI 10.1016/j.jmb.2009.02.020; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157	49	13	13	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11802	11817		10.1074/jbc.M115.638627	http://dx.doi.org/10.1074/jbc.M115.638627			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25745109	Green Published, hybrid			2022-12-28	WOS:000354388600001
J	Chernov, AV; Dolkas, J; Hoang, K; Angert, M; Srikrishna, G; Vogl, T; Baranovskaya, S; Strongin, AY; Shubayev, VI				Chernov, Andrei V.; Dolkas, Jennifer; Hoang, Khang; Angert, Mila; Srikrishna, Geetha; Vogl, Thomas; Baranovskaya, Svetlana; Strongin, Alex Y.; Shubayev, Veronica I.			The Calcium-binding Proteins S100A8 and S100A9 Initiate the Early Inflammatory Program in Injured Peripheral Nerves	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHWANN-CELL PROLIFERATION; WALLERIAN DEGENERATION; SCIATIC-NERVE; GENE-EXPRESSION; BIOINFORMATIC ANALYSIS; AXONAL DEGENERATION; FUNCTIONAL RECOVERY; NEUROPATHIC PAIN; IN-VIVO; REGENERATION	To shed light on the early immune response processes in severed peripheral nerves, we performed genome-wide transcriptional profiling and bioinformatics analyses of the proximal (P, regenerating) and distal (D, degenerating) nerve stumps on day 1 in the sciatic nerve axotomy model in rats. Multiple cell death-related pathways were activated in the degenerating D stump, whereas activation of the cytoskeletal motility and gluconeogenesis/glycolysis pathways was most prominent in the P stump of the axotomized nerve. Our bioinformatics analyses also identified the specific immunomodulatory genes of the chemokine, IL, TNF, MHC, immunoglobulin-binding Fc receptor, calcium-binding S100, matrix metalloproteinase, tissue inhibitor of metalloproteinase, and ion channel families affected in both the P and D segments. S100a8 and S100a9 were the top up-regulated genes in both the P and D segments. Stimulation of cultured Schwann cells using the purified S100A8/A9 heterodimer recapitulated activation of the myeloid cell and phagocyte chemotactic genes and pathways, which we initially observed in injured nerves. S100A8/A9 heterodimer injection into the intact nerve stimulated macrophage infiltration. We conclude that, following peripheral nerve injury, an immediate acute immune response occurs both distal and proximal to the lesion site and that the rapid transcriptional activation of the S100a8 and S100a9 genes results in S100A8/A9 hetero- and homodimers, which stimulate the release of chemokines and cytokines by activated Schwann cells and generate the initial chemotactic gradient that guides the transmigration of hematogenous immune cells into the injured nerve.	[Chernov, Andrei V.; Srikrishna, Geetha; Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Dolkas, Jennifer; Hoang, Khang; Angert, Mila; Shubayev, Veronica I.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Dolkas, Jennifer; Hoang, Khang; Angert, Mila; Shubayev, Veronica I.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92037 USA; [Vogl, Thomas] Univ Munster, Inst Immunol, D-48149 Munster, Germany; [Baranovskaya, Svetlana] Agilent Technol, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Munster; Agilent Technologies	Shubayev, VI (corresponding author), Univ Calif San Diego, Mail Code 0629,9500 Gilman Dr, La Jolla, CA 92093 USA.	vshubayev@ucsd.edu	Chernov, Andrei/I-1623-2019; Regan, Clinton/E-6250-2012; Strongin, Alex/R-6609-2019	Chernov, Andrei/0000-0002-3294-5418; Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [RO1DE022757]; Department of Veterans Affairs Merit Review Award [5I01BX000638]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022757] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DE022757 (to V. I. S. and A. Y. S.). This work was also supported by Department of Veterans Affairs Merit Review Award 5I01BX000638 (to V. I. S.).	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Bosse F, 2006, J NEUROCHEM, V96, P1441, DOI 10.1111/j.1471-4159.2005.03635.x; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Chattopadhyay S, 2009, GLIA, V57, P1316, DOI 10.1002/glia.20851; Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; D'Antonio M, 2006, GLIA, V53, P501, DOI 10.1002/glia.20309; FERNANDEZVALLE C, 1995, J NEUROCYTOL, V24, P667, DOI 10.1007/BF01179817; Goethals S, 2010, GLIA, V58, P1701, DOI 10.1002/glia.21041; Gordon T, 2003, J PERIPHER NERV SYST, V8, P236, DOI 10.1111/j.1085-9489.2003.03029.x; Gordon T, 2011, J NEUROSCI, V31, P5325, DOI 10.1523/JNEUROSCI.6156-10.2011; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Jiang N, 2014, NEURAL REGEN RES, V9, P1186, DOI 10.4103/1673-5374.135325; Kamon y Cajal S., 1991, CAJALS DEGENERATION, p144 ; Kenney AM, 1998, J NEUROSCI, V18, P1318; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kieseier BC, 2006, CURR OPIN NEUROL, V19, P437, DOI 10.1097/01.wco.0000245365.51823.72; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033664; Kubo T, 2002, J NEUROCHEM, V82, P1129, DOI 10.1046/j.1471-4159.2002.01060.x; LACKMANN M, 1992, J BIOL CHEM, V267, P7499; LACKMANN M, 1993, J IMMUNOL, V150, P2981; Li SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057000; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Mcdonald D, 2006, NEURON GLIA BIOL, V2, P139, DOI 10.1017/S1740925X05000347; Myers RR, 2006, DRUG DISCOV TODAY, V11, P8, DOI 10.1016/S1359-6446(05)03637-8; Nagarajan R, 2002, P NATL ACAD SCI USA, V99, P8998, DOI 10.1073/pnas.132080999; Nix P, 2011, P NATL ACAD SCI USA, V108, P10738, DOI 10.1073/pnas.1104830108; Perrone L, 2008, J CELL PHYSIOL, V217, P60, DOI 10.1002/jcp.21474; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Sheu JY, 2000, EXP NEUROL, V166, P392, DOI 10.1006/exnr.2000.7508; Shubayev VI, 2006, MOL CELL NEUROSCI, V31, P407, DOI 10.1016/j.mcn.2005.10.011; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; Thacker MA, 2007, ANESTH ANALG, V105, P838, DOI 10.1213/01.ane.0000275190.42912.37; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Wang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043436; Wood MD, 2011, ANN ANAT, V193, P321, DOI 10.1016/j.aanat.2011.04.008; Yao DB, 2013, NEUROSCI BULL, V29, P321, DOI 10.1007/s12264-013-1340-0; Zochodne DW, 2012, J PERIPHER NERV SYST, V17, P1, DOI 10.1111/j.1529-8027.2012.00378.x; Zrouri H, 2004, EUR J NEUROSCI, V20, P1811, DOI 10.1111/j.1460-9568.2004.03641.x	51	44	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11771	11784		10.1074/jbc.M114.622316	http://dx.doi.org/10.1074/jbc.M114.622316			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792748	Green Published, hybrid			2022-12-28	WOS:000353719400049
J	Pardo, V; Gonzalez-Rodriguez, A; Guijas, C; Balsinde, J; Valverde, AM				Pardo, Virginia; Gonzalez-Rodriguez, Agueda; Guijas, Carlos; Balsinde, Jesus; Valverde, Angela M.			Opposite Cross-Talk by Oleate and Palmitate on Insulin Signaling in Hepatocytes through Macrophage Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE 1B; NECROSIS-FACTOR-ALPHA; ENDOPLASMIC-RETICULUM STRESS; SATURATED FATTY-ACIDS; NF-KAPPA-B; ADIPOSE-TISSUE; INDUCED INFLAMMATION; GLUCOSE-HOMEOSTASIS; METABOLIC SYNDROME; LIPID HOMEOSTASIS	Chronic low grade inflammation in adipose tissue during obesity is associated with an impairment of the insulin signaling cascade. In this study, we have evaluated the impact of palmitate or oleate overload of macrophage/Kupffer cells in triggering stress-mediated signaling pathways, in lipoapoptosis, and in the cross-talk with insulin signaling in hepatocytes. RAW 264.7 macrophages or Kupffer cells were stimulated with oleate or palmitate, and levels of M1/M2 polarization markers and the lipidomic profile of eicosanoids were analyzed. Whereas proinflammatory cytokines and total eicosanoids were elevated in macrophages/Kupffer cells stimulated with palmitate, enhanced arginase 1 and lower leukotriene B-4 (LTB4) levels were detected in macrophages stimulated with oleate. When hepatocytes were pretreated with conditioned medium (CM) from RAW 264.7 or Kupffer cells loaded with palmitate (CM-P), phosphorylation of stress kinases and endoplasmic reticulum stress signaling was increased, insulin signaling was impaired, and lipoapoptosis was detected. Conversely, enhanced insulin receptor-mediated signaling and reduced levels of the phosphatases protein tyrosine phosphatase 1B (PTP1B) and phosphatase and tensin homolog (PTEN) were found in hepatocytes treated with CM from macrophages stimulated with oleate (CM-O). Supplementation ofCM-OwithLTB(4) suppressed insulin sensitization and increased PTP1B and PTEN. Furthermore, LTB4 decreased insulin receptor tyrosine phosphorylation in hepatocytes, activated the NF kappa B pathway, and up-regulated PTP1B and PTEN, these effects being mediated by LTB4 receptor BTL1. In conclusion, oleate and palmitate elicit an opposite cross-talk between macrophages/Kupffer cells and hepatocytes. Whereas CM-P interferes at the early steps of insulin signaling, CM-O increases insulin sensitization, possibly by reducing LTB4.	[Pardo, Virginia; Gonzalez-Rodriguez, Agueda] Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain; [Pardo, Virginia; Gonzalez-Rodriguez, Agueda; Guijas, Carlos; Balsinde, Jesus; Valverde, Angela M.] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid 28029, Spain; [Guijas, Carlos; Balsinde, Jesus; Valverde, Angela M.] CSIC, Inst Biol & Genet Mol, Valladolid 47003, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM)	Valverde, AM (corresponding author), Inst Invest Biomed Alberto Sols, C Arturo Duperier 4, Madrid 28029, Spain.	avalverde@iib.uam.es	Balsinde, Jesús/C-7833-2018; Pardo Marques, Virginia/B-3062-2015	Balsinde, Jesús/0000-0002-4157-6714; Guijas, Carlos/0000-0001-7993-3388; Gonzalez-Rodriguez, Agueda/0000-0003-2851-2318; Pardo Marques, Virginia/0000-0001-9787-8722	Ministerio de Economia y Competitividad, Spain [SAF2012-33283, SAF2013-48201-R]; Comunidad de Madrid (Spain) [S2010/BMD-2423]; European Foundation for the Studies of Diabetes and Amylin Paul Langerhans grant; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM, Instituto de Salud Carlos III, Spain); CIBERDEM (ISCIII) postdoctoral contract	Ministerio de Economia y Competitividad, Spain; Comunidad de Madrid (Spain)(Comunidad de Madrid); European Foundation for the Studies of Diabetes and Amylin Paul Langerhans grant; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM, Instituto de Salud Carlos III, Spain); CIBERDEM (ISCIII) postdoctoral contract	This work was supported by Ministerio de Economia y Competitividad, Spain, Grants SAF2012-33283 and SAF2013-48201-R; Comunidad de Madrid Grant S2010/BMD-2423 (Spain); an European Foundation for the Studies of Diabetes and Amylin Paul Langerhans grant; and the Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM, Instituto de Salud Carlos III, Spain).; Holder of a CIBERDEM (ISCIII) postdoctoral contract. To whom correspondence may be addressed: Instituto de Investigaciones Biomedicas Alberto Sols, C/Arturo Duperier 4, 28029 Madrid, Spain. Tel.: 34-915854497; Fax: 34-915854401; E-mail: aguedagr@iib.uam.es.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Attie AD, 2009, J LIPID RES, V50, pS395, DOI 10.1194/jlr.R800057-JLR200; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; BENVENISTE R, 1988, CELL BIOCHEM FUNCT, V6, P231, DOI 10.1002/cbf.290060403; Camell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075147; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Dumlao DS, 2011, BBA-MOL CELL BIOL L, V1811, P724, DOI 10.1016/j.bbalip.2011.06.005; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Gao B, 2010, HEPATOLOGY, V51, P8, DOI 10.1002/hep.23320; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Gonzalez-Rodriguez A, 2007, ENDOCRINOLOGY, V148, P594, DOI 10.1210/en.2006-0644; Gonzalez-Rodriguez A, 2012, AGING CELL, V11, P284, DOI 10.1111/j.1474-9726.2011.00786.x; Gonzalez-Rodriguez A, 2010, DIABETES, V59, P588, DOI 10.2337/db09-0796; Grant L, 2014, DIABETES, V63, P456, DOI 10.2337/db13-0885; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Haeggstrom JZ, 2004, J BIOL CHEM, V279, P50639, DOI 10.1074/jbc.R400027200; Han SW, 2008, AM J PHYSIOL-LUNG C, V294, pL1238, DOI 10.1152/ajplung.00017.2008; Henkel J, 2009, HEPATOLOGY, V50, P781, DOI 10.1002/hep.23064; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Horrillo R, 2010, J IMMUNOL, V184, P3978, DOI 10.4049/jimmunol.0901355; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Kewalramani G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026947; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Lei HW, 2011, J HUAZHONG U SCI-MED, V31, P185, DOI 10.1007/s11596-011-0249-y; Leng SH, 2010, J ENDOCRINOL, V206, P171, DOI 10.1677/JOE-09-0456; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lopez-Parra M, 2008, J LIPID RES, V49, P2513, DOI 10.1194/jlr.M800101-JLR200; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Meshkani R, 2009, CLIN BIOCHEM, V42, P1331, DOI 10.1016/j.clinbiochem.2009.05.018; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Nieto-Vazquez I, 2007, DIABETES, V56, P404, DOI 10.2337/db06-0989; Nieto-Vazquez I, 2008, DIABETES, V57, P3211, DOI 10.2337/db07-1062; Norris Paul C., 2014, Advances in Biological Regulation, V54, P99, DOI 10.1016/j.jbior.2013.09.009; Novgorodtseva TP, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-82; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Owen C, 2013, DIABETOLOGIA, V56, P2286, DOI 10.1007/s00125-013-2992-z; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park E, 2007, J ENDOCRINOL, V195, P323, DOI 10.1677/JOE-07-0005; Pichard Lydiane, 2006, Methods Mol Biol, V320, P283; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Samokhvalov V, 2009, AM J PHYSIOL-ENDOC M, V296, pE37, DOI 10.1152/ajpendo.90667.2008; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Schwenger KJP, 2014, WORLD J GASTROENTERO, V20, P1712, DOI 10.3748/wjg.v20.i7.1712; Scull CM, 2011, ARTERIOSCL THROM VAS, V31, P2792, DOI 10.1161/ATVBAHA.111.224881; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Song P, 2009, J BIOL CHEM, V284, P17120, DOI 10.1074/jbc.M109.012583; SPECTOR AA, 1986, METHOD ENZYMOL, V128, P320; Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196; Suchy D, 2013, CELL BIOCHEM FUNCT, V31, P181, DOI 10.1002/cbf.2940; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu JF, 2003, AM J HUM GENET, V72, P208, DOI 10.1086/345802; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhao Y, 2012, BIOCHEM BIOPH RES CO, V418, P647, DOI 10.1016/j.bbrc.2012.01.068; Zhou L, 2007, FEBS LETT, V581, P4303, DOI 10.1016/j.febslet.2007.07.076	75	38	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11663	11677		10.1074/jbc.M115.649483	http://dx.doi.org/10.1074/jbc.M115.649483			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792746	hybrid, Green Published			2022-12-28	WOS:000353719400040
J	Brennenstuhl, C; Tanimoto, N; Burkard, M; Wagner, R; Bolz, S; Trifunovic, D; Kabagema-Bilan, C; Paquet-Durand, F; Beck, SC; Huber, G; Seeliger, MW; Ruth, P; Wissinger, B; Lukowski, R				Brennenstuhl, Christina; Tanimoto, Naoyuki; Burkard, Markus; Wagner, Rebecca; Bolz, Sylvia; Trifunovic, Dragana; Kabagema-Bilan, Clement; Paquet-Durand, Francois; Beck, Susanne C.; Huber, Gesine; Seeliger, Mathias W.; Ruth, Peter; Wissinger, Bernd; Lukowski, Robert			Targeted Ablation of the Pde6h Gene in Mice Reveals Cross-species Differences in Cone and Rod Phototransduction Protein Isoform Inventory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic GMP (cGMP); Mouse Genetics; Phosphodiesterases; Retina; Retinal Degeneration; Second Messenger; Vision	MEMBRANE GUANYLYL CYCLASE; AUTOSOMAL-DOMINANT CONE; RECESSIVE RETINITIS-PIGMENTOSA; CGMP-PHOSPHODIESTERASE; GAMMA-SUBUNIT; PHOTORECEPTOR CELLS; ALPHA-SUBUNIT; MOUSE RETINA; ACTIVATING PROTEIN-1; MAMMALIAN RETINAS	Phosphodiesterase-6 (PDE6) is a multisubunit enzyme that plays a key role in the visual transduction cascade in rod and cone photoreceptors. Each type of photoreceptor utilizes discrete catalytic and inhibitory PDE6 subunits to fulfill its physiological tasks, i.e. the degradation of cyclic guanosine-3,5-monophosphate at specifically tuned rates and kinetics. Recently, the human PDE6H gene was identified as a novel locus for autosomal recessive (incomplete) color blindness. However, the three different classes of cones were not affected to the same extent. Short wave cone function was more preserved than middle and long wave cone function indicating that some basic regulation of the PDE6 multisubunit enzyme was maintained albeit by a unknown mechanism. To study normal and disease-related functions of cone Pde6h in vivo, we generated Pde6h knock-out (Pde6h(-/-)) mice. Expression of PDE6H in murine eyes was restricted to both outer segments and synaptic terminals of short and long/middle cone photoreceptors, whereas Pde6h(-/-) retinae remained PDE6H-negative. Combined in vivo assessment of retinal morphology with histomorphological analyses revealed a normal overall integrity of the retinal organization and an unaltered distribution of the different cone photoreceptor subtypes upon Pde6h ablation. In contrast to human patients, our electroretinographic examinations of Pde6h(-/-) mice suggest no defects in cone/rod-driven retinal signaling and therefore preserved visual functions. To this end, we were able to demonstrate the presence of rod PDE6G in cones indicating functional substitution of PDE6. The disparities between human and murine phenotypes caused by mutant Pde6h/PDE6H suggest species-to-species differences in the vulnerability of biochemical and neurosensory pathways of the visual signal transduction system.	Univ Tubingen, Ctr Ophthalmol, Inst Pharm, D-72076 Tubingen, Germany; [Brennenstuhl, Christina; Burkard, Markus; Wagner, Rebecca; Kabagema-Bilan, Clement; Ruth, Peter; Lukowski, Robert] Univ Tubingen, Ctr Ophthalmol, Dept Pharmacol Toxicol & Clin Pharm, D-72076 Tubingen, Germany; [Tanimoto, Naoyuki; Beck, Susanne C.; Huber, Gesine; Seeliger, Mathias W.] Univ Tubingen, Ctr Ophthalmol, Div Ocular Neurodegenerat, D-72076 Tubingen, Germany; [Bolz, Sylvia; Trifunovic, Dragana; Paquet-Durand, Francois] Univ Tubingen, Ctr Ophthalmol, Div Expt Ophthalmol, D-72076 Tubingen, Germany; [Wissinger, Bernd] Univ Tubingen, Mol Genet Lab, Ctr Ophthalmol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Wissinger, B (corresponding author), Univ Tubingen, Mol Genet Lab, Ctr Ophthalmol, D-72076 Tubingen, Germany.	bernd.wissinger@uni-tuebingen.de; robert.lukowski@uni-tuebingen.de	Paquet-Durand, Francois/G-6709-2015; Trifunovic, Dragana/ABB-8165-2020; Trifunovic, Dragana/AAA-1823-2020	Paquet-Durand, Francois/0000-0001-7355-5742; Trifunovic, Dragana/0000-0003-3168-4196; Burkard, Markus/0000-0001-6113-2275	Deutsche Forschungsgemeinschaft [KFO134, Ru573/5, KFO134-Se837/5-2, Se837/6-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants KFO134 and Ru573/5 (to P. R. and B. W.) and KFO134-Se837/5-2 and Se837/6-2 (to M. W. S.).	Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Biel Martin, 2009, V191, P111, DOI 10.1007/978-3-540-68964-5_7; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chen CK, 2001, MOL VIS, V7, P305; Chrispell JD, 2009, J BIOL CHEM, V284, P21468, DOI 10.1074/jbc.M109.020966; Cooper N, 1995, J MOL NEUROSCI, V6, P211, DOI 10.1007/BF02736766; Cuenca N, 1998, INVEST OPHTH VIS SCI, V39, P1243; Deng WT, 2013, J NEUROSCI, V33, P11745, DOI 10.1523/JNEUROSCI.1536-13.2013; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Downes SM, 2001, ARCH OPHTHALMOL-CHIC, V119, P96; Dvir L, 2010, AM J HUM GENET, V87, P258, DOI 10.1016/j.ajhg.2010.06.016; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; GAL A, 1994, NAT GENET, V7, P551, DOI 10.1038/ng0894-551c; Geller SF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000607; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; Grau T, 2011, HUM MOL GENET, V20, P719, DOI 10.1093/hmg/ddq517; Haire SE, 2006, INVEST OPHTH VIS SCI, V47, P3745, DOI 10.1167/iovs.06-0086; HAMILTON SE, 1990, J BIOL CHEM, V265, P11259; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; Janne PA, 1998, J CLIN INVEST, V101, P2042, DOI 10.1172/JCI2414; Kachi S, 1999, EXP EYE RES, V68, P465, DOI 10.1006/exer.1998.0629; Karan S, 2010, MOL CELL BIOCHEM, V334, P141, DOI 10.1007/s11010-009-0322-z; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Kemp-Harper Barbara, 2009, V191, P447, DOI 10.1007/978-3-540-68964-5_19; Kleppisch Thomas, 2009, V191, P549, DOI 10.1007/978-3-540-68964-5_24; Kohl S, 2005, EUR J HUM GENET, V13, P302, DOI 10.1038/sj.ejhg.5201269; Kohl S, 2002, AM J HUM GENET, V71, P422, DOI 10.1086/341835; Kohl S, 2012, AM J HUM GENET, V91, P527, DOI 10.1016/j.ajhg.2012.07.006; Kolandaivelu S, 2011, J BIOL CHEM, V286, P33252, DOI 10.1074/jbc.M111.259101; Leiss V, 2014, BIOCHEM BIOPH RES CO, V452, P151, DOI 10.1016/j.bbrc.2014.08.071; Leiss V, 2011, DIABETES, V60, P148, DOI 10.2337/db10-0595; Lev S, 2001, CELL MOL NEUROBIOL, V21, P575, DOI 10.1023/A:1015183500719; Liu JW, 2005, INVEST OPHTH VIS SCI, V46, P3836, DOI 10.1167/iovs.04-1283; LIU XR, 1994, EXP EYE RES, V59, P761, DOI 10.1006/exer.1994.1162; Lukowski R, 2008, ARTERIOSCL THROM VAS, V28, P1244, DOI 10.1161/ATVBAHA.108.166405; Lukowski R, 2010, P NATL ACAD SCI USA, V107, P5646, DOI 10.1073/pnas.1001360107; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Mavlyutov TA, 2002, HUM MOL GENET, V11, P1899, DOI 10.1093/hmg/11.16.1899; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; Miyake Y, 1996, JPN J OPHTHALMOL, V40, P511; Muradov H, 2010, J BIOL CHEM, V285, P39828, DOI 10.1074/jbc.M110.170068; Muradov H, 2009, J BIOL CHEM, V284, P32662, DOI 10.1074/jbc.M109.049916; Muradov KG, 2002, BIOCHEMISTRY-US, V41, P3884, DOI 10.1021/bi015935m; Nickle B, 2007, CELL MOL LIFE SCI, V64, P2917, DOI 10.1007/s00018-007-7253-1; NIHIRA M, 1995, INVEST OPHTH VIS SCI, V36, P1259; OttoBruc A, 1997, P NATL ACAD SCI USA, V94, P4727, DOI 10.1073/pnas.94.9.4727; Palczewski K, 2004, BIOCHEM BIOPH RES CO, V322, P1123, DOI 10.1016/j.bbrc.2004.07.122; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Pfeiffer-Guglielmi B, 2005, GLIA, V49, P84, DOI 10.1002/glia.20102; Sahaboglu A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.12; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Shen J, 2005, MOL CELL BIOL, V25, P3639, DOI 10.1128/MCB.25.9.3639-3647.2005; ShimizuMatsumoto A, 1996, GENOMICS, V32, P121, DOI 10.1006/geno.1996.0085; SHYJAN AW, 1992, NEURON, V9, P727, DOI 10.1016/0896-6273(92)90035-C; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Sleat DE, 2004, J NEUROSCI, V24, P9117, DOI 10.1523/JNEUROSCI.2729-04.2004; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Stearns G, 2007, J NEUROSCI, V27, P13866, DOI 10.1523/JNEUROSCI.3136-07.2007; SZEL A, 1992, J COMP NEUROL, V325, P327, DOI 10.1002/cne.903250302; Tanimoto Naoyuki, 2013, Methods Mol Biol, V935, P69, DOI 10.1007/978-1-62703-080-9_4; Tanimoto N, 2009, FRONT BIOSCI-LANDMRK, V14, P2730, DOI 10.2741/3409; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; Weiss ER, 2001, J NEUROSCI, V21, P9175, DOI 10.1523/JNEUROSCI.21-23-09175.2001; Wen XH, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00045; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; Zhang XJ, 2005, FRONT BIOSCI-LANDMRK, V10, P1191, DOI 10.2741/1612	83	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10242	10255		10.1074/jbc.M114.611921	http://dx.doi.org/10.1074/jbc.M114.611921			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25739440	Green Published, hybrid			2022-12-28	WOS:000353241100030
J	Mbefo, MK; Fares, MB; Paleologou, K; Oueslati, A; Yin, GW; Tenreiro, S; Pinto, M; Outeiro, T; Zweckstetter, M; Masliah, E; Lashuel, HA				Mbefo, Martial Kamdem; Fares, Mohamed-Bilal; Paleologou, Katerina; Oueslati, Abid; Yin, Guowei; Tenreiro, Sandra; Pinto, Madalena; Outeiro, Tiago; Zweckstetter, Markus; Masliah, Eliezer; Lashuel, Hilal A.			Parkinson Disease Mutant E46K Enhances alpha-Synuclein Phosphorylation in Mammalian Cell Lines, in Yeast, and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR KINASES; CENTRAL-NERVOUS-SYSTEM; NUCLEAR TRANSLOCATION; MEMBRANE INTERACTIONS; PHOSPHOLIPID-BINDING; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; TRANSGENIC MICE; MUTATION; AGGREGATION	Although alpha-synuclein (alpha-syn) phosphorylation has been considered as a hallmark of sporadic and familial Parkinson disease (PD), little is known about the effect of PD-linked mutations on alpha-syn phosphorylation. In this study, we investigated the effects of the A30P, E46K, and A53T PD-linked mutations on alpha-syn phosphorylation at residues Ser-87 and Ser-129. Although the A30P and A53T mutants slightly affected Ser(P)-129 levels compared with WT alpha-syn, the E46K mutation significantly enhanced Ser-129 phosphorylation in yeast and mammalian cell lines. This effect was not due to the E46K mutant being a better kinase substrate nor due to alterations in endogenous kinase levels, but was mostly linked with enhanced nuclear and endoplasmic reticulum accumulation. Importantly, lentivirus-mediated overexpression in mice also showed enhanced Ser-129 phosphorylation of the E46K mutant compared to WT alpha-syn, thus providing in vivo validation of our findings. Altogether, our findings suggest that the different PD-linked mutations may contribute to PD pathogenesis via different mechanisms.	[Mbefo, Martial Kamdem; Fares, Mohamed-Bilal; Paleologou, Katerina; Oueslati, Abid; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol & Chem Biol Neurodegenerat, Stn 15, CH-1015 Lausanne, Switzerland; [Yin, Guowei; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Tenreiro, Sandra; Pinto, Madalena; Outeiro, Tiago] Univ Lisbon, Inst Med Mol, Cell & Mol Neurosci Unit, P-1649028 Lisbon, Portugal; [Outeiro, Tiago] Univ Lisbon, Fac Med, Inst Fisiol, P-1649028 Lisbon, Portugal; [Outeiro, Tiago] Univ Med Ctr Goettingen, Dept NeuroDegenerat & Restorat Res, D-37077 Gottingen, Germany; [Zweckstetter, Markus] German Ctr Neurodegenerat Dis, D-37077 Gottingen, Germany; [Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Pathol, San Diego, CA 92103 USA; [Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci, San Diego, CA 92103 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Max Planck Society; Universidade de Lisboa; Universidade de Lisboa; University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of California System; University of California San Diego; University of California System; University of California San Diego	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol & Chem Biol Neurodegenerat, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Outeiro, Tiago F/C-1067-2008; Oueslati, Abid/ABG-8116-2020; Lashuel, Hilal/M-3500-2017; Outeiro, Tiago/L-7351-2019; Outeiro, Tiago/M-8106-2019; Tenreiro, Sandra/A-9289-2013; Pinto, Madalena/L-1835-2014	Outeiro, Tiago F/0000-0003-1679-1727; Outeiro, Tiago/0000-0003-1679-1727; Tenreiro, Sandra/0000-0001-7272-5842; Zweckstetter, Markus/0000-0002-2536-6581; Oueslati, Abid/0000-0003-1122-7086; Pinto, Madalena/0000-0002-4676-1409	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation [31003A_120653]; Michael J. Fox Foundation; Merck Serono; Cluster of Excellence and Deutsche Forschungsgemeinschaft Research Center "Nanoscale Microscopy and Molecular Physiology of the Brain"; Fundacao pare a Ciencia e Tecnologia [PTDC/SAU-NEU/105215/2008, PTDC/BIA-BCM/117975/2010]; EMBO;  [SFRH/BPD/35767/2007];  [IMM/BTI/1-2012]; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Michael J. Fox Foundation; Merck Serono(Merck & Company); Cluster of Excellence and Deutsche Forschungsgemeinschaft Research Center "Nanoscale Microscopy and Molecular Physiology of the Brain"; Fundacao pare a Ciencia e Tecnologia; EMBO(European Molecular Biology Organization (EMBO)); ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Ecole Polytechnique Federale de Lausanne, Swiss National Science Foundation Grant 31003A_120653, the Michael J. Fox Foundation, Merck Serono, a Marie Curie post-doctoral fellowship (to A. O.), the Cluster of Excellence and Deutsche Forschungsgemeinschaft Research Center "Nanoscale Microscopy and Molecular Physiology of the Brain" (to M. Z.), Fundacao pare a Ciencia e Tecnologia Projects PTDC/SAU-NEU/105215/2008 and PTDC/BIA-BCM/117975/2010, and Post-doctoral Fellowships SFRH/BPD/35767/2007 (to S. T.) and IMM/BTI/1-2012 (to M. R. P.).r Supported by an EMBO Installation Grant.	Ahn KJ, 2006, J NEUROCHEM, V97, P265, DOI 10.1111/j.1471-4159.2006.03731.x; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Boone AN, 2002, AM J PHYSIOL-REG I, V283, pR680, DOI 10.1152/ajpregu.00125.2002; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Chau KY, 2009, J NEUROCHEM, V110, P1005, DOI 10.1111/j.1471-4159.2009.06191.x; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Colla E, 2012, J NEUROSCI, V32, P3301, DOI 10.1523/JNEUROSCI.5368-11.2012; Colla E, 2012, J NEUROSCI, V32, P3306, DOI 10.1523/JNEUROSCI.5367-11.2012; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dotan I, 2001, BIOCHEM BIOPH RES CO, V288, P603, DOI 10.1006/bbrc.2001.5804; El-Agnaf OMA, 1998, FEBS LETT, V440, P67, DOI 10.1016/S0014-5793(98)01419-7; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Emmer KL, 2011, J BIOL CHEM, V286, P35104, DOI 10.1074/jbc.M111.247965; Fares MB, 2014, HUM MOL GENET, V23, P4491, DOI 10.1093/hmg/ddu165; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Ghosh D, 2014, BIOCHEMISTRY-US, V53, P6419, DOI 10.1021/bi5010365; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; GOLBE LI, 1990, ANN NEUROL, V27, P276, DOI 10.1002/ana.410270309; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Huang Z, 2011, NEUROSCIENCE, V199, P318, DOI 10.1016/j.neuroscience.2011.10.016; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Ishii A, 2007, FEBS LETT, V581, P4711, DOI 10.1016/j.febslet.2007.08.067; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jiang ML, 2010, J NEUROCHEM, V114, P419, DOI 10.1111/j.1471-4159.2010.06752.x; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Kim YS, 2006, J MOL BIOL, V360, P386, DOI 10.1016/j.jmb.2006.05.004; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Machiya Y, 2010, J BIOL CHEM, V285, P40732, DOI 10.1074/jbc.M110.141952; Martin-Clemente B, 2004, J BIOL CHEM, V279, P52984, DOI 10.1074/jbc.M409028200; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Neznanov N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001887; Nonaka T, 2009, BIOCHEMISTRY-US, V48, P8014, DOI 10.1021/bi900619j; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Paleologou KE, 2010, J NEUROSCI, V30, P3184, DOI 10.1523/JNEUROSCI.5922-09.2010; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Perlmutter JD, 2009, J BIOL CHEM, V284, P7177, DOI 10.1074/jbc.M808895200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; PREMONT RT, 1994, METHOD ENZYMOL, V238, P116; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Puschmann A, 2009, PARKINSONISM RELAT D, V15, P627, DOI 10.1016/j.parkreldis.2009.06.007; Sakamoto M, 2009, BIOCHEM BIOPH RES CO, V384, P378, DOI 10.1016/j.bbrc.2009.04.130; Salvi M, 2012, BIOCHEM BIOPH RES CO, V418, P156, DOI 10.1016/j.bbrc.2011.12.152; Schell H, 2009, NEUROSCIENCE, V160, P796, DOI 10.1016/j.neuroscience.2009.03.002; Schmid AW, 2009, J BIOL CHEM, V284, P13128, DOI 10.1074/jbc.M809067200; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Wakamatsu M, 2007, J NEUROSCI RES, V85, P1819, DOI 10.1002/jnr.21310; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Xu SL, 2006, BIOCHEM BIOPH RES CO, V342, P330, DOI 10.1016/j.bbrc.2006.01.148; Yonetani M, 2009, J BIOL CHEM, V284, P7940, DOI 10.1074/jbc.M807482200; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou M, 2013, BRAIN RES, V1500, P19, DOI 10.1016/j.brainres.2013.01.024	78	41	42	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9412	9427		10.1074/jbc.M114.610774	http://dx.doi.org/10.1074/jbc.M114.610774			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25657004	Green Published, hybrid			2022-12-28	WOS:000352729400010
J	Siatecka, M; Soni, S; Planutis, A; Bieker, JJ				Siatecka, Miroslawa; Soni, Shefali; Planutis, Antanas; Bieker, James J.			Transcriptional Activity of Erythroid Kruppel-like Factor (EKLF/KLF1) Modulated by PIAS3 (Protein Inhibitor of Activated STAT3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-RECEPTOR; GENE-ACTIVATION; LXXLL MOTIF; BINDING SPECIFICITY; SIGNATURE MOTIF; FACTOR EKLF; REPRESSION; DIFFERENTIATION; CELLS; EXPRESSION	Erythroid Kruppel-like factor (EKLF or KLF1) is a transcription factor crucial for red cell development that is directly involved in regulation of a large number of erythroid genes. EKLF serves mostly as an activator of expression of these genes; however, it can act also as a repressor. Here, we present evidence that EKLF interacts with proteins from the PIAS (protein inhibitor of activated STAT) family that convey repressive activity to EKLF in the absence of sumoylation. Our studies identify PIAS3 as a transcriptional corepressor of EKLF for at least a subset of its target genes during erythropoiesis (e.g. beta-globin, alpha-hemoglobin stabilizing protein). We demonstrate an interaction between EKLF and PIAS proteins confirmed by in vivo coimmunoprecipitation assays with both exogenous and endogenous proteins. We identified an LXXLL signature motif located near the N terminus of PIAS proteins that, although not involved in the EKLF-PIAS3 interaction, is required for the transrepression activity. Knockdown of endogenous PIAS3 accelerates differentiation of both murine erythroleukemia cells, as well as fetal liver cells, whereas an increase in PIAS3 levels inhibits this increase. Using chromatin immunoprecipitation assays, we show that PIAS3 preferentially occupies the beta-globin promoter in undifferentiated murine erythroleukemia cells. Together these results demonstrate that an interaction between EKLF and PIAS3 provides a novel mode of regulation of EKLF activity in the absence of sumolylation and furthermore shows an important involvement of PIAS proteins in erythropoiesis.	[Siatecka, Miroslawa; Soni, Shefali; Planutis, Antanas; Bieker, James J.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Siatecka, Miroslawa] Adam Mickiewicz Univ, Inst Expt Biol, Dept Genet, Ul Umultowska 89, PL-61614 Poznan, Poland	Icahn School of Medicine at Mount Sinai; Adam Mickiewicz University	Siatecka, M (corresponding author), Adam Mickiewicz Univ, Inst Expt Biol, Dept Genet, Ul Umultowska 89, PL-61614 Poznan, Poland.	msiatecka@amu.edu.pl			National Institutes of Health from the U.S. Public Health Service [R01 DK46865]; National Science Centre [2013/09/B/NZ1/01879]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046865] Funding Source: NIH RePORTER	National Institutes of Health from the U.S. Public Health Service; National Science Centre(National Science Centre, Poland); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK46865 from the U.S. Public Health Service (to J. J. B.). National Science Centre Grant 2013/09/B/NZ1/01879 (to M.S.).	Ahmad A, 2003, BIOCHEM BIOPH RES CO, V312, P1266, DOI 10.1016/j.bbrc.2003.11.073; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bieker JJ, 1996, DNA CELL BIOL, V15, P347, DOI 10.1089/dna.1996.15.347; Chen XY, 2004, MOL CELL BIOL, V24, P10416, DOI 10.1128/MCB.24.23.10416-10424.2004; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Coulthard VH, 2003, J BIOL CHEM, V278, P10942, DOI 10.1074/jbc.M212950200; England SJ, 2011, BLOOD, V117, P2708, DOI 10.1182/blood-2010-07-299743; Frontelo P, 2007, BLOOD, V110, P3871, DOI 10.1182/blood-2007-03-082065; Gohring F, 1997, EMBO J, V16, P7361, DOI 10.1093/emboj/16.24.7361; Gross M, 2004, ONCOGENE, V23, P3059, DOI 10.1038/sj.onc.1207443; Gross M, 2001, ONCOGENE, V20, P3880, DOI 10.1038/sj.onc.1204489; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hikata T, 2009, BLOOD, V113, P2202, DOI 10.1182/blood-2008-06-162594; Im H, 2005, P NATL ACAD SCI USA, V102, P17065, DOI 10.1073/pnas.0506164102; Jang HD, 2004, J BIOL CHEM, V279, P24873, DOI 10.1074/jbc.M313018200; Kim K, 2007, J IMMUNOL, V178, P5588, DOI 10.4049/jimmunol.178.9.5588; Kingsley PD, 2013, BLOOD, V121, pE5, DOI 10.1182/blood-2012-04-422394; Lee H, 2006, GENE DEV, V20, P784, DOI 10.1101/gad.1392006; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598; Liu B, 2014, EMBO J, V33, P101, DOI 10.1002/embj.201283326; Liu B, 2010, SCIENCE, V330, P521, DOI 10.1126/science.1193787; Long JY, 2003, P NATL ACAD SCI USA, V100, P9791, DOI 10.1073/pnas.1733973100; Matushansky I, 2000, P NATL ACAD SCI USA, V97, P14317, DOI 10.1073/pnas.250488697; Merryweather-Clarke AT, 2011, BLOOD, V117, pE96, DOI 10.1182/blood-2010-07-290825; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Nakae J, 2006, J CLIN INVEST, V116, P2473, DOI 10.1172/JCI25518; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Park JI, 2001, CELL GROWTH DIFFER, V12, P481; PERKINS AC, 1995, NATURE, V375, P318; Quadrini KJ, 2008, EXP CELL RES, V314, P1595, DOI 10.1016/j.yexcr.2008.01.033; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Sengupta T, 2009, P NATL ACAD SCI USA, V106, P4213, DOI 10.1073/pnas.0808347106; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Siatecka M, 2007, MOL CELL BIOL, V27, P8547, DOI 10.1128/MCB.00589-07; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Southwood CM, 1996, DEV DYNAM, V206, P248, DOI 10.1002/(SICI)1097-0177(199607)206:3<248::AID-AJA3>3.0.CO;2-I; Tallack MR, 2010, IUBMB LIFE, V62, P886, DOI 10.1002/iub.404; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tan JA, 2002, J BIOL CHEM, V277, P16993, DOI 10.1074/jbc.M109217200; Tazawa H, 2003, MOL CELL BIOL, V23, P4187, DOI 10.1128/MCB.23.12.4187-4198.2003; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Wang JB, 2013, J BIOL CHEM, V288, P12580, DOI 10.1074/jbc.M112.374561; Yien YY, 2013, MOL CELL BIOL, V33, P4, DOI 10.1128/MCB.01058-12; Zhang WJ, 2001, MOL CELL BIOL, V21, P2413, DOI 10.1128/MCB.21.7.2413-2422.2001; Zhou S, 2008, J BIOL CHEM, V283, P20137, DOI 10.1074/jbc.M801307200	50	5	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9929	9940		10.1074/jbc.M114.610246	http://dx.doi.org/10.1074/jbc.M114.610246			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713074	Green Published, hybrid			2022-12-28	WOS:000352729400051
J	Wilkie-Grantham, RP; Magon, NJ; Harwood, DT; Kettle, AJ; Vissers, MC; Winterbourn, CC; Hampton, MB				Wilkie-Grantham, Rachel P.; Magon, Nicholas J.; Harwood, D. Tim; Kettle, Anthony J.; Vissers, Margreet C.; Winterbourn, Christine C.; Hampton, Mark B.			Myeloperoxidase-dependent Lipid Peroxidation Promotes the Oxidative Modification of Cytosolic Proteins in Phagocytic Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASE ACTIVATION; ARACHIDONIC-ACID; CROSS-LINKING; CALPROTECTIN; BINDING; BACTERIAL; CALCIUM; S100A8; ACTIN; STIMULATION	Phagocytic neutrophils generate reactive oxygen species to kill microbes. Oxidant generation occurs within an intracellular phagosome, but diffusible species can react with the neutrophil and surrounding tissue. To investigate the extent of oxidative modification, we assessed the carbonylation of cytosolic proteins in phagocytic neutrophils. A 4-fold increase in protein carbonylation was measured within 15 min of initiating phagocytosis. Carbonylation was dependent on NADPH oxidase and myeloperoxidase activity and was inhibited by butylated hydroxytoluene and Trolox, indicating a role for myeloperoxidase-dependent lipid peroxidation. Proteomic analysis of target proteins revealed significant carbonylation of the S100A9 subunit of calprotectin, a truncated form of Hsp70, actin, and hemoglobin from contaminating erythrocytes. The addition of the reactive aldehyde 4-hydroxynonenal (HNE) caused carbonylation, and HNE-glutathione adducts were detected in the cytosol of phagocytic neutrophils. The posttranslational modification of neutrophil proteins will influence the functioning and fate of these immune cells in the period following phagocytic activation, and provides a marker of neutrophil activation during infection and inflammation.	[Wilkie-Grantham, Rachel P.; Magon, Nicholas J.; Harwood, D. Tim; Kettle, Anthony J.; Vissers, Margreet C.; Winterbourn, Christine C.; Hampton, Mark B.] Univ Otago, Dept Pathol, Ctr Free Rad Res, Christchurch 8140, New Zealand	University of Otago	Hampton, MB (corresponding author), Univ Otago, Dept Pathol, POB 4345, Christchurch 8140, New Zealand.	mark.hampton@otago.ac.nz	Hampton, Mark B/A-8490-2008; Vissers, Margreet C M/T-4159-2017; Harwood, Tim/H-3636-2012	Hampton, Mark B/0000-0002-7349-3729; Kettle, Tony/0000-0002-8218-7766	Health Research Council of New Zealand; University of Otago	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago	This work was supported by the Health Research Council of New Zealand, and Ph.D. scholarships from the University of Otago to R.W. and N.M.	Aldini G, 2005, J MASS SPECTROM, V40, P946, DOI 10.1002/jms.872; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Baty JW, 2002, PROTEOMICS, V2, P1261, DOI 10.1002/1615-9861(200209)2:9<1261::AID-PROT1261>3.0.CO;2-Q; Bouzidi F, 2004, BIOCHEM BIOPH RES CO, V325, P1060, DOI 10.1016/j.bbrc.2004.10.134; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P7; Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4; CHAI YC, 1994, ARCH BIOCHEM BIOPHYS, V310, P273, DOI 10.1006/abbi.1994.1167; Chapman ALP, 2002, J BIOL CHEM, V277, P9757, DOI 10.1074/jbc.M106134200; Chapman ALP, 2013, J BIOL CHEM, V288, P6465, DOI 10.1074/jbc.M112.418970; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V42, P583, DOI 10.1016/j.freeradbiomed.2006.11.026; Doussiere J, 2002, EUR J BIOCHEM, V269, P3246, DOI 10.1046/j.1432-1033.2002.03002.x; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Guignard F, 1996, EUR J BIOCHEM, V241, P265, DOI 10.1111/j.1432-1033.1996.0265t.x; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HAMPTON MB, 1994, J LEUKOCYTE BIOL, V55, P147, DOI 10.1002/jlb.55.2.147; Harrison CA, 1999, J BIOL CHEM, V274, P8561, DOI 10.1074/jbc.274.13.8561; Heinecke JW, 2002, TOXICOLOGY, V177, P11, DOI 10.1016/S0300-483X(02)00192-0; Ilg EC, 1996, BIOCHEM BIOPH RES CO, V225, P146, DOI 10.1006/bbrc.1996.1144; Kerkhoff C, 2005, FASEB J, V19, P467, DOI 10.1096/fj.04-2377fje; Kerkhoff C, 1999, J BIOL CHEM, V274, P32672, DOI 10.1074/jbc.274.46.32672; Klempt M, 1997, FEBS LETT, V408, P81, DOI 10.1016/S0014-5793(97)00394-3; LEMARCHAND P, 1992, J BIOL CHEM, V267, P19379; Lim SY, 2010, J BIOL CHEM, V285, P14377, DOI 10.1074/jbc.M109.075242; Lusitani D, 2003, INFECT IMMUN, V71, P4711, DOI 10.1128/IAI.71.8.4711-4716.2003; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; OLIVER CN, 1987, ARCH BIOCHEM BIOPHYS, V253, P62, DOI 10.1016/0003-9861(87)90637-0; Parker H, 2012, J LEUKOCYTE BIOL, V92, P841, DOI 10.1189/jlb.1211601; Poullis A, 2003, J GASTROEN HEPATOL, V18, P756, DOI 10.1046/j.1440-1746.2003.03014.x; QUINN MT, 1995, J LEUKOCYTE BIOL, V57, P415, DOI 10.1002/jlb.57.3.415; Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698; Roseth AG, 1999, SCAND J GASTROENTERO, V34, P50; Roulin K, 1999, EXP CELL RES, V247, P410, DOI 10.1006/excr.1998.4382; Sahara S, 2010, BIOCHEM BIOPH RES CO, V393, P806, DOI 10.1016/j.bbrc.2010.02.087; Sohnle PG, 2000, J INFECT DIS, V182, P1272, DOI 10.1086/315810; UCHIDA K, 1993, J BIOL CHEM, V268, P6388; VISSERS MCM, 1991, ARCH BIOCHEM BIOPHYS, V285, P53, DOI 10.1016/0003-9861(91)90327-F; Yousefi R, 2007, ACTA BIOCH BIOPH SIN, V39, P795, DOI 10.1111/j.1745-7270.2007.00343.x; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200	39	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9896	9905		10.1074/jbc.M114.613422	http://dx.doi.org/10.1074/jbc.M114.613422			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25697357	Green Published, hybrid			2022-12-28	WOS:000352729400048
J	Dewi, V; Kwok, A; Lee, S; Lee, MM; Tan, YM; Nicholas, HR; Isono, K; Wienert, B; Mak, KS; Knights, AJ; Quinlan, KGR; Cordwell, SJ; Funnell, APW; Pearson, RCM; Crossley, M				Dewi, Vitri; Kwok, Alister; Lee, Stella; Lee, Ming Min; Tan, Yee Mun; Nicholas, Hannah R.; Isono, Kyo-ichi; Wienert, Beeke; Mak, Ka Sin; Knights, Alexander J.; Quinlan, Kate G. R.; Cordwell, Stuart J.; Funnell, Alister P. W.; Pearson, Richard C. M.; Crossley, Merlin			Phosphorylation of Kruppel-like Factor 3 (KLF3/BKLF) and C-terminal Binding Protein 2 (CtBP2) by Homeodomain-interacting Protein Kinase 2 (HIPK2) Modulates KLF3 DNA Binding and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; IN-VIVO; P53 ACTIVITY; REPRESSION; APOPTOSIS; DOMAIN; CELLS; PROTEIN-KINASE-2; DIFFERENTIATION; DEGRADATION	Kruppel-like factor 3 (KLF3/BKLF), a member of the Kruppel-like factor (KLF) family of transcription factors, is a widely expressed transcriptional repressor with diverse biological roles. Although there is considerable understanding of the molecular mechanisms that allow KLF3 to silence the activity of its target genes, less is known about the signal transduction pathways and post-translational modifications that modulate KLF3 activity in response to physiological stimuli. We observed that KLF3 is modified in a range of different tissues and found that the serine/threonine kinase homeodomain-interacting protein kinase 2 (HIPK2) can both bind and phosphorylate KLF3. Mass spectrometry identified serine 249 as the primary phosphorylation site. Mutation of this site reduces the ability of KLF3 to bind DNA and repress transcription. Furthermore, we also determined that HIPK2 can phosphorylate the KLF3 co-repressor C-terminal binding protein 2 (CtBP2) at serine 428. Finally, we found that phosphorylation of KLF3 and CtBP2 by HIPK2 strengthens the interaction between these two factors and increases transcriptional repression by KLF3. Taken together, our results indicate that HIPK2 potentiates the activity of KLF3.	[Dewi, Vitri; Wienert, Beeke; Mak, Ka Sin; Knights, Alexander J.; Quinlan, Kate G. R.; Funnell, Alister P. W.; Pearson, Richard C. M.; Crossley, Merlin] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Kwok, Alister; Lee, Stella; Lee, Ming Min; Tan, Yee Mun; Nicholas, Hannah R.; Cordwell, Stuart J.; Crossley, Merlin] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Isono, Kyo-ichi] RIKEN Res Ctr Allergy & Immunol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	University of New South Wales Sydney; University of Sydney; RIKEN	Crossley, M (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	m.crossley@unsw.edu.au	Crossley, Merlin/D-7888-2011; Knights, Alexander/AAL-1769-2021	Crossley, Merlin/0000-0003-2057-3642; Nicholas, Hannah/0000-0002-2239-9249; Cordwell, Stuart/0000-0002-0995-0171; Isono, Kyoichi/0000-0002-4609-8985; Knights, Alexander/0000-0001-8402-2212; Quinlan, Kate/0000-0002-5722-8183	Australian National Health and Medical Research Council (NHMRC); Australian Research Council (ARC); Australian Postgraduate Award	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Australian Postgraduate Award(Australian Government)	This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC) and the Australian Research Council (ARC).; Supported by an Australian Postgraduate Award.	Bell-Anderson KS, 2013, DIABETES, V62, P2728, DOI 10.2337/db12-1745; BIEMANN K, 1992, ANNU REV BIOCHEM, V61, P977, DOI 10.1146/annurev.bi.61.070192.004553; Burdach J, 2014, NUCLEIC ACIDS RES, V42, P276, DOI 10.1093/nar/gkt895; Calzado MA, 2007, CELL CYCLE, V6, P139, DOI 10.4161/cc.6.2.3788; Cecchinelli B, 2006, MOL CELL BIOL, V26, P4746, DOI 10.1128/MCB.00959-05; Chen XY, 1996, EMBO J, V15, P5888, DOI 10.1002/j.1460-2075.1996.tb00975.x; Crossley M, 1996, MOL CELL BIOL, V16, P1695; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Funnell APW, 2013, MOL CELL BIOL, V33, P2976, DOI 10.1128/MCB.00074-13; Funnell APW, 2012, MOL CELL BIOL, V32, P3281, DOI 10.1128/MCB.00173-12; Guerra FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035533; Hancock D, 2010, BIOCHEM MOL BIOL EDU, V38, P309, DOI 10.1002/bmb.20414; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hattangadi SM, 2010, BLOOD, V115, P4853, DOI 10.1182/blood-2009-07-235093; Himeda CL, 2010, MOL CELL BIOL, V30, P3430, DOI 10.1128/MCB.00302-10; Hofmann TG, 2003, CANCER RES, V63, P8271; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kelsey L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003612; Kim EA, 2006, J BIOL CHEM, V281, P7489, DOI 10.1074/jbc.M507227200; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; Mak KS, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r58; Matthews JM, 2000, EUR J BIOCHEM, V267, P1030, DOI 10.1046/j.1432-1327.2000.01095.x; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Ouyang L, 1998, J BIOL CHEM, V273, P23019, DOI 10.1074/jbc.273.36.23019; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Pearson RCM, 2011, IUBMB LIFE, V63, P86, DOI 10.1002/iub.422; Pei JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081109; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Puca R, 2010, ONCOGENE, V29, P4378, DOI 10.1038/onc.2010.183; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8202, DOI 10.1128/MCB.00445-06; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8159, DOI 10.1128/MCB.00680-06; Rinaldo C, 2008, BBA-MOL CELL RES, V1783, P2124, DOI 10.1016/j.bbamcr.2008.06.006; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sjolund J, 2014, P NATL ACAD SCI USA, V111, P7373, DOI 10.1073/pnas.1322275111; Sombroek D, 2009, CELL DEATH DIFFER, V16, P187, DOI 10.1038/cdd.2008.154; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Sunde M, 2004, CANCER RES, V64, P2766, DOI 10.1158/0008-5472.CAN-03-2093; Vu TT, 2011, J IMMUNOL, V187, P5032, DOI 10.4049/jimmunol.1101450; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Turchinovich G, 2011, BLOOD, V117, P3780, DOI 10.1182/blood-2010-09-308742; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Turner J, 2003, J BIOL CHEM, V278, P12786, DOI 10.1074/jbc.M300587200; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhang QH, 2005, P NATL ACAD SCI USA, V102, P2802, DOI 10.1073/pnas.0409373102	54	17	19	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8591	8605		10.1074/jbc.M115.638338	http://dx.doi.org/10.1074/jbc.M115.638338			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25659434	Green Published, hybrid			2022-12-28	WOS:000351662600049
J	Newman, JA; Cooper, CDO; Aitkenhead, H; Gileadi, O				Newman, Joseph A.; Cooper, Christopher D. O.; Aitkenhead, Hazel; Gileadi, Opher			Structural Insights into the Autoregulation and Cooperativity of the Human Transcription Factor Ets-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; STROMELYSIN-1 PROMOTER; FAMILY; SEQUENCES; SITES; PHOSPHORYLATION; EXPRESSION; DOMAIN	Ets-2, like its closely related homologue Ets-1, is a member of the Ets family of DNA binding transcription factors. Both proteins are subject to multiple levels of regulation of their DNA binding and transactivation properties. One such regulatory mechanism is the presence of an autoinhibitory module, which in Ets-1 allosterically inhibits the DNA binding activity. This inhibition can be relieved by interaction with protein partners or cooperative binding to closely separated Ets binding sites in a palindromic arrangement. In this study we describe the 2.5 angstrom resolution crystal structure of a DNA complex of the Ets-2 Ets domain. The Ets domain crystallized with two distinct species in the asymmetric unit, which closely resemble the autoinhibited and DNA bound forms of Ets-1. This discovery prompted us to re-evaluate the current model for the autoinhibitory mechanism and the structural basis for cooperative DNA binding. In contrast to Ets-1, in which the autoinhibition is caused by a combination of allosteric and steric mechanisms, we were unable to find clear evidence for the allosteric mechanism in Ets-2. We also demonstrated two possibly distinct types of cooperative binding to substrates with Ets binding motifs separated by four and six base pairs and suggest possible molecular mechanisms for this behavior.	[Newman, Joseph A.; Cooper, Christopher D. O.; Aitkenhead, Hazel; Gileadi, Opher] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England	University of Oxford	Gileadi, O (corresponding author), Univ Oxford, SGC, ORCRB, Roosevelt Dr, Oxford OX3 7DQ, England.	christopher.cooper@path.ox.ac.uk; opher.gileadi@sgc.ox.ac.uk	Cooper, Chris/G-9982-2014; Gileadi, Opher/F-1105-2013	Cooper, Chris/0000-0002-9197-8041; Gileadi, Opher/0000-0001-6886-898X; newman, Joseph/0000-0003-4488-0516	Structural Genomics Consortium, a registered charity [1097737]; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]	Structural Genomics Consortium, a registered charity(University of Toronto); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust (092809/Z/10/Z).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Babayeva ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033698; Babayeva ND, 2010, CELL CYCLE, V9, P3054, DOI 10.4161/cc.9.14.12257; Baillat D, 2006, ONCOGENE, V25, P5764, DOI 10.1038/sj.onc.1209583; Baillat D, 2002, J BIOL CHEM, V277, P29386, DOI 10.1074/jbc.M200088200; Cowley DO, 2000, GENE DEV, V14, P366; DEGNAN BM, 1993, NUCLEIC ACIDS RES, V21, P3479, DOI 10.1093/nar/21.15.3479; Desjardins G, 2014, P NATL ACAD SCI USA, V111, P11019, DOI 10.1073/pnas.1401891111; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Guen VJ, 2013, P NATL ACAD SCI USA, V110, P19525, DOI 10.1073/pnas.1306814110; HAGMAN J, 1992, P NATL ACAD SCI USA, V89, P8889, DOI 10.1073/pnas.89.19.8889; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lamber EP, 2008, EMBO J, V27, P2006, DOI 10.1038/emboj.2008.117; Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200; Lee GM, 2008, J MOL BIOL, V382, P1014, DOI 10.1016/j.jmb.2008.07.064; LIM F, 1992, EMBO J, V11, P643, DOI 10.1002/j.1460-2075.1992.tb05096.x; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Shaikhibrahim Z, 2012, INT J MOL MED, V30, P1029, DOI 10.3892/ijmm.2012.1097; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Venanzoni MC, 1996, ONCOGENE, V12, P1199; Wang H, 2002, J BIOL CHEM, V277, P2225, DOI 10.1074/jbc.M109430200; Wang ZP, 2009, EVOL BIOINFORM, V5, P119; WASYLYK C, 1992, GENE DEV, V6, P965, DOI 10.1101/gad.6.6.965; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106	30	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8539	8549		10.1074/jbc.M114.619270	http://dx.doi.org/10.1074/jbc.M114.619270			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25670864	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000351662600044
J	Sun, F; Xiao, YD; Qu, ZX				Sun, Fan; Xiao, Yadong; Qu, Zhaoxia			Oncovirus Kaposi Sarcoma Herpesvirus (KSHV) Represses Tumor Suppressor PDLIM2 to Persistently Activate Nuclear Factor kappa B (NF-kappa B) and STAT3 Transcription Factors for Tumorigenesis and Tumor Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; NF-kappa B (NF-KB); STAT3; Tumor Suppressor Gene; Tumor Virus; HIV; AIDS-related Malignancies; KSHV; HHV8; PDLIM2	DOMAIN-CONTAINING PROTEIN-2; DNA-SEQUENCES; MOLECULAR-BIOLOGY; VIRUS; HUMAN-HERPESVIRUS-8; EXPRESSION; APOPTOSIS; LYMPHOMA; TAX; DEGRADATION	Background: Kaposi sarcoma herpesvirus (KSHV) causes malignancies in patients with AIDS or immunosuppression. Results: KSHV represses tumor suppressor gene PDLIM2, whose reconstitution suppresses tumorigenesis of KSHV-associated cancer cells. Conclusion: KSHV suppresses PDLIM2 for tumorigenesis. Significance: These studies not only reveal an important mechanism underlying KSHV pathogenesis but also provide immediate therapeutic strategies for KSHV-mediated cancers. Kaposi sarcoma herpesvirus (KSHV) is the most common cause of malignancies among AIDS patients. However, how KSHV induces tumorigenesis remains largely unknown. Here, we demonstrate that one important mechanism underlying the tumorigenesis of KSHV is through transcriptional repression of the tumor suppressor gene PDZ-LIM domain-containing protein 2 (PDLIM2). PDLIM2 expression is repressed in KSHV-transformed human umbilical vascular endothelial cells as well as in KSHV-associated cancer cell lines and primary tumors. Importantly, PDLIM2 repression is essential for KSHV-induced persistent activation of nuclear factor B (NF-B) and signal transducer and activator of transcription 3 (STAT3) and subsequent tumorigenesis and tumor maintenance. Our mechanistic studies indicate that PDLIM2 repression by KSHV involves DNA methylation. Notably, the epigenetic repression of PDLIM2 can be reversed by 5-aza-2-deoxycytidine and vitamin D to suppress KSHV-associated cancer cell growth. These studies not only improve our understanding of KSHV pathogenesis but also provide immediate therapeutic strategies for KSHV-mediated cancers, particularly those associated with AIDS.	[Sun, Fan; Xiao, Yadong; Qu, Zhaoxia] Univ Pittsburgh, Inst Canc, Sch Med, Pittsburgh, PA 15232 USA; [Sun, Fan; Qu, Zhaoxia] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Qu, ZX (corresponding author), Hillman Canc Ctr Res Pavil, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.	quz@upmc.edu	SUN, FAN/K-8683-2017; SUN, FAN/GWA-1524-2022	SUN, FAN/0000-0002-3538-9701	National Institutes of Health through the NCI [P30CA047904-24S]; Competitive Medical Research Fund (CMRF); NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER	National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Competitive Medical Research Fund (CMRF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P30CA047904-24S through the NCI (to Z. Q.). This work was also supported by a grant from the Competitive Medical Research Fund (CMRF).	Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Boshoff C, 1998, BLOOD, V91, P1671, DOI 10.1182/blood.V91.5.1671.1671_1671_1679; Bottero V, 2011, J VIROL, V85, P1980, DOI 10.1128/JVI.01911-10; Brinkmann MM, 2003, J VIROL, V77, P9346, DOI 10.1128/JVI.77.17.9346-9358.2003; Brown HJ, 2003, J VIROL, V77, P8532, DOI 10.1128/JVI.77.15.8532-8540.2003; Burger M, 2005, ONCOGENE, V24, P2067, DOI 10.1038/SJ.ONC.1208442; Cai QL, 2010, ADV VIRUS RES, V78, P87, DOI 10.1016/S0065-3527(10)78003-9; Casper C, 2008, REV MED VIROL, V18, P321, DOI 10.1002/rmv.583; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chugh P, 2005, P NATL ACAD SCI USA, V102, P12885, DOI 10.1073/pnas.0408577102; Cousins E, 2013, J VIROL, V87, P10816, DOI 10.1128/JVI.02047-13; Cousins E, 2014, RECENT RESULTS CANC, V193, P227, DOI 10.1007/978-3-642-38965-8_13; de Oliveira DE, 2010, TRENDS MICROBIOL, V18, P248, DOI 10.1016/j.tim.2010.04.001; Fu J, 2010, ONCOGENE, V29, P6499, DOI 10.1038/onc.2010.374; Fu J, 2011, BLOOD, V117, P1652, DOI 10.1182/blood-2010-08-303073; Gwack Y, 2002, J BIOL CHEM, V277, P6438, DOI 10.1074/jbc.M108289200; He ZH, 2014, J VIROL, V88, P444, DOI 10.1128/JVI.01716-13; Keller SA, 2006, BLOOD, V107, P3295, DOI 10.1182/blood-2005-07-2730; Keller SA, 2000, BLOOD, V96, P2537; Konrad A, 2009, J VIROL, V83, P2563, DOI 10.1128/JVI.01512-08; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Martin D, 2008, ONCOGENE, V27, P1844, DOI [10.1038/sj.onc.1210817, 10.1038/onc.2009.351]; Matta H, 2007, ONCOGENE, V26, P1656, DOI 10.1038/sj.onc.1209931; Matta H, 2007, J BIOL CHEM, V282, P24858, DOI 10.1074/jbc.M700118200; Molden J, 1997, J BIOL CHEM, V272, P19625, DOI 10.1074/jbc.272.31.19625; Muromoto R, 2006, FEBS LETT, V580, P93, DOI 10.1016/j.febslet.2005.11.057; Pati S, 2001, J VIROL, V75, P8660, DOI 10.1128/JVI.75.18.8660-8673.2001; Punjabi AS, 2007, J VIROL, V81, P2449, DOI 10.1128/JVI.01769-06; Qing GL, 2005, J BIOL CHEM, V280, P18, DOI 10.1074/jbc.M406619200; Qing GL, 2007, P NATL ACAD SCI USA, V104, P5324, DOI 10.1073/pnas.0609914104; Qu ZX, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-23; Qu ZX, 2011, VIRUSES-BASEL, V3, P714, DOI 10.3390/v3060714; Qu ZX, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-18; Qu ZX, 2010, CANCER RES, V70, P1766, DOI 10.1158/0008-5472.CAN-09-3263; Qu ZX, 2010, J BIOL CHEM, V285, P11786, DOI 10.1074/jbc.M109.086561; Qu ZX, 2004, J BIOL CHEM, V279, P44563, DOI 10.1074/jbc.M403689200; Robe PA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-372; Schwarz M, 2001, J IMMUNOL, V167, P505, DOI 10.4049/jimmunol.167.1.505; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Sun QM, 2003, J BIOL CHEM, V278, P52437, DOI 10.1074/jbc.M304199200; Suthaus J, 2012, BLOOD, V119, P5173, DOI 10.1182/blood-2011-09-377705; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tanaka T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001637; Vanoirbeek E, 2014, ONCOGENE, V33, P1904, DOI 10.1038/onc.2013.123; Wen KW, 2010, CANCER LETT, V289, P140, DOI 10.1016/j.canlet.2009.07.004; Xiao GT, 2006, CYTOKINE GROWTH F R, V17, P281, DOI 10.1016/j.cytogfr.2006.04.005; Xiao GT, 2011, AM J CANCER RES, V1, P192; Yan PR, 2009, NEOPLASIA, V11, P1036, DOI 10.1593/neo.09752; Yan PR, 2009, BLOOD, V113, P4370, DOI 10.1182/blood-2008-10-185660; Zhou J, 2015, ONCOGENE, V34, P3804, DOI 10.1038/onc.2014.318	52	37	37	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7362	7368		10.1074/jbc.C115.637918	http://dx.doi.org/10.1074/jbc.C115.637918			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25681443	Green Published, hybrid			2022-12-28	WOS:000351613600006
J	Shi, J; Pabon, K; Scotto, KW				Shi, Jia; Pabon, Kirk; Scotto, Kathleen W.			Methylxanthines Increase Expression of the Splicing Factor SRSF2 by Regulating Multiple Post-transcriptional Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; NONSENSE-MEDIATED DECAY; ACUTE MYELOID-LEUKEMIA; LUNG-CANCER; BINDING PROTEINS; TRANSLATIONAL CONTROL; MICRORNA-183 FAMILY; CELL-PROLIFERATION; MAMMALIAN-CELLS; GENE-EXPRESSION	We have previously reported that the methylxanthine caffeine increases expression of the splicing factor SRSF2, the levels of which are normally controlled by a negative autoregulatory loop. In the present study we have investigated the mechanisms by which methylxanthines induce this aberrant overexpression. RT-PCR analyses suggested little impact of caffeine on SRSF2 total mRNA levels. Instead, caffeine induced changes in the levels of SRSF2 3' UTR splice variants. Although some of these variants were substrates for nonsense-medicated decay (NMD), and could potentially have been stabilized by caffeine-mediated inhibition of NMD, down-regulation of NMD by a genetic approach was not sufficient to reproduce the phenotype. Furthermore, cell-based assays demonstrated that some of the caffeine-induced variants were intrinsically more efficiently translated than others; the addition of caffeine increased the translational efficiency of most SRSF2 transcripts. MicroRNA array analyses revealed a significant caffeine-mediated decrease in the expression of two SRSF2-targeting miRs, both of which were shown to repress translation of specific SRSF2 splice variants. These data support a complex model whereby caffeine down-regulates SRSF2-targeting microRNAs, leading to an increase in SRSF2 translation, which in turn induces SRSF2 splicing. SRSF2 splice variants are then stabilized by caffeine-mediated NMD inhibition, breaking the normal negative feedback loop and allowing the aberrant increase in SRSF2 protein levels. These findings highlight the complexity of SRSF2 gene regulation, and suggest ways in which SRSF2 expression may be dysregulated in disease.	Rutgers State Univ, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; Rutgers State Univ, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA; Rutgers State Univ, Grad Sch Biomed Sci, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Scotto, KW (corresponding author), 195 Little Albany St, New Brunswick, NJ 08903 USA.	scottoka@cinj.rutgers.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [NCI-R01 CA 122573, NCI-P30CA072720]; Rutgers Cancer Institute of New Jersey [P30CA072720]; NATIONAL CANCER INSTITUTE [R01CA122573, P30CA072720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers Cancer Institute of New Jersey; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants NCI-R01 CA 122573 (to K. W. S.) and NCI-P30CA072720 to the Rutgers Cancer Institute of New Jersey and Microarray Core facility and Bioinformatics Core facility of the Rutgers Cancer Institute of New Jersey Grant P30CA072720.	Ajay SS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-155; Akaike Y, 2011, J MED INVESTIG, V58, P180, DOI 10.2152/jmi.58.180; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bauman John A, 2011, Bioeng Bugs, V2, P125; Bhattacharya S, 1999, NUCLEIC ACIDS RES, V27, P1464, DOI 10.1093/nar/27.6.1464; Braeutigam C, 2014, ONCOGENE, V33, P1082, DOI 10.1038/onc.2013.50; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Cirera-Salinas D, 2012, CELL CYCLE, V11, P922, DOI 10.4161/cc.11.5.19421; Coelho MB, 2014, METHODS MOL BIOL, V1126, P55, DOI 10.1007/978-1-62703-980-2_5; Dang YJ, 2009, J BIOL CHEM, V284, P23613, DOI 10.1074/jbc.M109.009985; Dassesse D, 1999, EUR J NEUROSCI, V11, P3101, DOI 10.1046/j.1460-9568.1999.00725.x; Dreumont N, 2010, NUCLEIC ACIDS RES, V38, P1353, DOI 10.1093/nar/gkp1086; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; FU XD, 1992, P NATL ACAD SCI USA, V89, P11224, DOI 10.1073/pnas.89.23.11224; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Gudikote JP, 2005, NAT STRUCT MOL BIOL, V12, P801, DOI 10.1038/nsmb980; Hardingham GE, 1998, CELL CALCIUM, V23, P131, DOI 10.1016/S0143-4160(98)90111-7; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Jia J, 2013, CURR OPIN GENET DEV, V23, P29, DOI 10.1016/j.gde.2012.12.004; Johnson J. K., 2012, BMC CANCER, V12, P246, DOI DOI 10.1186/1471-2407-12-246; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kato Yasuko, 2009, Tanpakushitsu Kakusan Koso, V54, P2159; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kuo PL, 2013, BBA-GEN SUBJECTS, V1830, P3756, DOI 10.1016/j.bbagen.2013.02.022; Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x; Lareau LF, 2007, ADV EXP MED BIOL, V623, P190, DOI 10.1007/978-0-387-77374-2_12; Larsson CA, 2013, MOL CANCER RES, V11, P815, DOI 10.1158/1541-7786.MCR-12-0695; Lasho TL, 2012, BLOOD, V120, P4168, DOI 10.1182/blood-2012-05-429696; Lee HH, 2013, FEBS LETT, V587, P1518, DOI 10.1016/j.febslet.2013.03.031; Lin QF, 2012, J CANCER RES CLIN, V138, P85, DOI 10.1007/s00432-011-1068-z; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Lu Y, 2014, CELL STEM CELL, V15, P92, DOI 10.1016/j.stem.2014.04.002; Ma KL, 2012, J BIOL CHEM, V287, P5639, DOI 10.1074/jbc.M111.291229; Maitra S, 2008, RNA, V14, P950, DOI 10.1261/rna.983708; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; McIlwain DR, 2010, P NATL ACAD SCI USA, V107, P12186, DOI 10.1073/pnas.1007336107; Meerson A, 2010, J MOL NEUROSCI, V40, P47, DOI 10.1007/s12031-009-9252-1; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Miki T, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-48; Moriniere M, 2010, BLOOD CELL MOL DIS, V45, P284, DOI 10.1016/j.bcmd.2010.08.011; Muller-Thomas C, 2014, HAEMATOLOGICA, V99, pE179, DOI 10.3324/haematol.2014.104760; Muroski ME, 2012, J AM CHEM SOC, V134, P19722, DOI 10.1021/ja307502x; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Rao FV, 2005, CHEM BIOL, V12, P973, DOI 10.1016/j.chembiol.2005.07.009; Ratti A, 2008, J BIOL CHEM, V283, P7531, DOI 10.1074/jbc.M706082200; Risso G, 2012, IUBMB LIFE, V64, P809, DOI 10.1002/iub.1075; Rizos E, 2012, ONCOL REP, V28, P2200, DOI 10.3892/or.2012.2052; Saltzman AL, 2008, MOL CELL BIOL, V28, P4320, DOI 10.1128/MCB.00361-08; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Shi J, 2008, MOL CELL BIOL, V28, P883, DOI 10.1128/MCB.01345-07; Shi XY, 2014, INT J MOL MED, V33, P59, DOI 10.3892/ijmm.2013.1536; Silva-Santos RM, 2013, BRIT J CANCER, V109, P2646, DOI 10.1038/bjc.2013.552; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Sun SY, 2010, NAT STRUCT MOL BIOL, V17, P306, DOI 10.1038/nsmb.1750; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; Svenningsson P, 1999, J NEUROSCI, V19, P4011; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; Takeda J, 2010, NUCLEIC ACIDS RES, V38, pD86, DOI 10.1093/nar/gkp984; Tang XL, 2014, NUCLEIC ACIDS RES, V42, P2988, DOI 10.1093/nar/gkt1275; Thomas M, 2012, ONCOGENE, V31, P918, DOI 10.1038/onc.2011.278; TORNALETTI S, 1989, BIOCHIM BIOPHYS ACTA, V1007, P112, DOI 10.1016/0167-4781(89)90138-3; Usuki F, 2004, ANN NEUROL, V55, P740, DOI 10.1002/ana.20107; Usuki F, 2006, MOL THER, V14, P351, DOI 10.1016/j.ymthe.2006.04.011; von Roretz C, 2011, WIRES RNA, V2, P336, DOI 10.1002/wrna.55; Vosa U, 2013, INT J CANCER, V132, P2884, DOI 10.1002/ijc.27981; Wijesekara N, 2012, DIABETES, V61, P653, DOI 10.2337/db11-0944; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Yamada Y, 2011, CANCER SCI, V102, P522, DOI 10.1111/j.1349-7006.2010.01816.x; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Yoshino H, 2013, NAT REV UROL, V10, P396, DOI 10.1038/nrurol.2013.113; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhang QH, 2013, GENE, V527, P26, DOI 10.1016/j.gene.2013.06.006; Zhang ZD, 2013, J BIOMED RES, V27, P486, DOI 10.7555/JBR.27.20130010; Zhu JF, 2012, AM J PATHOL, V180, P2440, DOI 10.1016/j.ajpath.2012.02.023; Zhu WY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-393; Zhuang R, 2013, NUCLEIC ACIDS RES, V41, P7905, DOI 10.1093/nar/gkt565	85	7	9	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14986	15003		10.1074/jbc.M114.624254	http://dx.doi.org/10.1074/jbc.M114.624254			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25818199	Green Published, hybrid			2022-12-28	WOS:000356177300016
J	Balasubramaniam, SL; Gopalakrishnapillai, A; Gangadharan, V; Duncan, RL; Barwe, SP				Balasubramaniam, Sona Lakshme; Gopalakrishnapillai, Anilkumar; Gangadharan, Vimal; Duncan, Randall L.; Barwe, Sonali P.			Sodium-Calcium Exchanger 1 Regulates Epithelial Cell Migration via Calcium-dependent Extracellular Signal-regulated Kinase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA,K-ATPASE BETA-SUBUNIT; NA+/K+-ATPASE BETA-1-SUBUNIT; NA+/CA2+ EXCHANGERS; NA+-CA2+ EXCHANGER; REVERSE-MODE; MAP KINASES; CA2+ INFLUX; PHOSPHORYLATION; ACTIVATION; EXPRESSION	Na+/Ca(2+)exchanger-1 (NCX1) is a major calcium extrusion mechanism in renal epithelial cells enabling the efflux of one Ca2+ ion and the influx of three Na+ ions. The gradient for this exchange activity is provided by Na, K-ATPase, a hetero-oligomer consisting of a catalytic alpha-subunit and a regulatory beta-subunit (Na, K-beta) that also functions as a motility and tumor suppressor. We showed earlier that mice with heart-specific ablation (KO) of Na, K-beta had a specific reduction in NCX1 protein and were ouabain-insensitive. Here, we demonstrate that Na, K-beta associates with NCX1 and regulates its localization to the cell surface. Madin-Darby canine kidney cells with Na, K-beta knockdown have reduced NCX1 protein and function accompanied by 2.1-fold increase in free intracellular calcium and a corresponding increase in the rate of cell migration. Increased intracellular calcium up-regulated ERK1/2 via calmodulin-dependent activation of PI3K. Both myosin light chain kinase and Rho-associated kinase acted as mediators of ERK1/2-dependent migration. Restoring NCX1 expression in beta-KD cells reduced migration rate and ERK1/2 activation, suggesting that NCX1 functions downstream of Na, K-beta in regulating cell migration. In parallel, inhibition of NCX1 by KB-R7943 in Madin-Darby canine kidney cells, LLC-PK1, and human primary renal epithelial cells (HREpiC) increased ERK1/2 activation and cell migration. This increased migration was associated with high myosin light chain phosphorylation by PI3K/ERK-dependent mechanism in HREpiC cells. These data confirm the role of NCX1 activity in regulating renal epithelial cell migration.	[Balasubramaniam, Sona Lakshme; Gopalakrishnapillai, Anilkumar; Barwe, Sonali P.] Alfred I duPont Hosp Children, Nemours Ctr Childhood Canc Res, Wilmington, DE 19803 USA; [Balasubramaniam, Sona Lakshme; Gangadharan, Vimal; Duncan, Randall L.; Barwe, Sonali P.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA	Nemours Alfred I. duPont Hospital for Children; University of Delaware	Barwe, SP (corresponding author), Alfred I duPont Hosp Children, Nemours Ctr Childhood Canc Res, 1701 Rockland Rd, Wilmington, DE 19803 USA.	barwe@medsci.udel.edu	Duncan, Randall/AAK-3888-2020; Regan, Clinton/E-6250-2012; gopala, Anilkumar/AAG-2713-2021	Barwe, Sonali/0000-0003-4162-3004; Duncan, Randall/0000-0001-5733-6603; Gopalakrishnapillai, Anilkumar/0000-0002-0465-578X	National Institutes of Health [8 P20GM103446-13, P20GM103464, U54GM104941]; American Heart Association [10SDG260011]; Nemours Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103464, U54GM104941, P20GM103446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Nemours Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 8 P20GM103446-13 (to the Delaware Bioimaging Center (IDeA Networks of Biomedical Research Excellence (INBRE)-NIGMS), P20GM103464 (to the Cell Science Core of the Center for Pediatric Research), and U54GM104941 (to DE-CTR ACCEL). This work was also supported by American Heart Association Grant 10SDG260011 and by the Nemours Foundation.	Amran MS, 2003, CARDIOVASC DRUG REV, V21, P255; Andrikopoulos P, 2011, J BIOL CHEM, V286, P37919, DOI 10.1074/jbc.M111.251777; Barwe SP, 2007, J MOL BIOL, V365, P706, DOI 10.1016/j.jmb.2006.10.029; Barwe SP, 2012, J CELL SCI, V125, P5711, DOI 10.1242/jcs.108795; Barwe SP, 2009, J MOL CELL CARDIOL, V47, P552, DOI 10.1016/j.yjmcc.2009.07.018; Barwe SP, 2005, MOL BIOL CELL, V16, P1082, DOI 10.1091/mbc.E04-05-0427; Billman G E, 2001, Curr Opin Investig Drugs, V2, P1740; BLAUSTEIN MP, 1993, AM J PHYSIOL, V264, pC1367, DOI 10.1152/ajpcell.1993.264.6.C1367; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Brouland JP, 2005, AM J PATHOL, V167, P233, DOI 10.1016/S0002-9440(10)62968-9; Buchanan CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071337; Carmosino M, 2014, J HYPERTENS, V32, P1842, DOI 10.1097/HJH.0000000000000258; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; Chambers KF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-45; Chifflet S, 2012, WOUND REPAIR REGEN, V20, P28, DOI 10.1111/j.1524-475X.2011.00749.x; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Dong H, 2010, AM J PHYSIOL-CELL PH, V299, pC1493, DOI 10.1152/ajpcell.00242.2010; Dunn J, 2002, J BIOL CHEM, V277, P33957, DOI 10.1074/jbc.M206677200; Easley CA, 2008, CELL MOTIL CYTOSKEL, V65, P662, DOI 10.1002/cm.20294; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Goldhaber JI, 2013, ADV EXP MED BIOL, V961, P355, DOI 10.1007/978-1-4614-4756-6_30; Hamming KSC, 2010, DIABETES, V59, P1686, DOI 10.2337/db09-0630; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Ifuku M, 2007, J NEUROSCI, V27, P13065, DOI 10.1523/JNEUROSCI.3467-07.2007; IKEBE M, 1985, J BIOL CHEM, V260, P27; Inge LJ, 2008, HISTOL HISTOPATHOL, V23, P459, DOI 10.14670/HH-23.459; Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391; Jha S, 2009, FEBS LETT, V583, P3109, DOI 10.1016/j.febslet.2009.08.039; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; Kemeny LV, 2013, AM J PHYSIOL-GASTR L, V305, pG552, DOI 10.1152/ajpgi.00394.2012; Khan A, 2014, MOL PHARMACOL, V86, P1, DOI 10.1124/mol.114.091595; Kip SN, 2003, AM J PHYSIOL-RENAL, V284, pF122, DOI 10.1152/ajprenal.00161.2002; Kitamura N, 2005, P NATL ACAD SCI USA, V102, P2796, DOI 10.1073/pnas.0409344102; Li J, 2010, BIOCHEM BIOPH RES CO, V392, P516, DOI 10.1016/j.bbrc.2009.12.183; Li W, 1997, AM J PHYSIOL-ENDOC M, V273, pE599, DOI 10.1152/ajpendo.1997.273.3.E599; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Matsuda T, 1997, JPN J PHARMACOL, V74, P1, DOI 10.1254/jjp.74.1; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; Ottolia M, 2007, J BIOL CHEM, V282, P3695, DOI 10.1074/jbc.M610425200; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Prevarskaya N, 2013, EXPERT OPIN THER TAR, V17, P225, DOI 10.1517/14728222.2013.741594; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Raizman JE, 2007, J CELL PHYSIOL, V213, P540, DOI 10.1002/jcp.21134; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; Rajasekaran SA, 2005, SEMIN NEPHROL, V25, P328, DOI 10.1016/j.semnephrol.2005.03.008; Rajasekaran SA, 1999, J UROLOGY, V162, P574, DOI 10.1016/S0022-5347(05)68629-6; Rajasekaran SA, 2004, MOL BIOL CELL, V15, P3224, DOI 10.1091/mbc.e04-03-0222; Reeves JP, 1998, J BIOENERG BIOMEMBR, V30, P151, DOI 10.1023/A:1020569224915; Reuter H, 2002, CIRC RES, V90, P305, DOI 10.1161/hh0302.104562; Rondinone CM, 2000, J BIOL CHEM, V275, P10093, DOI 10.1074/jbc.275.14.10093; Rotfeld H, 2014, REPRODUCTION, V147, P347, DOI 10.1530/REP-13-0560; Sakamoto K, 2009, J PHYSIOL-LONDON, V587, P5345, DOI 10.1113/jphysiol.2009.172080; Schwab A, 1997, PFLUG ARCH EUR J PHY, V434, P70, DOI 10.1007/s004240050364; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Tong XP, 2009, J CELL BIOL, V186, P113, DOI 10.1083/jcb.200811071; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Treloar KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067389; Tsavaler L, 2001, CANCER RES, V61, P3760; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200; Wiegert JS, 2011, CELL CALCIUM, V49, P296, DOI 10.1016/j.ceca.2010.11.009; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003	68	13	14	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12463	12473		10.1074/jbc.M114.629519	http://dx.doi.org/10.1074/jbc.M114.629519			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25770213	hybrid, Green Published			2022-12-28	WOS:000354569000003
J	Heine, EM; Berger, TR; Pluciennik, A; Orr, CR; Zboray, L; Merry, DE				Heine, Erin M.; Berger, Tamar R.; Pluciennik, Anna; Orr, Christopher R.; Zboray, Lori; Merry, Diane E.			Proteasome-mediated Proteolysis of the Polyglutamine-expanded Androgen Receptor Is a Late Event in Spinal and Bulbar Muscular Atrophy (SBMA) Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MOUSE MODEL; HUNTINGTONS-DISEASE; INTRANUCLEAR INCLUSIONS; MUTANT HUNTINGTIN; AGGREGATE FORMATION; IN-VITRO; TOXICITY; NEURODEGENERATION; EXPRESSION; FRAGMENTS	Proteolysis of polyglutamine-expanded proteins is thought to be a required step in the pathogenesis of several neurodegenerative diseases. The accepted view for many polyglutamine proteins is that proteolysis of the mutant protein produces a "toxic fragment" that induces neuronal dysfunction and death in a soluble form; toxicity of the fragment is buffered by its incorporation into amyloid-like inclusions. In contrast to this view, we show that, in the polyglutamine disease spinal and bulbar muscular atrophy, proteolysis of the mutant androgen receptor (AR) is a late event. Immunocytochemical and biochemical analyses revealed that the mutant AR aggregates as a full-length protein, becoming proteolyzed to a smaller fragment through a process requiring the proteasome after it is incorporated into intranuclear inclusions. Moreover, the toxicity-predicting conformational antibody 3B5H10 bound to soluble full-length AR species but not to fragment-containing nuclear inclusions. These data suggest that the AR is toxic as a full-length protein, challenging the notion of polyglutamine protein fragment-associated toxicity by redefining the role of AR proteolysis in spinal and bulbar muscular atrophy pathogenesis.	[Heine, Erin M.; Berger, Tamar R.; Pluciennik, Anna; Orr, Christopher R.; Zboray, Lori; Merry, Diane E.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Merry, DE (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 228 Bluemle Life Sci Bldg,233 S 10th St, Philadelphia, PA 19107 USA.	Diane.merry@jefferson.edu			National Institutes of Health National Cancer Institute [5 P30 CA-56036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076919, R01NS032214] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Yolanda Covarrubias and the Bio-imaging Shared Resource of the Sidney Kimmel Cancer Center (supported by National Institutes of Health National Cancer Institute Grant 5 P30 CA-56036) for imaging support, Yuhong Liu for technical assistance, Dr. Marc Diamond (University of Texas Southwestern, Dallas, TX) for CFP/YFP-AR plasmids, Dr. Steven Finkbeiner (Gladstone Institutes, University of California, San Francisco) for antibody 3B5H10, and Dr. Emily Sontag (University of California, San Francisco) and Dr. Leslie Thompson (University of California, Irvine) for advice on SDS-AGE. We also thank Dr. Heather Montie for discussions and critical reading of the paper.	Abel A, 2001, HUM MOL GENET, V10, P107, DOI 10.1093/hmg/10.2.107; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Diamond MI, 2000, P NATL ACAD SCI USA, V97, P657, DOI 10.1073/pnas.97.2.657; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ellerby LM, 1999, J NEUROCHEM, V72, P185, DOI 10.1046/j.1471-4159.1999.0720185.x; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Klein FAC, 2013, HUM MOL GENET, V22, P4215, DOI 10.1093/hmg/ddt273; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Li I, 1998, AM J PATHOL, V153, P695, DOI 10.1016/S0002-9440(10)65612-X; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; Li M, 2007, J BIOL CHEM, V282, P3157, DOI 10.1074/jbc.M609972200; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Mitra S, 2009, J BIOL CHEM, V284, P4398, DOI 10.1074/jbc.M806269200; Mojsilovic-Petrovic J, 2009, J NEUROSCI, V29, P8236, DOI 10.1523/JNEUROSCI.1805-09.2009; Montie HL, 2011, J NEUROSCI, V31, P17425, DOI 10.1523/JNEUROSCI.3958-11.2011; Montie HL, 2009, HUM MOL GENET, V18, P1937, DOI 10.1093/hmg/ddp115; Nedelsky NB, 2010, NEURON, V67, P936, DOI 10.1016/j.neuron.2010.08.034; Orr CR, 2010, J BIOL CHEM, V285, P35567, DOI 10.1074/jbc.M110.146845; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Ortega Z, 2010, J NEUROSCI, V30, P3675, DOI 10.1523/JNEUROSCI.5673-09.2010; Peters-Libeu C, 2012, J MOL BIOL, V421, P587, DOI 10.1016/j.jmb.2012.01.034; Roy J, 1998, J NEUROSCI, V18, P9673; Rusmini P, 2007, NEUROBIOL AGING, V28, P1099, DOI 10.1016/j.neurobiolaging.2006.05.015; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schilling G, 1999, NEURON, V24, P275, DOI 10.1016/S0896-6273(00)80839-9; Schipper-Krom S, 2014, FEBS LETT, V588, P151, DOI 10.1016/j.febslet.2013.11.023; Simeoni S, 2000, HUM MOL GENET, V9, P133, DOI 10.1093/hmg/9.1.133; SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209; Sontag EM, 2012, J HUNTINGTONS DIS, V1, P119, DOI 10.3233/JHD-2012-129004; Sontag EM, 2012, J NEUROSCI, V32, P11109, DOI 10.1523/JNEUROSCI.0895-12.2012; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Walcott JL, 2002, J BIOL CHEM, V277, P50855, DOI 10.1074/jbc.M209466200; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Young JE, 2009, J NEUROSCI, V29, P1987, DOI 10.1523/JNEUROSCI.4072-08.2009; Yu Z, 2006, J CLIN INVEST, V116, P2663, DOI 10.1172/JCI28773	43	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12572	12584		10.1074/jbc.M114.617894	http://dx.doi.org/10.1074/jbc.M114.617894			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25795778	Green Published, hybrid			2022-12-28	WOS:000354569000013
J	Sirrieh, RE; MacLean, DM; Jayaraman, V				Sirrieh, Rita E.; MacLean, David M.; Jayaraman, Vasanthi			Subtype-dependent N-Methyl-D-aspartate Receptor Amino-terminal Domain Conformations and Modulation by Spermine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMDA RECEPTOR; BINDING DOMAIN; SUBUNIT ARRANGEMENT; ZN2+ INHIBITION; ZINC-BINDING; POLYAMINES; AFFINITY; IFENPRODIL; GLUN1; DESENSITIZATION	The N-methyl-D-aspartate (NMDA) subtype of the ionotropic glutamate receptors is the primary mediator of calcium-permeable excitatory neurotransmission in the central nervous system. Subunit composition and binding of allosteric modulators to the amino-terminal domain determine the open probability of the channel. By using luminescence resonance energy transfer with functional receptors expressed in CHO cells, we show that the cleft of the amino-terminal domain of the GluN2B subunit, which has a lower channel open probability, is on average more closed than the GluN2A subunit, which has a higher open probability. Furthermore, the GluN1 amino-terminal domain adopts a more open conformation when coassembled with GluN2A than with GluN2B. Binding of spermine, an allosteric potentiator, opens the amino-terminal domain cleft of both the GluN2B subunit and the adjacent GluN1 subunit. These studies provide direct structural evidence that the inherent conformations of the amino-terminal domains vary based on the subunit and match the reported open probabilities for the receptor.	[Sirrieh, Rita E.; MacLean, David M.; Jayaraman, Vasanthi] Univ Texas Houston, Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Jayaraman, V (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Dept Biochem & Mol Biol, 6431 Fannin St,MSB 6-174, Houston, TX 77030 USA.	vasanthi.jayaraman@uth.tmc.edu	Regan, Clinton/E-6250-2012	MacLean, David/0000-0001-8294-6075	National Institutes of Health [R01GM094245, R01GM113212, 2T32GM008280]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113212, R01GM094246, T32GM008280] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM094245 and R01GM113212 (to V. J.) 2T32GM008280 (to R. E. S.).	Amico-Ruvio SA, 2012, MOL PHARMACOL, V82, P1074, DOI 10.1124/mol.112.078998; BRACKLEY P, 1990, NEUROSCI LETT, V114, P51, DOI 10.1016/0304-3940(90)90427-B; Chazot PL, 1999, METH MOL B, V128, P33; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; DURAND GM, 1993, P NATL ACAD SCI USA, V90, P6731, DOI 10.1073/pnas.90.14.6731; Erreger K, 2005, J PHYSIOL-LONDON, V569, P381, DOI 10.1113/jphysiol.2005.095497; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Gallagher MJ, 1996, J BIOL CHEM, V271, P9603, DOI 10.1074/jbc.271.16.9603; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Gonzalez J, 2008, BIOCHEMISTRY-US, V47, P10027, DOI 10.1021/bi800690b; Gonzalez J, 2010, P NATL ACAD SCI USA, V107, P9891, DOI 10.1073/pnas.0911854107; Kapanidis AN, 2001, J AM CHEM SOC, V123, P12123, DOI 10.1021/ja017074a; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Madry C, 2007, MOL PHARMACOL, V72, P1535, DOI 10.1124/mol.107.040071; Masuko T, 2003, J NEUROCHEM, V84, P610, DOI 10.1046/j.1471-4159.2003.01558.x; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; MCGURK JF, 1990, P NATL ACAD SCI USA, V87, P9971, DOI 10.1073/pnas.87.24.9971; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; Mony L, 2011, EMBO J, V30, P3134, DOI 10.1038/emboj.2011.203; Paoletti P, 1997, J NEUROSCI, V17, P5711; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Rambhadran A, 2011, J BIOL CHEM, V286, P16953, DOI 10.1074/jbc.M111.224576; Rambhadran A, 2010, J BIOL CHEM, V285, P15296, DOI 10.1074/jbc.M109.085035; ROCK DM, 1992, MOL PHARMACOL, V41, P83; Sirrieh RE, 2013, J BIOL CHEM, V288, P22555, DOI 10.1074/jbc.M113.482356; SPROSEN TS, 1990, EUR J PHARMACOL, V179, P477, DOI 10.1016/0014-2999(90)90193-A; Talukder I, 2011, J GEN PHYSIOL, V138, P179, DOI 10.1085/jgp.201110623; Tang C. M., 2001, CURR PROTOC NEUROSCI; Tomitori H, 2012, J PHARMACOL EXP THER, V343, P82, DOI 10.1124/jpet.112.192286; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; WILLIAMS K, 1990, NEURON, V5, P199, DOI 10.1016/0896-6273(90)90309-4; WILLIAMS K, 1994, MOL PHARMACOL, V45, P803; Woster PM, 2006, POLYAMINE CELL SIGNALING: PHYSIOLOGY, PHARMACOLOGY, AND CANCER RESEARCH, P3, DOI 10.1007/978-1-59745-145-1_1; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Zhu SJ, 2013, NAT STRUCT MOL BIOL, V20, P477, DOI 10.1038/nsmb.2522	39	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12812	12820		10.1074/jbc.M115.649723	http://dx.doi.org/10.1074/jbc.M115.649723			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25829490	Green Published, hybrid			2022-12-28	WOS:000354569000032
J	Flores-Kim, J; Darwin, AJ				Flores-Kim, Josue; Darwin, Andrew J.			Activity of a Bacterial Cell Envelope Stress Response Is Controlled by the Interaction of a Protein Binding Domain with Different Partners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGE-SHOCK-PROTEIN; PHOTO-CROSS-LINKING; HIGH-LEVEL EXPRESSION; INDUCED PSP OPERON; ESCHERICHIA-COLI; YERSINIA-ENTEROCOLITICA; GENE-EXPRESSION; IN-VIVO; SALMONELLA-ENTERICA; SYSTEM	The bacterial phage shock protein (Psp) system is a highly conserved cell envelope stress response required for virulence in Yersinia enterocolitica and Salmonella enterica. In non-inducing conditions the transcription factor PspF is inhibited by an interaction with PspA. In contrast, PspA associates with the cytoplasmic membrane proteins PspBC during inducing conditions. This has led to the proposal that PspBC exists in an OFF state, which cannot recruit PspA, or an ON state, which can. However, nothing was known about the difference between these two states. Here, we provide evidence that it is the C-terminal domain of Y. enterocolitica PspC (PspC(CT)) that interacts directly with PspA, both in vivo and in vitro. Site-specific photocross-linking revealed that this interaction occurred only during Psp-inducing conditions in vivo. Importantly, wehavealsodiscoveredthatPspC(CT) can interact with the C-terminal domain of PspB (PspC(CT)center dot PspB(CT)). However, the PspC(CT)center dot PspB(CT) and PspC(CT)center dot PspA interactions were mutually exclusive in vitro. Furthermore, in vivo, PspC(CT) contacted PspB(CT) in the OFF state, whereas it contacted PspA in the ON state. These findings provide the first description of the previously proposed PspBC OFF and ON states and reveal that the regulatory switch is centered on a PspC(CT) partner-switching mechanism.	[Flores-Kim, Josue; Darwin, Andrew J.] NYU, Dept Microbiol, Sch Med, New York, NY 10016 USA	New York University	Darwin, AJ (corresponding author), NYU, Dept Microbiol MSB 202, Sch Med, 550 First Ave, New York, NY 10016 USA.	andrew.darwin@med.nyu.edu	Regan, Clinton/E-6250-2012	Darwin, Andrew/0000-0002-7751-1293	National Institutes of Health [R01AI052148]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI052148 (NIAID; to A. J. D.).; Holds an Investigators in Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund. To whom correspondence should be addressed: Dept. of Microbiology MSB 202, New York University School of Medicine, 550 First Ave., New York, NY 10016. Tel.: 212-263-3223; Fax: 212-263-8276; E-mail: andrew.darwin@med.nyu.edu.	Adams H, 2003, J BACTERIOL, V185, P1174, DOI 10.1128/JB.185.4.1174-1180.2003; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Bensing BA, 2012, J BIOL CHEM, V287, P24438, DOI 10.1074/jbc.M112.378059; BERGLER H, 1994, MICROBIOL-SGM, V140, P1937, DOI 10.1099/13500872-140-8-1937; BRISSETTE JL, 1991, J MOL BIOL, V220, P35, DOI 10.1016/0022-2836(91)90379-K; BRISSETTE JL, 1990, P NATL ACAD SCI USA, V87, P862, DOI 10.1073/pnas.87.3.862; Chin JW, 2002, CHEMBIOCHEM, V3, P1135, DOI 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M; DALE GE, 1994, PROTEIN ENG, V7, P925, DOI 10.1093/protein/7.7.925; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; Darwin AJ, 2001, MOL MICROBIOL, V39, P429, DOI 10.1046/j.1365-2958.2001.02235.x; Darwin AJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003388; Das S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182931; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Flores-Kim J, 2012, J BACTERIOL, V194, P6548, DOI 10.1128/JB.01250-12; Green RC, 2004, J BACTERIOL, V186, P4910, DOI 10.1128/JB.186.15.4910-4920.2004; Gueguen E, 2011, J BACTERIOL, V193, P5747, DOI 10.1128/JB.05080-11; Gueguen E, 2009, MOL MICROBIOL, V74, P619, DOI 10.1111/j.1365-2958.2009.06885.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hara N, 2012, J BACTERIOL, V194, P5353, DOI 10.1128/JB.01028-12; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Horstman NK, 2012, MOL MICROBIOL, V85, P445, DOI 10.1111/j.1365-2958.2012.08120.x; Huvet M, 2011, MOL BIOL EVOL, V28, P1141, DOI 10.1093/molbev/msq301; Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Jovanovic G, 1996, J BACTERIOL, V178, P1936, DOI 10.1128/jb.178.7.1936-1945.1996; Jovanovic G, 2010, MICROBIOL-SGM, V156, P2920, DOI 10.1099/mic.0.040055-0; Karlinsey JE, 2010, MOL MICROBIOL, V78, P669, DOI 10.1111/j.1365-2958.2010.07357.x; KINDER SA, 1993, GENE, V136, P271, DOI 10.1016/0378-1119(93)90478-L; Kleerebezem M, 1996, EMBO J, V15, P162, DOI 10.1002/j.1460-2075.1996.tb00344.x; Kobayashi R, 2007, MOL MICROBIOL, V66, P100, DOI 10.1111/j.1365-2958.2007.05893.x; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Lin SX, 2011, J AM CHEM SOC, V133, P20581, DOI 10.1021/ja209008w; Lloyd LJ, 2004, J BIOL CHEM, V279, P55707, DOI 10.1074/jbc.M408994200; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; MacRitchie DM, 2008, ADV EXP MED BIOL, V631, P80, DOI 10.1007/978-0-387-78885-2_6; Maloy S. R., 1996, GENETIC ANAL PATHOGE, P493; Maxson ME, 2006, MOL MICROBIOL, V59, P1610, DOI 10.1111/j.1365-2958.2006.05047.x; Maxson ME, 2004, J BACTERIOL, V186, P4199, DOI 10.1128/JB.186.13.4199-4208.2004; Merriam JJ, 1997, INFECT IMMUN, V65, P2497, DOI 10.1128/IAI.65.6.2497-2501.1997; Miller J. H, 1972, EXPT MOL GENETICS; Model P, 1997, MOL MICROBIOL, V24, P255, DOI 10.1046/j.1365-2958.1997.3481712.x; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Pham ND, 2013, CURR OPIN CHEM BIOL, V17, P90, DOI 10.1016/j.cbpa.2012.10.034; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Seo J, 2007, MOL MICROBIOL, V65, P714, DOI 10.1111/j.1365-2958.2007.05821.x; Singh S, 2011, J BACTERIOL, V193, P6436, DOI 10.1128/JB.05942-11; Standar K, 2008, FEBS LETT, V582, P3585, DOI 10.1016/j.febslet.2008.09.002; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Vega NM, 2012, NAT CHEM BIOL, V8, P431, DOI [10.1038/NCHEMBIO.915, 10.1038/nchembio.915]; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; WEINER L, 1991, GENE DEV, V5, P1912, DOI 10.1101/gad.5.10.1912; Yamaguchi S, 2013, MOL MICROBIOL, V87, P656, DOI 10.1111/mmi.12122; Yamaguchi S, 2010, MOL MICROBIOL, V78, P429, DOI 10.1111/j.1365-2958.2010.07344.x; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	58	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11417	11430		10.1074/jbc.M114.614107	http://dx.doi.org/10.1074/jbc.M114.614107			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25802329	hybrid, Green Published			2022-12-28	WOS:000353719400018
J	Holley, CL; Li, MW; Scruggs, BS; Matkovich, SJ; Ory, DS; Schaffer, JE				Holley, Christopher L.; Li, Melissa W.; Scruggs, Benjamin S.; Matkovich, Scot J.; Ory, Daniel S.; Schaffer, Jean E.			Cytosolic Accumulation of Small Nucleolar RNAs (snoRNAs) Is Dynamically Regulated by NADPH Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRERIBOSOMAL RNA; NUCLEAR; DOXORUBICIN; STRESS; U8	Small nucleolar RNAs (snoRNAs) guide nucleotide modifications of cellular RNAs in the nucleus. We previously showed that box C/D snoRNAs from the Rpl13a locus are unexpected mediators of physiologic oxidative stress, independent of their predicted ribosomal RNA modifications. Here we demonstrate that oxidative stress induced by doxorubicin causes rapid cytoplasmic accumulation of the Rpl13a snoRNAs through a mechanism that requires superoxide and a nuclear splice variant of NADPH oxidase. RNA-sequencing analysis reveals that box C/D snoRNAs as a class are present in the cytoplasm, where their levels are dynamically regulated by NADPH oxidase. These findings suggest that snoRNAs may orchestrate the response to environmental stress through molecular interactions outside of the nucleus.	[Holley, Christopher L.; Li, Melissa W.; Scruggs, Benjamin S.; Ory, Daniel S.; Schaffer, Jean E.] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA; [Matkovich, Scot J.] Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Schaffer, JE (corresponding author), Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA.	jschaff@wustl.edu	Holley, Christopher/T-1312-2019; Matkovich, Scot J/B-9077-2009; Matkovich, Scot J/AFP-0908-2022; Holley, Christopher/ABB-6677-2020; Regan, Clinton/E-6250-2012	Holley, Christopher/0000-0002-2870-3352; Matkovich, Scot J/0000-0002-7398-6857; Matkovich, Scot J/0000-0002-7398-6857; Scruggs, Benjamin/0000-0002-0990-9478	National Institutes of Health [P30 CA91842, UL1 TR000448, P30 DK052574]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007081, K08HL114889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK064989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to John Edwards for critical reading of this manuscript and to Xiaowen Wang for assistance with Partek analysis. RNA-seq was performed by the Genome Technology Access Center at Washington University School of Medicine, supported by National Institutes of Health Grants P30 CA91842, UL1 TR000448, and P30 DK052574.	Anilkumar N, 2013, ARTERIOSCL THROM VAS, V33, pE104, DOI 10.1161/ATVBAHA.112.300956; Avitabile D, 2011, P NATL ACAD SCI USA, V108, P6145, DOI 10.1073/pnas.1017935108; Deng SW, 2007, FREE RADICAL BIO MED, V42, P466, DOI 10.1016/j.freeradbiomed.2006.11.013; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kiss T, 2006, COLD SPRING HARB SYM, V71, P407, DOI 10.1101/sqb.2006.71.025; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Matsushima S, 2013, CIRC RES, V112, P651, DOI 10.1161/CIRCRESAHA.112.279760; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Rio Donald C, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5441; Samarsky DA, 1998, EMBO J, V17, P3747, DOI 10.1093/emboj/17.13.3747; Schubert T, 2012, MOL CELL, V48, P434, DOI 10.1016/j.molcel.2012.08.021; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Scruggs BS, 2012, MOL CELL BIOL, V32, P4092, DOI 10.1128/MCB.00022-12; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; TYC K, 1989, EMBO J, V8, P3113, DOI 10.1002/j.1460-2075.1989.tb08463.x; Vitali P, 2005, J CELL BIOL, V169, P745, DOI 10.1083/jcb.200411129; Watkins NJ, 2007, MOL CELL BIOL, V27, P7018, DOI 10.1128/MCB.00516-07; Zhao YY, 2010, CANCER RES, V70, P9287, DOI 10.1158/0008-5472.CAN-10-2664	21	46	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11741	11748		10.1074/jbc.M115.637413	http://dx.doi.org/10.1074/jbc.M115.637413			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792744	Green Published, hybrid			2022-12-28	WOS:000353719400046
J	Inaguma, A; Tsukamoto, H; Kato, HE; Kimura, T; Ishizuka, T; Oishi, S; Yawo, H; Nureki, O; Furutani, Y				Inaguma, Asumi; Tsukamoto, Hisao; Kato, Hideaki E.; Kimura, Tetsunari; Ishizuka, Toru; Oishi, Satomi; Yawo, Hiromu; Nureki, Osamu; Furutani, Yuji			Chimeras of Channelrhodopsin-1 and-2 from Chlamydomonas reinhardtii Exhibit Distinctive Light-induced Structural Changes from Channelrhodopsin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL CHROMOPHORE; PROTONATION CHANGES; RESONANCE RAMAN; WATER-MOLECULES; OPTICAL CONTROL; CHANNEL; SPECTROSCOPY; PHOTOINTERMEDIATE; PHOTOCYCLE; RHODOPSINS	Channelrhodopsin-2 (ChR2) from the green alga Chlamydomonas reinhardtii functions as a light-gated cation channel that has been developed as an optogenetic tool to stimulate specific nerve cells in animals and control their behavior by illumination. The molecular mechanism of ChR2 has been extensively studied by a variety of spectroscopic methods, including light-induced difference Fourier transform infrared (FTIR) spectroscopy, which is sensitive to structural changes in the protein upon light activation. An atomic structure of channelrhodopsin was recently determined by x-ray crystallography using a chimera of channelrhodopsin-1 (ChR1) and ChR2. Electrophysiological studies have shown that ChR1/ChR2 chimeras are less desensitized upon continuous illumination than native ChR2, implying that there are some structural differences between ChR2 and chimeras. In this study, we applied light-induced difference FTIR spectroscopy to ChR2 and ChR1/ChR2 chimeras to determine the molecular basis underlying these functional differences. Upon continuous illumination, ChR1/ChR2 chimeras exhibited structural changes distinct from those in ChR2. In particular, the protonation state of a glutamate residue, Glu-129 (Glu-90 in ChR2 numbering), in the ChR chimeras is not changed as dramatically as in ChR2. Moreover, using mutants stabilizing particular photointermediates as well as time-resolved measurements, we identified some differences between the major photointermediates of ChR2 and ChR1/ChR2 chimeras. Taken together, our data indicate that the gating and desensitizing processes in ChR1/ChR2 chimeras are different from those in ChR2 and that these differences should be considered in the rational design of new optogenetic tools based on channelrhodopsins.	[Inaguma, Asumi; Tsukamoto, Hisao; Kimura, Tetsunari; Furutani, Yuji] Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, Okazaki, Aichi 4448585, Japan; [Inaguma, Asumi; Furutani, Yuji] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Inaguma, Asumi; Tsukamoto, Hisao; Kimura, Tetsunari; Furutani, Yuji] Grad Univ Adv Studies SOKENDAI, Dept Struct Mol Sci, Okazaki, Aichi 4448585, Japan; [Kato, Hideaki E.; Oishi, Satomi; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan; [Ishizuka, Toru; Yawo, Hiromu] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Ishizuka, Toru; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 9808577, Japan	National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Japan Science & Technology Agency (JST); Graduate University for Advanced Studies - Japan; University of Tokyo; Japan Science & Technology Agency (JST); Tohoku University	Furutani, Y (corresponding author), Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, 38 Nishigo Naka, Okazaki, Aichi 4448585, Japan.	furutani@ims.ac.jp	Ishizuka, Toru/L-8191-2017; Furutani, Yuji/J-8337-2019; Kimura, Tetsunari/AAN-9156-2021; Yawo, Hiromu/I-4871-2015; NUREKI, OSAMU/G-4960-2014; Kato, Hideaki/AAQ-4323-2020	Ishizuka, Toru/0000-0003-4405-8792; Furutani, Yuji/0000-0001-5284-8773; Kimura, Tetsunari/0000-0003-1650-7298; Yawo, Hiromu/0000-0002-4299-3288; Kato, Hideaki/0000-0002-1941-5535	Core Research for Evolutional Science and Technology (CREST) Program of "Creation of Nanosystems with Novel Function through Process Integration" from the Japan Science and Technology Agency (JST); Precursory Research for Embryonic Science and Technology (PRESTO) Program of "Chemical Conversion of Light Energy" from the Japan Science and Technology Agency (JST); KAKENHI Japan Society for Promotion of Science (JSPS) [22770159, 24650203]; Grants-in-Aid for Scientific Research [25840122, 15K15025, 26640047, 15H01413] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST) Program of "Creation of Nanosystems with Novel Function through Process Integration" from the Japan Science and Technology Agency (JST); Precursory Research for Embryonic Science and Technology (PRESTO) Program of "Chemical Conversion of Light Energy" from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); KAKENHI Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Core Research for Evolutional Science and Technology (CREST) Program of "Creation of Nanosystems with Novel Function through Process Integration" and the Precursory Research for Embryonic Science and Technology (PRESTO) Program of "Chemical Conversion of Light Energy" from the Japan Science and Technology Agency (JST). This work was also supported in part by KAKENHI Japan Society for Promotion of Science (JSPS) Grant 22770159 and 24650203 (to Y. F.).	ATON B, 1977, BIOCHEMISTRY-US, V16, P2995, DOI 10.1021/bi00632a029; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; Eisenhauer K, 2012, J BIOL CHEM, V287, P6904, DOI 10.1074/jbc.M111.327700; Furutani Y, 2002, BIOPHYS J, V83, P3482, DOI 10.1016/S0006-3495(02)75347-2; Furutani Y, 2013, J PHYS CHEM B, V117, P3449, DOI 10.1021/jp308765t; Furutani Y, 2012, J PHYS CHEM LETT, V3, P2964, DOI 10.1021/jz301287n; Gerwert K, 2014, BBA-BIOENERGETICS, V1837, P606, DOI 10.1016/j.bbabio.2013.09.006; Hososhima S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119558; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Ito S, 2014, J AM CHEM SOC, V136, P3475, DOI 10.1021/ja410836g; Kandori H, 2002, BIOCHEMISTRY-US, V41, P4554, DOI 10.1021/bi0120749; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kuhne J, 2015, ANGEW CHEM INT EDIT, V54, P4953, DOI 10.1002/anie.201410180; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Lorenz-Fonfria VA, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4895796; Lorenz-Fonfria VA, 2014, BBA-BIOENERGETICS, V1837, P626, DOI 10.1016/j.bbabio.2013.10.014; Lorenz-Fonfria VA, 2013, P NATL ACAD SCI USA, V110, pE1273, DOI 10.1073/pnas.1219502110; Muders V, 2014, FEBS LETT, V588, P2301, DOI 10.1016/j.febslet.2014.05.019; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Ogren JI, 2014, BIOCHEMISTRY-US, V53, P3961, DOI 10.1021/bi500445c; Radu I, 2009, PHOTOCH PHOTOBIO SCI, V8, P1517, DOI 10.1039/b9pp00050j; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Tsukamoto H, 2013, J BIOL CHEM, V288, P28207, DOI 10.1074/jbc.M113.472464; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Watanabe HC, 2013, J MOL BIOL, V425, P1795, DOI 10.1016/j.jmb.2013.01.033; Wen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012893; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	41	23	23	2	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11623	11634		10.1074/jbc.M115.642256	http://dx.doi.org/10.1074/jbc.M115.642256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25796616	hybrid, Green Published			2022-12-28	WOS:000353719400037
J	Saur, IML; Conlan, BF; Rathjen, JP				Saur, Isabel Marie-Luise; Conlan, Brendon Francis; Rathjen, John Paul			The N-Terminal Domain of the Tomato Immune Protein Prf Contains Multiple Homotypic and Pto Kinase Interaction Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT-DISEASE RESISTANCE; RICH REPEAT DOMAINS; STRUCTURAL BASIS; CELL-DEATH; PATHOGEN INTERACTIONS; EFFECTOR RECOGNITION; SELF-ASSOCIATION; LRR PROTEINS; BACTERIAL; AVRPTO	Resistance to Pseudomonas syringae bacteria in tomato (Solanum lycopersicum) is conferred by the Prf recognition complex, composed of the nucleotide-binding leucine-rich repeats protein Prf and the protein kinase Pto. The complex is activated by recognition of the P. syringae effectors AvrPto and AvrPtoB. The N-terminal domain is responsible for Prf homodimerization, which brings two Pto kinases into close proximity and holds them in inactive conformation in the absence of either effector. Negative regulation is lost by effector binding to the catalytic cleft of Pto, leading to disruption of its P+1 loop within the activation segment. This change is translated through Prf to a second Pto molecule in the complex. Here we describe a schematic model of the unique Prf N-terminal domain dimer and its interaction with the effector binding determinant Pto. Using heterologous expression in Nicotiana benthamiana, we define multiple sites of N domain homotypic interaction and infer that it forms a parallel dimer folded centrally to enable contact between the N and C termini. Furthermore, we found independent binding sites for Pto at either end of the N-terminal domain. Using the constitutively active mutant ptoL205D, we identify a potential repression site for Pto in the first similar to 100 amino acids of Prf. Finally, we find that the Prf leucine-rich repeats domain also binds the N-terminal region, highlighting a possible mechanism for transfer of the effector binding signal to the NB-LRR regulatory unit (consisting of a central nucleotide binding and C-terminal leucine-rich repeats).	[Saur, Isabel Marie-Luise; Conlan, Brendon Francis; Rathjen, John Paul] Australian Natl Univ, Res Sch Biol, Acton, ACT 2601, Australia	Australian National University	Rathjen, JP (corresponding author), Australian Natl Univ, Res Sch Biol, GPO Box 4, Acton, ACT 2601, Australia.	john.rathjen@anu.edu.au	rathjen, john p/C-9327-2009; Conlan, Brendon F/A-7013-2012	rathjen, john p/0000-0003-4073-8088; Conlan, Brendon F/0000-0002-0934-3865	Australian Research Council [FT0992129, DP110103322]; Australian National University	Australian Research Council(Australian Research Council); Australian National University(Australian National University)	This work was supported by Grants FT0992129 and DP110103322 from the Australian Research Council (to J. P. R.). This work was also supported by a Tuition Fee Exemption Sponsorship from the Australian National University (to I. M. L. S.).	Balmuth A, 2007, PLANT J, V51, P978, DOI 10.1111/j.1365-313X.2007.03199.x; Banerjee D, 2001, GENETICS, V158, P439; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Cesari S, 2014, EMBO J, V33, P1941, DOI 10.15252/embj.201487923; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dong J, 2009, PLANT CELL, V21, P1846, DOI 10.1105/tpc.109.066878; Du XR, 2012, MOL PLANT, V5, P1058, DOI 10.1093/mp/sss014; Gutierrez JR, 2010, PLANT J, V61, P507, DOI 10.1111/j.1365-313X.2009.04078.x; Hao W, 2013, J BIOL CHEM, V288, P35868, DOI 10.1074/jbc.M113.517417; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Linhoff MW, 2001, MOL CELL BIOL, V21, P3001, DOI 10.1128/MCB.21.9.3001-3011.2001; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Moffett P, 2002, EMBO J, V21, P4511, DOI 10.1093/emboj/cdf453; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Mucyn TS, 2009, MOL PLANT MICROBE IN, V22, P391, DOI 10.1094/MPMI-22-4-0391; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Ntoukakis V, 2014, CURR OPIN PLANT BIOL, V20, P69, DOI 10.1016/j.pbi.2014.04.002; Ntoukakis V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003123; Ntoukakis V, 2009, SCIENCE, V324, P784, DOI 10.1126/science.1169430; Panstruga R, 2009, SCIENCE, V324, P748, DOI 10.1126/science.1171652; Rathjen JP, 1999, EMBO J, V18, P3232, DOI 10.1093/emboj/18.12.3232; Slootweg EJ, 2013, PLANT PHYSIOL, V162, P1510, DOI 10.1104/pp.113.218842; Staskawicz BJ, 2001, PLANT PHYSIOL, V125, P73, DOI 10.1104/pp.125.1.73; Takken FLW, 2012, CURR OPIN PLANT BIOL, V15, P375, DOI 10.1016/j.pbi.2012.05.001; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; van Doorn WG, 2005, TRENDS PLANT SCI, V10, P117, DOI 10.1016/j.tplants.2005.01.006; van Ooijen G, 2008, MOL PLANT, V1, P401, DOI 10.1093/mp/ssn009; Warren RF, 1998, PLANT CELL, V10, P1439, DOI 10.1105/tpc.10.9.1439; Wu AJ, 2004, PLANT CELL, V16, P2809, DOI 10.1105/tpc.104.024141; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109	37	18	18	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11258	11267		10.1074/jbc.M114.616532	http://dx.doi.org/10.1074/jbc.M114.616532			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792750	Green Published, hybrid			2022-12-28	WOS:000353719400005
J	Ghosh, A; Jana, M; Modi, K; Gonzalez, FJ; Sims, KB; Berry-Kravis, E; Pahan, K				Ghosh, Arunava; Jana, Malabendu; Modi, Khushbu; Gonzalez, Frank J.; Sims, Katherine B.; Berry-Kravis, Elizabeth; Pahan, Kalipada			Activation of Peroxisome Proliferator-activated Receptor alpha Induces Lysosomal Biogenesis in Brain Cells IMPLICATIONS FOR LYSOSOMAL STORAGE DISORDERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Astrocyte; Lysosomal Storage Disease; Neurodegeneration; Peroxisome proliferator-activated Receptor (PPAR); Retinoic Acid	RETINOID-X-RECEPTOR; LIPID-LOWERING DRUG; GENE-EXPRESSION; CELLULAR CLEARANCE; ADOPTIVE TRANSFER; MESSENGER-RNAS; UP-REGULATION; GEMFIBROZIL; AUTOPHAGY; GAMMA	Lysosomes are ubiquitous membrane-enclosed organelles filled with an acidic interior and are central to the autophagic, endocytic, or phagocytic pathway. In contrast to its classical function as the waste management machinery, lysosomes are now considered to be an integral part of various cellular signaling processes. The diverse functionality of this single organelle requires a very complex and coordinated regulation of its activity with transcription factor EB (TFEB), a master regulator of lysosomal biogenesis, at its core. However, mechanisms by which TFEB is regulated are poorly understood. This study demonstrates that gemfibrozil, an agonist of peroxisome proliferator-activated receptor (PPAR) , alone and in conjunction with all-trans-retinoic acid is capable of enhancing TFEB in brain cells. We also observed that PPAR, but not PPAR and PPAR, is involved in gemfibrozil-mediated up-regulation of TFEB. Reporter assay and chromatin immunoprecipitation studies confirmed the recruitment of retinoid X receptor , PPAR, and PGC1 on the PPAR-binding site on the Tfeb promoter as well. Subsequently, the drug-mediated induction of TFEB caused an increase in lysosomal protein and the lysosomal abundance in cell. Collectively, this study reinforces the link between lysosomal biogenesis and lipid metabolism with TFEB at the crossroads. Furthermore, gemfibrozil may be of therapeutic value in the treatment of lysosomal storage disorders in which autophagy-lysosome pathway plays an important role.	[Ghosh, Arunava; Jana, Malabendu; Modi, Khushbu; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Berry-Kravis, Elizabeth] Rush Univ, Med Ctr, Dept Pediat Neurol Sci & Biochem, Chicago, IL 60612 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Sims, Katherine B.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02114 USA; [Pahan, Kalipada] Jesse Brown Vet Affairs Med Ctr, Div Res & Dev, Chicago, IL 60612 USA	Rush University; Rush University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 1735 West Harrison St,Ste Cohn 320, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu		GHOSH, ARUNAVA/0000-0002-8471-8161	National Institutes of Health [AT6681, NS083054]; Veteran Affairs [I01BX003033-01]; Noah's Hope, Hope for Bridgett, Cures Within Reach, and Two Hearts Rock; NATIONAL CANCER INSTITUTE [ZIABC005562] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083054] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran Affairs; Noah's Hope, Hope for Bridgett, Cures Within Reach, and Two Hearts Rock; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants AT6681 and NS083054. This work was also supported by Merit Award I01BX003033-01 from Veteran Affairs and funds from Noah's Hope, Hope for Bridgett, Cures Within Reach, and Two Hearts Rock.	Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Bai J, 2013, J GENE MED, V15, P182, DOI 10.1002/jgm.2707; Boitier Eric, 2003, Comp Hepatol, V2, P3, DOI 10.1186/1476-5926-2-3; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Brahmachari S, 2007, J IMMUNOL, V179, P275, DOI 10.4049/jimmunol.179.1.275; Brignull LM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-853; Brun S, 1999, DIABETES, V48, P1217, DOI 10.2337/diabetes.48.6.1217; Chen MH, 2008, INVEST OPHTH VIS SCI, V49, P4760, DOI 10.1167/iovs.08-2020; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Corbett GT, 2012, J IMMUNOL, V189, P1002, DOI 10.4049/jimmunol.1102624; Cullingford TE, 1998, J NEUROCHEM, V70, P1366; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Dasgupta S, 2007, MOL PHARMACOL, V72, P934, DOI 10.1124/mol.106.033787; DE DUVE CHRISTIAN, 1963, SCI AMER, V208, P64; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Ferron M, 2013, GENE DEV, V27, P955, DOI 10.1101/gad.213827.113; Fuster JJ, 2010, FASEB J, V24, P2998, DOI 10.1096/fj.09-138255; Ghosh A, 2012, J BIOL CHEM, V287, P38922, DOI 10.1074/jbc.M112.365148; GIESELMANN V, 1995, BBA-MOL BASIS DIS, V1270, P103, DOI 10.1016/0925-4439(94)00075-2; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Jana M, 2005, FREE RADICAL BIO MED, V39, P823, DOI 10.1016/j.freeradbiomed.2005.05.014; Jana M, 2007, J IMMUNOL, V179, P4142, DOI 10.4049/jimmunol.179.6.4142; Jana M, 2012, NEUROCHEM RES, V37, P1718, DOI 10.1007/s11064-012-0781-6; JUGEAUBRY CE, 1995, J BIOL CHEM, V270, P18117, DOI 10.1074/jbc.270.30.18117; Karageorgos LE, 1997, EXP CELL RES, V234, P85, DOI 10.1006/excr.1997.3581; Kelly DP, 2001, CIRC RES, V89, P935, DOI 10.1161/res.89.11.935; Khasnavis S, 2012, J BIOL CHEM, V287, P29529, DOI 10.1074/jbc.M111.338012; Khasnavis S, 2012, J NEUROIMMUNE PHARM, V7, P424, DOI 10.1007/s11481-011-9286-3; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; KREY G, 1995, MOL ENDOCRINOL, V9, P219, DOI 10.1210/me.9.2.219; Marcus Sandra L., 1995, Gene Expression, V4, P227; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Moskot M, 2014, J BIOL CHEM, V289, P17054, DOI 10.1074/jbc.M114.555300; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Nishizawa H, 2003, J REPROD DEVELOP, V49, P539, DOI 10.1262/jrd.49.539; Pahan K, 2002, J BIOL CHEM, V277, P45984, DOI 10.1074/jbc.M200250200; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Parast MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008055; Perez-Sala D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008117; Pshezhetsky AV, 2001, PROG NUCLEIC ACID RE, V69, P81, DOI 10.1016/S0079-6603(01)69045-7; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Roy A, 2013, CELL REP, V4, P724, DOI 10.1016/j.celrep.2013.07.028; Roy A, 2009, IMMUNOPHARM IMMUNOT, V31, P339, DOI 10.1080/08923970902785253; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; RUBINS HB, 1992, J INTERN MED, V231, P421, DOI 10.1111/j.1365-2796.1992.tb00954.x; Saftig P., 2006, FABRY DIS PERSPECTIV; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Saha RN, 2007, FREE RADICAL BIO MED, V42, P1866, DOI 10.1016/j.freeradbiomed.2007.03.022; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sarkar S, 2013, CELL REP, V5, P1302, DOI 10.1016/j.celrep.2013.10.042; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Singh R, 2012, INT J CELL BIOL, DOI DOI 10.1155/2012/282041; Song WS, 2014, J BIOL CHEM, V289, P10211, DOI 10.1074/jbc.M113.506246; Song WS, 2013, HUM MOL GENET, V22, P1994, DOI 10.1093/hmg/ddt052; Tsunemi T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003799; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; WEISSMANN G, 1967, ANNU REV MED, V18, P97, DOI 10.1146/annurev.me.18.020167.000525; Xu JH, 2007, J NEUROCHEM, V103, P1801, DOI 10.1111/j.1471-4159.2007.04875.x; Xu JH, 2006, J NEUROIMMUNOL, V176, P95, DOI 10.1016/j.jneuroim.2006.04.019; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001	69	80	84	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10309	10324		10.1074/jbc.M114.610659	http://dx.doi.org/10.1074/jbc.M114.610659			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25750174	hybrid, Green Published			2022-12-28	WOS:000353241100034
J	Kanda, A; Noda, K; Ishida, S				Kanda, Atsuhiro; Noda, Kousuke; Ishida, Susumu			ATP6AP2/(Pro)renin Receptor Contributes to Glucose Metabolism via Stabilizing the Pyruvate Dehydrogenase E1 beta Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; ALPHA-KETOGLUTARATE DEHYDROGENASE; RETINAL-PIGMENT EPITHELIUM; PRORENIN RECEPTOR; POSTTRANSLATIONAL MODIFICATIONS; DIHYDROLIPOAMIDE DEHYDROGENASE; COMPLEX DEFICIENCY; RENIN; CELLS; GENE	Aerobic glucose metabolism is indispensable for metabolically active cells; however, the regulatory mechanism of efficient energy generation in the highly evolved mammalian retina remains incompletely understood. Here, we revealed an unsuspected role for (pro)renin receptor, also known as ATP6AP2, in energy metabolism. Immunoprecipitation and mass spectrometry analyses identified the pyruvate dehydrogenase (PDH) complex as Atp6ap2-interacting proteins in the mouse retina. Yeast two-hybrid assays demonstrated direct molecular binding between ATP6A P2 and the PDH El 13 subunit (PDHB). Pdhb immunoreactivity co-localized with Atp6ap2 in multiple retinal layers including the retinal pigment epithelium (RPE). A TP6AP2 knockdown in RPE cells reduced PDH activity, showing a predilection to anaerobic glycolysis. ATP6AP2 protected PDHB from phosphorylation, thus controlling its protein stability. Down-regulated PDH activity due to ATP6AP2 knockdown inhibited glucose-stimulated oxidative stress in RPE cells. Our present data unraveled the novel function of ATP6AP2/(P)RR as a PDHB stabilizer, contributing to aerobic glucose metabolism together with oxidative stress.	[Kanda, Atsuhiro; Noda, Kousuke; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Lab Ocular Cell Biol & Visual Sci, Dept Ophthalmol, Sapporo, Hokkaido 0608638, Japan	Hokkaido University	Ishida, S (corresponding author), Hokkaido Univ, Grad Sch Med, Lab Ocular Cell Biol & Visual Sci, Dept Ophthalmol, Sapporo, Hokkaido 0608638, Japan.	ishidasu@med.hokudai.ac.jp			Takeda Science Foundation; Institute of Science of Blood Pressure and Hormone; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Ministry of Education, Science and Culture of Japan [24791823]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Institute of Science of Blood Pressure and Hormone; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Takeda Science Foundation, Institute of Science of Blood Pressure and Hormone, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, and Grant-in-Aid 24791823 from the Ministry of Education, Science and Culture of Japan (to A. K.).	Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; AMES A, 1992, J NEUROSCI, V12, P4234; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Bonifacino J. S., 2007, CURR PROTOC CELL BIO; BROWN GK, 1994, J MED GENET, V31, P875, DOI 10.1136/jmg.31.11.875; Buechling T, 2010, CURR BIOL, V20, P1263, DOI 10.1016/j.cub.2010.05.028; Burckle C, 2006, HYPERTENSION, V48, P549, DOI 10.1161/01.HYP.0000241132.48495.df; Coffe V, 2006, NEUROCHEM RES, V31, P103, DOI 10.1007/s11064-005-9236-7; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Du XL, 2003, J CLIN INVEST, V112, P1049, DOI 10.1172/JCI200318127; Han Z, 2008, J BIOL CHEM, V283, P237, DOI 10.1074/jbc.M704748200; Hermle T, 2010, CURR BIOL, V20, P1269, DOI 10.1016/j.cub.2010.05.057; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Ichihara A, 2010, HYPERTENS RES, V33, P177, DOI 10.1038/hr.2009.214; Johns D R, 1995, Semin Ophthalmol, V10, P295, DOI 10.3109/08820539509063800; Johnson MT, 1997, P NATL ACAD SCI USA, V94, P14512, DOI 10.1073/pnas.94.26.14512; Johnson MT, 2001, MOL GENET METAB, V74, P293, DOI 10.1006/mgme.2001.3249; Kanda A, 2012, DIABETOLOGIA, V55, P3104, DOI 10.1007/s00125-012-2702-2; Kanda A, 2013, J NEUROSCI, V33, P19341, DOI 10.1523/JNEUROSCI.1362-13.2013; Kanda A, 2013, BRIT J OPHTHALMOL, V97, P666, DOI 10.1136/bjophthalmol-2012-302680; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Kumar V, 2008, BIOL REPROD, V79, P190, DOI 10.1095/biolreprod.107.066704; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Lissens W, 2000, HUM MUTAT, V15, P209, DOI 10.1002/(SICI)1098-1004(200003)15:3<209::AID-HUMU1>3.0.CO;2-K; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; MacCormick IJC, 2014, BRAIN, V137, P2119, DOI 10.1093/brain/awu001; Maurer CM, 2010, J NEUROSCI, V30, P11962, DOI 10.1523/JNEUROSCI.2848-10.2010; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Ola MS, 2006, AM J PHYSIOL-ENDOC M, V290, pE1057, DOI 10.1152/ajpendo.00323.2005; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Rahimi R, 2005, BIOMED PHARMACOTHER, V59, P365, DOI 10.1016/j.biopha.2005.07.002; Riediger F, 2011, J AM SOC NEPHROL, V22, P2193, DOI 10.1681/ASN.2011020200; Satofuka Shingo, 2012, Front Biosci (Schol Ed), V4, P1449; Satofuka S, 2009, DIABETES, V58, P1625, DOI 10.2337/db08-0254; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Stone J, 2008, BRAIN RES, V1189, P58, DOI 10.1016/j.brainres.2007.10.083; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Taylor MR, 2004, P NATL ACAD SCI USA, V101, P4584, DOI 10.1073/pnas.0307074101; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Tsacopoulos M, 1998, PROG RETIN EYE RES, V17, P429, DOI 10.1016/S1350-9462(98)00010-X; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Winkler BS, 2000, INVEST OPHTH VIS SCI, V41, P3183; Wong-Riley M, 2010, EYE BRAIN, V2, P99; Wood JPM, 2004, INVEST OPHTH VIS SCI, V45, P1272, DOI 10.1167/iovs.03-0693; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002	46	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9690	9700		10.1074/jbc.M114.626713	http://dx.doi.org/10.1074/jbc.M114.626713			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25720494	Green Published, hybrid			2022-12-28	WOS:000352729400031
J	Misra, UK; Pizzo, SV				Misra, Uma Kant; Pizzo, Salvatore Vincent			Activated alpha(2)-Macroglobulin Binding to Human Prostate Cancer Cells Triggers Insulin-like Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RECOGNIZED FORMS; FATTY-ACID SYNTHASE; ALPHA-M-2 SIGNALING RECEPTOR; UNFOLDED PROTEIN RESPONSE; COOH-TERMINAL DOMAIN; ATP CITRATE LYASE; SURFACE GRP78; UP-REGULATION; CELLULAR PROLIFERATION; COORDINATE REGULATION	Ligation of cell surface GRP78 by activated alpha(2)-macroglobulin (alpha M-2*) promotes cell proliferation and suppresses apoptosis. alpha M-2*-treated human prostate cancer cells exhibit a 2-3-fold increase in glucose uptake and lactate secretion, an effect similar to insulin treatment. In both alpha M-2* and insulin-treated cells, the mRNA levels of SREBP1-c, SREBP2, fatty-acid synthase, acetyl-CoA carboxylase, ATP citrate lyase, and Glut-1 were significantly increased together with their protein levels, except for SREBP2. Pretreatment of cells with alpha M-2* antagonist antibody directed against the carboxyl-terminal domain of GRP78 blocks these alpha M-2*-mediated effects, and silencing GRP78 expression by RNAi inhibits up-regulation of ATP citrate lyase and fatty-acid synthase. alpha M-2* induces a 2-3-fold increase in lipogenesis as determined by 6-[C-14] glucose or 1-[C-14]acetate incorporation into free cholesterol, cholesterol esters, triglycerides, free fatty acids, and phosphatidylcholine, which is blocked by inhibitors of fatty-acid synthase, PI 3-kinase, mTORC, or an antibody against the carboxyl-terminal domain of GRP78. We also assessed the incorporation of [(CH3)-C-14]choline into phosphatidylcholine and observed similar effects. Lipogenesis is significantly affected by pretreatment of prostate cancer cells with fatostatin A, which blocks sterol regulatory element-binding protein proteolytic cleavage and activation. This study demonstrates that alpha M-2* functions as a growth factor, leading to proliferation of prostate cancer cells by promoting insulin-like responses. An antibody against the carboxyl-terminal domain of GRP78 may have important applications in prostate cancer therapy.	[Misra, Uma Kant; Pizzo, Salvatore Vincent] Duke Univ, Med Ctr, Dept Pathol, Box 3712, Durham, NC 27710 USA	Duke University	Pizzo, SV (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Box 3712, Durham, NC 27710 USA.	salvatore.pizzo@duke.edu						Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; ADAMSON ED, 1987, DEVELOPMENT, V99, P449; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Asplin IR, 2000, ARCH BIOCHEM BIOPHYS, V383, P135, DOI 10.1006/abbi.2000.2052; Baenke F, 2013, DIS MODEL MECH, V6, P1353, DOI 10.1242/dmm.011338; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; Bhattacharjee G, 2001, J CELL BIOCHEM, V82, P260, DOI 10.1002/jcb.1152; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; de Ridder GG, 2012, MELANOMA RES, V22, P225, DOI 10.1097/CMR.0b013e32835312fd; de Ridder GG, 2011, MELANOMA RES, V21, P35, DOI 10.1097/CMR.0b013e3283426805; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; ENGHILD JJ, 1990, BIOCHEMISTRY-US, V29, P10070, DOI 10.1021/bi00495a009; FELDMAN SR, 1985, P NATL ACAD SCI USA, V82, P5700, DOI 10.1073/pnas.82.17.5700; FELDMAN SR, 1984, ARCH BIOCHEM BIOPHYS, V235, P267, DOI 10.1016/0003-9861(84)90275-3; FELDMAN SR, 1986, BIOCHEMISTRY-US, V25, P721, DOI 10.1021/bi00351a032; Flavin R, 2011, J PATHOL, V223, P283, DOI 10.1002/path.2809; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gonzalez-Gronow M., 2013, CELLULAR TRAFFICKING, P229; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Griffiths B, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-3; Hart J. P., 2006, PRINCIPLES CLIN PRAC, P395; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Kanoh W, 2001, ANTICANCER RES, V21, P551; Kato Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-89; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Krycer JR, 2013, BBA-REV CANCER, V1835, P219, DOI 10.1016/j.bbcan.2013.01.002; Lagace TK, 2000, J BIOL CHEM, V275, P14367, DOI 10.1074/jbc.275.19.14367; Li XY, 2014, MOL CANCER THER, V13, P855, DOI 10.1158/1535-7163.MCT-13-0797; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu Y, 2006, PROSTATE CANCER P D, V9, P230, DOI 10.1038/sj.pcan.4500879; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MEDES G, 1953, CANCER RES, V13, P27; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Misra U. K., 2013, J BIOCH PHARM RES, V1, P219; Misra UK, 1998, CELL SIGNAL, V10, P441, DOI 10.1016/S0898-6568(97)00171-X; Misra UK, 1998, BBA-MOL CELL RES, V1401, P121, DOI 10.1016/S0167-4889(97)00123-7; Misra UK, 1997, J BIOL CHEM, V272, P497; Misra UK, 1999, J BIOL CHEM, V274, P25785, DOI 10.1074/jbc.274.36.25785; MISRA UK, 1993, BIOCHEM J, V290, P885, DOI 10.1042/bj2900885; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Misra UK, 2005, J BIOL CHEM, V280, P38276, DOI 10.1074/jbc.M507332200; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Misra UK, 1998, J BIOL CHEM, V273, P13399, DOI 10.1074/jbc.273.22.13399; MISRA UK, 1994, J BIOL CHEM, V269, P12541; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Misra UK, 2004, CELL SIGNAL, V16, P487, DOI 10.1016/j.cellsig.2003.09.010; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Misra UK, 2002, J BIOL CHEM, V277, P4069, DOI 10.1074/jbc.M109764200; Misra UK, 2002, J BIOL CHEM, V277, P36509, DOI 10.1074/jbc.M203543200; Misra UK, 2001, CELL SIGNAL, V13, P801, DOI 10.1016/S0898-6568(01)00202-9; Misra UK, 1999, ARCH BIOCHEM BIOPHYS, V363, P68, DOI 10.1006/abbi.1998.1074; Misra UK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051735; Misra UK, 2012, J CELL BIOCHEM, V113, P1488, DOI 10.1002/jcb.24018; Misra UK, 2010, CANCER BIOL THER, V9, P142, DOI 10.4161/cbt.9.2.10422; Misra UK, 2007, J CELL BIOCHEM, V100, P1022, DOI 10.1002/jcb.21086; Misra UK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088373; Misra UK, 2013, BIOCHEMISTRY-US, V52, P4014, DOI 10.1021/bi400376s; Misra UK, 2009, J CELL BIOCHEM, V108, P998, DOI 10.1002/jcb.22333; Misra UK, 2009, MOL CANCER THER, V8, P1350, DOI 10.1158/1535-7163.MCT-08-0990; Montano X, 2004, FEBS LETT, V571, P1, DOI 10.1016/j.febslet.2004.06.088; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pelton K, 2012, CURR OPIN PHARMACOL, V12, P751, DOI 10.1016/j.coph.2012.07.006; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Bayascas JR, 2010, CURR TOP MICROBIOL, V346, P9, DOI 10.1007/82_2010_43; Ridgway ND, 2013, CRIT REV BIOCHEM MOL, V48, P20, DOI 10.3109/10409238.2012.735643; Rossi S, 2003, MOL CANCER RES, V1, P707; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; STEINER DF, 1985, ANNU REV GENET, V19, P463, DOI 10.1146/annurev.ge.19.120185.002335; THOGERSEN IB, 1992, BIOCHEM J, V285, P521, DOI 10.1042/bj2850521; Van de Sande T, 2005, J PATHOL, V206, P214, DOI 10.1002/path.1760; Van de Sande T, 2002, CANCER RES, V62, P642; Van der Sanden MHM, 2003, BIOCHEM J, V369, P643, DOI 10.1042/BJ20020285; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Walenta S, 1997, AM J PATHOL, V150, P409; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yellaturu CR, 2009, J BIOL CHEM, V284, P31726, DOI 10.1074/jbc.M109.050914; Yoshii Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064570; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019	96	16	16	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9571	9587		10.1074/jbc.M114.617837	http://dx.doi.org/10.1074/jbc.M114.617837			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25720493	hybrid, Green Published			2022-12-28	WOS:000352729400023
J	Dey, S; Biswas, M; Sen, U; Dasgupta, J				Dey, Sanjay; Biswas, Maitree; Sen, Udayaditya; Dasgupta, Jhimli			Unique ATPase Site Architecture Triggers cis-Mediated Synchronized ATP Binding in Heptameric AAA(+)-ATPase Domain of Flagellar Regulatory Protein FlrC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIBRIO-CHOLERAE MOTILITY; ENHANCER-BINDING; TRANSCRIPTIONAL ACTIVATOR; CONFORMATIONAL-CHANGES; RECEIVER DOMAINS; STRUCTURAL BASIS; AAA+ ATPASE; AAA(+); PHOSPHORYLATION; ORGANIZATION	Bacterial enhancer-binding proteins (bEBPs) oligomerize through AAA(+) domains and use ATP hydrolysis-driven energy to isomerize the RNA polymerase-sigma(54) complex during transcriptional initiation. Here, we describe the first structure of the central AAA(+) domain of the flagellar regulatory protein FlrC (FlrC(C)), a bEBP that controls flagellar synthesis in Vibrio cholerae. Our results showed that FlrC(C) forms heptamer both in nucleotide (Nt)-free and -bound states without ATP-dependent subunit remodeling. Unlike the bEBPs such as NtrC1 or PspF, a novel cis-mediated "all or none" ATP binding occurs in the heptameric FlrC(C), because constriction at the ATPase site, caused by loop L3 and helix alpha 7, restricts the proximity of the trans-protomer required for Nt binding. A unique "closed to open" movement of Walker A, assisted by trans-acting "Glu switch" Glu-286, facilitates ATP binding and hydrolysis. Fluorescence quenching and ATPase assays on FlrC(C) and mutants revealed that although Arg-349 of sensor II, positioned by trans-acting Glu-286 and Tyr-290, acts as a key residue to bind and hydrolyze ATP, Arg-319 of alpha 7 anchors ribose and controls the rate of ATP hydrolysis by retarding the expulsion of ADP. Heptameric state of FlrC(C) is restored in solution even with the transition state mimicking ADP center dot AlF3. Structural results and pull-down assays indicated that L3 renders an in-built geometry to L1 and L2 causing sigma(54)-FlrC(C) interaction independent of Nt binding. Collectively, our results underscore a novel mechanism of ATP binding and sigma(54) interaction that strives to understand the transcriptional mechanism of the bEBPs, which probably interact directly with the RNA polymerase-sigma(54) complex without DNA looping.	[Dey, Sanjay; Biswas, Maitree; Dasgupta, Jhimli] St Xaviers Coll, Dept Biotechnol, Kolkata 700016, India; [Sen, Udayaditya] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata 700064, India	St. Xavier's College Kolkata; Saha Institute of Nuclear Physics	Dasgupta, J (corresponding author), St Xaviers Coll, Dept Biotechnol, 30 Pk St, Kolkata 700016, India.	jhimli@sxccal.edu		Sen, Udayaditya/0000-0001-5742-2907; Dasgupta, Jhimli/0000-0002-8030-1262	Department of Biotechnology, Government of India (DBT(IYBA)) [BT/03/IYBA/2010]	Department of Biotechnology, Government of India (DBT(IYBA))	This work was supported by the Department of Biotechnology, Government of India (DBT(IYBA)) Grant BT/03/IYBA/2010.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ades SE, 2006, CURR BIOL, V16, pR46, DOI 10.1016/j.cub.2006.01.005; Batchelor JD, 2009, J MOL BIOL, V393, P634, DOI 10.1016/j.jmb.2009.08.033; Batchelor JD, 2008, J MOL BIOL, V384, P1058, DOI 10.1016/j.jmb.2008.10.024; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bose D, 2008, MOL CELL, V32, P337, DOI 10.1016/j.molcel.2008.09.015; Bush M, 2012, MICROBIOL MOL BIOL R, V76, P497, DOI 10.1128/MMBR.00006-12; Chen BY, 2010, STRUCTURE, V18, P1420, DOI 10.1016/j.str.2010.08.018; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; Correa NE, 2005, J BACTERIOL, V187, P3158, DOI 10.1128/JB.187.9.3158-3170.2005; Correa NE, 2000, MOL MICROBIOL, V35, P743, DOI 10.1046/j.1365-2958.2000.01745.x; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; De Carlo S, 2006, GENE DEV, V20, P1485, DOI 10.1101/gad.1418306; Dey S, 2013, ACTA CRYSTALLOGR F, V69, P800, DOI 10.1107/S1744309113015613; Doucleff M, 2005, J MOL BIOL, V353, P242, DOI 10.1016/j.jmb.2005.08.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Hendrixson DR, 2003, MOL MICROBIOL, V50, P687, DOI 10.1046/j.1365-2958.2003.03731.x; Jagannathan A, 2001, J BACTERIOL, V183, P2937, DOI 10.1128/JB.183.9.2937-2942.2001; Joly N, 2012, MOL CELL, V47, P484, DOI 10.1016/j.molcel.2012.06.012; Joly N, 2010, J BIOL CHEM, V285, P15178, DOI 10.1074/jbc.M110.103150; Jyot J, 2002, J BACTERIOL, V184, P5251, DOI 10.1128/JB.184.19.5251-5260.2002; Klose KE, 1998, MOL MICROBIOL, V28, P501, DOI 10.1046/j.1365-2958.1998.00809.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEE JH, 1995, P NATL ACAD SCI USA, V92, P9702, DOI 10.1073/pnas.92.21.9702; Lee JH, 2000, J BACTERIOL, V182, P5188, DOI 10.1128/JB.182.18.5188-5195.2000; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Mani RS, 2003, BIOCHEMISTRY-US, V42, P12077, DOI 10.1021/bi030127b; McCarter LL, 2001, MICROBIOL MOL BIOL R, V65, P445, DOI 10.1128/MMBR.65.3.445-462.2001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mir MA, 2001, BIOCHEMISTRY-US, V40, P11578, DOI 10.1021/bi010731r; Neuwald AF, 1999, GENOME RES, V9, P27; Prouty MG, 2001, MOL MICROBIOL, V39, P1595, DOI 10.1046/j.1365-2958.2001.02348.x; Rappas M, 2006, J MOL BIOL, V357, P481, DOI 10.1016/j.jmb.2005.12.052; Rappas M, 2005, SCIENCE, V307, P1972, DOI 10.1126/science.1105932; Schumacher J, 2006, J STRUCT BIOL, V156, P190, DOI 10.1016/j.jsb.2006.01.006; Shi YM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000514; Srivastava D, 2013, MOL MICROBIOL, V90, P1262, DOI 10.1111/mmi.12432; Syed KA, 2009, J BACTERIOL, V191, P6555, DOI 10.1128/JB.00949-09; Sysoeva TA, 2013, GENE DEV, V27, P2500, DOI 10.1101/gad.229385.113; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Xu H, 2001, CURR OPIN MICROBIOL, V4, P138, DOI 10.1016/S1369-5274(00)00179-X; Zhang N, 2012, NUCLEIC ACIDS RES, V40, P9139, DOI 10.1093/nar/gks661; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	48	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8734	8747		10.1074/jbc.M114.611434	http://dx.doi.org/10.1074/jbc.M114.611434			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25688103	Green Published, hybrid			2022-12-28	WOS:000352207100005
J	Sakurai, K; Chen, J; Khani, SC; Kefalov, VJ				Sakurai, Keisuke; Chen, Jeannie; Khani, Shahrokh C.; Kefalov, Vladimir J.			Regulation of Mammalian Cone Phototransduction by Recoverin and Rhodopsin Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-PHOTON RESPONSES; VISUAL PIGMENT PHOSPHORYLATION; LIGHT ADAPTATION; ROD PHOTORECEPTORS; RETINAL RODS; GUANYLATE-CYCLASE; TRANSGENIC MICE; FROG RETINA; S-MODULIN; CALCIUM	Cone photoreceptors function under daylight conditions and are essential for color perception and vision with high temporal and spatial resolution. A remarkable feature of cones is that, unlike rods, they remain responsive in bright light. In rods, light triggers a decline in intracellular calcium, which exerts a well studied negative feedback on phototransduction that includes calcium-dependent inhibition of rhodopsin kinase (GRK1) by recoverin. Rods and cones share the same isoforms of recoverin and GRK1, and photoactivation also triggers a calcium decline in cones. However, the molecular mechanisms by which calcium exerts negative feedback on cone phototransduction through recoverin and GRK1 are not well understood. Here, we examined this question using mice expressing various levels of GRK1 or lacking recoverin. We show that although GRK1 is required for the timely inactivation of mouse cone photoresponse, gradually increasing its expression progressively delays the cone response recovery. This surprising result is in contrast with the known effect of increasing GRK1 expression in rods. Notably, the kinetics of cone responses converge and become independent of GRK1 levels for flashes activating more than similar to 1% of cone pigment. Thus, mouse cone response recovery in bright light is independent of pigment phosphorylation and likely reflects the spontaneous decay of photoactivated visual pigment. We also find that recoverin potentiates the sensitivity of cones in dim light conditions but does not contribute to their capacity to function in bright light.	[Sakurai, Keisuke; Kefalov, Vladimir J.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Chen, Jeannie] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Chen, Jeannie] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Khani, Shahrokh C.] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA; [Khani, Shahrokh C.] Harvard Univ, Sch Med, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA	Washington University (WUSTL); University of Southern California; University of Southern California; Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Kefalov, VJ (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave,Campus Box 8096, St Louis, MO 63110 USA.	kefalov@vision.wustl.edu		Kefalov, Vladimir/0000-0002-1659-008X	National Institutes of Health [EY19543, EY19312, EY12703, EY12155, EY02687]; Research to Prevent Blindness; Uehara Memorial Foundation, Japan; NATIONAL EYE INSTITUTE [P30EY002687, R01EY019312, R01EY012155, R21EY019543, R01EY012703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Uehara Memorial Foundation, Japan(Uehara Memorial Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY19543 and EY19312 (to V. J. K.), EY12703 and EY12155 (to J. C.), and EY02687 (to Washington University Department Ophthalmology). This work was also supported by Research to Prevent Blindness and a grant from the Uehara Memorial Foundation, Japan (to K. S.).	Altimimi HF, 2007, CHANNELS, V1, P62, DOI 10.4161/chan.4366; Arinobu D, 2010, J NEUROCHEM, V115, P259, DOI 10.1111/j.1471-4159.2010.06925.x; BOLNICK DA, 1979, VISION RES, V19, P1117, DOI 10.1016/0042-6989(79)90006-3; BOYNTON RM, 1970, SCIENCE, V170, P1423, DOI 10.1126/science.170.3965.1423; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chan S, 2007, INVEST OPHTH VIS SCI, V48, P1968, DOI 10.1167/iovs.06-1287; Chen CK, 2012, J NEUROSCI, V32, P15998, DOI 10.1523/JNEUROSCI.1639-12.2012; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P328, DOI 10.1073/pnas.95.1.328; DIZHOOR AM, 1993, SCIENCE, V259, P829, DOI 10.1126/science.8430337; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; Doan T, 2006, SCIENCE, V313, P530, DOI 10.1126/science.1126612; Doan T, 2009, J NEUROSCI, V29, P11867, DOI 10.1523/JNEUROSCI.0819-09.2009; Estevez ME, 2009, J GEN PHYSIOL, V134, P137, DOI 10.1085/jgp.200910232; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; GREEN DG, 1971, SCIENCE, V174, P598, DOI 10.1126/science.174.4009.598; Gross OP, 2012, NEURON, V76, P370, DOI 10.1016/j.neuron.2012.07.029; Hurley J B, 2001, Prog Brain Res, V131, P395; IMAI H, 1995, BIOCHEMISTRY-US, V34, P10525, DOI 10.1021/bi00033a026; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; Kawamura S, 1999, Novartis Found Symp, V224, P208; Kawamura S, 1996, J BIOL CHEM, V271, P21359, DOI 10.1074/jbc.271.35.21359; Kennedy MJ, 2004, NEURON, V41, P915, DOI 10.1016/S0896-6273(04)00086-8; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; Matthews HR, 2010, J GEN PHYSIOL, V135, P355, DOI 10.1085/jgp.200910394; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; MILAM AH, 1993, VISUAL NEUROSCI, V10, P1, DOI 10.1017/S0952523800003175; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; Nikonov SS, 2008, NEURON, V59, P462, DOI 10.1016/j.neuron.2008.06.011; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; OKADA T, 1994, BIOCHEMISTRY-US, V33, P4940, DOI 10.1021/bi00182a024; Palczewski K, 2000, BIOESSAYS, V22, P337, DOI 10.1002/(SICI)1521-1878(200004)22:4<337::AID-BIES4>3.0.CO;2-Z; PALCZEWSKI K, 1992, J BIOL CHEM, V267, P18991; ROHLICH P, 1994, NEURON, V13, P1159, DOI 10.1016/0896-6273(94)90053-1; Sakurai K, 2011, INVEST OPHTH VIS SCI, V52, P6793, DOI 10.1167/iovs.11-7158; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; SILLMAN AJ, 1969, VISION RES, V9, P1435, DOI 10.1016/0042-6989(69)90059-5; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Vogalis F, 2011, J PHYSIOL-LONDON, V589, P2321, DOI 10.1113/jphysiol.2010.204156; Weiss ER, 2001, J NEUROSCI, V21, P9175, DOI 10.1523/JNEUROSCI.21-23-09175.2001; Whitcomb T, 2010, INVEST OPHTH VIS SCI, V51, P1728, DOI 10.1167/iovs.09-4499; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9; Zang JJ, 2012, J GEN PHYSIOL, V140, P219, DOI 10.1085/jgp.201110762; Zhao XY, 1998, J BIOL CHEM, V273, P5124, DOI 10.1074/jbc.273.9.5124; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	52	23	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9239	9250		10.1074/jbc.M115.639591	http://dx.doi.org/10.1074/jbc.M115.639591			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25673692	Green Published, hybrid			2022-12-28	WOS:000352207100045
J	Vidal-Melgosa, S; Pedersen, HL; Schuckel, J; Arnal, G; Dumon, C; Amby, DB; Monrad, RN; Westereng, B; Willats, WGT				Vidal-Melgosa, Silvia; Pedersen, Henriette L.; Schuckel, Julia; Arnal, Gregory; Dumon, Claire; Amby, Daniel B.; Monrad, Rune Nygaard; Westereng, Bjorge; Willats, William G. T.			A New Versatile Microarray-based Method for High Throughput Screening of Carbohydrate-active Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; BINDING MODULES; CELL-WALLS; XYLOGLUCAN; EXPRESSION; HOMOGALACTURONAN; BIOSYNTHESIS; PROTEINS; LOCATION; EPITOPES	Carbohydrate-active enzymes have multiple biological roles and industrial applications. Advances in genome and transcriptome sequencing together with associated bioinformatics tools have identified vast numbers of putative carbohydrate-degrading and -modifying enzymes including glycoside hydrolases and lytic polysaccharide monooxygenases. However, there is a paucity of methods for rapidly screening the activities of these enzymes. By combining the multiplexing capacity of carbohydrate microarrays with the specificity of molecular probes, we have developed a sensitive, high throughput, and versatile semiquantitative enzyme screening technique that requires low amounts of enzyme and substrate. The method can be used to assess the activities of single enzymes, enzyme mixtures, and crude culture broths against single substrates, substrate mixtures, and biomass samples. Moreover, we show that the technique can be used to analyze both endo-acting and exo-acting glycoside hydrolases, polysaccharide lyases, carbohydrate esterases, and lytic polysaccharide monooxygenases. We demonstrate the potential of the technique by identifying the substrate specificities of purified uncharacterized enzymes and by screening enzyme activities from fungal culture broths.	[Vidal-Melgosa, Silvia; Pedersen, Henriette L.; Schuckel, Julia; Amby, Daniel B.; Westereng, Bjorge; Willats, William G. T.] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, DK-1871 Frederiksberg, Denmark; [Arnal, Gregory; Dumon, Claire] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Arnal, Gregory; Dumon, Claire] Univ Toulouse, INSA, UPS, INP,LISBP, F-31077 Toulouse, France; [Arnal, Gregory; Dumon, Claire] CNRS, UMR5504, F-31400 Toulouse, France; [Monrad, Rune Nygaard] Novozymes AS, DK-2880 Bagsvaerd, Denmark; [Westereng, Bjorge] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	University of Copenhagen; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Novozymes; Norwegian University of Life Sciences	Willats, WGT (corresponding author), Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, DK-1871 Frederiksberg, Denmark.	willats@plen.ku.dk	Westereng, Bjørge/A-1688-2013; amby, daniel/GQI-1580-2022; Schückel, Julia/AAH-3948-2019; Claire, Dumon/AAI-2553-2021; Schückel, Julia/F-7450-2014	Westereng, Bjørge/0000-0002-5141-7231; Claire, Dumon/0000-0003-4925-7336; Schückel, Julia/0000-0001-7402-8768; buchvaldt amby, daniel/0000-0003-1362-9193	European Community [238084]; WallTraC project [263916]; Novo Nordisk Fonden [NNF12OC0000771] Funding Source: researchfish	European Community(European Commission); WallTraC project; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported in part by the European Community's Seventh Framework Program (FP7/2007-2013) under the LEANGREENFOOD project (Grant Agreement No. 238084).; Supported by the WallTraC project (Grant Agreement No. 263916).	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Albersheim P., 2011, PLANT CELL WALLS CHE, P37; Bastien G, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-78; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Biely P, 2013, BBA-GEN SUBJECTS, V1830, P5075, DOI 10.1016/j.bbagen.2013.07.018; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Burton RA, 2006, SCIENCE, V311, P1940, DOI 10.1126/science.1122975; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Clausen MH, 2003, CARBOHYD RES, V338, P1797, DOI 10.1016/S0008-6215(03)00272-6; Coenen GJ, 2007, CARBOHYD POLYM, V70, P224, DOI 10.1016/j.carbpol.2007.04.007; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; Flint HJ, 2008, ANN NY ACAD SCI, V1125, P280, DOI 10.1196/annals.1419.022; Frankova L, 2013, J EXP BOT, V64, P3519, DOI 10.1093/jxb/ert201; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Honda Y, 2004, J BIOL CHEM, V279, P55097, DOI 10.1074/jbc.M409832200; Irbe I, 2014, INT BIODETER BIODEGR, V86, P71, DOI 10.1016/j.ibiod.2013.06.027; Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405; Jorgensen H, 2007, BIOFUEL BIOPROD BIOR, V1, P119, DOI 10.1002/bbb.4; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; KNOX JP, 1991, PLANT J, V1, P317, DOI 10.1046/j.1365-313X.1991.t01-9-00999.x; Lagaert S, 2007, APPL ENVIRON MICROB, V73, P5374, DOI 10.1128/AEM.00722-07; Lagaert S, 2011, APPL MICROBIOL BIOT, V92, P1179, DOI 10.1007/s00253-011-3396-y; LEVER M, 1973, BIOCHEM MED METAB B, V7, P274, DOI 10.1016/0006-2944(73)90083-5; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; MEIKLE PJ, 1991, PLANTA, V185, P1, DOI 10.1007/BF00194507; MEIKLE PJ, 1994, PLANT J, V5, P1, DOI 10.1046/j.1365-313X.1994.5010001.x; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moller I, 2007, PLANT J, V50, P1118, DOI 10.1111/j.1365-313X.2007.03114.x; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Pedersen HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.396598; Pena MJ, 2012, METHOD ENZYMOL, V510, P121, DOI 10.1016/B978-0-12-415931-0.00007-0; PENNELL RI, 1991, PLANT CELL, V3, P1317, DOI 10.1105/tpc.3.12.1317; Peres NA, 2005, PLANT DIS, V89, P784, DOI 10.1094/PD-89-0784; Pettolino FA, 2001, PLANTA, V214, P235, DOI 10.1007/s004250100606; Prusky D, 2004, PHYTOPATHOLOGY, V94, P44, DOI 10.1094/PHYTO.2004.94.1.44; Ralet MC, 2010, PLANTA, V231, P1373, DOI 10.1007/s00425-010-1116-y; Ribeiro T, 2010, BBA-PROTEINS PROTEOM, V1804, P2054, DOI 10.1016/j.bbapap.2010.07.006; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Sorensen I, 2008, PLANT J, V54, P510, DOI 10.1111/j.1365-313X.2008.03453.x; Steele HL, 2009, J MOL MICROB BIOTECH, V16, P25, DOI 10.1159/000142892; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; Vincentelli R, 2011, METHODS, V55, P65, DOI 10.1016/j.ymeth.2011.08.010; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Wan YF, 2014, PLANTA, V239, P1041, DOI 10.1007/s00425-014-2034-1; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; Westereng B, 2009, MOL NUTR FOOD RES, V53, P780, DOI 10.1002/mnfr.200800199; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066	59	39	39	2	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9020	9036		10.1074/jbc.M114.630673	http://dx.doi.org/10.1074/jbc.M114.630673			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25657012	Green Published, hybrid			2022-12-28	WOS:000352207100027
J	Li, K; Zhang, J; Yu, JJ; Liu, B; Guo, YJ; Deng, JL; Chen, SH; Wang, CX; Guo, FF				Li, Kai; Zhang, Jin; Yu, Junjie; Liu, Bin; Guo, Yajie; Deng, Jiali; Chen, Shanghai; Wang, Chunxia; Guo, Feifan			MicroRNA-214 Suppresses Gluconeogenesis by Targeting Activating Transcriptional Factor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-FAT DIET; REGULATES GLUCOSE-METABOLISM; INDUCED HEPATIC STEATOSIS; PERFUSED-RAT-LIVER; PHOSPHOENOLPYRUVATE CARBOXYKINASE; DIABETES-MELLITUS; COACTIVATOR PGC-1; LIPID-METABOLISM; ACUTE EXERCISE; EXPRESSION	Although the gluconeogenesis pathway is already a target for the treatment of type 2 diabetes, the potential role of microRNAs (miRNAs) in gluconeogenesis remains unclear. Here, we investigated the physiological functions of miR-214 in gluconeogenesis. The expression of miR-214 was suppressed by glucagon via protein kinase A signaling in primary hepatocytes, and miR-214 was down-regulated in the livers of fasted, high fat diet-induced diabetic and leptin receptor-mutated (db/db) mice. The overexpression of miR-214 in primary hepatocytes suppressed glucose production, and silencing miR-214 reversed this effect. Gluconeogenesis was suppressed in the livers of mice injected with an adenovirus expressing miR-214 (Ad-miR-214). Additionally, Ad-miR-214 alleviated high fat diet-induced elevation of gluconeogenesis and hyperglycemia. Furthermore, we found that activating transcription factor 4 (ATF4), a reported target of miR-214, can reverse the suppressive effect of miR-214 on gluconeogenesis in primary hepatocytes, and this suppressive effect was blocked in liver-specific ATF4 knock-out mice. ATF4 regulated gluconeogenesis via affecting forkhead box protein O1(FOXO1) transcriptional activity. Finally, liver-specific miR214 transgenic mice exhibited suppressed gluconeogenesis and reduced expression of ATF4, phosphoenolpyruvate carboxykinase, and glucose-6-phosphatase in liver. Taken together, our results suggest that the miR-214-ATF4 axis is a novel pathway for the regulation of hepatic gluconeogenesis.	[Li, Kai; Yu, Junjie; Liu, Bin; Guo, Yajie; Deng, Jiali; Chen, Shanghai; Wang, Chunxia; Guo, Feifan] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai 200031, Peoples R China; [Zhang, Jin] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Key Lab Mol Med,Minist Educ,Inst Med Sci, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Fudan University	Guo, FF (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	ffguo@sibs.ac.cn		Li, Kai/0000-0002-4040-8604	National Natural Science Foundation [81130076, 81325005, 31271269, 81100615, 81390350]; Ministry of Science and Technology of China 973 Program [2010CB912502]; Basic Research Project of Shanghai Science and Technology Commission [13JC1409000]; International S&T Cooperation Program of China Grant Singapore [2014DFG32470]; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2011KIP307]; SA-SIBS Scholarship Program; One Hundred Talents Program of the Chinese Academy of Sciences	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China 973 Program(Ministry of Science and Technology, ChinaNational Basic Research Program of China); Basic Research Project of Shanghai Science and Technology Commission; International S&T Cooperation Program of China Grant Singapore; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences); SA-SIBS Scholarship Program; One Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by National Natural Science Foundation Grants 81130076, 81325005, 31271269, 81100615, and 81390350, Ministry of Science and Technology of China 973 Program 2010CB912502, Basic Research Project of Shanghai Science and Technology Commission Grant 13JC1409000, and International S&T Cooperation Program of China Grant Singapore 2014DFG32470.; Supported by the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences Grant 2011KIP307, and the SA-SIBS Scholarship Program. To whom correspondence may be addressed. E-mail: wangcx@sibs.ac.cn.; Supported by the One Hundred Talents Program of the Chinese Academy of Sciences. To whom correspondence may be addressed. E-mail: ffguo@sibs.ac.cn.	ALFORD FP, 1974, LANCET, V2, P974; BARON AD, 1987, DIABETES, V36, P274, DOI 10.2337/diabetes.36.3.274; Berglund ED, 2009, J CLIN INVEST, V119, P2412, DOI 10.1172/JCI38650; Borba-Murad GR, 2005, CELL BIOCHEM FUNCT, V23, P405, DOI 10.1002/cbf.1163; Brown JL, 2002, ENDOCRINE, V19, P327, DOI 10.1385/ENDO:19:3:327; Charbonneau A, 2005, AM J PHYSIOL-ENDOC M, V289, pE8, DOI 10.1152/ajpendo.00570.2004; Charbonneau A, 2007, J PHYSIOL-LONDON, V579, P255, DOI 10.1113/jphysiol.2006.121954; Chen DL, 2014, HEPATOLOGY, V60, P598, DOI 10.1002/hep.27118; Cheng Y, 2011, MOL ENDOCRINOL, V25, P1624, DOI 10.1210/me.2011-0028; D'souza AM, 2012, AM J PHYSIOL-GASTR L, V302, pG850, DOI 10.1152/ajpgi.00378.2011; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Exton J H, 1979, Monogr Endocrinol, V12, P535; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Kamo N, 2013, HEPATOLOGY, V57, P289, DOI 10.1002/hep.25958; Kode A, 2012, J BIOL CHEM, V287, P8757, DOI 10.1074/jbc.M111.282897; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Li HK, 2011, BIOCHEM J, V438, P283, DOI 10.1042/BJ20110263; Li K, 2012, MOL CELL ENDOCRINOL, V348, P21, DOI 10.1016/j.mce.2011.07.026; Li XL, 2014, GENE, V533, P1, DOI 10.1016/j.gene.2013.09.105; Liang JC, 2013, J HEPATOL, V58, P535, DOI 10.1016/j.jhep.2012.10.024; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; Lynn FC, 2009, TRENDS ENDOCRIN MET, V20, P452, DOI 10.1016/j.tem.2009.05.007; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Mendez-Lucas A, 2014, J BIOL CHEM, V289, P22090, DOI 10.1074/jbc.M114.566927; MITRAKOU A, 1992, NEW ENGL J MED, V326, P22, DOI 10.1056/NEJM199201023260104; Nemecz M, 1999, HEPATOLOGY, V29, P166, DOI 10.1002/hep.510290110; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; Oh KJ, 2013, ARCH PHARM RES, V36, P189, DOI 10.1007/s12272-013-0018-5; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Perriello G, 1997, DIABETES, V46, P1010, DOI 10.2337/diabetes.46.6.1010; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Ramirez CM, 2013, MOL CELL BIOL, V33, P2891, DOI 10.1128/MCB.00016-13; REAVEN GM, 1987, J CLIN ENDOCR METAB, V64, P106, DOI 10.1210/jcem-64-1-106; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Schwarzenbach H, 2012, BREAST CANCER RES TR, V134, P933, DOI 10.1007/s10549-012-1988-6; Wajngot A, 2001, METABOLISM, V50, P47, DOI 10.1053/meta.2001.19422; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; Wang CX, 2014, J CELL MOL MED, V18, P80, DOI 10.1111/jcmm.12166; Wang CX, 2010, CELL RES, V20, P174, DOI 10.1038/cr.2010.4; Wang F, 2013, FEBS LETT, V587, P488, DOI 10.1016/j.febslet.2013.01.016; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Xu CX, 2012, J BIOL CHEM, V287, P34970, DOI 10.1074/jbc.M112.374611; Yan HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055276; Yang TS, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-68; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366; Zhang DW, 2004, ONCOGENE, V23, P8720, DOI 10.1038/sj.onc.1208153; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang Q, 2013, DIABETES, V62, P2230, DOI 10.2337/db12-1050	57	57	61	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8185	8195		10.1074/jbc.M114.633990	http://dx.doi.org/10.1074/jbc.M114.633990			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25657009	Green Published, hybrid			2022-12-28	WOS:000351662600016
J	Aguileta, MA; Korac, J; Durcan, TM; Trempe, JF; Haber, M; Gehring, K; Elsasser, S; Waidmann, O; Fon, EA; Husnjak, K				Aguileta, Miguel A.; Korac, Jelena; Durcan, Thomas M.; Trempe, Jean-Francois; Haber, Michael; Gehring, Kalle; Elsasser, Suzanne; Waidmann, Oliver; Fon, Edward A.; Husnjak, Koraljka			The E3 Ubiquitin Ligase Parkin Is Recruited to the 26 S Proteasome via the Proteasomal Ubiquitin Receptor Rpn13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; Parkin; Parkinson Disease; Proteasome; Ubiquitin; Ubiquitylation (Ubiquitination); Rpn13	PROTEIN LIGASE; MITOCHONDRIAL DEPOLARIZATION; DEUBIQUITINATING ENZYME; INTERACTING PROTEIN; ACTIVATE PARKIN; DISEASE; DOMAIN; SUBUNIT; BINDING; MITOPHAGY	Background: The role of the N-terminal ubiquitin-like domain of the E3 ligase parkin is not fully understood. Results: Parkin is recruited to the 26 S proteasome through the interaction of its ubiquitin-like domain with the intrinsic proteasomal ubiquitin receptor Rpn13. Conclusion: Parkin turnover and E3 ligase activity can be regulated by its recruitment to the 26 S proteasome via Rpn13. Significance: Parkin-Rpn13 interaction might be exploited as a potential therapeutic strategy. Mutations in the Park2 gene, encoding the RING-HECT hybrid E3 ubiquitin ligase parkin, are responsible for a common familial form of Parkinson disease. By mono- and polyubiquitinating target proteins, parkin regulates various cellular processes, including degradation of proteins within the 26 S proteasome, a large multimeric degradation machine. In our attempt to further elucidate the function of parkin, we have identified the proteasomal ubiquitin receptor Rpn13/ADRM1 as a parkin-interacting protein. We show that the N-terminal ubiquitin-like (Ubl) domain of parkin binds directly to the pleckstrin-like receptor for ubiquitin (Pru) domain within Rpn13. Using mutational analysis and NMR, we find that Pru binding involves the hydrophobic patch surrounding Ile-44 in the parkin Ubl, a region that is highly conserved between ubiquitin and Ubl domains. However, compared with ubiquitin, the parkin Ubl exhibits greater than 10-fold higher affinity for the Pru domain. Moreover, knockdown of Rpn13 in cells increases parkin levels and abrogates parkin recruitment to the 26 S proteasome, establishing Rpn13 as the major proteasomal receptor for parkin. In contrast, silencing Rpn13 did not impair parkin recruitment to mitochondria or parkin-mediated mitophagy upon carbonyl cyanide m-chlorophenyl hydrazone-induced mitochondrial depolarization. However, it did delay the clearance of mitochondrial proteins (TIM23, TIM44, and TOM20) and enhance parkin autoubiquitination. Taken together, these findings implicate Rpn13 in linking parkin to the 26 S proteasome and regulating the clearance of mitochondrial proteins during mitophagy.	[Aguileta, Miguel A.; Durcan, Thomas M.; Haber, Michael; Fon, Edward A.] McGill Univ, Montreal Neurol Inst, McGill Parkinson Program, Montreal, PQ H3A 2B4, Canada; [Aguileta, Miguel A.; Durcan, Thomas M.; Haber, Michael; Fon, Edward A.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Korac, Jelena; Fon, Edward A.] Univ Split, Sch Med, Split 21000, Croatia; [Trempe, Jean-Francois; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Elsasser, Suzanne] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Waidmann, Oliver; Husnjak, Koraljka] Goethe Univ Frankfurt, Sch Med, D-60590 Frankfurt, Germany	McGill University; McGill University; University of Split; McGill University; Harvard University; Harvard Medical School; Goethe University Frankfurt	Husnjak, K (corresponding author), Goethe Univ Frankfurt, Sch Med, D-60590 Frankfurt, Germany.	husnjak@biochem2.de	Prlic, Jelena Korac/AAJ-1029-2021; Prlic, Jelena Korac/I-7988-2012; Husnjak, Koraljka/C-3717-2015; Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Prlic, Jelena Korac/0000-0002-7840-9979; Prlic, Jelena Korac/0000-0002-7840-9979; Husnjak, Koraljka/0000-0003-0573-6239; Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	Canadian Institutes of Health Research [MOP-62714, MOP-125924]; LOEWE program of the State of Hesse (Germany); Consejo Nacional de Ciencia y Tecnologia Scholarship [206679/303781]; City of Split, Croatia; National Institutes of Health [GM043601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043601, R01GM043601] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); LOEWE program of the State of Hesse (Germany); Consejo Nacional de Ciencia y Tecnologia Scholarship; City of Split, Croatia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Canadian Institutes of Health Research Operating Grants MOP-62714 and MOP-125924, as well as the LOEWE program of the State of Hesse (Germany).; Supported by Consejo Nacional de Ciencia y Tecnologia Scholarship 206679/303781.; Supported by National Institutes of Health Grant GM043601.	Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chen X, 2010, MOL CELL, V38, P404, DOI 10.1016/j.molcel.2010.04.019; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Dachsel JC, 2005, FEBS LETT, V579, P3913, DOI 10.1016/j.febslet.2005.06.003; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; Durcan TM, 2014, EMBO J, V33, P2473, DOI 10.15252/embj.201489729; Durcan TM, 2011, HUM MOL GENET, V20, P141, DOI 10.1093/hmg/ddq452; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Finney N, 2003, J BIOL CHEM, V278, P16054, DOI 10.1074/jbc.C300051200; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Giasson BI, 2001, NEURON, V31, P885, DOI 10.1016/S0896-6273(01)00439-1; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imam SZ, 2011, J NEUROSCI, V31, P157, DOI 10.1523/JNEUROSCI.1833-10.2011; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; Safadi SS, 2007, BIOCHEMISTRY-US, V46, P14162, DOI 10.1021/bi7016969; Safadi SS, 2011, BIOCHEMISTRY-US, V50, P2603, DOI 10.1021/bi200065g; Safadi SS, 2010, J BIOL CHEM, V285, P1424, DOI 10.1074/jbc.M109.041970; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tomoo K, 2008, BBA-PROTEINS PROTEOM, V1784, P1059, DOI 10.1016/j.bbapap.2008.04.009; Trempe JF, 2009, MOL CELL, V36, P1034, DOI 10.1016/j.molcel.2009.11.021; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Um JW, 2010, J NEUROSCI, V30, P11805, DOI 10.1523/JNEUROSCI.2862-09.2010; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	61	32	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7492	7505		10.1074/jbc.M114.614925	http://dx.doi.org/10.1074/jbc.M114.614925			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25666615	Green Published, hybrid			2022-12-28	WOS:000351613600017
J	Walker, RG; Angerman, EB; Kattamuri, C; Lee, YS; Lee, SJ; Thompson, TB				Walker, Ryan G.; Angerman, Elizabeth B.; Kattamuri, Chandramohan; Lee, Yun-Sil; Lee, Se-Jin; Thompson, Thomas B.			Alternative Binding Modes Identified for Growth and Differentiation Factor-associated Serum Protein (GASP) Family Antagonism of Myostatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Analytical Ultracentrifugation; Myostatin; Small Angle X-ray Scattering (SAXS); Structural Biology; Transforming Growth Factor Beta (TGF-B); Growth and Differentiation-associated Serum Protein; Growth and Differentiation factor-8 (GDF-8); WFIKKN	BONE-MORPHOGENETIC PROTEIN; SKELETAL-MUSCLE MASS; RECEPTOR-BINDING; BIOLOGICAL-ACTIVITY; INHIBITORY MODULES; SURFACE BINDING; MULTIPLE TYPES; ACTIVIN-A; FOLLISTATIN; DOMAINS	Background: GASP-1 and GASP-2 are highly specific antagonists for the TGF- ligand myostatin, a negative regulator of muscle growth. Results: GASP-1 and GASP-2 form asymmetric and symmetric complexes with myostatin, respectively. Conclusion: Despite the different binding modes, the GASP proteins retain a high specificity for myostatin. Significance: Inhibition of myostatin can be achieved using different binding modes and may facilitate future development of novel anti-myostatin therapeutics. Myostatin, a member of the TGF- family of ligands, is a strong negative regulator of muscle growth. As such, it is a prime therapeutic target for muscle wasting disorders. Similar to other TGF- family ligands, myostatin is neutralized by binding one of a number of structurally diverse antagonists. Included are the antagonists GASP-1 and GASP-2, which are unique in that they specifically antagonize myostatin. However, little is known from a structural standpoint describing the interactions of GASP antagonists with myostatin. Here, we present the First low resolution solution structure of myostatin-free and myostatin-bound states of GASP-1 and GASP-2. Our studies have revealed GASP-1, which is 100 times more potent than GASP-2, preferentially binds myostatin in an asymmetrical 1:1 complex, whereas GASP-2 binds in a symmetrical 2:1 complex. Additionally, C-terminal truncations of GASP-1 result in less potent myostatin inhibitors that form a 2:1 complex, suggesting that the C-terminal domains of GASP-1 are the primary mediators for asymmetric complex formation. Overall, this study provides a new perspective on TGF- antagonism, where closely related antagonists can utilize different ligand-binding strategies.	[Walker, Ryan G.; Angerman, Elizabeth B.; Kattamuri, Chandramohan; Thompson, Thomas B.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Coll Med, Cincinnati, OH 45267 USA; [Lee, Yun-Sil; Lee, Se-Jin] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	University System of Ohio; University of Cincinnati; Johns Hopkins University	Thompson, TB (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Med Sci Bldg,231 Albert Sabin Way, Cincinnati, OH 45267 USA.	tom.thompson@uc.edu		Walker, Ryan/0000-0001-6160-8026; Thompson, Thomas/0000-0002-7041-5047	National Institutes of Health [R01AR060636, R01GM105404]; Integrated Diffraction Analysis Technologies Program of the Department of Energy Office of Basic Energy Sciences; American Heart Association [12PRE11790027]; Muscular Dystrophy Association [240087]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS072027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrated Diffraction Analysis Technologies Program of the Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); American Heart Association(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AR060636 (to S.-J. L.) and R01GM105404 (to Project MINOS). This work was also supported by the Integrated Diffraction Analysis Technologies Program of the Department of Energy Office of Basic Energy Sciences (to Advanced Light Source at Lawrence Berkeley National Laboratory), American Heart Association Grant 12PRE11790027 (to R. G. W.), and Muscular Dystrophy Association Grant 240087 (to T. B. T.).	Amthor H, 2004, DEV BIOL, V270, P19, DOI 10.1016/j.ydbio.2004.01.046; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Brun C, 2012, CELL PHYSIOL BIOCHEM, V30, P791, DOI 10.1159/000341458; Cash JN, 2013, J BIOMOL SCREEN, V18, P837, DOI 10.1177/1087057113482585; Cash JN, 2012, MOL ENDOCRINOL, V26, P1167, DOI 10.1210/me.2012-1061; Cash JN, 2012, J BIOL CHEM, V287, P1043, DOI 10.1074/jbc.M111.270801; Cash JN, 2009, EMBO J, V28, P2662, DOI 10.1038/emboj.2009.205; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Kondas K, 2008, J BIOL CHEM, V283, P23677, DOI 10.1074/jbc.M803025200; Lee Se-Jin, 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P183; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lee YS, 2013, P NATL ACAD SCI USA, V110, pE3713, DOI 10.1073/pnas.1309907110; McCroskery S, 2005, J CELL SCI, V118, P3531, DOI 10.1242/jcs.02482; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Monestier O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043710; Nakatani M, 2008, FASEB J, V22, P477, DOI 10.1096/fj.07-8673com; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; Stamler R, 2008, J BIOL CHEM, V283, P32831, DOI 10.1074/jbc.M801266200; Svitel J, 2003, BIOPHYS J, V84, P4062, DOI 10.1016/S0006-3495(03)75132-7; Szlama G, 2013, FEBS J, V280, P3822, DOI 10.1111/febs.12377; Szlama G, 2010, FEBS J, V277, P5040, DOI 10.1111/j.1742-4658.2010.07909.x; Thies RS, 2001, GROWTH FACTORS, V18, P251; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Trexler M, 2002, BIOL CHEM, V383, P223, DOI 10.1515/BC.2002.023; Trexler M, 2001, P NATL ACAD SCI USA, V98, P3705, DOI 10.1073/pnas.061028398; Troilo H, 2014, P NATL ACAD SCI USA, V111, P13063, DOI 10.1073/pnas.1404166111; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wagner KR, 2005, P NATL ACAD SCI USA, V102, P2519, DOI 10.1073/pnas.0408729102; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017; Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200	39	18	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7506	7516		10.1074/jbc.M114.624130	http://dx.doi.org/10.1074/jbc.M114.624130			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25657005	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000351613600018
J	Avasarala, S; Van Scoyk, M; Rathinam, MKK; Zerayesus, S; Zhao, XM; Zhang, W; Pergande, MR; Borgia, JA; DeGregori, J; Port, JD; Winn, RA; Bikkavilli, RK				Avasarala, Sreedevi; Van Scoyk, Michelle; Rathinam, Manoj Kumar Karuppusamy; Zerayesus, Sereke; Zhao, Xiangmin; Zhang, Wei; Pergande, Melissa R.; Borgia, Jeffrey A.; DeGregori, James; Port, J. David; Winn, Robert A.; Bikkavilli, Rama Kamesh			PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ARGININE METHYLTRANSFERASES; E-CADHERIN; UP-REGULATION; TWIST; METHYLATION; EXPRESSION; PHOSPHORYLATION; BREAST; TRANSCRIPTION; SURVIVAL	Protein arginine methyl transferase 1 (PRMT1) was shown to be up-regulated in cancers and important for cancer cell proliferation. However, the role of PRMT1 in lung cancer progression and metastasis remains incompletely understood. In the present study, we show that PRMT1 is an important regulator of epithelial-mesenchymal transition (EMT), cancer cell migration, and invasion, which are essential processes during cancer progression, and metastasis. Additionally, we have identified Twist1, a basic helix-loop-helix transcription factor and a well-known E-cadherin repressor, as a novel PRMT1 substrate. Taken together, we show that PRMT1 is a novel regulator of EMT and arginine 34 (Arg-34) methylation of Twist1 as a unique "methyl arginine mark" for active E-cadherin repression. Therefore, targeting PRMT1-mediated Twist1 methylation might represent a novel strategy for developing new anti-invasive/anti-metastatic drugs. Moreover, methylated Twist1 (Arg-34), as such, could also emerge as a potential important biomarker for lung cancer.	[Avasarala, Sreedevi; Van Scoyk, Michelle; Rathinam, Manoj Kumar Karuppusamy; Zerayesus, Sereke; Zhao, Xiangmin; Winn, Robert A.; Bikkavilli, Rama Kamesh] Univ Illinois, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60612 USA; [Zhang, Wei] Univ Illinois, Dept Pediat, Chicago, IL 60612 USA; [Pergande, Melissa R.; Borgia, Jeffrey A.] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Pergande, Melissa R.; Borgia, Jeffrey A.] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [DeGregori, James] Univ Colorado, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Port, J. David] Univ Colorado, Dept Med Cardiol & Pharmacol, Aurora, CO 80045 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; Rush University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Bikkavilli, RK (corresponding author), Univ Illinois, Div Pulm Crit Care Sleep & Allergy, Dept Med, Coll Med, Rm 3091,Res Bldg,909 S Wolcott Ave, Chicago, IL 60612 USA.	kamesh@uic.edu	Regan, Clinton/E-6250-2012	DeGregori, James/0000-0002-1287-1976; Pergande, Melissa/0000-0003-1197-4057; Port, Jonathan D./0000-0001-7048-3544	National Institutes of Health [R01CA138528]; Merit Award from the U.S. Dept. of Veterans Affairs	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Award from the U.S. Dept. of Veterans Affairs(US Department of Veterans Affairs)	This study was supported, in whole or in part, by National Institutes of Health Grant R01CA138528 (to R. W.) and a Merit Award from the U.S. Dept. of Veterans Affairs.	Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bikkavilli RK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00805; Bikkavilli RK, 2012, J CELL SCI, V125, P2446, DOI 10.1242/jcs.100933; Bikkavilli RK, 2011, J CELL SCI, V124, P2310, DOI 10.1242/jcs.084046; BOFFA LC, 1977, BIOCHEM BIOPH RES CO, V74, P969, DOI 10.1016/0006-291X(77)91613-8; Bren-Mattison Y, 2005, ONCOGENE, V24, P1412, DOI 10.1038/sj.onc.1208333; Cha B, 2012, EXPERT OPIN THER TAR, V16, P651, DOI 10.1517/14728222.2012.688030; Silva BSD, 2014, J ORAL PATHOL MED, V43, P125, DOI 10.1111/jop.12096; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Devine DJ, 2014, ONCOGENE, V33, P2620, DOI 10.1038/onc.2013.215; Dhar S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01311; Elakoum R, 2014, BIOCHIMIE, V97, P210, DOI 10.1016/j.biochi.2013.10.021; Feng ZZ, 2013, JPN J CLIN ONCOL, V43, P396, DOI 10.1093/jjco/hys237; Han SU, 2005, ANN SURG, V242, P676, DOI 10.1097/01.sla.0000186171.85804.fe; Hong J, 2011, CANCER RES, V71, P3980, DOI 10.1158/0008-5472.CAN-10-2914; Hosono S, 2007, BRIT J CANCER, V96, P314, DOI 10.1038/sj.bjc.6603533; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Kyo S, 2006, HUM PATHOL, V37, P431, DOI 10.1016/j.humpath.2005.12.021; Lander R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2543; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Limm K, 2013, EUR J CANCER, V49, P1305, DOI 10.1016/j.ejca.2012.11.026; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Montserrat N, 2011, HUM PATHOL, V42, P103, DOI 10.1016/j.humpath.2010.05.019; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; PAIK WK, 1968, J BIOL CHEM, V243, P2108; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Shaw KRM, 2004, J MAMMARY GLAND BIOL, V9, P297, DOI 10.1007/s10911-004-1402-z; Singh S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-47; Tadesse H, 2008, HUM MOL GENET, V17, P506, DOI 10.1093/hmg/ddm327; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Vichalkovski A, 2010, ONCOGENE, V29, P3554, DOI 10.1038/onc.2010.115; Wang WS, 2013, ASIAN PAC J CANCER P, V14, P669, DOI 10.7314/APJCP.2013.14.2.669; Wilson-Rawls J, 2004, J BIOL CHEM, V279, P37685, DOI 10.1074/jbc.M401319200; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yoshimatsu M, 2011, INT J CANCER, V128, P562, DOI 10.1002/ijc.25366; Yuen HF, 2007, J CLIN PATHOL, V60, P510, DOI 10.1136/jcp.2006.039099	47	72	83	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13479	13489		10.1074/jbc.M114.636050	http://dx.doi.org/10.1074/jbc.M114.636050			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847239	Green Published, hybrid			2022-12-28	WOS:000354975700042
J	Yan, JP; Hao, CL; DeLucia, M; Swanson, S; Florens, L; Washburn, MP; Ahn, J; Skowronski, J				Yan, Junpeng; Hao, Caili; DeLucia, Maria; Swanson, Selene; Florens, Laurence; Washburn, Michael P.; Ahn, Jinwoo; Skowronski, Jacek			CyclinA2-Cyclin-dependent Kinase Regulates SAMHD1 Protein Phosphohydrolase Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTION FACTOR SAMHD1; AICARDI-GOUTIERES SYNDROME; E3 UBIQUITIN LIGASE; ALLOSTERIC ACTIVATION; RECOGNITION MOTIF; STRUCTURAL BASIS; HIV-1 INFECTION; DNA-DAMAGE; CELL; PHOSPHORYLATION	SAMHD1 is a nuclear deoxyribonucleoside triphosphate triphosphohydrolase that contributes to the control of cellular deoxyribonucleoside triphosphate (dNTP) pool sizes through dNTP hydrolysis and modulates the innate immune response to viruses. CyclinA2-CDK1/2 phosphorylates SAMHD1 at Thr-592, but how this modification controls SAMHD1 functions in proliferating cells is not known. Here, we show that SAMHD1 levels remain relatively unchanged during the cell division cycle in primary human T lymphocytes and in monocytic cell lines. Inactivation of the bipartite cyclinA2-CDK-binding site in the SAMHD1 C terminus described herein abolished SAMHD1 phosphorylation on Thr-592 during S and G(2) phases thus interfering with DNA replication and progression of cells through S phase. The effects exerted by Thr-592 phosphorylation-defective SAMHD1 mutants were associated with activation of DNA damage checkpoint and depletion of dNTP concentrations to levels lower than those seen upon expression of wild type SAMHD1 protein. These disruptive effects were relieved by either mutation of the catalytic residues of the SAMHD1 phosphohydrolase domain or by a Thr-592 phosphomimetic mutation, thus linking the Thr-592 phosphorylation state to the control of SAMHD1 dNTPase activity. Our findings support a model in which phosphorylation of Thr-592 by cyclinA2-CDK down-modulates, but does not inactivate, SAMHD1 dNTPase in S phase, thereby fine-tuning SAMHD1 control of dNTP levels during DNA replication.	[Yan, Junpeng; Hao, Caili; Skowronski, Jacek] Case Western Reserve Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [DeLucia, Maria; Ahn, Jinwoo] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Ahn, Jinwoo; Skowronski, Jacek] Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA; [Swanson, Selene; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Case Western Reserve University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Skowronski, J (corresponding author), Case Western Reserve Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	jacek.skowronski@case.edu	Regan, Clinton/E-6250-2012	Washburn, Michael/0000-0001-7568-2585; Florens, Laurence/0000-0002-9310-6650	National Institutes of Health [AI077459, AI100673, P50GM082251]; CFAR [P30 AI036219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, R01AI100673, R01AI077459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077459 and AI100673 (to J. S.), P50GM082251 (to J. A.), and CFAR Grant P30 AI036219.	Adams PD, 1996, MOL CELL BIOL, V16, P6623; Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Amie SM, 2013, J BIOL CHEM, V288, P25001, DOI 10.1074/jbc.C113.493619; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Crow YJ, 2013, HAND CLINIC, V113, P1629, DOI 10.1016/B978-0-444-59565-2.00031-9; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Gramberg T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-26; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hansen EC, 2014, P NATL ACAD SCI USA, V111, pE1843, DOI 10.1073/pnas.1401706111; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Janardhan A, 2004, PLOS BIOL, V2, P65, DOI 10.1371/journal.pbio.0020006; Ji XY, 2014, P NATL ACAD SCI USA, V111, pE4305, DOI 10.1073/pnas.1412289111; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Koharudin LMI, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.591958; Kretschmer S, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204845; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Niida H, 2010, GENE DEV, V24, P333, DOI 10.1101/gad.1863810; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pauls E, 2014, J IMMUNOL, V193, P1988, DOI 10.4049/jimmunol.1400873; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rehwinkel J, 2013, EMBO J, V32, P2454, DOI 10.1038/emboj.2013.163; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Stillman B, 2013, P NATL ACAD SCI USA, V110, P14120, DOI 10.1073/pnas.1312901110; Takeda DY, 2001, J BIOL CHEM, V276, P1993, DOI 10.1074/jbc.M005719200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	50	70	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13279	13292		10.1074/jbc.M115.646588	http://dx.doi.org/10.1074/jbc.M115.646588			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847232	Green Published, hybrid			2022-12-28	WOS:000354975700028
J	Pieren, M; Desfougeres, Y; Michaillat, L; Schmidt, A; Mayer, A				Pieren, Michel; Desfougeres, Yann; Michaillat, Lydie; Schmidt, Andrea; Mayer, Andreas			Vacuolar SNARE Protein Transmembrane Domains Serve as Nonspecific Membrane Anchors with Unequal Roles in Lipid Mixing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEC17P ALPHA-SNAP; YEAST VACUOLES; IN-VITRO; T-SNARE; NEUROTRANSMITTER RELEASE; JUXTAMEMBRANE REGION; FUSION REQUIRES; PEPTIDE MIMICS; COMPLEX; DOCKING	Membrane fusion is induced by SNARE complexes that are anchored in both fusion partners. SNAREs zipper up from the N to C terminus bringing the two membranes into close apposition. Their transmembrane domains (TMDs) might be mere anchoring devices, deforming bilayers by mechanical force. Structural studies suggested that TMDs might also perturb lipid structure by undergoing conformational transitions or by zipping up into the bilayer. Here, we tested this latter hypothesis, which predicts that the activity of SNAREs should depend on the primary sequence of their TMDs. We replaced the TMDs of all vacuolar SNAREs (Nyv1, Vam3, and Vti1) by a lipid anchor, by a TMD from a protein unrelated to the membrane fusion machinery, or by artificial leucine-valine sequences. Individual exchange of the native SNARE TMDs against an unrelated transmembrane anchor or an artificial leucine-valine sequence yielded normal fusion activities. Fusion activity was also preserved upon pairwise exchange of the TMDs against unrelated peptides, which eliminates the possibility for specific TMD-TMD interactions. Thus, a specific primary sequence or zip-pering beyond the SNARE domains is not a prerequisite for fusion. Lipid-anchored Vti1 was fully active, and lipid-anchored Nyv1 permitted the reaction to proceed up to hemifusion, and lipid-anchored Vam3 interfered already before hemifusion. The unequal contribution of proteinaceous TMDs on Vam3 and Nyv1 suggests that Q-and R-SNAREs might make different contributions to the hemifusion intermediate and the opening of the fusion pore. Furthermore, our data support the view that SNARE TMDs serve as nonspecific membrane anchors in vacuole fusion.	[Pieren, Michel; Desfougeres, Yann; Michaillat, Lydie; Schmidt, Andrea; Mayer, Andreas] Univ Lausanne, Dept Biochim, CH-1066 Epalinges, Switzerland	University of Lausanne	Mayer, A (corresponding author), Univ Lausanne, Dept Biochim, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	andreas.mayer@unil.ch	Mayer, Andreas/AAE-4315-2020	Mayer, Andreas/0000-0001-6131-313X; Desfougeres, Yann/0000-0002-6450-5863	Roche Research Foundation; Swiss National Science Foundation	Roche Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Roche Research Foundation and the Swiss National Science Foundation.	Alpadi K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001243; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Choi UB, 2010, NAT STRUCT MOL BIOL, V17, P318, DOI 10.1038/nsmb.1763; Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104; Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658; CONRADT B, 1994, J CELL BIOL, V126, P99, DOI 10.1083/jcb.126.1.99; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Dietrich LEP, 2004, EMBO J, V23, P45, DOI 10.1038/sj.emboj.7600015; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fdez E, 2010, J CELL SCI, V123, P2473, DOI 10.1242/jcs.061325; Gao JH, 2009, AM J TRANSL RES, V1, P312; Grote E, 2000, J CELL BIOL, V151, P453, DOI 10.1083/jcb.151.2.453; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Hofmann MW, 2006, J MOL BIOL, V364, P1048, DOI 10.1016/j.jmb.2006.09.077; Hofmann MW, 2004, P NATL ACAD SCI USA, V101, P14776, DOI 10.1073/pnas.0405175101; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; JONES EW, 1982, GENETICS, V102, P665; Jun Y, 2007, EMBO J, V26, P4935, DOI 10.1038/sj.emboj.7601915; Kee Y, 1996, J NEUROSCI, V16, P1975; Kesavan J, 2007, CELL, V131, P351, DOI 10.1016/j.cell.2007.09.025; Kim JY, 2012, EMBO J, V31, P2144, DOI 10.1038/emboj.2012.57; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Langosch D, 2001, J BIOL CHEM, V276, P32016, DOI 10.1074/jbc.M102579200; Langosch D, 2001, J MOL BIOL, V311, P709, DOI 10.1006/jmbi.2001.4889; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3; Milovanovic D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6984; Neumann S, 2011, PROTEINS, V79, P2418, DOI 10.1002/prot.23063; Ngatchou AN, 2010, P NATL ACAD SCI USA, V107, P18463, DOI 10.1073/pnas.1006727107; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Orzaez M, 2004, J MOL BIOL, V335, P631, DOI 10.1016/j.jmb.2003.10.062; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Parlati F, 2000, NATURE, V407, P194, DOI 10.1038/35025076; Pieren M, 2010, NAT STRUCT MOL BIOL, V17, P710, DOI 10.1038/nsmb.1809; Poschner BC, 2010, MOL MEMBR BIOL, V27, P1, DOI 10.3109/09687680903362044; Poschner BC, 2009, J MOL BIOL, V386, P733, DOI 10.1016/j.jmb.2008.12.077; Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722; Risselada HJ, 2012, CURR OPIN STRUC BIOL, V22, P187, DOI 10.1016/j.sbi.2012.01.007; Rohde J, 2003, J BIOL CHEM, V278, P1656, DOI 10.1074/jbc.M209522200; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; SCOTT JH, 1980, J BACTERIOL, V142, P414, DOI 10.1128/JB.142.2.414-423.1980; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Tong JS, 2009, P NATL ACAD SCI USA, V106, P5141, DOI 10.1073/pnas.0813138106; Ungermann C, 1998, EMBO J, V17, P3269, DOI 10.1093/emboj/17.12.3269; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Van Komen JS, 2005, EUKARYOT CELL, V4, P2017, DOI 10.1128/EC.4.12.2017-2028.2005; Wang L, 2000, J BIOL CHEM, V275, P22862, DOI 10.1074/jbc.M001447200; Wang Y, 2001, J BIOL CHEM, V276, P28598, DOI 10.1074/jbc.M101644200; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2002, EMBO J, V21, P1241, DOI 10.1093/emboj/21.6.1241; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Xu H, 2011, P NATL ACAD SCI USA, V108, P17325, DOI 10.1073/pnas.1113888108; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Yassine W, 2009, BBA-BIOMEMBRANES, V1788, P1722, DOI 10.1016/j.bbamem.2009.05.014; Zhou P, 2013, NEURON, V80, P470, DOI 10.1016/j.neuron.2013.09.010	67	21	21	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12821	12832		10.1074/jbc.M115.647776	http://dx.doi.org/10.1074/jbc.M115.647776			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25817997	Green Published, hybrid			2022-12-28	WOS:000354569000033
J	Bianchetti, CM; Takasuka, TE; Deutsch, S; Udell, HS; Yik, EJ; Bergeman, LF; Fox, BG				Bianchetti, Christopher M.; Takasuka, Taichi E.; Deutsch, Sam; Udell, Hannah S.; Yik, Eric J.; Bergeman, Lai F.; Fox, Brian G.			Active Site and Laminarin Binding in Glycoside Hydrolase Family 55	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Genomics; Glycoside Hydrolase; Hydrolase; Proteomics; X-ray Crystallography; -1; 3-Glucanase; GH55; Cell-free Translation; Exo-glucanase; Proteomics	AROMATIC-CARBOHYDRATE INTERACTIONS; FUNCTIONAL-ANALYSIS; TRICHODERMA-REESEI; CLONING; GENE; EXPRESSION; BIOMASS; ENZYME; ENDO-BETA-1,3-GLUCANASE; BETA-1,3-GLUCANASE	Background: SacteLam55A is a GH55 enzyme from highly cellulolytic Streptomyces sp. SirexAA-E. Results: Substrate-bound structures identify residues involved in binding, catalysis, enforcement of reaction specificity, and possibly processivity. Conclusion: Natural GH55 are exo--1,3-glucanases with a broad range of temperature and pH optima. Significance: Experimental annotation of GH phylogenetic space by use of bioinformatics, high throughput cell-free translation, biochemical assay, and structure determination is feasible. The Carbohydrate Active Enzyme (CAZy) database indicates that glycoside hydrolase family 55 (GH55) contains both endo- and exo--1,3-glucanases. The founding structure in the GH55 is PcLam55A from the white rot fungus Phanerochaete chrysosporium (Ishida, T., Fushinobu, S., Kawai, R., Kitaoka, M., Igarashi, K., and Samejima, M. (2009) Crystal structure of glycoside hydrolase family 55 -1,3-glucanase from the basidiomycete Phanerochaete chrysosporium. J. Biol. Chem. 284, 10100-10109). Here, we present high resolution crystal structures of bacterial SacteLam55A from the highly cellulolytic Streptomyces sp. SirexAA-E with bound substrates and product. These structures, along with mutagenesis and kinetic studies, implicate Glu-502 as the catalytic acid (as proposed earlier for Glu-663 in PcLam55A) and a proton relay network of four residues in activating water as the nucleophile. Further, a set of conserved aromatic residues that define the active site apparently enforce an exo-glucanase reactivity as demonstrated by exhaustive hydrolysis reactions with purified laminarioligosaccharides. Two additional aromatic residues that line the substrate-binding channel show substrate-dependent conformational flexibility that may promote processive reactivity of the bound oligosaccharide in the bacterial enzymes. Gene synthesis carried out on approximate to 30% of the GH55 family gave 34 active enzymes (19% functional coverage of the nonredundant members of GH55). These active enzymes reacted with only laminarin from a panel of 10 different soluble and insoluble polysaccharides and displayed a broad range of specific activities and optima for pH and temperature. Application of this experimental method provides a new, systematic way to annotate glycoside hydrolase phylogenetic space for functional properties.	[Bianchetti, Christopher M.; Takasuka, Taichi E.; Udell, Hannah S.; Bergeman, Lai F.; Fox, Brian G.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Bianchetti, Christopher M.] Univ Wisconsin, Dept Chem, Oshkosh, WI 54901 USA; [Takasuka, Taichi E.] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Deutsch, Sam] Joint Genome Inst, Walnut Creek, CA 94598 USA; [Yik, Eric J.] Calif State Univ Fullerton, Dept Chem & Biochem, Fullerton, CA 92831 USA	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; Hokkaido University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; California State University System; California State University Fullerton	Fox, BG (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	bgfox@biochem.wisc.edu	Takasuka, Taichi/AAF-9441-2020	Takasuka, Taichi/0000-0002-4413-2924; Deutsch, Samuel/0000-0001-9456-7101	Department of Energy Great Lakes Bioenergy Research Center BER Office of Science [DE-FC02-07ER64494]; U.S. Department of Energy, Basic Energy Sciences, Offices of Science [W-31-109-ENG-38]; College of Agricultural and Life Sciences, Department of Biochemistry; Graduate School of the University of Wisconsin; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant [085P1000817]	Department of Energy Great Lakes Bioenergy Research Center BER Office of Science(United States Department of Energy (DOE)); U.S. Department of Energy, Basic Energy Sciences, Offices of Science(United States Department of Energy (DOE)); College of Agricultural and Life Sciences, Department of Biochemistry; Graduate School of the University of Wisconsin; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant	This work was supported by Department of Energy Great Lakes Bioenergy Research Center BER Office of Science Grant DE-FC02-07ER64494. The use of Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Offices of Science Contract W-31-109-ENG-38. Use of the Life Science Collaborative Access Team at the Advanced Photon Source was supported by the College of Agricultural and Life Sciences, Department of Biochemistry, the Graduate School of the University of Wisconsin, the Michigan Economic Development Corporation, and Michigan Technology Tri-Corridor Grant 085P1000817.	Adams AS, 2011, ISME J, V5, P1323, DOI 10.1038/ismej.2011.14; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aylward FO, 2014, MBIO, V5, DOI 10.1128/mBio.02077-14; Aylward FO, 2012, ISME J, V6, P1688, DOI 10.1038/ismej.2012.10; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bianchetti CM, 2013, J BIOL CHEM, V288, P18574, DOI 10.1074/jbc.M113.475848; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Blommel Paul G., 2009, V498, P55, DOI 10.1007/978-1-59745-196-3_4; Book AJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-109; Book AJ, 2014, APPL ENVIRON MICROB, V80, P4692, DOI 10.1128/AEM.01133-14; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Burnley BT, 2012, ELIFE, V1, DOI 10.7554/eLife.00311; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carnegie AJ, 2006, ANN FOREST SCI, V63, P119, DOI 10.1051/forest:2005104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XY, 2009, PLANT SIGNAL BEHAV, V4, P489, DOI 10.4161/psb.4.6.8359; Cockburn D, 2014, BIOLOGIA, V69, P705, DOI 10.2478/s11756-014-0373-9; Cohen-Kupiec R, 1999, GENE, V226, P147, DOI 10.1016/S0378-1119(98)00583-6; DAMUDE HG, 1995, BIOCHEMISTRY-US, V34, P2220, DOI 10.1021/bi00007a016; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DELACRUZ J, 1995, J BACTERIOL, V177, P6937, DOI 10.1128/jb.177.23.6937-6945.1995; Donzelli BGG, 2001, GENE, V277, P199, DOI 10.1016/S0378-1119(01)00681-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fox Brian G, 2009, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0523s56; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Giczey G, 2001, APPL ENVIRON MICROB, V67, P865, DOI 10.1128/AEM.67.2.865-871.2001; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Huang EL, 2014, ENV MICROBIOL REP, V6, P389, DOI 10.1111/1758-2229.12163; Igarashi Y, 2007, BIOORG MED CHEM LETT, V17, P3702, DOI 10.1016/j.bmcl.2007.04.039; Ishida T, 2009, J BIOL CHEM, V284, P10100, DOI 10.1074/jbc.M808122200; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Kallimanis A, 2009, INT J SYST EVOL MICR, V59, P275, DOI 10.1099/ijs.0.000984-0; Kawai R, 2006, BIOTECHNOL LETT, V28, P365, DOI 10.1007/s10529-005-6179-7; Kim DJ, 2002, CURR GENET, V40, P374, DOI 10.1007/s00294-001-0267-6; Kitamura M, 2008, J BIOL CHEM, V283, P36328, DOI 10.1074/jbc.M806115200; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUKOR JJ, 1983, SCIENCE, V220, P1161, DOI 10.1126/science.220.4602.1161; Labourel A, 2014, J BIOL CHEM, V289, P2027, DOI 10.1074/jbc.M113.538843; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Levin EJ, 2007, STRUCTURE, V15, P1040, DOI 10.1016/j.str.2007.06.019; Ludwiczek ML, 2007, J MOL BIOL, V373, P337, DOI 10.1016/j.jmb.2007.07.057; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nakamura A, 2013, J BIOL CHEM, V288, P13503, DOI 10.1074/jbc.M113.452623; Nobe R, 2004, BIOSCI BIOTECH BIOCH, V68, P2111, DOI 10.1271/bbb.68.2111; Nobe R, 2003, BIOSCI BIOTECH BIOCH, V67, P1349, DOI 10.1271/bbb.67.1349; Okazaki K, 2007, BIOSCI BIOTECH BIOCH, V71, P1568, DOI 10.1271/bbb.70030; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; PEAT S, 1958, J CHEM SOC, P729, DOI 10.1039/jr9580000729; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ramadhar TR, 2014, J ANTIBIOT, V67, P53, DOI 10.1038/ja.2013.77; Read SM, 1996, CARBOHYD RES, V281, P187, DOI 10.1016/0008-6215(95)00350-9; Richardson SM, 2010, NUCLEIC ACIDS RES, V38, P2603, DOI 10.1093/nar/gkq143; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Savatin DV, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00470; SCHAEFFER HJ, 1994, APPL ENVIRON MICROB, V60, P594, DOI 10.1128/AEM.60.2.594-598.1994; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Takasuka TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094166; Takasuka TE, 2014, METHODS MOL BIOL, V1118, P71, DOI 10.1007/978-1-62703-782-2_5; Takasuka TE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01030; Taylor CB, 2013, J PHYS CHEM B, V117, P4924, DOI 10.1021/jp401410h; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Vuong TV, 2010, BIOTECHNOL BIOENG, V107, P195, DOI 10.1002/bit.22838; Vuong TV, 2009, FEBS J, V276, P4261, DOI 10.1111/j.1742-4658.2009.07097.x; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wojtkowiak A, 2013, ACTA CRYSTALLOGR D, V69, P52, DOI 10.1107/S0907444912042175; Wu HM, 2009, J BIOL CHEM, V284, P26708, DOI 10.1074/jbc.M109.010983; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200	75	24	25	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11819	11832		10.1074/jbc.M114.623579	http://dx.doi.org/10.1074/jbc.M114.623579			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25752603	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000354388600002
J	Kara, N; Hossain, M; Prasanth, SG; Stillman, B				Kara, Nihan; Hossain, Manzar; Prasanth, Supriya G.; Stillman, Bruce			Orc1 Binding to Mitotic Chromosomes Precedes Spatial Patterning during G(1) Phase and Assembly of the Origin Recognition Complex in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; DNA-binding Protein; DNA Replication; Mitosis; Protein-DNA Interaction; FOXA1; Origin Recognition Complex	EUKARYOTIC DNA-REPLICATION; MEIER-GORLIN SYNDROME; EARLY G1 PHASE; S-PHASE; FISSION YEAST; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS; IN-VIVO; SACCHAROMYCES-CEREVISIAE; CHROMATIN ASSOCIATION	Background: Orc1 is the largest subunit of the origin recognition complex that promotes genome duplication. Results: We studied the dynamics of Orc1 during the cell division cycle. Conclusion: Orc1 binds to mitotic chromosomes, and during G(1) phase in the daughter cells it then forms spatial-temporal patterns in the nucleus. Significance: The large subunit of ORC orchestrates the earliest stages of chromosome inheritance. Replication of eukaryotic chromosomes occurs once every cell division cycle in normal cells and is a tightly controlled process that ensures complete genome duplication. The origin recognition complex (ORC) plays a key role during the initiation of DNA replication. In human cells, the level of Orc1, the largest subunit of ORC, is regulated during the cell division cycle, and thus ORC is a dynamic complex. Upon S phase entry, Orc1 is ubiquitinated and targeted for destruction, with subsequent dissociation of ORC from chromosomes. Time lapse and live cell images of human cells expressing fluorescently tagged Orc1 show that Orc1 re-localizes to condensing chromatin during early mitosis and then displays different nuclear localization patterns at different times during G(1) phase, remaining associated with late replicating regions of the genome in late G(1) phase. The initial binding of Orc1 to mitotic chromosomes requires C-terminal amino acid sequences that are similar to mitotic chromosome-binding sequences in the transcriptional pioneer protein FOXA1. Depletion of Orc1 causes concomitant loss of the mini-chromosome maintenance (Mcm2-7) helicase proteins on chromatin. The data suggest that Orc1 acts as a nucleating center for ORC assembly and then pre-replication complex assembly by binding to mitotic chromosomes, followed by gradual removal from chromatin during the G(1) phase.	[Kara, Nihan; Hossain, Manzar; Prasanth, Supriya G.; Stillman, Bruce] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kara, Nihan] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11779 USA; [Prasanth, Supriya G.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Illinois System; University of Illinois Urbana-Champaign	Stillman, B (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	stillman@cshl.edu	Hossain, Manzar/AAT-7482-2021	Hossain, Manzar/0000-0003-3399-581X	National Institutes of Health Program Project from the NCI [CA13106];  [CA45508]; NATIONAL CANCER INSTITUTE [P01CA013106, P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099669] Funding Source: NIH RePORTER	National Institutes of Health Program Project from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Program Project Grant CA13106 from the NCI and Support Grant CA45508 (to Cold Spring Harbor Laboratory Cancer Center).	Abdurashidova G, 2003, EMBO J, V22, P4294, DOI 10.1093/emboj/cdg404; Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Aparicio OM, 2013, GENE DEV, V27, P117, DOI 10.1101/gad.209999.112; Araki M, 2005, GENE DEV, V19, P2458, DOI 10.1101/gad.1361905; Asano M, 1999, EMBO J, V18, P2435, DOI 10.1093/emboj/18.9.2435; Baldinger T, 2009, MOL CELL BIOL, V29, P140, DOI 10.1128/MCB.00981-08; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bell SD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012807; Bell SP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010124; Bleichert F, 2015, NATURE, V519, P321, DOI 10.1038/nature14239; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Caravaca JM, 2013, GENE DEV, V27, P251, DOI 10.1101/gad.206458.112; CELIS JE, 1985, P NATL ACAD SCI USA, V82, P3262, DOI 10.1073/pnas.82.10.3262; Chesnokov I, 2001, P NATL ACAD SCI USA, V98, P11997, DOI 10.1073/pnas.211342798; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 2007, J MOL BIOL, V366, P720, DOI 10.1016/j.jmb.2006.11.087; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; DePamphilis ML, 2003, GENE, V310, P1, DOI 10.1016/S0378-1119(03)00546-8; Dhar SK, 2001, J BIOL CHEM, V276, P29067, DOI 10.1074/jbc.M103078200; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Fujita M, 1998, J BIOL CHEM, V273, P17095, DOI 10.1074/jbc.273.27.17095; Gaudier M, 2007, SCIENCE, V317, P1213, DOI 10.1126/science.1143664; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; Giordano-Coltart J, 2005, P NATL ACAD SCI USA, V102, P69, DOI 10.1073/pnas.0408690102; Grallert B, 1996, GENE DEV, V10, P2644, DOI 10.1101/gad.10.20.2644; Harlow E., 1988, ANTIBODIES LAB MANUA; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Hossain M, 2012, GENE DEV, V26, P1797, DOI 10.1101/gad.197178.112; Hua XQH, 1998, J CELL BIOL, V140, P271, DOI 10.1083/jcb.140.2.271; HUMBERT C, 1992, CYTOMETRY, V13, P603, DOI 10.1002/cyto.990130608; Jackson D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a010389; Kaykov A, 2015, GENOME RES, V25, P391, DOI 10.1101/gr.180372.114; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; Kong DC, 2001, MOL CELL BIOL, V21, P8095, DOI 10.1128/MCB.21.23.8095-8103.2001; Kreitz S, 2001, J BIOL CHEM, V276, P6337, DOI 10.1074/jbc.M009473200; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Li CJ, 2004, MOL CELL BIOL, V24, P5875, DOI 10.1128/MCB.24.13.5875-5886.2004; Li F, 2003, J CELL BIOL, V161, P257, DOI 10.1083/jcb.200211127; Li F, 2001, J CELL BIOL, V154, P283, DOI 10.1083/jcb.200104043; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Liu JY, 2000, MOL CELL, V6, P637, DOI 10.1016/S1097-2765(00)00062-9; Lu JJ, 2010, J CELL BIOL, V189, P967, DOI 10.1083/jcb.201002002; Lygerou Z, 1999, J CELL SCI, V112, P3703; Ma H, 1998, J CELL BIOL, V143, P1415, DOI 10.1083/jcb.143.6.1415; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; McNairn AJ, 2003, BIOESSAYS, V25, P647, DOI 10.1002/bies.10305; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Moindrot B, 2012, NUCLEIC ACIDS RES, V40, P9470, DOI 10.1093/nar/gks736; Muller P, 2010, GENE DEV, V24, P1418, DOI 10.1101/gad.1906410; NAKAYASU H, 1989, J CELL BIOL, V108, P1, DOI 10.1083/jcb.108.1.1; Natale DA, 2000, EMBO J, V19, P2728, DOI 10.1093/emboj/19.11.2728; Neuwald AF, 1999, GENOME RES, V9, P27; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Noguchi K, 2006, EMBO J, V25, P5372, DOI 10.1038/sj.emboj.7601396; O'Donnell M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010108; Ogawa Y, 1999, MOL CELL BIOL, V19, P7228; Ohta S, 2003, J BIOL CHEM, V278, P41535, DOI 10.1074/jbc.M307535200; Ohtani K, 1996, MOL CELL BIOL, V16, P6977; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Prasanth SG, 2004, PHILOS T R SOC B, V359, P7, DOI 10.1098/rstb.2003.1360; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; Raghuraman MK, 1997, SCIENCE, V276, P806, DOI 10.1126/science.276.5313.806; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Ranjan A, 2006, P NATL ACAD SCI USA, V103, P4864, DOI 10.1073/pnas.0510305103; Rhind N., 2013, COLD SPRING HARB PER, V3; Romanowski P, 1996, CURR BIOL, V6, P1416, DOI 10.1016/S0960-9822(96)00746-4; Romanowski P, 1996, P NATL ACAD SCI USA, V93, P10189, DOI 10.1073/pnas.93.19.10189; Rowles A, 1999, J CELL SCI, V112, P2011; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Sadoni N, 2004, J CELL SCI, V117, P5353, DOI 10.1242/jcs.01412; SANDERS MM, 1978, J CELL BIOL, V79, P97, DOI 10.1083/jcb.79.1.97; Shen Z, 2010, MOL CELL, V40, P99, DOI 10.1016/j.molcel.2010.09.021; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; Sun WH, 2002, EMBO J, V21, P1437, DOI 10.1093/emboj/21.6.1437; Takebayashi S, 2012, NUCLEUS-PHILA, V3, P500, DOI 10.4161/nucl.22318; Tatsumi Y, 2003, J BIOL CHEM, V278, P41528, DOI 10.1074/jbc.M307534200; Vashee S, 2001, J BIOL CHEM, V276, P26666, DOI 10.1074/jbc.M102493200; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wu JR, 1997, MOL CELL BIOL, V17, P4312, DOI 10.1128/MCB.17.8.4312; Wu PYJ, 2009, CELL, V136, P852, DOI 10.1016/j.cell.2009.01.017; Wu R, 2006, J CELL BIOL, V174, P185, DOI 10.1083/jcb.200601113; Yaffe E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001011; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	101	25	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12355	12369		10.1074/jbc.M114.625012	http://dx.doi.org/10.1074/jbc.M114.625012			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25784553	hybrid, Green Published			2022-12-28	WOS:000354388600044
J	Shakeel, SN; Gao, ZY; Amir, M; Chen, YF; Rai, MI; Ul Haq, N; Schaller, GE				Shakeel, Samina N.; Gao, Zhiyong; Amir, Madiha; Chen, Yi-Feng; Rai, Muneeza Iqbal; Ul Haq, Noor; Schaller, G. Eric			Ethylene Regulates Levels of Ethylene Receptor/CTR1 Signaling Complexes in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; histidine kinase; hormone receptor; membrane protein; protein complex; protein turnover; serine; threonine protein kinase; ethylene	HISTIDINE KINASE-ACTIVITY; SEEDLING-GROWTH-RESPONSE; RAF-LIKE KINASE; ENDOPLASMIC-RETICULUM; FAMILY-MEMBERS; ETR1; CTR1; GENE; PATHWAY; INSENSITIVITY	Background: Plant responses to the hormone ethylene depend on ethylene receptors and the kinase CTR1. Results: The receptors and CTR1 exist as signaling complexes whose levels change in response to ethylene. Conclusion: A model incorporating transcriptional induction and ethylene-dependent turnover of receptor/CTR1 complexes is proposed. Significance: Results presented here reconcile molecular responses at the receptor level with physiological changes in sensitivity to ethylene. The plant hormone ethylene is perceived by a five-member family of receptors in Arabidopsis thaliana. The receptors function in conjunction with the Raf-like kinase CTR1 to negatively regulate ethylene signal transduction. CTR1 interacts with multiple members of the receptor family based on co-purification analysis, interacting more strongly with receptors containing a receiver domain. Levels of membrane-associated CTR1 vary in response to ethylene, doing so in a post-transcriptional manner that correlates with ethylene-mediated changes in levels of the ethylene receptors ERS1, ERS2, EIN4, and ETR2. Interactions between CTR1 and the receptor ETR1 protect ETR1 from ethylene-induced turnover. Kinetic and dose-response analyses support a model in which two opposing factors control levels of the ethylene receptor/CTR1 complexes. Ethylene stimulates the production of new complexes largely through transcriptional induction of the receptors. However, ethylene also induces turnover of receptors, such that levels of ethylene receptor/CTR1 complexes decrease at higher ethylene concentrations. Implications of this model for ethylene signaling are discussed.	[Shakeel, Samina N.; Gao, Zhiyong; Amir, Madiha; Chen, Yi-Feng; Rai, Muneeza Iqbal; Ul Haq, Noor; Schaller, G. Eric] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Shakeel, Samina N.; Amir, Madiha; Rai, Muneeza Iqbal; Ul Haq, Noor] Quaid I Azam Univ, Dept Biochem, Islamabad 45320, Pakistan; [Chen, Yi-Feng] Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing 210014, Peoples R China	Dartmouth College; Quaid I Azam University; Jiangsu Academy of Agricultural Sciences	Schaller, GE (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	george.e.schaller@dartmouth.edu	Chen, Yi/HIR-2608-2022	RAI, MUNEEZA IQBAL/0000-0001-5016-9451	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Dept. of Energy [DE-FG02-05ER15704]; International Research Support Initiative Program of Higher Education Commission of Pakistan	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Dept. of Energy; International Research Support Initiative Program of Higher Education Commission of Pakistan	This work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Dept. of Energy (Grant no. DE-FG02-05ER15704, to G. E. S.) and by the International Research Support Initiative Program of Higher Education Commission of Pakistan (to M. A., M. I. R., and N. U. H.).	Abeles F, 1992, ETHYLENE PLANT BIOL; Binder BM, 2004, PLANT PHYSIOL, V136, P2913, DOI 10.1104/pp.104.050369; Binder BM, 2004, PLANT PHYSIOL, V136, P2921, DOI 10.1104/pp.104.050393; Binder BM, 2012, ANNU PLANT REV, V44, P117, DOI 10.1002/9781118223086.ch5; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Cancel JD, 2002, PLANT PHYSIOL, V129, P1557, DOI 10.1104/pp.003780; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chang KN, 2013, ELIFE, V2, DOI 10.7554/eLife.00675; CHEN QHG, 1995, PLANT PHYSIOL, V108, P597, DOI 10.1104/pp.108.2.597; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Chen YF, 2007, J BIOL CHEM, V282, P24752, DOI 10.1074/jbc.M704419200; Christians MJ, 2008, PLANT J, V55, P467, DOI 10.1111/j.1365-313X.2008.03521.x; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dong CH, 2008, PLANT J, V53, P275, DOI 10.1111/j.1365-313X.2007.03339.x; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gamble RL, 2002, PLANT PHYSIOL, V128, P1428, DOI 10.1104/pp.010777; Gao Z, 2008, J BIOL CHEM, V283, P23801, DOI 10.1074/jbc.M800641200; Gao ZY, 2009, PLANT SIGNAL BEHAV, V4, P1152, DOI 10.4161/psb.4.12.9943; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Hall AE, 1999, PLANT PHYSIOL, V121, P291, DOI 10.1104/pp.121.1.291; Hall BP, 2012, PLANT PHYSIOL, V159, P682, DOI 10.1104/pp.112.196790; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; Kevany BM, 2007, PLANT J, V51, P458, DOI 10.1111/j.1365-313X.2007.03170.x; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen PB, 2003, PLANT J, V34, P709, DOI 10.1046/j.1365-313X.2003.01762.x; Liu Q, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-60; Moussatche P, 2004, J BIOL CHEM, V279, P48734, DOI 10.1074/jbc.M403100200; O'Malley RC, 2005, PLANT J, V41, P651, DOI [10.1111/j.1365-313X.2004.02331.x, 10.1111/j.1365-313X.2004.02331.X]; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; Qu X, 2004, PLANT PHYSIOL, V136, P2961, DOI 10.1104/pp.104.047126; Qu X, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-3; Resnick JS, 2006, P NATL ACAD SCI USA, V103, P7917, DOI 10.1073/pnas.0602239103; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; SCHALLER GE, 1995, J BIOL CHEM, V270, P12526, DOI 10.1074/jbc.270.21.12526; Schaller GE, 1995, METHOD CELL BIOL, V50, P129, DOI 10.1016/S0091-679X(08)61027-4; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; Xie F, 2006, PLANT PHYSIOL, V142, P492, DOI 10.1104/pp.106.082628; Zhao XC, 2002, PLANT PHYSIOL, V130, P1983, DOI 10.1104/pp.011635	47	44	50	7	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12415	12424		10.1074/jbc.M115.652503	http://dx.doi.org/10.1074/jbc.M115.652503			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25814663	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000354388600049
J	Jang, JY; Wang, SB; Min, JH; Chae, YH; Baek, JY; Yu, DY; Chang, TS				Jang, Ji Yong; Wang, Su Bin; Min, Ji Hyun; Chae, Yun Hee; Baek, Jin Young; Yu, Dae-Yeul; Chang, Tong-Shin			Peroxiredoxin II Is an Antioxidant Enzyme That Negatively Regulates Collagen-stimulated Platelet Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE SYK; GLYCOPROTEIN-VI; LIPID RAFTS; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; REDOX REGULATION; CELL-ADHESION; GAMMA-CHAIN; IN-VIVO; ACTIVATION	Collagen-induced platelet signaling is mediated by binding to the primary receptor glycoprotein VI (GPVI). Reactive oxygen species produced in response to collagen have been found to be responsible for the propagation of GPVI signaling pathways in platelets. Therefore, it has been suggested that antioxidant enzymes could down-regulate GPVI-stimulated platelet activation. Although the antioxidant enzyme peroxiredoxin II (PrxII) has emerged as having a role in negatively regulating signaling through various receptors by eliminating H2O2 generated upon receptor stimulation, the function of PrxII in collagen-stimulated platelets is not known. We tested the hypothesis that PrxII negatively regulates collagen-stimulated platelet activation. We analyzed PrxII-deficient murine platelets. PrxII deficiency enhanced GPVI-mediated platelet activation through the defective elimination of H2O2 and the impaired protection of SH2 domain-containing tyrosine phosphatase 2 (SHP-2) against oxidative inactivation, which resulted in increased tyrosine phosphorylation of key components for the GPVI signaling cascade, including Syk, Btk, and phospholipase C gamma 2. Interestingly, PrxII-mediated antioxidative protection of SHP-2 appeared to occur in the lipid rafts. PrxII-deficient platelets exhibited increased adhesion and aggregation upon collagen stimulation. Furthermore, in vivo experiments demonstrated that PrxII deficiency facilitated platelet-dependent thrombus formation in injured carotid arteries. This study reveals that PrxII functions as a protective antioxidant enzyme against collagen-stimulated platelet activation and platelet-dependent thrombosis.	[Jang, Ji Yong; Wang, Su Bin; Min, Ji Hyun; Chae, Yun Hee; Baek, Jin Young; Chang, Tong-Shin] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul 120750, South Korea; [Chang, Tong-Shin] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea; [Yu, Dae-Yeul] Korea Res Inst Biosci & Biotechnol, Dis Model Res Lab, Aging Res Ctr, Taejon 605806, South Korea	Ewha Womans University; Ewha Womans University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Chang, TS (corresponding author), Ewha Womans Univ, Sci Bldg C,Rm 208,52 Ewhayeodae Gil, Seoul 120750, South Korea.	changts@ewha.ac.kr	Jang, Jiyong/AAA-3074-2020		National Research Foundation - Korean Ministry of Science, ICT, and Future Planning [M10642040002-07N4204-00210]; Health Technology R&D Project - Korean Ministry of Health and Welfare [HI13C1046]; Brain Korea 21 Plus Program - Korean Ministry of Education	National Research Foundation - Korean Ministry of Science, ICT, and Future Planning; Health Technology R&D Project - Korean Ministry of Health and Welfare; Brain Korea 21 Plus Program - Korean Ministry of Education	This study was supported by National Research Foundation Grant M10642040002-07N4204-00210 funded by the Korean Ministry of Science, ICT, and Future Planning; by Health Technology R&D Project Grant HI13C1046 funded by the Korean Ministry of Health and Welfare; and by the Brain Korea 21 Plus Program (to J. Y. J., S. B. W., and J. Y. B.) funded by the Korean Ministry of Education.	Anfossi G, 2001, EUR J CLIN INVEST, V31, P452, DOI 10.1046/j.1365-2362.2001.00815.x; Atkinson BT, 2003, BLOOD, V102, P3592, DOI 10.1182/blood-2003-04-1142; Bakdash N, 2008, FREE RADICAL BIO MED, V45, P158, DOI 10.1016/j.freeradbiomed.2008.03.021; Begonja AJ, 2005, BLOOD, V106, P2757, DOI 10.1182/blood-2005-03-1047; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Bhatt DL, 2007, NEW ENGL J MED, V357, P2078, DOI 10.1056/NEJMe0706859; Chari R, 2009, BLOOD, V114, P3056, DOI 10.1182/blood-2008-11-188516; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Dutting S, 2012, TRENDS PHARMACOL SCI, V33, P583, DOI 10.1016/j.tips.2012.07.004; Farrehi PM, 1998, CIRCULATION, V97, P1002; Freedman JE, 2008, ARTERIOSCL THROM VAS, V28, pS11, DOI 10.1161/ATVBAHA.107.159178; FUJII C, 1994, EUR J BIOCHEM, V226, P243, DOI 10.1111/j.1432-1033.1994.tb20047.x; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Gibbins J. M., 2004, PLATELETS MEGAKARYOC, P233; Gibbins JM, 2004, J CELL SCI, V117, P3415, DOI 10.1242/jcs.01325; JandrotPerrus M, 1997, J BIOL CHEM, V272, P27035, DOI 10.1074/jbc.272.43.27035; Jang JY, 2014, ANTIOXID REDOX SIGN, V20, P2528, DOI 10.1089/ars.2013.5337; Jin RC, 2011, CIRCULATION, V123, P1963, DOI 10.1161/CIRCULATIONAHA.110.000034; Kang DH, 2011, MOL CELL, V44, P545, DOI 10.1016/j.molcel.2011.08.040; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Krotz F, 2002, BLOOD, V100, P917, DOI 10.1182/blood.V100.3.917; Kurosaki T, 2000, IMMUNOL REV, V176, P19; KURZ KD, 1990, THROMB RES, V60, P269, DOI 10.1016/0049-3848(90)90106-M; Kwon J, 2005, EMBO J, V24, P2331, DOI 10.1038/sj.emboj.7600706; Lee FA, 2006, J BIOL CHEM, V281, P39330, DOI 10.1074/jbc.M607930200; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Li W, 2010, J CLIN INVEST, V120, P3996, DOI 10.1172/JCI42823; Lill G, 2003, FEBS LETT, V546, P265, DOI 10.1016/S0014-5793(03)00599-4; Locke D, 2002, J BIOL CHEM, V277, P18801, DOI 10.1074/jbc.M111520200; Maeda A, 1999, ONCOGENE, V18, P2291, DOI 10.1038/sj.onc.1202552; Mairhofer M, 2002, BLOOD, V100, P897, DOI 10.1182/blood.V100.3.897; Mancini F, 2007, BLOOD, V110, P1871, DOI 10.1182/blood-2007-03-081414; Monteiro HP, 2008, ANTIOXID REDOX SIGN, V10, P843, DOI 10.1089/ars.2007.1853; Morrell CN, 2008, CIRC RES, V103, P571, DOI 10.1161/CIRCRESAHA.108.184325; Murphy AJ, 2013, NAT MED, V19, P586, DOI 10.1038/nm.3150; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; PALABRICA T, 1992, NATURE, V359, P848, DOI 10.1038/359848a0; Park JG, 2011, CIRC RES, V109, P739, DOI 10.1161/CIRCRESAHA.111.245530; Pearce AC, 2002, BLOOD, V100, P3561, DOI 10.1182/blood.V100.10.3561; Pignatelli P, 1998, BLOOD, V91, P484, DOI 10.1182/blood.V91.2.484.484_484_490; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Salmeen A, 2005, ANTIOXID REDOX SIGN, V7, P560, DOI 10.1089/ars.2005.7.560; Seno T, 2001, THROMB RES, V103, P399, DOI 10.1016/S0049-3848(01)00341-3; Sobotkova A, 2009, FREE RADICAL BIO MED, V47, P1707, DOI 10.1016/j.freeradbiomed.2009.09.015; Suzuki-Inoue K, 2004, BIOCHEM J, V378, P1023, DOI 10.1042/BJ20031430; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Tseng MT, 2006, THROMB RES, V118, P275, DOI 10.1016/j.thromres.2005.09.004; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Vial C, 2006, BIOCHEM BIOPH RES CO, V343, P415, DOI 10.1016/j.bbrc.2006.02.174; Wakino S, 2004, CIRC RES, V95, pE45, DOI 10.1161/01.RES.0000142313.68389.92; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Weng Z, 2010, BLOOD, V116, P2579, DOI 10.1182/blood-2010-03-277236; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009	61	17	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11432	11442		10.1074/jbc.M115.644260	http://dx.doi.org/10.1074/jbc.M115.644260			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25802339	hybrid, Green Published			2022-12-28	WOS:000353719400020
J	Tan, SX; Fisher-Wellman, KH; Fazakerley, DJ; Ng, Y; Pant, H; Li, J; Meoli, CC; Coster, ACF; Stockli, J; James, DE				Tan, Shi-Xiong; Fisher-Wellman, Kelsey H.; Fazakerley, Daniel J.; Ng, Yvonne; Pant, Himani; Li, Jia; Meoli, Christopher C.; Coster, Adelle C. F.; Stoeckli, Jacqueline; James, David E.			Selective Insulin Resistance in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DIABETES-MELLITUS; PROTEIN-KINASE PATHWAY; NECROSIS-FACTOR-ALPHA; HIGH-FAT DIET; OB-OB MICE; GLUCOSE-TRANSPORTER; 3T3-L1 ADIPOCYTES; SIGNALING PATHWAY; RECEPTOR SUBSTRATE-1; PLASMA-MEMBRANE	Aside from glucose metabolism, insulin regulates a variety of pathways in peripheral tissues. Under insulin-resistant conditions, it is well known that insulin-stimulated glucose uptake is impaired, and many studies attribute this to a defect in Akt signaling. Here we make use of several insulin resistance models, including insulin-resistant 3T3-L1 adipocytes and fat explants prepared from high fat-fed C57BL/6J and ob/ob mice, to comprehensively distinguish defective from unaffected aspects of insulin signaling and its downstream consequences in adipocytes. Defective regulation of glucose uptake was observed in all models of insulin resistance, whereas other major actions of insulin such as protein synthesis and anti-lipolysis were normal. This defect corresponded to a reduction in the maximum response to insulin. The pattern of change observed for phosphorylation in the Akt pathway was inconsistent with a simple defect at the level of Akt. The only Akt substrate that showed consistently reduced phosphorylation was the RabGAP AS160 that regulates GLUT4 translocation. We conclude that insulin resistance in adipose tissue is highly selective for glucose metabolism and likely involves a defect in one of the components regulating GLUT4 translocation to the cell surface in response to insulin.	[Tan, Shi-Xiong; Fisher-Wellman, Kelsey H.; Ng, Yvonne; Pant, Himani; Li, Jia; Meoli, Christopher C.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Fazakerley, Daniel J.; Meoli, Christopher C.; Stoeckli, Jacqueline; James, David E.] Univ Sydney, Charles Perkins Ctr, Sch Mol Biosci, Sydney, NSW 2006, Australia; [James, David E.] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia; [Coster, Adelle C. F.] Univ New S Wales, Sch Math & Stat, Sydney, NSW 2052, Australia	Garvan Institute of Medical Research; University of Sydney; University of Sydney; University of New South Wales Sydney	Stockli, J (corresponding author), Univ Sydney, Charles Perkins Ctr, Sch Mol Biosci, Sch Med, Sydney, NSW 2006, Australia.	jacqueline.stoeckli@sydney.edu.au	Tan, Shi-Xiong/Y-3728-2019; Coster, Adelle CF/A-7234-2013; Stoeckli, Jacqueline/D-7053-2016; Fisher-Wellman, Kelsey/O-8209-2019; Fazakerley, Daniel/J-2652-2019; Coster, Adelle/AAX-4829-2020; Stoeckli, Jacqueline/Z-4443-2019	Coster, Adelle CF/0000-0002-5572-6832; Stoeckli, Jacqueline/0000-0002-6446-7350; Fisher-Wellman, Kelsey/0000-0002-0300-829X; Fazakerley, Daniel/0000-0001-8241-2903; Coster, Adelle/0000-0002-5572-6832; Stoeckli, Jacqueline/0000-0002-6446-7350; James, David/0000-0001-5946-5257; Tan, Shi-Xiong/0000-0002-0020-2572	National Health and Medical Research Council [GNT1061122, GNT1047067]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council Project Grants GNT1061122 and GNT1047067.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Adams-Huet B, 2014, METAB SYNDR RELAT D, V12, P503, DOI 10.1089/met.2014.0092; Ahmad F, 2007, BIOCHEM J, V404, P257, DOI 10.1042/BJ20060960; Alessi DR, 1998, BBA-MOL CELL BIOL L, V1436, P151, DOI 10.1016/S0005-2760(98)00133-7; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Book CB, 1999, J CLIN ENDOCR METAB, V84, P3110, DOI 10.1210/jc.84.9.3110; Burchfield JG, 2013, TRAFFIC, V14, P259, DOI 10.1111/tra.12035; Carvalho Eugenia, 2001, FASEB Journal, V15, P1101; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; Clark SF, 2000, J BIOL CHEM, V275, P3819, DOI 10.1074/jbc.275.6.3819; Cleasby ME, 2005, DIABETES, V54, P2702, DOI 10.2337/diabetes.54.9.2702; DOHM GL, 1988, J CLIN INVEST, V82, P486, DOI 10.1172/JCI113622; FAIN JN, 1966, ENDOCRINOLOGY, V78, P773, DOI 10.1210/endo-78-4-773; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; GARVEY WT, 1991, J CLIN INVEST, V87, P1072, DOI 10.1172/JCI115068; GARVEY WT, 1992, DIABETES, V41, P465, DOI 10.2337/diabetes.41.4.465; GLASS AR, 1981, METABOLISM, V30, P578, DOI 10.1016/0026-0495(81)90134-7; GNUDI L, 1995, ENDOCRINOLOGY, V136, P995, DOI 10.1210/en.136.3.995; GODBOLE VY, 1980, AM J PHYSIOL, V239, pE265; Gonzalez E, 2011, P NATL ACAD SCI USA, V108, P10162, DOI 10.1073/pnas.1019268108; GRUNDLEGER ML, 1980, AM J PHYSIOL, V239, pE363, DOI 10.1152/ajpendo.1980.239.5.E363; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; IKEMOTO S, 1995, P NATL ACAD SCI USA, V92, P3096, DOI 10.1073/pnas.92.8.3096; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; KAHN CR, 1978, METABOLISM, V27, P1893; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; KASHIWAGI A, 1983, J CLIN INVEST, V72, P1246, DOI 10.1172/JCI111080; Le Lay S, 2002, J BIOL CHEM, V277, P35625, DOI 10.1074/jbc.M203913200; Li J, 2000, FASEB J, V14, P1117, DOI 10.1096/fasebj.14.9.1117; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Lin K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002618; Lo KA, 2013, CELL REP, V5, P259, DOI 10.1016/j.celrep.2013.08.039; MARSHALL S, 1989, J BIOL CHEM, V264, P2029; MARSHALL S, 1989, J BIOL CHEM, V264, P2037; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; Ng Y, 2010, J BIOL CHEM, V285, P5232, DOI 10.1074/jbc.M109.060632; Ng Y, 2010, J BIOL CHEM, V285, P2255, DOI 10.1074/jbc.M109.060236; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; REVERS RR, 1984, J CLIN INVEST, V73, P664, DOI 10.1172/JCI111258; RICE KM, 1993, BIOCHEM BIOPH RES CO, V190, P961, DOI 10.1006/bbrc.1993.1143; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sabio G, 2010, MOL CELL BIOL, V30, P106, DOI 10.1128/MCB.01162-09; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Tan SX, 2012, MOL CELL BIOL, V32, P4946, DOI 10.1128/MCB.00761-12; Tan SX, 2012, J BIOL CHEM, V287, P6128, DOI 10.1074/jbc.M111.318238; Tan SX, 2011, BIOCHEM J, V435, P539, DOI 10.1042/BJ20110040; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Teruel T, 2001, DIABETES, V50, P2563, DOI 10.2337/diabetes.50.11.2563; Tonks KT, 2013, DIABETOLOGIA, V56, P875, DOI 10.1007/s00125-012-2811-y; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035; Yu Z, 2011, DIABETOLOGIA, V54, P922, DOI 10.1007/s00125-010-2001-8; Zierath JB, 1997, DIABETES, V46, P215, DOI 10.2337/diabetes.46.2.215	68	73	75	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11337	11348		10.1074/jbc.M114.623686	http://dx.doi.org/10.1074/jbc.M114.623686			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25720492	Green Published, hybrid			2022-12-28	WOS:000353719400011
J	Tossounian, MA; Pedre, B; Wahni, K; Erdogan, H; Vertommen, D; Van Molle, I; Messens, J				Tossounian, Maria-Armineh; Pedre, Brandan; Wahni, Khadija; Erdogan, Huriye; Vertommen, Didier; Van Molle, Inge; Messens, Joris			Corynebacterium diphtheriae Methionine Sulfoxide Reductase A Exploits a Unique Mycothiol Redox Relay Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; THIOL; GLUTATHIONE; OXIDATION; PHENIX	Methionine sulfoxide reductases are conserved enzymes that reduce oxidized methionines in proteins and play a pivotal role in cellular redox signaling. We have unraveled the redox relay mechanisms of methionine sulfoxide reductase A of the pathogen Corynebacterium diphtheriae (Cd-MsrA) and shown that this enzyme is coupled to two independent redox relay pathways. Steady-state kinetics combined with mass spectrometry of Cd-MsrA mutants give a view of the essential cysteine residues for catalysis. Cd-MsrA combines a nucleophilic cysteine sulfenylation reaction with an intramolecular disulfide bond cascade linked to the thioredoxin pathway. Within this cascade, the oxidative equivalents are transferred to the surface of the protein while releasing the reduced substrate. Alternatively, MsrA catalyzes methionine sulfoxide reduction linked to the mycothiol/mycoredoxin-1 pathway. After the nucleophilic cysteine sulfenylation reaction, MsrA forms a mixed disulfide with mycothiol, which is transferred via a thiol disulfide relay mechanism to a second cysteine for reduction by mycoredoxin-1. With x-ray crystallography, we visualize two essential intermediates of the thioredoxin relay mechanism and a cacodylate molecule mimicking the substrate interactions in the active site. Theinterplay of both redox pathways in redox signaling regulation forms the basis for further research into the oxidative stress response of this pathogen.	[Tossounian, Maria-Armineh; Pedre, Brandan; Wahni, Khadija; Erdogan, Huriye; Van Molle, Inge; Messens, Joris] Vlaams Inst Biotechnol, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Tossounian, Maria-Armineh; Pedre, Brandan; Wahni, Khadija; Erdogan, Huriye; Van Molle, Inge; Messens, Joris] Brussels Ctr Redox Biol, B-1050 Brussels, Belgium; [Tossounian, Maria-Armineh; Pedre, Brandan; Wahni, Khadija; Erdogan, Huriye; Van Molle, Inge; Messens, Joris] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Vertommen, Didier] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Universite Catholique Louvain	Van Molle, I (corresponding author), Vrije Univ Brussel, Struct Biol Res Ctr, Oxidat Stress Signaling Lab, VIB, Pl Laan 2, B-1050 Brussels, Belgium.	Inge.VanMolle@vib-vub.be; joris.messens@vib-vub.be	Pedre, Brandan/E-7591-2013; Messens, Joris/AAH-3008-2020; Dagdas, Huriye Erdogan/AAH-6098-2019; Erdogan, Huriye/AAV-7170-2020	Pedre, Brandan/0000-0003-2158-2807; Messens, Joris/0000-0002-2128-8264; Erdogan, Huriye/0000-0003-0057-5579; Van Molle, Inge/0000-0003-0114-9379; Tossounian, Maria-Armineh/0000-0003-3679-7376; Vertommen, Didier/0000-0001-7648-8282	Agentschap voor Innovatie door Wetenschap en Technologie (IWT); Vlaams Instituut voor Biotechnologie (VIB); HOA project of the onderzoeksraad of the Vrije Universiteit Brussel (VUB); Omics@VIB Marie Curie COFUND fellowship; VUB bridging grant; VUB Strategic Research Program [SRP34]; Hercules Foundation [HERC16, UABR/09/005]	Agentschap voor Innovatie door Wetenschap en Technologie (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Vlaams Instituut voor Biotechnologie (VIB); HOA project of the onderzoeksraad of the Vrije Universiteit Brussel (VUB); Omics@VIB Marie Curie COFUND fellowship; VUB bridging grant; VUB Strategic Research Program; Hercules Foundation	This work was supported by Agentschap voor Innovatie door Wetenschap en Technologie (IWT), Vlaams Instituut voor Biotechnologie (VIB), the HOA project of the onderzoeksraad of the Vrije Universiteit Brussel (VUB), an Omics@VIB Marie Curie COFUND fellowship, a VUB bridging grant, VUB Strategic Research Program Grant SRP34, and Hercules Foundation Equipment Grants HERC16 and UABR/09/005.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Boschi-Muller S, 2014, BIOORG CHEM, V57, P222, DOI 10.1016/j.bioorg.2014.07.002; Chi BK, 2014, ANTIOXID REDOX SIGN, V20, P589, DOI 10.1089/ars.2013.5423; Coudevylle N, 2007, J MOL BIOL, V366, P193, DOI 10.1016/j.jmb.2006.11.042; Couturier J, 2012, FEBS LETT, V586, P3894, DOI 10.1016/j.febslet.2012.09.020; Drazic A, 2014, BBA-PROTEINS PROTEOM, V1844, P1367, DOI 10.1016/j.bbapap.2014.01.001; Drazic A, 2013, P NATL ACAD SCI USA, V110, P9493, DOI 10.1073/pnas.1300578110; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Hugo M, 2014, J BIOL CHEM, V289, P5228, DOI 10.1074/jbc.M113.510248; Jacob C, 2011, FEBS LETT, V585, P1905, DOI 10.1016/j.febslet.2011.04.070; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kriznik A, 2014, ARCH BIOCHEM BIOPHYS, V548, P54, DOI 10.1016/j.abb.2014.03.002; Lee BC, 2011, FREE RADICAL BIO MED, V50, P221, DOI 10.1016/j.freeradbiomed.2010.11.008; Lee WL, 2009, MOL MICROBIOL, V71, P583, DOI 10.1111/j.1365-2958.2008.06548.x; Lim JC, 2013, FREE RADICAL BIO MED, V61, P257, DOI 10.1016/j.freeradbiomed.2013.04.004; Lim JC, 2011, P NATL ACAD SCI USA, V108, P10472, DOI 10.1073/pnas.1101275108; Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269; Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mouaheb N, 1998, P NATL ACAD SCI USA, V95, P3312, DOI 10.1073/pnas.95.6.3312; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Ranaivoson FM, 2008, J MOL BIOL, V377, P268, DOI 10.1016/j.jmb.2008.01.021; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Roos G, 2011, FREE RADICAL BIO MED, V51, P314, DOI 10.1016/j.freeradbiomed.2011.04.031; Rouhier N, 2007, J BIOL CHEM, V282, P3367, DOI 10.1074/jbc.M605007200; Ruys SPD, 2012, BIOCHEM J, V442, P681, DOI 10.1042/BJ20111530; Sharov VS, 1999, FEBS LETT, V455, P247, DOI 10.1016/S0014-5793(99)00888-1; Si MR, 2015, APPL ENVIRON MICROB, V81, P2781, DOI 10.1128/AEM.04221-14; Taylor AB, 2003, J BACTERIOL, V185, P4119, DOI 10.1128/JB.185.14.4119-4126.2003; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tete-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8; Van Laer K, 2013, ANTIOXID REDOX SIGN, V18, P1642, DOI 10.1089/ars.2012.4964; Van Laer K, 2012, MOL MICROBIOL, V86, P787, DOI 10.1111/mmi.12030; Wizemann TM, 1996, P NATL ACAD SCI USA, V93, P7985, DOI 10.1073/pnas.93.15.7985	41	20	20	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11365	11375		10.1074/jbc.M114.632596	http://dx.doi.org/10.1074/jbc.M114.632596			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25752606	Green Published, hybrid			2022-12-28	WOS:000353719400013
J	Duda, T; Wen, XH; Isayama, T; Sharma, RK; Makino, CL				Duda, Teresa; Wen, Xiao-Hong; Isayama, Tomoki; Sharma, Rameshwar K.; Makino, Clint L.			Bicarbonate Modulates Photoreceptor Guanylate Cyclase (ROS-GC) Catalytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBONIC-ANHYDRASE ACTIVITY; HYDROGEN-ION BUFFERS; VERTEBRATE PHOTORECEPTOR; FUNCTIONAL CONSEQUENCES; TISSUE METABOLISM; FLASH RESPONSES; SALAMANDER RODS; CA2+ SENSOR; ROS-GC1; CALCIUM	By generating the second messenger cGMP in retinal rods and cones, ROS-GC plays a central role in visual transduction. Guanylate cyclase-activating proteins (GCAPs) link cGMP synthesis to the light-induced fall in [Ca2+](i) to help set absolute sensitivity and assure prompt recovery of the response to light. The present report discloses a surprising feature of this system: ROS-GC is a sensor of bicarbonate. Recombinant ROS-GCs synthesized cGMP from GTP at faster rates in the presence of bicarbonate with an ED50 of 27 mM for ROS-GC1 and 39 mM for ROS-GC2. The effect required neither Ca2+ nor use of the GCAPs domains; however, stimulation of ROS-GC1 was more powerful in the presence of GCAP1 or GCAP2 at low [Ca2+]. When applied to retinal photoreceptors, bicarbonate enhanced the circulating current, decreased sensitivity to flashes, and accelerated flash response kinetics. Bicarbonate was effective when applied either to the outer or inner segment of red-sensitive cones. In contrast, bicarbonate exerted an effect when applied to the inner segment of rods but had little efficacy when applied to the outer segment. The findings define a new regulatory mechanism of the ROS-GC system that affects visual transduction and is likely to affect the course of retinal diseases caused by cGMP toxicity.	[Duda, Teresa; Sharma, Rameshwar K.] Salus Univ, Div Biochem Res, Unit Regulatory & Mol Biol, Elkins Pk, PA 19027 USA; [Duda, Teresa; Sharma, Rameshwar K.] Salus Univ, Res Div Mol Biol, Unit Regulatory & Mol Biol, Elkins Pk, PA 19027 USA; [Wen, Xiao-Hong; Isayama, Tomoki; Makino, Clint L.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; [Wen, Xiao-Hong; Isayama, Tomoki; Makino, Clint L.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School	Makino, CL (corresponding author), Massachusetts Eye & Ear Infirm, Dept Ophthalmol, 243 Charles St, Boston, MA 02114 USA.	cmakino@meei.harvard.edu	Makino, Clint Lawrence/H-8428-2019; Cote, Rick H/G-3363-2013	Makino, Clint Lawrence/0000-0002-6005-9069; Cote, Rick H/0000-0002-1573-6526	National Institutes of Health [EY011358, EY014104, EY023980]; Research to Prevent Blindness; Howe Laboratory Endowment of the Massachusetts Eye and Ear Infirmary; NATIONAL EYE INSTITUTE [R29EY011358, R01EY023980, R01EY011358, P30EY014104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Howe Laboratory Endowment of the Massachusetts Eye and Ear Infirmary; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY011358, EY014104, and EY023980. This work was also supported by Research to Prevent Blindness and the Howe Laboratory Endowment of the Massachusetts Eye and Ear Infirmary.	Astakhova LA, 2012, J GEN PHYSIOL, V140, P421, DOI 10.1085/jgp.201210811; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; Bok D, 2003, NAT GENET, V34, P313, DOI 10.1038/ng1176; Bright SR, 2005, MOL VIS, V11, P1141; BROEDERS GCJM, 1988, OPHTHALMOLOGICA, V196, P103, DOI 10.1159/000309884; Brooks MJ, 2011, MOL VIS, V17, P3034; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Craig FN, 1943, J GEN PHYSIOL, V26, P473, DOI 10.1085/jgp.26.5.473; DONNER K, 1990, J PHYSIOL-LONDON, V426, P297, DOI 10.1113/jphysiol.1990.sp018139; Duda T, 2005, BIOCHEMISTRY-US, V44, P7336, DOI 10.1021/bi050068x; Duda T, 1999, BIOCHEMISTRY-US, V38, P509, DOI 10.1021/bi9824137; Duda T, 2002, EMBO J, V21, P2547, DOI 10.1093/emboj/21.11.2547; Duda T, 2008, BIOCHEM BIOPH RES CO, V367, P440, DOI 10.1016/j.bbrc.2007.12.153; Duda T, 2011, BIOCHEM BIOPH RES CO, V408, P236, DOI 10.1016/j.bbrc.2011.03.134; Duda T, 2010, BIOCHEM BIOPH RES CO, V391, P1379, DOI 10.1016/j.bbrc.2009.12.068; FERGUSON WJ, 1980, ANAL BIOCHEM, V104, P300, DOI 10.1016/0003-2697(80)90079-2; FINDL O, 1995, INVEST OPHTH VIS SCI, V36, P1019; FLEISCHMAN D, 1979, BIOCHEMISTRY-US, V18, P5060, DOI 10.1021/bi00590a006; Fletcher EL, 2011, PROG MOL BIOL TRANSL, V100, P211, DOI 10.1016/B978-0-12-384878-9.00006-6; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; GORACZNIAK RM, 1994, BIOCHEM J, V302, P455, DOI 10.1042/bj3020455; Guo DG, 2009, BIOCHEMISTRY-US, V48, P4417, DOI 10.1021/bi900441v; Han JJ, 2013, MOL VIS, V19, P2579; Heikkinen H, 2012, INVEST OPHTH VIS SCI, V53, P5653, DOI 10.1167/iovs.12-9678; Hetling JR, 1999, J PHYSIOL-LONDON, V516, P593, DOI 10.1111/j.1469-7793.1999.0593v.x; Hunt DM, 2010, MOL CELL BIOCHEM, V334, P157, DOI 10.1007/s11010-009-0331-y; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; JIN J, 1994, VISUAL NEUROSCI, V11, P389, DOI 10.1017/S0952523800001735; Kalamkarov G, 1996, VISION RES, V36, P3029, DOI 10.1016/0042-6989(96)00052-1; Kao LY, 2011, J BIOL CHEM, V286, P32563, DOI 10.1074/jbc.M111.249961; Koenekoop RK, 2002, ARCH OPHTHALMOL-CHIC, V120, P1325, DOI 10.1001/archopht.120.10.1325; Kolandaivelu S, 2014, ADV EXP MED BIOL, V801, P43, DOI 10.1007/978-1-4614-3209-8_6; KOSKELAINEN A, 1994, VISION RES, V34, P983, DOI 10.1016/0042-6989(94)90002-7; KOSKELAINEN A, 1993, VISION RES, V33, P2181, DOI 10.1016/0042-6989(93)90098-H; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; LAMB TD, 1981, J PHYSIOL-LONDON, V319, P463, DOI 10.1113/jphysiol.1981.sp013921; LAMB TD, 1984, J PHYSIOL-LONDON, V346, P557, DOI 10.1113/jphysiol.1984.sp015041; Lange C, 1999, FEBS LETT, V460, P27, DOI 10.1016/S0014-5793(99)01312-5; Laser H, 1937, BIOCHEM J, V31, P1671, DOI 10.1042/bj0311671; LIEBMAN PA, 1984, J PHYSIOL-LONDON, V347, P85, DOI 10.1113/jphysiol.1984.sp015055; Liu CM, 2005, AM J PHYSIOL-CELL PH, V289, pC187, DOI 10.1152/ajpcell.00490.2004; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; MacLeish PR, 2007, J NEUROPHYSIOL, V98, P86, DOI 10.1152/jn.00775.2006; Makino CL, 1999, BIOPHYS J, V77, P1024, DOI 10.1016/S0006-3495(99)76953-5; MEYERTHOLEN EP, 1980, BIOCHEM BIOPH RES CO, V96, P785, DOI 10.1016/0006-291X(80)91423-0; MEYERTHOLEN EP, 1986, VISION RES, V26, P521, DOI 10.1016/0042-6989(86)90001-5; MUSSER GL, 1973, EXP EYE RES, V15, P467, DOI 10.1016/0014-4835(73)90138-3; MUSSER GL, 1973, EXP EYE RES, V15, P105, DOI 10.1016/0014-4835(73)90195-4; NAMBI P, 1982, ARCH BIOCHEM BIOPHYS, V217, P638, DOI 10.1016/0003-9861(82)90545-8; NORK TM, 1990, INVEST OPHTH VIS SCI, V31, P1451; ODOM JV, 1994, VISION RES, V34, P829, DOI 10.1016/0042-6989(94)90220-8; Ogilvie JM, 2007, P NATL ACAD SCI USA, V104, P8514, DOI 10.1073/pnas.0702899104; PARTHE V, 1981, J NEUROSCI RES, V6, P119, DOI 10.1002/jnr.490060112; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Qu ZQ, 2000, J GEN PHYSIOL, V116, P825, DOI 10.1085/jgp.116.6.825; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sampath AP, 2002, BIOPHYS J, V83, P184, DOI 10.1016/S0006-3495(02)75160-6; Sharma RK, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00056; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Sun LM, 2009, P NATL ACAD SCI USA, V106, P2041, DOI 10.1073/pnas.0812220106; van Hateren J H, 2006, BMC Neurosci, V7, P34; Venkataraman V, 2008, BIOCHEMISTRY-US, V47, P6590, DOI 10.1021/bi800394s; Wen XH, 2014, INVEST OPHTH VIS SCI, V55; Wen XH, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00045; Wen XH, 2012, CELL PHYSIOL BIOCHEM, V29, P417, DOI 10.1159/000338496; WINKLER BS, 1977, INVEST OPHTH VIS SCI, V16, P1151; WISTRAND PJ, 1986, INVEST OPHTH VIS SCI, V27, P419; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013	70	11	11	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11052	11060		10.1074/jbc.M115.650408	http://dx.doi.org/10.1074/jbc.M115.650408			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25767116	Green Published, hybrid			2022-12-28	WOS:000353404500041
J	Maurya, SK; Bal, NC; Sopariwala, DH; Pant, M; Rowland, LA; Shaikh, SA; Periasamy, M				Maurya, Santosh K.; Bal, Naresh C.; Sopariwala, Danesh H.; Pant, Meghna; Rowland, Leslie A.; Shaikh, Sana A.; Periasamy, Muthu			Sarcolipin Is a Key Determinant of the Basal Metabolic Rate, and Its Overexpression Enhances Energy Expenditure and Resistance against Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; ADAPTIVE THERMOGENESIS; HEAT-PRODUCTION; FIBER-TYPE; CALCIUM; CALCINEURIN; TRANSPORT; PROTEIN; ACTIVATION; DISTINCT	Sarcolipin (SLN) is a novel regulator of sarcoplasmic reticulum Ca2+ ATPase (SERCA) in muscle. SLN binding to SERCA uncouples Ca2+ transport from ATP hydrolysis. By this mechanism, SLN promotes the futile cycling of SERCA, contributing to muscle heat production. We recently showed that SLN plays an important role in cold- and diet-induced thermogenesis. However, the detailed mechanism of how SLN regulates muscle metabolism remains unclear. In this study, we used both SLN knockout (Sln(-/-)) and skeletal muscle-specific SLN overexpression (Sln(OE)) mice to explore energy metabolism by pair feeding (fixed calories) and high-fat diet feeding (ad libitum). Our results show that, upon pair feeding, Sln(OE) mice lost weight compared with the WT, but Sln(-/-) mice gained weight. Interestingly, when fed with a high-fat diet, Sln(OE) mice consumed more calories but gained less weight and maintained a normal metabolic profile in comparison with WT and Sln(-/-) mice. We found that oxygen consumption and fatty acid oxidation were increased markedly in Sln(OE) mice. There was also an increase in both mitochondrial number and size in Sln(OE) muscle, together with increased expression of peroxisome proliferator-activated receptor delta (PPAR delta) and PPAR gamma coactivator 1 alpha (PGC1 alpha), key transcriptional activators of mitochondrial biogenesis and enzymes involved in oxidative metabolism. These results, taken together, establish an important role for SLN in muscle metabolism and energy expenditure. On the basis of these data we propose that SLN is a novel target for enhancing whole-body energy expenditure.	[Bal, Naresh C.; Sopariwala, Danesh H.; Pant, Meghna; Rowland, Leslie A.; Shaikh, Sana A.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Maurya, Santosh K.; Periasamy, Muthu] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL 32827 USA	University System of Ohio; Ohio State University; Sanford Burnham Prebys Medical Discovery Institute	Periasamy, M (corresponding author), 013 Hamilton Hall & 1645 Neil Ave, Columbus, OH 43210 USA.	periasamy.1@osu.edu	Maurya, Santosh/O-9066-2017	Maurya, Santosh/0000-0002-7610-2463; Periasamy, Muthu/0000-0001-8834-5975	NCI/National Institutes of Health [P30 CA016058]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098240] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. Sanjeewa A. Goonasekera and Jeffery D. Molkentin for skeletal muscle-specific sarcolipin overexpression mice (Sln<SUP>OE</SUP>). We also thank the Ohio State University's Comparative Pathology and Mouse Phenotyping Shared Resource for histology (Supported in part by NCI/National Institutes of Health Grant P30 CA016058) and the histology core of Sanford-Burnham Medical Research, Orlando for SDH staining.	Alevizopoulos A, 1997, J BIOL CHEM, V272, P23597, DOI 10.1074/jbc.272.38.23597; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; BLANCO CE, 1988, HISTOCHEM J, V20, P230, DOI 10.1007/BF01747468; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Boerries M, 2007, MOL CELL BIOL, V27, P4365, DOI 10.1128/MCB.02045-06; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Engeli S, 2012, J CLIN INVEST, V122, P4675, DOI 10.1172/JCI64526; Fajardo VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084304; Gan ZJ, 2013, J CLIN INVEST, V123, P2564, DOI 10.1172/JCI67652; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hopper RK, 2006, BIOCHEMISTRY-US, V45, P2524, DOI 10.1021/bi052475e; Hubbard MJ, 1996, FEBS LETT, V391, P323, DOI 10.1016/0014-5793(96)00767-3; Hughes SM, 1999, J CELL BIOL, V145, P633, DOI 10.1083/jcb.145.3.633; Hurt Ryan T, 2010, Gastroenterol Hepatol (N Y), V6, P780; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kanzleiter T, 2014, MOL CELL BIOL, V34, P290, DOI 10.1128/MCB.01232-13; Lai L, 2014, J BIOL CHEM, V289, P2250, DOI 10.1074/jbc.M113.523654; Lee P, 2013, INT J OBESITY, V37, P593, DOI 10.1038/ijo.2012.90; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; MacDonald MJ, 1996, ARCH BIOCHEM BIOPHYS, V326, P79, DOI 10.1006/abbi.1996.0049; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; MCCORMACK JG, 1990, BIOCHIM BIOPHYS ACTA, V1018, P287, DOI 10.1016/0005-2728(90)90269-A; Mercier Jacques, 1999, Molecular Aspects of Medicine, V20, P319, DOI 10.1016/S0098-2997(00)00002-9; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Rao XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081364; Reis M, 2002, MOL MEMBR BIOL, V19, P301, DOI 10.1080/09687680210166217; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Ryder JW, 2003, J BIOL CHEM, V278, P44298, DOI 10.1074/jbc.M304510200; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Schaeffer PJ, 2004, J BIOL CHEM, V279, P39593, DOI 10.1074/jbc.M403649200; Smith IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068924; Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Tupling AR, 2011, AM J PHYSIOL-CELL PH, V301, pC841, DOI 10.1152/ajpcell.00409.2010; van den Berg SAA, 2011, CURR OPIN CLIN NUTR, V14, P243, DOI 10.1097/MCO.0b013e3283455d7a; Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wijers SLJ, 2009, OBES REV, V10, P218, DOI 10.1111/j.1467-789X.2008.00538.x; Wright DC, 2005, AM J PHYSIOL-ENDOC M, V288, pE1062, DOI 10.1152/ajpendo.00561.2004; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang FP, 2012, BIOMATERIALS, V33, P5638, DOI 10.1016/j.biomaterials.2012.04.035; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008	46	91	92	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10840	10849		10.1074/jbc.M115.636878	http://dx.doi.org/10.1074/jbc.M115.636878			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25713078	Green Published, hybrid			2022-12-28	WOS:000353404500024
J	Jang, H; Abraham, SJ; Chavan, TS; Hitchinson, B; Khavrutskii, L; Tarasova, NI; Nussinov, R; Gaponenko, V				Jang, Hyunbum; Abraham, Sherwin J.; Chavan, Tanmay S.; Hitchinson, Ben; Khavrutskii, Lyuba; Tarasova, Nadya I.; Nussinov, Ruth; Gaponenko, Vadim			Mechanisms of Membrane Binding of Small GTPase K-Ras4B Farnesylated Hypervariable Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; PHOSPHOLIPID-BILAYER NANODISCS; MOLECULAR-DYNAMICS SIMULATIONS; FORMS ION CHANNELS; ALL-D-ENANTIOMER; K-RAS; PLASMA-MEMBRANE; LIPID RAFTS; H-RAS; ONCOGENIC KRAS	K-Ras4B belongs to a family of small GTPases that regulates cell growth, differentiation and survival. K-ras is frequently mutated in cancer. K-Ras4B association with the plasma membrane through its farnesylated and positively charged C-terminal hypervariable region (HVR) is critical to its oncogenic function. However, the structural mechanisms of membrane association are not fully understood. Here, using confocal microscopy, surface plasmon resonance, and molecular dynamics simulations, we observed that K-Ras4B can be distributed in rigid and loosely packed membrane domains. Its membrane binding domain interaction with phospholipids is driven by membrane fluidity. The farnesyl group spontaneously inserts into the disordered lipid microdomains, whereas the rigid microdomains restrict the farnesyl group penetration. We speculate that the resulting farnesyl protrusion toward the cell interior allows oligomerization of the K-Ras4B membrane binding domain in rigid microdomains. Unlike other Ras isoforms, K-Ras4B HVR contains a single farnesyl modification and positively charged polylysine sequence. The high positive charge not only modulates specific HVR binding to anionic phospholipids but farnesyl membrane orientation. Phosphorylation of Ser-181 prohibits spontaneous farnesyl membrane insertion. The mechanism illuminates the roles of HVR modifications in K-Ras4B targeting microdomains of the plasma membrane and suggests an additional function for HVR in regulation of Ras signaling.	[Jang, Hyunbum; Khavrutskii, Lyuba; Nussinov, Ruth] Leidos Biomed Res Inc, Basic Sci Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Jang, Hyunbum; Khavrutskii, Lyuba; Tarasova, Nadya I.; Nussinov, Ruth] NCI, Canc & Inflammat Program, NIH, Frederick, MD 21702 USA; [Abraham, Sherwin J.; Chavan, Tanmay S.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Abraham, Sherwin J.; Hitchinson, Ben; Gaponenko, Vadim] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Chavan, Tanmay S.; Gaponenko, Vadim] Univ Illinois, Dept Med Chem, Chicago, IL 60607 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tel Aviv University; Sackler Faculty of Medicine	Tarasova, NI (corresponding author), NCI, Canc & Inflammat Program, NIH, Frederick, MD 21702 USA.	Nadya.Tarasova@nih.gov; NussinoR@helix.nih.gov; vadimg@uic.edu	Gaponenko, Vadim/K-9729-2019	Gaponenko, Vadim/0000-0002-7891-9223; Nussinov, Ruth/0000-0002-8115-6415; Tarasova, Nadya/0000-0002-4949-0069; Chavan, Tanmay/0000-0002-2702-6863	National Institutes of Health [R01 CA135341]; Frederick National Laboratory for Cancer Research [HHSN261200800001E]; Intramural Research Program, Frederick National Laboratory Center for Cancer Research; American Cancer Society [RGS-09-057-01-GMC]; NATIONAL CANCER INSTITUTE [ZIABC010440, ZIABC010441, ZIABC011306, R01CA135341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick National Laboratory for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program, Frederick National Laboratory Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA135341 (to V. G.), Frederick National Laboratory for Cancer Research Contract HHSN261200800001E, and by the Intramural Research Program, Frederick National Laboratory Center for Cancer Research. This work was also supported by American Cancer Society Grant RGS-09-057-01-GMC (to V. G.).	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Abraham SJ, 2010, PROTEIN EXPRES PURIF, V73, P125, DOI 10.1016/j.pep.2010.05.015; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Ashery U, 2006, TRAFFIC, V7, P1119, DOI 10.1111/j.1600-0854.2006.00459.x; Barcelo C, 2014, CANCER RES, V74, P1190, DOI 10.1158/0008-5472.CAN-13-1750; Barcelo C, 2013, J CELL SCI, V126, P4553, DOI 10.1242/jcs.123737; Bialek-Wyrzykowska U, 2000, MOL MICROBIOL, V35, P1295, DOI 10.1046/j.1365-2958.2000.01782.x; Bifulco M, 2005, LIFE SCI, V77, P1740, DOI 10.1016/j.lfs.2005.05.017; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Blum R, 2008, RECENT PAT ANTI-CANC, V3, P31; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buckner Frederick S, 2005, Curr Opin Investig Drugs, V6, P791; Bustinza-Linares E, 2010, FUTURE ONCOL, V6, P885, DOI [10.2217/fon.10.71, 10.2217/FON.10.71]; Calvert RJ, 2002, BIOCHEM PHARMACOL, V64, P41, DOI 10.1016/S0006-2952(02)01077-8; Capone R, 2012, J CHEM THEORY COMPUT, V8, P1143, DOI 10.1021/ct200885r; Capone R, 2012, BIOCHEMISTRY-US, V51, P776, DOI 10.1021/bi2017427; Capone R, 2010, BIOPHYS J, V98, P2644, DOI 10.1016/j.bpj.2010.02.024; Chavan TS, 2013, MOLECULES, V18, P7103, DOI 10.3390/molecules18067103; Cho KJ, 2012, CURR BIOL, V22, P945, DOI 10.1016/j.cub.2012.03.067; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Connelly L, 2012, BIOCHEMISTRY-US, V51, P3031, DOI 10.1021/bi300257e; Connelly L, 2012, J PHYS CHEM B, V116, P1728, DOI 10.1021/jp2108126; Cox Adrienne D., 1992, Current Opinion in Cell Biology, V4, P1008, DOI 10.1016/0955-0674(92)90133-W; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Dietrich C, 2001, P NATL ACAD SCI USA, V98, P10642, DOI 10.1073/pnas.191168698; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; DURELL SR, 1994, J PHYS CHEM-US, V98, P2198, DOI 10.1021/j100059a038; Einav S, 2003, J ANTIMICROB CHEMOTH, V52, P883, DOI 10.1093/jac/dkg490; Eisenberg S, 2008, CELL SIGNAL, V20, P31, DOI 10.1016/j.cellsig.2007.07.012; Ellis CA, 2000, CELL SIGNAL, V12, P425, DOI 10.1016/S0898-6568(00)00084-X; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Friday BB, 2005, BBA-REV CANCER, V1756, P127, DOI 10.1016/j.bbcan.2005.08.001; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Fritz G, 2009, CURR CANCER DRUG TAR, V9, P626, DOI 10.2174/156800909789057033; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; GHOMASHCHI F, 1995, BIOCHEMISTRY-US, V34, P11910, DOI 10.1021/bi00037a032; Gillman AL, 2014, J PHYS CHEM B, V118, P7335, DOI 10.1021/jp5040954; Gomez GA, 2007, FEBS J, V274, P2210, DOI 10.1111/j.1742-4658.2007.05758.x; Gonzalez Jose M, 2011, Front Biosci (Schol Ed), V3, P1133; Gupta K, 2013, BIOPHYS J, V105, P2093, DOI 10.1016/j.bpj.2013.09.040; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Jang H, 2004, BIOPHYS J, V87, P129, DOI 10.1529/biophysj.104.039602; Jang H, 2008, BIOPHYS J, V95, P4631, DOI 10.1529/biophysj.108.134551; Jang H, 2008, PROTEINS, V72, P299, DOI 10.1002/prot.21925; Jang H, 2014, CHEM SOC REV, V43, P6750, DOI 10.1039/c3cs60459d; Jang H, 2013, J PHYS CHEM B, V117, P11518, DOI 10.1021/jp405389n; Janosi L, 2012, P NATL ACAD SCI USA, V109, P8097, DOI 10.1073/pnas.1200773109; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Leonenko ZV, 2004, BIOPHYS J, V86, P3783, DOI 10.1529/biophysj.103.036681; Linares GEG, 2007, CURR MED CHEM, V14, P289; Lopez-Alcala C, 2008, J BIOL CHEM, V283, P10621, DOI 10.1074/jbc.M706238200; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; Meister A, 2006, BIOPHYS J, V91, P1388, DOI 10.1529/biophysj.106.084624; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; Nakagami H, 2003, ANN MED, V35, P398, DOI 10.1080/07853890310001294; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; Nussinov R, 2015, BIOL REV, V90, P587, DOI 10.1111/brv.12124; Nussinov R, 2014, PROG BIOPHYS MOL BIO, V116, P158, DOI 10.1016/j.pbiomolbio.2014.07.002; Nussinov R, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/4/045004; Pechlivanis M, 2006, BBA-PROTEINS PROTEOM, V1764, P1914, DOI 10.1016/j.bbapap.2006.09.017; Petrache HI, 2004, BIOPHYS J, V86, P1574, DOI 10.1016/S0006-3495(04)74225-3; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Plowman SJ, 2003, MOL CELL BIOL, V23, P9245, DOI 10.1128/MCB.23.24.9245-9250.2003; Prakash P, 2013, BBA-GEN SUBJECTS, V1830, P5211, DOI 10.1016/j.bbagen.2013.07.024; Prior IA, 2001, J CELL SCI, V114, P1603; Pylypenko O, 2008, J MOL BIOL, V377, P1334, DOI 10.1016/j.jmb.2008.01.099; RAND RP, 1989, BIOCHIM BIOPHYS ACTA, V988, P351, DOI 10.1016/0304-4157(89)90010-5; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rizzo MA, 2001, J BIOL CHEM, V276, P34928, DOI 10.1074/jbc.M105918200; Rouquette-Jazdanian AK, 2005, J IMMUNOL, V175, P5637, DOI 10.4049/jimmunol.175.9.5637; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Sorek N, 2009, CURR OPIN PLANT BIOL, V12, P714, DOI 10.1016/j.pbi.2009.09.003; Weise K, 2011, J AM CHEM SOC, V133, P880, DOI 10.1021/ja107532q; Welman A, 2000, ONCOGENE, V19, P4582, DOI 10.1038/sj.onc.1203818; White MA, 2001, NAT CELL BIOL, V3, pE172, DOI 10.1038/35087098; WILLUMSEN BM, 1984, EMBO J, V3, P2581, DOI 10.1002/j.1460-2075.1984.tb02177.x; WOOLF TB, 1994, P NATL ACAD SCI USA, V91, P11631, DOI 10.1073/pnas.91.24.11631; Woolf TB, 1996, PROTEINS, V24, P92; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	91	82	82	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9465	9477		10.1074/jbc.M114.620724	http://dx.doi.org/10.1074/jbc.M114.620724			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713064	Green Published, hybrid			2022-12-28	WOS:000352729400014
J	Stankiewicz, TR; Ramaswami, SA; Bouchard, RJ; Aktories, K; Linseman, DA				Stankiewicz, Trisha R.; Ramaswami, Sai Anandi; Bouchard, Ron J.; Aktories, Klaus; Linseman, Daniel A.			Neuronal Apoptosis Induced by Selective Inhibition of Rac GTPase versus Global Suppression of Rho Family GTPases Is Mediated by Alterations in Distinct Mitogen-activated Protein Kinase Signaling Cascades	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; ERK5 PATHWAY; SURVIVAL; BAD; PHOSPHORYLATION; TRANSDUCER; EXPRESSION; RAC/CDC42; MACHINERY; INTERACT	Rho family GTPases play integral roles in neuronal differentiation and survival. We have shown previously that Clostridium difficile toxin B (ToxB), an inhibitor of RhoA, Rac1, and Cdc42, induces apoptosis of cerebellar granule neurons (CGNs). In this study, we compared the effects of ToxB to a selective inhibitor of the Rac-specific guanine nucleotide exchange factors Tiam1 and Trio (NSC23766). In a manner similar to ToxB, selective inhibition of Rac induces CGN apoptosis associated with enhanced caspase-3 activation and reduced phosphorylation of the Rac effector p21-activated kinase. In contrast to ToxB, caspase inhibitors do not protect CGNs from targeted inhibition of Rac. Also dissimilar to ToxB, selective inhibition of Rac does not inhibit MEK1/2/ERK1/2 or activate JNK/c-Jun. Instead, targeted inhibition of Rac suppresses distinct MEK5/ERK5, p90Rsk, and Akt-dependent signaling cascades known to regulate the localization and expression of the Bcl-2 homology 3 domain-only protein Bad. Adenoviral expression of a constitutively active mutant of MEK5 is sufficient to attenuate neuronal cell death induced by selective inhibition of Rac with NSC23766 but not apoptosis induced by global inhibition of Rho GTPases with Tox B. Collectively, these data demonstrate that global suppression of Rho family GTPases with ToxB causes a loss of MEK1/2/ERK1/2 signaling and activation of JNK/c-Jun, resulting in diminished degradation and enhanced transcription of the Bcl-2 homology 3 domain-only protein Bim. In contrast, selective inhibition of Rac induces CGN apoptosis by repressing unique MEK5/ERK5, p90Rsk, and Akt-dependent prosurvival pathways, ultimately leading to enhanced expression, dephosphorylation, and mitochondrial localization of proapoptotic Bad.	[Stankiewicz, Trisha R.; Bouchard, Ron J.; Linseman, Daniel A.] Vet Affairs Med Ctr, Res Serv, Denver, CO 80220 USA; [Stankiewicz, Trisha R.; Ramaswami, Sai Anandi; Linseman, Daniel A.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Stankiewicz, Trisha R.; Ramaswami, Sai Anandi; Linseman, Daniel A.] Univ Denver, Eleanor Roosevelt Inst, Denver, CO 80208 USA; [Aktories, Klaus] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany; [Linseman, Daniel A.] Univ Colorado Denver, Div Clin Pharmacol & Toxicol, Dept Med, Aurora, CO 80045 USA; [Linseman, Daniel A.] Univ Colorado Denver, Neurosci Program, Aurora, CO 80045 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Denver; University of Denver; University of Freiburg; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Linseman, DA (corresponding author), Vet Affairs Med Ctr, Res 151,1055 Clermont St, Denver, CO 80220 USA.	dan.linseman@ucdenver.edu	Linseman, Daniel/L-3846-2019; Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436	Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Merit Review award from the Department of Veterans Affairs (to D. A. L).	Ahonen TJ, 2003, J BIOL CHEM, V278, P27287, DOI 10.1074/jbc.M304307200; Barberan S, 2011, EUR J NEUROSCI, V34, P1737, DOI 10.1111/j.1460-9568.2011.07891.x; Bertolotto C, 2000, J BIOL CHEM, V275, P37246, DOI 10.1074/jbc.M007732200; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Cavanaugh JE, 2006, J NEUROSCI RES, V84, P1367, DOI 10.1002/jnr.21024; Cheng JZ, 2012, CIRC RES, V110, P230, DOI 10.1161/CIRCRESAHA.111.246025; Condorelli F, 2001, MOL CELL BIOL, V21, P3025, DOI 10.1128/MCB.21.9.3025-3036.2001; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; Desagher S, 2005, J BIOL CHEM, V280, P5693, DOI 10.1074/jbc.M408971200; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Finegan KG, 2009, CELL DEATH DIFFER, V16, P674, DOI 10.1038/cdd.2008.193; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Ha S, 2008, DEV NEUROBIOL, V68, P1565, DOI 10.1002/dneu.20682; Hakoshima T, 2003, J BIOCHEM, V134, P327, DOI 10.1093/jb/mvg149; Jacquier A, 2006, ANN NEUROL, V60, P105, DOI 10.1002/ana.20886; Jeon BT, 2013, NEUROTOX RES, V23, P238, DOI 10.1007/s12640-012-9339-2; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kanekura K, 2005, J BIOL CHEM, V280, P4532, DOI 10.1074/jbc.M410508200; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; Kitada S, 1998, AM J PATHOL, V152, P51; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; Le SS, 2005, J NEUROCHEM, V94, P1025, DOI 10.1111/j.1471-4159.2005.03252.x; Lennartsson J, 2010, CELL SIGNAL, V22, P955, DOI 10.1016/j.cellsig.2010.01.020; Linseman DA, 2001, J BIOL CHEM, V276, P39123, DOI 10.1074/jbc.M103959200; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Loucks FA, 2006, J NEUROCHEM, V97, P957, DOI 10.1111/j.1471-4159.2006.03802.x; Masters SC, 2001, MOL PHARMACOL, V60, P1325, DOI 10.1124/mol.60.6.1325; Nakamura K, 2003, J BIOL CHEM, V278, P36989, DOI 10.1074/jbc.C300313200; Park EM, 2006, NEUROSCI LETT, V402, P190, DOI 10.1016/j.neulet.2006.04.004; Porter AC, 1999, ONCOGENE, V18, P7794, DOI 10.1038/sj.onc.1203214; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Ranganathan A, 2006, ARCH BIOCHEM BIOPHYS, V449, P8, DOI 10.1016/j.abb.2006.02.023; Rikitake Y, 2005, STROKE, V36, P2251, DOI 10.1161/01.STR.0000181077.84981.11; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Stankiewicz TR, 2012, J BIOL CHEM, V287, P16835, DOI 10.1074/jbc.M111.302166; Sun WY, 2001, J BIOL CHEM, V276, P5093, DOI 10.1074/jbc.M003719200; Tanaka T, 2000, J NEUROSCI, V20, P2852; Topp JD, 2004, J BIOL CHEM, V279, P24612, DOI 10.1074/jbc.M313504200; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Yamanaka K, 2003, P NATL ACAD SCI USA, V100, P16041, DOI 10.1073/pnas.2635267100; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	46	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9363	9376		10.1074/jbc.M114.575217	http://dx.doi.org/10.1074/jbc.M114.575217			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25666619	Green Published, hybrid			2022-12-28	WOS:000352729400006
J	Yang, JG; Rees, DC				Yang, Janet G.; Rees, Douglas C.			The Allosteric Regulatory Mechanism of the Escherichia coli MetNI Methionine ATP Binding Cassette (ABC) Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; MALTOSE TRANSPORTER; CRYSTAL-STRUCTURE; R-DOMAIN; BTUCD-F; PHOSPHORYLATION; SYSTEMS; TRANSINHIBITION; INTERMEDIATE; SUPERFAMILY	The MetNI methionine importer of Escherichia coli, an ATP binding cassette (ABC) transporter, uses the energy of ATP binding and hydrolysis to catalyze the high affinity uptake of D- and L-methionine. Early in vivo studies showed that the uptake of external methionine is repressed by the level of the internal methionine pool, a phenomenon termed transinhibition. Our understanding of the MetNI mechanism has thus far been limited to a series of crystal structures in an inward-facing conformation. To understand the molecular mechanism of transinhibition, we studied the kinetics of ATP hydrolysis using detergent-solubilized MetNI. We find that transinhibition is due to noncompetitive inhibition by L-methionine, much like a negative feedback loop. Thermodynamic analyses revealed two allosteric methionine binding sites per transporter. This quantitative analysis of transinhibition, the first to our knowledge for a structurally defined transporter, builds upon the previously proposed structurally based model for regulation. This mechanism of regulation at the transporter activity level could be applicable to not only ABC transporters but other types of membrane transporters as well.	[Rees, Douglas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Rees, Douglas C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Rees, DC (corresponding author), CALTECH, Div Chem & Chem Engn, Mail Code 114-96,1200 E Calif Blvd, Pasadena, CA 91125 USA.	dcrees@caltech.edu	Yang, Janet/P-2003-2015		National Institutes of Health [R01 GM45162]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM45162 (to D. C. R.).	Baldursson O, 2001, J BIOL CHEM, V276, P1904, DOI 10.1074/jbc.M006934200; Bao H, 2013, J BIOL CHEM, V288, P23666, DOI 10.1074/jbc.M113.489567; Bao H, 2013, BBA-BIOMEMBRANES, V1828, P1723, DOI 10.1016/j.bbamem.2013.03.024; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Chen SS, 2013, NATURE, V499, P364, DOI 10.1038/nature12232; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; Davidson AL, 1996, J BIOL CHEM, V271, P4858; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Gal J, 2002, J BACTERIOL, V184, P4930, DOI 10.1128/JB.184.17.4930-4932.2002; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Hines KE, 2014, J GEN PHYSIOL, V143, P401, DOI 10.1085/jgp.201311116; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Ingraham J. L., 1983, GROWTH BACTERIAL CEL, P129; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Johnson E, 2012, PROTEIN SCI, V21, P84, DOI 10.1002/pro.765; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; KADNER RJ, 1975, J BACTERIOL, V122, P110, DOI 10.1128/JB.122.1.110-119.1975; KADNER RJ, 1974, J BACTERIOL, V117, P232, DOI 10.1128/JB.117.1.232-241.1974; KADNER RJ, 1974, J BACTERIOL, V119, P401, DOI 10.1128/JB.119.2.401-409.1974; Korkhov VM, 2014, NAT STRUCT MOL BIOL, V21, P1097, DOI 10.1038/nsmb.2918; Korkhov VM, 2012, NATURE, V490, P367, DOI 10.1038/nature11442; Liu CE, 1997, J BIOL CHEM, V272, P21883, DOI 10.1074/jbc.272.35.21883; Merlin C, 2002, J BACTERIOL, V184, P5513, DOI 10.1128/JB.184.19.5513-5517.2002; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; RICH DP, 1993, J BIOL CHEM, V268, P20259; Romeo Y, 2003, MOL MICROBIOL, V47, P1135, DOI 10.1046/j.1365-2958.2003.03362.x; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tal N, 2013, P NATL ACAD SCI USA, V110, P5434, DOI 10.1073/pnas.1209644110; Zhang ZG, 2003, ARCH MICROBIOL, V180, P88, DOI 10.1007/s00203-003-0561-4	36	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9135	9140		10.1074/jbc.M114.603365	http://dx.doi.org/10.1074/jbc.M114.603365			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25678706	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000352207100036
J	Repnik, U; Starr, AE; Overall, CM; Turk, B				Repnik, Urska; Starr, Amanda E.; Overall, Christopher M.; Turk, Boris			Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-LIKE GLYCOSAMINOGLYCANS; CXC CHEMOKINES; GRO-ALPHA; IN-VIVO; CELL-MIGRATION; PROCATHEPSIN-B; CUTTING EDGE; BINDING; CANCER; CHEMOATTRACTANT	Cysteine cathepsins are primarily lysosomal proteases involved in general protein turnover, but they also have specific proteolytic functions in antigen presentation and bone remodeling. Cathepsins are most stable at acidic pH, although growing evidence indicates that they have physiologically relevant activity also at neutral pH. Post-translational proteolytic processing of mature chemokines is a key, yet underappreciated, level of chemokine regulation. Although the role of selected serine proteases and matrix metalloproteases in chemokine processing has long been known, little has been reported about the role of cysteine cathepsins. Here we evaluated cleavage of CXC ELR (CXCL1, -2, -3, -5, and -8) and non-ELR (CXCL9-12) chemokines by cysteine cathepsins B, K, L, and S at neutral pH by high resolution Tris-Tricine SDS-PAGE and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Whereas cathepsin B cleaved chemokines especially in the C-terminal region, cathepsins K, L, and S cleaved chemokines at the N terminus with glycosaminoglycans modulating cathepsin processing of chemokines. The functional consequences of the cleavages were determined by Ca2+ mobilization and chemotaxis assays. We show that cysteine cathepsins inactivate and in some cases degrade non-ELR CXC chemokines CXCL9-12. In contrast, cathepsins specifically process ELR CXC chemokines CXCL1, -2, -3, -5, and -8 N-terminally to the ELR motif, thereby generating agonist forms. This study suggests that cysteine cathepsins regulate chemokine activity and thereby leukocyte recruitment during protective or pathological inflammation.	[Repnik, Urska; Turk, Boris] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, SI-1000 Ljubljana, Slovenia; [Starr, Amanda E.; Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Turk, Boris] Ctr Excellence Integrated Approaches Chem & Biol, SI-1000 Ljubljana, Slovenia; [Turk, Boris] Univ Ljubljana, Fac Chem & Chem Technol, SI-1000 Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of British Columbia; University of British Columbia; University of Ljubljana	Turk, B (corresponding author), Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Jamova 39, SI-1000 Ljubljana, Slovenia.	chris.overall@ubc.ca; boris.turk@ijs.si		Turk, Boris/0000-0002-9007-5764	Slovene Research Agency [P1-0140, J1-6739, N1-0022]; Canadian Institutes of Health Research (CIHR); Michael Smith Research Foundation (University of British Columbia Centre for Blood Research); British Columbia Proteomics Network; Natural Sciences and Engineering Research Council of Canada; Michael Smith Foundation for Health Research; CIHR [STP-53877]	Slovene Research Agency(Slovenian Research Agency - Slovenia); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Research Foundation (University of British Columbia Centre for Blood Research); British Columbia Proteomics Network; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by Grants P1-0140, J1-6739, and N1-0022 from the Slovene Research Agency (to B. T.). This research was also supported by a Canadian Institutes of Health Research (CIHR) grant and an Infrastructure Grant from the Michael Smith Research Foundation (University of British Columbia Centre for Blood Research) and the British Columbia Proteomics Network.; Supported by the Natural Sciences and Engineering Research Council of Canada, the Michael Smith Foundation for Health Research, and CIHR Strategic Training Program STP-53877.	Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Ajami K, 2008, FEBS LETT, V582, P819, DOI 10.1016/j.febslet.2008.02.005; Almeida PC, 2001, J BIOL CHEM, V276, P944, DOI 10.1074/jbc.M003820200; Almeida PC, 1999, J BIOL CHEM, V274, P30433, DOI 10.1074/jbc.274.43.30433; Bellac CL, 2014, CELL REP, V9, P618, DOI 10.1016/j.celrep.2014.09.006; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; Biniossek ML, 2011, J PROTEOME RES, V10, P5363, DOI 10.1021/pr200621z; Bromme D, 2011, BIOL EXTRACELL MATR, P23, DOI 10.1007/978-3-642-16861-1_2; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Caglic D, 2007, J BIOL CHEM, V282, P33076, DOI 10.1074/jbc.M705761200; Caglic D, 2013, BIOL CHEM, V394, P307, DOI 10.1515/hsz-2012-0283; Caglic D, 2011, BIOORGAN MED CHEM, V19, P1055, DOI 10.1016/j.bmc.2010.10.028; Clark AK, 2012, ARTHRITIS RHEUM-US, V64, P2038, DOI 10.1002/art.34351; Clark AK, 2009, J NEUROSCI, V29, P6945, DOI 10.1523/JNEUROSCI.0828-09.2009; ClarkLewis I, 1997, METHOD ENZYMOL, V287, P233; Cox JH, 2008, J BIOL CHEM, V283, P19389, DOI 10.1074/jbc.M800266200; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Fonovic M, 2014, BBA-GEN SUBJECTS, V1840, P2560, DOI 10.1016/j.bbagen.2014.03.017; Fortelny N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001869; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Hasan L, 2006, J IMMUNOL, V176, P6512, DOI 10.4049/jimmunol.176.11.6512; Hou WS, 2002, ARTHRITIS RHEUM, V46, P663, DOI 10.1002/art.10114; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; Ishidoh K, 1995, BIOCHEM BIOPH RES CO, V217, P624, DOI 10.1006/bbrc.1995.2820; Jones BA, 2013, ARTHRITIS RHEUM-US, V65, P2814, DOI 10.1002/art.38095; King AG, 2000, J IMMUNOL, V164, P3774, DOI 10.4049/jimmunol.164.7.3774; KIRSCHKE H, 1989, BIOCHEM J, V264, P467, DOI 10.1042/bj2640467; Lemaire R, 1997, BRIT J RHEUMATOL, V36, P735; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200; Ludwig A, 2002, J LEUKOCYTE BIOL, V72, P183; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Mihelic M, 2008, J BIOL CHEM, V283, P14453, DOI 10.1074/jbc.M801283200; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Mohamed MM, 2010, CELL PHYSIOL BIOCHEM, V25, P315, DOI 10.1159/000276564; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Mortier A, 2008, PHARMACOL THERAPEUT, V120, P197, DOI 10.1016/j.pharmthera.2008.08.006; Nufer O, 1999, BIOCHEMISTRY-US, V38, P636, DOI 10.1021/bi981294s; Ohashi K, 2003, BBA-PROTEINS PROTEOM, V1649, P30, DOI 10.1016/S1570-9639(03)00152-3; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554; Proost P, 2007, BLOOD, V110, P37, DOI 10.1182/blood-2006-10-049072; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Rozman J, 1999, FEBS LETT, V459, P358, DOI 10.1016/S0014-5793(99)01302-2; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Starr AE, 2012, J BIOL CHEM, V287, P13382, DOI 10.1074/jbc.M111.314179; Starr AE, 2012, J BIOL CHEM, V287, P5848, DOI 10.1074/jbc.M111.314609; Starr AE, 2009, METHOD ENZYMOL, V461, P281, DOI 10.1016/S0076-6879(09)05413-5; Staudt ND, 2012, STEM CELLS DEV, V21, P1924, DOI 10.1089/scd.2011.0307; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Turk B, 1999, EUR J BIOCHEM, V259, P926, DOI 10.1046/j.1432-1327.1999.00145.x; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; Turk D, 1998, BIOL CHEM, V379, P137, DOI 10.1515/bchm.1998.379.2.137; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Vasiljeva O, 2005, FEBS LETT, V579, P1285, DOI 10.1016/j.febslet.2004.12.093; Vasiljeva O, 2008, BIOCHIMIE, V90, P380, DOI 10.1016/j.biochi.2007.10.004; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; WALZ A, 1989, J EXP MED, V170, P1745, DOI 10.1084/jem.170.5.1745; Wuyts A, 1999, EUR J BIOCHEM, V260, P421, DOI 10.1046/j.1432-1327.1999.00166.x; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127	69	54	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13800	13811		10.1074/jbc.M115.638395	http://dx.doi.org/10.1074/jbc.M115.638395			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25833952	Green Published, hybrid			2022-12-28	WOS:000355313000015
J	Butler, PL; Staruschenko, A; Snyder, PM				Butler, Phillip L.; Staruschenko, Alexander; Snyder, Peter M.			Acetylation Stimulates the Epithelial Sodium Channel by Reducing Its Ubiquitination and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; LIDDLES-SYNDROME; HISTONE DEACETYLASE; ALPHA-SUBUNIT; GAMMA-SUBUNIT; CELL-SURFACE; PY MOTIF; A6 CELLS; ENAC; EXPRESSION	The epithelial Na+ channel (ENaC) functions as a pathway for Na+ absorption in the kidney and lung, where it is crucial for Na+ homeostasis and blood pressure regulation. ENaC is regulated in part through signaling pathways that control the ubiquitination state of ENaC lysines. A defect in ubiquitination causes Liddle syndrome, an inherited form of hypertension. Here we determined that alpha-, beta-, and gamma ENaC are also substrates for lysine acetylation. Trichostatin A (TSA), a histone deacetylase inhibitor, enhanced ENaC acetylation and increased ENaC abundance in the total cell lysate and at the cell surface. Moreover, TSA increased ENaC current in Fischer rat thyroid and kidney collecting duct epithelia. We found that HDAC7 is expressed in the kidney collecting duct, supporting a potential role for this histone deacetylase in ENaC regulation. HDAC7 overexpression reduced ENaC abundance and ENaC current, whereas ENaC abundance and current were increased by silencing of HDAC7. ENaC and HDAC7 form a complex, as detected by coimmunoprecipitation. We observed a reciprocal relationship between acetylation and ubiquitination; TSA reduced ENaC ubiquitination, whereas HDAC7 increased ubiquitination. By reducing ENaC ubiquitination, TSA decreased the rate of ENaC degradation. Thus, acetylation increases epithelial Na+ absorption by antagonizing ENaC ubiquitination. This stabilizes ENaC, and hence, increases its abundance at the cell surface.	[Butler, Phillip L.; Snyder, Peter M.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Butler, Phillip L.; Snyder, Peter M.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Snyder, Peter M.] Iowa City Vet Affairs Healthcare Syst, Iowa City, IA 52246 USA; [Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Medical College of Wisconsin	Snyder, PM (corresponding author), Univ Iowa, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu	Regan, Clinton/E-6250-2012	Staruschenko, Alexander/0000-0002-5190-8356	National Institutes of Health [HL058812, HL072256, HL108880]; Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant [BX001862]; American Heart Association Postdoctoral Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108880, R01HL072256, R01HL058812, R29HL058812] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant(US Department of Veterans Affairs); American Heart Association Postdoctoral Research Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants HL058812 and HL072256 (to P. M. S.) and HL108880 (A. S.), Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant BX001862 (to P. M. S.), and an American Heart Association Postdoctoral Research Fellowship (to P. B.).	Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bouchecareilh M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404707; BOUCHER RC, 1988, J PHYSIOL-LONDON, V405, P77, DOI 10.1113/jphysiol.1988.sp017322; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Gao CZ, 2010, BBA-MOL CELL RES, V1803, P1186, DOI 10.1016/j.bbamcr.2010.06.008; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Ilatovskaya DV, 2014, KIDNEY INT, V86, P506, DOI 10.1038/ki.2014.71; Jain L, 2001, AM J PHYSIOL-LUNG C, V280, pL646, DOI 10.1152/ajplung.2001.280.4.L646; Jain L, 1999, AM J PHYSIOL-LUNG C, V276, pL1046, DOI 10.1152/ajplung.1999.276.6.L1046; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jin ZX, 2013, MOL ENDOCRINOL, V27, P325, DOI 10.1210/me.2012-1302; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kao HY, 2000, GENE DEV, V14, P55; Kasler HG, 2011, J IMMUNOL, V186, P4782, DOI 10.4049/jimmunol.1001179; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Malik B, 2005, AM J PHYSIOL-RENAL, V289, pF107, DOI 10.1152/ajprenal.00179.2002; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Oberfeld B, 2011, AM J PHYSIOL-RENAL, V301, pF189, DOI 10.1152/ajprenal.00487.2010; Ruffieux-Daidie D, 2011, J BIOL CHEM, V286, P2416, DOI 10.1074/jbc.M110.176156; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2000, J CLIN INVEST, V105, P45, DOI 10.1172/JCI7869; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200; Zhou RF, 2013, J BIOL CHEM, V288, P5389, DOI 10.1074/jbc.M112.425272; Zhou RF, 2010, J BIOL CHEM, V285, P30523, DOI 10.1074/jbc.M110.150755; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	45	22	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12497	12503		10.1074/jbc.M114.635540	http://dx.doi.org/10.1074/jbc.M114.635540			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25787079	hybrid, Green Published			2022-12-28	WOS:000354569000006
J	Wong, ET; Maretzky, T; Peleg, Y; Blobel, CP; Sagi, I				Wong, Eitan; Maretzky, Thorsten; Peleg, Yoav; Blobel, Carl P.; Sagi, Irit			The Functional Maturation of A Disintegrin and Metalloproteinase (ADAM) 9, 10, and 17 Requires Processing at a Newly Identified Proprotein Convertase (PC) Cleavage Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM; Epidermal Growth Factor Receptor (EGFR); Furin; Metalloprotease; Shedding; Proenzyme Processing; Proprotein Convertase	ALPHA-SECRETASE ADAM10; GROWTH-FACTOR-ALPHA; 12 MELTRIN ALPHA; INTRACELLULAR MATURATION; CYSTEINE SWITCH; FURIN CLEAVAGE; PROTEIN; ACTIVATION; ECTODOMAIN; CLONING	Background: Proprotein convertases (PCs) control the maturation of several A Disintegrin and Metalloprotease (ADAM) proteases. Results: Mutating a newly identified upstream PC site interferes with activation of ADAMs 9, 10, and 17. Conclusion: Processing at the upstream PC site is important for the activation of these ADAMs. Significance: The upstream PC site in several ADAMs suggests a novel general mechanism for their maturation. Proenzyme maturation is a general mechanism to control the activation of enzymes. Catalytically active members of the A Disintegrin And Metalloprotease (ADAM) family of membrane-anchored metalloproteases are synthesized as proenzymes, in which the latency is maintained by their autoinhibitory pro-domains. A proteolytic processing then transforms the proenzyme into a catalytically active form. The removal of the pro-domain of ADAMs is currently thought to depend on processing at a canonical consensus site for the proprotein convertase Furin (RXXR) between the pro- and the catalytic domain. Here, we demonstrate that this previously described canonical site is a secondary cleavage site to a prerequisite cleavage in a newly characterized upstream PC site embedded within the pro-domain sequence. The novel upstream regulatory site is important for the maturation of several ADAM proenzymes. Mutations in the upstream regulatory site of ADAM17, ADAM10, and ADAM9 do not prevent pro-domain processing between the pro- and metalloprotease domain, but nevertheless, cause significantly reduced catalytic activity. Thus, our results have uncovered a novel functionally relevant PC processing site in the N-terminal part of the pro-domain that is important for the activation of these ADAMs. These results suggest that the novel PC site is part of a general mechanism underlying proenzyme maturation of ADAMs that is independent of processing at the previously identified canonical Furin cleavage site.	[Wong, Eitan; Sagi, Irit] Weizmann Inst Sci, Dept Regulat Biol, IL-7610001 Rehovot, Israel; [Peleg, Yoav] Weizmann Inst Sci, Israel Struct Prote Ctr, IL-7610001 Rehovot, Israel; [Maretzky, Thorsten; Blobel, Carl P.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Blobel, Carl P.] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA; [Blobel, Carl P.] Weill Cornell Med Coll, Dept Physiol Biophys & Syst Biol, New York, NY 10021 USA	Weizmann Institute of Science; Weizmann Institute of Science; Cornell University; Cornell University	Sagi, I (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-7610001 Rehovot, Israel.	Irit.Sagi@weizmann.ac.il	Regan, Clinton/E-6250-2012; Maretzky, Thorsten/GSN-2981-2022; Maretzky, Thorsten/AEN-1915-2022; Wong, Eitan/AHB-8360-2022; Wong, Eitan/GRN-9218-2022	Maretzky, Thorsten/0000-0003-1282-6080; 	SaveMe FP7, ISF; National Institutes of Health [GM64750]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER	SaveMe FP7, ISF; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by SaveMe FP7, ISF and by National Institutes of Health Grant GM64750 to C. P. B.	Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Buckley CA, 2005, AM J PHYSIOL-LUNG C, V288, pL1132, DOI 10.1152/ajplung.00429.2004; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Colciaghi F, 2002, MOL MED, V8, P67, DOI 10.1007/BF03402076; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Erijman A, 2011, J STRUCT BIOL, V175, P171, DOI 10.1016/j.jsb.2011.04.005; Golubkov VS, 2007, J BIOL CHEM, V282, P36283, DOI 10.1074/jbc.M706290200; Golubkov VS, 2010, J BIOL CHEM, V285, P27726, DOI 10.1074/jbc.M110.135442; Gonzales PE, 2004, J BIOL CHEM, V279, P31638, DOI 10.1074/jbc.M401311200; Guaiquil V, 2009, MOL CELL BIOL, V29, P2694, DOI 10.1128/MCB.01460-08; Hall T, 2009, BIOSCIENCE REP, V29, P217, DOI 10.1042/BSR20080145; Hooper NM, 2002, CURR MED CHEM, V9, P1107, DOI 10.2174/0929867023370121; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Howard L, 2000, BIOCHEM J, V348, P21, DOI 10.1042/0264-6021:3480021; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Kang TB, 2002, J BIOL CHEM, V277, P25583, DOI 10.1074/jbc.M203532200; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Loechel F, 1998, J BIOL CHEM, V273, P16993, DOI 10.1074/jbc.273.27.16993; Lum L, 1998, J BIOL CHEM, V273, P26236, DOI 10.1074/jbc.273.40.26236; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Merlos-Suarez A, 2001, J BIOL CHEM, V276, P48510, DOI 10.1074/jbc.M103488200; Milla ME, 1999, J BIOL CHEM, V274, P30563, DOI 10.1074/jbc.274.43.30563; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; Rosenblum G, 2007, J AM CHEM SOC, V129, P13566, DOI 10.1021/ja073941l; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sanderson MP, 2005, J BIOL CHEM, V280, P1826, DOI 10.1074/jbc.M408804200; Sandy JD, 2001, BIOCHEM J, V358, P615, DOI 10.1042/0264-6021:3580615; Schlomann U, 2002, J BIOL CHEM, V277, P48210, DOI 10.1074/jbc.M203355200; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schwarz J, 2013, BBA-MOL CELL RES, V1833, P3355, DOI 10.1016/j.bbamcr.2013.10.005; Solomon A, 2007, P NATL ACAD SCI USA, V104, P4931, DOI 10.1073/pnas.0700066104; Srour N, 2003, FEBS LETT, V554, P275, DOI 10.1016/S0014-5793(03)01159-1; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Weskamp G, 1996, J CELL BIOL, V132, P717, DOI 10.1083/jcb.132.4.717; Wiley HS, 1998, J CELL BIOL, V143, P1317, DOI 10.1083/jcb.143.5.1317; Yoda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054412; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200	50	49	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12135	12146		10.1074/jbc.M114.624072	http://dx.doi.org/10.1074/jbc.M114.624072			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25795784	Green Published, hybrid			2022-12-28	WOS:000354388600027
J	Geilfus, CM; Ober, D; Eichacker, LA; Muhling, KH; Zorb, C				Geilfus, Christoph-Martin; Ober, Dietrich; Eichacker, Lutz A.; Muehling, Karl Hermann; Zoerb, Christian			Down-Regulation of ZmEXPB6 (Zea mays beta-Expansin 6) Protein Is Correlated with Salt-mediated Growth Reduction in the Leaves of Z. mays L.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAIZE LEAF ELONGATION; TRITICUM-AESTIVUM L.; DEEP-WATER RICE; CELL-WALL; VICIA-FABA; HOMOSPERMIDINE SYNTHASE; PRIMARY ROOT; NACL STRESS; GENE; EXPRESSION	The salt-sensitive crop Zea mays L. shows a rapid leaf growth reduction upon NaCl stress. There is increasing evidence that salinity impairs the ability of the cell walls to expand, ultimately inhibiting growth. Wall-loosening is a prerequisite for cell wall expansion, a process that is under the control of cell wall-located expansin proteins. In this study the abundance of those proteins was analyzed against salt stress using gel-based two-dimensional proteomics and two-dimensional Western blotting. Results show that ZmEXPB6 (Z. mays beta-expansin 6) protein is lacking in growth-inhibited leaves of salt-stressed maize. Of note, the exogenous application of heterologously expressed and metal-chelate-affinity chromatography-purified ZmEXPB6 on growth-reduced leaves that lack native ZmEXPB6 under NaCl stress partially restored leaf growth. In vitro assays on frozen- thawed leaf sections revealed that recombinant ZmEXPB6 acts on the capacity of the walls to extend. Our results identify expansins as a factor that partially restores leaf growth of maize in saline environments.	[Geilfus, Christoph-Martin; Muehling, Karl Hermann; Zoerb, Christian] Univ Kiel, Inst Plant Nutr & Soil Sci, D-24118 Kiel, Germany; [Ober, Dietrich] Univ Kiel, Inst Bot, D-24118 Kiel, Germany; [Ober, Dietrich] Univ Kiel, Bot Gardens, Biochem Ecol & Mol Evolut, D-24118 Kiel, Germany; [Eichacker, Lutz A.] Univ Stavanger, Ctr Organelle Res CORE, N-4021 Stavanger, Norway; [Zoerb, Christian] Univ Hohenheim, Inst Crop Sci, Qual Plant Prod, D-70593 Stuttgart, Germany	University of Kiel; University of Kiel; University of Kiel; Universitetet i Stavanger; University Hohenheim	Geilfus, CM (corresponding author), Univ Kiel, Inst Plant Nutr & Soil Sci, Hermann Rodewald Str 2, D-24118 Kiel, Germany.	cmgeilfus@plantnutrition.uni-kiel.de	Mühling, Karl H./L-6443-2014	Mühling, Karl H./0000-0002-9922-6581				[Anonymous], 2010, Plant, Cell and Environment, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; [Anonymous], 1953, COLLECTED WORKS JW T; BERNSTEIN N, 1993, PLANTA, V191, P433, DOI 10.1007/BF00195744; Buchanan CD, 2005, PLANT MOL BIOL, V58, P699, DOI 10.1007/s11103-005-7876-2; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; Cho HT, 1998, PLANT J, V15, P805, DOI 10.1046/j.1365-313X.1998.00258.x; Cho HT, 1997, PLANT PHYSIOL, V113, P1137, DOI 10.1104/pp.113.4.1137; Cosgrove DJ, 1998, PLANT PHYSIOL, V118, P333, DOI 10.1104/pp.118.2.333; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; CRAMER GR, 1991, J EXP BOT, V42, P1417, DOI 10.1093/jxb/42.11.1417; Dai FW, 2012, PLANT PHYSIOL, V160, P2064, DOI 10.1104/pp.112.207720; Downes BP, 2001, PLANT PHYSIOL, V126, P244, DOI 10.1104/pp.126.1.244; Geilfus CM, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-31; Geilfus CM, 2013, NEW PHYTOL, V197, P1117, DOI 10.1111/nph.12046; Geilfus CM, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00013; Geilfus CM, 2012, PLANT CELL ENVIRON, V35, P578, DOI 10.1111/j.1365-3040.2011.02437.x; Geilfus CM, 2011, J PLANT GROWTH REGUL, V30, P387, DOI 10.1007/s00344-011-9201-4; Geilfus CM, 2010, PLANT PHYSIOL BIOCH, V48, P993, DOI 10.1016/j.plaphy.2010.09.011; Geilfus CM, 2010, J IMMUNOL METHODS, V362, P89, DOI 10.1016/j.jim.2010.09.006; Goh HH, 2012, PLANT PHYSIOL, V159, P1759, DOI 10.1104/pp.112.200881; Guo WB, 2011, PLANT J, V66, P541, DOI 10.1111/j.1365-313X.2011.04511.x; HAGER A, 1971, PLANTA, V100, P47, DOI 10.1007/BF00386886; Han YY, 2012, PLANT PHYSIOL BIOCH, V54, P49, DOI 10.1016/j.plaphy.2012.02.007; Hu YC, 2000, INT J PLANT SCI, V161, P575, DOI 10.1086/314280; Hutsch BW, 2014, J PLANT NUTR SOIL SC, V177, P278, DOI 10.1002/jpln.201300345; Ismail A, 2014, J EXP BOT, V65, P2963, DOI 10.1093/jxb/eru159; Jones L, 2004, FEBS LETT, V559, P61, DOI 10.1016/S0014-5793(04)00023-7; Kaltenegger E, 2013, PLANT CELL, V25, P1213, DOI 10.1105/tpc.113.109744; Kohler W., 1984, EINFUHRUNG STAT BIOL, P101; Kwon YR, 2008, BIOTECHNOL LETT, V30, P1281, DOI 10.1007/s10529-008-9678-5; Lasanthi-Kudahettige R, 2007, PLANT PHYSIOL, V144, P218, DOI 10.1104/pp.106.093997; Li F, 2011, J PLANT PHYSIOL, V168, P960, DOI 10.1016/j.jplph.2010.11.023; Li LC, 2003, PLANT PHYSIOL, V132, P2073, DOI 10.1104/pp.103.020024; Lu PT, 2013, PLANTA, V237, P1547, DOI 10.1007/s00425-013-1867-3; Magneschi L, 2009, J PLANT PHYSIOL, V166, P1576, DOI 10.1016/j.jplph.2009.03.008; MCQUEENMASON SJ, 1995, J EXP BOT, V46, P1639, DOI 10.1093/jxb/46.11.1639; Moll S, 2002, PLANT PHYSIOL, V130, P47, DOI 10.1104/pp.004259; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; NEUMANN PM, 1988, PLANT PHYSIOL, V88, P233, DOI 10.1104/pp.88.1.233; Ploscher M, 2011, J PROTEOMICS, V74, P1256, DOI 10.1016/j.jprot.2011.03.020; RAYLE DL, 1992, PLANT PHYSIOL, V99, P1271, DOI 10.1104/pp.99.4.1271; Rozema J, 2008, SCIENCE, V322, P1478, DOI 10.1126/science.1168572; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Shonjani S., 2002, THESIS JUSTUS LIEBIG; Sumer A, 2004, J APPL BOT FOOD QUAL, V78, P135; VANVOLKENBURGH E, 1985, PLANT PHYSIOL, V77, P190, DOI 10.1104/pp.77.1.190; Wu YJ, 1996, PLANT PHYSIOL, V111, P765, DOI 10.1104/pp.111.3.765; Wu YJ, 2001, PLANT PHYSIOL, V126, P222, DOI 10.1104/pp.126.1.222; Zhu JM, 2007, PLANT PHYSIOL, V145, P1533, DOI 10.1104/pp.107.107250; Zorb C, 2004, PLANT SCI, V167, P91, DOI [10.1016/S0168-9452(04)00111-6, 10.1016/j.plantsci.2004.03.004]	54	18	20	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11235	11245		10.1074/jbc.M114.619718	http://dx.doi.org/10.1074/jbc.M114.619718			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25750129	Green Published, hybrid			2022-12-28	WOS:000353719400003
J	Jiang, BJ; Shen, H; Chen, Z; Yin, L; Zan, LS; Rui, LY				Jiang, Bijie; Shen, Hong; Chen, Zheng; Yin, Lei; Zan, Linsen; Rui, Liangyou			Carboxyl Terminus of HSC70-interacting Protein (CHIP) Down-regulates NF-kappa B-inducing Kinase (NIK) and Suppresses NIK-induced Liver Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; C-TERMINUS; TUMOR-SUPPRESSOR; DEGRADATION; IMMUNODEFICIENCY; OVEREXPRESSION; IDENTIFICATION; ACTIVATION; SURVIVAL; MUTATION	Ser/Thr kinase NIK (NF-kappa B-inducing kinase) mediates the activation of the noncanonical NF-kappa B2 pathway, and it plays an important role in regulating immune cell development and liver homeostasis. NIK levels are extremely low in quiescent cells due to ubiquitin/proteasome-mediated degradation, and cytokines stimulate NIK activation through increasing NIK stability; however, regulation of NIK stability is not fully understood. Here we identified CHIP (carboxyl terminus of HSC70-interacting protein) as a new negative regulator of NIK. CHIP contains three N-terminal tetratricopeptide repeats (TPRs), a middle dimerization domain, and a C-terminal U-box. The U-box domain contains ubiquitin E3 ligase activity that promotes ubiquitination of CHIP-bound partners. We observed that CHIP bound to NIK via its TPR domain. In both HEK293 and primary hepatocytes, overexpression of CHIP markedly decreased NIK levels at least in part through increasing ubiquitination and degradation of NIK. Accordingly, CHIP suppressed NIK-induced activation of the noncanonical NF-kappa B2 pathway. CHIP also bound to TRAF3, and CHIP and TRAF3 acted coordinately to efficiently promote NIK degradation. The TPR but not the U-box domain was required for CHIP to promote NIK degradation. In mice, hepatocyte-specific overexpression of NIK resulted in liver inflammation and injury, leading to death, and liver-specific expression of CHIP reversed the detrimental effects of hepatic NIK. Our data suggest that CHIP/TRAF3/NIK interactions recruit NIK to E3 ligase complexes for ubiquitination and degradation, thus maintaining NIK at low levels. Defects in CHIP regulation of NIK may result in aberrant NIK activation in the liver, contributing to live injury, inflammation, and disease.	[Jiang, Bijie; Zan, Linsen] Northwest A&F Univ, Coll Anim Sci & Technol, Natl Beef Cattle Improvement Ctr, Yangling 712100, Shaanxi, Peoples R China; [Jiang, Bijie; Shen, Hong; Chen, Zheng; Yin, Lei; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Rui, Liangyou] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	Northwest A&F University - China; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zan, LS (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Natl Beef Cattle Improvement Ctr, Yangling 712100, Shaanxi, Peoples R China.	zanlinsen@163.com; ruily@umich.edu	shen, hong/I-6179-2016	SHEN, HONG/0000-0002-1559-3633	Michigan Diabetes Research and Training Center (National Institutes of Health) [DK020572]; Michigan Metabolomics and Obesity Center (National Institutes of Health) [DK089503]; University of Michigan Comprehensive Cancer Center (National Institutes of Health) [CA46592]; University of Michigan Nathan Shock Center (National Institutes of Health) [P30AG013283]; University of Michigan Gut Peptide Research Center (National Institutes of Health) [DK34933]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK091591, P30DK089503, R01DK094014, P30DK034933, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	Michigan Diabetes Research and Training Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Metabolomics and Obesity Center (National Institutes of Health); University of Michigan Comprehensive Cancer Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Nathan Shock Center (National Institutes of Health); University of Michigan Gut Peptide Research Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. Liang Sheng, Lin Jiang, and Zheng Chen and Nish Patel for assistance and discussion. We thank Dr. Klaus Rajewsky (Immune Disease Institute, Harvard Medical School, Boston, MA) for providing STOP-NIK mice, and we thank Drs. Patterson (University of North Carolina, Chapel Hill) and Yoichi Osawa (University of Michigan) for providing CHIP and HSC70 cDNAs. This work utilized the cores supported by the Michigan Diabetes Research and Training Center (National Institutes of Health Grant DK020572), Michigan Metabolomics and Obesity Center (National Institutes of Health Grant DK089503), the University of Michigan Comprehensive Cancer Center (National Institutes of Health Grant CA46592), the University of Michigan Nathan Shock Center (National Institutes of Health Grant P30AG013283), and the University of Michigan Gut Peptide Research Center (National Institutes of Health Grant DK34933).	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Aya K, 2005, J CLIN INVEST, V115, P1848, DOI 10.1172/JCI23763; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Belova L, 2006, BIOCHEM J, V400, P235, DOI 10.1042/BJ20060905; Blessing NA, 2014, MOL CELL BIOL, V34, P3132, DOI 10.1128/MCB.00296-14; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; Gaude H, 2012, ONCOGENE, V31, P1582, DOI 10.1038/onc.2011.342; Hacker H, 2012, J IMMUNOL, V188, P4602, DOI 10.4049/jimmunol.1200021; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Koike R, 1996, EUR J IMMUNOL, V26, P669, DOI 10.1002/eji.1830260324; Li F, 2009, J BIOL CHEM, V284, P20090, DOI 10.1074/jbc.M109.017046; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Saitoh Y, 2008, BLOOD, V111, P5118, DOI 10.1182/blood-2007-09-110635; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Shang Y, 2014, BIOCHEM BIOPH RES CO, V446, P387, DOI 10.1016/j.bbrc.2014.02.124; Shen H, 2014, HEPATOLOGY, V60, P2065, DOI 10.1002/hep.27348; Sheng L, 2012, NAT MED, V18, P943, DOI 10.1038/nm.2756; Stricher F, 2013, AUTOPHAGY, V9, P1937, DOI 10.4161/auto.26448; Su CH, 2011, CELL SIGNAL, V23, P1824, DOI 10.1016/j.cellsig.2011.06.018; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang TX, 2014, ONCOTARGET, V5, P1969, DOI 10.18632/oncotarget.1890; Wang YQ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010132; Willmann KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6360; Woo CH, 2010, FASEB J, V24, P4917, DOI 10.1096/fj.10-162636; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	38	29	30	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11704	11714		10.1074/jbc.M114.635086	http://dx.doi.org/10.1074/jbc.M114.635086			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25792747	hybrid, Green Published			2022-12-28	WOS:000353719400043
J	Li, JB; Matye, DJ; Li, TG				Li, Jibiao; Matye, David J.; Li, Tiangang			Insulin Resistance Induces Posttranslational Hepatic Sortilin 1 Degradation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-B; CYTOPLASMIC TAIL; ACID SYNTHESIS; VHS DOMAIN; CHOLESTEROL; ACTIVATION; RECEPTORS; SECRETION; SIGNALS; MTORC1	Insulin promotes hepatic apolipoprotein B100 (apoB100) degradation, whereas insulin resistance is a major cause of hepatic apoB100/triglyceride overproduction in type 2 diabetes. The cellular trafficking receptor sortilin 1 (Sort1) was recently identified to transport apoB100 to the lysosome for degradation in the liver and thus regulate plasma cholesterol and triglyceride levels. Genetic variation of SORT1 was strongly associated with cardiovascular disease risk in humans. The major goal of this study is to investigate the effect and molecular mechanism of insulin regulation of Sort1. Results showed that insulin induced Sort1 protein, but not mRNA, in AML12 cells. Treatment of PI3K or AKT inhibitors decreased Sort1 protein, whereas expression of constitutively active AKT induced Sort1 protein in AML12 cells. Consistently, hepatic Sort1 was down-regulated in diabetic mice, which was partially restored after the administration of the insulin sensitizer metformin. LC-MS/MS analysis further revealed that serine phosphorylation of Sort1 protein was required for insulin induction of Sort1 in a casein kinase 2-dependent manner and that inhibition of PI3K signaling or prevention of Sort1 phosphorylation accelerated proteasome-dependent Sort1 degradation. Administration of a PI3K inhibitor to mice decreased hepatic Sort1 protein and increased plasma cholesterol and triglyceride levels. Adenovirus-mediated overexpression of Sort1 in the liver prevented PI3K inhibitor-induced Sort1 down-regulation and decreased plasma triglyceride but had no effect on plasma cholesterol in mice. This study identified Sort1 as a novel target of insulin signaling and suggests that Sort1 may play a role in altered hepatic apoB100 metabolism in insulin-resistant conditions.	[Li, Jibiao; Matye, David J.; Li, Tiangang] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Li, TG (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	tli@kumc.edu	Regan, Clinton/E-6250-2012; Li, Jibiao/A-5627-2017	Matye, David/0000-0001-6655-803X	National Institutes of Health [U24 DK059630]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102487, U24DK059630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Mouse Metabolic Phenotyping Center at the University of Cincinnati (supported by National Institutes of Health Grant U24 DK059630) for the FPLC analysis of the plasma lipoprotein profile.	Ai D, 2012, J CLIN INVEST, V122, P1677, DOI 10.1172/JCI61248; Ai D, 2012, J CLIN INVEST, V122, P1262, DOI 10.1172/JCI61919; Bi LP, 2013, J LIPID RES, V54, P2754, DOI 10.1194/jlr.M039347; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chamberlain JM, 2013, BIOCHEM BIOPH RES CO, V430, P66, DOI 10.1016/j.bbrc.2012.11.022; Chirieac DV, 2006, AM J PHYSIOL-GASTR L, V291, pG382, DOI 10.1152/ajpgi.00472.2005; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Crooke RM, 2005, J LIPID RES, V46, P872, DOI 10.1194/jlr.M400492-JLR200; Dumaresq-Doiron K, 2013, BIOCHEM BIOPH RES CO, V433, P90, DOI 10.1016/j.bbrc.2013.02.059; Fisher EA, 2012, BBA-MOL CELL BIOL L, V1821, P778, DOI 10.1016/j.bbalip.2012.02.001; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Ihle NT, 2004, MOL CANCER THER, V3, P763; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kato Y, 2002, NAT STRUCT BIOL, V9, P532, DOI 10.1038/nsb807; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; Lee RG, 2013, J LIPID RES, V54, P602, DOI 10.1194/jlr.M029215; Li JB, 2014, J BIOL CHEM, V289, P22437, DOI 10.1074/jbc.M114.548933; Li TG, 2012, J BIOL CHEM, V287, P1861, DOI 10.1074/jbc.M111.305789; Linsel-Nitschke P, 2010, ATHEROSCLEROSIS, V208, P183, DOI 10.1016/j.atherosclerosis.2009.06.034; MARTOS C, 1985, BIOCHEM J, V225, P321, DOI 10.1042/bj2250321; McCormick PJ, 2008, TRAFFIC, V9, P1984, DOI 10.1111/j.1600-0854.2008.00814.x; Mullick AE, 2011, J LIPID RES, V52, P885, DOI 10.1194/jlr.M011791; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Reaven GM, 2002, DIABETES OBES METAB, V4, pS13, DOI 10.1046/j.1462-8902.2001.00037.x; SOMMERCORN J, 1987, P NATL ACAD SCI USA, V84, P8834, DOI 10.1073/pnas.84.24.8834; Strong A, 2012, J CLIN INVEST, V122, P2807, DOI 10.1172/JCI63563; Verges B, 2010, ATHEROSCLEROSIS, V211, P353, DOI 10.1016/j.atherosclerosis.2010.01.028; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	37	35	35	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11526	11536		10.1074/jbc.M115.641225	http://dx.doi.org/10.1074/jbc.M115.641225			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25805502	Green Published, hybrid			2022-12-28	WOS:000353719400028
J	Walton, RG; Zhu, BB; Unal, R; Spencer, M; Sunkara, M; Morris, AJ; Charnigo, R; Katz, WS; Daugherty, A; Howatt, DA; Kern, PA; Finlin, BS				Walton, R. Grace; Zhu, Beibei; Unal, Resat; Spencer, Michael; Sunkara, Manjula; Morris, Andrew J.; Charnigo, Richard; Katz, Wendy S.; Daugherty, Alan; Howatt, Deborah A.; Kern, Philip A.; Finlin, Brian S.			Increasing Adipocyte Lipoprotein Lipase Improves Glucose Metabolism in High Fat Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERITABLE HYPERLIPIDEMIC RABBITS; PPAR-GAMMA ACTIVATION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; BODY-WEIGHT; MICE; MACROPHAGES; OVEREXPRESSION; EXPRESSION; MUSCLE	Lipid accumulation in liver and skeletal muscle contributes to co-morbidities associated with diabetes and obesity. We made a transgenic mouse in which the adiponectin (Adipoq) promoter drives expression of lipoprotein lipase (LPL) in adipocytes to potentially increase adipose tissue lipid storage. These mice (Adipoq-LPL) have improved glucose and insulin tolerance as well as increased energy expenditure when challenged with a high fat diet (HFD). To identify the mechanism(s) involved, we determined whether the Adipoq-LPL mice diverted dietary lipid to adipose tissue to reduce peripheral lipotoxicity, but we found no evidence for this. Instead, characterization of the adipose tissue of the male mice after HFD challenge revealed that the mRNA levels of peroxisome proliferator-activated receptor-gamma (PPAR gamma) and a number of PPAR gamma-regulated genes were higher in the epididymal fat pads of Adipoq-LPL mice than control mice. This included adiponectin, whose mRNA levels were increased, leading to increased adiponectin serum levels in the Adipoq-LPL mice. In many respects, the adipose phenotype of these animals resembles thiazolidinedione treatment except for one important difference, the Adipoq-LPL mice did not gain more fat mass on HFD than control mice and did not have increased expression of genes in adipose such as glycerol kinase, which are induced by high affinity PPAR agonists. Rather, there was selective induction of PPAR gamma-regulated genes such as adiponectin in the adipose of the Adipoq-LPL mice, suggesting that increasing adipose tissue LPL improves glucose metabolism in diet-induced obesity by improving the adipose tissue phenotype. Adipoq-LPL mice also have increased energy expenditure.	[Walton, R. Grace; Zhu, Beibei; Spencer, Michael; Kern, Philip A.; Finlin, Brian S.] Univ Kentucky, Barnstable Brown Diabet & Obes Ctr, Dept Med, Div Endocrinol, Lexington, KY 40536 USA; [Sunkara, Manjula; Morris, Andrew J.] Univ Kentucky, Div Cardiovasc Med, Lexington, KY 40536 USA; [Charnigo, Richard] Univ Kentucky, Dept Biostat, Coll Publ Hlth, Lexington, KY 40536 USA; [Katz, Wendy S.] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA; [Daugherty, Alan; Howatt, Deborah A.] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Unal, Resat] Mugla Sitki Kocman Univ, Dept Mol Biol & Genet, Fac Life Sci, TR-48000 Mugla, Turkey	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; Mugla Sitki Kocman University	Finlin, BS (corresponding author), Univ Kentucky, Barnstable Brown Diabet & Obes Ctr, Dept Med, Div Endocrinol, Lexington, KY 40536 USA.	bfinlin@uky.edu	sunkara, Manjula/H-7944-2016; Daugherty, Alan/C-8282-2009	sunkara, Manjula/0000-0001-6151-1929; Daugherty, Alan/0000-0003-2093-3775; Katz, Wendy/0000-0003-3038-6314	National Institutes of Health Institutional Development Award [P20 GM103527-06]; NIGMS [DK039176, DK071349]; Clinical and Translational Science Award [UL1TR000117]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598, P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK039176, R37DK039176, R01DK039176, R01DK071349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	National Institutes of Health Institutional Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Clinical and Translational Science Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Institutional Development Award P20 GM103527-06 (to B. S. F.) and Grants DK039176 (to P. A. K.) and DK071349 (to P. A. K.) from NIGMS. This work was also supported in part by Clinical and Translational Science Award Grant UL1TR000117.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Chawla A, 2003, P NATL ACAD SCI USA, V100, P1268, DOI 10.1073/pnas.0337331100; Chui PC, 2005, J CLIN INVEST, V115, P2244, DOI 10.1172/JCI24130; DAUGHERTY A, 1994, ARTERIOSCLER THROMB, V14, P2017, DOI 10.1161/01.ATV.14.12.2017; Deevska G, 2014, J LIPID RES, V55, P2041, DOI 10.1194/jlr.M048223; Deevska GM, 2012, BIOSCIENCE REP, V32, P479, DOI 10.1042/BSR20120036; Finlin BS, 2013, J NUTR BIOCHEM, V24, P1571, DOI 10.1016/j.jnutbio.2013.01.007; Finlin BS, 2012, J NUTR BIOCHEM, V23, P885, DOI 10.1016/j.jnutbio.2011.04.013; GREENWOOD MRC, 1985, INT J OBESITY, V9, P67; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Guan HP, 2002, NAT MED, V8, P1122, DOI 10.1038/nm780; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Hosseini M, 2012, ARTERIOSCL THROM VAS, V32, P1204, DOI 10.1161/ATVBAHA.112.245696; Ichikawa T, 2004, LAB INVEST, V84, P715, DOI 10.1038/labinvest.3700102; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Koike T, 2004, J BIOL CHEM, V279, P7521, DOI 10.1074/jbc.M311514200; LevakFrank S, 1997, J BIOL CHEM, V272, P17182, DOI 10.1074/jbc.272.27.17182; Lodhi IJ, 2012, CELL METAB, V16, P189, DOI 10.1016/j.cmet.2012.06.013; Morino K, 2012, DIABETES, V61, P877, DOI 10.2337/db11-1391; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Ranganathan G, 1999, J BIOL CHEM, V274, P9122, DOI 10.1074/jbc.274.13.9122; RANGANATHAN G, 1995, J BIOL CHEM, V270, P7149, DOI 10.1074/jbc.270.13.7149; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Rasouli N, 2005, AM J PHYSIOL-ENDOC M, V288, pE930, DOI 10.1152/ajpendo.00522.2004; Ravussin Y, 2014, CELL METAB, V20, P565, DOI 10.1016/j.cmet.2014.09.002; Reue K, 2000, J LIPID RES, V41, P1067; Salous AK, 2013, J LIPID RES, V54, P2775, DOI 10.1194/jlr.M039685; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; SHIMADA M, 1993, J BIOL CHEM, V268, P17924; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Wang H, 2011, CELL METAB, V13, P105, DOI 10.1016/j.cmet.2010.12.006; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang H, 2009, DIABETES, V58, P116, DOI 10.2337/db07-1839; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wang ZV, 2010, ENDOCRINOLOGY, V151, P2933, DOI 10.1210/en.2010-0136; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100	41	34	36	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11547	11556		10.1074/jbc.M114.628487	http://dx.doi.org/10.1074/jbc.M114.628487			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25784555	Green Published, hybrid			2022-12-28	WOS:000353719400030
J	Chan, GKL; Witkowski, A; Gantz, DL; Zhang, TQO; Zanni, MT; Jayaraman, S; Cavigiolio, G				Chan, Gary K. L.; Witkowski, Andrzej; Gantz, Donald L.; Zhang, Tianqi O.; Zanni, Martin T.; Jayaraman, Shobini; Cavigiolio, Giorgio			Myeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; ABCA1-DEPENDENT CHOLESTEROL EFFLUX; HUMAN ATHEROSCLEROTIC LESIONS; MASS-SPECTROMETRY; FIBRIL FORMATION; HUMAN ATHEROMA; BETA-SHEET; REVEALS; CHLORINATION; NITRATION	High plasma levels of apolipoprotein A-I (apoA-I) correlate with cardiovascular health, whereas dysfunctional apoA-I is a cause of atherosclerosis. In the atherosclerotic plaques, amyloid deposition increases with aging. Notably, apoA-I is the main component of these amyloids. Recent studies identified high levels of oxidized lipid-free apoA-I in atherosclerotic plaques. Likely, myeloperoxidase (MPO) secreted by activated macrophages in atherosclerotic lesions is the promoter of such apoA-I oxidation. We hypothesized that apoA-I oxidation by MPO levels similar to those present in the artery walls in atherosclerosis can promote apoA-I structural changes and amyloid fibril formation. ApoA-I was exposed to exhaustive chemical (H2O2) oxidation or physiological levels of enzymatic (MPO) oxidation and incubated at 37 degrees C and pH 6.0 to induce fibril formation. Both chemically and enzymatically oxidized apoA-I produced fibrillar amyloids after a few hours of incubation. The amyloid fibrils were composed of full-length apoA-I with differential oxidation of the three methionines. Met to Leu apoA-I variants were used to establish the predominant role of oxidation of Met-86 and Met-148 in the fibril formation process. Importantly, a small amount of preformed apoA-I fibrils was able to seed amyloid formation in oxidized apoA-I at pH7.0. In contrast to hereditary amyloidosis, wherein specific mutations of apoA-I cause protein destabilization and amyloid deposition, oxidative conditions similar to those promoted by local inflammation in atherosclerosis are sufficient to transform full-length wild-type apoA-I into an amyloidogenic protein. Thus, MPO-mediated oxidation may be implicated in the mechanism that leads to amyloid deposition in the atherosclerotic plaques in vivo.	[Chan, Gary K. L.; Witkowski, Andrzej; Cavigiolio, Giorgio] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Gantz, Donald L.; Jayaraman, Shobini] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Zhang, Tianqi O.; Zanni, Martin T.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Boston University; University of Wisconsin System; University of Wisconsin Madison	Cavigiolio, G (corresponding author), Childrens Hosp Oakland, Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	gcavigiolio@chori.org	Regan, Clinton/E-6250-2012	Cavigiolio, Giorgio/0000-0002-1622-0628; Witkowski, Andrzej/0000-0002-0442-4586; /0000-0003-1616-5347	National Institutes of Health [HL113059, DK79895]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL113059 (to G. C.) and DK79895 (to M. T. Z.).	Amarzguioui M, 1998, BIOCHEM BIOPH RES CO, V242, P534, DOI 10.1006/bbrc.1997.8005; Andreola A, 2003, J BIOL CHEM, V278, P2444, DOI 10.1074/jbc.M204801200; Audet A, 2012, HISTOPATHOLOGY, V61, P610, DOI 10.1111/j.1365-2559.2012.04265.x; Benson MD, 2005, AMYLOID, V12, P75, DOI 10.1080/13506120500106925; BRAHMS S, 1977, P NATL ACAD SCI USA, V74, P3208, DOI 10.1073/pnas.74.8.3208; Buchanan LE, 2013, P NATL ACAD SCI USA, V110, P19285, DOI 10.1073/pnas.1314481110; Coelho-Cerqueira E, 2014, BIOORG MED CHEM LETT, V24, P3194, DOI 10.1016/j.bmcl.2014.04.072; CORNWELL GG, 1983, AM J MED, V75, P618, DOI 10.1016/0002-9343(83)90443-6; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; DiDonato JA, 2014, J BIOL CHEM, V289, P10276, DOI 10.1074/jbc.M114.556506; DiDonato JA, 2013, CIRCULATION, V128, P1644, DOI 10.1161/CIRCULATIONAHA.113.002624; Eriksson M, 2009, J MOL DIAGN, V11, P257, DOI 10.2353/jmoldx.2009.080161; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Jayaraman S, 2011, J BIOL CHEM, V286, P35610, DOI 10.1074/jbc.M111.262485; Jonas A., 1982, BIOL CHEM, V257, P10961; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kim YS, 2009, P NATL ACAD SCI USA, V106, P17751, DOI 10.1073/pnas.0909888106; Klunk WE, 1999, ANAL BIOCHEM, V266, P66, DOI 10.1006/abio.1998.2933; Loavenbruck AJ, 2012, MUSCLE NERVE, V46, P817, DOI 10.1002/mus.23415; Mangione P, 2001, PROTEIN SCI, V10, P187, DOI 10.1110/ps.29201; MATSUNAGA T, 1991, P NATL ACAD SCI USA, V88, P2793, DOI 10.1073/pnas.88.7.2793; Mehta R, 2003, J MOL BIOL, V328, P183, DOI 10.1016/S0022-2836(03)00155-4; Middleton CT, 2012, NAT CHEM, V4, P355, DOI [10.1038/nchem.1293, 10.1038/NCHEM.1293]; Miti T, 2015, BIOMACROMOLECULES, V16, P326, DOI 10.1021/bm501521r; Moran SD, 2012, P NATL ACAD SCI USA, V109, P3329, DOI 10.1073/pnas.1117704109; MUCCHIANO G, 1992, AM J PATHOL, V140, P871; Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S; Mucchiano GI, 2001, AM J CLIN PATHOL, V115, P298; Murphy C, 2011, AMYLOID, V18, P219, DOI 10.3109/13506129.2011.574354082; Nicholls SJ, 2005, TRENDS CARDIOVAS MED, V15, P212, DOI 10.1016/j.tcm.2005.06.004; Obici L, 1999, AM J PATHOL, V155, P695, DOI 10.1016/S0002-9440(10)65167-X; Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288; Petrlova J, 2012, J LIPID RES, V53, P390, DOI 10.1194/jlr.M020883; Raimondi S, 2011, J MOL BIOL, V407, P465, DOI 10.1016/j.jmb.2011.01.044; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P11714, DOI 10.1021/bi973112k; Rowczenio D, 2011, AM J PATHOL, V179, P1978, DOI 10.1016/j.ajpath.2011.06.024; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2008, METHOD ENZYMOL, V440, P33, DOI 10.1016/S0076-6879(07)00803-8; Shao BH, 2014, CIRC RES, V114, P1733, DOI 10.1161/CIRCRESAHA.114.303454; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Shao BH, 2010, J LIPID RES, V51, P1849, DOI 10.1194/jlr.M004085; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Smith JD, 2010, J CLIN LIPIDOL, V4, P382, DOI 10.1016/j.jacl.2010.08.007; Solomon A, 2006, ARTHRITIS RHEUM, V54, P3545, DOI 10.1002/art.22201; Srinivasan S, 2013, J BIOL CHEM, V288, P2744, DOI 10.1074/jbc.M112.394155; Tubb MR, 2009, J LIPID RES, V50, P1497, DOI 10.1194/jlr.D900003-JLR200; WESTERMARK P, 1995, AM J PATHOL, V147, P1186; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200	51	30	32	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10958	10971		10.1074/jbc.M114.630442	http://dx.doi.org/10.1074/jbc.M114.630442			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25759391	Green Published, hybrid			2022-12-28	WOS:000353404500033
J	Chang, AN; Battiprolu, PK; Cowley, PM; Chen, GH; Gerard, RD; Pinto, JR; Hill, JA; Baker, AJ; Kamm, KE; Stull, JT				Chang, Audrey N.; Battiprolu, Pavan K.; Cowley, Patrick M.; Chen, Guohua; Gerard, Robert D.; Pinto, Jose R.; Hill, Joseph A.; Baker, Anthony J.; Kamm, Kristine E.; Stull, James T.			Constitutive Phosphorylation of Cardiac Myosin Regulatory Light Chain in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-C; SMOOTH-MUSCLE MYOSIN; PERFUSED RAT-HEART; SKELETAL-MUSCLE; TROPONIN-I; HYPERTROPHIC CARDIOMYOPATHY; MYOFILAMENT PHOSPHORYLATION; DIFFERENTIAL ROLES; TARGET SUBUNIT; KINASE	In beating hearts, phosphorylation of myosin regulatory light chain (RLC) at a single site to 0.45 mol of phosphate/mol by cardiac myosin light chain kinase (cMLCK) increases Ca2+ sensitivity of myofilament contraction necessary for normal cardiac performance. Reduction of RLC phosphorylation in conditional cMLCK knock-out mice caused cardiac dilation and loss of cardiac performance by 1 week, as shown by increased left ventricular internal diameter at end-diastole and decreased fractional shortening. Decreased RLC phosphorylation by conventional or conditional cMLCK gene ablation did not affect troponin-I or myosin-binding protein-C phosphorylation in vivo. The extent of RLC phosphorylation was not changed by prolonged infusion of dobutamine or treatment with a beta-adrenergic antagonist, suggesting that RLC is constitutively phosphorylated to maintain cardiac performance. Biochemical studies with myofilaments showed that RLC phosphorylation up to 90% was a random process. RLC is slowly dephosphorylated in both noncontracting hearts and isolated cardiac myocytes from adult mice. Electrically paced ventricular trabeculae restored RLC phosphorylation, which was increased to 0.91 mol of phosphate/mol of RLC with inhibition of myosin light chain phosphatase (MLCP). The two RLCs in each myosin appear to be readily available for phosphorylation by a soluble cMLCK, but MLCP activity limits the amount of constitutive RLC phosphorylation. MLCP with its regulatory subunit MYPT2 bound tightly to myofilaments was constitutively phosphorylated in beating hearts at a site that inhibits MLCP activity. Thus, the constitutive RLC phosphorylation is limited physiologically by low cMLCK activity in balance with low MLCP activity.	[Chang, Audrey N.; Chen, Guohua; Kamm, Kristine E.; Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Battiprolu, Pavan K.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept lnternal Med Cardiol, Dallas, TX 75390 USA; [Gerard, Robert D.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Cowley, Patrick M.; Baker, Anthony J.] Vet Affairs Med Ctr, San Francisco, CA 94143 USA; [Gerard, Robert D.; Baker, Anthony J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Pinto, Jose R.] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; State University System of Florida; Florida State University	Stull, JT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	james.stull@utsouthwestern.edu	Pinto, Jose Renato/H-2631-2017; Regan, Clinton/E-6250-2012	Pinto, Jose Renato/0000-0001-9092-4976; 	National Institutes of Health [HL080536, HL06296, HL103840]; Department of Veterans Affairs Merit Review Award [I01BX000740]; Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080536, K99HL103840, P01HL006296, R00HL103840] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants HL080536 (to J. T. S.), HL06296 (to R. D. G.), and HL103840 (to J. R. P.). This work was also supported by Department of Veterans Affairs Merit Review Award I01BX000740 (to A. J. B.), the Moss Heart Fund (to J. T. S.), and the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology (to J. T. S.).	BENSON ES, 1955, CIRC RES, V3, P221, DOI 10.1161/01.RES.3.2.221; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Chang AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066720; Chang AN, 2010, J BIOL CHEM, V285, P5122, DOI 10.1074/jbc.C109.076489; Collins KA, 2001, AM J PHYSIOL-HEART C, V280, pH1954, DOI 10.1152/ajpheart.2001.280.5.H1954; Colson BA, 2012, P NATL ACAD SCI USA, V109, P20437, DOI 10.1073/pnas.1213027109; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; Dias FAL, 2006, J MOL CELL CARDIOL, V41, P330, DOI 10.1016/j.yjmcc.2006.05.012; Ding PG, 2010, J BIOL CHEM, V285, P40819, DOI 10.1074/jbc.M110.160499; Dweck D, 2014, J BIOL CHEM, V289, P23097, DOI 10.1074/jbc.M114.561472; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Grimm M, 2005, CARDIOVASC RES, V65, P211, DOI 10.1016/j.cardiores.2004.09.019; Hamdani N, 2013, CARDIOVASC RES, V97, P464, DOI 10.1093/cvr/cvs353; HERRING BP, 1986, BIOCHEM J, V240, P205, DOI 10.1042/bj2400205; HIGH CW, 1980, AM J PHYSIOL, V239, pH756, DOI 10.1152/ajpheart.1980.239.6.H756; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; JEACOCKE SA, 1980, BIOCHEM J, V188, P763, DOI 10.1042/bj1880763; KAMM KE, 1989, J BIOL CHEM, V264, P21223; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kamm KE, 2011, J BIOL CHEM, V286, P9941, DOI 10.1074/jbc.R110.198697; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Kuster DWD, 2012, J MUSCLE RES CELL M, V33, P43, DOI 10.1007/s10974-011-9280-7; Lin PJ, 1999, J BIOL CHEM, V274, P5987, DOI 10.1074/jbc.274.9.5987; Lin PJ, 1997, J BIOL CHEM, V272, P7412, DOI 10.1074/jbc.272.11.7412; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Metzger JM, 1997, TRENDS CARDIOVAS MED, V7, P63, DOI 10.1016/S1050-1738(96)00138-7; Mizutani H, 2010, CIRC J, V74, P120, DOI 10.1253/circj.CJ-09-0462; Moorhead G, 1998, FEBS LETT, V438, P141, DOI 10.1016/S0014-5793(98)01276-9; Moss RL, 2015, CIRC RES, V116, P183, DOI 10.1161/CIRCRESAHA.116.300561; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Okamoto R, 2006, CELL SIGNAL, V18, P1408, DOI 10.1016/j.cellsig.2005.11.001; Orsi B A, 1979, Methods Enzymol, V63, P159; PERSECHINI A, 1983, BIOCHEMISTRY-US, V22, P470, DOI 10.1021/bi00271a033; PERSECHINI A, 1984, BIOCHEMISTRY-US, V23, P4144, DOI 10.1021/bi00313a021; Petzhold D, 2014, BIOCHEM BIOPH RES CO, V449, P284, DOI 10.1016/j.bbrc.2014.05.040; Ratti J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.156646; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; Sheikh F, 2014, TRENDS CARDIOVAS MED, V24, P133, DOI 10.1016/j.tcm.2013.07.004; Sheikh F, 2012, J CLIN INVEST, V122, P1209, DOI 10.1172/JCI61134; SILVER PJ, 1986, J MOL CELL CARDIOL, V18, P31, DOI 10.1016/S0022-2828(86)80980-4; Solaro RJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/105648; SOLARO RJ, 1971, BIOCHIM BIOPHYS ACTA, V245, P259, DOI 10.1016/0005-2728(71)90033-8; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Toepfer C, 2013, J BIOL CHEM, V288, P13446, DOI 10.1074/jbc.M113.455444; TRYBUS KM, 1985, J BIOL CHEM, V260, P5988; Tsai MH, 2014, J PHYSIOL-LONDON, V592, P3031, DOI 10.1113/jphysiol.2014.273011; van der Velden J, 2006, CARDIOVASC RES, V69, P876, DOI 10.1016/j.cardiores.2005.11.021; Wang YH, 2014, J MOL CELL CARDIOL, V72, P231, DOI 10.1016/j.yjmcc.2014.03.022; Wang YC, 2012, J BIOL CHEM, V287, P2156, DOI 10.1074/jbc.M111.294306; Warren SA, 2012, CIRCULATION, V126, P2575, DOI 10.1161/CIRCULATIONAHA.112.116202; Weisberg A, 1996, P NATL ACAD SCI USA, V93, P8999, DOI 10.1073/pnas.93.17.8999; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028; Zhi G, 2005, P NATL ACAD SCI USA, V102, P17519, DOI 10.1073/pnas.0506846102; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105	61	46	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10703	10716		10.1074/jbc.M115.642165	http://dx.doi.org/10.1074/jbc.M115.642165			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25733667	hybrid, Green Published			2022-12-28	WOS:000353404500013
J	Lazard, M; Dauplais, M; Blanquet, S; Plateau, P				Lazard, Myriam; Dauplais, Marc; Blanquet, Sylvain; Plateau, Pierre			Trans-sulfuration Pathway Seleno-amino Acids Are Mediators of Selenomethionine Toxicity in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; CANCER PREVENTION; DNA-DAMAGE; YEAST; METABOLISM; METHIONINE; SUPEROXIDE; CYSTEINE; GENES; SELENOPROTEINS	Toxicity of selenomethionine, an organic derivative of selenium widely used as supplement in human diets, was studied in the model organism Saccharomyces cerevisiae. Several DNA repair-deficient strains hypersensitive to selenide displayed wild-type growth rate properties in the presence of selenomethionine indicating that selenide and selenomethionine exert their toxicity via distinct mechanisms. Cytotoxicity of selenomethionine decreased when the extracellular concentration of methionine or S-adenosylmethionine was increased. This protection resulted from competition between the S-and Se-compounds along the downstream metabolic pathways inside the cell. By comparing the sensitivity to selenomethionine of mutants impaired in the sulfur amino acid pathway, we excluded a toxic effect of Se-adenosylmethionine, Se-adenosylhomocysteine, or of any compound in the methionine salvage pathway. Instead, we found that selenomethionine toxicity is mediated by the trans-sulfuration pathway amino acids selenohomocysteine and/or selenocysteine. Involvement of superoxide radicals in selenomethionine toxicity in vivo is suggested by the hypersensitivity of a Delta sod1 mutant strain, increased resistance afforded by the superoxide scavenger manganese, and inactivation of aconitase. In parallel, we showed that, in vitro, the complete oxidation of the selenol function of selenocysteine or selenohomocysteine by dioxygen is achieved within a few minutes at neutral pH and produces superoxide radicals. These results establish a link between superoxide production and trans-sulfuration pathway seleno-amino acids and emphasize the importance of the selenol function in the mechanism of organic selenium toxicity.	[Lazard, Myriam; Dauplais, Marc; Blanquet, Sylvain; Plateau, Pierre] Ecole Polytech, Biochim Lab, CNRS, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris	Lazard, M (corresponding author), Ecole Polytech, Biochim Lab, F-91128 Palaiseau, France.	myriam.lazard@polytechnique.edu		Lazard, Myriam/0000-0002-7154-1352				Arnaudguilhem C, 2012, ANAL CHIM ACTA, V757, P26, DOI 10.1016/j.aca.2012.10.029; Azad GK, 2014, FEBS OPEN BIO, V4, P77, DOI 10.1016/j.fob.2014.01.002; Bierla K, 2013, J PROTEOMICS, V87, P26, DOI 10.1016/j.jprot.2013.05.010; Bockhorn J, 2008, P NATL ACAD SCI USA, V105, P17682, DOI 10.1073/pnas.0805642105; Brozmanova J, 2010, ARCH TOXICOL, V84, P919, DOI 10.1007/s00204-010-0595-8; Chan G, 2007, J BIOCHEM MOL TOXIC, V21, P252, DOI 10.1002/jbt.20189; CHAUDIERE J, 1992, ARCH BIOCHEM BIOPHYS, V296, P328, DOI 10.1016/0003-9861(92)90580-P; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; DARDEL F, 1994, COMPUT APPL BIOSCI, V10, P273; DICKSON RC, 1969, ARCH BIOCHEM BIOPHYS, V130, P547, DOI 10.1016/0003-9861(69)90068-X; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; Gopalakrishna R, 2001, NUTR CANCER, V40, P55, DOI 10.1207/S15327914NC401_11; Hiraishi H, 2008, CURR GENET, V53, P225, DOI 10.1007/s00294-008-0181-2; HUBER RE, 1967, ARCH BIOCHEM BIOPHYS, V122, P164, DOI 10.1016/0003-9861(67)90136-1; Imura N., 1989, SE BIOL MED, P70, DOI [10.1007/978-3-642-74421-1_14, DOI 10.1007/978-3-642-74421-1_14]; Izquierdo A, 2010, MICROBIOL-SGM, V156, P2608, DOI 10.1099/mic.0.039719-0; Kade IJ, 2008, NEUROCHEM RES, V33, P167, DOI 10.1007/s11064-007-9432-8; KAJANDER EO, 1990, BIOCHEM J, V267, P767, DOI 10.1042/bj2670767; Kanai M, 2013, APPL MICROBIOL BIOT, V97, P1183, DOI 10.1007/s00253-012-4261-3; Kitajima T, 2012, J BIOL CHEM, V287, P10032, DOI 10.1074/jbc.M111.324244; Kitajima T, 2010, APPL ENVIRON MICROB, V76, P6351, DOI 10.1128/AEM.01026-10; Larabee JL, 2009, J INORG BIOCHEM, V103, P419, DOI 10.1016/j.jinorgbio.2008.12.007; Lazard M, 2011, FEBS J, V278, P4112, DOI 10.1111/j.1742-4658.2011.08318.x; Letauayova L, 2006, DNA REPAIR, V5, P602, DOI 10.1016/j.dnarep.2006.01.004; Letavayova L, 2008, MUTAT RES-GEN TOX EN, V652, P198, DOI 10.1016/j.mrgentox.2008.03.001; Letavayova L, 2008, MUTAT RES-FUND MOL M, V638, P1, DOI 10.1016/j.mrfmmm.2007.08.009; Letavayova L, 2006, TOXICOLOGY, V227, P1, DOI 10.1016/j.tox.2006.07.017; Lewinska A, 2008, FUNGAL GENET BIOL, V45, P1182, DOI 10.1016/j.fgb.2008.05.011; Malkowski MG, 2007, P NATL ACAD SCI USA, V104, P6678, DOI 10.1073/pnas.0610337104; Manikova D, 2012, CHEM RES TOXICOL, V25, P1598, DOI 10.1021/tx300061n; Misra S, 2010, METALLOMICS, V2, P710, DOI 10.1039/c0mt00008f; Okuno T, 2001, TOXICOL APPL PHARM, V176, P18, DOI 10.1006/taap.2001.9260; Palace VP, 2004, ECOTOX ENVIRON SAFE, V58, P17, DOI 10.1016/j.ecoenv.2003.08.019; Papp LV, 2010, ANTIOXID REDOX SIGN, V12, P793, DOI 10.1089/ars.2009.2973; Park HS, 2000, J BIOL CHEM, V275, P2527, DOI 10.1074/jbc.275.4.2527; Peyroche G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036343; Pinson B, 2000, MOL MICROBIOL, V36, P679, DOI 10.1046/j.1365-2958.2000.01890.x; Pirkov I, 2008, FEBS J, V275, P4111, DOI 10.1111/j.1742-4658.2008.06552.x; Rahmanto AS, 2012, IUBMB LIFE, V64, P863, DOI 10.1002/iub.1084; SAEZ G, 1982, BIOCHIM BIOPHYS ACTA, V719, P24, DOI 10.1016/0304-4165(82)90302-6; Sanchez RJ, 2005, J BIOL INORG CHEM, V10, P913, DOI 10.1007/s00775-005-0044-y; Seitomer E, 2008, MOL NUTR FOOD RES, V52, P1305, DOI 10.1002/mnfr.200700347; Seko Y, 1997, BIOMED ENVIRON SCI, V10, P333; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; SODA K, 1967, AGR BIOL CHEM TOKYO, V31, P1054, DOI 10.1080/00021369.1967.10858916; SPALLHOLZ JE, 1994, FREE RADICAL BIO MED, V17, P45, DOI 10.1016/0891-5849(94)90007-8; Spallholz JE, 1997, BIOMED ENVIRON SCI, V10, P260; Spallholz JE, 2004, BIOCHEM PHARMACOL, V67, P547, DOI 10.1016/j.bcp.2003.09.004; Tarze A, 2007, J BIOL CHEM, V282, P8759, DOI 10.1074/jbc.M610078200; Tehlivets O, 2013, BBA-MOL BASIS DIS, V1832, P204, DOI 10.1016/j.bbadis.2012.09.007; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Valdiglesias V, 2010, ARCH TOXICOL, V84, P337, DOI 10.1007/s00204-009-0505-0; Van Hoewyk D, 2013, ANN BOT-LONDON, V112, P965, DOI 10.1093/aob/mct163; Wallace MA, 2005, CHEM RES TOXICOL, V18, P1279, DOI 10.1021/tx050050n; Wallenberg M, 2014, BASIC CLIN PHARMACOL, V114, P377, DOI 10.1111/bcpt.12207; Weekley CM, 2013, CHEM SOC REV, V42, P8870, DOI 10.1039/c3cs60272a; YAMAGATA S, 1993, J BACTERIOL, V175, P4800, DOI 10.1128/JB.175.15.4800-4808.1993; Zhou ZS, 2000, BIOORG MED CHEM LETT, V10, P2471, DOI 10.1016/S0960-894X(00)00498-4	59	28	29	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10741	10750		10.1074/jbc.M115.640375	http://dx.doi.org/10.1074/jbc.M115.640375			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25745108	Green Published, hybrid			2022-12-28	WOS:000353404500016
J	Fu, DC; Lala-Tabbert, N; Lee, HB; Wiper-Bergeron, N				Fu, Dechen; Lala-Tabbert, Neena; Lee, Hwabin; Wiper-Bergeron, Nadine			Mdm2 Promotes Myogenesis through the Ubiquitination and Degradation of CCAAT/Enhancer-binding Protein beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CCAAT-enhancer-binding protein (C; EBP); mouse double minute 2 homolog (MDM2); muscle regeneration; myogenesis; ubiquitylation (ubiquitination)	C/EBP-BETA; TRANSCRIPTIONAL ACTIVITY; SATELLITE CELLS; MESSENGER-RNA; DIFFERENTIATION; MYOD; LAP; ADIPOGENESIS; TRANSLATION; EXPRESSION	Myogenesis is a tightly regulated differentiation process during which precursor cells express in a coordinated fashion the myogenic regulatory factors, while down-regulating the satellite cell marker Pax7. CCAAT/Enhancer-binding protein (C/EBP) is also expressed in satellite cells and acts to maintain the undifferentiated state by stimulating Pax7 expression and by triggering a decrease in MyoD protein expression. Herein, we show that C/EBP protein is rapidly down-regulated upon induction of myogenesis and this is not due to changes in Cebpb mRNA expression. Rather, loss of C/EBP protein is accompanied by an increase in Mdm2 expression, an E3 ubiquitin ligase. We demonstrate that Mdm2 interacts with, ubiquitinates and targets C/EBP for degradation by the 26 S proteasome, leading to increased MyoD expression. Knockdown of Mdm2 expression in myoblasts using a shRNA resulted in high C/EBP levels and a blockade of myogenesis, indicating that Mdm2 is necessary for myogenic differentiation. Primary myoblasts expressing the shMdm2 construct were unable to contribute to muscle regeneration when grafted into cardiotoxin-injured muscle. The differentiation defect imposed by loss of Mdm2 could be partially rescued by loss of C/EBP, suggesting that the regulation of C/EBP turnover is a major role for Mdm2 in myoblasts. Taken together, we provide evidence that Mdm2 regulates entry into myogenesis by targeting C/EBP for degradation by the 26 S proteasome.	[Fu, Dechen; Wiper-Bergeron, Nadine] Univ Ottawa, Dept Cellular & Mol Med, Fac Med, Ottawa, ON K1H 8M5, Canada; [Lala-Tabbert, Neena; Lee, Hwabin] Univ Ottawa, Grad Program Cellular & Mol Med, Fac Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa	Wiper-Bergeron, N (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Fac Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	Nadine.WiperBergeron@uottawa.ca	Wiper-Bergeron, Nadine/AAO-4370-2021	Wiper-Bergeron, Nadine/0000-0001-8448-3246				Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; Fiddler TA, 1996, MOL CELL BIOL, V16, P5048; Gu L, 2012, ONCOGENE, V31, P1342, DOI 10.1038/onc.2011.343; Gu LB, 2009, CANCER CELL, V15, P363, DOI 10.1016/j.ccr.2009.03.002; Guo CS, 2003, J BIOL CHEM, V278, P22615, DOI 10.1074/jbc.M301943200; Hallenborg P, 2012, CELL DEATH DIFFER, V19, P1381, DOI 10.1038/cdd.2012.15; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Joung H, 2014, CELL SIGNAL, V26, P2240, DOI 10.1016/j.cellsig.2014.07.006; Karagiannides I, 2006, J BIOL CHEM, V281, P23025, DOI 10.1074/jbc.M513187200; Kim CH, 2012, J PINEAL RES, V53, P289, DOI 10.1111/j.1600-079X.2012.00998.x; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lechner S, 2013, DIFFERENTIATION, V85, P20, DOI 10.1016/j.diff.2012.11.001; Liu YF, 2013, STAT INTERFACE, V6, P1; Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333; Luft FC, 2015, J MOL MED, V93, P1, DOI 10.1007/s00109-014-1224-4; Marchildon F, 2012, STEM CELLS, V30, P2619, DOI 10.1002/stem.1248; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sebastian T, 2009, CANCER RES, V69, P2588, DOI 10.1158/0008-5472.CAN-08-2312; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; Tan SB, 2014, CHEM BIOL, V21, P1265, DOI 10.1016/j.chembiol.2014.06.011; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Wiper-Bergeron N, 2007, MOL ENDOCRINOL, V21, P2124, DOI 10.1210/me.2006-0452; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Yam CH, 1999, CANCER RES, V59, P5075	41	28	28	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10200	10207		10.1074/jbc.M115.638577	http://dx.doi.org/10.1074/jbc.M115.638577			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25720496	hybrid, Green Published			2022-12-28	WOS:000353241100026
J	Tilleman, L; Germani, F; De Henau, S; Helbo, S; Desmet, F; Berghmans, H; Van Doorslaer, S; Hoogewijs, D; Schoofs, L; Braeckman, BP; Moens, L; Fago, A; Dewilde, S				Tilleman, Lesley; Germani, Francesca; De Henau, Sasha; Helbo, Signe; Desmet, Filip; Berghmans, Herald; Van Doorslaer, Sabine; Hoogewijs, David; Schoofs, Liliane; Braeckman, Bart P.; Moens, Luc; Fago, Angela; Dewilde, Sylvia			A Globin Domain in a Neuronal Transmembrane Receptor of Caenorhabditis elegans and Ascaris suum MOLECULAR MODELING AND FUNCTIONAL PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electron Paramagnetic Resonance (EPR); Hemoglobin; Kinetics; Oxygen Binding; Redox Signaling	ELECTRON-PARAMAGNETIC RESONANCE; FMRFAMIDE-RELATED NEUROPEPTIDE; PROTEIN-COUPLED RECEPTORS; CYTOCHROME-C PEROXIDASE; SPERM-WHALE MYOGLOBIN; LIGAND-BINDING; NITRIC-OXIDE; GENE FAMILY; HEME OXYGENASE; HORSERADISH-PEROXIDASE	We report the structural and biochemical characterization of GLB-33, a putative neuropeptide receptor that is exclusively expressed in the nervous system of the nematode Caenorhabditis elegans. This unique chimeric protein is composed of a 7-transmembrane domain (7TM), GLB-33 7TM, typical of a G-protein-coupled receptor, and of a globin domain (GD), GLB-33 GD. Comprehensive sequence similarity searches in the genome of the parasitic nematode, Ascaris suum, revealed a chimeric protein that is similar to a Phe-Met-Arg-Phe-amide neuropeptide receptor. The three-dimensional structures of the separate domains of both species and of the full-length proteins were modeled. The 7TM domains of both proteins appeared very similar, but the globin domain of the A. suum receptor surprisingly seemed to lack several helices, suggesting a novel truncated globin fold. The globin domain of C. elegans GLB-33, however, was very similar to a genuine myoglobin-type molecule. Spectroscopic analysis of the recombinant GLB-33 GD showed that the heme is pentacoordinate when ferrous and in the hydroxide-ligated form when ferric, even at neutral pH. Flash-photolysis experiments showed overall fast biphasic CO rebinding kinetics. In its ferrous deoxy form, GLB-33 GD is capable of reversibly binding O-2 with a very high affinity and of reducing nitrite to nitric oxide faster than other globins. Collectively, these properties suggest that the globin domain of GLB-33 may serve as a highly sensitive oxygen sensor and/or as a nitrite reductase. Both properties are potentially able to modulate the neuropeptide sensitivity of the neuronal transmembrane receptor.	[Tilleman, Lesley; Germani, Francesca; Berghmans, Herald; Moens, Luc; Dewilde, Sylvia] Univ Antwerp, Dept Biomed Sci, B-2610 Antwerp, Belgium; [Desmet, Filip; Van Doorslaer, Sabine] Univ Antwerp, Dept Phys, B-2610 Antwerp, Belgium; [De Henau, Sasha; Braeckman, Bart P.] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; [Helbo, Signe; Fago, Angela] Aarhus Univ, Dept Biosci, DK-8000 Aarhus, Denmark; [Hoogewijs, David] Univ Zurich, Inst Physiol, CH-8006 Zurich, Switzerland; [Hoogewijs, David] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8006 Zurich, Switzerland; [Hoogewijs, David] Univ Duisburg Essen, Inst Physiol, D-45147 Essen, Germany; [Schoofs, Liliane] Katholieke Univ Leuven, Funct Genom & Prote Grp, B-3000 Leuven, Belgium	University of Antwerp; University of Antwerp; Ghent University; Aarhus University; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Duisburg Essen; KU Leuven	Dewilde, S (corresponding author), Univ Antwerp, Dept Biomed Sci, Univ Pl 1, B-2610 Antwerp, Belgium.	sylvia.dewilde@uantwerpen.be	Van Doorslaer, Sabine/E-5050-2017; Fago, Angela/J-5946-2013; Hoogewijs, David/L-5144-2016; schoofs, liliane/ABD-2943-2020; Schoofs, Liliane/F-2815-2010	Van Doorslaer, Sabine/0000-0002-1685-9202; Fago, Angela/0000-0001-7315-2628; Schoofs, Liliane/0000-0002-1673-432X	Bijzonder Onderzoeksfonds TOP University of Antwerp; Fund for Scientific Research Project [G.0247.09]; Lundbeck Foundation; Danish Council for Independent Research, Natural Sciences Grant [10-084565]; KU Leuven; Fund for Scientific Research	Bijzonder Onderzoeksfonds TOP University of Antwerp; Fund for Scientific Research Project; Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research, Natural Sciences Grant; KU Leuven(KU Leuven); Fund for Scientific Research	This work was supported in part by Bijzonder Onderzoeksfonds TOP University of Antwerp 2006 (to S. D. and L. M.) and by Fund for Scientific Research Project G.0247.09 (to S. D., L. M., S. V. D., and B. B.).; Supported by the Lundbeck Foundation and The Danish Council for Independent Research, Natural Sciences Grant 10-084565.; Supported by KU Leuven and the Fund for Scientific Research.	ALLOCATELLI CT, 1993, BIOCHEMISTRY-US, V32, P6041; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Aono S, 2002, J BIOL CHEM, V277, P13528, DOI 10.1074/jbc.M112256200; ATTWOOD TK, 1994, PROTEIN ENG, V7, P195, DOI 10.1093/protein/7.2.195; BASHFORD D, 1987, J MOL BIOL, V196, P199, DOI 10.1016/0022-2836(87)90521-3; BAUMGARTL H, 1994, ACTA OECOL, V15, P781; BIRNBAUMER L, 1990, AM REV RESPIR DIS, V141, pS106, DOI 10.1164/ajrccm/141.3_Pt_2.S106; Blumberg W. E., 1972, WENNER GREN CTR INT, V18, P219; BLUMBERG WE, 1968, J BIOL CHEM, V243, P1854; BOUTILIER RG, 1984, FISH PHYSIOL, V10, P403; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; BOWMAN JW, 1995, J NEUROPHYSIOL, V74, P1880, DOI 10.1152/jn.1995.74.5.1880; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Cantacessi C, 2009, MOL CELL PROBE, V23, P205, DOI 10.1016/j.mcp.2009.03.003; CASEY PJ, 1988, J BIOL CHEM, V263, P2577; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; CHO KC, 1981, BIOCHIM BIOPHYS ACTA, V668, P186, DOI 10.1016/0005-2795(81)90162-8; Couture M, 2001, J BIOL CHEM, V276, P38280; COWDEN C, 1989, NEURON, V2, P1465, DOI 10.1016/0896-6273(89)90192-X; Cutruzzola F, 1996, BIOCHEM J, V314, P83, DOI 10.1042/bj3140083; Das TK, 1999, J BIOL CHEM, V274, P4207, DOI 10.1074/jbc.274.7.4207; Davis RE, 2001, PEPTIDES, V22, P7, DOI 10.1016/S0196-9781(00)00351-X; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; DEBAERE I, 1994, P NATL ACAD SCI USA, V91, P1594, DOI 10.1073/pnas.91.4.1594; DeLano W.L, PYMOL MOL GRAPHICS S; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dunham CM, 2003, BIOCHEMISTRY-US, V42, P7701, DOI 10.1021/bi0343370; Fierro-Gonzalez JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016561; FOOTE N, 1987, BIOCHEM J, V246, P659, DOI 10.1042/bj2460659; Geuens E, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-17; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; HANANIA GIH, 1966, BIOCHEM J, V98, P189, DOI 10.1042/bj0980189; Helbo S, 2011, AM J PHYSIOL-REG I, V300, pR101, DOI 10.1152/ajpregu.00374.2010; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hoogewijs D, 2004, IUBMB LIFE, V56, P697, DOI 10.1080/15216540500037562; Hoogewijs D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-279; Hoogewijs D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-356; HORI H, 1985, J BIOL CHEM, V260, P349; Howes BD, 2011, J BIOL INORG CHEM, V16, P299, DOI 10.1007/s00775-010-0726-y; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; Hu ZT, 2011, NEURON, V71, P92, DOI 10.1016/j.neuron.2011.04.021; Husson SJ, 2005, BIOCHEM BIOPH RES CO, V335, P76, DOI 10.1016/j.bbrc.2005.07.044; Husson SJ, 2007, PROG NEUROBIOL, V82, P33, DOI 10.1016/j.pneurobio.2007.01.006; Janssen T, 2008, J BIOL CHEM, V283, P15241, DOI 10.1074/jbc.M709060200; Janssen T, 2008, ENDOCRINOLOGY, V149, P2826, DOI 10.1210/en.2007-1772; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Li C, 2005, PARASITOLOGY, V131, pS109, DOI 10.1017/S0031182005009376; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lindemans M, 2009, P NATL ACAD SCI USA, V106, P1642, DOI 10.1073/pnas.0809881106; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Martin J, 2009, NUCLEIC ACIDS RES, V37, pD571, DOI 10.1093/nar/gkn744; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Meelkop E, 2012, MOL CELL ENDOCRINOL, V361, P232, DOI 10.1016/j.mce.2012.05.001; Mitreva M, 2005, TRENDS GENET, V21, P573, DOI 10.1016/j.tig.2005.08.003; Moens L, 1996, MOL BIOL EVOL, V13, P324, DOI 10.1093/oxfordjournals.molbev.a025592; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Nicoletti FP, 2013, BBA-PROTEINS PROTEOM, V1834, P1901, DOI 10.1016/j.bbapap.2013.02.033; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Pedersen CL, 2010, J EXP BIOL, V213, P2755, DOI 10.1242/jeb.041624; Persson A, 2009, NATURE, V458, P1030, DOI 10.1038/nature07820; Pesce A, 2001, J MOL BIOL, V309, P1153, DOI 10.1006/jmbi.2001.4731; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Proulx K, 2002, ENDOCRINOLOGY, V143, P4683, DOI 10.1210/en.2002-220593; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; ROUSSEAU DL, 1989, J BIOL CHEM, V264, P7878; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salhany JM, 2008, BIOCHEMISTRY-US, V47, P6059, DOI 10.1021/bi8000819; Schmidt H. H. W., 1996, METHODS NITRIC OXIDE, P491; Shikama K, 1998, CHEM REV, V98, P1357, DOI 10.1021/cr970042e; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; SICK H, 1969, ANAL BIOCHEM, V32, P362, DOI 10.1016/S0003-2697(69)80002-3; SITTER AJ, 1988, J BIOL CHEM, V263, P13032; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; Suzuki T, 1998, CELL MOL LIFE SCI, V54, P979, DOI 10.1007/s000180050227; TAKAHASHI S, 1995, J AM CHEM SOC, V117, P6002, DOI 10.1021/ja00127a013; Tilleman L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048768; Tilleman L, 2011, IUBMB LIFE, V63, P166, DOI 10.1002/iub.443; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; TRAVAGLINI ALLOCATELLI C, 1994, FEBS LETT, V352, P63, DOI 10.1016/0014-5793(94)00918-X; Vergara A, 2007, BIOPHYS J, V93, P2822, DOI 10.1529/biophysj.107.105700; Vinogradov SN, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-31; Vinogradov SN, 2005, P NATL ACAD SCI USA, V102, P11385, DOI 10.1073/pnas.0502103102; WEBER RE, 1992, J APPL PHYSIOL, V72, P1611, DOI 10.1152/jappl.1992.72.4.1611; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WITTENBERG BA, 1968, J BIOL CHEM, V243, P1863; Yook K, 2012, NUCLEIC ACIDS RES, V40, pD735, DOI 10.1093/nar/gkr954; Yoon J, 2010, BIOCHEMISTRY-US, V49, P5662, DOI 10.1021/bi100710a; Yoshida T, 2000, J INORG BIOCHEM, V82, P33, DOI 10.1016/S0162-0134(00)00156-2; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	102	5	6	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10336	10352		10.1074/jbc.M114.576520	http://dx.doi.org/10.1074/jbc.M114.576520			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25666609	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000353241100036
J	Nagarajan, SN; Upadhyay, S; Chawla, Y; Khan, S; Naz, S; Subramanian, J; Gandotra, S; Nandicoori, VK				Nagarajan, Sathya Narayanan; Upadhyay, Sandeep; Chawla, Yogesh; Khan, Shazia; Naz, Saba; Subramanian, Jayashree; Gandotra, Sheetal; Nandicoori, Vinay Kumar			Protein Kinase A (PknA) of Mycobacterium tuberculosis Is Independently Activated and Is Critical for Growth in Vitro and Survival of the Pathogen in the Host	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION; TYROSINE KINASE; GENE-EXPRESSION; SER/THR KINASE; SERINE/THREONINE KINASES; STREPTOCOCCUS-PNEUMONIAE; SIGNAL-TRANSDUCTION; REGULATES GROWTH; PHOSPHORYLATION; INFECTION	The essential mycobacterial protein kinases PknA and PknB play crucial roles in modulating cell shape and division. However, the precise in vivo functional aspects of PknA have not been investigated. This study aims to dissect the role of PknA in mediating cell survival in vitro as well as in vivo. We observed aberrant cell shape and severe growth defects when PknA was depleted. Using the mouse infection model, we observe that PknA is essential for survival of the pathogen in the host. Complementation studies affirm the importance of the kinase, juxtamernbrane, and transmembrane domains of PknA. Surprisingly, the extracytoplasmic domain is dispensable for cell growth and survival in vitro. We find that phosphorylation of the activation loop at Thr(172) of PknA is critical for bacterial growth. PknB has been previously suggested to be the receptor kinase, which activates multiple kinases, including PknA, by trans-phosphorylating their activation loop residues. Using phospho-specific PknA antibodies and conditional pknB mutant, we find that PknA autophosphorylates its activation loop independent of PknB. Fluorescently tagged PknA and PknB show distinctive distribution patterns within the cell, suggesting that although both kinases are known to modulate cell shape and division, their modes of action are likely to be different. This is supported by our findings that expression of kinase-dead PknA versus kinase-dead PknB in mycobacterial cells leads to different cellular phenotypes. Data indicate that although PknA and PknB are expressed as part of the same operon, they appear to be regulating cellular processes through divergent signaling pathways.	[Nagarajan, Sathya Narayanan; Upadhyay, Sandeep; Chawla, Yogesh; Khan, Shazia; Naz, Saba; Nandicoori, Vinay Kumar] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India; [Nagarajan, Sathya Narayanan; Subramanian, Jayashree] Nehru Arts & Sci Coll, Dept Biotechnol, Coimbatore 641105, Tamil Nadu, India; [Gandotra, Sheetal] CSIR Inst Genom & Integrat Biol, New Delhi 110020, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.ac.in	Upadhyay, Sandeep/ABF-5956-2020; Upadhyay, Sandeep/X-5218-2019; Chawla, Yogesh/AAB-8025-2019	Upadhyay, Sandeep/0000-0001-5958-5419; Chawla, Yogesh/0000-0002-6679-518X; NAGARAJAN, Sathya Narayanan/0000-0002-3902-3678; Nandicoori, Vinay/0000-0002-5682-4178	Department of Biotechnology, Government of India [BT/PR5557/Med/29/526/2012]; Council of Scientific and Industrial Research [BSC0403]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Department of Biotechnology, Government of India, Grant BT/PR5557/Med/29/526/2012 (to V. K. N.) and Council of Scientific and Industrial Research, Grant BSC0403 (to S. G.).	Arora G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010772; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bach H, 2009, BIOCHEM J, V420, P155, DOI 10.1042/BJ20090478; Baer CE, 2014, J BIOL CHEM, V289, P20422, DOI 10.1074/jbc.M114.559054; Bakal CJ, 2000, TRENDS CELL BIOL, V10, P32, DOI 10.1016/S0962-8924(99)01681-5; Be NA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-7; Carroll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009823; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Chakraborti PK, 2011, TUBERCULOSIS, V91, P432, DOI 10.1016/j.tube.2011.04.005; Chawla Y, 2014, J BIOL CHEM, V289, P13858, DOI 10.1074/jbc.M114.563536; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; DOREE M, 1994, FASEB J, V8, P1114, DOI 10.1096/fasebj.8.14.7958616; Duran R, 2005, BIOCHEM BIOPH RES CO, V333, P858, DOI 10.1016/j.bbrc.2005.05.173; Ferreira AS, 2013, APPL ENVIRON MICROB, V79, P3009, DOI 10.1128/AEM.00222-13; Fleurie A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004275; Fleurie A, 2012, MOL MICROBIOL, V83, P746, DOI 10.1111/j.1365-2958.2011.07962.x; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Gopalaswamy R, 2009, FEMS MICROBIOL LETT, V295, P23, DOI 10.1111/j.1574-6968.2009.01570.x; Graves JD, 1999, PHARMACOL THERAPEUT, V82, P111, DOI 10.1016/S0163-7258(98)00056-4; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Jang J, 2010, MICROBIOL-SGM, V156, P1619, DOI 10.1099/mic.0.038133-0; Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Khan S, 2010, J BIOL CHEM, V285, P37860, DOI 10.1074/jbc.M110.143131; Kumar P, 2009, J BIOL CHEM, V284, P11090, DOI 10.1074/jbc.M808705200; Lacour S, 2006, RES MICROBIOL, V157, P637, DOI 10.1016/j.resmic.2006.01.003; Malhotra V, 2010, MICROBIOL-SGM, V156, P2829, DOI 10.1099/mic.0.040675-0; Mir M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002182; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2006, PROTEOMICS, V6, P3754, DOI 10.1002/pmic.200500900; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ortega C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001746; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Parikh A, 2013, APPL ENVIRON MICROB, V79, P1718, DOI 10.1128/AEM.03695-12; Parikh A, 2009, J MOL BIOL, V386, P451, DOI 10.1016/j.jmb.2008.12.031; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Petranovic D, 2007, MOL MICROBIOL, V63, P1797, DOI 10.1111/j.1365-2958.2007.05625.x; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Reddy PV, 2013, J INFECT DIS, V208, P1255, DOI 10.1093/infdis/jit250; Saskova L, 2007, J BACTERIOL, V189, P4168, DOI 10.1128/JB.01616-06; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scherr N, 2009, J BACTERIOL, V191, P4546, DOI 10.1128/JB.00245-09; Sharma K, 2006, FEBS J, V273, P2711, DOI 10.1111/j.1742-4658.2006.05289.x; Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Thakur M, 2008, J BIOL CHEM, V283, P8023, DOI 10.1074/jbc.M707535200; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Tiwari D, 2009, J BIOL CHEM, V284, P27467, DOI 10.1074/jbc.M109.036095; Triccas JA, 1998, FEMS MICROBIOL LETT, V167, P151, DOI 10.1111/j.1574-6968.1998.tb13221.x; Whitmarsh AJ, 2000, CELL MOL LIFE SCI, V57, P1172, DOI 10.1007/PL00000757; Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001	60	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9626	9645		10.1074/jbc.M114.611822	http://dx.doi.org/10.1074/jbc.M114.611822			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25713147	Green Published, hybrid			2022-12-28	WOS:000352729400027
J	Radhakrishnan, VM; Kojs, P; Ramalingam, R; Midura-Kiela, MT; Angeli, P; Kiela, PR; Ghishan, FK				Radhakrishnan, Vijayababu M.; Kojs, Pawel; Ramalingam, Rajalakshmy; Midura-Kiela, Monica T.; Angeli, Peter; Kiela, Pawel R.; Ghishan, Fayez K.			Experimental Colitis Is Associated with Transcriptional Inhibition of Na+/Ca2+ Exchanger Isoform 1 (NCX1) Expression by Interferon gamma in the Renal Distal Convoluted Tubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; CARDIAC-SPECIFIC EXPRESSION; KNOCKOUT MICE; CROHNS-DISEASE; UP-REGULATION; IFN-GAMMA; VITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; CALCIUM TRANSPORTER; NA+-CA2+ EXCHANGER	NCX1 is a Na+/Ca2+ exchanger, which is believed to provide a key route for basolateral Ca2+ efflux in the renal epithelia, thus contributing to renal Ca2+ reabsorption. Altered mineral homeostasis, including intestinal and renal Ca2+ transport may represent a significant component of the pathophysiology of the bone mineral density loss associated with Inflammatory Bowel Diseases (IBD). The objective of our research was to investigate the effects of TNBS and DSS colitis and related inflammatory mediators on renal Ncx1 expression. Colitis was associated with decreased renal Ncx1 expression, as examined by real-time RTPCR, Western blotting, and immunofluorescence. In mIMCD3 cells, IFN gamma significantly reduced Ncx1 mRNA and protein expression. Similar effects were observed in cells transiently transfected with a reporter construct bearing the promoter region of the kidney-specific Ncx1 gene. This inhibitory effect of IFN gamma is mediated by STAT1 recruitment to the proximal promoter region of Ncx1. Further in vivo study with Stat1(-/-) mice confirmed that STAT1 is indeed required for the IFN gamma mediated Ncx1 gene regulation. These results strongly support the hypothesis that impaired renal Ca2+ handling occurs in experimental colitis. Negative regulation of NCX1-mediated renal Ca2+ absorption by IFN gamma may significantly contribute to the altered Ca2+ homeostasis in IBD patients and to IBD-associated loss of bone mineral density.	[Radhakrishnan, Vijayababu M.; Kojs, Pawel; Ramalingam, Rajalakshmy; Midura-Kiela, Monica T.; Kiela, Pawel R.; Ghishan, Fayez K.] Univ Arizona, Hlth Sci Ctr, Steele Childrens Res Ctr, Dept Pediat, Tucson, AZ 85724 USA; [Kiela, Pawel R.] Univ Arizona, Hlth Sci Ctr, Dept Immunobiol, Tucson, AZ 85724 USA; [Angeli, Peter] Johns Hopkins Univ, Zanvyl Krieger Sch Arts & Sci, Baltimore, MD 21218 USA	University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona Health Sciences; Johns Hopkins University	Ghishan, FK (corresponding author), Univ Arizona, Hlth Sci Ctr, Steele Childrens Res Ctr, Dept Pediat, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	fghishan@peds.arizona.edu	Kiela, Pawel/AAF-5320-2020	Angeli, Peter/0000-0002-0208-5808; Kiela, Pawel/0000-0002-0014-3517	National Institutes of Health [R37DK033209]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R37DK033209 (to F. K. G.).	ABITBOL V, 1995, GASTROENTEROLOGY, V108, P417, DOI 10.1016/0016-5085(95)90068-3; Ali T, 2009, AM J MED, V122, P599, DOI 10.1016/j.amjmed.2009.01.022; Barnes KV, 1997, J BIOL CHEM, V272, P11510, DOI 10.1074/jbc.272.17.11550; Billerey-Larmonier C, 2008, INFLAMM BOWEL DIS, V14, P780, DOI 10.1002/ibd.20348; Bisping G, 2001, CLIN EXP IMMUNOL, V123, P15, DOI 10.1046/j.1365-2249.2001.01443.x; Bjarnason I, 1997, GUT, V40, P228, DOI 10.1136/gut.40.2.228; BREUER RI, 1970, GUT, V11, P314, DOI 10.1136/gut.11.4.314; Brown AJ, 1999, AM J PHYSIOL-RENAL, V277, pF157, DOI 10.1152/ajprenal.1999.277.2.F157; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Di Stefano M, 2002, GASTROENTEROLOGY, V122, P1793, DOI 10.1053/gast.2002.33600; FAIS S, 1994, J INTERFERON RES, V14, P235, DOI 10.1089/jir.1994.14.235; Ghishan FK, 2011, AM J PHYSIOL-GASTR L, V300, pG191, DOI 10.1152/ajpgi.00496.2010; Gobbi P, 2007, PHARMACOL RES, V56, P556, DOI 10.1016/j.phrs.2007.10.005; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2002, FASEB J, V16, P1398, DOI 10.1096/fj.02-0225com; Hoenderop JGJ, 2002, ANNU REV PHYSIOL, V64, P529, DOI 10.1146/annurev.physiol.64.081501.155921; Hoenderop JGJ, 1999, BIOCHEM BIOPH RES CO, V261, P488, DOI 10.1006/bbrc.1999.1059; Hofmeister MV, 2011, ADV EXP MED BIOL, V704, P277, DOI 10.1007/978-94-007-0265-3_15; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Huybers S, 2008, INFLAMM BOWEL DIS, V14, P803, DOI 10.1002/ibd.20385; Kiela PR, 2009, GASTROENTEROLOGY, V137, P965, DOI 10.1053/j.gastro.2009.05.043; Ko SH, 2009, J REPROD DEVELOP, V55, P137, DOI 10.1262/jrd.20139; KOFUJI P, 1994, J BIOL CHEM, V269, P5145; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Lortat-Jacob H, 1996, J BIOL CHEM, V271, P16139, DOI 10.1074/jbc.271.27.16139; Majewski PM, 2010, J BIOL CHEM, V285, P34828, DOI 10.1074/jbc.M110.152868; Muller JG, 2002, CIRC RES, V90, P158, DOI 10.1161/hh0202.103231; Nagano T, 2004, J NEUROCHEM, V90, P784, DOI 10.1111/j.1471-4159.2004.02511.x; Navath S, 2012, ACS MED CHEM LETT, V3, P710, DOI 10.1021/ml300086c; Nicholas SB, 1998, AM J PHYSIOL-HEART C, V274, pH217, DOI 10.1152/ajpheart.1998.274.1.H217; NOGUCHI M, 1995, J GASTROENTEROL, V30, P52; Peng JB, 2000, J BIOL CHEM, V275, P28186; Pollak RD, 1998, AM J GASTROENTEROL, V93, P1483; Qiu ZY, 2001, J BIOL CHEM, V276, P194, DOI 10.1074/jbc.M005571200; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Radhakrishnan VM, 2013, GASTROENTEROLOGY, V145, P613, DOI 10.1053/j.gastro.2013.06.002; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Samanta K, 2010, J BIOCHEM, V147, P225, DOI 10.1093/jb/mvp176; Schwaller B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004051; Targownik LE, 2014, CURR OPIN GASTROEN, V30, P168, DOI 10.1097/MOG.0000000000000037; Thurston RD, 2010, GASTROENTEROLOGY, V138, P1384, DOI 10.1053/j.gastro.2009.12.002; Tilg H, 2008, GUT, V57, P684, DOI 10.1136/gut.2006.117382; Uno JK, 2006, GASTROENTEROLOGY, V131, P497, DOI 10.1053/j.gastro.2006.05.020; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; VanBaal J, 1996, AM J PHYSIOL-RENAL, V271, pF985, DOI 10.1152/ajprenal.1996.271.5.F985; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wu GS, 2009, P NATL ACAD SCI USA, V106, P10829, DOI 10.1073/pnas.0903408106; Xu L, 2006, J BIOL CHEM, V281, P34430, DOI 10.1074/jbc.M607446200	49	4	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8964	8974		10.1074/jbc.M114.616516	http://dx.doi.org/10.1074/jbc.M114.616516			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25648899	hybrid, Green Published			2022-12-28	WOS:000352207100023
J	Matsuoka, T; Kaneto, H; Kawashima, S; Miyatsuka, T; Tochino, Y; Yoshikawa, A; Imagawa, A; Miyazaki, J; Gannon, M; Stein, R; Shimomura, I				Matsuoka, Taka-aki; Kaneto, Hideaki; Kawashima, Satoshi; Miyatsuka, Takeshi; Tochino, Yoshihiro; Yoshikawa, Atsushi; Imagawa, Akihisa; Miyazaki, Jun-ichi; Gannon, Maureen; Stein, Roland; Shimomura, Iichiro			Preserving Mafa Expression in Diabetic Islet beta-Cells Improves Glycemic Control in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Glucose Metabolism; Insulin Synthesis; Islet; Oxidative Stress; Mafa; Insulin Transcription Factor	ENZYME GENE-EXPRESSION; PANCREATIC-ISLETS; REGULATORY PROTEIN; INSULIN-SECRETION; GLUCOSE TOXICITY; CRE-RECOMBINASE; MOUSE MODEL; TRANSCRIPTION; GLUCOKINASE; FAMILY	Background: MAFA expression is markedly decreased in islet -cells of type 2 diabetes mellitus. Results: Mis-expression of Mafa in mouse diabetic db/db -cells ameliorated glucose-stimulated insulin secretion and -cell mass. Conclusion: Mafa alone is sufficient to improve -cell function and mass under diabetic conditions. Significance: These results establish how consequential this transcription factor is to islet -cells under pathological conditions. The murine Mafa transcription factor is a key regulator of postnatal islet -cell activity, affecting insulin transcription, insulin secretion, and -cell mass. Human MAFA expression is also markedly decreased in islet -cells of type 2 diabetes mellitus (T2DM) patients. Moreover, levels are profoundly reduced in db/db islet -cells, a mouse model of T2DM. To examine the significance of this key islet -cell-enriched protein to glycemic control under diabetic conditions, we generated transgenic mice that conditionally and specifically produced Mafa in db/db islet -cells. Sustained expression of Mafa resulted in significantly lower plasma glucose levels, higher plasma insulin, and augmented islet -cell mass. In addition, there was increased expression of insulin, Slc2a2, and newly identified Mafa-regulated genes involved in reducing -cell stress, like Gsta1 and Gckr. Importantly, the levels of human GSTA1 were also compromised in T2DM islets. Collectively, these results illustrate how consequential the reduction in Mafa activity is to islet -cell function under pathophysiological conditions.	[Matsuoka, Taka-aki; Kaneto, Hideaki; Kawashima, Satoshi; Miyatsuka, Takeshi; Tochino, Yoshihiro; Yoshikawa, Atsushi; Imagawa, Akihisa; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan; [Miyazaki, Jun-ichi] Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka 5650871, Japan; [Gannon, Maureen] Vanderbilt Univ, Med Ctr, Div Diabet Endocrinol & Metab, Dept Med, Nashville, TN 37232 USA; [Stein, Roland] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Osaka University; Osaka University; Vanderbilt University; Vanderbilt University	Matsuoka, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	matsuoka@endmet.med.osaka-u.ac.jp	Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X	National Institutes of Health [DK090570]; Juvenile Diabetes Research Foundation Career Development Award [2-2005-946]; JSPS KAKENHI [10379258]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090570] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24591328] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation Career Development Award(Juvenile Diabetes Research Foundation); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant DK090570 (to R. S.), Juvenile Diabetes Research Foundation Career Development Award 2-2005-946 (to T. Matsuoka), and JSPS KAKENHI Grant 10379258 (to T. Matsuoka).	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; Butler AE, 2012, DIABETOLOGIA, V55, P2985, DOI 10.1007/s00125-012-2666-2; D'Aleo V, 2009, MOL CELL ENDOCRINOL, V309, P63, DOI 10.1016/j.mce.2009.05.010; de la Iglesia N, 2000, J BIOL CHEM, V275, P10597, DOI 10.1074/jbc.275.14.10597; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Hang Y, 2014, DIABETES, V63, P1994, DOI 10.2337/db13-1001; Harmon JS, 2009, ENDOCRINOLOGY, V150, P4855, DOI 10.1210/en.2009-0708; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; HUMMEL KP, 1972, BIOCHEM GENET, V7, P1, DOI 10.1007/BF00487005; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Kawashima S, 2011, BIOCHEM BIOPH RES CO, V404, P534, DOI 10.1016/j.bbrc.2010.12.021; Kjorholt C, 2005, DIABETES, V54, P2755, DOI 10.2337/diabetes.54.9.2755; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lupi R, 2007, DIABETES METAB, V33, P340, DOI 10.1016/j.diabet.2007.03.005; Mahadevan J, 2013, DIABETES, V62, P3582, DOI 10.2337/db13-0357; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Matsuoka TA, 2007, MOL ENDOCRINOL, V21, P2764, DOI 10.1210/me.2007-0028; Matsuoka T, 2010, DIABETES, V59, P1709, DOI 10.2337/db08-0693; Nebert Daniel W., 2004, Human Genomics, V1, P460; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Shiota C, 1999, J BIOL CHEM, V274, P37125, DOI 10.1074/jbc.274.52.37125; Steck AK, 2011, CURR OPIN ENDOCRINOL, V18, P252, DOI 10.1097/MED.0b013e3283488275; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; Taylor BL, 2013, CELL REP, V4, P1262, DOI 10.1016/j.celrep.2013.08.010; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Waguri M, 1997, DIABETES, V46, P1281, DOI 10.2337/diabetes.46.8.1281; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhang HJ, 2005, GENESIS, V42, P210, DOI 10.1002/gene.20137	38	46	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7647	7657		10.1074/jbc.M114.595579	http://dx.doi.org/10.1074/jbc.M114.595579			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25645923	Green Published, hybrid			2022-12-28	WOS:000351613600027
